PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Deeb, SK; Guzik-Lendrum, S; Jeffrey, JD; Gilbert, SP				Deeb, Stephanie K.; Guzik-Lendrum, Stephanie; Jeffrey, Jasper D.; Gilbert, Susan P.			The ability of the kinesin-2 heterodimer KIF3AC to navigate microtubule networks is provided by the KIF3A motor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; fluorescence; intracellular trafficking; kinesin; microtubule; neuron; molecular motor; processivity; single-molecule biophysics; TIRF microscopy	LEFT-RIGHT ASYMMETRY; TUG-OF-WAR; SUPERFAMILY PROTEIN; TRANSPORT; SUBUNIT; FAMILY; INTERSECTIONS; COORDINATION; MECHANISMS; EXPRESSION	Heterodimeric kinesin family member KIF3AC is a mammalian kinesin-2 that is highly expressed in the central nervous system and has been implicated in intracellular transport. KIF3AC is unusual in that the motility characteristics of KIF3C when expressed as a homodimer are exceeding slow, whereas homodimeric KIF3AA, as well as KIF3AC, have much faster ATPase kinetics and single molecule velocities. Heterodimeric KIF3AC and homodimeric KIF3AA and KIF3CC are processive, although the run length of KIF3AC exceeds that of KIF3AA and KIF3CC. KIF3C is of particular interest because it exhibits a signature 25-residue insert of glycine and serine residues in loop L11 of its motor domain, and this insert is not present in any other kinesin, suggesting that it confers specific properties to mammalian heterodimeric KIF3AC. To gain a better understanding of the mechanochemical potential of KIF3AC, we pursued a single molecule study to characterize the navigation ability of KIF3AC, KIF3AA, and KIF3CC when encountering microtubule intersections. The results show that all three motors exhibited a preference to remain on the same microtubule when approaching an intersection from the top microtubule, and the majority of track switches occurred from the bottom microtubule onto the top microtubule. Heterodimeric KIF3AC and homodimeric KIF3AA displayed a similar likelihood of switching tracks (36.1 and 32.3%, respectively). In contrast, KIF3CC detached at intersections (67.7%) rather than switch tracks. These results indicate that it is the properties of KIF3A that contribute largely to the ability of KIF3AC to switch microtubule tracks to navigate intersections.	[Deeb, Stephanie K.; Guzik-Lendrum, Stephanie; Jeffrey, Jasper D.; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA.; Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	sgilbert@rpi.edu			National Institutes of Health [R37-GM054141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R37-GM054141 (to S. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Arpag G, 2019, BIOPHYS J, V116, P1115, DOI 10.1016/j.bpj.2019.01.036; Bensel B. M. W., 2019, STRAIN DEPENDENT KIN, P793075, DOI [10.1101/793075, DOI 10.1101/793075]; Bensel BM, 2017, P NATL ACAD SCI USA, V114, pE4281, DOI 10.1073/pnas.1701482114; Bentley M, 2016, NAT REV NEUROSCI, V17, P611, DOI 10.1038/nrn.2016.100; Bergman JP, 2018, P NATL ACAD SCI USA, V115, P537, DOI 10.1073/pnas.1707936115; Conway L, 2012, P NATL ACAD SCI USA, V109, P20814, DOI 10.1073/pnas.1209304109; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; Engelke MF, 2019, CURR BIOL, V29, P1137, DOI 10.1016/j.cub.2019.02.043; Feng QZ, 2018, BIOPHYS J, V114, P400, DOI 10.1016/j.bpj.2017.11.016; Ferro LS, 2019, ELIFE, V8, DOI 10.7554/eLife.48629; Gao Y, 2018, BIOPHYS J, V114, P2900, DOI 10.1016/j.bpj.2018.05.010; Gilbert SP, 2018, J BIOL CHEM, V293, P4510, DOI 10.1074/jbc.R117.001324; Gindhart JG, 1996, TRENDS CELL BIOL, V6, P415, DOI 10.1016/S0962-8924(96)20037-6; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; Guzik-Lendrum S, 2017, BIOPHYS J, V113, P1845, DOI 10.1016/j.bpj.2017.09.015; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hoeprich GJ, 2017, TRAFFIC, V18, P304, DOI 10.1111/tra.12478; Huang CF, 2012, TRAFFIC, V13, P549, DOI 10.1111/j.1600-0854.2011.01325.x; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Navone F, 2001, J NEUROCHEM, V77, P741, DOI 10.1046/j.1471-4159.2001.00277.x; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Osunbayo O, 2015, BIOPHYS J, V108, P1480, DOI 10.1016/j.bpj.2015.02.016; Prevo B, 2017, FEBS J, V284, P2905, DOI 10.1111/febs.14068; Quinn SM, 2018, J BIOL CHEM, V293, P13389, DOI 10.1074/jbc.RA118.002767; Rank KC, 2013, BIOL CELL, V105, P1, DOI 10.1111/boc.201200044; Ross JL, 2008, BIOPHYS J, V94, P3115, DOI 10.1529/biophysj.107.120014; Sardella M, 1998, GENOMICS, V47, P405, DOI 10.1006/geno.1997.5123; Schneider R, 2015, BIOPHYS J, V108, P2249, DOI 10.1016/j.bpj.2015.03.048; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Silverman MA, 2010, CYTOSKELETON, V67, P784, DOI 10.1002/cm.20487; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Woll KA, 2018, J BIOL CHEM, V293, P11283, DOI 10.1074/jbc.RA118.002182; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang R, 2019, TRAFFIC, V20, P851, DOI 10.1111/tra.12692; Yang ZH, 2001, MOL CELL BIOL, V21, P5306, DOI 10.1128/MCB.21.16.5306-5311.2001; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Zhang PW, 2016, J BIOL CHEM, V291, P4407, DOI 10.1074/jbc.M115.705970	55	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20070	20083		10.1074/jbc.RA119.010725	http://dx.doi.org/10.1074/jbc.RA119.010725			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748411	Green Published, hybrid			2022-12-26	WOS:000505005800020
J	Aljayyousi, GF; Abdel-Rahman, ME; El-Heneidy, A; Kurdi, R; Faisal, E				Aljayyousi, Ghadir Fakhri; Abdel-Rahman, Manar E.; El-Heneidy, Asmaa; Kurdi, Rana; Faisal, Eman			Public practices on antibiotic use: A cross-sectional study among Qatar University students and their family members	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; PRIMARY-CARE; KNOWLEDGE; PERCEPTIONS; ATTITUDES; PHARMACISTS; ADULTS; CALL	Background Antimicrobial resistance (AMR) is a serious public health problem and a global concern. The inappropriate use of antibiotics has been identified by the World Health Organization as a major risk factor for AMR. Methods The purpose of this research study is to assess the prevalence of inappropriate antibiotic use among Qatar University students and their family members, detect sociodemographic factors associated with inappropriate use, evaluate the knowledge and attitude towards antibiotic use, and assess respondents' opinions on healthcare providers' antibiotic prescription practices. Participants (N = 596) completed a self-administered questionnaire. Descriptive analysis, the Pearson chi-squared test, and multivariate logistic regression analyses were performed. Results The major inappropriate antibiotic use practices followed by the respondents were using antibiotics without prescription (82%), not completing the antibiotic course (45%), and obtaining antibiotics from the pharmacy without prescription (23%). The chi-square test results showed that age (p = 0.031) and nationality (p = 0.041) were associated with using antibiotics without prescription. In addition, respondents less than 21 years of age (p< 0.001), who had only a secondary education (p = 0.007), and who lived in one of the large and crowded cities in Qatar (p = 0.011) had higher odds of stopping the antibiotic before completing the course. Our study also revealed that almost 60% of the respondents had inadequate knowledge and a negative attitude towards antibiotic use. Nationality and municipality were the independent factors associated with having appropriate knowledge of antibiotic use. Univariate logistic regression analyses in our study demonstrated that older (> 26 years), married and university-graduated participants were more likely to have a positive attitude towards antibiotic use than others. Respondents also reported that neither doctors nor pharmacists were providing adequate patient education about appropriate antibiotic use. The Socio-Ecological Model was applied to interpret the findings and frame implications. Conclusion The findings shed light on various factors shaping antibiotic use practices and provide evidence to design multilevel behavioral interventions to improve public practices of antibiotic use.	[Aljayyousi, Ghadir Fakhri; Abdel-Rahman, Manar E.; Kurdi, Rana; Faisal, Eman] Qatar Univ, Coll Hlth Sci, Dept Publ Hlth, Doha, Qatar; [El-Heneidy, Asmaa] Griffith Univ, Sch Med, Gold Coast, Australia	Qatar University; Griffith University	Aljayyousi, GF (corresponding author), Qatar Univ, Coll Hlth Sci, Dept Publ Hlth, Doha, Qatar.	g.aljayyousi@qu.edu.qa	Abdel-Rahman, Manar/R-4652-2016	Abdel-Rahman, Manar/0000-0001-9968-9853; El-Heneidy, Asmaa/0000-0003-4937-1673; Al-Jayyousi, Ghadir Fakhri/0000-0001-5995-1693				Al-Niemat SI, 2008, SAUDI MED J, V29, P743; Alhomoud F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6088-z; Alhomoud F, 2017, INT J INFECT DIS, V57, P3, DOI 10.1016/j.ijid.2017.01.014; Alkhuzaei AMJB, 2018, J TAIBAH UNIV MED SC, V13, P77, DOI 10.1016/j.jtumed.2017.09.001; Almohammed RA, 2019, J INFECT PUBLIC HEAL, V12, P159, DOI 10.1016/j.jiph.2018.09.002; Aly M, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-26; Anderson A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204878; [Anonymous], 2013, ANT RES; [Anonymous], 2018, EPI INFO SOFTWARE VE; [Anonymous], ANTIMICROBIAL RESIST; Awad AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117910; Bashwar Z, 2006, QATAR MED J, V2006; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Bert F, 2017, EUR J PUBLIC HEALTH, V27, P506, DOI 10.1093/eurpub/ckw209; Bianco A, 2018, INFECT DRUG RESIST, V11, P2199, DOI 10.2147/IDR.S170349; Bin Nafisah S, 2017, J INFECT PUBLIC HEAL, V10, P522, DOI 10.1016/j.jiph.2016.09.016; Black E, 2014, INT J CLIN PHARM-NET, V36, P787, DOI 10.1007/s11096-014-9960-7; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; CDC, 2019, IMPR ANT PRESCR 2019; Centers for Disease Control and Prevention, 2018, ANT RES; Centers for Disease Control and Prevention, 2013, ANT RES THREAT US; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Currie J, 2011, J HEALTH ECON, V30, P933, DOI 10.1016/j.jhealeco.2011.05.009; Emeka PM, 2014, SAUDI PHARM J, V22, P550, DOI 10.1016/j.jsps.2014.02.014; Goggin K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020981; Gualano MR, 2015, PHARMACOEPIDEM DR S, V24, P2, DOI 10.1002/pds.3716; Hawke KL, 2016, FAM PRACT, V33, P75, DOI 10.1093/fampra/cmv083; Hawkings NJ, 2008, PATIENT EDUC COUNS, V73, P146, DOI 10.1016/j.pec.2008.05.025; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Lindberg BH, 2017, SCAND J PRIM HEALTH, V35, P178, DOI 10.1080/02813432.2017.1333301; Little P, 2004, BMJ-BRIT MED J, V328, P444, DOI 10.1136/bmj.38013.644086.7C; Lum EPM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4813-7; MACKENBACH JP, 1988, INT J EPIDEMIOL, V17, P618, DOI 10.1093/ije/17.3.618; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Memish Z A, 2007, J Chemother, V19 Suppl 1, P17; Moienzadeh A, 2017, INT J PHARM PRACT, V25, P133, DOI 10.1111/ijpp.12233; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Nunez M., 2016, PERU MED U, V18, P205; Okeke I.N., 2003, RESISTANCE PHENOMENO; Ong S, 2007, ANN EMERG MED, V50, P213, DOI 10.1016/j.annemergmed.2007.03.026; Saam M., 2017, EVALUATION ANTIBIOTI; Scicluna Elizabeth Anne, 2009, J Infect Public Health, V2, P189, DOI 10.1016/j.jiph.2009.09.004; Shaikhan F, 2018, JRSM OPEN, V9; Shapiro DJ, 2014, J ANTIMICROB CHEMOTH, V69, P234, DOI 10.1093/jac/dkt301; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; WHO, 2001, WHO GLOB STRAT CONT; WHO, 2015, ANT RES MULT PUBL AW; Zhang RF, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-6; Zucco R, 2018, INT J MED INFORM, V111, P131, DOI 10.1016/j.ijmedinf.2017.12.005; Zwisler G, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010403	52	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225499	10.1371/journal.pone.0225499	http://dx.doi.org/10.1371/journal.pone.0225499			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8RE	31770408	gold, Green Published			2022-12-26	WOS:000533892300023
J	Charlton, BD; Owen, MA; Zhou, XP; Zhang, HM; Swaisgood, RR				Charlton, Benjamin D.; Owen, Megan A.; Zhou, Xiaoping; Zhang, Hemin; Swaisgood, Ronald R.			Influence of season and social context on male giant panda (Ailuropoda melanoleuca) vocal behaviour	PLOS ONE			English	Article							CHEMICAL COMMUNICATION; SEXUAL SELECTION; CUES; DISCRIMINATION; BELLOWS; ROARS; VOCALIZATIONS; TESTOSTERONE; METABOLITES; REPERTOIRE	Documenting the different social and behavioural contexts that vocalisations are produced in remains an important step towards understanding the functional relevance of specific call types in a given species' vocal repertoire. In this study we investigated whether seasonal differences and the presence or absence of male and female conspecifics influence the production of male giant panda vocal signals. To this end, captive male giant pandas were observed during and outside of the breeding season in three social contexts: only male conspecific neighbours, only female conspecific neighbours, and a context with no neighbours. We found that males were more likely to bleat, chirp, honk and moan during the breeding season, and showed a tendency to growl more outside of the reproductive period. The contextual analysis revealed that bleats were more likely to be produced by males when opposite-sexed conspecifics are in close attendance during the breeding season. Conversely, males were more likely to chirp when neighboured by males than females or no neighbours. In addition, males were more likely to honk in the absence of neighbouring conspecifics during the breeding season, raising the possibility that these calls function to signal location and gain the attention of potential mates. Moans were produced more often when male giant pandas had male than female neighbours during the breeding season, which may reflect mild aggression towards these same-sexed rivals, whereas the production of barks and growls did not vary according to season or the sex of conspecific neighbours. Our findings underscore the importance of male giant panda bleats for coordinating reproduction and promoting contact with potential mating partners in this non-gregarious species, and yield fresh insights into the function of male honks that warrant further investigation. They also provide a basis for comparison with free-ranging giant panda vocal behaviour that could potentially inform conservation efforts.	[Charlton, Benjamin D.; Owen, Megan A.; Swaisgood, Ronald R.] San Diego Zoo Global, Inst Conservat Res, San Diego, CA 92101 USA; [Zhou, Xiaoping; Zhang, Hemin] China Conservat & Res Ctr Giant Panda, Wolong, Sichuan, Peoples R China		Charlton, BD (corresponding author), San Diego Zoo Global, Inst Conservat Res, San Diego, CA 92101 USA.	bencharlton829@gmail.com		Charlton, Benjamin/0000-0002-0218-7177				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Barelli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082748; Barros KS, 2011, ETHOLOGY, V117, P83, DOI 10.1111/j.1439-0310.2010.01853.x; Berger J, 1991, BEHAV ECOL, V2, P1, DOI 10.1093/beheco/2.1.1; Blumstein D, 2005, ANIM BEHAV; BOINSKI S, 1992, ETHOLOGY, V92, P316; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bowyer RT, 2011, BEHAV ECOL SOCIOBIOL, V65, P2251, DOI 10.1007/s00265-011-1234-y; Charlton BD, 2008, ETHOLOGY, V114, P1023, DOI 10.1111/j.1439-0310.2008.01539.x; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.181323; Charlton BD, 2015, J ACOUST SOC AM, V138, P1305, DOI 10.1121/1.4928606; Charlton BD, 2012, ANIM BEHAV, V84, P1565, DOI 10.1016/j.anbehav.2012.09.034; Charlton BD, 2012, BEHAV ECOL SOCIOBIOL, V66, P969, DOI 10.1007/s00265-012-1345-0; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Charlton BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021066; Charlton BD, 2011, BIOL LETTERS, V7, P71, DOI 10.1098/rsbl.2010.0582; Charlton BD, 2010, ANIM BEHAV, V79, P1221, DOI 10.1016/j.anbehav.2010.02.018; Charlton BD, 2010, P R SOC B, V277, P1101, DOI 10.1098/rspb.2009.1431; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charlton BD, 2009, BIOL LETTERS, V5, P597, DOI 10.1098/rsbl.2009.0331; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; COHEN JA, 1976, BEHAV PROCESS, V1, P77, DOI 10.1016/0376-6357(76)90008-5; Connor T, 2016, INTEGR ZOOL, V11, P295, DOI 10.1111/1749-4877.12197; Gilad O, 2016, CURR ZOOL, V62, P333, DOI 10.1093/cz/zow025; HARRINGTON FH, 1979, BEHAVIOUR, V68, P207, DOI 10.1163/156853979X00322; Kleiman D.G., 1979, International Zoo Yearbook, V19, P217, DOI 10.1111/j.1748-1090.1979.tb00568.x; KLEIMAN DG, 1983, Z TIERPSYCHOL, V62, P1; Kleiman DG, 1990, 2 INT S GIANT PAND T; Koren L, 2009, BEHAV ECOL SOCIOBIOL, V63, P581, DOI 10.1007/s00265-008-0693-2; Liu XH, 2002, J WILDLIFE MANAGE, V66, P1179, DOI 10.2307/3802951; MacDonald Edith, 2006, Acta Zoologica Sinica, V52, P242; Manser M. B., 1998, EVOLUTION AUDITORY C; MARLER P, 1955, NATURE, V176, P6, DOI 10.1038/176006a0; Martin P., 1993, MEASURING BEHAV, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; McElligott AG, 1999, ANIM BEHAV, V58, P1095, DOI 10.1006/anbe.1999.1237; McGeehan L, 2002, ZOO BIOL, V21, P449, DOI 10.1002/zoo.10047; MCSHANE LJ, 1995, J MAMMAL, V76, P414, DOI 10.2307/1382352; Minami Masato, 1992, Journal of the Mammalogical Society of Japan, V17, P71; MITANI JC, 1985, ANIM BEHAV, V33, P272, DOI 10.1016/S0003-3472(85)80141-X; Nie YG, 2012, EUR J WILDLIFE RES, V58, P235, DOI 10.1007/s10344-011-0569-z; Nie YG, 2012, BEHAV ECOL SOCIOBIOL, V66, P721, DOI 10.1007/s00265-012-1320-9; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Owen MA, 2016, ANIM BEHAV, V111, P157, DOI 10.1016/j.anbehav.2015.10.008; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; PETERS G, 1982, Z SAUGETIERKD, V47, P236; Peters G., 1985, Bongo Sonderband, V10, P197; Reby D, 1999, ANIM BEHAV, V57, P1121, DOI 10.1006/anbe.1998.1056; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Schaller G.B., 1985, GIANT PANDAS WOLONG; SEKULIC R, 1982, BEHAVIOUR, V81, P38, DOI 10.1163/156853982X00517; Semple S, 2002, AM J PRIMATOL, V56, P43, DOI 10.1002/ajp.1062; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; Snyder Rebecca J., 2004, P125; Swaisgood R., 2016, IUCN RED LIST THREAT; Swaisgood Ronald R., 2004, P106; Swaisgood RR, 2000, ANIM BEHAV, V60, P227, DOI 10.1006/anbe.2000.1464; Swaisgood RR, 1999, ANIM BEHAV, V57, P1045, DOI 10.1006/anbe.1998.1070; Swaisgood RR, 2002, J ZOOL, V257, P381, DOI 10.1017/S0952836902000985; Taylor A, SPRINGER HDB AUDITOR; White AM, 2003, J ZOOL, V259, P171, DOI 10.1017/S0952836902003187; White AM, 2002, BEHAV ECOL SOCIOBIOL, V51, P519, DOI 10.1007/s00265-002-0473-3; Wong J, 1999, J MAMMAL, V80, P570, DOI 10.2307/1383302; Wyman MT, 2012, ANIM BEHAV, V84, P1381, DOI 10.1016/j.anbehav.2012.08.037; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016	67	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225772	10.1371/journal.pone.0225772	http://dx.doi.org/10.1371/journal.pone.0225772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8RE	31770420	Green Published, gold			2022-12-26	WOS:000533892300037
J	Moura, BP; Rufino, RL; Faria, RC; Amorim, PRS				Moura, Bruno P.; Rufino, Rogerio L.; Faria, Ricardo C.; Amorim, Paulo Roberto S.			Effects of isotemporal substitution of sedentary behavior with light-intensity or moderate-to-vigorous physical activity on cardiometabolic markers in male adolescents	PLOS ONE			English	Article							METABOLIC SYNDROME; CHILDREN; FITNESS; IMPACT; TIME; RISK; GT3X	Increasing prevalence of sedentary behavior (SB) combined with low levels of physical activity (PA) in children and adolescents has become a growing public health concern. Therefore, this study aimed to identify the daily behavioral pattern of adolescents and examine the isotemporal substitution effects of SB with light-intensity PA (LIPA) or moderate-tovigorous PA (MVPA) on cardiometabolic markers. In this cross-sectional study, the daily behavioral pattern of Brazilian male adolescents was objectively measured for 7 days. Vector magnitude activity counts were used to estimate SB, LIPA, and MVPA with cut-points specifically validated for youth. The isotemporal substitution model was used to assess the effects of replacing different SB bouts (5, 10, 30, and 60 min) with LIPA or MVPA on cardiometabolic markers [body mass index, waist circumference, body fat percentage (BF%), total cholesterol, high-density lipoprotein cholesterol (HDL-C), non-HDL-C, low-density lipoprotein cholesterol, triglyceride (TG), glucose, insulin, homeostatic model assessment of insulin resistance (HOMA2-IR), insulin sensitivity (HOMA2-S), beta cell function (HOMA2-beta), systolic-blood pressure (SBP), diastolic-blood pressure, and cardiometabolic risk score]. Male adolescents (n = 84; age, 16.7 +/- 0.9 years) wore the GT3X+ for 6.7 +/- 0.6 days, during 15.2 +/- 2.3 h, and spent 72.9% of the time in SB, 17.3% in LIPA, and 9.8% in MVPA. SB replacement with LIPA was associated with increased HDL-C, TG, HOMA2-IR, and HOMA2-S and decreased SBP. In contrast, SB replacement with MVPA was associated with decreased BF%. Therefore, our findings suggest that replacing SB with LIPA showed positive results on HDL-C, HOMA2-S and SBP, while replacing SB with MVPA was associated with only one obesity indicator (BF%). Moreover, participants met the daily MVPA recommendations, but they still had a daily behavioral pattern with high SB. In this context, LIPAs can be considered an effective alternative to reduce SB and improve the health indicators of this population.	[Moura, Bruno P.; Rufino, Rogerio L.] Univ Estado Rio De Janeiro, Med Sci Fac, Med Sci Grad Program, Rio De Janeiro, RJ, Brazil; [Faria, Ricardo C.; Amorim, Paulo Roberto S.] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal de Vicosa	Amorim, PRS (corresponding author), Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil.	pramorim@ufv.br	; Amorim, Paulo/D-3519-2013	Moura, Bruno/0000-0002-8439-4523; Amorim, Paulo/0000-0002-4327-9190				2018 Physical Activity Guidelines Advisory Committee, 2018, 2018 PHYS ACT GUID A; Amagasa S, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0695-z; [Anonymous], 2004, HOMA2 CALC; Ayala AMC, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121227; Baranowski T, 2019, J SPORT HEALTH SCI, V8, P1, DOI 10.1016/j.jshs.2018.09.011; Bays HE, 2016, J CLIN LIPIDOL, V10, P240, DOI 10.1016/j.jacl.2015.11.006; Benzo RM, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080823; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Cardon G, 2004, PATIENT EDUC COUNS, V54, P133, DOI 10.1016/S0738-3991(03)00215-5; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Department of Health, 2017, AUSTR PHYS ACT SED B; Ekelund U, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4570; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Grgic J, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0691-3; Hansen BH, 2018, SPORTS MED, V48, P2401, DOI 10.1007/s40279-018-0909-1; Hinckson E, 2016, SPORTS MED, V46, P977, DOI 10.1007/s40279-015-0436-2; Hoffman DJ, 2012, ANN HUM BIOL, V39, P156, DOI 10.3109/03014460.2012.660989; Howard B, 2015, MED SCI SPORT EXER, V47, P2093, DOI 10.1249/MSS.0000000000000631; Klenk J, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5051; Knaeps S, 2018, J PHYS ACT HEALTH, V15, P197, DOI 10.1123/jpah.2017-0102; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Macgregor AP, 2019, APPL PHYSIOL NUTR ME, V44, P937, DOI 10.1139/apnm-2018-0323; Malachias Mvb, 2016, Arq Bras Cardiol, V107, P1, DOI 10.5935/abc.20160151; Mekary RA, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050797; Mekary RA, 2009, AM J EPIDEMIOL, V170, P519, DOI 10.1093/aje/kwp163; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Moore JB, 2017, MED SCI SPORT EXER, V49, P1362, DOI 10.1249/MSS.0000000000001249; Romanzini M, 2014, EUR J SPORT SCI, V14, P91, DOI 10.1080/17461391.2012.732614; Santos-Lozano A, 2012, MED ENG PHYS, V34, P787, DOI 10.1016/j.medengphy.2012.02.005; Sartini C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1976-y; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Sherar LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-485; Sherry Aron P, 2016, Prev Med Rep, V3, P338, DOI 10.1016/j.pmedr.2016.03.016; Silva DR, 2018, J SCI MED SPORT, V21, P919, DOI 10.1016/j.jsams.2018.01.007; Sudholz B, 2016, AIMS PUBLIC HEALTH, V3, P274, DOI 10.3934/publichealth.2016.2.274; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pIII, DOI [10.1139/apnm-2016-0203, 10.1139/apnm-2016-0151]; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; U.S. Department of Health and Human Services, 2018, PHYS ACT GUID AM; UK Department of Health and Social Care, 2011, START ACT STAY ACT R; Whitaker KM, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010212; Whitaker KM, 2018, AM J EPIDEMIOL, V187, P181, DOI 10.1093/aje/kwx209; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; World Health Organization, 2020, GROWTH REF 5 19 YEAR	48	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225856	10.1371/journal.pone.0225856	http://dx.doi.org/10.1371/journal.pone.0225856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8RE	31770423	Green Published, Green Submitted, gold			2022-12-26	WOS:000533892300042
J	Combes, G; Damery, S; Sein, K; Allen, K; Nicholas, J; Baharani, J				Combes, Gill; Damery, Sarah; Sein, Kim; Allen, Kerry; Nicholas, Johann; Baharani, Jyoti			Distress in patients with end-stage renal disease: Staff perceptions of barriers to the identification of mild-moderate distress and the provision of emotional support	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PSYCHOLOGICAL DISTRESS; CANCER-PATIENTS; HEALTH-PROFESSIONALS; DEPRESSION; HEMODIALYSIS; PREVALENCE; COMMUNICATION; ONCOLOGISTS; MANAGEMENT	Objectives To explore staff perceptions of barriers to the identification of mild to moderate distress and the provision of emotional support in patients with end-stage renal disease. Methods Qualitative semi-structured interviews with staff in two hospitals (n = 31), with data analysed using a hybrid approach combining thematic analysis with aspects of grounded theory. Results Staff appeared very aware that many patients with end-stage renal disease experience distress, and most thought distressed patients should be helped as part of routine care. However, practice was variable and looking for and addressing distress was not embedded in care pathways. Interviews identified six themes: i) staff perceptions about how distress is manifested and what causes distress were variable; ii) staff perceptions of patients could lead to distress being overlooked because patients were thought to hide their distress whilst some groups were assumed to be more prone to distress than others; iii) role perceptions varied, with many staff believing it to be their role but not feeling comfortable with it, with doctors being particularly ambivalent; iv) fears held back some staff, who were concerned about what might happen when talking about distress, or who found the emotional load for themselves to be too high; v) staff felt they lacked skills, confidence and training, vi) capacity to respond may be limited, as staff perceive there to be insufficient time, with little or no specialist support services to refer patients to. Conclusions Staff perceived significant barriers in identifying and responding to patient distress. Barriers related to skills and knowledge could be addressed through training, with training ideally targeted at staff with positive attitudes, but who currently lack skills and confidence. Barriers related to role perceptions would be harder to address. The study is relevant internationally as part of improving long-term condition pathways.	[Combes, Gill; Damery, Sarah; Sein, Kim] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Allen, Kerry] Univ Birmingham, Hlth Serv Management Ctr, Birmingham, W Midlands, England; [Nicholas, Johann] Royal Wolverhampton NHS Trust, New Cross Hosp, Wolverhampton, W Midlands, England; [Baharani, Jyoti] Univ Hosp Birmingham NHS Trust, Birmingham Heartlands Hosp, Birmingham, W Midlands, England; [Nicholas, Johann] Royal Shrewsbury Hosp, Shrewsbury, Shrops, England	University of Birmingham; University of Birmingham; New Cross Hospital; Heart of England NHS Foundation Trust; University of Birmingham	Combes, G (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England.	g.combes@bham.ac.uk	Damery, Sarah/ABA-8641-2021	Damery, Sarah/0000-0003-3681-8608	National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care West Midlands initiative (CLAHRCWM)	National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care West Midlands initiative (CLAHRCWM)	GC, SD, KS and KA were funded by the National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care West Midlands initiative (CLAHRCWM) (https://warwick.ac.uk/fac/sci/med/about/centres/clahrc/).This is an infrastructure grant and thus has no specific grant number. JB and JN received no funding for their participation in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absolom K, 2011, PSYCHO-ONCOLOGY, V20, P601, DOI 10.1002/pon.1916; Anderson WG, 2008, SUPPORT CARE CANCER, V16, P803, DOI 10.1007/s00520-007-0350-8; [Anonymous], 2017, UK RENAL REGISTRY 20; Bass EB, 1999, MED DECIS MAKING, V19, P287, DOI 10.1177/0272989X9901900307; Bautovich A, 2014, AUST NZ J PSYCHIAT, V48, P530, DOI 10.1177/0004867414528589; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Botti M, 2006, CANCER NURS, V29, P309, DOI 10.1097/00002820-200607000-00010; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bristowe K, 2015, PALLIATIVE MED, V29, P443, DOI 10.1177/0269216314560209; Butow PN, 2002, PSYCHO-ONCOLOGY, V11, P47, DOI 10.1002/pon.556; Charmaz K, 2012, SAGE HDB INTERVIEW R; Chilcot J, 2008, NEPHRON CLIN PRACT, V108, pC256, DOI 10.1159/000124749; Chilcot J, 2014, TRANSPLANTATION, V97, P717, DOI 10.1097/01.TP.0000438212.72960.ae; Clark S, 2014, SEMIN DIALYSIS, V27, P42, DOI 10.1111/sdi.12159; Cohen SD, 2007, CLIN J AM SOC NEPHRO, V2, P1332, DOI 10.2215/CJN.03951106; Cukor D, 2007, PSYCHIAT SERV, V58, P711, DOI 10.1176/appi.ps.58.5.711; Cukor D, 2009, KIDNEY INT, V75, P1223, DOI 10.1038/ki.2009.51; Del Piccolo L, 2019, PATIENT EDUC COUNS, V102, P1767, DOI 10.1016/j.pec.2019.04.002; Department of Health, 2014, CLOS GAP PRIOR ESS C; Department of Health, 2012, LONG TERM CONDITIONS, Vthird; Department of Health, 2005, NAT SERV FRAM REN SE; Dilworth S, 2014, PSYCHO-ONCOLOGY, V23, P601, DOI 10.1002/pon.3474; Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614; Gregory DM, 1998, QUAL HEALTH RES, V8, P764, DOI 10.1177/104973239800800604; Hack TF, 2012, PSYCHO-ONCOLOGY, V21, P809, DOI 10.1002/pon.1984; Hedayati SS, 2008, KIDNEY INT, V74, P930, DOI 10.1038/ki.2008.311; Jenkins K, 2010, PALLIAT SUPPORT CARE, V8, P27, DOI 10.1017/S1478951509990678; Kimmel PL, 2005, SEMIN DIALYSIS, V18, P91, DOI 10.1111/j.1525-139X.2005.18209.x; Kimmel PL, 2002, J PSYCHOSOM RES, V53, P951, DOI 10.1016/S0022-3999(02)00310-0; McDade-Montez EA, 2006, HEALTH PSYCHOL, V25, P198, DOI 10.1037/0278-6133.25.2.198; National Comprehensive Cancer Network (NCCN), 1998, NCCN CLIN PRACT GUID; National Institute for Health and Care Excellence, 2011, GSS CHRON KIDN DIS Q; NHS, 2014, NHS 5 YEAR FORW VIEW; Palmer S, 2013, KIDNEY INT, V84, P179, DOI 10.1038/ki.2013.77; Schell JO, 2012, AM J KIDNEY DIS, V59, P495, DOI 10.1053/j.ajkd.2011.11.023; Sensky T, 1996, PSYCHOTHER PSYCHOSOM, V65, P36, DOI 10.1159/000289029; Soni RK, 2010, CURR OPIN NEPHROL HY, V19, P153, DOI 10.1097/MNH.0b013e328335f939; Taylor F, 2016, J RENAL CARE, V42, P212, DOI 10.1111/jorc.12182; Taylor F, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0327-2; .The Kidney Health Advisory Group, 2013, KIDN HLTH DEL EXC; Turner J, 2018, SUPPORT CARE CANCER, V26, P1105, DOI 10.1007/s00520-017-3929-8; Vail L, 2011, PATIENT EDUC COUNS, V83, P185, DOI 10.1016/j.pec.2010.05.016; Wagena EJ, 2005, EUR RESPIR J, V26, P242, DOI 10.1183/09031936.05.00010604; Waraich P, 2004, CAN J PSYCHIAT, V49, P124, DOI 10.1177/070674370404900208; Weisbord SD, 2007, CLIN J AM SOC NEPHRO, V2, P960, DOI 10.2215/CJN.00990207; WELLS KB, 1992, ARCH GEN PSYCHIAT, V49, P788; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.3.CO;2-Y; Zalai D, 2012, SEMIN DIALYSIS, V25, P428, DOI 10.1111/j.1525-139X.2012.01100.x	48	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225269	10.1371/journal.pone.0225269	http://dx.doi.org/10.1371/journal.pone.0225269			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8PC	31751382	Green Published, gold			2022-12-26	WOS:000533886900040
J	Meriki, HD; Tufon, KA; Anong, DN; Atanga, PN; Anyangwe, IA; Cho-Ngwa, F; Nkuo-Akenji, T				Meriki, Henry Dilonga; Tufon, Kukwah Anthony; Anong, Damian Nota; Atanga, Pascal Nji; Anyangwe, Irene Ane; Cho-Ngwa, Fidelis; Nkuo-Akenji, Theresa			Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE; HIV TYPE-1; PREVALENCE; INDIVIDUALS; EXPOSURE; PROTEASE; THERAPY; FAILURE; UPDATE	Background Antiretroviral therapy (ART) has improved the survival of HIV infected persons. However, rapid scale-up of ART and the high HIV-1 genetic variability, has greatly influenced the emergence of drug-resistant strains. This constitutes a potential threat to achieving the UNAIDS' 90-90-90 goals by 2020. We investigated the prevalent HIV-1 genotypes, drug resistance-associated mutations and assessed some predictors of the occurrence of these mutations. Methods This was a hospital-based cross-sectional study conducted between October 2010 and June 2012. Participants were consecutively enrolled from selected HIV treatment centers of the Southwest and Northwest regions of Cameroon. Viral load was determined with the automated Abbott Real-time HIV-1 m2000rt System. HIV genotyping and antiretroviral resistance mutations analysis were performed using Bayer's HIV-1 TRUGENET Genotyping Kit and OpenGene DNA Sequencing system. The drug resistance mutation was interpreted with the Stanford HIV database. Epidemiological data were obtained using pretested semi-structured questionnaires. Results Of the 387 participants, 239 were successfully genotyped. The median age of these participants was 33 years (interquartile range, IQR: 28-40 years), and a majority (65.7%) were female. A total of 29.3% of the participants were receiving ART. The median duration of ART was 10.5 months (IQR: 4-17.25 months). The median CD4 count and log10 viral load of study participants were 353.5 cells/ml (IQR:145-471) and 4.89 copies/ml (IQR: 3.91-5.55) respectively. CRF02 (A/G) (69%) was the most prevalent subtype followed by G (8.2%) and F (6.7%). Overall, resistance mutations were present in 37.1% of ART-experienced and 10.7% of ART-naive patients. Nucleoside reverse transcriptase inhibitors (NRTI) mutations occurred in 30% of ART-experienced and 2.4% of ART-naive patients, while nonnucleoside reverse transcriptase inhibitors (NNRTI) mutations occurred in 34.2% of ARTexperienced and 10.1% of -naive patients. M184V (8.4%, 20/239) and K103N (5.4%, 13/ 239) were the most prevalent mutations. Major protease inhibitor mutations occurred in 3 (1.3%) out of the 239 sequences. The duration of ART independently predicted the occurrence of resistance mutation among ART-experienced patients. Conclusion The high resistance to NNRTIs, which are the main support to the backbone (NRTIs) firstline antiretroviral regimen in Cameroon, has prompted the need to rollout an integrase strand transfer inhibitor regimen (containing Dolutegravir) with a higher genetic barrier to resistance as the preferred first line regimen.	[Meriki, Henry Dilonga; Tufon, Kukwah Anthony; Anong, Damian Nota; Anyangwe, Irene Ane; Nkuo-Akenji, Theresa] Univ Buea, Dept Microbiol & Parasitol, Buea, Sw Region, Cameroon; [Meriki, Henry Dilonga] BioCollect Worldwide Inc, Reg Off, Buea, Sw Region, Cameroon; [Meriki, Henry Dilonga; Tufon, Kukwah Anthony] Univ Buea, Dept Biochem & Mol Biol, Buea, Sw Region, Cameroon; [Atanga, Pascal Nji] Cameroon Baptist Convent Hlth Serv, Mutengene, South West Regi, Cameroon; [Cho-Ngwa, Fidelis] Buea Reg Hosp, Lab Dept, Buea, Sw Region, Cameroon		Meriki, HD (corresponding author), Univ Buea, Dept Microbiol & Parasitol, Buea, Sw Region, Cameroon.; Meriki, HD (corresponding author), BioCollect Worldwide Inc, Reg Off, Buea, Sw Region, Cameroon.; Meriki, HD (corresponding author), Univ Buea, Dept Biochem & Mol Biol, Buea, Sw Region, Cameroon.	merilonga@yahoo.com		Meriki, Henry Dilonga/0000-0002-9148-0171	BioCollections Worldwide Inc.	BioCollections Worldwide Inc.	The author(s) received no specific funding for this work. Henry Dilonga Meriki is affiliated to BioCollections Worldwide Inc. BioCollections Worldwide Inc. provided support in the form of consultancy fees for author HDM as Country manager, data and sample collection and; We would like to acknowledge and thank immensely all participants and staff of the HIV treatment centers/units where this study was conducted. BioCollections Worldwide Inc., Miami, Florida, USA, performed viral load and drug resistance analysis. The content of this paper is exclusively the responsibility of the authors and does not necessarily represent the official views of the funding institutions.laboratory analysis, but did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the `author contributions' section.	AGHOKENG AF, 2013, J INT AIDS SOC, V16, DOI DOI 10.7448/IAS.16.1.18567; Agyingi L, 2012, GENETIC VARIABILITY, V9, P158, DOI [10.1186/1742-4690-9-S2-P158, DOI 10.1186/1742-4690-9-S2-P158]; Akrim M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-5; [Anonymous], 2018, KEY FACTS HIV AIDS; Arimide DA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205446; Bouzeghoub S, 2006, AIDS RES HUM RETROV, V22, P367, DOI 10.1089/aid.2006.22.367; Brooks K, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20798; Bunupuradah T, 2011, ANTIVIR THER, V16, P1113, DOI 10.3851/IMP1906; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; Carvajal-Rodriguez A, 2007, NIH PUBLIC ACCESS, V7, P476, DOI [10.1016/j.meegid.2007.02.001, DOI 10.1016/J.MEEGID.2007.02.001]; Castro-Nallar E, 2012, FUTURE VIROL, V7, P239, DOI 10.2217/FVL.12.4; Ceccarelli L, 2012, J MED VIROL, V84, P721, DOI 10.1002/jmv.23244; Coffin J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012526; Delaugerre C, 2010, MED MALADIES INFECT, V40, pS1, DOI 10.1016/S0399-077X(10)70001-9; El Sayed NM, 2000, J INFECT DIS, V181, P91, DOI 10.1086/315167; Falagas ME, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-13; Gao F, 2001, AIDS RES HUM RETROV, V17, P675, DOI 10.1089/088922201750236951; Kiepiela P., 2014, Journal of AIDS and Clinical Research, V5, P299; Lal RB, 2005, INDIAN J MED RES, V121, P287; Lehman JS, 2014, AIDS BEHAV, V18, P997, DOI 10.1007/s10461-014-0724-0; Lessells RJ, 2012, CURR OPIN VIROL, V2, P636, DOI 10.1016/j.coviro.2012.08.006; Lihana RW, 2012, AIDS REV, V14, P83; Lin B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181997; Maldarelli F, 2013, J VIROL, V87, P10313, DOI 10.1128/JVI.01225-12; Mata-Munguia C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-72; Medeiros MS, 2007, BRAZ J INFECT DIS, V11, P390, DOI 10.1590/S1413-86702007000400003; Meriki HD, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-5; Mondinde lkomey G, 2017, GERMS, DOI [10.18683/germs.2017.1124, DOI 10.18683/GERMS.2017.1124]; Moradigaravand D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004439; Nanfack AJ, 2017, J CLIN MICROBIOL, V55, P2785, DOI 10.1128/JCM.00634-17; Ndembi N, 2004, JAIDS-J ACQ IMM DEF, V37, P1641, DOI 10.1097/00126334-200412150-00019; Ndongmo CB, 2006, AIDS RES HUM RETROV, V22, P812, DOI 10.1089/aid.2006.22.812; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Powell RLR, 2009, JAIDS-J ACQ IMM DEF, V50, P84, DOI 10.1097/QAI.0b013e31818d5a40; Ragupathy V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-185; Reda AA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/574656; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Santoro Maria Mercedes, 2013, ISRN Microbiol, V2013, P481314, DOI 10.1155/2013/481314; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Santos AFA, 2012, ANTIMICROB AGENTS CH, V56, P2719, DOI 10.1128/AAC.06079-11; Semvua SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189460; Shao YM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007187; Siefried KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174613; Silverman RA, 2017, J INFECT DIS, V216, P1569, DOI 10.1093/infdis/jix544; Skhosana L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118145; Soria A, 2009, ANTIVIR THER, V14, P339; Teto G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14095-4; Toni TD, 2007, AIDS RES HUM RETROV, V23, P1155, DOI 10.1089/aid.2007.0072; Torimiro JN, 2011, J ACQ IMMUN DEF SYND, V56, P83, DOI [10.1097/QAI.010, DOI 10.1097/QAI.010]; UNAIDS, 2014, 90 90 90 AMB TREATM, DOI [10.7448/IAS.16.4.18751, DOI 10.7448/IAS.16.4.18751, 10.7448/IA5.16.4.18751]; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Vallari A, 2010, AIDS RES HUM RETROV, V26, P109, DOI 10.1089/aid.2009.0178; WHO CDC TheGlobalFund, 2017, HIV DRUG RES 2017 TR; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062408; Yilmaz NK, 2016, TRENDS MICROBIOL, V24, P547, DOI 10.1016/j.tim.2016.03.010; Zhong P, 2003, AIDS RES HUM RETROV, V19, P1167, DOI 10.1089/088922203771881284	58	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225575	10.1371/journal.pone.0225575	http://dx.doi.org/10.1371/journal.pone.0225575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751428	Green Published, gold			2022-12-26	WOS:000533886900079
J	Zar, HJ; Pellowski, JA; Cohen, S; Barnett, W; Vanker, A; Koen, N; Stein, DJ				Zar, Heather J.; Pellowski, Jennifer A.; Cohen, Sophie; Barnett, Whitney; Vanker, Aneesa; Koen, Nastassja; Stein, Dan J.			Maternal health and birth outcomes in a South African birth cohort study	PLOS ONE			English	Article							FOOD INSECURITY; PRETERM BIRTH; RISK-FACTORS; IN-UTERO; PREGNANCY; WOMEN; DETERMINANTS; ALCOHOL; SMOKING; LIFE	Background Maternal physical and mental health during pregnancy are key determinants of birth outcomes. There are relatively few prospective data that integrate physical and mental maternal health measures with birth outcomes in low- and middle-income country settings. We aimed to investigate maternal health during pregnancy and the impact on birth outcomes in an African birth cohort study, the Drakenstein Child Health Study. Methods Pregnant women attending 2 public health clinics, Mbekweni (serving a predominantly black African population) and TC Newman (predominantly mixed ancestry) in a poor peri-urban area of South Africa were enrolled in their second trimester and followed through childbirth. All births occurred at a single public hospital. Maternal sociodemographic, physical and psychosocial characteristics were comprehensively assessed. Multivariable linear regression models were used to explore associations between maternal health and birth outcomes. Results Over 3 years, 1137 women (median age 25.8 years; 21% HIV-infected) gave birth to 1143 live babies. Most pregnancies were uncomplicated but gestational diabetes (1%), anaemia (22%) or pre-eclampsia (2%) occurred in a minority. Most households (87%) had a monthly income of less than USD 350; only 27% of moms were employed and food insecurity was common (37%). Most babies (80%) were born by vaginal delivery at full term; 17% were preterm, predominantly late preterm. Only 74 (7%) of babies required hospitalisation immediately after birth and only 2 babies were HIV-infected. Food insecurity, socioeconomic status, pregnancy-associated hypertension, pre-eclampsia, gestational diabetes and mixed ancestry were associated with lower infant gestational age while maternal BMI at enrolment was associated with higher infant gestational age. Primigravida or alcohol use during pregnancy were negatively associated with infant birth weight and head circumference. Maternal BMI at enrolment was positively associated with birth weight and gestational diabetes was positively associated with birth weight and head circumference for gestational age. Smoking during pregnancy was associated with lower infant birth weight. Conclusion Several modifiable risk factors including food insecurity, smoking, and alcohol consumption during pregnancy were identified as associated with negative birth outcomes, all of which are amenable to public health interventions. Interventions to address key exposures influencing birth outcomes are needed to improve maternal and child health in low-middle income country settings.	[Zar, Heather J.; Cohen, Sophie; Barnett, Whitney; Vanker, Aneesa] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa; [Zar, Heather J.; Cohen, Sophie; Barnett, Whitney; Vanker, Aneesa] Univ Cape Town, SA MRC Unit Child & Adolescent Hlth, Cape Town, South Africa; [Pellowski, Jennifer A.] Brown Univ, Dept Behav & Social Sci, Sch Publ Hlth, Providence, RI 02912 USA; [Koen, Nastassja; Stein, Dan J.] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Koen, Nastassja; Stein, Dan J.] Univ Cape Town, SA MRC Unit Risk & Resilience Mental Disorders, Cape Town, South Africa	University of Cape Town; University of Cape Town; Brown University; University of Cape Town; University of Cape Town	Zar, HJ (corresponding author), Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa.; Zar, HJ (corresponding author), Univ Cape Town, SA MRC Unit Child & Adolescent Hlth, Cape Town, South Africa.	Heather.zar@uct.ac.za	Vanker, Aneesa/ABC-3364-2021; Stein, Dan/A-1752-2008; Zar, Heather/GZL-5350-2022; Mashiya, Nombeko Monica/AET-3950-2022	Vanker, Aneesa/0000-0001-7396-5506; Stein, Dan/0000-0001-7218-7810; Zar, Heather/0000-0002-9046-759X; Mashiya, Nombeko Monica/0000-0003-0124-9118; Barnett, Whitney/0000-0001-5082-7864	Bill and Melinda Gates Foundation [OPP 1017641]; National Research Foundation; Discovery Foundation; South African Medical Research Council (SA-MRC); SA-MRC; NIMH [K01MH112443]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH112443] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Research Foundation; Discovery Foundation; South African Medical Research Council (SA-MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SA-MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Drakenstein Child Health study was funded by the Bill and Melinda Gates Foundation (OPP 1017641). Environmental aspects were funded by the National Research Foundation, the Discovery Foundation, the South African Medical Research Council (SA-MRC). Heather Zar and Dan Stein are supported by the SA-MRC; Nastassja Koen is supported by the SA-MRC under a SelfInitiated Research Grant. Whitney Barnett is supported by the SA-MRC through the National Health Scholars Program. The views and opinions expressed are those of the authors and do not necessarily represent the official views of the SAMRC. Jennifer Pellowski is supported by NIMH grant K01MH112443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2002, ADDICTION, V97, P1183; Bickel D, 2000, US DEP AGR USDA GUID; Borders AEB, 2007, OBSTET GYNECOL, V109, P331, DOI 10.1097/01.AOG.0000250535.97920.b5; Brittain K, 2015, PAEDIATR PERINAT EP, V29, P505, DOI 10.1111/ppe.12216; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Cois Annibale, 2015, BMC Obes, V2, P42, DOI 10.1186/s40608-015-0072-2; Dahlen HG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0681-2; Dewing S, 2013, J AFFECT DISORDERS, V150, P460, DOI 10.1016/j.jad.2013.04.040; Dolatian M, 2018, INT J REPROD BIOMED, V16, P563, DOI 10.29252/ijrm.16.9.563; Donald KA, 2018, BMJ PAEDIATR OPEN, V2, DOI 10.1136/bmjpo-2018-000282; Donald KA, 2016, METAB BRAIN DIS, V31, P81, DOI 10.1007/s11011-015-9771-0; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Gray D, 2017, THORAX, V72, P445, DOI 10.1136/thoraxjnl-2015-207401; Hannigan J H, 2000, Semin Neonatol, V5, P243; Harville EW, 2018, ENVIRON RES, V161, P153, DOI 10.1016/j.envres.2017.11.012; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Koen N, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.28720; Koen N, 2017, PSYCHOL TRAUMA-US, V9, P292, DOI 10.1037/tra0000234; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; le Roux DM, 2015, LANCET GLOB HEALTH, V3, pE95, DOI 10.1016/S2214-109X(14)70360-2; Myer L, 2008, SOC SCI MED, V66, P1828, DOI 10.1016/j.socscimed.2008.01.025; Myers B, 2018, ALCOHOL CLIN EXP RES, V42, P369, DOI 10.1111/acer.13566; Narang I, 2012, SEMIN FETAL NEONAT M, V17, P112, DOI 10.1016/j.siny.2012.01.002; Nnam NM, 2015, P NUTR SOC, V74, P454, DOI 10.1017/S0029665115002396; Orley B., 1994, USERS GUIDE SELF REP; Pellowski JA, 2017, SOC SCI MED, V187, P76, DOI 10.1016/j.socscimed.2017.06.022; Republic of South Africa Department of Health, 2018, S AFR ANT TREATM GUI; Skorge TD, 2005, AM J RESP CRIT CARE, V172, P61, DOI 10.1164/rccm.200409-1158OC; Smid MC, 2016, AM J PERINAT, V33, P276, DOI 10.1055/s-0035-1571199; Stein DJ, 2015, J NEUROSCI METH, V252, P27, DOI 10.1016/j.jneumeth.2015.03.016; Tucker CM, 2015, MATERN CHILD HLTH J, V19, P2438, DOI 10.1007/s10995-015-1763-5; Upton MN, 2004, THORAX, V59, P274, DOI 10.1136/thx.2003.018424; Vanker A, 2016, INT J TUBERC LUNG D, V20, P729, DOI 10.5588/ijtld.15.0697; Vogel JP, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-56; Yamamoto S, 2017, J MIDWIFERY WOM HEAL, V62, P696, DOI 10.1111/jmwh.12658; Yaya S, J MATERN FETAL NEONA; Zar HJ, 2015, THORAX, V70, P592, DOI 10.1136/thoraxjnl-2014-206242	37	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0222399	10.1371/journal.pone.0222399	http://dx.doi.org/10.1371/journal.pone.0222399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8PC	31751344	Green Published, gold			2022-12-26	WOS:000533886900004
J	Jasper, ME; Yang, Q; Ross, PA; Endersby-Harshman, N; Bell, N; Hoffmann, AA				Jasper, Moshe E.; Yang, Qiong; Ross, Perran A.; Endersby-Harshman, Nancy; Bell, Nicholas; Hoffmann, Ary A.			A LAMP assay for the rapid and robust assessment of Wolbachia infection in Aedes aegypti under field and laboratory conditions	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; DENGUE; ESTABLISHMENT; POPULATIONS; DNA; PCR	With Wolbachia-based arbovirus control programs being scaled and operationalised around the world, cost effective and reliable detection of Wolbachia in field samples and laboratory stocks is essential for quality control. Here we validate a modified loop-mediated isothermal amplification (LAMP) assay for routine scoring of Wolbachia in mosquitoes from laboratory cultures and the field, applicable to any setting. We show that this assay is a rapid and robust method for highly sensitive and specific detection of wAlbB Wolbachia infection within Aedes aegypti under a variety of conditions. We test the quantitative nature of the assay by evaluating pooled mixtures of Wolbachia-infected and uninfected mosquitoes and show that it is capable of estimating infection frequencies, potentially circumventing the need to perform large-scale individual analysis for wAlbB infection status in the course of field monitoring. These results indicate that LAMP assays are useful for routine screening particularly under field conditions away from laboratory facilities.	[Jasper, Moshe E.; Yang, Qiong; Ross, Perran A.; Endersby-Harshman, Nancy; Bell, Nicholas; Hoffmann, Ary A.] Univ Melbourne, Sch BioSci, Pest & Environm Adaptat Res Grp, Melbourne, Vic, Australia	University of Melbourne	Jasper, ME (corresponding author), Univ Melbourne, Sch BioSci, Pest & Environm Adaptat Res Grp, Melbourne, Vic, Australia.	moshe.jasper@unimelb.edu.au	Ross, Perran/O-1049-2015	Ross, Perran/0000-0001-7645-7523; Endersby-Harshman, Nancy/0000-0002-9834-4068; Jasper, Moshe Elijah/0000-0003-4541-3223; Bell, Nicholas/0000-0002-2420-6682; Hoffmann, Ary/0000-0001-9497-7645	Wellcome Trust [108508]; National Health and Medical Research Council (AU) [1118640, 1132412]	Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council (AU)	AH received a grant (#108508) from the Wellcome Trust (https://wellcome.ac.uk/).AH received a grant (Program Grant #1132412) from the National Health and Medical Research Council (AU), (https://www.nhmrc.gov.au/).AH received a grant (Fellowship Grant #1118640) from the National Health and Medical Research Council (AU), (https://www.nhmrc.gov.au/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ant TH, 2018, PLOS PATHOG, V14, P19, DOI DOI 10.1371/J0URNAL.PPAT.1006815; Aoi Y, 2006, J BIOTECHNOL, V125, P484, DOI 10.1016/j.jbiotec.2006.04.007; Bhadra Sanchita, 2018, PLoS Negl Trop Dis, V12, pe0006671, DOI 10.1371/journal.pntd.0006671; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; Callahan AG, 2018, PARASITE VECTOR, V11, P7; Chen BJ, 2019, BIOSENS BIOELECTRON, V129, P277, DOI 10.1016/j.bios.2018.09.056; Dauner AL, 2015, DIAGN MICR INFEC DIS, V83, P30, DOI 10.1016/j.diagmicrobio.2015.05.004; Fujiwara-Nagata E, 2009, J FISH DIS, V32, P873, DOI 10.1111/j.1365-2761.2009.01066.x; Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023; Goncalves DD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-228; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Huang X, 2018, ENVIRON SCI TECHNOL, V52, P6399, DOI 10.1021/acs.est.8b00241; Kitamura M, 2018, INT J LEGAL MED, V132, P975, DOI 10.1007/s00414-017-1661-z; Kulkarni A, 2019, ECOL EVOL, V9, P6148, DOI 10.1002/ece3.5198; Lee PLM, 2017, MOL ECOL RESOUR, V17, P138, DOI 10.1111/1755-0998.12548; Lee SF, 2012, APPL ENVIRON MICROB, V78, P4740, DOI 10.1128/AEM.00069-12; Lucchi NW, 2018, EXPERT REV MOL DIAGN, V18, P195, DOI 10.1080/14737159.2018.1431529; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nazni WA, 2019, ESTABLISHMENT WOLBAC, DOI [10.1101/775965, DOI 10.1101/775965]; Nguyen TH, 2015, PARASITE VECTOR, V8, P14, DOI DOI 10.1186/S13071-014-0609-0; Noor-Shazleen-Husnie MM, 2018, TROP BIOMED, V35, P330; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Ross PA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007357; Schenkel CD, 2019, MED VET ENTOMOL, V33, P345, DOI 10.1111/mve.12366; Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894; Su YX, 2019, J MICROBIOL METH, V160, P68, DOI 10.1016/j.mimet.2019.01.013; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Wheeler SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147962; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607	31	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225321	10.1371/journal.pone.0225321	http://dx.doi.org/10.1371/journal.pone.0225321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747432	Green Published, gold, Green Submitted			2022-12-26	WOS:000533881900033
J	Caeiro, C; Canhao, H; Paiva, S; Gomes, LA; Fernandes, R; Rodrigues, AM; Sousa, R; Pimentel-Santos, F; Branco, J; Fryxell, AC; Vicente, L; Cruz, EB				Caeiro, Carmen; Canhao, Helena; Paiva, Sofia; Gomes, Luis A.; Fernandes, Rita; Rodrigues, Ana Maria; Sousa, Rute; Pimentel-Santos, Fernando; Branco, Jaime; Fryxell, Ana Cristina; Vicente, Lilia; Cruz, Eduardo B.			Interdisciplinary stratified care for low back pain: A qualitative study on the acceptability, potential facilitators and barriers to implementation	PLOS ONE			English	Article							MUSCULOSKELETAL HEALTH; START BACK; MODELS; MANAGEMENT; SERVICES; OUTCOMES	Background and objective The SPLIT project aims to introduce an interdisciplinary stratified model of care for patients with low back pain. This study aimed to explore the acceptability and identify potential barriers and facilitators regarding the upcoming implementation of this project, based on the general practitioners' and physiotherapists' perceptions. Methods A qualitative study was carried out supported by two focus groups, which were conducted by two researchers. A focus group was carried out with each professional group. One focus group included six general practitioners and the other included six physiotherapists. The focus groups were based on a semi-structured interview schedule, audio-recorded and transcribed verbatim. A thematic analysis was conducted. Results The participants explored aspects related to the acceptability of the SPLIT project, emphasising the satisfactory amount of effort that is expected to be required for its implementation. Potential facilitators to the implementation of the model were identified, such as the participants' motivation. Potential barriers were also explored, with particular emphasis on the challenges related to the change of routine care. Lastly, the need for particular adjustments in the health services was also highlighted. Conclusions This study's participants highlighted the feasibility and acceptability of the SPLIT project. The identification of potential barriers and facilitators to its implementation also attained major relevance to better prepare the upcoming implementation of this project. The generalizability of findings to the larger population of relevant practitioners is limited, since only two focus groups were carried out. Therefore, this study's findings should be considered in terms of transferability to contexts that may have some similarities to the context where the study was carried out.	[Caeiro, Carmen; Paiva, Sofia; Gomes, Luis A.; Fernandes, Rita; Cruz, Eduardo B.] Setubal Polytech Inst, Physiotherapy Dept, Setubal, Portugal; [Canhao, Helena; Rodrigues, Ana Maria; Sousa, Rute; Pimentel-Santos, Fernando; Branco, Jaime] NOVA Med Sch, EpiDoC Unit, CEDOC, Lisbon, Portugal; [Fryxell, Ana Cristina; Vicente, Lilia] Reg Hlth Adm Lisbon & Tagus Valley, ACES Arrabida, Setubal, Portugal		Caeiro, C (corresponding author), Setubal Polytech Inst, Physiotherapy Dept, Setubal, Portugal.	carmen.caeiro@ess.ips.pt	Rodrigues, Ana/GYQ-6273-2022; Cruz, Eduardo B/L-5577-2017; VICENTE, LIERN/B-6112-2008; Cruz, Eduardo/AAA-3907-2019; Canhao, Helena/C-9611-2018	Cruz, Eduardo B/0000-0003-1812-1815; VICENTE, LIERN/0000-0001-5883-9640; Cruz, Eduardo/0000-0003-1812-1815; Canhao, Helena/0000-0003-1894-4870; Fernandes, Rita/0000-0003-4023-9326; Branco, Jaime/0000-0001-7024-4375; Sousa, Rute Dinis de/0000-0001-9713-0204; Gomes, Luis Antunes/0000-0002-4359-0122; Rodrigues, Ana Maria/0000-0003-2046-8017	LISBOA 2020 - Regional Operational Program; Portuguese Science & Technology Foundation [SAICTPOL/23439/2016\LISBOA-01-0145-FEDER-023439]	LISBOA 2020 - Regional Operational Program; Portuguese Science & Technology Foundation	The work presented in this paper is associated to a research project co-financed by the LISBOA 2020 - Regional Operational Program for Lisbon and Vale do Tejo and the Portuguese Science & Technology Foundation (Grant#SAICTPOL/23439/2016 vertical bar LISBOA-01-0145-FEDER-023439).	ARSLVT, 2015, ACES ARR CAR, P1; Ash LM, 2008, AM J NEURORADIOL, V29, P1098, DOI 10.3174/ajnr.A0999; Azevedo LF, 2013, MED CARE, V51, P859, DOI 10.1097/MLR.0b013e3182a53e4e; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Branco JC, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000166; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Briggs AM, 2014, AUST HEALTH REV, V38, P401, DOI 10.1071/AH14032; Buchbinder R, 2018, LANCET, V391, P2384, DOI 10.1016/S0140-6736(18)30488-4; Busetto L, 2018, INT J INTEGR CARE, V18, DOI 10.5334/ijic.3587; Castaño Juan G., 2010, Ing. Desarro., P1; Charmaz K, 2008, QUALITATIVE PSYCHOL, P240, DOI DOI 10.4135/9781412963909.N189; Clarke V, 2013, PSYCHOLOGIST, V26, P120; Correia T., 2015, NOVOS TEMAS SAUDE NO, P99; Cruz EB, 2019, ANN RHEUM DIS, V78, P2088, DOI 10.1136/annrheumdis-2019-eular.7670; Dziedzic KS, 2016, BEST PRACT RES CL RH, V30, P375, DOI 10.1016/j.berh.2016.08.004; Fernandes JV, 2011, PLHARES FUTURO SAUDE, P15; Finch H, 2014, QUALITATIVE RES PRAC, P211; Flick U., 2009, INTRO QUALITATIVE RE, P194; Foster Nadine E, 2018, Lancet, V391, P2368, DOI 10.1016/S0140-6736(18)30489-6; Foster NE, 2014, ANN FAM MED, V12, P102, DOI 10.1370/afm.1625; Foster NE, 2013, BEST PRACT RES CL RH, V27, P649, DOI 10.1016/j.berh.2013.10.005; Gareth J., 2015, QUALITATIVE RES CLIN, P57, DOI 10.1007/978-1-137-29105-9_5; Gouveia N, 2016, RHEUMATOL INT, V36, P183, DOI 10.1007/s00296-015-3398-7; Grant A, 2005, MANUAL THER, V10, P1, DOI 10.1016/j.math.2004.07.001; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Johnson Ros, 2004, Physiother Res Int, V9, P121, DOI 10.1002/pri.312; Karstens S, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2991-3; Karstens S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136119; Krueger RA, 2015, FOCUS GROUPS PRATICA, P39; Lau R, 2016, IMPLEMENT SCI; Layne EI, 2018, SPINE J, V18, P614, DOI 10.1016/j.spinee.2017.08.259; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; Murphy SE, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-342; Murray E, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-63; Proctor EK, 2009, ADM POLICY MENT HLTH, V36, P24, DOI 10.1007/s10488-008-0197-4; Raimundo A, 2017, ACTA REUMATOL PORT, V42, P38; Rutten GM, 2010, PHYS THER, V90, P1111, DOI 10.2522/ptj.20090173; Sanders T, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-65; Sanders T, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-49; Savigny P, 2009, LOW BACK PAIN EARLY, V14, P9; Scott NA, 2010, PAIN RES MANAG, V15, P392, DOI 10.1155/2010/252695; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; Simoes JD, 2017, HEALT SYST TRANSIT, V19, P1; Sousa P, 2009, REV PORTUGUESA SAU P; Sowden G, 2011, FAM PRACT, P1; Sowden G, 2018, BRAZ J PHYS THER, V22, P255, DOI 10.1016/j.bjpt.2018.06.003; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vardasca R, 2015, EXPERIMENT AT INT C, P1, DOI 10.1109/EXPAT.2015.7463204; Warwick R, 2004, PSYCHOL HEALTH, V19, P117, DOI 10.1080/08870440310001613482; Whitehurst DGT, 2012, ANN RHEUM DIS, V71, P1796, DOI 10.1136/annrheumdis-2011-200731	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225336	10.1371/journal.pone.0225336	http://dx.doi.org/10.1371/journal.pone.0225336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2YM	31730676	Green Published, gold			2022-12-26	WOS:000532809500035
J	Gu, Y; Zheng, F; Wang, Y; Su, XY; Bai, YG; Yao, B; Huang, HQ; Luo, HY				Gu, Yuan; Zheng, Fei; Wang, Yuan; Su, Xiaoyun; Bai, Yingguo; Yao, Bin; Huang, Huoqing; Luo, Huiying			Characterization of two thermophilic cellulases from Talaromyces leycettanus JCM12802 and their synergistic action on cellulose hydrolysis	PLOS ONE			English	Article							TRICHODERMA-REESEI; BIOCHEMICAL-CHARACTERIZATION; HETEROLOGOUS EXPRESSION; ENDOGLUCANASE-II; PICHIA-PASTORIS; SWISS-MODEL; CELLOBIOHYDROLASE; CLONING; PURIFICATION; MECHANISM	Talaromyces leycettanus JCM12802 is a great producer of thermophilic glycoside hydrolases (GHs). In this study, two cellulases (TlCel5A and TlCel6A) belonging to GH5 and GH6 respectively were expressed in Pichia pastoris and functionally characterized. The enzymes had acidic and thermophilic properties, showing optimal activities at pH 3.5-4.5 and 75-80 degrees C, and retained stable at temperatures up to 60 degrees C and over a broad pH range of 2.0-8.0. TlCel5A and TlCel6A acted against several cellulose substrates with varied activities (3,101.1 vs. 92.9 U/mg to barley beta-glucan, 3,905.6 U/mg vs. 109.0 U/mg to lichenan, and 840.3 and 0.09 U/mg to CMC-Na). When using Avicel, phosphoric acid swollen cellulose (PASC) or steam-exploded corn straw (SECS) as the substrate, combination of TlCel5A and TlCel6A showed significant synergistic action, releasing more reduced sugars (1.08-2.87 mM) than the individual enzymes. These two cellulases may represent potential enzyme additives for the efficient biomass conversion and bioethanol production.	[Gu, Yuan; Zheng, Fei; Wang, Yuan; Su, Xiaoyun; Bai, Yingguo; Yao, Bin; Huang, Huoqing; Luo, Huiying] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing, Peoples R China; [Zheng, Fei] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Forestry University	Huang, HQ; Luo, HY (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing, Peoples R China.	huanghuoqing@caas.cn; luohuiying@caas.cn			National Natural Science Foundation of China [31572446]; China Modern Agriculture Research System [CARS-41]; Collaborative Innovation Project of Chinese Academy of Agricultural Sciences [CAAS-463 XTCX2016011-04-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Modern Agriculture Research System; Collaborative Innovation Project of Chinese Academy of Agricultural Sciences	This research was supported by the National Natural Science Foundation of China (31572446), the China Modern Agriculture Research System (CARS-41), and the Collaborative Innovation Project of Chinese Academy of Agricultural Sciences, CAAS-463 XTCX2016011-04-5 (http://www.nsfc.gov.cn/english/site_1/) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore A, 2017, P NATL ACAD SCI USA, V114, P13667, DOI 10.1073/pnas.1714249114; Badino SF, 2017, BBA-PROTEINS PROTEOM, V1865, P1739, DOI 10.1016/j.bbapap.2017.08.013; Baramee S, 2017, APPL MICROBIOL BIOT, V101, P1175, DOI 10.1007/s00253-016-7895-8; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boonvitthya N, 2013, MOL BIOTECHNOL, V54, P158, DOI 10.1007/s12033-012-9557-0; CHIR J, 1994, BIOTECHNOL BIOENG, V44, P1064; Chir JL, 2011, BIOTECHNOL LETT, V33, P777, DOI 10.1007/s10529-010-0500-9; de Almeida MN, 2013, BIORESOURCE TECHNOL, V143, P413, DOI 10.1016/j.biortech.2013.06.021; Druzhinina IS, 2017, MICROB BIOTECHNOL, V10, P1485, DOI 10.1111/1751-7915.12726; Fang H, 2019, MICROB CELL FACT, V18, DOI 10.1186/s12934-019-1060-x; Fusco FA, 2018, EXTREMOPHILES, V22, P131, DOI 10.1007/s00792-017-0983-6; Gao L, 2011, BIORESOURCE TECHNOL, V102, P8339, DOI 10.1016/j.biortech.2011.06.033; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gusakov AV, 2017, BIOCHIMIE, V132, P102, DOI 10.1016/j.biochi.2016.11.004; Hong J, 2003, BIOTECHNOL LETT, V25, P657, DOI 10.1023/A:1023072311980; Kamal S., 2018, BIOCH MOL BIOL, V3, P15, DOI [10.11648/j.bmb.20180301.13, DOI 10.11648/J.BMB.20180301.13]; Kamal S, 2018, INT J BASIC MED SCI, V7, P43; Kostylev M, 2014, BIOTECHNOL BIOENG, V111, P664, DOI 10.1002/bit.25139; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li B, 2017, APPL MICROBIOL BIOT, V101, P1; LI CI, 2009, ENZYME MICROBIAL TEC, V44, P359; Li D C, 2019, FUNGI EXTREME ENV EC, P395; LI T, 2017, BIOTECHNOL BIOENG, V115, P831; LIMAM F, 1995, ENZYME MICROB TECH, V17, P340, DOI 10.1016/0141-0229(94)00033-6; Liu JA, 2011, APPL MICROBIOL BIOT, V89, P1083, DOI 10.1007/s00253-010-2828-4; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Miller G., 1969, USE DINITROSALICYCLI, V31, P426; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Poidevin L, 2013, APPL ENVIRON MICROB, V79, P4220, DOI 10.1128/AEM.00327-13; Qin YQ, 2008, J BIOTECHNOL, V135, P190, DOI 10.1016/j.jbiotec.2008.03.016; Rattu G, 2016, EXTREMOPHILES, V20, P831, DOI 10.1007/s00792-016-0870-6; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Sharma A, 2016, APPL BIOCHEM BIOTECH, V179, P1346, DOI 10.1007/s12010-016-2070-3; Shi RR, 2013, BIORESOURCE TECHNOL, V142, P338, DOI 10.1016/j.biortech.2013.05.037; Song JZ, 2010, MOL BIOL REP, V37, P2135, DOI 10.1007/s11033-009-9683-3; Takada G, 2000, J BIOSCI BIOENG, V94, P482; Touijer H, 2019, ENZYME RES, P1; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang CH, 2015, APPL MICROBIOL BIOT, V99, P1217, DOI 10.1007/s00253-014-5979-x; Wang K, 2014, APPL MICROBIOL BIOT, V98, P7051, DOI 10.1007/s00253-014-5680-0; Wang W, 2017, J MICROBIOL METH, V143, P63, DOI 10.1016/j.mimet.2017.10.006; Wonganu B, 2008, PROTEIN EXPRES PURIF, V58, P78, DOI 10.1016/j.pep.2007.10.022; Xia W, 2016, APPL ENVIRON MICROB, V82, P2718, DOI 10.1128/AEM.04071-15; Xu XX, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153693; Yan JJ, 2016, BIOCHEM BIOPH RES CO, V475, P8, DOI 10.1016/j.bbrc.2016.05.012; Zhang YHP, 2006, APPL MICROBIOL BIOT, V70, P123, DOI 10.1007/s00253-005-0278-1	48	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224803	10.1371/journal.pone.0224803	http://dx.doi.org/10.1371/journal.pone.0224803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730665	Green Published, gold			2022-12-26	WOS:000532809500008
J	Jobin, PG; Solis, N; Machado, Y; Bell, PA; Rai, SK; Kwon, NH; Kim, S; Overall, CM; Butler, GS				Jobin, Parker G.; Solis, Nestor; Machado, Yoan; Bell, Peter A.; Rai, Simran K.; Kwon, Nam Hoon; Kim, Sunghoon; Overall, Christopher M.; Butler, Georgina S.			Moonlighting matrix metalloproteinase substrates: Enhancement of proinflammatory functions of extracellular tyrosyl-tRNA synthetase upon cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						multifunctional protein; aminoacyl tRNA synthetase; proteolysis; matrix metalloproteinase (MMP); inflammation; toll-like receptor (TLR); macrophage; innate immunity; moonlighting proteins	NF-KAPPA-B; MASS-SPECTROMETRY; DIADENOSINE POLYPHOSPHATES; MULTISYNTHETASE COMPLEX; NEUTROPHIL APOPTOSIS; CYTOKINE ACTIVITIES; CRYSTAL-STRUCTURE; POTENTIAL ROLE; IDENTIFICATION; PROTEINS	Tyrosyl-tRNA synthetase ligates tyrosine to its cognate tRNA in the cytoplasm, but it can also be secreted through a noncanonical pathway. We found that extracellular tyrosyl-tRNA synthetase (YRS) exhibited proinflammatory activities. In addition to acting as a monocyte/macrophage chemoattractant, YRS initiated signaling through Toll-like receptor 2 (TLR2) resulting in NF-?B activation and release of tumor necrosis factor ? (TNF?) and multiple chemokines, including MIP-1?/?, CXCL8 (IL8), and CXCL1 (KC) from THP1 monocyte and peripheral blood mononuclear cell?derived macrophages. Furthermore, YRS up-regulated matrix metalloproteinase (MMP) activity in a TNF?-dependent manner in M0 macrophages. Because MMPs process a variety of intracellular proteins that also exhibit extracellular moonlighting functions, we profiled 10 MMPs for YRS cleavage and identified 55 cleavage sites by amino-terminal oriented mass spectrometry of substrates (ATOMS) positional proteomics and Edman degradation. Stable proteoforms resulted from cleavages near the start of the YRS C-terminal EMAPII domain. All of the MMPs tested cleaved at ADS(386)?(LYV)-L-387 and VSG(405)?(406)LVQ, generating 43- and 45-kDa fragments. The highest catalytic efficiency for YRS was demonstrated by MMP7, which is highly expressed by monocytes and macrophages, and by neutrophil-specific MMP8. MMP-cleaved YRS enhanced TLR2 signaling, increased TNF? secretion from macrophages, and amplified monocyte/macrophage chemotaxis compared with unprocessed YRS. The cleavage of YRS by MMP8, but not MMP7, was inhibited by tyrosine, a substrate of the YRS aminoacylation reaction. Overall, the proinflammatory activity of YRS is enhanced by MMP cleavage, which we suggest forms a feed-forward mechanism to promote inflammation.	[Jobin, Parker G.; Overall, Christopher M.] Univ British Columbia, Fac Dent, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Jobin, Parker G.; Solis, Nestor; Machado, Yoan; Bell, Peter A.; Rai, Simran K.; Overall, Christopher M.; Butler, Georgina S.] Univ British Columbia, Fac Dent, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Solis, Nestor; Machado, Yoan; Bell, Peter A.; Overall, Christopher M.; Butler, Georgina S.] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Rai, Simran K.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V5T 4S6, Canada; [Kwon, Nam Hoon; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Kwon, Nam Hoon; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul 151742, South Korea	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Seoul National University (SNU); Seoul National University (SNU)	Overall, CM (corresponding author), Univ British Columbia, 2350 Hlth Sci Mall,Rm 4-401, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca	Butler, Georgina/GQP-7553-2022; Machado, Yoan/D-9429-2016	Butler, Georgina/0000-0003-1172-1578; Machado, Yoan/0000-0002-8251-3744; Jobin, Parker/0000-0001-5852-7890	Canadian Institutes of Health Research (CIHR) Foundation Grant [FDN-148408]; CIHR [MOP-111055]; Canada Foundation for Innovation [31059]; Michael Smith Foundation for Health Research [IN-NPG-00105]; University of British Columbia (UBC) 4-year doctoral fellowship; CIHR Vanier Canada graduate scholarship; Centre for Blood Research graduate award; Vancouver Coastal Health Research Institute (VCHRI)-CIHR-UBC MD/Ph.D. studentship; Australian Early Career Fellowship; Canadian MSFHR Research Trainee Fellowship	Canadian Institutes of Health Research (CIHR) Foundation Grant(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); University of British Columbia (UBC) 4-year doctoral fellowship; CIHR Vanier Canada graduate scholarship(Canadian Institutes of Health Research (CIHR)); Centre for Blood Research graduate award; Vancouver Coastal Health Research Institute (VCHRI)-CIHR-UBC MD/Ph.D. studentship; Australian Early Career Fellowship; Canadian MSFHR Research Trainee Fellowship	This work was supported by Canadian Institutes of Health Research (CIHR) Foundation Grant FDN-148408 (to C. M. O.), CIHR Grant MOP-111055 (to C. M. O. and G. S. B.), Canada Foundation for Innovation Grant 31059 (to C. M. O.), and the Michael Smith Foundation for Health Research to establish the British Columbia Proteomics Network Grant IN-NPG-00105 (to C. M. O.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by University of British Columbia (UBC) 4-year doctoral fellowship, CIHR Vanier Canada graduate scholarship, a Centre for Blood Research graduate award, and a Vancouver Coastal Health Research Institute (VCHRI)-CIHR-UBC MD/Ph.D. studentship.; Recipient of an Australian Early Career Fellowship.; Recipients of a Canadian MSFHR Research Trainee Fellowship.	Abbey SR, 2018, J DENT RES, V97, P338, DOI 10.1177/0022034517736054; Ahn YH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.191; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BAXI MD, 1995, J PHARMACOL TOX MET, V33, P121, DOI 10.1016/1056-8719(94)00127-P; Bellac CL, 2014, CELL REP, V9, P618, DOI 10.1016/j.celrep.2014.09.006; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Butler GS, 2002, J BIOL CHEM, V277, P17511, DOI 10.1074/jbc.M201461200; Casas-Tinto S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10022; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; Cox JH, 2010, ARTHRITIS RHEUM-US, V62, P3645, DOI 10.1002/art.27757; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Doucet A, 2011, METHOD ENZYMOL, V501, P275, DOI 10.1016/B978-0-12-385950-1.00013-4; Doucet A, 2011, METHODS MOL BIOL, V753, P273, DOI 10.1007/978-1-61779-148-2_18; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Dufour A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04717-4; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Eckhard U, 2015, DATA BRIEF, V5, P542, DOI 10.1016/j.dib.2015.10.003; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; Eckhard U, 2015, J PROTEOME RES, V14, P3568, DOI 10.1021/acs.jproteome.5b00579; Fortelny N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001869; Gasmi L, 1996, BRIT J HAEMATOL, V95, P637, DOI 10.1046/j.1365-2141.1996.d01-1960.x; Geisler S, 2015, PTERIDINES, V26, P31, DOI 10.1515/pterid-2014-0015; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Jankowski J, 2003, ARTERIOSCL THROM VAS, V23, P1231, DOI 10.1161/01.ATV.0000075913.00428.FD; Jobin PG, 2019, J BIOL CHEM, V294, P12866, DOI 10.1074/jbc.RA119.009584; Jobin PG, 2017, BBA-MOL CELL RES, V1864, P2043, DOI 10.1016/j.bbamcr.2017.05.013; Jovanovic A, 1996, PFLUG ARCH EUR J PHY, V431, P800, DOI 10.1007/BF02253848; Kanaji T, 2018, P NATL ACAD SCI USA, V115, pEB228, DOI 10.1073/pnas.1807000115; Kapoor M, 2009, CHEM BIOL, V16, P531, DOI 10.1016/j.chembiol.2009.03.006; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Lee HC, 2019, J VIROL, V93, DOI 10.1128/JVI.01291-18; Lijnen HR, 2001, BBA-PROTEIN STRUCT M, V1547, P206, DOI 10.1016/S0167-4838(01)00186-8; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Marcus K, 2000, ELECTROPHORESIS, V21, P2622, DOI 10.1002/1522-2683(20000701)21:13<2622::AID-ELPS2622>3.0.CO;2-3; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Millar AW, 1998, BRIT J CLIN PHARMACO, V45, P21, DOI 10.1046/j.1365-2125.1998.00639.x; Mistry P, 2015, P NATL ACAD SCI USA, V112, P5455, DOI 10.1073/pnas.1422576112; Nakajima H., 1990, ANN NY ACAD SCI, V613, p734 ? 737, DOI [10.1111/j.1749-6632.1990.tb18255.x2076013, DOI 10.1111/J.1749-6632.1990.TB18255.X2076013]; Neurauter G, 2008, CURR DRUG METAB, V9, P622, DOI 10.2174/138920008785821738; Park SR, 2018, CELL DEATH DIFFER, V25, P2023, DOI 10.1038/s41418-018-0099-2; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Planesse C, 2015, CYTOKINE, V73, P190, DOI 10.1016/j.cyto.2015.01.028; Ploder M, 2008, AMINO ACIDS, V35, P303, DOI 10.1007/s00726-007-0625-x; Prudova A, 2014, BLOOD, V124, pE49, DOI 10.1182/blood-2014-04-569640; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Ruiz S, 1999, J LEUKOCYTE BIOL, V66, P416, DOI 10.1002/jlb.66.3.416; Sajish M, 2015, NATURE, V519, P370, DOI 10.1038/nature14028; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Starr AE, 2012, J BIOL CHEM, V287, P5848, DOI 10.1074/jbc.M111.314609; Starr AE, 2009, METHOD ENZYMOL, V461, P281, DOI 10.1016/S0076-6879(09)05413-5; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Tshori S, 2014, TOP CURR CHEM, V344, P189, DOI 10.1007/128_2013_426; VARSHAVSKY A, 1983, CELL, V34, P711, DOI 10.1016/0092-8674(83)90526-3; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yang XL, 2007, CHEM BIOL, V14, P1323, DOI 10.1016/j.chembiol.2007.10.016; Yang XL, 2003, HELV CHIM ACTA, V86, P1246, DOI 10.1002/hlca.200390107; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Zangerle R, 2010, BRAIN BEHAV IMMUN, V24, P403, DOI 10.1016/j.bbi.2009.11.004	88	8	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2186	2202		10.1074/jbc.RA119.010486	http://dx.doi.org/10.1074/jbc.RA119.010486			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31771979	Green Published, hybrid			2022-12-26	WOS:000517330200004
J	Xiao, YL; Matsuda, I; Inoue, M; Sasahara, T; Hoshi, M; Ishii, Y				Xiao, Yiling; Matsuda, Isamu; Inoue, Masafumi; Sasahara, Tomoya; Hoshi, Minako; Ishii, Yoshitaka			NMR-based site-resolved profiling of ?-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (AB); amyloid; solid state NMR; protein misfolding; structural biology; oligomer; Alzheimer disease; neurodegeneration; protein aggregation; amylospheroid (ASPD); fibrillization; neurotoxic protein; spherical amyloid assembly (SPA); Abeta42	A-BETA OLIGOMER; SOLID-STATE NMR; ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; CHEMICAL-SHIFTS; MOLECULAR-BASIS; PROTEIN; BRAIN; INTERMEDIATE; ARCHITECTURE	Increasing evidence highlights the central role of neurotoxic oligomers of the 42-residue-long ?-amyloid (A?42) in Alzheimer's disease (AD). However, very limited information is available on the structural transition from oligomer to fibril, particularly for pathologically relevant amyloids. To the best of our knowledge, we present here the first site-specific structural characterization of A?42 misfolding, from toxic oligomeric assembly yielding a similar conformation to an AD-associated A?42 oligomer, into a fibril. Transmission EM (TEM) analysis revealed that a spherical amyloid assembly (SPA) of A?42 with a 15.6 ? 2.1-nm diameter forms in a ?30-?m A?42 solution after a ?10-h incubation at 4 ?C, followed by a slow conversion into fibril at ?180 h. Immunological analysis suggested that the SPA has a surface structure similar to that of amylospheroid (ASPD), a patient-derived toxic A? oligomer, which had a diameter of 10?15 nm in negative-stain TEM. Solid-state NMR analyses indicated that the SPA structure involves a ?-loop-? motif, which significantly differed from the triple-? motif observed for the A?42 fibril. The comparison of the C-13 chemical shifts of SPA with those of the fibril prepared in the above conditions and interstrand distance measurements suggested a large conformational change involving rearrangements of intermolecular ?-sheet into in-register parallel ?-sheet during the misfolding. A comparison of the SPA and ASPD C-13 chemical shifts indicated that SPA is structurally similar to the ASPD relevant to AD. These observations provide insights into the architecture and key structural transitions of amyloid oligomers relevant for AD pathology.	[Xiao, Yiling; Matsuda, Isamu; Ishii, Yoshitaka] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Matsuda, Isamu; Ishii, Yoshitaka] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Inoue, Masafumi; Sasahara, Tomoya] Kyoto Univ, Grad Sch Med, TAO Hlth Life Pharma Co Ltd, Med Pharma Collaborat Bldg, Kyoto 6068501, Japan; [Inoue, Masafumi] Niigata Univ, Brain Res Inst, Ctr Bioresources, Dept Syst Pathol Neurol Disorders,Chuo Ku, 1-757 Asahimachidori, Niigata 9518585, Japan; [Sasahara, Tomoya; Hoshi, Minako] Fdn Biomed Res & Innovat, Inst Biomed Res & Innovat, Dept Brain & Neurodegenerat Dis Res, Kobe, Hyogo 6500047, Japan; [Hoshi, Minako] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Kyoto 6068501, Japan; [Ishii, Yoshitaka] RIKEN, RIKEN SPring 8 Ctr RSC, NMR Sci & Dev Div, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tokyo Institute of Technology; Kyoto University; Niigata University; Institute for Biomedical Research & Innovation (IBRI); Kyoto University; RIKEN	Ishii, Y (corresponding author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.; Ishii, Y (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Yokohama, Kanagawa 2268503, Japan.; Ishii, Y (corresponding author), RIKEN, RIKEN SPring 8 Ctr RSC, NMR Sci & Dev Div, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	ishii@bio.titech.ac.jp	Matsuda, Isamu/GXZ-7907-2022; Xiao, Yiling/ABC-5970-2021; Ishii, Yoshitaka/F-4558-2014	Matsuda, Isamu/0000-0002-3032-8934; Xiao, Yiling/0000-0002-4548-4833; Ishii, Yoshitaka/0000-0002-7724-6469; jing shang, ya wen/0000-0002-2553-053X	National Institutes of Health [U01 GM098033, R01 GM098033]; JST-Mirai, Japan [JPMJMI17A2]; Japan Society for the Promotion of Science (SSPS) KAKENHI Grant [17H04055]; JSPS KAKENHI [JP15K21772]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JST-Mirai, Japan; Japan Society for the Promotion of Science (SSPS) KAKENHI Grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The initial part of this work was supported primarily by National Institutes of Health Grants U01 GM098033 and R01 GM098033 (to Y. I.). This work was also supported by JST-Mirai, Japan, Program Grant JPMJMI17A2 (to Y. I.) and Japan Society for the Promotion of Science (SSPS) KAKENHI Grant 17H04055 (to M. H.). The instruments employed in this work were supported in part by JSPS KAKENHI Grant JP15K21772 (to Y. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Amar F, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2021; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Chimon S, 2005, J AM CHEM SOC, V127, P13472, DOI 10.1021/ja054039l; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Cline EN, 2018, J ALZHEIMERS DIS, V64, pS567, DOI 10.3233/JAD-179941; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Fu Z, 2015, BIOCHEMISTRY-US, V54, P4197, DOI 10.1021/acs.biochem.5b00467; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gu L, 2014, J BIOL CHEM, V289, P27300, DOI 10.1074/jbc.M114.569004; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; Ishii Y, 2001, CHEM PHYS, V266, P231, DOI 10.1016/S0301-0104(01)00250-6; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Ohnishi T, 2015, P NATL ACAD SCI USA, V112, pE4465, DOI 10.1073/pnas.1421182112; Opazo P, 2018, CELL REP, V23, P3137, DOI 10.1016/j.celrep.2018.05.036; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Parthasarathy S, 2015, J AM CHEM SOC, V137, P6480, DOI 10.1021/jacs.5b03373; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sahoo BR, 2018, CHEM COMMUN, V54, P12883, DOI 10.1039/c8cc07921h; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Takegoshi K, 2003, J CHEM PHYS, V118, P2325, DOI 10.1063/1.1534105; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Veshtort M, 2006, J MAGN RESON, V178, P248, DOI 10.1016/j.jmr.2005.07.018; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Yang T, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0100-y; Yoshihara T, 2008, J BIOCHEM, V143, P475, DOI 10.1093/jb/mvm239; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	51	11	11	4	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					458	467		10.1074/jbc.RA119.008522	http://dx.doi.org/10.1074/jbc.RA119.008522			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31771980	Green Published, hybrid			2022-12-26	WOS:000507373600016
J	Chen, H; Previero, A; Deutscher, MP				Chen, Hua; Previero, Angelica; Deutscher, Murray P.			A novel mechanism of ribonuclease regulation: GcvB and Hfq stabilize the mRNA that encodes RNase BN/Z during exponential phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonuclease; mRNA decay; bacteria; post-transcriptional regulation; RNA; growth-phase regulation; mRNA stability; regulatory RNA	ESCHERICHIA-COLI; ANTISENSE RNAS; BN/RNASE Z; E. COLI; 6S RNA; PROTEIN; GENE; IDENTIFICATION; TRANSCRIPTION; ACETYLATION	RNase BN, the Escherichia coli RNase Z family member, plays a limited role in tRNA metabolism, in contrast to most other organisms. However, RNase BN does act on 6S RNA, the global transcription regulator, degrading it in exponential-phase cells and maintaining it at low levels during this phase of growth. RNase BN levels decrease in stationary-phase cells, leading to elevation of 6S RNA and subsequent regulation of RNA polymerase. These findings were the first indication that RNase BN itself is growth phase?regulated. Here, we analyze the mechanism of this regulation of RNase BN. We find that RNase BN decreases in stationary phase because its mRNA becomes unstable, due primarily to its degradation by RNase E. However, in exponential-phase cells rbn mRNA is stabilized due to binding by the sRNA, GcvB, and the protein, Hfq, which reduce cleavage by RNase E. Because the amount of GcvB decreases in stationary phase, rbn mRNA is less protected and becomes increasingly unstable resulting in reduction in the amount of RNase BN. The small RNA-dependent, positive regulation of RNase BN in exponential-phase cells is the first example of this novel mechanism for RNase regulation.	[Chen, Hua; Previero, Angelica; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	m.deutscher@med.miami.edu		chen, hua/0000-0001-8838-1095	National Institutes of Health [GM016317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The National Institutes of Health Grant GM016317 (to M. P. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Barria C., 2016, STRESS ENV CONTROL G, P174; Beckmann BM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq437; Bilusic I, 2014, RNA BIOL, V11, P641, DOI 10.4161/rna.29299; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAO GJ, 1992, P NATL ACAD SCI USA, V89, P10380, DOI 10.1073/pnas.89.21.10380; Cavanagh AT, 2014, ANNU REV MICROBIOL, V68, P45, DOI 10.1146/annurev-micro-092611-150135; Cech GM, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00036; Chen H, 2016, J BIOL CHEM, V291, P26435, DOI 10.1074/jbc.M116.757450; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Deutscher MP, 2015, FEMS MICROBIOL REV, V39, P350, DOI 10.1093/femsre/fuv012; Deutscher MP, 2015, RNA, V21, P597, DOI 10.1261/rna.049692.115; Douchin V, 2006, J BIOL CHEM, V281, P12253, DOI 10.1074/jbc.M600819200; Dutta T, 2018, GENE, V656, P60, DOI 10.1016/j.gene.2018.02.068; Dutta T, 2013, J BIOL CHEM, V288, P30636, DOI 10.1074/jbc.M113.514570; Dutta T, 2012, J BIOL CHEM, V287, P35747, DOI 10.1074/jbc.M112.407403; Dutta T, 2009, J BIOL CHEM, V284, P15425, DOI 10.1074/jbc.M109.005462; Ezraty B, 2005, J BIOL CHEM, V280, P16542, DOI 10.1074/jbc.C500098200; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; JAIN C, 1993, GENE, V133, P99, DOI 10.1016/0378-1119(93)90231-Q; Kavita K, 2018, CURR OPIN MICROBIOL, V42, P53, DOI 10.1016/j.mib.2017.10.014; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Kushner SR, 2015, RNA, V21, P673, DOI 10.1261/rna.049700.115; Lalaouna D, 2019, MOL MICROBIOL, V111, P473, DOI 10.1111/mmi.14168; Li L, 2013, NUCLEIC ACIDS RES, V41, pD233, DOI 10.1093/nar/gks1264; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Mann M, 2017, NUCLEIC ACIDS RES, V45, pW435, DOI 10.1093/nar/gkx279; Melamed S, 2016, MOL CELL, V63, P884, DOI 10.1016/j.molcel.2016.07.026; Miller JH., 1972, EXPT MOL GENETICS; Miyakoshi M, 2015, EMBO J, V34, P1478, DOI 10.15252/embj.201490546; Mohanty BK, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0011-2017; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Pulvermacher SC, 2009, MICROBIOL-SGM, V155, P115, DOI 10.1099/mic.0.023432-0; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Song LM, 2016, NUCLEIC ACIDS RES, V44, P1979, DOI 10.1093/nar/gkw053; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Wang X, 2015, P NATL ACAD SCI USA, V112, P7581, DOI 10.1073/pnas.1424683112; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001	47	10	11	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19997	20008		10.1074/jbc.RA119.011367	http://dx.doi.org/10.1074/jbc.RA119.011367			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31744883	hybrid, Green Published			2022-12-26	WOS:000505005800015
J	Alemu, F; Mecha, M; Medhin, G				Alemu, Fikralem; Mecha, Medhanit; Medhin, Girmay			Impact of permagarden intervention on improving fruit and vegetable intake among vulnerable groups in an urban setting of Ethiopia: A quasi-experimental study	PLOS ONE			English	Article							HOME-GARDENS; CONSUMPTION; COMMUNITY; NUTRITION; CHILDREN	Background Increasing nutrient intake through home gardening is a sustainable way to address multiple micronutrient deficiencies in developing countries. This study investigated the impact of permagarden intervention in increasing the frequency and diversity of vegetable and fruit consumption among vulnerable families in seven cities of Ethiopia. Method A quasi-experimental study was conducted from August 10 to September 30, 2015. A total of 884 care givers (427 from intervention and 457 from control) participated in the study. Data were collected through face to face interviews with caregivers of highly vulnerable children. Propensity score matching (PSM) was used as implemented in STATA software. Program impact on the frequency and diversity of households' fruit and vegetable consumption between intervention and control groups was assessed using chi square test. Results Intervention participants had a 13% higher increase in frequency of vegetable and fruit consumption compared with control participants (p<0.01). Diversity (consumption of 2 or more groups of vegetable and fruit) is higher among intervention groups than control groups (percentage difference = 9, p-value<0.05). A significant higher percentage of participants in intervention group reported getting the one-week vegetable and fruit mainly from their own garden (percentage difference 58.3%, p<0.05). A significantly larger proportion of participants in the intervention group compared to control group reported "high likelihood" on intention to grow vegetables in the future (percentage difference = 30%, and P<0.01). Perceived importance to include vegetable in everyday meal was higher among intervention group participants than control group participants (percentage difference = 11.5%, P<0.01). Conclusions The observed higher FV intake among permagarden intervention group compared to control group suggest that nutrition and health programs need to promote permagarden as a means to improve FV intake among vulnerable societies in resource limited countries.	[Alemu, Fikralem] Ethiopian Inst Water Resources, Addis Ababa, Ethiopia; [Mecha, Medhanit] Family Hlth Int Ethiopia, Addis Ababa, Ethiopia; [Medhin, Girmay] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia	Addis Ababa University	Alemu, F (corresponding author), Ethiopian Inst Water Resources, Addis Ababa, Ethiopia.	fikeralemme@yahoo.com		Medhin, Girmay/0000-0003-2146-4261	FHI360 through Pact Ethiopia from USAID Ethiopia [AID - 663 - A - 11 - 00005]; yekokeb berhan project	FHI360 through Pact Ethiopia from USAID Ethiopia; yekokeb berhan project	Full support for this study was provided by FHI360 funded through Pact Ethiopia from USAID Ethiopia cooperative agreement number AID - 663 - A - 11 - 00005. This study was funded as one activity of yekokeb berhan project. The project was launched in 2011 and phased out in 2017. Results and remarks expressed in this publication don't necessarily reflect USAID's view. The sponsor didn't have any role in the study design, data collection, decision to publish, or preparation of the manuscript.	Alaimo K, 2008, J NUTR EDUC BEHAV, V40, P94, DOI 10.1016/j.jneb.2006.12.003; Algert S, 2016, CALIF AGR, V70, P77, DOI 10.3733/ca.v070n02p77; [Anonymous], 2017, TECHNICAL OPERATIONA; [Anonymous], 2017, YEKOKEB BERHAN PROGR; [Anonymous], 2013, GUIDE MEASURING DIET; Berti PR, 2004, PUBLIC HEALTH NUTR, V7, P599, DOI 10.1079/PHN2003595; Bhaskaram P, 1992, INDIAN PEDIATR, V29, P14; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blanchette L, 2005, J HUM NUTR DIET, V18, P431, DOI 10.1111/j.1365-277X.2005.00648.x; Chadha M.L., 2003, FOOD NUTR AGR, V32, P17; Clayton S, 2007, J ENVIRON PSYCHOL, V27, P215, DOI 10.1016/j.jenvp.2007.06.001; CSA, 2008, FED DEM REP ETH SUMM; CSA, 2012, 2011 ETH DEM HLTH SU; CSA ICF, 2012, ETH DEM HLTH SURV 20; Ethiopia CSA (CSA) [Ethiopia], 2017, ETH DEM HLTH SURV 20; Faber M, 2002, PUBLIC HEALTH NUTR, V5, P11, DOI 10.1079/PHN2001239; FAO, 2013, VIT A MOV FOOD BAS A; FAO, 2016, FOOD SIT REP ETH FOO; FMOH, 2007, SINGL POINT EST; Galhena DH, 2013, AGR FOOD SECUR, V2, P8, DOI 10.1186/2048-7010-2-8; Ganann Rebecca, 2014, BMC Res Notes, V7, P422, DOI 10.1186/1756-0500-7-422; Guenther PM, 2006, J AM DIET ASSOC, V106, P1371, DOI 10.1016/j.jada.2006.06.002; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029; Jensen P., 2013, URBAN GARDENS PROGRA; Kaplan R, 2001, ENVIRON BEHAV, V33, P507, DOI 10.1177/00139160121973115; Krolner R, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-112; Leregger F, MICRO GARDENING CONT; Levuur, 2018, VOEDS LEUV; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Lock K, 2005, B WHO, V83; Lowe CF, 2004, EUROPEAN J CLIN NUTR, V510, P522; Morris J. L., 2001, California Agriculture, V55, P43, DOI 10.3733/ca.v055n01p43; Morris JL, 2002, J NUTR EDUC BEHAV, V34, P175, DOI 10.1016/S1499-4046(06)60088-2; OHLS JC, 1999, FOOD STAMP PARTICIPA; Organization WH, 2009, GLOB HLTH RISKS MORT; PACT, 2012, CHILD SUPPORT INDEX; Raab C, 2005, J EXTENSION, V43; Rivers J, FOOD NUTR B, V31, p264S; Robinson T, 2008, J COMMUN HEALTH, V33, P395, DOI 10.1007/s10900-008-9109-5; Ruel M.J., 2000, ASSESSING POTENTIAL; Swindale A, 2005, HOUSEHOLD DIETARY DI; Talukder A, 2001, UA MAGAZINE      DEC, P45; UNICEF, 2016, SIT AN CHILDR PHIL; USAID, 2017, YEK BERH PROGR HIGH; Weber D, 2012, MOL NUTR FOOD RES, V56, P251, DOI 10.1002/mnfr.201100230; WHO/FAO, 2003, DIET NUTR; World Health Organization, 1990, DIET NUTR PREV CHRON; World Health Organization, 2004, WORLD HLTH ASS 55 M	49	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0213705	10.1371/journal.pone.0213705	http://dx.doi.org/10.1371/journal.pone.0213705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO9FT	31790404	Green Published, gold, Green Submitted			2022-12-26	WOS:000533930800001
J	Mukai, K; Nakajima, Y; Asano, K; Nakatani, T				Mukai, Kanae; Nakajima, Yukari; Asano, Kimi; Nakatani, Toshio			Topical estrogen application to wounds promotes delayed cutaneous wound healing in 80-week-old female mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INFLAMMATORY CYTOKINES; MACROPHAGE ACTIVATION; AGE; INTERLEUKIN-6; SUPPRESSES; EXPRESSION; RESPONSES; ALTERS; REPAIR	Topical estrogen application to wounds is effective in promoting cutaneous wound healing. However, whether it promotes cutaneous wound healing in delayed cutaneous wound healing associated with advanced age remains to be elucidated. This study aimed to evaluate the effect of topical estrogen application to wounds in cutaneous wound healing in 80-week-old female mice. C57BL/6J female mice aged 82-85 and 12 weeks old were submitted to two full-thickness wounds. Mice were divided into four groups: aged group, topical estrogen wound treatment aged group (aged-E), vehicle wound treatment aged group (aged-vehicle), and young group. Wound healing was observed until day 14. In the aged group, wound area ratio (wound area / initial wound area) was significantly higher on days 3-14, ratio of re-epithelialization was significantly lower on day 3 and tended to be lower on day 14, and neutrophil number was significantly higher on day 7 compared with the young group. In contrast, in the aged-E group, wound area ratio was significantly smaller on days 1-14, re-epithelialization ratio was significantly higher on days 3-14, and neutrophil and macrophage number was significantly lower on days 3 and 7 compared with the aged group. These results demonstrate that topical estrogen application to wounds in 80-week-old female mice promoted cutaneous wound healing by reducing wound area and inflammatory response and promoting re-epithelialization.	[Mukai, Kanae; Nakajima, Yukari; Nakatani, Toshio] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, Kanazawa, Ishikawa, Japan; [Asano, Kimi] Kanazawa Univ, Grad Sch Med Sci, Dept Clin Nursing, Grad Course Nursing Sci,Div Hlth Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Mukai, K (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, Kanazawa, Ishikawa, Japan.	kanae_m@staff.kanazawa-u.ac.jp			JSPS KAKENHI [18H03071]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI, grant no. 18H03071 to KM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RE, 1998, ARCH SURG-CHICAGO, V133, P1002, DOI 10.1001/archsurg.133.9.1002; Ahn J, 2016, BURNS, V42, P1534, DOI 10.1016/j.burns.2016.04.016; Ashcroft GS, 2003, J CLIN INVEST, V111, P1309, DOI 10.1172/KCO200316288; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Ashcroft GS, 1999, AM J PATHOL, V155, P1137, DOI 10.1016/S0002-9440(10)65217-0; Ashcroft GS, 1997, J INVEST DERMATOL, V108, P430, DOI 10.1111/1523-1747.ep12289705; Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; ASHCROFT GS, 1995, J ANAT, V187, P1; Ashcroft GS, 1998, LAB INVEST, V78, P47; Brufani M, 2009, MOL PHARMACEUT, V6, P543, DOI 10.1021/mp800206b; Bruunsgaard H, 2002, EUR CYTOKINE NETW, V13, P389; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Butcher SK, 2001, J LEUKOCYTE BIOL, V70, P881; Campbell L, 2014, J INVEST DERMATOL, V134, P2447, DOI 10.1038/jid.2014.175; Campbell L, 2010, J EXP MED, V207, P1825, DOI 10.1084/jem.20100500; Chan JMK, 2002, MOL THER, V6, P727, DOI 10.1006/mthe.2002.0808; Delgado AV, 2003, NEUROPEPTIDES, V37, P355, DOI 10.1016/j.npep.2003.09.005; Donato-Trancoso A, 2016, J DERMATOL SCI, V83, P60, DOI 10.1016/j.jdermsci.2016.03.012; Emmerson E, 2010, MOL CELL ENDOCRINOL, V321, P184, DOI 10.1016/j.mce.2010.02.026; Emmerson E, 2009, ENDOCRINOLOGY, V150, P2749, DOI 10.1210/en.2008-1569; Farzadinia P, 2016, INT J LOW EXTR WOUND, V15, P241, DOI 10.1177/1534734616645031; Feldmann M, 2010, ANN RHEUM DIS, V69, P97, DOI 10.1136/ard.2009.117143; FELICIO LS, 1980, EXP GERONTOL, V15, P139, DOI 10.1016/0531-5565(80)90085-6; FENSKE NA, 1986, J AM ACAD DERMATOL, V15, P571, DOI 10.1016/S0190-9622(86)70208-9; Franceschi C., 2014, J GERONTOL A BIOL S1, V69, P4, DOI [DOI 10.1093/GER0NA/GLU057, 10.1093/gerona/glu057, DOI 10.1093/GERONA/GLU057]; Gilliver SC, 2008, ENDOCRINOLOGY, V149, P5747, DOI 10.1210/en.2008-0355; Gilliver SC, 2010, AM J PATHOL, V176, P2707, DOI 10.2353/ajpath.2010.090432; Hardman MJ, 2008, ENDOCRINOLOGY, V149, P551, DOI 10.1210/en.2007-1042; Hardman MJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r80; He W., 2016, INT POPUL REP, V95, P1; Hozzein WN, 2015, CELL PHYSIOL BIOCHEM, V37, P940, DOI 10.1159/000430221; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Ishak WMW, 2019, DRUG DELIV TRANSL RE, V9, P418, DOI 10.1007/s13346-018-0522-8; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; KURBAN RS, 1990, J DERMATOL SURG ONC, V16, P908, DOI 10.1111/j.1524-4725.1990.tb01554.x; LIPSCHITZ DA, 1986, J GERONTOL, V41, P690, DOI 10.1093/geronj/41.6.690; Mercado AM, 2002, J NEUROIMMUNOL, V129, P74, DOI 10.1016/S0165-5728(02)00174-1; MONTAGNA W, 1990, BRIT J DERMATOL, V122, P61, DOI 10.1111/j.1365-2133.1990.tb16127.x; Mukai K, 2014, J HORM, DOI 10.1371/journal.pone.0115564; Mukai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163560; Mukai K, 2016, INT WOUND J, V13, P636, DOI 10.1111/iwj.12336; Mukai K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115564; Naraginti S, 2016, MAT SCI ENG C-MATER, V62, P293, DOI 10.1016/j.msec.2016.01.069; RICHARD S, 1993, J INVEST DERMATOL, V100, P705, DOI 10.1111/1523-1747.ep12472356; Routley CE, 2009, WOUND REPAIR REGEN, V17, P42, DOI 10.1111/j.1524-475X.2008.00440.x; Schanuel FS, 2019, APPL PHYSIOL NUTR ME, V44, P1199, DOI 10.1139/apnm-2018-0845; Sgonc R, 2013, GERONTOLOGY, V59, P159, DOI 10.1159/000342344; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Song XY, 1999, J EXP MED, V190, P535, DOI 10.1084/jem.190.4.535; URABE H, 2013, JAK STAT, V4, DOI DOI 10.4161/JKST.25763; Valacchi G, 2011, WOUND REPAIR REGEN, V19, P107, DOI 10.1111/j.1524-475X.2010.00649.x; Velarde MC, 2015, P NATL ACAD SCI USA, V112, P10407, DOI 10.1073/pnas.1505675112; Wenisch C, 2000, J LEUKOCYTE BIOL, V67, P40, DOI 10.1002/jlb.67.1.40	54	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225880	10.1371/journal.pone.0225880	http://dx.doi.org/10.1371/journal.pone.0225880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774863	Green Published, gold			2022-12-26	WOS:000533896400065
J	Schuhmann, T; Kemmerer, SK; Duecker, F; de Graaf, TA; ten Oever, S; De Weerd, P; Sack, AT				Schuhmann, Teresa; Kemmerer, Selma K.; Duecker, Felix; de Graaf, Tom A.; ten Oever, Sanne; De Weerd, Peter; Sack, Alexander T.			Left parietal tACS at alpha frequency induces a shift of visuospatial attention	PLOS ONE			English	Article							ALTERNATING-CURRENT STIMULATION; VISUAL-SPATIAL ATTENTION; ELECTRICAL-STIMULATION; UNILATERAL NEGLECT; NEURAL ACTIVITY; 10 HZ; EEG; OSCILLATIONS; CORTEX; POWER	Background Voluntary shifts of visuospatial attention are associated with a lateralization of parieto-occipital alpha power (7-13Hz), i.e. higher power in the hemisphere ipsilateral and lower power contralateral to the locus of attention. Recent noninvasive neuromodulation studies demonstrated that alpha power can be experimentally increased using transcranial alternating current stimulation (tACS). Objective/Hypothesis We hypothesized that tACS at alpha frequency over the left parietal cortex induces shifts of attention to the left hemifield. However, spatial attention shifts not only occur voluntarily (endogenous/top-down), but also stimulus-driven (exogenous/bottom-up). To study the task-specificity of the potential effects of tACS on attentional processes, we administered three conceptually different spatial attention tasks. Methods 36 healthy volunteers were recruited from an academic environment. In two separate sessions, we applied either high-density tACS at 10Hz, or sham tACS, for 35-40 minutes to their left parietal cortex. We systematically compared performance on endogenous attention, exogenous attention, and stimulus detection tasks. Results In the endogenous attention task, a greater leftward bias in reaction times was induced during left parietal 10Hz tACS as compared to sham. There were no stimulation effects in either the exogenous attention or the stimulus detection task. Conclusion The study demonstrates that high-density tACS at 10Hz can be used to modulate visuospatial attention performance. The tACS effect is task-specific, indicating that not all forms of attention are equally susceptible to the stimulation.	[Schuhmann, Teresa; Kemmerer, Selma K.; Duecker, Felix; de Graaf, Tom A.; ten Oever, Sanne; De Weerd, Peter; Sack, Alexander T.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Schuhmann, Teresa; Kemmerer, Selma K.; Duecker, Felix; de Graaf, Tom A.; ten Oever, Sanne; De Weerd, Peter; Sack, Alexander T.] Brain Imaging Ctr, Maastricht, Netherlands; [Sack, Alexander T.] Maastricht Univ Med Ctr MUMC, Brain Nerve Ctr, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci MHeNs, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Schuhmann, T (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.; Schuhmann, T (corresponding author), Brain Imaging Ctr, Maastricht, Netherlands.	t.schuhmann@maastrichtuniversity.nl	Oever, Sanne ten/AAV-5859-2021	Oever, Sanne ten/0000-0001-7547-5842; Kemmerer, Selma/0000-0003-3755-2258; Sack, Alexander/0000-0002-1471-0885	Netherlands Organization for Scientific Research (NWO) [451-13-024, 453-15-008]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was funded by the Netherlands Organization for Scientific Research (NWO, Veni to T.G. 451-13-024; Vici to A.S. 453-15-008, https://www.nwo.nl/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; Antal A, 2017, CLIN NEUROPHYSIOL, V128, P1774, DOI 10.1016/j.clinph.2017.06.001; Antal A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00317; Antal A, 2012, CLIN EEG NEUROSCI, V43, P175, DOI 10.1177/1550059412448030; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Bartolomeo P, 2001, EXP BRAIN RES, V137, P432; Basar E, 1999, NEUROSCI LETT, V259, P165, DOI 10.1016/S0304-3940(98)00934-3; Boayue Nya Mehnwolo, 2018, F1000Res, V7, P704, DOI 10.12688/f1000research.15125.2; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; BRINDLEY GS, 1955, J PHYSIOL-LONDON, V127, P189, DOI 10.1113/jphysiol.1955.sp005248; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; Capilla A, 2014, CEREB CORTEX, V24, P550, DOI 10.1093/cercor/bhs343; CAPPA S, 1987, NEUROPSYCHOLOGIA, V25, P775, DOI 10.1016/0028-3932(87)90115-1; CHAN CY, 1986, J PHYSIOL-LONDON, V371, P89, DOI 10.1113/jphysiol.1986.sp015963; CHEAL ML, 1991, Q J EXP PSYCHOL-A, V43, P859, DOI 10.1080/14640749108400960; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; DEWEERD AW, 1988, ELECTROEN CLIN NEURO, V70, P197, DOI 10.1016/0013-4694(88)90080-6; Duecker F, 2017, J COGNITIVE NEUROSCI, V29, P1267, DOI 10.1162/jocn_a_01119; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Feurra M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00013; Fierro B, 2006, BEHAV NEUROL, V17, P169, DOI 10.1155/2006/465323; Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; GIAQUINTO S, 1994, STROKE, V25, P2204, DOI 10.1161/01.STR.25.11.2204; Gould IC, 2011, J NEUROPHYSIOL, V105, P1318, DOI 10.1152/jn.00653.2010; Griskova I, 2007, NEUROSCI LETT, V419, P162, DOI 10.1016/j.neulet.2007.04.030; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Heise KF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39900-0; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Herrmann CS, 2016, INT J PSYCHOPHYSIOL, V103, P12, DOI 10.1016/j.ijpsycho.2015.02.003; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Hopfinger JB, 2017, COGN NEUROSCI-UK, V8, P102, DOI 10.1080/17588928.2016.1194261; Johnson L, 2019, BIORXIV, DOI [https://doi.org/10.1101/696344., 10.1101/696344., DOI 10.1101/696344]; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Kar K, 2012, J NEUROPHYSIOL, V108, P2173, DOI 10.1152/jn.00505.2012; Kasten FH, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0069-18.2018; Kasten FH, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00002; Kasten FH, 2016, FRONT HUM NEUROSCI, V10, DOI [10.3389/fnhum.2016.00245, 10.3389/fnhum.2016.00135]; Kato C, 2001, NEUROSCI LETT, V314, P5, DOI 10.1016/S0304-3940(01)02207-8; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Kerkhoff G, 2012, NEUROPSYCHOLOGIA, V50, P1072, DOI 10.1016/j.neuropsychologia.2012.01.024; KIM H, 1991, NEUROPSYCHOLOGIA, V29, P877, DOI 10.1016/0028-3932(91)90053-B; Kim Y-H, 2018, NEUROIMAGE, DOI 10.1016/s1053-8119(18)30900-5; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Laakso I, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046009; Liu Xiang, 2006, Sichuan Da Xue Xue Bao Yi Xue Ban, V37, P798; Lorenz I, 2009, NEUROSCI LETT, V453, P225, DOI 10.1016/j.neulet.2009.02.028; Lundqvist M, 2011, J COGNITIVE NEUROSCI, V23, P3008, DOI 10.1162/jocn_a_00029; Marx E, 2004, NEUROIMAGE, V21, P1818, DOI 10.1016/j.neuroimage.2003.12.026; Marzi CA, 2002, COGNITIVE NEURAL BAS, P274, DOI [10.1093/acprof:oso/9780198508335.003.0020, DOI 10.1093/ACPROF:OSO/9780198508335.003.0020]; Meehan TP, 2017, BRAIN STRUCT FUNCT, V222, P3127, DOI 10.1007/s00429-017-1390-6; Meyer KN, 2018, NEUROPSYCHOLOGIA, V111, P307, DOI 10.1016/j.neuropsychologia.2018.02.006; MORROW LA, 1988, PSYCHOBIOLOGY, V16, P261; Mueller M, 1996, EXP BRAIN RES, V112, DOI [10.1007/BF00227182, DOI 10.1007/BF00227182]; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Neuling T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00161; Okamura H, 2001, J CLIN NEUROPHYSIOL, V18, P318, DOI 10.1097/00004691-200107000-00003; Oliveri M, 2001, NEUROLOGY, V57, P1338, DOI 10.1212/WNL.57.7.1338; Ozaki TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020079; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Ringman JM, 2004, NEUROLOGY, V63, P468, DOI 10.1212/01.WNL.0000133011.10689.CE; Ros T, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7407241; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; RUBENS AB, 1985, NEUROLOGY, V35, P1019, DOI 10.1212/WNL.35.7.1019; Ruhnau P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27138; SAINIO K, 1983, ELECTROEN CLIN NEURO, V56, P117, DOI 10.1016/0013-4694(83)90066-4; Saturnino G.B., 2018, SIMNIBS 2 1 COMPREHE, DOI [10.1101/500314, DOI 10.1101/500314]; Saturnino GB, 2019, NEUROIMAGE, V188, P821, DOI 10.1016/j.neuroimage.2018.12.053; Saturnino GB, 2015, NEUROIMAGE, V120, P25, DOI 10.1016/j.neuroimage.2015.06.067; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Schutter DJLG, 2010, CLIN NEUROPHYSIOL, V121, P1080, DOI 10.1016/j.clinph.2009.10.038; Schwiedrzik CM, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.006.2009; SHEPHERD M, 1989, PERCEPT PSYCHOPHYS, V46, P146, DOI 10.3758/BF03204974; Shipp S, 1995, J ANAT, V187, P547; Sincich LC, 2005, J NEUROSCI, V25, P10087, DOI 10.1523/JNEUROSCI.3313-05.2005; Smania N, 1998, BRAIN, V121, P1759, DOI 10.1093/brain/121.9.1759; Spaak E, 2012, CURR BIOL, V22, P2313, DOI 10.1016/j.cub.2012.10.020; Szelies B, 2002, BRAIN LANG, V82, P87, DOI 10.1016/S0093-934X(02)00004-4; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Vallar G., 1998, PROG NEUROBIOL, DOI [10.1016/S0301-0082(00)00028-9, DOI 10.1016/S0301-0082(00)00028-9]; van der Lubbe RHJ, 2005, EXP BRAIN RES, V164, P464, DOI 10.1007/s00221-005-2267-0; Veniero D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00952; Veniero D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00477; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Wach C, 2013, BEHAV BRAIN RES, V241, P1, DOI 10.1016/j.bbr.2012.11.038; Wach C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00511; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Witkowski M, 2016, NEUROIMAGE, V140, P89, DOI 10.1016/j.neuroimage.2015.10.024; Wostmann M, 2018, BRAIN STIMUL, V11, P752, DOI 10.1016/j.brs.2018.04.006; Worden MS, 2000, J NEUROSCI, V20; Wozniak-Kwasniewska A, 2014, NEUROIMAGE, V88, P91, DOI 10.1016/j.neuroimage.2013.11.029; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	105	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0217729	10.1371/journal.pone.0217729	http://dx.doi.org/10.1371/journal.pone.0217729			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8SS	31774818	Green Published, Green Submitted, gold			2022-12-26	WOS:000533896400002
J	Park, SM; Moon, BY; Kim, SY; Yu, DS				Park, Sun-Mi; Moon, Byeong-Yeon; Kim, Sang-Yeob; Yu, Dong-Sik			Diurnal variations of amplitude of accommodation in different age groups	PLOS ONE			English	Article								Clinical assessment of amplitude of accommodation (AA) involves measuring the ability of the eye to change its optical power and focus on near tasks/objects. AA gradually decreases with increasing age. However, details of age-related diurnal changes in AA are not well known. This study compared diurnal changes in AA in the adolescents, the twenties, and the forties age groups. Measurement of AA using the push-up method was performed in six sessions at two-hourly intervals for 154 subjects (48, 56, 50 subjects for the adolescents, twenties, and forties age groups, respectively); the first measurements were taken from 9:00-10:00 a.m. and the final measurements from 7:00-8:00 p.m. The mean AA was 14.67 D (highest: 16.15 D in the 3:00-4:00 p.m. session, lowest: 13.35 D in the 9:00-10:00 a.m. session) for the adolescent group; 11.13 D (highest: 11.69 D in the 3:00-4:00 p.m. session; lowest: 10.61 D in the 9:00-10:00 a.m. session) in the twenties group; and 5.53 D (highest: 5.80 D in the 1:00-2:00 p.m. session, lowest: 5.11 D in the 7:00-8:00 p.m. session) in the forties age group. The measured AA showed significant difference between sessions; however, diurnal variations were greater in the younger groups. The measured AA was low at the beginning of the day in the adolescents and twenties groups and low at the end of the day in the forties age group. All age groups showed a high AA during the afternoon hours of the day (1:00-4:00 p.m.). Since the difference between each session was larger in younger subjects, AA should be evaluated while taking the age-related diurnal variations into account.	[Park, Sun-Mi] Kyungwoon Univ, Dept Optometry & Vis Sci, Gumi, South Korea; [Moon, Byeong-Yeon; Kim, Sang-Yeob; Yu, Dong-Sik] Kangwon Natl Univ, Dept Optometry, Samcheok, South Korea	Kyungwoon University; Kangwon National University	Yu, DS (corresponding author), Kangwon Natl Univ, Dept Optometry, Samcheok, South Korea.	yds@kangwon.ac.kr	Park, Sun/GSD-9620-2022	Yu, Dong-Sik/0000-0002-4387-4408; Moon, Byeong-Yeon/0000-0003-0645-4938				Abraham Lekha Mary, 2005, Indian Journal of Ophthalmology, V53, P105; Akujobi AU, 2018, W J OPTHALMOL VISION, V1, DOI [10.33552/WJOVR.2018.01.000509, DOI 10.33552/WJOVR.2018.01.000509]; American Optometric Association, 2011, OPT CLIN PRACT GUID, P24; [Anonymous], 2010, OPTOM VIS DEV; Atchison DA, 1997, OPTOMETRY VISION SCI, V74, P511, DOI 10.1097/00006324-199707000-00019; BurnsD EvansBJ, 2014, OPTOMETPRACT, V15, P75; CHARMAN WN, 1989, OPHTHAL PHYSL OPT, V9, P424, DOI 10.1111/j.1475-1313.1989.tb00946.x; Garcia-munoz A, 2016, CLIN EXP OPTOM, V99, P313, DOI 10.1111/cxo.12376; Grisham David, 2007, Optometry, V78, P542, DOI 10.1016/j.optm.2007.02.017; HAMASAKI D, 1956, Am J Optom Arch Am Acad Optom, V33, P3; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hasebe S, 2001, OPHTHAL PHYSL OPT, V21, P151, DOI 10.1046/j.1475-1313.2001.00558.x; Hashemi H, 2018, CLIN EXP OPTOM, V101, P123, DOI 10.1111/cxo.12550; Hofstetter H. U., 1950, OPTOM WORLD, V38, P42; Kasthurirangan S, 2006, VISION RES, V46, P1507, DOI 10.1016/j.visres.2005.11.012; KRUMHOLZ DM, 1986, INVEST OPHTH VIS SCI, V27, P552; Kundart J., 2011, J BEHAV OPTOMETRY, V11, P130; KURTEV AD, 1990, INVEST OPHTH VIS SCI, V31, P2456; Leon A, 2016, OPHTHAL PHYSL OPT, V36, P5, DOI 10.1111/opo.12244; Majumber C., 2015, OPTOM VISUAL PERFORM, V3, P276; Mathebula SD, 2018, AFR VIS EYE HEALTH J, V77, DOI 10.4102/aveh.v77i1.437; MCBRIEN NA, 1986, INVEST OPHTH VIS SCI, V27, P1187; Momeni-Moghaddam H, 2014, INDIAN J OPHTHALMOL, V62, P683, DOI 10.4103/0301-4738.126990; Momeni-Moghaddam H, 2014, CLIN EXP OPTOM, V97, P62, DOI 10.1111/cxo.12090; Mordi JA, 1998, VISION RES, V38, P1643, DOI 10.1016/S0042-6989(97)00336-2; Morgan MW, 1944, AM J OPTOM PHYS OPT, V21, P477, DOI DOI 10.1097/00006324-194412000-00001; Ostrin LA, 2004, J CATARACT REFR SURG, V30, P1435, DOI 10.1016/j.jcrs.2003.12.045; Ovenseri-Ogbomo GO, 2018, CLIN EXP OPTOM, V101, P571, DOI 10.1111/cxo.12520; Prokopich CL, 2008, CLIN OCULAR PHARM, P701; Rosenfield M, 1996, OPHTHAL PHYSL OPT, V16, P247, DOI 10.1016/0275-5408(95)00093-3; ROSENFIELD M, 1995, OPHTHAL PHYSL OPT, V15, P231, DOI 10.1016/0275-5408(95)90576-N; Scheiman M., 2014, CLIN MANAGEMENT BINO, P5; Sheppard AL, 2018, BMJ OPEN OPHTHALMOL, V3, DOI 10.1136/bmjophth-2018-000146; Tidbury LP, 2016, GRAEF ARCH CLIN EXP, V254, P1091, DOI 10.1007/s00417-016-3329-7; Ullah N, 2016, OPHTHALMOLOGY PAKIST, V6, P29; WINN B, 1989, OPHTHAL PHYSL OPT, V9, P277, DOI 10.1111/j.1475-1313.1989.tb00906.x; 이정윤, 2011, [Journal of Korean Ophthalmic Optics Society, 한국안광학회지], V16, P75	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225754	10.1371/journal.pone.0225754	http://dx.doi.org/10.1371/journal.pone.0225754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770414	Green Published, gold			2022-12-26	WOS:000533892300036
J	Bagheri, S; Mirzaie, M				Bagheri, Shahin; Mirzaie, Mehdi			A mathematical model of honey bee colony dynamics to predict the effect of pollen on colony failure	PLOS ONE			English	Article							DIVISION-OF-LABOR; BEHAVIORAL MATURATION; NEST CONSTRUCTION; COMMON STOMACH; SURVIVAL; BROOD; HYMENOPTERA; NUTRITION; BEEHAVE; EXPLORE	The decline in colony populations of the honey bee, known as the Colony Collapse Disorder (CCD), is a global concern. Numerous studies have reported possible causes, including pesticides, parasites, and nutritional stress. Poor nutrition affects the immune system at both the individual and colony level, amplifying effects of other stress factors. Pollen is the only source of ten amino acids that are essential to honey bee development, brood rearing and reproduction. This paper presents a new mathematical model to explore the effect of pollen on honey bee colony dynamics. In this model, we considered pollen and nectar as the required food for the colony. The effect of pollen and nectar collected by foragers was evaluated at different mortality rates of pupa, pollen and nectar foragers.	[Bagheri, Shahin; Mirzaie, Mehdi] Tarbiat Modares Univ, Fac Math Sci, Dept Appl Math, Jalal Ale Ahmad Highway, Tehran, Iran	Tarbiat Modares University	Mirzaie, M (corresponding author), Tarbiat Modares Univ, Fac Math Sci, Dept Appl Math, Jalal Ale Ahmad Highway, Tehran, Iran.	mirzaie@modares.ac.ir		Mirzaie, Mehdi/0000-0003-4434-5118	Tarbiat Modares University [IG-39706]; Research Core: "Bio-Mathematics with computational approach" of Tarbiat Modares University [IG-39706]	Tarbiat Modares University; Research Core: "Bio-Mathematics with computational approach" of Tarbiat Modares University	This work was financially supported by the Tarbiat Modares University under grant number IG-39706.; This research was supported by Research Core: "Bio-Mathematics with computational approach" of Tarbiat Modares University, with grant number "IG-39706".	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Becher MA, 2014, J APPL ECOL, V51, P470, DOI 10.1111/1365-2664.12222; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Betti MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110237; Bodenheimer FS, 1937, Q REV BIOL, V12, P406, DOI 10.1086/394540; Booton RD, 2017, J THEOR BIOL, V420, P213, DOI 10.1016/j.jtbi.2017.03.009; CAMAZINE S, 1990, J THEOR BIOL, V147, P553, DOI 10.1016/S0022-5193(05)80264-4; Carroll MJ, 2012, APIDOLOGIE, V43, P715, DOI 10.1007/s13592-012-0153-x; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; ECKERT CD, 1994, OECOLOGIA, V97, P248, DOI 10.1007/BF00323157; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Gervasi DDL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14691; Haydak M.H., 1967, APIACTA, V1, P3; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Horn J, 2016, OIKOS, V125, P1001, DOI 10.1111/oik.02636; Huang Z., 2008, ENCY LIFE SCI, V1, P15; Huang Zachary, 2012, Terrestrial Arthropod Reviews, V5, P175, DOI 10.1163/187498312X639568; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Janmaat AF, 2000, APIDOLOGIE, V31, P377, DOI 10.1051/apido:2000129; Jay S.C., 1974, Journal apic Res, V13, P149; JEFFREE EP, 1957, J ECON ENTOMOL, V50, P211, DOI 10.1093/jee/50.2.211; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Karsai I, 2000, J INSECT BEHAV, V13, P111, DOI 10.1023/A:1007771727503; Karsai I, 2011, BEHAV ECOL, V22, P819, DOI 10.1093/beheco/arr060; Karsai I, 2012, J THEOR BIOL, V294, P98, DOI 10.1016/j.jtbi.2011.10.037; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; Khoury DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059084; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Kleinschmidt G, 1976, INFLUENCE CRUDE PROT; Knisley J, 2011, MATH MODEL NAT PHENO, V6, P245, DOI 10.1051/mmnp/20116613; KNOX DA, 1971, J ECON ENTOMOL, V64, P1415, DOI 10.1093/jee/64.6.1415; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Paiva JPLM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167054; Mattila HR, 2006, ENVIRON ENTOMOL, V35, P708, DOI 10.1603/0046-225X-35.3.708; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Ramsey SD, 2019, P NATL ACAD SCI USA, V116, P1792, DOI 10.1073/pnas.1818371116; Requier F, 2017, J APPL ECOL, V54, P1161, DOI 10.1111/1365-2664.12836; ROBINSON GE, 1989, BEHAV ECOL SOCIOBIOL, V24, P317, DOI 10.1007/BF00290908; Russell S, 2013, ECOL MODEL, V265, P158, DOI 10.1016/j.ecolmodel.2013.06.005; Scheiner R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00116; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schmickl T, 2016, J THEOR BIOL, V389, P274, DOI 10.1016/j.jtbi.2015.10.036; Schmickl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114611; Scofield HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121731; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Seeley T. D., 2009, WISDOM HIVE SOCIAL P; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720	56	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225632	10.1371/journal.pone.0225632	http://dx.doi.org/10.1371/journal.pone.0225632			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LE2ET	31756236	gold, Green Published			2022-12-26	WOS:000526536900001
J	Gebeyehu, E; Nigatu, D; Engidawork, E				Gebeyehu, Endalew; Nigatu, Desalegn; Engidawork, Ephrem			Self-reported adverse drug effects and associated factors among H. pylori infected patients on standard triple therapy: Prospective follow up study	PLOS ONE			English	Article							HELICOBACTER-PYLORI; PATIENTS ADHERENCE; ERADICATION; CLARITHROMYCIN; MANAGEMENT; EFFICACY; AMOXICILLIN; OMEPRAZOLE; RESISTANCE; OBESE	Background One of the most common reasons for poor medication adherence and associated treatment failure of triple therapy is adverse drug effect (ADEs) of medications. Objective Assessment of ADEs and associated factors during H. pylori eradication therapy. Method Consented H. pylori positive adult outpatients on standard triple therapy (proton pump inhibitor, amoxicillin and clarithromycin) were involved in this facility based follow up study from May 2016 to April 2018 at Bahir Dar city in Ethiopia. Pre-developed questionnaire and formats were used to collect sociodemographic, medical information, and patient practice data before, during, and after therapy. Bivariate and backward stepwise multivariate logistic regression was used to analyze data. P-value < 0.05 at 95%CI was considered as significant. Result A total of 421 patients were involved in the study. Almost 80% of the patients were urban residents. Mean (+/- SD) age and body weight of patients were 30.63 (+/- 10.74) years and 56.79 (+/- 10.17) kg, respectively. ADE was reported from 26.1% of the patients and of all the reported ADEs, more than 85% was manifested with gastrointestinal symptoms which include gastrointestinal discomfort(39.1%), nausea (13.6%), constipation(12.7%), diarrhea (12.9%) and anorexia(10%). Determinants of self-reported ADEs among patients in the present study were body mass index above 25 (AOR: 2.55; 95%CI (1.21-5.38), p = 0.014), duration of acid-pepsin disorder more than 3weeks (AOR: 3.57; 95%CI (1.63-7.81), p = 0.001), pain feeling during long interval between meals (AOR: 2.14; 95%CI (1.19-3.84), p = 0.011), and residence in urban area (AOR: 1.95; 95% CI (1.04-3.67), p = 0.038). Conclusion Significant proportion of patients reported ADEs which commonly manifested with gastrointestinal symptoms. Consideration of patients' body mass index, duration of the disorder, period of the day when patients feel pain, and patients' area of residence could help to reduce ADEs experienced during H. pylori eradication therapy.	[Gebeyehu, Endalew] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Hlth Sci, Dept Pharmacol, Bahir Dar, Ethiopia; [Nigatu, Desalegn] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Med, Dept Internal Med, Bahir Dar, Ethiopia; [Engidawork, Ephrem] Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia	Bahir Dar University; Bahir Dar University; Addis Ababa University	Gebeyehu, E (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Hlth Sci, Dept Pharmacol, Bahir Dar, Ethiopia.	endalew2008@gmail.com	Engidawork, Ephrem/K-7551-2019	Engidawork, Ephrem/0000-0002-9931-6421; Gebeyehu, Endalew/0000-0003-3330-4513	Bahir Dar Universsity; Addis Ababa Universsity	Bahir Dar Universsity; Addis Ababa Universsity	The principal investigator, EG, has got finantial and material support from Bahir Dar and Addis Ababa Universsities for this work as any of graduate program students. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasinazari M, 2013, J CLIN DIAGN RES, V7, P462, DOI 10.7860/JCDR/2013/4673.2799; Abdullahi M, 2008, OBES SURG, V18, P1450, DOI 10.1007/s11695-008-9477-z; Abuhammour A, 2016, ARAB J GASTROENTEROL, V17, P131, DOI 10.1016/j.ajg.2016.07.001; Al-Eidan FA, 2002, BRIT J CLIN PHARMACO, V53, P163, DOI 10.1046/j.0306-5251.2001.01531.x; Alomar MJ, 2014, SAUDI PHARM J, V22, P83, DOI 10.1016/j.jsps.2013.02.003; Arkkila PET, 2005, EUR J GASTROEN HEPAT, V17, P93, DOI 10.1097/00042737-200501000-00018; B P AS, 2017, J APPL PHARM SCI, V7; Bardhan KD, 1996, EUR J GASTROEN HEPAT, V8, pS27, DOI 10.1097/00042737-199610001-00006; Bazzoli F, 1998, ALIMENT PHARM THERAP, V12, P439; Chen YI, 2015, CAN J GASTROENTEROL, V29, pE7, DOI 10.1155/2015/659390; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Dore MP, 2019, CAN J INFECT DIS MED, V2019, DOI 10.1155/2019/3409820; Fennerty MB, 1998, ARCH INTERN MED, V158, P1651, DOI 10.1001/archinte.158.15.1651; FISH DN, 1994, ANTIMICROB AGENTS CH, V38, P876, DOI 10.1128/AAC.38.4.876; Gebeyehu E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217645; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; GRAHAM DY, 1992, GASTROENTEROLOGY, V102, P493, DOI 10.1016/0016-5085(92)90095-G; GRANSTROM L, 1985, ACTA CHIR SCAND, V151, P367; Hamrah Mohammad Shoaib, 2018, Asian Pac J Cancer Prev, V19, P1035; HONEYBOURNE D, 1994, EUR RESPIR J, V7, P1275, DOI 10.1183/09031936.94.07071275; Hori K, 2017, CURR DRUG SAF; Howden CW, 1998, AM J GASTROENTEROL, V93, P2330, DOI 10.1111/j.1572-0241.1998.00684.x; Jaka H, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4085-1; Joshi A, 2015, NATL J PHYS PHARM PH, V5, P280, DOI [10.5455/njppp.2015.5.2502201543, DOI 10.5455/NJPPP.2015.5.2502201543]; KA K, 2015, PHARM PHARM, V6, P556; Kim SY, 2008, HELICOBACTER, V13, P282, DOI 10.1111/j.1523-5378.2008.00615.x; Ksiadzyna D, 2012, PRZ GASTROENTEROL, V7, P70, DOI 10.5114/pg.2012.28647; Kwok A, 2008, EXPERT OPIN DRUG SAF, V7, P271, DOI [10.1517/14740338.7.3.271, 10.1517/14740338.7.3.271 ]; Labigne A, 1996, INFECT AGENT DIS, V5, P191; Lee HJ, 2015, WORLD J GASTROENTERO, V21, P351, DOI 10.3748/wjg.v21.i1.351; Lee M, 1999, ARCH INTERN MED, V159, P2312, DOI 10.1001/archinte.159.19.2312; Liang CM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3762194; Liu Q, 2015, EUR J GASTROEN HEPAT, V27, P221, DOI 10.1097/MEG.0000000000000186; Lu MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163743; Mabek LBK, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3146-1; MADDOX A, 1989, SCAND J GASTROENTERO, V24, P593, DOI 10.3109/00365528909093095; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x; Masjedizadeh A, 2015, PRZ GASTROENTEROL, V10, P94, DOI 10.5114/pg.2015.49001; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; de Sousa LAO, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00040017, 10.1590/0102-311x00040017]; Onder G, 2002, PHARMACOEPIDEM DR S, V11, P385, DOI 10.1002/pds.721; Pai MP, 2007, PHARMACOTHERAPY, V27, P1081, DOI 10.1592/phco.27.8.1081; Park CS, 2014, AM J GASTROENTEROL, V109, P1595, DOI 10.1038/ajg.2014.222; Queiroz DMM, 2002, J CLIN GASTROENTEROL, V35, P315, DOI 10.1097/00004836-200210000-00007; Rademaker M, 2001, Am J Clin Dermatol, V2, P349, DOI 10.2165/00128071-200102060-00001; Ramas M, 2017, GASTROENT HEPAT-BARC, V40, P658, DOI 10.1016/j.gastrohep.2017.05.017; SELLERS EM, 1978, CLIN PHARMACOKINET, V3, P440, DOI 10.2165/00003088-197803060-00002; Shakya Shrestha S, 2016, Kathmandu Univ Med J (KUMJ), V14, P58; Shimoyama T, 2013, WORLD J GASTROENTERO, V19, P8188, DOI 10.3748/wjg.v19.i45.8188; Silva F M, 2001, Rev Hosp Clin Fac Med Sao Paulo, V56, P11; Sperandei S, 2014, BIOCHEM MEDICA, V24, P12, DOI 10.11613/BM.2014.003; Spiller RC, 1999, EUR J GASTROEN HEPAT, V11, pS25; Spiller RC, 1999, EUR J GASTROEN HEPAT, V11, pS43; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun WH, 2005, WORLD J GASTROENTERO, V11, P2477, DOI 10.3748/wjg.v11.i16.2477; Tepes B, 2012, HELICOBACTER, V17, P36, DOI 10.1111/j.1523-5378.2012.00981.x; Vakil N, 1998, Am J Ther, V5, P197, DOI 10.1097/00045391-199805000-00011; Yu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24955; Zhou YQ, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/405425	60	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225585	10.1371/journal.pone.0225585	http://dx.doi.org/10.1371/journal.pone.0225585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756217	gold, Green Published			2022-12-26	WOS:000533889300042
J	Falcon-Brindis, A; Rodriguez-Estrella, R; Jimenez, ML				Falcon-Brindis, Armando; Rodriguez-Estrella, Ricardo; Luisa Jimenez, Maria			Disentangling the coexistence strategies of mud-daubing wasp species through trophic analysis in oases of Baja California peninsula	PLOS ONE			English	Article							NICHE OVERLAP; INDIVIDUAL SPECIALIZATION; PREY SELECTION; SPIDER PREY; BODY SIZES; HYMENOPTERA; POMPILIDAE; DAUBER; POLLINATION; CRABRONIDAE	Species within the same trophic level show different strategies to avoid competition. Among these mechanisms, differences in body size, spatio-temporal segregation, and diet preference often leads to a niche partitioning. Nonetheless, little attention on coexisting predatory insects and their network interactions has been paid. In this study, we analyzed the strategies to avoid competition among three sympatric mud-daubing wasps of the genus Trypoxylon (Hymenoptera: Crabronidae) in oases and their surrounding xeric area from the Baja California peninsula, Mexico. We compared the prey richness, composition and proportion of spider guilds that were captured by the wasps. We tested whether the differences in wasp body size explained the niche breadth, niche overlap and the size of spider prey. We assessed the spider-wasp interactions through a network analysis. With the use of trap-nests, we collected 52 spider species captured by the wasps. Both the guild and species composition of preyed spiders was different between the three wasp species. Differential proportions in the capture of spider guilds and a little diet overlap were found among the wasp species. We found that the wasp body size was positively correlated with prey size, but it was not a proxy of niche breadth. Moreover, the largest wasp species was able to nest in both mesic and xeric habitats, while the two smaller species were restricted to the oases. This study reveals that the diversity of spiders in oases of Baja California peninsula is crucial to maintain highly specialized oasis-dependent wasp species. The niche partitioning between mud-daubing wasps can be shaped by their inherent body size limitations and hunting strategies through foraging specialization for specific spider guilds. Food selection and slight differences in body size reduce competition and allow the coexistence of sympatric wasps. Our study is the first approach exploring the interaction networks between mud-daubing wasps and their spider preys, highlighting new insights into the morphological and ecological factors that shape antagonistic interactions, and allow the coexistence of predators in deserts.	[Falcon-Brindis, Armando; Rodriguez-Estrella, Ricardo; Luisa Jimenez, Maria] Northwest Biol Res Ctr, Entomol & Arachnol Lab, Conservat & Environm Planning Program, La Paz, Baja Calif Sur, Mexico		Jimenez, ML (corresponding author), Northwest Biol Res Ctr, Entomol & Arachnol Lab, Conservat & Environm Planning Program, La Paz, Baja Calif Sur, Mexico.	ljimenez04@cibnor.mx	Falcón-Brindis, Armando/AGR-4931-2022	Falcón-Brindis, Armando/0000-0003-2496-2178; Jimenez, Maria Luisa/0000-0002-3250-9755	Consejo Nacional de Ciencia y Tecnologia (CONACyT); Centro de Investigaciones Biologicas del Noroeste, S. C. (CIBNOR); CONACyT [273254]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Centro de Investigaciones Biologicas del Noroeste, S. C. (CIBNOR); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The Consejo Nacional de Ciencia y Tecnologi ' a (CONACyT) and the Centro de Investigaciones Biolo ' gicas del Noroeste, S. C. (CIBNOR) provided financial support. AFB received a doctoral scholarship (No. 273254) from the CONACyT.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1967, TRAP NESTING WASPS B; [Anonymous], 1976, SPHECID WASPS WORLD; Araujo MS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1855, DOI 10.1007/s00265-007-0425-z; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Begon M, 2006, ECOLOGY INDIVIDUALS, V4th; Blackledge TA, 2003, ECOL LETT, V6, P13, DOI 10.1046/j.1461-0248.2003.00384.x; Blackledge TA, 2001, BEHAVIOUR, V138, P155, DOI 10.1163/15685390151074357; Blackledge TA, 2000, J ARACHNOL, V28, P211, DOI 10.1636/0161-8202(2000)028[0211:PIBMDW]2.0.CO;2; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2001, NATURE, V410, P463, DOI 10.1038/35068555; Brandle M, 2002, EVOL ECOL RES, V4, P993; Buschini MLT, 2008, BRAZ J BIOL, V68, P519, DOI 10.1590/S1519-69842008000300008; Buschini MLT, 2010, BRAZ J BIOL, V70, P529, DOI 10.1590/S1519-69842010000300009; Cardoso Pedro, 2011, PLoS One, V6, pe21710, DOI 10.1371/journal.pone.0021710; Chao AN, 2014, ANNU REV ECOL EVOL S, V45, P297, DOI 10.1146/annurev-ecolsys-120213-091540; Churchfield S, 1999, J ZOOL, V248, P349, DOI 10.1111/j.1469-7998.1999.tb01034.x; Clewlow HL, 2019, J ANIM ECOL, V88, P223, DOI 10.1111/1365-2656.12919; Coello C., 2011, PREDATION HYMENOPTER, P23; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; CORNELL H, 1976, AM NAT, V110, P317, DOI 10.1086/283068; Cornell H., 2012, ENCY THEORETICAL ECO, P489; Costa-Pereira R, 2018, J ANIM ECOL, V87, P1452, DOI 10.1111/1365-2656.12879; Coville R.E., 1982, U CALIF PUBL ENTOMOL, V97, P1; CROSS EA, 1975, ANN ENTOMOL SOC AM, V68, P901, DOI 10.1093/aesa/68.5.901; Daugherty THF, 2011, MOL ECOL, V20, P5337, DOI 10.1111/j.1365-294X.2011.05344.x; Dominguez K, 2008, CAN ENTOMOL, V140, P388, DOI 10.4039/N08-006; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Drake DR, 2002, J BIOGEOGR, V29, P563, DOI 10.1046/j.1365-2699.2002.00706.x; EBERHARD W, 1970, Psyche (Cambridge), V77, P243, DOI 10.1155/1970/18317; Evans HE., 2007, SAND WASPS NATURAL H; EVANS HOWARD E., 1966, MEM AMER ENTOMOL SOC, V20, P1; Foelix R. F, 2011, BIOL SPIDERS; Grant PR, 1998, EVOLUTION ISLANDS; Heinrich B., 1993, The hot-blooded insects: strategies and mechanisms of thermoregulation.; HEINRICH B, 1974, SCIENCE, V185, P747, DOI 10.1126/science.185.4153.747; HERRERA CM, 1995, ECOLOGY, V76, P218, DOI 10.2307/1940644; HURLBERT SH, 1978, ECOLOGY, V59, P67, DOI 10.2307/1936632; INEGI, 2017, CLIM MAPS DAT; Izenman A.J., 2013, MODERN MULTIVARIATE, DOI DOI 10.1007/978-0-387-78189-1_8; Jeglinski JWE, 2013, J ANIM ECOL, V82, P694, DOI 10.1111/1365-2656.12019; JIMENEZ ML, 1994, SOUTHWEST ENTOMOL, V19, P173; Judd TM, 2010, J INSECT PHYSIOL, V56, P42, DOI 10.1016/j.jinsphys.2009.09.002; Kasper ML, 2004, MOL ECOL, V13, P2037, DOI 10.1111/j.1365-294X.2004.02193.x; Kruskal J.B., 1978, MULTIDIMENSIONAL SCA; Kuhsel S, 2017, INSECT SCI, V24, P829, DOI 10.1111/1744-7917.12362; Levins R., 1968, EVOLUTION CHANGING E; Llinas-Gutierrez Jorge, 2004, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V75, P283; Jimenez ML, 2015, REV MEX BIODIVERS, V86, P319, DOI 10.1016/j.rmb.2015.04.028; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacArthur R.H., 1969, POPULATION BIOL EVOL, P159; Machovsky-Capuska GE, 2018, J ANIM ECOL, V87, P1286, DOI 10.1111/1365-2656.12856; Memmott J, 2000, J ANIM ECOL, V69, P1, DOI 10.1046/j.1365-2656.2000.00367.x; Morato EF, 2006, NEOTROP ENTOMOL, V35, P285, DOI 10.1590/S1519-566X2006000300001; Novosolov M, 2018, J ANIM ECOL, V87, P285, DOI 10.1111/1365-2656.12762; Oksanen J., 2017, COMMUNITY ECOLOGY PA; ONEILL KM, 1988, J THERM BIOL, V13, P15, DOI 10.1016/0306-4565(88)90004-6; Piel William H., 2001, Bulletin of the Museum of Comparative Zoology, V157, P1; Pitilin RB, 2012, ZOOL STUD, V51, P655; Poisot T, 2015, OIKOS, V124, P243, DOI 10.1111/oik.01719; Polidori C, 2011, PREDATION HYMENOPTER, P101; Polidori C, 2009, J NAT HIST, V43, P2985, DOI 10.1080/00222930903383511; Punzo F, 2006, J ENTOMOL SCI, V41, P202, DOI 10.18474/0749-8004-41.3.202; Punzo F, 2005, J NEW YORK ENTOMOL S, V113, P222, DOI 10.1664/0028-7199(2005)113[0222:EAHBOT]2.0.CO;2; Punzo F, 2005, J INSECT BEHAV, V18, P757, DOI 10.1007/s10905-005-8738-0; R Core Team, 2021, R LANGUAGE ENV STAT; Rayor LS, 1996, J KANSAS ENTOMOL SOC, V69, P67; Revelle W, PSYCH PROCEDURES PER; Rodriguez-Estrella R, 1997, OASIS PENINSULA BAJA, P285; Rodriguez-Estrella R., 2004, REUNION ANALISIS OAS, P1; Sanders D, 2015, J ANIM ECOL, V84, P134, DOI 10.1111/1365-2656.12271; Santoro D, 2011, J ANIM ECOL, V80, P1123, DOI 10.1111/j.1365-2656.2011.01874.x; Santos GMD, 2010, SOCIOBIOLOGY, V56, P121; Saulino HHL, 2019, NEOTROP ENTOMOL, V48, P136, DOI 10.1007/s13744-018-0620-9; Schowalter TD, 2011, INSECT ECOLOGY: AN ECOSYSTEM APPROACH, 3RD EDITION, P1; Scriven JJ, 2016, ECOL EVOL, V6, P1328, DOI 10.1002/ece3.1965; Sexton JP, 2017, ANNU REV ECOL EVOL S, V48, P183, DOI 10.1146/annurev-ecolsys-110316-023003; Traveset A, 2016, GLOBAL ECOL BIOGEOGR, V25, P880, DOI 10.1111/geb.12362; Uetz GW, 1999, J ARACHNOL, V27, P270; Uma DB, 2010, ETHOLOGY, V116, P85, DOI 10.1111/j.1439-0310.2009.01715.x; Wiggins I. L., 1980, Flora of Baja California.; WILSON DS, 1975, AM NAT, V109, P769, DOI 10.1086/283042; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x; Yang PH, 2018, IEEE INT C ELECTR TA; Yu DW, 2004, J ANIM ECOL, V73, P1102, DOI 10.1111/j.0021-8790.2004.00877.x; Zhang J., R PACKAGE VERSION 0	93	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225266	10.1371/journal.pone.0225266	http://dx.doi.org/10.1371/journal.pone.0225266			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751408	Green Published, gold			2022-12-26	WOS:000533886900039
J	Patel, B; Pauk, M; Amigo-Benavent, M; Nongonierma, AB; Fitzgerald, RJ; Jakeman, PM; Carson, BP				Patel, Bijal; Pauk, Martina; Amigo-Benavent, Miryam; Nongonierma, Alice B.; Fitzgerald, Richard J.; Jakeman, Philip M.; Carson, Brian P.			A cell-based evaluation of a non-essential amino acid formulation as a non-bioactive control for activation and stimulation of muscle protein synthesis using ex vivo human serum	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; IN-VIVO; LEUCINE; CARBOHYDRATE; ANABOLISM; INGESTION; EXERCISE; INSULIN	Purpose The purpose of this study was to compare the effect of treating skeletal muscle cells with media conditioned by postprandial ex vivo human serum fed with either isonitrogenous Non-Essential Amino Acid (NEAA) or a whey protein hydrolysate (WPH) on stimulating Muscle Protein Synthesis (MPS) in C2C12 skeletal muscle cells. Methods Blood was taken from six young healthy males following overnight fast (fasted) and 60 min postprandial (fed) ingestion of either WPH or NEAA (0.33 g.kg(-1) Body Mass). C2C12 myotubes were treated with media conditioned by ex vivo human serum (20%) for 4 h. Activation of MPS signalling (phosphorylation of mTOR, P70S6K and 4E-BP1) were determined in vitro by Western Blot and subsequent MPS were determined in vitro by Western Blot and surface sensing of translation technique (SUnSET) techniques, respectively. Results Media conditioned by NEAA fed serum had no effect on protein signalling or MPS compared to fasted, whereas media conditioned by WPH fed serum significantly increased mTOR (Ser2448), P70S6K and 4E-BP1 phosphorylation (p< 0.01, p< 0.05) compared to fasted serum. Furthermore, the effect of media conditioned by WPH fed serum on protein signalling and MPS was significantly increased (p< 0.01, p< 0.05) compared to NEAA fed serum. Conclusion In summary, media conditioned by NEAA fed serum did not result in activation of MPS. Therefore, these in vitro findings suggest the use of isonitrogenous NEAA acts as an effective control for comparing bioactivity of different proteins on activation of MPS.	[Patel, Bijal; Pauk, Martina; Amigo-Benavent, Miryam; Nongonierma, Alice B.; Fitzgerald, Richard J.; Jakeman, Philip M.; Carson, Brian P.] Univ Limerick, Food Hlth Ireland, Limerick, Ireland; [Patel, Bijal; Pauk, Martina; Amigo-Benavent, Miryam; Jakeman, Philip M.; Carson, Brian P.] Univ Limerick, Human Sci Res Unit, Limerick, Ireland; [Patel, Bijal; Pauk, Martina; Amigo-Benavent, Miryam; Jakeman, Philip M.; Carson, Brian P.] Univ Limerick, Fac Educ & Hlth Sci, Dept Phys Educ & Sport Sci, Limerick, Ireland; [Amigo-Benavent, Miryam; Jakeman, Philip M.; Carson, Brian P.] Univ Limerick, Ctr Intervent Infect Inflammat & Immun 4i, Limerick, Ireland; [Nongonierma, Alice B.; Fitzgerald, Richard J.] Univ Limerick, Dept Biol Sci, Limerick, Ireland; [Carson, Brian P.] Univ Limerick, Hlth Res Inst, Limerick, Ireland	University of Limerick; University of Limerick; University of Limerick; University of Limerick; University of Limerick; University of Limerick	Carson, BP (corresponding author), Univ Limerick, Food Hlth Ireland, Limerick, Ireland.; Carson, BP (corresponding author), Univ Limerick, Human Sci Res Unit, Limerick, Ireland.; Carson, BP (corresponding author), Univ Limerick, Fac Educ & Hlth Sci, Dept Phys Educ & Sport Sci, Limerick, Ireland.; Carson, BP (corresponding author), Univ Limerick, Ctr Intervent Infect Inflammat & Immun 4i, Limerick, Ireland.; Carson, BP (corresponding author), Univ Limerick, Hlth Res Inst, Limerick, Ireland.	brian.carson@ul.ie	Carson, Brian P/D-3438-2012; Amigo-Benavent, Miryam/K-2112-2012	Carson, Brian P/0000-0001-8350-1481; Amigo-Benavent, Miryam/0000-0002-5376-9708	Food for Health Ireland [TC20130001]	Food for Health Ireland	This work was supported by Food for Health Ireland, http://www.fhi.ie/(Enterprise Ireland grant TC20130001 to PMJ & BPC). The funders played no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Abdulla H, 2016, DIABETOLOGIA, V59, P44, DOI 10.1007/s00125-015-3751-0; Atherton PJ, 2012, J PHYSIOL-LONDON, V590, P1049, DOI 10.1113/jphysiol.2011.225003; Atherton PJ, 2017, CLIN NUTR, V36, P888, DOI 10.1016/j.clnu.2016.04.025; Atherton PJ, 2010, AM J CLIN NUTR, V92, P1080, DOI 10.3945/ajcn.2010.29819; Atherton PJ, 2010, AMINO ACIDS, V38, P1533, DOI 10.1007/s00726-009-0377-x; Bohe J, 2003, J PHYSIOL-LONDON, V552, P315, DOI 10.1113/jphysiol.2003.050674; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; Borsheim E, 2002, AM J PHYSIOL-ENDOC M, V283, pE648, DOI 10.1152/ajpendo.00466.2001; Carson BP, 2018, EXP PHYSL; Dickinson JM, 2011, J NUTR, V141, P856, DOI 10.3945/jn.111.139485; EFSA Panel on Dietetic Products NaAENP, 2018, EFSA J, V16, P5434; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Koopman R, 2005, AM J PHYSIOL-ENDOC M, V288, pE645, DOI 10.1152/ajpendo.00413.2004; McCormack WG, 2017, AMINO ACIDS, V49, P151, DOI 10.1007/s00726-016-2343-8; Mitchell WK, 2017, CLIN SCI, V131, P2643, DOI 10.1042/CS20171230; Morton RW, 2018, BRIT J SPORT MED, V52, P376, DOI 10.1136/bjsports-2017-097608; Murphy SM, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160036; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Phillips SM, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0124-8; Power-Grant O, 2016, INT J FOOD SCI NUTR, V67, P325, DOI 10.3109/09637486.2016.1153607; Rennie MJ, 2007, BIOCHEM SOC T, V35, P1302, DOI 10.1042/BST0351302; SMITH K, 1992, AM J PHYSIOL, V262, pE372, DOI 10.1152/ajpendo.1992.262.3.E372; Smith K, 1998, AM J PHYSIOL-ENDOC M, V275, pE73, DOI 10.1152/ajpendo.1998.275.1.E73; TANG JE, 1985, J APPL PHYSIOL, V107, P987, DOI DOI 10.1152/JAPPLPHYSI0L; Tipton KD, 1999, J NUTR BIOCHEM, V10, P89, DOI 10.1016/S0955-2863(98)00087-4; Volpi E, 2003, AM J CLIN NUTR, V78, P250, DOI 10.1093/ajcn/78.2.250; Wilkes EA, 2009, AM J CLIN NUTR, V90, P1343, DOI 10.3945/ajcn.2009.27543; Wilkinson DJ, 2013, J PHYSIOL-LONDON, V591, P2911, DOI 10.1113/jphysiol.2013.253203; Wilkinson DJ, 2017, CLIN NUTR; Wilkinson SB, 2006, APPL PHYSIOL NUTR ME, V31, P518, DOI 10.1139/h06-028; Xu ZR, 2015, BRIT J NUTR, V113, P25, DOI 10.1017/S0007114514002475; Xu ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109141	33	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0220757	10.1371/journal.pone.0220757	http://dx.doi.org/10.1371/journal.pone.0220757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743341	Green Submitted, Green Published, gold			2022-12-26	WOS:000533877300003
J	Rezazadeh, A; Berniker, M				Rezazadeh, Alireza; Berniker, Max			Force field generalization and the internal representation of motor learning	PLOS ONE			English	Article							INTERVAL DISCRIMINATION; UNSTABLE DYNAMICS; ADAPTATION; ARM; SPECIFICITY; SYSTEM; ORIENTATION; MULTIJOINT; IMPEDANCE; LOCATION	When learning a new motor behavior, e.g. reaching in a force field, the nervous system builds an internal representation. Examining how subsequent reaches in unpracticed directions generalize reveals this representation. Although often studied, it is not known how this representation changes across training directions, or how changes in reach direction and the corresponding changes in limb impedance, influence these measurements. We ran a force field adaptation experiment using eight groups of subjects each trained on one of eight standard directions and then tested for generalization in the remaining seven directions. Generalization in all directions was local and asymmetric, providing limited and unequal transfer to the left and right side of the trained target. These asymmetries were not consistent in either magnitude or direction, even after correcting for changes in limb impedance. Relying on a standard model for generalization the inferred representations inconsistently shifted to one side or the other of their respective training direction. A second model that accounted for limb impedance and variations in baseline trajectories explained more data and the inferred representations were centered on their respective training directions. Our results highlight the influence of limb mechanics and impedance on psychophysical measurements and their interpretations for motor learning.	[Rezazadeh, Alireza; Berniker, Max] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rezazadeh, A (corresponding author), Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA.	arezaz2@uic.edu		Rezazadeh, Alireza/0000-0002-2457-9470				Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Castro LNG, 2011, IEEE ENG MED BIO, P4050, DOI 10.1109/IEMBS.2011.6091006; Castro LNG, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002052; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Darainy M, 2009, J NEUROPHYSIOL, V101, P3158, DOI 10.1152/jn.91336.2008; Demany L, 2002, J ACOUST SOC AM, V111, P1377, DOI 10.1121/1.1445791; Donchin O, 2003, J NEUROSCI, V23, P9032; FIORENTINI A, 1981, VISION RES, V21, P1149, DOI 10.1016/0042-6989(81)90017-1; Fitzgerald MB, 2011, J ACOUST SOC AM, V129, P898, DOI 10.1121/1.3531841; FLASH T, 1987, BIOL CYBERN, V57, P257, DOI 10.1007/BF00338819; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Harrar V, 2014, J EXP PSYCHOL HUMAN, V40, P15, DOI 10.1037/a0033200; Huang VS, 2007, J NEUROPHYSIOL, V97, P3976, DOI 10.1152/jn.01281.2006; Hwang EJ, 2006, EXP BRAIN RES, V169, P496, DOI 10.1007/s00221-005-0163-2; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Linster C, 1999, PHYSIOL BEHAV, V66, P701, DOI 10.1016/S0031-9384(99)00007-4; Linster C, 2001, BEHAV NEUROSCI, V115, P826, DOI 10.1037//0735-7044.115.4.826; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Sathian K, 1997, NEUROLOGY, V49, P168, DOI 10.1212/WNL.49.1.168; Sathian K, 1997, PERCEPT PSYCHOPHYS, V59, P119, DOI 10.3758/BF03206854; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Shadmehr R, 2004, HUM MOVEMENT SCI, V23, P543, DOI 10.1016/j.humov.2004.04.003; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Sowden PT, 2002, VISION RES, V42, P1249, DOI 10.1016/S0042-6989(02)00019-6; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Thoroughman KA, 2005, J NEUROSCI, V25, P8948, DOI 10.1523/JNEUROSCI.1771-05.2005; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wright BA, 1997, J NEUROSCI, V17, P3956; ZWISLOCKI J, 1958, J ACOUST SOC AM, V30, P254, DOI 10.1121/1.1909559	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225002	10.1371/journal.pone.0225002	http://dx.doi.org/10.1371/journal.pone.0225002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8LN	31743347	Green Published, Green Submitted, gold			2022-12-26	WOS:000533877300014
J	Li, XS; Li, TY; Wu, J; Xie, ZL; Shi, JY				Li, Xinsheng; Li, Taiyong; Wu, Jiang; Xie, Zhilong; Shi, Jiayi			Joint image compression and encryption based on sparse Bayesian learning and bit-level 3D Arnold cat maps	PLOS ONE			English	Article							ALGORITHM; PERMUTATION; MATRIX	Image compression and image encryption are two essential tasks in image processing. The former aims to reduce the cost for storage or transmission of images while the latter aims to change the positions or values of pixels to protect image content. Nowadays, an increasing number of researchers are focusing on the combination of these two tasks. In this paper, we propose a novel joint image compression and encryption approach that integrates a quantum chaotic system, sparse Bayesian learning (SBL) and a bit-level 3D Arnold cat map, socalled QSBLA, for such a purpose. Specifically, the QSBLA consists of 6 stages. First, a quantum chaotic system is employed to generate chaotic sequences for subsequent compression and encryption. Second, as one method of compressive sensing, SBL is used to compress images. Third, an operation of diffusion is performed on the compressed image. Fourth, the compressed and diffused image is transformed into several bit-level cubes. Fifth, 3D Arnold cat maps are used to permute each bit-level cube. Finally, all the bit-level cubes are integrated and transformed into a 2D pixel-level image, resulting in the compressed and encrypted image. Extensive experiments on 8 publicly-accessed images demonstrate that the proposed QSBLA is superior or comparable to some state-of-the-art approaches in terms of several measurement indices, indicating that the QSBLA is promising for joint image compression and encryption.	[Li, Xinsheng] Sichuan Univ, Coll Comp Sci, Chengdu, Peoples R China; [Li, Taiyong; Wu, Jiang; Xie, Zhilong; Shi, Jiayi] Southwestern Univ Finance & Econ, Sch Econ Informat Engn, Chengdu, Peoples R China	Sichuan University; Southwestern University of Finance & Economics - China	Li, TY (corresponding author), Southwestern Univ Finance & Econ, Sch Econ Informat Engn, Chengdu, Peoples R China.	litaiyong@gmail.com	li, xin/HHS-9461-2022; Li, Taiyong/ABG-3630-2020; Li, Taiyong/ABE-4602-2021	Li, Taiyong/0000-0002-1546-8015; 	Fundamental Research Funds for the Central Universities [JBK1902029, JBK1802073, JBK170505]; Sichuan Science and Technology Program [2019YFG0117]; Ministry of Education of Humanities and Social Science Project [19YJAZH047]; Natural Science Foundation of China [71473201]; Scientific Research Fund of Sichuan Provincial Education Department [17ZB0433]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Sichuan Science and Technology Program; Ministry of Education of Humanities and Social Science Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Sichuan Provincial Education Department	This research was supported the Fundamental Research Funds for the Central Universities (Grant No. JBK1902029, No. JBK1802073 and No. JBK170505), Sichuan Science and Technology Program (Grant No. 2019YFG0117), the Ministry of Education of Humanities and Social Science Project (Grant No. 19YJAZH047), the Natural Science Foundation of China (Grant No. 71473201) and the Scientific Research Fund of Sichuan Provincial Education Department (Grant No. 17ZB0433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Latif AA, 2018, IEEE ACCESS, V6, P1073, DOI 10.1109/ACCESS.2017.2777869; Akhshani A, 2012, COMMUN NONLINEAR SCI, V17, P4653, DOI 10.1016/j.cnsns.2012.05.033; Cai ST, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208503; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Cavusoglu U, 2017, CHAOS SOLITON FRACT, V95, P92, DOI 10.1016/j.chaos.2016.12.018; Chai X., 2019, NEURAL COMPUT APPL, P1; Chai XL, 2020, NEURAL COMPUT APPL, V32, P4961, DOI 10.1007/s00521-018-3913-3; Chai XL, 2019, SIGNAL PROCESS, V155, P44, DOI 10.1016/j.sigpro.2018.09.029; Chai XL, 2018, SIGNAL PROCESS, V148, P124, DOI 10.1016/j.sigpro.2018.02.007; Chai XL, 2019, NEURAL COMPUT APPL, V31, P219, DOI 10.1007/s00521-017-2993-9; Chai XL, 2017, SIGNAL PROCESS, V134, P35, DOI 10.1016/j.sigpro.2016.11.016; Chen GR, 2004, CHAOS SOLITON FRACT, V21, P749, DOI 10.1016/j.chaos.2003.12.022; Chen JX, 2015, SIGNAL PROCESS, V111, P294, DOI 10.1016/j.sigpro.2015.01.003; Chen JX, 2018, OPT LASER TECHNOL, V99, P238, DOI 10.1016/j.optlastec.2017.09.008; Deng J, 2017, MULTIMED TOOLS APPL, V76, P10097, DOI 10.1007/s11042-016-3600-2; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Grgic S, 2001, IEEE T IND ELECTRON, V48, P682, DOI 10.1109/41.925596; Gu SH, 2014, PROC CVPR IEEE, P2862, DOI 10.1109/CVPR.2014.366; Guan ZH, 2005, PHYS LETT A, V346, P153, DOI 10.1016/j.physleta.2005.08.006; Hu GQ, 2017, J VIS COMMUN IMAGE R, V44, P116, DOI 10.1016/j.jvcir.2017.01.022; Hu YQ, 2017, INT J THEOR PHYS, V56, P2192, DOI 10.1007/s10773-017-3365-z; Hua ZY, 2017, INFORM SCIENCES, V396, P97, DOI 10.1016/j.ins.2017.02.036; Kumar S, 2017, MULTIMED TOOLS APPL, V76, P8757, DOI 10.1007/s11042-016-3504-1; Landir M, 2019, OPT LASER TECHNOL, V109, P534, DOI 10.1016/j.optlastec.2018.08.040; Li PY, 2017, J VIS COMMUN IMAGE R, V44, P61, DOI 10.1016/j.jvcir.2017.01.021; Li TY, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21030319; Li TY, 2018, ENERGIES, V11, DOI 10.3390/en11071882; Li TY, 2017, COMPLEXITY, DOI 10.1155/2017/9010251; Li TY, 2016, ENERGIES, V9, DOI 10.3390/en9121014; Li TY, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/695976; Li XB, 1997, PATTERN RECOGN LETT, V18, P1253, DOI 10.1016/S0167-8655(97)00099-8; Li XS, 2019, COMPLEXITY, DOI 10.1155/2019/7485621; Liu L, 2011, ADV SCI LETT, V4, P3537, DOI 10.1166/asl.2011.1910; Liu XB, 2016, OPT COMMUN, V366, P22, DOI 10.1016/j.optcom.2015.12.024; Ou SC, 2006, MULTIMED TOOLS APPL, V28, P5, DOI 10.1007/s11042-006-5117-6; Pak C, 2017, SIGNAL PROCESS, V138, P129, DOI 10.1016/j.sigpro.2017.03.011; Schneier B., 2007, APPL CRYPTOGRAPHY PR; Seyedzadeh SM, 2015, NONLINEAR DYNAM, V81, P511, DOI 10.1007/s11071-015-2008-2; Skodras A, 2001, IEEE SIGNAL PROC MAG, V18, P36, DOI 10.1109/79.952804; Stinson D. R., 2005, CRYPTOGRAPHY THEORY; Sun B, 2015, IEEE SENS J, V15, P7161, DOI 10.1109/JSEN.2015.2473697; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Tong XJ, 2013, NONLINEAR DYNAM, V72, P229, DOI 10.1007/s11071-012-0707-5; VILLASENOR JD, 1993, IEEE T MED IMAGING, V12, P803, DOI 10.1109/42.251132; Wang QZ, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0239-1; Wang Z, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/1/010504; Williams O, 2005, IEEE T PATTERN ANAL, V27, P1292, DOI 10.1109/TPAMI.2005.167; Wipf DP, 2004, IEEE T SIGNAL PROCES, V52, P2153, DOI 10.1109/TSP.2004.831016; Wu J, 2019, ENERGIES, V12, DOI 10.3390/en12071239; Wu XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119660; Wu Y, 2011, CYBER J J SEL AREAS, V1, P31, DOI [DOI 10.1021/AB500130D, DOI 10.1109/TITS.2018.2848461]; Yang M, 2013, IEEE T IND APPL, V49, P2783, DOI 10.1109/TIA.2013.2265292; Yuen CH, 2011, APPL SOFT COMPUT, V11, P5092, DOI 10.1016/j.asoc.2011.05.050; Zhan K, 2017, J ELECTRON IMAGING, V26, DOI 10.1117/1.JEI.26.1.013021; Zhang K, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/501054; Zhang T., 2016, MATH PROBL ENG, V2016, P1, DOI DOI 10.1155/2016/8045749; Zhang XQ, 2017, OPT LASER ENG, V92, P6, DOI 10.1016/j.optlaseng.2016.12.005; ZHANG Y, 2017, OPT COMMUN, V392, P223, DOI DOI 10.1016/J.0PTC0M.2017.01.061; Zhang ZL, 2014, IEEE T NEUR SYS REH, V22, P1186, DOI 10.1109/TNSRE.2014.2319334; Zhang ZL, 2013, IEEE T BIO-MED ENG, V60, P300, DOI 10.1109/TBME.2012.2226175; Zhang ZL, 2011, IEEE J-STSP, V5, P912, DOI 10.1109/JSTSP.2011.2159773; Zhou NR, 2017, QUANTUM INF PROCESS, V16, DOI 10.1007/s11128-016-1461-2; Zhou NR, 2014, OPTIK, V125, P5075, DOI 10.1016/j.ijleo.2014.06.054; Zhou NR, 2014, OPT LASER TECHNOL, V62, P152, DOI 10.1016/j.optlastec.2014.02.015; Zhou YR, 2019, COMPLEXITY, DOI 10.1155/2019/4392785; Zhu CX, 2012, ACTA PHYS SIN-CH ED, V61, DOI 10.7498/aps.61.120503; Zhu CX, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20110843; Zhu CX, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10090399; [朱从旭 Zhu Congxu], 2012, [电子与信息学报, Journal of Electronics & Information Technology], V34, P1735; Zhu SQ, 2018, IEEE ACCESS, V6, P67095, DOI 10.1109/ACCESS.2018.2874336; Zhu SQ, 2018, MULTIMED TOOLS APPL, V77, P29119, DOI 10.1007/s11042-018-6078-2	72	6	6	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0224382	10.1371/journal.pone.0224382	http://dx.doi.org/10.1371/journal.pone.0224382			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738772	gold, Green Published			2022-12-26	WOS:000532826300013
J	Xie, JL; Li, XB; Zhao, F; Wang, CC; Yang, KL				Xie Jinglong; Li Xiaobin; Zhao Fang; Wang Chenchen; Yang Kailun			Isolation and identification of an isoflavone reducing bacterium from feces from a pregnant horse	PLOS ONE			English	Article							SOY ISOFLAVONES; EQUOL; PHYTOESTROGENS; METABOLITE; CULTURE	The aim of this research was to isolate bacteria capable of biotransforming daidzein from fresh feces from pregnant horses. A Hungate anaerobic roller tube was used for anaerobic culture. Single colonies were picked at random and incubated with daidzein. High performance liquid chromatography was used to detect whether the isolated bacteria were able to biotransform the substrate. A strain capable of reducing daidzein was selected and characterized using sequence analysis of 16S rDNA, and a phylogenetic tree was constructed. The morphological physiological and biochemical characteristics of the strain were investigated. A facultative anaerobic, Gram-positive bacterium capable of converting daidzein to dihydrodaidzein was isolated and named HXBM408 (MF992210). A BLAST search of HXBM408's 16S rDNA sequence against the GenBank database suggested that the strain has 99% similarity with Pediococcus acidilactici strain DSM (NR042057). The morphological, physiological, and biochemical characteristics of HXBM408 are very similar to those of Pediococcus. Based on these characteristics, the strain was identified as Pediococcus acidilactici. The bacterial strain HXBM408 isolated from the feces of pregnant horses was able to reduce the isoflavone daidzein to dihydrodaidzein.	[Xie Jinglong; Li Xiaobin; Zhao Fang; Wang Chenchen; Yang Kailun] Xinjiang Agr Univ, Xinjiang Lab Meat & Milk Prod Herbivore Nutr, Urumqi, Peoples R China	Xinjiang Agricultural University	Yang, KL (corresponding author), Xinjiang Agr Univ, Xinjiang Lab Meat & Milk Prod Herbivore Nutr, Urumqi, Peoples R China.	1447591725@qq.com		JingLong, Xie/0000-0002-4556-8260	Ministry of Science and Technology of Xinjiang Uygur Autonomous Region, Autonomous Region Key Laboratory Project [2016D03012]	Ministry of Science and Technology of Xinjiang Uygur Autonomous Region, Autonomous Region Key Laboratory Project	This work was funded by the Ministry of Science and Technology of Xinjiang Uygur Autonomous Region, Autonomous Region Key Laboratory Project (2016D03012) to YK.; This work was funded by the Ministry of Science and Technology of Xinjiang Uygur Autonomous Region, Autonomous Region Key Laboratory Project (2016D03012).	Atkinson C, 2004, J NUTR, V134, P596, DOI 10.1093/jn/134.3.596; Beck VB, 2005, J STEROID BIOCHEM, V94, P499, DOI 10.1016/j.jsbmb.2004.12.038; Bowey E, 2003, FOOD CHEM TOXICOL, V41, P631, DOI 10.1016/S0278-6915(02)00324-1; Cassidy A, 2006, J NUTR, V136, P45, DOI 10.1093/jn/136.1.45; Chin-Dusting JPF, 2001, BRIT J PHARMACOL, V133, P595, DOI 10.1038/sj.bjp.0704088; Decroos K, 2005, ARCH MICROBIOL, V183, P45, DOI 10.1007/s00203-004-0747-4; HUNGATE RE, 1966, J BACTERIOL, V91, P908, DOI 10.1128/JB.91.2.908-909.1966; Hur HG, 2000, ARCH MICROBIOL, V174, P422, DOI 10.1007/s002030000222; ISHIMI Y, 2008, J CLIN BIOCH NUTR S1, V43, P48; Jin JS, 2010, INT J SYST EVOL MICR, V60, P1721, DOI 10.1099/ijs.0.016774-0; Liang XL, 2010, J AGR FOOD CHEM, V58, P11548, DOI 10.1021/jf102372t; Magee PJ, 2011, P NUTR SOC, V70, P10, DOI 10.1017/S0029665110003940; Magee PJ, 2004, BRIT J NUTR, V91, P513, DOI 10.1079/BJN20031075; Marrian GF, 1932, BIOCHEM J, V26, P1227, DOI 10.1042/bj0261227; Maruo T, 2008, INT J SYST EVOL MICR, V58, P1221, DOI 10.1099/ijs.0.65404-0; Muthyala RS, 2004, BIOORGAN MED CHEM, V12, P1559, DOI 10.1016/j.bmc.2003.11.035; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Tamura M, 2007, ANAEROBE, V13, P32, DOI 10.1016/j.anaerobe.2006.10.001; Tsangalis D, 2002, J FOOD SCI, V67, P3104, DOI 10.1111/j.1365-2621.2002.tb08866.x; Ueno T., 2002, ANN NUTR METAB, V45, P114; Wang XL, 2005, J BIOTECHNOL, V115, P261, DOI 10.1016/j.jbiotec.2004.08.014; Yang DZ, 2016, ANAL METHODS-UK, V8, P89, DOI [10.1039/c5ay02304a, 10.1039/C5AY02304A]; Yu ZT, 2008, FEMS MICROBIOL LETT, V282, P73, DOI 10.1111/j.1574-6968.2008.01108.x	25	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0223503	10.1371/journal.pone.0223503	http://dx.doi.org/10.1371/journal.pone.0223503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738752	Green Published, gold			2022-12-26	WOS:000532826300009
J	van Woesik, R; Cacciapaglia, CW				van Woesik, Robert; Cacciapaglia, Christopher William			Carbonate production of Micronesian reefs suppressed by thermal anomalies and Acanthaster as sea-level rises	PLOS ONE			English	Article							CORAL-REEFS; CLIMATE-CHANGE; GROWTH; RATES; CALCIFICATION; RECOVERY; PLANCI	Coral reefs are essential to millions of island inhabitants. Yet, coral reefs are threatened by thermal anomalies associated with climate change and by local disturbances that include land-use change, pollution, and the coral-eating sea star Acanthaster solaris. In combination, these disturbances cause coral mortality that reduce the capacity of reefs to produce enough carbonate to keep up with sea-level rise. This study compared the reef-building capacity of shallow-water inner, patch, and outer reefs in the two islands of Pohnpei and Kosrae, Federated States of Micronesia. We identified which reefs were likely to keep up with sea-level rise under different climate-change scenarios, and estimated whether there were differences across habitats in the threshold of percentage coral cover at which net carbonate production becomes negative. We also quantified the influence of A. solaris on carbonate production. Whereas the northwestern outer reefs of Pohnpei and Kosrae had the highest net rates of carbonate production (18.5 and 16.4 kg CaCO3 m(-2) yr(-1), respectively), the southeastern outer reefs had the lowest rates of carbonate production (1.2-1.3 and 0.7 kg CaCO3 m(-2) yr(-1), respectively). The patch reefs of Pohnpei had on average higher net carbonate production rates (9.5 kg CaCO3 m(-2) yr(-1)) than the inner reefs of both Pohnpei and Kosrae (7.0 and 7.8 kg CaCO3 m(-2) yr(-1), respectively). A. solaris were common on Kosrae and caused an average reduction in carbonate production of 0.6 kg CaCO3 m(-2) yr(-1) on Kosraean reefs. Northern outer reefs are the most likely habitats to keep up with sea-level rise in both Pohnpei and Kosrae. Overall, the inner reefs of Pohnpei and Kosrae need similar to 5.5% more coral cover to generate the same amount of carbonate as outer reefs. Therefore, inner reefs need special protection from land-use change and local pollution to keep pace with sea-level rise under all climate-change scenarios.	[van Woesik, Robert; Cacciapaglia, Christopher William] Florida Inst Technol, Inst Global Ecol, Dept Ocean Engn & Sci, Melbourne, FL 32901 USA	Florida Institute of Technology	van Woesik, R (corresponding author), Florida Inst Technol, Inst Global Ecol, Dept Ocean Engn & Sci, Melbourne, FL 32901 USA.	rvw@fit.edu		van Woesik, Robert/0000-0002-1864-0263	National Science Foundation [NSF OCE-1657633]	National Science Foundation(National Science Foundation (NSF))	RvW received funding for the research from the National Science Foundation, award NSF OCE-1657633. The funders did not play a role in the study design, data collection, data analysis, decision to publish, and preparation of the manuscript.	ADEY WH, 1978, SCIENCE, V202, P831, DOI 10.1126/science.202.4370.831; Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BIRKELAND C, 1989, AM SCI, V77, P154; Bonaldo RM, 2008, MAR ECOL PROG SER, V360, P237, DOI 10.3354/meps07413; CHAPPELL J, 1991, NATURE, V349, P147, DOI 10.1038/349147a0; CHESHER RH, 1969, SCIENCE, V165, P280, DOI 10.1126/science.165.3890.280; Courtney TA, 2018, LIMNOL OCEANOGR LETT, V3, P1, DOI 10.1002/lol2.10056; Davies P.J., 1983, Australian Institute of Marine Science Contribution, P69; DeCarlo TM, 2017, J GEOPHYS RES-OCEANS, V122, P745, DOI 10.1002/2016JC012326; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Engels MS, 2004, J SEDIMENT RES, V74, P255, DOI 10.1306/073003740255; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Glynn Peter W., 1997, P68; GLYNN PW, 1973, SCIENCE, V180, P504, DOI 10.1126/science.180.4085.504; Hijmans R., 2014, RASTER RASTER GEOGRA, V517, P2; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hubbard Dennis K., 1997, P43; Januchowski-Hartley FA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2533; Jevrejeva S, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104008; Kayanne H, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002400; KEESING JK, 1992, J EXP MAR BIOL ECOL, V156, P89, DOI 10.1016/0022-0981(92)90018-6; Kleypas JA, 1997, PALEOCEANOGRAPHY, V12, P533, DOI 10.1029/97PA01134; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; McMahon A, 2019, J GEOPHYS RES-OCEANS, V124, P4003, DOI 10.1029/2018JC014698; Montaggioni LF, 2005, EARTH-SCI REV, V71, P1, DOI 10.1016/j.earscirev.2005.01.002; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Mueller B, 2011, AQUAT BIOL, V12, P157, DOI 10.3354/ab00326; Neumann A.C., 1985, PROC 5 INT CORAL REE, V3, P105; Ong L, 2010, MAR BIOL, V157, P1313, DOI 10.1007/s00227-010-1411-y; Pebesma E.J., 2005, R NEWS, V5, P9; Perry CT, 2008, CORAL REEFS, V27, P853, DOI 10.1007/s00338-008-0418-z; Perry CT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40581; Perry CT, 2012, CORAL REEFS, V31, P853, DOI 10.1007/s00338-012-0901-4; Perry CT, 2018, NATURE, V558, P396, DOI 10.1038/s41586-018-0194-z; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Plummer M., 2013, R PACKAGE VERSION, V3; Pratchett MS, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9040041; R Core Team, 2012, R LANG ENV STAT COMP; ROGERS CS, 1983, MAR POLLUT BULL, V14, P378, DOI 10.1016/0025-326X(83)90602-1; Ryan EJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42985-2; SMITH SV, 1976, SCIENCE, V194, P937, DOI 10.1126/science.194.4268.937; Storlazzi CD, 2011, CORAL REEFS, V30, P83, DOI 10.1007/s00338-011-0723-9; van Woesik R, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150181; van Woesik R, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044051; van Woesik R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197077; Vecsei A, 2004, GLOBAL PLANET CHANGE, V43, P1, DOI 10.1016/j.gloplacha.2003.12.002; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Victor S, 2006, ESTUAR COAST SHELF S, V66, P409, DOI 10.1016/j.ecss.2005.07.025; Wand MP, 2008, AUST NZ J STAT, V50, P179, DOI 10.1111/j.1467-842X.2008.00507.x; Zuur A. F., 2014, BEGINNERS GUIDE GEN	53	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224887	10.1371/journal.pone.0224887	http://dx.doi.org/10.1371/journal.pone.0224887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730649	Green Published, Green Submitted, gold			2022-12-26	WOS:000532809500013
J	Loveridge, CJ; Slater, S; Campbell, KJ; Nam, NA; Knight, J; Ahmad, I; Hedley, A; Lilla, S; Repiscak, P; Patel, R; Salji, M; Fleming, J; Mitchell, L; Nixon, C; Strathdee, D; Neilson, M; Ntala, C; Bryson, S; Zanivan, S; Edwards, J; Robson, CN; Goodyear, CS; Blyth, K; Leung, HY				Loveridge, Carolyn J.; Slater, Sarah; Campbell, Kirsteen J.; Nam, Noor A.; Knight, John; Ahmad, Imran; Hedley, Ann; Lilla, Sergio; Repiscak, Peter; Patel, Rachana; Salji, Mark; Fleming, Janis; Mitchell, Louise; Nixon, Colin; Strathdee, Douglas; Neilson, Matthew; Ntala, Chara; Bryson, Sheila; Zanivan, Sara; Edwards, Joanne; Robson, Craig N.; Goodyear, Carl S.; Blyth, Karen; Leung, Hing Y.			BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration	ONCOGENE			English	Article							RNA-POLYMERASE III; MOUSE MODEL; CANCER; OVEREXPRESSION; COMPLEMENT	BRF1 is a rate-limiting factor for RNA Polymerase III-mediated transcription and is elevated in numerous cancers. Here, we report that elevated levels of BRF1 associate with poor prognosis in human prostate cancer. In vitro studies in human prostate cancer cell lines demonstrated that transient overexpression of BRF1 increased cell proliferation whereas the transient downregulation of BRF1 reduced proliferation and mediated cell cycle arrest. Consistent with our clinical observations, BRF1 overexpression in a Pten-deficient mouse (Pten(Delta/Delta)BRF1(Tg)) prostate cancer model accelerated prostate carcinogenesis and shortened survival. In Pten(Delta/Delta)BRF1(Tg) tumours, immune and inflammatory processes were altered, with reduced tumoral infiltration of neutrophils and CD4 positive T cells, which can be explained by decreased levels of complement factor D (CFD) and C7 components of the complement cascade, an innate immune pathway that influences the adaptive immune response. We tested if the secretome was involved in BRF1-driven tumorigenesis. Unbiased proteomic analysis on BRF1-overexpresing PC3 cells confirmed reduced levels of CFD in the secretome, implicating the complement system in prostate carcinogenesis. We further identify that expression of C7 significantly correlates with expression of CD4 and has the potential to alter clinical outcome in human prostate cancer, where low levels of C7 associate with poorer prognosis.	[Loveridge, Carolyn J.; Campbell, Kirsteen J.; Ahmad, Imran; Salji, Mark; Ntala, Chara; Zanivan, Sara; Edwards, Joanne; Leung, Hing Y.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland; [Loveridge, Carolyn J.; Slater, Sarah; Campbell, Kirsteen J.; Nam, Noor A.; Knight, John; Ahmad, Imran; Hedley, Ann; Lilla, Sergio; Repiscak, Peter; Patel, Rachana; Salji, Mark; Fleming, Janis; Mitchell, Louise; Nixon, Colin; Strathdee, Douglas; Neilson, Matthew; Ntala, Chara; Bryson, Sheila; Zanivan, Sara; Blyth, Karen; Leung, Hing Y.] CRUK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Robson, Craig N.] Newcastle Univ, Med Sch, Northern Inst Canc Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Goodyear, Carl S.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Nam, Noor A.] Univ Sains Islam Malaysia, Fac Dent, Dept Basic Sci & Oral Biol, Kuala Lumpur, Malaysia	University of Glasgow; Beatson Institute; Newcastle University - UK; University of Glasgow; Universiti Sains Islam Malaysia	Leung, HY (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland.; Leung, HY (corresponding author), CRUK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.	h.leung@beatson.gla.ac.uk	Edwards, Joanne/J-1903-2015; Zanivan, Sara/GOV-5505-2022; Knight, John/V-2922-2019; NAM, NOOR AKMAR/AAG-2571-2019	Edwards, Joanne/0000-0002-7192-6906; Knight, John/0000-0002-8771-5484; Ahmad, Imran/0000-0002-4404-1926; Zanivan, Sara/0000-0002-9880-9099; Loveridge, Carolyn/0000-0002-6237-8661; NAM, NOOR AKMAR/0000-0002-7703-2049; Campbell, Kirsteen/0000-0002-0201-8736; Repiscak, Peter/0000-0002-7335-8324	Cancer Research UK [A15151, A10419, A17196]; Prostate Cancer UK [PG10-10]; Medical Research Council Clinical Research Training Fellowship; Ministry of Higher Education, Malaysia; SLAI Fellowship from University of Malaya	Cancer Research UK(Cancer Research UK); Prostate Cancer UK; Medical Research Council Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); SLAI Fellowship from University of Malaya	This work was funded by Cancer Research UK (A15151, A10419 and A17196; HYL) and Prostate Cancer UK (PG10-10; HYL). SS's PhD was supported by Medical Research Council Clinical Research Training Fellowship. NAN's PhD was sponsored by Ministry of Higher Education, Malaysia and SLAI Fellowship from University of Malaya. We thank the Cancer Research UK Beatson Institute core research services, including the biological services unit and the histology department. We acknowledge Arnaud Blomme for helpful discussions and commenting on the manuscript. We are grateful to Bob White for involvement and useful discussions in the initial stage of this project, and to Owen Sansom for general support in the development of the BRF1 mouse model.	Afshar-Kharghan V, 2017, J CLIN INVEST, V127, P780, DOI 10.1172/JCI90962; Arthurs C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186047; Birch J, 2016, BIOL OPEN, V5, P1371, DOI 10.1242/bio.019075; Bryant G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071542; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Clarke CJ, 2016, CURR BIOL, V26, P755, DOI 10.1016/j.cub.2016.01.045; Fang Z, 2017, MOL ONCOL, V11, P1752, DOI 10.1002/1878-0261.12141; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Hernandez MDLL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00563; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Goodfellow SJ, 2006, EMBO J, V25, P1522, DOI 10.1038/sj.emboj.7601040; Graczyk D, 2015, MOL CELL BIOL, V35, P1848, DOI 10.1128/MCB.00990-14; Kourtzelis I, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.26; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Liko D, 2019, CELL DEATH DIFFER, V26, P2535, DOI 10.1038/s41418-019-0316-7; Loveridge CJ, 2017, CANCER RES, V77, P3158, DOI 10.1158/0008-5472.CAN-16-2565; Moschini M, 2017, EUR UROL, V72, P238, DOI 10.1016/j.eururo.2017.03.009; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thakur Archana, 2013, Cancers (Basel), V5, P569, DOI 10.3390/cancers5020569; Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Wurzner R, 2000, CLIN EXP IMMUNOL, V121, P8, DOI 10.1046/j.1365-2249.2000.01263.x; Zhang YY, 2018, AM J PATHOL, V188, P367, DOI 10.1016/j.ajpath.2017.10.010; Zhong Q, 2016, ONCOTARGET, V7, P6243, DOI 10.18632/oncotarget.6668	26	9	9	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1797	1806		10.1038/s41388-019-1106-x	http://dx.doi.org/10.1038/s41388-019-1106-x			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31740786	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000514923000013
J	Rabeling, SC; Lim, JL; Tidon, R; Neff, JL; Simpson, BB; Pawar, S				Rabeling, Simone Cappellari; Lim, Jia Le; Tidon, Rosana; Neff, John L.; Simpson, Beryl B.; Pawar, Samraat			Seasonal variation of a plant-pollinator network in the Brazilian Cerrado: Implications for community structure and robustness	PLOS ONE			English	Article							NEOTROPICAL SAVANNAS; SOIL-WATER; CLIMATE; VEGETATION; PHENOLOGY; SYSTEMS; HYMENOPTERA; DIVERSITY; PATTERNS; DIPTERA	Seasonal variation in the availability of floral hosts or pollinators is a key factor influencing diversity in plant-pollinator communities. In seasonally dry Neotropical habitats, where month-long periods of extreme drought are followed by a long rainy season, flowering is often synchronized with the beginning of precipitation, when environmental conditions are most beneficial for plant reproduction. In the Brazilian Cerrado, a seasonally dry ecosystem considered one of the world's biodiversity hotspots for angiosperms, plants with shallow root systems flower predominantly during the rainy season. Foraging activity in social bees however, the major pollinators in this biome, is not restricted to any particular season because a constant supply of resources is necessary to sustain their perennial colonies. Despite the Cerrado's importance as a center of plant diversity, the influence of its extreme cycles of drought and precipitation on the dynamics and stability of plant-pollinator communities is not well understood. We sampled plant-pollinator interactions of a Cerrado community weekly for one year and used network analyses to characterize intra-annual seasonal variation in community structure. We also compared seasonal differences in community robustness to species loss by simulating extinctions of plants and pollinators. We find that the community shrinks significantly in size during the dry season, becoming more vulnerable to disturbance due to the smaller pool of floral hosts available to pollinators during this period. Major changes in plant species composition but not in pollinators has led to high levels of turnover in plant-pollinator associations across seasons, indicated by in interaction dissimilarity (< 3% of shared interactions). Aseasonal pollinators, which mainly include social bees and some solitary specialized bees, functioned as keystone species, maintaining robustness during periods of drastic changes in climatic conditions.	[Rabeling, Simone Cappellari; Simpson, Beryl B.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Lim, Jia Le] Imperial Coll London, Dept Life Sci, South Kensington Campus, London, England; [Tidon, Rosana] Univ Brasilia, Inst Ciencias Biol, Dept Genet & Morfol, Brasilia, DF, Brazil; [Neff, John L.] Cent Texas Melittol Inst, Austin, TX USA; [Pawar, Samraat] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England; [Rabeling, Simone Cappellari] Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ 85281 USA; [Lim, Jia Le] European Mol Biol Labs EMBL, Barcelona, Spain	University of Texas System; University of Texas Austin; Imperial College London; Universidade de Brasilia; Imperial College London; Arizona State University; Arizona State University-Tempe	Rabeling, SC (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.; Rabeling, SC (corresponding author), Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ 85281 USA.	scappellari@asu.edu	Tidon, Rosana/J-7597-2012	Tidon, Rosana/0000-0002-6837-9972; Lim, Jia Le/0000-0002-1504-7974; Pawar, Samraat/0000-0001-8375-5684; Cappellari-Rabeling, Simone/0000-0001-5277-6407	National Science Foundation Doctoral Dissertation Improvement Grant (DDIG) (DEB Award) [0909511]; C. L. Lundell Chair of The University of Texas at Austin; University of California at Los Angeles Biomathematics start-up funds; National Science Foundation Fund (DEB Award) [1021010]; Frank and Fern Blair Research Grant; Marion E. Eason Excellence Award in Student Research; University of Texas at Austin at Austin Endowed Continuing Fellowship for Student Excellence	National Science Foundation Doctoral Dissertation Improvement Grant (DDIG) (DEB Award); C. L. Lundell Chair of The University of Texas at Austin; University of California at Los Angeles Biomathematics start-up funds; National Science Foundation Fund (DEB Award); Frank and Fern Blair Research Grant; Marion E. Eason Excellence Award in Student Research; University of Texas at Austin at Austin Endowed Continuing Fellowship for Student Excellence	SCR and BBS were supported by National Science Foundation Doctoral Dissertation Improvement Grant (DDIG) (DEB Award 0909511); BBS was supported by endowment funds from the C. L. Lundell Chair of The University of Texas at Austin; SP was supported by University of California at Los Angeles Biomathematics start-up funds and by National Science Foundation Fund (DEB Award 1021010); SCR was supported by the Frank and Fern Blair Research Grant, the Marion E. Eason Excellence Award in Student Research, and the University of Texas at Austin Endowed Continuing Fellowship for Student Excellence.	Aguiar AJC, 2011, ZOOL J LINN SOC-LOND, V162, P351, DOI 10.1111/j.1096-3642.2010.00678.x; Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; [Anonymous], 2007, CATALOGUE BEES HYMEN; Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Armbruster WS, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P260; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Basilio AM, 2006, AUSTRAL ECOL, V31, P975, DOI 10.1111/j.1442-9993.2006.01666.x; Batalha MA, 2004, AUST J BOT, V52, P149, DOI 10.1071/BT03098; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Biesmeijer JC, 2006, APIDOLOGIE, V37, P240, DOI 10.1051/apido:2006014; Bullock Stephen H., 1995, P277, DOI 10.1017/CBO9780511753398.011; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Cappellari SC, 2011, RESERVA ECOLOGICA IB, V1, P275; CaraDonna PJ, 2017, ECOL LETT, V20, P385, DOI 10.1111/ele.12740; Morellato LPC, 2016, BIOL CONSERV, V195, P60, DOI 10.1016/j.biocon.2015.12.033; Chambers LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075514; COUTINHO L M, 1978, Revista Brasileira de Botanica, V1, P17; Dehmer M., 2011, APPL STAT NETWORK BI; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; Velazco SJE, 2019, DIVERS DISTRIB, V25, P660, DOI 10.1111/ddi.12886; Ferri MG., 1944, THESIS, P155; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; GOTTSBERGER G, 1986, PLANT SYST EVOL, V152, P29, DOI 10.1007/BF00985349; Gottsberger G, 2006, LIFE CERRADO ORIGIN, V1; Gottsberger G., 2006, LIFE CERRADO POLLINA, V2; HUBER O, 1987, TRENDS ECOL EVOL, V2, P67, DOI 10.1016/0169-5347(87)90151-0; Jackson PC, 1999, TREE PHYSIOL, V19, P717; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kay KM, 2009, ANNU REV ECOL EVOL S, V40, P637, DOI 10.1146/annurev.ecolsys.110308.120310; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Lundgren R, 2005, ARCT ANTARCT ALP RES, V37, P514, DOI 10.1657/1523-0430(2005)037[0514:TDAHCW]2.0.CO;2; MANTOVANI W, 1988, Revista Brasileira de Botanica, V11, P101; Martins F. Q., 2006, Braz. J. Biol., V66, P543, DOI 10.1590/S1519-69842006000300021; Mata R.A., 2015, REV BRAS ENTOMOL, V59, P50; Medan D, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P245; Meinzer FC, 1999, OECOLOGIA, V121, P293, DOI 10.1007/s004420050931; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Michener C. D., 2000, The bees of the world; Moure JS, 1962, MAMANGABAS SOCIAIS B; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEFF JL, 1981, J KANSAS ENTOMOL SOC, V54, P95; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Oliveira P.E., 2008, CERRADO ECOLOGIA FLO, P169; Oliveira Paulo E., 2002, P329; Oliveira PE, 2000, FLORA, V195, P311; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pawar S, 2014, SCIENCE, V345, P383, DOI 10.1126/science.1256466; Pennington RT, 2006, SYST ASSOC SPEC VOL, P1; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Pinheiro F, 2002, AUSTRAL ECOL, V27, P132, DOI 10.1046/j.1442-9993.2002.01165.x; Pinheiro-Machado C., 2002, POLLINATING BEES CON, P115; Poisot T, 2012, ECOL LETT, V15, P1353, DOI 10.1111/ele.12002; Ratter JA, 2006, SYST ASSOC SPEC VOL, P31; RAWITSCHER F, 1948, J ECOL, V36, P237, DOI 10.2307/2256669; RICKLEFS RE, 1994, EVOLUTION, V48, P1619, DOI 10.1111/j.1558-5646.1994.tb02200.x; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Roque F, 2013, BIODIVERS CONSERV, V22, P657, DOI 10.1007/s10531-013-0433-4; Roubik D.W., 1992, ECOLOGY NATURAL HIST; SILBERBAUER-GOTTSBERGER I, 1988, Revista Brasileira de Biologia, V48, P651; Silveira F.A., 2002, ABELHAS BRASILEIRAS, V1; Silveira Fernando A., 1995, Revista Brasileira de Entomologia, V39, P371; SIMPSON BB, 1981, ANN MO BOT GARD, V68, P301, DOI 10.2307/2398800; Souza CS, 2018, J ECOL, V106, P2409, DOI 10.1111/1365-2745.12978; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tidon R, 2006, BIOL J LINN SOC, V87, P233, DOI 10.1111/j.1095-8312.2006.00570.x; Valadao Henrique, 2010, International Journal of Ecology, V2010, P1, DOI 10.1155/2010/152437; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vilela AA, 2018, ARTHROPOD-PLANT INTE, V12, P215, DOI 10.1007/s11829-017-9572-y; Vogel S., 1974, TROPISCHE SUBTROPISC; Waser NM, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P3; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105	81	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224997	10.1371/journal.pone.0224997	http://dx.doi.org/10.1371/journal.pone.0224997			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790414	Green Published, gold			2022-12-26	WOS:000533930800021
J	D'Emic, MD; O'Connor, PM; Pascucci, TR; Gavras, JN; Mardakhayava, E; Lund, EK				D'Emic, Michael D.; O'Connor, Patrick M.; Pascucci, Thomas R.; Gavras, Joanna N.; Mardakhayava, Elizabeth; Lund, Eric K.			Evolution of high tooth replacement rates in theropod dinosaurs	PLOS ONE			English	Article							MAJUNGASAURUS-CRENATISSIMUS THEROPODA; BODY-MASS; ABELISAURIDAE	Tooth replacement rate is an important contributor to feeding ecology for polyphyodont animals. Dinosaurs exhibit a wide range of tooth replacement rates, mirroring their diverse craniofacial specializations, but little is known about broad-scale allometric or evolutionary patterns within the group. In the current broad but sparse dinosaurian sample, only three non-avian theropod tooth replacement rates have been estimated. We estimated tooth formation and replacement rates in three additional non-avian theropod dinosaurs, the derived latest Cretaceous abelisaurid Majungasaurus and the more generalized Late Jurassic Allosaurus and Ceratosaurus. We created the largest dental histological and CT dataset for any theropod dinosaur, sectioning and scanning over a dozen toothed elements of Majungasaurus and several additional elements from the other two genera. Using this large sample, we created models of tooth formation time that allow for theropod replacement rates to be estimated non-destructively. In contrast to previous results for theropods, we found high tooth replacement rates in all three genera, with Allosaurus and Ceratosaurus rates of similar to 100 days and 56 days for Majungasaurus. The latter rate is on par with those of derived herbivorous dinosaurs including some neosauropods, hadrosaurids, and ceratopsians. This elevated rate may be a response to high rates of tooth wear in Majungasaurus. Within Dinosauria, there is no relationship between body mass and tooth replacement rate and no trends in replacement rate over time. Rather, tooth replacement rate is clade-specific, with elevated rates in abelisaurids and diplodocoids and lower rates in coelurosaurs.	[D'Emic, Michael D.; Pascucci, Thomas R.; Gavras, Joanna N.; Mardakhayava, Elizabeth] Adelphi Univ, Dept Biol, Garden City, NY 11530 USA; [D'Emic, Michael D.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [O'Connor, Patrick M.; Lund, Eric K.] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA; [O'Connor, Patrick M.; Lund, Eric K.] Ohio Ctr Ecol & Evolutionary Studies, Athens, OH USA; [Lund, Eric K.] North Carolina Museum Nat Sci, Dept Biol Sci, Raleigh, NC USA	Adelphi University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Ohio; Ohio University	D'Emic, MD (corresponding author), Adelphi Univ, Dept Biol, Garden City, NY 11530 USA.; D'Emic, MD (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	mdemic@adelphi.edu	OConnor, Patrick M/I-9383-2012	OConnor, Patrick M/0000-0002-6762-3806; D'Emic, Michael/0000-0002-6162-7005; Gavras, Joanna Nicolette/0000-0001-7980-2767	National Geographic Foundation Committee for Research and Exploration [9252-13]; National Science Foundation [EAR-1525915, EAR-1664432]	National Geographic Foundation Committee for Research and Exploration; National Science Foundation(National Science Foundation (NSF))	Funded by MDD, National Geographic Foundation Committee for Research and Exploration, 9252-13. https://www.nationalgeographic.org/grants/grant-opportunities/. PMO, National Science Foundation, EAR-1525915. https://www.nsf.gov/. D.W.Krause, National Science Foundation EAR-1664432. https://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Brink KS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12338; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Button K, 2017, PEERJ, V5, DOI 10.7717/peerj.4129; Campione NE, 2014, METHODS ECOL EVOL, V5, P913, DOI 10.1111/2041-210X.12226; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Coria RA, 2001, AMEGHINIANA, V38, P463; D'Emic MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069375; D'Emic MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069235; DUMONT M., 2016, BMC EVOLUTIONARY BIO, V16, P1, DOI DOI 10.1186/S12862-016-0753-6; Edmund A. G., 1960, ROYAL ONTARIO MUSEUM, V52, P1; Erickson GM, 1996, J MORPHOL, V228, P189, DOI 10.1002/(SICI)1097-4687(199605)228:2<189::AID-JMOR7>3.0.CO;2-0; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Gignac P, 2018, J VERT PALEO PROGRAM, P134; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kosch JCD, 2014, SOC VERT PALAEONTOL, P162; Mishima H., 2003, BIOMINERALIZATION BI, V1st edn, P317; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P1; Renvoise E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00324; Rogers RR, 2003, NATURE, V422, P515, DOI 10.1038/nature01532; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Scheyer TM, 2011, SWISS J GEOSCI, V104, pS147, DOI 10.1007/s00015-011-0076-y; Schwarz D, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.1008134; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Smith JB, 2007, J VERTEBR PALEONTOL, V27, P103, DOI 10.1671/0272-4634(2007)27[103:DMAVIM]2.0.CO;2; Zhou Ya-Chun, 2019, VERTEBRATA PALASIATICA, V57, P38, DOI 10.19615/j.cnki.1000-3118.180307	28	18	18	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0224734	10.1371/journal.pone.0224734	http://dx.doi.org/10.1371/journal.pone.0224734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774829	Green Published, gold			2022-12-26	WOS:000533896400015
J	Dutra, LD; de Lima, LCM; Neves, ETB; Gomes, MC; de Araujo, LJS; Forte, FDS; Paiva, SM; Ferreira, FM; Granville-Garcia, AF				Dutra, Laio da Costa; Morais de Lima, Larissa Chaves; Barbosa Neves, Erick Tassio; Gomes, Monalisa Cesarino; Serafim de Araujo, Luiza Jordania; Soares Forte, Franklin Delano; Paiva, Saul Martins; Ferreira, Fernanda Morais; Granville-Garcia, Ana Flavia			Adolescents with worse levels of oral health literacy have more cavitated carious lesions	PLOS ONE			English	Article							DENTAL-CARIES; ASSOCIATION; RELIABILITY; KNOWLEDGE	The aim of the present study was to investigate whether the ability to recognize and read oral health terms is associated with the number of teeth with cavitated carious lesions in adolescents. A population-based cross-sectional study was conducted involving a sample of 746 adolescents representative of students aged 15 to 19 years at the public and private school systems in a city in northeast Brazil. Two examiners who had undergone a training and calibration exercise (inter-examiner and intra-examiner Kappa coefficient: 0.87 to 0.93) performed the diagnosis of caries using the Nyvad Index and evaluated the level of OHL (BREALD-30) of the adolescents. The participants answered questions regarding their history of visits to the dentist and the parents/caregivers answered a questionnaire addressing socioeconomic characteristics. A directed acyclic graph was created to direct the selection of covariables for adjustments in the Poisson multiple regression analysis to test the association between dental caries and OHL (alpha = 5%). Cavitated carious lesions (codes 3 to 6 on the Nyvad index) were found in 41.6% of the adolescents. Only 29.4% had a high level of OHL (BREALD-30 scores between 23 and 30); 42.3% of the families belonged to the A-B social class and 93% of the adolescents had been to the dentist at least once in their lifetimes. In the multivariate analysis, adolescents with inadequate (PR: 1.69; 95% CI: 1.18-2.41; p = 0.004) and marginal (PR; 1.42; 95% CI: 1.01-1.99; p = 0.042) OHL and those in the lower social classes (C-D-E) (PR: 1.85; 95% CI: 1.39-2.47; p<0.001) had more teeth with cavitated carious lesions. In conclusion, adolescents aged 15 to 19 years with poorer levels of OHL had a larger number of teeth with cavitated carious lesions, independently of their socioeconomic status and history of visiting a dentist.	[Dutra, Laio da Costa; Morais de Lima, Larissa Chaves; Barbosa Neves, Erick Tassio; Gomes, Monalisa Cesarino; Serafim de Araujo, Luiza Jordania; Granville-Garcia, Ana Flavia] State Univ Paraiba UEPB, Grad Program Dent, Campina Grande, Paraiba, Brazil; [Soares Forte, Franklin Delano] Fed Univ Paraiba UFPB, Grad Program Dent, Joao Pessoa, Paraiba, Brazil; [Paiva, Saul Martins; Ferreira, Fernanda Morais] Fed Univ Minas Gerais UFMG, Grad Program Dent, Belo Horizonte, MG, Brazil	Universidade Estadual da Paraiba; Universidade Federal da Paraiba; Universidade Federal de Minas Gerais	Granville-Garcia, AF (corresponding author), State Univ Paraiba UEPB, Grad Program Dent, Campina Grande, Paraiba, Brazil.	anaflaviagg@gmail.com	Ferreira, Fernanda/D-6361-2013	Ferreira, Fernanda/0000-0001-9400-1167	Coordination for the Advancement of Higher Education Personnel, Ministry of Education (CAPES) [88887.162455/2017-00]; State of Paraiba Research Foundation (FAPESQ PB) [88887.155389/2017-00]; National Council of Scientific and Technological Development (CNPQ) [304643/2016-5]	Coordination for the Advancement of Higher Education Personnel, Ministry of Education (CAPES); State of Paraiba Research Foundation (FAPESQ PB); National Council of Scientific and Technological Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funded by Coordination for the Advancement of Higher Education Personnel, Ministry of Education (CAPES-Process 88887.162455/2017-00), State of Paraiba Research Foundation (FAPESQ PB -Process 88887.155389/2017-00), and the National Council of Scientific and Technological Development (CNPQ -Process 304643/2016-5).	Antunes José Leopoldo Ferreira, 2008, Rev. Saúde Pública, V42, P191, DOI 10.1590/S0034-89102008000200002; Associacao Brasileira de Empresas de Pesquisa (ABEP), 2016, CRIT CLASS EC BRAS; Baskaradoss JK, 2016, J AM DENT ASSOC, V147, P867, DOI 10.1016/j.adaj.2016.05.011; Biazevic Maria Gabriela Haye, 2008, Braz. oral res., V22, P36, DOI 10.1590/S1806-83242008000100007; Blizniuk A, 2015, COMMUNITY DENT HLTH, V32, P148, DOI 10.1922/CDH_3584-Blizniuk05; Bridges SM, 2014, J PUBLIC HEALTH DENT, V74, P110, DOI 10.1111/jphd.12033; Cianetti S, 2017, EUR J PAEDIATR DENT, V18, P15, DOI 10.23804/ejpd.2017.18.01.03; Davoglio RS, 2009, CAD SAUDE PUBLICA, V25, P655, DOI 10.1590/S0102-311X2009000300020; DeWalt Darren A, 2009, Pediatrics, V124 Suppl 3, pS265, DOI 10.1542/peds.2009-1162B; Engelmann Janessa Luiza, 2016, Braz. Dent. J., V27, P72, DOI 10.1590/0103-6440201600435; Gomes Monalisa Cesarino, 2017, Braz. Dent. J., V28, P523, DOI 10.1590/0103-6440201601295; Gong DA, 2007, J PUBLIC HEALTH DENT, V67, P105, DOI 10.1111/j.1752-7325.2007.00023.x; Gushi Lívia Litsue, 2005, Cad. Saúde Pública, V21, P1383, DOI 10.1590/S0102-311X2005000500010; Haridas Reshmi, 2014, J Int Oral Health, V6, P61; Holtzman JS, 2014, COMMUNITY DENT ORAL, V42, P263, DOI 10.1111/cdoe.12089; Junkes MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131600; Kim JA, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0576-5; Lee JY, 2012, AM J PUBLIC HEALTH, V102, P923, DOI 10.2105/AJPH.2011.300291; Macek MD, 2017, COMMUNITY DENT ORAL, V45, P323, DOI 10.1111/cdoe.12294; Macek MD, 2010, J PUBLIC HEALTH DENT, V70, P197, DOI 10.1111/j.1752-7325.2010.00165.x; Malta M, 2010, REV SAUDE PUBL, V44, P559, DOI 10.1590/S0034-89102010000300021; Marthaler T, 2005, COMMUNITY DENT ORAL, V33, P159, DOI 10.1111/j.1600-0528.2005.00196.x; Miller E, 2010, PEDIATRICS, V126, P107, DOI 10.1542/peds.2009-2887; Ministerio da Saude. Secretaria de AtencAo a Saude. Secretaria de Vigilancia em Saude, 2012, SB BRAS 2010 PESQ NA, P116; de Lima LCM, 2019, REV SAUDE PUBL, V53, DOI [10.11606/S1518-8787.2019053000999, 10.11606/s1518-8787.2019053000999]; Newton JT, 2005, COMMUNITY DENT ORAL, V33, P25, DOI 10.1111/j.1600-0528.2004.00190.x; Nyvad B, 1999, CARIES RES, V33, P252, DOI 10.1159/000016526; Nyvad B, 2018, CARIES RES, V52, P397, DOI 10.1159/000480522; Peker K, 2017, ACTA ODONTOL SCAND, V75, P198, DOI 10.1080/00016357.2016.1278079; Peres M A, 2001, Cad Saude Publica, V17, P153, DOI 10.1590/S0102-311X2001000100016; Peres MA, 2018, BRAZ ORAL RES, V32, DOI 10.1590/1807-3107bor-2018.vol32.0036; Perry EL, 2014, J SPEC PEDIATR NURS, V19, P210, DOI 10.1111/jspn.12072; Roncalli AG, 2015, COMMUNITY DENT ORAL, V43, P317, DOI 10.1111/cdoe.12156; Sanders Lee M, 2009, Pediatrics, V124 Suppl 3, pS306, DOI 10.1542/peds.2009-1162G; Sanzone LA, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-24; Schiavo Julie H, 2011, J Dent Hyg, V85, P248; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Silveira MF, 2015, CIENC SAUDE COLETIVA, V20, P3351, DOI 10.1590/1413-812320152011.12262014; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Vichayanrat T., 2014, M DENT J, V34, P243; Vilella KD, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0090	41	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225176	10.1371/journal.pone.0225176	http://dx.doi.org/10.1371/journal.pone.0225176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8SS	31774850	gold, Green Submitted, Green Published			2022-12-26	WOS:000533896400028
J	Zhan, YF; Wu, YH; Chen, JQ				Zhan, Yuefu; Wu, Yehua; Chen, Jianqiang			Carbogen gas-challenge BOLD fMRI in assessment of liver hypoxia after portal microcapsules implantation	PLOS ONE			English	Article							ISLET TRANSPLANTATION; EDMONTON PROTOCOL; RAT MODEL; MRI; PIMONIDAZOLE; REVASCULARIZATION; OXYGENATION; BRAIN	Background Hypoxia is one of the key factors affecting the survival of islet cells transplanted via the portal vein. Blood oxygen level dependent functional magnetic resonance imaging (BOLD-fMRI) is the only imaging technique that can detect the level of blood oxygen level in vivo. However, so far no study has indicated that BOLD-fMRI can be applied to monitor the liver oxygen level after islet transplantation. Objective To evaluate the value of Carbogen-challenge BOLD MRI in assessing the level of hypoxia in liver tissue after portal microcapsules implanted. Methods Fifty-one New Zealand rabbits were randomly divided into three experimental groups (15 in each group) were transplanted microencapsulated 1000 microbeads/kg (PV1 group), 3000 microbeads/kg (PV2 group), 5000 microbeads/kg (PV3 group), and 6 rabbits were injected with the same amount of saline as the control group, BOLD-fMRI was performed following carbogen breathing in each group after transplantation on 1d, 2d, 3d and 7d, T2* weighted image, R2* value and Delta R2* value parameters for the liver tissue. Pathological examinations including liver gross pathology, H&E staining and pimonidazole immunohistochemistry were performed after BOLD-fMRI. The differences of pathological results among each group were compared. The Delta R2* values and transplanted doses were analyzed. Results and conclusions Delta R2* values at the 1-3d and 7d after transplantation were significantly different in each groups (P<0.05). Delta R2* values decreased gradually with the increase of transplanted dose, and was negatively correlated with transplant dose at 3d after transplantation (r = -0.929, P < 0.001). Liver histopathological examination showed that the degree of hypoxia of liver tissue increased with the increase of transplanted doses, Carbogen-challenge BOLD-fMRI can assess the degree of liver hypoxia after portal microcapsules implanted, which provided a monitoring method for early intervention.	[Zhan, Yuefu] Maternal & Child Hlth Hosp Hainan Prov, Dept Radiol, Haikou, Hainan, Peoples R China; [Wu, Yehua] Hainan Gen Hosp, Haikou, Hainan, Peoples R China; [Chen, Jianqiang] Cent South Univ, Dept Radiol, Xiangya Sch Med, Affiliated Haikou Hosp, Haikou, Hainan, Peoples R China		Chen, JQ (corresponding author), Cent South Univ, Dept Radiol, Xiangya Sch Med, Affiliated Haikou Hosp, Haikou, Hainan, Peoples R China.	hnchenjq@163.com		Zhan, Yuefu/0000-0002-9093-0599	Hainan Province Scientific and Technological Program [ZDYD2019164]; Health Family Planning Project in Hainan Province [16A200087]	Hainan Province Scientific and Technological Program; Health Family Planning Project in Hainan Province	This work was supported by Hainan Province Scientific and Technological Program (No. ZDYD2019164) and the Health Family Planning Project in Hainan Province (16A200087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barasli H, 2008, HEPATOLOGY, V48, P1232, DOI 10.1002/hep.22394; Brennan DC, 2016, AM J TRANSPLANT, V16, P509, DOI 10.1111/ajt.13458; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Bruni A, 2014, DIABETES METAB SYNDR, V7, P211, DOI 10.2147/DMSO.S50789; Cheng G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00453-9; Choi JW, 2013, ANTICANCER RES, V33, P1887; Christen T, 2013, AM J NEURORADIOL, V34, P1113, DOI 10.3174/ajnr.A3070; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461; Foster GA, 2017, ADV DRUG DELIVER REV, V114, P266, DOI 10.1016/j.addr.2017.05.012; Froud T, 2005, AM J TRANSPLANT, V5, P2037, DOI 10.1111/j.1600-6143.2005.00957.x; Gaber AO, 2004, TRANSPLANTATION, V77, P309, DOI 10.1097/01.TP.0000101509.35249.A0; Jin N, 2010, RADIOLOGY, V254, P129, DOI 10.1148/radiol.09090410; Kaanders JHAM, 2002, CANCER RES, V62, P7066; King AL, 2016, REDOX BIOL, V9, P188, DOI 10.1016/j.redox.2016.08.005; Lablanche S, 2015, DIABETES CARE, V38, P1714, DOI 10.2337/dc15-0094; Lim F, 1980, SCIENCE, V21, P210; Nordsmark M, 2003, RADIOTHER ONCOL, V67, P35, DOI 10.1016/S0167-8140(03)00010-0; Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211; Ragnum HB, 2015, BRIT J CANCER, V112, P382, DOI 10.1038/bjc.2014.604; Rodriguez-Brotons A, 2016, J DIABETES RES, V2016, P1; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Sakata N, 2009, TRANSPLANTATION, V87, P825, DOI 10.1097/TP.0b013e318199c7d2; Schoennagel BP, 2015, J MAGN RESON IMAGING, V41, P110, DOI 10.1002/jmri.24555; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Suszynski TM, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/7625947; Tomei AA, 2014, P NATL ACAD SCI USA, V111, P10514, DOI 10.1073/pnas.1402216111; Ullsten S, 2015, DIABETOLOGIA, V58, P132, DOI 10.1007/s00125-014-3385-7; Wallace TE, 2016, J MAGN RESON IMAGING, V44, P335, DOI 10.1002/jmri.25177; Wilhelm JJ, 2013, AM J TRANSPLANT, V13, P3183, DOI 10.1111/ajt.12482; Yang HK, 2015, J DIABETES COMPLICAT, V29, P737, DOI 10.1016/j.jdiacomp.2015.03.017	31	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225665	10.1371/journal.pone.0225665	http://dx.doi.org/10.1371/journal.pone.0225665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KY2FX	31774857	Green Published, gold			2022-12-26	WOS:000522387200001
J	Asghari, G; Yuzbashian, E; Wagner, CL; Mahdavi, M; Shamsi, R; Hosseinpanah, F; Mirmiran, P				Asghari, Golaleh; Yuzbashian, Emad; Wagner, Carol L.; Mahdavi, Maryam; Shamsi, Roya; Hosseinpanah, Farhad; Mirmiran, Parvin			The relation between circulating levels of vitamin D and parathyroid hormone in children and adolescents with overweight or obesity: Quest for a threshold	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D-DEFICIENCY; PUBERTAL CHANGES; PREVALENCE; PATTERN	The level of serum 25-hydroxyvitamin D (25(OH)D) at which intact parathyroid hormone (iPTH) is maximally suppressed (suppression point) and below which PTH begins to rise (inflection point) has been used to define optimum 25(OH)D concentration. We aimed to study the association of circulating iPTH with 25(OH)D concentrations and to determine a 25(OH)D threshold associated with a significant iPTH suppression. This cross-sectional study was conducted on 198 boys and 180 girls, aged 6-13 years with BMI >= 1SD (WHO criteria) recruited from primary schools. Adjusted iPTH for BMI z-score, pubertal status, and dietary calcium was used. Nonlinear regression was used to model the relationship between 25(OH)D and iPTH and identify a suppression point for 25(OH)D at which iPTH reached a plateau. Piecewise regression analysis with a single knot for all possible values of 25(OH)D were fitted. Furthermore, 95% confidence intervals (95%CI) for those point had been calculated. The mean age (SD) of girls and boys was 9.1 (1.6) and 9.4 (1.7) years, respectively. Median 25(OH)D and iPTH were 13.8 ng/mL and 33.9 pg/mL in boys and 9.9 ng/mL and 47.8 ng/mL in girls, respectively. The equation in girls was: log-iPTH = 3.598+0.868 exp [(-0.190x25( OH)D. The point for near maximal suppression of iPTH by 25(OH)D for girls occurred at a 25(OH)D concentration of 20 ng/mL (95% CI: 7.1 to 32.2). No point of maximal suppression was found for boys. We also found a 25(OH)D threshold of 10 ng/mL (95% CI: 4.6 to 22.5) for girls (f: 9.8) by linear piecewise regression modeling of adjusted iPTH. No significant inflection point for boys was observed. In overweight/obese girls, when the concentration of 25(OH)D was higher than 20 ng/mL, an iPTH mean plateau level is reached, and when its concentrations approach 10 ng/mL, the slope of iPTH concentration has been accelerated.	[Asghari, Golaleh; Yuzbashian, Emad; Shamsi, Roya; Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Nutr & Endocrine Res Ctr, Tehran, Iran; [Wagner, Carol L.] Shawn Jenkins Childrens Hosp, Dept Pediat, Div Neonatol, Charleston, SC USA; [Mahdavi, Maryam; Hosseinpanah, Farhad] Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Mirmiran, P (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Nutr & Endocrine Res Ctr, Tehran, Iran.; Hosseinpanah, F (corresponding author), Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	fhospanah@endocrine.ac.ir; mirmiran@endocrine.ac.ir	Mirmiran, Parvin/V-1433-2019; Yuzbashian, Emad/AAL-8268-2021	Asghari, Golaleh/0000-0002-7925-5158; Yuzbashian, Emad/0000-0002-1748-5978; mahdavi, maryam/0000-0002-8371-0694; Mirmiran, Parvin/0000-0003-2391-4924	Shahid Beheshti University of Medical Sciences, Tehran, Iran [10429-4]	Shahid Beheshti University of Medical Sciences, Tehran, Iran	This study was supported by the Shahid Beheshti University of Medical Sciences, Tehran, Iran (Grant no. 10429-4). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alyahya KO, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0963-0; Amini Z, 2013, HORM RES PAEDIAT, V80, P252, DOI 10.1159/000354645; Asghari G, 2019, J STEROID BIOCHEM, V188, P117, DOI 10.1016/j.jsbmb.2018.12.015; Asghari G, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1347-9; Atapattu N, 2013, PEDIATR RES, V74, P552, DOI 10.1038/pr.2013.139; Barja-Fernandez S, 2018, J PHYSIOL BIOCHEM, V74, P111, DOI 10.1007/s13105-017-0581-1; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; Dawson-Hughes B, 2005, ESTIMATES OPTIMAL VI; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Del Valle H.B., 2011, DIETARY REFERENCE IN; Di Monaco M, 2013, J NUTR HEALTH AGING, V17, P180, DOI 10.1007/s12603-012-0088-y; Frank GR, 2003, MED PEDIATR ONCOL, V41, P217, DOI 10.1002/mpo.10340; Guillemant J, 1999, OSTEOPOROSIS INT, V10, P222, DOI 10.1007/s001980050219; Habibesadat S, 2014, J PEDIATR ENDOCR MET, V27, P431, DOI 10.1515/jpem-2013-0198; Harkness L, 2005, OSTEOPOROSIS INT, V16, P109, DOI 10.1007/s00198-004-1656-8; Heaney RP, 2004, AM J CLIN NUTR, V80, p1706S, DOI 10.1093/ajcn/80.6.1706S; Hekimsoy Z, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-782; Hill KM, 2010, J NUTR, V140, P1983, DOI 10.3945/jn.110.124966; Hill TR, 2010, OSTEOPOROSIS INT, V21, P695, DOI 10.1007/s00198-009-0959-1; Hirani V, 2010, AGE AGEING, V39, P62, DOI [10.1093/ageing/afp195, 10.1093/ageing/afp102]; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Kang Jung In, 2017, Korean J Pediatr, V60, P45, DOI 10.3345/kjp.2017.60.2.45; Karaguzel G, 2014, J PEDIATR GASTR NUTR, V58, P654, DOI 10.1097/MPG.0000000000000274; Ke L, 2018, J STEROID BIOCHEM, V177, P270, DOI 10.1016/j.jsbmb.2017.07.010; Kim Se Young, 2013, Ann Pediatr Endocrinol Metab, V18, P45, DOI 10.6065/apem.2013.18.2.45; Lehtonen-Veromaa M, 1999, EUR J CLIN NUTR, V53, P746, DOI 10.1038/sj.ejcn.1600844; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Maguire JL, 2014, JAMA PEDIATR, V168, P383, DOI 10.1001/jamapediatrics.2013.5379; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Momenan AA, 2012, ARCH IRAN MED, V15, P279, DOI 012155/AIM.007; Newton DA, 2019, PEDIATR RES, V86, P662, DOI 10.1038/s41390-019-0322-y; Outila TA, 2001, AM J CLIN NUTR, V74, P206; Plesner JL, 2018, J PEDIATR ENDOCR MET, V31, P53, DOI 10.1515/jpem-2017-0246; Quaggiotto P, 2014, SINGAP MED J, V55, P271, DOI 10.11622/smedj.2014071; Razzaghy-Azar M, 2010, ANN HUM BIOL, V37, P692, DOI 10.3109/03014460903527348; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sahin ON, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0479-8; Srivastava T, 2002, CLIN PEDIATR, V41, P263, DOI 10.1177/000992280204100411; Turer CB, 2012, PEDIATRICS; Weydert JA, 2014, CHILDREN-BASEL, V1, P208, DOI 10.3390/children1020208; Yuzbashian E, 2019, J STEROID BIOCHEM, V187, P82, DOI 10.1016/j.jsbmb.2018.11.004	45	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225717	10.1371/journal.pone.0225717	http://dx.doi.org/10.1371/journal.pone.0225717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770397	gold, Green Published			2022-12-26	WOS:000533892300033
J	Kim, HS; Kim, YS; Lee, C; Shin, MS; Kim, JW; Jang, BG				Kim, Hye Sung; Kim, Young Sil; Lee, Chul; Shin, Myung Soo; Kim, Jae Wang; Jang, Bo Gun			Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma	PLOS ONE			English	Article							HAIR FOLLICLE; STEM-CELLS; HUMAN HOMOLOG; GLI1; ACTIVATION; MUTATIONS; PROTEIN; LGR6	Basal cell carcinoma (BCC) is the most common human cancer, characterized by aberrant activation of the hedgehog (HH) signaling pathway resulting from mutations in the patched 1 (PTCH1) or smoothened (SMO) genes. In the present study, to uncover the expression profile of HH signaling-related molecules, we thoroughly examined the mRNA and protein expression levels of six molecules including GLI1, GLI2, PTCH1, PTCH2, SHH, and SMO in BCC and various other cutaneous tumors. Real-time PCR analysis demonstrated that BCC showed remarkably enhanced mRNA expression of all HH molecules, except SMO compared to other skin tumors. However, immunohistochemical analysis revealed that only GLI1 protein was specifically upregulated in BCC, while the other HH-related proteins did not show any significant differences between the tumors. Notably, other skin malignancies such as squamous cell carcinoma, sebaceous carcinoma, and malignant melanoma showed no GLI1 expression and there was no difference in GLI1 expression between the BCC subtypes. In addition, GLI1 and GLI2 expression were strongly associated with the hair follicle stem cell markers, LGR4 and LGR5, which are known target genes of the Wnt pathway. Our results suggest that GLI1 has the potential to be a diagnostically useful marker for differentiating BCC from other skin malignancies and an interaction between the HH and Wnt signaling pathways may be involved in the development of BCCs.	[Kim, Hye Sung; Kim, Young Sil; Jang, Bo Gun] Jeju Natl Univ, Dept Pathol, Coll Med, Jeju, South Korea; [Lee, Chul] Seoul Natl Univ, Dept Pathol, Coll Med, Seoul, South Korea; [Shin, Myung Soo] Jeju Natl Univ, Dept Plast Surg, Coll Med, Jeju, South Korea; [Kim, Jae Wang] Jeju Natl Univ, Dept Dermatol, Coll Med, Jeju, South Korea	Jeju National University; Seoul National University (SNU); Jeju National University; Jeju National University	Jang, BG (corresponding author), Jeju Natl Univ, Dept Pathol, Coll Med, Jeju, South Korea.	Bgjang9633@gmail.com		Jang, Bogun/0000-0003-4683-8338; Lee, Cheol/0000-0001-5098-8529	Jeju National University Hospital	Jeju National University Hospital	This study was supported by a research grant from Jeju National University Hospital in 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2008, COLD SPRING HARBOR S; Bonifas JM, 2001, J INVEST DERMATOL, V116, P739, DOI 10.1046/j.1523-1747.2001.01315.x; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Martinez MF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020144; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Infante P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03339-0; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jang BG, 2017, VIRCHOWS ARCH, V470, P301, DOI 10.1007/s00428-016-2061-3; Jang BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082390; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kasper M, 2012, J CLIN INVEST, V122, P455, DOI 10.1172/JCI58779; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Niewiadomski P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020147; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Peterson SC, 2015, CELL STEM CELL, V16, P400, DOI 10.1016/j.stem.2015.02.006; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Schepeler T, 2014, DEVELOPMENT, V141, P2559, DOI 10.1242/dev.104588; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Tanese K, 2018, J DERMATOL, V45, P1181, DOI 10.1111/1346-8138.14543; Tojo M, 2002, BRIT J DERMATOL, V146, P69, DOI 10.1046/j.1365-2133.2002.04583.x; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225511	10.1371/journal.pone.0225511	http://dx.doi.org/10.1371/journal.pone.0225511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756206	gold, Green Published			2022-12-26	WOS:000533889300035
J	Lu, ZH; Jiang, WH; Zhang, J; Lynn, HS; Chen, Y; Zhang, SY; Ma, ZF; Geng, PH; Guo, XY; Zhang, HY; Zhang, ZJ				Lu, Zhenhui; Jiang, Wenhan; Zhang, Jing; Lynn, Henry S.; Chen, Yue; Zhang, Shaoyan; Ma, Zifeng; Geng, Peihua; Guo, Xiaoyan; Zhang, Huiyong; Zhang, Zhijie			Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PATTERNS; MDR; TB	As China is one of high MDR-TB burden countries, it is important to determine the drug resistant pattern and clinical characteristics of multidrug resistant tuberculosis (MDR-TB). We conducted a comprehensive and nationwide study on MDR-TB in 17 provinces for the period from June 2009 to June 2015, and a total of 1154 cases of MDR-TB were finally investigated. The study sought to assess the clinical features and contrast drug susceptibility profiles of MDR-TB patients in China. Cavitary disease, young age, and long duration of TB disease among MDR-TB patients were important predictors. A high resistance proportion of first-line drugs was observed in Beijing, Shanghai and Tianjin. Resistant proportions of second-line anti-TB drugs in western region for amikacin, aminosalicylic acid, and levofloxacin were higher than eastern and central regions. High levels of drug resistance were seen in earlier cases (before 2011) and outpatients. We found high levels of resistance to 1st-and 2nd-line drugs in all settings, with considerable variabilities in terms of different Directly Observed Treatment Short Course (DOTS) programme, level of economic development(eastern, central and western regions) and patient source (inpatients and outpatients). Timely drug susceptibility testing (DST) and effective management are necessary to ensure an early detection of MDR-TB and its proper treatment.	[Lu, Zhenhui; Zhang, Shaoyan; Ma, Zifeng; Geng, Peihua; Guo, Xiaoyan; Zhang, Huiyong] Shanghai Univ Tradit Chinese Med, Dept Resp, Longhua Hosp, Shanghai, Peoples R China; [Jiang, Wenhan; Zhang, Jing; Lynn, Henry S.; Zhang, Zhijie] Fudan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Shanghai, Peoples R China; [Chen, Yue] Univ Ottawa, Fac Med, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada	Shanghai University of Traditional Chinese Medicine; Fudan University; University of Ottawa	Zhang, HY (corresponding author), Shanghai Univ Tradit Chinese Med, Dept Resp, Longhua Hosp, Shanghai, Peoples R China.; Zhang, ZJ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Shanghai, Peoples R China.	tcmdoctorzhang@163.com; epistat@gmail.com	Zhang, Jing/GZG-5083-2022; jiang, wen/GYI-9662-2022	Zhang, Jing/0000-0003-4167-4311; 	Eleventh and Twelfth Five-Year Support Project of the Ministry of Science and Technology from Ministry of Public Health of China [2010ZX09101-107, 2012ZX10005-008]	Eleventh and Twelfth Five-Year Support Project of the Ministry of Science and Technology from Ministry of Public Health of China	This work was supported by the Eleventh and Twelfth Five-Year Support Project of the Ministry of Science and Technology from Ministry of Public Health of China [2010ZX09101-107 and 2012ZX10005-008].	[Anonymous], 2012, 5 NATL TUBERCULOSIS; Chen XY, 2004, LANCET, V364, P417; Chen Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2628913; Devasia RA, 2009, AM J RESP CRIT CARE, V180, P365, DOI 10.1164/rccm.200901-0146OC; Eker B, 2008, MULTIDRUG EXTENSIVEL, DOI [10.1016/j.tube.2008.07.004, DOI 10.1016/J.TUBE.2008.07.004]; He XC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003336; Hoa NB, 2014, TROP MED INT HEALTH, V19, P1076, DOI 10.1111/tmi.12347; Jaramillo E., 2008, GUIDELINES PROGRAMMA; Jenkins HE, 2013, EUROPEAN RESP J, V42; Kuksa L, 2014, PUBLIC HEALTH ACTION, V4, pS47, DOI 10.5588/pha.14.0041; Liang L, 2012, THORAX; Liu CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019399; [刘一典 Liu Yidian], 2011, [中华传染病杂志, Chinese Journal of Infections Diseases], V29, P544; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Organization W H, 2010, MULT EXT DRUG RES TB, V35, P2171; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P243; Qi YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032103; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Rodrigues C, 2008, INT J TUBERC LUNG D, V12, P1449; Siddiqi SH, 2006, MGIT PROCEDURE MANUA; States U Partnership STB Committee GL, 2006, ANN PHARMACOTHERAPY, V40; Sun Y., 2017, PLOS ONE, V12, P1, DOI DOI 10.1371/J0URNAL.P0NE; Tadesse M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106726; Tam KKG, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.00145-19, 10.1128/jcm.00145-19]; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2019, WHO CONS GUID DRUG R, DOI DOI 10.30978/TB2021-2-86; World Health Organization, 2011, WHOHTMTB20116; Yuan XL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-315; Zhang XL, 2015, TROP MED INT HEALTH, V20, P1431, DOI 10.1111/tmi.12566; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	33	6	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225361	10.1371/journal.pone.0225361	http://dx.doi.org/10.1371/journal.pone.0225361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751390	Green Published, gold			2022-12-26	WOS:000533886900053
J	Prpic, J; Keros, T; Vucelja, M; Bjedov, L; Rode, OD; Margaletic, J; Hebron, B; Jemersic, L				Prpic, Jelena; Keros, Tomislav; Vucelja, Marko; Bjedov, Linda; Rode, Oktavija Dakovic; Margaletic, Josip; Hebron, Boris; Jemersic, Lorena			First evidence of hepatitis E virus infection in a small mammal (yellow-necked mouse) from Croatia	PLOS ONE			English	Article							WILD RATS; WIDESPREAD INFECTION; ZOONOTIC PATHOGENS; SWINE; RODENTS; PREVALENCE; SEQUENCES	Since the role of wild rodents/small mammals in hepatitis E virus (HEV) epidemiology has been a subject of considerable debate, this study was conducted to investigate the potential presence of HEV RNA in small rodents collected within their natural habitats and to detect if they can be potential reservoirs of the virus. A total of 483 small rodents were captured using snap traps placed at 11 regions in Croatia. Sampling was undertaken in 2008 and repeated from 2010 to 2014. Liver samples were tested for the presence of HEV RNA. HEV RNA was detected in only one liver sample (0.21%) originated from Apodemus flavicollis from the location Medvednica, nearby Zagreb collected in 2014. According to the sequence analysis, the isolate has shown to be a member of Orthohepevirus A species, genotype HEV-3. The genotyping results confirmed grouping into subtype 3a, general cluster 3abchij. The detected HEV strain showed to be genetically highly related to strains found in humans and/or domestic pigs and wild boars from Croatia. Our finding indicates that wild small mammals could play a role in the epidemiology of HEV-3 infection and therefore should be taken under consideration as potential reservoirs or/and transmitters of the disease. However, further investigation is needed to recognize their potential for maintaining the infection in natural conditions.	[Prpic, Jelena; Keros, Tomislav; Hebron, Boris; Jemersic, Lorena] Croatian Vet Inst, Zagreb, Croatia; [Vucelja, Marko; Bjedov, Linda; Margaletic, Josip] Univ Zagreb, Forestry Fac, Zagreb, Croatia; [Rode, Oktavija Dakovic] Univ Hosp Infect Dis Dr Fran Mihaljevic, Zagreb, Croatia; [Rode, Oktavija Dakovic] Univ Zagreb, Sch Dent Med, Zagreb, Croatia	Croatian Veterinary Institute Zagreb; University of Zagreb; University of Zagreb; University of Zagreb, School of Dental Medicine	Prpic, J (corresponding author), Croatian Vet Inst, Zagreb, Croatia.	balatinec@veinst.hr	Prpic, Jelena/E-5133-2013; Prpic, Jelena/HHZ-3198-2022	Prpic, Jelena/0000-0001-7333-267X; Jemersic, Lorena/0000-0002-8379-4787				Aggarwal R, 2009, J GASTROEN HEPATOL, V24, P1484, DOI 10.1111/j.1440-1746.2009.05933.x; Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P223, DOI 10.1046/j.1365-2893.2001.00290.x; BALAYAN MS, 1990, J MED VIROL, V32, P58, DOI 10.1002/jmv.1890320110; Debing Y, 2016, J HEPATOL, V65, P200, DOI 10.1016/j.jhep.2016.02.045; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; Favorov MO, 2000, J INFECT DIS, V181, P449, DOI 10.1086/315273; Favorov MO, 1996, 9 TRIENN INT S VIR H; Fischer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119576; Geng YS, 2016, J HEPATOL, V64, P37, DOI 10.1016/j.jhep.2015.08.034; He WQ, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1746-z; Hirano M, 2003, HEPATOL RES, V27, P1, DOI 10.1016/S1386-6346(03)00192-X; Jemersic L, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3906-6; Jemersic L, 2017, VET ARHIV, V87, P651, DOI 10.24099/vet.arhiv.170208; Johne R, 2010, J GEN VIROL, V91, P750, DOI 10.1099/vir.0.016584-0; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Kabrane-Lazizi Y, 1999, AM J TROP MED HYG, V61, P331, DOI 10.4269/ajtmh.1999.61.331; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurucz K, 2019, ZOONOSES PUBLIC HLTH, V66, P259, DOI 10.1111/zph.12543; Lack JB, 2012, EMERG INFECT DIS, V18, P1268, DOI 10.3201/eid1808.120070; Li TC, 2005, EMERG INFECT DIS, V11, P1958, DOI 10.3201/eid1112.051041; Lipej Z, 2013, ACTA VET HUNG, V61, P517, DOI 10.1556/AVet.2013.031; Maneerat Y, 1996, J MED VIROL, V48, P121; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Obana S, 2017, J VET MED SCI, V79, P76, DOI 10.1292/jvms.16-0355; Prpic J, 2015, FOOD ENVIRON VIROL, V7, P195, DOI 10.1007/s12560-015-9193-5; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purcell RH, 2011, EMERG INFECT DIS, V17, P2216, DOI 10.3201/eid1712.110482; Rode OD, 2014, EUR J CLIN MICROBIOL, V33, P2231, DOI 10.1007/s10096-014-2187-7; Sayed IM, 2017, GUT, V66, P920, DOI 10.1136/gutjnl-2015-311109; Schmidt S, 2014, VECTOR-BORNE ZOONOT, V14, P467, DOI 10.1089/vbz.2013.1504; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simanavicius M, 2018, VET MICROBIOL, V221, P129, DOI 10.1016/j.vetmic.2018.06.014; Smith DB, 2016, J GEN VIROL, V97, P537, DOI 10.1099/jgv.0.000393; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Tadin A, 2016, AM J TROP MED HYG, V94, P466, DOI 10.4269/ajtmh.15-0517; Tadin A, 2012, VECTOR-BORNE ZOONOT, V12, P388, DOI 10.1089/vbz.2011.0632; USMANOV RK, 1994, VOP VIRUSOL+, V39, P165; van der Poel WHM, 2001, EMERG INFECT DIS, V7, P970, DOI 10.3201/eid0706.010608; Vilibic-Cavlek T, 2016, ZOONOSES PUBLIC HLTH, V63, P494, DOI 10.1111/zph.12254; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001	42	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225583	10.1371/journal.pone.0225583	http://dx.doi.org/10.1371/journal.pone.0225583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751424	Green Published, gold			2022-12-26	WOS:000533886900080
J	Shirisha, P				Shirisha, P.			Socioeconomic determinants of nutritional status among 'Baiga' tribal children In Balaghat district of Madhya Pradesh: A qualitative study	PLOS ONE			English	Article								The Baigas due to their primitive agricultural techniques, poor education status and poor population growth have been conferred the status of 'Scheduled Tribe' by the Government of India. The community bears the brunt of inequities, reflected in their poor nutritional and socioeconomic status. We have employed qualitative design for the study, as we wanted to understand the contextual factors for Baiga tribal children's inferior nutrition status. Twenty in-depth interviews with the mothers of the children suffering from moderate to severe malnutrition and several other interviews were conducted with the key stakeholders like anganwadi workers, Integrated Child Development Scheme supervisors, Accredited Social Health Activists, public distribution system shopkeeper and registered medical practitioners. Interviews with the key informants were conducted in the Balagahat district of Madhya Pradesh. Key factors responsible for perpetuating malnutrition were then identified through thematic analysis. It was found that dissatisfaction with public services and indifferent attitude of public servants resulting in poor uptake of public services further accentuated the problem. A qualitative enquiry into the issue of high and persistent levels of malnourishment among these tribal children revealed several aspects which quantitative method may not have captured. This implies that while framing a policy for improvement in the nutrition status in such population, a holistic approach is required instead of focussing on one aspect such as supplementation of nutrition alone.	[Shirisha, P.] Tata Inst Social Sci, Sch Hlth Syst Studies, Mumbai, Maharashtra, India	Tata Institute of Social Sciences	Shirisha, P (corresponding author), Tata Inst Social Sci, Sch Hlth Syst Studies, Mumbai, Maharashtra, India.	shirisha@zoho.com						Barun Kanjilal, 2010, INT J EQUITY HLTH OF, V9, P19; Chakma T., 2014, Journal of Nutrition and Food Sciences, V4, P275; Chakma T, 2009, ANTHROPOLOGIST, V11, P39, DOI 10.1080/09720073.2009.11891077; Chakma T, P NAT S TRIB HLTH IN; Crowe M, 2015, AUST NZ J PSYCHIAT, V49, P616, DOI 10.1177/0004867415582053; Education N Services R Women P., 2019, PRESS INF BUR GOV IN, P2018; Elwin V., 2000, LEAVES JUNGLE; Esrey SA, 2000, WATER WASTE WELL BEI, V143, P608; Fernandes W, 1998, ECON POLIT WEEKLY, V33, P2703; French SA, 2019, NUTR QUALITY FOOD PU, P1; Humphrey JH, 2009, CHILD UNDERNUTRITION, V374, P2009; International Institute for Population Sciences, 2007, NATL FAMILY HLTH SUR; Jain AK, 2016, IMPACT ED EC BAIGA T, P6896; Jhariya J, 2013, LIVING STANDARD ECON; Jhariya J., 2013, VOICE INTELLECTUAL M, V3, P95; Kader M, 2014, SOCIO EC NUTR DETERM, V6, P1; Meshram II, 2012, ASIA PAC J CLIN NUTR, V21, P568; Mishra A, 2019, NEW GODS NEW LIVES L, P1; Mittal A, 2019, EFFECT MATERNAL FACT, P30; Patton M., 1990, USE QUALITATIVE METH; Ramalingaswami V., 1996, ASIAN ENIGMA PROGR N; Sah D., 2004, TRIBAL ISSUES INDIA; Subramanyam M A, 2010, PLOS ONE, V5, P1; Tiwari D.N., 1984, PRIMITIVE TRIBES M P; wfp.org, 2010, FIGHTN HUNG WORLW	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225119	10.1371/journal.pone.0225119	http://dx.doi.org/10.1371/journal.pone.0225119			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751370	Green Published, Green Submitted, gold			2022-12-26	WOS:000533886900030
J	Maeda, S; Osaga, S; Maeda, T; Takeda, N; Tamechika, S; Naniwa, T; Niimi, A				Maeda, Shinji; Osaga, Satoshi; Maeda, Tomoyo; Takeda, Norihisa; Tamechika, Shinya; Naniwa, Taio; Niimi, Akio			Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research	PLOS ONE			English	Article							RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; T-CELLS; PLASTICITY; REMISSION; CTLA-4	T-helper (Th)17.1 cells exhibit high pathogenicity in inflammatory diseases. This study aimed to identify the changes in the proportions of Th subsets, including Th17.1, which are associated with abatacept treatment response in Japanese patients with rheumatoid arthritis. On the basis of the results, we assessed whether Th17.1 is a potential cellular biomarker. Multicolor flow cytometry was used to determine the circulating Th subsets among CD4+ T lymphocytes in 40 patients with rheumatoid arthritis before abatacept treatment. All the patients received abatacept treatment for 24 weeks; changes in disease activity score, including 28-joint count C-reactive protein, and responsiveness indicated by other indices to abatacept treatment were evaluated according the European League Against Rheumatism criteria (good and moderate responders and nonresponders). The correlation between the abatacept responses and the proportions of Th subsets (baseline) was analyzed. Logistic regression analysis with inverse probability weighting method was performed to calculate the odds ratio adjusted for patient characteristics. The proportion of baseline Th17.1 cells was significantly lower in patients categorized as good responders than in those categorized as non-good responders (moderate responders and nonresponders; p = 0.0064). The decrease in 28-joint count C-reactive protein after 24 weeks of abatacept therapy showed a significant negative correlation with the proportion of Th17.1 cells. The adjusted odds ratio for achieving good response in patients with baseline Th17.1 levels below the median value was 14.6 (95% confidence interval, 2.9-72.3; p = 0.0021) relative to that in the remaining patients. The proportion of Th17.1 cells at baseline is a good candidate for predicting abatacept treatment response in Japanese patients. These novel findings may represent a significant step in the pursuit of precision medicine.	[Maeda, Shinji; Maeda, Tomoyo; Takeda, Norihisa; Tamechika, Shinya; Naniwa, Taio; Niimi, Akio] Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Nagoya, Aichi, Japan; [Osaga, Satoshi] Nagoya City Univ Hosp, Clin Res Management Ctr, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University	Maeda, S (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Nagoya, Aichi, Japan.	snb51961@med.nagoya-cu.ac.jp	Naniwa, Taio/AAJ-3965-2020		Ministry of Education, Culture, Sports, Science, and Technology [JP24791002, JP15K09555]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology under a Grant-in-Aid for Scientific Research (KAKENHI) Grant Numbers JP24791002, JP15K09555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2018, J AUTOIMMUN, V87, P50, DOI 10.1016/j.jaut.2017.12.003; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Basdeo SA, 2017, J IMMUNOL, V198, P2249, DOI 10.4049/jimmunol.1600737; Behrens F, 2015, ANN RHEUM DIS, V74, P1058, DOI 10.1136/annrheumdis-2013-204816; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bouguermouh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005087; Chikanza IC, 2004, RHEUMATOLOGY, V43, P1337, DOI 10.1093/rheumatology/keh333; Ermann J, 2015, NAT REV RHEUMATOL, V11, P541, DOI 10.1038/nrrheum.2015.71; Falconer J, 2018, RHEUMATOLOGY, V57, P10, DOI 10.1093/rheumatology/kex283; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Gottenberg JE, 2012, ANN RHEUM DIS, V71, P1815, DOI 10.1136/annrheumdis-2011-201109; Harigai M, 2016, MOD RHEUMATOL, V26, P491, DOI 10.3109/14397595.2015.1123211; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Krummey SM, 2014, AM J TRANSPLANT, V14, P607, DOI 10.1111/ajt.12600; Kubo S, 2014, MOD RHEUMATOL, V24, P42, DOI 10.3109/14397595.2013.854051; Leffers HC, 2011, ANN RHEUM DIS, V70, P1216, DOI 10.1136/ard.2010.140129; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Maxwell LJ, 2010, J RHEUMATOL, V37, P234, DOI 10.3899/jrheum.091066; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nagafuji K, 2010, INT J HEMATOL, V91, P855, DOI 10.1007/s12185-010-0581-1; Nakayamada S, 2018, RHEUMATOLOGY, V57, P164, DOI 10.1093/rheumatology/kex012; Paulissen SMJ, 2015, CYTOKINE, V74, P43, DOI 10.1016/j.cyto.2015.02.002; Penatti A, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1305-1; Piantoni S, 2016, CLIN RHEUMATOL, V35, P1065, DOI 10.1007/s10067-016-3185-1; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Revu S, 2018, CELL REP, V22, P2642, DOI 10.1016/j.celrep.2018.02.044; Scarsi M, 2014, CLIN EXP RHEUMATOL, V32, P204; Scarsi M, 2011, J RHEUMATOL, V38, P2105, DOI 10.3899/jrheum.110386; Smolen JS, 2016, LANCET, V388, P1984; Stadhouders R, 2018, J AUTOIMMUN, V87, P1, DOI 10.1016/j.jaut.2017.12.007; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; van Hamburg JP, 2018, J AUTOIMMUN, V87, P69, DOI 10.1016/j.jaut.2017.12.006; van Tuyl LHD, 2009, ARTHRIT RHEUM-ARTHR, V61, P704, DOI 10.1002/art.24392; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Ying HY, 2010, J IMMUNOL, V185, P1375, DOI 10.4049/jimmunol.0903369; Zhang QX, 2016, IMMUNITY, V44, P1034, DOI 10.1016/j.immuni.2016.04.017	48	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0215192	10.1371/journal.pone.0215192	http://dx.doi.org/10.1371/journal.pone.0215192			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747403	Green Submitted, Green Published, gold			2022-12-26	WOS:000533881900001
J	Porteus, TA; Reynolds, JC; McAllister, MK				Porteus, Tom A.; Reynolds, Jonathan C.; McAllister, Murdoch K.			Population dynamics of foxes during restricted-area culling in Britain: Advancing understanding through state-space modelling of culling records	PLOS ONE			English	Article							VULPES-VULPES; RED FOX; DENSITY-DEPENDENCE; BREEDING SUCCESS; STOCK ASSESSMENT; PREDATOR CONTROL; MANAGEMENT; ABUNDANCE; CARNIVORE; FORMULATION	Lethal control is widely employed to suppress the numbers of target wildlife species within restricted management areas. The success of such measures is expected to vary with local circumstances affecting rates of removal and replacement. There is a need both to evaluate success in individual cases and to understand variability and its causes. In Britain, red fox (Vulpes vulpes) populations are culled within the confines of shooting estates to benefit game and wildlife prey species. We developed a Bayesian state-space model for within-year fox population dynamics within such restricted areas and fitted it to data on culling effort and success obtained from gamekeepers on 22 shooting estates of 2 to 36 km(2). We used informative priors for key population processes-immigration, cub recruitment and non-culling mortality-that could not be quantified in the field. Using simulated datasets we showed that the model reliably estimated fox density and demographic parameters, and we showed that conclusions drawn from real data were robust to alternative model assumptions. All estates achieved suppression of the fox population, with pre-breeding fox density on average 47% (range 20%-90%) of estimated carrying capacity. As expected, the number of foxes killed was a poor indicator of effectiveness. Estimated rates of immigration were variable among estates, but in most cases indicated rapid replacement of culled foxes so that intensive culling efforts were required to maintain low fox densities. Due to this short-term impact, control effort focussed on the spring and summer period may be essential to achieve management goals for prey species. During the critical March-July breeding period, mean fox densities on all estates were suppressed below carrying capacity, and some maintained consistently low fox densities throughout this period. A similar model will be useful in other situations to quantify the effectiveness of lethal control on restricted areas.	[Porteus, Tom A.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Porteus, Tom A.; Reynolds, Jonathan C.] Game & Wildlife Conservat Trust, Fordingbridge, Hants, England; [McAllister, Murdoch K.] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Porteus, TA (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.; Porteus, TA (corresponding author), Game & Wildlife Conservat Trust, Fordingbridge, Hants, England.	tporteus@gwct.org.uk	Porteus, Tom/I-3778-2019; Reynolds, Jonathan/N-6079-2018	Porteus, Tom/0000-0003-0666-2593; 	Game & Wildlife Conservation Trust [1112023, SC038868]	Game & Wildlife Conservation Trust	The work was funded entirely by the Game & Wildlife Conservation Trust (www.gwct.org.uk), registered as a charity in England & Wales (1112023) and Scotland (SC038868).	Abadi F, 2010, ECOLOGY, V91, P7, DOI 10.1890/08-2235.1; Ahrestani FS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03125; Arnold S.F., 1990, MATH STAT; Auger-Methe M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26677; Bacon P.J., 1985, P147; Baker P. A., 2008, MAMMALS BRIT ISLES H, P407; Baker PJ, 2006, EUR J WILDLIFE RES, V52, P99, DOI 10.1007/s10344-005-0018-y; Boatman N.D., 1998, Gibier Faune Sauvage, V15, P563; Bolker B, 2008, ECOLOGICAL MODELS DA; Buckland ST, 2007, STAT SCI, V22, P44, DOI 10.1214/088342306000000673; Clark F, 2010, METHODS ECOL EVOL, V1, P253, DOI 10.1111/j.2041-210X.2010.00029.x; Conn PB, 2008, BIOMETRICS, V64, P1170, DOI 10.1111/j.1541-0420.2008.00987.x; Defra, 2012, DET EXT US HUM SNAR; DELURY DB, 1947, BIOMETRICS, V3, P145, DOI 10.2307/3001390; Devenish-Nelson ES, 2013, OIKOS, V122, P705, DOI 10.1111/j.1600-0706.2012.20706.x; Dunham K, 2016, ECOL MODEL, V340, P28, DOI 10.1016/j.ecolmodel.2016.08.010; Fall MW, 2002, INT BIODETER BIODEGR, V49, P87, DOI 10.1016/S0964-8305(01)00107-X; Fletcher K, 2010, J APPL ECOL, V47, P263, DOI 10.1111/j.1365-2664.2010.01793.x; Gauthier G, 2007, ECOLOGY, V88, P1420, DOI 10.1890/06-0953; Gelman A., 2004, BAYESIAN DATA ANAL; Gervasi V, 2015, BIOL CONSERV, V191, P632, DOI 10.1016/j.biocon.2015.07.024; GILPIN ME, 1973, P NATL ACAD SCI USA, V70, P3590, DOI 10.1073/pnas.70.12.3590; Gimenez O., 2004, Animal Biodiversity and Conservation, V27, P561; Guthery FS, 2013, J WILDLIFE MANAGE, V77, P33, DOI 10.1002/jwmg.450; Harding EK, 2001, CONSERV BIOL, V15, P1114, DOI 10.1046/j.1523-1739.2001.0150041114.x; HARRIS S, 1988, J APPL ECOL, V25, P409, DOI 10.2307/2403833; Heydon MJ, 2000, J ZOOL, V251, P253, DOI 10.1111/j.1469-7998.2000.tb00608.x; Heydon MJ, 2000, J ZOOL, V251, P265, DOI 10.1111/j.1469-7998.2000.tb00609.x; Hilborn R, 1998, REV FISH BIOL FISHER, V8, P273, DOI 10.1023/A:1008877912528; HILBORN R, 1992; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hostetler JA, 2015, ECOLOGY, V96, P1713, DOI 10.1890/14-1487.1; Kammerle JL, 2019, BMC ECOL, V19, DOI 10.1186/s12898-019-0235-y; Kammerle JL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207545; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Knape J, 2011, J ANIM ECOL, V80, P1269, DOI 10.1111/j.1365-2656.2011.01868.x; KOLB HH, 1980, J APPL ECOL, V17, P7, DOI 10.2307/2402959; Lebreton JD, 2013, J WILDLIFE MANAGE, V77, P12, DOI 10.1002/jwmg.425; Lennox RJ, 2018, BIOL CONSERV, V224, P277, DOI 10.1016/j.biocon.2018.05.003; Leslie PH, 1939, J ANIM ECOL, V8, P94, DOI 10.2307/1255; Lieury N, 2015, J WILDLIFE MANAGE, V79, P425, DOI 10.1002/jwmg.850; Lloyd H.G., 1973, Journal Reprod Fert, V19, P119; LLOYD HG, 1980, THE RED FOX; Macdonald DW, 2004, CANIDS FOXES WOLVES, P129; Magnusson A, 2007, FISH FISH, V8, P337, DOI 10.1111/j.1467-2979.2007.00258.x; McAllister M, 2004, CAN J FISH AQUAT SCI, V61, P1048, DOI 10.1139/F04-084; McAllister M.K., 2014, COLLECT VOL SCI PAP, V70, P1725; McAllister MK, 1998, CAN J FISH AQUAT SCI, V55, P2642, DOI 10.1139/cjfas-55-12-2642; McAllister MK, 1999, ICES J MAR SCI, V56, P900, DOI 10.1006/jmsc.1999.0547; McDonald RA, 1999, J APPL ECOL, V36, P679, DOI 10.1046/j.1365-2664.1999.00433.x; McLeod SR, 2014, ECOL MODEL, V273, P1, DOI 10.1016/j.ecolmodel.2013.10.016; Meyer R, 1999, CAN J FISH AQUAT SCI, V56, P1078, DOI 10.1139/cjfas-56-6-1078; Minnie L, 2016, J APPL ECOL, V53, P379, DOI 10.1111/1365-2664.12581; Newman KB, 2014, METH STAT ECOL, P197, DOI 10.1007/978-1-4939-0977-3_10; Newsome TM, 2014, EUR J WILDLIFE RES, V60, P749, DOI 10.1007/s10344-014-0844-x; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Porteus TA, 2019, WILDLIFE RES, V46, P285, DOI 10.1071/WR18025; Porteus TA, 2018, J WILDLIFE MANAGE, V82, P1645, DOI 10.1002/jwmg.21543; Porteus TA, 2018, WILDLIFE BIOL, DOI 10.2981/wlb.00416; R Core Team, 2018, R LANG ENV STAT COMP; Rademeyer RA, 2007, ICES J MAR SCI, V64, P618, DOI 10.1093/icesjms/fsm050; Reynolds J. C., 1993, Gibier Faune Sauvage, V10, P319; Reynolds JC, 1996, MAMMAL REV, V26, P127, DOI 10.1111/j.1365-2907.1996.tb00150.x; Reynolds JC, 2000, FOX CONTROL COUNTRYS; Reynolds JC, 2013, J WILDLIFE MANAGE, V77, P545, DOI 10.1002/jwmg.500; Reynolds JC, 2010, EUR J WILDLIFE RES, V56, P541, DOI 10.1007/s10344-009-0355-3; Robert M, 2010, ICES J MAR SCI, V67, P1272, DOI 10.1093/icesjms/fsq020; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Sadlier LMJ, 2004, MAMMAL REV, V34, P75, DOI 10.1046/j.0305-1838.2003.00029.x; Schaub M, 2011, J ORNITHOL, V152, P227, DOI 10.1007/s10336-010-0632-7; SCHNUTE JT, 1994, CAN J FISH AQUAT SCI, V51, P1676, DOI 10.1139/f94-168; Scroggie MP, 2018, J APPL ECOL, V55, P2621, DOI 10.1111/1365-2664.13253; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Smith A.D.M., 1985, P131; Sollmann R, 2013, BIOL CONSERV, V159, P405, DOI 10.1016/j.biocon.2012.12.025; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Spiegelhalter D., 2007, WINBUGS; Stoate C., 2002, Aspects of Applied Biology, V67, P191; Stoate C, 2002, ALLERTON PROJECT 10; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tapper SC, 1996, J APPL ECOL, V33, P965, DOI 10.2307/2404678; Thorson JT, 2014, ECOLOGY, V95, P329, DOI 10.1890/13-0187.1; Trenkel VM, 2008, CAN J FISH AQUAT SCI, V65, P1024, DOI 10.1139/F08-028; Trewby ID, 2008, BIOL LETTERS, V4, P170, DOI 10.1098/rsbl.2007.0516; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; Webbon CC, 2004, J APPL ECOL, V41, P768, DOI 10.1111/j.0021-8901.2004.00930.x; White PJC, 2014, J WILDLIFE MANAGE, V78, P402, DOI 10.1002/jwmg.687	88	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225201	10.1371/journal.pone.0225201	http://dx.doi.org/10.1371/journal.pone.0225201			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743363	Green Published, Green Submitted, gold			2022-12-26	WOS:000533877300023
J	Byrd, DA; Chen, J; Vogtmann, E; Hullings, A; Song, SJ; Amir, A; Kibriya, MG; Ahsan, H; Chen, Y; Nelson, H; Knight, R; Shi, JX; Chia, N; Sinha, R				Byrd, Doratha A.; Chen, Jun; Vogtmann, Emily; Hullings, Autumn; Song, Se Jin; Amir, Amnon; Kibriya, Muhammad G.; Ahsan, Habibul; Chen, Yu; Nelson, Heidi; Knight, Rob; Shi, Jianxin; Chia, Nicholas; Sinha, Rashmi			Reproducibility, stability, and accuracy of microbial profiles by fecal sample collection method in three distinct populations	PLOS ONE			English	Article							GUT MICROBIOME; DNA EXTRACTION; BACTERIAL; PRESERVATION; METAGENOME	The gut microbiome likely plays a role in the etiology of multiple health conditions, especially those affecting the gastrointestinal tract. Little consensus exists as to the best, standard methods to collect fecal samples for future microbiome analysis. We evaluated three distinct populations (N = 132 participants) using 16S rRNA gene amplicon sequencing data to investigate the reproducibility, stability, and accuracy of microbial profiles in fecal samples collected and stored via fecal occult blood test (FOBT) or Flinders Technology Associates (FTA) cards, fecal immunochemical tests (FIT) tubes, 70% and 95% ethanol, RNAlater, or with no solution. For each collection method, based on relative abundance of select phyla and genera, two alpha diversity metrics, and four beta diversity metrics, we calculated intraclass correlation coefficients (ICCs) to estimate reproducibility and stability, and Spearman correlation coefficients (SCCs) to estimate accuracy of the fecal microbial profile. Comparing duplicate samples, reproducibility ICCs for all collection methods were excellent (ICCs >= 75%). After 4-7 days at ambient temperature, ICCs for microbial profile stability were excellent (>= 75%) for most collection methods, except those collected via no-solution and 70% ethanol. SCCs comparing each collection method to immediately-frozen no-solution samples ranged from fair to excellent for most methods; however, accuracy of genus-level relative abundances differed by collection method. Our findings, taken together with previous studies and feasibility considerations, indicated that FOBT/FTA cards, FIT tubes, 95% ethanol, and RNAlater are excellent choices for fecal sample collection methods in future microbiome studies. Furthermore, establishing standard collection methods across studies is highly desirable.	[Byrd, Doratha A.; Vogtmann, Emily; Hullings, Autumn; Sinha, Rashmi] NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Chen, Jun; Nelson, Heidi; Chia, Nicholas] Mayo Clin, Microbiome Program, Ctr Individualized Med, Rochester, MN USA; [Chen, Jun; Chia, Nicholas] Mayo Clin, Hlth Sci Res, Rochester, MN USA; [Song, Se Jin; Amir, Amnon; Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kibriya, Muhammad G.; Ahsan, Habibul] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Chen, Yu] New York Sch Med, New York, NY USA; [Nelson, Heidi; Chia, Nicholas] Mayo Clin, Dept Surg, Rochester, MN USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Shi, Jianxin] NCI, Biostat Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chia, Nicholas] Mayo Coll, Biomed Engn & Physiol, Rochester, MN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Mayo Clinic; University of California System; University of California San Diego; University of Chicago; Mayo Clinic; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic	Byrd, DA (corresponding author), NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	byrdda@nih.gov	Vogtmann, Emily/O-9125-2017	Vogtmann, Emily/0000-0003-1355-5593; Hullings, Autumn G./0000-0003-3400-7887; Knight, Rob/0000-0002-0975-9019	Intramural Research Program of the National Cancer Institute at the National Institutes of Health; National Institutes of Health [1R01CA179243, P42ES10349, R01CA107431]; Center for Individualized Medicine at the Mayo Clinic; Howard Hughes Medical Institute; Sloan Foundation; NATIONAL CANCER INSTITUTE [R01CA179243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES027792, R24ES028532, P42ES010349] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Individualized Medicine at the Mayo Clinic; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Cancer Institute at the National Institutes of Health; grants from the National Institutes of Health [1R01CA179243 to NC; P42ES10349 and R01CA107431 to HA]; the Center for Individualized Medicine at the Mayo Clinic [to JC]; and the Howard Hughes Medical Institute and the Sloan Foundation awards [to RK]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00199-16; Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00191-16; [Anonymous], 2018, PACKAGE GUNIFRAC; Baxter NT, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0205-y; Bundgaard-Nielsen C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35843-0; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Chen Z, 2019, MSYSTEMS, V4, P1; Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103; Drew DA, 2016, CANCER EPIDEM BIOMAR, V25, P869, DOI 10.1158/1055-9965.EPI-16-0063; Flores R, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0092-7; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Fu BC, 2016, ANN EPIDEMIOL, V26, P373, DOI 10.1016/j.annepidem.2016.02.009; Gloor GB, 2016, ANN EPIDEMIOL, V26, P322, DOI 10.1016/j.annepidem.2016.03.003; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Gudra D, 2019, GUT, V68, P1723, DOI 10.1136/gutjnl-2018-316225; Hale VL, 2015, J MICROBIOL METH, V113, P16, DOI 10.1016/j.mimet.2015.03.021; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kilpatrick CW, 2002, BIOCHEM GENET, V40, P53, DOI 10.1023/A:1014541222816; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Loftfield E, 2016, CANCER EPIDEM BIOMAR, V25, P1483, DOI 10.1158/1055-9965.EPI-16-0409; McInnes P., 2010, MANUAL PROCEDURES HU; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Rosner B., 2016, FUNDAMENTALS BIOSTAT, pxix; Rounge TB, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0896-6; Shah MS, 2018, GUT, V67, P882, DOI 10.1136/gutjnl-2016-313189; Shaw AG, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0186-x; Sinha R, 2016, CANCER EPIDEM BIOMAR, V25, P870, DOI 10.1158/1055-9965.EPI-16-0161; Sinha R, 2016, CANCER EPIDEM BIOMAR, V25, P407, DOI 10.1158/1055-9965.EPI-15-0951; Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16; Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170; Tap J, 2019, SCI REPORTS, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Taylor M, 2017, J CLIN PATHOL, V70, P600, DOI 10.1136/jclinpath-2016-204165; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vandeputte D, 2017, FEMS MICROBIOL REV, V41, pS154, DOI 10.1093/femsre/fux027; Vlckova K, 2012, J MICROBIOL METH, V91, P45, DOI 10.1016/j.mimet.2012.07.015; Vogtmann E, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00361-17; Vogtmann E, 2017, AM J EPIDEMIOL, V185, P115, DOI 10.1093/aje/kww177; Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang X, 2017, FREE RADICAL BIO MED, V105, P3, DOI 10.1016/j.freeradbiomed.2016.10.504; WANG Z, 2018, FRONTIERS CELLULAR I, V8, DOI DOI 10.3389/FCIMB.2018.00001	54	12	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0224757	10.1371/journal.pone.0224757	http://dx.doi.org/10.1371/journal.pone.0224757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738775	Green Published, gold			2022-12-26	WOS:000532826300021
J	Ojelabi, AO; Bamgboye, AE; Ling, J				Ojelabi, Adedokun Oluwafemi; Bamgboye, Afolabi Elijah; Ling, Jonathan			Preference-based measure of health-related quality of life and its determinants in sickle cell disease in Nigeria	PLOS ONE			English	Article							HEMOGLOBIN DISORDERS; COEFFICIENT-ALPHA; CARE UTILIZATION; RISK-FACTORS; SELF-REPORT; DEPRESSION; ADULTS; SF-6D; SF-36; PAIN	Background Health-related quality of life (HRQL) and economic burden are important issues for people with sickle cell disease (SCD) owing to better survival due to medical advances. Preference-based or utility information is necessary to make informed economic decisions on treatment and alternative therapies. This study aimed to assess preference-based measures of HRQL in sickle cell patients. Methods and findings Data were collected from two SCD outpatient clinics in Ibadan, Nigeria. A standard algorithm was used to derive utility scores, and measure SF-6D from the SF-36. A multivariate regression model was used to assess predictors and their impact. A combination of socio-demographic, bio-physiological and psychosocial variables predicted utility score in people with SCD. Socio-demographic and bio-physiological factors explained 7.5% and 17.9% of the variance respectively, while psychosocial factors explained 4.9%. Women had lower utility scores with a small effect size (d = 0.17). Utility score increased with level of education but decreased with age, anxiety, frequency of pain episodes and number of co-morbidities. Conclusions Utility score in SCD was low indicating a substantial impact of the disease on HRQL of patients and the value they place on their health state due to the limitations they experienced. Interventions should include both clinical and psychosocial approach to help in improving their quality of life of the patients.	[Ojelabi, Adedokun Oluwafemi; Bamgboye, Afolabi Elijah] Univ Ibadan, Ibadan, Nigeria; [Ojelabi, Adedokun Oluwafemi; Ling, Jonathan] Univ Sunderland, Sch Nursing & Hlth Sci, Sunderland, England	University of Ibadan; University of Sunderland	Ojelabi, AO (corresponding author), Univ Ibadan, Ibadan, Nigeria.; Ojelabi, AO (corresponding author), Univ Sunderland, Sch Nursing & Hlth Sci, Sunderland, England.	adeoje2507@gmail.com	Ling, Jonathan/AAY-4098-2020	Ling, Jonathan/0000-0003-2932-4474; Ojelabi, Adedokun Oluwafemi/0000-0002-0041-4129	University of Ibadan	University of Ibadan	The authors received no specific funding for this work. However, the PhD study leading to this publication was funded by the University of Ibadan. The Institution had no role in the preparation of the manuscript.	Aliyu ZY, 2008, AM J HEMATOL, V83, P485, DOI 10.1002/ajh.21162; Anie KA, 2002, BRIT J HEALTH PSYCH, V7, P331, DOI 10.1348/135910702760213715; Anie KA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001274; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Asnani M, 2007, W INDIAN MED J, V56, P491; Asnani MR, 2009, PSYCHOL HEALTH MED, V14, P606, DOI 10.1080/13548500903016567; Ballas SK, 2011, HEMOGLOBIN, V35, P520, DOI 10.3109/03630269.2011.610478; BALLAS SK, 1982, AM J HEMATOL, V13, P37, DOI 10.1002/ajh.2830130106; Bayliss Elizabeth A, 2005, Health Qual Life Outcomes, V3, P51; Bramlett RE, 2006, J SPEECH LANG HEAR R, V49, P381, DOI 10.1044/1092-4388(2006/030); Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Brazier J, 1999, HEALTH ECON, V8, P41, DOI 10.1002/(SICI)1099-1050(199902)8:1<41::AID-HEC395>3.0.CO;2-#; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Brown G C, 2001, Trans Am Ophthalmol Soc, V99, P199; Brown GC, 2000, ARCH OPHTHALMOL-CHIC, V118, P47; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Caird H, 2011, BRIT J HEALTH PSYCH, V16, P542, DOI 10.1348/135910710X529278; CASTRO O, 1994, BLOOD, V84, P643, DOI 10.1182/blood.V84.2.643.643; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coleman B, 2016, BRIT J HEALTH PSYCH, V21, P190, DOI 10.1111/bjhp.12157; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dampier C, 2011, AM J HEMATOL, V86, P203, DOI 10.1002/ajh.21905; Davison SN, 2009, VALUE HEALTH, V12, P340, DOI 10.1111/j.1524-4733.2008.00433.x; de Graaff B, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0431-9; de Oliveira CC, 2008, ARQ NEURO-PSIQUIAT, V66, P30, DOI 10.1590/S0004-282X2008000100008; Drummond M, 2001, ANN MED, V33, P344, DOI 10.3109/07853890109002088; Edwards R, 2001, PSYCHOSOM MED, V63, P850, DOI 10.1097/00006842-200109000-00020; El-Shinnawy H, 2013, MIDDLE E CURR PSYCHI, V20, P80, DOI [10.1097/, DOI 10.1097/]; Ellison AM, 2007, PEDIATR EMERG CARE, V23, P832, DOI 10.1097/PEC.0b013e31815a05e2; Engel L, 2014, QUAL LIFE RES, V23, P2383, DOI 10.1007/s11136-014-0677-9; Espallargues M, 2005, INVEST OPHTH VIS SCI, V46, P4016, DOI 10.1167/iovs.05-0072; Feeny D, 2012, MED DECIS MAKING, V32, P273, DOI 10.1177/0272989X11418671; Gibson RC, 2013, PSYCHOL HEALTH MED, V18, P451, DOI 10.1080/13548506.2012.749353; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Halvorsrud L, 2010, RES THEOR NURS PRACT, V24, P241, DOI 10.1891/1541-6577.24.4.241; Han SH, 2015, SEIZURE-EUR J EPILEP, V25, P26, DOI 10.1016/j.seizure.2014.11.011; Hays RD, 2014, QUAL LIFE RES, V23, P385, DOI 10.1007/s11136-013-0503-9; Henkel V, 2004, GEN HOSP PSYCHIAT, V26, P190, DOI 10.1016/j.genhosppsych.2004.02.003; HERNIGOU P, 1991, J BONE JOINT SURG AM, V73A, P81, DOI 10.2106/00004623-199173010-00011; Johnson EK, 2004, EPILEPSIA, V45, P544, DOI 10.1111/j.0013-9580.2004.47003.x; Khanna D, 2007, QUAL LIFE RES, V16, P1083, DOI 10.1007/s11136-007-9207-3; Kharroubi SA, 2007, J HEALTH ECON, V26, P597, DOI 10.1016/j.jhealeco.2006.09.002; Kohne E, 2011, DTSCH ARZTEBL INT, V108, P532, DOI 10.3238/arztebl.2011.0532; KONOTEYA.FI, 1974, ARCH INTERN MED, V133, P611, DOI 10.1001/archinte.133.4.611; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Ladizinski B, 2012, ADV SKIN WOUND CARE, V25, P420, DOI 10.1097/01.ASW.0000419408.37323.0c; Lanzkron S, 2013, PUBLIC HEALTH REP, V128, P110, DOI 10.1177/003335491312800206; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Lucchesi F, 2016, J NATL MED ASSOC, V108, P113, DOI 10.1016/j.jnma.2016.04.004; Mastandrea EB, 2015, SAO PAULO MED J, V133, P421, DOI 10.1590/1516-3180.2015.00171105; McCabe C, 2006, J HEALTH ECON, V25, P418, DOI 10.1016/j.jhealeco.2005.07.008; McClish DK, 2006, J WOMENS HEALTH, V15, P146, DOI 10.1089/jwh.2006.15.146; McClish Donna K, 2005, Health Qual Life Outcomes, V3, P50, DOI 10.1186/1477-7525-3-50; Menezes Adeline Soraya de O. da P., 2013, Rev. paul. pediatr., V31, P24; Miller DR, 2008, J AMBUL CARE MANAG, V31, P161, DOI 10.1097/01.JAC.0000314707.88160.9c; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Ohene-Frempong K, 1998, BLOOD, V91, P288; Ojelabi A., 2017, INT J TROP DIS HLTH, V22, P1, DOI [10.9734/IJTDH/2017/31954., DOI 10.9734/IJTDH/2017/31954, 10.9734/IJTDH/2017/31954]; Ola BA, 2016, SOC SCI MED, V161, P27, DOI 10.1016/j.socscimed.2016.05.029; Panepinto JA, 2012, HEMATOL-AM SOC HEMAT, P284, DOI 10.1182/asheducation-2012.1.284; Peasgood T, 2016, MED DECIS MAKING, V36, P1020, DOI 10.1177/0272989X16658660; Penninx BWJH, 1996, J PSYCHOSOM RES, V40, P521, DOI 10.1016/0022-3999(95)00620-6; Phaladze NA, 2005, J NURS SCHOLARSHIP, V37, P120, DOI 10.1111/j.1547-5069.2005.00023.x; Pinto AM, 2011, QUAL LIFE RES, V20, P1655, DOI 10.1007/s11136-011-9896-5; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1993, AM J DIS CHILD, V147, P1197, DOI 10.1001/archpedi.1993.02160350071011; POWARS DR, 1990, HEMOGLOBIN, V14, P573, DOI 10.3109/03630269009046967; Richardson J, 2015, QUAL LIFE RES, V24, P2045, DOI 10.1007/s11136-015-0926-6; Rijken M, 2005, QUAL LIFE RES, V14, P45, DOI 10.1007/s11136-004-0616-2; Scheinman JI, 2009, NAT CLIN PRACT NEPHR, V5, P78, DOI 10.1038/ncpneph1008; SCHUESSLER KF, 1985, ANNU REV SOCIOL, V11, P129; Sharma S, 2002, BRIT J OPHTHALMOL, V86, P493, DOI 10.1136/bjo.86.5.493; Shiu ATY, 2014, J DIABETES INVEST, V5, P677, DOI 10.1111/jdi.12198; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Sogutlu A, 2011, PSYCHOSOMATICS, V52, P272, DOI 10.1016/j.psym.2011.01.010; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Tavakol M, 2011, INT J MED EDUC, V2, P1, DOI 10.5116/ijme.4d27.32ff; Thomas PW, 1997, J CLIN EPIDEMIOL, V50, P121, DOI 10.1016/S0895-4356(96)00320-4; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Treadwell M.J., 2015, J CLIN OUTCOMES MANA, V22, P10; United Nations, 2008, ARES63237, V1, DOI [10.1093/oxfordhb/9780199560103.003.0005, DOI 10.1093/OXFORDHB/9780199560103.003.0005]; Van den Berg B, 2012, HEALTH ECON, V21, P1508, DOI 10.1002/hec.1823; van den Bos GAM, 1995, EUR J PUBLIC HEALTH, V5, P29, DOI DOI 10.1093/EURPUB/5.1.29; van Litsenburg RRL, 2013, QUAL LIFE RES, V22, P677, DOI 10.1007/s11136-012-0183-x; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Walters Stephen J, 2003, Health Qual Life Outcomes, V1, P4, DOI 10.1186/1477-7525-1-4; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware RE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002120; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; WHO, 2006, A599 WHO; Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0; Wrotniak BH, 2014, J PEDIATR HEALTH CAR, V28, P14, DOI 10.1016/j.pedhc.2012.09.004; Wyld M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001307	100	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0223043	10.1371/journal.pone.0223043	http://dx.doi.org/10.1371/journal.pone.0223043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN3EY	31738762	Green Published, gold, Green Accepted			2022-12-26	WOS:000532826300006
J	Castillo, L; Young, AIJ; Mawson, A; Schafranek, P; Steinmann, AM; Nessem, D; Parkin, A; Johns, A; Chou, A; Law, AMK; Lucas, MC; Murphy, KJ; Deng, N; Gallego-Ortega, D; Caldon, CE; Timpson, P; Pajic, M; Ormandy, CJ; Oakes, SR				Castillo, Lesley; Young, Adelaide I. J.; Mawson, Amanda; Schafranek, Pia; Steinmann, Angela M.; Nessem, Danielle; Parkin, Ashleigh; Johns, Amber; Chou, Angela; Law, Andrew M. K.; Lucas, Morghan C.; Murphy, Kendelle J.; Deng, Niantao; Gallego-Ortega, David; Caldon, Catherine E.; Timpson, Paul; Pajic, Marina; Ormandy, Christopher J.; Oakes, Samantha R.		Australian Pancreatic Canc Genome	MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma	ONCOGENE			English	Article							SRC; CANCER; SURVIVAL; FAMILY; EXPRESSION; INHIBITOR; MIGRATION; THERAPY; BCL-2	Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies. It is phenotypically heterogeneous with a highly unstable genome and provides few common therapeutic targets. We found that MCL1, Cofilin1 (CFL1) and SRC mRNA were highly expressed by a wide range of these cancers, suggesting that a strategy of dual MCL-1 and SRC inhibition might be efficacious for many patients. Immunohistochemistry revealed that MCL-1 protein was present at high levels in 94.7% of patients in a cohort of PDACs from Australian Pancreatic Genome Initiative (APGI). High MCL1 and Cofilin1 mRNA expression was also strongly predictive of poor outcome in the TCGA dataset and in the APGI cohort. In culture, MCL-1 antagonism reduced the level of the cytoskeletal remodeling protein Cofilin1 and phosphorylated SRC on the active Y416 residue, suggestive of reduced invasive capacity. The MCL-1 antagonist S63845 synergized with the SRC kinase inhibitor dasatinib to reduce cell viability and invasiveness through 3D-organotypic matrices. In preclinical murine models, this combination reduced primary tumor growth and liver metastasis of pancreatic cancer xenografts. These data suggest that MCL-1 antagonism, while reducing cell viability, may have an additional benefit in increasing the antimetastatic efficacy of dasatinib for the treatment of PDAC.	[Castillo, Lesley; Young, Adelaide I. J.; Mawson, Amanda; Schafranek, Pia; Steinmann, Angela M.; Nessem, Danielle; Parkin, Ashleigh; Johns, Amber; Law, Andrew M. K.; Lucas, Morghan C.; Murphy, Kendelle J.; Deng, Niantao; Gallego-Ortega, David; Caldon, Catherine E.; Timpson, Paul; Pajic, Marina; Ormandy, Christopher J.; Oakes, Samantha R.] Garvan Inst Med Res, Canc Res Div, 384 Victoria St, Darlinghurst, NSW 2010, Australia; [Castillo, Lesley; Young, Adelaide I. J.; Mawson, Amanda; Schafranek, Pia; Steinmann, Angela M.; Nessem, Danielle; Parkin, Ashleigh; Johns, Amber; Law, Andrew M. K.; Lucas, Morghan C.; Murphy, Kendelle J.; Deng, Niantao; Gallego-Ortega, David; Caldon, Catherine E.; Timpson, Paul; Pajic, Marina; Ormandy, Christopher J.; Oakes, Samantha R.] Kinghorn Canc Ctr, 384 Victoria St, Darlinghurst, NSW 2010, Australia; [Johns, Amber; Deng, Niantao; Gallego-Ortega, David; Caldon, Catherine E.; Timpson, Paul; Pajic, Marina; Ormandy, Christopher J.; Oakes, Samantha R.] UNSW Med, St Vincents Clin Sch, 384 Victoria St, Kensington, NSW 2052, Australia; [Chou, Angela] Univ Sydney, Camperdown, NSW 2006, Australia	Garvan Institute of Medical Research; University of Sydney	Oakes, SR (corresponding author), Garvan Inst Med Res, Canc Res Div, 384 Victoria St, Darlinghurst, NSW 2010, Australia.; Oakes, SR (corresponding author), Kinghorn Canc Ctr, 384 Victoria St, Darlinghurst, NSW 2010, Australia.; Oakes, SR (corresponding author), UNSW Med, St Vincents Clin Sch, 384 Victoria St, Kensington, NSW 2052, Australia.	s.oakes@garvan.org.au	Lucas, Morghan C/Y-6452-2019; Gallego-Ortega, David/AAK-9067-2020	Lucas, Morghan C/0000-0001-7654-9137; Gallego-Ortega, David/0000-0002-2347-7835; Herrmann, David/0000-0002-9514-7501; Deng, Niantao/0000-0001-9717-2236; Ormandy, Christopher/0000-0002-2504-7919; Murphy, Angela/0000-0002-8910-7626; Young, Adelaide/0000-0002-5714-0501; Timpson, Paul/0000-0002-5514-7080; Pereira, Brooke/0000-0003-3513-1214; Murphy, Kendelle/0000-0002-3234-3812; Pajic, Marina/0000-0002-3871-3829; Chou, Angela/0000-0001-9212-6927; Oakes, Samantha/0000-0003-1838-2310	Cancer Council NSW; NHMRC Australia; National Breast Cancer Foundation; Cancer Institute NSW; Len Ainsworth Pancreatic Cancer Fellowship; Avner Pancreatic Cancer Foundation; Sutton Motor Pancreatic cancer fund	Cancer Council NSW(Cancer Council New South Wales); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Cancer Institute NSW; Len Ainsworth Pancreatic Cancer Fellowship; Avner Pancreatic Cancer Foundation; Sutton Motor Pancreatic cancer fund	This work was supported by grants from the Cancer Council NSW (SRO and CJO), NHMRC Australia (CJO, DGO, PT, MP, and SRO), National Breast Cancer Foundation (ND and CEC), Cancer Institute NSW (DGO, PT, MP), Sutton Motor Pancreatic cancer funding (PT), Len Ainsworth Pancreatic Cancer Fellowship (PT), Avner Pancreatic Cancer Foundation Grant (PT) as well as philanthropic support through the Mostyn Family Foundation (SRO) and Cue Clothing Co. (SRO), Estee Lauder Australia (SRO, DGO and CJO), RT Hall Trust (CJO). We thank Gillian Lehrbach for tissue culture support and Anaiis Zaratzian and Andrew Da Silva for histology services.	Abulwerdi F, 2014, MOL CANCER THER, V13, P565, DOI 10.1158/1535-7163.MCT-12-0767; Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; CARDIN DB, 2018, INVEST NEW DRUG, V36, P442, DOI DOI 10.1007/S10637-017-0519-Z; Chee CE, 2013, ONCOLOGIST, V18, P1091, DOI 10.1634/theoncologist.2013-0255; Chou A, 2018, GUT, V67, P2142, DOI 10.1136/gutjnl-2017-315144; Chowdry R.P., 2014, ONCOTARGET, P5, DOI [10.18632/oncotarget.7485, DOI 10.18632/ONCOTARGET.7485]; Creedon Helen, 2012, Critical Reviews in Oncogenesis, V17, P145; Donahue TR, 2012, CLIN CANCER RES, V18, P1352, DOI 10.1158/1078-0432.CCR-11-1539; Duxbury MS, 2004, CLIN CANCER RES, V10, P2307, DOI 10.1158/1078-0432.CCR-1183-3; Evans TRJ, 2017, ANN ONCOL, V28, P354, DOI 10.1093/annonc/mdw607; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Goodwin CM, 2015, CELL DEATH DIFFER, V22, P2098, DOI 10.1038/cdd.2015.73; Johns AL, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0430-4; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Law AMK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15885-6; Leverson JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.561; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; Miyamoto Y, 1999, ONCOLOGY-BASEL, V56, P73, DOI 10.1159/000011933; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Opferman JT, 2016, FEBS J, V283, P2661, DOI 10.1111/febs.13472; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Patel A, 2016, LIFE SCI, V157, P52, DOI 10.1016/j.lfs.2016.05.036; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Rawla P, 2019, WORLD J ONCOL, V10, P10, DOI 10.14740/wjon1166; Renouf Daniel J, 2012, Invest New Drugs, V30, P779, DOI 10.1007/s10637-010-9611-3; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Timpson P, 2011, JOVE-J VIS EXP, DOI 10.3791/3089; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang JT, 2015, NEUROSCIENCE, V292, P90, DOI 10.1016/j.neuroscience.2015.02.025; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Young AIJ, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0781-6; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	40	13	13	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1821	1829		10.1038/s41388-019-1091-0	http://dx.doi.org/10.1038/s41388-019-1091-0			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31735913	Green Published, hybrid			2022-12-26	WOS:000514923000015
J	Dengler, MA; Teh, CE; Thijssen, R; Gangoda, L; Lan, P; Herold, MJ; Gray, DH; Kelly, GL; Roberts, AW; Adams, JM				Dengler, Michael A.; Teh, Charis E.; Thijssen, Rachel; Gangoda, Lahiru; Lan, Ping; Herold, Marco J.; Gray, Daniel H.; Kelly, Gemma L.; Roberts, Andrew W.; Adams, Jerry M.			Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma	ONCOGENE			English	Article							BRUTON TYROSINE KINASE; PHASE-I; BCL-2; VENETOCLAX; APOPTOSIS; EXPRESSION; CANCER; MICROENVIRONMENT; MUTATIONS; IBRUTINIB	Apoptosis-regulating BCL-2 family members, which can promote malignant transformation and resistance to therapy, have become prime therapeutic targets, as illustrated by the striking efficacy in certain lymphoid malignancies of the BCL-2-specific inhibitor venetoclax. In other lymphoid malignancies, however, such as the aggressive mantle cell lymphoma (MCL), cell survival might rely instead or also on BCL-2 relative MCL-1. We have explored MCL-1 as a target for killing MCL cells by both genetic and pharmacologic approaches. In several MCL cell lines, MCL-1 knockout with an inducible CRISPR/Cas9 system triggered spontaneous apoptosis. Accordingly, most MCL cell lines proved sensitive to the specific MCL-1 inhibitor S63845, and MCL-1 inhibition also proved efficacious in an MCL xenograft model. Furthermore, its killing efficacy rose on combination with venetoclax, the BCL-X-L-specific inhibitor A-1331852, or Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, which reduced pro-survival signals. We also tested the MCL-1 inhibitor in primary samples from 13 MCL patients, using CD40L-expressing feeder cells to model their microenvironmental support. Notably, all unstimulated primary MCL samples were very sensitive to S63845, but the CD40L stimulation attenuated their sensitivity. Mass cytometric analysis revealed that the stimulation likely conveyed protection by elevating BCL-X-L and MCL-1. Accordingly, sensitivity of the CD40L-stimulated cells to S63845 was substantially restored by co-treatment with venetoclax, the BCL-X-L-specific inhibitor or ibrutinib. Overall, our findings indicate that MCL-1 is very important for survival of MCL cells and that the MCL-1 inhibitor, both alone and together with ibrutinib, venetoclax or a BCL-X-L inhibitor, offers promise for novel improved MCL therapies.	[Dengler, Michael A.; Teh, Charis E.; Thijssen, Rachel; Gangoda, Lahiru; Lan, Ping; Herold, Marco J.; Gray, Daniel H.; Kelly, Gemma L.; Roberts, Andrew W.; Adams, Jerry M.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3052, Australia; [Dengler, Michael A.; Teh, Charis E.; Thijssen, Rachel; Gangoda, Lahiru; Lan, Ping; Herold, Marco J.; Gray, Daniel H.; Kelly, Gemma L.; Roberts, Andrew W.; Adams, Jerry M.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Lan, Ping] Jinan Univ, Inst Adv & Appl Chem Synth, Zhuhai 519070, Guangdong, Peoples R China	Walter & Eliza Hall Institute; University of Melbourne; Jinan University	Adams, JM (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3052, Australia.; Adams, JM (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia.	adams@wehi.edu.au	Herold, Marco J/C-8039-2013; Adams, Jerry M/E-1199-2013; Dengler, Michael/AFR-3509-2022; Kelly, Gemma/AAG-6352-2020; Roberts, Andrew W./C-6736-2012; Thijssen, Rachel/AAE-7599-2022; Gray, Daniel/A-3293-2013	Herold, Marco J/0000-0001-7539-7581; Roberts, Andrew W./0000-0002-7341-5720; Thijssen, Rachel/0000-0002-4493-306X; Kelly, Gemma/0000-0002-6533-1201; Dengler, Michael/0000-0002-1693-1761; Adams, Jerry/0000-0002-4360-8628; Gangoda, Lahiru/0000-0003-1931-6809; Gray, Daniel/0000-0002-8457-8242	Metro South Health; CASS Foundation Science Medicine Grant [SM/18/7801]; National Health and Medical Research Council (NHMRC) [1016701, 1079560]; SCOR from the Leukemia and Lymphoma Society [7015-18, 5467-18]; NHMRC [1089072, 1090236]; Victorian Cancer Agency Fellowship [MCRF 17028]; Cancer Council of Victoria [1146518, 1147328]; Leukaemia Foundation Australia grant; Australian Government Independent Research Institute Infrastructure Support Scheme [9000220]; Victorian State Government Operational Infrastructure Support Program	Metro South Health; CASS Foundation Science Medicine Grant; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); SCOR from the Leukemia and Lymphoma Society; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency Fellowship; Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukaemia Foundation Australia grant; Australian Government Independent Research Institute Infrastructure Support Scheme(Australian Government); Victorian State Government Operational Infrastructure Support Program	We thank Naomi Sprigg (Royal Melbourne Hospital) for assistance with fresh clinical samples, Leonie Gibson and Tania Tan for excellent technical assistance, and Connie Li Wai Suen for statistical advice. We would like to acknowledge the Metro South Health Cancer Collaborative Biobank, Brisbane for the provision of hematologic malignancy samples for this project. The Cancer Collaborative Biobank is supported by Metro South Health funding. This work was supported by a CASS Foundation Science & Medicine Grant SM/18/7801 (to MAD); program grant 1016701 (to JMA) and Practitioner Fellowship 1079560 (to AWR) from the National Health and Medical Research Council (NHMRC); SCOR grant 7015-18 (to JMA and AWR) and Fellowship 5467-18 (to RT) from the Leukemia and Lymphoma Society; NHMRC Fellowship 1089072 (to CET), NHMRC Fellowship 1090236 (to DHG), Victorian Cancer Agency Fellowship MCRF 17028 (to GLK), Cancer Council of Victoria Grants-in-Aid 1146518 (to DHG) and 1147328 (to GLK), Leukaemia Foundation Australia grant (to GLK), and operational infrastructure grants through the Australian Government Independent Research Institute Infrastructure Support Scheme (9000220) and the Victorian State Government Operational Infrastructure Support Program. This work was performed in part at the Materials Characterization and Fabrication Platform at the University of Melbourne and the Victorian Node of the Australian National Fabrication Facility.	Adams JM, 2018, CELL DEATH DIFFER, V25, P27, DOI 10.1038/cdd.2017.161; Agarwal R, 2019, NAT MED, V25, P119, DOI 10.1038/s41591-018-0243-z; Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Anderson MA, 2016, BLOOD, V127, P3215, DOI 10.1182/blood-2016-01-688796; Arbour N, 2008, J NEUROSCI, V28, P6068, DOI 10.1523/JNEUROSCI.4940-07.2008; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Brennan MS, 2018, BLOOD, V132, P1573, DOI 10.1182/blood-2018-06-859405; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Burger JA, 2011, SEMIN CANCER BIOL, V21, P308, DOI 10.1016/j.semcancer.2011.09.006; Caenepeel S, 2018, CANCER DISCOV, V8, P1582, DOI 10.1158/2159-8290.CD-18-0387; Campo E, 2015, BLOOD, V125, P48, DOI 10.1182/blood-2014-05-521898; Camps J, 2006, LEUKEMIA RES, V30, P923, DOI 10.1016/j.leukres.2005.11.013; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chang BY, 2013, BLOOD, V122, P2412, DOI 10.1182/blood-2013-02-482125; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chiron D, 2016, BLOOD, V128, P2808, DOI 10.1182/blood-2016-06-720490; Chiron D, 2015, ONCOTARGET, V6, P8750, DOI 10.18632/oncotarget.3275; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Davids MS, 2017, J CLIN ONCOL, V35, P826, DOI 10.1200/JCO.2016.70.4320; Dengler MA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.552; Eyre TA, 2019, HAEMATOLOGICA, V104, pE68, DOI 10.3324/haematol.2018.198812; Fakhri B, 2017, THER ADV HEMATOL, V8, P223, DOI 10.1177/2040620717719616; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Gomez-Bougie P, 2018, BLOOD, V132, P2656, DOI 10.1182/blood-2018-03-836718; Gong JN, 2016, BLOOD, V128, P1834, DOI 10.1182/blood-2016-03-704908; Good Z, 2018, NAT MED, V24, P474, DOI 10.1038/nm.4505; Greaves G, 2019, CELL DEATH DIFFER, V26, P1037, DOI 10.1038/s41418-018-0183-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang S, 2018, P IEEE SEMICOND THER, P8; Jares P, 2012, J CLIN INVEST, V122, P3416, DOI 10.1172/JCI61272; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Khoury JD, 2003, J PATHOL, V199, P90, DOI 10.1002/path.1254; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kurtova AV, 2009, BLOOD, V113, P4604, DOI 10.1182/blood-2008-10-185827; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Ma J, 2014, BRIT J HAEMATOL, V166, P849, DOI 10.1111/bjh.12974; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Montero J, 2018, CELL DEATH DIFFER, V25, P56, DOI 10.1038/cdd.2017.183; Moujalled DM, 2019, LEUKEMIA, V33, P905, DOI 10.1038/s41375-018-0261-3; Nagy B, 2003, BRIT J HAEMATOL, V120, P434, DOI 10.1046/j.1365-2141.2003.04121.x; PRICHARD MN, 1991, ANTIMICROB AGENTS CH, V35, P1060, DOI 10.1128/AAC.35.6.1060; Prukova D, 2019, CLIN CANCER RES, V25, P4455, DOI 10.1158/1078-0432.CCR-18-3275; Ramsey HE, 2018, CANCER DISCOV, V8, P1566, DOI 10.1158/2159-8290.CD-18-0140; Rauert-Wunderlich H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0157-6; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Rudolph C, 2004, CANCER GENET CYTOGEN, V153, P144, DOI 10.1016/j.cancergencyto.2004.01.006; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Tam CS, 2018, NEW ENGL J MED, V378, P1211, DOI 10.1056/NEJMoa1715519; Teh TC, 2018, LEUKEMIA, V32, P303, DOI 10.1038/leu.2017.243; Thomas RL, 2013, GENE DEV, V27, P1365, DOI 10.1101/gad.215871.113; Tucker CA, 2006, LEUKEMIA RES, V30, P449, DOI 10.1016/j.leukres.2005.08.016; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304	62	13	13	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					2009	2023		10.1038/s41388-019-1122-x	http://dx.doi.org/10.1038/s41388-019-1122-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31772331				2022-12-26	WOS:000516579800014
J	Hara, K; Iida, N; Tamafune, R; Ohashi, E; Sakurai, H; Ishikawa, Y; Hishiki, A; Hashimoto, H				Hara, Kodai; Iida, Nao; Tamafune, Ryota; Ohashi, Eiji; Sakurai, Hitomi; Ishikawa, Yoshinobu; Hishiki, Asami; Hashimoto, Hiroshi			Structure of the RAD9-RAD1-HUS1 checkpoint clamp bound to RHINO sheds light on the other side of the DNA clamp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage response; structural biology; proliferating cell nuclear antigen (PCNA); checkpoint control; protein structure; protein complex; 9-1-1; DNA clamp; crystal structure; DNA damage checkpoint; protein-protein interaction	CRYSTAL-STRUCTURE; PCNA; COMPLEX	DNA clamp, a highly conserved ring-shaped protein, binds dsDNA within its central pore. Also, DNA clamp interacts with various nuclear proteins on its front, thereby stimulating their enzymatic activities and biological functions. It has been assumed that the DNA clamp is a functionally single-faced ring from bacteria to humans. Here, we report the crystal structure of the heterotrimeric RAD9-RAD1-HUS1 (9-1-1) checkpoint clamp bound to a peptide of RHINO, a recently identified cancer-related protein that interacts with 9-1-1 and promotes activation of the DNA damage checkpoint. This is the first structure of 9-1-1 bound to its partner. The structure reveals that RHINO is unexpectedly bound to the edge and around the back of the 9-1-1 ring through specific interactions with the RAD1 subunit of 9-1-1. Our finding indicates that 9-1-1 is a functionally double-faced DNA clamp.	[Hara, Kodai; Iida, Nao; Tamafune, Ryota; Sakurai, Hitomi; Ishikawa, Yoshinobu; Hishiki, Asami; Hashimoto, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Yada 52-1, Shizuoka, Shizuoka 4228002, Japan; [Ohashi, Eiji] Kyushu Univ, Fac Sci, Dept Biol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan	University of Shizuoka; Kyushu University	Hashimoto, H (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228002, Japan.	hash@u-shizuoka-ken.ac.jp	Ohashi, Eiji/AAO-5794-2021	Ohashi, Eiji/0000-0002-1771-5585; hara, kodai/0000-0002-1586-6312; Hashimoto, Hiroshi/0000-0003-1503-6789	Japan Society for the Promotion of Science (JSPS)/MEXT KAKENHI Grants [25291017, 16H04755, 17H06014, 15K18491, 17K07314]; Collaborated Research Program [VFCR-14-02]	Japan Society for the Promotion of Science (JSPS)/MEXT KAKENHI Grants; Collaborated Research Program	This work was supported by Japan Society for the Promotion of Science (JSPS)/MEXT KAKENHI Grants 25291017, 16H04755, and 17H06014 (to H. H.) and Grants 15K18491 and 17K07314 (to K. H.) and by the Collaborated Research Program as the Visiting Fellow of the Institute for Protein Research, Osaka University, VFCR-14-02 (to H. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Eichinger CS, 2011, TRENDS BIOCHEM SCI, V36, P563, DOI 10.1016/j.tibs.2011.08.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelch BA, 2016, BIOPOLYMERS, V105, P532, DOI 10.1002/bip.22827; Kim JW, 2010, INT J ONCOL, V37, P861, DOI 10.3892/ijo_00000737; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lindsey-Boltz LA, 2015, CELL CYCLE, V14, P99, DOI 10.4161/15384101.2014.967076; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Ohashi E, 2017, ADV EXP MED BIOL, V1042, P135, DOI 10.1007/978-981-10-6955-0_7; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Venclovas C, 2002, PROTEIN SCI, V11, P2403, DOI 10.1110/ps.0214302; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Yao NNY, 2016, CRIT REV BIOCHEM MOL, V51, P135, DOI 10.3109/10409238.2015.1125845	25	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2020	295	4					899	904		10.1074/jbc.AC119.011816	http://dx.doi.org/10.1074/jbc.AC119.011816			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KG4WV	31776186	Green Published, hybrid			2022-12-26	WOS:000509949300001
J	Liu, K; Tang, MX; Jin, HW; Liu, QZ; He, LJ; Zhu, H; Liu, XX; Han, XM; Li, Y; Zhang, LB; Tang, J; Pu, WJ; Lv, Z; Wang, HX; Ji, HB; Zhou, B				Liu, Kuo; Tang, Muxue; Jin, Hengwei; Liu, Qiaozhen; He, Lingjuan; Zhu, Huan; Liu, Xiuxiu; Han, Ximeng; Li, Yan; Zhang, Libo; Tang, Juan; Pu, Wenjuan; Lv, Zan; Wang, Haixiao; Ji, Hongbin; Zhou, Bin			Triple-cell lineage tracing by a dual reporter on a single allele	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lung; lung injury; cardiomyocyte; cardiovascular; stem cells; regeneration; development; bronchioalveolar stem cells (BASCs); Cre-loxP; Dre-rox; heart development; lineage tracing	STEM-CELLS; LUNG EPITHELIUM; CRE; RECOMBINASE; PROGENITORS; ALVEOLAR; SYSTEM; AIRWAY; MODEL; IDENTIFICATION	Genetic lineage tracing is widely used to study organ development and tissue regeneration. Multicolor reporters are a powerful platform for simultaneously tracking discrete cell populations. Here, combining Dre-rox and Cre-loxP systems, we generated a new dual-recombinase reporter system, called Rosa26 traffic light reporter (R26-TLR), to monitor red, green, and yellow fluorescence. Using this new reporter system with the three distinct fluorescent reporters combined on one allele, we found that the readouts of the two recombinases Cre and Dre simultaneously reflect Cre(+)Dre(?), Cre(?)Dre(+), and Cre(+)Dre(+) cell lineages. As proof of principle, we show specific labeling in three distinct progenitor/stem cell populations, including club cells, AT2 cells, and bronchoalveolar stem cells, in Sftpc-DreER;Scgb1a1-CreER;R26-TLR mice. By using this new dual-recombinase reporter system, we simultaneously traced the cell fate of these three distinct cell populations during lung repair and regeneration, providing a more comprehensive picture of stem cell function in distal airway repair and regeneration. We propose that this new reporter system will advance developmental and regenerative research by facilitating a more sophisticated genetic approach to studying in vivo cell fate plasticity.	[Liu, Kuo; Tang, Muxue; Jin, Hengwei; Liu, Qiaozhen; He, Lingjuan; Zhu, Huan; Liu, Xiuxiu; Han, Ximeng; Li, Yan; Zhang, Libo; Tang, Juan; Pu, Wenjuan; Lv, Zan; Wang, Haixiao; Ji, Hongbin; Zhou, Bin] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci,State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci,Inst Biochem & Cell B, Shanghai 200031, Peoples R China; [Liu, Kuo; Han, Ximeng; Zhou, Bin] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Zhou, Bin] 320 Yueyang Rd,Life Sci Res Bldg,A-2112, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Zhou, B (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci,State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci,Inst Biochem & Cell B, Shanghai 200031, Peoples R China.; Zhou, B (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Zhou, B (corresponding author), 320 Yueyang Rd,Life Sci Res Bldg,A-2112, Shanghai 200031, Peoples R China.	zhoubin@sibs.ac.cn		Zhu, Huan/0000-0002-0731-2547	National Key Research and Development Program of China [2018YFA0108100, 2019YFA0110400, 2018YFA0107900, 2016YFC1300600, 2017YFC1001303]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16010507, XDB19000000]; National Science Foundation of China [31730112, 91639302, 31625019, 91849202, 81761138040, 81872241, 31701292, 31922032]	National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China Grants 2018YFA0108100, 2019YFA0110400, 2018YFA0107900, 2016YFC1300600, and 2017YFC1001303; Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDA16010507 and XDB19000000; and National Science Foundation of China Grants 31730112, 91639302, 31625019, 91849202, 81761138040, 81872241, 31701292, and 31922032. The authors declare that they have no conflicts of interest with the contents of this article.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Buckingham ME, 2011, DEV CELL, V21, P394, DOI 10.1016/j.devcel.2011.07.019; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chen Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12422; Glenny RW, 2011, J APPL PHYSIOL, V110, P1119, DOI 10.1152/japplphysiol.01293.2010; Gonzalez G, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.303; He LJ, 2017, NAT MED, V23, P1488, DOI 10.1038/nm.4437; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jiang M, 2017, NATURE, V550, P529, DOI 10.1038/nature24269; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Liu K, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167775; Liu QZ, 2019, NAT GENET, V51, P728, DOI 10.1038/s41588-019-0346-6; Liu QZ, 2014, CELL RES, V24, P1367, DOI 10.1038/cr.2014.125; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lynch TJ, 2018, CELL STEM CELL, V22, P653, DOI 10.1016/j.stem.2018.03.017; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mirkovic J, 2015, J PATHOL, V236, P265, DOI 10.1002/path.4533; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nabhan AN, 2018, SCIENCE, V359, P1118, DOI 10.1126/science.aam6603; Plummer NW, 2015, DEVELOPMENT, V142, P4385, DOI 10.1242/dev.129981; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rockich BE, 2013, P NATL ACAD SCI USA, V110, pE4456, DOI 10.1073/pnas.1311847110; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Salwig I, 2019, EMBO J, V38, DOI 10.15252/embj.2019102099; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tata A, 2018, CELL STEM CELL, V22, P668, DOI 10.1016/j.stem.2018.03.018; Tian XY, 2015, CIRC RES, V116, P515, DOI 10.1161/CIRCRESAHA.116.305097; Tian XY, 2014, SCIENCE, V345, P90, DOI 10.1126/science.1251487; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Yamamoto M, 2009, GENESIS, V47, P107, DOI 10.1002/dvg.20474; Yang EJ, 2015, MODERN PATHOL, V28, P994, DOI 10.1038/modpathol.2015.54; Yang Y, 2018, DEV CELL, V44, P752, DOI 10.1016/j.devcel.2018.03.001; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786; Zepp JA, 2019, NAT REV MOL CELL BIO, V20, P551, DOI 10.1038/s41580-019-0141-3; Zhang H, 2017, CELL RES, V27, P1157, DOI 10.1038/cr.2017.103; Zhang H, 2016, CIRC RES, V118, P254, DOI 10.1161/CIRCRESAHA.115.307202; Zhao H, 2019, CURR OPIN CELL BIOL, V61, P101, DOI 10.1016/j.ceb.2019.07.004; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	52	12	12	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					690	700		10.1074/jbc.RA119.011349	http://dx.doi.org/10.1074/jbc.RA119.011349			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31771978	Green Published, hybrid			2022-12-26	WOS:000508382900002
J	Wang, SF; Crisman, L; Miller, J; Datta, I; Gulbranson, DR; Tian, Y; Yin, Q; Yu, HJ; Shen, JS				Wang, Shifeng; Crisman, Lauren; Miller, Jessica; Datta, Ishara; Gulbranson, Daniel R.; Tian, Yuan; Yin, Qian; Yu, Haijia; Shen, Jingshi			Inducible Exoc7/Exo70 knockout reveals a critical role of the exocyst in insulin-regulated GLUT4 exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exocytosis; membrane fusion; membrane protein; membrane trafficking; vesicles; glucose transporter type 4 (GLUT4); CRISPR genome editing; exocyst; exocyst complex component 7 (Exoc7); insulin signaling	SECRETORY VESICLES; STRUCTURAL BASIS; ESSENTIAL GENES; GLUCOSE-UPTAKE; SUBUNIT SEC6; MEMBRANE; SNARE; COMPLEX; FUSION; TRAFFICKING	Insulin promotes glucose uptake by triggering the translocation of glucose transporter type 4 (GLUT4) from intracellular vesicles to the plasma membrane through exocytosis. GLUT4 exocytosis is a vesicle fusion event involving fusion of GLUT4-containing vesicles with the plasma membrane. For GLUT4 vesicle fusion to occur, GLUT4 vesicles must first be tethered to the plasma membrane. A key tethering factor in exocytosis is a heterooctameric protein complex called the exocyst. The role of the exocyst in GLUT4 exocytosis, however, remains incompletely understood. Here we first systematically analyzed data from a genome-scale CRISPR screen in HeLa cells that targeted virtually all known genes in the human genome, including 12 exocyst genes. The screen recovered only a subset of the exocyst genes, including exocyst complex component 7 (Exoc7/Exo70). Other exocyst genes, however, were not isolated in the screen, likely because of functional redundancy. Our findings suggest that selection of an appropriate exocyst gene is critical for genetic studies of exocyst functions. Next we developed an inducible adipocyte genome editing system that enabled Exoc7 gene deletion in adipocytes without interfering with adipocyte differentiation. We observed that insulin-stimulated GLUT4 exocytosis was markedly inhibited in Exoc7 KO adipocytes. Insulin signaling, however, remained intact in these KO cells. These results indicate that the exocyst plays a critical role in insulin-stimulated GLUT4 exocytosis in adipocytes. We propose that the strategy outlined in this work could be instrumental in genetically dissecting other membrane-trafficking pathways in adipocytes.	[Wang, Shifeng; Crisman, Lauren; Miller, Jessica; Datta, Ishara; Gulbranson, Daniel R.; Yu, Haijia; Shen, Jingshi] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wang, Shifeng] Beijing Univ Chinese Med, Dept Chinese Med Informat Sci, Beijing 102488, Peoples R China; [Tian, Yuan; Yin, Qian] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Tian, Yuan; Yin, Qian] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Yu, Haijia] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Jiangsu, Peoples R China	University of Colorado System; University of Colorado Boulder; Beijing University of Chinese Medicine; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Nanjing Normal University	Shen, JS (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	jingshi.shen@colorado.edu	Gulbranson, Daniel/AAE-4338-2020; Gulbranson, Daniel/AAE-4807-2020; Yu, Haijia/GXV-5159-2022	Yu, Haijia/0000-0002-7193-8034; Wang, Shifeng/0000-0002-1663-1312; Datta, Ishara/0000-0002-4493-5487; Yin, Qian/0000-0002-8481-150X	National Institutes of Health [GM088759, DK095367, GM126960, AI108793]; American Diabetes Association basic science award; Postdoctoral Overseas Training Program at Beijing University of Chinese Medicine; American Heart Association predoctoral fellowship; Undergraduate Research Opportunities Program at University of Colorado Boulder; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI108793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095367, R56DK095367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, R35GM126960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG061829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association basic science award(American Diabetes Association); Postdoctoral Overseas Training Program at Beijing University of Chinese Medicine; American Heart Association predoctoral fellowship(American Heart Association); Undergraduate Research Opportunities Program at University of Colorado Boulder; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants DK095367 (to J. S.), GM126960 (to J. S.), and AI108793 (Q. Y.); an American Diabetes Association basic science award (to J. S.); a fellowship from the Postdoctoral Overseas Training Program at Beijing University of Chinese Medicine (to S. W.); National Institutes of Health Institutional Predoctoral Training Grant GM088759 (to L. C.), an American Heart Association predoctoral fellowship (to D. R. G.), and a fellowship from the Undergraduate Research Opportunities Program at University of Colorado Boulder (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07467-5; Antonescu CN, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016964; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Barger CJ, 2019, CANCERS, V11, DOI 10.3390/cancers11020251; Blot Vincent, 2008, V457, P347, DOI 10.1007/978-1-59745-261-8-26; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Brunger AT, 2009, ANNU REV BIOCHEM, V78, P903, DOI 10.1146/annurev.biochem.77.070306.103621; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Dubuke ML, 2015, J BIOL CHEM, V290, P28245, DOI 10.1074/jbc.M115.673806; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gulbranson DR, 2019, DEV CELL, V50, P436, DOI 10.1016/j.devcel.2019.06.013; Gulbranson DR, 2017, P NATL ACAD SCI USA, V114, pE8224, DOI 10.1073/pnas.1712176114; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Heider MR, 2016, NAT STRUCT MOL BIOL, V23, P59, DOI 10.1038/nsmb.3146; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hughson FM, 2010, CURR OPIN CELL BIOL, V22, P454, DOI 10.1016/j.ceb.2010.03.011; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Inoue M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120289; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kioumourtzoglou D, 2015, J CELL SCI, V128, P2423, DOI 10.1242/jcs.166561; Lepore DM, 2018, TRENDS BIOCHEM SCI, V43, P714, DOI 10.1016/j.tibs.2018.06.012; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lizunov VA, 2009, J BIOL CHEM, V284, P7914, DOI 10.1074/jbc.M806460200; Martin-Urdiroz M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00024; Mei KR, 2018, NAT STRUCT MOL BIOL, V25, P139, DOI 10.1038/s41594-017-0016-2; Menasche Bridget L, 2019, Curr Protoc Cell Biol, V82, pe68, DOI 10.1002/cpcb.68; Morgera F, 2012, MOL BIOL CELL, V23, P337, DOI 10.1091/mbc.E11-08-0670; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Pan X, 2017, MOL BIOL CELL, V28, P1667, DOI 10.1091/mbc.E16-11-0777; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Picco A, 2017, CELL, V168, P400, DOI 10.1016/j.cell.2017.01.004; Polgar N, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a031401; Rai A, 2016, ELIFE, V5, DOI 10.7554/eLife.18675; Rivera-Molina F, 2013, J CELL BIOL, V201, P673, DOI 10.1083/jcb.201212103; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sano H, 2015, BIOCHEM BIOPH RES CO, V465, P601, DOI 10.1016/j.bbrc.2015.08.069; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shen D, 2013, J CELL BIOL, V202, P509, DOI 10.1083/jcb.201211148; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Skorobogatko Y, 2018, P NATL ACAD SCI USA, V115, P7819, DOI 10.1073/pnas.1801050115; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398; Yue P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14236	69	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19988	19996		10.1074/jbc.RA119.010821	http://dx.doi.org/10.1074/jbc.RA119.010821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31740584	hybrid, Green Published			2022-12-26	WOS:000505005800014
J	Cossey, SM; Yu, YTN; Cossu, L; Velicer, GJ				Cossey, Sarah M.; Yu, Yuen-Tsu Nicco; Cossu, Laura; Velicer, Gregory J.			Kin discrimination and outer membrane exchange in Myxococcus xanthus: Experimental analysis of a natural population	PLOS ONE			English	Article							VI SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; CUTICULAR-HYDROCARBONS; SOCIAL BEHAVIORS; SELF-IDENTITY; RECOGNITION; MYXOBACTERIA; COOPERATION; EVOLUTION; GROWTH	In some species of myxobacteria, adjacent cells sufficiently similar at the adhesin protein TraA can exchange components of their outer membranes. The primary benefits of such outer membrane exchange (OME) in natural populations are unclear, but in some OME interactions, transferred OM content can include SitA toxins that kill OME participants lacking an appropriate immunity gene. Such OME-dependent toxin transfer across Myxococcus xanthus strains that differ only in their sitBAI toxin/antitoxin cassette can mediate inter-strain killing and generate colony-merger incompatibilities (CMIs)-inter-colony border phenotypes between distinct genotypes that differ from respective self-self colony interfaces. Here we ask whether OME-dependent toxin transfer is a common cause of prevalent CMIs and antagonisms between M. xanthus natural isolates identical at TraA. We disrupted traA in eleven isolates from a cm-scale soil population and assayed whether traA disruption eliminated or reduced CMIs between swarming colonies or antagonisms between strains in mixed cultures. Among 33 isolate pairs identical at traA that form clear CMIs, in no case did functional disruption of traA in one partner detectably alter CMI phenotypes. Further, traA disruption did not alleviate strong antagonisms observed during starvation-induced fruitingbody development in seven pairs of strains identical at traA. Collectively, our results suggest that most mechanisms of interference competition and inter-colony kin discrimination in natural populations of myxobacteria do not require OME. Finally, our experiments also indicate that several closely related laboratory reference strains kill some natural isolates by toxins delivered by a shared, OME-independent type VI secretion system (T6SS), suggesting that some antagonisms between sympatric natural isolates may also involve T6SS toxins.	[Cossey, Sarah M.; Yu, Yuen-Tsu Nicco; Velicer, Gregory J.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Integrat Biol, Zurich, Switzerland; [Cossu, Laura] Eawag, Dept Environm Microbiol, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Cossey, SM (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Integrat Biol, Zurich, Switzerland.	sarah.cossey@env.ethz.ch			SNSF [31003A_16005]	SNSF(Swiss National Science Foundation (SNSF))	This work was supported by SNSF grant 31003A_16005 to GJV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003608; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; BEECHER MD, 1981, ANIM BEHAV, V29, P95, DOI 10.1016/S0003-3472(81)80156-X; Berleman JE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00474; Berleman JE, 2009, FEMS MICROBIOL REV, V33, P942, DOI 10.1111/j.1574-6976.2009.00185.x; BREED MD, 1988, P NATL ACAD SCI USA, V85, P8766, DOI 10.1073/pnas.85.22.8766; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; Cao P., 2019, MBIO, V10, P1; Cao PB, 2017, P NATL ACAD SCI USA, V114, P3732, DOI 10.1073/pnas.1700315114; Cao PB, 2015, J MOL BIOL, V427, P3709, DOI 10.1016/j.jmb.2015.07.022; Cianfanelli FR, 2016, TRENDS MICROBIOL, V24, P51, DOI 10.1016/j.tim.2015.10.005; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Dey A, 2016, J BACTERIOL, V198, P994, DOI 10.1128/JB.00964-15; DIENES L, 1946, P SOC EXP BIOL MED, V63, P265; Dietemann V, 2005, BEHAV ECOL SOCIOBIOL, V58, P486, DOI 10.1007/s00265-005-0939-1; Evans AGL, 2012, MICROBIOL-SGM, V158, P2742, DOI 10.1099/mic.0.060343-0; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Gong Y, 2018, ENVIRON MICROBIOL, V20, P2552, DOI 10.1111/1462-2920.14282; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hawlena H, 2010, AM NAT, V175, P374, DOI 10.1086/650375; Ho HI, 2013, CURR BIOL, V23, P1590, DOI 10.1016/j.cub.2013.06.049; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jamet A, 2015, MBIO, V6, DOI 10.1128/mBio.00285-15; Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996; Kahnt J, 2010, J PROTEOME RES, V9, P5197, DOI 10.1021/pr1004983; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2004, ANNU REV MICROBIOL, V58, P75, DOI 10.1146/annurev.micro.58.030603.123620; Keane R, 2016, MICROBIOL-SGM, V162, P1, DOI 10.1099/mic.0.000208; Komdeur J, 1999, TRENDS ECOL EVOL, V14, P237, DOI 10.1016/S0169-5347(98)01573-0; Konovalova A, 2010, FEMS MICROBIOL REV, V34, P89, DOI 10.1111/j.1574-6976.2009.00194.x; Kraemer SA, 2016, MOL ECOL, V25, P4875, DOI 10.1111/mec.13803; Krug D, 2008, APPL ENVIRON MICROB, V74, P3058, DOI 10.1128/AEM.02863-07; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lyons NA, 2016, CURR BIOL, V26, P733, DOI 10.1016/j.cub.2016.01.032; Makarova K, 2019, MBIO, V10; MCCURDY HD, 1974, CAN J MICROBIOL, V20, P131, DOI 10.1139/m74-021; Mehdiabadi NJ, 2006, NATURE, V442, P881, DOI 10.1038/442881a; Muller S, 2013, GENOME ANNOUNC, V1; Munson EL, 2002, J CLIN MICROBIOL, V40, P4285, DOI 10.1128/JCM.40.11.4285-4288.2002; Nair RR, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0054; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; Pathak DT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003891; Pathak DT, 2012, PLOS GENET, V8, P160, DOI 10.1371/journal.pgen.1002626; Patra P, 2017, BIOPHYS J, V113, P2477, DOI 10.1016/j.bpj.2017.09.020; Peeters C, 1999, P ROY SOC B-BIOL SCI, V266, P1323, DOI 10.1098/rspb.1999.0782; Rendueles O, 2015, P NATL ACAD SCI USA, V112, P9076, DOI 10.1073/pnas.1502251112; Rendueles O, 2015, CURR BIOL, V25, P1673, DOI 10.1016/j.cub.2015.04.057; Rodriguez AM, 1999, J BACTERIOL, V181, P4381, DOI 10.1128/JB.181.14.4381-4390.1999; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; SMITH DR, 1994, J BACTERIOL, V176, P1201, DOI 10.1128/JB.176.4.1201-1205.1994; Stefanic P, 2015, P NATL ACAD SCI USA, V112, P14042, DOI 10.1073/pnas.1512671112; Strassmann JE, 2011, ANNU REV MICROBIOL, V65, P349, DOI 10.1146/annurev.micro.112408.134109; SUDO S, 1972, J BACTERIOL, V110, P236, DOI 10.1128/JB.110.1.236-245.1972; Troselj V, 2018, MBIO, V9, DOI 10.1128/mBio.01645-17; Unterweger D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4549; Vassallo C, 2015, P NATL ACAD SCI USA, V112, pE2939, DOI 10.1073/pnas.1503553112; Vassallo CM, 2017, ELIFE, V6, DOI 10.7554/eLife.29397; Vassallo CN, 2016, BIOESSAYS, V38, P306, DOI 10.1002/bies.201500132; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Vos M, 2008, CURR BIOL, V18, P386, DOI 10.1016/j.cub.2008.02.050; Vos M, 2009, CURR BIOL, V19, P1763, DOI 10.1016/j.cub.2009.08.061; Wall D, 1999, J BACTERIOL, V181, P24, DOI 10.1128/JB.181.1.24-33.1999; Wall D, 2016, ANNU REV MICROBIOL, V70, P143, DOI 10.1146/annurev-micro-102215-095325; Wall D, 2014, MOL MICROBIOL, V91, P209, DOI 10.1111/mmi.12450; Wenren LM, 2013, MBIO, V4, DOI 10.1128/mBio.00374-13; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Wielgoss S, 2018, MOL ECOL, V27, P3146, DOI 10.1111/mec.14773; Wielgoss S, 2016, ISME J, V10, P2468, DOI 10.1038/ismej.2016.34; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018	79	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0224817	10.1371/journal.pone.0224817	http://dx.doi.org/10.1371/journal.pone.0224817			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774841	Green Published, gold			2022-12-26	WOS:000533896400019
J	Thakur, JS; Jeet, G; Nangia, R; Singh, D; Grover, S; Lyngdoh, T; Pal, A; Verma, R; Aggarwal, R; Khan, MH; Saran, R; Jain, S; Gupta, KL; Kumar, V				Thakur, J. S.; Jeet, Gursimer; Nangia, Ria; Singh, Divya; Grover, Sandeep; Lyngdoh, Tanica; Pal, Arnab; Verma, Ramesh; Aggarwal, Ramnika; Khan, Mohd Haroon; Saran, Rajiv; Jain, Sanjay; Gupta, K. L.; Kumar, Vivek			Non-communicable diseases risk factors and their determinants: A cross-sectional state-wide STEPS survey, Haryana, North India	PLOS ONE			English	Article							KERALA	Background Recent studies have documented high variation in epidemiologic transition levels among Indian states with noncommunicable disease epidemic rising swiftly. However, the estimates suffer from non-availability of reliable data for NCDs from sub populations. In order to fill the knowledge gap, the distribution and determinants of NCD risk factors were studied along with awareness, treatment and control of NCDs among the adult population in Haryana, India. Methods NCD risk factors survey was conducted among 5078 residents, aged 18-69 years during 2016-17. Behavioural risk factors were assessed using STEPS instrument, administered through an android software (mSTEPS). This was followed by physical measurements using standard protocols. Finally, biological risk factors were determined through the analysis of serum and urine samples. Results Males were found to be consuming tobacco and alcohol at higher rates of 38.9% (95% CI: 35.3-42.4) and 18.8% (95% CI: 15.8-21.8). One-tenth (11%) (95% CI: 8.6-13.4) of the respondents did not meet the specified WHO recommendations for physical activity for health. Around 35.2% (95%CI: 32.6-37.7) were overweight or obese. Hypertension and diabetes were prevalent at 26.2% (95% CI: 24.6-27.8) and 15.5% (95% CI: 11.0-20.0). 91.3% (95% CI: 89.3-93.3) of the population had higher salt intake than recommended 5gms per day. Conclusion The documentation of strikingly high and uniform distribution of different NCDs and their risk factors in state warrants urgent need for evidence based interventions and advocacy of policy measures.	[Thakur, J. S.; Jeet, Gursimer; Nangia, Ria; Singh, Divya] Post Grad Inst Med Educ & Res, Dept Community Med, Chandigarh, India; [Thakur, J. S.; Jeet, Gursimer; Nangia, Ria; Singh, Divya] Post Grad Inst Med Educ & Res, Sch Publ Heath, Chandigarh, India; [Grover, Sandeep] Post Grad Med Educ & Res, Dept Psychiat, Chandigarh, India; [Lyngdoh, Tanica] Indian Inst Publ Hlth Assoc, Publ Hlth Fdn India, Gurugram, India; [Pal, Arnab] Post Grad Inst Med Educ & Res, Dept Biochem, Chandigarh, India; [Verma, Ramesh] Post Grad Inst Med Sci, Dept Social & Prevent Med, Rohtak, Haryana, India; [Aggarwal, Ramnika] Kalpana Chawla Med Coll, Dept Community Med, Karnal, India; [Khan, Mohd Haroon] Shaheed Hasan Khan Mewati Govt Med Coll, Dept Community Med, Mewat, India; [Saran, Rajiv] Univ Michigan, Dept Internal Med & Epidemiol, Ann Arbor, MI 48109 USA; [Jain, Sanjay] Post Grad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India; [Gupta, K. L.; Kumar, Vivek] Post Grad Med Educ & Res, Dept Nephrol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Public Health Foundation of India; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Michigan System; University of Michigan; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Thakur, JS (corresponding author), Post Grad Inst Med Educ & Res, Dept Community Med, Chandigarh, India.; Thakur, JS (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Heath, Chandigarh, India.	jsthakur64@gmail.com	Pal, Arnab/B-6024-2012; Pal, Arnab/AAK-7311-2021; Shao, Ruitai/AAU-7642-2021	Pal, Arnab/0000-0002-0850-3118; Pal, Arnab/0000-0002-0850-3118; /0000-0003-3727-9941; Grover, Sandeep/0000-0002-2714-2055	National Health Mission, Haryana under Ministry of Health and Family Welfare, Government of India	National Health Mission, Haryana under Ministry of Health and Family Welfare, Government of India	The study was funded by National Health Mission, Haryana under Ministry of Health and Family Welfare, Government of India.	[Anonymous], 2010, GLOB AD TOB SURV GAT; [Anonymous], 2013, NONC DIS RISK FACT S; [Anonymous], 2012, IBM SPSS STAT WIND 2; [Anonymous], 2004, EP INF 3 5 2 ED; [Anonymous], 2008, WAIST CIRC WAIST HIP; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bhutta ZA, 2010, WHO GLOBAL HLTH WORK; Bui TV, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3160-4; Das C., 2017, 1 WORLD NCD C 2017; Esteghamati A, 2008, AM J HYPERTENS, V21, P620, DOI 10.1038/ajh.2008.154; Friedrich MJ, 2017, JAMA-J AM MED ASSOC, V318, P603, DOI 10.1001/jama.2017.10693; Gebremariam LW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27519-6; Government of India, 2013, WORK GROUP REP PROD; Government of India, 2015, REV PERF; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Government of India. National Programme for Prevention and Control of Cancer, 2010, CARD DIS STROK NPCDC; Hakim Shariful, 2017, Prev Med Rep, V8, P122, DOI 10.1016/j.pmedr.2017.08.007; Huse O, 2018, OBES RES CLIN PRACT, V12, P29, DOI 10.1016/j.orcp.2017.10.002; Indian Alcohol Policy Alliances, 2008, ALC ATL IND; Indian Council of Medical Research Public Health Foundation of India and Institute for Health Metrics and Evaluation, 2017, IND HLTH NAT STAT IN; Islami F, 2015, TRANSL LUNG CANCER R, V4, P327, DOI 10.3978/j.issn.2218-6751.2015.08.04; Jayakrishnan R, 2013, ASIAN PAC J CANCER P, V14, P6797, DOI 10.7314/APJCP.2013.14.11.6797; Jeet Gursimer, 2013, Indian J Public Health, V57, P113, DOI 10.4103/0019-557X.115007; Juntura A, 2018, STROKE, V49; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kurt Kroenke RLS, 2001, J GEN INTERNAL MED, V16; Lavrakas P. J., 2008, ENCY SURVEY RES METH, DOI [DOI 10.4135/9781412963947, 10.4135/9781412963947]; Lin JS, 2014, BEHAV COUNSELING PRO; Liu M, 2011, DIABETES TECHNOL THE, V13, P501, DOI 10.1089/dia.2010.0106; Maimela E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147926; Ministry of Health and Family Welfare World Bank Niti Aayog, 2018, HLTH STAT PROGR IND; Ministry of Health Republic of Marshall Islands WHO Western Pacific Region, 2007, NCD RISK FACT STEP R; Ministry of Statistics and Programme Implementation National Statistics Organization National Sample Survey Office, 2014, NUTR INT IND 2011 20; Murthy RS, 2017, INDIAN J PSYCHIAT, V59, P21, DOI 10.4103/psychiatry.IndianJPsychiatry_102_17; National Institute for Medical Research World Health Organization, 2013, TANZANIA STEPS SURVE; National Institute of Medical Statistics Indian Council of Medical Research (ICMR), 2009, IDSP NONC DIS RISK F; National Institute of Mental Health and Neuro Sciences Bengaluru, 2016, NAT MENT HLTH SURV I; Oliver Huse JH, 2018, OBES RES CLIN PRACT, P29, DOI [10.1016/j.orcp.2017.10.002, DOI 10.1016/J.ORCP.2017.10.002]; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Pelzom D, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4989-x; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Registrar General of India Ministry of Home Affairs Government of India, 2011, CENS PRIM CENS ABSTR; Riley L, 2016, AM J PUBLIC HEALTH, V106, P74, DOI 10.2105/AJPH.2015.302962; Ritchie H., 2018, URBANIZATION OUR WOR; SECA, SECA 203 ERG CIRC ME; Sinha D N, 2003, Indian J Cancer, V40, P43; Soliman EZ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-3; Srivastava R K, 2011, Indian J Community Med, V36, pS7, DOI 10.4103/0970-0218.94703; Sugathan TN, 2008, INDIAN J MED RES, V127, P555; Thakur J, 2016, INT J NONCOMMUNICABL, V1, P91, DOI [10.4103/2468-8827.192018, DOI 10.4103/2468-8827.192018]; Thakur JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157705; Vogel L, 2017, CAN MED ASSOC J, V189, pE1202, DOI 10.1503/cmaj.109-5472; Washington DCWB. World Bank, 2013, WORLD DEV IND; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO Government of India. Ministry of Health and Family Welfare, 2013, NAT ACT PLAN MON FRA, P9; World Health Organization, 2005, WHO STEPS SURV MAN W; World Health Organization, 2018, GLOB SCH BAS STUD HL; Zaman MM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1938-4; 2018, MMWR SURVEILL SUMM, V67, P1	59	15	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0208872	10.1371/journal.pone.0208872	http://dx.doi.org/10.1371/journal.pone.0208872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774812	Green Published, gold			2022-12-26	WOS:000533896400001
J	Theodoro, SD; Putarov, TC; Tiemi, C; Volpe, LM; de Oliveira, CAF; Gloria, MBD; Carciofi, AC				Theodoro, Stephanie de Souza; Putarov, Thaila Cristina; Tiemi, Caroline; Volpe, Lara Mantovani; Ferreira de Oliveira, Carlos Alberto; de Abreu Gloria, Maria Beatriz; Carciofi, Aulus Cavalieri			Effects of the solubility of yeast cell wall preparations on their potential prebiotic properties in dogs	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; FERMENTATION PRODUCTS; DIETARY FIBER; NUTRIENT DIGESTIBILITY; MICROBIAL-POPULATIONS; PROTEIN CATABOLITES; GUT MICROBIOTA; FECAL IGA; IMMUNE; GROWTH	Derivatives of yeast cell wall (YCW) have been studied for their potential prebiotic effects. Recently, new purified and soluble preparations have been developed in an attempt to increase their biological actions. Two YCW preparations, one conventional and another with higher solubility of the mannan oligosaccharide fraction, were evaluated on dogs. One food formulation was used, divided into the following treatments: CON-control, without yeast cell wall addition; YCW-addition of 0.3% of a conventional yeas cell wall extract; YCWs-addition of 0.3% of a yeast cell wall extract with high mannan oligosaccharide solubility. Twentyfour beagle dogs were used, eight per food, distributed on a block design. Blocks lasted 32 days, and TNF-alpha, IL-6, IL-10, ex vivo production of hydrogen peroxide and nitric oxide by peripheral neutrophils and monocytes, phagocytic index, and fecal IgA were evaluated at the beginning and end of each period. Additionally, nutrient digestibility, feces production and quality, and fermentation products were quantified. The results were evaluated by analysis of variance and compared using the Tukey test (P< 0.05), using the basal immunological parameters as a covariate. The inclusion of YCWs reduced fat digestibility (P< 0.05), increased the concentration of butyrate and putrescine, and reduced lactate in feces (P< 0.05), showing that mannan oligosaccharide solubilization resulted in higher fermentation of this compound and altered the metabolism of the gut microbiota. Lower IL-6 on serum was verified for dogs fed the YCWs diet (P<0.05), suggesting a reduction in the inflammatory activity of dogs. Higher phagocytic index was verified for peripheral monocytes after the intake of the YCW food, suggesting better innate immunity. In conclusion, the solubilization of the mannooligosaccharide fraction alters its interaction with gut microbiota and biological actions in animals, although both yeast cell wall preparations exhibited prebiotic effects on dogs.	[Theodoro, Stephanie de Souza; Putarov, Thaila Cristina; Tiemi, Caroline; Volpe, Lara Mantovani; Carciofi, Aulus Cavalieri] Sao Paulo State Univ UNESP, Vet Med & Surg Dept, Coll Agr & Vet Sci FCAV, Jaboticabal, SP, Brazil; [Ferreira de Oliveira, Carlos Alberto] Biorigin Brasil, Lencois Paulistas, SP, Brazil; [de Abreu Gloria, Maria Beatriz] Minas Gerais Fed Univ UFMG, Pharm Fac, Belo Horizonte, MG, Brazil	Universidade Estadual Paulista	Carciofi, AC (corresponding author), Sao Paulo State Univ UNESP, Vet Med & Surg Dept, Coll Agr & Vet Sci FCAV, Jaboticabal, SP, Brazil.	aulus.carciofi@gmail.com	Carciofi, Aulus Cavalieri/B-1994-2008; Gloria, Maria Beatriz A./AAG-2506-2021; Gloria, Maria Beatriz/N-2479-2018	Carciofi, Aulus Cavalieri/0000-0003-3859-3983; Ferreira de Oliveira, Carlos Alberto/0000-0002-6304-6562; Gloria, Maria Beatriz/0000-0002-4137-0396; Theodoro, Stephanie/0000-0001-8075-458X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Sao Paulo Research Foundation (FAPESP) [2017/13623-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [47379/PIBIC]; Biorigin (Lencois Paulista, Brazil)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Biorigin (Lencois Paulista, Brazil)	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) (S. S. T.) - Finance Code 001. The authors would like to thank Sao Paulo Research Foundation (FAPESP) for a fellowship for the first author (S. S. T.) (grant number 2017/13623-7), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for fellowship for the third author (C. T.) (grand number 47379/PIBIC), Biorigin (Lencois Paulista, Brazil) for the financial support of the study and the donation of the yeast cell wall preparations, Affinity Petcare (Campinas, Brazil) and Manfrim (Santa Cruz do Rio Pardo, Brazil) for the support to Laboratorio de Pesquisa em Nutricao e Doencas Nutricionais de Caes e Gatos "Prof. Flavio Prada" and Manzoni Industrial Ltda. (Campinas, Brazil) for the donation of the extruder used in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elala N, 2013, INT J VET SCI MED, V1, P21, DOI 10.1016/j.ijvsm.2013.05.001; Aguilar-Uscanga B, 2003, LETT APPL MICROBIOL, V37, P268, DOI 10.1046/j.1472-765X.2003.01394.x; ANDERSON RA, 1982, CEREAL CHEM, V59, P265; Ballesteros-Pomar MD, 2018, NUTR HOSP, V35, P18, DOI 10.20960/nh.1956; Bibi S, 2019, AM J POTATO RES, V96, P170, DOI 10.1007/s12230-018-09706-3; Calabro S, 2013, ITAL J ANIM SCI, V12, DOI 10.4081/ijas.2013.e4; Carciofi AC, 2008, J ANIM PHYSIOL AN N, V92, P326, DOI 10.1111/j.1439-0396.2007.00794.x; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; Cave C, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0148-1; Chung WSF, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix127; Coman MM, 2019, J APPL MICROBIOL, V126, P1245, DOI 10.1111/jam.14197; de-Oliveira LD, 2012, J ANIM PHYSIOL AN N, V96, P895, DOI 10.1111/j.1439-0396.2011.01203.x; Delzenne NM, 2013, BRIT J NUTR, V109, pS81, DOI 10.1017/S0007114512004047; Devi G, 2019, FISH SHELLFISH IMMUN, V86, P965, DOI 10.1016/j.fsi.2018.12.051; Diez M, 1998, RES VET SCI, V64, P91, DOI 10.1016/S0034-5288(98)90001-7; ERWIN ES, 1961, J DAIRY SCI, V44, P1768, DOI 10.3168/jds.S0022-0302(61)89956-6; Esteban MA, 2004, FISH SHELLFISH IMMUN, V16, P447, DOI 10.1016/j.fsi.2003.07.004; FEDIAF-Federation Europeenne de L'industrie des Aliments pour Animaux Familiers, 2017, NUTR GUID; Fischer MM, 2012, J ANIM SCI, V90, P2233, DOI 10.2527/jas.2011-4334; Flickinger EA, 2003, J ANIM SCI, V81, P2008; Fowler J, 2015, J APPL POULTRY RES, V24, P66, DOI 10.3382/japr/pfv010; Frei R, 2015, CURR OPIN GASTROEN, V31, P153, DOI 10.1097/MOG.0000000000000151; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Gouveia EMMF, 2013, BRAZ J MICROBIOL, V44, P499, DOI 10.1590/S1517-83822013000200027; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hanfrey CC, 2011, J BIOL CHEM, V286, P43301, DOI 10.1074/jbc.M111.307835; Heinrichs A. J., 2013, Professional Animal Scientist, V29, P457; Holscher HD, 2017, GUT MICROBES, V8, P172, DOI 10.1080/19490976.2017.1290756; Hoyles L, 2019, INFLUENCE HUMAN GUT; Hussein HS, 1999, J NUTR, V129, p1454S, DOI 10.1093/jn/129.7.1454S; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; ISHIDA N, 1994, BIOSCI BIOTECH BIOCH, V58, P9, DOI 10.1271/bbb.58.9; Jiminez JA, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00243-17, 10.1128/msphere.00243-17]; Kaisar MMM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01429; Kalac P, 2014, FOOD CHEM, V161, P27, DOI 10.1016/j.foodchem.2014.03.102; Kyu-Song S, 2014, FISH SHELLFISH IMMUN, V40, P40, DOI 10.1016/j.fsi.2014.06.016; Laflamme D, 1997, CANINE PRACT, V22, P10; Lin CY, 2019, J ANIM SCI, V97, P1586, DOI 10.1093/jas/skz064; Loser C, 1999, GUT, V44, P12, DOI 10.1136/gut.44.1.12; Loureiro BA, 2017, J ANIM PHYSIOL AN N, V101, P824, DOI 10.1111/jpn.12468; Lycke N, 1999, J IMMUNOL, V163, P913; Maria APJ, 2017, J ANIM SCI, V95, P2452, DOI 10.2527/jas.2016.1302; Mayer L, 2000, J PEDIATR GASTR NUTR, V30, pS4, DOI 10.1097/00005176-200001001-00002; Middelbos IS, 2007, J ANIM SCI, V85, P3033, DOI 10.2527/jas.2007-0080; Milovic V, 2003, BIOCHEM SOC T, V31, P381, DOI 10.1042/BST0310381; Moens F, 2019, INT J PHARMACEUT, V555, P1, DOI 10.1016/j.ijpharm.2018.11.020; Monti M, 2016, ANIM FEED SCI TECH, V220, P93, DOI 10.1016/j.anifeedsci.2016.07.009; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Neaga A, 2013, J IMMUNOL METHODS, V390, P9, DOI 10.1016/j.jim.2011.06.027; Norris CR, 2003, J AM ANIM HOSP ASSOC, V39, P247, DOI 10.5326/0390247; NORTHCOTE DH, 1952, BIOCHEM J, V51, P232, DOI 10.1042/bj0510232; Oliveira CAF, 2019, COMP IMMUNOL MICROB, V62, P1, DOI [10.1016/j.cimid.2018.11.006, DOI 10.1016/J.CIMID.2018.11.006]; Park SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151944; PEAT S, 1961, J CHEM SOC, P29, DOI 10.1039/jr9610000029; Peixoto MC, 2018, J ANIM PHYSIOL AN N, V102, pE111, DOI 10.1111/jpn.12711; Peters IR, 2004, CLIN DIAGN LAB IMMUN, V11, P841, DOI 10.1128/CDLI.11.5.841-848.2004; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3; Podpora B, 2016, CZECH J FOOD SCI, V34, P554, DOI 10.17221/419/2015-CJFS; Posadas SJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-58; Propst EL, 2003, J ANIM SCI, V81, P3057; PRYCE JD, 1969, ANALYST, V94, P1151, DOI 10.1039/an9699401151; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; RIVIERE A, 2016, FRONT MICROBIOL, V7, P31419, DOI DOI 10.3389/FRNICH.2016.00979; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Rodriguez-Estrada U, 2013, N AM J AQUACULT, V75, P416, DOI 10.1080/15222055.2013.799620; Gomes MDS, 2011, BRIT J NUTR, V106, pS187, DOI 10.1017/S0007114511002960; Santos JPF, 2018, J ANIM PHYSIOL AN N, V102, P1091, DOI 10.1111/jpn.12918; Schley PD, 2002, BRIT J NUTR, V87, pS221, DOI 10.1079/BJN/2002541; Schmitz S, 2013, VET IMMUNOL IMMUNOP, V153, P170, DOI 10.1016/j.vetimm.2013.02.014; Spring P., 2015, Journal of Applied Animal Nutrition, V2015, pe8; Swanson KS, 2002, ARCH ANIM NUTR, V56, P309, DOI 10.1080/00039420214344; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Teng PY, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00245; Torrecillas S, 2011, AQUACULT NUTR, V17, P223, DOI 10.1111/j.1365-2095.2009.00730.x; Townsend GE, 2019, P NATL ACAD SCI USA, V116, P233, DOI 10.1073/pnas.1813780115; Vale SR, 1997, J AOAC INT, V80, P1006; Vetvicka V, 2008, J MED FOOD, V11, P615, DOI 10.1089/jmf.2007.0588; Vetvicka V, 2014, BRIT J PHARM RES, V4, P981, DOI 10.9734/BJPR/2014/7862; WANG JY, 1990, AM J PHYSIOL, V259, pG584; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Zaine L, 2011, BRIT J NUTR, V106, pS183, DOI 10.1017/S0007114511000559	85	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225659	10.1371/journal.pone.0225659	http://dx.doi.org/10.1371/journal.pone.0225659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765439	gold, Green Published			2022-12-26	WOS:000533891000042
J	Pineda, MV; Bouzas, MB; Remesar, M; Fridman, A; Remondegui, C; Mammana, L; Altamirano, N; Paradiso, P; Costantini, P; Tadey, L; Aulicino, PC; Mangano, A				Veronica Pineda, Maria; Belen Bouzas, Maria; Remesar, Mirta; Fridman, Ariel; Remondegui, Carlos; Mammana, Lilia; Altamirano, Natalia; Paradiso, Patricia; Costantini, Patricia; Tadey, Luciana; Aulicino, Paula C.; Mangano, Andrea			Relevance of HTLV-1 proviral load in asymptomatic and symptomatic patients living in endemic and non-endemic areas of Argentina	PLOS ONE			English	Article							T-CELL LEUKEMIA; VIRUS TYPE-I; TROPICAL SPASTIC PARAPARESIS; COMMUNITY VIRAL LOAD; CARRIERS; BLOOD; MYELOPATHY; DNA; TRANSMISSION; POPULATION	HTLV-1 proviral load (pVL) in peripheral blood mononuclear cell (PBMCs) is proposed as a marker of disease progression but its role still remains controversial. The aim of this study was to evaluate the levels of HTLV-1 pVL in symptomatic patients and asymptomatic HTLV-1 carriers. In this cross-sectional study the pVL was measured by Real Time PCR in 102 asymptomatic carriers and 22 symptomatic patients (5ATLL, 15 TSP and 2 uveitis). We observed that the HTLV-1 pVL was significantly higher in symptomatic patients (median = 4.99 log10 HTLV-1 copies/10(6) PBMCs) compared to asymptomatic HTLV-1 carriers (median = 4.38 log(10) HTLV-1 copies/10(6) PBMCs; p = 0.0030). A wide variation on the HTLV1 pVL levels among asymptomatic HTLV-1 carriers was observed with some pVL as high as those observed in symptomatic patients. The asymptomatic HTLV-1 carriers were divided according to the place of birth and the highest levels of pVL were detected among patients from endemics areas from the North of Argentina. Our results reinforce the usefulness of the proviral load would be a prognostic marker of HTLV-1 disease progression. Moreover, host, viral or socio-environmental factors cannot be excluded as determinant of high proviral load.	[Veronica Pineda, Maria; Altamirano, Natalia; Aulicino, Paula C.; Mangano, Andrea] Hosp Pediat Prof Dr Juan P Garrahan, Lab Biol Celular & Retrovirus, CONICET, Unidad Virol & Epidemiol Mol, Buenos Aires, DF, Argentina; [Belen Bouzas, Maria; Mammana, Lilia; Tadey, Luciana] Hosp Infecciosas Francisco J Muniz, Unidad Virol, Buenos Aires, DF, Argentina; [Belen Bouzas, Maria] Hosp Infecciosas Francisco J Muniz, Div Anal Clin, Buenos Aires, DF, Argentina; [Remesar, Mirta] Hosp Pediat Prof Dr Juan P Garrahan, Ctr Reg Hemoterapia Garrahan, Buenos Aires, DF, Argentina; [Fridman, Ariel] Lab Cent Jujuy, San Salvador De Jujuy, Argentina; [Remondegui, Carlos] Hosp San Roque, Serv & Infectol & Enfermedades Trop, San Salvador De Jujuy, Argentina; [Paradiso, Patricia] Hosp Durand, Serv Hemoterapia, Buenos Aires, DF, Argentina; [Costantini, Patricia] Inst Oncol Angel H Roffo, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires	Mangano, A (corresponding author), Hosp Pediat Prof Dr Juan P Garrahan, Lab Biol Celular & Retrovirus, CONICET, Unidad Virol & Epidemiol Mol, Buenos Aires, DF, Argentina.	andreamangano@gmail.com		altamirano, natalia/0000-0001-5822-6879	Fondo Nacional para Ciencia y Tecnologia (FONCYT) [PICT 2010-0502]	Fondo Nacional para Ciencia y Tecnologia (FONCYT)(FONCyT)	This work was supported by Fondo Nacional para Ciencia y Tecnologia (FONCYT) [grant number PICT 2010-0502], http://www.agencia.mincyt.gob.ar/foncyt.php.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano NA, 2010, J VIROL METHODS, V170, P160, DOI 10.1016/j.jviromet.2010.08.021; Blejer Jorgelina L., 1995, Sangre (Saragossa), V40, P447; BOUZAS MB, 1992, J ACQ IMMUN DEF SYND, V5, P1275, DOI 10.1097/00126334-199212000-00014; Furtado MDBS, 2012, J MED VIROL, V84, P664, DOI 10.1002/jmv.23227; Castel AD, 2012, AIDS, V26, P345, DOI 10.1097/QAD.0b013e32834de5fe; Demontis MA, 2013, AIDS RES HUM RETROV, V29, P359, DOI [10.1089/AID.2012.0132, 10.1089/aid.2012.0132]; Furukawa Y, 2003, JAIDS-J ACQ IMM DEF, V32, P328, DOI 10.1097/00126334-200303010-00013; Gastaldello R, 2004, JAIDS-J ACQ IMM DEF, V35, P301, DOI 10.1097/00126334-200403010-00012; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926; Gotuzzo E, 2000, Int J Infect Dis, V4, P59, DOI 10.1016/S1201-9712(00)90094-8; Hino S, 2011, P JPN ACAD B-PHYS, V87, P152, DOI 10.2183/pjab.87.152; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; ISHAK R, 1995, AIDS RES HUM RETROV, V11, P813, DOI 10.1089/aid.1995.11.813; Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kwaan N, 2006, J INFECT DIS, V194, P1557, DOI 10.1086/508899; Maloney EM, 1998, J ACQ IMMUN DEF SYND, V17, P167, DOI 10.1097/00042560-199802010-00011; Manns A, 1999, J INFECT DIS, V180, P1487, DOI 10.1086/315088; Miller WC, 2013, LANCET INFECT DIS, V13, P459, DOI 10.1016/S1473-3099(12)70314-6; MOCHIZUKI M, 1992, JPN J CANCER RES, V83, P236, DOI 10.1111/j.1349-7006.1992.tb00092.x; Murphy EL, 2004, J INFECT DIS, V190, P504, DOI 10.1086/422398; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; NISHIOKA K, 1989, LANCET, V1, P441; Okayama A, 2004, INT J CANCER, V110, P621, DOI 10.1002/ijc.20144; OSAME M, 1986, LANCET, V1, P1031; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Ramezani S, 2017, MED MICROBIOL IMMUN, V206, P327, DOI 10.1007/s00430-017-0506-1; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; STUVER SO, 1993, J INFECT DIS, V167, P57, DOI 10.1093/infdis/167.1.57; Taylor GP, 1999, J ACQ IMMUN DEF SYND, V22, P92, DOI 10.1097/00042560-199909010-00012; WATTEL E, 1995, J VIROL, V69, P2863, DOI 10.1128/JVI.69.5.2863-2868.1995; Wiktor SZ, 1997, J HUM VIROL, V1; Yamaguchi K, 2002, INT J HEMATOL, V76, P240, DOI 10.1007/BF03165123	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225596	10.1371/journal.pone.0225596	http://dx.doi.org/10.1371/journal.pone.0225596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756234	Green Published, gold			2022-12-26	WOS:000533889300045
J	Aworh, MK; Kwaga, J; Okolocha, E; Mba, N; Thakur, S				Aworh, Mabel Kamweli; Kwaga, Jacob; Okolocha, Emmanuel; Mba, Nwando; Thakur, Siddhartha			Prevalence and risk factors for multi-drug resistant Escherichia coli among poultry workers in the Federal Capital Territory, Abuja, Nigeria	PLOS ONE			English	Article							EXTENDED-SPECTRUM; ANTIMICROBIAL RESISTANCE; PLASMIDS	Background Antimicrobial resistance has emerged as a global health threat. Antimicrobial resistant Escherichia coli infections are associated with high morbidity and expenditure when compared with infections caused by susceptible strains. In Nigeria, antimicrobial drugs are readily available over-the-counter with potential for indiscriminate use by poultry farmers and eventual development of drug resistance. The objective of this study was to investigate prevalence and risk factors for multi-drug resistant E. coli among poultry workers (PW) in Abuja, Nigeria. Materials and methods A cross-sectional study was conducted among 122 randomly selected apparently healthy poultry workers (poultry-farmers/ sellers) in Municipal and Kuje Area Councils from December 2018 to April 2019. Data was collected on socio-demographics and exposure factors using a structured interviewer-administered questionnaire. E. coli was isolated and identified from stool samples of poultry workers. Antibiotic susceptibility testing was done using KirbyBauer disk diffusion method. Multidrug resistance (MDR) was defined as resistance to three or more classes of antimicrobials. Data was analyzed by computing proportions, prevalence odds-ratios (POR) and logistic regression at 5% significance level. Results Among PW, there were 121 males (99.2%). Mean age of the male workers was 30.6 +/- 9.7years, 54.6% (n = 66) married, 57.9% (n = 70) had secondary education and 62.0% (n = 75) were farm-workers. Prevalence of E. coli was 39.7% (n = 48), highest among farm-workers (POR = 2.7, 95% Confidence Interval [CI] = 1.3-5.7; p = 0.01) compared to poultrysellers. Of the 48 E. coli isolates, 16.7% (n = 8) were extended spectrum beta lactamase (ESBL) producers and 79.2% (n = 38) were MDR. We detected resistance against Tetracycline: (83.3%, n = 40), Sulfamethoxazole-Trimethoprim: (79.2%, n = 38), Ampicillin: (77.1%, n = 37), Streptomycin: (72.9%, n = 35), Nalidixic acid: (50%, n = 24), Gentamicin: (41.7%, n = 20), Chloramphenicol: (31.3%, n = 15), Cephalothin: (27.1%, n = 13), Nitrofurantoin: (10.4%, n = 5) and Imipenem: (6.3%, n = 3). Absence of lavatory (POR = 2.7, 95% CI = 1.16.7); existence of farm/market for >10years (POR = 2.5, 95% CI = 1.1-5.4) and PW's history of diarrhea in last three months (POR = 2.8, CI = 1.2-6.3) were associated with MDR. Controlling for age, absence of lavatory (adjusted OR [aOR] = 4.31, 95% CI = 1.6-11.9); PW's history of diarrhea in last three months (aOR = 3.3,95%CI = 1.3-8.5) and work exposure >10years (aOR = 0.3, 95%CI = 0.1-0.9) remained independent risk factors for MDR. Conclusion Prevalence of resistant E. coli was highest among farm-workers and associated with older farms/markets, occupational exposure of over 10 years and poor hygienic measures. The management of Municipal and Kuje Area Councils were recommended to provide lavatories for public use in farm-settlements/markets. The importance of hand-hygiene and responsible use of antimicrobials in poultry production was emphasized.	[Aworh, Mabel Kamweli] Fed Minist Agr & Rural Dev, Dept Vet & Pest Control Serv, Abuja, Nigeria; [Aworh, Mabel Kamweli] Nigeria Field Epidemiol & Lab Training Programme, Abuja, Nigeria; [Aworh, Mabel Kamweli; Kwaga, Jacob; Okolocha, Emmanuel] Ahmadu Bello Univ, Dept Vet Publ Hlth & Prevent Med, Zaria, Nigeria; [Mba, Nwando] Nigeria Ctr Dis Control, Natl Reference Lab, Abuja, Nigeria; [Aworh, Mabel Kamweli; Thakur, Siddhartha] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA	Ahmadu Bello University; University of North Carolina; North Carolina State University	Aworh, MK (corresponding author), Fed Minist Agr & Rural Dev, Dept Vet & Pest Control Serv, Abuja, Nigeria.; Aworh, MK (corresponding author), Nigeria Field Epidemiol & Lab Training Programme, Abuja, Nigeria.; Aworh, MK (corresponding author), Ahmadu Bello Univ, Dept Vet Publ Hlth & Prevent Med, Zaria, Nigeria.	mabelaworh@yahoo.com	AWORH, MABEL/S-8923-2018	AWORH, MABEL/0000-0003-4213-6929; Thakur, Siddhartha/0000-0003-3787-9939	Nigeria Center for Disease Control (NCDC), Abuja	Nigeria Center for Disease Control (NCDC), Abuja	The authors would like to appreciate Dr. Chikwe Ihekweazu, Director General, Nigeria Center for Disease Control (NCDC), Abuja for providing laboratory space and support towards this research at the NCDC National Reference Laboratory, Gaduwa, Abuja. The authors also acknowledge the intellectual contributions of Dr. Adebayo Adedeji, Miss Eme Ekeng, Mr. Muftan Akinpelu and Mr. Chris Chukwu of the Bacteriology Laboratory at NCDC National Reference Laboratory, Gaduwa, Abuja, towards the success of this research.	Agyare C., 2018, ANTIMICROBIAL RESIST, P33, DOI 10.5772/intechopen.79371; Akintunde O. K., 2015, Asian Journal of Poultry Science, V9, P1, DOI 10.3923/ajpsaj.2015.1.18; Amaechi N, 2015, J AGR VET MED, V8, P55; [Anonymous], 2009, KIRBY BAUER DISK DIF; Anzaku SA, 2017, NEW J SCI, V2017, P1, DOI [10.1155/2017/9646138, DOI 10.1155/2017/9646138]; Campbell JI, 2015, PREVALENCE RISK FACT, P2144, DOI [10.1093/jac/dkv053, DOI 10.1093/JAC/DKV053]; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Carter MW, 2000, J CLIN MICROBIOL, V38, P4228, DOI 10.1128/JCM.38.11.4228-4232.2000; Caudell MA, 2018, LANCET PLANET HEALTH, V2, pE489, DOI [10.1016/S2542-5196(18)30225-0, 10.1016/s2542-5196(18)30225-0]; Chishimba K, 2016, Int J Microbiol, V2016, P5275724, DOI 10.1155/2016/5275724; Cho Seung-Hak, 2012, Osong Public Health Res Perspect, V3, P151, DOI 10.1016/j.phrp.2012.07.002; Daniels JB, 2009, APPL ENVIRON MICROB, V75, P3648, DOI 10.1128/AEM.02435-08; Eltai NO, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0369-2; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Founou LL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01881; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Ibrahim A., 2012, INTERNET J VET MED, V8, P6; Igwe J.C., 2016, CLIN MICROBIOL OPEN, V5, P1000268, DOI [10.4172/2327-5073.1000268, DOI 10.4172/2327-5073.1000268]; Jasovsky D, 2016, UPSALA J MED SCI, V121, P159, DOI 10.1080/03009734.2016.1195900; Kariuki S, 2014, ANN NY ACAD SCI, V1323, P43, DOI 10.1111/nyas.12380; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Li BY, 2018, J ORTHOP RES, V36, P22, DOI 10.1002/jor.23656; Manyi-Loh C, 2018, MOLECULES, V23, DOI 10.3390/molecules23040795; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Miles Tricia D, 2006, BMC Vet Res, V2, P7, DOI 10.1186/1746-6148-2-7; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Oloso NO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061284; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; Sandhu R, 2016, INDIAN J MICROBIOLOG, V3, P299, DOI [10.5958/2394-5478.2016.00064.9, DOI 10.5958/2394-5478.2016.00064.9]; Shahzad B, 2017, J INF SCI ENG, V33; Shakya S, 2016, OCCURRENCE CHARACTER, DOI [10.14202/vetworld.2016.996-1000, DOI 10.14202/VETWORLD.2016.996-1000]; Swatantra Singh, 2014, Pharma Science Monitor, V5, P184; Szmolka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00258; Thenmozhi S, 2014, INT J PHARM SCI RES, V5, P2908, DOI 10.13040/IJPSR.0975-8232.5(7).2908-18; van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763; Wadoum REG, 2016, BRIT POULTRY SCI, V57, P483, DOI 10.1080/00071668.2016.1180668; Winokur PL, 2001, ANTIMICROB AGENTS CH, V45, P2716, DOI 10.1128/AAC.45.10.2716-2722.2001; Zhang HN, 2016, J FOOD PROTECT, V79, P1630, DOI 10.4315/0362-028X.JFP-16-093; Zhuge X, 2017, POPULATION STRUCTURE	39	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225379	10.1371/journal.pone.0225379	http://dx.doi.org/10.1371/journal.pone.0225379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751388	Green Published, gold, Green Submitted			2022-12-26	WOS:000533886900056
J	Hammad, DBM; Liyanapathirana, V; Tonge, DP				Hammad, Dargham Bayan Mohsen; Liyanapathirana, Veranja; Tonge, Daniel Paul			Molecular characterisation of the synovial fluid microbiome in rheumatoid arthritis patients and healthy control subjects	PLOS ONE			English	Article							ORAL BACTERIAL-DNA; PERIODONTAL-DISEASE; LUNG MICROBIOME; SEPTIC ARTHRITIS; RAOULTELLA-PLANTICOLA; BLOOD MICROBIOME; RIBOSOMAL-RNA; ANTIBODIES; PATHOGENESIS; INFLAMMATION	The colonisation of specific body sites in contact with the external environment by microorganisms is both well-described and universally accepted, whereas, the existence of microbial evidence in other "classically sterile" locations including the blood, synovial space, and lungs, is a relatively new concept. Increasingly, a role for the microbiome in disease is being considered, and it is therefore necessary to increase our understanding of these. To date, little data support the existence of a "synovial fluid microbiome". Methods The presence and identity of bacterial and fungal DNA in the synovial fluid of rheumatoid arthritis (RA) patients and healthy control subjects was investigated through amplification and sequencing of the bacterial 16S rRNA gene and fungal internal transcribed spacer region 2 respectively. Synovial fluid concentrations of the cytokines IL-6, IL-17A, IL22 and IL-23 were determined by ELISA. Results Bacterial 16S rRNA genes were detected in 87.5% RA patients, and all healthy control subjects. At the phylum level, the microbiome was predominated by Proteobacteria (Control = 83.5%, RA = 79.3%) and Firmicutes (Control = 16.1%, RA = 20.3%), and to a much lesser extent, Actinobacteria (Control = 0.2%, RA = 0.3%) and Bacteroidetes (Control = 0.1%, RA = 0.1%). Fungal DNA was identified in 75% RA samples, and 88.8% healthy controls. At the phylum level, synovial fluid was predominated by members of the Basidiomycota (Control = 53.9%, RA = 46.9%) and Ascomycota (Control = 35.1%, RA = 50.8%) phyla. Statistical analysis revealed key taxa that were differentially present or abundant dependent on disease status. Conclusions This study reports the presence of a synovial fluid microbiome, and determines that this is modulated by disease status (RA) as are other classical microbiome niches.	[Hammad, Dargham Bayan Mohsen; Tonge, Daniel Paul] Keele Univ, Fac Nat Sci, Sch Life Sci, Newcastle, England; [Liyanapathirana, Veranja] Univ Peradeniya, Fac Med, Dept Microbiol, Kandy, Sri Lanka	Keele University; University of Peradeniya	Tonge, DP (corresponding author), Keele Univ, Fac Nat Sci, Sch Life Sci, Newcastle, England.	d.p.tonge@keele.ac.uk		Tonge, Daniel/0000-0002-3499-2752	DBMH/DPT R35 Higher Committe for Education Development	DBMH/DPT R35 Higher Committe for Education Development	DBMH/DPT R35 Higher Committe for Education Development http://www.hcediraq.org/HCED_english_website/homeen.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054461; Atianand MK, 2013, J IMMUNOL, V190, P1911, DOI 10.4049/jimmunol.1203162; Bartold PM, 2005, J PERIODONTOL, V76, P2066, DOI 10.1902/jop.2005.76.11-S.2066; Beatty M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-933; Bhattacharyya M, 2017, MOL PHYLOGENET EVOL, V109, P404, DOI 10.1016/j.ympev.2017.02.001; Bonnet E, 2017, INFECTION, V45, P703, DOI 10.1007/s15010-017-1006-3; Brusca SB, 2014, CURR OPIN RHEUMATOL, V26, P101, DOI 10.1097/BOR.0000000000000008; Castaneda-Delgado Julio E, 2017, Front Immunol, V8, P285, DOI 10.3389/fimmu.2017.00285; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7; Cheng ZJ, 2017, BEST PRACT RES CL RH, V31, P19, DOI 10.1016/j.berh.2017.08.001; Chi HB, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-211; de Pablo P, 2008, J RHEUMATOL, V35, P70; Demoruelle M Kristen, 2014, Int J Clin Rheumtol, V9, P295; Dinakaran V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105221; Ebringer A, 2006, CLIN DEV IMMUNOL, V13, P41, DOI 10.1080/17402520600576578; Ebringer A, 2014, APMIS, V122, P363, DOI 10.1111/apm.12154; Enninga EAL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00424; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Gerard HC, 2001, ARTHRITIS RHEUM-US, V44, P1689, DOI 10.1002/1529-0131(200107)44:7<1689::AID-ART293>3.0.CO;2-K; Gibofsky Allan, 2012, Am J Manag Care, V18, pS295; Hallen-Adams HE, 2017, VIRULENCE, V8, P352, DOI 10.1080/21505594.2016.1247140; Hammad DB, 2018, BIORXIV, DOI [10.1101/405613, DOI 10.1101/405613]; Hitchon CA, 2010, J RHEUMATOL, V37, P1105, DOI 10.3899/jrheum.091323; Horie M, 2016, RESPIR INVESTIG, V54, P44, DOI 10.1016/j.resinv.2015.08.002; Jahreis S, 2017, FOOD CHEM TOXICOL, V109, P405, DOI 10.1016/j.fct.2017.09.027; Jeon SJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0328-9; Kanki M, 2002, APPL ENVIRON MICROB, V68, P3462, DOI 10.1128/AEM.68.7.3462-3466.2002; Kell DB, 2015, INTEGR BIOL-UK, V7, P1339, DOI 10.1039/c5ib00158g; Kempsell KE, 2000, INFECT IMMUN, V68, P6012, DOI 10.1128/IAI.68.10.6012-6026.2000; Kim KW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01101-y; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Koziel J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0408-9; Levorova J, 2017, INT J ORAL MAX SURG, V46, P111, DOI 10.1016/j.ijom.2016.09.008; Li RB, 2017, INT J RHEUM DIS, V20, P1887, DOI 10.1111/1756-185X.13240; Liu XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30594; Liu XF, 2013, CURR MICROBIOL, V67, P170, DOI 10.1007/s00284-013-0338-1; Lopez-Oliva I, 2018, ARTHRITIS RHEUMATOL, V70, P1008, DOI 10.1002/art.40485; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; Maeda Y, 2016, ARTHRITIS RHEUMATOL, V68, P2646, DOI 10.1002/art.39783; Mangul S., 2016, BIORXIV; Mao QX, 2018, CANCER LETT, V415, P40, DOI 10.1016/j.canlet.2017.11.036; Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5; Markova ND, 2017, DISCOV MED, V23, P305; Martel J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10479-8; Martinez-Martinez RE, 2009, J CLIN PERIODONTOL, V36, P1004, DOI 10.1111/j.1600-051X.2009.01496.x; Matsumoto T, 2006, RHEUMATOL INT, V26, P1096, DOI 10.1007/s00296-006-0143-2; Moen K, 2006, CLIN EXP RHEUMATOL, V24, P656; Moen K, 2003, CLIN DIAGN LAB IMMUN, V10, P1043, DOI 10.1128/CDLI.10.6.1043-1050.2003; Moffatt MF, 2017, CLIN MED, V17, P525, DOI 10.7861/clinmedicine.17-6-525; Moura RA, 2010, ANN RHEUM DIS, V69, DOI 10.1136/ard.2010.129643g; O'Dwyer DN, 2016, J IMMUNOL, V196, P4839, DOI 10.4049/jimmunol.1600279; Ogrendik Mesut, 2005, MedGenMed, V7, P2; Ogrendik M, 2009, MOD RHEUMATOL, V19, P453, DOI 10.1007/s10165-009-0194-9; Olsen-Bergem H, 2016, INT J ORAL MAX SURG, V45, P318, DOI 10.1016/j.ijom.2015.08.986; Ortiz P, 2009, J PERIODONTOL, V80, P535, DOI 10.1902/jop.2009.080447; Paisse S, 2016, TRANSFUSION, V56, P1138, DOI 10.1111/trf.13477; Peters BA, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1064-9; Potempa J, 2017, NAT REV RHEUMATOL, V13, P606, DOI 10.1038/nrrheum.2017.132; Potgieter M, 2015, FEMS MICROBIOL REV, V39, P567, DOI 10.1093/femsre/fuv013; Pretorius E, 2017, EXP BIOL MED, V242, P355, DOI 10.1177/1535370216681549; Rajaei E, 2019, CURR RHEUMATOL REV; Rajendhran J, 2013, INT J CARDIOL, V168, P5118, DOI 10.1016/j.ijcard.2013.07.232; Horliana ACRT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098271; Reichert S, 2013, J CLIN PERIODONTOL, V40, P591, DOI 10.1111/jcpe.12102; Ross JJ, 2017, INFECT DIS CLIN N AM, V31, P203, DOI 10.1016/j.idc.2017.01.001; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Sandoval-Denis M, 2015, J CLIN MICROBIOL, V53, P2990, DOI 10.1128/JCM.01482-15; Scher JU, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0206-x; Scher JU, 2016, ARTHRITIS RHEUMATOL, V68, P35, DOI 10.1002/art.39259; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Siala M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2398; Singh H, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P87, DOI 10.1016/B978-0-12-381422-7.10004-5; Srirangan S, 2010, THER ADV MUSCULOSKEL, V2, P247, DOI 10.1177/1759720X10378372; Sun W, 2008, ORAL SURG ORAL MED O, V105, P566, DOI 10.1016/j.tripleo.2007.08.015; Sze MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111228; Taneja V, 2014, FEBS LETT, V588, P4244, DOI 10.1016/j.febslet.2014.05.034; Tani Y, 1997, J RHEUMATOL, V24, P109; Temoin S, 2012, JCR-J CLIN RHEUMATOL, V18, P117, DOI 10.1097/RHU.0b013e3182500c95; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; van Hamburg JP, 2018, J AUTOIMMUN, V87, P69, DOI 10.1016/j.jaut.2017.12.006; Venus K, 2016, INFECTION, V44, P691, DOI 10.1007/s15010-016-0930-y; Wang L, 2017, CHINESE MED J-PEKING, V130, P2107, DOI 10.4103/0366-6999.211452; Whittle E, 2018, MULTIMETHOD CHARACTE, DOI [10.1101/359760, DOI 10.1101/359760]; Whittle E, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03266; Wilson C, 1997, RHEUMATOL INT, V16, P187, DOI 10.1007/BF01330294; Wu X, 2017, OSTEOARTHR CARTILAGE, V25, pS287, DOI 10.1016/j.joca.2017.02.484; Yoshida Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698313; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zhao XY, 2018, MED SCI MONITOR, V24, P5802, DOI 10.12659/MSM.909117; Zhao Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32675-w	93	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225110	10.1371/journal.pone.0225110	http://dx.doi.org/10.1371/journal.pone.0225110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751379	Green Submitted, Green Published, gold			2022-12-26	WOS:000533886900029
J	Jekarl, DW; Lee, S; Kwon, JH; Nam, SW; Kim, M; Kim, Y; Jang, JW				Jekarl, Dong Wook; Lee, Seungok; Kwon, Jung Hyun; Nam, Soon Woo; Kim, Myungshin; Kim, Yonggoo; Jang, Jeong Won			Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma	PLOS ONE			English	Article							BIOLOGY; PROTEIN	Treating hepatocellular carcinoma with transarterial chemoembolization (TACE) induces both local inflammation in the tumor microenvironment as well as systemic inflammation. We analyzed serum cytokine response to TACE to evaluate this. Serum samples obtained from 203 HCC patients treated with TACE were analyzed for inflammatory cytokines including interleukin (IL)-1 beta, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12, IL-13, IL-17, IL-22, TNF-alpha, IFN-gamma, and C-reactive protein (CRP) levels. Cytokine concentrations were measured at day 0 (D0, baseline, n = 203), day3 (D3, n = 156), day7 (D7, n = 147), and day 60 (D60, n = 115) after TACE. Network analysis of the cytokines was performed to understand their interactive relationship. After TACE, IL-1 beta,-6,-9,-12, and-22 increased by D60. IL-2,-5,-10,-17A and INF-. decreased by D60, and IL-4,-13 and TNF-alpha revealed stable concentration. D0 network revealed that IL-2,-4,-5, and-10 formed a module. D3 network had the highest clustering coefficient and average degree that revealed similar pattern as CRP. D7 network revealed that IL-6,-9 and CRP were isolated from the network. D60 network had the lower network heterogeneity and lower clustering coefficient, network diameter, shortest path and characteristic path length. Degree correlation revealed that assortative network turned to disassortative network by D60 indicating that the network gained scale free feature. D60 cytokine network retained inflammatory function and these parameters indicated that the systemic inflammation induced by TACE appeared to be attenuated by D60. IL-9 at D3 and D7 seemed to be related to anti-tumor effect and IL-6 at D7 and D60, and IL-22 at D60 was related to regenerative but not pro-or anti-inflammatory function. Median survival month of patient group with high and low values of cytokine with P-values were as follows: D0 CRP, 9.5 and 54.2 months (P< 0.0001); D0 IL-2, 39.9 and 56.1 months (P = 0.0084); D3 CRP, 31.3 and 55.1 months (P = 0.0056); D7 CRP, 28.7 and 50.7 months (P = 0.0065), respectively. TACE is associated with systemic inflammation which appears to peak at Day 3 and resolve by D60. Among the tested cytokines, IL-6 and IL-22 appear to play a regenerative role.	[Jekarl, Dong Wook; Kim, Myungshin; Kim, Yonggoo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Lab Med, Seoul, South Korea; [Jekarl, Dong Wook; Lee, Seungok; Kim, Myungshin; Kim, Yonggoo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Lab Dev & Evaluat Ctr, Seoul, South Korea; [Lee, Seungok] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Kwon, Jung Hyun; Nam, Soon Woo] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Jang, Jeong Won] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Jang, JW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea.	garden@catholic.ac.kr						Aino H, 2016, MOL CLIN ONCOL, V5, P83, DOI 10.3892/mco.2016.879; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi A.-L., 2016, NETWORK SCI; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cheng J, 2016, ACTA PHYS SIN-CH ED, V65, DOI 10.7498/aps.65.060302; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Estrada E., 2015, EVOLUTIONARY EQUATIO; Estrada E, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066102; Gaggianesi M, 2017, CANCER RES, V77, P3268, DOI 10.1158/0008-5472.CAN-16-3126; He CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174769; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Jacob R, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160757; Jang JW, 2012, CYTOKINE, V60, P686, DOI 10.1016/j.cyto.2012.07.017; Jekarl DW, 2018, EUR CYTOKINE NETW, V29, P103, DOI 10.1684/ecn.2018.0414; Kim BH, 2018, CLIN MOL HEPATOL, V24, P1, DOI 10.3350/cmh.2017.0112; Kim MJ, 2013, CYTOKINE, V64, P516, DOI 10.1016/j.cyto.2013.07.021; Lee HL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40078-8; Liu C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4121-3; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; Ren XD, 2010, AM J PHYSIOL-GASTR L, V298, pG74, DOI 10.1152/ajpgi.00075.2009; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Xu K, 2011, PROTEOMICS, V11, P1857, DOI 10.1002/pmic.201000684; Xue TC, 2015, TUMOR BIOL, V36, P8797, DOI 10.1007/s13277-015-3632-7; Zhang YF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005000; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	35	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0224318	10.1371/journal.pone.0224318	http://dx.doi.org/10.1371/journal.pone.0224318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751357	Green Published, Green Submitted, gold			2022-12-26	WOS:000533886900010
J	Kinoshita-Kikuta, E; Tanikawa, A; Hosokawa, T; Kiwado, A; Moriya, K; Kinoshita, E; Koike, T; Utsumi, T				Kinoshita-Kikuta, Emiko; Tanikawa, Ayane; Hosokawa, Takuro; Kiwado, Aya; Moriya, Koko; Kinoshita, Eiji; Koike, Tohru; Utsumi, Toshihiko			A strategy to identify protein-N-myristoylation-dependent phosphorylation reactions of cellular proteins by using Phostag SDS-PAGE	PLOS ONE			English	Article							ACTIN; TAG; MEMBRANE; FORMINS; TARGET; FMNL2; IDENTIFICATION; TRAFFICKING; METASTASIS; SEPARATION	To establish a strategy for identifying protein-N-myristoylation-dependent phosphorylation of cellular proteins, Phos-tag SDS-PAGE was performed on wild-type (WT) and nonmyristoylated mutant (G2A-mutant) FMNL2 and FMNL3, phosphorylated N-myristoylated model proteins expressed in HEK293 cells. The difference in the banding pattern in Phos-tag SDS-PAGE between the WT and G2A-mutant FMNL2 indicated the presence of N-myristoylation-dependent phosphorylation sites in FMNL2. Phos-tag SDS-PAGE of FMNL2 mutants in which the putative phosphorylation sites listed in PhosphoSitePlus (an online database of phosphorylation sites) were changed to Ala revealed that Ser-171 and Ser-1072 are N-myristoylation-dependent phosphorylation sites in FMNL2. Similar experiments with FMNL3 demonstrated that N-myristoylation-dependent phosphorylation occurs at a single Ser residue at position 174, which is a Ser residue conserved between FMNL2 and FMNL3, corresponding to Ser-171 in FMNL2. The facts that phosphorylation of Ser-1072 in FMNL2 has been shown to play a critical role in integrin beta 1 internalization mediated by FMNL2 and that Ser-171 in FMNL2 and Ser-174 in FMNL3 are novel putative phosphorylation sites conserved between FMNL2 and FMNL3 indicate that the strategy used in this study is a useful tool for identifying and characterizing physiologically important phosphorylation reactions occurring on N-myristoylated proteins.	[Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Koike, Tohru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Hiroshima, Japan; [Tanikawa, Ayane; Hosokawa, Takuro; Kiwado, Aya; Moriya, Koko; Utsumi, Toshihiko] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yamaguchi, Japan; [Utsumi, Toshihiko] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi, Japan	Hiroshima University; Yamaguchi University; Yamaguchi University	Utsumi, T (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yamaguchi, Japan.; Utsumi, T (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi, Japan.	utsumi@yamaguchi-u.ac.jp		Emiko, Kinoshita/0000-0001-7355-1784	KAKENHI Grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan [18K065960, 19K071470, 17K08237, 17K07758]	KAKENHI Grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI Grants (No.18K065960 to EK-K, No.19K071470 to EK, No.17K08237 to TK, and No.17K07758 to TU, https://www.jsps.go.jp/jgrantsinaid/index.html) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fong LWR, 2017, CANCER METAST REV, V36, P737, DOI 10.1007/s10555-017-9709-6; Giglione C, 2015, BIOCHIMIE, V114, P134, DOI 10.1016/j.biochi.2014.11.008; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243; Kinoshita E, 2016, PROTEOMICS, V16, P1825, DOI 10.1002/pmic.201500494; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Kinoshita-Kikuta E, 2014, PROTEOMICS, V14, P2437, DOI 10.1002/pmic.201400380; Kuhn S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8088; Li YF, 2010, MOL CANCER RES, V8, P1579, DOI 10.1158/1541-7786.MCR-10-0081; Liang L, 2013, GASTROENTEROLOGY, V144, P624, DOI 10.1053/j.gastro.2012.11.033; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Moriya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078235; Moriya K, 2012, BIOSCI BIOTECH BIOCH, V76, P1201, DOI 10.1271/bbb.120069; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Peng T, 2016, CURR OPIN CHEM BIOL, V30, P77, DOI 10.1016/j.cbpa.2015.11.008; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Saito S, 2018, NEW PHYTOL, V218, P1504, DOI 10.1111/nph.15053; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Suzuki T, 2010, PROTEOMICS, V10, P1780, DOI 10.1002/pmic.200900783; Takamitsu E, 2014, ANAL BIOCHEM, V464, P83, DOI 10.1016/j.ab.2014.07.006; Taniguchi H, 1999, BIOPHYS CHEM, V82, P129, DOI 10.1016/S0301-4622(99)00112-X; Tillo SE, 2017, CELL REP, V19, P617, DOI 10.1016/j.celrep.2017.03.070; Udenwobele DI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00751; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; UTSUMI T, 1988, FEBS LETT, V238, P13, DOI 10.1016/0014-5793(88)80215-1; Utsumi T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206355; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wang Y, 2015, DEV CELL, V34, P475, DOI 10.1016/j.devcel.2015.06.015; Watanabe N, 2004, EXP CELL RES, V301, P16, DOI 10.1016/j.yexcr.2004.08.020; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhu XL, 2011, J PATHOL, V224, P377, DOI 10.1002/path.2871	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225510	10.1371/journal.pone.0225510	http://dx.doi.org/10.1371/journal.pone.0225510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751425	gold, Green Published			2022-12-26	WOS:000533886900073
J	Riaz, M; Abid, M; Nazir, HZ; Abbasi, SA				Riaz, Muhammad; Abid, Muhammad; Nazir, Hafiz Zafar; Abbasi, Saddam Akber			An enhanced nonparametric EWMA sign control chart using sequential mechanism	PLOS ONE			English	Article								Control charts play a significant role to monitor the performance of a process. Nonparametric control charts are helpful when the probability model of the process output is not known. In such cases, the sampling mechanism becomes very important for picking a suitable sample for process monitoring. This study proposes a nonparametric arcsine exponentially weighted moving average sign chart by using an efficient scheme, namely, sequential sampling scheme. The proposal intends to enhance the detection ability of the arcsine exponentially weighted moving average sign chart, particularly for the detection of small shifts. The performance of the proposal is assessed, and compared with its counterparts, by using some popular run length properties including average, median and standard deviation run lengths. The proposed chart shows efficient shift detection ability as compared to the other charts, considered in this study. A real-life application based on the smartphone accelerometer data-set, for the implementation of the proposed scheme, is also presented.	[Riaz, Muhammad] King Fahad Univ Petr & Minerals, Dept Math & Stat, Dhahran, Saudi Arabia; [Abid, Muhammad] Govt Coll Univ Faisalabad, Dept Stat, Faisalabad, Pakistan; [Nazir, Hafiz Zafar] Univ Sargodha, Dept Stat, Sargodha, Pakistan; [Abbasi, Saddam Akber] Qatar Univ, Dept Math Stat & Phys, Doha, Qatar	King Fahd University of Petroleum & Minerals; Government College University Faisalabad; University of Sargodha; Qatar University	Riaz, M (corresponding author), King Fahad Univ Petr & Minerals, Dept Math & Stat, Dhahran, Saudi Arabia.	riazm@kfupm.edu.sa			King Fahd University of Petroleum and Minerals [IN171016]	King Fahd University of Petroleum and Minerals	This work was supported by King Fahd University of Petroleum and Minerals grant IN171016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi SA, 2012, EXPERT SYST APPL, V39, P8503, DOI 10.1016/j.eswa.2012.01.122; Abid M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195762; Al-Omari A. I., 2014, INVESTIGACIO N OPERA, V35, P215; Aslam M, 2014, J PROCESS CONTR, V24, P1149, DOI 10.1016/j.jprocont.2014.05.001; Aslam M, 2013, APPL MATH MODEL, V37, P10027, DOI 10.1016/j.apm.2013.05.058; Balamurali S, 2006, J APPL STAT, V33, P327, DOI 10.1080/02664760500446010; Chakraborti S, 2001, J QUAL TECHNOL, V33, P304; Chakraborti S., 2019, NONPARAMETRIC STAT P; Coelho MLI, 2017, QUAL RELIAB ENG INT, V33, P2181, DOI 10.1002/qre.2177; Croasdale R., 1974, INT J PROD RES, V12, P585, DOI [10.1080/00207547408919577, DOI 10.1080/00207547408919577]; Dyer JN, 2016, J MOD APPL STAT METH, V15, P580, DOI 10.22237/jmasm/1478003580; Haq A, 2016, QUAL RELIAB ENG INT, V32, P269, DOI 10.1002/qre.1747; Koti KM, 1996, COMMUN STAT THEORY, V25, P1617, DOI 10.1080/03610929608831789; Koutras MV, 2018, QUAL RELIAB ENG INT, V34, P427, DOI 10.1002/qre.2263; Lee LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126331; Li CL, 2019, COMPUT IND ENG, V129, P259, DOI 10.1016/j.cie.2019.01.013; Montgomery SL, 2009, J SPEC TRANSL, P6; Mukherjee A, 2018, EUR J OPER RES, V266, P147, DOI 10.1016/j.ejor.2017.09.013; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Qiu P, 2018, J QUAL TECHNOL, V50, P49, DOI 10.1080/00224065.2018.1404315; Riaz M, 2017, QUAL TECHNOL QUANT M, V14, P378, DOI 10.1080/16843703.2017.1304034; Roberts SW., 1959, TECHNOMETRICS, V1, P239, DOI [10.1080/00401706.1959.10489860, DOI 10.1080/00401706.1959.10489860]; Shewhart WA., 1931, EC CONTROL QUALITY M; Triantafyllou IS, 2019, J NONPARAMETR STAT, V31, P1, DOI 10.1080/10485252.2018.1518524; Triantafyllou IS, 2018, COMMUN STAT-SIMUL C, V47, P2684, DOI 10.1080/03610918.2017.1359283; Wald A, 1943, SEQUENTIAL ANAL STAT; Yang SF, 2011, QUAL RELIAB ENG INT, V27, P867, DOI 10.1002/qre.1171; Yang SF, 2011, EXPERT SYST APPL, V38, P6239, DOI 10.1016/j.eswa.2010.11.044; Yue J, 2017, APPL MATH MODEL, V52, P603, DOI 10.1016/j.apm.2017.08.005	29	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225330	10.1371/journal.pone.0225330	http://dx.doi.org/10.1371/journal.pone.0225330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751403	gold, Green Published			2022-12-26	WOS:000533886900050
J	Behrens, KA; Jania, LA; Snouwaert, JN; Nguyen, M; Moy, SS; Tikunov, AP; Macdonald, JM; Koller, BH				Behrens, Kelsey A.; Jania, Leigh A.; Snouwaert, John N.; MyTrang Nguyen; Moy, Sheryl S.; Tikunov, Andrey P.; Macdonald, Jeffrey M.; Koller, Beverly H.			Beyond detoxification: Pleiotropic functions of multiple glutathione S-transferase isoforms protect mice against a toxic electrophile	PLOS ONE			English	Article							HEMOGLOBIN ADDUCT FORMATION; URINARY METABOLITES; RAT-LIVER; ACRYLAMIDE; GLYCIDAMIDE; TOXICOKINETICS; NEUROTOXICITY; POLYMORPHISMS; CONJUGATION; EXPRESSION	Environmental and endogenous electrophiles cause tissue damage through their high reactivity with endogenous nucleophiles such as DNA, proteins, and lipids. Protection against damage is mediated by glutathione (GSH) conjugation, which can occur spontaneously or be facilitated by the glutathione S-transferase (GST) enzymes. To determine the role of GST enzymes in protection against electrophiles as well as the role of specific GST families in mediating this protection, we exposed mutant mouse lines lacking the GSTP, GSTM, and/or GSTT enzyme families to the model electrophile acrylamide, a ubiquitous dietary contaminant known to cause adverse effects in humans. An analysis of urinary metabolites after acute acrylamide exposure identified the GSTM family as the primary mediator of GSH conjugation to acrylamide. However, surprisingly, mice lacking only this enzyme family did not show increased toxicity after an acute acrylamide exposure. Therefore, GSH conjugation is not the sole mechanism by which GSTs protect against the toxicity of this substrate. Given the prevalence of null GST polymorphisms in the human population (approximately 50% for GSTM1 and 20-50% for GSTT1), a substantial portion of the population may also have impaired acrylamide metabolism. However, our study also defines a role for GSTP and/or GSTT in protection against acrylamide mediated toxicity. Thus, while the canonical detoxification function of GSTs may be impaired in GSTM null individuals, disease risk secondary to acrylamide exposure may be mitigated through non-canonical pathways involving members of the GSTP and/or GSTT families.	[Behrens, Kelsey A.; Koller, Beverly H.] Univ N Carolina, Curriculum Toxicol & Environm Med, Chapel Hill, NC 27515 USA; [Jania, Leigh A.; Snouwaert, John N.; MyTrang Nguyen; Koller, Beverly H.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Moy, Sheryl S.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27515 USA; [Moy, Sheryl S.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Tikunov, Andrey P.; Macdonald, Jeffrey M.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Koller, BH (corresponding author), Univ N Carolina, Curriculum Toxicol & Environm Med, Chapel Hill, NC 27515 USA.; Koller, BH (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	bkoller@email.unc.edu	, UNC Biomolecular NMR Facility/AAD-7901-2022	Behrens, Kelsey/0000-0002-4011-709X	NIEHS [T32 ES007126]; National Cancer Institute of the National Institutes of Health [P30CA016086]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54 HD079124]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079124] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007126] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	K.A.B. was supported by NIEHS T32 ES007126. Studies using 1H NMR were supported by the National Cancer Institute of the National Institutes of Health under award number P30CA016086. Studies using the Mouse Behavioral Phenotyping Core were supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54 HD079124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jackson Parker, Rebecca Dye, and Peter Repenning for their assistance with preparing the experimental cohorts of mice. We thank Stu Parnham for his assistance with 1H NMR spectroscopy and Viktoriya Nikolova and Natallia Riddick for their assistance with mouse behavioral testing. We thank Ilona Jaspers for her helpful discussion. K.A.B. was supported by NIEHS T32 ES007126. Studies using 1H NMR were supported by the National Cancer Institute of the National Institutes of Health under award number P30CA016086. Studies using the Mouse Behavioral Phenotyping Core were supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54 HD079124).	Abel EL, 2004, TOXICOL SCI, V80, P230, DOI 10.1093/toxsci/kfh152; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; BAARS AJ, 1978, BIOCHEM PHARMACOL, V27, P2487, DOI 10.1016/0006-2952(78)90314-3; Barber DS, 2001, NEUROTOXICOLOGY, V22, P341, DOI 10.1016/S0161-813X(01)00024-9; BRAT DJ, 1993, J NEUROCHEM, V60, P2145, DOI 10.1111/j.1471-4159.1993.tb03499.x; BYARD JL, 1973, FOOD COSMET TOXICOL, V11, P391, DOI 10.1016/0015-6264(73)90005-9; CALLEMAN CJ, 1994, TOXICOL APPL PHARM, V126, P361, DOI 10.1006/taap.1994.1127; Chang J, 2013, AM J PHYSIOL-RENAL, V304, pF348, DOI 10.1152/ajprenal.00568.2012; COSTA LG, 1995, TOXICOLOGY, V98, P151, DOI 10.1016/0300-483X(94)02986-5; da Costa GG, 2003, CHEM RES TOXICOL, V16, P1328, DOI 10.1021/tx034108e; DIXIT R, 1981, BIOCHEM PHARMACOL, V30, P1739, DOI 10.1016/0006-2952(81)90003-4; DIXIT R, 1980, CHEM-BIOL INTERACT, V32, P353, DOI 10.1016/0009-2797(80)90103-9; Doerge DR, 2007, TOXICOL LETT, V169, P34, DOI 10.1016/j.toxlet.2006.12.002; Doerge DR, 2005, TOXICOL APPL PHARM, V202, P258, DOI 10.1016/j.taap.2004.07.001; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; Fennell TR, 2006, TOXICOL SCI, V93, P256, DOI 10.1093/toxsci/kfl069; Fennell TR, 2005, TOXICOL SCI, V85, P447, DOI 10.1093/toxsci/kfi069; Ghanayem BI, 2005, MUTAT RES-FUND MOL M, V578, P284, DOI 10.1016/j.mrfmmm.2005.05.004; GILBERT SG, 1982, J TOXICOL ENV HEALTH, V10, P31, DOI 10.1080/15287398209530228; Ginsberg G, 2009, J TOXICOL ENV HEAL B, V12, P389, DOI 10.1080/10937400903158375; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Henderson CJ, 2000, P NATL ACAD SCI USA, V97, P12741, DOI 10.1073/pnas.220176997; Henderson CJ, 2011, DRUG METAB REV, V43, P152, DOI 10.3109/03602532.2011.562900; Jemth P, 1997, ARCH BIOCHEM BIOPHYS, V348, P247, DOI 10.1006/abbi.1997.0357; Jones JT, 2016, REDOX BIOL, V8, P375, DOI 10.1016/j.redox.2016.03.005; Josephy PD., 2010, HUM GENOMICS PROTEOM, V2010, P876940, DOI [10.4061/2010/876940, DOI 10.4061/2010/876940]; Knight TR, 2007, TOXICOL SCI, V100, P513, DOI 10.1093/toxsci/kfm233; Ko MH, 1999, EXP NEUROL, V158, P37, DOI 10.1006/exnr.1999.7102; LETHCO EJ, 1975, TOXICOLOGY, V3, P287, DOI 10.1016/0300-483X(75)90030-X; Lineback DR, 2012, ANNU REV FOOD SCI T, V3, P15, DOI 10.1146/annurev-food-022811-101114; Martyniuk CJ, 2013, TOXICOL LETT, V219, P279, DOI 10.1016/j.toxlet.2013.03.031; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; McMillan DH, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85717; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; SEIDEGARD J, 1988, P NATL ACAD SCI USA, V85, P7293, DOI 10.1073/pnas.85.19.7293; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; SHELBY MD, 1986, MUTAT RES, V173, P35, DOI 10.1016/0165-7992(86)90008-4; Sumner SCJ, 2003, TOXICOL SCI, V75, P260, DOI 10.1093/toxsci/kfg191; SUMNER SCJ, 1992, CHEM RES TOXICOL, V5, P81, DOI 10.1021/tx00025a014; Sun JC, 2010, METABOLOMICS, V6, P550, DOI 10.1007/s11306-010-0225-8; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Testa B, 2008, CHEM BIODIVERS, V5, P2171, DOI 10.1002/cbdv.200890199; Tew KD, 2011, FREE RADICAL BIO MED, V51, P299, DOI 10.1016/j.freeradbiomed.2011.04.013; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Twaddle NC, 2004, J AGR FOOD CHEM, V52, P4344, DOI 10.1021/jf0497657; Virk-Baker MK, 2014, NUTR CANCER, V66, P774, DOI 10.1080/01635581.2014.916323; Von Burg R, 1981, J Appl Toxicol, V1, P227, DOI 10.1002/jat.2550010409; World Health Organization, 2002, HLTH IMPL ACR FOOD; Xiang ZD, 2014, DRUG METAB DISPOS, V42, P1074, DOI 10.1124/dmd.113.056481; Yoon E, 2016, J CLIN TRANSL HEPATO, V4, P131, DOI 10.14218/JCTH.2015.00052; ZAIDI SIA, 1994, IMMUNOPHARM IMMUNOT, V16, P247, DOI 10.3109/08923979409007093; Zhang J, 2018, FREE RADICAL BIO MED, V120, P204, DOI 10.1016/j.freeradbiomed.2018.03.038; Zhang J, 2014, ADV CANCER RES, V122, P143, DOI 10.1016/B978-0-12-420117-0.00004-9	57	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225449	10.1371/journal.pone.0225449	http://dx.doi.org/10.1371/journal.pone.0225449			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747445	Green Submitted, Green Published, gold			2022-12-26	WOS:000533881900042
J	Miron, A; Spinozzi, D; Dhubhghaill, SN; Lie, JT; Oellerich, S; Melles, GRJ				Miron, Alina; Spinozzi, Daniele; Dhubhghaill, Sorcha Ni; Lie, Jessica T.; Oellerich, Silke; Melles, Gerrit R. J.			In vitro endothelial cell migration from limbal edge-modified Quarter-DMEK grafts	PLOS ONE			English	Article							KERATOPLASTY	Endothelial cell migration plays a crucial role in achieving corneal clearance after corneal transplantation when using smaller-sized endothelial grafts to increase the donor pool. In this study we investigated how different strategies of Quarter-Descemet Membrane Endothelial Keratoplasty (Quarter-DMEK) limbal graft edge modification influence peripheral endothelial cell migration in an in vitro culture environment. For this study, 15 Quarter-DMEK grafts, prepared from 7 corneas deemed ineligible for transplantation but with intact and viable endothelial cells, were embedded in a cooled biocompatible, thermoresponsive matrix for culture. The limbal edge of ten Quarter-DMEK grafts were modified, either by using a small diameter punch or by peripheral radial cuts. All Quarter-DMEK grafts showed substantial collective endothelial cell migration from the radial cut graft edges, as observed by light microscopy at standardized time intervals. Grafts were retrieved from the polymer matrix after the two-week culture for immunohistochemistry analyses of the newly formed cell monolayers; this demonstrated the presence of tightly packed and viable cells that showed higher migratory ability at the leading edge. Peripheral endothelial cell migration, however, was not triggered by increasing cell exposure to free space through surgical modifications of the far periphery. Our data suggest that alterations in the far peripheral area of Quarter-DMEK grafts were insufficient to triggering cell migration from the limbal graft edge. This may be due to transient-amplifying cells that reside in the far periphery and which lack cytokinetic directional cues. Understanding the migration capacity of the peripheral endothelium could unlock cells' therapeutic potential which are, at present, routinely discarded from transplantation. Encouraging peripheral cell migration may also improve clinical outcomes from Quarter-DMEK, but a more effective solution is required prior to clinical implementation of modified grafts.	[Miron, Alina; Spinozzi, Daniele; Dhubhghaill, Sorcha Ni; Lie, Jessica T.; Oellerich, Silke; Melles, Gerrit R. J.] Netherlands Inst Innovat Ocular Surg, Rotterdam, Netherlands; [Miron, Alina; Dhubhghaill, Sorcha Ni; Melles, Gerrit R. J.] Melles Cornea Clin Rotterdam, Rotterdam, Netherlands; [Lie, Jessica T.; Melles, Gerrit R. J.] Amnitrans EyeBank Rotterdam, Rotterdam, Netherlands		Melles, GRJ (corresponding author), Netherlands Inst Innovat Ocular Surg, Rotterdam, Netherlands.; Melles, GRJ (corresponding author), Melles Cornea Clin Rotterdam, Rotterdam, Netherlands.; Melles, GRJ (corresponding author), Amnitrans EyeBank Rotterdam, Rotterdam, Netherlands.	research@niios.com	Ní Dhubhghaill, Sorcha/D-4278-2015	Ní Dhubhghaill, Sorcha/0000-0002-1115-7834; Spinozzi, Daniele/0000-0003-0231-9368; Oellerich, Silke/0000-0002-5703-5971	European Union [667400]	European Union(European Commission)	Part of the project leading to this study has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement number 667400 [ARREST BLINDNESS Consortium]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzic M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00153; Baydoun L, 2018, ACTA OPHTHALMOL, V96, pE656, DOI 10.1111/aos.13720; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; He ZG, 2012, STEM CELLS, V30, P2523, DOI 10.1002/stem.1212; Lie JT, 2016, BRIT J OPHTHALMOL, V100, P420, DOI 10.1136/bjophthalmol-2015-307335; Liu YS, 2017, INT J MED SCI, V14, P705, DOI 10.7150/ijms.19018; Miron A, 2018, ACTA OPHTHALMOL, V96, P828, DOI 10.1111/aos.13841; Muller TM, 2017, CORNEA, V36, P104, DOI 10.1097/ICO.0000000000001008; Scarpa E, 2016, J CELL BIOL, V212, P143, DOI 10.1083/jcb.201508047; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Trepat X, 2012, COMPR PHYSIOL, V2, P2369, DOI 10.1002/cphy.c110012; Zygoura V, 2018, BRIT J OPHTHALMOL, V102, P1425, DOI 10.1136/bjophthalmol-2017-311398	13	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225462	10.1371/journal.pone.0225462	http://dx.doi.org/10.1371/journal.pone.0225462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747441	Green Published, gold, Green Submitted			2022-12-26	WOS:000533881900046
J	Seaman, AT; Taylor, KL; Davis, K; Nepple, KG; Lynch, JH; Oberle, AD; Hall, IJ; Volk, RJ; Reisinger, HS; Hoffman, RM				Seaman, Aaron T.; Taylor, Kathryn L.; Davis, Kimberly; Nepple, Kenneth G.; Lynch, John H.; Oberle, Anthony D.; Hall, Ingrid J.; Volk, Robert J.; Reisinger, Heather Schacht; Hoffman, Richard M.			Why men with a low-risk prostate cancer select and stay on active surveillance: A qualitative study	PLOS ONE			English	Article							TREATMENT DECISION-MAKING; THE-SCIENCE CONFERENCE; FOLLOW-UP; OF-LIFE; MANAGEMENT; PREFERENCES; TRENDS; TIME	Objective Active surveillance (AS) is an increasingly utilized strategy for monitoring men with low-risk prostate cancer (PCa) that allows them to defer active treatment (AT) in the absence of cancer progression. Studies have explored reasons for selecting AS and for then switching to AT, but less is known about men's experiences being on AS. We interviewed men to determine the clinical and psychological factors associated with selecting and adhering to AS protocols. Methods We conducted semi-structured interviews with men with a low-risk PCa at two academic medical centers. Subjects had either been on AS for >= 1 year or had opted for AT after a period of AS. We used an iterative, content-driven approach to analyze the interviews and to identify themes. Results We enrolled 21 subjects, mean age 70.4 years, 3 racial/ethnic minorities, and 16 still on AS. Men recognized the favorable prognosis of their cancer (some had sought second opinions when initially offered AT), valued avoiding treatment complications, were reassured that close monitoring would identify progression early enough to be successfully treated, and trusted their urologists. Although men reported feeling anxious around the time of surveillance testing, those who switched to AT did so based only on evidence of cancer progression. Conclusions Our selected sample was comfortable being on AS because they understood and valued the rationale for this approach. However, this highlights the importance of ensuring that men newly diagnosed with a low-risk PCa are provided sufficient information about prognosis and treatment options to make informed decisions.	[Seaman, Aaron T.; Reisinger, Heather Schacht; Hoffman, Richard M.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Taylor, Kathryn L.; Davis, Kimberly] Georgetown Univ, Canc Prevent & Control Program, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Nepple, Kenneth G.; Oberle, Anthony D.] Univ Iowa, Dept Urol, Carver Coll Med, Iowa City, IA 52242 USA; [Nepple, Kenneth G.; Hoffman, Richard M.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Lynch, John H.] Georgetown Univ, Dept Urol, Washington, DC USA; [Lynch, John H.] Georgetown Univ, Prostate Canc Ctr, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Hall, Ingrid J.] Ctr Dis Control & Prevent, Epidemiol & Appl Res Branch, Div Canc Prevent & Control, Atlanta, GA USA; [Volk, Robert J.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA	University of Iowa; Georgetown University; University of Iowa; University of Iowa; Georgetown University; Georgetown University; Centers for Disease Control & Prevention - USA; University of Texas System; UTMD Anderson Cancer Center	Hoffman, RM (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA.; Hoffman, RM (corresponding author), Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.	Richard-M-Hoffman@uiowa.edu	Seaman, Aaron/AAG-1349-2019	Seaman, Aaron/0000-0002-1680-1334; Nepple, Kenneth/0000-0001-8100-4190; Reisinger, Heather/0000-0002-5348-063X; Hoffman, Richard/0000-0002-4714-7726	Centers for Disease Control and Prevention [3U48DP005017]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP005017] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication was supported by the Grant or Cooperative Agreement Number 3U48DP005017 and is a product of the Health Promotion and Disease Research Center, funded by the Centers for Disease Control and Prevention. The grant was awarded to RH. The funders did not play any role in the study design, data collection and analysis, decision to publish. They provided editorial comments on an earlier draft of the manuscript.	Anandadas CN, 2011, BJU INT, V107, P1762, DOI 10.1111/j.1464-410X.2010.09833.x; Bellardita L, 2015, EUR UROL, V67, P637, DOI 10.1016/j.eururo.2014.10.028; Berger ZD, 2014, PATIENT, V7, P427, DOI 10.1007/s40271-014-0066-z; Bernard H. R., 2017, RES METHODS ANTHR; Carter G, 2015, CANCER TREAT REV, V41, P46, DOI 10.1016/j.ctrv.2014.11.001; Centers for Medicare & Medicaid Services, 2015, DEC MEM SCREEN LUNG; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Davison BJ, 2009, ONCOL NURS FORUM, V36, P89, DOI 10.1188/09.ONF.89-96; Davison BJ, 2012, PATIENT EDUC COUNS, V87, P369, DOI 10.1016/j.pec.2011.11.009; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Ganz PA, 2012, ANN INTERN MED, V156, P591, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00010]; Gorin MA, 2011, UROLOGY, V77, P588, DOI 10.1016/j.urology.2010.10.039; Hall Ingrid J, 2012, J Natl Cancer Inst Monogr, V2012, P135, DOI 10.1093/jncimonographs/lgs040; Kazer MW, 2011, J CLIN NURS, V20, P581, DOI 10.1111/j.1365-2702.2010.03489.x; Kelly SP, 2016, J UROLOGY, V196, P734, DOI 10.1016/j.juro.2016.04.045; Latini DM, 2007, J UROLOGY, V178, P826, DOI 10.1016/j.juro.2007.05.039; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Loeb S, 2017, BJU INT, V120, P32, DOI 10.1111/bju.13651; Loeb S, 2016, J UROLOGY, V196, P721, DOI 10.1016/j.juro.2016.02.2963; Mader EM, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0225-3; Mallapareddi A, 2017, FAM PRACT, V34, P90, DOI 10.1093/fampra/cmw123; Marzouk M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020655; Matheson L, 2019, PSYCHO-ONCOLOGY, V28, P1567, DOI 10.1002/pon.5133; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; National Comprehensive Cancer Network, 2018, PROSTATE CANC; O'Callaghan C, 2014, PSYCHO-ONCOLOGY, V23, P1391, DOI 10.1002/pon.3576; Oliffe JL, 2009, QUAL HEALTH RES, V19, P432, DOI 10.1177/1049732309332692; Punnen S, 2015, EUR UROL, V68, P600, DOI 10.1016/j.eururo.2014.08.074; Ritch CR, 2015, J UROLOGY, V193, P801, DOI 10.1016/j.juro.2014.08.102; Ruane-McAteer E, 2019, PSYCHO-ONCOLOGY, V28, P1743, DOI 10.1002/pon.5161; Sanda MG, 2018, J UROLOGY, V199, P990, DOI 10.1016/j.juro.2018.01.002; Scherr KA, 2017, MED DECIS MAKING, V37, P56, DOI 10.1177/0272989X16662841; Simpkin AJ, 2015, EUR UROL, V67, P993, DOI 10.1016/j.eururo.2015.01.004; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Taylor KL, 2016, CANCER EPIDEM BIOMAR, V25, P1240, DOI 10.1158/1055-9965.EPI-15-1079; van den Bergh RCN, 2010, J UROLOGY, V183, P1786, DOI 10.1016/j.juro.2009.12.099; Venderbos LDF, 2017, QUAL LIFE RES, V26, P1635, DOI 10.1007/s11136-017-1507-7; Volk RJ, 2014, PSYCHO-ONCOLOGY, V23, P467, DOI 10.1002/pon.3444; Weiner AB, 2015, J UROLOGY, V193, P95, DOI 10.1016/j.juro.2014.07.111; Womble PR, 2015, EUR UROL, V67, P44, DOI 10.1016/j.eururo.2014.08.024; Xu JP, 2012, J AM BOARD FAM MED, V25, P763, DOI 10.3122/jabfm.2012.06.120128	44	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225134	10.1371/journal.pone.0225134	http://dx.doi.org/10.1371/journal.pone.0225134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8NF	31747396	gold, Green Published			2022-12-26	WOS:000533881900023
J	Jang, E; Son, M; Jang, J; Lee, IH; Kim, S; Kwon, T; Jeon, YH; Koh, WS; Kim, KS; Kim, SK				Jang, Eunseo; Son, Minhee; Jang, Junhee; Lee, In-Hyun; Kim, Sol; Kwon, Taejun; Jeon, Yong-hyun; Koh, Woo-Suk; Kim, Kil-Soo; Kim, Sang Kyoon			DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy	PLOS ONE			English	Article							MORTALITY PREDICTIONS; CREMOPHOR EL; VEHICLE; DHP107	Objective This study aimed to develop a new oral paclitaxel formulation (DHP23002) and to evaluate its absorption and antitumor effects in a pancreatic tumor mouse model. Methods To investigate the oral absorption of DHP23002, a newly developed lipid-based orally active paclitaxel formulation, a pharmacokinetic study of DHP23002, was conducted in mice (62.5 and 125 mg/kg). Moreover, to evaluate the antitumor effect of DHP23002 in pancreatic cancer treatment, the drug was administered to female athymic nude mice at 0 (vehicle), 25, 62.5, and 125 mg/kg on alternate days; the efficacy of the agent was compared with the efficacy of intravenous Taxol (R) injections at 10 mg/kg once per week. After 3 weeks of administration, tumor growth in mice belonging to each group was further monitored for 4 weeks after discontinuing medication. Moreover, to examine paclitaxel (DHP23002) accumulation in the tumor tissue, the amount of paclitaxel in tumor/blood was quantified using liquid chromatography with quadruple-TOF mass spectrometry. Results In the mouse pharmacokinetic study, oral Taxol (R) showed a negligible absorption, whereas DHP23002 showed a high absorption rate dependent on dosage, with a bioavailability of approximately 40% at a dose of 62.5 mg/kg. In efficacy-related studies, DHP23002 administration at a dose of 25, 62.5, or 125 mg/kg on alternate days for 3 weeks showed a superior tumor inhibitory effect of 80%, 92%, and 97% in a xenograft mouse model, respectively, after 7 weeks. Paclitaxel accumulation in tumors persisted for >24 h in mice, when orally administered once at doses of 25, 62.5, and 125 mg/kg DHP23002. Conclusion Oral chemotherapy with DHP23002 showed excellent absorption in animals owing to a strong antitumor activity in a pancreatic cancer mouse model. This demonstrates that paclitaxel is largely distributed and persists for a prolonged period at the tumor site owing to oral DHP23002 administration.	[Jang, Eunseo; Kwon, Taejun; Jeon, Yong-hyun; Koh, Woo-Suk; Kim, Kil-Soo; Kim, Sang Kyoon] Daegu Gyeongbuk Med Innovat Fdn, Lab Anim Ctr, Daegu, South Korea; [Son, Minhee; Jang, Junhee; Lee, In-Hyun; Kim, Sol] Dae Hwa Pharmaceut Co Ltd, Pangyo Res Lab, Sungnam City, South Korea; [Kim, Kil-Soo] Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea	Kyungpook National University	Kim, SK (corresponding author), Daegu Gyeongbuk Med Innovat Fdn, Lab Anim Ctr, Daegu, South Korea.	ksk1420@dgmif.re.kr		SON, Minhee/0000-0001-5874-5556	Medical Cluster R&D Support Project through the Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF); Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health Welfare [HT13C0002, HI15C0001]	Medical Cluster R&D Support Project through the Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF); Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health Welfare	This work was supported by a grant from the Medical Cluster R&D Support Project through the Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF) and by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, which were funded by the Ministry of Health & Welfare (grant number: HT13C0002 and HI15C0001). The funder provided support in the form of research grant for authors (ESJ, TJK, YHJ, WSK, KSK, SKK) but did not play any additional role in the study design, data collection, data analysis, decision to publish, or manuscript preparation. Dae Hwa Pharmaceutical Co. Ltd. provided support in the form of salaries for authors (MHS, JHJ, IHL, SK) but did not play any additional role in study design, data collection, data analysis, decision to publish, or manuscript preparation. The specific roles of these authors are articulated in the "Author Contributions" section.	Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Conroy T, 2010, J CLIN ONCOL, V28, p303s; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hidalgo M, 2014, ANN ONCOL, V25, DOI 10.1093/annonc/mdu334.2; Hong JW, 2007, MOL CANCER THER, V6, P3239, DOI 10.1158/1535-7163.MCT-07-0261; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; Lambert A, 2017, THER ADV GASTROENTER, V10, P631, DOI 10.1177/1756283X17713879; Lee HJ, 2014, CANCER RES TREAT, V46, P234, DOI 10.4143/crt.2014.46.3.234; Lee I. H., 2012, NEW ADV BASIC CLIN G, P357; Lee I, 2017, ADV OPT MATER, V5, DOI 10.1002/adom.201600888; Malvezzi M, 2015, ANN ONCOL, V26, P779, DOI 10.1093/annonc/mdv001; Malvezzi M, 2014, ANN ONCOL, V25, P1650, DOI 10.1093/annonc/mdu138; Miele E, 2009, INT J NANOMED, V4, P99; Ryu MH, 2017, ONCOLOGIST, V22, P129, DOI 10.1634/theoncologist.2016-0273; Seidman AD, 1998, ONCOLOGY-NY, V12, P19; Sparreboom A, 1999, CANCER RES, V59, P1454; Sparreboom A, 1996, CANCER RES, V56, P2112; WOODCOCK DM, 1990, CANCER RES, V50, P4199	18	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225095	10.1371/journal.pone.0225095	http://dx.doi.org/10.1371/journal.pone.0225095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743348	Green Published, gold			2022-12-26	WOS:000533877300017
J	Rozova, ON; Mustakhimov, II; But, SY; Reshetnikov, AS; Khmelenina, VN				Rozova, Olga N.; Mustakhimov, Ildar I.; But, Sergei Y.; Reshetnikov, Aleksandr S.; Khmelenina, Valentina N.			Role of the malic enzyme in metabolism of the halotolerant methanotroph Methylotuvimicrobium alcaliphilum 20Z	PLOS ONE			English	Article							OXALOACETATE DECARBOXYLASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; AMINO-ACID; PURIFICATION; GENE; MECHANISM; SEQUENCE; ISOFORMS; PATHWAY; METHANE	The bacteria utilizing methane as a growth substrate (methanotrophs) are important constituents of the biosphere. Methanotrophs mitigate the emission of anthropogenic and natural greenhouse gas methane to the environment and are the promising agents for future biotechnologies. Many aspects of CH4 bioconversion by methanotrophs require further clarification. This study was aimed at characterizing the biochemical properties of the malic enzyme (Mae) from the halotolerant obligate methanotroph Methylotuvimicrobium alcaliphilum 20Z. The His(6)-tagged Mae was obtained by heterologous expression in Escherichia coli BL21 (DE3) and purified by affinity metal chelating chromatography. As determined by gel filtration and non-denaturating gradient gel electrophoresis, the molecular mass of the native enzyme is 260 kDa. The homotetrameric Mae (65x4 kDa) catalyzed an irreversible NAD(+)-dependent reaction of L-malate decarboxylation into pyruvate with a specific activity of 32 +/- 2 units mg(-1) and K-m value of 5.5 +/- 0.8 mM for malate and 57 +/- 5 mu M for NAD(+). The disruption of the mae gene by insertion mutagenesis resulted in a 20-fold increase in intracellular malate level in the mutant compared to the wild type strain. Based on both enzyme and mutant properties, we conclude that the malic enzyme is involved in the control of intracellular L-malate level in Mtm. alcaliphilum 20Z. Genomic analysis has revealed that Maes present in methanotrophs fall into two different clades in the amino acid-based phylogenetic tree, but no correlation of the division with taxonomic affiliations of the host bacteria was observed.	[Rozova, Olga N.; Mustakhimov, Ildar I.; But, Sergei Y.; Reshetnikov, Aleksandr S.; Khmelenina, Valentina N.] Russian Acad Sci, GK Skryabin Inst Biochem & Physiol Microorganisms, Fed Res Ctr, Pushchino Sci Ctr Biol Res, Pushchino, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences	Khmelenina, VN (corresponding author), Russian Acad Sci, GK Skryabin Inst Biochem & Physiol Microorganisms, Fed Res Ctr, Pushchino Sci Ctr Biol Res, Pushchino, Moscow Region, Russia.	khmelenina@ibpm.pushchino.ru	Rozova, Olga/E-6902-2014; Mustakhimov, Ildar/I-2381-2014	Rozova, Olga/0000-0001-6052-9756; Mustakhimov, Ildar/0000-0003-3406-0653	RFBR [18-04-00771]; Russian Foundation of Basic Research [18-04-00771]	RFBR(Russian Foundation for Basic Research (RFBR)); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by a grant from RFBR (https://www.rfbr.ru/rffi/ru/) 18-04-00771, grant chief Olga N. Rozova.; The authors are grateful to all members of the Organization for Methanotroph Genome Analysis for collaboration (OMeGA), the U.S. Department of Energy Joint Genome Institute and Genoscope for the access to methanotrophic genomes for comparative analyses. This work was supported by Russian Foundation of Basic Research (18-04-00771).	Akberdin IR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23088-w; Nguyen AD, 2020, METAB ENG, V57, P1, DOI 10.1016/j.ymben.2019.10.004; Anvar SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-914; BARTOLUCCI S, 1987, J BIOL CHEM, V262, P7725; Bologna FP, 2007, J BACTERIOL, V189, P5937, DOI 10.1128/JB.00428-07; But SY, 2019, ANTON LEEUW INT J G, V112, P741, DOI 10.1007/s10482-018-1208-4; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Chen F, 1998, APPL ENVIRON MICROB, V64, P4073; Chen F, 1997, BIOSCI BIOTECH BIOCH, V61, P384, DOI 10.1271/bbb.61.384; Chiba Y, 2015, J BIOL CHEM, V290, P23960, DOI 10.1074/jbc.M115.672907; Chistoserdova L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01425; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Choi PH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12713; Dahinden P, 2005, ARCH MICROBIOL, V183, P121, DOI 10.1007/s00203-004-0754-5; de la Torre A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0377-3; Dedysh SN, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01555-14; Dimroth P, 2001, BBA-BIOENERGETICS, V1505, P1, DOI 10.1016/S0005-2728(00)00272-3; Doan T, 2003, MICROBIOL-SGM, V149, P2331, DOI 10.1099/mic.0.26256-0; Erikstad HA, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00065-15; Espariz M, 2011, FEBS J, V278, P2140, DOI 10.1111/j.1742-4658.2011.08131.x; Fu YF, 2019, MBIO, V10, DOI 10.1128/mBio.00406-19; Fu YF, 2017, METAB ENG, V42, P43, DOI 10.1016/j.ymben.2017.05.003; Garg S, 2018, METAB ENG, V48, P175, DOI 10.1016/j.ymben.2018.06.001; Gourdon P, 2000, APPL ENVIRON MICROB, V66, P2981, DOI 10.1128/AEM.66.7.2981-2987.2000; Groisillier A, 1999, INT J SYST BACTERIOL, V49, P1417, DOI 10.1099/00207713-49-4-1417; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Henard CA, 2017, METAB ENG, V41, P152, DOI 10.1016/j.ymben.2017.03.007; Henard CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21585; Kalyuzhnaya MG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3785; Kalyuzhnaya MG, 2015, METAB ENG, V29, P142, DOI 10.1016/j.ymben.2015.03.010; Kalyuzhnaya MG, 2016, BIOTECHNOLOGY BIOFUE, P353; Kawai S, 1996, APPL ENVIRON MICROB, V62, P2692, DOI 10.1128/AEM.62.8.2692-2700.1996; Khmelenina VN, 1999, ARCH MICROBIOL, V172, P321, DOI 10.1007/s002030050786; Khmelenina VN, 2018, AEROBIC UTILIZATION, P1, DOI DOI 10.1007/978-3-319-39782-5_4-1; Khmelenina VN, 2018, METHANE BIOCATALYSIS, P83, DOI DOI 10.1007/978-3-319-74866-5_6; KOBAYASHI K, 1989, J BIOL CHEM, V264, P3200; Lea PJ, 2001, AMINO ACIDS, V20, P225, DOI 10.1007/s007260170041; Lerondel G, 2006, J BACTERIOL, V188, P4727, DOI 10.1128/JB.00167-06; Lietzan AD, 2014, ARCH BIOCHEM BIOPHYS, V544, P75, DOI 10.1016/j.abb.2013.10.014; MALLICK S, 1991, J BIOL CHEM, V266, P2732; Mitsch MJ, 1998, J BIOL CHEM, V273, P9330, DOI 10.1074/jbc.273.15.9330; MURAI T, 1971, BIOCHEM BIOPH RES CO, V43, P875, DOI 10.1016/0006-291X(71)90698-X; Mustakhimov I I, 2016, Prikl Biokhim Mikrobiol, V52, P279, DOI 10.7868/S0555109916030156; Mustakhimov II, 2019, 12 INT C BIOC 2019 F, P119; Ratledge C, 2014, BIOTECHNOL LETT, V36, P1557, DOI 10.1007/s10529-014-1532-3; Reshetnikov AS, 2008, FEMS MICROBIOL LETT, V288, P202, DOI 10.1111/j.1574-6968.2008.01366.x; Rozova ON, 2019, BIOCHEMISTRY-MOSCOW+, V84, P390, DOI 10.1134/S0006297919040060; Rozova Olga N, 2015, Microorganisms, V3, P47, DOI 10.3390/microorganisms3010047; Rozova ON, 2015, ANTON LEEUW INT J G, V108, P965, DOI 10.1007/s10482-015-0549-5; Sambrook J., 2001, MOL CLONING LAB MANU; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P654, DOI 10.1016/0003-2697(73)90523-X; Sender PD, 2004, FEBS LETT, V570, P217, DOI 10.1016/j.febslet.2004.06.038; Strong PJ, 2016, BIORESOURCE TECHNOL, V215, P314, DOI 10.1016/j.biortech.2016.04.099; Taillefer M, 2015, APPL ENVIRON MICROB, V81, P2423, DOI 10.1128/AEM.03360-14; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Voegele RT, 1999, BBA-PROTEIN STRUCT M, V1432, P275, DOI 10.1016/S0167-4838(99)00112-0; Vuilleumier S, 2012, J BACTERIOL, V194, P551, DOI 10.1128/JB.06392-11; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Ye W, 2010, MICROBIOL RES, V165, P268, DOI 10.1016/j.micres.2009.05.008; Zhang Y, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0780-x	61	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225054	10.1371/journal.pone.0225054	http://dx.doi.org/10.1371/journal.pone.0225054			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738793	Green Published, gold			2022-12-26	WOS:000532826300028
J	Fredriksson, M; Thybring, EE				Fredriksson, Maria; Thybring, Emil Engelund			On sorption hysteresis in wood: Separating hysteresis in cell wall water and capillary water in the full moisture range	PLOS ONE			English	Article							FIBER SATURATION POINT; NORWAY SPRUCE; POTENTIAL RELATIONSHIP; PHYSICAL-PROPERTIES; PHASE-TRANSITIONS; LIQUID WATER; BOUND WATER; CELLULOSE; SILICA; PORES	Moisture influences most physical wood properties and plays an important role in degradation processes. Like most other porous materials, wood exhibits sorption hysteresis. That is, the moisture content is higher if equilibrium is reached by desorption than if it is reached by absorption under the same ambient climate conditions. The mechanism of moisture uptake by wood are different in the hygroscopic and over-hygroscopic moisture ranges and due to methodical issues, most studies of sorption hysteresis have been performed in the hygroscopic range. In the present study, total sorption hysteresis was separated into hysteresis in cell wall water and capillary water respectively in the whole moisture range by a novel combination of experimental techniques. Wood specimens were conditioned to several high moisture contents using a new system based on the pressure plate technique, and the distinction between cell wall water and capillary water was done with differential scanning calorimetry. The results showed that sorption hysteresis in wood cell walls exists in the whole moisture range. The cell walls were not saturated with water until the whole wood specimen was saturated which contradicts the long-held dogma that cell walls are saturated before significant amounts of capillary water are present in wood.	[Fredriksson, Maria] Lund Univ, Div Bldg Mat, Dept Bldg & Environm Technol, Lund, Sweden; [Thybring, Emil Engelund] Univ Copenhagen, Dept Geosci & Nat Resource Management, Biomass Sci & Technol, Forest Nat & Biomass, Frederiksberg, Denmark	Lund University; University of Copenhagen	Fredriksson, M (corresponding author), Lund Univ, Div Bldg Mat, Dept Bldg & Environm Technol, Lund, Sweden.	maria.fredriksson@byggtek.lth.se	Thybring, Emil Engelund/I-5477-2012; Fredriksson, Maria/E-6819-2015	Thybring, Emil Engelund/0000-0003-0471-6922; Fredriksson, Maria/0000-0002-6500-9706	Swedish Research Council FORMAS [2013-1024, 2018-00387]; Crafoord Foundation [20140948]; Ake och Greta Lissheds stiftelse [2014-00006]; Villum Foundation Postdoc programme	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Crafoord Foundation; Ake och Greta Lissheds stiftelse; Villum Foundation Postdoc programme(Villum Fonden)	MF acknowledges the funding from the Swedish Research Council FORMAS (Project no. 2013-1024 and 2018-00387) https://formas.se/, the Crafoord Foundation (project no. 20140948) https://www.crafoord.se/, Ake och Greta Lissheds stiftelse (2014-00006) http://www.lisshedsstiftelse.a.se/.EET acknowledges the funding from the Villum Foundation Postdoc programme https://veluxfoundations.dk/en.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida G, 2006, WOOD SCI TECHNOL, V40, P599, DOI 10.1007/s00226-006-0083-8; Almeida G, 2006, WOOD FIBER SCI, V38, P74; Askfelt H, 2016, INT J ENG SCI, V109, P54, DOI 10.1016/j.ijengsci.2016.08.005; BERTHOLD J, 1994, POLYMER, V35, P5729, DOI 10.1016/S0032-3861(05)80048-5; Berthold J, 1996, COLLOID SURFACE A, V112, P117, DOI 10.1016/0927-7757(95)03419-6; Borrega M, 2011, WOOD FIBER SCI, V43, P206; Chen MY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05897-9; CLOUTIER A, 1994, DRY TECHNOL, V12, P1793, DOI 10.1080/07373939408962207; CLOUTIER A, 1991, WOOD SCI TECHNOL, V25, P263, DOI 10.1007/BF00225466; Cote W.A., 1968, PRINCIPLES WOOD SCI, DOI [10.1007/978-3-642-87928-9_5, 10.1007/978-3-642-87928-9_1, DOI 10.1007/978-3-642-87928-9_1]; Digaitis R, 2017, WOOD SCI TECHNOL, V51, P1067, DOI 10.1007/s00226-017-0939-0; Endo A, 2008, J PHYS CHEM C, V112, P9034, DOI 10.1021/jp8016248; Engelund ET, 2013, WOOD SCI TECHNOL, V47, P141, DOI 10.1007/s00226-012-0514-7; ERICKSON HD, 1974, WOOD SCI TECHNOL, V8, P207, DOI 10.1007/BF00352024; FLOURNOY DS, 1991, HOLZFORSCHUNG, V45, P383, DOI 10.1515/hfsg.1991.45.5.383; FLOURNOY DS, 1993, HOLZFORSCHUNG, V47, P297, DOI 10.1515/hfsg.1993.47.4.297; Fortin Y, 1979, THESIS; Fredriksson M, 2018, CELLULOSE, V25, P4477, DOI 10.1007/s10570-018-1898-9; Fredriksson M, 2016, DRY TECHNOL, V34, P132, DOI 10.1080/07373937.2015.1041035; Gezici-Koc O, 2017, CELLULOSE, V24, P535, DOI 10.1007/s10570-016-1173-x; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; Haglund M, 2007, WOOD SCI TECHNOL, V41, P477, DOI 10.1007/s00226-007-0131-z; HATAKEYAMA T, 1983, MAKROMOL CHEM, V184, P1265; Hernandez RE, 2006, WOOD FIBER SCI, V38, P474; Hernandez RE, 2010, WOOD FIBER SCI, V42, P259; Hill CAS, 2012, HOLZFORSCHUNG, V66, P35, DOI 10.1515/HF.2011.115; Hill CAS, 2005, INT BIODETER BIODEGR, V55, P69, DOI 10.1016/j.ibiod.2004.07.003; Hoffmeyer P, 2011, HOLZFORSCHUNG, V65, P875, DOI 10.1515/HF.2011.112; Hofstetter K, 2006, CELLULOSE, V13, P131, DOI 10.1007/s10570-006-9055-2; ISHIKIRIYAMA K, 1995, THERMOCHIM ACTA, V256, P213, DOI 10.1016/0040-6031(94)02174-M; Jeoh T, 2017, ACS SUSTAIN CHEM ENG, V5, P8785, DOI 10.1021/acssuschemeng.7b01588; Kekkonen PM, 2014, J PHYS CHEM C, V118, P2146, DOI 10.1021/jp411199r; Maloney TC, 1999, J PULP PAP SCI, V25, P430; MENON RS, 1987, J APPL POLYM SCI, V33, P1141, DOI 10.1002/app.1987.070330408; NAKAMURA K, 1981, TEXT RES J, V51, P607, DOI 10.1177/004051758105100909; Niklewski J, 2018, WOOD MATER SCI ENG, V13, P129, DOI 10.1080/17480272.2017.1384758; Passarini L, 2017, WOOD SCI TECHNOL, V51, P1291, DOI 10.1007/s00226-017-0963-0; Passarini L, 2015, WOOD SCI TECHNOL, V49, P1251, DOI 10.1007/s00226-015-0751-7; Penner E., 1965, HUMIDITY MOISTURE, V4, P245; Salin JG, 2008, DRY TECHNOL, V26, P560, DOI 10.1080/07373930801944747; Salmen L, 2018, CARBOHYD POLYM, V182, P15, DOI 10.1016/j.carbpol.2017.11.005; SIMPSON LA, 1991, WOOD SCI TECHNOL, V25, P301, DOI 10.1007/BF00225469; Thybring EE, 2017, CELLULOSE, V24, P2375, DOI 10.1007/s10570-017-1278-x; Tiemann HD, 1906, BULLETIN, V70; Tremblay C, 1996, WOOD SCI TECHNOL, V30, P361, DOI 10.1007/BF00223556; Wadso L, 2004, DRY TECHNOL, V22, P2427, DOI 10.1081/DRT-200032898; Weiss ND, 2018, CELLULOSE, V25, P3423, DOI 10.1007/s10570-018-1798-z; Zanotti JM, 2007, EUR PHYS J-SPEC TOP, V141, P227, DOI 10.1141/epjst/e2007-00039-5; Zelinka SL, 2016, WOOD SCI TECHNOL, V50, P443, DOI 10.1007/s00226-015-0788-7; Zelinka SL, 2012, THERMOCHIM ACTA, V533, P39, DOI 10.1016/j.tca.2012.01.015; Zimmer B, 1998, HOLZ ROH WERKST, V56, P252, DOI 10.1007/s001070050313	51	29	29	8	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225111	10.1371/journal.pone.0225111	http://dx.doi.org/10.1371/journal.pone.0225111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730652	Green Published, Green Submitted, gold			2022-12-26	WOS:000532809500024
J	Fukuda, T; Nagashima, S; Inatome, R; Yanagi, S				Fukuda, Toshifumi; Nagashima, Shun; Inatome, Ryoko; Yanagi, Shigeru			CAMDI interacts with the human memory-associated protein KIBRA and regulates AMPAR cell surface expression and cognition	PLOS ONE			English	Article							RECEPTORS; TRAFFICKING; PICK1	Little is known about the molecular mechanisms of cognitive deficits in psychiatric disorders. CAMDI is a psychiatric disorder-related factor, the deficiency of which in mice results in delayed neuronal migration and psychiatrically abnormal behaviors. Here, we found that CAMDI-deficient mice exhibited impaired recognition memory and spatial reference memory. Knockdown of CAMDI in hippocampal neurons increased the amount of internalized alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor (AMPAR) and attenuated the chemical long-term potentiation (LTP)-dependent cell surface expression of AMPAR. KIBRA was identified as a novel CAMDI-binding protein that retains AMPAR in the cytosol after internalization. KIBRA inhibited CAMDI-dependent Rab11 activation, thereby attenuating AMPAR cell surface expression. These results suggest that CAMDI regulates AMPAR cell surface expression during LTP. CAMDI dysfunction may partly explain the mechanism underlying cognitive deficits in psychiatric diseases.	[Fukuda, Toshifumi; Nagashima, Shun; Inatome, Ryoko; Yanagi, Shigeru] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Hachioji, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences	Fukuda, T; Yanagi, S (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Hachioji, Tokyo, Japan.	tfukuda@toyaku.ac.jp; syanagi@toyaku.ac.jp	Yanagi, Shigeru/AAU-9513-2020	Yanagi, Shigeru/0000-0002-1392-8663	Ministry of Education, Culture, Sports, Science, and Technology [18H04869]; Japan Society for the Promotion of Science [17K08793, 17H04053]; Takeda Science Foundation; AMED [JP17gm5010002]; Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); AMED; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (18H04869) and the Japan Society for the Promotion of Science (17K08793 to T.F. and 17H04053 to S.Y.). T.F. was supported by grant from the Takeda Science Foundation. S.Y. was supported by AMED under Grant Number JP17gm5010002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Harumitsu Inoue, Kaito Wakamatsu, Kengo Tsuboi for technical assistance. This study was supported in part by Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology and the Japan Society for the Promotion of Science (to T.F. and S.Y.). T.F. was supported by grant from the Takeda Science Foundation. S.Y. was supported by AMED under Grant Number JP17gm5010002.	Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Blanque A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00013; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fukuda T, 2017, CELL MOL LIFE SCI, V74, P3533, DOI 10.1007/s00018-017-2539-4; Fukuda T, 2016, EMBO REP, V17, P1785, DOI 10.15252/embr.201642416; Fukuda T, 2010, J BIOL CHEM, V285, P40554, DOI 10.1074/jbc.M110.179481; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; Hanley JG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00381; Hanley JG, 2010, BIOCHEM SOC T, V38, P460, DOI 10.1042/BST0380460; Heitz FD, 2016, NEUROBIOL LEARN MEM, V135, P100, DOI 10.1016/j.nlm.2016.07.028; Kos MZ, 2016, SCHIZOPHRENIA BULL, V42, P288, DOI 10.1093/schbul/sbv135; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; Mao LF, 2010, P NATL ACAD SCI USA, V107, P19038, DOI 10.1073/pnas.1013494107; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Ortega-Alonso A, 2017, SCHIZOPHRENIA BULL, V43, P1304, DOI 10.1093/schbul/sbx006; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Rubio MD, 2011, J NEUROSCI, V31, P1448, DOI 10.1523/JNEUROSCI.3294-10.2011; Tomppo L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030643; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008	32	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224967	10.1371/journal.pone.0224967	http://dx.doi.org/10.1371/journal.pone.0224967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2YM	31730661	Green Published, gold			2022-12-26	WOS:000532809500017
J	Rogers, LRK; Verlinde, M; Mias, GI				Rogers, Lavida R. K.; Verlinde, Madison; Mias, George I.			Gene expression microarray public dataset reanalysis in chronic obstructive pulmonary disease	PLOS ONE			English	Article							FALSE DISCOVERY RATE; COPD; KEGG; EXPOSURE; CELLS	Chronic obstructive pulmonary disease (COPD) was classified by the Centers for Disease Control and Prevention in 2014 as the 3rd leading cause of death in the United States (US). The main cause of COPD is exposure to tobacco smoke and air pollutants. Problems associated with COPD include under-diagnosis of the disease and an increase in the number of smokers worldwide. The goal of our study is to identify disease variability in the gene expression profiles of COPD subjects compared to controls, by reanalyzing pre-existing, publicly available microarray expression datasets. Our inclusion criteria for microarray datasets selected for smoking status, age and sex of blood donors reported. Our datasets used Affymetrix, Agilent microarray platforms (7 datasets, 1,262 samples). We re-analyzed the curated raw microarray expression data using R packages, and used Box-Cox power transformations to normalize datasets. To identify significant differentially expressed genes we used generalized least squares models with disease state, age, sex, smoking status and study as effects that also included binary interactions, followed by likelihood ratio tests (LRT). We found 3,315 statistically significant (Storey-adjusted q-value < 0.05) differentially expressed genes with respect to disease state (COPD or control). We further filtered these genes for biological effect using results from LRT q-value < 0.05 and model estimates' 10% two-tailed quantiles of mean differences between COPD and control), to identify 679 genes. Through analysis of disease, sex, age, and also smoking status and disease interactions we identified differentially expressed genes involved in a variety of immune responses and cell processes in COPD. We also trained a logistic regression model using the common array genes as features, which enabled prediction of disease status with 81.7% accuracy. Our results give potential for improving the diagnosis of COPD through blood and highlight novel gene expression disease signatures.	[Rogers, Lavida R. K.] Michigan State Univ, Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Rogers, Lavida R. K.; Verlinde, Madison; Mias, George I.] Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA; [Mias, George I.] Michigan State Univ, Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Mias, GI (corresponding author), Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA.; Mias, GI (corresponding author), Michigan State Univ, Biochem & Mol Biol, E Lansing, MI 48824 USA.	gmias@msu.edu		Mias, George/0000-0002-9083-1216; Rogers, Lavida/0000-0002-3764-899X	University Enrichment Fellowship at Michigan State University - Jean P. Schultz Endowed Biomedical Research Fund	University Enrichment Fellowship at Michigan State University - Jean P. Schultz Endowed Biomedical Research Fund	LRKR is funded through the University Enrichment Fellowship at Michigan State University. GIM is funded by Jean P. Schultz Endowed Biomedical Research Fund.	Agusti A, 2003, HYPOTHESIS DOES COPD; Amadou Boubacar H, 2017, EUROPEAN RESP J S61, V50; American Lung Association, 2019, CHRONIC OBSTRUCTIVE; Arimilli S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3565-1; Aryal S, 2013, TRANSL RES, V162, P208, DOI 10.1016/j.trsl.2013.04.003; Bahr TM, 2013, AM J RESP CELL MOL, V49, P316, DOI 10.1165/rcmb.2012-0230OC; Barnes PJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.76; Barnes PJ, 2016, SEX DIFFERENCES CHRO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Brooks LRK, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00392; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Centers for Disease Control and Prevention, 2019, CHRONIC OBSTRUCTIVE; Chang Y, 2016, GENOMICS, V107, P51, DOI 10.1016/j.ygeno.2016.01.004; Cheplygina V, 2018, IEEE J BIOMED HEALTH, V22, P1486, DOI 10.1109/JBHI.2017.2769800; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esteban C, 2015, EUROPEAN RESP J S59, V46; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Irizarry R., 2015, PH525X SERIES BIOMED; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Koo JB, 2016, J TOXICOL SCI, V41, P77, DOI 10.2131/jts.41.77; Laniado-Laborin R, 2009, INT J ENV RES PUB HE, V6, P209, DOI 10.3390/ijerph6010209; MacDonald J. W, 2018, AFFYCORETOOLS FUNCTI; Martin F, 2015, HUM EXP TOXICOL, V34, P1200, DOI 10.1177/0960327115600364; Mayo Clinic Staff, 2019, CHRONIC OBSTRUCTIVE; Mias G., 2018, MATH BIOINFORMATICS, P283; Mias G., 2018, MATH BIOINFORMATICS, P133; Mias GI, 2016, SCI REP-UK, V6, DOI 10.1038/srep37237; Mirza S, 2018, MAYO CLIN PROC, V93, P1488, DOI 10.1016/j.mayocp.2018.05.026; Obeidat M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140022; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Paul S., 2014, J CARCINOGENESIS MUT, V06; Paul S, 2011, INT J RADIAT BIOL, V87, P791, DOI 10.3109/09553002.2011.568574; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Quaderi SA, 2018, GLOB HEALTH EPIDEM G, V3, DOI 10.1017/gheg.2018.1; R Core Team, 2018, R LANG ENV STAT COMP; Rabe KF, 2017, LANCET, V389, P1931, DOI 10.1016/S0140-6736(17)31222-9; Reimer MK, 2011, CLIN VACCINE IMMUNOL, V18, P2050, DOI 10.1128/CVI.05275-11; Reinhold D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185682; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rutgers SR, 2000, THORAX, V55, P12, DOI 10.1136/thorax.55.1.12; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Sekine Y, 2012, EUR RESPIR J, V39, P1230, DOI 10.1183/09031936.00126011; Shi J, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3520581; Singh D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107381; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Storey J.D., 2019, R PACKAGE VERSION 22; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Vijayan VK, 2013, INDIAN J MED RES, V137, P251; Wolfram Research Inc, 2017, MATHEMATICA; World Health Organization, 2019, CHRONIC OBSTRUCTIVE; World Health Organization, 2017, CHRONIC OBSTRUCTIVE; Xie XJ, 2012, 2012 IEEE INTERNATIONAL TOPICAL MEETING ON MICROWAVE PHOTONICS (MWP), P88, DOI 10.1109/MWP.2012.6474061; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e	59	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224750	10.1371/journal.pone.0224750	http://dx.doi.org/10.1371/journal.pone.0224750			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730674	Green Published, Green Submitted, gold			2022-12-26	WOS:000532809500006
J	Liu, MH; Chen, CT; Chuang, LC; Lin, WM; Wan, GH				Liu, Ming-Hui; Chen, Chi-Tsung; Chuang, Li-Chuan; Lin, Wen-Ming; Wan, Gwo-Hwa			Removal efficiency of central vacuum system and protective masks to suspended particles from dental treatment	PLOS ONE			English	Article							AEROSOLS; BIOAEROSOL; EXPOSURE; HEALTH	Background High levels of suspended particulate matters (PMs) and bioaerosols are created by dental procedures. The present study aimed to evaluate the size and concentration of PMs produced by drilling and grinding teeth, and to assess the efficiency of central vacuum system and protective masks for the removal of PMs. Methods A total of 20 extracted permanent teeth were collected. A novel experimental system and particle counter were used to evaluate the PMs produced by dental procedures and the PM removal efficiency of a central vacuum system and surgical/N95 masks. Results The number concentration of total PMs produced by drilling and grinding teeth was significantly higher than the indoor background concentration. The average aerodynamic diameter of particle was generally less than 1 mu m. The average number concentration of ultrafine particles was 2.1x10(11) particles/m(3) during tooth drilling and grinding. The efficiency of the central vacuum system was 35.74% for PM >= 0.5 and 35.41% for PM10. For PM >= 0.5, the ratios of inside and outside masks were 0.8-1.34 without vacuum and 1.18-1.36 with vacuum. No difference was found with the use of surgical/N95 masks during dental therapy, with or without vacuum use. Conclusions High levels of PMs were found during tooth drilling and grinding procedures, especially among PM1. The PM removal efficiency of a central vacuum system and surgical/N95 masks were limited.	[Liu, Ming-Hui] Taoyuan Chang Gung Mem Hosp, Dept Pediat Dent, Taoyuan, Taiwan; [Chen, Chi-Tsung] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chuang, Li-Chuan] Linkou Chang Gung Mem Hosp, Dept Pediat Dent, Taoyuan, Taiwan; [Lin, Wen-Ming] Taoyuan Chang Gung Mem Hosp, Dept Gen Practice Dent, Taoyuan, Taiwan; [Wan, Gwo-Hwa] Chang Gung Univ, Coll Med, Dept Resp Therapy, Taoyuan, Taiwan; [Wan, Gwo-Hwa] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi, Taiwan; [Wan, Gwo-Hwa] Taipei Chang Gung Mem Hosp, Dept Obstet & Gynaecol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital	Wan, GH (corresponding author), Chang Gung Univ, Coll Med, Dept Resp Therapy, Taoyuan, Taiwan.; Wan, GH (corresponding author), Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi, Taiwan.; Wan, GH (corresponding author), Taipei Chang Gung Mem Hosp, Dept Obstet & Gynaecol, Taipei, Taiwan.	ghwan@mail.cgu.edu.tw		WAN, GWO-HWA/0000-0003-4149-1478	Chang Gung Medical Foundation, Taiwan [CMRPG5F0171, BMRP0441]	Chang Gung Medical Foundation, Taiwan	MHL received CMRPG5F0171 from the Chang Gung Medical Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GHW received BMRP0441 from the Chang Gung Medical Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zubaidi ES, 2017, INHAL TOXICOL, V29, P397, DOI 10.1080/08958378.2017.1369601; Bennett AM, 2000, BRIT DENT J, V189, P664, DOI 10.1038/sj.bdj.4800859a; BENTLEY CD, 1994, J AM DENT ASSOC, V125, P579, DOI 10.14219/jada.archive.1994.0093; Checchi L, 2005, J AM DENT ASSOC, V136, P877, DOI 10.14219/jada.archive.2005.0288; Darquenne C, 2012, J AEROSOL MED PULM D, V25, P140, DOI 10.1089/jamp.2011.0916; El-Din A. M. T., 1997, Eastern Mediterranean Health Journal, V3, P530; GRENIER D, 1995, APPL ENVIRON MICROB, V61, P3165, DOI 10.1128/AEM.61.8.3165-3168.1995; Harrel SK, 1996, J PERIODONTOL, V67, P28, DOI 10.1902/jop.1996.67.1.28; Harrel SK, 2004, J AM DENT ASSOC, V135, P429, DOI 10.14219/jada.archive.2004.0207; Hong YJ, 2015, J ENVIRON SCI HEAL A, V50, P1205, DOI 10.1080/10934529.2015.1055129; Hu SW, 2006, AM J IND MED, V49, P85, DOI 10.1002/ajim.20249; Lang A, 2018, J OCCUP ENVIRON HYG, V15, P441, DOI 10.1080/15459624.2018.1432864; Polednik B, 2014, ENVIRON RES, V134, P405, DOI 10.1016/j.envres.2014.06.027; Rengasamy Samy, 2009, J Int Soc Respir Prot, V26, P54; Rupf S, 2015, CLIN ORAL INVEST, V19, P823, DOI 10.1007/s00784-014-1300-8; Sotiriou M, 2008, ENVIRON MONIT ASSESS, V137, P351, DOI 10.1007/s10661-007-9770-7; Szymanska J, 2007, ANN AGR ENV MED, V14, P203; Van Landuyt KL, 2014, ACTA BIOMATER, V10, P365, DOI 10.1016/j.actbio.2013.09.044; WHO (World Health Organization), 2019, WHAT IS BURD OR DIS; Wu XM, 2012, ENVIRON SCI TECHNOL, V46, P12355, DOI 10.1021/es302140h	20	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225644	10.1371/journal.pone.0225644	http://dx.doi.org/10.1371/journal.pone.0225644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770413	Green Published, gold			2022-12-26	WOS:000533892300032
J	Mitting, RB; Ray, S; Raffles, M; Egan, H; Goley, P; Peters, M; Nadel, S				Mitting, Rebecca B.; Ray, Samiran; Raffles, Michael; Egan, Helen; Goley, Paul; Peters, Mark; Nadel, Simon			Improved oxygenation following methylprednisolone therapy and survival in paediatric acute respiratory distress syndrome	PLOS ONE			English	Article							ACUTE LUNG INJURY; INHALED NITRIC-OXIDE; CLINICAL-OUTCOMES; CHILDREN; ARDS; CORTICOSTEROIDS; VENTILATION; MORTALITY	Background Methylprednisolone remains a commonly used ancillary therapy for paediatric acute respiratory distress syndrome (PARDS), despite a lack of level 1 evidence to justify its use. When planning prospective trials it is useful to define response to therapy and to identify if there is differential response in certain patients, i.e. existence of 'responders' and 'non responders' to therapy. This retrospective, observational study carried out in 2 tertiary referral paediatric intensive care units aims to characterize the change in Oxygen Saturation Index, following the administration of low dose methylprednisolone in a cohort of patients with PARDS, to identify what proportion of children treated demonstrated response, whether any particular characteristics predict response to therapy, and to determine if a positive response to corticosteroids is associated with reduced Paediatric Intensive Care Unit mortality. Methods All patients who received prolonged, low dose, IV methylprednisolone for the specific indication of PARDS over a 5-year period (2011-2016) who met the PALICC criteria for PARDS at the time of commencement of steroid were included (n = 78).OSI was calculated four times per day from admission until discharge from PICU (or death). Patients with.20% improvement in their mean daily OSI within 72 hours of commencement of methylprednisolone were classified as 'responders'. Primary outcome measure was survival to PICU discharge. Results Mean OSI of the cohort increased until the day of steroid commencement then improved thereafter. 59% of patients demonstrated a response to steroids. Baseline characteristics were similar between responders and non-responders. Survival to PICU discharge was significantly higher in 'responders' (74% vs 41% OR 4.14(1.57-10.87) p = 0.004). On multivariable analysis using likely confounders, response to steroid was an independent predictor of survival to PICU discharge (p = 0.002). Non-responders died earlier after steroid administration than responders (p = 0.003). Conclusions An improvement in OSI was observed in 60% of patients following initiation of low dose methylprednisolone therapy in this cohort of patients with PARDS. Baseline characteristics fail to demonstrate a difference between responders and non-responders. A 20% improvement in OSI after commencement of methylprednisolone was independently predictive of survival, Prospective trials are needed to establish if there is a benefit from this therapy.	[Mitting, Rebecca B.; Raffles, Michael; Egan, Helen; Goley, Paul; Nadel, Simon] Imperial Coll Healthcare NHS Trust, Paediat Intens Care Unit, London, England; [Mitting, Rebecca B.; Ray, Samiran; Peters, Mark] Great Ormond St Hosp NHS Trust, Paediat & Neonatal Intens Care Unit, London, England; [Ray, Samiran; Peters, Mark] UCL Great Ormond St Inst Child Hlth, Resp Crit Care & Anaesthesia Sect, London, England	Imperial College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Mitting, RB (corresponding author), Imperial Coll Healthcare NHS Trust, Paediat Intens Care Unit, London, England.; Mitting, RB (corresponding author), Great Ormond St Hosp NHS Trust, Paediat & Neonatal Intens Care Unit, London, England.	rbprice@doctors.org.uk	Ray, Samiran/AAZ-4916-2020	Ray, Samiran/0000-0002-3738-4672; Mitting, Rebecca/0000-0002-0740-5153; Peters, Mark/0000-0003-3653-4808				Annane D, 2017, CRIT CARE MED, V45, P2078, DOI 10.1097/CCM.0000000000002737; Calfee CS, 2015, CHEST, V147, P1539, DOI 10.1378/chest.14-2454; DesPrez K, 2017, CHEST, V152, P1151, DOI 10.1016/j.chest.2017.08.002; Dowell JC, 2017, PEDIATR CRIT CARE ME, V18, P1019, DOI 10.1097/PCC.0000000000001305; Field-Ridley A, 2016, PEDIATR CRIT CARE ME, V17, P53, DOI 10.1097/PCC.0000000000000538; Gebistorf F, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002787.pub3; Goldman AP, 1997, CHEST, V112, P752, DOI 10.1378/chest.112.3.752; Goligher EC, 2015, AM J RESP CRIT CARE, V192, P1416, DOI 10.1164/rccm.201410-1832CP; Goligher EC, 2014, AM J RESP CRIT CARE, V190, P70, DOI 10.1164/rccm.201404-0688OC; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Khemani RG, 2015, PEDIATR CRIT CARE ME, V16, pS23, DOI 10.1097/PCC.0000000000000432; Khemani RG, 2015, INTENS CARE MED, V41, P94, DOI 10.1007/s00134-014-3486-2; Khemani RG, 2012, CRIT CARE MED, V40, P1309, DOI 10.1097/CCM.0b013e31823bc61b; Kimura D, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00031; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Luo L, 2017, CHEST, V151, P755, DOI 10.1016/j.chest.2016.09.004; Madotto F, 2018, INTENS CARE MED, V44, P564, DOI 10.1007/s00134-018-5152-6; Martinot A, 1997, PEDIATR PULM, V23, P314; Meduri GU, 2018, CRIT CARE MED, V46, P884, DOI 10.1097/CCM.0000000000003021; Meduri GU, 2016, INTENS CARE MED, V42, P829, DOI 10.1007/s00134-015-4095-4; MEDURI GU, 1991, CHEST, V100, P943, DOI 10.1378/chest.100.4.943; O'Brien S, 2017, PEDIATR CRIT CARE ME, V18, P1, DOI 10.1097/PCC.0000000000000976; O'Donnell DR, 2010, ACTA PAEDIATR, V99, P1186, DOI 10.1111/j.1651-2227.2010.01803.x; Onland W, 2017, COCHRAN DATABASE SYS, V1; Peters MJ, 2015, INTENS CARE MED, V41, P1685, DOI 10.1007/s00134-015-3963-2; Quasney MW, 2015, PEDIATR CRIT CARE ME, V16, pS118, DOI 10.1097/PCC.0000000000000438; Rowan CM, 2018, RESP CARE, V63, P404, DOI 10.4187/respcare.05765; Santschi M, 2010, PEDIATR CRIT CARE ME, V11, P681, DOI 10.1097/PCC.0b013e3181d904c0; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Tamburro RF, 2015, PEDIATR CRIT CARE ME, V16, pS61, DOI 10.1097/PCC.0000000000000434; Valentine SL, 2012, CRIT CARE MED, V40, P2883, DOI 10.1097/CCM.0b013e31825bc54d; Wong JJM, 2019, J INTENSIVE CARE MED, V34, P563, DOI 10.1177/0885066617705109; Yehya N, 2015, INTENS CARE MED, V41, P1658, DOI 10.1007/s00134-015-3953-4	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225737	10.1371/journal.pone.0225737	http://dx.doi.org/10.1371/journal.pone.0225737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770398	Green Published, gold			2022-12-26	WOS:000533892300035
J	Wanlapakorn, N; Wasitthankasem, R; Vichaiwattana, P; Auphimai, C; Yoocharoen, P; Vongpunsawad, S; Poovorawan, Y				Wanlapakorn, Nasamon; Wasitthankasem, Rujipat; Vichaiwattana, Preeyaporn; Auphimai, Chompoonut; Yoocharoen, Pornsak; Vongpunsawad, Sompong; Poovorawan, Yong			Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey	PLOS ONE			English	Article							MUMPS; IMMUNITY	Measles and rubella are highly contagious viral diseases transmitted via respiratory secretions and aerosolized droplets. Thailand has implemented universal vaccination against measles using the monovalent measles (M) or the trivalent measles-mumps-rubella (MMR) vaccine for the past 30 years. Nevertheless, incidence of measles and rubella remains in some parts of the country. We conducted a seroprevalence study to evaluate the antibodies to measles and rubella virus among Thais of all ages and to determine pre-existing immunity resulting from either vaccination and/or natural exposure. A total of 1,781 serum samples collected in 2014 was tested for IgG to measles and rubella virus by commercial enzyme-linked immunosorbent assays (ELISA). Percentages of individuals with protective antibody levels and the geometric mean concentrations (GMC) of IgG in each age group were analysed. The GMC of anti-measles IgG and anti-rubella IgG were 653.7 IU/L (95% confidence interval (CI); 555.9-751.4) and 39.5 IU/mL (95% CI;35.0-43.9), respectively. Thais between the ages of six months and 25 years did not demonstrate sufficient protective herd immunity for measles. This observation is consistent with the recent measles outbreaks in this age group. Lower prevalence of immunity against rubella was found among children ages 5-6 years who may not have completed vaccination as infants. Our findings identify gaps in rubella and measles immunity in specific age groups and support recommendations for catch-up MMR vaccination in individuals 30 years of age or younger.	[Wanlapakorn, Nasamon; Wasitthankasem, Rujipat; Vichaiwattana, Preeyaporn; Auphimai, Chompoonut; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok, Thailand; [Wanlapakorn, Nasamon] Chulalongkorn Univ, Div Acad Affairs, Fac Med, Bangkok, Thailand; [Wasitthankasem, Rujipat] Natl Sci & Technol Dev Agcy, Natl Biobank Thailand, Pathum Thani, Thailand; [Yoocharoen, Pornsak] Minist Publ Hlth, Div Vaccine Preventable Dis, Dept Dis Control, Nonthaburi, Thailand	Chulalongkorn University; Chulalongkorn University; National Science & Technology Development Agency - Thailand; Ministry of Public Health - Thailand	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok, Thailand.	Yong.P@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Yong/0000-0002-2337-6807	Health Systems Research Institute (HSRI), Thailand; Rachadapisek Sompote Fund of Chulalongkorn University; National Research Council of Thailand; Research Chair Grant from the National Science and Technology Development Agency [P-155004]; Center of Excellence in Clinical Virology, Chulalongkorn University; King Chulalongkorn Memorial Hospital	Health Systems Research Institute (HSRI), Thailand; Rachadapisek Sompote Fund of Chulalongkorn University; National Research Council of Thailand(National Research Council of Thailand (NRCT)); Research Chair Grant from the National Science and Technology Development Agency; Center of Excellence in Clinical Virology, Chulalongkorn University(Chulalongkorn University); King Chulalongkorn Memorial Hospital(Chulalongkorn University)	The main funder is The Health Systems Research Institute (HSRI), Thailand. YP received the award. The Rachadapisek Sompote Fund of Chulalongkorn University supported the postdoctoral fellowship position to Rujipat Wasitthankasem. This work was also supported by the National Research Council of Thailand, the Research Chair Grant from the National Science and Technology Development Agency (P-155004), the Center of Excellence in Clinical Virology, Chulalongkorn University and King Chulalongkorn Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amela C, 2003, EUR J EPIDEMIOL, V18, P71, DOI 10.1023/A:1022567811765; [Anonymous], 2018, VACC COV SURV 2561; [Anonymous], 2019, VACC PREV DIS MON SY; [Anonymous], GUID DIS SURV OUTBR; Bureau of Epidemiology Department of Disease Control Ministry of Public Health Thailand, 2018, SURV DAT RUB; Bureau of Epidemiology Department of Disease Control Ministry of Public Health Thailand, 2018, SURV DAT MEASL; Bureau of Epidemiology Department of Disease Control Ministry of Public Health Thailand, 2015, SURV DAT MEASL; Choisy M, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz030; Edirisuriya C, 2018, VACCINE, V36, P2794, DOI 10.1016/j.vaccine.2018.03.086; Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9; Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0; Meng QH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31283-y; Mollema L, 2014, EPIDEMIOL INFECT, V142, P1100, DOI 10.1017/S0950268813001532; Ngaovithunvong V, 2016, J INFECT DEV COUNTR, V10, P735, DOI 10.3855/jidc.7560; Pei L, 2017, VACCINE, V35, P7250, DOI 10.1016/j.vaccine.2017.11.012; Posuwan N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150499; Skendzel LP, 1996, AM J CLIN PATHOL, V106, P170; Tharmaphornpilas P, 2009, J HEALTH POPUL NUTR, V27, P80, DOI 10.3329/jhpn.v27i1.3320; Tomaskova H, 2018, CENT EUR J PUBL HEAL, V26, P22, DOI 10.21101/cejph.a5251; Wolfe S, 2015, EPIDEMIOLOGY PREVENT	20	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225606	10.1371/journal.pone.0225606	http://dx.doi.org/10.1371/journal.pone.0225606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770412	Green Published, gold			2022-12-26	WOS:000533892300029
J	Lin, Z; Xiong, YY; Xue, YB; Mao, MQ; Xiang, YX; He, YH; Rafique, F; Hu, H; Liu, JW; Li, X; Sun, LX; Huang, Z; Ma, J				Lin, Zhen; Xiong, Yingyuan; Xue, Yanbin; Mao, Meiqin; Xiang, Yixuan; He, Yehua; Rafique, Fatima; Hu, Hao; Liu, Jiawen; Li, Xi; Sun, Lingxia; Huang, Zhuo; Ma, Jun			Screening and characterization of long noncoding RNAs involved in the albinism of Ananas comosus var. bracteatus leaves	PLOS ONE			English	Article							BACILLUS-SUBTILIS; MESSENGER-RNA; TRANSCRIPTOME; INSIGHTS; CHLOROPHYLL; ARABIDOPSIS; MECHANISM; SYSTEM; MODULE; GREEN	Long noncoding RNAs (lncRNAs) have been reported to play key regulatory roles in plant growth, development, and biotic and abiotic stress physiology. Revealing the mechanism of lncRNA regulation in the albino portions of leaves is important for understanding the development of chimeric leaves in Ananas comosus var. bracteatus. In this study, a total of 3,543 candidate lncRNAs were identified, among which 1,451 were differentially expressed between completely green (CGr) and completely white (CWh) leaves. LncRNAs tend to have shorter transcripts, lower expression levels, and greater expression specificity than protein-coding genes. Predicted lncRNA targets were functionally annotated by the Gene Ontology (GO), Clusters of Orthologous Groups (COG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. A lncRNA-mRNA interaction network was constructed, and 36 target mRNAs related to chlorophyll metabolism were predicted to interact with 86 lncRNAs. Among these, 25 significantly differentially expressed lncRNAs putatively interacted with 16 target mRNAs. Based on an expression pattern analysis of the lncRNAs and their target mRNAs, the lncRNAs targeting magnesium chelatase subunit H (ChlH), protochlorophyllide oxidoreductase (POR), and heme o synthase (COX10) were suggested as key regulators of chlorophyll metabolism. This study provides the first lncRNA database for A. comosus var. bracteatus and contributes greatly to understanding the mechanism of epigenetic regulation of leaf albinism.	[Lin, Zhen; Xiong, Yingyuan; Xue, Yanbin; Mao, Meiqin; Xiang, Yixuan; Rafique, Fatima; Hu, Hao; Liu, Jiawen; Li, Xi; Sun, Lingxia; Huang, Zhuo; Ma, Jun] Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Sichuan, Peoples R China; [He, Yehua] South China Agr Univ, Hort Biotechnol Coll, Guangzhou, Guangdong, Peoples R China	Sichuan Agricultural University; South China Agricultural University	Ma, J (corresponding author), Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Sichuan, Peoples R China.	junma365@hotmail.com			National Natural Science Foundation of China [31570698, 31770743, 31300585]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, 31570698; 31770743; 31300585 (http://www.nsfc.gov.cn) to JM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11706; Alexa A, 2006, TOPGO ENRICHMENT ANA; APEL K, 1980, EUR J BIOCHEM, V111, P251, DOI 10.1111/j.1432-1033.1980.tb06100.x; Archipowa N, 2018, ANGEW CHEM INT EDIT, V57, P2682, DOI 10.1002/anie.201712729; Ariel F, 2015, TRENDS PLANT SCI, V20, P362, DOI 10.1016/j.tplants.2015.03.003; Bardou F, 2014, DEV CELL, V30, P166, DOI 10.1016/j.devcel.2014.06.017; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beckedorff Felipe C, 2013, Biosci Rep, V33, DOI 10.1042/BSR20130054; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Brown BM, 2004, BIOCHEMISTRY-US, V43, P13541, DOI 10.1021/bi048469k; Chao YH, 2019, PLANT MOL BIOL, V99, P219, DOI 10.1007/s11103-018-0813-y; Chekanova JA, 2015, CURR OPIN PLANT BIOL, V27, P207, DOI 10.1016/j.pbi.2015.08.003; Chen G, 2005, PLANT J, V41, P364, DOI 10.1111/j.1365-313X.2004.02308.x; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; Chen Y, 2015, PLANT CELL TISS ORG, V123, P283, DOI 10.1007/s11240-015-0831-2; Collins JL, 1960, PINEAPPLE BOT UTILIS; d'Eeckenbrugge Geo Coppens, 2003, P13, DOI 10.1079/9780851995038.0013; De Quattro C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11206-z; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Ghosh S, 2016, METHODS MOL BIOL, V1374, P339, DOI 10.1007/978-1-4939-3167-5_18; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Henriques R, 2017, NEW PHYTOL, V216, P854, DOI 10.1111/nph.14703; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jenkins AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1507-3; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34109; Li JW, 2015, BRIEF BIOINFORM, V16, P806, DOI 10.1093/bib/bbu048; Li X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169838; Lin CS, 2006, PLANT CELL TISS ORG, V86, P169, DOI 10.1007/s11240-006-9105-3; Liu J, 2015, PLANT BIOTECHNOL J, V13, P319, DOI 10.1111/pbi.12336; Ma JX, 2008, J CELL BIOCHEM, V105, P136, DOI 10.1002/jcb.21807; Ma J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119153; Malouf GG, 2015, MOL ONCOL, V9, P32, DOI 10.1016/j.molonc.2014.07.007; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mogi T, 2009, J BIOCHEM, V145, P669, DOI 10.1093/jb/mvp024; Montinola LR, 1991, PINA; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Necsulea A, 2014, NAT REV GENET, V15, P734, DOI 10.1038/nrg3802; Novikova Irina V, 2012, Bioarchitecture, V2, P189, DOI 10.4161/bioa.22592; Okazawa A, 2006, Z NATURFORSCH C, V61, P111; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Shafiq S, 2016, BBA-GENE REGUL MECH, V1859, P155, DOI 10.1016/j.bbagrm.2015.06.009; Sugimoto H, 2004, PLANT CELL PHYSIOL, V45, P985, DOI 10.1093/pcp/pch111; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; TAUSSIG SJ, 1988, J ETHNOPHARMACOL, V22, P191, DOI 10.1016/0378-8741(88)90127-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/nrg.2016.85; Us-Camas R, 2017, PLANT SCI, V263, P156, DOI 10.1016/j.plantsci.2017.07.010; WALKER CJ, 1991, P NATL ACAD SCI USA, V88, P5789, DOI 10.1073/pnas.88.13.5789; Walker CJ, 1997, BIOCHEM J, V327, P321; Wang B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11708; Wang CY, 2017, SCI REP-UK, V7, DOI 10.1038/srep43226; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang ZP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05377-y; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wei Q, 2013, PLANT CELL TISS ORG, V114, P1, DOI 10.1007/s11240-013-0298-y; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xiong YY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20261-z; Xu Jiajia, 2017, BMC Res Notes, V10, P108, DOI 10.1186/s13104-016-2367-x; Yuan JP, 2018, PLANT J, V93, P814, DOI 10.1111/tpj.13804; Zhou BL, 2018, NUCLEIC ACIDS RES, V46, pD100, DOI 10.1093/nar/gkx677; Zhu LX, 2017, PLANT MOL BIOL, V93, P579, DOI 10.1007/s11103-017-0583-y	73	5	5	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225602	10.1371/journal.pone.0225602	http://dx.doi.org/10.1371/journal.pone.0225602			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756232	Green Published, gold, Green Submitted			2022-12-26	WOS:000533889300047
J	Wexler, C; Maloba, M; Brown, M; Mabachi, N; Goggin, K; Gautney, B; Odeny, B; Finocchario-Kessler, S				Wexler, Catherine; Maloba, May; Brown, Melinda; Mabachi, Natabhona; Goggin, Kathy; Gautney, Brad; Odeny, Beryne; Finocchario-Kessler, Sarah			Factors affecting acceptance of at-birth point of care HIV testing among providers and parents in Kenya: A qualitative study	PLOS ONE			English	Article							INFANT DIAGNOSIS SERVICES; IMPACT; GAPS	Background At-birth and point-of-care (POC) HIV testing are emerging strategies to streamline infant HIV diagnosis and expedite ART initiation for HIV-positive infants. The purpose of this qualitative study was to evaluate factors influencing the provision and acceptance of at-birth POC testing among both HIV care providers and parents of HIV-exposed infants in Kenya. Methods We conducted semi-structured interviews with 26 HIV care providers and 35 parents of HIVexposed infants (including 23 mothers, 6 fathers, and 3 mother-father pairs) at four study hospitals prior to POC implementation. An overview of best available evidence related to POC was presented to participants prior to each interview. Interviews probed about standard EID services, perceived benefits and risk of at-birth and POC testing, and suggested logistics of providing at-birth and POC. Interviews were audio recorded, translated (if necessary), and transcribed verbatim. Using the Transdisciplinary Model of Evidence Based Practice to guide analysis, transcripts were coded based on a priori themes related to environmental context, patient characteristics, and resources. Results Most providers (24/26) and parents (30/35) held favorable attitudes towards at-birth POC testing. The potential for earlier results to improve infant care and reduce parental anxiety drove preferences for at-birth POC testing. Parents with unfavorable views towards at-birth POC testing preferred standard testing at 6 weeks so that mothers could heal after birth and have time to bond with their newborn before-possibly-learning that their child was HIV-positive. Providers identified lack of resources (shortage of staff, expertise, and space) as a barrier. Discussion While overall acceptability of at-birth POC testing among HIV care providers and parents of HIV-exposed infants may facilitate uptake, barriers remain. Applying a task-shifting approach to implementation and ensuring providers receive training on at-birth POC testing may mitigate provider-related challenges. Comprehensive counseling throughout the antenatal and postpartum periods may mitigate patient-related challenges.	[Wexler, Catherine; Brown, Melinda; Mabachi, Natabhona; Odeny, Beryne; Finocchario-Kessler, Sarah] Univ Kansas, Med Ctr, Dept Family Med, Kansas City, KS 66103 USA; [Maloba, May] Global Hlth Innovat, Nairobi, Kenya; [Goggin, Kathy] Childrens Mercy Kansas City, Hlth Serv & Outcomes Res, Kansas City, KS USA; [Goggin, Kathy] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Gautney, Brad] Global Hlth Innovat, Dallas, TX USA	University of Kansas; University of Kansas Medical Center; University of Missouri System; University of Missouri Kansas City	Wexler, C (corresponding author), Univ Kansas, Med Ctr, Dept Family Med, Kansas City, KS 66103 USA.	cwexler@kumc.edu			National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health [3R01HD076673-04S2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076673] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this publication was supported by the National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health under award number 3R01HD076673-04S2, awarded to FinoccharioKessler at the University of Kansas Medical Center. A percent of each author's effort was supported by this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons GA, 2016, JAIDS-J ACQ IMM DEF, V72, pS202, DOI 10.1097/QAI.0000000000001064; Bhairavabhotla R, 2018, POINT OF CARE TESTIN; Bhardwaj S, 2015, CURR HIV-AIDS REP, V12, P246, DOI 10.1007/s11904-015-0260-1; Burmen B, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0186-3; Cawley C, 2017, HEALTH POLICY PLANN, V32, P1316, DOI 10.1093/heapol/czx091; Deller B, 2015, INT J GYNECOL OBSTET, V130, pS25, DOI 10.1016/j.ijgo.2015.03.005; Dunning L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189226; Dunning L, 2017, PEDIATR INFECT DIS J, V36, P1159, DOI 10.1097/INF.0000000000001677; Edwards N, 2017, WORLDV EVID-BASED NU, V14, P492, DOI 10.1111/wvn.12247; Finocchario-Kessler S, 2018, LANCET HIV, V5, pE696, DOI 10.1016/S2352-3018(18)30245-5; Gill MM, 2017, AIDS RES TREAT, V2017, DOI 10.1155/2017/2572594; Goggin K, 2016, AIDS BEHAV, V20, P2141, DOI 10.1007/s10461-016-1404-z; Gupta S, 2016, S AFR J HIV MED, V17, DOI 10.4102/sajhivmed.v17i1.459; Gupta S, 2013, JAIDS-J ACQ IMM DEF, V62, pE87, DOI 10.1097/QAI.0b013e31827e4992; Hassan AS, 2012, AIDS BEHAV, V16, P5, DOI 10.1007/s10461-010-9877-7; Hoffmann G, 2016, LABORATORY DIAGNOSTIC PATHWAYS: CLINICAL MANUAL OF SCREENING METHODS AND STEPWISE DIAGNOSIS, 2ND EDITION, P3; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Hsiao NY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152672; Jani IV, 2018, AIDS, V32, P1453, DOI [10.1097/QAD.0000000000001846, 10.1097/qad.0000000000001846]; JANI IV, 2014, J ACQ IMMUN DEF SYND, V67, pE, DOI DOI 10.1097/QAI; Jordan PJ, BARRIERS IMPLEMENTIN; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V70, P99, DOI 10.1097/QAI.0000000000000692; Medley AM, 2009, QUAL HEALTH RES, V19, P1744, DOI 10.1177/1049732309353417; Meggi B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.019834; Meyer DZ, 2009, FIELD METHOD, V21, P91, DOI 10.1177/1525822X08323985; Ministry of Health, 2018, NAT POINT CAR TEST I; Ministry of Health, 2017, KEN TASK SHAR POL GU; Ministry of Health, 2016, GUID US ANT DRUGS TR; Mulenga Chisomo, 2017, Curationis, V40, P1, DOI 10.4102/curationis.v40i1.1656; Organization WH, 2019, HLTH WORKF CRIS 2019; Ose S.O., 2016, J APPL SOCIAL SCI, V10, P147, DOI [10.1177/1936724416664948, DOI 10.1177/1936724416664948]; PARKER LA, 2015, J ACQ IMMUN DEF SYND, V69, pE2, DOI DOI 10.1097/QAI; PEPFAR, 2018, PEPFAR 2018 COUNTR O; Pricilla RA, 2018, MATERN CHILD HLTH J, V22, P1685, DOI 10.1007/s10995-018-2612-0; Rogers AJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0936-6; Sabi I, 2019, CLIN INFECT DIS, V68, P615, DOI 10.1093/cid/ciy538; Satterfield JM, 2009, MILBANK Q, V87, P368, DOI 10.1111/j.1468-0009.2009.00561.x; Smith J, 2016, J ASSOC NURSE AIDS C, V27, P322, DOI 10.1016/j.jana.2016.01.005; Spring B, 2010, CORSINI ENCY PSYCHOL; Technau KG, 2017, LANCET HIV, V4, pE442, DOI 10.1016/S2352-3018(17)30097-8; Ujiji OA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-151; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wachira J, 2014, INT J QUAL HEALTH C, V26, P190, DOI 10.1093/intqhc/mzu004; Wakaba M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-6; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; Wexler C, 2018, PREDICTORS TIMELY AR; Wexler C, EVALUATING RETENTION; Wexler C, 2019, AIDS BEHAV, V23, P1073, DOI 10.1007/s10461-018-2363-3; Wexler C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181005	49	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225642	10.1371/journal.pone.0225642	http://dx.doi.org/10.1371/journal.pone.0225642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QA	31756242	gold, Green Submitted, Green Published			2022-12-26	WOS:000533889300050
J	Huff, RM; Pitts, RJ				Huff, Robert Mark; Pitts, R. Jason			An odorant receptor from Anopheles gambiae that demonstrates enantioselectivity to the plant volatile, linalool	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL RESPONSE; DIPTERA-CULICIDAE; FLORAL SCENT; MOSQUITO; ATTRACTION; PREFERENCES; ENANTIOMERS; OLFACTION; NEURONS; CULEX	Insects express chemical receptors within sensory neurons that are activated by specific cues in the environment, thereby influencing the acquisition of critical resources. A significant gap in our current understanding of insect chemical ecology is defining the molecular mechanisms that underlie sensitivity to plant-emitted volatiles. Linalool is a commonly-occurring monoterpene that has various effects on insect behavior, either acting as an attractant or a repellent, and existing in nature as one of two possible stereoisomers, (R)(-)-linalool and (S)-(+)-linalool. In this study, we have used a cell-based functional assay to identify linalool and structurally-related compounds as ligands of Odorant receptor 29, a labellum-expressed receptor in the malaria vector mosquito, Anopheles gambiae (AgamOr29). While (R)-(-)-linalool activates Aga-mOr29, a mixture of the (R) and (S) stereoisomers activates the receptor with higher potency, implying enantiomeric selectivity. Orthologs of Or29 are present in the genomes of Anophelines within the Cellia subgenus. The conservation of this receptor across Anopheline lineages suggests that this ecologically important compound might serve as an attraction cue for nectar-seeking mosquitoes. Moreover, the characterization of a mosquito terpene receptor could serve as a foundation for future ligand-receptor studies of plant volatiles and for the discovery of compounds that can be integrated into push-pull vector control strategies.	[Huff, Robert Mark; Pitts, R. Jason] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Baylor University	Pitts, RJ (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	Jason_Pitts@Baylor.edu		Pitts, Jason/0000-0002-4863-9634; Huff, Robert/0000-0002-4472-8656	Baylor University startup funds	Baylor University startup funds	This work was funded by Baylor University startup funds to the Principal Investigator to RJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SA, 2005, J AM MOSQUITO CONTR, V21, P268, DOI 10.2987/8756-971X(2005)21[268:EOOSAO]2.0.CO;2; Bedoukian RH, 2005, U.S. Patent Application, Patent No. 20050090563; Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; BYERS JA, 1992, J CHEM ECOL, V18, P2385, DOI 10.1007/BF00984957; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Carroll MJ, 2006, J CHEM ECOL, V32, P1911, DOI 10.1007/s10886-006-9117-9; Chaiphongpachara T, 2018, TROP BIOMED, V35, P653; Chen ZY, 2015, ACTA TROP, V146, P81, DOI 10.1016/j.actatropica.2015.03.010; Clements AN., 1992, BIOL MOSQUITOES DEV; Degenhardt J, 2003, CURR OPIN BIOTECH, V14, P169, DOI 10.1016/S0958-1669(03)00025-9; Dekel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37330; FOSTER WA, 1994, J AM MOSQUITO CONTR, V10, P288; Freeman EG, 2014, P NATL ACAD SCI USA, V111, P1598, DOI 10.1073/pnas.1311724111; Gaire S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40275-5; Gillij YG, 2008, BIORESOURCE TECHNOL, V99, P2507, DOI 10.1016/j.biortech.2007.04.066; Gouagna LC, 2010, J VECTOR ECOL, V35, P267, DOI 10.1111/j.1948-7134.2010.00082.x; Harbach RE, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P3, DOI 10.5772/54695; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jarvis GE, 2016, J PHARMACOL EXP THER, V356, P549, DOI 10.1124/jpet.115.230011; Jonsson M, 1999, PHYSIOL ENTOMOL, V24, P377, DOI 10.1046/j.1365-3032.1999.00154.x; Jun HJ, 2014, J LIPID RES, V55, P1098, DOI 10.1194/jlr.M045807; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; Koulivand PH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/681304; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; Lopez V, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00280; Lutz EK, 2017, CURR OPIN INSECT SCI, V20, P75, DOI 10.1016/j.cois.2017.03.002; Malo EA, 2004, ANN ENTOMOL SOC AM, V97, P1273, DOI 10.1603/0013-8746(2004)097[1273:ASAERO]2.0.CO;2; McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964; Menger DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123415; Milanos S, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00046; Muller GC, 2008, J AM MOSQUITO CONTR, V24, P150, DOI 10.2987/8756-971X(2008)24[150:IPAMAS]2.0.CO;2; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Nikbakhtzadeh MR, 2014, J VECTOR ECOL, V39, P372, DOI 10.1111/jvec.12113; Norris LC, 2015, J VECTOR ECOL, V40, P16, DOI 10.1111/jvec.12128; Nyasembe VO, 2012, PARASITE VECTOR, V5, P1; Obermayr U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134063; Omondi AB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46220-w; Otienoburu PE, 2012, J CHEM ECOL, V38, P873, DOI 10.1007/s10886-012-0150-6; Pajaro-Castro N, 2017, MOLECULES, V22, DOI 10.3390/molecules22122052; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; PICHERSKY E, 1995, ARCH BIOCHEM BIOPHYS, V316, P803, DOI 10.1006/abbi.1995.1107; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Re L, 2000, PHARMACOL RES, V42, P177, DOI 10.1006/phrs.2000.0671; Reisenman CE, 2010, P ROY SOC B-BIOL SCI, V277, P2371, DOI 10.1098/rspb.2010.0163; Riffell JA, 2011, INTEGR COMP BIOL, V51, P781, DOI 10.1093/icb/icr094; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Rostelien T, 2005, CHEM SENSES, V30, P443, DOI 10.1093/chemse/bji039; Saveer AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23987-y; Sugawara Y, 2000, CHEM SENSES, V25, P77, DOI 10.1093/chemse/25.1.77; Suh E, 2014, CURR OPIN INSECT SCI, V6, P86, DOI 10.1016/j.cois.2014.10.006; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Takken W, 2010, MALARIA J, V9, P2010, DOI [10.1186/1475-2875-9-s2-i16, DOI 10.1186/1475-2875-9-S2-I16]; Ulland S, 2006, CHEM SENSES, V31, P325, DOI 10.1093/chemse/bjj036; Yu BT, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1212-8; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	60	10	10	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225637	10.1371/journal.pone.0225637	http://dx.doi.org/10.1371/journal.pone.0225637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751420	Green Published, gold			2022-12-26	WOS:000533886900084
J	Tavoian, D; Arnold, WD; Mort, SC; de Lacalle, S				Tavoian, Dallin; Arnold, W. David; Mort, Sophia C.; de Lacalle, Sonsoles			Sex differences in body composition but not neuromuscular function following long-term, doxycycline-induced reduction in circulating levels of myostatin in mice	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; UNIT NUMBER ESTIMATION; AGE-RELATED-CHANGES; CONTRACTILE PROPERTIES; PHYSICAL-DISABILITY; PROLONGED ABSENCE; DEFICIENT MICE; GROWTH; INHIBITION; INCREASES	Age-related declines in muscle function result from changes in muscle structure and contractile properties, as well as from neural adaptations. Blocking myostatin to drive muscle growth is one potential therapeutic approach. While the effects of myostatin depletion on muscle characteristics are well established, we have very little understanding of its effects on the neural system. Here we assess the effects of long-term, post-developmental myostatin reduction on electrophysiological motor unit characteristics and body composition in aging mice. We used male (N = 21) and female (N = 26) mice containing a tetracyclineinducible system to delete the myostatin gene in skeletal muscle. Starting at 12 months of age, half of the mice were administered doxycycline (tetracycline) through their chow for one year. During that time we measured food intake, body composition, and hindlimb electromyographic responses. Doxycycline-induced myostatin reduction had no effect on motor unit properties for either sex, though significant age-dependent declines in motor unit number occurred in all mice. However, treatment with doxycycline induced different changes in body composition between sexes. All female mice increased in total, lean and fat mass, but doxycycline-treated female mice experienced a significantly larger increase in lean mass than controls. All male mice also increased total and lean mass, but administration of doxycycline had no effect. Additionally, doxycycline-treated male mice maintained their fat mass at baseline levels, while the control group experienced a significant increase from baseline and compared to the doxycycline treated group. Our results show that longterm administration of doxycycline results in body composition adaptations that are distinctive between male and female mice, and that the effects of myostatin reduction are most pronounced during the first three months of treatment. We also report that age-related changes in motor unit number are not offset by reduced myostatin levels, despite increased lean mass exhibited by female mice.	[Tavoian, Dallin; Mort, Sophia C.] Ohio Univ, Program Translat Biomed Sci, Athens, OH 45701 USA; [Arnold, W. David] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Arnold, W. David] Ohio State Univ, Dept PM&R & Neurosci, Columbus, OH 43210 USA; [Arnold, W. David] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [de Lacalle, Sonsoles] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA; [de Lacalle, Sonsoles] Calif State Univ Channel Isl, Dept Hlth Sci, One Univ Dr, Camarillo, CA 93012 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio University; California State University System; California State University Channel Islands	de Lacalle, S (corresponding author), Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA.; de Lacalle, S (corresponding author), Calif State Univ Channel Isl, Dept Hlth Sci, One Univ Dr, Camarillo, CA 93012 USA.	sdelacalle@mac.com	Mort, Sophia C./AAM-5763-2020; Tavoian, Dallin/AAZ-6910-2021	Mort, Sophia C./0000-0002-4659-0574; Arnold, W. David/0000-0001-9889-7036	National Institutes of Health [R03AG050877]; Vision 2020 Award from the Osteopathic Heritage Foundations; NATIONAL INSTITUTE ON AGING [R03AG050877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision 2020 Award from the Osteopathic Heritage Foundations; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially funded through the National Institutes of Health Grant number R03AG050877 to WDA, and a Vision 2020 Award from the Osteopathic Heritage Foundations to SL, SCM and DT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; [Anonymous], CONS CHOOS CONTR; Arnold WD, 2014, ANN CLIN TRANSL NEUR, V1, P34, DOI 10.1002/acn3.23; Arnold WD, 2015, JOVE-J VIS EXP, V103, P1; Burgess K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017090; Byron CD, 2006, ARCH ORAL BIOL, V51, P396, DOI 10.1016/j.archoralbio.2005.09.006; Camporez JPG, 2016, P NATL ACAD SCI USA, V113, P2212, DOI 10.1073/pnas.1525795113; Chabi B, 2016, EXP GERONTOL, V78, P23, DOI 10.1016/j.exger.2016.01.016; Chatzispyrou IA, 2015, CANCER RES, V75, P4446, DOI 10.1158/0008-5472.CAN-15-1626; Chen L, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-74; Clark BC, 2012, NUTRITION, V28, P495, DOI 10.1016/j.nut.2011.12.002; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Elashry MI, 2011, J ANAT, V218, P173, DOI 10.1111/j.1469-7580.2010.01327.x; Falke LL, 2017, J CELL COMMUN SIGNAL, V11, P205, DOI 10.1007/s12079-017-0390-x; Gay S, 2012, MUSCLE NERVE, V45, P698, DOI 10.1002/mus.23242; Gooch CL, 2014, MUSCLE NERVE, V50, P884, DOI 10.1002/mus.24442; GRIMBY G, 1983, CLIN PHYSIOL, V3, P209, DOI 10.1111/j.1475-097X.1983.tb00704.x; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Hennebry A, 2009, AM J PHYSIOL-CELL PH, V296, pC525, DOI 10.1152/ajpcell.00259.2007; Hepple RT, 2016, J PHYSIOL-LONDON, V594, P1965, DOI 10.1113/JP270561; Jackson MF, 2012, J ENDOCRINOL, V213, P263, DOI 10.1530/JOE-11-0455; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Kahlert S, 1997, BIOCHEM BIOPH RES CO, V232, P373, DOI 10.1006/bbrc.1997.6223; Latres E, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0060-8; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Leveille SG, 2000, J GERONTOL B-PSYCHOL, V55, pS41; Lozier NR, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01418; Luger A-L, 2018, INT J MOL SCI, V19, P17; Luo ZB, 2019, J SCI FOOD AGR, V99, P6788, DOI 10.1002/jsfa.9962; Martinez Bruno Prata, 2016, Rev. bras. geriatr. gerontol., V19, P257, DOI 10.1590/1809-98232016019.140228; Matsakas A, 2009, NEUROMUSCULAR DISORD, V19, P489, DOI 10.1016/j.nmd.2009.06.367; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V285, pE82, DOI 10.1152/ajpendo.00275.2002; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V284, pE377, DOI 10.1152/ajpendo.00282.2002; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mendias CL, 2015, AGING CELL, V14, P704, DOI 10.1111/acel.12339; Metter EJ, 2005, J GERONTOL A-BIOL, V60, P840, DOI 10.1093/gerona/60.7.840; Mosler S, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.262; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; Murtagh KN, 2004, AM J PUBLIC HEALTH, V94, P1406, DOI 10.2105/AJPH.94.8.1406; Oldham JM, 2009, J PHYSIOL-LONDON, V587, P669, DOI 10.1113/jphysiol.2008.161521; Oman D, 1999, AM J EPIDEMIOL, V150, P834; Palmer AJ, 2009, ENDOCRINOLOGY, V150, P1353, DOI 10.1210/en.2008-1199; Personius KE, 2010, J APPL PHYSIOL, V109, P886, DOI 10.1152/japplphysiol.00300.2010; Piasecki M, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12987; Purves D., 2001, NEUROSCIENCE; Rao PC, 2009, DEV NEUROBIOL, V69, P401, DOI 10.1002/dneu.20714; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Russ DW, 2012, J CACHEXIA SARCOPENI, V3, P95, DOI 10.1007/s13539-011-0054-2; Shafiee G, 2017, J DIABETES METAB DIS, V16, P10; Shefner JM, 2001, CLIN NEUROPHYSIOL, V112, P955, DOI 10.1016/S1388-2457(01)00520-X; Sheth KA, 2018, NEUROBIOL AGING, V67, P128, DOI 10.1016/j.neurobiolaging.2018.03.016; Siriett V, 2007, MOL THER, V15, P1463, DOI 10.1038/sj.mt.6300182; Siriett V, 2006, J CELL PHYSIOL, V209, P866, DOI 10.1002/jcp.20778; Smith GI, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-11; TOTH MJ, 2001, AM J PHYSIOL-ENDOC M, V280, pE49, DOI DOI 10.1152/AJPENDO.2001.280.3.E496; Ueberschlag-Pitiot V, 2017, AM J PHYSIOL-ENDOC M, V313, pE12, DOI 10.1152/ajpendo.00446.2016; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; Wang N, 2019, INT J COOP INF SYST, V28, DOI 10.1142/S0218843019500072; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Welle S, 2009, AM J PHYSIOL-ENDOC M, V297, pE935, DOI 10.1152/ajpendo.00179.2009; White TA, 2014, GERONTOLOGY, V60, P289, DOI 10.1159/000356740; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wilkinson DJ, 2018, AGEING RES REV, V47, P123, DOI 10.1016/j.arr.2018.07.005; Williams SH, 2015, PLOS ONE, V10, P12; Wu LF, 2018, J CELL MOL MED, V22, P1329, DOI 10.1111/jcmm.13438; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	77	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225283	10.1371/journal.pone.0225283	http://dx.doi.org/10.1371/journal.pone.0225283			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751423	gold, Green Published			2022-12-26	WOS:000533886900042
J	Wang, WT; Liu, Q; Wang, Y; Piao, HL; Li, B; Zhu, ZC; Li, D; Wang, TC; Xu, RH; Liu, KX				Wang, Weitie; Liu, Qing; Wang, Yong; Piao, Hulin; Li, Bo; Zhu, Zhicheng; Li, Dan; Wang, Tiance; Xu, Rihao; Liu, Kexiang			Verification of hub genes in the expression profile of aortic dissection	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RESPONSES PREVAIL; PROLIFERATION; INFLAMMATION	Background To assess the mRNA expression profile and explore the hub mRNAs and potential molecular mechanisms in the pathogenesis of human thoracic aortic dissection (TAD). Methodology mRNA microarray expression signatures of TAD tissues (n = 6) and non-TAD tissues (NT; n = 6) were analyzed by an Arraystar human mRNA microarray. Real-time PCR (qRT-PCR) was used to validate the results of the mRNA microarray. Bioinformatic tools, including Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis, were utilized. Protein-protein interaction (PPI) networks were constructed based on data from the STRING database. Molecular Complex Detection (MCODE) and cytoHubba analyses were used to predict the strongest hub gene and pathway. Results The top 10 hub genes were CDK1, CDC20, CCNB2, CCNB1, MAD2L1, AURKA, C3AR1, NCAPG, CXCL12 and ASPM, which were identified from the PPI network. Module analysis revealed that TAD was associated with the cell cycle, oocyte meiosis, the p53 signaling pathway, and progesterone-mediated oocyte maturation. The qRT-PCR results showed that the expression of all hub genes was significantly increased in TAD samples (p < 0.05). Immunostaining of Ki-67 and CDK1 showed a high proliferation state and high expression in TAD, respectively. Conclusions CDK1 could be used as a potential diagnostic biomarker and therapeutic target of TAD.	[Wang, Weitie; Wang, Yong; Piao, Hulin; Li, Bo; Zhu, Zhicheng; Li, Dan; Wang, Tiance; Xu, Rihao; Liu, Kexiang] Second Hosp Jilin Univ, Dept Cardiovasc Surg, Changchun, Jilin, Peoples R China; [Liu, Qing] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Liu, Qing] Univ Tokyo, Fac Med, Tokyo, Japan	Jilin University; University of Tokyo; University of Tokyo	Liu, KX (corresponding author), Second Hosp Jilin Univ, Dept Cardiovasc Surg, Changchun, Jilin, Peoples R China.	kxliu64@hotmail.com			Bethune Medical Department Doctoral Postgraduate Excellent Talents Training Program Project of Jilin Province, China [20181201]; Project of Direct Health Project of Jilin Provincial, China [20180101, 20170101]	Bethune Medical Department Doctoral Postgraduate Excellent Talents Training Program Project of Jilin Province, China; Project of Direct Health Project of Jilin Provincial, China	This work was supported by the project supported by the Bethune Medical Department Doctoral Postgraduate Excellent Talents Training Program Project of Jilin Province, China (Grant no. 20181201), the Project of Direct Health Project of Jilin Provincial, China (Grant no. 20170101), and Project of Direct Health Project of Jilin Provincial, China (Grant no. 20180101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Z, 2017, HEART VESSELS, V32, P1523, DOI 10.1007/s00380-017-1054-8; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barchiesi F, 2006, CIRC RES, V99, P266, DOI 10.1161/01.RES.0000233318.85181.2e; Berger T, 2019, EUR J CARDIO-THORAC, V7; Brown NR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7769; Cheng JC, 2018, J THORAC DIS, V10, DOI 10.21037/jtd.2018.07.75; Del Porto F, 2010, ANN MED, V42, P622, DOI 10.3109/07853890.2010.518156; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Fry JL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002384; Gawinecka J, 2017, SWISS MED WEEKLY, V147, P14489; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Herman AB, 2017, CLIN SCI, V131, P2687, DOI 10.1042/CS20171373; Hsieh TC, 2010, INT J MOL MED, V26, P741, DOI 10.3892/ijmm_00000521; Huang DW, 2017, GENOME BIOL, V9; Iida Y, 2018, ANN VASC SURG, V48, P195, DOI 10.1016/j.avsg.2017.10.005; Kimura N, 2017, EUR J CARDIO-THORAC, V52, P810, DOI 10.1093/ejcts/ezx095; Li Y, 2018, MOL MED REP, V18, P3167, DOI 10.3892/mmr.2018.9308; Li ZY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9482726; Li ZZ, 2017, SCI CHINA LIFE SCI, V60, P57, DOI 10.1007/s11427-016-0333-3; Liao WL, 2015, J THORAC CARDIOV SUR, V150, P1292, DOI 10.1016/j.jtcvs.2015.08.010; Lindeman JHN, 2008, CLIN SCI, V114, P687, DOI 10.1042/CS20070352; Luo F, 2009, AGEING RES REV, V8, P31, DOI 10.1016/j.arr.2008.08.001; Mallat Z, 2016, ARTERIOSCL THROM VAS, V36, P1742, DOI 10.1161/ATVBAHA.116.307909; McCoy Jr TH, 2018, JBMR PLUS, V3, P23; Nienaber CA, 2015, LANCET, V385, P800, DOI 10.1016/S0140-6736(14)61005-9; Ohno-Urabe S, 2018, J AM HEART ASSOC, V17; Reinstein E, 2013, EUR J HUM GENET, V21, P233, DOI 10.1038/ejhg.2012.132; Schonbeck U, 2002, AM J PATHOL, V161, P499, DOI 10.1016/S0002-9440(10)64206-X; Schulte S, 2008, AM J PATHOL, V172, P1500, DOI 10.2353/ajpath.2008.070776; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Wang FY, 2015, MOL VIS, V21, P194; Wei XL, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0588-0; Weis-Muller BT, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-29; Zhao ZM, 2019, AM J TRANSL RES, V11, P509; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	36	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0224922	10.1371/journal.pone.0224922	http://dx.doi.org/10.1371/journal.pone.0224922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751374	gold, Green Published			2022-12-26	WOS:000533886900021
J	Lopes, E; Conceicao, T; Poirel, L; de Lencastre, H; Aires-de-Sousa, M				Lopes, Elizeth; Conceicao, Teresa; Poirel, Laurent; de Lencastre, Herminia; Aires-de-Sousa, Marta			Epidemiology and antimicrobial resistance of methicillin-resistant Staphylococcus aureus isolates colonizing pigs with different exposure to antibiotics	PLOS ONE			English	Article							GENES; CC398; BACTERIA; VARIANT; CLONES	Background In 2016, very high rates of methicillin-resistant Staphylococcus aureus (MRSA)-ST398 (99%) were found in Portuguese pig farms that used colistin, amoxicillin, and zinc oxide as feed additives. Since then, farms A and B banned the use of colistin, and farm C banned the use of both antibiotics. Objective The aim of the present study was to evaluate the impact of the ban of colistin and amoxicillin on pig MRSA carriage rates, clonal types and antimicrobial resistance, compared to the results obtained in 2016. Methods In 2018, 103 pigs (52 from farm B using amoxicillin only as a feed additive and 51 from farm C where no antibiotics were included in the feed regimen) were nasally swabbed for MRSA colonization. Isolates were tested for antimicrobial susceptibility, and characterised by spa typing, SCCmec typing and MLST. Whole genome sequencing (WGS) was performed for representative isolates. Results Overall, 96% of the pigs swabbed in 2018 carried MRSA, mostly ST398-SCCmec V-spa types t011/t108. MRSA from pigs not receiving antibiotics in the feed regimen showed susceptibility to a higher number of antibiotics, namely erythromycin, ciprofloxacin, gentamicin, and chloramphenicol. Notably, most of these isolates (n = 52) presented an unusual erythromycin-susceptibility/ clindamycin-resistance phenotype. WGS showed that these isolates lacked the erm and the lnu genes encoding resistance to macrolides and lincosamides, respectively, but carried the vgaA(LC) gene encoding resistance to lincosamides, which is here firstly identified in S. aureus ST398. Conclusion After two years the ban of colistin and amoxicillin as feed additives had no significant impact on the MRSA nasal carriage rates. Nevertheless, the MRSA strains circulating in those farms showed resistance to a lower number of antibiotic classes.	[Lopes, Elizeth; Conceicao, Teresa; de Lencastre, Herminia; Aires-de-Sousa, Marta] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Lab Mol Genet, Oeiras, Portugal; [Poirel, Laurent] Univ Fribourg, Dept Med, Emerging Antibiot Resistance Unit, Med & Mol Microbiol, Fribourg, Switzerland; [Poirel, Laurent] Univ Fribourg LEA IAME, French INSERM European Unit, Fribourg, Switzerland; [Poirel, Laurent] Natl Reference Ctr Emerging Antibiot Resistance, Fribourg, Switzerland; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Aires-de-Sousa, Marta] Escola Super Saude Cruz Vermelha Portuguese, Lisbon, Portugal	Universidade Nova de Lisboa; University of Fribourg; Rockefeller University	Aires-de-Sousa, M (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Lab Mol Genet, Oeiras, Portugal.; Aires-de-Sousa, M (corresponding author), Escola Super Saude Cruz Vermelha Portuguese, Lisbon, Portugal.	msousa@esscvp.eu	Poirel, Laurent/ABE-6736-2020; Conceicao, Teresa/M-3449-2014	Poirel, Laurent/0000-0001-5160-5286; Aires-de-Sousa, Marta/0000-0001-5036-2446; Conceicao, Teresa/0000-0002-9818-2767; Lopes, Elizeth/0000-0002-9837-5155	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/DTP-EPI/0842/2014]; FEDER funds through COMPETE2020 Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER-007660]; FCT; ONEIDA project - FEEI -"Fundos Europeus Estruturais e de Investimento" from "Programa Operacional Regional Lisboa 2020" [LISBOA-01-0145FEDER-016417]; FCT, Portugal [03/BI/2017]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FEDER funds through COMPETE2020 Programa Operacional Competitividade e Internacionalizacao (POCI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ONEIDA project - FEEI -"Fundos Europeus Estruturais e de Investimento" from "Programa Operacional Regional Lisboa 2020"; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partly supported by project PTDC/DTP-EPI/0842/2014 from Fundac comma ao para a Ciencia e a Tecnologia (FCT), Portugal, and Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020 Programa Operacional Competitividade e Internacionalizac comma Sao (POCI) and by national funds through FCT. This work was also partially supported by ONEIDA project (LISBOA-01-0145FEDER-016417) co-funded by FEEI -"Fundos Europeus Estruturais e de Investimento" from "Programa Operacional Regional Lisboa 2020" and by national funds from FCT. Elizeth Lopes was supported by grant 03/BI/2017 from FCT, Portugal.	Agency EM, 2018, SAL VET ANT AG 30 EU; Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Aires-De-Sousa M, 2017, CLIN MICROBIOL INFEC, V23, P373, DOI 10.1016/j.cmi.2016.11.002; Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Bibbal D, 2007, APPL ENVIRON MICROB, V73, P4785, DOI 10.1128/AEM.00252-07; Blake DP, 2003, J APPL MICROBIOL, V94, P1087, DOI 10.1046/j.1365-2672.2003.01937.x; Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10; Conceicao T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175340; Direcao Geral de Alimentaco e Veterinaria Ministerio da Agricultura e do Mar, 2014, PLAN AC NAC RED US A; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Fessler AT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02063; GELLIN G, 1989, APPL ENVIRON MICROB, V55, P2287, DOI 10.1128/AEM.55.9.2287-2292.1989; Hau SJ, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00791-17; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; LANGLOIS BE, 1983, APPL ENVIRON MICROB, V46, P1433, DOI 10.1128/AEM.46.6.1433-1434.1983; Larsen J, 2016, ANTIMICROB AGENTS CH, V60, P4401, DOI 10.1128/AAC.00426-16; Lozano C, 2011, CLIN MICROBIOL INFEC, V17, P923, DOI 10.1111/j.1469-0691.2010.03437.x; Lozano C, 2012, J ANTIMICROB CHEMOTH, V67, P2804, DOI 10.1093/jac/dks320; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Monecke S, 2018, VET MICROBIOL, V217, P36, DOI 10.1016/j.vetmic.2018.02.024; Novotna G, 2006, ANTIMICROB AGENTS CH, V50, P4070, DOI 10.1128/AAC.00799-06; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Otarigho B, 2018, BIOINFORMATION, V14, P113, DOI 10.6026/97320630014113; Qin X, 2011, INT J ANTIMICROB AG, V38, P81, DOI 10.1016/j.ijantimicag.2011.03.007; Tang YY, 2017, INT J FOOD MICROBIOL, V249, P72, DOI 10.1016/j.ijfoodmicro.2017.03.001; Trong HNG, 2005, ANTIMICROB AGENTS CH, V49, P2098, DOI 10.1128/AAC.49.5.2098-2101.2005; van Alen S, 2017, VET MICROBIOL, V200, P19, DOI 10.1016/j.vetmic.2016.01.021; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	31	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225497	10.1371/journal.pone.0225497	http://dx.doi.org/10.1371/journal.pone.0225497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747427	Green Published, gold			2022-12-26	WOS:000533881900047
J	McCoy, DC; Cuartas, J; Waldman, M; Fink, G				McCoy, Dana C.; Cuartas, Jorge; Waldman, Marcus; Fink, Gunther			Contextual variation in young children's acquisition of social-emotional skills	PLOS ONE			English	Article							CULTURAL-DIFFERENCES; SCHOOL READINESS; LOW-INCOME; BEHAVIOR; SOCIALIZATION; HEALTH; SELF; CONSEQUENCES; TODDLERS; CHINESE	This study examined variation in the timing of 5,447 infants' and toddlers' reported acquisition of 12 basic social-emotional skills across and within 11 developing and developed country sites. Although children differed significantly across sites in when they attained social-emotional skills on average (e.g., M age Brazil = 20.50 months vs. M age India = 26.92 months), there was also substantial heterogeneity across skills. For example, children in Pakistan were reported to demonstrate sympathy on average seven months earlier than their peers in Ghana, whereas the opposite was true for sharing. Overall, country-level health and education were strongly associated (r > .60) with earlier site-level skill attainment. In addition to heterogeneity across sites, we also observed notable within-site variability in skill development (ICCs = .03 to .38). Future research is needed to identify sources of variability and how to promote skills that matter within a given context.	[McCoy, Dana C.; Cuartas, Jorge; Waldman, Marcus] Harvard Grad Sch Educ, Cambridge, MA 02138 USA; [Fink, Gunther] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Fink, Gunther] Univ Basel, Basel, Switzerland	Harvard University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	McCoy, DC (corresponding author), Harvard Grad Sch Educ, Cambridge, MA 02138 USA.	dana_mccoy@gse.harvard.edu		Cuartas, Jorge/0000-0002-0451-3298	Grand Challenges Canada [0073-03]	Grand Challenges Canada(CGIAR)	DCM and GF received the funding for this work through grant Grant Number 0073-03 from Grand Challenges Canada (https://www.grandchallenges.ca/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, HUMAN DEV REPORTS; [Anonymous], 2017, ED SUS DEV GOALS LEA; Bronfenbrenner U., 2007, HDB CHILD DEV, V6th ed., P793, DOI DOI 10.1002/9780470147658.CHPSY0114; Carter AS, 2004, J CHILD PSYCHOL PSYC, V45, P109, DOI 10.1046/j.0021-9630.2003.00316.x; Chen XY, 1998, DEV PSYCHOL, V34, P677, DOI 10.1037/0012-1649.34.4.677; Chen XY, 2000, INTERNATIONAL PERSPECTIVES ON HUMAN DEVELOPMENT, P331; Cole PM, 2002, CHILD DEV, V73, P983, DOI 10.1111/1467-8624.00451; Dawson-McClure S, 2017, PREV SCI, V18, P660, DOI 10.1007/s11121-017-0763-7; De Feyter JJ, 2009, EARLY CHILD RES Q, V24, P411, DOI 10.1016/j.ecresq.2009.07.004; Denham S.A., 2006, EARLY EDUC DEV, V17, P57, DOI [10.1207/s15566935eed1701_4, DOI 10.1207/S15566935EED1701_4]; Eisenberg N, 1998, PSYCHOL INQ, V9, P317, DOI 10.1207/s15327965pli0904_1; Eisenberg N., 2015, HDB CHILD PSYCHOLOGY, V7th, P610, DOI [10.1002/9781118963418.childpsy315, DOI 10.1002/9781118963418.CHILDPSY315]; Eisenberg N., 1989, ROOTS PROSOCIAL BEHA; Fernald L.C.H., 2017, TOOLKIT MEASURING EA; Friedlmeier W, 2011, SOC PERSONAL PSYCHOL, V5, P410, DOI 10.1111/j.1751-9004.2011.00362.x; Gopnik A, 1996, COGNITIVE DEV, V11, P197, DOI 10.1016/S0885-2014(96)90003-9; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; Jukes M.C.H., 2018, GLOBAL ED REV, V5, P160; Kane C., 2016, C P INTERNET; Keller H, 2004, CHILD DEV, V75, P1745, DOI 10.1111/j.1467-8624.2004.00814.x; Keller H, 2009, J CROSS CULT PSYCHOL, V40, P996, DOI 10.1177/0022022109348576; Levine RV, 2001, J CROSS CULT PSYCHOL, V32, P543, DOI 10.1177/0022022101032005002; Martorell R, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035320500495563; McCoy DC, 2018, EARLY CHILD RES Q, V45, P58, DOI 10.1016/j.ecresq.2018.05.002; McCoy DC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002034; McWayne CM, 2012, J EDUC PSYCHOL, V104, P862, DOI 10.1037/a0028884; MILLER KF, 1987, COGNITIVE DEV, V2, P279, DOI 10.1016/S0885-2014(87)90091-8; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Munroe RL, 2018, CROSS-CULT RES, V52, P334, DOI 10.1177/1069397117733450; Organisation for Economic Co-operation and Development (OECD), 2015, SKILLS SOC PROGR POW; Payton JW, 2000, J SCHOOL HEALTH, V70, P179, DOI 10.1111/j.1746-1561.2000.tb06468.x; Altafim ERP, 2018, CHILD YOUTH SERV REV, V89, P93, DOI 10.1016/j.childyouth.2018.04.025; Pitchik HO, 2018, CHILD CARE HLTH DEV, V44, P841, DOI 10.1111/cch.12605; ROGOFF B, 1993, MONOGR SOC RES CHILD, V58, pR5; Rogoff B., 2003, CULTURAL NATURE HUMA; Rubin KH, 2002, CHILD DEV, V73, P483, DOI 10.1111/1467-8624.00419; Sameroff A, 2010, CHILD DEV, V81, P6, DOI 10.1111/j.1467-8624.2009.01378.x; SUPER CM, 1976, DEV MED CHILD NEUROL, V18, P561; SUPER CM, 1986, INT J BEHAV DEV, V9, P545, DOI 10.1177/016502548600900409; Tamis-LeMonda CS, 2008, SOC DEV, V17, P183, DOI 10.1111/j.1467-9507.2007.00419.x; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037/0033-295X.96.3.506; Trommsdorff G., 2012, GLOB STUD CHILDHOOD, V2, P158, DOI [10.2304/gsch.2012.2.2.158, DOI 10.2304/GSCH.2012.2.2.158]; Trommsdorff G, 2011, EMOTION SELF REGULAT, P131; Varela A. D., 2013, LEARNING RESILIENCE; Yoshikawa H, 2012, AM PSYCHOL, V67, P272, DOI 10.1037/a0028015	47	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0223056	10.1371/journal.pone.0223056	http://dx.doi.org/10.1371/journal.pone.0223056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN3EY	31738767	Green Accepted, Green Published, gold			2022-12-26	WOS:000532826300007
J	Jalali, A; Alvarez-Iglesias, A; Roshan, D; Newell, J				Jalali, Amirhossein; Alvarez-Iglesias, Alberto; Roshan, Davood; Newell, John			Visualising statistical models using dynamic nomograms	PLOS ONE			English	Article							MEDICINE	Translational Statistics proposes to promote the use of Statistics within research and improve the communication of statistical findings in an accurate and accessible manner to diverse audiences. When statistical models become more complex, it becomes harder to evaluate the role of explanatory variables on the response. For example, the interpretation and communication of the effect of predictors in regression models where interactions or smoothing splines are included can be challenging. Informative graphical representations of statistical models play a critical translational role; static nomograms are one such useful tool to visualise statistical models. In this paper, we propose the use of dynamic nomogram as a translational tool which can accommodate models of increased complexity. In theory, all models appearing in the literature could be accompanied by the corresponding dynamic nomogram to translate models in an informative manner. The R package presented will facilitate this communication for a variety of linear and non-linear models.	[Jalali, Amirhossein; Roshan, Davood; Newell, John] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland; [Alvarez-Iglesias, Alberto] Natl Univ Ireland, HRB Clin Res Facil, Galway, Ireland; [Newell, John] Natl Univ Ireland, CURAM, SFI Res Ctr Med Devices, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Jalali, A (corresponding author), Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland.	amir.jalali@ucd.ie	Jalali, Amirhossein/AAC-9771-2022	Jalali, Amirhossein/0000-0001-7227-8261; Alvarez-Iglesias, Alberto/0000-0001-5011-9008; Roshan Sangachin, Davood/0000-0002-6553-640X	Health Research Board via HRB Clinical Research Facility, Galway	Health Research Board via HRB Clinical Research Facility, Galway	A. Jalali received funding through the Health Research Board (https://www.hrb.ie/funding/) via HRB Clinical Research Facility, Galway (http://www.nuigalway.ie/hrb_crfg/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2005, PEDIATRICS, V116, P1612, DOI 10.1542/peds.2005-2269; Agresti A., 2011, CATEGORICAL DATA ANA; Allcock H.J., 1963, NOMOGRAM THEORY PRAC, Vfifth, P241; ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; Andersen MO, 2019, GLOB SPINE J, V9, P850, DOI 10.1177/2192568219838535; Banks J, 2004, ENCY STAT SCI; Bellam BL, 2019, PANCREATOLOGY, V19, P658, DOI 10.1016/j.pan.2019.05.467; Bowman A, 2007, J STAT SOFTW, V17, P1; BOYD WC, 1965, J AM STAT ASSOC, V60, P344; Broadbent S., 1954, J ROYAL STAT SOC C, V3, P33; Brodetsky S., 1925, BELLS MATH SERIES; Chen QY, 2019, J ONCOL, V2019, DOI 10.1155/2019/6012826; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Doerfler R., 2009, CREATING NOMOGRAMS P; Evesham HA, 2010, HIST DEV NOMOGRAPHY; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Goltz DE, 2019, J BONE JOINT SURG AM, V101, P547, DOI 10.2106/JBJS.18.00843; Harrell FE, 2001, REGRESSION MODELING; Held L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-21; Jones TB, 2009, ONLINE TOOL CREATING; Kattan MW, 2003, CURR OPIN UROL, V13, P111, DOI 10.1097/00042307-200303000-00005; Kim H, 2018, TOP SPINAL CORD INJ, V24, P97, DOI 10.1310/sci2402-97; Levens AS, 1937, NOMOGRAPHY; Li W, 2018, EBIOMEDICINE, V35, P307, DOI 10.1016/j.ebiom.2018.08.009; Madsen H., 2010, INTRO GEN GEN LINEAR; Marschner IC, 2011, R J, V3, P12; McCullagh P., 1989, MONOGRAPHS STAT APPL; Mozina M, 2004, LECT NOTES ARTIF INT, V3202, P337; Newell J, 2014, 34 C APPL STAT IR, P73; PARTIN AW, 1993, J UROLOGY, V150, P110, DOI 10.1016/S0022-5347(17)35410-1; Rico-Villademoros F, 2012, CLIN J PAIN, V28, P462, DOI 10.1097/AJP.0b013e318237d659; Ruppert D., 2003, SEMIPARAMETRIC REGRE, V12; Safari S, 2016, EMERGENCY, V4, P48; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Van Belle V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132614; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Xiao N., 2016, BIORXIV; Yang D, 2013, P SAS GLOB FOR; Zlotnik A, 2015, STATA J, V15, P537, DOI 10.1177/1536867X1501500212	39	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225253	10.1371/journal.pone.0225253	http://dx.doi.org/10.1371/journal.pone.0225253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730633	gold, Green Published			2022-12-26	WOS:000532809500032
J	Lei, XJ; Tie, JJ				Lei, Xiujuan; Tie, Jiaojiao			Prediction of disease-related metabolites using bi-random walks	PLOS ONE			English	Article							SPECTROMETRY; SIMILARITY; DATABASE	Metabolites play a significant role in various complex human disease. The exploration of the relationship between metabolites and diseases can help us to better understand the underlying pathogenesis. Several network-based methods have been used to predict the association between metabolite and disease. However, some methods ignored hierarchical differences in disease network and failed to work in the absence of known metabolite-disease associations. This paper presents a bi-random walks based method for disease-related metabolites prediction, called MDBIRW. First of all, we reconstruct the disease similarity network and metabolite functional similarity network by integrating Gaussian Interaction Profile (GIP) kernel similarity of diseases and GIP kernel similarity of metabolites, respectively. Then, the bi-random walks algorithm is executed on the reconstructed disease similarity network and metabolite functional similarity network to predict potential disease-metabolite associations. At last, MDBIRW achieves reliable performance in leave-one-out cross validation (AUC of 0.910) and 5-fold cross validation (AUC of 0.924). The experimental results show that our method outperforms other existing methods for predicting disease-related metabolites.	[Lei, Xiujuan; Tie, Jiaojiao] Shaanxi Normal Univ, Sch Comp Sci, Xian, Peoples R China	Shaanxi Normal University	Lei, XJ (corresponding author), Shaanxi Normal Univ, Sch Comp Sci, Xian, Peoples R China.	xjlei@snnu.edu.cn			National Natural Science Foundation of China [61972451, 61672334, 61902230]; Fundamental Research Funds for the Central Universities [GK201901010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the funding from National Natural Science Foundation of China (61972451, 61672334, 61902230) and the Fundamental Research Funds for the Central Universities (no. GK201901010).	Baumgartner C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208953; Chen X, 2018, BIOINFORMATICS, V34, P3178, DOI 10.1093/bioinformatics/bty333; Cheng L, 2019, BRIEF BIOINFORM, V20, P203, DOI 10.1093/bib/bbx103; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Czech C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031501; Dong H, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/625659; Ebbel EN, 2010, ANAL BIOCHEM, V399, P152, DOI 10.1016/j.ab.2010.01.010; Gonzalez-Dominguez R, 2014, J PROTEOMICS, V104, P37, DOI 10.1016/j.jprot.2014.01.014; Hu Y, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2098-1; Ibanez C, 2012, ANAL CHEM, V84, P8532, DOI 10.1021/ac301243k; Kaur S, 2017, METAB BRAIN DIS, V32, P727, DOI 10.1007/s11011-017-9961-z; Kibbe WA, 2015, NUCLEIC ACIDS RES, V43, pD1071, DOI 10.1093/nar/gku1011; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Liu LY, 2015, DIABETES RES CLIN PR, V108, P84, DOI 10.1016/j.diabres.2015.01.014; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Luo HM, 2016, BIOINFORMATICS, V32, P2664, DOI 10.1093/bioinformatics/btw228; MOATS RA, 1994, MAGNET RESON MED, V32, P110, DOI 10.1002/mrm.1910320115; Ni Y, 2014, J PROTEOME RES, V13, P3857, DOI 10.1021/pr500443c; Pieragostino D, 2015, MOL BIOSYST, V11, P1563, DOI 10.1039/c4mb00700j; Shang DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104934; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Wang C, 2011, J CHROMATOGR B, V879, P2871, DOI 10.1016/j.jchromb.2011.08.014; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Weinberg B. A., 2017, ONCOLOGY, V31; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia YC, 2006, FRONTIERS IN STATISTICS: DEDICATED TO PETER JOHN BICKEL IN HONOR OF HIS 65TH BIRTHDAY, P63, DOI 10.1142/9781860948886_0004; Ya-Wei N, 2018, MATH BIOSCI, V306, P1, DOI 10.1016/j.mbs.2018.10.004; Yan C., 2017, IEEE ACM T COMPUT BI, DOI [10.1109/TCBB.2017.2776101., DOI 10.1109/TCBB.2017.2776101]; Yan C, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2522-6; Yu GX, 2018, IEEE ACM T COMPUT BI, V15, P1390, DOI 10.1109/TCBB.2017.2715842; Yu GX, 2017, ONCOTARGET, V8, P60429, DOI 10.18632/oncotarget.19588; Zhao H, 2016, OBES SCI PRACT, V2, P309, DOI 10.1002/osp4.63; Zou Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/416323	35	10	10	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225380	10.1371/journal.pone.0225380	http://dx.doi.org/10.1371/journal.pone.0225380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730648	gold, Green Published			2022-12-26	WOS:000532809500036
J	Chen, LP; De Menna, M; Groenewoud, A; Thalmann, GN; Kruithof-de Julio, M; Snaar-Jagalska, BE				Chen, Lanpeng; De Menna, Marta; Groenewoud, Arwin; Thalmann, George N.; Kruithof-de Julio, Marianna; Snaar-Jagalska, B. Ewa			A NF-kappa B-Activin A signaling axis enhances prostate cancer metastasis	ONCOGENE			English	Article							TGF-BETA; BONE METASTASIS; GROWTH-FACTOR; SELF-RENEWAL; STEM-CELLS; ZEBRAFISH; MODEL; PROGRESSION; INHIBITION; BREAST	Metastasis is a main cause of death in prostate cancer (PCa). To dissect the molecular cues from cancer cell-microenvironment interaction that drive metastatic cascade, bone metastatic PCa cells were intravenously implanted into zebrafish embryos and mice tibia forming metastatic lesions. Transcriptomic analysis showed an elevated expression of stemness genes, pro-inflammatory cytokines and TGF-beta family member Activin A in the cancer cells at metastatic onset in both animal models. Consistently, analysis of clinical datasets revealed that the expression of Activin A is specifically elevated in metastases and correlates with poor prognosis in stratified high-risk PCa patients. It is further unveiled that the microenvironment induced Activin A expression by NF-kappa B activation. The elevated level of Activin A enhanced the invasive ALDH(hi) CSC-like phenotypes and PCa proliferation by activation of Smad and ERK1/2 signaling driving metastasis. Suppression of Activin A or Activin receptor significantly reduced the CSC-like subpopulation, invasion, metastatic growth, and bone lesion formation in zebrafish and mice xenografts, suggesting a functional role of NF-kappa B-dependent Activin A in PCa metastasis. Overall, our study demonstrates that human PCa cells can display a comparable response with the microenvironment in zebrafish and mice xenografts. Combining both animal models, we uncovered the microenvironment-dependent activin signaling as an essential driver in PCa metastasis with therapeutic potential.	[Chen, Lanpeng; Groenewoud, Arwin; Snaar-Jagalska, B. Ewa] Leiden Univ, Inst Biol, Leiden, Netherlands; [De Menna, Marta; Kruithof-de Julio, Marianna] Univ Bern, Dept BioMed Res, Urol Res Lab, Bern, Switzerland; [Thalmann, George N.] Inselspital Bern, Dept Urol, Bern, Switzerland	Leiden University; Leiden University - Excl LUMC; University of Bern; University of Bern; University Hospital of Bern	Snaar-Jagalska, BE (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.; Kruithof-de Julio, M (corresponding author), Univ Bern, Dept BioMed Res, Urol Res Lab, Bern, Switzerland.	marianna.kruithofdejulio@dbmr.unibe.ch; b.e.snaar-jagalska@biology.leidenuniv.nl		Kruithof-de Julio, Marianna/0000-0002-6085-7706; De Menna, Marta/0000-0002-6306-3485	Alpe D'HuZes (AdH)/KWF PROPER entitled "Near-patient prostate cancer models for the assessment of disease prognosis and therapy" [UL2014-7058]; SNF [31003A_169352]	Alpe D'HuZes (AdH)/KWF PROPER entitled "Near-patient prostate cancer models for the assessment of disease prognosis and therapy"; SNF	We thank Dr Gabriel van der Pluijm (Deportment of Urology, LUMC) for providing experimental material, Prof. Peter ten Dijke (Department of Molecular Cell Biology) for providing experimental material and critical scientific discussion and Guido de Roo from the Flow cytometry facility (Department of Hematology, LUMC) for technical support, Prof. Rob Hoeben and Martijn Rabelink (Department of Cell Biology, LUMC) for providing lentiviral shRNA vectors (Sigma-Aldrich). The present work was supported by a personalized medicine grant from Alpe D'HuZes (AdH)/KWF PROPER entitled "Near-patient prostate cancer models for the assessment of disease prognosis and therapy" (UL2014-7058) and SNF 31003A_169352.	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bashir M, 2015, NPJ BREAST CANCER, V1, DOI 10.1038/npjbcancer.2015.7; Brown CW, 2003, MOL ENDOCRINOL, V17, P2404, DOI 10.1210/me.2003-0051; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Chen L, 2017, METHOD CELL BIOL, V138, P471, DOI 10.1016/bs.mcb.2016.10.009; Clements M, 2011, CURR BIOL, V21, P1289, DOI 10.1016/j.cub.2011.06.048; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cui C, 2011, METHOD CELL BIOL, V105, P273, DOI 10.1016/B978-0-12-381320-6.00012-6; Dai JL, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.4; Dalkin AC, 1996, ENDOCRINOLOGY, V137, P5230, DOI 10.1210/en.137.12.5230; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Drabsch Y, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3573; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Fior R, 2017, P NATL ACAD SCI USA, V114, pE8234, DOI 10.1073/pnas.1618389114; Gold E, 2012, MOL CELL ENDOCRINOL, V359, P107, DOI 10.1016/j.mce.2011.07.005; Gray PC, 2012, FEBS LETT, V586, P1836, DOI 10.1016/j.febslet.2012.01.051; He SN, 2012, J PATHOL, V227, P431, DOI 10.1002/path.4013; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; Hofland J, 2012, ENDOCRINOLOGY, V153, P5726, DOI 10.1210/en.2011-2065; Hsu WK, 2008, J NUCL MED, V49, P414, DOI 10.2967/jnumed.107.045666; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jemal A, 2010, CANC EPIDEMIOLOGY PR, P1055; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; Karkampouna S, 2018, J PATHOL, V245, P297, DOI 10.1002/path.5083; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leto G, 2006, CLIN EXP METASTAS, V23, P117, DOI 10.1007/s10585-006-9010-5; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu TL, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1392; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Loomans HA, 2015, CANCERS, V7, P70, DOI 10.3390/cancers7010070; Lu HH, 2014, NAT CELL BIOL, V16, P1105, DOI 10.1038/ncb3041; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McKenzie S, 2006, J CELL BIOCHEM, V97, P18, DOI 10.1002/jcb.20634; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Quail DF, 2014, ONCOGENE, V33, P461, DOI 10.1038/onc.2012.608; Sacco A, 2016, CANCER RES, V76, P463, DOI 10.1158/0008-5472.CAN-15-1926; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shiozawa Y, 2016, ONCOTARGET, V7, P41217, DOI 10.18632/oncotarget.9251; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; THALMANN GN, 1994, CANCER RES, V54, P2577; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tulotta C, 2016, DIS MODEL MECH, V9, P141, DOI 10.1242/dmm.023275; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Wamsley JJ, 2015, CANCER RES, V75, P426, DOI 10.1158/0008-5472.CAN-13-2702; Wang Q, 2012, MED ONCOL, V29, P77, DOI 10.1007/s12032-010-9766-y; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606; Zoni E, 2017, ONCOGENE, V36, P4739, DOI 10.1038/onc.2017.87	56	17	20	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1634	1651		10.1038/s41388-019-1103-0	http://dx.doi.org/10.1038/s41388-019-1103-0			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31740783				2022-12-26	WOS:000514923000002
J	Yang, R; Xu, JH; Hua, XH; Tian, ZX; Xie, QP; Li, JX; Jiang, GS; Cohen, M; Sun, H; Huang, CS				Yang, Rui; Xu, Jiheng; Hua, Xiaohui; Tian, Zhongxian; Xie, Qipeng; Li, Jingxia; Jiang, Guosong; Cohen, Mitchell; Sun, Hong; Huang, Chuanshu			Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer/miR-16/JNK2/MMP-2 axis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX-METALLOPROTEINASE (MMP)-2; CELL-MIGRATION; UP-REGULATION; ISORHAPONTIGENIN ISO; TRANSCRIPTION FACTOR; MICRORNA MACHINERY; DICER EXPRESSION; REPRESSORS ZEB1; DOWN-REGULATION	Invasive bladder cancer (BC) is one of the most lethal malignant urological tumors. Although miR-200a has been reported as an onco-miRNA that targets the PTEN gene in endometrioid carcinoma, its biological significance in BC invasion has been poorly explored. In the current study, we found that miR-200a was markedly overexpressed in both human BC tissues and BBN-induced muscle-invasive BC tissues. We further showed that miR-200a overexpression specifically promoted human BC cell invasion, but not migration, via transcriptional upregulation of matrix metalloproteinase (MMP)-2. Mechanistic studies indicated that the increased phosphorylation of c-Jun mediated the increasing levels of MMP-2 mRNA transcription. Further investigation revealed that Dicer was decreased in miR-200a overexpressed BC cells; this resulted in inhibition of miR-16 maturation and consequently led to increased JNK2 protein translation and c-Jun activation. Taken together, the studies here showed that miR-200a overexpression inhibited Dicer expression, in turn, resulted in inhibition of miR-16 maturation, leading to upregulation of JNK2 expression, c-Jun phosphorylation, MMP-2 transcription and, ultimately, BC invasion. Collectively, these results demonstrate that miR-200a is an onco-miRNA that is a positive regulator for BC invasion. This finding could be very useful in the ongoing development of new strategies to treat invasive BC patients.	[Yang, Rui; Xu, Jiheng; Hua, Xiaohui; Tian, Zhongxian; Xie, Qipeng; Li, Jingxia; Jiang, Guosong; Cohen, Mitchell; Sun, Hong; Huang, Chuanshu] NYU, Dept Environm Med, Sch Med, 341 East 25th St, New York, NY 10010 USA	New York University	Huang, CS (corresponding author), NYU, Dept Environm Med, Sch Med, 341 East 25th St, New York, NY 10010 USA.	Chuanshu.huang@nyulangone.org	Yang, Rui/CAF-8397-2022; xie, qipeng/ABG-5941-2021; Xu, Jiheng/AAV-5732-2020	Yang, Rui/0000-0002-1737-7168; Xu, Jiheng/0000-0002-3538-3174; Huang, Chuanshu/0000-0003-4133-5096	NIH/NCI [CA217923, CA177665, CA165980, CA229234]; NIH/NIEHS [ES000260]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors wish to thank Dr. Etty N. Benveniste (University of Alabama at Birmingham) for providing the Human MMP-2 promoter luciferase reporter. We also thank Ms. Emily Davison for her critical reading of the manuscript. This work was partially supported by Grants NIH/NCI CA217923, CA177665, CA165980, CA229234, and NIH/NIEHS ES000260.	Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Becker LE, 2015, CARCINOGENESIS, V36, P2, DOI 10.1093/carcin/bgu202; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen JS, 2013, CARCINOGENESIS, V34, P10, DOI 10.1093/carcin/bgs274; Chen Y, 2017, EXP THER MED, V14, P10, DOI 10.3892/etm.2017.4488; Chen ZF, 2015, ONCOL LETT, V10, P329, DOI 10.3892/ol.2015.3179; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hua XH, 2020, CELL DEATH DIFFER, V27, P632, DOI 10.1038/s41418-019-0377-7; Hua XH, 2018, CANCER LETT, V436, P38, DOI 10.1016/j.canlet.2018.08.013; Huang C, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0376-9; Huang HS, 2017, MOL ONCOL, V11, P1579, DOI 10.1002/1878-0261.12132; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Jee D, 2018, MOL CELL, V69, P265, DOI 10.1016/j.molcel.2017.12.027; Jiang GS, 2016, CANCER PREV RES, V9, P567, DOI 10.1158/1940-6207.CAPR-15-0338; Jiang QQ, 2013, ASIAN PAC J CANCER P, V14, P4127, DOI 10.7314/APJCP.2013.14.7.4127; Jin HL, 2016, ONCOTARGET, V7, P56540, DOI 10.18632/oncotarget.10645; Jin HL, 2015, ONCOTARGET, V6, P522, DOI 10.18632/oncotarget.2680; Justus CR, 2014, JOVE-J VIS EXP, DOI 10.3791/51046; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Li SP, 2016, ONCOTARGET, V7, P42431, DOI 10.18632/oncotarget.9883; Li XL, 2013, INT J ONCOL, V43, P793, DOI 10.3892/ijo.2013.1992; Liang YG, 2016, AUTOPHAGY, V12, P1229, DOI 10.1080/15548627.2016.1179403; Liu JY, 2010, J BIOL CHEM, V285, P26058, DOI 10.1074/jbc.M110.100271; Miao C, 2015, INT J CLIN EXP PATHO, V8, P10512; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Pampalakis G, 2010, CLIN BIOCHEM, V43, P324, DOI 10.1016/j.clinbiochem.2009.09.014; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pectasides D, 2005, EUR UROL, V48, P60, DOI 10.1016/j.eururo.2005.03.025; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Shen Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705756; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Taki M, 2006, INT J ONCOL, V28, P487; Tao J, 2012, MOL MED REP, V5, P167, DOI 10.3892/mmr.2011.591; Troussard AA, 2000, ONCOGENE, V19, P5444, DOI 10.1038/sj.onc.1203928; Tseng JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03972-7; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Wu DY, 2012, MOL MED REP, V5, P695, DOI 10.3892/mmr.2011.711; Xie QP, 2016, ONCOTARGET, V7, P16636, DOI 10.18632/oncotarget.7674; Yan LM, 2010, INT J MOL SCI, V11, P4441, DOI 10.3390/ijms11114441; Zhang Z, 2015, TUMOR BIOL, V36, P5071, DOI 10.1007/s13277-015-3158-z; Zhu JL, 2017, NEOPLASIA, V19, P672, DOI 10.1016/j.neo.2017.06.002; Zhu JL, 2014, CANCER PREV RES, V7, P1270, DOI 10.1158/1940-6207.CAPR-14-0233; Zhuang WZ, 2015, STEM CELLS, V33, P1985, DOI 10.1002/stem.1989; Zuo W, 2014, INT J MOL SCI, V15, P14298, DOI 10.3390/ijms150814298	58	25	25	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1983	1996		10.1038/s41388-019-1120-z	http://dx.doi.org/10.1038/s41388-019-1120-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31772330	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000516579800012
J	Han, H; Schubert, HL; McCullough, J; Monroe, N; Purdy, MD; Yeager, M; Sundquist, WI; Hill, CP				Han, Han; Schubert, Heidi L.; McCullough, John; Monroe, Nicole; Purdy, Michael D.; Yeager, Mark; Sundquist, Wesley I.; Hill, Christopher P.			Structure of spastin bound to a glutamate-rich peptide implies a hand-over-hand mechanism of substrate translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases associated with diverse cellular activities (AAA); protein structure; peptide interaction; cryo-electron microscopy; structure-function; microtubule severing mechanism; molecular machine	CRYO-EM; PROTEIN; TUBULIN; ELECTROSTATICS; RECOGNITION; ORIENTATION; VALIDATION; ATPASE; PORE	Many members of the AAA+ ATPase family function as hexamers that unfold their protein substrates. These AAA unfoldases include spastin, which plays a critical role in the architecture of eukaryotic cells by driving the remodeling and severing of microtubules, which are cytoskeletal polymers of tubulin subunits. Here, we demonstrate that a human spastin binds weakly to unmodified peptides from the C-terminal segment of human tubulin ?1A/B. A peptide comprising alternating glutamate and tyrosine residues binds more tightly, which is consistent with the known importance of glutamylation for spastin microtubule severing activity. A cryo-EM structure of the spastin-peptide complex at 4.2 ? resolution revealed an asymmetric hexamer in which five spastin subunits adopt a helical, spiral staircase configuration that binds the peptide within the central pore, whereas the sixth subunit of the hexamer is displaced from the peptide/substrate, as if transitioning from one end of the helix to the other. This configuration differs from a recently published structure of spastin from Drosophila melanogaster, which forms a six-subunit spiral without a transitioning subunit. Our structure resembles other recently reported AAA unfoldases, including the meiotic clade relative Vps4, and supports a model in which spastin utilizes a hand-over-hand mechanism of tubulin translocation and microtubule remodeling.	[Han, Han; Schubert, Heidi L.; McCullough, John; Monroe, Nicole; Sundquist, Wesley I.; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Purdy, Michael D.; Yeager, Mark] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Yeager, Mark] Univ Virginia, Sch Med, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22908 USA; [Yeager, Mark] Univ Virginia, Sch Med, Ctr Membrane & Cell Physiol, Charlottesville, VA 22908 USA; [Yeager, Mark] Univ Virginia, Sch Med, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	Utah System of Higher Education; University of Utah; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Hill, CP (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.; Sundquist, WI (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; chris@biochem.utah.edu		McCullough, John/0000-0001-6836-4394; Schubert, Heidi/0000-0003-1762-8390	National Institutes of Health, NCI [P30CA042014]; National Institutes of Health [S10 OD018210]	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank James Fulcher and Michael Kay for the labeled E<INF>8</INF> peptide. The (EY)<INF>5</INF> peptide synthesis, sequencing of constructs, and validation of proteins was performed at the peptide synthesis, DNA sequencing, and MS core facilities at the University of Utah, which are supported by National Institutes of Health, NCI Grant P30CA042014. Mass spectrometry equipment in the Core was obtained through an National Institutes of Health Shared Instrumentation Grant S10 OD018210. Data processing and image reconstruction used the University of Utah Center for High Performance Computing.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Alfieri C, 2018, NATURE, V559, P274, DOI 10.1038/s41586-018-0281-1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barad BA, 2015, NAT METHODS, V12, P943, DOI [10.1038/NMETH.3541, 10.1038/nmeth.3541]; Claudiani P, 2005, EXP CELL RES, V309, P358, DOI 10.1016/j.yexcr.2005.06.009; de la Pena AH, 2018, SCIENCE, V362, P1018, DOI 10.1126/science.aav0725; Deville C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701726; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong YC, 2019, NATURE, V565, P49, DOI 10.1038/s41586-018-0736-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fan XY, 2018, FEBS LETT, V592, P1625, DOI 10.1002/1873-3468.13075; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Han H, 2019, ELIFE, V8, DOI 10.7554/eLife.44071; Han H, 2019, BIOCHEM SOC T, V47, P37, DOI 10.1042/BST20180260; Han H, 2017, ELIFE, V6, DOI 10.7554/eLife.31324; Han H, 2015, J BIOL CHEM, V290, P13490, DOI 10.1074/jbc.M115.642355; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Mancuso G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-31; McNally FJ, 2018, J CELL BIOL, V217, P4057, DOI 10.1083/jcb.201612104; Monroe N, 2017, ELIFE, V6, DOI 10.7554/eLife.24487; Monroe N, 2016, J MOL BIOL, V428, P1897, DOI 10.1016/j.jmb.2015.11.004; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Nyquist K, 2014, TRENDS BIOCHEM SCI, V39, P53, DOI 10.1016/j.tibs.2013.11.003; Plaud C, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.033704; Puchades C, 2017, SCIENCE, V358, P609, DOI 10.1126/science.aao0464; Ripstein ZA, 2017, ELIFE, V6, DOI 10.7554/eLife.25754; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2019, CURR OPIN CELL BIOL, V56, P102, DOI 10.1016/j.ceb.2018.10.009; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sandate CR, 2019, NAT STRUCT MOL BIOL, V26, P671, DOI 10.1038/s41594-019-0257-3; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700325; Svenson IK, 2001, AM J HUM GENET, V68, P1077, DOI 10.1086/320111; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Valenstein ML, 2016, CELL, V164, P911, DOI 10.1016/j.cell.2016.01.019; Vemu A, 2018, SCIENCE, V361, DOI 10.1126/science.aau1504; White KI, 2018, ELIFE, V7, DOI 10.7554/eLife.38888; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yu HJ, 2018, P NATL ACAD SCI USA, V115, pE9560, DOI 10.1073/pnas.1810648115; Zehr E, 2017, NAT STRUCT MOL BIOL, V24, P717, DOI 10.1038/nsmb.3448; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	48	18	18	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					435	443		10.1074/jbc.AC119.009890	http://dx.doi.org/10.1074/jbc.AC119.009890			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31767681	Green Published, hybrid			2022-12-26	WOS:000507373600014
J	El-Baba, M; Lewis, DJ; Fang, Z; Owen, AM; Fogel, SM; Morton, JB				El-Baba, Mazen; Lewis, Daniel J.; Fang, Zhuo; Owen, Adrian M.; Fogel, Stuart M.; Morton, J. Bruce			Functional connectivity dynamics slow with descent from wakefulness to sleep	PLOS ONE			English	Article							CYCLIC ALTERNATING PATTERN; DEFAULT MODE NETWORK; BRAIN ACTIVITY; CORTEX	The transition from wakefulness to sleep is accompanied by widespread changes in brain functioning. Here we investigate the implications of this transition for interregional functional connectivity and their dynamic changes over time. Simultaneous EEG-fMRI was used to measure brain functional activity of 21 healthy participants as they transitioned from wakefulness into sleep. fMRI volumes were independent component analysis (ICA)-decomposed, yielding 42 neurophysiological sources. Static functional connectivity (FC) was estimated from independent component time courses. A sliding window method and k-means clustering (k = 7, L2-norm) were used to estimate dynamic FC. Static FC in Wake and Stage-2 Sleep (NREM2) were largely similar. By contrast, FC dynamics across wake and sleep differed, with transitions between FC states occurring more frequently during wakefulness than during NREM2. Evidence of slower FC dynamics during sleep is discussed in relation to sleep-related reductions in effective connectivity and synaptic strength.	[El-Baba, Mazen] Univ Toronto, Fac Med, Toronto, ON, Canada; [Lewis, Daniel J.; Owen, Adrian M.; Fogel, Stuart M.; Morton, J. Bruce] Western Univ, Dept Psychol, London, ON, Canada; [Fang, Zhuo; Owen, Adrian M.; Fogel, Stuart M.; Morton, J. Bruce] Western Univ, Brain & Mind Inst, London, ON, Canada; [Fogel, Stuart M.] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Fogel, Stuart M.] Univ Ottawa, Royals Inst Mental Hlth Res, Ottawa, ON, Canada; [Fogel, Stuart M.] Univ Ottawa, Brain & Mind Inst, Ottawa, ON, Canada	University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Ottawa; University of Ottawa; University of Ottawa	Morton, JB (corresponding author), Western Univ, Dept Psychol, London, ON, Canada.; Morton, JB (corresponding author), Western Univ, Brain & Mind Inst, London, ON, Canada.	jbrucemorton@gmail.com	Fogel, Stuart/F-7179-2017	Fogel, Stuart/0000-0002-3227-5370	Canada Excellence Research Chairs (CERC) Program [215063]; NSERC Discovery Grant	Canada Excellence Research Chairs (CERC) Program; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported in part by the Canada Excellence Research Chairs (CERC) Program (215063). This research was also supported by an NSERC Discovery Grant awarded to JBM. Research was conducted with the assistance of the Centre for Metabolic Mapping, Robarts Research Institute, Western University. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by the Canada Excellence Research Chairs (CERC) Program (215063). This research was also supported by an NSERC Discovery Grant awarded to JBM. Research was conducted with the assistance of the Centre for Metabolic Mapping, Robarts Research Institute, Western University.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Allen EA, 2018, BRAIN TOPOGR, V31, P101, DOI 10.1007/s10548-017-0546-2; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Barttfeld P, 2015, P NATL ACAD SCI USA, V112, pE5219, DOI 10.1073/pnas.1515029112; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Brissenden JA, 2016, J NEUROSCI, V36, P6083, DOI 10.1523/JNEUROSCI.0344-16.2016; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Deco G, 2014, CEREB CORTEX, V24, P3180, DOI 10.1093/cercor/bht176; Diering GH, 2017, SCIENCE, V355, P511, DOI 10.1126/science.aai8355; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Hinard V, 2012, J NEUROSCI, V32, P12506, DOI 10.1523/JNEUROSCI.2306-12.2012; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Huber R, 2013, CEREB CORTEX, V23, P1, DOI 10.1093/cercor/bhs014; Hutchison RM, 2015, J NEUROSCI, V35, P6849, DOI 10.1523/JNEUROSCI.4638-14.2015; Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Maquet P, 2005, PROG BRAIN RES, V150, P219, DOI 10.1016/S0079-6123(05)50016-5; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; Molle M, 2002, J NEUROSCI; Parrino L, 1998, ELECTROEN CLIN NEURO, V107, P439, DOI 10.1016/S0013-4694(98)00108-4; Peigneux P, 2017, PRINCIPLES PRACTICE, P335; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Samann PG, 2011, CEREB CORTEX, V21, P2082, DOI 10.1093/cercor/bhq295; Saxe GN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191582; Schabus Manuel, 2012, Front Neurol, V3, P40, DOI 10.3389/fneur.2012.00040; Tagliazucchi E, 2016, BRAIN STRUCT FUNCT, V221, P4221, DOI 10.1007/s00429-015-1162-0; Tagliazucchi E, 2012, NEUROIMAGE, V63, P63, DOI 10.1016/j.neuroimage.2012.06.036; Terzano MG, 2002, SLEEP MED, V3, P185; TERZANO MG, 1985, SLEEP, V8, P137, DOI 10.1093/sleep/8.2.137; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Vahdat S, 2017, ELIFE, V6, DOI 10.7554/eUfe.249t37; Xie H, 2018, NEUROIMAGE, V180, P495, DOI 10.1016/j.neuroimage.2017.05.050	38	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224669	10.1371/journal.pone.0224669	http://dx.doi.org/10.1371/journal.pone.0224669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790422	Green Published, gold			2022-12-26	WOS:000533930800010
J	Wasir, R; Irawati, S; Makady, A; Postma, M; Goettsch, W; Feenstra, T; Buskens, E				Wasir, Riswandy; Irawati, Sylvi; Makady, Amr; Postma, Maarten; Goettsch, Wim; Feenstra, Talitha; Buskens, Erik			The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders	PLOS ONE			English	Article							HEALTH TECHNOLOGY-ASSESSMENT	Objectives This study aimed to identify the barriers and facilitators to improve the use of health technology assessment (HTA) for the selection of medicines listed in the e-Catalogue and the national formulary in Indonesia. Methods Semi-structured interviews were conducted to collect qualitative data. Purposive sampling was used to recruit the stakeholders consisting of policymakers, a pharmaceutical industry representative, healthcare providers, and patients. The data were analyzed using directed content analysis and following the COnsolidated criteria for REporting Qualitative studies (COREQ). Results The twenty-five participants interviewed agreed with the use of HTA for supporting the eCatalogue and the national formulary and perceived the advantages of HTA implementation outweighed the disadvantages. Barriers mentioned were a lack of capability of local human resources, financial incentives, a clear framework and insufficient data. Strategies suggested to overcome the barriers were establishing (inter)national networks to build up capacity, setting up departments of HTA in several universities in Indonesia, and introducing a clear HTA framework. Facilitators mentioned were the ambition to achieve universal health coverage, the presence of legal frameworks to implement HTA in the e-Catalogue and the national formulary, and the demands for appropriate medicine policies. Conclusions Several barriers are currently hampering broad implementation of HTA in medicine pricing and reimbursement policy in Indonesia. Solutions to these issues appear feasible and important facilitators exist.	[Wasir, Riswandy; Feenstra, Talitha; Buskens, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wasir, Riswandy] Sekolah Tinggi Ilmu Farmasi Makassar, Makassar, Indonesia; [Wasir, Riswandy; Irawati, Sylvi; Postma, Maarten; Feenstra, Talitha] Univ Groningen, Fac Sci & Engn, Groningen Res Inst Pharm, Groningen, Netherlands; [Irawati, Sylvi] Univ Surabaya, Fac Pharm, Ctr Med Informat & Pharmaceut Care, Surabaya, Indonesia; [Irawati, Sylvi] Univ Surabaya, Fac Pharm, Dept Clin & Community Pharm, Surabaya, Indonesia; [Makady, Amr; Goettsch, Wim] Natl Hlth Care Inst, Diemen, Netherlands; [Makady, Amr; Goettsch, Wim] Univ Utrecht, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Postma, Maarten] Univ Groningen, Dept Hlth Sci, Groningen, Netherlands; [Postma, Maarten] Univ Groningen, Fac Econ & Business, Dept Econ Econometr & Finance, Groningen, Netherlands; [Postma, Maarten] Univ Airlangga, Fac Med, Dept Pharmacol & Therapy, Surabaya, Indonesia; [Feenstra, Talitha] Dutch Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Buskens, Erik] Univ Groningen, Fac Econ & Business, Dept Operat, Groningen, Netherlands	University of Groningen; University of Groningen; Universitas Surabaya (UBAYA); Universitas Surabaya (UBAYA); Utrecht University; University of Groningen; University of Groningen; Airlangga University; Netherlands National Institute for Public Health & the Environment; University of Groningen	Wasir, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.; Wasir, R (corresponding author), Sekolah Tinggi Ilmu Farmasi Makassar, Makassar, Indonesia.; Wasir, R (corresponding author), Univ Groningen, Fac Sci & Engn, Groningen Res Inst Pharm, Groningen, Netherlands.	r.wasir@umcg.nl	Irawati, Sylvi/GLQ-9438-2022	buskens, erik/0000-0002-6463-1106; Irawati, Sylvi/0000-0001-6278-9017; Wasir, Riswandy/0000-0001-6184-925X; Postma, Maarten/0000-0002-6306-3653	DIKTI scholarship from the Ministry of Research, Technology and Higher Education; LPDP scholarship from the Ministry of Research, Technology and Higher Education; Ministry of Finance of the Republic Indonesia	DIKTI scholarship from the Ministry of Research, Technology and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); LPDP scholarship from the Ministry of Research, Technology and Higher Education; Ministry of Finance of the Republic Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This work was financially supported by DIKTI (to RW) and LPDP (to SI) scholarships from the Ministry of Research, Technology and Higher Education, and the Ministry of Finance of the Republic Indonesia, respectively. The DIKTI and LPDP had no direct role in research design, data collection, analysis and interpretation, or manuscript writing and publication.	Angelis A, 2018, EUR J HEALTH ECON, V19, P123, DOI 10.1007/s10198-017-0871-0; [Anonymous], 2013, MALAYSIA HEAL SYST R, V3, P103; Babar Z, 2017, PHARM POLICY COUNTRI; Babigumira JB, 2016, J PHARM HEALTH SERV, V7, P37, DOI 10.1111/jphs.12120; Bigdeli M, 2015, MED UNIVERSAL HLTH C, DOI [10.1186/s40545-015-0028-4, DOI 10.1186/S40545-015-0028-4]; Chalkidou K, 2013, LANCET, V382, pE48, DOI 10.1016/S0140-6736(13)62559-3; Dirjen Binfar dan Alkes Kemenkes RI, 2015, IMPL FORM NAS DAL PE; Hidayat B, 2015, OUT POCKET PAYMENTS; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kalo Z, 2016, HEALTH ECON, V25, P179, DOI 10.1002/hec.3298; Kementrian Kesehatan R, 2013, PED PEN KAJ FARM; Kemetrian Kesehatan Republik Indonesia, 2015, PED PEN FORM NAS; Khan JAM, 2017, HEALTH POLICY PLANN, V32, P1102, DOI 10.1093/heapol/czx048; Kieny MP, 2017, B WORLD HEALTH ORGAN, V95, P537, DOI 10.2471/BLT.16.187476; Mundiharno TH, 2012, PETA JALAN MENUJU JA; Nguyen TA, 2017, PHARM POLICY COUNTRI, P75; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; Teerawattananon Y, 2009, INT J TECHNOL ASSESS, V25, P241, DOI 10.1017/S0266462309090709; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wasir R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212328; WHO, GLOB HLTH EXP DAT; World Health Organization, 2015, TRACK UN HLTH COV 1; World Health Organization, 2019, HLTH TECHN ASS HTA W; World Health Organization, 2015, WHO GUID COUNTR PHAR; Yoongthong W, 2012, VALUE HEALTH, V15, pS126, DOI 10.1016/j.jval.2011.11.003	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225626	10.1371/journal.pone.0225626	http://dx.doi.org/10.1371/journal.pone.0225626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8SS	31774854	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000533896400044
J	Li, WC; Chen, AY; Liu, YP; Lee, YY; Yeh, WC; Yu, W; Tsao, YC				Li, Wen-Cheng; Chen, Jau-Yuan; Liu, Yu-Ping; Lee, Yi-Yen; Yeh, Wei-Chung; Yu, Wei; Tsao, Yu-Chung			Association between metabolic body composition status and risk for impaired renal function: A cross-sectional study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; HEALTHY OBESITY; MASS INDEX; VISCERAL OBESITY; SERUM-LEVELS; JAPANESE; GLUCOSE; GENDER; MICROALBUMINURIA	Background The risk for obesity-related disorders is proportional to the visceral region and had been observed to be highly related with impaired renal function. In the current study, we aimed to evaluate renal function impairment, according to sex, age, and different status of metabolic body composition. Methods We retrospectively collected from the medical records the basic information and metabolic titers of Chinese adults (13,373 men and 10,175 women) who underwent health checkup from 2013 to 2016. The population was divided into four groups, according to metabolic body composition, including metabolic healthy norms-weight (MHNW), metabolic healthy obesity (MHO), metabolic unhealthy norms-weight (MUNW), and metabolic unhealthy obesity (MUO). The categorical data were compared among the groups and logistic regression analyses were conducted to investigate the association between metabolic body composition status and risk for renal function impairment. Results Across all ages in both sexes, the odds ratios (OR) for renal function impairment were higher in the MHO, MUNW, and MUO groups than in the MHNW group, except for women < 45 years old in the MUNW group. However, after adjustment, the trend was no longer significant in all groups under 45 years old. For individuals > 45 years old, the relatively high risk for renal function impairment remained significantly associated with the MUNW group (OR 2.95, 95% CI 2.02-4.30 in men and OR 1.95, 95% CI 1.35-2.82 in women) and MUO group (OR 2.33, 95% CI 1.82-3.00 in men and OR 2.67, 95% CI 2.04-3.48 in women). Conclusion Impaired renal function was independently associated with the status of metabolic obesity. However, the trend was only observed in individuals > 45 years old, with significant sex difference.	[Li, Wen-Cheng; Chen, Jau-Yuan; Yeh, Wei-Chung] Chang Gung Mem Hosp, Dept Family Med, Taoyuan, Taiwan; [Li, Wen-Cheng; Chen, Jau-Yuan; Yeh, Wei-Chung; Tsao, Yu-Chung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Li, Wen-Cheng; Yu, Wei; Tsao, Yu-Chung] Xiamen Chang Gung Hosp, Dept Hlth Management, Xiamen, Peoples R China; [Liu, Yu-Ping] Xiamen Chang Gung Hosp, Dept Endocrinol & Metab, Xiamen, Peoples R China; [Lee, Yi-Yen] Taipei Vet Gen Hosp, Neurol Inst, Div Pediat Neurosurg, Taipei, Taiwan; [Lee, Yi-Yen] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Tsao, Yu-Chung] Chang Gung Mem Hosp, Dept Occupat Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital	Tsao, YC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Tsao, YC (corresponding author), Xiamen Chang Gung Hosp, Dept Hlth Management, Xiamen, Peoples R China.; Tsao, YC (corresponding author), Chang Gung Mem Hosp, Dept Occupat Med, Taoyuan, Taiwan.	eusden@gmail.com	Tsao, Yu-Chung/GNW-5939-2022	Tsao, Yu-Chung/0000-0001-7355-5208				Bosetti F, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004389; Chang Y, 2016, ANN INTERN MED, V164, P305, DOI 10.7326/M15-1323; Chang Y, 2014, J AM COLL CARDIOL, V63, P2679, DOI 10.1016/j.jacc.2014.03.042; Conus F, 2004, J CLIN ENDOCR METAB, V89, P5013, DOI 10.1210/jc.2004-0265; de Jong PE, 2002, INT J OBESITY, V26, pS21, DOI 10.1038/sj.ijo.0802213; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Dvorak RV, 1999, DIABETES, V48, P2210, DOI 10.2337/diabetes.48.11.2210; Fruhbeck G, 2001, FASEB J, V15, P333, DOI 10.1096/fj.00-0249com; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Garland JS, 2014, DIABET METAB SYND OB, V7, P347, DOI 10.2147/DMSO.S46674; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; GRETZ N, 1989, AM J KIDNEY DIS, V14, P178, DOI 10.1016/S0272-6386(89)80068-X; Hashimoto Y, 2015, CLIN J AM SOC NEPHRO, V10, P578, DOI 10.2215/CJN.08980914; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Ishizaka N, 2007, HYPERTENS RES, V30, P1059, DOI 10.1291/hypres.30.1059; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Jung CH, 2015, KIDNEY INT, V88, P843, DOI 10.1038/ki.2015.183; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Katsuki A, 2003, DIABETES CARE, V26, P2341, DOI 10.2337/diacare.26.8.2341; Katsuki A, 2003, DIABETES CARE, V26, P2964, DOI 10.2337/diacare.26.10.2964; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Kubo S, 2016, J ATHEROSCLER THROMB, V23, P1089, DOI 10.5551/jat.33530; Lee JM, 2006, DIABETES CARE, V29, P2427, DOI 10.2337/dc06-0709; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Mangge H, 2013, OBESITY, V21, pE71, DOI 10.1002/oby.20061; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Marques-Vidal P, 2012, EUR J CLIN NUTR, V66, P426, DOI 10.1038/ejcn.2011.170; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Messier V, 2010, METABOLISM, V59, P20, DOI 10.1016/j.metabol.2009.06.020; MOGENSEN CE, 1985, UREMIA INVEST, V9, P85, DOI 10.3109/08860228509088195; Morkedal B, 2014, J AM COLL CARDIOL, V63, P1071, DOI 10.1016/j.jacc.2013.11.035; Naukkarinen J, 2014, DIABETOLOGIA, V57, P167, DOI 10.1007/s00125-013-3066-y; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; RUDERMAN NB, 1982, INT J OBESITY, V6, P151; SAKEMI T, 1994, NEPHRON, V67, P469, DOI 10.1159/000188022; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Singh Y, 2013, J CLIN RES PEDIATR E, V5, P245, DOI 10.4274/Jcrpe.1127; St-Onge MP, 2004, DIABETES CARE, V27, P2222, DOI 10.2337/diacare.27.9.2222; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tsao YC, 2019, OBESITY FACTS, V12, P67, DOI 10.1159/000496626; Tsao YC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36860-9; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Yamada C, 2011, J DIABETES INVEST, V2, P373, DOI 10.1111/j.2040-1124.2011.00113.x	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0223664	10.1371/journal.pone.0223664	http://dx.doi.org/10.1371/journal.pone.0223664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770376	Green Published, gold			2022-12-26	WOS:000533892300003
J	Do, TV; Thang, NT; Lam, VT; Thuyet, DV; Trung, PD; Quy, TH; Phuong, NTT; Huyen, LTT; Thinh, NH; Tuan, NV; Duc, DT; Ha, DTH; Trung, DQ; Luong, HT; Anh, NTH; Nykiel, P				Tran Van Do; Nguyen Toan Thang; Vu Tien Lam; Dang Van Thuyet; Phung Dinh Trung; Tran Hoang Quy; Nguyen Thi Thu Phuong; Ly Thi Thanh Huyen; Nguyen Huu Thinh; Nguyen Van Tuan; Dao Trung Duc; Dang Thi Hai Ha; Duong Quang Trung; Ho Trung Luong; Nguyen Thi Hoai Anh; Nykiel, Patrick			Monitoring fine root growth to identify optimal fertilization timing in a forest plantation: A case study in Northeast Vietnam	PLOS ONE			English	Article							LOBLOLLY-PINE; DOUGLAS-FIR; LEAF-AREA; RESPONSES; NITROGEN; SOIL; PHOSPHORUS; MANAGEMENT; NUTRIENT; SYSTEM	Fertilizer is applied widely to improve the productivity of plantations. Traditionally, fertilization is conducted in spring and/or in the early rainy season, and it is believed to support the growth of planted trees in the growing season. Little attention to date has been paid on identification of the optimal timing of fertilization and fertilizer dose. In this study, application of the fine root monitoring technique in identifying optimal fertilization timing for an Acacia plantation in Vietnam is described. The study used two fertilizer doses (100 and 200 g NPK/tree) and three fertilization timings (in spring; in the early rainy season; and based on the fine root monitoring technique to identify when the fine roots reach their growth peak). As expected fertilization timings significantly affected growth and above-ground biomass (AGB) of the plantation. Fertilization based on the fine root monitoring technique resulted in the highest growths and AGB, followed by fertilization in the early rainy season and then in spring. Applying fertilizer at 200 g NPK/tree based on the fine root monitoring technique increased diameter at breast height (DBH) by 16%, stem height by 8%, crown diameter (Dc) by 16%, and AGB by 40% as compared to early rainy season fertilization. Increases of 32% DBH, 23% stem height, 44% Dc, and 87% AGB were found in fertilization based on fine root monitoring technique compared to spring fertilization. This study concluded that forest growers should use the fine root monitoring technique to identify optimal fertilization timing for higher productivity.	[Tran Van Do; Nguyen Toan Thang; Vu Tien Lam; Dang Van Thuyet; Phung Dinh Trung; Tran Hoang Quy; Nguyen Thi Thu Phuong; Ly Thi Thanh Huyen; Nguyen Huu Thinh; Nguyen Van Tuan; Dao Trung Duc; Dang Thi Hai Ha; Duong Quang Trung; Ho Trung Luong; Nguyen Thi Hoai Anh] Vietnamese Acad Forest Sci, Silviculture Res Inst, Hanoi, Vietnam; [Nykiel, Patrick] Vietnamese Acad Forest Sci, Hanoi, Vietnam		Do, TV (corresponding author), Vietnamese Acad Forest Sci, Silviculture Res Inst, Hanoi, Vietnam.	dotranvan@hotmail.com		Do, Tran Van/0000-0001-9059-5842	Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106-NN.06-2016.10]	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED))	This research was funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106-NN.06-2016.10.	Adu MO, 2014, J EXP BOT, V65, P2039, DOI 10.1093/jxb/eru048; Albaugh TJ, 1998, FOREST SCI, V44, P317; [Anonymous], 2009, QCVN02; Bah A., 2014, ADV AGR, V2014, P9, DOI [10.1155/2014/285387, DOI 10.1155/2014/285387]; Balster NJ, 2000, CAN J FOREST RES, V30, P733, DOI 10.1139/cjfr-30-5-733; Blazier MA, 2015, FORESTS, V6, P1061, DOI 10.3390/f6041061; BOUMA J, 1994, SOIL SCI SOC AM J, V58, P645, DOI 10.2136/sssaj1994.03615995005800030001x; Campbell J.J., 2003, COMMUNICATION SOIL S, V33, P1027; Carlson CA, 2014, FOREST SCI, V60, P157, DOI 10.5849/forsci.12-158; Cislaghi A, 2017, ECOL ENG, V109, P169, DOI 10.1016/j.ecoleng.2017.04.034; Dang V.T., 2010, SCI REPORT; Dannoural M, 2008, PLANT ROOT, V2, P14, DOI 10.3117/plantroot.2.14; Di Iorio A, 2013, TREES-STRUCT FUNCT, V27, P1503, DOI 10.1007/s00468-013-0897-6; Dickens E. D., 2003, Better Crops with Plant Food, V87, P12; Doran JW, 2002, AGR ECOSYST ENVIRON, V88, P119, DOI 10.1016/S0167-8809(01)00246-8; Du XZ, 2018, J FORESTRY RES, V29, P1321, DOI 10.1007/s11676-017-0561-x; FAO, 2016, AR WORLDS FOR CHANG, P54; FERGUSON JC, 1989, SOIL SCI SOC AM J, V53, P1601, DOI 10.2136/sssaj1989.03615995005300050054x; Forrester DI, 2013, FOREST ECOL MANAG, V310, P336, DOI 10.1016/j.foreco.2013.08.047; Forrester DI, 2012, FOREST ECOL MANAG, V266, P286, DOI 10.1016/j.foreco.2011.11.019; Fox TR, 2007, SOUTH J APPL FOR, V31, P5, DOI 10.1093/sjaf/31.1.5; Goncalves JLM, 2007, SOUTH HEMISPH FOR J, V69, P95, DOI 10.2989/SHFJ.2007.69.2.4.289; Guo J, 2016, FORESTS, V7, DOI 10.3390/f7120293; Helmisaari H.S., 2000, FOREST CONDITION CHA, V65; Hung T.T., 2009, NEW FORESTS; Indufor, 2012, A1206869 IND FOR STE; Laclau JP, 2009, TREE PHYSIOL, V29, P111, DOI 10.1093/treephys/tpn010; Lamani V. K., 2004, Karnataka Journal of Agricultural Sciences, V17, P872; Lee KL, 2015, TURK J AGRIC FOR, V39, P154, DOI 10.3906/tar-1404-20; Li H, 2012, J EXP BOT, V63, P6173, DOI 10.1093/jxb/ers271; Lobet G., 2008, PLANT PHYSIOL, V177, P549; Mainwaring DB, 2014, FOREST ECOL MANAG, V327, P178, DOI 10.1016/j.foreco.2014.05.005; Maraseni TN, 2017, FOREST POLICY ECON, V83, P80, DOI 10.1016/j.forpol.2017.06.010; Mcintyre J., 2011, THESIS; da Silva PHM, 2013, FOREST ECOL MANAG, V301, P67, DOI 10.1016/j.foreco.2012.10.033; Bich NV, 2018, FORESTS, V9, DOI 10.3390/f9090577; Osawa A, 2012, PLANT SOIL, V355, P167, DOI 10.1007/s11104-011-1090-6; Pham T.D., 2005, SCI REPORT; PRITCHETT WL, 1972, SOIL SCI SOC AM PRO, V36, P660, DOI 10.2136/sssaj1972.03615995003600040043x; Raymond JE, 2016, FORESTS, V7, DOI 10.3390/f7110270; Rudhe J., 2014, THESIS; Shi WH, 2019, FORESTRY, V92, P97, DOI 10.1093/forestry/cpy035; Sulaiman A., 1990, J TROP FOR SCI, V4, P119; Thanh T.X., 2015, P NATL SCI C ECOLOGI, V6, P1660; Timander P., 2011, THESIS; Do TV, 2016, TREES-STRUCT FUNCT, V30, P545, DOI 10.1007/s00468-015-1195-2; Van Do T, 2016, TREE PHYSIOL, V36, P513, DOI 10.1093/treephys/tpv121; Vergani C, 2017, FOREST ECOL MANAG, V400, P339, DOI 10.1016/j.foreco.2017.06.005; Wertz S, 2012, FEMS MICROBIOL ECOL, V79, P142, DOI 10.1111/j.1574-6941.2011.01204.x; Zar JH., 2010, BIOSTAT ANAL, V5th; Zech W., 1995, SOILS TROPICAL FORES, V5, P5; Zhou WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28230	52	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225567	10.1371/journal.pone.0225567	http://dx.doi.org/10.1371/journal.pone.0225567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765411	gold, Green Published			2022-12-26	WOS:000533891000036
J	Zhang, Y; Shi, LX; Zhang, Q; Peng, NC; Chen, LL; Lian, XL; Liu, C; Shan, ZY; Shi, BY; Tong, NW; Wang, S; Weng, JP; Zhao, JJ; Teng, WP				Zhang, Yan; Shi, Lixin; Zhang, Qiao; Peng, Nianchun; Chen, Lulu; Lian, Xiaolan; Liu, Chao; Shan, Zhongyan; Shi, Bingyin; Tong, Nanwei; Wang, Shu; Weng, Jianping; Zhao, Jiajun; Teng, Weiping			The association between cigarette smoking and serum thyroid stimulating hormone, thyroid peroxidase antibodies and thyroglobulin antibodies levels in Chinese residents: A cross-sectional study in 10 cities	PLOS ONE			English	Article							TOBACCO SMOKING; RISK-FACTOR; NATIONAL-HEALTH; GRAVES-DISEASE; FOLLOW-UP; GOITER; DYSFUNCTION; PREVALENCE; EXPOSURE; TSH	Objectives Although several studies have shown that cigarette smoking is associated with thyroid stimulating hormone (TSH), thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb), the exact relationship between smoking and thyroid function is controversial. As little is known about the effects of smoking on TSH, TPOAb and TgAb in Chinese residents. This study aimed to evaluate the association between cigarette smoking and TSH, TPOAb and TgAb in ten-city residents of China. Study design This was a population-based cross-sectional study. Methods In this cross-sectional study, 15,181 subjects from ten major cities of China were investigated. Data regarding demographic characteristics, smoking status and consumption of iodine status were collected using in-person interviews based on a self-designed structured questionnaire. Serum concentrations of TSH, TPOAb and TgAb were measured using electrochemiluminescence immunoassays. Univariate analysis and multivariate linear stepwise regression analyses were used to analyze the data. Results The regular smokers had lower concentrations of TSH, TPOAb and TgAb than occasional smokers, former smokers and never smokers. Multivariate analysis demonstrated that regular smoking was associated with the decreased concentrations of TSH (beta = -0.178), TPOAb (beta = -0.287) and TGAb (beta = -0.453) after adjusting other factors. Furthermore, daily smoking number was significantly associated with the decreased level of TSH (beta = -0.045) and TPOAb(beta = -0.080), and smoking duration was associated with the decreased TSH level (beta = -0.030). Conclusions Our findings suggest that cigarette smoking is related to a significant decline in the concentrations of TSH, TPOAb and TgAb. In addition, daily smoking number and long-term smoking decrease serum TSH and TPOAb levels. Cigarette smoking plays a significant role in the development of thyroid dysfunction.	[Zhang, Yan; Shi, Lixin; Zhang, Qiao; Peng, Nianchun] Guizhou Med Univ, Dept Endocrinol, Affiliated Hosp, Guiyang, Peoples R China; [Chen, Lulu] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Endocrinol, Wuhan, Peoples R China; [Lian, Xiaolan] Peking Union Med Coll Hosp, Dept Endocrinol, Beijing, Peoples R China; [Liu, Chao] Jiangsu Prov Hosp Integrat Chinese & Western Med, Dept Endocrinol, Nanjing, Peoples R China; [Shan, Zhongyan; Teng, Weiping] China Med Univ, Dept Endocrinol & Metab, Key Lab Thyroid Dis Liaoning Prov, Hosp 1, Shenyang, Peoples R China; [Shi, Bingyin] Xi An Jiao Tong Univ, Dept Endocrinol, Affiliated Hosp 1, Med Coll, Xian, Peoples R China; [Tong, Nanwei] Sichuan Univ, West China Hosp, Dept Endocrinol, Chengdu, Peoples R China; [Wang, Shu] Shanghai Jiao Tong Univ, Dept Endocrinol, Ruijin Hosp, Shanghai, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou, Peoples R China; [Zhao, Jiajun] Shandong First Med Univ, Dept Endocrinol, Prov Hosp, Jinan, Peoples R China	Guizhou Medical University; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Nanjing University of Chinese Medicine; China Medical University; Xi'an Jiaotong University; Sichuan University; Shanghai Jiao Tong University; Sun Yat Sen University; Shandong First Medical University & Shandong Academy of Medical Sciences	Shi, LX (corresponding author), Guizhou Med Univ, Dept Endocrinol, Affiliated Hosp, Guiyang, Peoples R China.; Teng, WP (corresponding author), China Med Univ, Dept Endocrinol & Metab, Key Lab Thyroid Dis Liaoning Prov, Hosp 1, Shenyang, Peoples R China.	slx1962@medical.com.cn; twp@vip.163.com		Weng, Jianping/0000-0002-7889-1697	International Medical Exchange Foundation of China	International Medical Exchange Foundation of China	This study was supported by International Medical Exchange Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2014, CLIN ENDOCRINOL, V80, P307, DOI 10.1111/cen.12279; Asvold BO, 2007, ARCH INTERN MED, V167, P1428, DOI 10.1001/archinte.167.13.1428; Bartalena L, 2016, POL ARCH MED WEWN, V126, P725, DOI 10.20452/pamw.3592; Belin RM, 2004, J CLIN ENDOCR METAB, V89, P6077, DOI 10.1210/jc.2004-0431; Benedict MD, 2012, ENVIRON TOXICOL PHAR, V34, P761, DOI 10.1016/j.etap.2012.09.010; Bernecker C, 2014, EXP CLIN ENDOCR DIAB, V122, P107, DOI 10.1055/s-0033-1361088; Brown SJ, 2016, CLIN ENDOCRINOL, V85, P789, DOI 10.1111/cen.13107; Carle A, 2012, CLIN ENDOCRINOL, V77, P764, DOI 10.1111/j.1365-2265.2012.04455.x; Cho NH, 2010, CLIN ENDOCRINOL, V73, P264, DOI 10.1111/j.1365-2265.2010.03790.x; CHRISTENSEN SB, 1984, J CLIN ENDOCR METAB, V58, P615, DOI 10.1210/jcem-58-4-615; EDEN S, 1984, CLIN ENDOCRINOL, V21, P605, DOI 10.1111/j.1365-2265.1984.tb01402.x; Effraimidis G, 2009, J CLIN ENDOCR METAB, V94, P1324, DOI 10.1210/jc.2008-1548; Ehlers M, 2012, J CLIN ENDOCR METAB, V97, P1347, DOI 10.1210/jc.2011-2178; Goh SY, 2004, CLIN ENDOCRINOL, V60, P600, DOI 10.1111/j.1365-2265.2004.02033.x; Gopinath B, 2016, INVEST OPHTH VIS SCI, V57, P5273, DOI 10.1167/iovs.16-19735; Harrison BJ, 2002, CURR OPIN RHEUMATOL, V14, P93, DOI 10.1097/00002281-200203000-00003; HEGEDUS L, 1985, CLIN ENDOCRINOL, V22, P287, DOI 10.1111/j.1365-2265.1985.tb03242.x; HERSEY P, 1983, MED J AUSTRALIA, V2, P425, DOI 10.5694/j.1326-5377.1983.tb122565.x; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hou X, 2011, THYROID, V21, P1353, DOI 10.1089/thy.2011.0035; Ittermann T, 2008, EUR J ENDOCRINOL, V159, P761, DOI 10.1530/EJE-08-0386; Ittermann T, 2013, THYROID, V23, P262, DOI 10.1089/thy.2012.0110; JEREMY JY, 1990, ADV EXP MED BIOL, V273, P135; Jia MW, 2019, BIOL TRACE ELEM RES, V187, P383, DOI 10.1007/s12011-018-1410-2; Jorde R, 2006, EXP CLIN ENDOCR DIAB, V114, P343, DOI 10.1055/s-2006-924264; Kapoor D, 2005, EUR J ENDOCRINOL, V152, P491, DOI 10.1530/eje.1.01867; KARAKAYA A, 1987, HUM TOXICOL, V6, P507, DOI 10.1177/096032718700600610; Knudsen N, 2002, J ENDOCRINOL, V175, P571, DOI 10.1677/joe.0.1750571; Li WJ, 2019, HOLIST NURS PRACT, V33, P45, DOI 10.1097/HNP.0000000000000303; LIO S, 1989, J ENDOCRINOL INVEST, V12, P93, DOI 10.1007/BF03349928; Liu SW, 2017, J EPIDEMIOL COMMUN H, V71, P154, DOI 10.1136/jech-2016-207805; Luijckx E, 2019, CANCER CAUSE CONTROL, V30, P549, DOI 10.1007/s10552-019-01160-8; Mannisto T, 2012, THYROID, V22, P944, DOI 10.1089/thy.2011.0377; Mehran L, 2012, EXP CLIN ENDOCR DIAB, V120, P80, DOI 10.1055/s-0031-1285910; Mehran L, 2017, THYROID, V27, P886, DOI 10.1089/thy.2016.0557; Meral I, 2015, ALTERN THER HEALTH M, V21, P24; Min JY, 2011, INT J CARDIOL, V146, P251, DOI 10.1016/j.ijcard.2010.10.063; Nie XM, 2017, ENVIRON POLLUT, V230, P320, DOI 10.1016/j.envpol.2017.06.052; NYSTROM E, 1993, J ENDOCRINOL INVEST, V16, P129, DOI 10.1007/BF03347665; Park S, 2018, CLIN ENDOCRINOL, V88, P969, DOI 10.1111/cen.13606; Pedersen IB, 2008, EUR J ENDOCRINOL, V158, P367, DOI 10.1530/EJE-07-0595; PETERSEN K, 1991, J INTERN MED, V229, P407, DOI 10.1111/j.1365-2796.1991.tb00367.x; Pontikides Nikolaos, 2002, Hormones (Athens), V1, P91; PRUMMEL MF, 1993, JAMA-J AM MED ASSOC, V269, P479, DOI 10.1001/jama.269.4.479; Qiu FF, 2017, ONCOTARGET, V8, P268, DOI 10.18632/oncotarget.13613; Samet JM, 2013, THORAC SURG CLIN, V23, P103, DOI 10.1016/j.thorsurg.2013.01.009; Sawicka-Gutaj N, 2014, ENDOKRYNOL POL, V65, P54, DOI 10.5603/EP.2014.0008; Shan ZY, 2016, THYROID, V26, P1125, DOI 10.1089/thy.2015.0613; Soldin OP, 2009, THYROID, V19, P817, DOI 10.1089/thy.2009.0023; Song B, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0232-8; Strieder TGA, 2003, CLIN ENDOCRINOL, V59, P396, DOI 10.1046/j.1365-2265.2003.01862.x; Teumer A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06356-1; Vestergaard P, 2002, THYROID, V12, P69, DOI 10.1089/105072502753451995; Wiersinga WM, 2013, CLIN ENDOCRINOL, V79, P145, DOI 10.1111/cen.12222	54	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225435	10.1371/journal.pone.0225435	http://dx.doi.org/10.1371/journal.pone.0225435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765419	Green Published, gold			2022-12-26	WOS:000533891000028
J	Zhao, JG; Wang, JF; Feng, JF; Jin, XY; Ye, WL				Zhao, Jian-Guo; Wang, Jian-Fang; Feng, Jiang-Feng; Jin, Xue-Ying; Ye, Wan-Li			HHIP overexpression inhibits the proliferation, migration and invasion of non-small cell lung cancer	PLOS ONE			English	Article							HEDGEHOG-INTERACTING PROTEIN; PATHWAY	Objective The primary purpose of this study is to investigate the effect of hedgehog-interacting protein (HHIP) overexpression on the proliferation, migration and invasion of non-small cell lung cancer (NSCLC). Methods Firstly, HHIP gene expression data of NSCLC tissues and normal tissues were obtained from GSE18842/GSE19804/GSE43458 databases of the Gene Expression Omnibus (GEO) database and then validated by TCGA NSCLC database in a cohort of 1027 cases of NSCLC patients and 108 cases of normal people. A chi-square test was used to analyze the relationship between HHIP expression and clinicopathological characteristics of NSCLC. The expression levels of HHIP in NSCLC cells were detected by quantitative-real time PCR. The function of HHIP was investigated by a series of in vitro assays. CCK-8, wounding healing, Transwell invasion assay were utilized to explore the mechanisms of HHIP. Results HHIP mRNA were significantly down-regulated in NSCLC in three GEO databases and TCGA database (P< 0.05). This result was confirmed in NSCLC cell lines by qRT-PCR analysis, its expression in normal NSCLC cell line BEAS-2B was significantly higher than that in NSCLC cells. Chi-square test results showed that the low expression of HHIP was correlated with gender, cancer type, TNM stage and tumor size. Functional experimental results showed that over-expressing HHIP significantly decreased the ability of cell proliferation, migration and invasion in NSCLC cells (P< 0.05). Conclusion Overall, the above results indicated that HHIP could regulate proliferation, migration and invasion, and could be used as a judging criterion for identifying NSCLC classification and stage.	[Zhao, Jian-Guo; Wang, Jian-Fang; Feng, Jiang-Feng; Jin, Xue-Ying] Zhejiang Univ, Shaoxing Hosp, Shaoxing Peoples Hosp, Dept Oncol,Sch Med, Shaoxing, Zhejiang, Peoples R China; [Ye, Wan-Li] Zhejiang Univ, Shaoxing Hosp, Shaoxing Peoples Hosp, Dept Radiotherapy,Sch Med, Shaoxing, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ye, WL (corresponding author), Zhejiang Univ, Shaoxing Hosp, Shaoxing Peoples Hosp, Dept Radiotherapy,Sch Med, Shaoxing, Zhejiang, Peoples R China.	yewlsx@163.com			Zhejiang Provincial Natural Science Foundation of China [LY18H160035]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported in part by grants from the Zhejiang Provincial Natural Science Foundation of China (LY18H160035). There was no additional external funding received for this study.	Bak M, 2001, CYTOGENET CELL GENET, V92, P300, DOI 10.1159/000056918; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Buller NVJA, 2012, PHYSIOLOGY, V27, P148, DOI 10.1152/physiol.00003.2012; Cobourne MT, 2012, FRONT ORAL BIOL, V16, P52, DOI 10.1159/000337543; Grabowski J, 2016, AM J HEALTH-SYST PH, V73, P957, DOI 10.2146/ajhp150188; Kayed H, 2005, MOL CARCINOGEN, V42, P183, DOI 10.1002/mc.20088; Lin EH, 2016, ONCOTARGET, V7, P24179, DOI 10.18632/oncotarget.8253; Queiroz KCS, 2012, DRUG RESIST UPDATE, V15, P211, DOI 10.1016/j.drup.2012.05.002; Siegel RL, 2018, CA-CANCER J CLIN, V68, P30; Sun H, 2018, J CANCER, V9, P4642, DOI 10.7150/jca.27686; Tada M, 2008, CLIN CANCER RES, V14, P3768, DOI 10.1158/1078-0432.CCR-07-1181; Thatcher EJ, 2010, RNA BIOL, V7, P333, DOI 10.4161/rna.7.3.12085; Wei SH, 2018, J CANCER RES CLIN, V144, P145, DOI 10.1007/s00432-017-2522-3; Yang L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-112; Zuo Y, 2018, CELL PHYSIOL BIOCHEM, V45, P1840, DOI 10.1159/000487875	15	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225755	10.1371/journal.pone.0225755	http://dx.doi.org/10.1371/journal.pone.0225755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765425	Green Published, gold			2022-12-26	WOS:000533891000045
J	Guo, QQ; Ng, PQ; Shi, SS; Fan, DW; Li, J; Zhao, J; Wang, H; David, R; Mittal, P; Do, T; Bock, R; Zhao, M; Zhou, WB; Searle, I				Guo, Qianqian; Ng, Pei Qin; Shi, Shanshan; Fan, Diwen; Li, Jun; Zhao, Jing; Wang, Hua; David, Rakesh; Mittal, Parul; Trung Do; Bock, Ralph; Zhao, Ming; Zhou, Wenbin; Searle, Iain			Arabidopsis TRM5 encodes a nuclear-localised bifunctional tRNA guanine and inosine-N1-methyltransferase that is important for growth	PLOS ONE			English	Article							MODIFIED NUCLEOSIDE; PROTEIN-SYNTHESIS; ANTICODON; ADENOSINE; REVEALS; CODON; 1-METHYLGUANOSINE; 5-METHYLCYTOSINE; IDENTIFICATION; ANNOTATION	Modified nucleosides in tRNAs are critical for protein translation. N-1-methylguanosine-37 and N-1-methylinosine-37 in tRNAs, both located at the 3'-adjacent to the anticodon, are formed by Trm5. Here we describe Arabidopsis thaliana AtTRM5 (At3g56120) as a Trm5 ortholog. Attrm5 mutant plants have overall slower growth as observed by slower leaf initiation rate, delayed flowering and reduced primary root length. In Attrm5 mutants, mRNAs of flowering time genes are less abundant and correlated with delayed flowering. We show that AtTRM5 complements the yeast trm5 mutant, and in vitro methylates tRNA guanosine37 to produce N-1-methylguanosine (m(1)G). We also show in vitro that AtTRM5 methylates tRNA inosine-37 to produce N-1-methylinosine (m(1)I) and in Attrm5 mutant plants, we show a reduction of both N-1-methylguanosine and N-1-methylinosine. We also show that AtTRM5 is localized to the nucleus in plant cells. Proteomics data showed that photosynthetic protein abundance is affected in Attrm5 mutant plants. Finally, we show tRNA-Ala aminoacylation is not affected in Attrm5 mutants. However the abundance of tRNA-Ala and tRNA-Asp 5' half cleavage products are deduced. Our findings highlight the bifunctionality of AtTRM5 and the importance of the post-transcriptional tRNA modifications m(1)G and m(1)I at tRNA position 37 in general plant growth and development.	[Guo, Qianqian; Shi, Shanshan; Fan, Diwen; Zhao, Ming; Zhou, Wenbin] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Ng, Pei Qin; Li, Jun; Zhao, Jing; Trung Do; Searle, Iain] Univ Adelaide, Sch Agr Food & Wine, Sch Biol Sci, Univ Adelaide & Shanghai Jiao Tong Univ Joint Int, Adelaide, SA, Australia; [Wang, Hua] Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [David, Rakesh] Univ Adelaide, ARC Ctr Excellence Plant Energy Biol, Sch Agr Food & Wine, Adelaide, SA, Australia; [Mittal, Parul] Univ Adelaide, Adelaide Prote Ctr, Sch Biol Sci, Adelaide, SA, Australia; [Bock, Ralph] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanghai Jiao Tong University; University of Adelaide; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Adelaide; University of Adelaide; Max Planck Society	Zhou, WB (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.; Searle, I (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Sch Biol Sci, Univ Adelaide & Shanghai Jiao Tong Univ Joint Int, Adelaide, SA, Australia.	zhouwenbin@caas.cn; Iain.Searle@adelaide.edu.au	David, Rakesh/AAH-9045-2019; Bock, Ralph/B-4352-2009	Bock, Ralph/0000-0001-7502-6940; Mittal, Parul/0000-0003-0139-9757; Zhou, Wenbin/0000-0001-5911-1686; Do, Trung/0000-0001-5661-4181; Ng, Pei Qin/0000-0003-0944-1913; Shi, Shanshan/0000-0001-5702-6963; Searle, Iain/0000-0003-4306-9756; Li, Jun/0000-0001-9988-9409	ARC [FT130100525, ACSRF48187]; National Natural Science Foundation [31570234]; Innovation Program of Chinese Academy of Agricultural Sciences; Elite Youth Program of the Chinese Academy of Agricultural Science; APA	ARC(Australian Research Council); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Innovation Program of Chinese Academy of Agricultural Sciences; Elite Youth Program of the Chinese Academy of Agricultural Science; APA	The research was partially supported by ARC grant FT130100525, partially funded an Australia-China Science and Research Fund grant ACSRF48187 awarded to I.S. and an APA awarded to PQ.N and J.L. This research was also partially supported by the National Natural Science Foundation (31570234) awarded to W.Z., W.Z. was supported by the Innovation Program of Chinese Academy of Agricultural Sciences and the Elite Youth Program of the Chinese Academy of Agricultural Science.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Allner O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ASTROM SU, 1994, CELL, V79, P535, DOI 10.1016/0092-8674(94)90262-3; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Brule H, 2004, BIOCHEMISTRY-US, V43, P9243, DOI 10.1021/bi049671q; Burgess A, 2016, J INTEGR PLANT BIOL, V58, P822, DOI 10.1111/jipb.12483; Burgess AL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0580-8; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Chong YE, 2018, P NATL ACAD SCI USA, V115, P7527, DOI 10.1073/pnas.1807109115; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; David R, 2017, PLANT CELL, V29, P445, DOI 10.1105/tpc.16.00751; Davis AM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-3; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2015, CURRENT PROTOCOLS BI, V51; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; Torres AG, 2014, FEBS LETT, V588, P4279, DOI 10.1016/j.febslet.2014.09.025; Gamper HB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8226; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Grosjean H, 1996, BIOCHIMIE, V78, P488, DOI 10.1016/0300-9084(96)84755-9; Guo QQ, 2017, PLANT GROWTH REGUL, V83, P83, DOI 10.1007/s10725-017-0285-0; HAGERVALL TG, 1993, J MOL BIOL, V232, P756, DOI 10.1006/jmbi.1993.1429; Helm M, 2014, CHEM BIOL, V21, P174, DOI 10.1016/j.chembiol.2013.10.015; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hori H, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010023; Jackman JE, 2013, WIRES RNA, V4, P35, DOI 10.1002/wrna.1144; Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303; Jin XH, 2019, NUCLEIC ACIDS RES, V47, P883, DOI 10.1093/nar/gky1205; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; LaBrant E, 2018, PHOTOSYNTH RES, P1; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Lee C, 2007, J BIOL CHEM, V282, P27744, DOI 10.1074/jbc.M704572200; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; LI JN, 1995, J BACTERIOL, V177, P6593, DOI 10.1128/jb.177.22.6593-6600.1995; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Manna S, 2015, BIOCHIMIE, V113, P93, DOI 10.1016/j.biochi.2015.04.004; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mleczko AM, 2018, BBA-GENE REGUL MECH, V1861, P647, DOI 10.1016/j.bbagrm.2018.06.001; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; Nasvall SJ, 2004, RNA, V10, P1662, DOI 10.1261/rna.7106404; Negi Simarjeet, 2015, Database (Oxford), V2015, DOI 10.1093/database/bav003; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Ohira T, 2011, P NATL ACAD SCI USA, V108, P10502, DOI 10.1073/pnas.1105645108; Paris Z, 2013, RNA, V19, P649, DOI 10.1261/rna.036665.112; PERRET V, 1990, NATURE, V344, P787, DOI 10.1038/344787a0; Phizicky EM, 2010, FEBS LETT, V584, P265, DOI 10.1016/j.febslet.2009.11.049; Pound MP, 2013, PLANT PHYSIOL, V162, P1802, DOI 10.1104/pp.113.221531; Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011; Ryvkin P, 2013, RNA, V19, P1684, DOI 10.1261/rna.036806.112; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Shaheen HH, 2007, P NATL ACAD SCI USA, V104, P8845, DOI 10.1073/pnas.0700765104; Sperschneider J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44598; Takano A, 2005, SCIENCE, V309, P140, DOI 10.1126/science.1113346; Urbonavicius J, 2003, RNA, V9, P760, DOI 10.1261/rna.5210803; Wang CY, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700195; Wang YM, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1206-0; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu HL, 2005, PLANT CELL PHYSIOL, V46, P1505, DOI 10.1093/pcp/pci163; Zhou WB, 2013, NUCLEIC ACIDS RES, V41, P3362, DOI 10.1093/nar/gkt013	73	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225064	10.1371/journal.pone.0225064	http://dx.doi.org/10.1371/journal.pone.0225064			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756231	Green Submitted, Green Published, gold			2022-12-26	WOS:000533889300008
J	Meskendahl, L; Fontes, RP; Herrmann, JP; Temming, A				Meskendahl, Laura; Fontes, Rene Pascal; Herrmann, Jens-Peter; Temming, Axel			Metabolic costs of spontaneous swimming in Sprattus sprattus L., at different water temperatures	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; OXYGEN-CONSUMPTION; MULTIMODEL INFERENCE; BIOENERGETICS MODEL; BEAT FREQUENCY; ENERGY COSTS; SPEED; FISH; BODY; RESPIRATION	Oxygen uptake (MO2; mgO(2) fish(-1)h(-1)) of fish groups was measured at temperatures between 10-19 degrees C in an intermittent-flow respirometer to quantify the metabolic costs of spontaneous swimming patterns in the small clupeid Sprattus sprattus. Movements of individual fish within the school were tracked automatically during respirometry. Oxygen uptake was then related to mean swimming speeds and the number of sharp turns (>90 degrees), which are common behavioural elements of spontaneous swimming in clupeid fish. Different possible model formulations for describing the relationship between respiration and swimming patterns were compared via the AIC. The final model revealed that costs for sharp turns at a frequency of 1 s(-1) doubled the metabolic costs compared to those with zero turns but with likewise a moderate swimming speed of 0.28 body length(-1). The cost for swimming doubled if the swimming speed was doubled from 0.28 to 0.56 BLs(-1) but increased by a factor of 4.5 if tripled to 0.84 BLs(-1). Costs for transport were minimal at a speed of 0.4 body lengths s(-1) at all temperatures. New basic input parameters to estimate energy losses during spontaneous movements, which occur typically during foraging in this small pelagic fish, are provided.	[Meskendahl, Laura; Herrmann, Jens-Peter; Temming, Axel] Univ Hamburg, Inst Marine Ecosyst & Fisheries Sci, Hamburg, Germany; [Fontes, Rene Pascal] Reederei Laeisz GmbH, Rostock, Germany	University of Hamburg	Temming, A (corresponding author), Univ Hamburg, Inst Marine Ecosyst & Fisheries Sci, Hamburg, Germany.	atemming@uni-hamburg.de						Barriga-Rivera A, 2011, IEEE ENG MED BIO, P4860, DOI 10.1109/IEMBS.2011.6091204; Bernreuther M., 2007, INVESTIGATIONS FEEDI; BLAKE RW, 1983, CAN J ZOOL, V61, P2491, DOI 10.1139/z83-330; Blake RW, 1992, EFFICIENCY EC ANIMAL, P13, DOI [10.1017/CBO9780511565588.003, DOI 10.1017/CBO9780511565588.003]; Blank JM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P167, DOI 10.1086/510637; BOGGS CH, 1991, FISH B-NOAA, V89, P555; BOISCLAIR D, 1993, J FISH BIOL, V42, P169, DOI 10.1111/j.1095-8649.1993.tb00319.x; BOISCLAIR D, 1989, CAN J FISH AQUAT SCI, V46, P1859, DOI 10.1139/f89-234; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Brachvogel R, 2013, MAR BIOL, V160, P465, DOI 10.1007/s00227-012-2104-5; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cardinale M, 2000, ICES J MAR SCI, V57, P882, DOI 10.1006/jmsc.2000.0575; Chabot D, 2016, J FISH BIOL, V88, P81, DOI 10.1111/jfb.12845; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Colby P.J., 1973, P163; Davis LE, 1997, T AM FISH SOC, V126, P248, DOI 10.1577/1548-8659(1997)126&lt;0248:TERTHS&gt;2.3.CO;2; Delcourt J, 2013, FISH FISH, V14, P186, DOI 10.1111/j.1467-2979.2012.00462.x; Enders EC, 2003, ARCH FISH MAR RES, V50, P205; HARALICK RM, 1987, IEEE T PATTERN ANAL, V9, P532, DOI 10.1109/TPAMI.1987.4767941; Hein AM, 2012, BIOL LETTERS, V8, P266, DOI 10.1098/rsbl.2011.0885; Herrmann JP, 2000, J FISH BIOL, V57, P746, DOI [10.1006/jfbi.2000.1348, 10.1111/j.1095-8649.2000.tb00272.x]; Hewett SW, 1992, TECHNICAL REPORT; Johnston IA, 2002, J EXP BIOL, V205, P2305; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Killen SS, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1588; KITCHELL JF, 1977, J FISH RES BOARD CAN, V34, P1922, DOI 10.1139/f77-258; Klumb RA, 2003, T AM FISH SOC, V132, P1089, DOI 10.1577/T03-038; KOCH F, 1983, J EXP BIOL, V107, P141; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Koster FW, 2000, ICES J MAR SCI, V57, P310, DOI 10.1006/jmsc.1999.0528; KROHN MM, 1994, CAN J FISH AQUAT SCI, V51, P1119, DOI 10.1139/f94-111; Leonard JBK, 1999, J COMP PHYSIOL B, V169, P287, DOI 10.1007/s003600050223; Lochmatter T, 2008, IEEE RSJ INT C INT R, DOI [10.1109/IROS.2008.4650937, DOI 10.1109/IROS.2008.4650937]; Macy WK, 1999, FISH B-NOAA, V97, P282; Marras S, 2015, BEHAV ECOL SOCIOBIOL, V69, P219, DOI 10.1007/s00265-014-1834-4; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; Meskendahl L, 2010, MAR BIOL, V157, P1917, DOI 10.1007/s00227-010-1461-1; Meskendahl L., 2013, METABOLIC RATES FEED; Nilsson LAF, 2003, AQUAT LIVING RESOUR, V16, P317, DOI 10.1016/S0990-7440(03)00039-1; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Ohlberger J, 2005, J EXP ZOOL PART A, V303A, P657, DOI 10.1002/jez.a.181; Ohlberger J, 2007, J COMP PHYSIOL B, V177, P905, DOI 10.1007/s00360-007-0189-9; Papadopoulos A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004852; Pinkiewicz T, 2008, P DIG IM COMP TECHN, P997, DOI [10.1109/DICTA.2008.28, DOI 10.1109/DICTA.2008.28]; R Development Core Team R, 2011, R FDN STAT COMP, DOI [10.1016/S1015-9584(10)60025-5, DOI 10.1016/S1015-9584(10)60025-5]; Ritz C, 2008, USE R, P1; Rustam L.G., 1988, Kieler Meeresforschungen Sonderheft, P312; SCHAEFER KM, 1986, COPEIA, P39; Schleuter D, 2007, T AM FISH SOC, V136, P43, DOI 10.1577/T06-123.1; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; SIROIS P, 1995, J FISH BIOL, V46, P787, DOI 10.1111/j.1095-8649.1995.tb01602.x; Speers-Roesch B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1593; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; Steinhausen MF, 2007, J FISH BIOL, V71, P957, DOI 10.1111/j.1095-8649.2007.01563.x; Steinhausen MF, 2010, MAR FRESHW BEHAV PHY, V43, P227, DOI 10.1080/10236244.2010.501135; Steinhausen MF, 2005, MAR BIOL, V148, P197, DOI 10.1007/s00227-005-0055-9; STEWART DJ, 1986, T AM FISH SOC, V115, P643, DOI 10.1577/1548-8659(1986)115<643:DOCAFC>2.0.CO;2; Tang M, 2000, CAN J FISH AQUAT SCI, V57, P1482, DOI 10.1139/cjfas-57-7-1482; Tudorache C, 2009, ENVIRON BIOL FISH, V84, P121, DOI 10.1007/s10641-008-9395-x; vanderLingen CD, 1995, MAR ECOL PROG SER, V129, P41, DOI 10.3354/meps129041; Videler, 1993, FISH SWIMMING; VIDELER JJ, 1990, COMP BIOCHEM PHYS A, V97, P91, DOI 10.1016/0300-9629(90)90155-L; WARE DM, 1978, J FISH RES BOARD CAN, V35, P220, DOI 10.1139/f78-036; WARE DM, 1975, J FISH RES BOARD CAN, V32, P33, DOI 10.1139/f75-005; WEBB PW, 1991, CAN J FISH AQUAT SCI, V48, P583, DOI 10.1139/f91-074; Whitney NM, 2016, J EXP MAR BIOL ECOL, V477, P40, DOI 10.1016/j.jembe.2015.12.009; Winberg G. G., 1960, FISHERIES RES BOARD, V194; Zimmermann C, 2001, MAR ECOL PROG SER, V219, P229, DOI 10.3354/meps219229	69	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225568	10.1371/journal.pone.0225568	http://dx.doi.org/10.1371/journal.pone.0225568			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756238	Green Published, gold			2022-12-26	WOS:000533889300039
J	Hardy, SK; Deutsch, CJ; Cross, TA; de Wit, M; Hostetler, JA				Hardy, Stacie K.; Deutsch, Charles J.; Cross, Tiffanie A.; de Wit, Martine; Hostetler, Jeffrey A.			Cold-related Florida manatee mortality in relation to air and water temperatures	PLOS ONE			English	Article							WEST-INDIAN MANATEES; TRICHECHUS-MANATUS; POWER-PLANTS; PATTERNS; REGRESSION; REFUGES; ECOLOGY; EVENTS; MODELS; BAY	Many tropical and subtropical species are sensitive to sudden temperature changes, especially drops in temperature. During winters 2009-2010 and 2010-2011, unusually cold temperatures occurred in many parts of Florida, USA, resulting in increased mortality of Florida manatees, sea turtles, fish, corals, and other species. The Florida manatee, in particular, is highly susceptible to cold stress and death when water temperatures drop below 20 degrees C. We sought to characterize the magnitude and timing of reports of cold-related manatee carcasses in relation to fluctuations in water and air temperatures in central-east and centralwest Florida during the six winters from 2008 to 2014. We used a generalized linear model to predict counts of manatee carcasses with a cold-related cause of death reported over 7day bins in relation to various short-term (two weeks or less) and cumulative (incrementally summed from the start of the winter) heating-degree-day effects (HDD; < 20 degrees C) and a categorical winter variable. Using water temperature data, the top-ranked model in both regions included a short-term temperature effect (14-day HDD sum) that preceded increases in reports of cold-related manatee carcasses by 7 days. Cumulative exposure to cold weather over the winter amplified effects on mortality in the central-east region. Quantifying the relationship between cold events and manatee mortality helps us prepare for rescue and salvage operations when extremely cold weather is forecast. This is especially important because anticipated loss or degradation of warm-water refuges due to human activities and sea level rise could potentially impact the manatee population in the future. These methods could also be applied to other species susceptible to cold-related mortality.	[Hardy, Stacie K.; Cross, Tiffanie A.; de Wit, Martine; Hostetler, Jeffrey A.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA; [Deutsch, Charles J.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Gainesville, FL USA; [Hardy, Stacie K.] NOAA, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA	Florida Fish & Wildlife Conservation Commission; Florida Fish & Wildlife Conservation Commission; National Oceanic Atmospheric Admin (NOAA) - USA	Hardy, SK (corresponding author), Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA.; Hardy, SK (corresponding author), NOAA, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA.	Stacie.Hardy@noaa.gov	Hostetler, Jeffrey A./A-3345-2011	Hostetler, Jeffrey A./0000-0003-3669-1758; Hardy, Stacie/0000-0002-9476-5383	Disney Worldwide Conservation Fund [WFF-12-01]; Florida Fish and Wildlife Conservation Commission's Save the Manatee Trust Fund - Florida Fish and Wildlife Conservation Commission's Fish and Wildlife Research Institute Marine Mammal Program	Disney Worldwide Conservation Fund; Florida Fish and Wildlife Conservation Commission's Save the Manatee Trust Fund - Florida Fish and Wildlife Conservation Commission's Fish and Wildlife Research Institute Marine Mammal Program	This work was supported in part by the Disney Worldwide Conservation Fund, Project Reference Number WFF-12-01. More details about the Conservation Fund can be found here: https://thewaltdisneycompany.com/disney-conservationfund/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remainder of funds that supported this project came from the Florida Fish and Wildlife Conservation Commission's Save the Manatee Trust Fund (http://myfwc.com/research/manatee/trust-fund/), which funds most of the research by the Florida Fish and Wildlife Conservation Commission's Fish and Wildlife Research Institute Marine Mammal Program, including staff time, supplies, and other resources for conducting this study. Staff who contributed to this work have been acknowledged as either authors on this manuscript or in the Acknowledgments.	Ackerman BB, 1995, 1 NAT BIOL SERV INF; Barlas ME, 2011, FLORIDA MANATEE COLD; Bloetscher F., 2009, FLORIDA WATER RESOUR; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonde R.K., 1983, MANUAL PROCEDURES SA; Bossart Gregory D., 2003, Aquatic Mammals, V29, P9, DOI 10.1578/016754203101024031; Brownscombe JW, 2019, ENVIRON BIOL FISH, V102, P329, DOI 10.1007/s10641-018-0820-5; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; Deutsch CJ, 2016, F28641015F FWCFWRI; Deutsch CJ, 2015, WFF1201; Edwards HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151450; Florida Fish and Wildlife Conservation Commission, 2007, FLOR MAN MAN PLAN; Gannon JG, 2007, MAR MAMMAL SCI, V23, P133, DOI 10.1111/j.1748-7692.2006.00096.x; Hartman D.S, 1979, ECOLOGY BEHAV MANATE; IRVINE AB, 1983, BIOL CONSERV, V25, P315; Knight R. L., 2015, SILENCED SPRINGS MOV; Laist DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058978; Laist DW, 2005, MAR MAMMAL SCI, V21, P739, DOI 10.1111/j.1748-7692.2005.tb01263.x; Laist DW, 2005, COAST MANAGE, V33, P279, DOI 10.1080/08920750590952018; Lefebvre Lynn W., 2001, P425; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; Liu HB, 2005, J INFRASTRUCT SYST, V11, P258, DOI 10.1061/(ASCE)1076-0342(2005)11:4(258); Martin J, 2015, BIOL CONSERV, V186, P44, DOI 10.1016/j.biocon.2015.02.029; Mazzotti FJ, 2011, BIOL INVASIONS, V13, P143, DOI 10.1007/s10530-010-9797-5; McCullagh P, 1989, GEN LINEAR MODELS; OSHEA TJ, 1985, J WILDLIFE MANAGE, V49, P1, DOI 10.2307/3801830; Pirhalla DE, 2015, ESTUAR COAST, V38, P2310, DOI 10.1007/s12237-014-9918-y; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Rayer S, 2017, PROJECTIONS FLORIDA; REID JP, 1991, MAR MAMMAL SCI, V7, P180, DOI 10.1111/j.1748-7692.1991.tb00564.x; REYNOLDS JE, 1994, MAR MAMMAL SCI, V10, P163, DOI 10.1111/j.1748-7692.1994.tb00258.x; Roberts K, 2014, PHYS GEOGR, V35, P134, DOI 10.1080/02723646.2014.898573; Runge MC, 2016, STATUS THREATS ANAL, V5030, P40; Shaver DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173920; Stevens PW, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1400; Stith BM, 2011, ESTUAR COAST, V34, P106, DOI 10.1007/s12237-010-9286-1; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; U.S. Fish and Wildlife Service,, 2001, FLOR MAN REC PLAN TR, P138; Venables WN., 2002, MODERN APPL STAT S 4; Walsh CJ, 2005, VET IMMUNOL IMMUNOP, V103, P247, DOI 10.1016/j.vetimm.2004.09.026; Weigle B. L., 2001, TR7 FLOR MAR RES I; Worthy GA, 1999, P WARM WAT WORKSH US, P17	45	4	4	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225048	10.1371/journal.pone.0225048	http://dx.doi.org/10.1371/journal.pone.0225048			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751355	Green Published, gold			2022-12-26	WOS:000533886900026
J	Sin, T; Gazzola, A; Chiriac, S; Risnoveanu, G				Sin, Teodora; Gazzola, Andrea; Chiriac, Silviu; Risnoveanu, Geta			Wolf diet and prey selection in the South-Eastern Carpathian Mountains, Romania	PLOS ONE			English	Article							WOLVES CANIS-LUPUS; NATIONAL-PARK; NICHE OVERLAP; FOOD-HABITS; WILD; PREDATION; BEHAVIOR; WESTERN; EUROPE; SCATS	The Romanian wolf population, one of the largest in Europe, occupies a total home-range of 154500 km(2) and is spread across a variety of landscapes-from anthropized hills and plateaus to remote, densely forested mountains. However, this population is markedly understudied, and even basic knowledge of the species' feeding habits is deficient. Wolf diet was assessed based on 236 scat samples collected between November 2013 and October 2014, by following pre-established transects (total length = 774 km). The study area (600 km2) is a multi-prey ecosystem in the southern sector of the Eastern Romanian Carpathians. Our results emphasize that more than 80% of the wolf diet is based on wild ungulates. The wild boar is clearly selected (D = 0.74) and is the most common species in the diet (Bio = 72%), while roe deer (Bio = 10%) and red deer (Bio = 5%) have a smaller contribution. Domestic species represented the second-largest prey category in both seasons. Among them, dog is a particularly important source of food (Bio 3.5-10.9%). Other domestic species (goat, sheep, horse) have marginal importance in the wolf diet and seasonal occurrence. Standardized niche breadths are low in both seasons (B-Aw = 0.07, B-As = 0.12), and a high degree of overlap in the resources used has been observed (O-ws = 0.99). Our study represents the first step towards understanding the wolf foraging behaviour in the Romanian Carpathians and is valuable to address the complex issues of wolf and wild ungulate population management and conservation.	[Sin, Teodora; Risnoveanu, Geta] Univ Bucharest, Fac Biol, Dept Syst Ecol & Sustainabil, Bucharest, Romania; [Sin, Teodora; Gazzola, Andrea] Assoc Conservat Biol Divers, Focsani, Vrancea County, Romania; [Chiriac, Silviu] Environm Protect Agcy, Focsani, Vrancea County, Romania	University of Bucharest	Sin, T; Risnoveanu, G (corresponding author), Univ Bucharest, Fac Biol, Dept Syst Ecol & Sustainabil, Bucharest, Romania.; Sin, T (corresponding author), Assoc Conservat Biol Divers, Focsani, Vrancea County, Romania.	teodora.sin@g.unibuc.ro; geta.risnoveanu@g.unibuc.ro	Risnoveanu, Geta/Q-3790-2019; Sin, Teodora/AAY-5825-2021	Risnoveanu, Geta/0000-0002-5194-5448; Sin, Teodora/0000-0001-7624-0471	Project "Doctoral and Post-doctoral programs of excellence for highly qualified human resources training for research in the field of Life sciences, Environment and Earth Science" [POSDRU/159/1.5/S/133391]; European Social Fund within the Sectorial Operational Program Human Resources Development 2007-2013; Pro Biodiversitas SRL; WolfLife project [LIFE13NAT/RO/000205]	Project "Doctoral and Post-doctoral programs of excellence for highly qualified human resources training for research in the field of Life sciences, Environment and Earth Science"; European Social Fund within the Sectorial Operational Program Human Resources Development 2007-2013; Pro Biodiversitas SRL; WolfLife project	Putna-Vrancea Natural Park Administration (http://parculputnavrancea.ro/), Association for the Conservation of Biological Diversity (www.acdb.ro) and the Environmental Protection Agency, Vrancea County (http://apmvn.anpm.ro/) provided logistic support during data collection. Part of staff costs for TS and laboratory work has been supported from the strategic grant POSDRU/159/1.5/S/133391, Project "Doctoral and Post-doctoral programs of excellence for highly qualified human resources training for research in the field of Life sciences, Environment and Earth Science" co-financed by the European Social Fund within the Sectorial Operational Program Human Resources Development 2007-2013 (http://fondurieuropene.centre.ubbcluj.ro/posdru1591-5g133391-programe-doctorale-si-post-doctorale-de-excelenta-pentru-formarea-de-resurse-umaneinalt-calificate-pentru-cercetare-in-domeniile-stiintelor-vietii-mediului-si-pamantului/).Additional support for TS has been provided by Pro Biodiversitas SRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The help of WolfLife project (LIFE13NAT/RO/000205) volunteers and colleagues Andrea Corradini, Gabriela Rizzardini, Kieran O'Mahony, Guido Rastrelli during the fieldwork activities is very much appreciated. We thank Hannah Kirkland for the help with language editing and to the reviewers, Sandro Lovari and Maria Petridou, for the valuable suggestions and constructive comments made to improve this MS.	Altenburg W, 2006, SAFEGUARDING ROMANIA; Annoni A, 2004, P 1 EUR WORKSH REF G; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2012, VERS 18 2; Biris I.A., 2005, VIRGIN FORESTS ROMAN; Boitani L., 2003, WOLVES BEHAV ECOLOGY, P448; Bongi P, 2008, J ZOOL, V276, P242, DOI 10.1111/j.1469-7998.2008.00481.x; Bongi P., 2009, ENV HUMAN FACTORS AF; Borkowski J, 2001, ACTA THERIOL, V46, P195, DOI 10.1007/BF03192428; Cavallini P, 1995, ANN ZOOLOGICI FENNIC; Chakrabarti S, 2016, J ANIM ECOL, V85, P660, DOI 10.1111/1365-2656.12508; Chapron G, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2939; Chiriac S. SR, 2008, PLANUL MANAGEMENT PA; Ciucci P., 1994, THESIS; Ciucci P, 1996, WILDLIFE BIOL, V2, P37, DOI 10.2981/wlb.1996.006; De Groot GA, 2016, MAMMAL REV, V46, P44, DOI 10.1111/mam.12052; De Marinis AM, 2006, WILDLIFE BIOL, V12, P305, DOI 10.2981/0909-6396(2006)12[305:HIKOWA]2.0.CO;2; Debrot S., 1982, ATLAS POILS MAMMIFER, P208; Fuller TK, 2003, WOLVES BEHAV ECOLOGY, P448; Gazzola A, 2005, J ZOOL, V266, P205, DOI 10.1017/S0952836905006801; Geacu S, 2009, REV ROUMAINE GEOGRAP, V53, P219; Glowacinski Z, 1997, BIOL CONSERV, V80, P99, DOI 10.1016/S0006-3207(96)00067-5; Griffiths P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/045024; Huband S., 2010, PASTOR RES POLICY PR, V1, P55, DOI [DOI 10.3362/2041-7136.2010.004, 10.3362/2041-7136.2010.004]; HUGGARD DJ, 1993, CAN J ZOOL, V71, P130, DOI 10.1139/z93-019; HURLBERT SH, 1978, ECOLOGY, V59, P67, DOI 10.2307/1936632; Imbert C, 2016, BIOL CONSERV, V195, P156, DOI 10.1016/j.biocon.2016.01.003; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JEDRZEJEWSKI W, 1992, OECOLOGIA, V90, P27, DOI 10.1007/BF00317805; Jedrzejewski W, 2012, J MAMMAL, V93, P1480, DOI 10.1644/10-MAMM-A-132.1; Kaczensky P, 2012, 070307 IUCNSSC LARG; Keith LB, 1983, POPULATION DYNAMICS; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; KRUUK H, 1981, J ANIM ECOL, V50, P773, DOI 10.2307/4136; Lescureux N, 2014, BIOL CONSERV, V171, P232, DOI 10.1016/j.biocon.2014.01.032; LEVINS RICHARD, 1968; Llaneza L, 1996, ACTA VERTEBRATA, V23, P201; Llaneza L, 2015, EUR J WILDLIFE RES, V61, P895, DOI 10.1007/s10344-015-0966-9; LOCKIE J. D., 1959, JOUR WILDLIFE MANAGEMENT, V23, P224, DOI 10.2307/3797647; Lumetsberger T, 2017, J ZOOL, V302, P201, DOI 10.1111/jzo.12449; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Marucco F, 2012, HYSTRIX, V23, P1, DOI 10.4404/hystrix-23.1-6364; Mattioli L, 1995, ACTA THERIOL, V40, P387, DOI 10.4098/AT.arch.95-36; Mattioli L, 2011, EUR J WILDLIFE RES, V57, P909, DOI 10.1007/s10344-011-0503-4; Mech D., 2003, WOLVES BEHAV ECOLOGY; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Milanesi P, 2012, ETHOL ECOL EVOL, V24, P81, DOI 10.1080/03949370.2011.592220; Mori E, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-016-1060-7; Newsome TM, 2016, MAMMAL REV, V46, P255, DOI 10.1111/mam.12067; Nowak S, 2011, MAMM BIOL, V76, P709, DOI 10.1016/j.mambio.2011.06.007; Petridou M, 2019, MAMMALIA; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Popescu VD, 2016, J APPL ECOL, V53, P1248, DOI 10.1111/1365-2664.12660; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; RIGG R, 2004, OECOL MONT, V13, P30; Rogala JK, 2011, ECOL SOC, V16, DOI 10.5751/ES-04251-160316; Rozylowicz L, 2011, BIODIVERS CONSERV, V20, P561, DOI 10.1007/s10531-010-9967-x; Scarlatescu G, 1977, ANALELE ICAS, V35, P53; SERAFINI P, 1993, ACTA THERIOL, V38, P233, DOI 10.4098/AT.arch.93-19; SMIETANA W, 1993, ACTA THERIOL, V38, P245; Steenweg R, 2015, MAMMAL RES, V60, P207, DOI 10.1007/s13364-015-0222-4; Stephens D.W., 1986, pi; Strimbu BM, 2005, FOREST CHRON, V81, P350, DOI 10.5558/tfc81350-3; Teerink B. J., 2003, HAIR W EUROPEAN MAMM; Thurfjell H, 2013, WILDLIFE BIOL, V19, P87, DOI 10.2981/12-027; Torres RT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129379; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278; Wolf-Romania Ionescu O., 2012, REPORT EU COMMISSION; Zlatanova D, 2014, ACTA ZOOL BULGAR, V66, P439; [No title captured]	70	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225424	10.1371/journal.pone.0225424	http://dx.doi.org/10.1371/journal.pone.0225424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751409	gold, Green Published			2022-12-26	WOS:000533886900060
J	Torres, D; Hou, XN; Bale, L; Heinzen, EP; Maurer, MJ; Zanfagnin, V; Oberg, AL; Conover, C; Weroha, SJ				Torres, Diogo; Hou, Xiaonan; Bale, Laurie; Heinzen, Ethan P.; Maurer, Matthew J.; Zanfagnin, Valentina; Oberg, Ann L.; Conover, Cheryl; Weroha, S. John			Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A	PLOS ONE			English	Article							GROWTH-FACTOR-I; FACTOR 1 RECEPTOR; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; PHASE-I; VIVO; INHIBITION; PACLITAXEL; PATHWAYS; EFFICACY	Objectives Inhibition of pregnancy-associated plasma protein-A (PAPP-A), an upstream activator of the insulin-like growth factor (IGF) pathway, is known to augment sensitivity to platinum-based chemotherapy. This study further tests the efficacy of PAPP-A inhibition with a monoclonal antibody inhibitor (mAb-PA) in ovarian cancer (OC) platinum-resistant patient-derived xenograft (PDX) models. Methods PAPP-A expression was quantitated in platinum-resistant PDX models by ELISA. A subset with High (n = 5) and Low (n = 2) expression were revived in female SCID/beige mice for studies with either saline, carboplatin/paclitaxel (CP) + mAb-PA, or CP + IgG2a. The primary endpoint was tumor area by ultrasound on day 28 relative to baseline. Conversion to platinum-sensitive was defined by average tumor regression below baseline. Statistical analyses included linear mixed effects modeling and Kaplan Meier curves. Response to therapy was correlated with changes in the ratio of phosphorylated/total AKT and ERK 1/2 using Wes analysis. Results The addition of mAb-PA to CP induced tumor regression below baseline in one High PAPP-A PDX model; another three models exhibited notable growth inhibition relative to CP + IgG2a. None of the Low PAPP-A PDX models regressed below baseline. The PDX model with the greatest magnitude of tumor regression from baseline after combination therapy was maintained on single agent mAb-PA or IgG2a, but no benefit was observed. Decreased phosphorylation of ERK1/2 correlated with conversion to platinum-sensitive. Conclusions The addition of mAb-PA to CP overcame platinum-resistance in one of five High PAPP-A PDX models; three other models demonstrated improved platinum-response. This supports further clinical development of this novel therapeutic.	[Torres, Diogo; Maurer, Matthew J.] Mayo Clin, Div Gynecol Surg, Dept Obstet & Gynecol, Rochester, MN USA; [Hou, Xiaonan; Zanfagnin, Valentina; Weroha, S. John] Mayo Clin, Div Med Oncol, Dept Oncol, Rochester, MN 55905 USA; [Bale, Laurie; Conover, Cheryl] Mayo Clin, Div Endocrinol, Rochester, MN USA; [Heinzen, Ethan P.; Oberg, Ann L.] Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Weroha, SJ (corresponding author), Mayo Clin, Div Med Oncol, Dept Oncol, Rochester, MN 55905 USA.	Weroha.Saravut@mayo.edu		Torres, Diogo/0000-0002-2096-0864	Minnesota Ovarian Cancer Alliance (MOCA); Mayo Clinic Ovarian SPORE [CA136393]; Fraternal Order of Eagles; Department of Obstetrics and Gynecology at Mayo Clinic	Minnesota Ovarian Cancer Alliance (MOCA); Mayo Clinic Ovarian SPORE; Fraternal Order of Eagles; Department of Obstetrics and Gynecology at Mayo Clinic	Minnesota Ovarian Cancer Alliance (MOCA) and Mayo Clinic Ovarian SPORE (CA136393) (SJW), Fraternal Order of Eagles, and the Department of Obstetrics and Gynecology at Mayo Clinic (DT).	Aletti GD, 2006, OBSTET GYNECOL, V107, P77, DOI 10.1097/01.AOG.0000192407.04428.bb; AlHilli MM, 2016, GYNECOL ONCOL, V143, P379, DOI 10.1016/j.ygyno.2016.08.328; Becker MA, 2015, MOL CANCER THER, V14, P973, DOI 10.1158/1535-7163.MCT-14-0880; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beltran PJ, 2014, CLIN CANCER RES, V20, P2947, DOI 10.1158/1078-0432.CCR-13-3448; Boldt HB, 2011, ENDOCRINOLOGY, V152, P1470, DOI 10.1210/en.2010-1095; Butler KA, 2017, NEOPLASIA, V19, P628, DOI 10.1016/j.neo.2017.04.007; Conover CA, 2012, TRENDS ENDOCRIN MET, V23, P242, DOI 10.1016/j.tem.2012.02.008; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Glaser G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126867; Haluska P, 2014, CLIN CANCER RES, V20, P4747, DOI 10.1158/1078-0432.CCR-14-0114; HEITJAN DF, 1993, CANCER RES, V53, P6042; Iams WT, 2015, CLIN CANCER RES, V21, P4270, DOI 10.1158/1078-0432.CCR-14-2518; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Juergens H, 2011, J CLIN ONCOL, V29, P4534, DOI 10.1200/JCO.2010.33.0670; KALLI KR, 2003, FRONT BIOSCI, V8, pD71; Kehoe S, 2015, LANCET, V386, P2143, DOI 10.1016/S0140-6736(15)01052-1; King ER, 2011, GYNECOL ONCOL, V123, P13, DOI 10.1016/j.ygyno.2011.06.016; Konecny GE, 2014, ASCO M, V32, P5529, DOI DOI 10.1200/JC0.2014.32.15_SUPPL.5529; Lee AV, 1999, MOL ENDOCRINOL, V13, P787, DOI 10.1210/me.13.5.787; LITTELL RC, 2002, SAS SYSTEM MIXED MOD; Markman M, 2002, J CLIN ONCOL, V20, P2365, DOI 10.1200/JCO.2002.09.130; Meehan TF, 2017, CANCER RES, V77, pE62, DOI 10.1158/0008-5472.CAN-17-0582; Mikkelsen JH, 2008, J BIOL CHEM, V283, P16772, DOI 10.1074/jbc.M802429200; Mikkelsen JH, 2014, ONCOTARGET, V5, P1014, DOI 10.18632/oncotarget.1629; Oberg AL, TOPICS BIOSTATISTICS; Oberg Ann L., 2007, V404, P213, DOI 10.1007/978-1-59745-530-5_11; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Puzanov I, 2015, CLIN CANCER RES, V21, P701, DOI 10.1158/1078-0432.CCR-14-0303; RESNICOFF M, 1993, LAB INVEST, V69, P756; Schoffski P, 2013, EUR J CANCER, V49, P3219, DOI 10.1016/j.ejca.2013.06.010; Staflin K, 2006, INT J GYNECOL CANCER, V16, P1557, DOI 10.1111/j.1525-1438.2006.00627.x; Wang Y, 2005, MOL CANCER THER, V4, P1214, DOI 10.1158/1535-7163.MCT-05-0048; Weroha SJ, 2014, CLIN CANCER RES, V20, P1288, DOI 10.1158/1078-0432.CCR-13-2611; YAMAUCHI K, 1994, J BIOL CHEM, V269, P31107	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0224564	10.1371/journal.pone.0224564	http://dx.doi.org/10.1371/journal.pone.0224564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751381	Green Published, gold			2022-12-26	WOS:000533886900012
J	Handireketi, N; Timire, C; Shewade, HD; Munemo, E; Nyagupe, C; Chipuka, S; Sisya, L; Gumbo, H; Dhitima, E; Harries, AD				Handireketi, Newten; Timire, Collins; Shewade, Hemant Deepak; Munemo, Ellen; Nyagupe, Charles; Chipuka, Sandra; Sisya, Lucia; Gumbo, Hlanai; Dhitima, Ezekiel; Harries, Anthony D.			Can visual interpretation of NucliSens graphs reduce the need for repeat viral load testing?	PLOS ONE			English	Article								Background In Zimbabwe, viral load (VL) testing for people living with HIV on antiretroviral therapy is performed at the National Microbiology Reference Laboratory using a NucliSens machine. Anecdotal evidence has shown that invalid graphs for "Target Not Detectable (TND)" will upon repeat VL testing produce a valid result for virus not detected, therefore removing the need to repeat the test. This needs formal assessment. Objectives To determine i) intra-and inter-rater agreement of the visual interpretation of NucliSens graphs (Target Detectable [TD], TND and No Line [NL]) between two laboratory scientists and ii) sensitivity, specificity and predictive values of the NucliSens graphs compared with repeat VL results. Method Cross sectional study using secondary data. Two laboratory scientists independently rated graphs one week apart for intra-rater agreement and compared final ratings with each other for inter-rater agreement. Consensus interpretations of graphs were compared with repeat VL results. Kappa coefficients were used to obtain measures of agreement. Results There were 562 patients with NucliSens graphs and repeat VL. Kappa scores were: 0.98 (Scientist A); 0.99 (Scientist B); 0.96 (Scientist A versus Scientist B); and 0.65 (NucliSens graphs versus VL). Sensitivity, specificity, positive predictive value and negative predictive value for graphs compared with VL were 71%, 92%, 79% and 89% respectively. Conclusion Intra- and inter-rater agreements were almost perfect. The negative predictive value translates to a false negative rate of 11%. If repeat VL testing is not done, the clinical consequences need to be balanced against cost savings and the risks outweigh the benefits.	[Handireketi, Newten] Minist Hlth & Child Care Zimbabwe, Natl Inst Hlth Res NIHR, Harare, Zimbabwe; [Timire, Collins; Munemo, Ellen; Nyagupe, Charles; Chipuka, Sandra; Sisya, Lucia; Gumbo, Hlanai; Dhitima, Ezekiel] Minist Hlth & Child Care Zimbabwe, Natl HIV AIDS & TB Programme, Harare, Zimbabwe; [Timire, Collins] Int Union TB & Lung Dis, Harare, Zimbabwe; [Timire, Collins; Shewade, Hemant Deepak; Harries, Anthony D.] Int Union TB & Lung Dis, New Delhi, India; [Shewade, Hemant Deepak] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	Handireketi, N (corresponding author), Minist Hlth & Child Care Zimbabwe, Natl Inst Hlth Res NIHR, Harare, Zimbabwe.	handinew@gmail.com		TIMIRE, COLLINS/0000-0003-0997-9799; Shewade MBBS MD PhD, Hemant D/0000-0002-8242-1911; Handireketi, Newten/0000-0003-2043-1839				[Anonymous], STAND OP PROC 300P07; [Anonymous], NAT MICR REF LAB HDB; Beyrer C, 2017, NEW ENGL J MED, V377, P1605, DOI 10.1056/NEJMp1710608; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Columbia University, ZIMB POP BAS HIV IMP; Gupta RK, 2018, LANCET INFECT DIS, V18, P346, DOI [10.1016/s1473-3099(17)30702-8, 10.1016/S1473-3099(17)30702-8]; Hammer SM, 2011, NEW ENGL J MED, V365, P561, DOI 10.1056/NEJMe1107487; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; UNAIDS, 2014, 90 90 90 AMB TREATM; Viera AJ, 2005, FAM MED, V37, P360; WHO, 2016, CONGUID UANT DRU; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2018, WHO HIV UPD; World Health Organization, 2003, SCAL ANT THER RES LT; ZIMSTATS and Macro ICF Inc, ZIMB POP CENS 2012	16	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0223597	10.1371/journal.pone.0223597	http://dx.doi.org/10.1371/journal.pone.0223597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747448	gold, Green Published, Green Accepted			2022-12-26	WOS:000533881900004
J	Iacuzzi, V; Posocco, B; Zanchetta, M; Montico, M; Marangon, E; Poetto, AS; Buzzo, M; Gagno, S; Buonadonna, A; Guardascione, M; Casetta, B; Toffoli, G				Iacuzzi, Valentina; Posocco, Bianca; Zanchetta, Martina; Montico, Marcella; Marangon, Elena; Poetto, Ariana Soledad; Buzzo, Mauro; Gagno, Sara; Buonadonna, Angela; Guardascione, Michela; Casetta, Bruno; Toffoli, Giuseppe			Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients	PLOS ONE			English	Article							DRIED BLOOD SPOTS; MAIN METABOLITE; DRUG; BENEFIT	The introduction of imatinib, an oral tyrosine kinase inhibitor, as first-line standard therapy in patients with unresectable, metastatic, or recurrent gastro-intestinal stromal tumor (GIST), strongly improved their treatment outcomes. However, therapeutic drug monitoring (TDM) is recommended for this drug due to the large inter-individual variability in plasma concentration when standard dose is administered. A C-min higher than 760 ng/mL was associated with a longer progression free survival. Thus, a LC-MS/MS method has been developed and fully validated to quantify imatinib and its active metabolite, norimatinib, in finger-prick dried blood spot (DBS). The influence of hematocrit, sample homogeneity, and spot size and the correlation between finger-prick and venous DBS measurements were also assessed. The method showed a good linearity (R-2 > 0,996) between 50-7500 ng/mL for imatinib and 10-1500 ng/mL for norimatinib. Analytes were extracted from DBS samples by simply adding to 3 mm-discs 150 mu L of acidified methanol containing IMA-D8. The collected extract was then injected on a LC Nexera system in-house configured for the on-line cleanup, coupled with an API-4000 QT. The chromatographic separation was conducted on a Synergi Fusion-RP column (4 mu m, 2x50 mm) while the trapping column was a POROS R1/20 (20 mu m, 2x30 mm). The total run time was 8.5 min. DBSs stored at room temperature in plastic envelopes containing a silica-gel drying bag were stable up to 16 months. The proposed method was applied to 67 clinical samples, showing a good correlation between patients' finger-prick DBS and plasma concentrations, measured by the reference LC-MS/MS method, internally validated. Imatinib and norimatinib concentrations found in finger-prick DBS were adjusted by hematocrit or by an experimental correction factor to estimate the corresponding plasma measurements. At the best of our knowledge, the proposed LC-MS/MS method is the first analytical assay to measure imatinib and norimatinib in DBS samples.	[Iacuzzi, Valentina; Posocco, Bianca; Zanchetta, Martina; Marangon, Elena; Poetto, Ariana Soledad; Buzzo, Mauro; Gagno, Sara; Guardascione, Michela; Casetta, Bruno; Toffoli, Giuseppe] Ctr Riferimento Oncol Aviano CRO IRCCS, Expt & Clin Pharmacol Unit, Aviano, Italy; [Iacuzzi, Valentina] Univ Trieste, Doctoral Sch Nanotechnol, Trieste, Italy; [Zanchetta, Martina] Univ Trieste, Dept Chem & Pharmaceut Sci, Trieste, Italy; [Montico, Marcella] Ctr Riferimento Oncol Aviano CRO IRCCS, Sci Directorate, Aviano, Italy; [Poetto, Ariana Soledad] Univ Padua, Doctoral Sch Pharmacol Sci, Padua, Italy; [Buonadonna, Angela] Ctr Riferimento Oncol CRO IRCCS, Med Oncol Dept, Aviano, Italy; [Casetta, Bruno] Polo Tecnol Pordenone, Pordenone, Italy	University of Trieste; University of Trieste; University of Padua; IRCCS Aviano (CRO)	Posocco, B (corresponding author), Ctr Riferimento Oncol Aviano CRO IRCCS, Expt & Clin Pharmacol Unit, Aviano, Italy.	bposocco@cro.it	Toffoli, Giuseppe/F-6642-2018; Posocco, Bianca/AAX-6323-2020; Poetto, Ariana Soledad/ABD-8748-2020; Zanchetta, Martina/AAX-6274-2020; Buonadonna, Angela/ABE-2374-2020; Gagno, Sara/AAX-6330-2020; Montico, Marcella/B-5290-2013; IACUZZI, VALENTINA/AAZ-6569-2020	Toffoli, Giuseppe/0000-0002-5323-4762; Posocco, Bianca/0000-0002-3424-8827; Poetto, Ariana Soledad/0000-0001-9069-7523; Zanchetta, Martina/0000-0002-5018-7032; Buonadonna, Angela/0000-0002-1930-0308; Gagno, Sara/0000-0003-4877-6900; Montico, Marcella/0000-0003-0377-8232; IACUZZI, VALENTINA/0000-0003-1708-336X				Adaway JE, 2012, J CHROMATOGR B, V883, P33, DOI 10.1016/j.jchromb.2011.09.041; Antunes MV, 2016, CLIN BIOCHEM, V49, P1035, DOI 10.1016/j.clinbiochem.2016.05.004; Antunes MV, 2015, BIOANALYSIS, V7, P2105, DOI 10.4155/bio.15.101; Bouchet S, 2013, FUND CLIN PHARMACOL, V27, P690, DOI 10.1111/fcp.12007; Delbaldo C, 2006, CLIN CANCER RES, V12, P6073, DOI 10.1158/1078-0432.CCR-05-2596; Demetri GD, 2009, J CLIN ONCOL, V27, P3141, DOI 10.1200/JCO.2008.20.4818; Eechoute K, 2012, CLIN CANCER RES, V18, P5780, DOI 10.1158/1078-0432.CCR-12-0490; European Medicines Agency, 2011, GUIDELINE BIOANALYTI; Fda Cder, 2018, BIOAN METH VAL GUID; Kralj E, 2012, J CHROMATOGR B, V903, P150, DOI 10.1016/j.jchromb.2012.07.011; Lakshmy Ramakrishnan, 2008, J Diabetes Sci Technol, V2, P242; le Coutre P, 2004, CANCER CHEMOTH PHARM, V53, P313, DOI 10.1007/s00280-003-0741-6; Mohammed BS, 2010, BRIT J CLIN PHARMACO, V70, P52, DOI 10.1111/j.1365-2125.2010.03668.x; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; PASSING H, 1984, J CLIN CHEM CLIN BIO, V22, P431; Rowland M, 2010, AAPS J, V12, P290, DOI 10.1208/s12248-010-9188-y; Tang N, 2017, J CLIN VIROL, V92, P56, DOI 10.1016/j.jcv.2017.05.002; Timmerman P, 2011, BIOANALYSIS, V3, P1567, DOI [10.4155/BIO.11.132, 10.4155/bio.11.132]; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; von Mehren M, 2011, CANCER TREAT REV, V37, P291, DOI 10.1016/j.ctrv.2010.10.001; Widmer N, 2014, EUR J CANCER, V50, P2020, DOI 10.1016/j.ejca.2014.04.015; Wilhelm AJ, 2014, CLIN PHARMACOKINET, V53, P961, DOI 10.1007/s40262-014-0177-7; Wolf D, 2009, DRUG SAFETY, V32, P1001, DOI 10.2165/11314600-000000000-00000; Yu HX, 2014, CLIN PHARMACOKINET, V53, P305, DOI 10.1007/s40262-014-0137-2	24	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225225	10.1371/journal.pone.0225225	http://dx.doi.org/10.1371/journal.pone.0225225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743371	Green Published, gold			2022-12-26	WOS:000533877300024
J	Lee, MY; Lee, DW; Joo, HK; Jeong, KH; Lee, JY				Lee, Myeong Yeon; Lee, Dong Won; Joo, Hyun Kyu; Jeong, Kang Hwa; Lee, Jae Young			Structural analysis of the manganese transport regulator MntR from Bacillus halodurans in apo and manganese bound forms	PLOS ONE			English	Article							DIPHTHERIA-TOXIN REPRESSOR; IRON-DEPENDENT REGULATOR; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; DNA-BINDING; ACTIVATION; HOMEOSTASIS; SUBTILIS; PROTEIN; COMPLEX	The manganese transport regulator MntR is a metal-ion activated transcriptional repressor of manganese transporter genes to maintain manganese ion homeostasis. MntR, a member of the diphtheria toxin repressor (DtxR) family of metalloregulators, selectively responds to Mn2+ and Cd2+ over Fe2+, Co2+ and Zn2+. The DtxR/MntR family members are well conserved transcriptional repressors that regulate the expression of metal ion uptake genes by sensing the metal ion concentration. MntR functions as a homo-dimer with one metal ion binding site per subunit. Each MntR subunit contains two domains: an N-terminal DNA binding domain, and a C-terminal dimerization domain. However, it lacks the C-terminal SH3-like domain of DtxR/IdeR. The metal ion binding site of MntR is located at the interface of the two domains, whereas the DtxR/IdeR subunit contains two metal ion binding sites, the primary and ancillary sites, separated by 9 A. In this paper, we reported the crystal structures of the apo and Mn2+-bound forms of MntR from Bacillus halodurans, and analyze the structural basis of the metal ion binding site. The crystal structure of the Mn2+-bound form is almost identical to the apo form of MntR. In the Mn2+-bound structure, one subunit contains a binuclear cluster of manganese ions, the A and C sites, but the other subunit forms a mononuclear complex. Structural data about MntR from B. halodurans supports the previous hypothesizes about manganese-specific activation mechanism of MntR homologues.	[Lee, Myeong Yeon; Lee, Dong Won; Joo, Hyun Kyu; Jeong, Kang Hwa; Lee, Jae Young] Dongguk Univ Seoul, Dept Life Sci, Goyang Si, Gyeonggi Do, South Korea	Dongguk University	Lee, JY (corresponding author), Dongguk Univ Seoul, Dept Life Sci, Goyang Si, Gyeonggi Do, South Korea.	jylee001@dongguk.edu		Lee, Jae Young/0000-0003-1136-5817	National Research Foundation of Korea (NRF) - Korea government [2017R1D1A1B03032109]; Agriculture Research Center (ARC) program of the Ministry for Food, Agriculture, Forestry and Fisheries, Korea [710013-03-1-SB120]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); Agriculture Research Center (ARC) program of the Ministry for Food, Agriculture, Forestry and Fisheries, Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (2017R1D1A1B03032109 to JYL); and the Agriculture Research Center (ARC) program of the Ministry for Food, Agriculture, Forestry and Fisheries, Korea [710013-03-1-SB120 to JYL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cong XY, 2018, BIOCHEM BIOPH RES CO, V501, P423, DOI 10.1016/j.bbrc.2018.05.005; DeWitt MA, 2007, J MOL BIOL, V365, P1257, DOI 10.1016/j.jmb.2006.10.080; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glasfeld A, 2003, NAT STRUCT BIOL, V10, P652, DOI 10.1038/nsb951; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang XJ, 2017, MOL MICROBIOL, V103, P253, DOI 10.1111/mmi.13554; Kliegman JI, 2006, BIOCHEMISTRY-US, V45, P3493, DOI 10.1021/bi0524215; Lieser SA, 2003, BIOCHEMISTRY-US, V42, P12634, DOI 10.1021/bi0350248; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuire AM, 2013, BIOCHEMISTRY-US, V52, P701, DOI 10.1021/bi301550t; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey R, 2015, MOL MICROBIOL, V98, P1168, DOI 10.1111/mmi.13207; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pohl E, 1998, J BIOL CHEM, V273, P22420, DOI 10.1074/jbc.273.35.22420; Pohl E, 1999, J MOL BIOL, V285, P1145, DOI 10.1006/jmbi.1998.2339; QIU XY, 1995, STRUCTURE, V3, P87, DOI 10.1016/S0969-2126(01)00137-X; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; SCHIERING N, 1995, P NATL ACAD SCI USA, V92, P9843, DOI 10.1073/pnas.92.21.9843; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tanaka T, 2009, PROTEINS, V77, P741, DOI 10.1002/prot.22541; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; White A, 1998, NATURE, V394, P502, DOI 10.1038/28893; Wisedchaisri G, 2004, J MOL BIOL, V342, P1155, DOI 10.1016/j.jmb.2004.07.083; Yeo HK, 2014, ACTA CRYSTALLOGR D, V70, P1281, DOI 10.1107/S1399004714004118	28	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0224689	10.1371/journal.pone.0224689	http://dx.doi.org/10.1371/journal.pone.0224689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738781	Green Published, gold			2022-12-26	WOS:000532826300018
J	Shoumariyeh, K; Schneider, N; Poggio, T; Veratti, P; Ehrenfeld, S; Redhaber, DM; Khan, R; Pfeifer, D; Klingeberg, C; Kreutmair, S; Rudelius, M; Quintanilla-Martinez, L; Fend, F; Illert, AL; Duyster, J; Miething, C				Shoumariyeh, Khalid; Schneider, Nicolas; Poggio, Teresa; Veratti, Pia; Ehrenfeld, Sophia; Redhaber, Desiree M.; Khan, Robin; Pfeifer, Dietmar; Klingeberg, Cathrin; Kreutmair, Stefanie; Rudelius, Martina; Quintanilla-Martinez, Leticia; Fend, Falko; Illert, Anna L.; Duyster, Justus; Miething, Cornelius			A novel conditional NPM-ALK-driven model of CD30+T-cell lymphoma mediated by a translational stop cassette	ONCOGENE			English	Article							LARGE-CELL LYMPHOMA; T-CELLS; GENE; EXPRESSION; MACROPHAGES; MECHANISMS; DISEASE	Targeted expression of transgenes is essential for the accurate representation of human disease in in vivo models. Current approaches to generate conditional transgenic mouse models are cumbersome and not amenable to high-throughput analysis since they require de novo generation and characterization of genetically modified mice. Here we describe a new system for lineage-restricted expression of transgenes based on a retroviral vector incorporating a translational stop cassette flanked by loxP recombination sites. Conditional transgene expression in chimeric mice is achieved by retroviral infection and transplantation of hematopoietic stem cells (HSC) derived from transgenic mice expressing Cre-recombinase from a lineage-specific promoter. For validation, we directed expression of NPM-ALK, the fusion oncogene driving a subset of anaplastic large cell lymphoma (ALCL), to T-cells by infecting hematopoietic stem cells from Lck-Cre-transgenic mice with a retroviral construct containing the NPM-ALK cDNA preceded by a translational stop cassette. These mice developed T-cell lymphomas within 12-16 weeks, featuring increased expression of the ALCL hallmark antigen CD30 as well as other cytotoxic T-cell markers, similar to the human disease. The new model represents a versatile tool for the rapid analysis of gene function in a defined lineage or in a developmental stage in vivo.	[Shoumariyeh, Khalid; Poggio, Teresa; Veratti, Pia; Ehrenfeld, Sophia; Redhaber, Desiree M.; Khan, Robin; Pfeifer, Dietmar; Klingeberg, Cathrin; Kreutmair, Stefanie; Illert, Anna L.; Duyster, Justus; Miething, Cornelius] Univ Freiburg, Fac Med, Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, D-79106 Freiburg, Germany; [Shoumariyeh, Khalid; Veratti, Pia; Ehrenfeld, Sophia; Redhaber, Desiree M.; Kreutmair, Stefanie; Illert, Anna L.; Duyster, Justus; Miething, Cornelius] German Canc Consortium DKTK, Partner Site Freiburg, D-79106 Freiburg, Germany; [Schneider, Nicolas] Tech Univ Munich, Klinikum Rechts Isar, Dept Hematol Oncol & Stem Cell Transplantat, D-81675 Munich, Germany; [Poggio, Teresa; Ehrenfeld, Sophia; Redhaber, Desiree M.] Albert Ludwigs Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Veratti, Pia; Ehrenfeld, Sophia; Redhaber, Desiree M.; Illert, Anna L.; Duyster, Justus; Miething, Cornelius] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Rudelius, Martina] Ludwig Maximilians Univ Munchen, Inst Pathol, D-81377 Munich, Germany; [Quintanilla-Martinez, Leticia; Fend, Falko] Univ Hosp Tubingen, Dept Pathol, D-72076 Tubingen, Germany	University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Miething, C (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, D-79106 Freiburg, Germany.; Miething, C (corresponding author), German Canc Consortium DKTK, Partner Site Freiburg, D-79106 Freiburg, Germany.; Miething, C (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.	cornelius.miething@uniklinik-freiburg.de	Kreutmair, Stefanie/AAE-6952-2022; Kreutmair, Stefanie/GOK-2757-2022; Shoumariyeh, Khalid/AAB-8421-2021	Kreutmair, Stefanie/0000-0001-8466-6675; Poggio, Teresa/0000-0003-2560-8488; Schneider, Nicolas/0000-0002-9044-446X	European Union [675712]; German Research Council (DFG) [TRR54, 34712712]	European Union(European Commission); German Research Council (DFG)(German Research Foundation (DFG))	This work was in part funded by the European Union Horizon 2020 Marie Sklodowska-Curie Innovative Training Network Grant No 675712 (ALI and TP) and by the German Research Council (DFG) TRR54 grant No 34712712 (JD).	Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Brierley I, 2007, NAT REV MICROBIOL, V5, P598, DOI 10.1038/nrmicro1704; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Dow LE, 2015, TRENDS MOL MED, V21, P609, DOI 10.1016/j.molmed.2015.07.006; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; HANNA Z, 1994, MOL CELL BIOL, V14, P1084, DOI 10.1128/MCB.14.2.1084; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Hemann Michael, 2015, Cold Spring Harb Protoc, V2015, P725, DOI 10.1101/pdb.top069872; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Heyer J, 2010, NAT REV CANCER, V10, P470, DOI 10.1038/nrc2877; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jager R, 2005, ANTICANCER RES, V25, P3191; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Miething C, 2003, ONCOGENE, V22, P4642, DOI 10.1038/sj.onc.1206575; Mou HW, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0178-7; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pfleger BF, 2005, BIOTECHNOL BIOENG, V92, P553, DOI 10.1002/bit.20630; Roth TL, 2018, NATURE, V559, P405, DOI 10.1038/s41586-018-0326-5; Sperschneider J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq021; Stein H, 2000, BLOOD, V96, P3681; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Turner SD, 2003, ONCOGENE, V22, P7750, DOI 10.1038/sj.onc.1207048; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1904	1913		10.1038/s41388-019-1058-1	http://dx.doi.org/10.1038/s41388-019-1058-1			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31754210				2022-12-26	WOS:000516579800006
J	Ritter, C; Shriver, A; McConnachie, E; Robbins, J; von Keyserlingk, MAG; Weary, DM				Ritter, Caroline; Shriver, Adam; McConnachie, Emilie; Robbins, Jesse; von Keyserlingk, Marina A. G.; Weary, Daniel M.			Public attitudes toward genetic modification in dairy cattle	PLOS ONE			English	Article							CONSUMER ACCEPTANCE; FOOD; PERCEPTIONS; ANIMALS; SUPPORT; WELFARE; RISK	Genetic modification has been used to create dairy cattle without horns and with increased resistance to disease; applications that could be beneficial for animal welfare, farm profits, and worker safety. Our aim was to assess how different stated purposes were associated with public attitudes toward these two applications using a mixed methods approach. Using an online survey, U.S. participants were randomly assigned to one of ten treatments in a 2 (application: hornless or disease-resistant) x 5 (purposes: improved animal welfare, reduced costs, increased worker safety, all three purposes, or no purpose) factorial design. Each participant was asked to read a short description of the assigned treatment (e.g. hornlessness to improve calf welfare) and then respond to a series of questions designed to assess attitude toward the treatment using 7-point Likert scales (1 = most negative; 7 = most positive). Responses of 957 participants were averaged to creative an attitude construct score. Participants were also asked to explain their response to the treatment. Qualitative analysis of these text responses was used to identify themes associated with the participants' reasoning. Participant attitudes were more favorable to disease resistance than to hornlessness (mean +/- SE attitude score: 4.5 +/- 0.15 vs. 3.7 +/- 0.14). In the `disease-resistance' group participants had more positive attitudes toward genetic modification when the described purpose was animal welfare versus reduction of costs (contrast = 1.00; 95% CI = 0.12-1.88). Attitudes were less favorable to the `hornless' application if no purpose was provided versus when the stated purpose was either to improve animal welfare (contrast = 0.95; 95% CI = 0.26-1.64) or when all purposes were provided (contrast = 0.88; 95% CI = 0.19-1.58). Similarly, attitudes were less positive when the stated purpose was to reduce costs versus either improving animal welfare (contrast = 0.86; 95% CI = 0.09-1.64) or when all purposes were provided (contrast = 0.79; 95% CI = 0.02-1.56). Quantitative and qualitative analysis indicated that both the specific application and perceived purpose (particularly when related to animal welfare) can affect public attitudes toward genetic modification.	[Ritter, Caroline; Shriver, Adam; McConnachie, Emilie; Robbins, Jesse; von Keyserlingk, Marina A. G.; Weary, Daniel M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada; [Shriver, Adam] Univ Oxford, Wellcome Ctr Eth & Humanities, Nuffield Dept Populat Hlth, Oxford, England; [Robbins, Jesse] Iowa State Univ, Coll Vet Med, Vet Diagnost & Prod Anim Med, 2412 Lloyd, Ames, IA USA	University of British Columbia; University of Oxford; Iowa State University	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada.	dan.weary@ubc.ca	Weary, Daniel/A-8868-2010	Weary, Daniel/0000-0002-0917-3982	Genome BC [SOC007]; Government of Canada Banting Post-Doctoral Fellowship; Wellcome Trust [203132/Z/16/Z]	Genome BC; Government of Canada Banting Post-Doctoral Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by a grant #SOC007 from Genome BC (www.genomebc.ca) to DMW, MAGvK and AS. While writing this paper CR was supported by a Government of Canada Banting Post-Doctoral Fellowship (banting. fellowships-bourses.gc.ca/en/home-accueil.htm)l. AS work on this was project was supported, in part, by the Wellcome Trust (wellcome.ac.uk) grant #203132/Z/16/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JE, 2010, CORP REPUT REV, V13, P38, DOI 10.1057/crr.2010.6; American Community Survey (ACS), 2017, 1 YEAR PUMS DAT; AVMA, 2012, LIT REV WELF IMPL DE; Awad A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-105; Boyatzis RE, 1998, TRANSFORMING QUALITA; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cardoso CS, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7120089; Cardoso CS, 2016, J DAIRY SCI, V99, P1663, DOI 10.3168/jds.2015-9925; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Ceccoli S, 2012, INT POLIT SCI REV, V33, P301, DOI 10.1177/0192512111418788; Cook AJ, 2002, J ECON PSYCHOL, V23, P557, DOI 10.1016/S0167-4870(02)00117-4; Costa-Font M, 2008, FOOD POLICY, V33, P99, DOI 10.1016/j.foodpol.2007.07.002; Crabtree B, 1999, DOING QUALITATIVE RE, V2nd; Davey Gareth, 2006, Journal of Applied Animal Welfare Science, V9, P289, DOI 10.1207/s15327604jaws0904_4; DeBell M, 2009, USERS GUIDE ADV RELE; FDA, 2017, AQUADVANTAGE SALM FA; Fernbach PM, 2019, NAT HUM BEHAV, V3, P251, DOI 10.1038/s41562-018-0520-3; Frewer LJ, 2011, TRENDS FOOD SCI TECH, V22, P442, DOI 10.1016/j.tifs.2011.05.005; Frewer LJ, 1997, SCI TECHNOL HUM VAL, V22, P98, DOI 10.1177/016224399702200105; Frewer LJ, 2014, BRIT FOOD J, V116, P1291, DOI 10.1108/BFJ-08-2013-0211; Frewer LJ, 2013, TRENDS FOOD SCI TECH, V30, P142, DOI 10.1016/j.tifs.2013.01.003; Gallup Poll, AM ID VIEWS YEAR 199; Grunert KG, 2001, FOOD QUAL PREFER, V12, P527, DOI 10.1016/S0950-3293(01)00049-0; Herzog H, 2015, ANTHROZOOS, V28, P145, DOI 10.2752/089279315X14129350721894; Hornsey MJ, 2006, J APPL SOC PSYCHOL, V36, P1701, DOI 10.1111/j.0021-9029.2006.00077.x; Hossain F., 2003, INT J CONSUM STUD, V27, P353, DOI [10.1046/j.1470-6431.2003.00303.x, DOI 10.1046/J.1470-6431.2003.00303.X]; Jaganathan D, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00985; Knight A, 2007, RISK ANAL, V27, P1553, DOI 10.1111/j.1539-6924.2007.00988.x; Lesch William C, 2005, Health Mark Q, V22, P59; Liu X, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3368; Lusk JL, 2010, SOC INDIC RES, V96, P551, DOI 10.1007/s11205-009-9492-z; Malyska A, 2016, TRENDS BIOTECHNOL, V34, P530, DOI 10.1016/j.tibtech.2016.03.005; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McComas KA, 2014, APPETITE, V78, P8, DOI 10.1016/j.appet.2014.02.006; McConnachie E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216542; Onyango B., 2004, Journal of Food Distribution Research, V35, P154; Petersen B, 2017, REPROD DOMEST ANIM, V52, P4, DOI 10.1111/rda.13012; Popping R., 2015, B METHODOLOGIE SOCIO, V128, P23, DOI [10.1177/0759106315597389, DOI 10.1177/0759106315597389]; Qin W., 2008, Journal of Consumer Behaviour, V7, P127, DOI 10.1002/cb.242; Robbins JA, 2015, ANIM WELFARE, V24, P399, DOI 10.7120/09627286.24.4.399; Ruby MB, 2012, APPETITE, V58, P141, DOI 10.1016/j.appet.2011.09.019; Savadori L, 2004, RISK ANAL, V24, P1289, DOI 10.1111/j.0272-4332.2004.00526.x; Scott SE, 2018, ANNU REV NUTR, V38, P459, DOI 10.1146/annurev-nutr-071715-051223; Shrock E, 2017, PROG MOL BIOL TRANSL, V152, P95, DOI 10.1016/bs.pmbts.2017.07.010; Stafford KJ, 2005, VET J, V169, P337, DOI 10.1016/j.tvjl.2004.02.005; Tenbult P, 2005, APPETITE, V45, P47, DOI 10.1016/j.appet.2005.03.004; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Traill W. B., 2006, Acta Agricultura Scandinavica. Section C, Food Economics, V3, P12, DOI 10.1080/16507540600733900; USDA, 2018, DAIR 2014 HLTH MAN P; USDA, 2016, MILK QUAL MILK PROC; Van Eenennaam AL, 2017, CURR OPIN BIOTECH, V44, P27, DOI 10.1016/j.copbio.2016.10.007; Wan C, 2014, RESOUR CONSERV RECY, V83, P141, DOI 10.1016/j.resconrec.2013.12.009; Wolf CA, 2016, J DAIRY SCI, V99, P5892, DOI 10.3168/jds.2015-10619; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112	55	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0225372	10.1371/journal.pone.0225372	http://dx.doi.org/10.1371/journal.pone.0225372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO9FT	31790436	Green Published, gold, Green Submitted			2022-12-26	WOS:000533930800031
J	Li, XW; Yang, YJ; Ahmad, S; Sun, M; Yuan, CQ; Zheng, TC; Han, Y; Cheng, TR; Wang, J; Zhang, QX				Li, Xiaowei; Yang, Yujie; Ahmad, Sagheer; Sun, Ming; Yuan, Cunquan; Zheng, Tangchun; Han, Yu; Cheng, Tangren; Wang, Jia; Zhang, Qixiang			Selection of optimal reference genes for qRT-PCR analysis of shoot development and graviresponse in prostrate and erect chrysanthemums	PLOS ONE			English	Article							TIME RT-PCR; SUITABLE REFERENCE GENES; EXPRESSION NORMALIZATION; QPCR ANALYSIS; AUXIN; GRAVITROPISM; LAZY1; GRAVITY; FAMILY; IDENTIFICATION	The prostrate cultivars of ground-cover chrysanthemum have been used in landscape gardening due to their small stature, large crown width and strong branching ability. qRT-PCR is a rapid and powerful tool for gene expression analysis, while its accuracy highly depends on the stability of reference genes. The paucity of authentic reference genes presents a major hurdle in understanding the genetic regulators of prostrate architecture. Therefore, in order to reveal the regulatory mechanism of prostrate growth of chrysanthemum stems, here, stable reference genes were selected for expression analysis of key genes involved in shoot development and graviresponse. Based on transcriptome data, eleven reference genes with relatively stable expression were identified as the candidate reference genes. After the comprehensive analysis of the stability of these reference genes with four programs (geNorm, NormFinder, BestKeeper and RefFinder), we found that TIP41 was the most stable reference gene in all of the samples. SAND was determined as a superior reference gene in different genotypes and during the process of shoot development. The optimal reference gene for gravitropic response was PP2A-1. In addition, the expression patterns of LA1 and PIN1 further verified the reliability of the screened reference genes. These results can provide more accurate and reliable qRT-PCR normalization for future studies on the expression patterns of genes regulating plant architecture of chrysanthemums.	[Li, Xiaowei; Yang, Yujie; Ahmad, Sagheer; Sun, Ming; Yuan, Cunquan; Zheng, Tangchun; Han, Yu; Cheng, Tangren; Wang, Jia; Zhang, Qixiang] Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing Key Lab Ornamental Plants Germplasm Innov, Natl Engn Res Ctr Floriculture,Beijing Lab Urban, Beijing, Peoples R China	Beijing Forestry University	Zhang, QX (corresponding author), Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing Key Lab Ornamental Plants Germplasm Innov, Natl Engn Res Ctr Floriculture,Beijing Lab Urban, Beijing, Peoples R China.	zqxbjfu@126.com	Ahmad, Sagheer/AAV-1945-2021; Cheng, Tangren/HDM-6455-2022	Ahmad, Sagheer/0000-0003-2218-8350; 	Special Fund for Beijing Common Construction Project	Special Fund for Beijing Common Construction Project	The research was supported by the Special Fund for Beijing Common Construction Project.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by the Special Fund for Beijing Common Construction Project.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson NO, 2006, FLOWER BREEDING AND GENETICS: ISSUES, CHALLENGES AND OPPORTUNITIES FOR THE 21ST CENTURY, P389; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Chen Fadi, 2005, Acta Horticulturae Sinica, V32, P1167; Chen JT, 2018, PHYTOTAXA, V374, P92, DOI 10.11646/phytotaxa.374.1.9; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dai SL, 2005, J INTEGR PLANT BIOL, V47, P783, DOI 10.1111/j.1744-7909.2005.00068.x; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Dong ZB, 2013, PLANT PHYSIOL, V163, P1306, DOI 10.1104/pp.113.227314; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fu JX, 2013, MOL BREEDING, V31, P205, DOI 10.1007/s11032-012-9784-x; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hong Y, 2015, J AM SOC HORTIC SCI, V140, P68, DOI 10.21273/JASHS.140.1.68; Hu LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074646; Hu YN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082258; Huang D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01633; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jin XH, 2013, SCI HORTIC-AMSTERDAM, V153, P64, DOI 10.1016/j.scienta.2013.01.023; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li HF, 2013, FUNCT PLANT BIOL, V40, P1249, DOI 10.1071/FP13075; Li J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00516; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Liu H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2733-z; Liu Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061322; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Noh B, 2003, NATURE, V423, P999, DOI 10.1038/nature01716; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606; Punzo P, 2018, PLANT J, V94, P991, DOI 10.1111/tpj.13913; Qi S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00287; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Taniguchi M, 2017, PLANT CELL, V29, P1984, DOI 10.1105/tpc.16.00575; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08094; WANG P, 1990, Acta Horticulturae Sinica, V17, P223; Wang T, 2014, SCI HORTIC-AMSTERDAM, V169, P130, DOI 10.1016/j.scienta.2014.02.006; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Withers JC, 2013, AM J BOT, V100, P183, DOI 10.3732/ajb.1200436; Xia SJ, 2013, MOL BIOL REP, V40, P237, DOI 10.1007/s11033-012-2054-5; Xiao Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01547; Xue S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092339; Ye X, 2015, SCI HORTIC-AMSTERDAM, V181, P182, DOI 10.1016/j.scienta.2014.10.027; Yeap WC, 2014, PLANT CELL TISS ORG, V116, P55, DOI 10.1007/s11240-013-0382-3; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yoshihara T, 2017, PLANT PHYSIOL, V175, P959, DOI 10.1104/pp.17.00942; Yoshihara T, 2013, PLANT J, V74, P267, DOI 10.1111/tpj.12118; Zhang N, 2018, PLANT CELL, V30, P1461, DOI 10.1105/tpc.18.00063; Zhang S, 2012, RUSS J PLANT PHYSL+, V59, P364, DOI 10.1134/S1021443712020203; Zhang SM, 2008, PLANT GROWTH REGUL, V56, P141, DOI 10.1007/s10725-008-9295-2; Zheng TC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195004	58	3	7	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225241	10.1371/journal.pone.0225241	http://dx.doi.org/10.1371/journal.pone.0225241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774840	Green Published, gold			2022-12-26	WOS:000533896400030
J	Sandstrom, A; Snowden, JM; Hoijer, J; Bottai, M; Wikstrom, AK				Sandstrom, Anna; Snowden, Jonathan M.; Hoijer, Jonas; Bottai, Matteo; Wikstrom, Anna-Karin			Clinical risk assessment in early pregnancy for preeclampsia in nulliparous women: A population based cohort study	PLOS ONE			English	Article							PREDICTION MODELS; 1ST TRIMESTER; ASPIRIN; PRETERM; HEMOGLOBIN	Objective To evaluate the capacity of multivariable prediction of preeclampsia during pregnancy, based on detailed routinely collected early pregnancy data in nulliparous women. Design and setting A population-based cohort study of 62 562 pregnancies of nulliparous women with deliveries 2008-13 in the Stockholm-Gotland Counties in Sweden. Methods Maternal social, reproductive and medical history and medical examinations (including mean arterial pressure, proteinuria, hemoglobin and capillary glucose levels) routinely collected at the first visit in antenatal care, constitute the predictive variables. Predictive models for preeclampsia were created by three methods; logistic regression models using 1) prespecified variables (similar to the Fetal Medicine Foundation model including maternal factors and mean arterial pressure), 2) backward selection starting from the full suite of variables, and 3) a Random forest model using the same candidate variables. The performance of the British National Institute for Health and Care Excellence (NICE) binary risk classification guidelines for preeclampsia was also evaluated. The outcome measures were diagnosis of preeclampsia with delivery < 34, < 37, and.37 weeks' gestation. Results A total of 2 773 (4.4%) nulliparous women subsequently developed preeclampsia. The prespecified variables model was superior the other two models, regarding prediction of preeclampsia with delivery < 34 and < 37 weeks, both with areas under the curve of 0.68, and sensitivity of 30.6% (95% CI 24.5-37.2) and 29.2% (95% CI 25.2-33.4) at a 10% false positive rate, respectively. The performance of these customizable multivariable models at the chosen false positive rate, was significantly better than the binary NICE-guidelines for preeclampsia with delivery <37 and.37 weeks' gestation. Conclusion Multivariable models in early pregnancy had a modest performance, although providing advantages over the NICE-guidelines, in predicting preeclampsia in nulliparous women. Use of a machine learning algorithm (Random forest) did not result in superior prediction.	[Sandstrom, Anna; Wikstrom, Anna-Karin] Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, Stockholm, Sweden; [Sandstrom, Anna; Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Snowden, Jonathan M.] Oregon Hlth & Sci Univ, Portland State Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Hoijer, Jonas; Bottai, Matteo] Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden	Karolinska Institutet; Uppsala University; Oregon Health & Science University; Portland State University; Karolinska Institutet	Sandstrom, A (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, Stockholm, Sweden.; Sandstrom, A (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	anna.sandstrom@ki.se		Sandstrom, Anna/0000-0003-2879-4271	Swedish Research Council [2014-3561]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from the Swedish Research Council (2014-3561), A-K W, (https://www.vr.se/english.html).The Swedish Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolekar R, 2013, FETAL DIAGN THER, V33, P8, DOI 10.1159/000341264; Al-Rubaie ZTA, 2016, BJOG-INT J OBSTET GY, V123, P1441, DOI 10.1111/1471-0528.14029; American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy, 2013, OBSTET GYNECOL, V122, P1122, DOI [DOI 10.1097/01.AOG.0000437382.03963.88, 10.1097/01.AOG.0000437382.03963.88]; [Anonymous], 2018, Obstet Gynecol, V132, pe44, DOI 10.1097/AOG.0000000000002708; Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; Beatrice M, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14498; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004; Brunelli VB, 2015, BJOG-INT J OBSTET GY, V122, P904, DOI 10.1111/1471-0528.13334; Darcy AM, 2016, JAMA-J AM MED ASSOC, V315, P551, DOI 10.1001/jama.2015.18421; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fu YW, 2014, I C VIRTUAL REALITY, P103, DOI 10.1109/ICVRV.2014.52; Hernandez-Diaz Sonia, 2009, BMJ, V338, pb2255, DOI 10.1136/bmj.b2255; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Macdonald-Wallis C, 2012, HYPERTENSION, V59, P1241, DOI 10.1161/HYPERTENSIONAHA.111.187039; Meertens LJE, 2019, FETAL DIAGN THER, V45, P381, DOI 10.1159/000490385; Myers JE, 2013, BJOG-INT J OBSTET GY, V120, P1215, DOI 10.1111/1471-0528.12195; National Board of Health and Welfare, 2009, DIAGN COD BIRTH DEF; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; O'Gorman N, 2017, ULTRASOUND OBST GYN, V49, P751, DOI 10.1002/uog.17399; O'Gorman N, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.034; Oliveira N, 2014, ULTRASOUND OBST GYN, V44, P279, DOI 10.1002/uog.13435; Pan I, 2017, AM J PUBLIC HEALTH, V107, P938, DOI 10.2105/AJPH.2017.303711; Phaloprakarn C, 2008, J PERINAT MED, V36, P115, DOI 10.1515/JPM.2008.018; Poon LC, 2014, PRENATAL DIAG, V34, P618, DOI 10.1002/pd.4397; Lobo GAR, 2019, J MATERN-FETAL NEO M, V32, P286, DOI 10.1080/14767058.2017.1378332; Roberge S, 2018, AM J OBSTET GYNECOL, V218, P287, DOI 10.1016/j.ajog.2017.11.561; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sentilhes L, 2017, NEW ENGL J MED, V377, P2399, DOI [10.1056/NEJMc1713798, 10.1056/NEJMoa1704559]; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Swedish Society for Obstetrics and Gynecology (SFOG) Reference group for Perinatology, 2014, 72 SFOG; Tan MY, 2018, ULTRASOUND OBST GYN, V51, P743, DOI 10.1002/uog.19039; The National Board of Health and Welfare. Official Statistics of Sweden, 1991, PREGN DEL NEWB INF; The National Institute for Health and Care Excellence (NICE), 2019, NICE GUID NG133; von Tempelhoff GF, 2008, CLIN APPL THROMB-HEM, V14, P19, DOI 10.1177/1076029607304748; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wikstrom AK, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.003; Wright D, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.018	42	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225716	10.1371/journal.pone.0225716	http://dx.doi.org/10.1371/journal.pone.0225716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774875	Green Published, gold			2022-12-26	WOS:000533896400052
J	Khong, LAM; Buckley, A; Johnson, W; Cavalheri, V				Khong, Linda A. M.; Buckley, Amma; Johnson, Wendy; Cavalheri, Vinicius			Lower limb chronic edema management program: Perspectives of disengaged patients on challenges, enablers and barriers to program attendance and adherence	PLOS ONE			English	Article							LYMPHOEDEMA/CHRONIC EDEMA; LYMPHEDEMA; CARE; UK; PREVALENCE; EDUCATION; THERAPY; OBESITY; IMPACT; CANCER	Background Chronic edema (CO) is a progressive, physically disfiguring and currently incurable condition. A multifaceted program has been recommended to manage the swelling. However, there is little evidence investigating patients' perspectives following the program, particularly for those who have poor adherence and/or are disengaged. Aim To investigate the perceived challenges faced by disengaged participants with lower limb CO by identifying their enablers and barriers to participating in a Physiotherapy CO program. Method An exploratory qualitative approach was used. A purposive sampling strategy was adopted to recruit participants. Those with more than three months swelling and who had low adherence and/or attendance (disengaged) to the CO program were invited to participate. Semistructured interviews with six participants from a CO clinic in a tertiary hospital were conducted. Data were thematically analyzed and findings in terms of enablers and barriers were subsequently reflected in the light of a theoretical framework. Results All six participants were morbidly obese (BMI 47 +/- 4 kg/m(2)) with multiple chronic comorbidities. Enablers and barriers detected included physical, psychological and social factors that interplay to present multidimensional challenges that influence the participants' adjustment to managing their CO. For the disengaged participants in this study, their under-managed lower limb CO was a progression towards being housebound and having a gradually increasing level of disability. Conclusion This study has identified the multidimensional challenges faced by low adherent and/or disengaged participants with lower limb CO to participating in a hospital-based CO program. Perceived enablers and barriers included physical, psychological and social factors. These were mapped using a health behavior change theoretical framework. Understanding these challenges has implications for developing a multidisciplinary approach aimed at enhancing patient engagement and participation in the physiotherapy CO program.	[Khong, Linda A. M.; Johnson, Wendy] Sir Charles Gairdner Hosp, Physiotherapy Dept, Nedlands, WA, Australia; [Khong, Linda A. M.] Univ Notre Dame Australia, Inst Hlth Res, Fremantle, WA, Australia; [Buckley, Amma] Curtin Univ, Media Cultural Studies & Social Inquiry, Perth, WA, Australia; [Cavalheri, Vinicius] Curtin Univ, Fac Hlth Sci, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia; [Cavalheri, Vinicius] South Metropolitan Hlth Serv, Allied Hlth, Perth, WA, Australia	University of Western Australia; University of Notre Dame Australia; Curtin University; Curtin University	Khong, LAM (corresponding author), Sir Charles Gairdner Hosp, Physiotherapy Dept, Nedlands, WA, Australia.; Khong, LAM (corresponding author), Univ Notre Dame Australia, Inst Hlth Res, Fremantle, WA, Australia.	Linda.Khong1@my.nd.edu.au	Cavalheri, Vinicius/V-2282-2017; Khong, Linda A.M./P-3148-2018	Cavalheri, Vinicius/0000-0001-8620-7499; Khong, Linda A.M./0000-0002-8042-7084	Sir Charles Gairdner and Osborne Park Health Care Group Research Advisory Committee; Cancer Council Western Australia Postdoctoral Research Fellowship; Royal Perth Hospital Library staff	Sir Charles Gairdner and Osborne Park Health Care Group Research Advisory Committee; Cancer Council Western Australia Postdoctoral Research Fellowship(Cancer Council Western Australia); Royal Perth Hospital Library staff	LK is supported by the Sir Charles Gairdner and Osborne Park Health Care Group Research Advisory Committee 2017Small Grant. The funding organization had no role in the study design, data collection and analysis nor in preparation of the manuscript. VC is supported by the Cancer Council Western Australia Postdoctoral Research Fellowship.; We would like to thank the following people for their help:; Sir Charles Gairdner Hospital Physiotherapy Department staff, in particular, Alison Williams (retired) and Patricia Lobo for their help with recruitment of participants.; Royal Perth Hospital Library staff especially Rina Rukmini for her help and support with literature search.; Patients and therapists who contributed to the questionnaire and interview guide.; LK Lymphoedema Centre for contributing some fund to the research.	Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; [Anonymous], 2003, ADHERENCE LONG TERM; Australian Bureau of Statistics, 2013, SOC IND AR POST AR; Australian Institute of Health and Welfare, 2018, AUSTR HLTH 2018; Barlow S, 2014, PRIM HEALTH CARE RES, V15, P452, DOI 10.1017/S1463423613000406; Bazeley P., 2009, MALAYSIAN J QUALITAT, V2, P6, DOI [DOI 10.1007/s10745-012-9538-8, DOI 10.1017/CB09781107415324,004]; Beenstock J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-36; Bissonnette JM, 2008, J ADV NURS, V63, P634, DOI 10.1111/j.1365-2648.2008.04745.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Creswell W. C., 2011, DESIGNING CONDUCTING; Damstra RJ, 2008, BRIT J DERMATOL, V158, P1210, DOI 10.1111/j.1365-2133.2008.08503.x; Dial M, 2018, APPL NURS RES, V39, P259, DOI 10.1016/j.apnr.2017.11.028; Faugier J, 1997, J ADV NURS, V26, P790, DOI 10.1046/j.1365-2648.1997.00371.x; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Fu MR, 2013, PSYCHO-ONCOLOGY, V22, P1466, DOI 10.1002/pon.3201; Greene A, 2017, INT WOUND J, V14, P561, DOI 10.1111/iwj.12648; Harvey G, 2018, INT J HEALTH POLICY, V7, P290, DOI 10.15171/ijhpm.2017.144; Helgeson VS, 2018, PERS SOC PSYCHOL REV, V22, P170, DOI 10.1177/1088868317735767; Helgeson VS, 2017, ANNU REV PSYCHOL, V68, P545, DOI 10.1146/annurev-psych-010416-044014; Holdsworth E, 2017, HEALTH PROMOT PRACT, V18, P245, DOI 10.1177/1524839916659847; International Society of Lymphology, 2013, LYMPHOLOGY, V49, P170; Keast DH, 2015, INT WOUND J, V12, P328, DOI 10.1111/iwj.12224; Keeley V, 2017, CURR OPIN SUPPORT PA, V11, P355, DOI 10.1097/SPC.0000000000000311; Khong LAM, 2018, INT J HEALTH PROMOT, V56, P195, DOI 10.1080/14635240.2018.1479650; Lasinski BB, 2012, PM&R, V4, P580, DOI 10.1016/j.pmrj.2012.05.003; Lincoln Y.S., 1985, ESTABLISHING TRUSTWO, P289, DOI [10.1016/0147-1767(85)90062-8, http://dx.doi.org/10.1016/0147-1767(85)90062-8]; Lymphoedema Framework, 2006, BEST PRACTICE MANAGE; Mattke Soeren, 2015, Rand Health Q, V5, P3; McCormack A, 2013, INT J AUDIOL, V52, P360, DOI 10.3109/14992027.2013.769066; Mehrara BJ, 2014, PLAST RECONSTR SURG, V134, p154E, DOI 10.1097/PRS.0000000000000268; Mercier G, 2019, LYMPHAT RES BIOL, V17, P163, DOI 10.1089/lrb.2018.0084; Michie S, 2014, BEHAV CHANGE WHEEL G, DOI DOI 10.1186/s13012-015-0322-1; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Miles M.B., 2014, QUALITATIVE DATA ANA, V3rd ed.; Moffatt C, 2012, COMPRESSION THERAPY; Moffatt C, 2019, LYMPHAT RES BIOL, V17, P127, DOI 10.1089/lrb.2018.0081; Moffatt CJ, 2019, LYMPHAT RES BIOL, V17, P147, DOI 10.1089/lrb.2018.0086; Moffatt CJ, 2017, INT WOUND J, V14, P772, DOI 10.1111/iwj.12694; Moffatt CJ, 2017, LYMPHAT RES BIOL, V15, P252, DOI 10.1089/lrb.2017.0022; Moffatt CJ, 2003, QJM-INT J MED, V96, P731, DOI 10.1093/qjmed/hcg126; Morgan PA, 2012, INT WOUND J, V9, P54, DOI 10.1111/j.1742-481X.2011.00845.x; Morse JM, 2010, QUAL INQ, V16, P483, DOI 10.1177/1077800410364741; Nelson EA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002303.pub3; Nelson EA, 2014, J CLIN NURS, V23, P768, DOI 10.1111/jocn.12105; Patton MQ., 2014, ANONYMOUS QUALITATIV; QSR International, 2012, NVIVO QUAL DAT AN SO; Quere I, 2019, LYMPHAT RES BIOL, V17, P135, DOI 10.1089/lrb.2019.0024; Ridner SH, 2014, LYMPHAT RES BIOL, V12, P258, DOI 10.1089/lrb.2014.0017; Ridner SH, 2012, NURS RES, V61, P291, DOI 10.1097/NNR.0b013e31824f82b2; Rimer B.K., THEORY GLANCE GUIDE; Runowicz CD, 1998, CANCER, V83, P2874, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2874::AID-CNCR42>3.0.CO;2-4; Savetsky IL, 2014, AM J PHYSIOL-HEART C, V307, pH165, DOI 10.1152/ajpheart.00244.2014; Stout N, 2012, INT ANGIOL, V31, P316; Stout NL, 2012, GLOB PUBLIC HEALTH, V7, P107, DOI 10.1080/17441692.2010.549140; Szuba A, 1998, Vasc Med, V3, P145, DOI 10.1177/1358836X9800300209; Tidhar D., 2018, J LYMPHOEDEMA, V13, P37; Tidhar D, 2010, SUPPORT CARE CANCER, V18, P383, DOI 10.1007/s00520-009-0669-4; Tinetti ME, 2019, ANN INTERN MED, V170, P199, DOI 10.7326/M18-3269; Tzani I, 2018, LYMPHOLOGY, V51, P1; Van Hecke A, 2011, INT J NURS STUD, V48, P145, DOI 10.1016/j.ijnurstu.2010.07.001; Van Hecke A, 2009, J CLIN NURS, V18, P337, DOI 10.1111/j.1365-2702.2008.02575.x; Watts G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3445; Watts TE, 2016, J ADV NURS, V72, P3147, DOI 10.1111/jan.13071; Williams Anne F, 2004, Int J Palliat Nurs, V10, P279	65	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0219875	10.1371/journal.pone.0219875	http://dx.doi.org/10.1371/journal.pone.0219875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QR	31765379	Green Published, Green Submitted, gold			2022-12-26	WOS:000533891000002
J	Adoonsook, D; Chia-Yuan, C; Wongrueng, A; Pumas, C				Adoonsook, Dome; Chia-Yuan, Chang; Wongrueng, Aunnop; Pumas, Chayakorn			A simple way to improve a conventional A/O-MBR for high simultaneous carbon and nutrient removal from synthetic municipal wastewater	PLOS ONE			English	Article							MOVING-BED BIOFILM; GLYCOGEN-ACCUMULATING ORGANISMS; SUBMERGED MEMBRANE BIOREACTOR; PHOSPHORUS REMOVAL; MICROBIAL COMMUNITY; ACTIVATED-SLUDGE; EXTRACELLULAR POLYMERS; PERFORMANCE; BACTERIA; ECOLOGY	In this study, two anoxic-oxic membrane bioreactor (A/O-MBR) systems, i.e. conventional and biofilm anoxic-oxic-membrane bioreactors (C-A/O-MBR and BF-A/O-MBR, respectively), were operated in parallel under conditions of complete sludge retention for the purposes of comparing system performance and microbial community composition. Moreover, with the microbial communities, comparisons were made between the adhesive stage and the suspended stage. High average removal of COD, NH4+- N and TN was achieved in both systems. However, TP removal efficiency was remarkably higher in BF-A/O-MBR when compared with C-A/O-MBR. TP mass balance analysis suggested that under complete sludge retention, polyurethane sponges that were added into the anoxic tank played a key role in both phosphorus release and accumulation. The qPCR analysis showed that sponge biomass could maintain a higher level of abundance of total bacteria than the suspended sludge. Meanwhile, AOB and denitrifiers were enriched in the suspended sludge but not in the sponge biomass. Results of illumina sequencing reveal that the compacted sponge in BF-A/O-MBR could promote the growth of bacteria involved in nutrient removal and reduce the amount of filamentous and bacterial growth that is related to membrane fouling in the suspended sludge.	[Adoonsook, Dome; Wongrueng, Aunnop] Chiang Mai Univ, Fac Engn, Dept Environm Engn, Chiang Mai, Thailand; [Wongrueng, Aunnop] Ctr Excellence Hazardous Subst Management HSM Ban, Res Program Control Hazardous Contaminants Raw Wa, Bangkok, Thailand; [Chia-Yuan, Chang] Chia Nan Univ Pharm & Sci, Dept Environm Engn & Sci, Tainan, Taiwan; [Chia-Yuan, Chang] Wuhan Univ Sci & Technol, Coll Resource & Environm Engn, Wuhan, Peoples R China; [Wongrueng, Aunnop; Pumas, Chayakorn] Chiang Mai Univ, Fac Sci, Dept Biol, Ctr Excellence Bioresources Agr Ind & Med, Chiang Mai, Thailand	Chiang Mai University; Chia Nan University of Pharmacy & Science; Wuhan University of Science & Technology; Chiang Mai University	Wongrueng, A (corresponding author), Chiang Mai Univ, Fac Engn, Dept Environm Engn, Chiang Mai, Thailand.; Wongrueng, A (corresponding author), Ctr Excellence Hazardous Subst Management HSM Ban, Res Program Control Hazardous Contaminants Raw Wa, Bangkok, Thailand.; Wongrueng, A (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Ctr Excellence Bioresources Agr Ind & Med, Chiang Mai, Thailand.	aunnop@eng.cmu.ac.th	Pumas, Chayakorn/AAH-2415-2019; Pumas, Chayakorn/ABA-7314-2021	Pumas, Chayakorn/0000-0002-1866-3641; WONGRUENG, AUNNOP/0000-0001-9180-3949	Kurita-AIT Research Grant; Graduate School, Chiang Mai University; Chiang Mai University; Office of Higher Education Commission (OHEC); SAMP;T Postgraduate Education and Research Development Office (PERDO), Thailand	Kurita-AIT Research Grant; Graduate School, Chiang Mai University; Chiang Mai University; Office of Higher Education Commission (OHEC)(Office of Higher Education Commission (OHEC)); SAMP;T Postgraduate Education and Research Development Office (PERDO), Thailand	The authors gratefully acknowledge the Kurita-AIT Research Grant. This research work was conducted during the course of study to fulfill a Ph.D. degree at Chiang Mai University. Warm thanks are also extended to the Graduate School, Chiang Mai University, for the help and support of this work. This research work was partially supported by Chiang Mai University. The authors also thank the Office of Higher Education Commission (OHEC) and the S&T Postgraduate Education and Research Development Office (PERDO), Thailand for support this work. We would like to express our sincere gratitude to Department of Environmental Engineering, Faculty of Engineering, Chiang Mai University, and the Center of Excellence on Hazardous Substance Management (HSM), Chulalongkorn University for invaluable supports in terms of facilities and scientific equipment.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Atabek A, 2007, J BACTERIOL, V189, P8503, DOI 10.1128/JB.00769-07; Baytshtok V, 2009, BIOTECHNOL BIOENG, V102, P1527, DOI 10.1002/bit.22213; BEECH IB, 1995, INT BIODETER BIODEGR, V35, P59, DOI 10.1016/0964-8305(95)00082-G; Beer M, 2006, J APPL MICROBIOL, V100, P233, DOI 10.1111/j.1365-2672.2005.02784.x; Chae KJ, 2008, CHEMOSPHERE, V71, P961, DOI 10.1016/j.chemosphere.2007.11.058; Cloete TE, 2001, WATER RES, V35, P3595, DOI 10.1016/S0043-1354(01)00093-8; Cydzik-Kwiatkowska A, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2012-9; Daims H, 2000, WATER SCI TECHNOL, V41, P85, DOI 10.2166/wst.2000.0430; DEGUCHI H, 1994, WATER SCI TECHNOL, V30, P143, DOI 10.2166/wst.1994.0261; Duan L, 2015, ENVIRON EARTH SCI, V73, P4891, DOI 10.1007/s12665-015-4245-6; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Falvo A, 2001, J APPL MICROBIOL, V91, P299, DOI 10.1046/j.1365-2672.2001.01384.x; Frolund B, 1996, WATER RES, V30, P1749, DOI 10.1016/0043-1354(95)00323-1; Gao DW, 2014, J MEMBRANE SCI, V458, P157, DOI 10.1016/j.memsci.2014.01.064; Gao DW, 2010, J MEMBRANE SCI, V364, P331, DOI 10.1016/j.memsci.2010.08.031; Gao XY, 2012, MAR BIODIVERS, V42, P1, DOI 10.1007/s12526-011-0086-z; Gonzalez-Martinez A, 2015, BIOFOULING, V31, P333, DOI 10.1080/08927014.2015.1040006; Guo JH, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0218-4; Guo WS, 2010, BIORESOURCE TECHNOL, V101, P1435, DOI 10.1016/j.biortech.2009.05.062; Guo WS, 2009, DESALINATION, V249, P672, DOI 10.1016/j.desal.2009.01.030; Han XM, 2015, ENVIRON SCI POLLUT R, V22, P11436, DOI 10.1007/s11356-015-4376-z; Hu DL, 2015, BIORESOURCE TECHNOL, V197, P217, DOI 10.1016/j.biortech.2015.08.082; Jiang X., 2008, EARTH SCI FRONT, V15, P163, DOI [DOI 10.1016/S1872-5791(09)60015-4, 10.1016/S1872-5791(09)60015-4]; Kamika I, 2014, INT J ENV RES PUB HE, V11, P2876, DOI 10.3390/ijerph110302876; Khan SJ, 2011, BIORESOURCE TECHNOL, V102, P5331, DOI 10.1016/j.biortech.2010.09.100; Kong YH, 2007, MICROBIOL-SGM, V153, P4061, DOI 10.1099/mic.0.2007/007245-0; Lee HW, 2002, FEMS MICROBIOL ECOL, V41, P85, DOI 10.1111/j.1574-6941.2002.tb00969.x; Lee WN, 2006, WATER RES, V40, P1827, DOI 10.1016/j.watres.2006.03.007; Li B, 2014, INT J ENV RES PUB HE, V11, P3553, DOI 10.3390/ijerph110403553; Loaec M, 1997, WATER RES, V31, P1171, DOI 10.1016/S0043-1354(96)00375-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu HJ, 2014, WATER RES, V64, P237, DOI 10.1016/j.watres.2014.06.042; Luo WH, 2016, BIORESOURCE TECHNOL, V200, P305, DOI 10.1016/j.biortech.2015.10.043; Mao YJ, 2008, J MICROBIOL METH, V75, P231, DOI 10.1016/j.mimet.2008.06.005; Meyer RL, 2006, MICROBIOL-SGM, V152, P419, DOI 10.1099/mic.0.28445-0; Ngo HH, 2006, WATER SCI TECHNOL, V54, P191, DOI 10.2166/wst.2006.727; Oehmen A, 2006, J BIOTECHNOL, V123, P22, DOI 10.1016/j.jbiotec.2005.10.009; Pan JR, 2010, DESALINATION, V250, P778, DOI 10.1016/j.desal.2008.11.040; Pavlostathis SG, 2006, BIOTECHNOL BIOENG, V95, P84, DOI 10.1002/bit.20962; Rosenberger S, 2002, WATER RES, V36, P413, DOI 10.1016/S0043-1354(01)00223-8; Rossi F, 2015, WATER-SUI, V7, P51, DOI 10.3390/w7010051; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Subtil EL, 2014, BRAZ J CHEM ENG, V31, P683, DOI 10.1590/0104-6632.20140313s00002890; Tang B, 2016, BIORESOURCE TECHNOL, V211, P574, DOI 10.1016/j.biortech.2016.03.136; Vaiopoulou E, 2008, CHEMOSPHERE, V72, P1062, DOI 10.1016/j.chemosphere.2008.04.044; Wagner J, 2000, WATER SCI TECHNOL, V41, P251, DOI 10.2166/wst.2000.0655; Wang R, 2011, ENVIRON SCI TECHNOL, V45, P6066, DOI 10.1021/es1036578; Wong PY, 2014, WATER RES, V64, P73, DOI 10.1016/j.watres.2014.06.046; Yang QY, 2006, DESALINATION, V189, P292, DOI 10.1016/j.desal.2005.07.011; Yigit NO, 2008, DESALINATION, V231, P124, DOI 10.1016/j.desal.2007.11.041; Yoon SH, 2006, DESALINATION, V191, P52, DOI 10.1016/j.desal.2005.04.124; Zhang HL, 2013, ENVIRON SCI TECHNOL, V47, P11482, DOI 10.1021/es403227p; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang ZC, 2011, INT J ENVIRON POLLUT, V45, P15, DOI 10.1504/IJEP.2011.039081	55	9	10	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0214976	10.1371/journal.pone.0214976	http://dx.doi.org/10.1371/journal.pone.0214976			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756182	Green Published, gold, Green Submitted			2022-12-26	WOS:000533889300001
J	Verma, S; Pandey, M; Shukla, GC; Singh, V; Gupta, S				Verma, Shiv; Pandey, Mitali; Shukla, Girish C.; Singh, Vaibhav; Gupta, Sanjay			Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer	PLOS ONE			English	Article							TUMOR-GROWTH; CELLS; PROGRESSION; TARGET; GENE; LINE; MECHANISMS; RESISTANCE; MUTATIONS; APOPTOSIS	Dysregulation of miRNAs has been demonstrated in several human malignancies including prostate cancer. Due to tissue limitation and variable disease progression, stage-specific miRNAs changes in prostate cancer is unknown. Using chip-based microarray, we investigated global miRNA expression in human prostate cancer LNCaP, PC3, DU145 and 22Rv1 cells representing early-stage, advanced-stage and castration resistant prostate cancer in comparison with normal prostate epithelial cells. A total of 292 miRNAs were differentially expressed with 125 upregulated and 167 downregulated. These miRNAs were involved in pathways including drug resistance drug-efflux, adipogenesis, epithelial-to-mesenchymal transition, bone metamorphosis, and Th1/Th2 signaling. Regulation of miRNAs were interlinked with upstream regulators such as Argonaut 2 (AGO2), Double-Stranded RNA-Specific Endoribonuclease (DICER1), Sjogren syndrome antigen B (SSB), neurofibromatosis 2 (NF2), and peroxisome proliferator activated receptor alpha (PPARA), activated during stage-specific disease progression. Candidate target genes and pathways dysregulated in stage-specific prostate cancer were identified using CS-miRTar database and confirmed in clinical specimens. Integrative network analysis suggested some genes targeted by miRNAs include miR-17, let7g, miR-146, miR-204, miR-205, miR-221, miR-301 and miR-520 having a major effect on their dysregulation in prostate cancer. MiRNA-microarray analysis further identified miR-130a, miR-181, miR-328, miR146 and miR-200 as a panel of novel miRNAs associated with drug resistance drug-efflux and epithelial-to-mesenchymal transition in prostate cancer. Our findings provide evidence on miRNA dysregulation and its association with key functional components in stage-specific prostate cancer.	[Verma, Shiv; Pandey, Mitali; Gupta, Sanjay] Case Western Reserve Univ, Sch Med, Dept Urol, Cleveland, OH 44106 USA; [Verma, Shiv; Gupta, Sanjay] Univ Hosp Cleveland, Urol Inst, Med Ctr, Cleveland, OH 44106 USA; [Shukla, Girish C.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Singh, Vaibhav] Cleveland Clin, Dept Inflammat & Immun, Cleveland, OH 44106 USA; [Gupta, Sanjay] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Gupta, Sanjay] Case Comprehens Canc Ctr, Div Gen Med Sci, Cleveland, OH 44106 USA; [Gupta, Sanjay] Louis Stokes Cleveland Vet Affairs Med Ctr, Dept Urol, Cleveland, OH 44106 USA; [Verma, Shiv; Pandey, Mitali] Vancouver Prostate Ctr, Vancouver, BC, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Gupta, S (corresponding author), Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA.; Gupta, S (corresponding author), Case Comprehens Canc Ctr, Div Gen Med Sci, Cleveland, OH 44106 USA.; Gupta, S (corresponding author), Louis Stokes Cleveland Vet Affairs Med Ctr, Dept Urol, Cleveland, OH 44106 USA.	sanjay.gupta@case.edu	Verma, Shiv Shankar/AAI-6913-2021; Verma, Shiv Shankar/N-3726-2016; singh, vaibhav/AAD-6960-2022	Shukla, Girish/0000-0003-1982-2218; Gupta, Sanjay/0000-0002-9492-3249; singh, vaibhav/0000-0001-5075-8045	United States Public Health Service Grant [R01CA108512]; VA Merit Award [1I01BX002494]; Department of Defense [W81XWH-15-10558, W81XWH-18-1-0618]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); VA Merit Award(US Department of Veterans Affairs); Department of Defense(United States Department of Defense)	The research work is supported by United States Public Health Service Grant R01CA108512, VA Merit Award 1I01BX002494 and Department of Defense grant W81XWH-15-10558 and W81XWH-18-1-0618 to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brawer Michael K, 2004, Rev Urol, V6 Suppl 8, pS3; Brawley Otis W., 2012, Journal of the National Cancer Institute Monographs, P152, DOI 10.1093/jncimonographs/lgs035; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cinar B, 2001, CANCER RES, V61, P7310; Damodaran C, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.03.009; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Gui B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184166; Jain P, 2016, BIOESSAYS, V38, P446, DOI 10.1002/bies.201500162; Jung-Hynes B, 2009, J BIOL CHEM, V284, P3823, DOI 10.1074/jbc.M807869200; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Katakowski M, 2013, CANCER LETT, V335, P201, DOI 10.1016/j.canlet.2013.02.019; Kolluru V, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2018.07.014; Lan H, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/493560; Li L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05479-7; Lin YT, 2007, CELL RES, V17, P531, DOI 10.1038/cr.2007.12; Loeb S, 2015, CANCER EPIDEM BIOMAR, V24, P213, DOI 10.1158/1055-9965.EPI-14-0786-T; Luk SUI, 2014, ONCOTARGET, V5, P6896, DOI 10.18632/oncotarget.2229; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Macha MA, 2014, CURR PHARM DESIGN, V20, P5287, DOI 10.2174/1381612820666140128213117; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Nevedomskaya E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051359; Paolillo C, 2017, CLIN CANCER RES, V23, P6086, DOI 10.1158/1078-0432.CCR-17-1173; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; RAFFO AJ, 1995, CANCER RES, V55, P4438; Sadeghi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168760; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh S, 2016, CANCER LETT, V371, P262, DOI 10.1016/j.canlet.2015.10.038; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Suer I, 2019, PROSTATE, V79, P265, DOI 10.1002/pros.23731; Sun RP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-93; Sun T, 2014, ONCOGENE, V33, P2790, DOI 10.1038/onc.2013.230; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Tang W, 2018, BIOINFORMATICS, V34, P398, DOI 10.1093/bioinformatics/btx622; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Verdoodt B, 2013, INT J ONCOL, V43, P307, DOI 10.3892/ijo.2013.1915; Wang Z, 2013, ONCOGENE, V32, P589, DOI 10.1038/onc.2012.83; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wei JS, 2009, CLIN CANCER RES, V15, P5560, DOI 10.1158/1078-0432.CCR-08-3287; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Wu WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181231; Xu B, 2015, PROSTATE, V75, P1896, DOI 10.1002/pros.23068; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Yang WJ, 2017, AM J TRANSL RES, V9, P1801; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152; Zhu HQ, 2014, AM J PATHOL, V184, P2828, DOI 10.1016/j.ajpath.2014.06.024	53	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0224071	10.1371/journal.pone.0224071	http://dx.doi.org/10.1371/journal.pone.0224071			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756185	Green Published, Green Submitted, gold			2022-12-26	WOS:000533889300004
J	Arnalich-Montiel, F; Moratilla, A; Fuentes-Julian, S; Aparicio, V; Martin, MC; Peh, G; Mehta, JS; Adnan, K; Porrua, L; Perez-Sarriegui, A; De Miguel, MP				Arnalich-Montiel, Francisco; Moratilla, Adrian; Fuentes-Julian, Sherezade; Aparicio, Veronica; Martin, Marta Cadenas; Peh, Gary; Mehta, Jodhbir S.; Adnan, Khadijah; Porrua, Laura; Perez-Sarriegui, Ane; De Miguel, Maria P.			Treatment of corneal endothelial damage in a rabbit model with a bioengineered graft using human decellularized corneal lamina and cultured human corneal endothelium	PLOS ONE			English	Article							CELL TRANSPLANTATION; DESCEMETS-MEMBRANE; SHEET; LAMELLAE; CARRIER; MEDIA	Objective We aimed to investigate the functionality of human decellularized stromal laminas seeded with cultured human corneal endothelial cells as a tissue engineered endothelial graft (TEEK) construct to perform endothelial keratoplasty in an animal model of corneal endothelial damage. Methods Engineered corneal endothelial grafts were constructed by seeding cultured human corneal endothelial cell (hCEC) suspensions onto decellularized human corneal stromal laminas with various coatings. The functionality and survival of these grafts with cultured hCECs was examined in a rabbit model of corneal endothelial damage after central descemetorhexis. Rabbits received laminas with and without hCECs (TEEK and control group, respectively). Results hCEC seeding over fibronectin-coated laminas provided an optimal and consistent endothelial cell count density and polygonal shape on the decellularized laminas, showing active pump fuction. Surgery was performed uneventfully as standard Descemet stripping automated endothelial keratoplasty (DSAEK). Corneal transparency gradually recovered in the TEEK group, whereas haze and edema persisted for up to 4 weeks in the controls. Histologic examination showed endothelial cells of human origin covering the posterior surface of the graft in the TEEK group. Conclusions Grafting of decellularized stroma carriers re-surfaced with human corneal endothelial cells ex vivo can be a readily translatable method to improve visual quality in corneal endothelial diseases.	[Arnalich-Montiel, Francisco; Porrua, Laura; Perez-Sarriegui, Ane] Hosp Ramon & Cajal, Ophthalmol Dept, Madrid, Spain; [Moratilla, Adrian; Fuentes-Julian, Sherezade; Aparicio, Veronica; Martin, Marta Cadenas; De Miguel, Maria P.] La Paz Hosp Res Inst, Cell Engn Lab, iDIPAZ, Madrid, Spain; [Peh, Gary; Mehta, Jodhbir S.; Adnan, Khadijah] Singapore Eye Res Inst, Singapore, Singapore	Hospital Universitario Ramon y Cajal; National University of Singapore; Singapore National Eye Center	De Miguel, MP (corresponding author), La Paz Hosp Res Inst, Cell Engn Lab, iDIPAZ, Madrid, Spain.	mariapdemiguel@gmail.com	Arnalich, Francisco/K-7723-2014; Peh, Gary/A-8327-2010; Aparicio Herranz, Veronica/Y-9833-2018	Peh, Gary/0000-0002-5387-4209; Aparicio Herranz, Veronica/0000-0001-6206-1763; Arnalich-Montiel, Francisco/0000-0002-1229-2018	Ministry of Health and Social Politics, Spain [EC-11, PI15/01447]; Instituto de Salud Carlos III (Plan Estatal de I+D+i 2013-2016) [PI15/01447]; European Development Regional Fund "A way to achieve Europe" (ERDF); Roche Farma SA; Ministry of Education, Culture and Sports, Spain [AP2010-0659]; BioMedical Foundation Mutua Madrilena, Spain; BioMedical Foundation Marato TV3, Spain; Consejeria de Educacion, Juventud y Deporte of Comunidad de Madrid; Fondo Social Europeo (Programa Operativo de Empleo Juvenil, and Iniciativa de Empleo Juvenil (YEI)) [PEJ15/BIO/AI/0045, PEJD-2018-PRE/BMD-8878, PEJ15/BIO/AI/0093, PEJD-2018-PRE/BMD-9040]	Ministry of Health and Social Politics, Spain; Instituto de Salud Carlos III (Plan Estatal de I+D+i 2013-2016); European Development Regional Fund "A way to achieve Europe" (ERDF); Roche Farma SA; Ministry of Education, Culture and Sports, Spain; BioMedical Foundation Mutua Madrilena, Spain; BioMedical Foundation Marato TV3, Spain; Consejeria de Educacion, Juventud y Deporte of Comunidad de Madrid; Fondo Social Europeo (Programa Operativo de Empleo Juvenil, and Iniciativa de Empleo Juvenil (YEI))	This study was supported in part by grants EC-11 and PI15/01447 from the Ministry of Health and Social Politics, Spain; PI15/01447 was supported by the Instituto de Salud Carlos III (Plan Estatal de I+D+i 2013-2016) and cofinanced by the European Development Regional Fund "A way to achieve Europe" (ERDF); and financing from Roche Farma SA; AP2010-0659 fellowship to SF-J from the Ministry of Education, Culture and Sports, Spain; and from the BioMedical Foundations Mutua Madrilena and Marato TV3, Spain. V Aparicio, M Cadenas and A Moratilla were supported by the Consejeria de Educacion, Juventud y Deporte of Comunidad de Madrid and by Fondo Social Europeo (Programa Operativo de Empleo Juvenil, and Iniciativa de Empleo Juvenil (YEI), (PEJ15/BIO/AI/0045, PEJD-2018-PRE/BMD-8878, PEJ15/BIO/AI/0093 and PEJD-2018-PRE/BMD-9040).	Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Del Barrio JLA, 2018, AM J OPHTHALMOL, V186, P47, DOI 10.1016/j.ajo.2017.10.026; del Barrio JLA, 2015, EXP EYE RES, V132, P91, DOI 10.1016/j.exer.2015.01.020; Bayyoud T, 2012, CURR EYE RES, V37, P179, DOI 10.3109/02713683.2011.644382; Bednarz J, 2001, BRIT J OPHTHALMOL, V85, P1416, DOI 10.1136/bjo.85.12.1416; Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Diao YM, 2015, MOL MED REP, V12, P1929, DOI 10.3892/mmr.2015.3665; EBAA, 2016, EYE BANKING STAT REP, P1; Fuentes-Julian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117945; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Gosselin EA, 2018, J TISSUE ENG REGEN M, V12, P285, DOI 10.1002/term.2499; He ZG, 2016, INVEST OPHTH VIS SCI, V57, P6639, DOI 10.1167/iovs.16-20256; Honda N, 2009, ARCH OPHTHALMOL-CHIC, V127, P1321, DOI 10.1001/archophthalmol.2009.253; Hong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061929; Jackel T, 2011, BRIT J OPHTHALMOL, V95, P123, DOI 10.1136/bjo.2010.183418; Kimoto M, 2014, INVEST OPHTH VIS SCI, V55, P2337, DOI 10.1167/iovs.13-13167; Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39; LANGE TM, 1993, J CATARACT REFR SURG, V19, P232, DOI 10.1016/S0886-3350(13)80947-9; Lopez-Iglesias Pilar, 2011, World J Stem Cells, V3, P53, DOI 10.4252/wjsc.v3.i6.53; MILLS RA, 1995, CORNEA, V14, P157; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Mimura T, 2013, PROG RETIN EYE RES, V35, P1, DOI 10.1016/j.preteyeres.2013.01.003; MINKOWSKI JS, 1984, INVEST OPHTH VIS SCI, V25, P1416; Moller-Pedersen T, 2001, GRAEF ARCH CLIN EXP, V239, P778, DOI 10.1007/s004170100354; Okumura N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191306; Okumura N, 2016, SCI REP-UK, V6, DOI 10.1038/srep26113; Peh GSL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14723-z; Peh GSL, 2015, CELL TRANSPLANT, V24, P287, DOI 10.3727/096368913X675719; Proulx S, 2012, EXP EYE RES, V95, P68, DOI 10.1016/j.exer.2011.06.013; Rice AM, 2000, TRANSPLANTATION, V69, P927; Rizwan M, 2017, BIOMATERIALS, V120, P139, DOI 10.1016/j.biomaterials.2016.12.026; Soh YQ, 2018, REGEN MED, V13, P97, DOI 10.2217/rme-2017-0081; Soh YQ, 2017, J TISSUE ENG REGEN M, V11, P2425, DOI 10.1002/term.2131; Song CD, 2006, MED MANAG SURG PATIE, V379, P700, DOI [10.1017/CBO9780511544590.105, DOI 10.1017/CBO9780511544590.105]; Stuart AJ, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.C.D012097.pub2; Van Horn DL, 1977, INVESTIGATIVE OPHTHA	37	17	17	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225480	10.1371/journal.pone.0225480	http://dx.doi.org/10.1371/journal.pone.0225480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751429	Green Published, gold			2022-12-26	WOS:000533886900070
J	Malebary, SJ; Rehman, MSU; Khan, YD				Malebary, Sharaf Jameel; Rehman, Muhammad Safi Ur; Khan, Yaser Daanial			iCrotoK-PseAAC: Identify lysine crotonylation sites by blending position relative statistical features according to the Chou's 5-step rule	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; MEMBRANE-PROTEIN; UBIQUITINATION SITES; ENSEMBLE CLASSIFIER; PSEUDO COMPONENTS; PREDICTION; SEQUENCE; MODES; PEPTIDES; DNA	Among different post-translational modifications (PTMs), one of the most important one is the lysine crotonylation in proteins. Its importance cannot be undermined related to different diseases and essential biological practice. The key step for finding the hidden mechanisms of crotonylation along with their occurrence sites is to completely apprehend the mechanism behind this biological process. In previously reported studies, researchers have used different techniques, like position weighted matrix (PWM), support vector machine (SVM), k nearest neighbors (KNN), and many others. However, the maximum prediction accuracy achieved was not such high. To address this, herein, we propose an improved predictor for lysine crotonylation sites named iCrotoK-PseAAC, in which we have incorporated various position and composition relative features along with statistical moments into PseAAC. The results of self-consistency testing were 100% accurate, while the 10-fold cross validation gave 99.0% accuracy. Based on the validation and comparison of model, it is concluded that the iCrotoK-PseAAC is more accurate than the previously proposed models.	[Malebary, Sharaf Jameel] King Abdulaziz Univ, Dept Informat Technol, Rabigh, Saudi Arabia; [Rehman, Muhammad Safi Ur; Khan, Yaser Daanial] Univ Management & Technol, Sch Syst & Technol, Dept Comp Sci, Lahore, Pakistan	King Abdulaziz University; University of Management & Technology (UMT)	Khan, YD (corresponding author), Univ Management & Technol, Sch Syst & Technol, Dept Comp Sci, Lahore, Pakistan.	yaser.khan@umt.edu.pk	Khan, Yaser Daanial/ABB-7928-2020; Malebary, Sharaf J/S-5018-2018	Malebary, Sharaf J/0000-0003-4339-3791; Khan, Yaser/0000-0002-2482-275X				Akmal MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181966; Ali F, 2015, J THEOR BIOL, V384, P78, DOI 10.1016/j.jtbi.2015.07.034; Andraos J, 2008, CAN J CHEM, V86, P342, DOI 10.1139/V08-020; [Anonymous], 2018, MOL BIOL REP; Awais M, 2019, IEEE ACM T COMPUTA T; Awais M, 2019, IPHOSH PSEAAC IDENTI; Bishop C.M., 1995, NEURAL NETWORKS PATT; Butt AH, 2017, J MEMBRANE BIOL, V250, P55, DOI 10.1007/s00232-016-9937-7; Cakebread JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094010; CALLAN N, 2016, PAKISTAN J SCI, V68; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Chatterjea M.N, 2011, TXB MED BIOCH; Chen W, 2017, ONCOTARGET, V8, P4208, DOI 10.18632/oncotarget.13758; Chen W, 2015, MOL BIOSYST, V11, P2620, DOI 10.1039/c5mb00155b; Chou K., 2018, CURRENT PHARM DESIGN; Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X; CHOU KC, 1980, CHEM SCRIPTA, V16, P109; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2020, INT J PEPT RES THER, V26, P873, DOI 10.1007/s10989-019-09893-5; Chou KC, 2015, MED CHEM, V11, P218, DOI 10.2174/1573406411666141229162834; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui XW, 2019, CHEMOMETR INTELL LAB, V184, P28, DOI 10.1016/j.chemolab.2018.11.012; Du PF, 2014, INT J MOL SCI, V15, P3495, DOI 10.3390/ijms15033495; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehsan A, 2019, CURR GENOMICS, V20, P124, DOI 10.2174/1389202920666190325162307; Ehsan A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19491-y; Feng PM, 2019, GENOMICS, V111, P96, DOI 10.1016/j.ygeno.2018.01.005; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gluhovsky A, 2009, J APPL METEOROL CLIM, V48, P1948, DOI 10.1175/2009JAMC2124.1; Hajisharifi Z, 2014, J THEOR BIOL, V341, P34, DOI 10.1016/j.jtbi.2013.08.037; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; He B, 2016, BIOMED RES INT, V2016; He WY, 2019, BIOINFORMATICS, V35, P593, DOI 10.1093/bioinformatics/bty668; Huang GH, 2016, MATCH-COMMUN MATH CO, V75, P717; Hussain W, 2019, J THEORETICAL BIOL; Hussain W, 2019, ANAL BIOCHEM, V568, P14, DOI 10.1016/j.ab.2018.12.019; Jia JH, 2019, J THEOR BIOL, V460, P195, DOI 10.1016/j.jtbi.2018.10.021; Jia JH, 2016, ANAL BIOCHEM, V497, P48, DOI 10.1016/j.ab.2015.12.009; Jia JH, 2016, J BIOMOL STRUCT DYN, V34, P1946, DOI 10.1080/07391102.2015.1095116; Ju Z, 2017, J MOL GRAPH MODEL, V77, P200, DOI 10.1016/j.jmgm.2017.08.020; Kabir M, 2019, GENOMICS; Kabir M, 2016, MOL GENET GENOMICS, V291, P285, DOI 10.1007/s00438-015-1108-5; Kang JJ, 2019, INTERDISCIP SCI, V11, P108, DOI 10.1007/s12539-018-0287-2; Khan, 2018, MOL BIOL REP, P1; Khan A, 2011, COMPUT BIOL CHEM, V35, P218, DOI 10.1016/j.compbiolchem.2011.05.003; Khan M, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/328592; Khan Y. D., 2012, WORLD APPL SCI J, V16, P678; Khan YD, 2018, ANAL BIOCHEM, V550, P109, DOI 10.1016/j.ab.2018.04.021; Khan YD, 2018, J THEORETICAL BIOL; Li SL, 2009, PROTEIN PEPTIDE LETT, V16, P977, DOI 10.2174/092986609788923338; LI TT, 1980, CHEM SCRIPTA, V16, P192; Lian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018587; Lin SK, 2013, J RISK FINANC MANAG, V6, P4, DOI 10.3390/jrfm6010004; Liu B, 2018, BIOINFORMATICS, V34, P33, DOI 10.1093/bioinformatics/btx579; Liu B, 2016, MOL GENET GENOMICS, V291, P473, DOI 10.1007/s00438-015-1078-7; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu H, 2005, BIOCHEM BIOPH RES CO, V336, P737, DOI 10.1016/j.bbrc.2005.08.160; Le NQK, 2019, ANAL BIOCHEM, V575, P17, DOI 10.1016/j.ab.2019.03.017; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; Qiu W. R., 2017, MOL INFORM, V36; Qiu W.-R, 2017, GENOMICS; Qiu WR, 2017, ARTIF INTELL MED, V83, P75, DOI 10.1016/j.artmed.2017.02.007; Qiu WR, 2016, BIOINFORMATICS, V32, P3116, DOI 10.1093/bioinformatics/btw380; Qiu WR, 2015, J BIOMOL STRUCT DYN, V33, P1731, DOI 10.1080/07391102.2014.968875; Qiu WR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/947416; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Tahir M, 2019, CHEMOMETR INTELL LAB, V189, P96, DOI 10.1016/j.chemolab.2019.04.007; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang LD, 2019, J THEOR BIOL, V461, P51, DOI 10.1016/j.jtbi.2018.10.046; Xiao X, 2016, ONCOTARGET, V7, P34180, DOI 10.18632/oncotarget.9057; Xiao X, 2013, ANAL BIOCHEM, V436, P168, DOI 10.1016/j.ab.2013.01.019; Xu Y, 2014, INT J MOL SCI, V15, P7594, DOI 10.3390/ijms15057594; Zhang M, 2019, MULTIPLY NOVEL MULTI; Zhong W-Z, 2014, MOL SCI DRUG DEV BIO; Zhou GP, 2016, CURR TOP MED CHEM, V16, P381, DOI 10.2174/156802661604151014114030; Zhou GP, 2011, J THEOR BIOL, V284, P142, DOI 10.1016/j.jtbi.2011.06.006; Zhu HQ, 2007, PATTERN RECOGN LETT, V28, P1688, DOI 10.1016/j.patrec.2007.04.013	81	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0223993	10.1371/journal.pone.0223993	http://dx.doi.org/10.1371/journal.pone.0223993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751380	Green Published, gold			2022-12-26	WOS:000533886900007
J	Brovedan, M; Repizo, GD; Marchiaro, P; Viale, AM; Limansky, A				Brovedan, Marco; Repizo, Guillermo D.; Marchiaro, Patricia; Viale, Alejandro M.; Limansky, Adriana			Characterization of the diverse plasmid pool harbored by the bla(NDM-1)-containing Acinetobacter bereziniae HPC229 clinical strain	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; COMPARATIVE GENOMICS; SEQUENCE; IDENTIFICATION; ACQUISITION; EVOLUTION; BAUMANNII; SYSTEM; GENES; DIVERSIFICATION	Acinetobacter bereziniae is an environmental microorganism with increasing clinical incidence, and may thus provide a model for a bacterial species bridging the gap between the environment and the clinical setting. A. bereziniae plasmids have been poorly studied, and their characterization could offer clues on the causes underlying the leap between these two different habitats. Here we characterized the whole plasmid content of A. bereziniae HPC229, a clinical strain previously reported to harbor a 44-kbp plasmid, pNDM229, conferring carbapenem and aminoglycoside resistance. We identified five extra plasmids in HPC229 ranging from 114 to 1.3 kbp, including pAbe229-114 (114 kbp) encoding a MOBP111 relaxase and carrying heavy metal resistance, a bacteriophage defense BREX system and four different toxin-antitoxin (TA) systems. Two other replicons, pAbe229-15 (15.4 kbp) and pAbe229-9 (9.1 kbp), both encoding MOBQ1 relaxases and also carrying TA systems, were found. The three latter plasmids contained Acinetobacter Rep_3 superfamily replication initiator protein genes, and functional analysis of their transfer regions revealed the mobilizable nature of them. HPC229 also harbors two smaller plasmids, pAbe229-4 (4.4 kbp) and pAbe229-1 (1.3 kbp), the former bearing a ColE1-type replicon and a TA system, and the latter lacking known replication functions. Comparative sequence analyses against deposited Acinetobacter genomes indicated that the above five HPC229 plasmids were unique, although some regions were also present in other of these genomes. The transfer, replication, and adaptive modules in pAbe229-15, and the stability module in pAbe229-9, were bordered by sites potentially recognized by XerC/XerD site-specific tyrosine recombinases, thus suggesting a potential mechanism for their acquisition. The presence of Rep_3 and ColE1-based replication modules, different mob genes, distinct adaptive functions including resistance to heavy metal and other environmental stressors, as well as antimicrobial resistance genes, and a high content of XerC/XerD sites among HPC229 plasmids provide evidence of substantial links with bacterial species derived from both environmental and clinical habitats.	[Brovedan, Marco; Repizo, Guillermo D.; Marchiaro, Patricia; Viale, Alejandro M.; Limansky, Adriana] Univ Nacl Rosario UNR, Inst Biol Mol & Celular Rosario IBR, Dept Microbiol, Fac Ciencias Bioquim & Farmaceut,CONICET, Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Viale, AM; Limansky, A (corresponding author), Univ Nacl Rosario UNR, Inst Biol Mol & Celular Rosario IBR, Dept Microbiol, Fac Ciencias Bioquim & Farmaceut,CONICET, Rosario, Argentina.	viale@ibr-conicet.gov.ar; limansky@ibr-conicet.gov.ar		Viale, Alejandro/0000-0002-1035-6479; Brovedan, Marco Alcides/0000-0002-1934-6306; Repizo, Guillermo Daniel/0000-0003-1318-8738	Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT PICT-2012-0680]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Provincia de Santa Fe, Argentina; CONICET [PIP 1055, PICT2015-1072]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Provincia de Santa Fe, Argentina; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT-2012-0680) to A.L.; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Provincia de Santa Fe, Argentina, to A. M.V and A.L.; and CONICET (PIP 1055) and PICT2015-1072 to A.M.V. M.B. is Fellow of CONICET, G. D.R. and A.M.V. are Career researchers of CONICET, and A.L. and P.M are Researchers of the UNR.	Adams MD, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000062; Afshari Elnaz, 2017, Avicenna Journal of Medical Biotechnology, V9, P169; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Bellanger X, 2014, FEMS MICROBIOL REV, V38, P720, DOI 10.1111/1574-6976.12058; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bertini A, 2010, ANTIMICROB AGENTS CH, V54, P4168, DOI 10.1128/AAC.00542-10; Blackwell GA, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00780-17; Bonnin RA, 2013, ANTIMICROB AGENTS CH, V57, P674, DOI 10.1128/AAC.01086-12; Brovedan M, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00117-16; Brovedan M, 2015, ANTIMICROB AGENTS CH, V59, P6667, DOI 10.1128/AAC.00367-15; Cameranesi MM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00066; Cameranesi MM., 2017, J INFECT DIS EPIDEMI, V3, P046, DOI [10.23937/2474-3658/1510046, DOI 10.23937/2474-3658/1510046]; Camps Manel, 2010, Recent Pat DNA Gene Seq, V4, P58; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; Chan JZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-302; Chan WT, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00009; Cho GS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00536; Cladera AM, 2004, J BACTERIOL, V186, P5239, DOI 10.1128/JB.186.16.5239-5248.2004; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; DiCello F, 1997, RES MICROBIOL, V148, P237, DOI 10.1016/S0923-2508(97)85244-8; Dorsey CW, 2006, PLASMID, V56, P112, DOI 10.1016/j.plasmid.2006.01.004; Farrugia Daniel N, 2013, PLoS One, V8, pe58628, DOI 10.1371/journal.pone.0058628; Feng Y, 2016, J ANTIMICROB CHEMOTH, V71, P71, DOI 10.1093/jac/dkv324; Fondi M, 2013, RES MICROBIOL, V164, P439, DOI 10.1016/j.resmic.2013.03.003; Fondi M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-59; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Gallagher LA, 2017, MBIO, V8, DOI 10.1128/mBio.01655-17; Garcia-Garcera M, 2017, ENVIRON MICROBIOL, V19, P5010, DOI 10.1111/1462-2920.13949; Gardner MN, 2001, J BACTERIOL, V183, P3303, DOI 10.1128/JB.183.11.3303-3309.2001; Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Grosso F, 2015, FUTURE MICROBIOL, V10, P1609, DOI 10.2217/fmb.15.88; Haines AS, 2006, MICROBIOL-SGM, V152, P2689, DOI 10.1099/mic.0.28941-0; Hu HY, 2012, ANTIMICROB AGENTS CH, V56, P1698, DOI 10.1128/AAC.06199-11; Jones LS, 2015, ANTIMICROB AGENTS CH, V59, P923, DOI 10.1128/AAC.03242-14; Jurenaite M, 2013, J BACTERIOL, V195, P3165, DOI 10.1128/JB.00237-13; Konieczny I, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0026-2014; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Krahn T, 2012, ANTIMICROB AGENTS CH, V56, P5591, DOI 10.1128/AAC.01446-12; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lean SS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01547; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Lee K, 2010, INT J ANTIMICROB AG, V36, P259, DOI 10.1016/j.ijantimicag.2010.05.018; Lee YK, 2006, FEMS MICROBIOL LETT, V257, P177, DOI 10.1111/j.1574-6968.2006.00130.x; Li AD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01025; Loftie-Eaton W, 2016, MOL BIOL EVOL, V33, P885, DOI 10.1093/molbev/msv339; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Merino M, 2010, ANTIMICROB AGENTS CH, V54, P2724, DOI 10.1128/AAC.01674-09; Meyer R, 2009, PLASMID, V62, P57, DOI 10.1016/j.plasmid.2009.05.001; Midonet C, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0056-2014; Mindlin S, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny047; Mugnier PD, 2009, J BACTERIOL, V191, P2414, DOI 10.1128/JB.01258-08; Nemec A, 2010, INT J SYST EVOL MICR, V60, P896, DOI 10.1099/ijs.0.013656-0; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Ou HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08643; Garcillan-Barcia MP, 2011, FEMS MICROBIOL REV, V35, P936, DOI 10.1111/j.1574-6976.2011.00291.x; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Porse A, 2016, MOL BIOL EVOL, V33, P2860, DOI 10.1093/molbev/msw163; Post V, 2009, ANTIMICROB AGENTS CH, V53, P2667, DOI 10.1128/AAC.01407-08; Rajewska M, 2012, FEMS MICROBIOL REV, V36, P408, DOI 10.1111/j.1574-6976.2011.00300.x; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Salto IP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26180-3; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smalla K, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.PLAS-0038-2014; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Touchon M, 2014, GENOME BIOL EVOL, V6, P2866, DOI 10.1093/gbe/evu225; Tran T, 2010, J BACTERIOL, V192, P883, DOI 10.1128/JB.01082-09; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Varani AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r30; Wright MS, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00833-16; Xie YZ, 2018, NUCLEIC ACIDS RES, V46, pD749, DOI 10.1093/nar/gkx1033; Zander E, 2014, J ANTIMICROB CHEMOTH, V69, P270, DOI 10.1093/jac/dkt313	80	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0220584	10.1371/journal.pone.0220584	http://dx.doi.org/10.1371/journal.pone.0220584			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LK1WQ	31743332	Green Submitted, gold, Green Published			2022-12-26	WOS:000530649700001
J	Cheong, HC; Yap, PSX; Chong, CW; Cheok, YY; Lee, CYQ; Tan, GMY; Sulaiman, S; Hassan, J; Sabet, NS; Looi, CY; Gupta, R; Arulanandam, B; AbuBakar, S; Teh, CSJ; Chang, LY; Wong, WF				Cheong, Heng Choon; Yap, Polly Soo Xi; Chong, Chun Wie; Cheok, Yi Ying; Lee, Chalystha Yie Qin; Tan, Grace Min Yi; Sulaiman, Sofiah; Hassan, Jamiyah; Sabet, Negar Shafiei; Looi, Chung Yeng; Gupta, Rishein; Arulanandam, Bernard; AbuBakar, Sazaly; Teh, Cindy Shuan Ju; Chang, Li Yen; Wong, Won Fen			Diversity of endocervical microbiota associated with genital Chlamydia trachomatis infection and infertility among women visiting obstetrics and gynecology clinics in Malaysia	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; BACTERIAL VAGINOSIS; VAGINAL MICROBIOTA; AEROCOCCUS-URINAE; DISEASE; PREVALENCE; GONORRHEA; TIME	The cervical microbiota constitutes an important protective barrier against the invasion of pathogenic microorganisms. A disruption of microbiota within the cervical milieu has been suggested to be a driving factor of sexually transmitted infections. These include Chlamydia trachomatis which frequently causes serious reproductive sequelae such as infertility in women. In this study, we profiled the cervical microbial composition of a population of 70 reproductive-age Malaysian women; among which 40 (57.1%) were diagnosed with genital C. trachomatis infection, and 30 (42.8%) without C. trachomatis infection. Our findings showed a distinct compositional difference between the cervical microbiota of C. trachomatis-infected subjects and subjects without C. trachomatis infection. Specifically, significant elevations of mostly strict and facultative anaerobes such as Streptococcus, Megasphaera, Prevotella, and Veillonella in the cervical microbiota of C. trachomatis-positive women were detected. The results from the current study highlights an interaction of C. trachomatis with the environmental microbiome in the endocervical region.	[Cheong, Heng Choon; Yap, Polly Soo Xi; Cheok, Yi Ying; Lee, Chalystha Yie Qin; Tan, Grace Min Yi; AbuBakar, Sazaly; Teh, Cindy Shuan Ju; Chang, Li Yen; Wong, Won Fen] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Chong, Chun Wie] Monash Univ Malaysia, Sch Pharm, Jalan Lagoon Selatan, Bandar Sunway, Selangor, Malaysia; [Sulaiman, Sofiah; Hassan, Jamiyah] Univ Malaya, Dept Obstet & Gynecol, Fac Med, Kuala Lumpur, Malaysia; [Sabet, Negar Shafiei] SEGi Univ, Fac Med, Kota Damansara, Selangor, Malaysia; [Looi, Chung Yeng] Taylors Univ, Sch Biosci, Subang Jaya, Selangor, Malaysia; [Gupta, Rishein; Arulanandam, Bernard] Univ Texas San Antonio, Ctr Excellence Infect Genom, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [AbuBakar, Sazaly] Univ Malaya, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Monash University; Monash University Sunway; Universiti Malaya; SEGi University; Taylor's University; University of Texas System; University of Texas at San Antonio (UTSA); Universiti Malaya	Wong, WF (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.; Looi, CY (corresponding author), Taylors Univ, Sch Biosci, Subang Jaya, Selangor, Malaysia.	ChungYeng.Looi@taylors.edu.my; wonfen@um.edu.my	Chong, Chun Wie/E-2909-2010; SULAIMAN, SOFIAH/B-9824-2010; hassan, jamiyah/ABD-2700-2020; Chong, Chun Wie/ABG-7676-2020; Yap, Polly Soo Xi/AAK-7251-2020; abubakar, sazaly/B-3957-2010; Teh, Cindy/D-7161-2019; CHANG, LI-YEN/B-8353-2010; Cheok, Yi Ying/GLR-7091-2022; Wong, Won Fen/D-3087-2012; Sulaiman, Sofiah/ABV-4778-2022	Chong, Chun Wie/0000-0002-6881-8883; SULAIMAN, SOFIAH/0000-0003-1044-920X; Chong, Chun Wie/0000-0002-6881-8883; abubakar, sazaly/0000-0002-9267-1420; Teh, Cindy/0000-0002-9062-3839; Wong, Won Fen/0000-0003-1082-1956; Sulaiman, Sofiah/0000-0003-1044-920X; Cheong, Heng Choon/0000-0002-9279-3591; Yap, Polly Soo Xi/0000-0002-1615-3138; Lee, Chalystha Yie Qin/0000-0002-5070-6269	Malaysian Ministry of Education [FP014-2017A]; University of Malaya Specialist Center (UMSC) C.A.R.E. Fund [PV061-2018]	Malaysian Ministry of Education; University of Malaya Specialist Center (UMSC) C.A.R.E. Fund	This study was supported by the Fundamental Research Grant Scheme (FP014-2017A) from the Malaysian Ministry of Education to WFW, and University of Malaya Specialist Center (UMSC) C.A.R.E. Fund (PV061-2018) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balle C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29320-x; Bautista CT, 2017, AM J PREV MED, V52, P632, DOI 10.1016/j.amepre.2016.09.016; Biagi E, 2009, EUR J CLIN MICROBIOL, V28, P281, DOI 10.1007/s10096-008-0617-0; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Carlstein Catrine, 2016, Open Microbiol J, V10, P27, DOI 10.2174/1874285801610010027; Cribby S, 2008, INTERDISCIP PERSPECT, V2008, DOI [10.1155/2008/256490, DOI 10.1155/2008/256490]; Davies B, 2016, LANCET INFECT DIS, V16, P1057, DOI 10.1016/S1473-3099(16)30092-5; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Di Pietro M, 2018, NEW MICROBIOL, V41, P34; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Filardo S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00321; Gallo MF, 2012, ANN EPIDEMIOL, V22, P213, DOI 10.1016/j.annepidem.2011.11.005; Gao WJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-271; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107758; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Higgins A, 2017, UROL CASE REP, V13, P24, DOI 10.1016/j.eucr.2017.03.022; Kaminska D, 2017, BENEF MICROBES, V8, P327, DOI 10.3920/BM2015.0174; Kebschull JM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv717; Kindinger LM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0223-9; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Manavi K, 2006, BEST PRACT RES CL OB, V20, P941, DOI 10.1016/j.bpobgyn.2006.06.003; MANJUNATHA HK, 2017, J CLIN DIAGN RES, V11, DOI DOI 10.7860/JCDR/2017/23997.9229; Mastromarino P, 2014, INT J MED MICROBIOL, V304, P654, DOI 10.1016/j.ijmm.2014.04.006; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller KE, 2006, AM FAM PHYSICIAN, V73, P1411; Molenaar MC, 2018, J REPROD IMMUNOL, V130, P11, DOI 10.1016/j.jri.2018.08.006; Moss NJ, 2006, J INFECT DIS, V193, P1336, DOI 10.1086/503114; Nardini P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29024; Nelson TM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00253; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; NGEOW YF, 1990, J CLIN PATHOL, V43, P400, DOI 10.1136/jcp.43.5.400; Mackern-Oberti JP, 2013, J REPROD IMMUNOL, V100, P37, DOI 10.1016/j.jri.2013.05.002; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Ranjit E, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/8349601; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Ravindran J, 1998, Med J Malaysia, V53, P16; Rours GIJG, 2011, EUR J EPIDEMIOL, V26, P493, DOI 10.1007/s10654-011-9586-1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi Y, 2009, J OBSTET GYNAECOL RE, V35, P525, DOI 10.1111/j.1447-0756.2008.00971.x; Sirichoat A, 2018, PEERJ, V6, DOI 10.7717/peerj.5977; Spiliopoulou A, 2005, CLIN MICROBIOL INFEC, V11, P687, DOI 10.1111/j.1469-0691.2005.01187.x; Stafford GP, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00615; Takada K, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.13027; Tamarelle J, 2018, SEX TRANSM INFECT, V94, P616, DOI 10.1136/sextrans-2017-053346; Tamrakar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128; Turovskiy Y, 2011, J APPL MICROBIOL, V110, P1105, DOI 10.1111/j.1365-2672.2011.04977.x; Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/s1473-3099(17)30310-9, 10.1016/S1473-3099(17)30310-9]; van der Veer C, 2017, CLIN INFECT DIS, V64, P24, DOI 10.1093/cid/ciw586; van Houdt R, 2018, SEX TRANSM INFECT, V94, P117, DOI 10.1136/sextrans-2017-053133; Vartivarian SE, 1996, ARCH INTERN MED, V156, P433, DOI 10.1001/archinte.156.4.433; Walker J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037778; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wilkowska-Trojniel M, 2009, ADV MED SCI-POLAND, V54, P86, DOI 10.2478/v10039-009-0008-5; Witkin SS, 2019, BJOG-INT J OBSTET GY, V126, P359, DOI 10.1111/1471-0528.15300; Yeow TC, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0671-1; You YA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01122; Zhang Q, 2000, J CLIN MICROBIOL, V38, P1703, DOI 10.1128/JCM.38.4.1703-1705.2000	62	8	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0224658	10.1371/journal.pone.0224658	http://dx.doi.org/10.1371/journal.pone.0224658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738795	gold, Green Published			2022-12-26	WOS:000532826300017
J	Manosrol, W; Phimphilai, M; Khorana, J; Atthakomol, P				Manosrol, Worapaka; Phimphilai, Mattabhorn; Khorana, Jiraporn; Atthakomol, Pichitchai			Diagnostic performance of basal cortisol level at 0900-1300h in adrenal insufficiency	PLOS ONE			English	Article							SHORT SYNACTHEN TEST; STIMULATION; STRESS; TESTS; ACTH	Objective An ACTH stimulation test is the standard diagnostic test for adrenal insufficiency (AI). We aimed to investigate the diagnostic performance between serum morning (0800 h) cortisol and serum basal (0900-1300 h) cortisol levels and determine the proper cut-off point to facilitate AI diagnosis to reduce the number of tests. Methods A six-year retrospective study was performed in a tertiary care medical center. We identified 416 patients who had undergone either low (LDT) or high dose (HDT) ACTH stimulation outpatient tests. AI was defined as a peak serum cortisol level of < 500 nmol/L at 30 or 60 minutes after LDT or HDT. The associations between AI and serum basal and morning cortisol levels were demonstrated by logistic regression model. Diagnostic performance was evaluated by ROC analysis. Results Of the 416 patients, 93 (22.4%) were categorized as having AI. The adjusted area under the curve (AUC) for the basal cortisol level for the diagnosis of AI was significantly higher than that for the morning cortisol (0.82 vs 0.69, p < 0.001) level. The proposed cut-off values for the basal cortisol were < 85 nmol/L (specificity 99.7%) and > 350 nmol/L(sensitivity 98.9%). By using these proposed cut-off points, approximately 30% of the ACTH stimulation tests could be eliminated. Conclusion The serum basal cortisol level with the proposed cut-off points were considered as an alternative option for diagnosis of AI. Utilizing the serum basal cortisol level can facilitate AI diagnosis as it is convenient, is not a time-specific test and has a high diagnostic performance.	[Manosrol, Worapaka; Phimphilai, Mattabhorn] Chiang Mai Univ Hosp, Div Endocrinol, Dept Internal Med, Fac Med, Chiang Mai, Thailand; [Khorana, Jiraporn] Chiang Mai Univ Hosp, Div Pediat Surg, Dept Surg, Fac Med, Chiang Mai, Thailand; [Khorana, Jiraporn] Chiang Mai Univ Hosp, Clin Epidemiol & Clin Statist Ctr, Fac Med, Chiang Mai, Thailand; [Atthakomol, Pichitchai] Chiang Mai Univ Hosp, Dept Orthoped, Fac Med, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Manosrol, W (corresponding author), Chiang Mai Univ Hosp, Div Endocrinol, Dept Internal Med, Fac Med, Chiang Mai, Thailand.	worapaka.m@gmail.com		Manosroi, Worapaka/0000-0002-3007-3951	Faculty of Medicine, Chiang Mai University	Faculty of Medicine, Chiang Mai University	This study was supported by the Faculty of Medicine, Chiang Mai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON GE, 1973, JOHNS HOPKINS MED J, V132, P127; Bornstein SR, 2016, J CLIN ENDOCR METAB, V101, P364, DOI 10.1210/jc.2015-1710; Charmandari E, 2014, LANCET, V383, P2152, DOI 10.1016/S0140-6736(13)61684-0; DAIDOH H, 1995, CLIN ENDOCRINOL, V43, P311, DOI 10.1111/j.1365-2265.1995.tb02037.x; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dorin RI, 2003, ANN INTERN MED, V139, P194, DOI 10.7326/0003-4819-139-3-200308050-00009; Fleseriu M, 2010, ENDOCR PRACT, V16, P64, DOI 10.4158/EP09153.OR; Hurel SJ, 1996, CLIN ENDOCRINOL, V44, P141, DOI 10.1046/j.1365-2265.1996.555381.x; Javorsky B, 2019, J ENDOCRINE SOC S, V3, DOI [10.1210/js.2019-SAT-390, DOI 10.1210/JS.2019-SAT-390]; Kline GA, 2017, CLIN BIOCHEM, V50, P475, DOI 10.1016/j.clinbiochem.2017.02.008; le Roux CW, 2002, ANN CLIN BIOCHEM, V39, P148, DOI 10.1258/0004563021901919; Mackenzie SD, 2019, CLIN ENDOCRINOL, V91, P608, DOI 10.1111/cen.14071; Ospina NS, 2016, J CLIN ENDOCR METAB, V101, P427, DOI 10.1210/jc.2015-1700; Perton FT, 2017, NETH J MED, V75, P14; Pura M, 2010, EXP CLIN ENDOCR DIAB, V118, P151, DOI 10.1055/s-0029-1202275; Raff H, 2013, ENDOCR CONNECT, V2, P24, DOI 10.1530/EC-12-0058; Reimondo G, 2008, PITUITARY, V11, P147, DOI 10.1007/s11102-008-0108-4; Struja T, 2017, ENDOCR PRACT, V23, P949, DOI 10.4158/EP171861.OR; Verbeeten KC, 2018, J PEDIATR ENDOCR MET, V31, P107, DOI 10.1515/jpem-2017-0270; Widmer IE, 2005, J CLIN ENDOCR METAB, V90, P4579, DOI 10.1210/jc.2005-0354	20	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225255	10.1371/journal.pone.0225255	http://dx.doi.org/10.1371/journal.pone.0225255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738804	Green Published, gold			2022-12-26	WOS:000532826300040
J	Thalwieser, Z; Kiraly, N; Fonodi, M; Csortos, C; Boratko, A				Thalwieser, Zsofia; Kiraly, Nikolett; Fonodi, Marton; Csortos, Csilla; Boratko, Anita			Protein phosphatase 2A?mediated flotillin-1 dephosphorylation up-regulates endothelial cell migration and angiogenesis regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphatase 2 (PP2A); endothelial cell; angiogenesis; cell migration; phosphorylation	MEMBRANE; 2A; REGGIE-1/FLOTILLIN-2; LOCALIZATION; MICRODOMAINS; DOMAIN; PHOSPHORYLATION; OLIGOMERIZATION; IDENTIFICATION; CYTOSKELETON	Endothelial cells have key functions in endothelial barrier integrity and in responses to angiogenic signals that promote cell proliferation, cell migration, cytoskeletal reorganization, and formation of new blood vessels. These functions highly depend on protein?protein interactions in cell?cell junction and cell attachment complexes and on interactions with cytoskeletal proteins. Protein phosphatase 2A (PP2A) dephosphorylates several target proteins involved in cytoskeletal dynamics and cell adhesion. Our goal was to find new interacting and substrate proteins of the PP2A-B55? holoenzyme in bovine pulmonary endothelial cells. Using LC-MS/MS analysis, we identified flotillin-1 as a protein that binds recombinant GSH S-transferase?tagged PP2A-B55?. Immunoprecipitation experiments, proximity ligation assays, and immunofluorescent staining confirmed the interaction between these two endogenous proteins in endothelial cells. Originally, flotillins were described as regulatory proteins for axon regeneration, but they appear to function in many cellular processes, such as membrane receptor signaling, endocytosis, and cell adhesion. Ser(315) is a known PKC-targeted site in flotillin-1. Utilizing phosphomutants of flotillin-1 and the NanoBiT luciferase assay, we show here that phosphorylation/dephosphorylation of Ser(315) in flotillin-1 significantly affects its interaction with PP2A-B55? and that PP2A-B55? dephosphorylates phospho-Ser(315). Spreading, attachment, migration, and in vitro tube formation rates of S315A variant?overexpressing cells were faster than those of nontransfected or S315D-transfected cells. These results indicate that the PP2A?flotillin-1 interaction identified here affects major physiological activities of pulmonary endothelial cells.	[Thalwieser, Zsofia; Kiraly, Nikolett; Fonodi, Marton; Csortos, Csilla; Boratko, Anita] Univ Debrecen, Fac Med, Dept Med Chem, Egyet Ter 1, H-4032 Debrecen, Hungary	University of Debrecen	Boratko, A (corresponding author), Univ Debrecen, Fac Med, Dept Med Chem, Egyet Ter 1, H-4032 Debrecen, Hungary.	boratko@med.unideb.hu		Boratko, Anita/0000-0002-3099-6692	National Research, Development and Innovation Fund (NKFI) [PD116262]; New National Excellence Program of the Ministry of Human Capacities [UNKP-18-4, UNKP-19-4, UNKP-19-3]; Hungarian Academy of Sciences	National Research, Development and Innovation Fund (NKFI); New National Excellence Program of the Ministry of Human Capacities; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported National Research, Development and Innovation Fund (NKFI) Grant PD116262 (to A. B.), Grants UNKP-18-4, UNKP-19-4 (to A. B.), and UNKP-19-3 (to Z. T.), New National Excellence Program of the Ministry of Human Capacities, and a Bolyai Fellowship from the Hungarian Academy of Sciences (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Bagchi S, 2015, METHODS MOL BIOL, V1318, P149, DOI 10.1007/978-1-4939-2742-5_15; Banning A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7040028; Barr RK, 2008, J BIOL CHEM, V283, P34994, DOI 10.1074/jbc.M804658200; Bodin S, 2014, J CELL SCI, V127, P5139, DOI 10.1242/jcs.159764; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boratko A, 2017, BBA-MOL CELL RES, V1864, P431, DOI 10.1016/j.bbamcr.2016.12.001; Boratko A, 2015, INT J BIOCHEM CELL B, V69, P105, DOI 10.1016/j.biocel.2015.10.021; Boratko A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-2; Boratko A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035595; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Edgar AJ, 2001, INT J BIOCHEM CELL B, V33, P53, DOI 10.1016/S1357-2725(00)00069-8; Fork C, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0439-4; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kasa A, 2013, MICROVASC RES, V89, P86, DOI 10.1016/j.mvr.2013.05.003; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Langhorst MF, 2007, FEBS LETT, V581, P4697, DOI 10.1016/j.febslet.2007.08.074; Li Y, 2012, J BIOL CHEM, V287, P523, DOI 10.1074/jbc.M111.306183; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Meister M, 2014, MEMBRANES-BASEL, V4, P356, DOI 10.3390/membranes4030356; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Riento K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197401; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Santamaria A, 2003, AM J PATHOL, V162, P897, DOI 10.1016/S0002-9440(10)63885-0; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Tar K, 2004, J CELL BIOCHEM, V92, P534, DOI 10.1002/jcb.20036; Tar K, 2006, J CELL BIOCHEM, V98, P931, DOI 10.1002/jcb.20829; Waschke J, 2006, HISTOCHEM CELL BIOL, V126, P17, DOI 10.1007/s00418-005-0140-7; Weeks KL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004861; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033	46	8	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20196	20206		10.1074/jbc.RA119.007980	http://dx.doi.org/10.1074/jbc.RA119.007980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31753918	Green Published, hybrid			2022-12-26	WOS:000505005800030
J	Lee, SY; Kang, B; Bok, SH; Cho, SS; Park, DH				Lee, Soon-Young; Kang, Bossng; Bok, So-Hyeon; Cho, Seung Sik; Park, Dae-Hun			Macmoondongtang modulates Th1-/Th2-related cytokines and alleviates asthma in a murine model	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; TNF-ALPHA; T-BET; AIRWAYS HYPERREACTIVITY; INTERLEUKIN-13; ABNORMALITIES; INFLAMMATION; EOSINOPHILIA; NEUTROPHILS; LIQUIRITIN	Objective Macmoondongtang has been used as a traditional medicine to treat pulmonary disease in Korea. However, the mechanism underlying its therapeutic effect has yet to be reported. In the present study, the role of macmoondongtang as a respiratory medicine, especially as an anti-asthmatic agent, has been attributed to the down-regulation of interleukin (IL)-4 and tumor necrosis factor (TNF)-alpha. Materials & methods BALB/c mice were divided into five groups: control, asthma-induced control, dexamethasone treatment, treatment with 150 mg/kg macmoondongtang, and treatment with 1500 mg/kg macmoondongtang. To evaluate the anti-asthmatic effect of macmoondongtang, we investigated its suppressive or inhibitory effects against typical asthmatic changes such as differential cell count in bronchioalveolar fluid (BALF), serum IgE levels, lung morphology, expression of Th1/Th2 cell transcription factors such as T-bet and GATA-3, and Th1-/Th2-/Th17-related cytokines such as interferon (IFN)-gamma, IL-12p40, IL-4, -5, -13, TNF-alpha, and IL-6. The active ingredients in macmoondongtang were further analyzed. Results Macmoondongtang treatment down-regulated serum IgE level, a very important marker of hyper-responsiveness. It reversed typical morphological changes such as mucous hypersecretion, lung epithelial cell hyperplasia, and inflammatory cell infiltration near bronchioalveolar space and veins. Macmoondongtang significantly decreased neutrophil count in BALF, as well as reduced T-bet, IFN-gamma, and TNF-alpha expression in the lung. It also showed a dose-dependent control of inflammatory cells in BALF, controlled the expression of IL-12, IL-4, and IL-5 genes in the lung, and the protein expression of IL12p40, GATA-3, IL-4, IL-5, and IL-13. The component analysis revealed glycyrrhizin and liquiritin as the active ingredients. Conclusions Macmoondongtang treatment alleviates asthma symptoms and modulate the Th1-/Th2-related cytokines. Glycyrrhizin and liquiritin could be the major the active therapeutic components.	[Lee, Soon-Young; Bok, So-Hyeon; Park, Dae-Hun] Dongshin Univ, Coll Oriental Med, Naju, Jeonnam, South Korea; [Kang, Bossng] Hanyang Univ, Coll Med, Dept Emergency Med, Guri, Gyunggi, South Korea; [Cho, Seung Sik] Mokpo Natl Univ, Coll Pharm, Dept Pharm, Muan, Jeonnam, South Korea	Dongshin University; Hanyang University; Mokpo National University	Park, DH (corresponding author), Dongshin Univ, Coll Oriental Med, Naju, Jeonnam, South Korea.; Cho, SS (corresponding author), Mokpo Natl Univ, Coll Pharm, Dept Pharm, Muan, Jeonnam, South Korea.	sscho@mokpo.ac.kr; dhj1221@hanmail.com		Park, Dae-Hun/0000-0002-3972-3690	National Research Foundation of Korea (NRF) - Korean government (MSIP: Ministry of Science, ICT & Future Planning) [NRF-2015R1D1A1A01059523, NRF2017R1C1B5015187]	National Research Foundation of Korea (NRF) - Korean government (MSIP: Ministry of Science, ICT & Future Planning)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP: Ministry of Science, ICT & Future Planning) (Grant Nos. NRF-2015R1D1A1A01059523 to D-HP and NRF2017R1C1B5015187 to SSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allswede DM, 2016, SCHIZOPHR RES, V172, P41, DOI 10.1016/j.schres.2016.02.022; Antczak A, 2016, INT J IMMUNOPATH PH, V29, P195, DOI 10.1177/0394632015623794; Bang MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117524; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V101, pS427, DOI 10.1016/S0091-6749(98)70154-X; Berry M, 2007, CURR OPIN PHARMACOL, V7, P279, DOI 10.1016/j.coph.2007.03.001; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Ciriaco M, 2013, J PHARMACOL PHARMACO, V4, pS94, DOI 10.4103/0976-500X.120975; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Huh J, 2002, DONGUIBOGAM; Kay AB, 2000, 1 2 PARTS N ENGL J M, V344, P30; Kidd Parris, 2003, Altern Med Rev, V8, P223; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Kumar Rakesh K., 2006, Inflammation & Allergy Drug Targets, V5, P253, DOI 10.2174/187152806779010909; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lee SY, 2018, MOL MED REP, V17, P11, DOI 10.3892/mmr.2017.7901; Lee SY, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1393307; LUKACS NW, 1995, J IMMUNOL, V154, P5411; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; Platts-Mills TAE, 2001, AM J RESP CRIT CARE, V164, pS1, DOI 10.1164/ajrccm.164.supplement_1.2103024; Ram A, 2006, INT IMMUNOPHARMACOL, V6, P1468, DOI 10.1016/j.intimp.2006.04.020; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; SCHEURICH P, 1987, J IMMUNOL, V138, P1786; Seo JH, 2016, INT J MOL MED, V37, P1221, DOI 10.3892/ijmm.2016.2541; Seo JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056447; Shefrin AE, 2009, CAN FAM PHYSICIAN, V55, P704; Shin Jang-Woo, 2010, [Journal of Korean Medicine, 대한한의학회지], V31, P1; Singh A, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-32; SKIPPER R, 1989, J HISTOTECHNOL, V12, P303; SLUNGAARD A, 1990, J EXP MED, V171, P2025, DOI 10.1084/jem.171.6.2025; STADNYK AW, 1994, FASEB J, V8, P1041, DOI 10.1096/fasebj.8.13.7926369; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wang J, 2014, J CHROMATOGR SCI, V52, P310, DOI 10.1093/chromsci/bmt029; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wills-Karp M, 2003, CURR OPIN PULM MED, V9, P21, DOI 10.1097/00063198-200301000-00004; Wise Jacqui, 2014, BMJ, V349, pg4623, DOI 10.1136/bmj.g4623; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Yu JY, 2015, MOLECULES, V20, P13041, DOI 10.3390/molecules200713041; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	50	5	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224517	10.1371/journal.pone.0224517	http://dx.doi.org/10.1371/journal.pone.0224517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790411	Green Published, gold			2022-12-26	WOS:000533930800008
J	de Oliveira, AG; Bailly, D; Cassemiro, FAS; do Couto, EV; Bond, N; Gilligan, D; Rangel, TF; Agostinho, AA; Kennard, MJ				de Oliveira, Anielly Galego; Bailly, Dayani; Cassemiro, Fernanda A. S.; do Couto, Edivando Vitor; Bond, Nick; Gilligan, Dean; Rangel, Thiago F.; Agostinho, Angelo Antonio; Kennard, Mark J.			Coupling environment and physiology to predict effects of climate change on the taxonomic and functional diversity of fish assemblages in the Murray-Darling Basin, Australia	PLOS ONE			English	Article							FRESH-WATER FISH; SPECIES DISTRIBUTION MODELS; RANGE SHIFTS; ECOSYSTEM SERVICES; FLOW REGIMES; CONSERVATION; BIODIVERSITY; ECOLOGY; RIVERS; FRAMEWORK	This study uses species distribution modeling and physiological and functional traits to predict the impacts of climate change on native freshwater fish in the Murray-Darling Basin, Australia. We modelled future changes in taxonomic and functional diversity in 2050 and 2080 for two scenarios of carbon emissions, identifying areas of great interest for conservation. Climatic-environmental variables were used to model the range of 23 species of native fish under each scenario. The consensus model, followed by the physiological filter of lethal temperature was retained for interpretation. Our study predicts a severe negative impact of climate change on both taxonomic and functional components of ichthyofauna of the Murray-Darling Basin. There was a predicted marked contraction of species ranges under both scenarios. The predictions showed loss of climatically suitable areas, species and functional characters. There was a decrease in areas with high values of functional richness, dispersion and uniqueness. Some traits are predicted to be extirpated, especially in the most pessimistic scenario. The climatic refuges for fish fauna are predicted to be in the southern portion of the basin, in the upper Murray catchment. Incorporating future predictions about the distribution of ichthyofauna in conservation management planning will enhance resilience to climate change.	[de Oliveira, Anielly Galego; Bailly, Dayani; Agostinho, Angelo Antonio] Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continentai, Nucleo Pesquisas Ictiol Limnol & Aquicultura NUPE, Maringa, Parana, Brazil; [Cassemiro, Fernanda A. S.; Rangel, Thiago F.] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [do Couto, Edivando Vitor] Univ Tecnol Fed Parana, Campo Mourao, PR, Brazil; [Bond, Nick] La Trobe Univ, Ctr Freshwater Ecosyst, Wodonga, Vic, Australia; [Gilligan, Dean] Batemans Bay Fisheries Off, NSW Dept Primary Ind Fisheries, Batemans Bay, NSW, Australia; [Kennard, Mark J.] Griffith Univ, Australian Rivers Inst, Brisbane, Qld, Australia	Universidade Estadual de Maringa; Universidade Federal de Goias; Universidade Tecnologica Federal do Parana; La Trobe University; NSW Department of Primary Industries; Griffith University	de Oliveira, AG (corresponding author), Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continentai, Nucleo Pesquisas Ictiol Limnol & Aquicultura NUPE, Maringa, Parana, Brazil.	anielly_oliveira@hotmail.com	Kennard, Mark James/C-3425-2008; do Couto, Edivando Vitor/O-3026-2019; Bond, Nick R./A-1129-2016; Rangel, Thiago F/H-8708-2012; do Couto, Edivando Vitor Vitor/GVS-0670-2022	Kennard, Mark James/0000-0003-4383-4999; do Couto, Edivando Vitor/0000-0003-4264-8449; Bond, Nick R./0000-0003-4294-6008; Rangel, Thiago F/0000-0002-2001-7382; do Couto, Edivando Vitor Vitor/0000-0003-4264-8449; Oliveira, Anielly/0000-0002-6185-1728	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [446123]; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES -PROEX) ph.D. scholarship in the ARI, Australia (PDSE ) [88881.131497/2016-01]; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES -PROEX) fellowship in the ARI, Australia (PDSE) [88881.131497/2016-01]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES -PROEX) ph.D. scholarship in the ARI, Australia (PDSE ); Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES -PROEX) fellowship in the ARI, Australia (PDSE)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Project 446123 Chamada MCTI/CNPq/ANA (Research in climate change) to AAA and Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES -PROEX) Ph.D. scholarship and fellowship in the ARI, Australia (PDSE -process number 88881.131497/2016-01) to AGO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge State University of Maringa/Nucleo de Pesquisas em Limnologia, Ictiologia e Aquicultura and Australian Rivers Institute/Griffith University for providing the institutional infrastructure. We are also very grateful to Federal University of Technology Parana ' (UTFPR), Campus Campo Mourao for paying for the Open Access publication. We thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for continuous support to AAA. We thank Stuart Bunn and Jon Olley for their leadership of the Ecological Responses to Environmental Flow Regimes Cluster Project. Michael Wilson from the MurrayDarling Basin Authority kindly provided access to the Sustainable Rivers Audit (SRA) fish records. Paul Wilson from the Victorian Department of Environment, Land, Water, and Planning provided access to Victorian fish surveys records. We also thank Matheus T. Baumgartner for the grid confection.	ALLEN GR, 2003, FIELD GUIDE FRESHWAT; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2011, CLIMATIC CHANGE, DOI DOI 10.1007/s10584-011-0157-y; [Anonymous], 2008, REPORT AUSTR GOVT CS; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bagchi R, 2018, ECOGRAPHY, V41, P401, DOI 10.1111/ecog.02712; Balcombe SR, 2011, MAR FRESHWATER RES, V62, P1099, DOI 10.1071/MF11059; Barros V.R., 2014, CLIM CHANG 2014 IMP, P688, DOI DOI 10.1017/CBO9781107415324; Beatty SJ, 2014, GLOBAL CHANGE BIOL, V20, P1794, DOI 10.1111/gcb.12444; Bishop-Taylor R, 2017, ECOL APPL, V27, P1124, DOI 10.1002/eap.1507; Biswas SR, 2017, HYDROBIOLOGIA, V799, P135, DOI 10.1007/s10750-017-3208-1; Bond N, 2011, MAR FRESHWATER RES, V62, P1043, DOI 10.1071/MF10286; Booth DJ, 2011, MAR FRESHWATER RES, V62, P1027, DOI 10.1071/MF10270; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Buisson L, 2013, GLOBAL CHANGE BIOL, V19, P387, DOI 10.1111/gcb.12056; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chessman BC, 2013, BIOL CONSERV, V160, P40, DOI 10.1016/j.biocon.2012.12.032; Clavero M, 2010, GLOBAL ECOL BIOGEOGR, V19, P684, DOI 10.1111/j.1466-8238.2010.00544.x; Closs G, 2016, CONSERV BIOL SER, pXVII; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Comte L, 2017, NAT CLIM CHANGE, V7, P718, DOI 10.1038/NCLIMATE3382; Comte L, 2017, GLOBAL CHANGE BIOL, V23, P728, DOI 10.1111/gcb.13427; Comte L, 2013, ECOGRAPHY, V36, P1236, DOI 10.1111/j.1600-0587.2013.00282.x; Cuyckens GAE, 2016, GLOBAL PLANET CHANGE, V137, P79, DOI 10.1016/j.gloplacha.2015.12.010; Davies PE, 2010, MAR FRESHWATER RES, V61, P764, DOI 10.1071/MF09043; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Ferro VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107792; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Franklin J., 2010, MAPPING SPECIES DIST, DOI [10.1017/CBO9780511810602, DOI 10.1017/CBO9780511810602]; Froese R, 2019, WORLD WIDE WEB, DOI [10.1007/s11280-018-0637-3, DOI 10.1007/S11280-018-0637-3]; Fuller RA, 2010, NATURE, V466, P365, DOI 10.1038/nature09180; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Hart BT, 2016, ECOHYDROL HYDROBIOL, V16, P229, DOI 10.1016/j.ecohyd.2016.09.002; Hasumi H., 2004, K 1 TECHNICAL REPORT; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hoeinghaus DJ, 2009, CONSERV BIOL, V23, P1222, DOI 10.1111/j.1523-1739.2009.01248.x; Humphries P, 2013, ECOLOGY OF AUSTRALIAN FRESHWATER FISHES, P1; James CS, 2017, J BIOGEOGR, V44, P489, DOI 10.1111/jbi.12926; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Kennard MJ, 2010, FRESHWATER BIOL, V55, P171, DOI 10.1111/j.1365-2427.2009.02307.x; Koehn JD, 2011, MAR FRESHWATER RES, V62, P1148, DOI 10.1071/MF11139; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Leadley P., 2010, BIODIVERSITY SCENARI; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lintermans M., 2009, FISHES MURRAY DARLIN; Liu X., 2011, JCIT J CONVERGENCE I, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018429; Lopes TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179684; McDowall R. M., 1996, FRESHWATER FISHES S; Mormul RP, 2012, FRESHWATER BIOL, V57, P1592, DOI 10.1111/j.1365-2427.2012.02820.x; Morrill JC, 2005, J ENVIRON ENG, V131, P139, DOI 10.1061/(ASCE)0733-9372(2005)131:1(139); Morrongiello JR, 2011, MAR FRESHWATER RES, V62, P1082, DOI 10.1071/MF10308; Moyle PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063883; Murray Darling Basin Authority, 2019, DISC BAS; Murray-Darling Basin Authority, 2004, NAT FISH STRAT MURR; Murray-Darling Basin Authority, 2017, BAS PLAN EV 2017; Overton JM, 2002, BIODIVERS CONSERV, V11, P2093, DOI 10.1023/A:1021386426790; Pandit SN, 2017, SCI TOTAL ENVIRON, V598, P1, DOI 10.1016/j.scitotenv.2017.03.228; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perez TM, 2016, SCIENCE, V351, P1392, DOI 10.1126/science.aaf3343; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Petitpierre B, 2017, GLOBAL ECOL BIOGEOGR, V26, P275, DOI 10.1111/geb.12530; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pillar VD, 2009, J VEG SCI, V20, P334, DOI 10.1111/j.1654-1103.2009.05666.x; PMSEIC Independent Working Group, 2007, CLIM CHANG AUSTR REG; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; R Core Team, 2019, R R PROJE STAT COMP; Revenga C, 2005, PHILOS T ROY SOC B, V360, P397, DOI 10.1098/rstb.2004.1595; Ricotta C, 2016, METHODS ECOL EVOL, V7, P1386, DOI 10.1111/2041-210X.12604; Schindler DE, 1997, ECOLOGY, V78, P1816; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stein JL, 2014, HYDROL EARTH SYST SC, V18, P1917, DOI 10.5194/hess-18-1917-2014; Sternberg D, 2013, FRESHWATER BIOL, V58, P1767, DOI 10.1111/fwb.12166; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Sutherst RW, 2007, GLOBAL CHANGE BIOL, V13, P1843, DOI 10.1111/j.1365-2486.2007.01396.x; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Trueman WT, 2011, MDBA PUBLICATION, V215/11; van Vliet MTH, 2013, CLIMATIC CHANGE, V121, P739, DOI 10.1007/s10584-013-0976-0; Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2017, AQUAT SCI, V79, P783, DOI 10.1007/s00027-017-0546-z; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Whiterod NR, 2010, BIOENERGETIC IMPLICA; Winemiller KO, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P115; Winter M, 2008, J BIOGEOGR, V35, P2289, DOI 10.1111/j.1365-2699.2008.01967.x	103	14	15	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225128	10.1371/journal.pone.0225128	http://dx.doi.org/10.1371/journal.pone.0225128			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774852	Green Published, gold			2022-12-26	WOS:000533896400026
J	Casteleiro, A; Paz-Zulueta, M; Paras-Bravoz, P; Ruiz-Azcona, L; Santibanez, M				Casteleiro, Ana; Paz-Zulueta, Maria; Paras-Bravoz, Paula; Ruiz-Azcona, Laura; Santibanez, Miguel			Association between advanced maternal age and maternal and neonatal morbidity: A cross-sectional study on a Spanish population	PLOS ONE			English	Article							PERINATAL OUTCOMES; PREGNANCY OUTCOMES; BIRTH-WEIGHT; RISK	Background and objective Over recent decades, a progressive increase in the maternal age at childbirth has been observed in developed countries, posing a health risk for both women and infants. The aim of this study was to analyze the association between advanced maternal age (AMA) and maternal and neonatal morbidity. Material and methods A cross-sectional study of 3,315 births was conducted in the north of Spain in 2014. We compared childbirth between women aged 35 years or older, with a reference group of women aged between 24 and 27 years. AMA was categorized based on ordinal ranking into 35-38 years, 39-42 years, and > 42 years to estimate a dose-response pattern (the older the age, the greater the risk). As an association measure, crude and adjusted Odds Ratios (OR) were estimated by non-conditional logistic regression and 95% Confidence Intervals (95%CI) were calculated. Results Repeated abortions were more common among women of AMA in comparison to pregnant women aged 24-27 years (reference group): adjusted OR = 2.68; 95%CI (1.52-4.73). A higher prevalence of gestational diabetes was also observed among women of AMA, reaching statistical significance when restricted to first time mothers: adjusted OR = 8.55; 95%CI (1.12-65.43). In addition, the possibility of an instrumental delivery was multiplied by 1.6 and the possibility of a cesarean by 1.5 among women of AMA, with these results reaching statistical significance, and observing a dose-response pattern. Lastly, there were associations between preeclampsia, preterm birth (< 37 weeks) and low birthweight, however without reaching statistical significance. Conclusion Our results support the association between AMA and suffering repeated abortions. Likewise, being of AMA was associated with a greater risk of suffering from gestational diabetes, especially among primiparous women, as well as being associated with both instrumental deliveries and cesareans among both primiparous and multiparous women.	[Casteleiro, Ana] Hosp Univ Basurto, Bilbao, Spain; [Paz-Zulueta, Maria; Paras-Bravoz, Paula; Ruiz-Azcona, Laura; Santibanez, Miguel] Univ Cantabria, Dept Nursing, Cantabria, Spain; [Paz-Zulueta, Maria] GRIDES, IDIVAL, Cantabria, Spain; [Paras-Bravoz, Paula; Santibanez, Miguel] Grp Invest Enfermeria, IDIVAL, Cantabria, Spain	Basurto Hospital; Universidad de Cantabria	Paz-Zulueta, M (corresponding author), Univ Cantabria, Dept Nursing, Cantabria, Spain.; Paz-Zulueta, M (corresponding author), GRIDES, IDIVAL, Cantabria, Spain.	maria.paz@unican.es	Parás-Bravo, Paula/AAC-7250-2020	Parás-Bravo, Paula/0000-0001-7745-3006; Paz-Zulueta, Maria/0000-0003-3025-9892; RUIZ AZCONA, LAURA/0000-0003-2213-2728				Almeida NKO, 2015, J PEDIAT-BRAZIL, V91, P493, DOI 10.1016/j.jped.2014.12.002; AlShami HAA, 2011, ARCH GYNECOL OBSTET, V284, P1113, DOI 10.1007/s00404-010-1821-6; Astolfi P, 2002, PAEDIATR PERINAT EP, V16, P67, DOI 10.1046/j.1365-3016.2002.00375.x; Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; Bayrampour H, 2010, BIRTH-ISS PERINAT C, V37, P219, DOI 10.1111/j.1523-536X.2010.00409.x; Blankenship SA, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.06.042; Carolan M, 2013, MIDWIFERY, V29, P479, DOI 10.1016/j.midw.2012.04.001; Carolan M, 2011, MIDWIFERY, V27, P793, DOI 10.1016/j.midw.2010.07.006; Carrascosa Lezcano A, 2008, An Pediatr (Barc), V68, P544; Gravena AAF, 2012, REV ESC ENFERM USP, V46, P15, DOI 10.1590/S0080-62342012000100002; Garrido-Gimenez C, 2015, POSTGRAD MED J, V91, P151, DOI 10.1136/postgradmedj-2014-132672; Goisis A, 2017, AM J EPIDEMIOL, V186, P1219, DOI 10.1093/aje/kwx177; Hinkle SN, 2014, BJOG-INT J OBSTET GY, V121, P1080, DOI 10.1111/1471-0528.12628; Hodes-Wertz B, 2013, FERTIL STERIL, V100, P1343, DOI 10.1016/j.fertnstert.2013.07.201; Instituto Nacional de Estadi stica, PRIM SEM 2018; Joseph KS, 2005, OBSTET GYNECOL, V105, P1410, DOI 10.1097/01.AOG.0000163256.83313.36; Kahveci B, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1984-x; Kalayci H, 2017, J MATERN-FETAL NEO M, V30, P1283, DOI 10.1080/14767058.2016.1211633; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Koo YJ, 2012, TAIWAN J OBSTET GYNE, V51, P60, DOI 10.1016/j.tjog.2012.01.012; Laopaiboon M, 2014, BJOG-INT J OBSTET GY, V121, P49, DOI 10.1111/1471-0528.12659; Leader J, 2018, J OBSTET GYNAECOL CA, V40, P1208, DOI 10.1016/j.jogc.2017.10.027; Mack LR, 2017, OBSTET GYN CLIN N AM, V44, P207, DOI 10.1016/j.ogc.2017.02.002; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Mora Cepeda P, 2011, PROGR OBSTET GINECOL, V54, P575, DOI [10.1186/s12884-018-1984-x, DOI 10.1186/S12884-018-1984-X]; Osmundson SS, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.103; Paz-Zulueta M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120765; Schimmel MS, 2015, ARCH GYNECOL OBSTET, V291, P793, DOI 10.1007/s00404-014-3469-0; Sheen JJ, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.08.034; Statistics National Institute, 2015, B DEM SYNTH CANT; Walker K, 2016, OBSTET GYNAECOL REPR, V26, P354, DOI DOI 10.1016/J.OGRM.2016.09.005	31	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225074	10.1371/journal.pone.0225074	http://dx.doi.org/10.1371/journal.pone.0225074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770385	Green Published, gold			2022-12-26	WOS:000533892300011
J	Rusanen, J; Toivonen, A; Hepojoki, J; Hepojoki, S; Arikoski, P; Heikkinen, M; Vaarala, O; Ilonen, J; Hedman, K				Rusanen, Juuso; Toivonen, Anne; Hepojoki, Jussi; Hepojoki, Satu; Arikoski, Pekka; Heikkinen, Markku; Vaarala, Outi; Ilonen, Jorma; Hedman, Klaus			LFRET, a novel rapid assay for anti-tissue transglutaminase antibody detection	PLOS ONE			English	Article							ADULT CELIAC-DISEASE; DIAGNOSIS; GUIDELINES; MANAGEMENT; HLA-DQB1; SOCIETY	The diagnosis of celiac disease (CD) is currently based on serology and intestinal biopsy, with detection of anti-tissue transglutaminase (tTG) IgA antibodies recommended as the first-line test. Emphasizing the increasing importance of serological testing, new guidelines and evidence suggest basing the diagnosis solely on serology without confirmatory biopsy. Enzyme immunoassays (EIAs) are the established approach for anti-tTG antibody detection, with the existing point-of-care (POC) tests lacking sensitivity and/or specificity. Improved POC methods could help reduce the underdiagnosis and diagnostic delay of CD. We have previously developed rapid homogenous immunoassays based on time-resolved Forster resonance energy transfer (TR-FRET), and demonstrated their suitability in serodiagnostics with hanta- and Zika virus infections as models. In this study, we set out to establish a protein L-based TR-FRET assay (LFRET) for the detection of anti-tTG antibodies. We studied 74 patients with biopsy-confirmed CD and 70 healthy controls, with 1) the new tTG-LFRET assay, and for reference 2) a well-established EIA and 3) an existing commercial POC test. IgG depletion was employed to differentiate between anti-tTG IgA and IgG positivity. The sensitivity and specificity of the first-generation tTG-LFRET POC assay in detection of CD were 87.8% and 94.3%, respectively, in line with those of the reference POC test. The sensitivity and specificity of EIA were 95.9% and 91.9%, respectively. This study demonstrates the applicability of LFRET to serological diagnosis of autoimmune diseases in general and of CD in particular.	[Rusanen, Juuso; Hepojoki, Jussi; Hepojoki, Satu; Hedman, Klaus] Univ Helsinki, Med, Dept Virol, Helsinki, Finland; [Toivonen, Anne; Hedman, Klaus] Univ Helsinki, Dept Virol & Immunol, Lab Serv HUSLAB, Helsinki, Finland; [Toivonen, Anne; Hedman, Klaus] Helsinki Univ Hosp, Helsinki, Finland; [Toivonen, Anne] Univ Eastern Finland, Inst Clin Med, Dept Clin Microbiol, Kuopio, Finland; [Hepojoki, Jussi] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland; [Arikoski, Pekka] Kuopio Univ Hosp, Dept Pediat, Kuopio, Finland; [Arikoski, Pekka] Univ Eastern Finland, Kuopio, Finland; [Heikkinen, Markku] Kuopio Univ Hosp, Dept Gastroenterol, Kuopio, Finland; [Vaarala, Outi] Univ Helsinki, Clinicum, Helsinki, Finland; [Ilonen, Jorma] Univ Turku, Inst Biomed, Immunogenet Lab, Turku, Finland; [Ilonen, Jorma] Turku Univ Hosp, Clin Microbiol, Turku, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Eastern Finland; University of Zurich; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; University of Turku; University of Turku	Rusanen, J (corresponding author), Univ Helsinki, Med, Dept Virol, Helsinki, Finland.	juuso.rusanen@helsinki.fi	Hedman, Klaus/D-5379-2009; Hepojoki, Jussi/W-4667-2017	Hepojoki, Jussi/0000-0001-5699-214X; Rusanen, Juuso/0000-0002-3954-5118; Hepojoki, Satu/0000-0002-0696-1879; Hedman, Klaus/0000-0003-1779-7960; Ilonen, Jorma/0000-0002-9973-2062	Special Research Funds for University Hospitals in Finland; Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation; Medical Society of Finland; Magnus Ehrnrooth Foundation; Finnish Society of Sciences and Letters; Research Funds of University of Helsinki; Academy of Finland [1308613]; Helsinki University Hospital	Special Research Funds for University Hospitals in Finland; Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Society of Finland; Magnus Ehrnrooth Foundation; Finnish Society of Sciences and Letters; Research Funds of University of Helsinki; Academy of Finland(Academy of Finland); Helsinki University Hospital	This work was funded by Special Research Funds for University Hospitals in Finland (to J.I., stm.fi), Paivikki and Sakari Sohlberg Foundation (to J.I., pss-saatio.fi), Sigrid Juselius Foundation (to J.I. and K.H., sigridjuselius.fi), Medical Society of Finland (FLS) (to K.H., fls.fi), Magnus Ehrnrooth Foundation (to K.H., magnusehrnroothinsaatio.fi), Finnish Society of Sciences and Letters (to K.H., scientiarum.fi), and the Research Funds of University of Helsinki and Helsinki University Hospital (to K.H., hus.fi) and the Academy of Finland (to J.H., grant 1308613, aka. fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Downey L, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4513; Fuchs V, 2019, ALIMENT PHARM THER, V49, P277, DOI 10.1111/apt.15109; Fuchs V, 2018, UNITED EUR GASTROENT, V6, P567, DOI 10.1177/2050640617751253; Gray AM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-105; Hemmila I, 2005, J FLUORESC, V15, P529, DOI 10.1007/s10895-005-2826-6; Hepojoki S, 2015, J CLIN MICROBIOL, V53, P636, DOI 10.1128/JCM.02994-14; Hepojoki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106432; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Kareinen L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219474; Kiviniemi M, 2005, CLIN BIOCHEM, V38, P1015, DOI 10.1016/j.clinbiochem.2005.08.001; Lebwohl B, 2018, LANCET, V391, P70, DOI 10.1016/S0140-6736(17)31796-8; Leffler DA, 2010, AM J GASTROENTEROL, V105, P2520, DOI 10.1038/ajg.2010.276; Lewis NR, 2009, ALIMENT PHARM THER, V31, P73, DOI 10.1111/j.1365-2036.2009.04110.x; Ludvigsson JF, 2014, GUT, V63, P1210, DOI 10.1136/gutjnl-2013-306578; Nejentsev S, 1999, DIABETIC MED, V16, P985, DOI 10.1046/j.1464-5491.1999.00186.x; Norstrom F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-118; Paarlahti P, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-75; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Saraheimo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062739; Singh P, 2019, J CLIN GASTROENTEROL, V53, P535, DOI 10.1097/MCG.0000000000001081; Singh P, 2018, CLIN GASTROENTEROL H, V16, P823, DOI 10.1016/j.cgh.2017.06.037; Trovato CM, 2015, AM J GASTROENTEROL, V110, P1485, DOI 10.1038/ajg.2015.285; Vavricka SR, 2016, DIGEST LIVER DIS, V48, P1148, DOI 10.1016/j.dld.2016.06.016	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225851	10.1371/journal.pone.0225851	http://dx.doi.org/10.1371/journal.pone.0225851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770411	Green Accepted, gold, Green Published			2022-12-26	WOS:000533892300041
J	Ahmed, MA; Saif, A; Quan, FS				Ahmed, Md Atique; Saif, Ahmed; Quan, Fu-Shi			Diversity pattern of Plasmodium knowlesi merozoite surface protein 4 (MSP4) in natural population of Malaysia	PLOS ONE			English	Article							MALARIA; FALCIPARUM; POLYMORPHISM; SOFTWARE; DISEASE; SABAH; VIVAX; GENE	Human infections due to the monkey malaria parasite Plasmodium knowlesi are increasingly being reported from Malaysia. The parasite causes high parasitaemia, severe and fatal malaria in humans thus there is a need for urgent measures for its control. The MSP4 is a potential vaccine candidate, which is well studied in Plasmodium falciparum and Plasmodium vivax; however, no study has been conducted in the orthologous gene of P. knowlesi. In this study, we investigated the level of polymorphisms, haplotypes, natural selection and population structure of full-length pkmsp4 in 32 clinical samples from Malaysian Borneo along with 4 lab-adapted strains. We found low levels of polymorphism across the gene with exon I showing higher diversity than the exon II. The C- terminal epidermal growth factor (EGF) domains and GPI-anchored region within exon II were mostly conserved with only 2 non-synonymous substitutions. Although 21 amino acid haplotypes were found, the frequency of mutation at the majority of the polymorphic positions was low. We found evidence of negative selection at the exon II of the gene indicating existence of functional constraints. Phylogenetic haplotype network analysis identified shared haplotypes and indicated geographical clustering of samples originating from Peninsular Malaysia and Malaysian Borneo. High population differentiation values were observed within parasite populations originating from Malaysian Borneo (Kapit, Sarikei and Betong) and laboratory-adapted strains obtained from Peninsular Malaysia and Philippines indicating distinct population structure. This is the first study to genetically characterize the full-length msp4 gene from clinical isolates of P. knowlesi from Malaysia and thus would be very useful for future rational vaccine studies. Further studies with higher number of samples and functional characterization of the protein will be necessary.	[Ahmed, Md Atique; Quan, Fu-Shi] Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea; [Saif, Ahmed] Najran Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Najran, Saudi Arabia; [Quan, Fu-Shi] Kyung Hee Univ, Grad Sch, Med Res Ctr Bioreact React Oxygen Species, Sch Med, Seoul, South Korea; [Quan, Fu-Shi] Kyung Hee Univ, Grad Sch, Biomed Sci Inst, Sch Med, Seoul, South Korea	Kyung Hee University; Najran University; Kyung Hee University; Kyung Hee University	Quan, FS (corresponding author), Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea.; Quan, FS (corresponding author), Kyung Hee Univ, Grad Sch, Med Res Ctr Bioreact React Oxygen Species, Sch Med, Seoul, South Korea.; Quan, FS (corresponding author), Kyung Hee Univ, Grad Sch, Biomed Sci Inst, Sch Med, Seoul, South Korea.	fquan01@gmail.com	Saif, Ahmed/AHB-7486-2022	Saif, Ahmed/0000-0002-9614-3238; Ahmed, Md Atique/0000-0002-3407-7220	National Research Foundation of Korea (NRF) [2018R1A2B6003535, 2018R1A6A1A03025124]; Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ01320501]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by grants from the National Research Foundation of Korea (NRF) (2018R1A2B6003535, 2018R1A6A1A03025124) and the Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01320501), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Research Foundation of Korea (NRF) (2018R1A2B6003535, 2018R1A6A1A03025124) and the Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01320501), Rural Development Administration, Republic of Korea.	Ahmed AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003086; Ahmed MA, 2019, BIORXIV, DOI [10.1101/537621, DOI 10.1101/537621]; Ahmed MA, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2583-z; Ahmed MA, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2423-1; Ahmed MA, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2256-y; Ahmed MA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1294-6; Amir A, 2018, INFECT DRUG RESIST, V11, P1145, DOI 10.2147/IDR.S148664; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Assefa S, 2015, P NATL ACAD SCI USA, V112, P13027, DOI 10.1073/pnas.1509534112; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; Barber BE, 2011, EMERG INFECT DIS, V17, P814, DOI 10.3201/eid1705.101489; Benet A, 2004, MOL BIOCHEM PARASIT, V134, P275, DOI 10.1016/j.molbiopara.2003.12.005; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; de Silva HD, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-266; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Kedzierski L, 2000, MOL BIOCHEM PARASIT, V105, P137, DOI 10.1016/S0166-6851(99)00178-4; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marshall VM, 1997, INFECT IMMUN, V65, P4460, DOI 10.1128/IAI.65.11.4460-4467.1997; Martinez Pilar, 2005, Infection Genetics and Evolution, V5, P354, DOI 10.1016/j.meegid.2004.12.001; Perraut R, 2017, VACCINE, V35, P6720, DOI 10.1016/j.vaccine.2017.10.012; Pinheiro MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121303; Putaporntip C, 2009, INFECT GENET EVOL, V9, P821, DOI 10.1016/j.meegid.2009.04.017; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang L, 2002, MOL BIOCHEM PARASIT, V120, P301, DOI 10.1016/S0166-6851(01)00457-1; Wang L, 2001, INFECT IMMUN, V69, P4390, DOI 10.1128/IAI.69.7.4390-4397.2001; Wang L, 1999, INFECT IMMUN, V67, P2193, DOI 10.1128/IAI.67.5.2193-2200.1999; William T, 2011, EMERG INFECT DIS, V17, P1248, DOI 10.3201/eid1707.101017; Willmann M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-363; World Health Organization, 2017, GLOB HEP REP, DOI DOI 10.1071/EC12504; Yusof R, 2016, EMERG INFECT DIS, V22, P1371, DOI 10.3201/eid2208.151885	34	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0224743	10.1371/journal.pone.0224743	http://dx.doi.org/10.1371/journal.pone.0224743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751362	Green Published, gold			2022-12-26	WOS:000533886900015
J	Gill, N; Van den Bergh, R; Kyaw, KWY; Laxmeshwar, C; Das, M; Rastogi, S; Galindo, MA; Mansoor, H; Kalon, S; Isaakidis, P				Gill, Naresh; Van den Bergh, Rafael; Kyaw, Khine Wut Yee; Laxmeshwar, Chinmay; Das, Mrinalini; Rastogi, Sarthak; Galindo, Miriam Arago; Mansoor, Homa; Kalon, Stobdan; Isaakidis, Petros			Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RESISTANCE; REGIMENS; PRIVATE; CLINICS	Background HIV programs are increasingly confronted with failing antiretroviral therapy (ART), including second-line regimens. WHO has provided guidelines on switching to third-line ART. In a Medecins Sans Frontieres clinic in Mumbai, India, receiving referred presumptive secondline ART failure cases, an evidence-based protocol consisting of viral load (VL) testing, enhanced adherence counselling (EAC) and genotype for switching was implemented. Objective To document the outcome and genotype of presumptive second-line ART failure cases switched to third-line or maintained on second-line ART. Design Retrospective cohort study of patients referred between January 2011 and September 2017. Results The cases (n = 120) were complex with median 9.2 years of ART exposure, poor adherence at baseline, and exposure to multiple ART regimens other than recommended by WHO. Out of 90 evaluated cases, 39(43%) were maintained on second-line ART. Forty-nine (54%) were ever switched to third-line ART. Twelve months virological suppression was 72% in the second-line and 93% in the third-line ART cohort, while retention in care was 80% and 94% respectively. Genotyping showed 62% resistance for PIs, and 52% triple class resistance to NRTIs, NNRTIs and PIs. Resistance was noted for the new class of integrase inhibitors, and for different drugs without any documented previous exposure to the same drug. Conclusion Adopting WHO guidelines on switching ART regimens and provision of EAC can prevent unnecessary switching/exposure to third-line ART regimens. Genotyping is urgently required in national HIV programs, which currently use only the exposure history of patients for switching to third-line ART regimens.	[Gill, Naresh; Laxmeshwar, Chinmay; Das, Mrinalini; Rastogi, Sarthak; Galindo, Miriam Arago; Mansoor, Homa; Kalon, Stobdan] Medecins Sans Frontieres, Mumbai, Maharashtra, India; [Van den Bergh, Rafael] Medecins Sans Frontieres, Brussels, Belgium; [Kyaw, Khine Wut Yee] Int Union TB & Lung Dis, Mandalay, Myanmar; [Isaakidis, Petros] Medecins Sans Frontieres, Southern Africa Med Unit SAMU, Cape Town, South Africa	Doctors Without Borders	Laxmeshwar, C (corresponding author), Medecins Sans Frontieres, Mumbai, Maharashtra, India.	chinmay2210@gmail.com	Kyaw, Khine Wut Yee/K-4130-2019; Laxmeshwar, Chinmay/AAC-3753-2021	Kyaw, Khine Wut Yee/0000-0003-0709-484X; Van den Bergh, Rafael/0000-0001-6277-8713; Isaakidis, Petros/0000-0002-7881-1554; Laxmeshwar, Chinmay/0000-0003-1561-3857	Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	The training programme and open access publications costs were funded by the Department for International Development (DFID), UK and La Fondation Veuve Emile Metz-Tesch (Luxembourg). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, RES MUT; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Department of Health & Family Welfare, 2017, 201617 NACO DEP HLTH; Fox MP, 2016, TROP MED INT HEALTH, V21, P1131, DOI 10.1111/tmi.12741; Gupta A, 2010, AIDS RES HUM RETROV, V26, P25, DOI 10.1089/aid.2009.0102; Isaakidis P, 2015, LANCET HIV, V2, pE414, DOI 10.1016/S2352-3018(15)00180-0; Khan S, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24861; Kumarasamy N, 2013, CURR OPIN HIV AIDS, V8, P586, DOI 10.1097/COH.0000000000000004; Ministry of Health and Family Welfare, 2016, GUID PROV 2 LIN ART, P2; Ministry of Health and Family Welfare Government of India, 2005, REP NAT COMM MACR HL; Mumbai District AIDS Control Society, CAR SUPP TREATM CST; National AIDS Control Organisation, 2017, NAT STRAT PLAN HIV A; National AIDS Control Organisation, 2007, TRAIN MOD MED OFF HI; O'Brien Daniel P, 2010, Confl Health, V4, P12, DOI 10.1186/1752-1505-4-12; Pujari SN, 2014, JAIDS-J ACQ IMM DEF, V65, pE82, DOI 10.1097/QAI.0b013e3182a6104a; Ramchandani SR, 2007, AIDS PATIENT CARE ST, V21, P129, DOI 10.1089/apc.2006.0045; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Saravanan S, 2012, CLIN INFECT DIS, V54, P995, DOI 10.1093/cid/cir967; Schoffelen AF, SUSTAINED VIROLOGICA, DOI [10.1371/journal.pone.0058526, DOI 10.1371/JOURNAL.PONE.0058526]; Sinha S, 2012, CURR HIV RES, V10, P532, DOI 10.2174/157016212802429785; Svard J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178942; UNAIDS, GLOB HIV AIDS STAT 2; UNAIDS, 2014, 90 90 90 AMB TREATM; United Nations, 2015, SUST DEV GOALS INT; Van Vaerenbergh K, 2001, Verh K Acad Geneeskd Belg, V63, P447; WHO, 2010, ANT THER HIV INF AD; Wilhelmson S, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.29943; World Health Organisation, 2013, CONS GUID US ANT DRU, V978, P92; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organization, 2015, HIV TREATM CAR; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2014, AV US HIV DIAGN A 20; World Health Organization, 2015, POL BRIEF CONS GUID, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225631	10.1371/journal.pone.0225631	http://dx.doi.org/10.1371/journal.pone.0225631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751433	Green Published, gold			2022-12-26	WOS:000533886900083
J	Jaffe, N; Eberl, R; Bucholz, J; Cohen, CS				Jaffe, Noah; Eberl, Renate; Bucholz, Jamie; Cohen, C. Sarah			Sea star wasting disease demography and etiology in the brooding sea star Leptasterias spp.	PLOS ONE			English	Article							INFECTIOUS-DISEASES; CLIMATE-CHANGE; MESOPREDATOR RELEASE; INTERTIDAL COMMUNITY; POPULATION-DYNAMICS; MAGNESIUM-CHLORIDE; LOW-SALINITY; ECHINODERMATA; FOOD; CONSEQUENCES	Sea star wasting disease (SSWD) describes a suite of disease signs believed to have led to catastrophic die-offs in many asteroid species, beginning in 2013. While most studies have focused on large, easily visible sea stars with widely-dispersing larvae, less information is available on the effect of this disease outbreak on smaller sea star species, such as the six-armed sea star Leptasterias spp. Unlike many larger sea stars, Leptasterias brood non-feeding young instead of broadcast-spawning planktonic larvae. Limited dispersal and thus limited gene flow may make these sea stars more vulnerable to local selective pressures, such as disease outbreaks. Here, we examined Leptasterias populations at sites along the California coast and documented abundance changes coincident with recent Pacific coast SSWD in 2014. Detection of Leptasterias in central California declined, and Leptasterias were not detected at multiple sites clustered around the San Francisco Bay outflow in the most recent surveys. Additionally, we categorized disease signs in Leptasterias in the field and laboratory, which mirrored those seen in larger sea stars in both settings. Finally, we found that magnesium chloride (MgCl2) slowed the progression of physical deterioration related to SSWD when applied to sea stars in the laboratory, suggesting that MgCl2 may prolong the survival of diseased individuals.	[Jaffe, Noah; Eberl, Renate; Bucholz, Jamie; Cohen, C. Sarah] San Francisco State Univ, Dept Biol, Estuary & Ocean Sci Ctr, San Francisco, CA 94132 USA; [Eberl, Renate] Santa Rosa Jr Coll, Santa Rosa, CA USA; [Bucholz, Jamie] Univ Wisconsin, River Falls, WI 54022 USA	California State University System; San Francisco State University; University of Wisconsin System	Cohen, CS (corresponding author), San Francisco State Univ, Dept Biol, Estuary & Ocean Sci Ctr, San Francisco, CA 94132 USA.	sarahcoh@sfsu.edu		Cohen, C. Sarah/0000-0003-1188-1854	NSF DBI [1156452]; NSF ROA [10227002]; COAST Rapid Response [RR-2015-005]; SFSU COSE; EOS/RTC; Ronald E. McNair Scholars Program;  [COAST-GDP2016-003]	NSF DBI(National Science Foundation (NSF)); NSF ROA(National Science Foundation (NSF)); COAST Rapid Response; SFSU COSE; EOS/RTC; Ronald E. McNair Scholars Program; 	Funding sources were NSF DBI #1156452 (SFSU REU site program) (JB), NSF ROA #10227002 (RE, CSC), COAST Rapid Response RR-2015-005 (CSC, RE), COAST-GDP2016-003 (CSC), SFSU COSE, Biology, EOS/RTC, Ronald E. McNair Scholars Program (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera A, 2015, J SEA RES, V99, P9, DOI 10.1016/j.seares.2015.01.003; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; Bates CR, 2007, BIOL CONSERV, V137, P617, DOI 10.1016/j.biocon.2007.03.019; Bingham BL, 2004, CAN J ZOOL, V82, P457, DOI 10.1139/Z04-009; Bingham BL, 2000, CAN J ZOOL, V78, P596, DOI 10.1139/cjz-78-4-596; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; Braun C, 2016, P 100 M W SOC NAT; Bucci C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188523; Burge CA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0207; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Butt D, 2008, AQUACULTURE, V275, P342, DOI 10.1016/j.aquaculture.2007.12.004; CHIA FS, 1966, BIOL BULL, V130, P304, DOI 10.2307/1539738; CONOMOS TJ, 1985, HYDROBIOLOGIA, V129, P1, DOI 10.1007/BF00048684; Courchamp F, 1999, J ANIM ECOL, V68, P282, DOI 10.1046/j.1365-2656.1999.00285.x; Crowe T. P., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P273, DOI 10.1023/A:1009911928100; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Eisenlord ME, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0212; Fuess LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133053; GEORGE SB, 1994, MAR ECOL PROG SER, V109, P95, DOI 10.3354/meps109095; Goddard J, 2011, LONG TERM FAUNAL CHA; Goddard Jeffrey H. R., 2016, Bulletin Southern California Academy of Sciences, V115, P15; Goddard JHR, 2013, MAR BIOL, V160, P1497, DOI 10.1007/s00227-013-2204-x; Gravem SA, 2019, MAR BIOL, V166, DOI 10.1007/s00227-019-3469-5; Gravem SA, 2017, ECOLOGY, V98, P1006, DOI 10.1002/ecy.1672; Gravem SA, 2016, FUNCT ECOL, V30, P1574, DOI 10.1111/1365-2435.12628; Groner ML, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0364; Groner ML, 2014, DIS AQUAT ORGAN, V108, P165, DOI 10.3354/dao02709; Gudenkauf BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128150; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harvell CD, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7042; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Held MBE, 2009, INVERTEBR BIOL, V128, P381, DOI 10.1111/j.1744-7410.2009.00175.x; Hemond EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008652; Hewson I, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00077; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jurgens LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126280; Kahle D, 2013, R J, V5, P144; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kohl WT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153670; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Lafferty KD, 2015, ANNU REV MAR SCI, V7, P471, DOI 10.1146/annurev-marine-010814-015646; LAWRENCE JM, 1975, J EXP MAR BIOL ECOL, V18, P271, DOI 10.1016/0022-0981(75)90111-2; Marchesiello P, 2003, J PHYS OCEANOGR, V33, P753, DOI 10.1175/1520-0485(2003)33<753:ESADOT>2.0.CO;2; Maynard J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0208; MELDRUM DR, 1994, J SURG RES, V56, P537, DOI 10.1006/jsre.1994.1086; Melroy LM, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3184-z; Melroy LM, 2016, THESIS; MENGE BA, 1972, ECOLOGY, V53, P635, DOI 10.2307/1934777; MENGE BA, 1974, ECOLOGY, V55, P84, DOI 10.2307/1934620; MENGE BA, 1975, MAR BIOL, V31, P87, DOI 10.1007/BF00390651; MENGE BA, 1992, ECOLOGY, V73, P755, DOI 10.2307/1940155; Menge BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153994; Miner CM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192870; Miner M, SEA STAR WASTING SYN; Montecino-Latorre D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163190; Morgan SG, 2016, MAR ECOL PROG SER, V552, P31, DOI 10.3354/meps11766; Moritsch MM, 2018, ECOL EVOL, V8, P3952, DOI 10.1002/ece3.3953; Munroe DM, 2015, MAR ECOL PROG SER, V531, P221, DOI 10.3354/meps11349; Murray SN, 2006, MONITORING ROCKY SHORES, P1, DOI 10.1525/california/9780520247284.001.0001; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Niesen TM, 1973, THESIS; Noble RT, 2006, APPL ENVIRON MICROB, V72, P1604, DOI 10.1128/AEM.72.2.1604-1612.2006; Nunez-Pons L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29684-0; Alarcon PO, 2014, MAGNESIUM RES, V27, P57, DOI 10.1684/mrh.2014.0362; PAINE RT, 1969, ECOLOGY, V50, P950, DOI 10.2307/1936888; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pearse J, WHAT IS LIMPETS; PEARSE JS, 1987, MAR ECOL PROG SER, V39, P275, DOI 10.3354/meps039275; Puritz JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1238; Richardson LL, 1998, REV BIOL TROP, V46, P187; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Robinson DA, 2010, ACTA BIOMATER, V6, P1869, DOI 10.1016/j.actbio.2009.10.007; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Santos R, 2005, J EXP BIOL, V208, P2277, DOI 10.1242/jeb.01641; Schiebelhut LM, 2018, P NATL ACAD SCI USA; Schoch GC, 2006, LIMNOL OCEANOGR, V51, P2564, DOI 10.4319/lo.2006.51.6.2564; Sherman CDH, 2008, BIOL J LINN SOC, V95, P106, DOI 10.1111/j.1095-8312.2008.01044.x; SHIRLEY TC, 1982, MAR BIOL, V69, P147, DOI 10.1007/BF00396894; Soderhall K, 1999, DEV COMP IMMUNOL, V23, P263; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; SOULE M E, 1988, Conservation Biology, V2, P75, DOI 10.1111/j.1523-1739.1988.tb00337.x; STICKLE WB, 1976, MAR BIOL, V37, P125, DOI 10.1007/BF00389123; Strathmann MF, 1987, REPROD DEV MARINE IN; STRATHMANN RR, 1986, B MAR SCI, V39, P616; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Wares JP, 2016, PEERJ, V4, DOI 10.7717/peerj.1876	92	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225248	10.1371/journal.pone.0225248	http://dx.doi.org/10.1371/journal.pone.0225248			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751376	Green Published, gold			2022-12-26	WOS:000533886900036
J	Taku, NA; Ndze, VN; Abernathy, E; Hao, LJ; Waku-Kouomou, D; Icenogle, JP; Wanji, S; Akoachere, JFKT				Taku, Nadesh Ashukem; Ndze, Valentine Ngum; Abernathy, Emily; Hao, Lijuan; Waku-Kouomou, Diane; Icenogle, Joseph P.; Wanji, Samuel; Akoachere, Jane-Francis K. T.			Seroprevalence of rubella virus antibodies among pregnant women in the Center and South-West regions of Cameroon	PLOS ONE			English	Article								Rubella infection in early pregnancy can lead to miscarriages, fetal death, or birth of an infant with congenital rubella syndrome (CRS). In Cameroon, like in many developing countries, rubella surveillance is not well-established. The aim of this study was to determine the prevalence of rubella virus specific antibodies among pregnant Cameroonians. We conducted a cross-sectional study for rubella infection among pregnant women attending antenatal clinics in the Center and South-West regions of Cameroon. Demographic data and blood were collected and tested for rubella specific antibodies (IgG and IgM), and for the IgM positive cases, IgG avidity and real time PCR was done. From December 2015 to July 2017, 522 serum samples were collected and tested from pregnant women. The seroprevalence of rubella specific IgG was 94.4%, presumably due to immunity induced by wild-type rubella virus. The seroprevalence of rubella specific IgM was 5.0%, possibly indicating rubella infection. However, IgG avidity testing of the IgM positive cases detected high avidity IgGs, ranging from 52.37% to 87.70%, indicating past rubella infection. 5.6% (29/522) of the participants had negative results for IgG to rubella virus, indicating susceptibility to rubella infection. None of the participants had received a rubella containing vaccine (RCV), but 51% (266/522) of the pregnant women lived in a house with a child with records of at least one dose of RCV. Rubella virus RNA was not detected in the urine of any IgM positive case. Findings from this study show that rubella infection is significant in Cameroon. Some pregnant women are still susceptible to rubella infection. For a better management of rubella infection in pregnancy in Cameroon, consideration should be taken to investigate for IgGavidity test in cases with positive rubella IgM result to distinguish between recent from past rubella infection.	[Taku, Nadesh Ashukem; Wanji, Samuel; Akoachere, Jane-Francis K. T.] Univ Buea, Fac Sci, Dept Microbiol & Parasitol, Buea, Cameroon; [Ndze, Valentine Ngum] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Abernathy, Emily; Hao, Lijuan; Waku-Kouomou, Diane; Icenogle, Joseph P.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Waku-Kouomou, Diane] IHRC Inc, Atlanta, GA USA	University of Yaounde I; Centers for Disease Control & Prevention - USA	Taku, NA (corresponding author), Univ Buea, Fac Sci, Dept Microbiol & Parasitol, Buea, Cameroon.	takuashukem@yahoo.com		Nadesh, Taku/0000-0002-6514-6743; Ndze, Valantine/0000-0003-2200-6203	IHRC Inc. [61249]	IHRC Inc.	We would like to clarify that IHRC Inc. is a contracting company to the Centers for Diseases Control in charge of contract administration and payment of staff salaries. DWK received support by appointment to the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Diseases Control, administered by IHRC Inc. through contract number 61249. DWK conceived the study, provided key technical guidance, critically revised the manuscript, read and approved the final manuscript. IHRC Inc. provided contract administration support in the form of salaries payments for authors [DWK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abernathy E, 2009, J CLIN MICROBIOL, V47, P182, DOI 10.1128/JCM.01231-08; Achonduh-Atijegbe OA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1996-y; Adam O, 2013, E MEDITERR HEALTH J, V19, P812, DOI 10.26719/2013.19.9.812; Adewumi Olubusuyi M, 2015, J Immunoassay Immunochem, V36, P613, DOI 10.1080/15321819.2015.1027404; Alleman MM, 2016, VACCINE, V34, P6502, DOI 10.1016/j.vaccine.2016.10.059; ANDERSON MJ, 1985, LANCET, V2, P663; [Anonymous], 2012, VACCINES-BASEL; Best JM, 2007, SEMIN FETAL NEONAT M, V12, P182, DOI 10.1016/j.siny.2007.01.017; Best JM, 2006, LAB DIAGNOSIS RUBELL; Fenner F, 1998, Bull World Health Organ, V76 Suppl 2, P68; Fokunang C. N., 2010, African Journal of Clinical and Experimental Microbiology, V11, P79; Jivraj I, 2014, INT J TELEMED APPL, V2014, DOI 10.1155/2014/981312; Mengouo MN, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012959; MILLER E, 1982, LANCET, V2, P781; Mirambo MM, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-017-0505-9; Munteh YN, 2015, CAMEROON TRIBUNE; NDUMBE PM, 1992, MED MICROBIOL IMMUN, V181, P127, DOI 10.1007/BF00202052; Njoh Andreas Ateke, 2016, J Med Case Rep, V10, P345; Noubom M, 2018, J TROPICAL DIS, V6; Public-Health-England, 2011, GUID VIR RASH PREGN; Reef SE, 2006, CLIN INFECT DIS, V43, pS126, DOI 10.1086/505944; Tahita MC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-164; THOMAS HIJ, 1992, J VIROL METHODS, V39, P149, DOI 10.1016/0166-0934(92)90133-X; WHO, 2012, STAT REP PROGR MEASL; Wondimeneh Y, 2018, INT J INFECT DIS, V76, P14, DOI 10.1016/j.ijid.2018.07.024; World Health Organization, 2000, Weekly Epidemiological Record, V75, P161; Zhu Z, 2007, J CLIN MICROBIOL, V45, P2847, DOI 10.1128/JCM.00289-07	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225594	10.1371/journal.pone.0225594	http://dx.doi.org/10.1371/journal.pone.0225594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751431	Green Published, gold			2022-12-26	WOS:000533886900081
J	Nonogaki, A; Heang, H; Yi, S; van Pelt, M; Yamashina, H; Taniguchi, C; Nishida, T; Sakakibara, H				Nonogaki, Akiyo; Heang, Hen; Yi, Siyan; van Pelt, Maurits; Yamashina, Hiroko; Taniguchi, Chie; Nishida, Tomoko; Sakakibara, Hisataka			Factors associated with medication adherence among people with diabetes mellitus in poor urban areas of Cambodia: A cross-sectional study	PLOS ONE			English	Article							PREDICTIVE-VALIDITY; OUTCOMES	Background In Cambodia, the age-standardized prevalence of diabetes mellitus has increased in both men and women. The main objective of this study was to identify factors associated with diabetes medication adherence among people with diabetes mellitus in poor urban areas of Phnom Penh, Cambodia. Methods A cross-sectional study was conducted in 2017 using a structured questionnaire for face-to-face interviews by trained interviewers. The participants were people with diabetes mellitus who were the active members of a peer educator network, lived in poor urban areas of Phnom Penh, and attended weekly educational sessions during the survey period. Diabetes medication adherence was measured using four items of modified Morisky Medication Adherence Scale. Participants were classified into two groups based on their adherence score: 0 (high adherence) and from 1 to 4 (medium or low adherence). Sociodemographic characteristics; medical history; accessibility to health services; and knowledge, attitude, and practices related to diabetes mellitus were examined. A multiple logistic regression analysis was conducted adjusting for sex, age, marital status, and education levels. Results Data from 773 people with diabetes were included in the analyses. Of the total, 49.3% had a high level of diabetes medication adherence. A high level of adherence was associated with higher family income (>= 50 USD per month) (adjusted odds ratio [AOR] = 5.00, 95% confidence interval [CI] = 2.25-11.08), absence of diabetes mellitus-related complications (AOR = 1.66, 95% CI = 1.19-2.32), use of health services more than once per month (AOR = 2.87, 95% CI = 1.64-5.04), following special diet for diabetes mellitus (AOR = 1.81, 95% CI = 1.17-2.81), and absence of alcohol consumption (AOR = 13.67, 95% CI = 2.86-65.34). Conclusions High diabetes medication adherence was associated with better family economic conditions, absence of diabetes mellitus-related complications, and healthy behaviors. It would be crucial to improve affordable access to regular follow-ups including promotion of healthy behaviors through health education and control of diabetes mellitus-related complications.	[Nonogaki, Akiyo] Nagoya Univ, Grad Sch Med, Dept Nursing, Nagoya, Aichi, Japan; [Heang, Hen; van Pelt, Maurits] MoPoTsyo Patient Informat Ctr, Phnom Penh, Cambodia; [Yi, Siyan] KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia; [Yi, Siyan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Yi, Siyan] Natl Univ Hlth Syst, Singapore, Singapore; [Yi, Siyan] Touro Univ Calif, Ctr Global Hlth Res, Vallejo, CA USA; [Yamashina, Hiroko] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Taniguchi, Chie] Aichi Med Univ, Coll Nursing, Nagakute, Aichi, Japan; [Nishida, Tomoko] Sugiyama Jogakuen Univ, Dept Nursing, Nagoya, Aichi, Japan; [Sakakibara, Hisataka] Ichinomiya Kenshin Coll, Sch Nursing, Ichinomiya, Aichi, Japan; [Sakakibara, Hisataka] Nagoya Univ, Nagoya, Aichi, Japan	Nagoya University; National University of Singapore; National University of Singapore; Touro University California; Hokkaido University; Aichi Medical University; Nagoya University	Nonogaki, A (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nursing, Nagoya, Aichi, Japan.	akiyo.t0326@gmail.com		Nonogaki, Akiyo/0000-0002-0415-2322				Ahmad NS, 2013, PATIENT PREFER ADHER, V7, P525, DOI 10.2147/PPA.S44698; Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857; Alessandro R, 2013, BMC, V13, P236, DOI DOI 10.1186/1471-2458-13-236; Arrelias CCA, 2015, ACTA PAUL ENFERM, V28, P315, DOI 10.1590/1982-0194201500054; [Anonymous], 2003, ADHERENCE LONG TERM; Bader RJK, 2015, E MEDITERR HEALTH J, V21, P5; Bigdeli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146147; Bryson CL, 2008, ANN INTERN MED, V149, P795, DOI 10.7326/0003-4819-149-11-200812020-00004; CBM Cambodia Australia project Takeo Eye Hospital, 2011, AUSTR PROJ TAK EYE H; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Ebenezer Adekunle Ajayi AOA, 2013, IOSR J DENT MED SCI, V8, P36; Elsous A, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00100; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Flessa S, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0024-4; Garcia-Perez LE, 2013, DIABETES THER, V4, P175, DOI 10.1007/s13300-013-0034-y; Hartz A, 2006, DIABETES RES CLIN PR, V74, P227, DOI 10.1016/j.diabres.2006.03.023; Iloh GUP, 2012, N AM J MED SCI, V4, P344, DOI 10.4103/1947-2714.99514; Institute for Health Metrics and Evaluation, 2018, GLOB BURD DIS COMP; International Diabetes Federation (IDF), 2015, IDF DIAB ATL 7 ED 20; International Diabetes Federation (IDF), 2017, IDF DIAB ATL 8 ED 20; Ir P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010930; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Jimmy Beena, 2011, Oman Med J, V26, P155, DOI 10.5001/omj.2011.38; Johnson KH, 2000, ARCH FAM MED, V9, P964, DOI 10.1001/archfami.9.10.964; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Lee GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062775; Mannava P, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1, DOI 10.1177/1010539513500336; Ministry of Health Kingdom of Cambodia, 2013, NAT STRAT PLAN PREV; MoPoTsyo Patient Information Centre, 2007, REP MIDT REV MOPOTSY; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Morisky DE, 2011, J CLIN EPIDEMIOL, V64, P255, DOI 10.1016/j.jclinepi.2010.09.002; Natalie E., 2011, THESIS; Okesina B.S., 2015, INT J MED RES PHARM, V2, P5; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Otgontuya D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-254; Oum S, 2010, PREVALENCE NONCOMMUN; Piette JD, 2004, MED CARE, V42, P102, DOI 10.1097/01.mlr.0000108742.26446.17; Ponnusankar S, 2004, PATIENT EDUC COUNS, V54, P55, DOI 10.1016/s0738-3991(03)00193-9; Raguenaud ME, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-33; Rajesh B, 2003, CLIN THER, V25, P11; Saleh F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-431; Smita S, 2015, J YOUNG PHARM, V7, P4; Stephanie S, 2016, BMJ OPEN, V6, DOI [10.1136/bmjopen-2015-010510, DOI 10.1136/BMJOPEN-2015-010510]; Taniguchi D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181582; United Nations Department of Economic and Social Affairs, 2018, EC AN LEAST DEV COUN; van Olmen Josefien, 2016, J Pharm Policy Pract, V9, P1, DOI 10.1186/s40545-016-0050-1; Van Pelt M., 2011, PEER ED NETWORKS PEO; World Health Organization, 2018, DIAB PROGR COUNTR RE; World Health Organization, 2008, STOP TB PARTNERSHIP; World Health Organization Western Pacific Region, 2006, NONC DIS POV NEED PR; Xi T, 2014, INNOV PHARM, V5; Yekta Z, 2011, J RES HEALTH SCI, V11, P33; Yun LS, 2007, PATIENT EDUC COUNS, V69, P47, DOI 10.1016/j.pec.2007.06.017	55	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225000	10.1371/journal.pone.0225000	http://dx.doi.org/10.1371/journal.pone.0225000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743349	Green Published, gold			2022-12-26	WOS:000533877300013
J	Muller, D; Elias, B; Collard, L; Pels, C; Holveck, MJ; Nieberding, CM				Muller, Doriane; Elias, Benjamin; Collard, Laurent; Pels, Christophe; Holveck, Marie-Jeanne; Nieberding, Caroline M.			Polyphenism of visual and chemical secondary sexually-selected wing traits in the butterfly Bicyclus anynana: How different is the intermediate phenotype?	PLOS ONE			English	Article							MALE MATING SUCCESS; MALE SEX-PHEROMONE; DEVELOPMENTAL PLASTICITY; SEASONAL POLYPHENISM; REACTION NORMS; FEMALE CHOICE; EVOLUTION; SATYRIDAE; PATTERN; CUES	Polyphenism is a type of phenotypic plasticity supposedly adaptive to drastic and recurrent changes in the environment such as seasonal alternation in temperate and tropical regions. The butterfly Bicyclus anynana shows polyphenism with well-described wet and dry seasonal forms in sub-Saharan Africa, displaying striking morphological, physiological and behavioural differences in response to higher or lower developmental temperatures. During the seasonal transition in the wild, the intermediate phenotype co-occurs with wet and dry phenotypes. In this study, we aimed to characterize the secondary sexually-selected wing traits of the intermediate form to infer its potential fitness compared to wet and dry phenotypes. Among the previously described wing morphological traits, we first showed that the area of the fifth eyespot on the ventral hindwing is the most discriminant trait to identify wet, dry and intermediate phenotypes in both sexes. Second, we characterized the intermediate form for two secondary sexually-selected wing traits: the area and UV reflectance of the dorsal forewing pupil and the composition of the male sex pheromone. We showed that values of these two traits are often between those of the wet and dry phenotypes. Third, we observed increasing male sex pheromone production in ageing dry and wet phenotypes. Our results contrast with previous reports of values for sexually-selected traits in wet and dry seasonal forms, which might be explained by differences in rearing conditions or sample size effects among studies. Wet, dry and intermediate phenotypes display redundant sexually dimorphic traits, including sexually-selected traits that can inform about their developmental temperature in sexual interactions.	[Muller, Doriane; Pels, Christophe; Holveck, Marie-Jeanne; Nieberding, Caroline M.] Univ Catholic Louvain UCLouvain, Earth & Life Inst, Grp Evolutionary Ecol & Genet, Biodivers Res Ctr, Louvain, Belgium; [Elias, Benjamin; Collard, Laurent] Univ Catholic Louvain UCLouvain, Inst Condensed Matter & Nanosci, Louvain, Belgium		Muller, D; Nieberding, CM (corresponding author), Univ Catholic Louvain UCLouvain, Earth & Life Inst, Grp Evolutionary Ecol & Genet, Biodivers Res Ctr, Louvain, Belgium.	doriane.muller@uclouvain.be; caroline.nieberding@uclouvain.be	Holveck, Marie-Jeanne/D-4004-2016	Holveck, Marie-Jeanne/0000-0002-6229-6367	ARC-grant of the UCLouvain [17/22-086]; Federation Wallonie-Bruxelles; FRIA grant for doctoral research by Fund for Scientific Research - FNRS (Belgium)	ARC-grant of the UCLouvain; Federation Wallonie-Bruxelles; FRIA grant for doctoral research by Fund for Scientific Research - FNRS (Belgium)	This study was supported by an ARC-grant (17/22-086) of the UCLouvain and the Federation Wallonie-Bruxelles, as well as by a FRIA grant for doctoral research provided by Fund for Scientific Research - FNRS (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Balmer AJ, 2018, OIKOS, V127, P1812, DOI 10.1111/oik.05291; Bear A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064061; Becker W. A, 1984, MANUAL QUANTITATIVE; Beldade P, 2003, EVOL DEV, V5, P169, DOI 10.1046/j.1525-142X.2003.03025.x; Botero CA, 2015, P NATL ACAD SCI USA, V112, P184, DOI 10.1073/pnas.1408589111; Brakefield PM, 2007, J BIOSCIENCES, V32, P465, DOI 10.1007/s12038-007-0046-8; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Burnham K P, 2003, MODEL SELECT MULTIMO; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Canfield M., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P65; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; Dawson R, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889610; de Jong MA, 2010, CLIM RES, V43, P91, DOI 10.3354/cr00881; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dion E., 2017, EARLY EXPOSURE NEW S, DOI 10.1101/214635; Dion E, 2016, SCI REP-UK, V6, DOI 10.1038/srep39002; Everett A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-232; Fischer K, 2008, P ROY SOC B-BIOL SCI, V275, P1517, DOI 10.1098/rspb.2007.1455; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Friberg M, 2007, BEHAV ECOL, V18, P758, DOI 10.1093/beheco/arm037; Fusco G, 2010, PHILOS T R SOC B, V365, P547, DOI 10.1098/rstb.2009.0267; Garcia JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096646; Heuskin S, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00037; Holveck MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050389; JANZEN FJ, 1991, Q REV BIOL, V66, P149, DOI 10.1086/417143; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Karl I, 2013, ANIM BEHAV, V85, P143, DOI 10.1016/j.anbehav.2012.10.018; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Levis NA, 2015, ECOL EVOL, V5, P1405, DOI 10.1002/ece3.1448; Lyytinen A, 2003, OIKOS, V100, P373, DOI 10.1034/j.1600-0706.2003.11935.x; Madewell R, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_21.1; Martin Gilles San, 2011, Proceedings of the Netherlands Entomological Society Meeting, V22, P9; Mateus ARA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0097-x; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Ng SY, 2017, J INSECT SCI, V17, P1, DOI 10.1093/jisesa/iex053; Nieberding CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32132-8; Nieberding CM, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2346-9; Nieberding CM, 2012, ECOL LETT, V15, P415, DOI 10.1111/j.1461-0248.2012.01748.x; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Nieberding CM, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-018-0256-y; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Oostra V, 2011, P ROY SOC B-BIOL SCI, V278, P789, DOI 10.1098/rspb.2010.1560; Papke RS, 2007, ANIM BEHAV, V73, P47, DOI 10.1016/j.anbehav.2006.07.004; Prudic KL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1531; Prudic KL, 2011, SCIENCE, V331, P73, DOI 10.1126/science.1197114; Rasband W., 2006, IMAGEJ; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Roskam JC, 1996, EVOLUTION, V50, P2360, DOI 10.2307/2410705; Roskam JC, 1999, BIOL J LINN SOC, V66, P345, DOI 10.1111/j.1095-8312.1999.tb01895.x; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Simoes PM, 2016, ENV ADAPTATION PHENO; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Troscianko J, 2015, METHODS ECOL EVOL, V6, P1320, DOI 10.1111/2041-210X.12439; van Bergen E, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0907-1; van Bergen E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0102; van't Hof AE, 2005, MOL ECOL NOTES, V5, P169, DOI 10.1111/j.1471-8286.2004.00870.x; Westerman EL, 2014, EVOLUTION, V68, P1661, DOI 10.1111/evo.12381; White TE, 2015, ANIM BEHAV, V106, P51, DOI 10.1016/j.anbehav.2015.05.007; Whitefoot D, 2009, WOODHEAD PUBL TEXT, P1, DOI 10.1533/9781845695859.1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wijngaarden PJ, 2001, HEREDITY, V87, P410, DOI 10.1046/j.1365-2540.2001.00933.x; WINDIG JJ, 1994, ECOL ENTOMOL, V19, P285, DOI 10.1111/j.1365-2311.1994.tb00420.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	66	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225003	10.1371/journal.pone.0225003	http://dx.doi.org/10.1371/journal.pone.0225003			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738776	gold, Green Published			2022-12-26	WOS:000532826300026
J	Xu, JY; Wang, GJ; Zhang, YQ; Zhang, GL; Xing, J; Qi, LH; Zhuang, Y; Zeng, HJ; Chang, JH				Xu, Jiying; Wang, Guojie; Zhang, Yanqiu; Zhang, Guolong; Xing, Jin; Qi, Lihong; Zhuang, Yan; Zeng, Hejun; Chang, Jianhua			An outbreak of tuberculosis in a middle school in Henan, China: Epidemiology and risk factors	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; REFUGEES	Background In 2013, a tuberculosis (TB) outbreak occurred in a middle school in Henan province of China. An outbreak survey was carried out in the school. Objectives This study was undertaken to investigate the detection rate of TB cases and those with strong Mantoux positive (SMP), defined as tuberculin skin test (TST) indurations of 15mm or larger and/or blisters, necrosis or lymphangitis, and to identify their risk factors. Methods The TST, chest x-ray/radiography, and TB-suspicious symptoms interview were used to screen for TB cases. Their diagnosis was made by sputum smear microscopy, liquid culture, computed tomography (CT), and diagnostic therapy if necessary. We retrospectively analyzed the outbreak survey data of 4082 students and 278 staff in the school. Logistic regression models were used to identify the risk factors associated with SMP and TB disease. Results Approximately 3.55% of students and 16.55% of staff were SMP. SMP rate in students was significantly lower than that in staff (p<0.001). 55 TB cases in students and none in staff were identified in the school from February to November, 2013, with a detection rate of 1.35% for students. SMP and TB case detection rates were 20.29% and 41.77%, respectively, in the index class, both significantly higher than that in the other classes (3.26% and 0.55%, respectively; both p<0.001). In the index class, TB case detection rate over the study period in students with SMP was not significantly higher than that with TST indurations of < 15mm (38.18% vs 21.43%, p = 0.24), but it was significantly higher in the other classes 7.81% vs 0.18%, p<0.001). Risk factors independently associated with SMP and TB cases shared the following with the index case: same dormitory-floor (adjusted odds ratio (AOR) 5.36, 95% CI 3.02-9.48, p<0.001 for SMP; AOR 2.67; 95% CI 1.03-6.96, p = 0.044 for TB cases), same classroom (AOR 4.01; 95% CI 1.95-8.26, p<0.001 for SMP; AOR 165.08; 95% CI 66.88-407.47, p<0.001 for TB cases), same teaching-floor in different classroom (AOR 5.41; 95% CI 3.02-9.71, p<0.001 for SMP; AOR 11.24; 95% CI 3.71-34.03, p<0.001 for TB cases) and same teaching-building on different floor (AOR 1.81; 95% CI 1.16-2.85, p = 0.009 for SMP; AOR 3.30; 95% CI 1.16-9.42, p = 0.025 for TB cases). The closer the contact was with the index case, the larger the AORs for SMP and TB cases were. Conclusion Same dormitory-floor, same classroom, same teaching-floor and same teaching-building with the index case were all risk factors for both TB infection and disease for students in the outbreak, and the closer the contact was with the index case, the higher the risk was observed. Attention should also be paid to students with TST indurations <15mm, as well as to those with that >= 15mm for the index class in dealing with the outbreak.	[Xu, Jiying; Zhang, Yanqiu; Zhang, Guolong; Xing, Jin; Zhuang, Yan] Henan Prov Ctr Dis Control & Prevent, Inst TB Control & Prevent, Zhengzhou, Henan, Peoples R China; [Wang, Guojie] Henan Med Coll, Dept Med, Zhengzhou, Henan, Peoples R China; [Qi, Lihong] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA USA; [Zeng, Hejun; Chang, Jianhua] Hebi Prefecture Ctr Dis Control & Prevent, Inst TB Control & Prevent, Hebi, Peoples R China	Henan Medical College; University of California System; University of California Davis	Xu, JY (corresponding author), Henan Prov Ctr Dis Control & Prevent, Inst TB Control & Prevent, Zhengzhou, Henan, Peoples R China.; Qi, LH (corresponding author), Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA USA.	xujiyingx@163.com; lqicool2003@yahoo.com	Zhang, Guolong/HCI-5587-2022	Xu, Jiying/0000-0001-8159-5664				Calder L, 2008, NEW ZEAL MED J, V121, P50; Chen HuiJie, 2018, Journal of Nanjing Agricultural University, V41, P662; Chen W, 2012, J INT MED RES, V40, P1830, DOI 10.1177/030006051204000521; Faccini M, 2013, EMERG INFECT DIS, V19, P485, DOI 10.3201/eid1902.120527; Fang YR, 2013, J EPIDEMIOL, V23, P307, DOI 10.2188/jea.JE20120216; Khalil NJ, 2013, CAN J PUBLIC HEALTH, V104, pE28, DOI 10.1007/BF03405650; Lu X, 2012, CHIN J ANTITUBERC, V34, P637; Rodriguez PJM, 2007, ARCH BRONCONEUMOL, V43, P611, DOI 10.1016/S1579-2129(07)60138-4; Ministry of Health and China CDC, 2008, GUID NAT TB CONTR PR; Moreau D, 2012, CAN J PUBLIC HEALTH, V103, pE408, DOI 10.1007/BF03405627; Neira-Munoz E, 2008, PEDIATR INFECT DIS J, V27, P836, DOI 10.1097/INF.0b013e31816ff7c5; Oeltmann JE, 2008, EMERG INFECT DIS, V14, P1715, DOI 10.3201/eid1411.071629; Schmid D, 2008, INT J TUBERC LUNG D, V12, P1190; Sheng X, 2013, CHINESE J SCH HLTH, V34, P975; Sheng X, 2013, CHINESE J SCH HLTH, V34, P971; Song J, 2007, PREV MED TRIB, V13, P843; Sosa LE, 2008, INT J TUBERC LUNG D, V12, P689; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Zhang T, 2010, CHINESE J ANTITUBERC, V32, P736	19	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225042	10.1371/journal.pone.0225042	http://dx.doi.org/10.1371/journal.pone.0225042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730664	gold, Green Published			2022-12-26	WOS:000532809500020
J	Cluzet, V; Devillers, MM; Petit, F; Chauvin, S; Francois, CM; Giton, F; Genestie, C; di Clemente, N; Cohen-Tannoudji, J; Guigon, CJ				Cluzet, Victoria; Devillers, Marie M.; Petit, Florence; Chauvin, Stephanie; Francois, Charlotte M.; Giton, Frank; Genestie, Catherine; di Clemente, Nathalie; Cohen-Tannoudji, Joelle; Guigon, Celine J.			Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary	ONCOGENE			English	Article							ANTI-MULLERIAN HORMONE; FOLLICULAR DEVELOPMENT; EXPRESSION; GENE; MUTATIONS; PROTEIN; PROLIFERATION; RECEPTOR; LOCALIZATION; INHIBITION	Ovarian granulosa cell tumors (GCTs) are indolent tumors of the ovary affecting women at all ages and potentially displaying late recurrence. Even if there is still little information regarding the mechanisms involved in GCT development and progression, FOXL2 would be a major tumor suppressor gene in granulosa cells. We analyzed the mechanisms underlying GCT initiation and progression by using mice with targeted expression of SV40 large T-antigen in granulosa cells (AT mouse), which develop GCTs. Consistent with patients, AT mice with developing GCTs displayed increased levels in circulating anti-Mullerian hormone (AMH), estradiol and androgens, as well as decreased FOXL2 protein abundance. Very few mice developed metastases (1 out of 30). In situ analyses revealed that GCT initiation resulted from both increased granulosa cell survival and proliferation in large antral follicles. Tumorigenesis was associated with the combined inactivation of p53 and Rb pathways, as shown by the impaired expression of respective downstream targets regulating cell apoptosis and proliferation, i.e., Bax, Bak, Gadd45a, Ccna2, Ccne1, E2f1, and Orc1. Importantly, the expression of FOXL2 was still present in newly developed GCTs and its downregulation only started during GCT growth. Collectively, our experiments provide evidence that disrupted p53/Rb signaling can drive tumor initiation and growth. This model challenges the current paradigm that impaired FOXL2 signaling is a major switch of granulosa cell tumorigenesis, albeit possibly contributing to tumor growth.	[Cluzet, Victoria; Devillers, Marie M.; Petit, Florence; Chauvin, Stephanie; Francois, Charlotte M.; Cohen-Tannoudji, Joelle; Guigon, Celine J.] Univ Paris Diderot, Physiol Axe Gonadotrope U1133, Biol Fonct & Adaptat UMR 8251, INSERM,Sorbonne Paris Cite, Paris, France; [Giton, Frank] Inserm IMRB U955 Eq07, Pole Biol Pathol Henri Mondor, AP HP, Creteil, France; [Genestie, Catherine] Inst Gustave Roussy, Dept Pathol, Villejuif, France; [di Clemente, Nathalie] Sorbonne Univ, CRSA, IHU ICAN, INSERM, Paris, France; [Guigon, Celine J.] Unite Biol Fonct & Adaptat, 4 Rue MA Lagroua Weill Halle,Case Courrier 7007, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Guigon, CJ (corresponding author), Univ Paris Diderot, Physiol Axe Gonadotrope U1133, Biol Fonct & Adaptat UMR 8251, INSERM,Sorbonne Paris Cite, Paris, France.; Guigon, CJ (corresponding author), Unite Biol Fonct & Adaptat, 4 Rue MA Lagroua Weill Halle,Case Courrier 7007, F-75013 Paris, France.	celine.guigon@univ-paris-diderot.fr	; guigon, celine/L-3518-2017	Chauvin, Stephanie/0000-0002-8439-1453; GITON, Frank/0000-0002-4959-1214; guigon, celine/0000-0002-4489-4304; di Clemente, Nathalie/0000-0001-9087-3486; PETIT, Florence/0000-0002-0363-280X	Ligue contre le Cancer Ile-de-France; Projet Fondation ARC [PJA 20151203391]; GEFLUC Paris-Ile de France; "Institut National de la Sante & de la Recherche Medicale" (Inserm), "Center National de la Recherche Scientifique" (CNRS), University Paris Diderot; Ecole Doctorale Bio-SPC	Ligue contre le Cancer Ile-de-France; Projet Fondation ARC; GEFLUC Paris-Ile de France; "Institut National de la Sante & de la Recherche Medicale" (Inserm), "Center National de la Recherche Scientifique" (CNRS), University Paris Diderot; Ecole Doctorale Bio-SPC	We wish to thank Pr. R Veitia, Dr. AL Todeschini (Institut Jacques Monod, Paris, France), and Dr. S Bouret (Institut du Cerveau et de la Moelle, Paris, France) for valuable discussions regarding this work. They acknowledge the technical assistance of M. Surenaud for gonadotropin assays (IMRB-INSERM U955, Hopital Henri Mondor, France), and Dr. B. Querat and Dr. D. L'hote (University Paris 7, BFA unit, France) for providing p53 antibody and Foxl2 primers. They also thank the technical help of Dr. M. Pannetier (INRA, Jouy en Josas, France) for the detection of FOXL2 by Western blots. They thank O. Trassard (UMS-32 INSERM, Hopital du Kremlin Bicetre, France) for his kind help in scanning histological slides. They acknowledge the great help of the technicians of the Buffon Animal Facility (University Paris Diderot, France). This work was supported by Ligue contre le Cancer Ile-de-France (attributed to NC), Projet Fondation ARC (PJA 20151203391, attributed to CJG) and GEFLUC Paris-Ile de France (CJG). It was also funded by "Institut National de la Sante & de la Recherche Medicale" (Inserm), "Center National de la Recherche Scientifique" (CNRS), University Paris Diderot, and by fellowships from Ecole Doctorale Bio-SPC (VC, MMD, CMF).	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Alexander BM, 2007, ANAT REC, V290, P59, DOI 10.1002/ar.20409; Alexiadis M, 2019, MOL CANCER RES, V17, P177, DOI 10.1158/1541-7786.MCR-18-0359; Andreu-Vieyra C, 2008, MOL ENDOCRINOL, V22, P2141, DOI 10.1210/me.2008-0033; Anttonen M, 2011, LAB INVEST, V91, P1605, DOI 10.1038/labinvest.2011.116; Arcellana-Panlilio MY, 2002, GENE CHROMOSOME CANC, V35, P176, DOI 10.1002/gcc.10108; Auguste A, 2015, HUM MOL GENET, V24, P6687, DOI 10.1093/hmg/ddv373; Batisse-Lignier M, 2017, ONCOGENE, V36, P4445, DOI 10.1038/onc.2017.54; Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; Bessiere L, 2015, EBIOMEDICINE, V2, P421, DOI 10.1016/j.ebiom.2015.03.002; BUKOVSKY A, 1995, BIOL REPROD, V52, P776, DOI 10.1095/biolreprod52.4.776; Caburet S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1283-0; Chu S, 2002, MOL HUM REPROD, V8, P426, DOI 10.1093/molehr/8.5.426; De Cian MC, 2017, ONCOGENE, V36, P208, DOI 10.1038/onc.2016.191; Devillers MM, 2019, J ENDOCRINOL, V240, P215, DOI 10.1530/JOE-18-0313; Dutertre M, 2001, ENDOCRINOLOGY, V142, P4040, DOI 10.1210/en.142.9.4040; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Fan HY, 2009, CANCER RES, V69, P6463, DOI 10.1158/0008-5472.CAN-08-3363; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Francois CM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46222; Francois CM, 2015, CARCINOGENESIS, V36, P564, DOI 10.1093/carcin/bgv041; Fuller PJ, 2017, CLIN GENET, V91, P285, DOI 10.1111/cge.12917; Georges A, 2014, J MOL ENDOCRINOL, V52, pR17, DOI 10.1530/JME-13-0159; Georges A, 2014, ELIFE, V3, DOI 10.7554/eLife.04207; Gershon R, 2011, GYNECOL ONCOL, V122, P580, DOI 10.1016/j.ygyno.2011.05.008; Goulvent T, 2016, HISTOPATHOLOGY, V68, P279, DOI 10.1111/his.12747; Guigon CJ, 2010, CARCINOGENESIS, V31, P1284, DOI 10.1093/carcin/bgq059; Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x; Hillman RT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04950-x; Jamieson S, 2012, ENDOCR REV, V33, P109, DOI 10.1210/er.2011-0014; Kalfa N, 2006, J CLIN ENDOCR METAB, V91, P1842, DOI 10.1210/jc.2005-2710; Kalfa N, 2007, FERTIL STERIL, V87, P896, DOI 10.1016/j.fertnstert.2006.11.016; Kalfa N, 2009, GYNECOL ENDOCRINOL, V25, P299, DOI 10.1080/09513590802630153; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; L'Hote D, 2012, HUM MOL GENET, V21, P3264, DOI 10.1093/hmg/dds170; Lague MN, 2008, CARCINOGENESIS, V29, P2062, DOI 10.1093/carcin/bgn186; Ligtenberg MJ, 1999, J CLIN ENDOCR METAB, V84, P2233, DOI 10.1210/jc.84.6.2233; Liu ZL, 2015, MOL ENDOCRINOL, V29, P1006, DOI 10.1210/me.2015-1103; Makrigiannakis A, 2000, J CLIN ENDOCR METAB, V85, P449, DOI 10.1210/jc.85.1.449; Mayr D, 2002, MODERN PATHOL, V15, P951, DOI 10.1097/01.MP.0000024290.55261.14; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Merras-Salmio L, 2002, PEDIATR HEMAT ONCOL, V19, P145, DOI 10.1080/088800102753541297; Nogales FF, 2004, MODERN PATHOL, V17, P868, DOI 10.1038/modpathol.3800133; Ogawa T, 2003, MOL CELL ENDOCRINOL, V210, P31, DOI 10.1016/j.mce.2003.08.008; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Ohtani K, 1996, MOL CELL BIOL, V16, P6977; Pannetier M, 2016, SEX DEV, V10, P167, DOI 10.1159/000448667; Pectasides D, 2008, CANCER TREAT REV, V34, P1, DOI 10.1016/j.ctrv.2007.08.007; Rey RA, 1996, AM J OBSTET GYNECOL, V174, P958, DOI 10.1016/S0002-9378(96)70333-2; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Sirotkin AV, 2008, REPRODUCTION, V136, P611, DOI 10.1530/REP-08-0229; TILLY KI, 1995, ENDOCRINOLOGY, V136, P1394, DOI 10.1210/en.136.4.1394; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Zhao HL, 2013, CANCER CELL, V24, P645, DOI 10.1016/j.ccr.2013.09.021	57	8	9	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1875	1890		10.1038/s41388-019-1109-7	http://dx.doi.org/10.1038/s41388-019-1109-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31745296				2022-12-26	WOS:000516579800004
J	Dai, K; Tanaka, M; Kamiyoshi, A; Sakurai, T; Ichikawa-Shindo, Y; Kawate, H; Cui, NQ; Wei, YX; Tanaka, M; Kakihara, S; Matsui, S; Shindo, T				Dai, Kun; Tanaka, Megumu; Kamiyoshi, Akiko; Sakurai, Takayuki; Ichikawa-Shindo, Yuka; Kawate, Hisaka; Cui, Nanqi; Wei, Yangxuan; Tanaka, Masaaki; Kakihara, Shinji; Matsui, Shuhei; Shindo, Takayuki			Deficiency of the adrenomedullin-RAMP3 system suppresses metastasis through the modification of cancer-associated fibroblasts	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SQUAMOUS-CELL CARCINOMAS; PANCREATIC-CANCER; POOR-PROGNOSIS; VASCULAR INTEGRITY; BREAST-CANCER; UP-REGULATION; PODOPLANIN; EXPRESSION; INVASION	Tumor metastasis is a primary source of morbidity and mortality in cancer. Adrenomedullin (AM) is a multifunctional peptide regulated by receptor activity-modifying proteins (RAMPs). We previously reported that the AM-RAMP2 system is involved in tumor angiogenesis, but the function of the AM-RAMP3 system remains largely unknown. Here, we investigated the actions of the AM-RAMP2 and 3 systems in the tumor microenvironment and their impact on metastasis. PAN02 pancreatic cancer cells were injected into the spleens of mice, leading to spontaneous liver metastasis. Tumor metastasis was enhanced in vascular endothelial cell-specific RAMP2 knockout mice (DI-E-RAMP2-/-). By contrast, metastasis was suppressed in RAMP3-/- mice, where the number of podoplanin (PDPN)-positive cancer-associated fibroblasts (CAFs) was reduced in the periphery of tumors at metastatic sites. Because PDPN-positive CAFs are a hallmark of tumor malignancy, we assessed the regulation of PDPN and found that Src/Cas/PDPN signaling is mediated by RAMP3. In fact, RAMP3 deficiency CAFs suppressed migration, proliferation, and metastasis in co-cultures with tumor cells in vitro and in vivo. Moreover, the activation of RAMP2 in RAMP3-/- mice suppressed both tumor growth and metastasis. Based on these results, we suggest that the upregulation of PDPN in DI-E-RAMP2-/- mice increases malignancy, while the downregulation of PDPN in RAMP3-/- mice reduces it. Selective activation of RAMP2 and inhibition of RAMP3 would therefore be expected to suppress tumor metastasis. This study provides the first evidence that understanding and targeting to AM-RAMP systems could contribute to the development of novel therapeutics against metastasis.	[Dai, Kun; Tanaka, Megumu; Kamiyoshi, Akiko; Sakurai, Takayuki; Ichikawa-Shindo, Yuka; Kawate, Hisaka; Cui, Nanqi; Wei, Yangxuan; Tanaka, Masaaki; Kakihara, Shinji; Matsui, Shuhei; Shindo, Takayuki] Shinshu Univ, Interdisciplinary Cluster Cutting Edge Res, Inst Biomed Sci, Dept Life Innovat, Matsumoto, Nagano 3908621, Japan; [Dai, Kun; Tanaka, Megumu; Kamiyoshi, Akiko; Sakurai, Takayuki; Ichikawa-Shindo, Yuka; Kawate, Hisaka; Cui, Nanqi; Wei, Yangxuan; Shindo, Takayuki] Shinshu Univ, Sch Med, Dept Cardiovasc Res, Matsumoto, Nagano 3908621, Japan; [Tanaka, Masaaki; Kakihara, Shinji] Shinshu Univ, Sch Med, Dept Ophthalmol, Matsumoto, Nagano 3908621, Japan; [Matsui, Shuhei] Shinshu Univ, Sch Med, Dept Anesthesiol, Matsumoto, Nagano 3908621, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University	Shindo, T (corresponding author), Shinshu Univ, Interdisciplinary Cluster Cutting Edge Res, Inst Biomed Sci, Dept Life Innovat, Matsumoto, Nagano 3908621, Japan.; Shindo, T (corresponding author), Shinshu Univ, Sch Med, Dept Cardiovasc Res, Matsumoto, Nagano 3908621, Japan.	tshindo@shinshu-u.ac.jp	Kakihara, Shinji/AAR-1855-2021	Kakihara, Shinji/0000-0002-8433-8169	Core Research for Evolutionary Science and Technology (CREST) of Japan Science and Technology Agency (JST); Japan Agency for Medical Research and Development (AMED); Bristol-Myers Squibb Company; Japan Foundation for Applied Enzymology; Naito Foundation; Public Foundation of Chubu Science and Technology Center; Yamaguchi Endocrine Research Foundation; Hoyu Science Foundation; Takahashi Industrial and Economic Research Foundation; Akaeda Medical Research Foundation; Shinshu Public Utility Foundation for Promotion of Medial Sciences; Japan Heart Foundation; Otsuka Toshimi Scholarship Foundation	Core Research for Evolutionary Science and Technology (CREST) of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Japan Foundation for Applied Enzymology; Naito Foundation(Naito Memorial Foundation); Public Foundation of Chubu Science and Technology Center; Yamaguchi Endocrine Research Foundation; Hoyu Science Foundation; Takahashi Industrial and Economic Research Foundation; Akaeda Medical Research Foundation; Shinshu Public Utility Foundation for Promotion of Medial Sciences; Japan Heart Foundation; Otsuka Toshimi Scholarship Foundation(Otsuka Pharmaceutical)	This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Core Research for Evolutionary Science and Technology (CREST) of Japan Science and Technology Agency (JST) and the Japan Agency for Medical Research and Development (AMED), and research grants from Bristol-Myers Squibb Company, Japan Foundation for Applied Enzymology, the Naito Foundation, the Public Foundation of Chubu Science and Technology Center, Yamaguchi Endocrine Research Foundation, Hoyu Science Foundation, Takahashi Industrial and Economic Research Foundation, Akaeda Medical Research Foundation, Shinshu Public Utility Foundation for Promotion of Medial Sciences, and Japan Heart Foundation. KD received a scholarship from Otsuka Toshimi Scholarship Foundation. The authors are grateful to Prof. Sachie Hiratsuka for valuable comments and tumor cells.	Aoki M, 2011, BRIT J CANCER, V104, P714, DOI 10.1038/sj.bjc.6606075; Berenguer-Daize C, 2013, CLIN CANCER RES, V19, P6138, DOI 10.1158/1078-0432.CCR-13-0691; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; Dauer P, 2018, CANCER RES, V78, P1321, DOI 10.1158/0008-5472.CAN-17-2320; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hikosaka T, 2011, PEPTIDES, V32, P1825, DOI 10.1016/j.peptides.2011.07.012; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hirabayashi K, 2019, AM J PATHOL, V189, P449, DOI 10.1016/j.ajpath.2018.10.021; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hirayama K, 2018, SURG TODAY, V48, P110, DOI 10.1007/s00595-017-1559-x; Iesato Y, 2013, AM J PATHOL, V182, P2380, DOI 10.1016/j.ajpath.2013.02.015; Iimuro S, 2004, CIRC RES, V95, P415, DOI 10.1161/01.RES.0000138018.61065.d1; Inoue H, 2012, J ORAL SCI, V54, P241, DOI 10.2334/josnusd.54.241; Kaafarani I, 2009, FASEB J, V23, P3424, DOI 10.1096/fj.08-127852; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Komohara Y, 2017, J PATHOL, V241, P313, DOI 10.1002/path.4824; Koukourakis MI, 2017, LAB INVEST, V97, P1321, DOI 10.1038/labinvest.2017.79; Koyama T, 2013, CIRCULATION, V127, P842, DOI 10.1161/CIRCULATIONAHA.112.000756; Lau EYT, 2016, CELL REP, V15, P1175, DOI 10.1016/j.celrep.2016.04.019; Liu T, 2018, PEPTIDES, V110, P10, DOI 10.1016/j.peptides.2018.10.006; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Marusyk A, 2016, CANCER RES, V76, P6495, DOI 10.1158/0008-5472.CAN-16-1457; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Miller MJ, 1996, J BIOL CHEM, V271, P23345; Murakami S, 2005, AM J RESP CRIT CARE, V172, P581, DOI 10.1164/rccm.200409-1280OC; Nakashima Y, 2013, CANCER SCI, V104, P1718, DOI 10.1111/cas.12286; Neesse A, 2015, GUT, V64, P1476, DOI 10.1136/gutjnl-2015-309304; Neri S, 2015, INT J CANCER, V137, P784, DOI 10.1002/ijc.29464; Nojiri T, 2015, P NATL ACAD SCI USA, V112, P4086, DOI 10.1073/pnas.1417273112; Nouguerede E, 2013, CANCER MED-US, V2, P196, DOI 10.1002/cam4.51; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Prakash J, 2017, ADV DRUG DELIVER REV, V121, P1, DOI 10.1016/j.addr.2017.11.008; Qi LS, 2016, ONCOTARGET, V7, P74015, DOI 10.18632/oncotarget.12187; Ramachandran V, 2007, CANCER RES, V67, P2666, DOI 10.1158/0008-5472.CAN-06-3362; Ramachandran V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007502; Raof NA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2267-9; Ren Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0758-4; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schoppmann SF, 2012, BREAST CANCER RES TR, V134, P237, DOI 10.1007/s10549-012-1984-x; Sexton PM, 2006, ANN NY ACAD SCI, V1070, P90, DOI 10.1196/annals.1317.076; Sexton PM, 2001, CELL SIGNAL, V13, P73, DOI 10.1016/S0898-6568(00)00143-1; Shindo K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-168; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; Shindo T, 2019, PEPTIDES, V111, P55, DOI 10.1016/j.peptides.2018.04.004; Siclari VA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0458-y; Singhal PK, 2016, P NATL ACAD SCI USA, V113, P122, DOI 10.1073/pnas.1522401112; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Suchanski J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184970; Tanaka M, 2016, CARDIOVASC RES, V111, P398, DOI 10.1093/cvr/cvw166; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Ugorski M, 2016, AM J CANCER RES, V6, P370; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Yamauchi A, 2014, J MOL CELL CARDIOL, V77, P73, DOI 10.1016/j.yjmcc.2014.09.017; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yazdani S, 2017, ADV DRUG DELIVER REV, V121, P101, DOI 10.1016/j.addr.2017.07.010; Ye L, 2010, CANCER SCI, V101, P2137, DOI 10.1111/j.1349-7006.2010.01648.x; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoshida T, 2015, CLIN CANCER RES, V21, P642, DOI 10.1158/1078-0432.CCR-14-0846; Zhang DX, 2018, CANCER RES, V78, P1700, DOI 10.1158/0008-5472.CAN-17-1366; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zou GY, 2018, CANCER SCI, V109, P3416, DOI 10.1111/cas.13780	67	7	7	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1914	1930		10.1038/s41388-019-1112-z	http://dx.doi.org/10.1038/s41388-019-1112-z			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31754214	Green Submitted			2022-12-26	WOS:000516579800007
J	Yasukawa, K; Kinoshita, D; Yaku, K; Nakagawa, T; Koshiba, T				Yasukawa, Kai; Kinoshita, Daisuke; Yaku, Keisuke; Nakagawa, Takashi; Koshiba, Takumi			The microRNAs miR-302b and miR-372 regulate mitochondrial metabolism via the SLC25A12 transporter, which controls MAVS-mediated antiviral innate immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; microRNA (miRNA); innate immunity; signaling; metabolic regulation; RNA virus	DEPENDENT PROTEIN-KINASE; DRP1; PHOSPHORYLATION; NORMALIZATION; TRANSCRIPTS; PYRUVATE; TARGETS; RAB32	MicroRNAs (miRNAs) are small noncoding RNAs that suppress the expression of multiple genes and are involved in numerous biologic functions and disorders, including human diseases. Here, we report that two miRNAs, miR-302b and miR-372, target mitochondrial-mediated antiviral innate immunity by regulating mitochondrial dynamics and metabolic demand. Using human cell lines transfected with the synthetic analog of viral dsRNA, poly(I-C), or challenged with Sendai virus, we found that both miRNAs are up-regulated in the cells late after viral infection and ultimately terminate the production of type I interferons and inflammatory cytokines. We found that miR-302b and miR-372 are involved in dynamin-related protein 1 (DRP1)-dependent mitochondrial fragmentation and disrupt mitochondrial metabolism by attenuating solute carrier family 25 member 12 (SLC25A12), a member of the SLC25 family. Neutralizing the effects of the two miRNAs through specific inhibitors re-established the mitochondrial dynamics and the antiviral responses. We found that SLC25A12 contributes to regulating the antiviral response by inducing mitochondrial-related metabolite changes in the organelle. Structure?function analysis indicated that SLC25A12, as part of a prohibitin complex, associates with the mitochondrial antiviral-signaling protein in mitochondria, providing structural insight into the regulation of the mitochondrial-mediated antiviral response. Our results contribute to the understanding of how miRNAs modulate the innate immune response by altering mitochondrial dynamics and metabolic demand. Manipulating the activities of miR-302b and miR-372 may be a potential therapeutic approach to target RNA viruses.	[Yasukawa, Kai; Kinoshita, Daisuke; Koshiba, Takumi] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan; [Yasukawa, Kai] Mitsubishi Tanabe Pharma Corp, Modal Labs, Innovat Res Div, Fujisawa, Kanagawa 2518555, Japan; [Yaku, Keisuke; Nakagawa, Takashi] Univ Toyama, Grad Sch Med & Pharmaceut Sci Res, Dept Metab & Nutr, Toyama 9300194, Japan; [Nakagawa, Takashi] Univ Toyama, Frontier Res Core Life Sci, Toyama 9300194, Japan; [Koshiba, Takumi] Fukuoka Univ, Dept Chem, Fac Sci, Fukuoka 8140180, Japan	Kyushu University; Mitsubishi Tanabe Pharma Corporation; University of Toyama; University of Toyama; Fukuoka University	Koshiba, T (corresponding author), Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	koshiba@kyudai.jp	Nakagawa, Takashi/F-3015-2010	Nakagawa, Takashi/0000-0001-5539-7605; Koshiba, Takumi/0000-0001-8535-5043; Yaku, Keisuke/0000-0002-2420-4265	JSPS KAKENHI [17H03667, 17K19561, 18H04863]; Takeda Science Foundation; KANEKA Corp.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); KANEKA Corp.	This work was supported by JSPS KAKENHI Grants 17H03667, 17K19561, and 18H04863, the Takeda Science Foundation, and the KANEKA Corp. (to T. K.). Kai Yasukawa is affiliated with Mitsubishi Tanabe Pharma Corp.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alkan HF, 2018, CELL METAB, V28, P706, DOI 10.1016/j.cmet.2018.07.021; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amoedo ND, 2016, BBA-MOL CELL RES, V1863, P2394, DOI 10.1016/j.bbamcr.2016.04.011; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chan YK, 2015, CURR OPIN VIROL, V12, P7, DOI 10.1016/j.coviro.2015.01.004; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen XY, 2017, J BIOL CHEM, V292, P21291, DOI 10.1074/jbc.M117.805937; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ingle H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3183; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Koshiba T, 2013, BBA-MOL CELL RES, V1833, P225, DOI 10.1016/j.bbamcr.2012.03.005; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Li YK, 2013, CELL MOL IMMUNOL, V10, P65, DOI 10.1038/cmi.2012.55; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Patterson JN, 2014, J BIOL CHEM, V289, P13335, DOI 10.1074/jbc.M113.521666; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sasaki O, 2013, BBA-MOL CELL RES, V1833, P1017, DOI 10.1016/j.bbamcr.2013.01.010; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Thangaratnarajah C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6491; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Wan SF, 2016, ONCOTARGET, V7, P76667, DOI 10.18632/oncotarget.12395; WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yaku K, 2018, BIOMED CHROMATOGR, V32, DOI 10.1002/bmc.4205; Yamamoto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147037; Yarbrough ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5963; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yoshinaka T, 2019, ISCIENCE, V19, P1065, DOI 10.1016/j.isci.2019.08.056; Yoshizumi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05808-w; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713	45	16	18	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					444	457		10.1074/jbc.RA119.010511	http://dx.doi.org/10.1074/jbc.RA119.010511			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31767682	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000507373600015
J	Kuiper, EG; Dey, D; LaMore, PA; Owings, JP; Prezioso, SM; Goldberg, JB; Conn, GL				Kuiper, Emily G.; Dey, Debayan; LaMore, Paige A.; Owings, Joshua P.; Prezioso, Samantha M.; Goldberg, Joanna B.; Conn, Graeme L.			Substrate recognition by the Pseudomonas aeruginosa EF-Tu?modifying methyltransferase EftM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; post-translational modification (PTM); protein methylation; Pseudomonas aeruginosa (P; aeruginosa); S-adenosylmethionine (SAM); substrate specificity; translation elongation factor; EF-Tu; EftM	POSTTRANSLATIONAL MODIFICATIONS; PROTEIN; PHOSPHORYLCHOLINE; MODULATION; GENERATION; CHROMATIN; SERVER; OMPB	The opportunistic bacterial pathogen Pseudomonas aeruginosa is a leading cause of serious infections in individuals with cystic fibrosis, compromised immune systems, or severe burns. P. aeruginosa adhesion to host epithelial cells is enhanced by surface-exposed translation elongation factor EF-Tu carrying a Lys-5 trimethylation, incorporated by the methyltransferase EftM. Thus, the EF-Tu modification by EftM may represent a target to prevent P. aeruginosa infections in vulnerable individuals. Here, we extend our understanding of EftM activity by defining the molecular mechanism by which it recognizes EF-Tu. Acting on the observation that EftM can bind to EF-Tu lacking its N-terminal peptide (encompassing the Lys-5 target site), we generated an EftM homology model and used it in protein/protein docking studies to predict EftM/EF-Tu interactions. Using site-directed mutagenesis of residues in both proteins, coupled with binding and methyltransferase activity assays, we experimentally validated the predicted protein/protein interface. We also show that EftM cannot methylate the isolated N-terminal EF-Tu peptide and that binding-induced conformational changes in EftM are likely needed to enable placement of the first 5?6 amino acids of EF-Tu into a conserved peptide-binding channel in EftM. In this channel, a group of residues that are highly conserved in EftM proteins position the N-terminal sequence to facilitate Lys-5 modification. Our findings reveal that EftM employs molecular strategies for substrate recognition common among both class I (Rossmann fold) and class II (SET domain) methyltransferases and pave the way for studies seeking a deeper understanding of EftM's mechanism of action on EF-Tu.	[Kuiper, Emily G.; Dey, Debayan; LaMore, Paige A.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA; [Kuiper, Emily G.; Conn, Graeme L.] Emory Univ, GDBBS, Grad Program Biochem Cell & Dev Biol BCDB, Atlanta, GA 30322 USA; [Prezioso, Samantha M.; Goldberg, Joanna B.] Emory Univ, GDBBS, Grad Program Microbiol & Mol Genet MMG, Atlanta, GA 30322 USA; [Owings, Joshua P.; Prezioso, Samantha M.; Goldberg, Joanna B.] Emory Univ, Dept Pediat, Div Pulmonol Allergy Immunol Cyst Fibrosis & Slee, Atlanta, GA 30322 USA; [Owings, Joshua P.; Prezioso, Samantha M.; Goldberg, Joanna B.] Emory Univ, Emory Childrens Ctr Cyst Fibrosis Res, Atlanta, GA 30322 USA; [Owings, Joshua P.; Prezioso, Samantha M.; Goldberg, Joanna B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Goldberg, Joanna B.; Conn, Graeme L.] Emory Univ, Sch Med, Emory Antibiot Resistance Ctr Arc, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University	Conn, GL (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu	Dey, Debayan/AAI-9790-2020	Dey, Debayan/0000-0002-0222-6092; Conn, Graeme/0000-0002-2419-380X	Cystic Fibrosis Foundation [GOLDBE17P0, DEY18F0]; NIAID from the National Institutes of Health [T32-AI106699]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI106699] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIAID from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Cystic Fibrosis Foundation Grant GOLDBE17P0 (to J. B. G. and G. L. C.), Postdoctoral Fellowship DEY18F0 (to D. D.), and in part by NIAID Training Grant T32-AI106699 from the National Institutes of Health to the Antimicrobial Resistance and Therapeutic Discovery Training Program of Emory University (awarded to S. M. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeykoon A, 2014, J BIOL CHEM, V289, P7691, DOI 10.1074/jbc.M113.535567; Abeykoon AH, 2016, J BIOL CHEM, V291, P19962, DOI 10.1074/jbc.M116.723460; Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105; Alvarez-Venegas R, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00065; Barbier M, 2008, J INFECT DIS, V197, P465, DOI 10.1086/525048; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Burgie ES, 2008, BIOCHEMISTRY-US, V47, P3982, DOI 10.1021/bi800063j; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Clark SE, 2013, INFECT IMMUN, V81, P392, DOI 10.1128/IAI.01168-12; Del Rizzo PA, 2014, BBA-GENE REGUL MECH, V1839, P1404, DOI 10.1016/j.bbagrm.2014.06.008; Demirci H, 2008, STRUCTURE, V16, P1059, DOI 10.1016/j.str.2008.03.016; Bastos PAD, 2017, J PROTEOMICS, V152, P254, DOI 10.1016/j.jprot.2016.11.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garcia-Fontana C, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004849; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Jurcik A, 2018, BIOINFORMATICS, V34, P3586, DOI 10.1093/bioinformatics/bty386; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Macek B, 2019, NAT REV MICROBIOL, V17, P651, DOI 10.1038/s41579-019-0243-0; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; Owings JP, 2016, J BIOL CHEM, V291, P3280, DOI 10.1074/jbc.M115.706853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prezioso SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39331-x; Quentin D, 2018, NAT MICROBIOL, V3, P1142, DOI 10.1038/s41564-018-0238-z; Savic M, 2015, ANTIMICROB AGENTS CH, V59, P2807, DOI 10.1128/AAC.00056-15; Sharma G, 2015, NUCLEIC ACIDS RES, V43, P3922, DOI 10.1093/nar/gkv261; Smani Y, 2012, J BIOL CHEM, V287, P26901, DOI 10.1074/jbc.M112.344556; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Valencia-Sanchez MI, 2019, MOL CELL, V74, P1010, DOI 10.1016/j.molcel.2019.03.029; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027; Widjaja M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10644-z; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang S, 2016, GENE DEV, V30, P1611, DOI 10.1101/gad.284323.116; Yaseen I, 2018, EMBO J, V37, P183, DOI 10.15252/embj.201796918	39	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20109	20121		10.1074/jbc.RA119.011213	http://dx.doi.org/10.1074/jbc.RA119.011213			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31753919	Green Published, hybrid			2022-12-26	WOS:000505005800023
J	Tong, ZW; Liu, YH; Yu, XB; Martinez, JD; Xu, JM				Tong, Zhangwei; Liu, Yonghong; Yu, Xiaobin; Martinez, Jarrod D.; Xu, Jianming			The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ER? and enhancing enhancer?promoter interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription factor; steroid hormone receptor; transcription co-activator; gene expression; chromatin modification; histone modification; cancer biology; epigenetics; endometrial cancer; nuclear receptor co-activator 6 (NCOA6)	ACTIVATING SIGNAL COINTEGRATOR-2; RECEPTOR COACTIVATOR; BREAST-CANCER; DEPENDENT TRANSACTIVATION; BINDING PROTEIN; OVARIAN-CANCER; NUCLEAR-FACTOR; IDENTIFICATION; COMPLEX; ALPHA	Estrogen and its cognate receptor, ER?, regulate cell proliferation, differentiation, and carcinogenesis in the endometrium by controlling gene transcription. ER? requires co-activators to mediate transcription via mechanisms that are largely uncharacterized. Herein, using growth-regulating estrogen receptor binding 1 (GREB1) as an ER? target gene in Ishikawa cells, we demonstrate that nuclear receptor co-activator 6 (NCOA6) is essential for estradiol (E2)/ER??activated GREB1 transcription. We found that NCOA6 associates with the GREB1 promoter and enhancer in an E2-independent manner and that NCOA6 knockout reduces chromatin looping, enhancer?promoter interactions, and basal GREB1 expression in the absence of E2. In the presence of E2, ER? bound the GREB1 enhancer and also associated with its promoter, and p300, myeloid/lymphoid or mixed-lineage leukemia protein 4 (MLL4), and RNA polymerase II were recruited to the GREB1 enhancer and promoter. Consequently, the levels of the histone modifications H3K4me1/3, H3K9ac, and H3K27ac were significantly increased; enhancer and promoter regions were transcribed; and GREB1 mRNA was robustly transcribed. NCOA6 knockout reduced ER? recruitment and abolished all of the aforementioned E2-induced events, making GREB1 completely insensitive to E2 induction. We also found that GREB1-deficient Ishikawa cells are much more resistant to chemotherapy and that human endometrial cancers with low GREB1 expression predict poor overall survival. These results indicate that NCOA6 has an essential role in ER?-mediated transcription by increasing enhancer?promoter interactions through chromatin looping and by recruiting RNA polymerase II and the histone-code modifiers p300 and MLL4. Moreover, GREB1 loss may predict chemoresistance of endometrial cancer.	[Tong, Zhangwei; Liu, Yonghong; Yu, Xiaobin; Martinez, Jarrod D.; Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA; [Tong, Zhangwei; Liu, Yonghong; Yu, Xiaobin; Martinez, Jarrod D.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Xu, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.	jxu@bcm.edu		Xu, Jianming/0000-0002-8208-9162	National Institutes of Health [R01 CA193455]; Cancer Prevention and Research Institute of Texas [RP150197]; NATIONAL CANCER INSTITUTE [R01CA193455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant R01 CA193455 and Cancer Prevention and Research Institute of Texas Grant RP150197 (to J. X.). The authors have declared a conflict of interest. J. X. is a shareholder of Coactigon, Inc. This company develops steroid receptor co-activator inhibitors, which are unrelated to the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bauerschlag DO, 2011, ONCOLOGY-BASEL, V80, P12, DOI 10.1159/000327746; Burakov D, 2000, J BIOL CHEM, V275, P20928, DOI 10.1074/jbc.M002013200; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Cooke PS, 1997, P NATL ACAD SCI USA, V94, P6535, DOI 10.1073/pnas.94.12.6535; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Fung JN, 2015, HUM REPROD, V30, P1263, DOI 10.1093/humrep/dev051; Gao WW, 2018, MOL CELL, V70, P340, DOI 10.1016/j.molcel.2018.03.006; Ghosh MG, 2000, CANCER RES, V60, P6367; Goo YH, 2004, J BIOL CHEM, V279, P7131, DOI 10.1074/jbc.M312563200; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; GUAN XY, 1994, NAT GENET, V8, P155, DOI 10.1038/ng1094-155; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hamilton KJ, 2017, CURR TOP DEV BIOL, V125, P109, DOI 10.1016/bs.ctdb.2016.12.005; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Hong S, 2001, BIOCHEM BIOPH RES CO, V282, P1257, DOI 10.1006/bbrc.2001.4727; Horvath G, 2002, GYNECOL ONCOL, V84, P271, DOI 10.1006/gyno.2001.6509; Huang YT, 2014, ONCOL REP, V31, P1235, DOI 10.3892/or.2014.2976; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kawagoe J, 2012, DEV CELL, V23, P858, DOI 10.1016/j.devcel.2012.09.002; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Kong HJ, 2003, MOL CANCER RES, V1, P948; Kuang SQ, 2002, J BIOL CHEM, V277, P45356, DOI 10.1074/jbc.C200509200; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Lee SK, 2001, MOL ENDOCRINOL, V15, P241, DOI 10.1210/me.15.2.241; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; NISHIDA M, 1985, Acta Obstetrica et Gynaecologica Japonica (Japanese Edition), V37, P1103; Panigrahi AK, 2018, MOL CELL, V70, P679, DOI 10.1016/j.molcel.2018.04.014; Punyadeera C, 2003, J STEROID BIOCHEM, V84, P393, DOI 10.1016/S0960-0760(03)00061-X; Rae JM, 2006, PROSTATE, V66, P886, DOI 10.1002/pros.20403; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Taylor AH, 2002, ANTICANCER RES, V22, P3993; Tien JCY, 2009, INT J BIOL SCI, V5, P256; Wang L, 2015, CANCER CELL, V28, P240, DOI 10.1016/j.ccell.2015.07.005; Winuthayanon W, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120170; Wu YM, 2018, CANCER RES, V78, P671, DOI 10.1158/0008-5472.CAN-17-1327; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yasar P, 2017, REPROD MED BIOL, V16, P4, DOI 10.1002/rmb2.12006; Zhang H, 2004, CANCER RES, V64, P7169, DOI 10.1158/0008-5472.CAN-04-1176; Zhang H, 2003, ENDOCRINOLOGY, V144, P1435, DOI 10.1210/en.2002-0018; Zhang W, 2016, MOL NUTR FOOD RES, V60, P2387, DOI 10.1002/mnfr.201600048; Zhu YJ, 2000, J BIOL CHEM, V275, P13510, DOI 10.1074/jbc.275.18.13510	57	4	5	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19667	19682		10.1074/jbc.RA119.010704	http://dx.doi.org/10.1074/jbc.RA119.010704			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31744881	hybrid, Green Published			2022-12-26	WOS:000504093200018
J	Isono, T; Suzaki, M				Isono, Takahiro; Suzaki, Masafumi			Analysis of the characteristics of chemotherapy-resistant renal cell carcinomas based on global transcriptional analysis of their tissues and cell lines	PLOS ONE			English	Article							INTERFERON-ALPHA; CANCER	Starvation-resistant renal cell carcinoma (RCC) cell lines are considered dormant-state cells that survive even under glucose starvation. The cellular biological and global transcriptional analysis using these cells identified potential markers of chemotherapy-resistant RCC and therapeutic agent candidates. Recently, we showed that ARL4C was a predictive biomarker for poor prognosis in patients with chemotherapy-resistant RCC by the global transcriptional analysis of patient primary tissues. The objective of this study was to identify the characteristics of chemotherapy-resistant RCC by the global transcriptional analysis of primary tissues of patients with RCC and RCC cell lines. The connective global transcriptional analysis showed that two starvation-resistant RCC cell lines, SW839 and KMRC-1, were strongly correlated to tissues of patients with chemotherapy-resistant RCC and showed high expressions of invasive- and proliferation-related genes. We found fibronectin (FN1) expression was a predictive biomarker in some patients with chemotherapy-resistant RCC, which especially correlated with two starvation-resistant RCC cell lines. These results indicate these cell lines emulate chemotherapy-resistant RCC and might be useful in the search for markers to predict poor prognosis and in the development of therapeutic agents and their index markers for chemotherapy-resistant RCCs.	[Isono, Takahiro; Suzaki, Masafumi] Shiga Univ Med Sci, Cent Res Lab, Otsu, Shiga, Japan	Shiga University of Medical Science	Isono, T (corresponding author), Shiga Univ Med Sci, Cent Res Lab, Otsu, Shiga, Japan.	isono@belle.shiga-med.ac.jp			JSPS KAKENHI [15K06854]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by JSPS KAKENHI Grant Numbers 15K06854 (TI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hutson TE, 2010, J CLIN ONCOL, V28, P475, DOI 10.1200/JCO.2008.21.6994; Isono T, 2019, AM J CANCER RES, V9, P415; Isono Takahiro, 2018, Oncotarget, V9, P23091, DOI 10.18632/oncotarget.25214; Isono T, 2016, AM J CANCER RES, V6, P2263; Isono T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25669; Isono T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096168; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Rixe O, 2007, LANCET ONCOL, V8, P975, DOI 10.1016/S1470-2045(07)70285-1; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Steffens S, 2012, ONCOL LETT, V3, P787, DOI 10.3892/ol.2012.566; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621	20	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225721	10.1371/journal.pone.0225721	http://dx.doi.org/10.1371/journal.pone.0225721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774870	Green Published, gold			2022-12-26	WOS:000533896400054
J	Romero-Alcala, P; Hernandez-Padilla, JM; Fernandez-Sola, C; Coin-Perez-Carrasco, MD; Ramos-Rodriguez, C; Ruiz-Fernandez, MD; Granero-Molina, J				Romero-Alcala, Patricia; Manuel Hernandez-Padilla, Jose; Fernandez-Sola, Cayetano; del Rosario Coin-Perez-Carrasco, Maria; Ramos-Rodriguez, Carmen; Dolores Ruiz-Fernandez, Maria; Granero-Molina, Jose			Sexuality in male partners of women with fibromyalgia syndrome: A qualitative study	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; FEMALE-PATIENTS; RISK-FACTORS; CHRONIC PAIN; OF-LIFE; DYSFUNCTION; SATISFACTION; ILLNESS; FATIGUE; SPOUSES	The aim of our study was to understand how male partners of women diagnosed with fibromyalgia syndrome perceive sexuality. Gadamerian hermeneutic phenomenology and the Roy Adaptation Model provided the overall framework for this research study. Eighteen participants were recruited through convenience and purposive sampling. Data collection was conducted between February and July of 2017 and included a focus group and twelve in-depth interviews. Two main themes were extracted: "facing a new sex life" and "resisting the loss of the couple's sexuality". Fibromyalgia syndrome compromises the couple's sex life. Enhancing intimacy, skin-to-skin contact (during acute FMS outbreaks), finding new positions, non-coital sex and use of sex toys can increase female desire and help coping.	[Romero-Alcala, Patricia] Univ Almeria, Fac Hlth Sci, Almeria, Spain; [Manuel Hernandez-Padilla, Jose; Fernandez-Sola, Cayetano; Dolores Ruiz-Fernandez, Maria; Granero-Molina, Jose] Univ Almeria, Dept Nursing Physiotherapy & Med, Almeria, Spain; [Manuel Hernandez-Padilla, Jose] Middlesex Univ, Sch Hlth & Educ, Adult Child & Midwifery Dept, London, England; [Fernandez-Sola, Cayetano; Granero-Molina, Jose] Univ Autonoma Chile, Fac Hlth Sci, Temuco, Chile; [del Rosario Coin-Perez-Carrasco, Maria] Clin Pharm, Malaga, Spain; [Ramos-Rodriguez, Carmen] Fibromyalgia Assoc Almeria, Almeria, Spain	Universidad de Almeria; Universidad de Almeria; Middlesex University; Universidad Autonoma de Chile	Granero-Molina, J (corresponding author), Univ Almeria, Dept Nursing Physiotherapy & Med, Almeria, Spain.; Granero-Molina, J (corresponding author), Univ Autonoma Chile, Fac Hlth Sci, Temuco, Chile.	jgranero@ual.es	Fernández-Sola, Cayetano/N-2668-2014; Ruiz-Fernández, María Dolores/Q-5232-2019; Hernandez-Padilla, Jose Manuel/V-9949-2018; Hernández-Padilla, Jose Manuel/ABF-6556-2020	Fernández-Sola, Cayetano/0000-0003-1721-0947; Ruiz-Fernández, María Dolores/0000-0002-6454-4723; Hernandez-Padilla, Jose Manuel/0000-0002-5032-9440; GRANERO-MOLINA, JOSE/0000-0002-7051-2584	Health Science Research Group (CTS-451); Health Research Centre (CEINSA/UAL), University of Almeria (Spain)	Health Science Research Group (CTS-451); Health Research Centre (CEINSA/UAL), University of Almeria (Spain)	This research was funded by Health Science Research Group (CTS-451) and Health Research Centre (CEINSA/UAL), University of Almeria (Spain).r Authors thank all men who volunteered to participate in this study. To Health Science Research Group (CTS-451) and Health Research Centre (CEINSA/UAL), University of Almeria (Spain) for their support.	Amasyali AS, 2016, INT J IMPOT RES, V28, P46, DOI 10.1038/ijir.2015.31; Armentor JL, 2017, QUAL HEALTH RES, V27, P462, DOI 10.1177/1049732315620160; Bazzichi L, 2013, CLIN EXP RHEUMATOL, V31, pS81; Bazzichi L, 2012, REUMATISMO, V64, P261, DOI 10.4081/reumatismo.2012.261; Besiroglu MDH, 2019, INT J IMPOT RES, V31, P288, DOI 10.1038/s41443-018-0098-3; Briones-Vozmediano E, 2013, PAIN RES MANAG, V18, P19, DOI 10.1155/2013/742510; Burri A, 2014, J SEX MED, V11, P2772, DOI 10.1111/jsm.12651; Burri A, 2012, J SEX MED, V9, P2671, DOI 10.1111/j.1743-6109.2012.02861.x; Checton MG, 2012, FAM SYST HEALTH, V30, P114, DOI 10.1037/a0028598; Clauw DJ, 2018, POSTGRAD MED, V130, P9, DOI 10.1080/00325481.2018.1411743; Collado A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0513-5; Fleming Valerie, 2003, Nurs Inq, V10, P113, DOI 10.1046/j.1440-1800.2003.00163.x; Francois D, 2017, PSYCHIAT ANN, V47, P154, DOI 10.3928/00485713-20170201-01; Gadamer H.G., 2005, VERDAD METODO; Gostine M, 2018, PAIN PRACT, V18, P67, DOI 10.1111/papr.12583; Granero-Molina J, 2018, CLIN NURS RES, V27, P296, DOI 10.1177/1054773816676941; Grape HE, 2015, QUAL HEALTH RES, V25, P679, DOI 10.1177/1049732314557333; Hayta E, 2017, SEX DISABIL, V35, P147, DOI 10.1007/s11195-016-9472-6; Juuso P, 2014, QUAL HEALTH RES, V24, P1381, DOI 10.1177/1049732314547540; Karaguzel EO, 2018, ISR J PSYCHIATR REL, V55, P10; Khoury C.B., 2014, J RELATIONSHIPS RES, V5, DOI [10.1017/jrr.2014.7, DOI 10.1017/JRR.2014.7, https://doi.org/10.1017/jrr.2014.7]; Kinzl JF, 2009, NEUROPSYCHIATRIE, V23, P134; Lisboa LL, 2015, REV BRAS REUMATOL, V55, P209, DOI [10.1016/j.rbre.2014.08.018, 10.1016/j.rbr.2014.08.019]; Macfarlane GJ, 2017, ANN RHEUM DIS, V76, P318, DOI 10.1136/annrheumdis-2016-209724; Jimenez TMM, 2017, J ADV NURS, V73, P1646, DOI 10.1111/jan.13262; McCann Edward, 2019, JBI Database System Rev Implement Rep, V17, P74, DOI 10.11124/JBISRIR-2017-003824; McCarthy B, 2012, J CONTEMP PSYCHOTHER, V42, P227, DOI 10.1007/s10879-012-9207-7; Munoz D, 2018, PLOS ONE, V13; Olson K, 2015, QUAL HEALTH RES, V25, P1410, DOI 10.1177/1049732315573954; Pluchino N, 2016, HUM REPROD UPDATE, V22, P762, DOI 10.1093/humupd/dmw031; Queiroz LP, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0356-5; Rasmussen MU, 2017, J CLIN NURS, V26, P931, DOI 10.1111/jocn.13521; Roy SC., 2009, ROY ADAPTATION MODEL, V3rd ed.; Schoenfeld EA, 2017, ARCH SEX BEHAV, V46, P489, DOI 10.1007/s10508-015-0672-4; Segura-Jimenez V, 2014, RHEUMATOLOGY, V53, P1803, DOI 10.1093/rheumatology/keu169; Soderberg S, 2003, J ADV NURS, V42, P143, DOI 10.1046/j.1365-2648.2003.02597.x; Taylor B, 2015, SEX DISABIL, V33, P365, DOI 10.1007/s11195-015-9394-8; Thiagarajah AS., 2014, INT J CLIN RHEUMTOL, V9, P371, DOI [10.2217/ijr.14.30, DOI 10.2217/IJR.14.30]; Traa MJ, 2014, SUPPORT CARE CANCER, V22, P763, DOI 10.1007/s00520-013-2032-z; Tristano AG, 2009, RHEUMATOL INT, V29, P853, DOI 10.1007/s00296-009-0850-6; Tutoglu A, 2014, RHEUMATOL INT, V34, P1079, DOI 10.1007/s00296-014-2944-z; Verspaandonk J, 2015, PSYCHOL MED, V45, P2345, DOI 10.1017/S0033291715000288; West C, 2012, J CLIN NURS, V21, P3352, DOI 10.1111/j.1365-2702.2012.04215.x; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Yilmaz H, 2012, SEX DISABIL, V30, P109, DOI 10.1007/s11195-011-9229-1; Zielinski RE, 2013, J MIDWIFERY WOM HEAL, V58, P321, DOI 10.1111/jmwh.12044; Zuk Beata, 2017, Reumatologia (Warsaw), V55, P237, DOI 10.5114/reum.2017.71640	47	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0224990	10.1371/journal.pone.0224990	http://dx.doi.org/10.1371/journal.pone.0224990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8SS	31774846	Green Published, gold			2022-12-26	WOS:000533896400021
J	Saraiva, FB; de Araujo, ACC; de Araujo, AEV; Senna, JPM				Saraiva, Felipe Betoni; Cavalcante de Araujo, Ana Caroline; Vieira de Araujo, Anna Erika; Moreno Senna, Jose Procopio			Monoclonal antibody anti-PBP2a protects mice against MRSA (methicillin-resistant Staphylococcus aureus) infections	PLOS ONE			English	Article							IMMUNE-RESPONSE; MECHANISMS; VACCINE; MODEL	Methicillin-resistant Staphylococcus aureus (MRSA) is a multidrug-resistant bacterium responsible for serious nosocomial and community-acquired infections worldwide. Since few antibiotics are effective for treating MRSA infections, the development of new therapies is of great importance. Previous studies demonstrated that PBP2a is a target that generates protective antibodies against MRSA. A murine monoclonal antibody (MAb) that recognizes PBP2a from MRSA strains was previously isolated and characterized. In this report, we evaluated the biodistribution of this MAb in blood and tissues, as well as the extent of protection conferred using prophylactic and therapeutic assays compared to vancomycin treatment. Biodistribution was evaluated 12-96 h after MAb administration. It predominantly remained in the serum, but it was also detectable in the kidneys, lungs, and spleen at low concentrations (about 4.5% in the kidneys, 1.9% in the lungs, and 0.7% the spleen) at all observed timepoints. Prophylactic studies in a murine model demonstrated a significant bacterial load reduction in the kidneys of the groups treated with either with IgG (greater than 3 logs) or F(ab')(2) (98%) when compared to that of the control groups (untreated). Mice were challenged with a lethal dose, and the survival rate was higher in the treated mice. Treatment with the MAb resulted in a bacterial load reduction in the kidneys similar to that of mice treated with vancomycin, and a MAb/vancomycin combination therapy was also effective. These results demonstrate that an anti-PBP2a MAb may be a promising therapeutic for treating MRSA infections.	[Saraiva, Felipe Betoni; Cavalcante de Araujo, Ana Caroline; Vieira de Araujo, Anna Erika; Moreno Senna, Jose Procopio] Inst Tecnol Imunobiol BioManguinhos FIOCRUZ, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Senna, JPM (corresponding author), Inst Tecnol Imunobiol BioManguinhos FIOCRUZ, Rio De Janeiro, Brazil.	jprocopio@bio.fiocruz.br	senna, jose procopio moreno/AAP-9405-2020; Saraiva, Felipe Betoni/ABH-1376-2020	Saraiva, Felipe Betoni/0000-0003-4873-5623; senna, jose/0000-0002-0837-7414	Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos (Fiocruz)	Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos (Fiocruz)	This work was supported by Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos (Fiocruz).	Araujo AEV., 2016, APPL BIOCHEM BIOTECH, V185, P72; Araujo AEV, 2015, J EXP APPL ANIMAL SC, V3, P336; Casadevall A, 2006, CLIN INFECT DIS, V42, P1414, DOI 10.1086/503431; Costa MOC, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00576-13; DiGiandomenico A, 2015, CURR OPIN MICROBIOL, V27, P78, DOI 10.1016/j.mib.2015.07.014; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Gardete S, 2014, J CLIN INVEST, V124, P2836, DOI 10.1172/JCI68834; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Naghshbandi RZ, 2018, INT IMMUNOPHARMACOL, V56, P186, DOI 10.1016/j.intimp.2018.01.035; O'Neil J., 2016, REV ANTIBIOTIC RESIS; Ohwada A, 1999, J ANTIMICROB CHEMOTH, V44, P767, DOI 10.1093/jac/44.6.767; Papakyriacou H, 2000, J INFECT DIS, V181, P2400; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; RYFFEL C, 1994, ANTIMICROB AGENTS CH, V38, P724, DOI 10.1128/AAC.38.4.724; Senna Jose Procopio M., 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P257, DOI 10.1089/mab.2015.0013; Senna JPM, 2003, VACCINE, V21, P2661, DOI 10.1016/S0264-410X(02)00738-7; Shah DK, 2013, MABS-AUSTIN, V5, P297, DOI 10.4161/mabs.23684; Weisman LE, 2009, ANTIMICROB AGENTS CH, V53, P2879, DOI 10.1128/AAC.01565-08	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225752	10.1371/journal.pone.0225752	http://dx.doi.org/10.1371/journal.pone.0225752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774881	Green Submitted, gold, Green Published			2022-12-26	WOS:000533896400056
J	Bral, M; Pawlick, R; Marfil-Garza, B; Dadheech, N; Hefler, J; Thiesen, A; Shapiro, AMJ				Bral, Mariusz; Pawlick, Rena; Marfil-Garza, Braulio; Dadheech, Nidheesh; Hefler, Joshua; Thiesen, Aducio; Shapiro, A. M. James			Pan-caspase inhibitor F573 mitigates liver ischemia reperfusion injury in a murine model	PLOS ONE			English	Article							ISLET TRANSPLANTATION; HEPATIC ISCHEMIA; MOUSE; PRESERVATION; ENGRAFTMENT; ANAKINRA	Background Liver ischemia reperfusion injury (IRI) remains a challenge in liver transplantation. A number of compounds have previously demonstrated efficacy in mitigating IRI. Herein, we applied three specific additive strategies to a mouse IRI screening model to determine their relative potencies in reducing such injury, with a view to future testing in a large animal and clinical ex situ normothermic perfusion setting: 1) F573, a pan-caspase inhibitor, 2) anti-inflammatory anakinra and etanrecept and 3) BMX-001, a mimetic of superoxide dismutase. Methods A non-lethal liver ischemia model in mice was used. Additives in the treatment groups were given at fixed time points before induction of injury, compared to a vehicle group that received no therapeutic treatment. Mice were recovered for 6 hours following the ischemic insult, at which point blood and tissue samples were obtained. Plasma was processed for transaminase levels. Whole liver tissue samples were processed for histology, markers of apoptosis, oxidative stress, and cytokine levels. Results In an in vivo murine IRI model, the F573 treatment group demonstrated statistically lower alanine aminotransferase (ALT) levels (p = 0.01), less evidence of apoptosis (p = 0.03), and lower cytokine levels compared to vehicle. The etanercept with anakinra treatment group demonstrated significantly lower cytokine levels. The BMX-001 group demonstrated significantly decreased apoptosis (p = 0.01) evident on TUNEL staining. Conclusions The administration of pan-caspase inhibitor F573 in a murine in vivo model likely mitigates liver IRI based on decreased markers of cellular injury, decreased evidence of apoptosis, and improved cytokine profiles. Anakinra with etanercept, and BMX-001 did not demonstrate convincing efficacy at reducing IRI in this model, and likely need further optimization. The positive findings set rational groundwork for future translational studies of applying F573 during normothermic ex situ liver perfusion, with the aim of improving the quality of marginal grafts.	[Bral, Mariusz; Pawlick, Rena; Marfil-Garza, Braulio; Dadheech, Nidheesh; Hefler, Joshua; Shapiro, A. M. James] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Thiesen, Aducio] Univ Alberta, Dept Pathol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Shapiro, AMJ (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	amjs@islet.ca	Dadheech, Nidheesh/E-3142-2017; Marfil-Garza, Braulio A/AAQ-4959-2020	Dadheech, Nidheesh/0000-0002-7155-0486; Marfil-Garza, Braulio A/0000-0002-7224-2127	Canada Research Chair in Transplantation Surgery and Regenerative Medicine; Alberta Innovates Healthcare Solutions; Canadian Donation and Transplant Research Program (CDTRP); Fundacion para la Salud y la Educacion Salvador Zubiran (FUNSaEd); Consejo Nacional de Ciencia y Tecnologia (CONACyT)	Canada Research Chair in Transplantation Surgery and Regenerative Medicine; Alberta Innovates Healthcare Solutions; Canadian Donation and Transplant Research Program (CDTRP); Fundacion para la Salud y la Educacion Salvador Zubiran (FUNSaEd); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	AMJS holds a Canada Research Chair in Transplantation Surgery and Regenerative Medicine, and a Senior Clinical Scholarship from Alberta Innovates Healthcare Solutions. Funding from the Canadian Donation and Transplant Research Program (CDTRP) is gratefully acknowledged. BMG gratefully acknowledges funding from the Fundacion para la Salud y la Educacion Salvador Zubiran (FUNSaEd) and the Consejo Nacional de Ciencia y Tecnologia (CONACyT).	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Baskin-Bey ES, 2007, AM J TRANSPLANT, V7, P218, DOI 10.1111/j.1600-6143.2006.01595.x; Brockmann J, 2009, ANN SURG, V250, P1, DOI 10.1097/SLA.0b013e3181a63c10; Bruni A, 2018, AM J TRANSPLANT, V18, P1879, DOI 10.1111/ajt.14705; Cheng F, 2008, TRANSPL P, V40, P2163, DOI 10.1016/j.transproceed.2008.07.082; Emamaullee JA, 2008, DIABETES, V57, P1556, DOI 10.2337/db07-1452; Emamaullee JA, 2007, DIABETES, V56, P1289, DOI 10.2337/db06-1653; Gad SC, 2016, INT J TOXICOL, V35, P438, DOI 10.1177/1091581816642766; Goldaracena N, 2017, AM J TRANSPLANT, V17, P970, DOI 10.1111/ajt.14100; Goldaracena N, 2016, LIVER TRANSPLANT, V22, P1573, DOI 10.1002/lt.24603; Hochhauser E, 2015, CELL PHYSIOL BIOCHEM, V36, P1971, DOI 10.1159/000430165; Linares I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195212; McCall M, 2012, AM J TRANSPLANT, V12, P322, DOI 10.1111/j.1600-6143.2011.03796.x; McCall MD, 2012, TRANSPLANTATION, V94, P30, DOI 10.1097/TP.0b013e318257745d; Palumbo T, 2017, TRANSPLANTATION, V101, P322, DOI 10.1097/TP.0000000000001552; Pepper AR, 2017, TRANSPLANTATION, V101, P2321, DOI 10.1097/TP.0000000000001638; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Rong YP, 2017, TRANSPL P, V49, P1455, DOI 10.1016/j.transproceed.2017.02.063; Yang Y, 2014, TRANSPL P, V46, P1573, DOI 10.1016/j.transproceed.2014.01.018; 2008, WOODHEAD PUBL MATER, P1	20	3	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0224567	10.1371/journal.pone.0224567	http://dx.doi.org/10.1371/journal.pone.0224567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770375	gold, Green Published			2022-12-26	WOS:000533892300007
J	Thakarar, K; Rokas, KE; Lucas, FL; Powers, S; Andrews, E; DeMatteo, C; Mooney, D; Sorg, MH; Valenti, A; Cohen, M				Thakarar, Kinna; Rokas, Kristina E.; Lucas, F. L.; Powers, Spencer; Andrews, Elizabeth; DeMatteo, Christina; Mooney, Deirdre; Sorg, Marcella H.; Valenti, August; Cohen, Mylan			Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services	PLOS ONE			English	Article							MANAGEMENT; INCREASES; DIAGNOSIS; FEATURES; HEALTH; ADULTS	Background The addiction crisis is widespread, and unsafe injection practices among people who inject drugs (PWID) can lead to infective endocarditis. Methods A retrospective analysis of adult patients with definite or possible infective endocarditis admitted to a tertiary care center in Portland, Maine was performed over three-year period. Our primary objective was to examine differences in demographics, health characteristics, and health service utilization between injection drug use (IDU)-associated infective endocarditis and non-IDU infective endocarditis. The association between IDU and mortality, morbidity (defined as emergency department visits within 3 months of discharge), and cardiac surgery was examined. Bivariate and multivariate analyses were performed. A subgroup descriptive analysis of PWID was also performed to better examine substance use disorder (SUD) characteristics, treatment with medication for opioid use disorder (MOUD) and health service utilization. Results One-hundred and seven patients were included in the study, of which 39.2% (n = 42) had IDU-associated infective endocarditis. PWID were more likely to be homeless, uninsured, and lack a primary care provider. PWID were notably younger and had less documented comorbidities, however had similar in-hospital mortality rates (10% vs. 14%, p = 0.30), ED visits (50% vs. 54%, p = 0.70) and cardiac surgery (33% vs. 26%, p = 0.42) compared to those with non-IDU infective endocarditis. Ninety-day mortality was less among PWID (19.0% vs. 36.9%, p = 0.05). IDU was not associated with morbidity (adjusted odds ratio (AOR) 0.73, 95% CI 0.18-3.36), 90-day mortality (AOR 0.72, 95% CI 0.17-3.01), or cardiac surgery (AOR 0.15, 95% CI 0.03-0.69). Ninety-day mortality among PWID who received MOUD was lower (3% vs 15%, p = 0.45), as were ED visits (10% vs. 41%, p = 0.42) compared to those who did not receive MOUD. Conclusions Our results highlight existing differences in health characteristics and social determinants of health in people with IDU-associated versus non-IDU infective endocarditis. PWID had less comorbidities and were significantly younger than those with non-IDU infective endocarditis and yet still had similar rates of cardiac surgery, ED visits, and in-hospital mortality. These findings emphasize the need to deliver comprehensive health services, particularly MOUD and other harm reduction services, to this marginalized population.	[Thakarar, Kinna; Lucas, F. L.; Cohen, Mylan] Maine Med Ctr, Res Inst, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA; [Thakarar, Kinna; Mooney, Deirdre; Valenti, August; Cohen, Mylan] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Thakarar, Kinna; Rokas, Kristina E.; Powers, Spencer; Andrews, Elizabeth; DeMatteo, Christina; Mooney, Deirdre; Valenti, August; Cohen, Mylan] Maine Med Ctr, Portland, ME 04102 USA; [Thakarar, Kinna; Valenti, August] InterMed Infect Dis, South Portland, ME 04106 USA; [Sorg, Marcella H.] Univ Maine, Margaret Chase Smith Policy Ctr, Orono, ME USA	Maine Medical Center; Tufts University; Maine Medical Center; University of Maine System; University of Maine Orono	Thakarar, K (corresponding author), Maine Med Ctr, Res Inst, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA.; Thakarar, K (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.; Thakarar, K (corresponding author), Maine Med Ctr, Portland, ME 04102 USA.; Thakarar, K (corresponding author), InterMed Infect Dis, South Portland, ME 04106 USA.	kthakarar@mmc.org		Thakarar, Kinna/0000-0003-4689-0240	NIGMS NIH HHS [U54 GM115516] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115516] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aidala A, 2005, AIDS BEHAV, V9, P251, DOI 10.1007/s10461-005-9000-7; Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chittick Paul, 2012, Morbidity and Mortality Weekly Report, V61, P262; Choo EK, 2014, ACAD EMERG MED, V21, P1438, DOI 10.1111/acem.12534; Church D., 2011, Morbidity and Mortality Weekly Report, V60, P1457; Clemans-Cape L AE, 2019, LEVERAGING MED ADDRE; Eaton EF, 2019, CLIN INFECT DIS, V68, P1041, DOI 10.1093/cid/ciy722; Ebright JR, 2002, INFECT DIS CLIN N AM, V16, P697, DOI 10.1016/S0891-5520(02)00017-X; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Gray ME, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3408-y; HECHT SR, 1992, ANN INTERN MED, V117, P560, DOI 10.7326/0003-4819-117-7-560; Honda H, 2010, AM J MED, V123, P631, DOI 10.1016/j.amjmed.2010.01.015; HRSA, 2010, LIST RUR COUNT DES E; Iversen K, 2019, NEW ENGL J MED, V380, P415, DOI 10.1056/NEJMoa1808312; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Jones CM, 2018, ADDICT BEHAV, V78, P145, DOI 10.1016/j.addbeh.2017.10.018; Leahey PA, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz089; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Linton SL, 2013, DRUG ALCOHOL DEPEN, V132, P457, DOI 10.1016/j.drugalcdep.2013.03.009; Marks LR, 2019, CLIN INFECT DIS, V68, P1935, DOI 10.1093/cid/ciy924; MATHEW J, 1995, ARCH INTERN MED, V155, P1641, DOI 10.1001/archinte.155.15.1641; Moss R, 2003, HEART, V89, P577, DOI 10.1136/heart.89.5.577; Prevention CfDCa, STD DIAGN KEY US POP; Prevention MCfDCa, 2016, REP INF DIS SUMM; Prevention MCfDCa, 2017, AC HEP B MAIN SURV R; Rabkin DG, 2012, ANN THORAC SURG, V93, P51, DOI 10.1016/j.athoracsur.2011.08.016; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Ronan MV, 2016, HEALTH AFFAIR, V35, P832, DOI 10.1377/hlthaff.2015.1424; Rosenthal ES, 2016, AM J MED, V129, P481, DOI 10.1016/j.amjmed.2015.09.024; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Services MDoHaH, 2015, SUBST AB TRENDS MAIN; Thakarar K, 2016, POSTGRAD MED J, V92, P356, DOI 10.1136/postgradmedj-2015-133720; Thakarar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124552; Wurcel AG, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw157; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	36	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225460	10.1371/journal.pone.0225460	http://dx.doi.org/10.1371/journal.pone.0225460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770395	gold, Green Published			2022-12-26	WOS:000533892300020
J	Alonso, E; Eizaguirre, D; Lopez-Etxaniz, I; Olaizola, JI; Ocabo, B; Barandika, JF; Jado, I; Alvarez-Alonso, R; Hurtado, A; Garcia-Perez, AL				Alonso, Eva; Eizaguirre, Domingo; Lopez-Etxaniz, Idoia; Ignacio Olaizola, Jose; Ocabo, Blanca; Felix Barandika, Jesus; Jado, Isabel; Alvarez-Alonso, Raquel; Hurtado, Ana; Luisa Garcia-Perez, Ana			A Q fever outbreak associated to courier transport of pets	PLOS ONE			English	Article							COXIELLA-BURNETII; SHEEP	On August 3rd, 2017, a Q fever outbreak alert was issued at a courier company that in addition to urgent freight transport offered pet delivery services. The epidemiological investigation set the exposition period between June 1 and August 8. In this period, 180 workers from two operational platforms for parcel distribution located in two provinces of the Basque Country (Bizkaia and Araba) were exposed; 64 filled a questionnaire and provided blood samples for serological testing, resulting in 10 confirmed cases (15.6%) and six (9.4%) probable cases. Nine workers (8 confirmed and 1 probable) showed Q fever symptoms, including pneumonia (five cases), and required medical care services, including one hospital admission. The attack rate was 25% (16/64), being higher among workers that visited the Bizkaia platform. This suggested that the origin of the outbreak was in the Bizkaia platform, where animals in transit waited at a pet holding site until being moved to their destination. Environmental samples consisting on 19 surface dust and two aerosol samples were collected at the Bizkaia platform to investigate the presence of C. burnetti DNA. All dust samples were positive by real time PCR, the lowest Ct values being found in dust collected at the pet holding facilities, and therefore suggesting that contamination originated at the pet holding site. The genotype identified in dust was SNP1/MST13, one of the most commonly identified genotypes in goats and sheep in the Basque Country. During the exposure period, two deliveries of miniature goats were made, of which only one could be investigated and tested negative. Although the contamination source could not be unequivocally identified, transport of ruminants was banned at the company, and Q fever was included among the occupational-associated health risks.	[Alonso, Eva] Subdirecc Salud Publ Bizkaia, Dept Epidemiol, Bilbao, Bizkaia, Spain; [Eizaguirre, Domingo] Subdirecc Salud Publ Bizkaia, Dept Epidemiol, Vitoria, Araba, Spain; [Lopez-Etxaniz, Idoia; Ignacio Olaizola, Jose] OSALAN Inst Vasco Seguridad & Salud Laborales, Dept Epidemiol, Baracaldo, Bizkaia, Spain; [Ocabo, Blanca] Diputac Foral Bizkaia, Dept Agr, Bilbao, Bizkaia, Spain; [Felix Barandika, Jesus; Alvarez-Alonso, Raquel; Hurtado, Ana; Luisa Garcia-Perez, Ana] NEIKER Inst Vasco Invest & Desarrollo Agr, Anim Hlth Dept, Derio, Bizkaia, Spain; [Jado, Isabel] Inst Salud Carlos III, Natl Microbiol Ctr, Madrid, Spain	Instituto de Salud Carlos III	Garcia-Perez, AL (corresponding author), NEIKER Inst Vasco Invest & Desarrollo Agr, Anim Hlth Dept, Derio, Bizkaia, Spain.	agarcia@neiker.eus	JADO, ISABEL/E-9952-2018; ALVAREZ-ALONSO, RAQUEL/C-9060-2017	JADO, ISABEL/0000-0002-4871-9407; Garcia-Perez, Ana L./0000-0001-7404-1380; ALVAREZ-ALONSO, RAQUEL/0000-0002-2446-7831; Hurtado, Ana/0000-0001-7089-9670	Spanish National Institute for Agricultural and Food Research and Technology (INIA) [RTA201700055-C02-00]; European Regional Development Funds (ERDF); Basque Government; INIA [FPI-2015-014]	Spanish National Institute for Agricultural and Food Research and Technology (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Regional Development Funds (ERDF)(European Commission); Basque Government(Basque Government); INIA(Instituto de Investigacion Agropecuaria (INIA))	This work was funded by the Spanish National Institute for Agricultural and Food Research and Technology (INIA) (RTA201700055-C02-00), the European Regional Development Funds (ERDF) and the Basque Government. RAA is beneficiary of a PhD contract funded by INIA (FPI-2015-014). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Alende-Castro V, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006338; Alonso E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138817; Alvarez-Alonso R, 2018, ACTA VET SCAND, V60, DOI 10.1186/s13028-018-0429-x; ALVAREZALONSO R, 2018, APPL ENVIRON MICROB, V84, DOI DOI 10.1128/AE84.01850-18; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Astobiza I, 2010, VET J, V184, P172, DOI 10.1016/j.tvjl.2009.01.017; Botner A, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1595; Buhariwalla F, 1996, CLIN INFECT DIS, V23, P753, DOI 10.1093/clinids/23.4.753; Clark NJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3135-4; de Cremoux R, 2012, FEMS IMMUNOL MED MIC, V64, P120, DOI 10.1111/j.1574-695X.2011.00893.x; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Georgiev M, 2013, EUROSURVEILLANCE, V18, P13; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Gonzalez-Barrio D, 2019, TRANSBOUND EMERG DIS, V66, P662, DOI 10.1111/tbed.13085; Huijsmans CJJ, 2011, APPL ENVIRON MICROB, V77, P2051, DOI 10.1128/AEM.02293-10; Hurtado A, 2017, EPIDEMIOL INFECT, V145, P1834, DOI 10.1017/S0950268817000796; Perez-Arellano JL, 2018, REV ESP QUIM, V31, P386; Malo JA, 2018, AUST NZ J PUBL HEAL, V42, P451, DOI 10.1111/1753-6405.12784; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Rodolakis A, 2007, J DAIRY SCI, V90, P5352, DOI 10.3168/jds.2006-815; Schets FM, 2013, INT J HYG ENVIR HEAL, V216, P698, DOI 10.1016/j.ijheh.2012.12.010; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; Tissot-Dupont H, 1999, AM J EPIDEMIOL, V150, P67, DOI 10.1093/oxfordjournals.aje.a009920; Van den Brom R, 2015, VET MICROBIOL, V181, P119, DOI 10.1016/j.vetmic.2015.07.011	24	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225605	10.1371/journal.pone.0225605	http://dx.doi.org/10.1371/journal.pone.0225605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765433	gold, Green Published			2022-12-26	WOS:000533891000039
J	Alwano, MG; Bachanas, P; Block, L; Roland, M; Sento, B; Behel, S; Lebelonyane, R; Wirth, K; Ussery, F; Bapati, W; Motswere-Chirwa, C; Abrams, W; Ussery, G; Miller, JA; Bile, E; Fonjungo, P; Kgwadu, A; Holme, MP; Del Castillo, L; Gaolathe, T; Leme, K; Majingo, N; Lockman, S; Makhema, J; Bock, N; Moore, J				Alwano, Mary Grace; Bachanas, Pamela; Block, Lisa; Roland, Michelle; Sento, Baraedi; Behel, Stephanie; Lebelonyane, Refeletswe; Wirth, Kathleen; Ussery, Faith; Bapati, William; Motswere-Chirwa, Catherine; Abrams, William; Ussery, Gene; Miller, James A.; Bile, Ebi; Fonjungo, Peter; Kgwadu, Agisanag; Holme, Molly Pretorius; Del Castillo, Lisetta; Gaolathe, Tendani; Leme, Kelebemang; Majingo, Nokuthula; Lockman, Shahin; Makhema, Joseph; Bock, Naomi; Moore, Janet			Increasing knowledge of HIV status in a country with high HIV testing coverage: Results from the Botswana Combination Prevention Project	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; VIRAL SUPPRESSION; OPEN-LABEL; COMMUNITY; CARE; LINKAGE; STRATEGIES; UGANDA; TRIAL	Introduction Achieving widespread knowledge of HIV-positive status is a crucial step to reaching universal ART coverage, population level viral suppression, and ultimately epidemic control. We implemented a multi-modality HIV testing approach to identify 90% or greater of HIV-positive persons in the Botswana Combination Prevention Project (BCPP) intervention communities. Methods BCPP is a cluster-randomized trial designed to evaluate the impact of combination prevention interventions on HIV incidence in 30 communities in Botswana. Community case finding and HIV testing that included home and targeted mobile testing were implemented in the 15 intervention communities. We described processes for identifying HIV-positive persons, uptake of HIV testing by age, gender and venue, characteristics of persons newly diagnosed through BCPP, and coverage of knowledge of status reached at the end of study. Results Of the 61,655 eligible adults assessed in home or mobile settings, 13,328 HIV-positive individuals, or 93% of the estimated 14,270 positive people in the communities were identified through BCPP. Knowledge of status increased by 25% over the course of the study with the greatest increases seen among men (37%) as compared to women (19%) and among youth aged 16-24 (77%) as compared to older age groups (21%). Although more men were tested through mobile than through home-based testing, higher rates of newly diagnosed HIV-positive men were found through home than mobile testing. Conclusions Even when HIV testing coverage is high, additional gains can be made using a multi-modality HIV testing strategy to reach different sub-populations who are being missed by non-targeted program activities. Men and youth can be reached and will engage in community testing when services are brought to places they access routinely.	[Alwano, Mary Grace; Roland, Michelle; Motswere-Chirwa, Catherine; Abrams, William; Bile, Ebi; Del Castillo, Lisetta] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Gaborone, Botswana; [Bachanas, Pamela; Behel, Stephanie; Ussery, Faith; Fonjungo, Peter; Bock, Naomi; Moore, Janet] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Block, Lisa; Ussery, Gene; Miller, James A.] Northrop Grumman, Atlanta, GA USA; [Sento, Baraedi; Bapati, William; Kgwadu, Agisanag; Leme, Kelebemang] Tebelopele HIV Counseling & Testing Ctr, Gaborone, Botswana; [Lebelonyane, Refeletswe; Majingo, Nokuthula] Botswana Minist Hlth & Wellness, Gaborone, Botswana; [Wirth, Kathleen; Holme, Molly Pretorius; Lockman, Shahin] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Gaolathe, Tendani; Lockman, Shahin; Makhema, Joseph] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Lockman, Shahin] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Harvard University; Brigham & Women's Hospital	Bachanas, P (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA.	pbachanas@cdc.gov		Bachanas, Pamela/0000-0001-9408-9904; Bile, Ebi Celestin/0000-0003-1930-7443	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2G GH000073, U2G GH000419, U01 GH000447, U2G GH001911]; CDC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI131928] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC), under the terms of Cooperative Agreements U2G GH000073, U2G GH000419, U01 GH000447 and U2G GH001911. CDC has contracts with Northrup Grumman for statistical analyses, data management, information technology, and project management and persons funded through these contracts were part of the study staff. CDC received funding to support salaries for all authors on this paper directly or through the above-mentioned mechanisms. All authors collaborated in various aspects of the study design, protocol and intervention development, data collection and analysis, and preparation of the manuscript.	Barnabas RV, 2016, LANCET HIV, V3, pE212, DOI 10.1016/S2352-3018(16)00020-5; Barnabas RV, 2014, LANCET HIV, V1, pE68, DOI 10.1016/S2352-3018(14)70024-4; Botswana Statistics, 2013, BOTSW AIDS IMP SURV; Chamie G, 2016, LANCET HIV, V3, pE111, DOI 10.1016/S2352-3018(15)00251-9; Chamie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084317; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Gaolathe T, 2016, LANCET HIV, V3, pE221, DOI 10.1016/S2352-3018(16)00037-0; Hayes R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002292; Hensen B, 2014, AIDS, V28, P2133, DOI 10.1097/QAD.0000000000000395; Iwuji CC, 2018, LANCET HIV, V5, pE116, DOI 10.1016/S2352-3018(17)30205-9; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kadede K, 2016, AIDS, V30, P2221, DOI 10.1097/QAD.0000000000001180; Karim QA, 2017, JAIDS-J ACQ IMM DEF, V75, pS17, DOI [10.1097/QAI.0000000000001316, 10.1097/qai.0000000000001316]; Lasry A, 2019, AIDS BEHAV, V23, P875, DOI 10.1007/s10461-019-02408-9; Makhema J, 2019, NEW ENGL J MED, P381; Maman D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20673; Novitsky V, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19918; Petersen M, 2017, JAMA-J AM MED ASSOC, V317, P2196, DOI 10.1001/jama.2017.5705; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Shanaube K, 2017, AIDS, V31, pS221, DOI 10.1097/QAD.0000000000001530; Shanaube K, 2017, AIDS, V31, P1555, DOI [10.1097/QAD.0000000000001514, 10.1097/qad.0000000000001514]; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; UNAIDS, 2015, GAP REP; UNAIDS, 2020, GLOB HIV AIDS STAT F; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; WHO, 2015, CONSOLIDATED GUIDELI	28	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225076	10.1371/journal.pone.0225076	http://dx.doi.org/10.1371/journal.pone.0225076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765394	gold, Green Published			2022-12-26	WOS:000533891000015
J	Minchom, A; Mak, D; Gunapala, R; Walder, D; Kumar, R; Yousaf, N; Hodgkiss, A; Bhosle, J; Popat, S; O'Brien, MER				Minchom, Anna; Mak, Daisy; Gunapala, Ranga; Walder, David; Kumar, Rajiv; Yousaf, Nadia; Hodgkiss, Andrew; Bhosle, Jaishree; Popat, Sanjay; O'Brien, Mary E. R.			A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma	PLOS ONE			English	Article							NSCLC PATIENTS; PHASE-III; CISPLATIN; FOLATE	Objectives Vitamin supplementation reduces pemetrexed toxicity. Raised plasma homocysteine reflects deficiency in vitamin B12 and folate, and is suppressed by supplementation. This observational study of 112 patients receiving pemetrexed-based chemotherapy assessed homocysteine levels after 3 weeks of vitamin supplementation, hypothesising high levels would correlate with ongoing deficiency, thus increased toxicity. Material and methods Primary endpoint was the composite of proportion of patients with treatment delay/ dose reduction/ drug change or hospitalisation during the first six weeks of chemotherapy, comparing those with normal plasma homocysteine (successfully supplemented, SS) and those with high homocysteine (unsuccessfully supplemented, USS). Secondary endpoints included toxicity and analyses for depression. Post-hoc analysis examined correlation between interval of vitamin and folate supplementation and pemetrexed on primary endpoint and grade 3-4 toxicities. Results Eighty-four patients (84%) were successfully supplemented (SS group). The proportion of patients undergoing a treatment delay/ dose reduction/ drug change or hospitalisation in SS group was 44.0% (95% confidence interval [CI] 33.2%-55.3%) and in USS group was 18.8% (95% CI 4.0%-45.6%) (p = 0.09). Twelve percent of patients gave a past history of depression however 66% of patients had an on study Hospital Anxiety and Depression (HAD) score of >7. Supplementation status was not associated with depression. The median overall survival (OS) was 11.8 months (95% CI 8.6-16.5) in the SS group and 8.8 months (95% CI 6.6-16.2) in the US group (p = 0.5). The number of days (<7 or. 7 days) between vitamin B12 and folate initiation and pemetrexed administration, had no effect on the primary endpoint and grade 3-4 toxicities. Conclusion On-treatment homocysteine levels were not a biomarker of toxicity or depression. Standard vitamin supplementation is adequate in the majority of patients receiving pemetrexed. High HAD score were noted in this population giving an opportunity for mental health intervention. The lead-in time for vitamin supplementation can be short.	[Minchom, Anna; Mak, Daisy; Gunapala, Ranga; Walder, David; Kumar, Rajiv; Bhosle, Jaishree; O'Brien, Mary E. R.] Royal Marsden NHS Fdn Trust, Lung Canc Unit, Sutton, Surrey, England; [Yousaf, Nadia; Popat, Sanjay] Royal Marsden NHS Fdn Trust, Lung Canc Unit, London, England; [Hodgkiss, Andrew] Royal Marsden NHS Fdn Trust, Adult Psychol Support Serv, Sutton, Surrey, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	O'Brien, MER (corresponding author), Royal Marsden NHS Fdn Trust, Lung Canc Unit, Sutton, Surrey, England.	mary.obrien@rmh.nhs.uk	Popat, Sanjay/AAO-1634-2021	Popat, Sanjay/0000-0003-2087-4963; Mak, Daisy/0000-0002-0493-6565	National Institute for Health Research (NIHR) Biomedical Research Centre (BRC)	National Institute for Health Research (NIHR) Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR))	Initials of the authors who received each award: MOB Grant numbers awarded to each author: Grant number not available for the BRC award. The full name of each funder: National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) URL of each funder website: https://www.nihr.ac.uk/about-us/how-weare-managed/our-structure/infrastructure/biomedical-research-centres.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostom AG, 1999, ANN INTERN MED, V131, P352, DOI 10.7326/0003-4819-131-5-199909070-00006; Bottiglieri T, 2000, J NEUROL NEUROSUR PS, V69, P228, DOI 10.1136/jnnp.69.2.228; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Clarke R, 1998, J Cardiovasc Risk, V5, P249, DOI 10.1097/00043798-199808000-00007; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Hanauske AR, 2001, ONCOLOGIST, V6, P363, DOI 10.1634/theoncologist.6-4-363; Minchom AR, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000061; Morabito A, 2013, LUNG CANCER, V81, P77, DOI 10.1016/j.lungcan.2013.04.008; Niyikiza C, 2002, MOL CANCER THER, V1, P545; Schlei Z, 2018, CLIN LUNG CANCER, V19, P467, DOI 10.1016/j.cllc.2018.05.017; Singh N, 2017, J THORAC ONCOL, V12, pS1807, DOI 10.1016/j.jtho.2017.09.461; Takagi Y, 2014, ONCOLOGIST, V19, P1194, DOI 10.1634/theoncologist.2014-0221; Tanaka H, 2015, ANTI-CANCER DRUG, V26, P573, DOI 10.1097/CAD.0000000000000220; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136	14	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225509	10.1371/journal.pone.0225509	http://dx.doi.org/10.1371/journal.pone.0225509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765437	gold, Green Published			2022-12-26	WOS:000533891000033
J	Oliviero, S; Giorgi, M; Laud, PJ; Dall'Ara, E				Oliviero, Sara; Giorgi, Mario; Laud, Peter J.; Dall'Ara, Enrico			Effect of repeated in vivo microCT imaging on the properties of the mouse tibia	PLOS ONE			English	Article							FINITE-ELEMENT MODELS; CORTICAL BONE; MECHANICAL-PROPERTIES; TOMOGRAPHY; VALIDATION; AGE; MICROSTRUCTURE; ARCHITECTURE; COMPRESSION; LOAD	In longitudinal studies, in vivo micro-Computed Tomography (microCT) imaging is used to investigate bone changes over time due to interventions in mice. However, ionising radiation can provoke significant variations in bone morphometric parameters. In a previous study, we evaluated the effect of reducing the integration time on the properties of the mouse tibia measured from microCT images. A scanning procedure (100 ms integration time, 256 mGy nominal radiation dose) was selected as the best compromise between image quality and radiation dose induced on the animal. In this work, the effect of repeated in vivo scans has been evaluated using the selected procedure. The right tibia of twelve female C57BL/6 (six wild type, WT, six ovariectomised, OVX) and twelve BALB/c (six WT, six OVX) mice was scanned every two weeks, starting at week 14 of age. At week 24, mice were sacrificed and both tibiae were scanned. Standard trabecular and cortical morphometric parameters were calculated. The spatial distribution of densitometric parameters (e.g. bone mineral content) was obtained by dividing each tibia in 40 partitions. Stiffness and strength in compression were estimated using homogeneous linear elastic microCT-based micro-Finite Element models. Differences between right (irradiated) and left (non-irradiated control) tibiae were evaluated for each parameter. The irradiated tibiae had higher Tb.Th (+3.3%) and Tb.Sp (+11.6%), and lower Tb.N (-14.2%) compared to non-irradiated tibiae, consistently across both strains and intervention groups. A reduction in Tb.BV/TV (-14.9%) was also observed in the C57BL/6 strain. In the OVX group, a small reduction was also observed in Tt.Ar (-5.0%). In conclusion, repeated microCT scans (at 256 mGy, 5 scans, every two weeks) had limited effects on the mouse tibia, compared to the expected changes induced by bone treatments. Therefore, the selected scanning protocol is acceptable for measuring the effect of bone interventions in vivo.	[Oliviero, Sara; Giorgi, Mario; Dall'Ara, Enrico] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Oliviero, Sara; Giorgi, Mario; Dall'Ara, Enrico] Univ Sheffield, Insigne Inst Silico Med, Sheffield, S Yorkshire, England; [Giorgi, Mario] Certara UK Ltd, Simcyp Div, Certara QSP, Sheffield, S Yorkshire, England; [Laud, Peter J.] Univ Sheffield, Stat Serv Unit, Sheffield, S Yorkshire, England; [Dall'Ara, Enrico] Univ Sheffield, MRC Arthrit Res UK Ctr Integrated Res Musculoskel, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; Certara UK Ltd; University of Sheffield; University of Sheffield	Oliviero, S (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.; Oliviero, S (corresponding author), Univ Sheffield, Insigne Inst Silico Med, Sheffield, S Yorkshire, England.	s.oliviero@sheffield.ac.uk	Dall'Ara, Enrico/ABA-5046-2020	Dall'Ara, Enrico/0000-0003-1471-5077; Giorgi, Mario/0000-0001-7763-8545	Engineering and Physical Sciences Research Council (EPSRC) [EP/K03877X/1]; National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/R001073/1]; Certara QSP; EPSRC [EP/K03877X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Certara QSP; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was partially supported by the Engineering and Physical Sciences Research Council (EPSRC, MultiSim project, Grant number: EP/K03877X/1; ED; https://www.epsrc.ac.uk/) and the National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs, Grant number: NC/R001073/1; ED; https://www.nc3rs.org.uk/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Certara QSP provided support in the form of salaries for authors during the writing of the manuscript [MG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; Birkhold AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep23480; Birkhold AI, 2014, BIOMATERIALS, V35, P9290, DOI 10.1016/j.biomaterials.2014.07.051; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Buie HR, 2008, J BONE MINER RES, V23, P2048, DOI 10.1359/JBMR.080808; Campbell GM, 2014, CALCIFIED TISSUE INT, V94, P282, DOI 10.1007/s00223-013-9809-4; Chen Y, 2017, J MECH BEHAV BIOMED, V65, P644, DOI 10.1016/j.jmbbm.2016.09.014; Christiansen Blaine A, 2016, Bone Rep, V5, P136, DOI 10.1016/j.bonr.2016.05.006; Dall'Ara E, 2016, MECH AGEING DEV, V160, P93, DOI 10.1016/j.mad.2016.08.001; Holguin N, 2014, BONE, V65, P83, DOI 10.1016/j.bone.2014.05.006; Judex S, 2005, MICROCT INDUCED RADI; Kazakia GJ, 2008, MED PHYS, V35, P3170, DOI 10.1118/1.2924210; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Laperre K, 2011, BONE, V49, P613, DOI 10.1016/j.bone.2011.06.031; Lu YT, 2017, J MECH BEHAV BIOMED, V75, P244, DOI 10.1016/j.jmbbm.2017.07.034; Lu YT, 2016, J BIOMECH, V49, P2095, DOI 10.1016/j.jbiomech.2016.05.022; Main RP, 2014, J EXP BIOL, V217, P1775, DOI 10.1242/jeb.085522; Margolis DS, 2004, MED ENG PHYS, V26, P349, DOI 10.1016/j.medengphy.2003.11.002; Meijering EHW, 2000, SIGN PROC C 2000 10, P1; Mustafy T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207323; Oliviero S, 2018, J MECH BEHAV BIOMED, V86, P172, DOI 10.1016/j.jmbbm.2018.06.022; Oliviero S, 2017, J BIOMECH, V65, P203, DOI 10.1016/j.jbiomech.2017.10.026; Pistoia W, 2002, BONE, V30, P842, DOI 10.1016/S8756-3282(02)00736-6; Roberts BC, 2019, BONE, V127, P260, DOI 10.1016/j.bone.2019.06.024; Sacco SM, 2017, BONEKEY REP, V6, DOI 10.1038/bonekey.2016.87; Webster DJ, 2008, COMPUT METHOD BIOMEC, V11, P435, DOI 10.1080/10255840802078014; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023	27	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225127	10.1371/journal.pone.0225127	http://dx.doi.org/10.1371/journal.pone.0225127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751367	gold, Green Accepted, Green Published			2022-12-26	WOS:000533886900031
J	Ly, A; Dhand, NK; Sergeant, ESG; Marsh, I; Plain, KM				Ly, Anna; Dhand, Navneet K.; Sergeant, Evan S. G.; Marsh, Ian; Plain, Karren M.			Determining an optimal pool size for testing beef herds for Johne's disease in Australia	PLOS ONE			English	Article							AVIUM SUBSP-PARATUBERCULOSIS; FECAL SAMPLES; BACTERIOLOGICAL CULTURE; DNA EXTRACTION; PCR; SENSITIVITY; FECES; INHIBITION; QUANTIFICATION; INFECTION	Bovine Johne's disease (JD) is a chronic debilitating disease affecting cattle breeds worldwide. Pooled faecal samples are routinely tested by culture to detect Mycobacterium avium subsp. paratuberculosis (Mptb) infection. More recently, a direct high throughput molecular test has been introduced in Australia for the detection of Mptb in faeces to circumvent the long culture times, however, the optimal pool size for beef cattle faeces is not known. This study aimed to determine the optimal pool size to achieve the highest test sensitivity and specificity for beef cattle. Individual archived faecal samples with low, medium and high quantities of Mptb (n = 30) were pooled with faecal samples from confirmed JD negative animals to create pool sizes of 5, 10, 15 and 20, to assess the diagnostic sensitivity relative to individual faecal qPCR. Samples from JD-free cattle (n = 10) were similarly evaluated for diagnostic specificity. Overall, 160 pools were created, with Mptb DNA extracted using magnetic bead isolation method prior to Mptb-specific IS900 quantitative PCR (qPCR). The pool size of 10 yielded the highest sensitivity 73% (95% CI: 54-88%), regardless of the quantity of Mptb DNA present in the faeces. There was no significant differences between the four different pool sizes for positive pool detection, however, there was statistical significance between low, medium and high quantities of Mptb. Diagnostic specificity was determined to be 100%. The increase in pool size greater than 10 increased the chances of PCR inhibition, which was successfully relieved with the process of DNA dilution. The results of this study demonstrate that the pool size of 10 performed optimally in the direct faecal qPCR. The results from this study can be applied in future simulation modelling studies to provide suggestions on the cost-effective testing for JD in beef cattle.	[Ly, Anna; Dhand, Navneet K.; Plain, Karren M.] Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Camden, NSW, Australia; [Sergeant, Evan S. G.] Ausvet Pty Ltd, Canberra, ACT, Australia; [Marsh, Ian] Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Menangle, Australia	University of Sydney; NSW Department of Primary Industries	Plain, KM (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Camden, NSW, Australia.	karren.plain@sydney.edu.au		Dhand, Navneet/0000-0002-4362-3596; Plain, Karren/0000-0001-7126-9865; Ly, Anna/0000-0002-1752-1588	Meat and Livestock Australia [B.AHE.0322]	Meat and Livestock Australia(Meat and Livestock Australia)	This project was supported by Meat and Livestock Australia through project grant B. AHE.0322. The funding body (MLA) provided support in the form of authors' salaries and research materials but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. We note that one of the authors is employed by a commercial company: Ausvet Pty Ltd. The specific roles of all authors are articulated in the `author contributions' section.; The authors would like thank Ms Anna Waldron and Ms Slavicka Patten for laboratory assistance and technical support. This project was supported by Meat and Livestock Australia through project grant B.AHE.0322.	Acharya KR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00115; Animal Health Australia, 2015, BJD HER; Animal Health Australia, JD CATTL TOOLS 2019; Begg DJ, 2018, VET MICROBIOL, V219, P53, DOI 10.1016/j.vetmic.2018.03.029; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cannon RM, 2002, J VET DIAGN INVEST, V14, P60, DOI 10.1177/104063870201400112; Cao Y, 2012, J APPL MICROBIOL, V113, P66, DOI 10.1111/j.1365-2672.2012.05305.x; CHIODINI RJ, 1984, CORNELL VET, V74, P218; Christensen J, 2000, PREV VET MED, V45, P83, DOI 10.1016/S0167-5877(00)00118-5; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Dhand NK, 2010, PREV VET MED, V95, P248, DOI 10.1016/j.prevetmed.2010.03.013; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Eamens GJ, 2015, AUSTR NZ STANDARD DI; Eamens GJ, 2007, VET MICROBIOL, V125, P22, DOI 10.1016/j.vetmic.2007.04.043; Geraghty T, 2014, PREV VET MED, V116, P1, DOI 10.1016/j.prevetmed.2014.06.003; Herd Health Pty Ltd, 2016, REV AUSTR JOHN DIS M; Kalis CHJ, 2000, J VET DIAGN INVEST, V12, P547, DOI 10.1177/104063870001200609; Kawaji S, 2007, VET MICROBIOL, V125, P36, DOI 10.1016/j.vetmic.2007.05.002; Kralik P, 2014, VET J, V201, P91, DOI 10.1016/j.tvjl.2014.02.011; Lehnert B., BLANDALTMANLEH PLOTS; Logar K, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-49; McKenna SLB, 2018, J DAIRY SCI, V101, P7463, DOI 10.3168/jds.2018-14458; Messam LLM, 2010, PREV VET MED, V94, P202, DOI 10.1016/j.prevetmed.2010.01.005; Meyer A, 2019, J DAIRY SCI, V102, P2427, DOI 10.3168/jds.2018-14883; Mita A, 2016, MICROBIOLOGYOPEN, V5, P134, DOI 10.1002/mbo3.318; Mitchell RM, 2015, VET RES, V46, DOI 10.1186/s13567-015-0188-x; Monteiro L, 1997, J CLIN MICROBIOL, V35, P995, DOI 10.1128/JCM.35.4.995-998.1997; Morre SA, 2001, J CLIN MICROBIOL, V39, P2375; Pedersen KS, 2014, J VET DIAGN INVEST, V26, P342, DOI 10.1177/1040638714524572; Plain KM, 2014, J CLIN MICROBIOL, V52, P745, DOI 10.1128/JCM.03233-13; Rapp D, 2010, J APPL MICROBIOL, V108, P1485, DOI 10.1111/j.1365-2672.2009.04606.x; Sergeant ESG, 2019, J DAIRY SCI, V102, P2525, DOI 10.3168/jds.2018-15696; Sergeant ESG, 2019, EPITOOLS EPIDEMIOLOG; Sweeney RW, 1996, VET CLIN N AM-FOOD A, V12, P305, DOI 10.1016/S0749-0720(15)30408-4; Thornton CG, 2004, J MICROBIOL METH, V59, P43, DOI 10.1016/j.mimet.2004.06.001; van Schaik G, 2003, J VET DIAGN INVEST, V15, P233, DOI 10.1177/104063870301500304; van Schaik G, 2007, PREV VET MED, V82, P159, DOI 10.1016/j.prevetmed.2007.05.018; Wells SJ, 2003, J AM VET MED ASSOC, V223, P1022, DOI 10.2460/javma.2003.223.1022; Wells SJ, 2002, AM J VET RES, V63, P1207, DOI 10.2460/ajvr.2002.63.1207; Whittington R, 2010, PARATUBERCULOSIS: ORGANISM, DISEASE, CONTROL, P244, DOI 10.1079/9781845936136.0244; Whittington RJ, 2013, J CLIN MICROBIOL, V51, P3993, DOI 10.1128/JCM.01373-13; Whittington RJ, 2000, J CLIN MICROBIOL, V38, P2550, DOI 10.1128/JCM.38.7.2550-2556.2000; Whittington RJ, 2000, AUST VET J, V78, P34, DOI 10.1111/j.1751-0813.2000.tb10355.x	43	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225524	10.1371/journal.pone.0225524	http://dx.doi.org/10.1371/journal.pone.0225524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747440	Green Published, gold			2022-12-26	WOS:000533881900049
J	Taylor, W; Clark, JK; Reichhardt, B; Hodgins, GWL; Bayarsaikhan, J; Batchuluun, O; Whitworth, J; Nansalmaa, M; Lee, CM; Dixon, EJ				Taylor, William; Clark, Julia K.; Reichhardt, Bjoern; Hodgins, Gregory W. L.; Bayarsaikhan, Jamsranjav; Batchuluun, Oyundelger; Whitworth, Jocelyn; Nansalmaa, Myagmar; Lee, Craig M.; Dixon, E. James			Investigating reindeer pastoralism and exploitation of high mountain zones in northern Mongolia through ice patch archaeology	PLOS ONE			English	Article							CARIBOU; POINTS	In interior Eurasia, high mountain zones are crucial to pastoral subsistence, providing seasonally productive pastures and abundant wild resources. In some areas of northern Mongolia, mountainous tundra zones also support a low-latitude population of domestic reindeer herders-a lifestyle whose origins are poorly characterized in the archaeological record of early Mongolia. Traditionally, reindeer pastoralists make significant seasonal use of munkh mus (eternal ice) for their domestic herds, using these features to cool heat-stressed animals and provide respite from insect harassment. In recent years, many of these features have begun to melt entirely for the first time, producing urgent threats to traditional management techniques, the viability of summer pastures, and reindeer health. The melting ice is also exposing fragile organic archaeological materials that had previously been contained in the patch. We present the results of horseback survey of ice patches in Baruun Taiga special protected area, providing the first archaeological insights from the region. Results reveal new evidence of historic tool production and wild resource use for fishing or other activities, and indicate that ice patches are likely to contain one of the few material records of premodern domestic reindeer use in Mongolia and lower Central Asia. The area's ancient ice appears to be rapidly melting due to changing climate and warming summer temperatures, putting both cultural heritage and traditional reindeer herding at extreme risk in the years to come.	[Taylor, William] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Taylor, William] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Clark, Julia K.] Flinders Univ S Australia, Dept Archaeol, Adelaide, SA, Australia; [Clark, Julia K.] NOMAD Sci, Ulaanbaatar, Mongolia; [Reichhardt, Bjoern] Humboldt Univ, Inst Asian & African Studies, Cent Asian Seminar, Berlin, Germany; [Reichhardt, Bjoern] Max Planck Inst Sci Human Hist, Dept Archaeogenet, Jena, Germany; [Hodgins, Gregory W. L.] Univ Arizona, Accelerator Mass Spectrometry Lab, Tucson, AZ USA; [Bayarsaikhan, Jamsranjav; Batchuluun, Oyundelger] Natl Museum Mongolia, Ulaanbaatar, Mongolia; [Whitworth, Jocelyn] Clearview Anim Hosp, Colorado Springs, CO USA; [Nansalmaa, Myagmar] State Cent Vet Lab, Unit Diag & Surveillance Infect & Parasit Dis, Ulaanbaatar, Mongolia; [Lee, Craig M.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Dixon, E. James] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	University of Colorado System; University of Colorado Boulder; Flinders University South Australia; Humboldt University of Berlin; University of Arizona; University of Colorado System; University of Colorado Boulder; University of New Mexico	Taylor, W (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany.; Taylor, W (corresponding author), Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA.	william.taylor@colorado.edu	Hodgins, Gregory/GVT-3022-2022	Hodgins, Gregory/0000-0002-6669-0396; Taylor, William/0000-0002-0836-7814				Anderson John R., 1998, Rangifer, V18, P3; [Anonymous], MODELING LATE PREHIS; Dixon EJ, 2005, AM ANTIQUITY, V70, P129, DOI 10.2307/40035272; Dixon EJ., 2014, J GLACIAL ARCHAEOLOG, V1, P1, DOI [10.1558/jga.v1i1.1, DOI 10.1558/JGA.V1I1.1]; Fernandez-Gimenez ME, 2017, ANTHROPOCENE, V17, P46, DOI 10.1016/j.ancene.2017.01.003; Finstad E., 2018, J GLACIAL ARCHAEOLOG, V3, P43, DOI [10.1558/jga.33147, DOI 10.1558/JGA.33147]; Fitzhugh WW, 2003, MONGOLIAS ARCTIC CON; Grayson DK, 2005, CONSERV BIOL, V19, P557; Hagemoen RIM, 2002, J ANIM ECOL, V71, P883, DOI 10.1046/j.1365-2656.2002.00654.x; Hare PG, 2004, ETHNOGRAPHIC ARCHAEO, V57, DOI [10.14430/arctic503, DOI 10.14430/ARCTIC503]; Hua Q, 2013, RADIOCARBON, V55, P2059, DOI 10.2458/azu_js_rc.v55i2.16177; ION PG, 1989, ARCTIC ALPINE RES, V21, P203, DOI 10.2307/1551633; Laaksonen S, 2010, ECOHEALTH, V7, P7, DOI 10.1007/s10393-010-0308-z; Lee CM, 2017, AM ANTIQUITY, V82, P223, DOI 10.1017/aaq.2016.32; Moen J, 2008, AMBIO, V37, P304, DOI 10.1579/0044-7447(2008)37[304:CCEOTE]2.0.CO;2; Nesje A, 2012, HOLOCENE, V22, P485, DOI 10.1177/0959683611425552; O'Brien MJ, 2017, ARCTIC ANTHROPOL, V54, P110, DOI 10.3368/aa.54.1.110; Oskal A., 2009, REINDEER HERDERS VOI; Pilo L, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171738; Putnam AE, 2016, QUATERNARY SCI REV, V131, P33, DOI 10.1016/j.quascirev.2015.10.033; Reckin R, 2013, J WORLD PREHIST, V26, P323, DOI 10.1007/s10963-013-9068-3; Ryd Y, 2013, J GLACIAL ARCHAEOLOG, V1, P11; Taylor WTT, 2017, J ARCHAEOL SCI, V81, P49, DOI 10.1016/j.jas.2017.03.006; United Nations United Nations Framework Convention on Climate Change, IN NAT COMM MONG; Vainshtein S., 1980, NOMADS S SIBERIA PAS; VanderHoek R, 2012, ARCTIC, V65, P153; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Wheeler WA., 1999, MONGOLIAN SURV, V6, P58	29	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0224741	10.1371/journal.pone.0224741	http://dx.doi.org/10.1371/journal.pone.0224741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8NF	31747407	Green Published, gold			2022-12-26	WOS:000533881900016
J	Villegas, EA; Alcon, E; Rubio, E; Marin, JM; Artal, P				Villegas, Eloy A.; Alcon, Encarna; Rubio, Elena; Maria Marin, Jose; Artal, Pablo			One-year follow-up of changes in refraction and aberrations induced by corneal incision	PLOS ONE			English	Article							SURGICALLY INDUCED ASTIGMATISM; INTRAOCULAR-LENS IMPLANTATION; HIGH-ORDER ABERRATIONS; CLEAR CORNEAL; FEMTOSECOND-LASER; CATARACT-SURGERY; OPTICAL-QUALITY; PHACOEMULSIFICATION; MODERATE; TIME	Purpose To evaluate the surgically induced changes in refraction (sphere and astigmatism) and higher order aberrations by corneal incision for one year. Setting University Hospital "Virgen de la Arrixaca", Murcia, Spain. Design Retrospective interventional case series. Methods Corneal power, astigmatism and higher order aberrations (HOA) were calculated from corneal topography measured in 27 eyes prior to surgery and at 2 weeks, 1, 2, 3 and 6 months and 1 year following cataract surgery with 3.2-mm corneal incision. At every stage, optical changes were calculated as the difference between pre- and post-surgery data (in each follow-up) using the formulas of obliquely crossed cylinders for the refraction and Zernikes coefficients for HOA. Results At 2 weeks after surgery the mean corneal values of induced sphere, cylinder and the root mean square (RMS) of HOA were +0.54 +/- 0.27 D, -0.77 +/- 0.32 D and 0.15 microns respectively. These parameters decreased significantly (p-values between 0 and 0.01) at 3 months to +0.33 +/- 0.27 D sphere, -0.50 +/- 0.24 D cylinder and 0.10 +/- 0.05 microns HOA and were stable at the next follow-ups. Induced spherical equivalent was around zero at all visits. The changes in HOA were mainly due to trefoil aberration. Conclusions Linear corneal incisions do not change the spherical power but can induce significant values of astigmatism and trefoil aberration in the cornea. However, these changes revert fully or partially to preoperative values by the third month after surgery and remain stable with time.	[Villegas, Eloy A.; Alcon, Encarna; Artal, Pablo] Univ Murcia, Lab Opt, Murcia, Spain; [Rubio, Elena; Maria Marin, Jose] Hosp Virgen Arrixaca, Serv Oftalmol, Murcia, Spain	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca	Villegas, EA (corresponding author), Univ Murcia, Lab Opt, Murcia, Spain.	villegas@um.es	Artal, Pablo/AGV-7547-2022	Artal, Pablo/0000-0003-1284-6591	European Research Council [ERC-2013-AdG-339228]; Ministerio de Economia, Industria y Competitividad (Gobierno de Espana) [FIS2016-76163-R]	European Research Council(European Research Council (ERC)European Commission); Ministerio de Economia, Industria y Competitividad (Gobierno de Espana)	This work was supported by ERC-2013-AdG-339228 European Research Council, https://erc.europa.eu/, to EAV; ERC-2013-AdG-339228 European Research Council, https://erc.europa.eu/, to PA; FIS2016-76163-R Ministerio de Economia, Industria y Competitividad (Gobierno de Espana), http://www.mineco.gob.es/, to EAV; FIS2016-76163-R Ministerio de Economia, Industria y Competitividad (Gobierno de Espana), http://www.mineco.gob.es/, to PA.	Artal P, 2004, J VISION, V4, P281, DOI 10.1167/4.4.4; Artal P., 2004, WAVEFRONT CUSTOMIZED, P311; Atchison DA, 2016, INVEST OPHTH VIS SCI, V57, P5263, DOI 10.1167/iovs.16-20067; Baharozian CJ, 2017, CLIN OPHTHALMOL, V11, P1841, DOI 10.2147/OPTH.S141255; Bohac M, 2017, SEMIN OPHTHALMOL, V32, P725, DOI 10.3109/08820538.2016.1170163; Chen L, 2007, J VISION, V7, DOI 10.1167/7.10.9; Diakonis VF, 2015, J CATARACT REFR SURG, V41, P2075, DOI 10.1016/j.jcrs.2015.11.004; Fabian E, 2002, DEV OPHTHALMOL, V34, P147; GILLS JP, 1991, J CATARACT REFR SURG, V17, P740, DOI 10.1016/S0886-3350(13)80695-5; Guirao A, 2000, J OPT SOC AM A, V17, P955, DOI 10.1364/JOSAA.17.000955; Guirao A, 2004, INVEST OPHTH VIS SCI, V45, P4312, DOI 10.1167/iovs.04-0693; Jauhari N, 2014, INT J OPHTHALMOL-CHI, V7, P1001, DOI 10.3980/j.issn.2222-3959.2014.06.16; Jiang YX, 2006, J REFRACT SURG, V22, pS1083, DOI 10.3928/1081-597X-20061102-14; Jin C, 2017, COCHRANE DB SYST REV, V20; Kamiya K, 2018, BRIT J OPHTHALMOL, V102, P177, DOI 10.1136/bjophthalmol-2017-310164; Kaufmann C, 2005, J CATARACT REFR SURG, V31, P2261, DOI 10.1016/j.jcrs.2005.08.046; Kim H, 2016, J REFRACT SURG, V32, P404, DOI 10.3928/1081597X-20160303-01; Klijn S, 2016, ACTA OPHTHALMOL, V94, P494, DOI 10.1111/aos.13003; Kohnen S, 2002, J CATARACT REFR SURG, V28, P821, DOI 10.1016/S0886-3350(01)01215-9; KOHNEN T, 1995, J CATARACT REFR SURG, V21, P417, DOI 10.1016/S0886-3350(13)80532-9; Lim RX, 2014, J CATARACT REFR SURG, V40, P1676, DOI 10.1016/j.jcrs.2014.01.045; Marcos S, 2007, J CATARACT REFR SURG, V33, P217, DOI 10.1016/j.jcrs.2006.10.021; Masket S, 2009, J REFRACT SURG, V25, P21, DOI 10.3928/1081597X-20090101-04; Nagy ZZ, 2014, J REFRACT SURG, V30, P522, DOI 10.3928/1081597X-20140711-04; Nikose AS, 2018, CLIN OPHTHALMOL, V12, P65, DOI 10.2147/OPTH.S149709; Park YM, 2016, INT J OPHTHALMOL-CHI, V9, P1785, DOI 10.18240/ijo.2016.12.14; Pfleger T, 1996, J CATARACT REFR SURG, V22, P72, DOI 10.1016/S0886-3350(96)80273-2; Tong N, 2008, J CATARACT REFR SURG, V34, P2085, DOI 10.1016/j.jcrs.2008.08.020; Villegas EA, 2008, INVEST OPHTH VIS SCI, V49, P4688, DOI 10.1167/iovs.08-2316; Villegas EA, 2014, J CATARACT REFR SURG, V40, P13, DOI 10.1016/j.jcrs.2013.09.010; Yao K, 2006, J REFRACT SURG, V22, pS1079, DOI 10.3928/1081-597X-20061102-13; Zhu S, 2017, J CATARACT REFR SURG, V43, P1430, DOI 10.1016/j.jcrs.2017.08.011	32	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0224823	10.1371/journal.pone.0224823	http://dx.doi.org/10.1371/journal.pone.0224823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738783	gold, Green Published			2022-12-26	WOS:000532826300023
J	Fili, N; Hari-Gupta, Y; Aston, B; dos Santos, A; Gough, RE; Alamad, B; Wang, L; Martin-Fernandez, ML; Toseland, CP				Fili, Natalia; Hari-Gupta, Yukti; Aston, Bjork; dos Santos, Alia; Gough, Rosemarie E.; Alamad, Bana; Wang, Lin; Martin-Fernandez, Marisa L.; Toseland, Christopher P.			Competition between two high- and low-affinity protein-binding sites in myosin VI controls its cellular function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; gene expression; gene regulation; kinetics; biophysics	DOMAIN; NDP52; ACTIVATION; EXPRESSION; DISABLED-2; DEAFNESS	Myosin VI is involved in many cellular processes ranging from endocytosis to transcription. This multifunctional potential is achieved through alternative isoform splicing and through interactions of myosin VI with a diverse network of binding partners. However, the interplay between these two modes of regulation remains unexplored. To this end, we compared two different binding partners and their interactions with myosin VI by exploring the kinetic properties of recombinant proteins and their distribution in mammalian cells using fluorescence imaging. We found that selectivity for these binding partners is achieved through a high-affinity motif and a low-affinity motif within myosin VI. These two motifs allow competition among partners for myosin VI. Exploring how this competition affects the activity of nuclear myosin VI, we demonstrate the impact of a concentration-driven interaction with the low-affinity binding partner DAB2, finding that this interaction blocks the ability of nuclear myosin VI to bind DNA and its transcriptional activity in vitro. We conclude that loss of DAB2, a tumor suppressor, may enhance myosin VI?mediated transcription. We propose that the frequent loss of specific myosin VI partner proteins during the onset of cancer leads to a higher level of nuclear myosin VI activity.	[Fili, Natalia; dos Santos, Alia; Gough, Rosemarie E.; Toseland, Christopher P.] Univ Sheffield, Dept Oncol & Metab, Sheffield Canc Ctr, Sheffield S10 2RX, S Yorkshire, England; [Hari-Gupta, Yukti; Aston, Bjork; Alamad, Bana] Univ Kent, Sch Biosci, Canterbury CT2 7NZ, Kent, England; [Wang, Lin; Martin-Fernandez, Marisa L.] Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Res Complex Harwell, Didcot OX11 0QX, Oxon, England	University of Sheffield; University of Kent; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Toseland, CP (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield Canc Ctr, Sheffield S10 2RX, S Yorkshire, England.	c.toseland@sheffield.ac.uk		Hari-Gupta, Yukti/0000-0002-8685-2153; Fili, Natalia/0000-0002-0898-0766; wang, lin/0000-0001-9141-5217; dos Santos, Alia/0000-0002-3176-8317; Gough, Rosemarie/0000-0002-5587-4683; martin-fernandez, marisa/0000-0001-5496-6300	Medical Research Council [MR/M020606/1]; Science and Technology Facilities Council [19130001]; MRC [MR/M020606/1, MR/M020606/2] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant MR/M020606/1 and Science and Technology Facilities Council Grant 19130001. The authors declare that they have no conflicts of interest with the contents of this article.	Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Cook A, 2018, BIOCHEM BIOPH RES CO, V496, P820, DOI 10.1016/j.bbrc.2018.01.147; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; Fili N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02050-w; He JQ, 2001, J BIOL CHEM, V276, P26814, DOI 10.1074/jbc.M101820200; KORIOTH F, 1995, J CELL BIOL, V130, P1, DOI 10.1083/jcb.130.1.1; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Mohiddin SA, 2004, J MED GENET, V41, P309, DOI 10.1136/jmg.2003.011973; Morriswood B, 2007, J CELL SCI, V120, P2574, DOI 10.1242/jcs.007005; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Postma M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000202; Puri C, 2010, ONCOGENE, V29, P188, DOI 10.1038/onc.2009.328; Roberts R, 2004, PHILOS T R SOC B, V359, P1931, DOI 10.1098/rstb.2004.1563; Soh YM, 2015, MOL CELL, V57, P290, DOI 10.1016/j.molcel.2014.11.023; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Sternsdorf T, 1997, J CELL BIOL, V138, P435, DOI 10.1083/jcb.138.2.435; Toseland Christopher P, 2014, Exp Suppl, V105, P67, DOI 10.1007/978-3-0348-0856-9_4; Toseland Christopher P, 2014, Exp Suppl, V105, P49, DOI 10.1007/978-3-0348-0856-9_3; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; Wollscheid HP, 2016, NAT STRUCT MOL BIOL, V23, P300, DOI 10.1038/nsmb.3187; Yang CK, 2006, MOL ENDOCRINOL, V20, P3251, DOI 10.1210/me.2006-0200; Yoshida H, 2004, P NATL ACAD SCI USA, V101, P8144, DOI 10.1073/pnas.0400400101	27	11	11	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					337	347		10.1074/jbc.RA119.010142	http://dx.doi.org/10.1074/jbc.RA119.010142			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31744880	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000507373600007
J	Cho, SJ; Yun, SM; Jo, C; Jeong, J; Park, MH; Han, C; Koh, YH				Cho, Sun-Jung; Yun, Sang-Moon; Jo, Chulman; Jeong, Jihyun; Park, Moon Ho; Han, Changsu; Koh, Young Ho			Altered expression of Notch1 in Alzheimer's disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DOWN-SYNDROME; ACTIVATION; MICROGLIA; DIAGNOSIS; INSIGHTS; VERSION; HEALTH; BRAIN; MOUSE	Notch signaling is an evolutionarily conserved pathway that regulates cell-cell interactions through binding of Notch family receptors to their cognate ligands. Notch signaling has an essential role in vascular development and angiogenesis. Recent studies have reported that Notch may be implicated in Alzheimer's disease (AD) pathophysiology. We measured the levels of soluble Notch1 (sNotch1) in the plasma samples from 72 dementia patients (average age 75.1 y), 89 subjects with amnestic mild cognitive impairment (MCI) (average age 73.72 y), and 150 cognitively normal controls (average age 72.34 y). Plasma levels of sNotch1 were 25.27% lower in dementia patients as compared to healthy control subjects. However, the level of Notch1 protein was significantly increased in human brain microvascular endothelial cells (HBMECs) after amyloid-beta treatment. Also, Notch1 mRNA level was significantly increased in HBMECs and iPSC-derived neuronal cells from AD patient compared to normal control. These results indicate that altered expression of Notch1 might be associated with the risk of Alzheimer's disease.	[Cho, Sun-Jung; Yun, Sang-Moon; Jo, Chulman; Jeong, Jihyun; Koh, Young Ho] Korea Natl Inst Hlth, Ctr Biomed Sci, Div Brain Dis, 187 Osongsaengmyeong2 Ro, Cheongju, Chungcheongbuk, South Korea; [Park, Moon Ho] Korea Univ, Ansan Hosp, Med Coll, Dept Neurol, 123 Jeokgeum Ro, Ansan, Gyeonggi Do, South Korea; [Han, Changsu] Korea Univ, Ansan Hosp, Med Coll, Dept Psychiat, 123 Jeokgeum Ro, Ansan, Gyeonggi Do, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Koh, YH (corresponding author), Korea Natl Inst Hlth, Ctr Biomed Sci, Div Brain Dis, 187 Osongsaengmyeong2 Ro, Cheongju, Chungcheongbuk, South Korea.	kohyoungho122@gmail.com		Park, Moon Ho/0000-0002-4892-3475	Korea Centers for Disease Control and Prevention (KCDC) [2016-NG62002-00, 2017-NI62001-00]	Korea Centers for Disease Control and Prevention (KCDC)	This work was supported by the Korea Centers for Disease Control and Prevention (KCDC) 2016-NG62002-00, 2017-NI62001-00, (http://www.cdc.go.kr).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberi L, 2013, AGEING RES REV, V12, P801, DOI 10.1016/j.arr.2013.03.004; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Basak O, 2012, J NEUROSCI, V32, P5654, DOI 10.1523/JNEUROSCI.0455-12.2012; Brai E, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0327-2; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cho SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41347-2; Cho SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18042-1; Cuello AC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00189; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Fischer DF, 2005, FASEB J, V19, P1451, DOI 10.1096/fj.04-3395.com; Fortini C, 2014, INDIAN J CARDIO BIOL, V1, P103; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Han C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-10; Jang BG, 2010, J ALZHEIMERS DIS, V21, P939, DOI 10.3233/JAD-2010-100384; Kim J, 2007, J NUTR, V137, P2093, DOI 10.1093/jn/137.9.2093; Krishnasamy K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00953-2; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; LEES GJ, 1993, J NEUROL SCI, V114, P119, DOI 10.1016/0022-510X(93)90285-7; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; Mack JJ, 2018, CURR OPIN HEMATOL, V25, P212, DOI 10.1097/MOH.0000000000000425; Mathieu Patricia, 2013, Biomol Concepts, V4, P465, DOI 10.1515/bmc-2013-0006; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nagarsheth MH, 2006, J NEUROL SCI, V244, P111, DOI 10.1016/j.jns.2006.01.007; Pedrosa AR, 2015, ARTERIOSCL THROM VAS, V35, P1134, DOI 10.1161/ATVBAHA.114.304741; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Ramasamy SK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13601; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Sainson RCA, 2006, TRENDS MOL MED, V12, P141, DOI 10.1016/j.molmed.2006.02.001; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shawber CJ, 2003, ANN NY ACAD SCI, V995, P162, DOI 10.1111/j.1749-6632.2003.tb03219.x; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Wang MM, 2011, INT J BIOCHEM CELL B, V43, P1550, DOI 10.1016/j.biocel.2011.08.005; Wang YW, 2015, LIFE SCI, V127, P39, DOI 10.1016/j.lfs.2015.02.009; Wei ZL, 2011, STROKE, V42, P2589, DOI 10.1161/STROKEAHA.111.614834; Whitehouse PJ, 1997, PSYCHOPHARMACOL BULL, V33, P129; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yoon KJ, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-40; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Youn SW, 2011, BLOOD, V117, P4376, DOI 10.1182/blood-2010-07-295964; Zhiyou BZ, 2016, MOL MED REP, V14, P2883, DOI [10.3892/mmr.2016.5641, DOI 10.3892/MMR.2016.5641]	44	18	18	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0224941	10.1371/journal.pone.0224941	http://dx.doi.org/10.1371/journal.pone.0224941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770379	Green Submitted, Green Published, gold			2022-12-26	WOS:000533892300009
J	Sammer, M; Zahnbrecher, E; Dobiasch, S; Girst, S; Greubel, C; Ilicic, K; Reindl, J; Schwarz, B; Siebenwirth, C; Walsh, DWM; Combs, SE; Dollinger, G; Schmid, TE				Sammer, Matthias; Zahnbrecher, Esther; Dobiasch, Sophie; Girst, Stefanie; Greubel, Christoph; Ilicic, Katarina; Reindl, Judith; Schwarz, Benjamin; Siebenwirth, Christian; Walsh, Dietrich W. M.; Combs, Stephanie E.; Dollinger, Gunther; Schmid, Thomas E.			Proton pencil minibeam irradiation of an in-vivo mouse ear model spares healthy tissue dependent on beam size	PLOS ONE			English	Article							RADIATION-THERAPY; RADIOTHERAPY; OPTIMIZATION; SKIN	Proton radiotherapy using minibeams of sub-millimeter dimensions reduces side effects in comparison to conventional proton therapy due to spatial fractionation. Since the proton minibeams widen with depth, the homogeneous irradiation of a tumor can be ensured by adjusting the beam distances to tumor size and depth to maintain tumor control as in conventional proton therapy. The inherent advantages of protons in comparison to photons like a limited range that prevents a dosage of distal tissues are maintained by proton minibeams and can even be exploited for interlacing from different beam directions. A first animal study was conducted to systematically investigate and quantify the tissue-sparing effects of proton pencil minibeams as a function of beam size and dose distributions, using beam widths between s = 95, 199, 306, 411, 561 and 883 mu m (standard deviation) at a defined center-to-center beam distance (ctc) of 1.8 mm. The average dose of 60 Gy was distributed in 4x4 minibeams using 20 MeV protons (LET similar to 2.7 keV/mu m). The induced radiation toxicities were measured by visible skin reactions and ear swelling for 90 days after irradiation. The largest applied beam size to ctc ratio (s/ctc = 0.49) is similar to a homogeneous irradiation and leads to a significant 3-fold ear thickness increase compared to the control group. Erythema and desquamation was also increased significantly 3-4 weeks after irradiation. With decreasing beam sizes and thus decreasing s/ctc, the maximum skin reactions are strongly reduced until no ear swelling or other visible skin reactions should occur for s/ctc < 0.032 (extrapolated from data). These results demonstrate that proton pencil minibeam radiotherapy has better tissue-sparing for smaller s/ctc, corresponding to larger peak-to-valley dose ratios PVDR, with the best effect for s/ctc < 0.032. However, even quite large s/ctc (e.g. s/ctc = 0.23 or 0.31, i.e. PVDR = 10 or 2.7) show less acute side effects than a homogeneous dose distribution. This suggests that proton minibeam therapy spares healthy tissue not only in the skin but even for dose distributions appearing in deeper layers close to the tumor enhancing its benefits for clinical proton therapy.	[Sammer, Matthias; Girst, Stefanie; Greubel, Christoph; Reindl, Judith; Schwarz, Benjamin; Siebenwirth, Christian; Walsh, Dietrich W. M.; Dollinger, Gunther] Univ Bundeswehr Munchen, Inst Angew Phys & Messtech LRT2, Neubiberg, Germany; [Zahnbrecher, Esther; Dobiasch, Sophie; Ilicic, Katarina; Siebenwirth, Christian; Walsh, Dietrich W. M.; Combs, Stephanie E.; Schmid, Thomas E.] Tech Univ Munich, Dept Radiat Oncol, Klinikum Rechts Isar, Munich, Germany; [Zahnbrecher, Esther; Dobiasch, Sophie; Ilicic, Katarina; Combs, Stephanie E.; Schmid, Thomas E.] Helmholtz Zentrum Munchen HMGU, Dept Radiat Sci DRS, Inst Radiat Med IRM, Oberschleissheim, Germany; [Dobiasch, Sophie; Ilicic, Katarina; Combs, Stephanie E.] Deutsch Konsortium Translat Krebsforsch DKTK, Partner Site Munich, Heidelberg, Germany; [Siebenwirth, Christian] Univ Ulm, Bundeswehr Inst Radiobiol, Munich, Germany	Bundeswehr University Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ulm University	Sammer, M (corresponding author), Univ Bundeswehr Munchen, Inst Angew Phys & Messtech LRT2, Neubiberg, Germany.	matthias.sammer@unibw.de		Reindl, Judith/0000-0002-3238-8586; Walsh, Dietrich/0000-0003-2067-1883	project 'LET-Verbund' of the German Federal Ministry of Education and Research [02NUK031A]; DFG-Cluster of Excellence 'Munich-Centre for Advanced Photonics'; Maier Leibnitz Laboratory Munich	project 'LET-Verbund' of the German Federal Ministry of Education and Research; DFG-Cluster of Excellence 'Munich-Centre for Advanced Photonics'(German Research Foundation (DFG)); Maier Leibnitz Laboratory Munich	Supported by the project 'LET-Verbund' (funding no. 02NUK031A; GD) of the German Federal Ministry of Education and Research, by the DFG-Cluster of Excellence 'Munich-Centre for Advanced Photonics' and by the Maier Leibnitz Laboratory Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauer-Krisch E, 2003, MED PHYS, V30, P583, DOI 10.1118/1.1562169; Deasy JO, 2003, MED PHYS, V30, P979, DOI 10.1118/1.1568978; Dilmanian FA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00269; Dilmanian FA, 2012, INT J RADIAT ONCOL, V84, P514, DOI 10.1016/j.ijrobp.2011.12.025; Dombrowsky AC, 2019, CANCERS, V11, DOI 10.3390/cancers11050727; Girst S, 2016, INT J RADIAT ONCOL, V95, P234, DOI 10.1016/j.ijrobp.2015.10.020; Greubel C, 2008, RADIAT ENVIRON BIOPH, V47, P415, DOI 10.1007/s00411-008-0181-0; Greubel C, 2011, RADIAT ENVIRON BIOPH, V50, P339, DOI 10.1007/s00411-011-0365-x; Hauptner A, 2004, RADIAT ENVIRON BIOPH, V42, P237, DOI 10.1007/s00411-003-0222-7; Liao WP, 2017, RADIAT RES, V187, P454, DOI 10.1667/RR007CC.1; Paganetti H, 2002, INT J RADIAT ONCOL, V53, P407, DOI 10.1016/S0360-3016(02)02754-2; PARKINSON EK, 1986, BRIT J CANCER, V53, P81; Prezado Y, 2013, MED PHYS, V40, DOI 10.1118/1.4791648; Prezado Y, 2009, MED PHYS, V36, P4897, DOI 10.1118/1.3232000; Prezado Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34796-8; Prezado Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14786-y; Prezado Y, 2012, J SYNCHROTRON RADIAT, V19, P60, DOI 10.1107/S0909049511047042; Sammer M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221454; Sammer M, 2017, MED PHYS, V44, P6096, DOI 10.1002/mp.12566; Schell S, 2010, MED PHYS, V37, P5330, DOI 10.1118/1.3491406; Zlobinskaya O, 2013, RADIAT ENVIRON BIOPH, V52, P123, DOI 10.1007/s00411-012-0450-9	21	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0224873	10.1371/journal.pone.0224873	http://dx.doi.org/10.1371/journal.pone.0224873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765436	Green Published, gold			2022-12-26	WOS:000533891000010
J	Piazzese, C; Foley, K; Whybra, P; Hurt, C; Crosby, T; Spezi, E				Piazzese, Concetta; Foley, Kieran; Whybra, Philip; Hurt, Chris; Crosby, Tom; Spezi, Emiliano			Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer	PLOS ONE			English	Article							TEXTURE ANALYSIS; TUMOR HETEROGENEITY; F-18-FDG PET/CT; LUNG-CANCER; CHEMORADIOTHERAPY; VARIABILITY; DELINEATION; STABILITY	The aim of this work was to investigate radiomic analysis of contrast and non-contrast enhanced planning CT images of oesophageal cancer (OC) patients in terms of stability, dimensionality and contrast agent dependency. The prognostic significance of CT-based radiomic features was also evaluated. Different 2D and 3D radiomic features were extracted from contrast and non-contrast enhanced CT images of 213 patients from the multi-centre SCOPE1 randomised controlled trial (RCT) in OC. Feature stability was evaluated by randomly dividing patients into three groups and identifying textures with similar distributions among groups with a Kruskal-Wallis analysis. A paired two-sided Wilcoxon signed rank test was used to assess for significant differences in the remaining corresponding 2D and 3D stable features. A prognostic model was constructed using clinical characteristics and remaining filtered features. The discriminative ability of significant variables was tested using Kaplan-Meier analysis. A total of 238 2D and 3D radiomic features were computed from oesophageal CT images. More than 75 features were stable if extracted from homogeneous cohort (contrast or non-contrast enhanced CT images) and inhomogeneous cohort (contrast and non-contrast enhanced CT images). Among the remaining corresponding stable features computed from both cohorts, only 4 features did not show a statistically significant difference if obtained in 2D or in 3D (p-value < 0.05). A Cox regression model constructed using 5 clinical variables (age, sex, tumour, node and metastasis (TNM) stage, WHO performance status and contrast administration) and 4 radiomic variables (inverse variance(GLCM), large distance emphasis(GLDZM), zone distance non uniformity norm(GLDZM), zone distance variance(GLDZM)), identified one radiomic feature (zone distance variance(GLDZM)) that was significantly associated with overall survival (p-value = 0.032, HR = 1.25, 95% CI = 1.02-1.52). A significant difference in overall survival between groups was found when considering a threshold of zone distance variance(GLDZM) equals to 1.70 (X-2 = 7.692, df = 1, p-value = 0.006). Zone distance variance(GLDZM) was identified as the only stable CT radiomic feature statistically correlated with overall survival, independent of dimensionality and contrast administration. This feature was able to identify high-risk patients and if validated, could be the subject of a future clinical trial aiming to improve clinical decision making and personalise OC treatment.	[Piazzese, Concetta; Whybra, Philip; Spezi, Emiliano] Cardiff Univ, Sch Engn, Cardiff, Wales; [Piazzese, Concetta; Foley, Kieran; Crosby, Tom; Spezi, Emiliano] Velindre Canc Ctr, Cardiff, Wales; [Hurt, Chris] Ctr Trials Res, Cardiff, Wales	Cardiff University; Velindre Cancer Centre	Piazzese, C (corresponding author), Cardiff Univ, Sch Engn, Cardiff, Wales.; Piazzese, C (corresponding author), Velindre Canc Ctr, Cardiff, Wales.	concettap@cardiff.ac.uk	Spezi, Emiliano/A-8917-2008; Whybra, Philip/E-3655-2019	Spezi, Emiliano/0000-0002-1452-8813; Hurt, Chris/0000-0003-1206-8355; Whybra, Philip/0000-0003-2214-6193; Piazzese, Concetta/0000-0002-3605-1809; Foley, Kieran/0000-0002-1299-1759	Velindre NHS Trust Charitable funds [2017/12]	Velindre NHS Trust Charitable funds	This work was funded by Velindre NHS Trust Charitable funds project number 2017/12 to ES.	Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Badic B, 2019, ACAD RADIOL, V26, P469, DOI 10.1016/j.acra.2018.06.004; Bogowicz M, 2017, ACTA ONCOL, V56, P1531, DOI 10.1080/0284186X.2017.1346382; Chalkidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124165; Cook GJR, 2013, J NUCL MED, V54, P173, DOI 10.2967/jnumed.112.116236; Crosby T, 2017, BRIT J CANCER, V116, P709, DOI 10.1038/bjc.2017.21; Deasy JO, 2003, MED PHYS, V30, P979, DOI 10.1118/1.1568978; Foley KG, 2018, EUR RADIOL, V28, P428, DOI 10.1007/s00330-017-4973-y; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Gwynne S, 2012, INT J RADIAT ONCOL, V84, P1037, DOI 10.1016/j.ijrobp.2012.01.094; Hou Z, 2017, ONCOTARGET, V8, P104444, DOI 10.18632/oncotarget.22304; Hurt CN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-466; Lambin P, 2017, ADV DRUG DELIVER REV, V109, P131, DOI 10.1016/j.addr.2016.01.006; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Larue RTHM, 2017, ACTA ONCOL, V56, P1544, DOI 10.1080/0284186X.2017.1351624; Mackin D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178524; MANTEL N, 1970, TECHNOMETRICS, V12, P621, DOI 10.2307/1267207; Nakajo M, 2017, EUR J NUCL MED MOL I, V44, P206, DOI 10.1007/s00259-016-3506-2; Ng F, 2013, EUR J RADIOL, V82, P342, DOI 10.1016/j.ejrad.2012.10.023; Pavic M, 2018, ACTA ONCOL, V57, P1070, DOI 10.1080/0284186X.2018.1445283; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Rice TW, 2017, J THORAC ONCOL, V12, P36, DOI 10.1016/j.jtho.2016.10.016; Shafiq-ul-Hassan M, 2017, MED PHYS, V44, P1050, DOI 10.1002/mp.12123; Shen C, 2017, TRANSL ONCOL, V10, P886, DOI 10.1016/j.tranon.2017.08.007; Singh J, 2008, J NUCL MED TECHNOL, V36, P69, DOI 10.2967/jnmt.107.047621; Thawani R, 2018, LUNG CANCER, V115, P34, DOI 10.1016/j.lungcan.2017.10.015; Traverso A, 2018, INT J RADIAT ONCOL, V102, P1143, DOI 10.1016/j.ijrobp.2018.05.053; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; van Rossum PSN, 2016, TRANSL CANCER RES, V5, P410, DOI 10.21037/tcr.2016.06.19; van Velden FHP, 2016, MOL IMAGING BIOL, V18, P788, DOI 10.1007/s11307-016-0940-2; Yip C, 2015, DIS ESOPHAGUS, V28, P172, DOI 10.1111/dote.12170; Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428; Zhao BS, 2014, TRANSL ONCOL, V7, P88, DOI 10.1593/tlo.13865; Zhao BS, 2005, RADIOLOGY, V234, P934, DOI 10.1148/radiol.2343040020; Zwanenburg A, 2016, RADOLOGY, DOI DOI 10.1148/RADIOL.2020191145	36	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225550	10.1371/journal.pone.0225550	http://dx.doi.org/10.1371/journal.pone.0225550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756181	Green Published, gold, Green Accepted			2022-12-26	WOS:000533889300038
J	Hamadeh, A; Feng, Z; Krahn, M; Wong, WWL				Hamadeh, Abdullah; Feng, Zeny; Krahn, Murray; Wong, William W. L.			A model-based framework for chronic hepatitis C prevalence estimation	PLOS ONE			English	Article							PERFECT INFORMATION; EXPECTED VALUE; ASSOCIATION; INFECTION	Chronic hepatitis C (CHC) continues to be a highly burdensome disease worldwide. The often-asymptomatic nature of early-stage CHC means that the disease often remains undiagnosed, leaving its prevalence highly uncertain. This generates significant uncertainty in the planning of hepatitis C eradication programs to meet WHO targets. The aim of this work is to establish a mathematical framework for the estimation of a geographic locale's CHC prevalence and the proportion of its CHC population that remains undiagnosed. A Bayesian MCMC approach is taken to infer these populations from the observed occurrence of CHCrelated events using a recently published natural history model of the disease. Using the Canadian context as a specific example, this study estimates that in 2013, the CHC prevalence rate in Canada was 0.63% (95% CI: 0.53% - 0.72%), with 27.1% (95% CI: 19.3% 36.1%) of the infected population undiagnosed.	[Hamadeh, Abdullah; Wong, William W. L.] Univ Waterloo, Sch Pharm, Kitchener, ON, Canada; [Feng, Zeny] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada; [Krahn, Murray] Univ Hlth Network, Toronto Gen Hosp, Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada; [Krahn, Murray] Toronto Gen Res Inst, Toronto, ON, Canada	University of Waterloo; University of Guelph; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Wong, WWL (corresponding author), Univ Waterloo, Sch Pharm, Kitchener, ON, Canada.	wwlwong@uwaterloo.ca		Wong, William W.L./0000-0003-4630-0052; Krahn, Murray/0000-0001-5836-397X	Tier 1 Canada Research Chair in Health Technology Assessment; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC); Canadian Liver Foundation; Ontario Ministry of Research, Innovation, and Science Early Researcher Award	Tier 1 Canada Research Chair in Health Technology Assessment; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Liver Foundation; Ontario Ministry of Research, Innovation, and Science Early Researcher Award	WWLW and MK received funding from the Canadian Liver Foundation, URL: www.liver.ca.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is funded by Canadian Liver Foundation. Dr. Krahn is supported by a Tier 1 Canada Research Chair in Health Technology Assessment. Dr. Wong's research program was supported by Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council (NSERC), Canadian Liver Foundation and Ontario Ministry of Research, Innovation, and Science Early Researcher Award.	Centre for Communicable Diseases and Infection Control, 2012, HEP C CAN 2005 2010; Goossens N, 2015, CLIN MOL HEPATOL, V21, P105, DOI 10.3350/cmh.2015.21.2.105; Grad R, 2017, CAN MED ASSOC J, V189, pE594, DOI 10.1503/cmaj.161521; Hamadeh A, 2018, SOC MED DEC MAK 40 A; Krajden M, 2019, INT J DRUG POLICY, V72, P114, DOI 10.1016/j.drugpo.2019.06.003; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Miller Cari L, 2007, Harm Reduct J, V4, P1, DOI 10.1186/1477-7517-4-1; Oostenbrink JB, 2008, VALUE HEALTH, V11, P1070, DOI 10.1111/j.1524-4733.2008.00389.x; Public Health Agency Canada, 2010, EP AC HEP C INF CAN; Public Health Agency of Canada, CAN NOT DIS SURV SY; Remis RS., 2009, MODELLING INCIDENCE; Rotermann M, 2013, HEALTH REP, V24, P3; Samji H, 2017, J HEPATOL, V67, P909, DOI 10.1016/j.jhep.2017.06.025; Shah H, 2018, CAN MED ASSOC J, V190, pE677, DOI 10.1503/cmaj.170453; Statistics Canada, TABL 13 10 0114 01 L; Statistics Canada, TABL 103 0550 NUMB R; Statistics Canada, EST POP AG GROUP SEX; Strong M, 2014, MED DECIS MAKING, V34, P311, DOI 10.1177/0272989X13505910; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Trubnikov M, 2014, Can Commun Dis Rep, V40, P429; US Department of Veterans Affairs, HEP C GEN; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; WHO, 2017, WHO PUBLISHES LIST B; Wong William W L, 2017, CMAJ Open, V5, pE662, DOI 10.9778/cmajo.20170048; Wong WWL, 2015, CAN MED ASSOC J, V187, pE110, DOI 10.1503/cmaj.140711	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225366	10.1371/journal.pone.0225366	http://dx.doi.org/10.1371/journal.pone.0225366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751393	gold, Green Submitted, Green Published			2022-12-26	WOS:000533886900054
J	Le Ster, C; Moreno, A; Mauconduit, F; Gras, V; Stirnberg, R; Poser, BA; Vignaud, A; Eger, E; Dehaene, S; Meyniel, F; Boulant, N				Le Ster, Caroline; Moreno, Antonio; Mauconduit, Franck; Gras, Vincent; Stirnberg, Ruediger; Poser, Benedikt A.; Vignaud, Alexandre; Eger, Evelyn; Dehaene, Stanislas; Meyniel, Florent; Boulant, Nicolas			Comparison of SMS-EPI and 3D-EPI at 7T in an fMRI localizer study with matched spatiotemporal resolution and homogenized excitation profiles	PLOS ONE			English	Article							STATE FUNCTIONAL MRI; TEMPORAL RESOLUTION; PHYSIOLOGICAL NOISE; WHOLE-BRAIN; RF PULSES; 3 T; PARALLEL; TESLA; 2D; TRANSMISSION	The simultaneous multi-slice EPI (SMS-EPI, a.k.a. MB-EPI) sequence has met immense popularity recently in functional neuroimaging. A still less common alternative is the use of 3D-EPI, which offers similar acceleration capabilities. The aim of this work was to compare the SMS-EPI and the 3D-EPI sequences in terms of sampling strategies for the detection of task-evoked activations at 7T using detection theory. To this end, the spatial and temporal resolutions of the sequences were matched (1.6 mm isotropic resolution, TR = 1200 ms) and their excitation profiles were homogenized by means of calibration-free parallel-transmission (Universal Pulses). We used a fast-event "localizer" paradigm of 5:20 min in order to probe sensorimotor functions (visual, auditory and motor tasks) as well as higher level functions (language comprehension, mental calculation), where results from a previous large-scale study at 3T (N = 81) served as ground-truth reference for the brain areas implicated in each cognitive function. In the current study, ten subjects were scanned while their activation maps were generated for each cognitive function with the GLM analysis. The SMS-EPI and 3D-EPI sequences were compared in terms of raw tSNR, t-score testing for the mean signal, activation strength and accuracy of the robust sensorimotor functions. To this end, the sensitivity and specificity of these contrasts were computed by comparing their activation maps to the reference brain areas obtained in the 3T study. Estimated flip angle distributions in the brain reported a normalized root mean square deviation from the target value below 10% for both sequences. The analysis of the t-score testing for the mean signal revealed temporal noise correlations, suggesting the use of this metric instead of the traditional tSNR for testing fMRI sequences. The SMS-EPI and 3D-EPI thereby yielded similar performance from a detection theory perspective.	[Le Ster, Caroline; Mauconduit, Franck; Gras, Vincent; Vignaud, Alexandre; Boulant, Nicolas] Univ Paris Saclay, CEA, NeuroSpin, Gif Sur Yvette, France; [Moreno, Antonio; Eger, Evelyn; Dehaene, Stanislas; Meyniel, Florent] Univ Paris Saclay, INSERM, CEA, NeuroSpin, Gif Sur Yvette, France; [Stirnberg, Ruediger] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Poser, Benedikt A.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Dehaene, Stanislas] Coll France, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Maastricht University; UDICE-French Research Universities; PSL Research University Paris; College de France	Boulant, N (corresponding author), Univ Paris Saclay, CEA, NeuroSpin, Gif Sur Yvette, France.	nicolas.boulant@cea.fr	Boulant, Nicolas/AAQ-9834-2020; Saint-Jalmes, Hervé/O-6140-2015; Eger, Evelyn/B-1393-2019	Mauconduit, Franck/0000-0002-0128-061X; Le Ster, Caroline/0000-0002-4767-8738; Eger, Evelyn/0000-0002-7164-2356; Stirnberg, Rudiger/0000-0001-7021-1063	European Research Council [700812]	European Research Council(European Research Council (ERC)European Commission)	NB: This work was supported by European Research Council, Proof of Concept #700812 (https://erc.europa.eu/funding/proofconcept).The funders provided support in the form of salaries for authors (CEA: CLS, VG, AV, NB), but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adriany G, 2005, MAGN RESON MED, V53, P434, DOI 10.1002/mrm.20321; Vu AT, 2017, NEUROIMAGE, V154, P23, DOI 10.1016/j.neuroimage.2016.11.049; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bollmann S, 2018, NEUROIMAGE, V166, P152, DOI 10.1016/j.neuroimage.2017.10.043; Boulant N, 2018, P 26 ANN ISMRM M PAR; Breuer FA, 2006, MAGN RESON MED, V55, P549, DOI 10.1002/mrm.20787; Cauley SF, 2014, MAGN RESON MED, V72, P93, DOI 10.1002/mrm.24898; Chen JYE, 2019, NEUROIMAGE, V188, P807, DOI 10.1016/j.neuroimage.2019.02.008; Chen L, 2015, NEUROIMAGE, V104, P452, DOI 10.1016/j.neuroimage.2014.10.027; Cloos MA, 2012, MAGN RESON MED, V67, P72, DOI 10.1002/mrm.22978; CONSTABLE RT, 1995, MAGNET RESON MED, V34, P57, DOI 10.1002/mrm.1910340110; Corbin N, 2018, HUM BRAIN MAPP, V39, P3884, DOI 10.1002/hbm.24218; Demetriou L, 2018, NEUROIMAGE, V176, P404, DOI 10.1016/j.neuroimage.2018.05.011; Eichfelder G, 2011, MAGN RESON MED, V66, P1468, DOI 10.1002/mrm.22927; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gras V, 2017, MAGNETIC RESONANCE M, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Gras V, 2019, NEUROIMAGE, V195, P1, DOI 10.1016/j.neuroimage.2019.03.040; Gras V, 2018, MAGN RESON MED, V80, P53, DOI 10.1002/mrm.27001; Gras V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183562; Gras V, 2017, MAGN RESON MED, V77, P635, DOI 10.1002/mrm.26148; Gras V, 2015, J MAGN RESON, V261, P181, DOI 10.1016/j.jmr.2015.10.017; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Huber L, 2018, NEUROIMAGE, V164, P131, DOI 10.1016/j.neuroimage.2016.11.039; Jorge J, 2013, MAGN RESON IMAGING, V31, P212, DOI 10.1016/j.mri.2012.07.001; Katscher U, 2003, MAGNET RESON MED, V49, P144, DOI 10.1002/mrm.10353; Kopanoglu E, 2019, P 27 ANN ISMRM M, P4686; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Larkman DJ, 2001, J MAGN RESON IMAGING, V13, P313, DOI 10.1002/1522-2586(200102)13:2<313::AID-JMRI1045>3.0.CO;2-W; Lutti A, 2013, MAGN RESON MED, V69, P1657, DOI 10.1002/mrm.24398; Macmillan NA, 2005, DETECTION THEORY USE; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Narsude M, 2016, MAGN RESON MED, V75, P2350, DOI 10.1002/mrm.25835; Padormo F, 2016, NMR BIOMED, V29, P1145, DOI 10.1002/nbm.3313; Pinel P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-91; Poser BA, 2010, NEUROIMAGE, V51, P261, DOI 10.1016/j.neuroimage.2010.01.108; Reynaud O, 2017, MAGN RESON MED, V78, P888, DOI 10.1002/mrm.26823; Risk BB, 2018, NEUROIMAGE, V172, P538, DOI 10.1016/j.neuroimage.2018.01.078; Saekho S, 2006, MAGN RESON MED, V55, P719, DOI 10.1002/mrm.20840; Sahib AK, 2016, MAGN RESON MED, V76, P1805, DOI 10.1002/mrm.26073; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Setsompop K, 2008, MAGN RESON MED, V60, P1422, DOI 10.1002/mrm.21739; Stirnberg R, 2017, NEUROIMAGE, V163, P81, DOI 10.1016/j.neuroimage.2017.08.031; Stirnberg R, 2016, MAGN RESON MED, V76, P1517, DOI 10.1002/mrm.26063; Todd N, 2016, NEUROIMAGE, V124, P32, DOI 10.1016/j.neuroimage.2015.08.056; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; van der Zwaag W, 2012, MAGN RESON MED, V67, P344, DOI 10.1002/mrm.23007; Webb AG, 2011, CONCEPT MAGN RESON A, V38A, P148, DOI 10.1002/cmr.a.20219; Wu X, 2018, P 26 ANN M ISMRM PAR, P1133; Wu XP, 2019, NEUROIMAGE, V184, P396, DOI 10.1016/j.neuroimage.2018.09.038; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	54	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225286	10.1371/journal.pone.0225286	http://dx.doi.org/10.1371/journal.pone.0225286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751410	Green Published, gold			2022-12-26	WOS:000533886900043
J	Wyder, PM; Chen, YS; Lasrado, AJ; Pelles, RJ; Kwiatkowski, R; Comas, EOA; Kennedy, R; Mangla, A; Huang, ZX; Hu, XT; Xiong, ZY; Aharoni, T; Chuang, TC; Lipson, H				Wyder, Philippe Martin; Chen, Yan-Song; Lasrado, Adrian J.; Pelles, Rafael J.; Kwiatkowski, Robert; Comas, Edith O. A.; Kennedy, Richard; Mangla, Arjun; Huang, Zixi; Hu, Xiaotian; Xiong, Zhiyao; Aharoni, Tomer; Chuang, Tzu-Chan; Lipson, Hod			Autonomous drone hunter operating by deep learning and all-onboard computations in GPS-denied environments	PLOS ONE			English	Article								This paper proposes a UAV platform that autonomously detects, hunts, and takes down other small UAVs in GPS-denied environments. The platform detects, tracks, and follows another drone within its sensor range using a pre-trained machine learning model. We collect and generate a 58,647-image dataset and use it to train a Tiny YOLO detection algorithm. This algorithm combined with a simple visual-servoing approach was validated on a physical platform. Our platform was able to successfully track and follow a target drone at an estimated speed of 1.5 m/s. Performance was limited by the detection algorithm's 77% accuracy in cluttered environments and the frame rate of eight frames per second along with the field of view of the camera.	[Wyder, Philippe Martin; Lasrado, Adrian J.; Pelles, Rafael J.; Xiong, Zhiyao; Lipson, Hod] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Chen, Yan-Song; Kwiatkowski, Robert; Comas, Edith O. A.; Kennedy, Richard; Mangla, Arjun; Aharoni, Tomer; Chuang, Tzu-Chan] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Huang, Zixi; Hu, Xiaotian] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Wyder, PM (corresponding author), Columbia Univ, Dept Mech Engn, New York, NY 10027 USA.	Philippe.Wyder@columbia.edu			U.S. National Science Foundation National Robotics Initiative [1527232]	U.S. National Science Foundation National Robotics Initiative	This work was supported by U.S. National Science Foundation National Robotics Initiative grant number 1527232 (M. A. Gore, R. J. Nelson, and H. Lipson) http://www.nsf.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors want to thank Professor Steven A. Edwards for generously offering his time and expertise in debugging our UART connection issues. In addition, we want to thank the Columbia Dodge Gym for giving us access to a squash court for a two-hour slot twice a week to test our platform.	Balamurugan G., 2016, 2016 International Conference on Signal Processing, Communication, Power and Embedded System (SCOPES), P198, DOI 10.1109/SCOPES.2016.7955787; Dinan S., 2017, WASHINGTON TIMES; Dronecode Project Inc, OP SOURC DRON PX4 OP; Federal Aviation Administration, 2018, FY201838 FED AV ADM, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Fu C.Y., 2017, ARXIV170106659; Gibbons-Neff T., 2017, WASHINGTON POST; Girshick R, 2014, P IEEE C COMP VIS PA, DOI [DOI 10.1109/CVPR.2014.81, 10.1109/CVPR.2014.81]; Honegger D, 2013, IEEE INT CONF ROBOT, P1736, DOI 10.1109/ICRA.2013.6630805; Lin TY, 2017, IEEE I CONF COMP VIS, P2999, DOI 10.1109/ICCV.2017.324; Lin Tsung-Yi, 2017, CVPR, DOI DOI 10.1109/CVPR.2017.106; Lohr D., 2018, HUFFINGTON POST; Lu YC, 2018, GEO-SPAT INF SCI, V21, P21, DOI 10.1080/10095020.2017.1420509; Mannes J., 2017, TECH CRUNCH; Nikolic J, 2014, IEEE INT CONF ROBOT, P431, DOI 10.1109/ICRA.2014.6906892; Nvidia, DEV NVIDIA; Nvidia Corp, 2018, NVIDIA DEV; Ong T., 2017, VERGE, P1; Opromolla R, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103391; Rady S., 2011, 2011 IEEE/SICE International Symposium on System Integration (SII 2011), P1269, DOI 10.1109/SII.2011.6147631; RAVEN R J, 1988, American Museum Novitates, P1; Redmon J, 2001, PLANT SOIL, DOI [10.1023/A:1011909414400, DOI 10.1023/A:1011909414400]; Redmon J, DARKNET OPEN SOURCE; REDMON J, 2017, PROC CVPR IEEE, DOI [DOI 10.1109/CVPR.2017.690, 10.1109/CVPR.2017.690]; Redmon J., 2016, PROC CVPR IEEE, DOI [10.1109/CVPR.2016.91, DOI 10.1109/CVPR.2016.91]; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Richey E., 2018, KSDK; Rizzo C., 2018, TRAVEL LEISURE; Selk A., 2017, WASHINGTON POST; SHAH G, 2019, OBJECT RECOGNITION T; Shah S., 2018, FIELD SERVICE ROBOTI, P621, DOI 10.1007/978-3-319-67361-5_40; Wall R. U.K., 2018, WALL STREET J; Wei Liu, 2016, Computer Vision - ECCV 2016. 14th European Conference. Proceedings: LNCS 9905, P21, DOI 10.1007/978-3-319-46448-0_2; Wong D., 2018, STRAITS TIMES; Wu YW, 2017, IEEE ACCESS, V5, P23969, DOI 10.1109/ACCESS.2017.2764419; Wyant RT, 2016, SMALL ARMS DEF J, V8; Xiang T., 2017, PROC IEEE INT C MULT, P400; Zhang Z., 2017, VISUAL INERTIAL ODOM	37	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225092	10.1371/journal.pone.0225092	http://dx.doi.org/10.1371/journal.pone.0225092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738785	Green Published, gold			2022-12-26	WOS:000532826300031
J	Daly, MB; Clayton, AM; Ruone, S; Mitchell, J; Dinh, C; Holder, A; Jolly, J; Garcia-Lerma, JG; Weed, JL				Daly, Michele B.; Clayton, April M.; Ruone, Susan; Mitchell, James; Dinh, Chuong; Holder, Angela; Jolly, Julian; Garcia-Lerma, J. Gerardo; Weed, James L.			Training rhesus macaques to take daily oral antiretroviral therapy for preclinical evaluation of HIV prevention and treatment strategies	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; HUMAN-IMMUNODEFICIENCY-VIRUS; CHLAMYDIA-TRACHOMATIS; INFECTION	Background Macaque models of simian or simian/human immunodeficiency virus (SIV or SHIV) infection are critical for the evaluation of antiretroviral (ARV)-based HIV treatment and prevention strategies. However, modelling human oral ARV administration is logistically challenging and fraught by limited adherence. Here, we developed a protocol for administering daily oral doses of ARVs to macaques with a high rate of compliance. Methods Parameters of positive reinforcement training (PRT), behavioral responses and optimal drug delivery foods were defined in 7 male rhesus macaques (Macaca mulatta). Animals were trained to sit in a specified cage location prior to receiving ARVs, emtricitabine (FTC) and tenofovir alafenamide (TAF), in a blended food mixture, which was followed immediately with a juice chaser. Consistency of daily oral adherence was evaluated in 4 trained macaques receiving clinically equivalent doses of FTC and TAF (20 and 1.5 mg/kg, respectively) in a short-term (1 month) and an extended (6 month) trial. Adherence was monitored using medication diaries and by quantifying intracellular FTC-triphosphate (FTC-TP) and tenofovir-diphosphate (TFV-DP) concentrations in peripheral mononuclear blood cells (PBMCs). Results Trained macaques quickly and consistently took daily oral ARVs for 1 month with an average 99.8% observed adherence. Intracellular concentrations of TFV-DP (median = 845.8 fmol/million cells [range, 620.8-1031.3]) and FTC-TP (median = 367.0 fmol/million cells [range, 289.5-413.5) in PBMCs were consistent with high adherence. Extended treatment with select subjects yielded similar observations for three months (99.5% adherence, 352/356 complete doses taken), although a sudden drop in adherence was observed after splenic biopsy surgery. Conclusions We demonstrate that trained macaques reliably adhere to a daily oral ARV regimen, although unexpected adherence issues are possible. Our approach, using clinical doses of oral FTC and TAF daily, further refines macaque models of HIV treatment and prevention by mimicking the human route and timing of ARV administration.	[Daly, Michele B.; Ruone, Susan; Mitchell, James; Dinh, Chuong; Holder, Angela; Garcia-Lerma, J. Gerardo] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Clayton, April M.; Jolly, Julian; Weed, James L.] Ctr Dis Control & Prevent, Div Sci Resources, Comparat Med Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Garcia-Lerma, JG (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.; Weed, JL (corresponding author), Ctr Dis Control & Prevent, Div Sci Resources, Comparat Med Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	jng5@cdc.gov; xyo6@cdc.gov			CDC intramural funds; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [P51OD011106]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	CDC intramural funds; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded with CDC intramural funds. The Wisconsin National Primate Research Center, which performed the cortisol analysis, is supported by the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Award Number P51OD011106.r We thank Brianna Skinner for serving as the attending veterinarian for this study protocol and the contracting staff for assistance with medication administration. The Wisconsin National Primate Research Center, which performed the cortisol analysis, is supported by the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Award Number P51OD011106.	[Anonymous], 2012, EMTR PACK INS; Del Prete GQ, 2018, CURR TOP MICROBIOL, V417, P69, DOI 10.1007/82_2017_73; Del Prete GQ, 2016, AIDS RES HUM RETROV, V32, P163, DOI [10.1089/AID.2015.0130, 10.1089/aid.2015.0130]; EGGER MD, 1963, J COMP PHYSIOL PSYCH, V56, P132, DOI 10.1037/h0040744; Gaalema DE, 2011, J APPL ANIM WELF SCI, V14, P33, DOI 10.1080/10888705.2011.527602; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2011, J VIROL, V85, P6610, DOI 10.1128/JVI.00311-11; Garcia-Lerma JG, 2009, 16 C RETROVIRUSES OP; Gibaldi M, 2008, BIOPHARMACEUTICS CLI, Vfourth; Hopper LM, 2019, BEHAV RES METHODS, V51, P639, DOI 10.3758/s13428-018-1065-0; I.P, 1927, P COND REFL, P380; Kuklenyik Z, 2009, J CHROMATOGR B, V877, P3659, DOI 10.1016/j.jchromb.2009.09.007; Laule Gail E., 2003, Journal of Applied Animal Welfare Science, V6, P163, DOI 10.1207/S15327604JAWS0603_02; Makarova N, 2017, AIDS, V31, P745, DOI 10.1097/QAD.0000000000001389; Martin AL, 2018, BEHAV PROCESS, V157, P445, DOI 10.1016/j.beproc.2018.07.002; Massud I., 2016, J INFECT DIS; McMillan JL, 2014, J AM ASSOC LAB ANIM, V53, P61; Mueller MM, 2004, J APPL BEHAV ANAL, V37, P159, DOI 10.1901/jaba.2004.37-159; NIH, 2016, DRUGS FIGHT HIV 1 RE; Otten RA, 2005, J INFECT DIS, V191, P164, DOI 10.1086/426452; Perlman J, 2012, IMPLEMENTING POSITIV; Radzio J, 2016, J INFECT DIS, V213, P1541, DOI 10.1093/infdis/jiw002; Ramirez K., 1999, ANIMAL TRAINING SUCC, P533; Reinhardt Viktor, 2003, Journal of Applied Animal Welfare Science, V6, P189, DOI 10.1207/S15327604JAWS0603_04; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; UNAIDS, 2020, GLOB HIV AIDS STAT F; Van Rompay KKA, 1998, AIDS, V12, pF79, DOI 10.1097/00002030-199809000-00001; Van Rompay KKA, 2006, JAIDS-J ACQ IMM DEF, V43, P6, DOI 10.1097/01.qai.0000224972.60339.7c; Van Rompay KKA, 2012, ANTIMICROB AGENTS CH, V56, P4980, DOI 10.1128/AAC.01095-12; Vaz PCM, 2012, J APPL BEHAV ANAL, V45, P97, DOI 10.1901/jaba.2012.45-97; Weiss HA, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-8	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225146	10.1371/journal.pone.0225146	http://dx.doi.org/10.1371/journal.pone.0225146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2YM	31730629	Green Published, gold			2022-12-26	WOS:000532809500027
J	Dugdale, CM; Phillips, TK; Myer, L; Hyle, EP; Brittain, K; Freedberg, KA; Cunnama, L; Walensky, RP; Zerbe, A; Weinstein, MC; Abrams, EJ; Ciaranello, AL				Dugdale, Caitlin M.; Phillips, Tamsin K.; Myer, Landon; Hyle, Emily P.; Brittain, Kirsty; Freedberg, Kenneth A.; Cunnama, Lucy; Walensky, Rochelle P.; Zerbe, Allison; Weinstein, Milton C.; Abrams, Elaine J.; Ciaranello, Andrea L.		MCH-ART Trial Team	Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa	PLOS ONE			English	Article							MOTHER-TO-CHILD; SINGLE-DOSE NEVIRAPINE; DAR-ES-SALAAM; HIV-1 TRANSMISSION; CAPE-TOWN; FOLLOW-UP; PREGNANCY; EFFICACY; PREVENTION; ZIDOVUDINE	Background Poor engagement in postpartum maternal HIV care is a challenge worldwide and contributes to adverse maternal outcomes and vertical transmission. Our objective was to project the clinical and economic impact of integrated postpartum maternal antiretroviral therapy (ART) and pediatric care in South Africa. Methods Using the CEPAC computer simulation models, parameterized with data from the Maternal and Child Health-Antiretroviral Therapy (MCH-ART) randomized controlled trial, we evaluated the cost-effectiveness of integrated postpartum care for women initiating ART in pregnancy and their children. We compared two strategies: 1) standard of care (SOC) referral to local clinics after delivery for separate standard ART services for women and pediatric care for infants, and 2) the MCH-ART intervention (MCH-ART) of co-located maternal/pediatric care integrated in Maternal and Child Health (MCH) services throughout breastfeeding. Trial-derived inputs included: 12-month maternal retention in care and virologic suppression (SOC: 49%, MCH-ART: 67%), breastfeeding duration (SOC: 6 months, MCH-ART: 8 months), and postpartum healthcare costs for mother-infant pairs (SOC: $50, MCH-ART: $69). Outcomes included pediatric HIV infections, maternal and infant life expectancy (LE), lifetime HIV-related per-person costs, and incremental cost-effectiveness ratios (ICERs; ICER <US$903/YLS considered "cost-effective"). Results Compared to SOC, MCH-ART increased maternal LE (SOC: 25.26 years, MCH-ART: 26.20 years) and lifetime costs (SOC: $9,912, MCH-ART: $10,207; discounted). Projected pediatric outcomes for all HIV-exposed children were similar between arms, although undiscounted LE for HIV-infected children was shorter in SOC (SOC: 23.13 years, MCH-ART: 23.40 years). Combining discounted maternal and pediatric outcomes, the ICER was $599/ YLS. Conclusion Co-located maternal HIV and pediatric care, integrated in MCH services throughout breastfeeding, is a cost-effective strategy to improve maternal and pediatric outcomes and should be implemented in South Africa.	[Dugdale, Caitlin M.; Hyle, Emily P.; Freedberg, Kenneth A.; Walensky, Rochelle P.; Ciaranello, Andrea L.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Dugdale, Caitlin M.; Hyle, Emily P.; Freedberg, Kenneth A.; Walensky, Rochelle P.; Ciaranello, Andrea L.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Dugdale, Caitlin M.; Hyle, Emily P.; Freedberg, Kenneth A.; Walensky, Rochelle P.; Ciaranello, Andrea L.] Harvard Med Sch, Boston, MA 02115 USA; [Phillips, Tamsin K.; Myer, Landon; Brittain, Kirsty] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Phillips, Tamsin K.; Myer, Landon; Brittain, Kirsty] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Freedberg, Kenneth A.; Walensky, Rochelle P.; Ciaranello, Andrea L.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Freedberg, Kenneth A.; Weinstein, Milton C.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Cunnama, Lucy] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, Cape Town, South Africa; [Zerbe, Allison; Abrams, Elaine J.] Columbia Univ, ICAP Columbia, New York, NY USA; [Zerbe, Allison; Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Abrams, Elaine J.] Columbia Univ, Coll Phys & Surg, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Cape Town; University of Cape Town; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Cape Town; Columbia University; Columbia University; Columbia University	Dugdale, CM (corresponding author), Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA.; Dugdale, CM (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA.; Dugdale, CM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	cdugdale@mgh.harvard.edu	Cunnama, Lucy/AAQ-6468-2021; , Andrea/ABB-3330-2021; Cunnama, Lucy/AAK-3159-2021	, Andrea/0000-0002-4268-3263; Cunnama, Lucy/0000-0003-2134-4905; Dugdale, Caitlin/0000-0002-6604-6111; Phillips, Tamsin/0000-0003-4554-2922	President's Emergency Plan for AIDS Relief (PEPFAR) through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD074558]; Elizabeth Glaser Pediatric AIDS Foundation; National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Disease [NIAID] [T32 AI007433, R01 AI058736, R37 AI09326]; NICHD [R01 HD079214]; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT.) Group; National Heart, Lung, and Blood Institute [K01 HL123349]; Steve and Deborah Gorlin Massachusetts General Hospital (MGH) Research Scholars Award; Harvard University Center for AIDS Research (CFAR), an NIH [P30 AI060354]; NIAID; NCI; NICHD; NIDCR; NHLBI; NIDA; NIMH; NIA; NIDDK; NIGMS; NIMHD; FIC; OAR; Department of Health and Human Services [HHSN275201300003C]; NIAID of the NIH [UM1 AI068632, UM1 AI068616]; National Institute of Mental Health (NIHM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079214] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL123349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, UM1AI068616, R37AI093269, T32AI007433, P30AI060354, UM1AI068632, R37AI058736] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Elizabeth Glaser Pediatric AIDS Foundation; National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Disease [NIAID]; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT.) Group; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Steve and Deborah Gorlin Massachusetts General Hospital (MGH) Research Scholars Award; Harvard University Center for AIDS Research (CFAR), an NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD; FIC; OAR; Department of Health and Human Services; NIAID of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIHM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The MCH-ART trial was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; R01 HD074558). Additional funding comes from the Elizabeth Glaser Pediatric AIDS Foundation. This work was supported by the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Disease [NIAID; T32 AI007433 (CMD), R01 AI058736 (KAF, RPW), R37 AI093269 (RPW)], NICHD [R01 HD079214 (ALC)], the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT.) Group (CMD, ALC, RPW, KAF), the National Heart, Lung, and Blood Institute [K01 HL123349 (EPH)], and the Steve and Deborah Gorlin Massachusetts General Hospital (MGH) Research Scholars Award (RPW). This research was funded in part by a 2017 developmental grant from the Harvard University Center for AIDS Research (CFAR), an NIH funded program (P30 AI060354: CMD) which is supported by the following NIH co-funding and participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NIGMS, NIMHD, FIC, and OAR. This project has been funded in whole or in part with federal funds from NICHD, NIH, and the Department of Health and Human Services, under Contract No. HHSN275201300003C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the MGH Research Scholars Award.. Overall support for IMPAACT was provided by NIAID of the NIH under Award Numbers UM1 AI068632 (IMPAACT LOC), UM1 AI068616 (IMPAACT SDMC), with co-funding from NICHD and the National Institute of Mental Health (NIHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu MH, 2016, LANCET HIV, V3, pE202, DOI 10.1016/S2352-3018(16)00018-7; Andrews JR, 2012, AIDS, V26, P987, DOI 10.1097/QAD.0b013e3283522d47; [Anonymous], 2016, GUID UPD HIV INF FEE, DOI [DOI 10.1103/PHYSREVA.63.023818, 10.1103/PhysRevA.63.023818]; Arikawa S, 2018, CLIN INFECT DIS, V66, P1668, DOI 10.1093/cid/cix1102; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Chammartin F, 2018, CLIN INFECT DIS, V67, P1643, DOI 10.1093/cid/ciy347; Chapman RH, 2004, HEALTH ECON, V13, P429, DOI 10.1002/hec.853; Chetty T, 2018, TROP MED INT HEALTH, V23, P79, DOI 10.1111/tmi.13001; Chigwedere P, 2008, AIDS RES HUM RETROV, V24, P827, DOI 10.1089/aid.2007.0291; Ciaranello AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083389; Cleary S, 2005, HLTH SYSTEMS TRUST S; Cohan D, 2015, AIDS, V29, P183, DOI 10.1097/QAD.0000000000000531; Dabis F, 2005, AIDS, V19, P309; Dunning L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002446; Fawzi W, 2002, JAIDS-J ACQ IMM DEF, V31, P331, DOI 10.1097/00126334-200211010-00010; Flynn PM, 2018, JAIDS-J ACQ IMM DEF, V77, P383, DOI 10.1097/QAI.0000000000001612; Francke JA, 2016, J INFECT DIS, V214, P1319, DOI 10.1093/infdis/jiw379; Goga AE, 2016, HIGHEST RISK MOTHER; Grimsrud AT, 2013, J CLIN EPIDEMIOL, V66, P1006, DOI 10.1016/j.jclinepi.2013.03.013; Guillaine Neza, 2017, Int J MCH AIDS, V6, P36, DOI 10.21106/ijma.186; Haas AD, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25084; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; International Monetary Fund, WORLD EC OUTLOOK DAT; Kalk E, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25212; Kilewo C, 2008, JAIDS-J ACQ IMM DEF, V48, P315, DOI 10.1097/QAI.0b013e31816e395c; Kiragu K, 2017, JAIDS-J ACQ IMM DEF, V75, pS36, DOI [10.1097/QAI.0000000000001323, 10.1097/qai.0000000000001323]; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; Mandelbrot L, 2015, CLIN INFECT DIS, V61, P1715, DOI 10.1093/cid/civ578; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; Massachusetts General Hospital Medical Practice Evaluation Center, COST EFF PREV AIDS C; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Meyer-Rath G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186496; Myer L, 2017, HIV MED, V18, P80, DOI 10.1111/hiv.12397; Myer L, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002547; Ngoma MS, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19352; Oanda, HIST EXCH RAT PER AV; Onoya D, 2017, AIDS, V31, P1593, DOI 10.1097/QAD.0000000000001517; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Perry MEO, 2016, HIV MED, V17, P28, DOI 10.1111/hiv.12277; Phillips T, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19242; Robinson LA, 2017, HEALTH POLICY PLANN, V32, P141, DOI 10.1093/heapol/czw096; Saba J, 2002, LANCET, V359, P1178; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; South Africa Department of Health, 2015, NAT CONS GUID PREV M; Stewart RD, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.020; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Winestone LE, 2012, GLOB PUBLIC HEALTH, V7, P149, DOI 10.1080/17441692.2011.621964; Woods B, 2015, COUNTRY LEVEL COST E; Zulliger R, 2014, AIDS BEHAV, V18, P697, DOI 10.1007/s10461-013-0641-7	55	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225104	10.1371/journal.pone.0225104	http://dx.doi.org/10.1371/journal.pone.0225104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2YM	31730630	Green Published, gold			2022-12-26	WOS:000532809500023
J	Liu, MY; Saha, N; Gajan, A; Saadat, N; Gupta, SV; Pile, LA				Liu, Mengying; Saha, Nirmalya; Gajan, Ambikai; Saadat, Nadia; Gupta, Smiti V.; Pile, Lori A.			A complex interplay between SAM synthetase and the epigenetic regulator SIN3 controls metabolism and transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone modification; transcription; metabolism; glycolysis; tricarboxylic acid cycle; TCA cycle; Krebs cycle; gene regulation; epigenetics; chromatin; SAM synthetase; SIN3	DEACETYLASE COMPLEX; CHROMATIN; GENES; COREPRESSOR; METHYLATION; GLYCOLYSIS; EXPRESSION; PATHWAYS; DYNAMICS; SERINE	The SIN3 histone-modifying complex regulates the expression of multiple methionine catabolic genes, including SAM synthetase (Sam-S), as well as SAM levels. To further dissect the relationship between methionine catabolism and epigenetic regulation by SIN3, we sought to identify genes and metabolic pathways controlled by SIN3 and SAM synthetase (SAM-S) in Drosophila melanogaster. Using several approaches, including RNAi-mediated gene silencing, RNA-Seq? and quantitative RT-PCR?based transcriptomics, and ultra-high-performance LC-MS/MS? and GC/MS?based metabolomics, we found that, as a global transcriptional regulator, SIN3 impacted a wide range of genes and pathways. In contrast, SAM-S affected only a narrow range of genes and pathways. The expression and levels of additional genes and metabolites, however, were altered in Sin3A+Sam-S dual knockdown cells. This analysis revealed that SIN3 and SAM-S regulate overlapping pathways, many of which involve one-carbon and central carbon metabolisms. In some cases, the factors acted independently; in some others, redundantly; and for a third set, in opposition. Together, these results, obtained from experiments with the chromatin regulator SIN3 and the metabolic enzyme SAM-S, uncover a complex relationship between metabolism and epigenetic regulation.	[Liu, Mengying; Saadat, Nadia; Gupta, Smiti V.] Wayne State Univ, Dept Nutr & Food Sci, Detroit, MI 48202 USA; [Liu, Mengying; Saha, Nirmalya; Gajan, Ambikai; Pile, Lori A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Saha, Nirmalya] Univ Michigan, Dept Pathol, Michigan Med, Ann Arbor, MI 48109 USA; [Gajan, Ambikai] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Gajan, Ambikai] Karmanos Canc Inst, Detroit, MI 48201 USA; [Saadat, Nadia] Univ Detroit Mercy, Coll Engn & Sci, Detroit, MI 48221 USA	Wayne State University; Wayne State University; University of Michigan System; University of Michigan; Wayne State University; Barbara Ann Karmanos Cancer Institute; University of Detroit Mercy	Pile, LA (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	loripile@wayne.edu	Saha, Nirmalya/AEF-3616-2022; Saadat, Nadia/AAP-5101-2020	Saadat, Nadia/0000-0001-8726-9245; Pile, Lori/0000-0002-7189-4828; SAHA, NIRMALYA/0000-0002-5624-8879	NIGMS, National Institutes of Health [R01GM088886]; Wayne State University	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wayne State University	This work was supported by NIGMS, National Institutes of Health Grant R01GM088886 and a Wayne State University research support grant (to L. A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akram M, 2014, CELL BIOCHEM BIOPHYS, V68, P475, DOI 10.1007/s12013-013-9750-1; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bansal N, 2016, ADV CANCER RES, V130, P113, DOI 10.1016/bs.acr.2016.01.006; Bansal N, 2015, ONCOTARGET, V6, P34087, DOI 10.18632/oncotarget.6048; Barnes VL, 2014, AGING-US, V6, P645, DOI 10.18632/aging.100684; Barnes VL, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-26; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Chaubal A, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0188-y; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Cluntun AA, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0135-3; Dai ZW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04426-y; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Ding W, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007812; Farias EF, 2010, P NATL ACAD SCI USA, V107, P11811, DOI 10.1073/pnas.1006737107; Fussl M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00461; Gajan A, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0053-9; Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3; Gonneaud A, 2015, FEBS LETT, V589, P2776, DOI 10.1016/j.febslet.2015.08.009; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kim JA, 2018, MOL CELLS, V41, P264, DOI 10.14348/molcells.2018.0076; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; Kwon YJ, 2015, MOL CANCER THER, V14, P1824, DOI 10.1158/1535-7163.MCT-14-0980-T; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Larsson J, 1998, FEBS LETT, V427, P119, DOI 10.1016/S0014-5793(98)00408-6; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Lewis MJ, 2016, ONCOTARGET, V7, P78713, DOI 10.18632/oncotarget.12805; Li SS, 2015, MOL CELL, V60, P408, DOI 10.1016/j.molcel.2015.09.024; Li WX, 2011, J PLANT PHYSIOL, V168, P1837, DOI 10.1016/j.jplph.2011.05.020; Li XB, 2015, THORAC CANCER, V6, P17, DOI 10.1111/1759-7714.12148; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu MY, 2017, J BIOL CHEM, V292, P1970, DOI 10.1074/jbc.M116.749754; Liu MY, 2016, G3-GENES GENOM GENET, V6, P121, DOI 10.1534/g3.115.024273; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Luengo A, 2017, CELL CHEM BIOL, V24, P1161, DOI 10.1016/j.chembiol.2017.08.028; Markham GD, 2009, CELL MOL LIFE SCI, V66, P636, DOI 10.1007/s00018-008-8516-1; Murray B, 2019, WORLD J GASTROENTERO, V25, P4300, DOI 10.3748/wjg.v25.i31.4300; Musselman LP, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.163881; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Reid MA, 2017, NAT CELL BIOL, V19, P1298, DOI 10.1038/ncb3629; Reytor E, 2009, FASEB J, V23, P3347, DOI 10.1096/fj.09-130187; Saha N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2428-5; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Strekalova E, 2019, BREAST CANCER RES TR, V175, P39, DOI 10.1007/s10549-019-05146-7; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ye CQ, 2019, MOL CELL, V73, P1115, DOI 10.1016/j.molcel.2019.01.012; Ye CQ, 2018, TRENDS ENDOCRIN MET, V29, P626, DOI 10.1016/j.tem.2018.06.002; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	59	5	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					375	389		10.1074/jbc.RA119.010032	http://dx.doi.org/10.1074/jbc.RA119.010032			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31776190	Green Published, hybrid			2022-12-26	WOS:000507373600010
J	Zani, A; Zhang, LZ; McMichael, TM; Kenney, AD; Chemudupati, M; Kwiek, JJ; Liu, SL; Yount, JS				Zani, Ashley; Zhang, Lizhi; McMichael, Temet M.; Kenney, Adam D.; Chemudupati, Mahesh; Kwiek, Jesse J.; Liu, Shan-Lu; Yount, Jacob S.			Interferon-induced transmembrane proteins inhibit cell fusion mediated by trophoblast syncytins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; virus; trophoblast; membrane fusion; fusion protein; IFITM; IFITM1; IFITM2; IFITM3; influenza virus; restriction factor; Zika virus; interferon-induced transmembrane protein; syncytin; placenta; cell fusion	IN-VITRO DEVELOPMENT; ZIKA VIRUS; ANTIVIRAL ACTIVITY; S-PALMITOYLATION; HERV-W; GLYCOPROTEIN; EXPRESSION; PROTECTION; RESISTANCE; INFECTION	Type I interferon (IFN) induced by virus infections during pregnancy can cause placental damage, but the mechanisms and identities of IFN-stimulated genes that are involved in this damage remain under investigation. The IFN-induced transmembrane proteins (IFITMs) inhibit virus infections by preventing virus membrane fusion with cells and by inhibiting fusion of infected cells (syncytialization). Fusion of placental trophoblasts via expression of endogenous retroviral fusogens known as syncytins forms the syncytiotrophoblast, a multinucleated cell structure essential for fetal development. We found here that IFN blocks fusion of BeWo human placental trophoblasts. Stably expressed IFITM1, -2, and -3 also blocked fusion of these trophoblasts while making them more resistant to virus infections. Conversely, stable IFITM knockdowns in BeWo trophoblasts increased their spontaneous fusion and allowed fusion in the presence of IFN while also making the cells more susceptible to virus infection. We additionally found that exogenous expression of IFITMs in HEK293T cells blocked fusion with cells expressing syncytin-1 or syncytin-2, confirming the ability of IFITMs to block individual syncytin-mediated fusion. Overall, our data indicate that IFITMs inhibit trophoblast fusion and suggest that there may be a critical balance between these antifusogenic effects and the beneficial antiviral effects of IFITMs in virus infections during pregnancy.	[Zani, Ashley; Zhang, Lizhi; McMichael, Temet M.; Kenney, Adam D.; Chemudupati, Mahesh; Yount, Jacob S.] Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,BRT 790, Columbus, OH 43210 USA; [Kwiek, Jesse J.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Liu, Shan-Lu] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Zani, Ashley; Zhang, Lizhi; McMichael, Temet M.; Kenney, Adam D.; Chemudupati, Mahesh; Kwiek, Jesse J.; Liu, Shan-Lu; Yount, Jacob S.] Ohio State Univ, Infect Dis Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yount, JS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,BRT 790, Columbus, OH 43210 USA.	jacob.yount@osumc.edu		Kwiek, Jesse/0000-0003-4277-8315; Yount, Jacob/0000-0002-6128-4575	National Institutes of Health [AI130110, AI142256, AI112542]; National Science Foundation Graduate Research Fellowship Program; NIGMS, National Institutes of Health [GM068412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130110, R21AI146690, R21AI142256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI130110 and AI142256 (to J. S. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the National Science Foundation Graduate Research Fellowship Program.; Supported by National Institutes of Health Training Grant AI112542 administered by the Ohio State University Infectious Diseases Institute.; Supported by NIGMS, National Institutes of Health, Training Grant GM068412 administered by the Ohio State University Biomedical Sciences Graduate Program.	Battles MB, 2016, NAT CHEM BIOL, V12, P87, DOI [10.1038/nchembio.1982, 10.1038/NCHEMBIO.1982]; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Borges M, 2003, PLACENTA, V24, P959, DOI 10.1016/S0143-4004(03)00173-5; Buchrieser J, 2019, SCIENCE, V365, P176, DOI 10.1126/science.aaw7733; Cameo M, 1999, HUM REPROD, V14, P959, DOI 10.1093/humrep/14.4.959; Casazza RL, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3446; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Chesarino NM, 2017, EMBO REP, V18, P1740, DOI 10.15252/embr.201744100; Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114; COUTIFARIS C, 1991, DEVELOPMENT, V113, P767; Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gauster M, 2010, PLACENTA, V31, P82, DOI 10.1016/j.placenta.2009.12.007; Gauster M, 2009, PLACENTA, V30, pS49, DOI 10.1016/j.placenta.2008.10.011; Gresser I, 1980, Ann N Y Acad Sci, V350, P12, DOI 10.1111/j.1749-6632.1980.tb20602.x; Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9; Ihara Toshio, 1999, Congenital Anomalies, V39, P223, DOI 10.1111/j.1741-4520.1999.tb00562.x; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Kudo Y, 2002, PLACENTA, V23, P536, DOI 10.1053/plac.2002.0839; Lavialle C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0507; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; McMichael TM, 2018, J INFECT DIS, V218, P1582, DOI 10.1093/infdis/jiy361; McMichael TM, 2017, J BIOL CHEM, V292, P21517, DOI 10.1074/jbc.M117.800482; Melvin WJ, 2015, VIRUSES-BASEL, V7, P3035, DOI 10.3390/v7062759; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Ozog S, 2019, BLOOD, V134, P1298, DOI 10.1182/blood.2019000040; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090; Shi GL, 2018, P NATL ACAD SCI USA, V115, pE10069, DOI 10.1073/pnas.1811892115; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055; ZUSMAN I, 1984, TERATOLOGY, V29, P405, DOI 10.1002/tera.1420290311	46	36	35	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19844	19851		10.1074/jbc.AC119.010611	http://dx.doi.org/10.1074/jbc.AC119.010611			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31735710	Green Published, hybrid			2022-12-26	WOS:000505005800002
J	Sauer, FJ; Hermann, M; Ramseyer, A; Burger, D; Riemer, S; Gerber, V				Sauer, Fay J.; Hermann, Marco; Ramseyer, Alessandra; Burger, Dominik; Riemer, Stefanie; Gerber, Vinzenz			Effects of breed, management and personality on cortisol reactivity in sport horses	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SALIVARY CORTISOL; PHYSIOLOGICAL-RESPONSES; PLASMA-CORTISOL; ADRENOCORTICAL-RESPONSE; ENDURANCE HORSES; CONDITION SCORE; STRESS; BEHAVIOR; ACTH	Sport horses need to fulfill high physical and psychological requirements during training and competition. These as well as certain conditions of modern husbandry may affect their wellbeing. Here we aimed to (1) evaluate effects of demographic and management factors as well as personality traits on stress reactivity of sport horses, (2) investigate if elite sport horses have elevated stress levels compared to amateur sport horses, and (3) assess whether different equestrian disciplines differentially influence equine adrenal cortex responsiveness. For this purpose, we visited 149 healthy elite (n = 94) and amateur (n = 54) sport horses in Switzerland and performed an adrenocorticotropic hormone (ACTH) stimulation test. Additionally, a person who was familiar with the horse completed a questionnaire about demographic and management factors and their horses' personality traits. Linear models were calculated to assess associations between the questionnaire data and salivary cortisol 60 (T60) and 90 (T90) minutes after ACTH stimulation. While the model at T90 was not significant, post-stimulatory cortisol after 60 minutes appears most informative in line with a previous study and was significantly affected by the breed and by three management factors: "number of riders", "hours spent outside" and "group housing" (adjusted r(2) = 15%, p<0.001). Thoroughbred and Warmblood horses displayed an increased adrenal response compared to Franches-Montagnes horses. Horses with several riders had a less pronounced reaction than horses with one rider, and horses that spent more time outside had a decreased response compared to horses that were stabled most of the time. Horses living in groups showed higher post-stimulatory cortisol values than horses that were housed singly. However, no significant associations of cortisol responsiveness with personality traits were found, and neither the use as elite or as amateur sport horses nor the discipline had an effect on the cortisol response. This suggests that optimizing husbandry conditions may be more important for improving equine welfare than changing their use.	[Sauer, Fay J.; Ramseyer, Alessandra; Burger, Dominik; Gerber, Vinzenz] Univ Bern, Vetsuisse Fac, Swiss Inst Equine Med ISME, Dept Clin Vet Med, Bern, Switzerland; [Sauer, Fay J.; Ramseyer, Alessandra; Burger, Dominik; Gerber, Vinzenz] Agroscope, Bern, Switzerland; [Hermann, Marco] Pferdemed Hermann GmbH, Niederlenz, Aargau, Switzerland; [Riemer, Stefanie] Univ Bern, Vetsuisse Fac, Div Anim Welf, Bern, Switzerland	University of Bern; Swiss Federal Research Station Agroscope; University of Bern	Sauer, FJ (corresponding author), Univ Bern, Vetsuisse Fac, Swiss Inst Equine Med ISME, Dept Clin Vet Med, Bern, Switzerland.; Sauer, FJ (corresponding author), Agroscope, Bern, Switzerland.	fay.sauer@web.de		Sauer, Fay/0000-0001-6469-365X; Riemer, Stefanie/0000-0001-8008-5291	Stiftung zur Forderung des Pferdesports (SFP); Federal Food Safety and Veterinary Office (FSVO)	Stiftung zur Forderung des Pferdesports (SFP); Federal Food Safety and Veterinary Office (FSVO)	The funder 'Federal Food Safety and Veterinary Office (FSVO)' provided support in the form of salary for the first author [FS] and to a smaller extent for research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The second funder 'Stiftung zur Forderung des Pferdesports (SFP)', also provided financial supported for research materials, but likewise did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. 'Pferdemedizin Hermann GmbH', the private equine veterinary practice of one of the authors (MH), was not at all involved with the study. The specific role of MH and the other authors are described in the `author contributions' section.	Alexander SL, 1998, J ENDOCRINOL, V157, P425, DOI 10.1677/joe.0.1570425; Anderson MK, 1999, APPL ANIM BEHAV SCI, V63, P11, DOI 10.1016/S0168-1591(98)00237-8; [Anonymous], 2019, R LANG ENV STAT COMP; Art T, 2005, LIVEST PROD SCI, V92, P101, DOI 10.1016/j.livprodsci.2004.11.013; Aurich J, 2015, DOMEST ANIM ENDOCRIN, V52, P11, DOI 10.1016/j.domaniend.2015.01.003; Bachmann I, 2003, APPL ANIM BEHAV SCI, V82, P297, DOI 10.1016/S0168-1591(03)00086-8; Bachmann I, 2003, EQUINE VET J, V35, P158, DOI 10.2746/042516403776114216; Bae YJ, 2016, CLIN CHEM LAB MED, V54, P811, DOI 10.1515/cclm-2015-0412; Bartolome E, 2016, J EQUINE VET SCI, V40, P84, DOI 10.1016/j.jevs.2016.01.016; Becker-Birck M, 2013, J VET BEHAV, V8, P87, DOI 10.1016/j.jveb.2012.05.002; Brockhurst J, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.34; BRUIN G, 1994, J APPL PHYSIOL, V76, P1908, DOI 10.1152/jappl.1994.76.5.1908; Castejon-Riber C, 2017, J EQUINE VET SCI, V56, P93, DOI 10.1016/j.jevs.2017.04.011; Cayado P, 2006, Equine Vet J Suppl, P274; Christie JL, 2006, CAN VET J, V47, P136; Cordero M, 2012, DOMEST ANIM ENDOCRIN, V43, P317, DOI 10.1016/j.domaniend.2012.05.005; Fazio E, 2013, J VET BEHAV, V8, P231, DOI 10.1016/j.jveb.2012.10.010; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Freymond SB, 2015, PHYSIOL BEHAV, V151, P121, DOI 10.1016/j.physbeh.2015.07.015; Golland LC, 1999, PFLUG ARCH EUR J PHY, V439, P11, DOI 10.1007/s004240051122; Goodwin D, 2002, EQUINE VET J, V34, P686, DOI 10.2746/042516402776250450; Harewood EJ, 2005, J EQUINE VET SCI, V25, P164, DOI 10.1016/j.jevs.2005.03.008; Hauner KKY, 2008, PSYCHONEUROENDOCRINO, V33, P1344, DOI 10.1016/j.psyneuen.2008.07.011; Hedberg Y, 2007, ANIM REPROD SCI, V100, P73, DOI 10.1016/j.anireprosci.2006.06.008; Heleski CR, 2002, APPL ANIM BEHAV SCI, V78, P291, DOI 10.1016/S0168-1591(02)00108-9; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Hinchcliff K., 2008, EQUINE EXERCISE PHYS; Hinchcliff K.W., 2013, EQUINE SPORTS MED SU; HOFFMAN RM, 1995, J ANIM SCI, V73, P2922; Houpt K. A., 2018, DOMESTIC ANIMAL BEHA; Ille N, 2013, ANIM WELFARE, V22, P457, DOI 10.7120/09627286.22.4.457; IRVINE CHG, 1994, DOMEST ANIM ENDOCRIN, V11, P227, DOI 10.1016/0739-7240(94)90030-2; Janczarek I, 2013, POL J VET SCI, V16, P533, DOI 10.2478/pjvs-2013-0074; Kiley-Worthington M., 1990, Journal of Equine Veterinary Science, V10, P62, DOI 10.1016/S0737-0806(06)80088-2; LADEWIG J, 1989, HORM BEHAV, V23, P344, DOI 10.1016/0018-506X(89)90048-2; Malmkvist J, 2012, APPL ANIM BEHAV SCI, V142, P160, DOI 10.1016/j.applanim.2012.10.002; Marc M, 2000, J ANIM SCI, V78, P1936; MAYES E, 1986, BEHAVIOUR, V96, P105, DOI 10.1163/156853986X00243; McGowan CM, 2008, COMP EXERC PHYSIOL, V5, P57, DOI 10.1017/S1478061508979202; MCGREEVY PD, 1995, VET REC, V137, P36, DOI 10.1136/vr.137.2.36; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Medill SA, P 3 INT EQ SCI M, P21; Mircean M., 2007, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Veterinary Medicine, V64, P488; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Momozawa Y, 2005, APPL ANIM BEHAV SCI, V92, P77, DOI 10.1016/j.applanim.2004.11.006; Munk R, 2017, DOMEST ANIM ENDOCRIN, V61, P108, DOI 10.1016/j.domaniend.2017.06.007; Munsters CCBM, 2012, VET J, V192, P75, DOI 10.1016/j.tvjl.2011.04.011; Nagy K, 2010, APPL ANIM BEHAV SCI, V122, P41, DOI 10.1016/j.applanim.2009.11.005; Parker KJ, 2004, ARCH GEN PSYCHIAT, V61, P933, DOI 10.1001/archpsyc.61.9.933; Parker M, 2008, APPL ANIM BEHAV SCI, V114, P206, DOI 10.1016/j.applanim.2008.02.003; Pawluski J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182257; Peeters M, 2011, EQUINE VET J, V43, P487, DOI 10.1111/j.2042-3306.2010.00294.x; PERSSON SGB, 1980, ZBL VET MED A, V27, P261; Rivera E, 2002, APPL ANIM BEHAV SCI, V78, P235, DOI 10.1016/S0168-1591(02)00091-6; Ruet A, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9090621; Sauer FJ, 2018, J ANIM SCI, V96, P2154, DOI 10.1093/jas/sky074; Sauer FJ, SALIVARY CORTISOL ME; Scheidegger MD, 2017, VET J, V228, P7, DOI 10.1016/j.tvjl.2017.09.002; Scheidegger MD, 2016, DOMEST ANIM ENDOCRIN, V57, P43, DOI 10.1016/j.domaniend.2016.04.002; Schmidt A, 2009, P 5 INT S EQ SCI SYD, P53; Schmidt A, 2010, HORM BEHAV, V58, P628, DOI 10.1016/j.yhbeh.2010.06.011; SELYE H, 1973, AM SCI, V61, P692; von Borstel UK, 2017, APPL ANIM BEHAV SCI, V190, P43, DOI 10.1016/j.applanim.2017.02.018; Valenchon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170783; Valenchon M, 2013, ANIM BEHAV, V86, P1233, DOI 10.1016/j.anbehav.2013.09.026; Valenchon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062324; van Reenen CG, 2000, VET MICROBIOL, V75, P135, DOI 10.1016/S0378-1135(00)00211-X; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; VON BORELL E, 1989, DOMEST ANIM ENDOCRIN, V6, P299, DOI 10.1016/0739-7240(89)90024-6; Wagner EL, 2011, J EQUINE VET SCI, V31, P706, DOI 10.1016/j.jevs.2011.05.002; Werhahn H, 2012, J EQUINE VET SCI, V32, P22, DOI 10.1016/j.jevs.2011.06.009; Wickens CL, 2010, APPL ANIM BEHAV SCI, V128, P1, DOI 10.1016/j.applanim.2010.07.002; Yarnell K, 2015, PHYSIOL BEHAV, V143, P51, DOI 10.1016/j.physbeh.2015.02.040	73	10	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0221794	10.1371/journal.pone.0221794	http://dx.doi.org/10.1371/journal.pone.0221794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790402	Green Submitted, Green Published, gold			2022-12-26	WOS:000533930800003
J	Gboko, KDT; Traore, SG; Sanhoun, AR; Kirioua, J; Otaru, N; Kurt, F; Jaeger, FN; Isenring, J; Kaindi, DWM; Kreikemeyer, B; Renault, P; Hattendorf, J; Meile, L; Jans, C; Nguetta, R; Bonfoh, B				Gboko, Kossia D. T.; Traore, Sylvain G.; Sanhoun, Aime R.; Kirioua, Jerome; Otaru, Nize; Kurt, Fabienne; Jaeger, Fabienne N.; Isenring, Julia; Kaindi, Dasel W. M.; Kreikemeyer, Bernd; Renault, Pierre; Hattendorf, Jan; Meile, Leo; Jans, Christoph; Nguetta, Roland; Bonfoh, Bassirou			Risk factors for the carriage of Streptococcus infantarius subspecies infantarius isolated from African fermented dairy products	PLOS ONE			English	Article							BOVIS/STREPTOCOCCUS-EQUINUS COMPLEX; BOVIS ENDOCARDITIS; FECAL CARRIAGE; ASSOCIATION; IDENTIFICATION; BACTEREMIA; NEOPLASIA; MICROORGANISMS; EPIDEMIOLOGY; MACEDONICUS	Streptococcus infantarius subsp. infantarius (Sii) has been identified as predominant lactic acid bacteria in spontaneously fermented dairy products (FDPs) in sub-Saharan Africa including Co<^> te d'Ivoire. However, Sii belongs to the Streptococcus bovis/Streptococcus equinus complex (SBSEC). Most SBSEC members are assumed to be involved as opportunistic pathogens in serious diseases in both humans and animals. A population-based cross-sectional survey, including 385 participants was conducted in Korhogo, northern Co<^> te d'Ivoire, to identify risk factors for Sii fecal carriage, including consumption of local FDPs. A structured questionnaire was used to gather participant's socio-demographic and economic characteristics, their relation to livestock and dietary habits. In addition, fresh stool and milk samples were collected. The identification of Sii was done using a SBSEC-specific PCR assay targeting 16S rRNA and groEL genes. The overall prevalence of SBSEC and Sii carriage was 23.2% (confidence interval CI 95% = 18.9-27.5) and 12.0% (CI 95% = 8.4-15.5) for stool, respectively. Prevalence of Sii was significantly higher in consumers of artisanal butter compared with non-consumers (57.1% vs 10.1%, odds ratio OR: 11.9, 95% CI: 3.936.6), as well as in persons handling livestock (OR = 3.9; 95% CI = 1.6-9.3) and livestock primary products (OR = 5.7; 95% CI = 2.3-14.3). The closer contact with livestock was a risk factor for Sii fecal carriage. Sii strains were isolated from fresh and fermented milk products with a prevalence of 30.4% and 45.4%, respectively. Analysis of Sii population structure through the SBSEC multi locus sequence typing assay revealed a close relationship across human and dairy isolates, possibly linked to a Kenyan human isolate. All these outcomes underline the interest of in-depth investigations on the ecology, potential reservoirs and pathways of contamination by Sii at the human-animal- environment interface in comparison to yet to be collected data from Europe, Asia and the Americas to further elucidate the various roles of Sii.	[Gboko, Kossia D. T.; Traore, Sylvain G.; Sanhoun, Aime R.; Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Ivoire CSRS, Abidjan, Cote Ivoire; [Traore, Sylvain G.; Kirioua, Jerome] Univ Peleforo Gon Coulibaly, Korhogo, Cote Ivoire; [Sanhoun, Aime R.] Univ Nangui Abrogoua, Abidjan, Cote Ivoire; [Otaru, Nize; Kurt, Fabienne; Isenring, Julia; Meile, Leo; Jans, Christoph] Swiss Fed Inst Technol, Lab Food Biotechnol, Inst Food Nutr & Hlth, Schmelzbergstr 7, Zurich, Switzerland; [Jaeger, Fabienne N.; Hattendorf, Jan; Bonfoh, Bassirou] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Jaeger, Fabienne N.; Hattendorf, Jan; Bonfoh, Bassirou] Univ Basel, Basel, Switzerland; [Kaindi, Dasel W. M.] Univ Nairobi, Dept Food Sci Nutr & Technol, Nairobi, Kenya; [Kreikemeyer, Bernd] Rostock Univ, Inst Med Microbiol Virol & Hyg, Med Ctr Rostock, Rostock, Germany; [Renault, Pierre] INRA, UMR MICALIS 1319, Jouy En Josas, France; [Nguetta, Roland] Inst Cardiol Abidjan ICA, Abidjan, Cote Ivoire; [Nguetta, Roland] Univ Felix Houphouet Boigny, Abidjan, Cote Ivoire	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Nairobi; University of Rostock; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Jans, C (corresponding author), Swiss Fed Inst Technol, Lab Food Biotechnol, Inst Food Nutr & Hlth, Schmelzbergstr 7, Zurich, Switzerland.	christoph.jans@hest.ethz.ch	Hattendorf, Jan/F-5371-2010	Hattendorf, Jan/0000-0002-1176-401X; SANHOUN, Aime Roland/0000-0002-7443-3808; Jans, Christoph/0000-0003-0387-606X; Kurt, Fabienne/0000-0001-7950-2721	ERAfrica/PASRES (Swiss National Science Foundation) [ERAfrica_NI_021, IZEAZ0_154308]; UBS Optimus Foundation; DELTAS Africa Initiative; African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust [107753/A/15/Z]; UK government	ERAfrica/PASRES (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); UBS Optimus Foundation; DELTAS Africa Initiative; African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This project was part of the Safe Dairy consortium (KDTG, SGT, ARS, JK, NZ, FK, FNJ, JI, DWMK, BK, PR, JH, LM, CJ, RN and BB) funded by ERAfrica/PASRES (https://www.erafrica.eu/) "New Ideas" project No ERAfrica_NI_021 (Swiss Partners NZ, FK, JI, JH, LM and CJ funded by the Swiss National Science Foundation (http://www.snf.ch) Project No IZEAZ0_154308). This study is partially based on work supported by the UBS Optimus Foundation (KDTG, SGT, ARS, JK; NO, FK, JI, DWMK, PR, JH, LM, CJ and BB; https://www.ubs.com/microsites/optimus-foundation/de/home.html) and the DELTAS Africa Initiative (KDTG, SGT, ARS, JK and BB; Afrique One-ASPIRE/DEL-15-008 http://afriqueoneaspire.org/).Afrique One-ASPIRE is funded by a consortium of donors including the African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA), the New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency, the Wellcome Trust [107753/A/15/Z] and the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir W, 2008, INT J FOOD MICROBIOL, V127, P215, DOI 10.1016/j.ijfoodmicro.2008.07.008; Alozie A, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0074-0; Alvarez A, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00092; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Ben-Chetrit E, 2017, EUR J CLIN MICROBIOL, V36, P387, DOI 10.1007/s10096-016-2814-6; Boleij A, 2011, CLIN INFECT DIS, V53, P870, DOI 10.1093/cid/cir609; Corredoira J, 2008, CLIN MICROBIOL INFEC, V14, P190, DOI 10.1111/j.1469-0691.2007.01913.x; Corredoira J, 2014, CLIN MICROBIOL INFEC, V20, P405, DOI 10.1111/1469-0691.12333; Corredoira J, 2015, J INFECTION, V71, P317, DOI 10.1016/j.jinf.2015.05.005; Corredoira Sanchez J, 2014, INT J CLIN PRACT, V68, P653, DOI 10.1111/ijcp.12376; Corredoira-Sanchez J, 2012, CLIN INFECT DIS, V55, P491, DOI 10.1093/cid/cis434; Counihan-Edgar KL, 2012, J CLIN MICROBIOL, V50, P4131, DOI 10.1128/JCM.02581-12; Dumke J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176515; Duval X, 2001, CLIN MICROBIOL INFEC, V7, P3, DOI 10.1046/j.1469-0691.2001.00190.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fernandez-Ruiz M, 2010, J INFECTION, V61, P307, DOI 10.1016/j.jinf.2010.07.007; Giannitsioti E, 2007, CLIN MICROBIOL INFEC, V13, P770, DOI 10.1111/j.1469-0691.2007.01753.x; Gold JS, 2004, ARCH SURG-CHICAGO, V139, P760, DOI 10.1001/archsurg.139.7.760; GOLDENBERGER D, 1995, PCR METH APPL, V4, P368; Grant RJ, 1997, CLIN INFECT DIS, V24, P1021, DOI 10.1093/clinids/24.5.1021; Gunnarsdottir R, 2012, ENVIRON SCI TECHNOL, V46, P12408, DOI 10.1021/es3018489; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Herrera P, 2009, ANAEROBE, V15, P44, DOI 10.1016/j.anaerobe.2008.11.003; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Jans C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00603; Jans C, 2017, INT J FOOD MICROBIOL, V250, P27, DOI 10.1016/j.ijfoodmicro.2017.03.012; Jans C, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0735-2; Jans C, 2015, INFECT GENET EVOL, V33, P419, DOI 10.1016/j.meegid.2014.09.017; Jans C, 2013, INT J FOOD MICROBIOL, V167, P186, DOI 10.1016/j.ijfoodmicro.2013.09.008; Jans C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-200; Jans C, 2012, LWT-FOOD SCI TECHNOL, V47, P371, DOI 10.1016/j.lwt.2012.01.034; Jans C, 2012, FEMS MICROBIOL LETT, V326, P144, DOI 10.1111/j.1574-6968.2011.02443.x; Kaindi DWM, 2018, ACTA TROP, V178, P10, DOI 10.1016/j.actatropica.2017.10.018; Kaindi DWM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27383-4; Krishnan S, 2014, COLORECTAL DIS, V16, P672, DOI 10.1111/codi.12662; Lazarovitch T, 2013, INFECTION, V41, P329, DOI 10.1007/s15010-012-0314-x; Lopes PGM, 2014, J CLIN MICROBIOL, V52, P974, DOI 10.1128/JCM.03253-13; ODonnell O., ANAL HLTH EQUITY USI; Pergola V, 2001, AM J CARDIOL, V88, P871, DOI 10.1016/S0002-9149(01)01914-2; RUOFF KL, 1989, J CLIN MICROBIOL, V27, P305, DOI 10.1128/JCM.27.2.305-308.1989; Schlegel L, 2003, INT J SYST EVOL MICR, V53, P631, DOI 10.1099/ijs.0.02361-0; Schulz J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144412; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; WHO, 1995, 854 WHO TRS; Wullschleger S, 2013, INT DAIRY J, V29, P28, DOI 10.1016/j.idairyj.2012.08.001	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225452	10.1371/journal.pone.0225452	http://dx.doi.org/10.1371/journal.pone.0225452			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774832	Green Published, Green Accepted, gold			2022-12-26	WOS:000533896400033
J	Chen, C; Liu, XJ; Wang, XF; Li, W; Qu, WX; Dong, LL; Li, XY; Rui, ZQ; Yang, XQ				Chen, Cai; Liu, Xuejian; Wang, Xianfeng; Li, Wei; Qu, Wenxiu; Dong, Leilei; Li, Xiyuan; Rui, Zhiqing; Yang, Xueqing			Risk of temperature, humidity and concentrations of air pollutants on the hospitalization of AECOPD	PLOS ONE			English	Article							PARTICULATE MATTER; RESPIRATORY-DISEASE; ACUTE EXACERBATION; PULMONARY; COPD; INFLAMMATION; POLLUTION; IMPACT; CHINA	Aim To investigate the effect of temperature, humidity and the concentration of ambient air pollution on the hospitalization of AECOPD. Method Hospitalization record was obtained from Shenyang Medical Insurance Bureau, concluding patient's age, gender, income hospital time, outcome hospital; Generalized additive model was used to analyze the relationship between temperature, humidity, the concentration of ambient air pollution and the hospitalization of AECOPD. Result The effect of ozone on admission rate in male group was higher than that in female group. Ambient air pollution had a weak influence on age <= 50 group. It was found that the optimal lag day for daily relative 40 humidity to age <= 50 group, 50<age <= 60, 60<age <= 70 group and age> 70 group was on lag5, lag4, lag4 and lag5, respectively. Conclusion Air pollution, relative humidity and temperature can increase the risk of admission for acute exacerbation of COPD, and in this process there was a lag effect.	[Chen, Cai; Li, Wei; Dong, Leilei; Li, Xiyuan] Shandong Univ, Sch Control Sci & Engn, Biomed Engn Inst, Jinan, Peoples R China; [Liu, Xuejian; Qu, Wenxiu] China Med Univ, Shengjing Hosp, Gen Internal Med 1, Shenyang, Liaoning, Peoples R China; [Wang, Xianfeng] Dept Ecol & Environm Peoples Republ Shandong, Jinan, Peoples R China; [Rui, Zhiqing] Chinese Acad Sci, Inst Software, Beijing, Peoples R China; [Yang, Xueqing] Helmholz Ctr Environm Res UFZ, Dept Bioenergy, Leipzig, Germany	Shandong University; China Medical University; Chinese Academy of Sciences; Institute of Software, CAS; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Li, W (corresponding author), Shandong Univ, Sch Control Sci & Engn, Biomed Engn Inst, Jinan, Peoples R China.; Qu, WX (corresponding author), China Med Univ, Shengjing Hosp, Gen Internal Med 1, Shenyang, Liaoning, Peoples R China.	cindy@sdu.edu.cn; quwx@sj-hospital.org		Yang, Xueqing/0000-0002-5816-8477	National Natural Science Foundation [21728701]; Ministry of Education postdoctoral fund [2015M572044]; Shandong Province Science and Technology Development Project [GG201709260070]; Shenyang Science and Technology Bureau Project [F15-199-1-44]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education postdoctoral fund; Shandong Province Science and Technology Development Project; Shenyang Science and Technology Bureau Project	This study was supported by the National Natural Science Foundation 21728701, Ministry of Education postdoctoral fund 2015M572044, and Shandong Province Science and Technology Development Project GG201709260070 to WL. This study was also supported by the Shenyang Science and Technology Bureau Project F15-199-1-44 to WQ.	Almagro P, 2015, INT J CHRONIC OBSTR, V10, P899, DOI 10.2147/COPD.S75710; Barbone F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061057; Chen C, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015634; Choi J, 2018, INT J CHRONIC OBSTR, V13, P1053, DOI 10.2147/COPD.S156617; Dehghan A, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0613-9; Gruzieva O, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4522; Han M, 2017, ENVIRON SCI POLLUT R, V24, P27843, DOI 10.1007/s11356-017-0402-7; Ho SC, 2019, SCI TOTAL ENVIRON, V677, P524, DOI 10.1016/j.scitotenv.2019.04.358; Jin YF, 2017, ENVIRON TOXICOL, V32, P1121, DOI 10.1002/tox.22308; Jo EJ, 2017, RESP MED, V124, P79, DOI 10.1016/j.rmed.2017.02.010; Ma YX, 2018, ENVIRON SCI POLLUT R, V25, P17942, DOI 10.1007/s11356-018-2013-3; Mu Z, 2017, INT J BIOMETEOROL, V61, P1919, DOI 10.1007/s00484-017-1379-0; Phosri A, 2019, SCI TOTAL ENVIRON, V651, P1144, DOI 10.1016/j.scitotenv.2018.09.183; Rocks N, 2019, THORAX, V74, P768, DOI 10.1136/thoraxjnl-2018-211990; Sun SZ, 2018, THORAX, V73, P951, DOI 10.1136/thoraxjnl-2017-211333; Sun XL, 2017, TOXICOL LETT, V278, P1, DOI 10.1016/j.toxlet.2017.07.853; Tasci SS, 2018, EMERG MED INT, V2018, DOI 10.1155/2018/4183203; Tian YH, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0369-y; Tseng CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057066; Vepkhvadze N, 2017, Georgian Med News, P1114; Waterston A, 2018, BIOPHYS J, V114, p334A; Wigenstam E, 2016, TOXICOLOGY, V368, P28, DOI 10.1016/j.tox.2016.08.018; Xie JG, 2019, INT J BIOMETEOROL, V63, P315, DOI 10.1007/s00484-018-01665-y; Zhu BF, 2018, INT J CHRONIC OBSTR, V13, P1353, DOI 10.2147/COPD.S161555	24	13	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225307	10.1371/journal.pone.0225307	http://dx.doi.org/10.1371/journal.pone.0225307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770406	Green Published, gold			2022-12-26	WOS:000533892300014
J	Nakamura, K; Tonouchi, H; Sasayama, A; Yamaji, T; Ashida, K				Nakamura, Kentaro; Tonouchi, Hidekazu; Sasayama, Akina; Yamaji, Taketo; Ashida, Kinya			Nutritional treatment with an immune-modulating enteral formula alleviates 5-fluorouracil-induced adverse effects in rats	PLOS ONE			English	Article							COMPRISING WHEY PEPTIDES; CANCER-CHEMOTHERAPY; ANTITUMOR EFFICACY; DIET; INFLAMMATION; BEARING	Cancer chemotherapy is frequently accompanied by adverse effects, such as diarrhoea and leukopenia, which lead to malnutrition and a decrease in the patients' quality of life. We previously demonstrated that an immune-modulating formula (IMF)-an enteral formula enriched with immunonutrients, whey-hydrolysed peptides, and fermented milk-had anti-inflammatory effects and protective effects on intestinal disorders in some experimental models. Here, we investigated whether nutritional treatment with the IMF could prevent 5-fluorouracil (5-FU)-induced adverse effects in rats. Rats were randomised into CTR and IMF groups, which received a control formula or the IMD supplemented formula ad libitum. Two weeks after starting the formula, rats were intraperitoneally injected with 5-FU (300 mg/kg) on day 0. The treatment with 5-FU decreased their body weights, food intake, and leukocyte counts, and worsened the diarrhoea score. However, the body weights, food intake, and leukocyte counts were significantly higher in the IMF rats than in the CTR rats on day 1. The IMF also delayed the incidence of diarrhoea and significantly preserved the villus heights in the jejunum on day 2. In conclusion, nutritional treatment with the IMF alleviated the adverse effects induced by 5-FU injection in rats.	[Nakamura, Kentaro; Tonouchi, Hidekazu; Sasayama, Akina; Yamaji, Taketo; Ashida, Kinya] Meiji Co Ltd, Nutr Res Dept, Food Microbiol & Funct Res Labs, R&D Div, Tokyo, Japan	Meiji Holdings Co., Ltd.	Nakamura, K (corresponding author), Meiji Co Ltd, Nutr Res Dept, Food Microbiol & Funct Res Labs, R&D Div, Tokyo, Japan.	kentarou.nakamura@meiji.com			Meiji Co., Ltd.	Meiji Co., Ltd.	This study was supported by Meiji Co., Ltd. The funders made the final approval of the experimental design and of the paper submission.	Arends J, 2006, CLIN NUTR, V25, P245, DOI 10.1016/j.clnu.2006.01.020; Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808; Cinausero M, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00354; Garcia-Albiach R, 2008, AM J CLIN NUTR, V87, P91, DOI 10.1093/ajcn/87.1.91; Kume H, 2018, MILK SCI, V67, P30, DOI [10.11465/milk.67.30, DOI 10.11465/MILK.67.30]; Kume H, 2014, CLIN NUTR, V33, P1140, DOI 10.1016/j.clnu.2013.12.014; Kume H, 2012, CLIN NUTR, V31, P283, DOI 10.1016/j.clnu.2011.10.012; Lee Hye-Ok, 2015, Clin Nutr Res, V4, P63, DOI 10.7762/cnr.2015.4.1.63; Li H, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00091; Logan RM, 2008, CANCER BIOL THER, V7, P1139; Masuda Y, 2009, INT IMMUNOPHARMACOL, V9, P620, DOI 10.1016/j.intimp.2009.02.005; Nakamura K, 2018, BIOSCI MICROB FOOD H, V37, P1, DOI 10.12938/bmfh.17-011; Nakamura K, 2015, NUTR CANCER, V67, P912, DOI 10.1080/01635581.2015.1053495; Nakamura K, 2011, CLIN NUTR, V30, P513, DOI 10.1016/j.clnu.2011.01.002; Nurgali K, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00245; Osterlund P, 2007, BRIT J CANCER, V97, P1028, DOI 10.1038/sj.bjc.6603990; Pontes-Arruda A, 2008, JPEN-PARENTER ENTER, V32, P596, DOI 10.1177/0148607108324203; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Ravasco P, 2004, SUPPORT CARE CANCER, V12, P246, DOI 10.1007/s00520-003-0568-z; Stringer AM, 2009, EXP BIOL MED, V234, P430, DOI 10.3181/0810-RM-301; Trifan OC, 2002, CANCER RES, V62, P5778; von Bultzingslowen I, 2003, ORAL MICROBIOL IMMUN, V18, P278, DOI 10.1034/j.1399-302X.2003.00075.x; Xue HY, 2007, CLIN CANCER RES, V13, P7146, DOI 10.1158/1078-0432.CCR-07-0823; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P74, DOI 10.1177/0148607110377338; Yang YH, 2000, J KOREAN ACAD NURS, V30, P720, DOI DOI 10.4040/jkan.2000.30.3.720	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225389	10.1371/journal.pone.0225389	http://dx.doi.org/10.1371/journal.pone.0225389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770400	gold, Green Published			2022-12-26	WOS:000533892300017
J	Huang, Y; Hong, YH; Huang, ZQ; Zhang, JL; Huang, Q				Huang, Yi; Hong, Yuhang; Huang, Zhiqiu; Zhang, Jilei; Huang, Qiang			Avermectin induces the oxidative stress, genotoxicity, and immunological responses in the Chinese Mitten Crab, Eriocheir sinensis	PLOS ONE			English	Article							DNA-DAMAGE; ABAMECTIN; CELLS; WATER; IVERMECTIN; HEMOCYTES; FAMILY; LIVER	Avermectin is commonly used in aquaculture systems for pest control in recent decades in China. However, no information is provided for the toxic effect to the important commercial species, Chinese mitten crab, Eriocheir sinensis. To investigate the aquatic toxicity of avermectin, an acute toxic test was performed in this study. The results showed that the 48 h- and 96 h- LC50 were 1.663 and 0.954 mg/L, respectively. For further research, crabs were exposed to sublethal concentrations of 0.03, 0.06, 0.12, 0.24 and 0.48 mg/L. Levels of antioxidants, including superoxide dismutase (SOD), catalase (CAT) and total antioxidant capacity (T-AOC) were significantly (P<0.05) decreased with dose- and time- dependent responses, meanwhile the oxidative products including malondialdehyde (MDA), hydrogen peroxide (H2O2) and protein carbonyl in serum increased significantly (P<0.05) at concentrations of 0.24 and 0.48 mg/L throughout the experiment. A significant (P<0.05) increase of intracellular ROS and decrease of phagocytic activity was observed in high concentration groups, with dose- and time- dependent manners during the exposure. In addition, serious genetic damage was detected, for the significant increase (P<0.05) of both comet ratio and %DNA in tail at each concentration, and micronucleus (MN) frequency at concentrations of 0.12, 0.24 and 0.48 mg/L at 96 h. These results indicated that sublethal concentration exposure of avermectin had a prominent toxic effect on E. sinensis based on the oxidative stress induced by generated ROS, immunological activity inhibition and genotoxicity.	[Huang, Yi; Hong, Yuhang; Huang, Zhiqiu; Zhang, Jilei; Huang, Qiang] Xichang Univ, Key Lab Anim Dis Detect & Prevent Panxi Dist, Xichang, Sichuan, Peoples R China		Hong, YH (corresponding author), Xichang Univ, Key Lab Anim Dis Detect & Prevent Panxi Dist, Xichang, Sichuan, Peoples R China.	aquaculturehong@hotmail.com	Hong, Yuhang/HFZ-9252-2022		general science research program of Sichuan Province [17ZB0405]; general science research programme of Sichuan Province [18ZB0554]	general science research program of Sichuan Province; general science research programme of Sichuan Province	YHH received the general science research program of Sichuan Province (Grant No. 17ZB0405) and YH received the general science research programme of Sichuan Province (Grant No. 18ZB0554). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Allah GA, 1999, MUTAT RES-GEN TOX EN, V446, P181, DOI 10.1016/S1383-5718(99)00181-3; Alak G, 2017, FISH SHELLFISH IMMUN, V65, P136, DOI 10.1016/j.fsi.2017.04.004; Amin KA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-45; [Anonymous], [No title captured]; Bai SH, 2016, CHEMOSPHERE, V154, P204, DOI 10.1016/j.chemosphere.2016.03.113; Barka S, 2016, MUTAT RES-GEN TOX EN, V803, P27, DOI 10.1016/j.mrgentox.2016.05.002; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Cavalcante DGSM, 2008, MUTAT RES-GEN TOX EN, V655, P41, DOI 10.1016/j.mrgentox.2008.06.010; Chen Jia-zhang, 2009, Asian Journal of Ecotoxicology, V4, P823; Chen Jinsong, 2016, Weishengwu Xuebao, V56, P543; Cheng L, 2011, IEEE ENG MED BIO, P4002, DOI 10.1109/IEMBS.2011.6090994; Davies IM, 1998, AQUACULTURE, V163, P29, DOI 10.1016/S0044-8486(98)00211-7; Deventer K, 1996, B ENVIRON CONTAM TOX, V56, P911, DOI 10.1007/s001289900132; Duce Ian R., 1995, MOL ACTION INSECTICI, P251; Hong YH, 2018, COMP BIOCHEM PHYS C, V212, P25, DOI 10.1016/j.cbpc.2018.06.004; Hong YH, 2017, FISH SHELLFISH IMMUN, V71, P19, DOI 10.1016/j.fsi.2017.09.062; Tu HT, 2012, CHEMOSPHERE, V86, P83, DOI 10.1016/j.chemosphere.2011.09.022; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; Li WF, 2012, FISH PHYSIOL BIOCHEM, V38, P1585, DOI 10.1007/s10695-012-9652-y; Liu C, 2014, CHEM-BIOL INTERACT, V210, P43, DOI 10.1016/j.cbi.2013.12.015; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Ma JG, 2014, ECOTOX ENVIRON SAFE, V101, P31, DOI 10.1016/j.ecoenv.2013.12.009; Sanches ALM, 2017, CHEMOSPHERE, V188, P582, DOI 10.1016/j.chemosphere.2017.09.027; Mayer F.L, 1987, ACUTE TOXICITY HDB C; Mayer M, 2013, IEEE INT ULTRA SYM, P1965, DOI 10.1109/ULTSYM.2013.0501; Novelli A, 2016, CHEMOSPHERE, V144, P1408, DOI 10.1016/j.chemosphere.2015.10.004; Novelli A, 2012, CHEMOSPHERE, V86, P36, DOI 10.1016/j.chemosphere.2011.08.047; Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023; [裴春梅 PEI Chun-mei], 2009, [江西农业大学学报, Acta Agriculturae Universitatis Jiangxiensis], V31, P659; Shen W, 2011, PESTIC BIOCHEM PHYS, V101, P159, DOI 10.1016/j.pestbp.2011.08.011; SIMON LM, 1974, BIOCHEM PHYSIOL PFL, V166, P387; Tisler T, 2006, ECOTOXICOLOGY, V15, P495, DOI 10.1007/s10646-006-0085-1; TSUCHIMOTO T, 1979, ARCH TOXICOL, V42, P239, DOI 10.1007/BF00334837; Wang J, 2016, CHEMOSPHERE, V144, P510, DOI 10.1016/j.chemosphere.2015.09.004; Wilson JT, 1998, MUTAT RES-FUND MOL M, V399, P87, DOI 10.1016/S0027-5107(97)00268-6; Wislocki P.G., 1989, ENV ASPECTS ABAMECTI; Xian JA, 2010, COMP BIOCHEM PHYS C, V152, P182, DOI 10.1016/j.cbpc.2010.04.003; Ying JJ, 2011, TOXICITY ABAMECTIN E; Zhang W, 2016, J FISHERY SCI CHINA; Zhang Y, 2017, ENVIRON POLLUT, V220, P1127, DOI 10.1016/j.envpol.2016.11.022	42	9	11	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225171	10.1371/journal.pone.0225171	http://dx.doi.org/10.1371/journal.pone.0225171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765405	Green Published, gold			2022-12-26	WOS:000533891000016
J	Muhwava, LS; Murphy, K; Zarowsky, C; Levitt, N				Muhwava, Lorrein Shamiso; Murphy, Katherine; Zarowsky, Christina; Levitt, Naomi			Experiences of lifestyle change among women with gestational diabetes mellitus (GDM): A behavioural diagnosis using the COM-B model in a low-income setting	PLOS ONE			English	Article							RISK; PREVENTION; KNOWLEDGE; PREGNANCY; HISTORY	Background Lifestyle change can reduce the risk of developing type 2 diabetes among women with prior gestational diabetes mellitus (GDM). While understanding women's lived experiences and views around GDM is critical to the development of behaviour change interventions to reduce this risk, few studies have addressed this issue in low- and middle- income countries. The aim of the study was to explore women's lived experiences of GDM and the feasibility of sustained lifestyle modification after GDM in a low-income setting. Methods This was a descriptive qualitative study on the lived experiences of women with prior GDM, who received antenatal care at a public sector tertiary hospital in Cape Town, South Africa. Nine focus groups and five in-depth interviews were conducted with a total of thirty-five women. Data were analysed using content analysis and the COM-B (Capabilities, Opportunities, Motivations and Behaviour) model to identify factors influencing lifestyle change during and beyond the GDM pregnancy. Results The results suggest that the COM-B model's concepts of capability (knowledge and skills for behaviour change), opportunity (resources for dietary change and physical activity) and motivation (perception of future diabetes risk) are relevant to lifestyle change among GDM women in South Africa. The results will contribute to the design of a postpartum health system intervention for women with recent GDM. Conclusion Our findings highlight the need for health services to improve counselling and education for women with GDM in South Africa. Support from family and health professionals is essential for women to achieve lifestyle change. The experience of GDM imposed a significant psychological burden on women, which affected motivation for lifestyle change. To achieve long-term lifestyle change, behaviour interventions for women with prior GDM need to address their capability, opportunity and motivation for lifestyle change during and beyond pregnancy.	[Muhwava, Lorrein Shamiso; Murphy, Katherine; Levitt, Naomi] Univ Cape Town, Fac Hlth Sci, Dept Med, Cape Town, South Africa; [Muhwava, Lorrein Shamiso; Murphy, Katherine; Zarowsky, Christina; Levitt, Naomi] Chron Dis Initiat Africa, Cape Town, South Africa; [Zarowsky, Christina] Univ Montreal, Hosp Res Ctr, Montreal, PQ, Canada; [Zarowsky, Christina] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada; [Zarowsky, Christina] Univ Western Cape, Fac Community & Hlth Sci, Sch Publ Hlth, Cape Town, South Africa	University of Cape Town; Universite de Montreal; Universite de Montreal; University of the Western Cape	Muhwava, LS (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, Cape Town, South Africa.; Muhwava, LS (corresponding author), Chron Dis Initiat Africa, Cape Town, South Africa.	lorrein.muhwava@uct.ac.za		Muhwava, Lorrein Shamiso/0000-0001-8585-0693; Zarowsky, Christina/0000-0002-0850-6212	International Development Research Centre (IDRC) through the Global Alliance for Chronic Disease (GACD) research programme [108002-001]; African Doctoral Dissertation Research Fellowship (ADDRF) award; International Development Research Centre (IDRC)	International Development Research Centre (IDRC) through the Global Alliance for Chronic Disease (GACD) research programme; African Doctoral Dissertation Research Fellowship (ADDRF) award; International Development Research Centre (IDRC)	The IINDIAGO project; principal investigators NL and CZ, is funded by the International Development Research Centre (IDRC) through the Global Alliance for Chronic Disease (GACD) research programme [108002-001], with additional funds provided to LSM by the African Doctoral Dissertation Research Fellowship (ADDRF) award, offered by the African Population and Health Research Center (APHRC), in partnership with the International Development Research Centre (IDRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouki K, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2159890; Barakat S, 2014, ARCH WOMEN MENT HLTH, V17, P587, DOI 10.1007/s00737-014-0460-5; Barker F, 2016, INT J AUDIOL, V55, pS90, DOI 10.3109/14992027.2015.1120894; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bennett WL, 2011, J WOMENS HEALTH, V20, P239, DOI 10.1089/jwh.2010.2233; Bhurosy Trishnee, 2014, ScientificWorldJournal, V2014, P964236, DOI 10.1155/2014/964236; Carolan M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-99; Collier SA, 2011, J WOMENS HEALTH, V20, P1333, DOI 10.1089/jwh.2010.2676; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Draffin CR, 2016, MIDWIFERY, V40, P141, DOI 10.1016/j.midw.2016.06.019; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Eades CE, 2018, DIABETIC MED, V35, P519, DOI 10.1111/dme.13580; Egan AM, 2017, QJM-INT J MED, V110, P721, DOI 10.1093/qjmed/hcx106; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Ferrara A, 2011, DIABETES CARE, V34, P1519, DOI 10.2337/dc10-2221; Ge L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017648; Gilinsky A S, 2015, Prev Med Rep, V2, P448, DOI 10.1016/j.pmedr.2015.05.009; Gray MF, 2017, MATERN CHILD HLTH J, V21, P1678, DOI 10.1007/s10995-017-2261-8; Handley MA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0426-2; Hirst JE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-81; Hjelm K, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0518-z; Howlett N, 2017, J HEALTH PSYCHOL; Jackson C, 2014, EUR HLTH PSYCHOL, V16, P7; Kaiser B, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-133; Keely E, 2010, CAN FAM PHYSICIAN, V56, P558; Lachat C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001465; Lie MLS, 2013, DIABETIC MED, V30, P986, DOI 10.1111/dme.12206; Macaulay S, 2018, DIABETES RES CLIN PR, V139, P278, DOI 10.1016/j.diabres.2018.03.012; Marchetti D, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/7058082; Martin B, 2018, DIABETES RES CLIN PR; Martis R, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1710-8; Mendenhall E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2615-3; Michie S, 2014, BEHAV CHANGE WHEEL G, DOI DOI 10.1186/s13012-015-0322-1; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Morrison MK, 2010, DIABETIC MED, V27, P882, DOI 10.1111/j.1464-5491.2010.03032.x; Morrison MK, 2014, WOMEN BIRTH, V27, P52, DOI 10.1016/j.wombi.2013.10.001; Muhwava LS, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3175-x; Mukona D, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/3578075; Muzigaba M, 2014, J PHYS ACT HEALTH, V11, P1276, DOI 10.1123/jpah.2012-0386; Nielsen KK, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-33; Olander EK, 2016, WOMEN BIRTH, V29, pE67, DOI 10.1016/j.wombi.2015.11.005; Parsons J, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1657-9; Peer N, 2014, DIABETES RES CLIN PR, V103, P197, DOI 10.1016/j.diabres.2013.11.006; Pierce M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X601316; Siad FM, 2018, CAN J DIABETES; Song C, 2018, OBES REV, V19, P421, DOI 10.1111/obr.12645; Stage E, 2004, DIABETES RES CLIN PR, V63, P67, DOI 10.1016/j.diabres.2003.08.009; Statistics South Africa, 2017, MORT CAUS DEATH S AF; Tierney M, 2015, HEALTH PSYCHOL BEHAV, V3, P204, DOI 10.1080/21642850.2015.1073111; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Van Ryswyk E, 2015, DIABETES RES CLIN PR, V110, P109, DOI 10.1016/j.diabres.2015.09.010; Weir Z, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-18; Youngwanichsetha S, 2017, J CLIN NURS, V26, P2915, DOI 10.1111/jocn.13571; Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x	54	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225431	10.1371/journal.pone.0225431	http://dx.doi.org/10.1371/journal.pone.0225431			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QR	31765431	gold, Green Published			2022-12-26	WOS:000533891000027
J	Hichert, M; Abbink, DA; Vardy, AN; van der Sluis, CK; Janssen, WGM; Brouwers, MAH; Plettenburg, DH				Hichert, Mona; Abbink, David A.; Vardy, Alistair N.; van der Sluis, Corry K.; Janssen, Wim G. M.; Brouwers, Michael A. H.; Plettenburg, Dick H.			Perception and control of low cable operation forces in voluntary closing body-powered upper-limb prostheses	PLOS ONE			English	Article							EFFICIENCY; HAND	Operating a body-powered prosthesis can be painful and tiring due to high cable operation forces, illustrating that low cable operation forces are a desirable design property for body-powered prostheses. However, lower operation forces might negatively affect controllability and force perception, which is plausible but not known. This study aims to quantify the accuracy of cable force perception and control for body-powered prostheses in a low cable operation force range by utilizing isometric and dynamic force reproduction experiments. Twenty-five subjects with trans-radial absence conducted two force reproduction tasks; first an isometric task of reproducing 10, 15, 20, 25, 30 or 40 N and second a force reproduction task of 10 and 20 N, for cable excursions of 10, 20, 40, 60 and 80 mm. Task performance was quantified by the force reproduction error and the variability in the generated force. The results of the isometric experiment demonstrated that increasing force levels enlarge the force variability, but do not influence the force reproduction error for the tested force range. The second experiment showed that increased cable excursions resulted in a decreased force reproduction error, for both tested force levels, whereas the force variability remained unchanged. In conclusion, the design recommendations for voluntary closing body-powered prostheses suggested by this study are to minimize cable operation forces: this does not affect force reproduction error but does reduce force variability. Furthermore, increased cable excursions facilitate users with additional information to meet a target force more accurately.	[Hichert, Mona; Vardy, Alistair N.; Plettenburg, Dick H.] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Abbink, David A.] Delft Univ Technol, Dept Cognit Robot, Delft, Netherlands; [van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Janssen, Wim G. M.] Erasmus MC, Rijndam Rehabil Ctr Rotterdam, Dept Rehabil Med, Rotterdam, Netherlands; [Brouwers, Michael A. H.] Rehabil Inst De Hoogstr, Utrecht, Netherlands	Delft University of Technology; Delft University of Technology; University of Groningen; Erasmus University Rotterdam; Erasmus MC	Hichert, M (corresponding author), Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands.	mona.hichert@gmail.com	; Abbink, David/G-2650-2015	Hichert, Mona/0000-0003-3264-9413; Abbink, David/0000-0001-7778-0090; Plettenburg, Dick/0000-0003-1022-5855	Fonds NutsOhra [1101-049]	Fonds NutsOhra	This study was financially supported by Fonds NutsOhra, grant number 1101-049 (https://www.fnozorgvoorkansen.nl/) to DHP and MH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Biddiss E, 2007, DISABIL REHABIL-ASSI, V2, P346, DOI 10.1080/17483100701714733; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Hichert M, 2014, P MYO EL CONTR S MEC, P91; Hichert M, 2018, PROSTHET ORTHOT INT, V42, P84, DOI 10.1177/0309364617708651; Hichert M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169996; JONES LA, 1982, BRAIN RES, V244, P186, DOI 10.1016/0006-8993(82)90919-2; Keller A.D., 1947, STUDIES DETERMINE FU; Latour D, 2007, P 12 WORLD C INT SOC, P555; MONOD H, 1985, ERGONOMICS, V28, P81, DOI 10.1080/00140138508963115; Mugge W, 2013, EXP BRAIN RES, V224, P635, DOI 10.1007/s00221-012-3341-z; Mugge W, 2009, J NEUROSCI, V29, P5476, DOI 10.1523/JNEUROSCI.0116-09.2009; Niet Van Der O, 2010, PROSTHET ORTHOT INT, V34, P216, DOI 10.3109/03093641003767207; Onneweer B, 2016, IEEE T HAPTICS, V9, P54, DOI 10.1109/TOH.2015.2508799; Plettenburg DH, 2011, P MYO EL CONTR S MEC, P74; Radocy B, 2015, TRS CUTANEOUS ANCHOR; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; SHAPERMAN J, 1995, J PROSTHET ORTHOT, V7, P61; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Simpson D., 1974, CONTROL UPPER EXTREM, P146; Smit G, 2012, J REHABIL RES DEV, V49, P523, DOI 10.1682/JRRD.2011.07.0125; Smit G, 2010, PROSTHET ORTHOT INT, V34, P411, DOI 10.3109/03093646.2010.486390; Taylor CL, 1954, HUMAN LIMBS THEIR SU, P169; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; TRS Prosthetics Inc, TRS SURE LOK; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P547, DOI 10.1113/jphysiol.2010.198689	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225263	10.1371/journal.pone.0225263	http://dx.doi.org/10.1371/journal.pone.0225263			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756222	gold, Green Published			2022-12-26	WOS:000533889300014
J	Kindler, S; Ittermann, T; Bulow, R; Holtfreter, B; Klausenitz, C; Metelmann, P; Mksoud, M; Pink, C; Seebauer, C; Kocher, T; Koppe, T; Krey, KF; Metelmann, HR; Volzke, H; Daboul, A				Kindler, Stefan; Ittermann, Till; Buelow, Robin; Holtfreter, Birte; Klausenitz, Catharina; Metelmann, Philine; Mksoud, Maria; Pink, Christiane; Seebauer, Christian; Kocher, Thomas; Koppe, Thomas; Krey, Karl-Friedrich; Metelmann, Hans-Robert; Voelzke, Henry; Daboul, Amro			Does craniofacial morphology affect third molars impaction? Results from a population-based study in northeastern Germany	PLOS ONE			English	Article							ORTHODONTIC DIAGNOSIS; PROPHYLACTIC REMOVAL; FACIAL KEYS; PREDICTORS; AGENESIS; HEALTH; COHORT; RISK	Objectives It is still not clear why impaction of third molars occurs. Craniofacial morphology and facial parameters have been discussed to be strong predictors for third molar impaction. Thus, this study aimed to investigate the effect of craniofacial morphology on erupted or impacted third molars in a German population sample. Materials and methods Erupted and impacted third molars in 2,484 participants from the Study of Health in Pomerania were assessed by whole-body magnetic resonance imaging. Markers of facial morphology were determined in 619 individuals of those participants in whose 421 participants (16.7%) had at least one impacted third molar. Craniofacial morphology was estimated as linear measurements and was associated in a cross-sectional study design with impacted and erupted third molars by multinomial logistic regression models. Erupted third molars were used as reference outcome category and regression models were adjusted for age and sex. Results Maximum Cranial Width (Eurion-Eurion distance) was significantly associated with impacted third molars (RR: 1.079; 95% confidence interval 1.028-1.132). This association was even more pronounced in the mandible. Individuals with a lower total anterior facial height (Nasion-Menton distance) and a lower facial index also have an increased risk for impacted third molars in the mandible (RR 0.953; 95% confidence interval 0.913-0.996 and RR: 0.943; 95% confidence interval 0.894-0.995). No significant associations of third molar status with facial width (Zygion-Zygion distance), and sagittal cranial dimension (NasionSella distance; Sella-Basion distance) were observed. Conclusion Individuals with an increased maximal cranial width have a higher risk for impaction of third molars in the mandible and in the maxilla. Individuals with a lower anterior total anterior facial height and lower facial index also have an increased risk for third molars impaction in the mandible. These findings could help orthodontic dentists, oral surgeons and oral and maxillofacial surgeons in decision-making for third molars removal in their treatment. These findings highlight the necessity of an additional analysis of the maximal cranial width by the Eurion-Eurion distance.	[Kindler, Stefan; Mksoud, Maria; Seebauer, Christian; Metelmann, Hans-Robert] Univ Med Greifswald, Dept Oral & Maxillofacial Surg Plast Surg, Greifswald, Germany; [Ittermann, Till; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Buelow, Robin; Klausenitz, Catharina] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Holtfreter, Birte; Pink, Christiane; Kocher, Thomas] Univ Med Greifswald, Dept Restorat Dent Periodontol Endodontol & Preve, Greifswald, Germany; [Metelmann, Philine; Krey, Karl-Friedrich] Univ Med Greifswald, Dept Orthodont, Greifswald, Germany; [Koppe, Thomas] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Daboul, Amro] Univ Med Greifswald, Dept Prosthodont Gerodontol & Biomat, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Kindler, S (corresponding author), Univ Med Greifswald, Dept Oral & Maxillofacial Surg Plast Surg, Greifswald, Germany.	kindlers@uni-greifswald.de	Doberschütz, Philine/AAR-7118-2021	Doberschütz, Philine/0000-0002-1120-8398	Federal State of Mecklenburg-West Pomerania; German Federal Ministry of Education and Research (BMBF) [01ZZ96030, 01ZZ0701]; Ministry of Education, Research and Cultural Affairs; Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania; DFG (German Research Foundation) [393148499]; University of Greifswald	Federal State of Mecklenburg-West Pomerania; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry of Education, Research and Cultural Affairs; Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania; DFG (German Research Foundation)(German Research Foundation (DFG)); University of Greifswald	While the authors of the present study received no specific funding for this project, they collected data from the Study of Health in Pomerania (SHIP) study. SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal State of Mecklenburg-West Pomerania. The Community Medicine Research net of the University of Greifswald is funded by the German Federal Ministry of Education and Research (BMBF, grants 01ZZ96030 and 01ZZ0701), the Ministry of Education, Research and Cultural Affairs as well as the Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania. We acknowledge support for the Article Processing Charge from the DFG (German Research Foundation, 393148499) and the Open Access Publication Fund of the University of Greifswald.	Adeyemo WL, 2006, ORAL SURG ORAL MED O, V102, P448, DOI 10.1016/j.tripleo.2005.08.015; Almaqrami Bushra-Sufyan, 2018, J Clin Exp Dent, V10, pe352, DOI 10.4317/jced.54578; [Anonymous], 2018, J DENT SCI, DOI DOI 10.1016/j.jds.2017.10.005; ARNETT GW, 1993, AM J ORTHOD DENTOFAC, V103, P299, DOI 10.1016/0889-5406(93)70010-L; Arnett GW, 2004, AM J ORTHOD DENTOFAC, V126, P290, DOI 10.1016/j.ajodo.2004.06.006; ARNETT GW, 1993, AM J ORTHOD DENTOFAC, V103, P395; Baykul T, 2005, ORAL SURG ORAL MED O, V99, P542, DOI 10.1016/j.tripleo.2004.08.010; Behbehani F, 2006, AM J ORTHOD DENTOFAC, V130, P47, DOI 10.1016/j.ajodo.2006.03.002; Bergman RT, 1999, AM J ORTHOD DENTOFAC, V116, P373, DOI 10.1016/S0889-5406(99)70222-2; Bozzatello Juana R, 2006, Rev Fac Cien Med Univ Nac Cordoba, V63, P38; Breik O, 2008, AUST DENT J, V53, P320, DOI 10.1111/j.1834-7819.2008.00073.x; Carter K, 2016, J DENT RES, V95, P267, DOI 10.1177/0022034515615857; Carter K, 2015, J DENT RES, V94, P886, DOI 10.1177/0022034515581644; Chu F. C. S., 2003, Hong Kong Medical Journal, V9, P158; Cotton F, 2005, SURG RADIOL ANAT, V27, P64, DOI 10.1007/s00276-004-0283-6; Daboul A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197675; Daboul A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048281; Di Dio M, 2002, Minerva Stomatol, V51, P473; Farkas LG, 2005, J CRANIOFAC SURG, V16, P615, DOI 10.1097/01.scs.0000171847.58031.9e; Ferretti F, 2009, DENTOMAXILLOFAC RAD, V38, P387, DOI 10.1259/dmfr/29929241; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Friedman JW, 2007, AM J PUBLIC HEALTH, V97, P1554, DOI 10.2105/AJPH.2006.100271; Goto TK, 2007, ORAL SURG ORAL MED O, V103, P550, DOI 10.1016/j.tripleo.2006.03.011; Gray CF, 1998, BRIT DENT J, V184, P603, DOI 10.1038/sj.bdj.4809707; Harradine N W, 1998, Br J Orthod, V25, P117; Hashemipour MA, 2013, MED ORAL PATOL ORAL, V18, pE140, DOI 10.4317/medoral.18028; HAZELKORN HM, 1994, J ORAL MAXIL SURG, V52, P681, DOI 10.1016/0278-2391(94)90478-2; Hegenscheid K, 2009, ROFO-FORTSCHR RONTG, V181, P748, DOI 10.1055/s-0028-1109510; Heil A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174524; INOUE N, 1980, J ANTHROPOL SOC NIP, V88, P69; Juerchott A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31384-8; KANAZAWA E, 1988, PRIMATES, V29, P525, DOI 10.1007/BF02381139; Keil U, 1998, EUR HEART J, V19, P1197, DOI 10.1053/euhj.1998.1089; Kindler S, 2018, J CLIN PERIODONTOL, V45, P1365, DOI 10.1111/jcpe.13008; Knutsson K, 1996, ORAL SURG ORAL MED O, V82, P10, DOI 10.1016/S1079-2104(96)80371-4; Ko EWC, 2013, J ORAL MAXIL SURG, V71, pE215, DOI 10.1016/j.joms.2012.12.025; Kragskov J, 1997, CLEFT PALATE-CRAN J, V34, P111, DOI 10.1597/1545-1569(1997)034<0111:COTROC>2.3.CO;2; Krecioch J., 2014, EXAMINING RELATIONSH; Kuijpers MAR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093442; Langowska-Adamczyk H, 2001, AM J ORTHOD DENTOFAC, V119, P67, DOI 10.1067/mod.2001.111225; Lytle J J, 1995, Northwest Dent, V74, P23; MATTESON SR, 1989, J ORAL MAXIL SURG, V47, P1053, DOI 10.1016/0278-2391(89)90180-8; Mehanna H, 2016, J LARYNGOL OTOL, V130, pS181, DOI 10.1017/S002221511600061X; Moller M, 2012, ORTHOD CRANIOFAC RES, V15, P103, DOI 10.1111/j.1601-6343.2012.01541.x; Monson TA, 2019, ANAT REC, V302, P1419, DOI 10.1002/ar.23979; Monson TA, 2018, AM J PHYS ANTHROPOL, V167, P217, DOI 10.1002/ajpa.23618; Mucci RJ, 1982, ROLE ATTRITION ETIOL; Niraj LK, 2016, J CLIN DIAGN RES, V10, pZE14, DOI 10.7860/JCDR/2016/19435.8658; OPDEBEECK H, 1978, AM J ORTHOD DENTOFAC, V73, P499, DOI 10.1016/0002-9416(78)90240-3; Pell G., 1942, AM J ORTHOD DENTOFAC, V28, P660; Quek SL, 2003, INT J ORAL MAX SURG, V32, P548, DOI 10.1054/ijom.2003.0413; Rupp Roger P., 2000, General Dentistry, V48, P344; Salti L, 2017, J CLIN PERIODONTOL, V44, P363, DOI 10.1111/jcpe.12661; Song F, 1997, BRIT DENT J, V182, P339, DOI 10.1038/sj.bdj.4809378; TYNDALL DA, 1992, J ORAL MAXIL SURG, V50, P1164, DOI 10.1016/0278-2391(92)90147-R; Verweij JP, 2014, J CRANIO MAXILL SURG, V42, pE359, DOI 10.1016/j.jcms.2014.03.019; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Vukelic A, 2017, HUM BIOL, V89, P157, DOI 10.13110/humanbiology.89.2.03; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Worrall SF, 1998, BRIT J ORAL MAX SURG, V36, P14, DOI 10.1016/S0266-4356(98)90740-9	60	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225444	10.1371/journal.pone.0225444	http://dx.doi.org/10.1371/journal.pone.0225444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QA	31756203	Green Published, gold			2022-12-26	WOS:000533889300030
J	Brovarets, OO; Hovorun, DM				Brovarets, Ol'ha O.; Hovorun, Dmytro M.			Intramolecular tautomerization of the quercetin molecule due to the proton transfer: QM computational study	PLOS ONE			English	Article							DNA-BASE MISPAIR; DPT TAUTOMERIZATION; ELECTRON-DENSITY; 2-AMINOPURINE MUTAGENICITY; ANTIOXIDANT ACTIVITY; HYDROGEN-BONDS; GAS-PHASE; FLAVONOIDS; ENERGY; MECHANISMS	Quercetin molecule (3, 3', 4', 5, 7-pentahydroxyflavone, C15H10O7) is an important flavonoid compound of natural origin, consisting of two aromatic A and B rings linked through the C ring with endocyclic oxygen atom and five hydroxyl groups attached to the 3, 3', 4', 5 and 7 positions. This molecule is found in many foods and plants, and is known to have a wide range of therapeutic properties, like an anti-oxidant, anti-toxic, anti-inflammatory etc. In this study for the first time we have revealed and investigated the pathways of the tautomeric transformations for the most stable conformers of the isolated quercetin molecule (Brovarets' & Hovorun, 2019) via the intramolecular proton transfer. Energetic, structural, dynamical and polar characteristics of these transitions, in particular relative Gibbs free and electronic energies, characteristics of the intramolecular specific interactions-H-bonds and attractive van der Waals contacts, have been analysed in details. It was demonstrated that the most probable process among all investigated is the proton transfer from the O3H hydroxyl group of the C ring to the C2' carbon atom of the C2'H group of the B ring along the intramolecular O3H center dot center dot center dot C2' H-bond with the further formation of the C2'H-2 group. It was established that the proton transfer from the hydroxyl groups to the carbon atoms of the neighboring CH groups is assisted at the transition states by the strong intramolecular HCH center dot center dot center dot O H-bond (similar to 28.5 kcal.mol(-1)). The least probable path of the proton transfer-from the C8H group to the endocyclic O1 oxygen atom-causes the decyclization of the C ring in some cases. It is shortly discussed the biological importance of the obtained results.	[Brovarets, Ol'ha O.; Hovorun, Dmytro M.] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Dept Mol & Quantum Biophys, Kiev, Ukraine; [Hovorun, Dmytro M.] Taras Shevchenko Natl Univ Kyiv, Inst High Technol, Dept Mol Biotechnol & Bioinformat, Kiev, Ukraine	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev	Hovorun, DM (corresponding author), Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Dept Mol & Quantum Biophys, Kiev, Ukraine.; Hovorun, DM (corresponding author), Taras Shevchenko Natl Univ Kyiv, Inst High Technol, Dept Mol Biotechnol & Bioinformat, Kiev, Ukraine.	dhovorun@imbg.org.ua		Hovorun, Dmytro/0000-0002-5579-5520				Afonin AV, 2019, INT J QUANTUM CHEM, V119, DOI 10.1002/qua.26001; Afonin AV, 2019, J MOL STRUCT, V1176, P73, DOI 10.1016/j.molstruc.2018.08.050; Palafox MA, 2014, J BIOMOL STRUCT DYN, V32, P831, DOI 10.1080/07391102.2013.789402; Alvareda E, 2016, COMPUT THEOR CHEM, V1091, P18, DOI 10.1016/j.comptc.2016.06.021; Amic D, 2013, J MOL MODEL, V19, P2593, DOI 10.1007/s00894-013-1800-5; Andersen M., 2006, FLAVONOIDS CHEM BIOC; [Anonymous], 2013, TAUTOMERISM METHODS; Antonczak S, 2008, J MOL STRUC-THEOCHEM, V856, P38, DOI 10.1016/j.theochem.2008.01.014; Antonov L., 2016, TAUTOMERISM CONCEPTS, DOI 10.1002/9783527695713; Bader R. F. W., 1990, ATOMS MOL QUANTUM TH; Bax B, 2017, ACTA CRYSTALLOGR D, V73, P131, DOI 10.1107/S2059798316020283; BAYLEY ST, 1951, T FARADAY SOC, V47, P509, DOI 10.1039/tf9514700509; Bogdan T. V., 2001, SCI NOTES NAUKMA, V19, P456; Brovarets O.O., 2019, INT S EFMC ACSMEDI M, P114; Brovarets O. O., 2009, UKRAINICA BIOORGANIC, V2, P19; Brovarets O.O., 2019, J BIOMOL STRUCT DYNA; Brovarets O.O., 2019, P BIOH 2019 18 INT C, P84; Brovarets O.O., CONFORMATIONAL UNPUB; Brovarets' O. O., 2018, MITOCHONDRIAL DNA NE, VI, P13, DOI [10.5772/intechopen.77366, DOI 10.5772/INTECHOPEN.77366]; Brovarets' OO, 2019, J BIOMOL STRUCT DYN, V37, P2716, DOI 10.1080/07391102.2018.1495577; Brovarets' OO, 2019, J BIOMOL STRUCT DYN, V37, P1880, DOI 10.1080/07391102.2018.1467795; Brovarets' OO, 2020, J BIOMOL STRUCT DYN, V38, P2817, DOI 10.1080/07391102.2019.1656671; Brovarets' OO, 2020, J BIOMOL STRUCT DYN, V38, P2865, DOI 10.1080/07391102.2019.1645734; Brovarets OO, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00532; Brovarets' OO, 2018, INT J QUANTUM CHEM, V118, DOI 10.1002/qua.25692; Brovarets OO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28636-y; Brovarets OO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199044; Brovarets OO, 2018, RSC ADV, V8, P13433, DOI 10.1039/c8ra01446a; Brovarets OO, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00008; Brovarets OO, 2018, PHYS CHEM CHEM PHYS, V20, P623, DOI 10.1039/c7cp05139e; Brovarets' OO, 2016, RSC ADV, V6, P99546, DOI 10.1039/c6ra17787e; Brovarets OO, 2015, J BIOMOL STRUCT DYN, V33, P1624, DOI 10.1080/07391102.2014.968623; Brovarets OO, 2014, MOL PHYS, V112, P2005, DOI 10.1080/00268976.2013.877170; Brovarets OO, 2014, PHYS CHEM CHEM PHYS, V16, P9074, DOI 10.1039/c4cp00488d; Brovarets' OO, 2014, J COMPUT CHEM, V35, P451, DOI 10.1002/jcc.23515; Brovarets' OO, 2014, J BIOMOL STRUCT DYN, V32, P1474, DOI 10.1080/07391102.2013.822829; Brovarets OO, 2013, PHYS CHEM CHEM PHYS, V15, P20091, DOI 10.1039/c3cp52644e; Brovarets' OO, 2013, J COMPUT CHEM, V34, P2577, DOI 10.1002/jcc.23412; Brovarets' OO, 2014, J BIOMOL STRUCT DYN, V32, P127, DOI 10.1080/07391102.2012.755795; Brovarets' OO, 2014, J BIOMOL STRUCT DYN, V32, P993, DOI 10.1080/07391102.2013.799439; Brovarets' OO, 2013, J BIOMOL STRUCT DYN, V31, P913, DOI 10.1080/07391102.2012.715041; Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m; Cadenas E, 2002, HDB ANTIOXIDANTS; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; DEWAR MJS, 1985, P NATL ACAD SCI USA, V82, P2225, DOI 10.1073/pnas.82.8.2225; El-Sayed AA, 2015, J BIOMOL STRUCT DYN, V33, P723, DOI 10.1080/07391102.2014.909743; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; Florian J, 1996, J AM CHEM SOC, V118, P3010, DOI 10.1021/ja951983g; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; FRISCH MJ, 1990, CHEM PHYS LETT, V166, P281, DOI 10.1016/0009-2614(90)80030-H; Galano A, 2016, ANNU REV FOOD SCI T, V7, P335, DOI 10.1146/annurev-food-041715-033206; GarciaMoreno B, 1997, BIOPHYS CHEM, V64, P211, DOI 10.1016/S0301-4622(96)02238-7; Grytsenko O. M., 1992, FARMATS ZH N, VN2, P34; Grytsenko O. M., 2003, FARM ZH N, V5, P62; Haenen GRMM, 1997, BIOCHEM BIOPH RES CO, V236, P591, DOI 10.1006/bbrc.1997.7016; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Hratchian HP, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P195, DOI 10.1016/B978-044451719-7/50053-6; Katritzky AR, 2010, J COMPUT AID MOL DES, V24, P475, DOI 10.1007/s10822-010-9359-z; Keith T.A., 2010, A L MALL; Kerry N, 1999, J NEUROCHEM, V73, P247, DOI 10.1046/j.1471-4159.1999.0730247.x; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leopoldini M, 2004, THEOR CHEM ACC, V111, P210, DOI 10.1007/s00214-003-0544-1; Li Y, 2016, NUTRIENTS, V8, P167, DOI DOI 10.3390/NU8030167; Liu RJ, 2018, PROCEEDINGS OF THE 3RD WORKSHOP ON SYSTEM SOFTWARE FOR TRUSTED EXECUTION (SYSTEX'18), P2, DOI 10.1145/3268935.3268937; Markova N, 2019, J PHYS CHEM B, V123, P622, DOI 10.1021/acs.jpcb.8b11316; Markovic Z, 2013, PHYS CHEM CHEM PHYS, V15, P7370, DOI 10.1039/c3cp44605k; Markovic ZS, 2010, THEOR CHEM ACC, V127, P69, DOI 10.1007/s00214-009-0706-x; Martin YC, 2009, J COMPUT AID MOL DES, V23, P693, DOI 10.1007/s10822-009-9303-2; Masoodi HR, 2019, J BIOMOL STRUCT DYN, V37, P1923, DOI 10.1080/07391102.2018.1475256; Mata I, 2011, CHEM PHYS LETT, V507, P185, DOI 10.1016/j.cplett.2011.03.055; Matta CF, 2003, J PHYS CHEM A, V107, P7496, DOI 10.1021/jp034952d; Matta CF, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2378720; Matta CF, 2014, J COMPUT CHEM, V35, P1165, DOI 10.1002/jcc.23608; Mertz EL, 2000, P NATL ACAD SCI USA, V97, P2081, DOI 10.1073/pnas.050316997; Modelli A, 2013, PHYS CHEM CHEM PHYS, V15, P1588, DOI 10.1039/c2cp43379f; Musialik M, 2009, J ORG CHEM, V74, P2699, DOI 10.1021/jo802716v; Nikitenko NG, 2018, RUSS CHEM B+, V67, P1794, DOI 10.1007/s11172-018-2291-4; Nikolaienko TY, 2012, PHYS CHEM CHEM PHYS, V14, P7441, DOI 10.1039/c2cp40176b; Olejniczak S, 2004, ORG BIOMOL CHEM, V2, P2315, DOI 10.1039/b406861k; Pannala AS, 2001, BIOCHEM BIOPH RES CO, V282, P1161, DOI 10.1006/bbrc.2001.4705; Parr R. G., 1989, DENSITY FUNCTIONAL T; Peng CY, 1996, J COMPUT CHEM, V17, P49, DOI 10.1002/(SICI)1096-987X(19960115)17:1<49::AID-JCC5>3.0.CO;2-0; Peter Atkins P., 2014, ATKINSPHYSICAL CHEM; PETRUSKA J, 1986, P NATL ACAD SCI USA, V83, P1559, DOI 10.1073/pnas.83.6.1559; Protsenko I. O., 2010, WDS 10 P CONTRIBUT 3, P51; Protsenko I.O., 2014, REPORTS NATL ACAD N, V3, P153, DOI [DOI 10.15407/DOPOVIDI2014.03.153, 10.15407/dopovidi2014.03.153]; Rong YZ, 2012, SPECTROCHIM ACTA A, V93, P235, DOI 10.1016/j.saa.2012.03.008; SAMOILOV AN, 2019, J MOL LIQ, V295, DOI DOI 10.1016/J.MOLLIQ.2018.11.050; Sharma A, 2018, PHARM PAT ANAL, V7, P15, DOI 10.4155/ppa-2017-0030; Sigalov MV, 2014, J MOL STRUCT, V1074, P302, DOI 10.1016/j.molstruc.2014.06.021; Taylor P.J., 2013, TAUTOMERISM METHODS, P1, DOI [10.1002/9783527658824.ch1, DOI 10.1002/9783527658824.CH1]; Tirado-Rives J, 2008, J CHEM THEORY COMPUT, V4, P297, DOI 10.1021/ct700248k; Tolosa S, 2018, J MOL LIQ, V251, P308, DOI 10.1016/j.molliq.2017.12.091; Tolosa S, 2017, J MOL LIQ, V237, P81, DOI 10.1016/j.molliq.2017.03.118; Trouillas P, 2006, FOOD CHEM, V97, P679, DOI 10.1016/j.foodchem.2005.05.042; Valters R., 1985, RING CHAIN TAUTOMERI; Vasilescu D, 2002, INT J QUANTUM CHEM, V90, P888, DOI 10.1002/qua.1801; Vermerris W, 2006, PHENOLIC COMPOUND BI; Vinnarasi S., 2019, J BIOMOL STRUCT DYN, DOI [10.1080/07391102.2019, DOI 10.1080/07391102.2019]; Wigner E, 1932, Z PHYS CHEM B-CHEM E, V19, P203; Yang JG, 2009, MOLECULES, V14, P46, DOI 10.3390/molecules14010046; Yang YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep32152	103	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0224762	10.1371/journal.pone.0224762	http://dx.doi.org/10.1371/journal.pone.0224762			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751372	gold, Green Published			2022-12-26	WOS:000533886900017
J	Michael, SA; Hayman, DTS; Gray, R; Zhang, J; Rogers, L; Roe, WD				Michael, Sarah A.; Hayman, David T. S.; Gray, Rachael; Zhang, Ji; Rogers, Lynn; Roe, Wendi D.			Pup mortality in New Zealand sea lions (Phocarctos hookeri) at Enderby Island, Auckland Islands, 2013-18	PLOS ONE			English	Article							STREPTOCOCCUS-HALICHOERI; KLEBSIELLA-PNEUMONIAE; PSYCHROBACTER-SANGUINIS; PATHOLOGICAL FINDINGS; AUSTRALIS-GRACILIS; GUAFO ISLAND; SANDY BAY; INFECTION; PHOCAE; PREVALENCE	New Zealand sea lions (Phocarctos hookeri) are an endemic and endangered species. Pup mortality at Enderby Island (50.5 degrees S, 166.28 degrees E) in the New Zealand sub-Antarctic has been well studied, with subsequent investigations yielding more intricate detail of the causes of mortality, as new diagnostic methods become available. Klebsiella pneumoniae was first reported in 2001-02 at this site, causing a pup mortality epizootic and is now known to be present at several colonies. This bacterium is a common mucosal commensal of humans and animals, however the agent found in pups at necropsy is a hypervirulent strain, readily recognised in microbial culture as being hypermucoviscous. Infection causes septicaemia with a common syndrome of subsequent meningitis and polyarthritis. This investigation uses histopathology and microbiology, with new modalities such as matrix assisted laser desorption/ionisation-time of flight mass spectrometry to show that Klebsiella septicaemia could have historically been, and continues to be, the most important cause of pup mortality, but has been previously underrepresented due to the often cryptic presentation and sometimes peracute course of disease. Hypermucoviscous K. pneumoniae should be considered a serious threat to pup survival in the species, causing on average 60.2% of pup deaths annually at Enderby Island between 2013 and 2018, with likely more continuing mortality following pup dispersal and the cessation of the summer monitoring season. Less common causes of death included starvation (14.8%), trauma/asphyxiation (9.9%) and other infections (7%). This study forms the basis for further evaluation of risk factors for pup mortality in the species, with a view to developing active mitigation.	[Michael, Sarah A.; Gray, Rachael] Univ Sydney, Sydney Sch Vet Sci, Camperdown, NSW, Australia; [Michael, Sarah A.; Roe, Wendi D.] Massey Univ, Sch Vet Sci, Palmerston North, New Zealand; [Hayman, David T. S.; Zhang, Ji; Rogers, Lynn] Massey Univ, Hopkirk Res Inst, Mol Epidemiol & Publ Hlth Lab, Palmerston North, New Zealand; [Michael, Sarah A.] Dept Primary Ind Pk Water & Environm, Hobart, Tas, Australia	University of Sydney; Massey University; Massey University	Michael, SA (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Camperdown, NSW, Australia.; Michael, SA (corresponding author), Massey Univ, Sch Vet Sci, Palmerston North, New Zealand.; Michael, SA (corresponding author), Dept Primary Ind Pk Water & Environm, Hobart, Tas, Australia.	sarah.a.michael@gmail.com		Hayman, David/0000-0003-0087-3015; Zhang, Ji/0000-0003-2582-2978; Michael, Sarah/0000-0002-7176-0774	New Zealand Department of Conservation; Massey University; Research Training Program [SC1999]; University of Sydney [SC0912]; Royal Society Te Aparangi Rutherford Discovery Fellowship [RDF-MAU1701]	New Zealand Department of Conservation; Massey University; Research Training Program; University of Sydney(University of Sydney); Royal Society Te Aparangi Rutherford Discovery Fellowship	This study was funded by the New Zealand Department of Conservation and Massey University. S. A. M was supported by a Research Training Program Stipend (SC1999) and a University of Sydney Vice-Chancellor's Research Scholarship (SC0912). D. T. S. H was supported by the Royal Society Te Aparangi Rutherford Discovery Fellowship (RDF-MAU1701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge AA, 2009, BEHAVIOUR, V146, P1287, DOI 10.1163/15683909X427687; Baker A., 1998, WORKSH HELD 8 9 JUN; Bartlett G, 2016, J WILDLIFE DIS, V52, P1, DOI 10.7589/2015-02-048; Bonwitt J, 2018, EMERG INFECT DIS, V24, P1942, DOI 10.3201/eid2410.171821; Castinel A, 2007, J WILDLIFE DIS, V43, P461, DOI 10.7589/0090-3558-43.3.461; Chang LS, 2013, INFECTION, V41, P559, DOI 10.1007/s15010-012-0374-y; Childerhouse S, 2001, NEW ZEAL J ZOOL, V28, P189, DOI 10.1080/03014223.2001.9518263; Childerhouse S, 2015, FINAL REPORT NZ SEA; Childerhouse S., 2018, FINAL REPORT CSP PRO; Chilvers BL, 2007, POLAR BIOL, V30, P459, DOI 10.1007/s00300-006-0203-9; Del Giudice P, 2018, ACTA DERM-VENEREOL, V98, P378, DOI 10.2340/00015555-2837; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Foo RM, 2014, J CLIN MICROBIOL, V52, P681, DOI 10.1128/JCM.03055-13; Gerdin JA, 2016, VET PATHOL, V53, P1087, DOI 10.1177/0300985815575049; GILMARTIN WG, 1979, J WILDLIFE DIS, V15, P511, DOI 10.7589/0090-3558-15.4.511; Gonzalez Argandona A-K, 2017, THESIS; Gonzalez-Contreras A, 2011, J FISH DIS, V34, P203, DOI 10.1111/j.1365-2761.2010.01228.x; Jang S, 2010, VET MICROBIOL, V141, P174, DOI 10.1016/j.vetmic.2009.07.032; Katz H, 2012, ISRN ZOOL, V2012, DOI DOI 10.5402/2012/586079; Lawson PA, 2004, INT J SYST EVOL MICR, V54, P1753, DOI 10.1099/ijs.0.63082-0; Le Guern R, 2014, J CLIN MICROBIOL, V52, P3475, DOI 10.1128/JCM.01197-14; Lee K, 2016, J WILDLIFE DIS, V52, P183, DOI 10.7589/2015-05-112; Lenting B, 2019, VET ANIM SCI, V7, DOI 10.1016/j.vas.2019.100057; McEwen BJ, 2016, VET PATHOL, V53, P1049, DOI 10.1177/0300985815625757; McIntosh RR, 2013, AUST MAMMAL, V35, P93, DOI 10.1071/AM12037; Meyer S, 2017, P NATL ACAD SCI USA, V114, P11781, DOI 10.1073/pnas.1703165114; Michael SA, 2016, VET PATHOL, V53, P1241, DOI 10.1177/0300985816638723; Moreno B, 2015, J COMP PATHOL, V152, P269, DOI 10.1016/j.jcpa.2014.12.012; Peirano G, 2013, CAN J INFECT DIS MED, V24, pE61, DOI 10.1155/2013/828741; Pinpimai K., 2018, THESIS; Pinpimai K, 2018, MICROBIOL RESOUR ANN, V7, DOI [10.1128/MRA.01328-18, 10.1128/mra.01328-18]; R Core Team, 2018, R LANG ENV STAT COMP; Roberts J., 2014, NZ SEA LION DEMOGRAP; Robertson BC, 2006, BIOL CONSERV, V127, P227, DOI 10.1016/j.biocon.2005.08.011; Roe WD, 2015, VET MICROBIOL, V176, P301, DOI 10.1016/j.vetmic.2015.01.019; Russo TA, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00001-19; Seguel M, 2017, VET PATHOL, V54, P288, DOI 10.1177/0300985816677151; Seguel M, 2011, J COMP PATHOL, V145, P308, DOI 10.1016/j.jcpa.2011.01.006; Seguel M, 2017, VET PATHOL, V54, P846, DOI 10.1177/0300985817705172; Seguel M, 2013, MAR MAMMAL SCI, V29, P36, DOI 10.1111/j.1748-7692.2011.00534.x; Shewmaker PL, 2016, J CLIN MICROBIOL, V54, P739, DOI 10.1128/JCM.03214-15; Spraker TR, 2007, J WILDLIFE DIS, V43, P179, DOI 10.7589/0090-3558-43.2.179; Spraker TR, 2010, J WILDLIFE DIS, V46, P450, DOI 10.7589/0090-3558-46.2.450; Stoddard RA, 2008, DIS AQUAT ORGAN, V81, P5, DOI 10.3354/dao01905; Sturm N, 2011, EMERG INFECT DIS, V17, P2377, DOI 10.3201/eid1712.111103; Taurisano ND, 2018, J WILDLIFE DIS, V54, P101, DOI 10.7589/2016-09-208; TAYLOR R H, 1971, New Zealand Journal of Botany, V9, P225; Twenhafel NA, 2008, VET PATHOL, V45, P226, DOI 10.1354/vp.45-2-226; Wilkinson IS, 2006, LOW WAKE FI, P385; Wirth SE, 2012, INT J SYST EVOL MICR, V62, P49, DOI 10.1099/ijs.0.029058-0; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46	51	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225461	10.1371/journal.pone.0225461	http://dx.doi.org/10.1371/journal.pone.0225461			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751414	gold, Green Published			2022-12-26	WOS:000533886900066
J	Javaid, S; Shaikh, M; Fatima, N; Choudhary, MI				Javaid, Sumaira; Shaikh, Muniza; Fatima, Narjis; Choudhary, M. Iqbal			Natural compounds as angiogenic enzyme thymidine phosphorylase inhibitors: In vitro biochemical inhibition, mechanistic, and in silico modeling studies	PLOS ONE			English	Article							CELL GROWTH-FACTOR; PROGNOSTIC-SIGNIFICANCE; ACCURATE DOCKING; COUMARINS; DERIVATIVES; GLIDE; EXPRESSION; ANALOGS; PROTEIN	Natural flora is the richest source of novel therapeutic agents due to their immense chemical diversity and novel biological properties. In this regard, eighteen natural products belonging to different chemical classes were evaluated for their thymidine phosphorylase (TP) inhibitory activity. TP shares identity with an angiogenic protein platelet derived endothelial cell growth factor (PD-ECGF). It assists tumor angiogenesis and is a key player in cancer progression, thus an ideal target to develop anti-angiogenic drugs. Eleven compounds 1-2, 5-10, 11, 15, and 18 showed a good to weak TP inhibitory activity (IC50 values between 44.0 to 420.3 mu M), as compared to standards i.e. tipiracil (IC50 = 0.014 +/- 0.002 mu M) and 7-deazaxanthine (IC50 = 41.0 +/- 1.63 mu M). Kinetic studies were also performed on active compounds, in order to deduce the mechanism of ligand binding to enzyme. To get further insight into receptor protein (enzyme) and ligand interaction at atomic level, in-sillico studies were also performed. Active compounds were finally evaluated for cytotoxicity test against mouse fibroblast (3T3) cell line. Compound 18 (Masoprocol) showed a significant TP inhibitory activity (IC50 = 44.0 +/- 0.5 mu M). Kinetic studies showed that it inhibits the enzyme in a competitive manner (Ki = 25.6 +/- 0.008 mu M), while it adopts a binding pose different than the substrate thymidine. It is further found to be non-toxic in MTT cytotoxicity assay. This is the first report on TP inhibitory activity of several natural compounds, some of which may serve as leads for further research towards drug the development.	[Javaid, Sumaira; Shaikh, Muniza; Fatima, Narjis; Choudhary, M. Iqbal] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan; [Choudhary, M. Iqbal] Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Pakistan; [Choudhary, M. Iqbal] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia	University of Karachi; University of Karachi; King Abdulaziz University	Choudhary, MI (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan.; Choudhary, MI (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Pakistan.; Choudhary, MI (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia.	iqbal.choudhary@iccs.edu	Shaikh, Muniza/ABE-5751-2020	Shaikh, Muniza/0000-0002-4956-9877				Abbasi MA, 2004, PLANTA MED, V70, P1189, DOI 10.1055/s-2004-835850; Abbaskhan A, 2012, PHYTOTHER RES, V26, P783, DOI 10.1002/ptr.3600; [Anonymous], 2015, PRIM VERS 4 2; [Anonymous], 2015, LIGPREP VERS 3 6; [Anonymous], 2015, PROT PREP WIZ 2015 4; [Anonymous], 2015, GLID VERS 6 9; Ballatore C, 2013, CHEMMEDCHEM, V8, P385, DOI 10.1002/cmdc.201200585; Balzarini J, 1998, FEBS LETT, V438, P91, DOI 10.1016/S0014-5793(98)01271-X; Bera H, 2013, CHEM BIOL DRUG DES, V82, P351, DOI 10.1111/cbdd.12171; Borges F, 2005, CURR MED CHEM, V12, P887, DOI 10.2174/0929867053507315; Bronckaers A, 2009, MED RES REV, V29, P903, DOI 10.1002/med.20159; Brown NS, 1998, BIOCHEM J, V334, P1; Casanova E, 2006, J MED CHEM, V49, P5562, DOI 10.1021/jm0605379; Sperotto NDD, 2019, J MED CHEM, V62, P1231, DOI 10.1021/acs.jmedchem.8b01305; de-Bruin M, 2006, CANC THER, V4, P954; Dias DA, 2012, METABOLITES, V2, DOI 10.3390/metabo2020303; Dimas K, 1998, PLANTA MED, V64, P208, DOI 10.1055/s-2006-957410; DJERASSI C, 1954, J AM CHEM SOC, V76, P4463, DOI 10.1021/ja01646a052; Dutta S, 2013, SAUDI PHARM J, V21, P337, DOI 10.1016/j.jsps.2012.12.007; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Faizi S, 2011, PHARM BIOL, V49, P516, DOI 10.3109/13880209.2010.523006; Fox SB, 1996, BRIT J CANCER, V73, P275, DOI 10.1038/bjc.1996.49; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gbaj A, 2006, J ENZYM INHIB MED CH, V21, P69, DOI 10.1080/14756360500424010; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hussain S, 2009, J ASIAN NAT PROD RES, V11, P159, DOI 10.1080/10286020802618860; Igarashi M, 1998, CANCER, V82, P1225, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1225::AID-CNCR3>3.0.CO;2-E; Javaid S, 2017, BIOORG CHEM, V70, P44, DOI 10.1016/j.bioorg.2016.11.007; Javaid S, 2015, BIOORG CHEM, V63, P142, DOI 10.1016/j.bioorg.2015.10.006; Khan JA, 2017, MED CHEM RES, V26, P2452, DOI 10.1007/s00044-017-1945-3; Khan KM, 2013, MED CHEM RES, V22, P6022, DOI 10.1007/s00044-013-0588-2; Khan KM, 2009, BIOORGAN MED CHEM, V17, P2983, DOI 10.1016/j.bmc.2009.03.020; Lacy A, 2004, CURR PHARM DESIGN, V10, P3797, DOI 10.2174/1381612043382693; Liekens S, 2006, NUCLEOS NUCLEOT NUCL, V25, P975, DOI 10.1080/15257770600888925; Liekens S, 2001, BIOCHEM PHARMACOL, V61, P253, DOI 10.1016/S0006-2952(00)00529-3; Liekens S, 2002, FEBS LETT, V510, P83, DOI 10.1016/S0014-5793(01)03233-1; Matsushita S, 1999, CANCER RES, V59, P1911; Mayer RJ, 2015, NEW ENGL J MED, V372, P1909, DOI 10.1056/NEJMoa1414325; McNally VA, 2007, J PHARM PHARMACOL, V59, P537, DOI 10.1211/jpp.59.4.0008; Miadokova Eva, 2009, Interdiscip Toxicol, V2, P211, DOI 10.2478/v10102-009-0021-3; Miftakhova AF, 2001, FITOTERAPIA, V72, P319, DOI 10.1016/S0367-326X(00)00301-4; Miyadera K., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P609; Moss GP, 2000, PURE APPL CHEM, V72, P1493, DOI 10.1351/pac200072081493; Mughal UR, 2010, J ASIAN NAT PROD RES, V12, P328, DOI 10.1080/10286021003627379; Nencka R, 2007, J MED CHEM, V50, P6016, DOI 10.1021/jm070644i; OBrien TS, 1996, CANCER RES, V56, P4799; Pomeisl K, 2007, NUCLEOS NUCLEOT NUCL, V26, P1025, DOI 10.1080/15257770701508679; Rauf A, 2013, WOLF AFR J PHARM PHA, V7, P2707; Saarinen N, 2003, ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS, VOL 13, P55; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shaheen F, 2006, J NAT PROD, V69, P823, DOI 10.1021/np050478m; Takebayashi Y, 1996, JNCI-J NATL CANCER I, V88, P1110, DOI 10.1093/jnci/88.16.1110; Tatuedom OK, 2014, Z NATURFORSCH B, V69, P747, DOI 10.5560/ZNB.2014-4055; Vane JR, 1998, INFLAMM RES, V47, pS78	56	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225056	10.1371/journal.pone.0225056	http://dx.doi.org/10.1371/journal.pone.0225056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743355	gold, Green Published			2022-12-26	WOS:000533877300016
J	Bernstein, JJJ; Holt, GB; Bernstein, J				Bernstein, John J. J.; Holt, Gerhard B.; Bernstein, Joseph			Price dispersion of generic medications	PLOS ONE			English	Article								Generic pharmaceuticals should have very little price dispersion. Economics' Law of One Price suggests that identical goods, in the absence of trade frictions and under conditions of free competition and price flexibility, should sell for the same price, and the FDA ensures that generics are identical. In this study, we examine whether generic pharmaceuticals indeed have the low price dispersion that theory predicts, and if not, whether the dispersion seen for pharmaceuticals used to treat neuropsychiatric conditions is substantially higher than that of other drugs. Such a difference may offer an explanation for the price dispersion seen: namely, a strategy that takes advantage of buyers' cognitive constraints and impaired ability to comparison shop. We thus assembled a list of generic pharmaceuticals and their prices using www.GoodRx.com, based on a convenience sample of the 5 most popular drugs for 10 common medical conditions listed there. Three neuropsychiatric diagnoses were used: Alzheimer's disease, depression and schizophrenia. Seven other diagnoses served as controls: asthma; diabetes mellitus-type II; high cholesterol; hypertension; osteoarthritis; osteoporosis; and urinary tract infection. For each drug, we identified the highest and lowest prices and calculated the mean, median and coefficient of variation (CV). We further calculated the ratios of the highest price to the median price and of the highest to lowest price. We found that the mean price CV was 43%. For neuropsychiatric drugs and controls, it was 61% and 35%, respectively. The mean high-to-median ratio was3.7 for neuropsychiatric drugs and 1.9 for controls. The mean high-to-low ratio was 5.9 for neuropsychiatric drugs and 2.8 for controls. In short, generic medications have high price dispersion, despite public availability of prices. Although our study did not examine why this price dispersion is present, the especially large high-to-low price ratio for neuropsychiatric medications suggests a strategy that exploits vulnerable patients.	[Bernstein, John J. J.] Haverford High Sch, Haverford, PA USA; [Bernstein, Joseph] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Bernstein, J (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	Joseph.Bernstein@uphs.upenn.edu						Dobkin HE, 2017, J AM ACAD DERMATOL, V77, P1181, DOI 10.1016/j.jaad.2017.07.017; Ellison G, 2009, ECONOMETRICA, V77, P427, DOI 10.3982/ECTA5708; Miller D., 2019, CLIN PSYCHIAT NEWS; Scholten P, EC INTERNET E COMMER, P63; Sorensen AT, 2000, J POLIT ECON, V108, P833, DOI 10.1086/316103	5	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225280	10.1371/journal.pone.0225280	http://dx.doi.org/10.1371/journal.pone.0225280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN3EY	31738807	gold, Green Published			2022-12-26	WOS:000532826300044
J	Dong, KS; Chen, Y; Yang, G; Liao, ZB; Zhang, HW; Liang, HF; Chen, XP; Dong, HH				Dong, Ke-shuai; Chen, Yan; Yang, Guang; Liao, Zhi-bin; Zhang, Hong-wei; Liang, Hui-fang; Chen, Xiao-ping; Dong, Han-hua			TGF-beta 1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; CANCER STEM-CELLS; TUMOR-INITIATING CELLS; HEPATOCELLULAR-CARCINOMA; TGF-BETA; HUMAN LIVER; ACTIVATION; MECHANISMS; MICRORNA; IDENTIFICATION	Increasing evidence has suggested that liver cancer arises partially from transformed hepatic progenitor cells (HPCs). However, the detailed mechanisms underlying HPC transformation are poorly understood. In this study, we provide evidence linking the coexistence of hepatitis B virus X protein (HBx) and transforming growth factor beta 1 (TGF-beta 1) with miR-199a-3p in the malignant transformation of HPCs. The examination of liver cancer specimens demonstrated that HBx and TGF-beta 1 expression was positively correlated with epithelial cell adhesion molecule (EpCAM) and cluster of differentiation 90 (CD90). Importantly, EpCAM and CD90 expression was much higher in the specimens expressing both high HBx and high TGF-beta 1 than in those with high HBx or high TGF-beta 1 and the double-low-expression group. HBx and TGF-beta 1 double-high expression was significantly associated with poor prognosis in primary liver cancer. We also found that HBx and TGF-beta 1 induced the transformation of HPCs into hepatic cancer stem cells and promoted epithelial-mesenchymal transformation, which was further enhanced by concomitant HBx and TGF-beta 1 exposure. Moreover, activation of the c-Jun N-terminal kinase (JNK)/c-Jun pathway was involved in the malignant transformation of HPCs. miR-199a-3p was identified as a significantly upregulated microRNA in HPCs upon HBx and TGF-beta 1 exposure, which were shown to promote miR-199a-3p expression via c-Jun-mediated activation. Finally, we found that miR-199a-3p was responsible for the malignant transformation of HPCs. In conclusion, our results provide evidence that TGF-beta 1 cooperates with HBx to promote the malignant transformation of HPCs through a JNK/c-Jun/miR-199a-3p-dependent pathway. This may open new avenues for therapeutic interventions targeting the malignant transformation of HPCs in treating liver cancer.	[Dong, Ke-shuai; Yang, Guang; Liao, Zhi-bin; Zhang, Hong-wei; Liang, Hui-fang; Chen, Xiao-ping; Dong, Han-hua] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr,Dept Hepat Surg, Wuhan, Peoples R China; [Dong, Ke-shuai] Wuhan Univ, Renmin Hosp, Dept Hepatobiliary & Laparoscop Surg, Hubei Key Lab Digest Syst Dis, Wuhan, Peoples R China; [Chen, Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gen Surg, Wuhan, Peoples R China	Huazhong University of Science & Technology; Wuhan University; Huazhong University of Science & Technology	Dong, HH (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr,Dept Hepat Surg, Wuhan, Peoples R China.	hanhua_dong@hotmail.com		Liao, Zhibin/0000-0003-0305-2079	National Natural Science Foundation of China [81402410, 81802767]; Edanz Group China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Edanz Group China	This work was supported by the National Natural Science Foundation of China (Grant No. 81402410, 81802767). We thank Sarah Williams, PhD, from Liwen Bianji, Edanz Group China (www.liwenbianji.cn), for editing the English text of a draft of this manuscript.	Alemdehy MF, 2015, BLOOD, V125, P3937, DOI 10.1182/blood-2014-11-612507; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Arzumanyan A, 2011, CANCER RES, V71, P3701, DOI 10.1158/0008-5472.CAN-10-3951; Celia-Terrassa T, 2017, NAT CELL BIOL, V19, P711, DOI 10.1038/ncb3533; Chen J, 2016, J CLIN INVEST, V126, P527, DOI 10.1172/JCI80937; Deng XG, 2014, LIVER INT, V34, P281, DOI 10.1111/liv.12239; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11365; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Henkler F, 1996, J VIRAL HEPATITIS, V3, P109, DOI 10.1111/j.1365-2893.1996.tb00001.x; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Jung KH, 2016, STEM CELLS, V34, P1284, DOI 10.1002/stem.2283; Kuo KK, 2016, STEM CELLS, V34, P2613, DOI 10.1002/stem.2447; Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Li CH, 2011, CANCER LETT, V311, P1, DOI 10.1016/j.canlet.2011.05.035; Liu FY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.46; Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076651; Liu Y, 2016, ONCOTARGET, V7, P33125, DOI 10.18632/oncotarget.8884; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Majumdar A, 2012, NAT REV GASTRO HEPAT, V9, P530, DOI 10.1038/nrgastro.2012.114; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsumoto T, 2017, CANCER RES, V77, P6131, DOI 10.1158/0008-5472.CAN-17-1800; Michalopoulos GK, 2015, GASTROENTEROLOGY, V149, P876, DOI 10.1053/j.gastro.2015.08.004; Mikhail S, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/486954; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Motavaf M, 2013, ACTA VIROL, V57, P389, DOI 10.4149/av_2013_04_389; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Oikawa T, 2016, HEPATOLOGY, V64, P645, DOI 10.1002/hep.28485; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh M, 2018, PHARMACOL THERAPEUT, V182, P80, DOI 10.1016/j.pharmthera.2017.08.009; Song WQ, 2014, CANCER RES, V74, P2444, DOI 10.1158/0008-5472.CAN-13-2136; Tanaka Y, 2006, ONCOGENE, V25, P633, DOI 10.1038/sj.onc.1209093; Teng CF, 2018, MOL ONCOL, V12, P1175, DOI 10.1002/1878-0261.12318; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tummala KS, 2017, CELL REP, V19, P584, DOI 10.1016/j.celrep.2017.03.059; Wang C, 2012, HEPATOLOGY, V55, P108, DOI 10.1002/hep.24675; Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934; Wu K, 2012, HEPATOLOGY, V56, P2255, DOI 10.1002/hep.26007; Wu QH, 2019, MED RES REV, V39, P2082, DOI 10.1002/med.21574; Wu Y, 2018, BIOCHIMIE, V148, P87, DOI 10.1016/j.biochi.2018.03.003; Xie X, 2017, ONCOGENE, V36, P2599, DOI 10.1038/onc.2016.417; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yoo YD, 1996, J CLIN INVEST, V97, P388, DOI 10.1172/JCI118427; Zhou SJ, 2017, CELL DEATH DIFFER, V24, P1577, DOI 10.1038/cdd.2017.87	58	9	10	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1807	1820		10.1038/s41388-019-1107-9	http://dx.doi.org/10.1038/s41388-019-1107-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31740785	hybrid, Green Published			2022-12-26	WOS:000514923000014
J	Kim, JY; Kim, JK; Kim, H				Kim, Jung Yun; Kim, Jun-Kyum; Kim, Hyunggee			ABCB7 simultaneously regulates apoptotic and non-apoptotic cell death by modulating mitochondrial ROS and HIF1 alpha-driven NF kappa B signaling	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; INDUCIBLE FACTOR-I; UP-REGULATION; HYPOXIA; CANCER; METABOLISM; IDENTIFICATION; PROLIFERATION; GLIOBLASTOMA; HOMEOSTASIS	Most of the mechanisms governing apoptotic and non-apoptotic cell death are regulated independently. However, cells may experience various stresses that lead to both apoptotic and non-apoptotic cell death. In particular, cancer cells require a program that simultaneously avoids these forms of cell death, but the mechanism by which they are able to do so is currently unclear. Here, we show that ABC transporter subfamily B member 7 (ABCB7), one of the mitochondrial iron transporters, induces the hypoxia-independent accumulation of hypoxia-inducible factor 1 alpha by controlling intracellular iron homeostasis and inhibits both apoptotic and non-apoptotic cell death. Mechanistically, ABCB7 mitigates non-apoptotic cell death by reducing levels of mitochondrial reactive oxygen species. ABCB7 also suppresses apoptosis by inhibiting the expression of leucine zipper downregulated in cancer 1, an inhibitor of nuclear factor-kappa B signaling. Therefore, our results support that ABCB7 is crucial in controlling both apoptotic and non-apoptotic cell death and indicate that the fine-tuning of intracellular iron homeostasis may be a novel anticancer strategy.	[Kim, Jung Yun; Kim, Jun-Kyum; Kim, Hyunggee] Korea Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Seoul 02841, South Korea; [Kim, Jung Yun; Kim, Jun-Kyum; Kim, Hyunggee] Korea Univ, Inst Anim Mol Biotechnol, Seoul 02841, South Korea; [Kim, Hyunggee] Korea Univ, Dept Med Engn, Coll Med, Seoul 02841, South Korea	Korea University; Korea University; Korea University; Korea University Medicine (KU Medicine)	Kim, H (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Seoul 02841, South Korea.; Kim, H (corresponding author), Korea Univ, Inst Anim Mol Biotechnol, Seoul 02841, South Korea.; Kim, H (corresponding author), Korea Univ, Dept Med Engn, Coll Med, Seoul 02841, South Korea.	hg-kim@korea.ac.kr			National Research Foundation (NRF) [2015R1A5A1009024, 2017R1E1A1A01074205, 2017M3A9A8031425]; School of Life Sciences and Biotechnology for BK21 Plus, Korea University	National Research Foundation (NRF); School of Life Sciences and Biotechnology for BK21 Plus, Korea University	The authors thank the members of the Cancer Growth Regulation Laboratory for their discussions and technical assistance. This work was supported by grants to Hyunggee Kim from the National Research Foundation (NRF) [grant numbers 2015R1A5A1009024, 2017R1E1A1A01074205 and 2017M3A9A8031425], and the School of Life Sciences and Biotechnology for BK21 Plus, Korea University.	Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bagnall J, 2014, J BIOL CHEM, V289, P5549, DOI 10.1074/jbc.M113.500405; Behan FM, 2019, NATURE, V568, P511, DOI 10.1038/s41586-019-1103-9; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004; Chen L, 2012, MOL CELL BIOCHEM, V365, P263, DOI 10.1007/s11010-012-1267-1; Chirasani SR, 2009, J MOL MED, V87, P153, DOI 10.1007/s00109-008-0414-3; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Depoix CL, 2017, MOL HUM REPROD, V23, P199, DOI 10.1093/molehr/gax002; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Drummen GPC, 2002, FREE RADICAL BIO MED, V33, P473, DOI 10.1016/S0891-5849(02)00848-1; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frost J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13312; Glassford AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1590, DOI 10.1152/ajpendo.00490.2007; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Huang JY, 2013, FASEB J, V27, P2845, DOI 10.1096/fj.12-216929; Hung HI, 2013, J BIOL CHEM, V288, P677, DOI 10.1074/jbc.M112.422667; Inoue H, 2014, CELL DEATH DIFFER, V21, P39, DOI 10.1038/cdd.2013.84; Joseph JV, 2015, CANCER LETT, V359, P107, DOI 10.1016/j.canlet.2015.01.010; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kaur D, 2009, FREE RADICAL BIO MED, V46, P593, DOI 10.1016/j.freeradbiomed.2008.11.012; Lee G, 2016, MOL CANCER THER, V15, P3064, DOI 10.1158/1535-7163.MCT-15-0675; Letai A, 2015, CLIN CANCER RES, V21, P5015, DOI 10.1158/1078-0432.CCR-15-1204; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Li W, 2016, DRUG RESIST UPDATE, V27, P14, DOI 10.1016/j.drup.2016.05.001; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Munoz LE, 2013, AUTOIMMUNITY, V46, P336, DOI 10.3109/08916934.2012.755960; Nagasaki K, 2003, INT J CANCER, V105, P454, DOI 10.1002/ijc.11122; Nagasaki K, 1999, CANCER LETT, V140, P227, DOI 10.1016/S0304-3835(99)00087-7; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Puliyappadamba VT, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.963478; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Schaedler TA, 2015, BIOCHEM SOC T, V43, P943, DOI 10.1042/BST20150118; Schonberg DL, 2015, CANCER CELL, V28, P441, DOI 10.1016/j.ccell.2015.09.002; Shah YM, 2014, GASTROENTEROLOGY, V146, P630, DOI 10.1053/j.gastro.2013.12.031; Sparreboom A, 2003, DRUG RESIST UPDATE, V6, P71, DOI 10.1016/S1368-7646(03)00005-0; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Tenopoulou M, 2007, BIOCHEM J, V403, P261, DOI 10.1042/BJ20061840; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yin F, 2014, ANTIOXID REDOX SIGN, V20, P353, DOI 10.1089/ars.2012.4774; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	58	12	12	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1969	1982		10.1038/s41388-019-1118-6	http://dx.doi.org/10.1038/s41388-019-1118-6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31772327				2022-12-26	WOS:000516579800011
J	Kumarasamy, V; Ruiz, A; Nambiar, R; Witkiewicz, AK; Knudsen, ES				Kumarasamy, Vishnu; Ruiz, Amanda; Nambiar, Ram; Witkiewicz, Agnieszka K.; Knudsen, Erik S.			Chemotherapy impacts on the cellular response to CDK4/6 inhibition: distinct mechanisms of interaction and efficacy in models of pancreatic cancer	ONCOGENE			English	Article							GEMCITABINE; REPLICATION; SUPPRESSION; PROGRESSION; RESISTANCE; APOPTOSIS; PATHWAY; REPAIR; CELLS; E2F	Pancreatic ductal adenocarcinoma (PDAC) is a therapy recalcitrant disease characterized by the aberrations in multiple genes that drive pathogenesis and limit therapeutic response. While CDK4/6 represents a downstream target of both KRAS mutation and loss of the CDKN2A tumor suppressor in PDAC, clinical and preclinical studies indicate that pharmacological CDK4/6 inhibitors are only modestly effective. Since chemotherapy represents the established backbone of PDAC treatment we evaluated the interaction of CDK4/6 inhibitors with gemcitabine and taxanes that are employed in the treatment of PDAC. Herein, we demonstrate that the difference in mechanisms of actions of chemotherapeutic agents elicit distinct effects on the cellular response to CDK4/6 inhibition. Gemcitabine largely ablates the function of CDK4/6 inhibition in S-phase arrested cells when administered contemporaneously; although, when cells recover from S-phase block they exhibit sensitivity to CDK4/6 inhibition. In contrast, pharmacological inhibition of CDK4/6 yields a cooperative cytostatic effect in combination with docetaxel and prevents adaptation and cell cycle re-entry, which is a common basis for resistance to such agents. Importantly, using organoid and PDX models we could confirm the cooperative effects between chemotherapy and CDK4/6 inhibition in vivo. These data indicate that the combination of cytotoxic and cytostatic agents could represent an important modality in those tumor types that are relatively resistant to CDK4/6 inhibitors.	[Kumarasamy, Vishnu; Nambiar, Ram; Witkiewicz, Agnieszka K.; Knudsen, Erik S.] Roswell Park Canc Inst, Ctr Personalized Med, Buffalo, NY 14263 USA; [Kumarasamy, Vishnu; Nambiar, Ram; Knudsen, Erik S.] Roswell Park Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Ruiz, Amanda] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Witkiewicz, Agnieszka K.] Roswell Park Canc Inst, Dept Pathol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Arizona Center Cancer Care; University of Arizona; Roswell Park Cancer Institute	Witkiewicz, AK; Knudsen, ES (corresponding author), Roswell Park Canc Inst, Ctr Personalized Med, Buffalo, NY 14263 USA.; Knudsen, ES (corresponding author), Roswell Park Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.; Witkiewicz, AK (corresponding author), Roswell Park Canc Inst, Dept Pathol, Buffalo, NY 14263 USA.	Agnieszka.Witkiewicz@Roswellpark.org; Erik.Knudsen@roswellpark.org	Kumarasamy, Vishnu/AAV-8896-2021		National Cancer Institute (NCI)	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The author thanks all members of the laboratory group and colleagues in the discussion and preparation of the manuscript. The research was supported by a grant to AKW and ESK from National Cancer Institute (NCI).	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu, 2017, Cancer Cell, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Cao J, 2019, ONCOGENE, V38, P4125, DOI 10.1038/s41388-019-0708-7; Cappella P, 2001, INT J CANCER, V93, P401, DOI 10.1002/ijc.1351.abs; Cheema AR, 2016, SURG CLIN N AM, V96, P1391, DOI 10.1016/j.suc.2016.07.011; Chou A, 2018, GUT, V67, P2142, DOI 10.1136/gutjnl-2017-315144; Clark AS, 2019, CLIN CANCER RES, V25, P2072, DOI 10.1158/1078-0432.CCR-18-0790; Cowan RW, 2014, CANCER J, V20, P80, DOI 10.1097/PPO.0000000000000011; Dean JL, 2012, J BIOL CHEM, V287, P29075, DOI 10.1074/jbc.M112.365494; Duronio Robert J, 2013, Cold Spring Harb Perspect Biol, V5, pa008904, DOI 10.1101/cshperspect.a008904; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; Francis AM, 2017, MOL CANCER THER, V16, P1751, DOI 10.1158/1535-7163.MCT-17-0040; Franco J, 2014, ONCOTARGET, V5, P6512, DOI 10.18632/oncotarget.2270; Haines Eric, 2018, Oncotarget, V9, P31572, DOI 10.18632/oncotarget.25803; He SH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3986; HEINEMANN V, 1995, SEMIN ONCOL, V22, P11; Hernandez-Vargas H, 2007, ONCOGENE, V26, P2902, DOI 10.1038/sj.onc.1210102; Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728; Hidalgo M, 2015, PANCREATOLOGY, V15, P8, DOI 10.1016/j.pan.2014.10.001; Hoskins EE, 2008, ONCOGENE, V27, P4798, DOI 10.1038/onc.2008.121; Iyengar Mangala, 2018, Oncotarget, V9, P15658, DOI 10.18632/oncotarget.24585; Jansen VM, 2017, CANCER RES, V77, P2488, DOI 10.1158/0008-5472.CAN-16-2653; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Knudsen ES, 2019, ONCOGENE, V38, P3355, DOI 10.1038/s41388-018-0650-0; Knudsen ES, 2018, GUT, V67, P508, DOI 10.1136/gutjnl-2016-313133; Knudsen ES, 2016, GASTROENTEROLOGY, V150, P48, DOI 10.1053/j.gastro.2015.08.056; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; McClendon AK, 2012, CELL CYCLE, V11, P2747, DOI 10.4161/cc.21127; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; O'Hayer KM, 2016, DISCOV MED, V21, P117; PAGANO M, 1994, GENE DEV, V8, P1627, DOI 10.1101/gad.8.14.1627; Pienta KJ, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.26892; Pontano LL, 2009, CELL CYCLE, V8, P824, DOI 10.4161/cc.8.6.7889; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Schutte M, 1997, CANCER RES, V57, P3126; Shangguan WJ, 2014, ONCOL REP, V31, P305, DOI 10.3892/or.2013.2815; Shen H, 2010, J BIOL CHEM, V285, P23103, DOI 10.1074/jbc.M110.124990; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Taylor-Harding B, 2015, ONCOTARGET, V6, P696, DOI 10.18632/oncotarget.2673; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Witkiewicz AK, 2018, CELL REP, V22, P1185, DOI 10.1016/j.celrep.2018.01.022; Witkiewicz AK, 2015, ONCOTARGET, V6, P15788, DOI 10.18632/oncotarget.3819; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744	48	20	20	1	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1831	1845		10.1038/s41388-019-1102-1	http://dx.doi.org/10.1038/s41388-019-1102-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31745297	Green Accepted			2022-12-26	WOS:000516579800001
J	Wong, W; Crane, ED; Kuo, Y; Kim, A; Crane, JD				Wong, Wesley; Crane, Elizabeth D.; Kuo, Yikai; Kim, Austin; Crane, Justin D.			The exercise cytokine interleukin-15 rescues slow wound healing in aged mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						wound healing; aging; exercise; epidermis; STAT3; interleukin 15; re-epithelialization; skin barrier; tissue repair; trauma	CELLULAR SENESCENCE; OXIDATIVE STRESS; ALARMIN HMGB1; GROWTH-FACTOR; STEM-CELLS; HUMAN SKIN; INFLAMMATION; STAT3; PREVALENCE; METABOLISM	Impaired wound healing in elderly individuals increases infection risk and prolongs surgical recovery, but current treatment options are limited. Low doses of interleukin-15 (IL-15) that mimic exercise responses in the circulation improve skin structure and increase mitochondria in uninjured aged skin, suggesting that IL-15 is an essential mitochondrial signal for healing that is lost during aging. Here we used gene microarray analysis of old and young murine epidermal stem cells and demonstrate that aging results in a gene signature characteristic of bioenergetic dysfunction. Intravenous IL-15 treatment rescued chronological aging-induced healing defects and restored youthful wound closure in old, sedentary mice. Additionally, exercise-mediated improvements in the healing of aged skin depend upon circulating IL-15. We show that IL-15 induces signal transducer and activator of transcription 3 (STAT3) signaling characteristic of young animals, reduces markers of growth arrest, and increases keratinocyte and fibroblast growth. Moreover, exercise or exercise-mimicking IL-15 treatment rescued the age-associated decrease in epidermal mitochondrial complex IV activity. Overall, these results indicate that IL-15 or its analogs represent promising therapies for treating impaired wound healing in elderly patients.	[Wong, Wesley; Crane, Elizabeth D.; Kuo, Yikai; Kim, Austin; Crane, Justin D.] Northeastern Univ, Dept Biol, 360 Huntington Ave, Boston, MA 02115 USA	Northeastern University	Crane, JD (corresponding author), Northeastern Univ, Dept Biol, 360 Huntington Ave, Boston, MA 02115 USA.	j.crane@northeastern.edu		Wong, Wesley/0000-0003-3333-6689; Kim, Austin/0000-0002-9675-9374; Crane, Justin/0000-0002-5380-5676	Northeastern University Provost's Office	Northeastern University Provost's Office	This work was supported by startup funding from the Northeastern University Provost's Office (to J. D. C.). J. D. C. is a co-holder of a patent involving the use of IL-15 as a therapy for skin disorders.	Aragona M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14684; Ashcroft GS, 2002, BIOGERONTOLOGY, V3, P337, DOI 10.1023/A:1021399228395; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Birch-Machin MA, 2016, BRIT J DERMATOL, V175, P26, DOI 10.1111/bjd.14906; Birch-Machin MA, 2010, MUTAGENESIS, V25, P101, DOI 10.1093/mutage/gep061; Carli F, 2005, CURR OPIN CLIN NUTR, V8, P23, DOI 10.1097/00075197-200501000-00005; Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Crane JD, 2015, AGING CELL, V14, P625, DOI 10.1111/acel.12341; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; Davidson JM, 2013, ADV WOUND CARE, V2, P142, DOI 10.1089/wound.2012.0424; Dillon LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044335; Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Eaglstein WH, 2012, WOUND REPAIR REGEN, V20, P793, DOI 10.1111/j.1524-475X.2012.00849.x; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Emery CF, 2005, J GERONTOL A-BIOL, V60, P1432, DOI 10.1093/gerona/60.11.1432; Flanagan M, 2003, J Wound Care, V12, P189; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Frankel HC, 2012, ARCH DERMATOL, V148, P918, DOI 10.1001/archdermatol.2012.943; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Giangreco A, 2008, AGING CELL, V7, P250, DOI 10.1111/j.1474-9726.2008.00372.x; Gould Lisa, 2015, Wound Repair Regen, V23, P1, DOI 10.1111/wrr.12245; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Han G, 2017, ADV THER, V34, P599, DOI 10.1007/s12325-017-0478-y; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; HOLT DR, 1992, SURGERY, V112, P293; Horiuchi T, 2017, J BIOL CHEM, V292, P8436, DOI 10.1074/jbc.M116.769380; Jones AM, 2016, INT J MOL MED, V38, P679, DOI 10.3892/ijmm.2016.2687; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Keylock KT, 2008, AM J PHYSIOL-REG I, V294, pR179, DOI 10.1152/ajpregu.00177.2007; Koster MI, 2009, ANN NY ACAD SCI, V1170, P7, DOI 10.1111/j.1749-6632.2009.04363.x; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Margolis DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/mjd.2002.121739; Margolis DJ, 2002, ANN EPIDEMIOL, V12, P321, DOI 10.1016/S1047-2797(01)00255-1; Naidoo K, 2018, EXP DERMATOL, V27, P124, DOI 10.1111/exd.13476; Park JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090245; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Quinn LS, 2010, EXP GERONTOL, V45, P106, DOI 10.1016/j.exger.2009.10.012; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sergushichev A., 2016, ALGORITHM FAST PRERA, DOI [10.1101/0600/2, DOI 10.1101/0600/2]; Smiell JM, 1999, WOUND REPAIR REGEN, V7, P335, DOI 10.1046/j.1524-475X.1999.00335.x; Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035; Sorrentino JA, 2014, TRENDS MOL MED, V20, P375, DOI 10.1016/j.molmed.2014.04.004; Steel JC, 2012, TRENDS PHARMACOL SCI, V33, P35, DOI 10.1016/j.tips.2011.09.004; Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212; Swift ME, 2001, J INVEST DERMATOL, V117, P1027, DOI 10.1046/j.0022-202x.2001.01539.x; Swift ME, 1999, LAB INVEST, V79, P1479; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Uhl E, 2003, WOUND REPAIR REGEN, V11, P361, DOI 10.1046/j.1524-475X.2003.11508.x; Urabe H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2536; Vujic A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04083-1; Wakahara R, 2012, GENES CELLS, V17, P132, DOI 10.1111/j.1365-2443.2011.01575.x; Wang AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15901-9; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143420; Zhang ML, 2009, P NATL ACAD SCI USA, V106, P7513, DOI 10.1073/pnas.0902637106	62	9	9	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20024	20038		10.1074/jbc.RA119.010740	http://dx.doi.org/10.1074/jbc.RA119.010740			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748415	hybrid, Green Published			2022-12-26	WOS:000505005800017
J	Dugovich, BS; Crane, LL; Alcantar, BB; Beechler, BR; Dolan, BP; Jolles, AE				Dugovich, Brian S.; Crane, Lucie L.; Alcantar, Benji B.; Beechler, Brianna R.; Dolan, Brian P.; Jolles, Anna E.			Multiple innate antibacterial immune defense elements are correlated in diverse ungulate species	PLOS ONE			English	Article							BLOOD; RECOGNITION; EXPRESSION; HEMATOLOGY; INFECTION; RESPONSES; PROTEINS; CAPTURE; DISEASE; STRESS	In this study, we aimed to evaluate to what extent different assays of innate immunity reveal similar patterns of variation across ungulate species. We compared several measures of innate antibacterial immune function across seven different ungulate species using blood samples obtained from captive animals maintained in a zoological park. We measured mRNA expression of two receptors involved in innate pathogen detection, toll-like receptors 2 and 5 (TLR2 and 5), the bactericidal capacity of plasma, as well as the number of neutrophils and lymphocytes. Species examined included aoudad (Ammotragus lervia), American bison (Bison bison bison), yak (Bos grunniens), Roosevelt elk (Cervus canadensis roosevelti), fallow deer (Dama dama), sika deer (Cervus nippon), and Damara zebra (Equus quagga burchellii). Innate immunity varied among ungulate species. However, we detected strong, positive correlations between the different measures of innate immunity-specifically, TLR2 and TLR5 were correlated, and the neutrophil to lymphocyte ratio was positively associated with TLR2, TLR5, and bacterial killing ability. Our results suggest that ecoimmunological study results may be quite robust to the choice of assays, at least for antibacterial innate immunity; and that, despite the complexity of the immune system, important sources of variation in immunity in natural populations may be discoverable with comparatively simple tools.	[Dugovich, Brian S.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Crane, Lucie L.; Alcantar, Benji B.; Beechler, Brianna R.; Dolan, Brian P.; Jolles, Anna E.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Alcantar, Benji B.] Wildlife Safari, Winston, OR USA	Oregon State University; Oregon State University	Dugovich, BS (corresponding author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.	bdugovich@gmail.com	Beechler, Brianna R/H-7972-2019	Beechler, Brianna R/0000-0002-9711-4340; Jolles, Anna/0000-0003-3074-9912	Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University	Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University	Funding for this study was provided by the Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beechler BR, 2012, PHYSIOL BIOCHEM ZOOL, V85, P255, DOI 10.1086/665276; Bernardino ALF, 2008, INFECT IMMUN, V76, P4385, DOI 10.1128/IAI.00394-08; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Cabral ES, 2006, J INFECT DIS, V193, P849, DOI 10.1086/500467; Cases-Diaz E, 2012, J WILDLIFE DIS, V48, P763, DOI 10.7589/0090-3558-48.3.763; Crawshaw G., 2003, ZOO WILD ANIMAL MED; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Demas GE, 2011, J ANIM ECOL, V80, P710, DOI 10.1111/j.1365-2656.2011.01813.x; Dolan BP, 2016, FISH SHELLFISH IMMUN, V48, P136, DOI 10.1016/j.fsi.2015.11.015; Downs CJ, 2014, CALIF FISH GAME, V100, P371; Dugovich BS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180415; Fair PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176202; French SS, 2012, BIOL OPEN, V1, P482, DOI 10.1242/bio.2012919; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gervasi SS, 2014, FUNCT ECOL, V28, P569, DOI 10.1111/1365-2435.12194; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Harada K, 2006, J CLIN PATHOL, V59, P184, DOI 10.1136/jcp.2004.023507; Homma T, 2004, AM J RESP CELL MOL, V31, P463, DOI 10.1165/rcmb.2004-0161OC; Jaeger BC, 2017, J APPL STAT, V44, P1086, DOI 10.1080/02664763.2016.1193725; Jolles AE, 2015, PARASITE IMMUNOL, V37, P255, DOI 10.1111/pim.12153; Jolles AE, 2015, J MAMMAL, V96, P4, DOI 10.1093/jmammal/gyu007; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Koller B, 2008, J IMMUNOL, V181, P2753, DOI 10.4049/jimmunol.181.4.2753; Levy O, 2000, BLOOD, V96, P2664; Liebl AL, 2009, FUNCT ECOL, V23, P1091, DOI 10.1111/j.1365-2435.2009.01592.x; Maeda S., 2009, VET DERMATOL, V20, P144; Mak TW, 2013, ELSEVIER SCI; Marco I, 1999, RES VET SCI, V66, P81, DOI 10.1053/rvsc.1998.0248; Martin C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-70; Martin LB, 2006, INTEGR COMP BIOL, V46, P1030, DOI 10.1093/icb/icl039; Matson KD, 2006, PHYSIOL BIOCHEM ZOOL, V79, P556, DOI 10.1086/501057; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Oksanen J, VEGAN PACKAGE; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Prall SP, 2014, INT J PRIMATOL, V35, P805, DOI 10.1007/s10764-014-9752-x; Roland L, 2014, J VET DIAGN INVEST, V26, P592, DOI 10.1177/1040638714546490; Silva MT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00174; Strobel S, 2015, MAMM BIOL, V80, P312, DOI 10.1016/j.mambio.2015.02.005; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; Viney M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01481; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Young HS, 2016, FUNCT ECOL, V30, P799, DOI 10.1111/1365-2435.12542	44	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225579	10.1371/journal.pone.0225579	http://dx.doi.org/10.1371/journal.pone.0225579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774834	gold, Green Published			2022-12-26	WOS:000533896400041
J	Ranucci, M; Aloisio, T; Di Dedda, U; Menicanti, L; de Vincentiis, C; Baryshnikova, E				Ranucci, Marco; Aloisio, Tommaso; Di Dedda, Umberto; Menicanti, Lorenzo; de Vincentiis, Carlo; Baryshnikova, Ekaterina		Surg Clinical Outcome REs SCORE Gr	Gender-based differences in platelet function and platelet reactivity to P2Y(12) inhibitors	PLOS ONE			English	Article							ANTIPLATELET THERAPY; SEX DIFFERENCE; CLOPIDOGREL; PRASUGREL; TICAGRELOR; AGGREGATION; RECEPTOR; WOMEN; METAANALYSIS; ESTROGEN	Background Gender influences platelet biology. Women have a larger platelet count, but gender-based differences in platelet function remain debated. We performed a study addressing gender-based differences in platelet function using point-of-care platelet function tests (PFT). Methods The patient population consisted of 760 cardiac surgery patients where preoperative PFT (multiple-electrode aggregometry [MEA]) were available. Platelet count and function at the ADPtest and TRAPtest were compared in the overall population and separately in patients with or without residual effects of P2Y12 inhibitors. Results Women had a significantly (P = 0.001) higher platelet count but a non-significantly higher platelet reactivity to ADP. In clopidogrel-treated patients, the platelets ADP reactivity was significantly (P = 0.031) higher in women, and platelet count was the main determinant of platelet hyper-reactivity. Within patients under full clopidogrel effects, women with a platelet count. 200,000 cells/mu L had a significantly (P = 0.023) higher rate of high-on-treatment platelet reactivity (HTPR, 45.5%) with respect to males with a platelet count < 200,000 cells/mu L (11.9%), with a relative risk of 6.2 (95% confidence interval 1.4-29). Conclusions Our findings confirm that women have a larger platelet count than men, and that this is associated to a trend towards a higher platelet reactivity. HTPR is largely represented in women with a high platelet count. This generates the hypothesis that women requiring P2Y12 inhibitors could potentially benefit from larger doses of drug or should be treated with anti-platelet agents with a low rate of HTPR.	[Ranucci, Marco; Aloisio, Tommaso; Di Dedda, Umberto; Baryshnikova, Ekaterina] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anaesthesia & Intens Care, Milan, Italy; [Menicanti, Lorenzo; de Vincentiis, Carlo] IRCCS Policlin San Donato, Dept Cardiac Surg, Milan, Italy	IRCCS Policlinico San Donato; IRCCS Policlinico San Donato	Ranucci, M (corresponding author), IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anaesthesia & Intens Care, Milan, Italy.	cardioanestesia@virgilio.it	Ranucci, Marco/K-1040-2016; menicanti, lorenzo/K-5649-2018; de Vincentiis, Carlo/ABG-3272-2020; Aloisio, Tommaso/AAB-3093-2021	Ranucci, Marco/0000-0002-4915-3572; menicanti, lorenzo/0000-0001-8530-6284; de Vincentiis, Carlo/0000-0002-9945-0057; Aloisio, Tommaso/0000-0002-6724-2122; Baryshnikova, Ekaterina/0000-0001-7476-2823				Al-Husein BA, 2018, J CARDIOVASC PHARM, V72, P296, DOI 10.1097/FJC.0000000000000627; Bavishi C, 2015, AM J CARDIOL, V116, P809, DOI 10.1016/j.amjcard.2015.05.058; Berger JS, 2009, J AM COLL CARDIOL, V54, P1935, DOI 10.1016/j.jacc.2009.05.074; CaulinGlaser T, 1997, CIRC RES, V81, P885; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Dehghani P, 2017, AM HEART J, V192, P105, DOI 10.1016/j.ahj.2017.07.013; Di Dedda U, 2014, EUR J CARDIO-THORAC, V45, P165, DOI 10.1093/ejcts/ezt279; Faraday N, 1997, THROMB HAEMOSTASIS, V77, P748; Franchi F, 2016, CIRCULATION, V134, P780, DOI 10.1161/CIRCULATIONAHA.116.023402; Haque SF, 2001, ENDOCR J, V48, P33, DOI 10.1507/endocrj.48.33; Jastrzebska M, 2018, J PHYSIOL PHARMACOL, V69, DOI [10.1210/jc.2005-0591, DOI 10.1210/JC.2005-0591]; JOHNSON M, 1975, NATURE, V253, P355, DOI 10.1038/253355a0; Lemesle G, 2015, J THROMB HAEMOST, V13, P931, DOI 10.1111/jth.12907; Li YG, 2009, PLATELETS, V20, P316, DOI 10.1080/09537100903046317; Musallam A, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2015.11.023; Ottani F, 2018, INT J CARDIOL, V255, P8, DOI 10.1016/j.ijcard.2017.12.055; Patti G, 2014, EUR HEART J, V35, P2213, DOI 10.1093/eurheartj/ehu279; Ranucci M, 2014, BRIT J ANAESTH, V113, P970, DOI 10.1093/bja/aeu315; Ranucci M, 2019, PLATELETS, V30, P908, DOI 10.1080/09537104.2018.1535706; Ranucci M, 2017, PLATELETS, V28, P794, DOI 10.1080/09537104.2017.1280148; Rath CL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00712; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Siller-Matula JM, 2013, JACC-CARDIOVASC INTE, V6, P1111, DOI 10.1016/j.jcin.2013.06.011; Sowers MR, 2005, J CLIN ENDOCR METAB, V90, P5942, DOI 10.1210/jc.2005-0591; STEVENS RF, 1977, BRIT J HAEMATOL, V37, P295, DOI 10.1111/j.1365-2141.1977.tb06847.x; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang TY, 2012, J AM COLL CARDIOL, V59, P891, DOI 10.1016/j.jacc.2011.09.075; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Williams ET, 2004, J PHARMACOL EXP THER, V311, P728, DOI 10.1124/jpet.104.068908; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; ZWIERZINA WD, 1987, THROMB RES, V48, P161, DOI 10.1016/0049-3848(87)90412-9	32	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225771	10.1371/journal.pone.0225771	http://dx.doi.org/10.1371/journal.pone.0225771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774869	Green Published, gold			2022-12-26	WOS:000533896400060
J	Danielsson, KC; Gilhus, NE; Borthen, I; Lie, RT; Morken, NH				Danielsson, Kim Christian; Gilhus, Nils Erik; Borthen, Ingrid; Lie, Rolv Terje; Morken, Nils-Halvdan			Maternal complications in pregnancy and childbirth for women with epilepsy: Time trends in a nationwide cohort	PLOS ONE			English	Article							MEDICAL BIRTH REGISTRY; ANTIEPILEPTIC DRUGS; CESAREAN-SECTION; EURAP EPILEPSY; OUTCOMES; DIAGNOSIS; SEIZURES; VALIDITY; NORWAY; RISK	Objective Obstetric trends show changes in complication rates and maternal characteristics such as caesarean section, induced labour, and maternal age. To what degree such general time trends and changing patterns of antiepileptic drug use influence pregnancies of women with epilepsy (WWE) is unknown. Our aim was to describe changes in maternal characteristics and obstetric complications in WWE over time, and to assess changes in complication risks in WWE relative to women without epilepsy. Methods This was a nationwide cohort study of all first births in the Medical Birth Registry of Norway, 1999-2016. We estimated maternal characteristics, complication rates, and risks for WWE compared to women without epilepsy. Main maternal outcome measures were hypertensive disorders, bleeding in pregnancy, induction of labour, caesarean section, postpartum hemorrhage, preterm birth, small for gestational age, and epidural analgesia. Time trends were analyzed by logistic regression and comparisons made with interaction analyses. Results 426 347 first births were analyzed, and 3077 (0.7%) women had epilepsy. In WWE there was an increase in proportions of induced labour (p< 0.005) and use of epidural analgesia (p< 0.005), and a reduction in mild preeclampsia (p = 0.006). However, the risk of these outcomes did not change over time. Only the risk of severe preeclampsia increased significantly over time relative to women without epilepsy (p = 0.006). In WWE, folic acid supplementation increased significantly over time (p< 0.005), and there was a decrease in smoking during pregnancy (p< 0.005), but these changes were less pronounced than for women without epilepsy (p< 0.005). Conclusions During 1999-2016 there were important changes in maternal characteristics and complication rates among WWE. However, outcome risks for WWE relative to women without epilepsy did not change despite changes in antiepileptic drug use patterns. The relative risk of severe preeclampsia increased in women with epilepsy.	[Danielsson, Kim Christian; Morken, Nils-Halvdan] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Danielsson, Kim Christian; Gilhus, Nils Erik; Borthen, Ingrid] Univ Bergen, Dept Clin Med, Bergen, Norway; [Gilhus, Nils Erik] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Lie, Rolv Terje] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Lie, Rolv Terje] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth, Oslo, Norway; [Morken, Nils-Halvdan] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Norwegian Institute of Public Health (NIPH); University of Bergen	Danielsson, KC (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway.; Danielsson, KC (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	kim.christian.danielsson@helse-bergen.no		Danielsson, Kim Christian/0000-0003-1090-0590				Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Aguglia U, 2009, EPILEPSIA, V50, P7, DOI 10.1111/j.1528-1167.2008.01964.x; Al Wattar BH, 2017, BJOG-INT J OBSTET GY, V124, P661, DOI 10.1111/1471-0528.14430; Al-Zirqi I, 2013, ACTA OBSTET GYN SCAN; Allotey J, 2017, EUR J OBSTET GYN R B, V215, P12, DOI 10.1016/j.ejogrb.2017.05.016; [Anonymous], 2011, WHO RECOMMENDATIONS; Artama M, 2013, DRUG SAFETY, V36, P359, DOI 10.1007/s40264-013-0052-8; Baghestan E, 2007, ACTA OBSTET GYN SCAN, V86, P205, DOI 10.1080/00016340601111364; Battino D, 2013, EPILEPSIA, V54, P1621, DOI 10.1111/epi.12302; BORTHEN I, 1989, ACTA OBSTET GYN SCAN, V68, P589, DOI 10.3109/00016348909013275; Borthen I, 2011, BJOG-INT J OBSTET GY, V118, P956, DOI 10.1111/j.1471-0528.2011.03004.x; Borthen I, 2010, BJOG-INT J OBSTET GY, V117, P1537, DOI 10.1111/j.1471-0528.2010.02694.x; Borthen I, 2009, BJOG-INT J OBSTET GY, V116, P1736, DOI 10.1111/j.1471-0528.2009.02354.x; Borthen I, 2012, CURR OPIN OBSTET GYN, V24, P78, DOI 10.1097/GCO.0b013e32834feb6a; Bromley R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010236.pub2; Burton GJ, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l2381; Danielsson KC, 2018, ACTA OBSTETRICIA ET; Danielsson KC, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020998; EURO-PERISTAT, 2012, SHARING NATL DATA RE; European Medicines Agency, 2014, CMDH AGR STRENGTH WA; Farmen AH, 2019, EUR J NEUROL, V26, P617, DOI 10.1111/ene.13865; Faught E, 2018, EPILEPSY BEHAV, V85, P37, DOI 10.1016/j.yebeh.2018.05.019; Forening NG, 2014, VEILEDER FODSELSHJEL; Gerard Elizabeth E, 2016, Continuum (Minneap Minn), V22, P204, DOI 10.1212/CON.0000000000000270; Grotvedt L, 2017, NICOTINE TOB RES, V19, P539, DOI 10.1093/ntr/ntw313; Harden C, 2013, EPILEPSY IN WOMEN; Harden CL, 2009, EPILEPSIA, V50, P1229, DOI 10.1111/j.1528-1167.2009.02128.x; Health NIoP, 2018, MBRN STAT; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Hoff JM, 2007, EUR J NEUROL, V14, P38, DOI 10.1111/j.1468-1331.2006.01538.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Kilic D, 2014, EPILEPSIA, V55, P1714, DOI 10.1111/epi.12758; Kinney MO, 2018, J NEUROL NEUROSUR PS, V89, P1320, DOI 10.1136/jnnp-2017-317368; MacDonald SC, 2015, JAMA NEUROL, V72, P981, DOI 10.1001/jamaneurol.2015.1017; Mostacci B, 2018, J NEUROL NEUROSUR PS, V89, P983, DOI 10.1136/jnnp-2017-317833; Moth FN, 2016, ACTA OBSTET GYN SCAN, V95, P519, DOI 10.1111/aogs.12868; NICE, 2018, EP DIAGN MAN; Razaz N, 2017, JAMA NEUROL, V74, P983, DOI 10.1001/jamaneurol.2017.1310; RCOG, 2016, GREEN TOP GUIDLINES; Skomsvoll JF, 2002, ACTA OBSTET GYN SCAN, V81, P831, DOI 10.1034/j.1600-0412.2002.810905.x; Thomas SV, 2012, EPILEPSIA, V53, pe85, DOI 10.1111/j.1528-1167.2012.03439.x; Thomsen LCV, 2013, ACTA OBSTET GYN SCAN, V92, P943, DOI 10.1111/aogs.12159; Tomson T, 2018, LANCET NEUROL, V17, P530, DOI 10.1016/S1474-4422(18)30107-8; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Vajda FJE, 2014, EPILEPSIA, V55, P1229, DOI 10.1111/epi.12711; Veiby G, 2014, J NEUROL, V261, P579, DOI 10.1007/s00415-013-7239-x; Viale L, 2015, LANCET, V386, P1845, DOI 10.1016/S0140-6736(15)00045-8; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X; Weston J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010224.pub2; WHO, 2017, OB HLTH TOP; World Health Organization Human Reproduction Programme 10 April 2015, 2015, Reprod Health Matters, V23, P149, DOI 10.1016/j.rhm.2015.07.007	51	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225334	10.1371/journal.pone.0225334	http://dx.doi.org/10.1371/journal.pone.0225334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765408	Green Published, gold			2022-12-26	WOS:000533891000021
J	Guedes, KS; Sanchez, BAM; Gomes, LT; Fontes, CJF				Guedes, Karla Sena; Marinho Sanchez, Bruno Antonio; Gomes, Luciano Teixeira; Fernandes Fontes, Cor Jesus			Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA RISK; LIVER FIBROSIS; FALCIPARUM-MALARIA; HEPATITIS; THROMBOCYTOPENIA; PREDICTOR; CIRRHOSIS; ACCURACY; PAPUA; FIB-4	Acute infection with Plasmodium vivax, classically associated with benign disease, has been presenting as serious and even fatal disease in recent years. Severe disease is mainly due to biochemical and hematological alterations during the acute phase of infection. In the present cross-sectional study, the aspartate aminotransferase-to-platelet ratio index (APRI) was evaluated as a method for identifying patients at risk of severe vivax malaria. This retrospective study included 130 patients with confirmed P. vivax infection between June 2006 and January 2018. Clinical-epidemiological data were obtained from medical records. Hematological and biochemical parameters were determined using automated equipment. The criteria of severity for infection by Plasmodium falciparum, established by the World Health Organization (WHO), were adapted to classify patients with danger signs of severe vivax malaria. Of the 130 patient's records evaluated, 19 (14.6%) had one or more signs and symptoms of severe malaria. The mean APRI values among patients with and without severe malaria were 2.11 and 1.09, respectively (p = 0.044). Among those with severe disease, the proportion with an APRI value above 1.50 was 30% compared to the 10% among those without severe disease (p = 0.007). The area under the receiver operating characteristic curve (95% CI), calculated to assess the accuracy of the APRI in discriminating between patients with and without severe disease, was 0.645 (0.494; 0.795). An APRI cutoff of 0.74 resulted in sensitivity of 74.0%, specificity of 56.0%, and accuracy of 65.0%. This study shows that the APRI is elevated in patients with evidence of infection by P. vivax. Based on the good sensitivity found in this study, we conclude that this simple index can serve as a diagnostic biomarker to identify patients at risk of severe disease during the acute phase of P. vivax infection.	[Guedes, Karla Sena; Marinho Sanchez, Bruno Antonio; Fernandes Fontes, Cor Jesus] Univ Fed Mato Grosso, Inst Hlth Sci, Sinop, Brazil; [Gomes, Luciano Teixeira; Fernandes Fontes, Cor Jesus] Univ Fed Mato Grosso, Julio Muller Univ Hosp, Cuiaba, Brazil	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso	Fontes, CJF (corresponding author), Univ Fed Mato Grosso, Inst Hlth Sci, Sinop, Brazil.; Fontes, CJF (corresponding author), Univ Fed Mato Grosso, Julio Muller Univ Hosp, Cuiaba, Brazil.	corfontes@gmil.com	Sanchez, Bruno A M/F-8543-2017	Sanchez, Bruno Antonio Marinho/0000-0001-9097-0112; Guedes, Karla de Sena/0000-0001-8508-575X	Brazilian National Council for Scientific and Technological Development [555652/2009-2]; State of Mato Grosso Research Foundation-PRONEX/CNPq/FAPEMAT (Malaria Network) [555652/2009-2]; FAPEMAT [041/2016]	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Mato Grosso Research Foundation-PRONEX/CNPq/FAPEMAT (Malaria Network); FAPEMAT(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT))	Financial support provided by the Brazilian National Council for Scientific and Technological Development and State of Mato Grosso Research Foundation-PRONEX/CNPq/FAPEMAT (Malaria Network), grant number 555652/2009-2. KSG was recipient of a FAPEMAT Doctor Scholarship, Grant number 041/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUIA PRAT TRAT MAL B; [Anonymous], 2012, MAN SEV MAL PRACT HD; Anstey NM, 2007, PLOS MED, V4, P1291, DOI 10.1371/journal.pmed.0040267; Arevalo-Herrera M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185435; Arevalo-Herrera M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0678-3; Bakhubaira S, 2013, TURK J HEMATOL, V30, P394, DOI 10.4274/Tjh.2012.0086; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Cruz LAB, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006306; Dayananda KK, 2018, J VECTOR DIS, V55, P1, DOI 10.4103/0972-9062.234620; Deng H, 2015, MED SCI MONITOR, V21, P3961, DOI 10.12659/MSM.895005; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gomes LT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117651; Gomes Luciano Teixeira, 2014, PLoS One, V9, pe109246, DOI 10.1371/journal.pone.0109246; Gonsalkorala ES, 2019, AM J GASTROENTEROL, V114, P267, DOI 10.1038/s41395-018-0181-x; Lacerda MVG, 2011, MEM I OSWALDO CRUZ, V106, P52, DOI 10.1590/S0074-02762011000900007; Gupta Narendra Kumar, 2013, Trop Parasitol, V3, P58, DOI 10.4103/2229-5070.113914; Hann HW, 2015, J GASTROEN HEPATOL, V30, P131, DOI 10.1111/jgh.12664; Jadhav U M, 2004, J Assoc Physicians India, V52, P615; Kaur H, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1646-9; Koksal I, 2018, TURK J GASTROENTEROL, V29, P464, DOI 10.5152/tjg.2018.16597; Kumar R, 2017, PATHOG GLOB HEALTH, V111, P148, DOI 10.1080/20477724.2017.1309342; Lampah DA, 2015, J INFECT DIS, V211, P623, DOI 10.1093/infdis/jiu487; Leal-Santos FA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-462; Lee J, 2018, BRIT J BIOMED SCI, V75, P128, DOI 10.1080/09674845.2018.1459147; Limaye Charulata S, 2012, J Assoc Physicians India, V60, P15; Liu XH, 2012, STAT MED, V31, P2676, DOI 10.1002/sim.4509; Lomar André V., 2005, Braz J Infect Dis, V9, P425, DOI 10.1590/S1413-86702005000500011; Maina RN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S4; Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]; Mesquita TC, 2016, ACTA TROP, V163, P1, DOI 10.1016/j.actatropica.2016.07.010; Nadkar Milind Y, 2012, J Assoc Physicians India, V60, P11; Naing C, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0392-9; Nurleila S, 2012, AM J TROP MED HYG, V87, P41, DOI 10.4269/ajtmh.2012.11-0577; Paik N, 2018, LIVER INT, V38, P68, DOI 10.1111/liv.13489; Price JC, 2018, AIDS, V32, P2636, DOI [10.1097/QAD.0000000000001977, 10.1097/qad.0000000000001977]; Price RN, 2009, NEW ENGL J MED, V360, P1254, DOI 10.1056/NEJMc090023; Quispe AM, 2014, AM J TROP MED HYG, V91, P11, DOI 10.4269/ajtmh.12-0610; Rahimi BA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-481; Reuling IJ, 2018, EBIOMEDICINE, V36, P131, DOI 10.1016/j.ebiom.2018.09.018; Rodriguez-Morales AJ, 2015, NEGLECT TROP DIS, P89, DOI 10.1007/978-3-7091-1422-3_5; Rota M, 2014, COMPUT STAT DATA AN, V69, P1, DOI 10.1016/j.csda.2013.07.015; Sasmaz MI, 2020, AM J EMERG MED, V38, P459, DOI 10.1016/j.ajem.2019.02.014; Shen SL, 2014, ANN SURG ONCOL, V21, P3802, DOI 10.1245/s10434-014-3771-x; Siqueira AM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0302-y; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Suwarto S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1671-3; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Tobon-Castano A, 2012, BIOMEDICA, V32, P79, DOI 10.1590/S0120-41572012000500010; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; World Health Organization, WORLD MAL REP 2015; Wu HM, 2018, WORLD J GASTROENTERO, V24, P737, DOI 10.3748/wjg.v24.i6.737; Yen YH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199760; Yu ZJ, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/906026; Zhang H, 2018, J MED VIROL, V90, P803, DOI 10.1002/jmv.25021	56	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0224877	10.1371/journal.pone.0224877	http://dx.doi.org/10.1371/journal.pone.0224877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765438	gold, Green Published			2022-12-26	WOS:000533891000011
J	Piszter, G; Kertesz, K; Horvath, ZE; Balint, Z; Biro, LP				Piszter, Gabor; Kertesz, Krisztian; Horvath, Zsolt Endre; Balint, Zsolt; Biro, Laszlo Peter			Reproducible phenotype alteration due to prolonged cooling of the pupae of Polyommatus icarus butterflies	PLOS ONE			English	Article							WING SCALES; PATTERN; COLOR; POLYPHENISM; EVOLUTION; LEPIDOPTERA; MECHANISMS; PHENOMICS; INSECT	The phenotypic changes induced by prolonged cooling (2-12 weeks at 5 degrees C in the dark) of freshly formed Polyommatus icarus pupae were investigated. Cooling halted the imaginal development of pupae collected shortly after transformation from the larval stage. After cooling, the pupae were allowed to continue their developmental cycle. The wings of the eclosed specimens were investigated by optical microscopy, scanning and cross-sectional transmission electron microscopy, UV-VIS spectroscopy and microspectroscopy. The eclosed adults presented phenotypic alterations that reproduced results that we published previously for smaller groups of individuals remarkably well; these changes included i) a linear increase in the magnitude of quantified deviation from normal ventral wing patterns with increasing cooling time; ii) slight alteration of the blue coloration of males; and iii) an increasing number of blue scales on the dorsal wing surface of females with increasing cooling time. Several independent factors, including disordering of regular scale rows in males, the number of blue scales in females, eclosion probability and the probability of defect-free eclosion, showed that the cooling time can be divided into three periods: 0-4 weeks, 4-8 weeks, and 8-12 weeks, each of which is characterized by specific changes. The shift from brown female scales to first blue scales with a female-specific shape and then to blue scales with a malespecific shape with longer cooling times suggests slow decomposition of a substance governing scale formation.	[Piszter, Gabor; Kertesz, Krisztian; Horvath, Zsolt Endre; Biro, Laszlo Peter] Ctr Energy Res, Inst Tech Phys & Mat Sci, Budapest, Hungary; [Balint, Zsolt] Hungarian Nat Hist Museum, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Energy Research; Hungarian Research Centre for Natural Sciences	Piszter, G (corresponding author), Ctr Energy Res, Inst Tech Phys & Mat Sci, Budapest, Hungary.	piszter@mfa.kfki.hu	Biro, Laszlo/GRO-3819-2022	Piszter, Gabor/0000-0001-7155-4025; Balint, Zsolt/0000-0001-8174-878X	National Research, Development and Innovation Office of Hungary-NKFIH [K 111741, K 115724]	National Research, Development and Innovation Office of Hungary-NKFIH	This research was supported by the National Research, Development and Innovation Office of Hungary-NKFIH K 111741 (LPB) and K 115724 (KK) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint Z, 2012, J R SOC INTERFACE, V9, P1745, DOI 10.1098/rsif.2011.0854; Bilder RM, 2009, NEUROSCIENCE, V164, P30, DOI 10.1016/j.neuroscience.2009.01.027; Biro LP, 2011, LASER PHOTONICS REV, V5, P27, DOI 10.1002/lpor.200900018; Brisson JA, 2016, CURR OPIN INSECT SCI, V13, P1, DOI 10.1016/j.cois.2015.09.011; Casas J, 2010, ADV INSECT PHYSIOL, V38, P1, DOI 10.1016/S0065-2806(10)38012-X; Davidowitz G, 2016, AM NAT, V188, P499, DOI 10.1086/688653; Dinwiddie A, 2014, DEV BIOL, V392, P404, DOI 10.1016/j.ydbio.2014.06.005; Fahlgren N, 2015, CURR OPIN PLANT BIOL, V24, P93, DOI 10.1016/j.pbi.2015.02.006; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; GHIRADELLA H, 1994, MICROSC RES TECHNIQ, V27, P429, DOI 10.1002/jemt.1070270509; GHIRADELLA H, 1974, J MORPHOL, V142, P395, DOI 10.1002/jmor.1051420404; GREENSTEIN ME, 1972, J MORPHOL, V136, P23, DOI 10.1002/jmor.1051360103; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Iwata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089500; Kertesz K, 2008, MATER SCI ENG B-ADV, V149, P259, DOI 10.1016/j.mseb.2007.10.013; Kertesz K, 2014, MAT SCI ENG C-MATER, V39, P221, DOI 10.1016/j.msec.2014.03.014; Kertesz K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38827-w; Kertesz K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01273-7; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Michielsen K, 2008, J R SOC INTERFACE, V5, P85, DOI 10.1098/rsif.2007.1065; Nijhout HF, 2010, ADV INSECT PHYSIOL, V38, P219, DOI 10.1016/S0065-2806(10)38002-7; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Nygren GH, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4701; Ohno Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128332; Otaki JM, 2004, DEV GROWTH DIFFER, V46, P1; Otaki JM, 2008, J INSECT PHYSIOL, V54, P1099, DOI 10.1016/j.jinsphys.2008.05.006; Paaby AB, 2014, NAT REV GENET, V15, P247, DOI 10.1038/nrg3688; Pirih N, 2018, OMICS, V22, P337, DOI 10.1089/omi.2017.0186; Piszter G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165857; RIMM D, 2011, SCI TRANSL MED, V3, P108, DOI DOI 10.1126/SCITRANSLMED.3003252; ROUNTREE DB, 1995, J INSECT PHYSIOL, V41, P987, DOI 10.1016/0022-1910(95)00046-W; Saranathan V, 2010, P NATL ACAD SCI USA, V107, P11676, DOI 10.1073/pnas.0909616107; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Steel CGH, 2006, COMP BIOCHEM PHYS A, V144, P351, DOI 10.1016/j.cbpa.2006.02.018; Suszczynska A, 2017, J INSECT PHYSIOL, V101, P113, DOI 10.1016/j.jinsphys.2017.07.009; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; van Bergen E, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0907-1; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Wilts BD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603119; Wilts BD, 2009, J R SOC INTERFACE, V6, pS185, DOI 10.1098/rsif.2008.0299.focus; Yang CH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00132; YOSHIDA A, 1989, DEV GROWTH DIFFER, V31, P601; Zhang LL, 2017, P NATL ACAD SCI USA, V114, P10707, DOI 10.1073/pnas.1709058114; Zitnan D., 2012, INSECT ENDOCNNOLOGY, P253, DOI DOI 10.1016/B978-0-12-384749-2.10007-X	45	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225388	10.1371/journal.pone.0225388	http://dx.doi.org/10.1371/journal.pone.0225388			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765404	Green Published, Green Accepted, gold			2022-12-26	WOS:000533891000023
J	Sheen, H; Kim, W; Byun, BH; Kong, CB; Song, WS; Cho, WH; Lim, I; Lim, SM; Woo, SK				Sheen, Heesoon; Kim, Wook; Byun, Byung Hyun; Kong, Chang-Bae; Song, Won Seok; Cho, Wan Hyeong; Lim, Ilhan; Lim, Sang Moo; Woo, Sang-Keun			Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model	PLOS ONE			English	Article							F-18-FDG PET/CT; HETEROGENEITY; MRI	Background Osteosarcoma (OS) is the most common primary bone tumor affecting humans and it has extreme heterogeneity. Despite modern therapy, it recurs in approximately 30-40% of patients initially diagnosed with no metastatic disease, with the long-term survival rates of patients with recurrent OS being generally 20%. Thus, early prediction of metastases in OS management plans is crucial for better-adapted treatments and survival rates. In this study, a radiomics model for metastasis risk prediction in OS was developed and evaluated using metabolic imaging phenotypes. Methods and findings The subjects were eighty-three patients with OS, and all were treated with surgery and chemotherapy for local control. All patients underwent a pretreatment F-18-FDG-PET scan. Forty-five features were extracted from the tumor region. The incorporation of features into multivariable models was performed using logistic regression. The multivariable modeling strategy involved cross validation in the following four steps leading to final prediction model construction: (1) feature set reduction and selection; (2) model coefficients computation through train and validation processing; and (3) prediction performance estimation. The multivariable logistic regression model was developed using two radiomics features, SUVmax and GLZLM-SZLGE. The trained and validated multivariable logistic model based on probability of endpoint (P) = 1/(1+exp (-Z)) was Z = -1.23 + 1.53*SUVmax + 1.68*GLZLM-SZLGE with significant p-values (SUVmax: 0.0462 and GLZLM_SZLGE: 0.0154). The final multivariable logistic model achieved an area under the curve (AUC) receiver operating characteristics (ROC) curve of 0.80, a sensitivity of 0.66, and a specificity of 0.88 in cross validation. Conclusions The SUVmax and GLZLM-SZLGE from metabolic imaging phenotypes are independent predictors of metastasis risk assessment. They show the association between F-18-FDG-PET and metastatic colonization knowledge. The multivariable model developed using them could improve patient outcomes by allowing aggressive treatment in patients with high metastasis risk.	[Sheen, Heesoon; Kim, Wook; Woo, Sang-Keun] Korea Inst Radiol & Med Sci KIRAMS, Div Appl RI, Seoul, South Korea; [Byun, Byung Hyun; Lim, Ilhan; Lim, Sang Moo] Korea Inst Radiol & Med Sci KIRAMS, Dept Nucl Med, Seoul, South Korea; [Kong, Chang-Bae; Song, Won Seok; Cho, Wan Hyeong] Korea Inst Radiol & Med Sci, Dept Orthoped Surg, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences	Woo, SK (corresponding author), Korea Inst Radiol & Med Sci KIRAMS, Div Appl RI, Seoul, South Korea.	skwoo@kirams.re.kr		Woo, Sang-Keun/0000-0002-6728-8876	Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science and ICT (MSIT), Republic of Korea [50473-2019]; National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT) [2019M2D2A1A02057204, 2019R1F1A1060190]	Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science and ICT (MSIT), Republic of Korea; National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT)	This work was supported by grants from the Korea Institute of Radiological and Medical Sciences (KIRAMS), funded by the Ministry of Science and ICT (MSIT), Republic of Korea (No.50473-2019) and the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT) (2019M2D2A1A02057204, 2019R1F1A1060190).	Analytics G, 2015, EUR J NUCL MED MOL I, V53, P1149; [Anonymous], 2018, TEXTURE USER GUIDE L; Asselin MC, 2012, EUR J CANCER, V48, P447, DOI 10.1016/j.ejca.2011.12.025; Bailly C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183841; Byun BH, 2013, J NUCL MED, V54, P1725, DOI 10.2967/jnumed.112.117697; Cao J, 2015, CANCER RES, V75, P4839, DOI 10.1158/0008-5472.CAN-15-0711; Chicklore S, 2013, EUR J NUCL MED MOL I, V40, P133, DOI 10.1007/s00259-012-2247-0; Daw NC, 2015, BRIT J CANCER, V112, P278, DOI 10.1038/bjc.2014.585; Daw NC, 2006, BRIT J CANCER, V112, P278; Durfee RA, 2016, RHEUMATOL THER, V3, P221, DOI 10.1007/s40744-016-0046-y; Eary JF, 2008, J NUCL MED, V49, P1973, DOI 10.2967/jnumed.108.053397; Eary JF, 2002, EUR J NUCL MED MOL I, V29, P1149, DOI 10.1007/s00259-002-0859-5; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Guan GF, 2015, CANCER LETT, V357, P254, DOI 10.1016/j.canlet.2014.11.034; Hatt M, 2017, EUR J NUCL MED MOL I, V44, P151, DOI 10.1007/s00259-016-3427-0; Heare T, 2009, CURR OPIN PEDIATR, V21, P365, DOI 10.1097/MOP.0b013e32832b1111; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hwang JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153281; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kirienko M, 2018, EUR J NUCL MED MOL I, V45, P207, DOI 10.1007/s00259-017-3837-7; Kong CB, 2013, EUR J NUCL MED MOL I, V40, P728, DOI 10.1007/s00259-013-2344-8; Lambin P, 2013, NAT REV CLIN ONCOL, V10, P27, DOI 10.1038/nrclinonc.2012.196; Lindsey BA, 2017, RHEUMATOL THER, V4, P25, DOI 10.1007/s40744-016-0050-2; Nioche C, 2018, CANCER RES, V78, P4786, DOI 10.1158/0008-5472.CAN-18-0125; Orlhac F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145063; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Skamene SR, 2014, J SURG ONCOL, V109, P410, DOI 10.1002/jso.23523; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; Whelan JS, 2012, ANN ONCOL, V23, P1607, DOI 10.1093/annonc/mdr491	31	24	24	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225242	10.1371/journal.pone.0225242	http://dx.doi.org/10.1371/journal.pone.0225242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765423	Green Published, gold			2022-12-26	WOS:000533891000019
J	Bailey, HM; Zuo, Y; Li, F; Min, J; Vaddiparti, K; Prosperi, M; Fagan, J; Galea, S; Kalesan, B				Bailey, Hannah M.; Zuo, Yi; Li, Feng; Min, Jae; Vaddiparti, Krishna; Prosperi, Mattia; Fagan, Jeffrey; Galea, Sandro; Kalesan, Bindu			Changes in patterns of mortality rates and years of life lost due to firearms in the United States, 1999 to 2016: A joinpoint analysis	PLOS ONE			English	Article							INJURIES	Background Firearm-related death rates and years of potential life lost (YPLL) vary widely between population subgroups and states. However, changes or inflections in temporal trends within subgroups and states are not fully documented. We assessed temporal patterns and inflections in the rates of firearm deaths and %YPLL due to firearms for overall and by sex, age, race/ethnicity, intent, and states in the United States between 1999 and 2016. Methods We extracted age-adjusted firearm mortality and YPLL rates per 100,000, and %YPLL from 1999 to 2016 by using the WONDER (Wide-ranging Online Data for Epidemiologic Research) database. We used Joinpoint Regression to assess temporal trends, the inflection points, and annual percentage change (APC) from 1999 to 2016. Results National firearm mortality rates were 10.3 and 11.8 per 100,000 in 1999 and 2016, with two distinct segments; a plateau until 2014 followed by an increase of APC = 7.2% (95% CI 3.1, 11.4). YPLL rates were from 304.7 and 338.2 in 1999 and 2016 with a steady APC increase in %YPLL of 0.65% (95% CI 0.43, 0.87) from 1999 to an inflection point in 2014, followed by a larger APC in %YPLL of 5.1% (95% CI 0.1, 10.4). The upward trend in firearm mortality and YPLL rates starting in 2014 was observed in subgroups of male, non-Hispanic blacks, Hispanic whites and for firearm assaults. The inflection points for firearm mortality and YPLL rates also varied across states. Conclusions Within the United States, firearm mortality rates and YPLL remained constant between 1999 and 2014 and has been increasing subsequently. There was, however, an increase in firearm mortality rates in several subgroups and individual states earlier than 2014.	[Bailey, Hannah M.; Zuo, Yi; Kalesan, Bindu] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Li, Feng] Cent Univ Finance & Econ, Sch Stat & Math, Beijing, Peoples R China; [Min, Jae; Vaddiparti, Krishna; Prosperi, Mattia] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA; [Fagan, Jeffrey] Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Fagan, Jeffrey] Columbia Law Sch, New York, NY USA; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Boston University; Central University of Finance & Economics; State University System of Florida; University of Florida; Columbia University; Boston University	Kalesan, B (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	kalesan@bu.edu	Galea, Sandro/GLR-6066-2022; Li, Feng/C-5468-2019; Min, Jae/L-6540-2015	Li, Feng/0000-0002-4248-9778; Zuo, Yi/0000-0002-6643-8326; Min, Jae/0000-0003-4112-9583; Kalesan, Bindu/0000-0002-6543-2774; Bailey, Hannah/0000-0002-0994-5751	National Institute of Justice [2017-IJ-CX-0018]	National Institute of Justice(US National Institute of Justice)	All the funding for this study was from National Institute of Justice, Grant number 2017-IJ-CX-0018 to BK, YZ, JF, and SG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, JOINP REGR PROGR COM; [Anonymous], 2017, JOINP REGR PROGR STA; Barber C, 2002, INJURY PREV, V8, P252, DOI 10.1136/ip.8.3.252; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P609; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P313; Davis AB, 2018, INT J EPIDEMIOL, V47, P1015, DOI 10.1093/ije/dyy059; Fowler KA, 2015, PREV MED, V79, P5, DOI 10.1016/j.ypmed.2015.06.002; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; Hemenway David, 2015, Inj Epidemiol, V2, P26; Ikeda RM, 1997, AM J PREV MED, V13, P396, DOI 10.1016/S0749-3797(18)30161-2; Kalesan B, 2017, AM J EPIDEMIOL, V185, P546, DOI 10.1093/aje/kww147; Kalesan B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005628; Kalesan B, 2014, AM J EPIDEMIOL, V179, P303, DOI 10.1093/aje/kwt255; Linden A, 2011, J EVAL CLIN PRACT, V17, P1231, DOI 10.1111/j.1365-2753.2010.01504.x; McGivern L, 2017, PUBLIC HEALTH REP, V132, P669, DOI 10.1177/0033354917736514; Riddell CA, 2018, ANN INTERN MED, V168, P712, DOI 10.7326/M17-2976; Tuan Wen-Jan, 2017, WMJ, V116, P194	17	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225223	10.1371/journal.pone.0225223	http://dx.doi.org/10.1371/journal.pone.0225223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756227	Green Published, gold			2022-12-26	WOS:000533889300012
J	Mandacaru, SC; Queiroz, RML; Alborghetti, MR; de Oliveira, LS; de Lima, CMR; Bastos, IMD; Santana, JM; Roepstorff, P; Ricart, CAO; Charneau, S				Mandacaru, Samuel C.; Queiroz, Rayner M. L.; Alborghetti, Marcos R.; de Oliveira, Lucas S.; de Lima, Consuelo M. R.; Bastos, Izabela M. D.; Santana, Jaime M.; Roepstorff, Peter; Ricart, Carlos Andre O.; Charneau, Sebastien			Exoproteome profiling of Trypanosoma cruzi during amastigogenesis early stages	PLOS ONE			English	Article							CHAGAS-DISEASE; MOLECULAR CHAPERONES; VIRULENCE FACTORS; MASP FAMILY; PROTEIN; SURFACE; EXPRESSION; DOMAIN; TRYPOMASTIGOTE; ACTIVATION	Chagas disease is caused by the protozoan Trypanosoma cruzi, affecting around 8 million people worldwide. After host cell invasion, the infective trypomastigote form remains 2-4 hours inside acidic phagolysosomes to differentiate into replicative amastigote form. In vitro acidic-pH-induced axenic amastigogenesis was used here to study this step of the parasite life cycle. After three hours of trypomastigote incubation in amastigogenesis promoting acidic medium (pH 5.0) or control physiological pH (7.4) medium samples were subjected to three rounds of centrifugation followed by ultrafiltration of the supernatants. The resulting exoproteome samples were trypsin digested and analysed by nano flow liquid chromatography coupled to tandem mass spectrometry. Computational protein identification searches yielded 271 and 483 protein groups in the exoproteome at pH 7.4 and pH 5.0, respectively, with 180 common proteins between both conditions. The total amount and diversity of proteins released by parasites almost doubled upon acidic incubation compared to control. Overall, 76.5% of proteins were predicted to be secreted by classical or non-classical pathways and 35.1% of these proteins have predicted transmembrane domains. Classical secretory pathway analysis showed an increased number of mucins and mucin-associated surface proteins after acidic incubation. However, the number of released trans-sialidases and surface GP63 peptidases was higher at pH 7.4. Trans-sialidases and mucins are anchored to the membrane and exhibit an enzyme-substrate relationship. In general, mucins are glycoproteins with immunomodulatory functions in Chagas disease, present mainly in the epimastigote and trypomastigote surfaces and could be enzymatically cleaved and released in the phagolysosome during amastigogenesis. Moreover, evidence for flagella discard during amastigogenesis are addressed. This study provides the first comparative analysis of the exoproteome during amastigogenesis, and the presented data evidence the dynamism of its profile in response to acidic pH-induced differentiation.	[Mandacaru, Samuel C.; Queiroz, Rayner M. L.; Alborghetti, Marcos R.; de Oliveira, Lucas S.; de Lima, Consuelo M. R.; Ricart, Carlos Andre O.; Charneau, Sebastien] Univ Brasilia, Inst Biol, Dept Cell Biol, Lab Prot Chem & Biochem, Brasilia, DF, Brazil; [Queiroz, Rayner M. L.; Roepstorff, Peter] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Bastos, Izabela M. D.; Santana, Jaime M.] Univ Brasilia, Inst Biol, Dept Cell Biol, Pathogen Host Interface Lab, Brasilia, DF, Brazil; [Queiroz, Rayner M. L.] Univ Cambridge, Cambridge Ctr Prote, Dept Biochem, Cambridge, England	Universidade de Brasilia; University of Southern Denmark; Universidade de Brasilia; University of Cambridge	Charneau, S (corresponding author), Univ Brasilia, Inst Biol, Dept Cell Biol, Lab Prot Chem & Biochem, Brasilia, DF, Brazil.	charneau@unb.br	Charneau, Sébastien/AAD-1145-2019; Alborghetti, Marcos/K-7547-2012	Charneau, Sébastien/0000-0002-9364-7289; Alborghetti, Marcos/0000-0003-4517-5579; Bastos, Izabela/0000-0002-2785-4255; Mandacaru, Samuel/0000-0001-9255-1958; S Oliveira, Lucas/0000-0002-3067-794X	MCTI/CNPq/FNDCT/PRO-CENTRO-OESTE; FAPDF; CAPES-COFECUB grant [923/18]; CNPq [433208/2016-3]; CAPES (PNPD fellowship); INCT-CNPqFAPEG [465771/2014-9]	MCTI/CNPq/FNDCT/PRO-CENTRO-OESTE; FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CAPES-COFECUB grant(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (PNPD fellowship)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT-CNPqFAPEG	This work was supported by MCTI/CNPq/FNDCT/PRO-CENTRO-OESTE, FAPDF, INCT-CNPqFAPEG (465771/2014-9), CAPES-COFECUB grant 923/18, CNPq grant 433208/2016-3, FAPDF (fellowship to SCM), CAPES (PNPD fellowship to MRA and fellowship to LSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; Albajar-Vinas P, 2011, EUROSURVEILLANCE, V16, P2; Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Alvarez VE, 2012, BBA-PROTEINS PROTEOM, V1824, P195, DOI 10.1016/j.bbapap.2011.05.011; Andrews Norma W., 1993, Biological Research, V26, P65; ANDREWS NW, 1982, J PROTOZOOL, V29, P264, DOI 10.1111/j.1550-7408.1982.tb04024.x; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Babaahmady K, 2007, J VIROL, V81, P3354, DOI 10.1128/JVI.02320-06; Bartholomeu DC, 2009, NUCLEIC ACIDS RES, V37, P3407, DOI 10.1093/nar/gkp172; Basso Beatriz, 2013, World J Exp Med, V3, P1, DOI 10.5493/wjem.v3.i1.1; Bastos IMD, 2013, CURR MED CHEM, V20, P3103; Bayer-Santos E, 2012, J PROTEOME RES; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Bernabo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071192; Branquinha MH, 2013, CURR MED CHEM, V20, P3174; BURLEIGH BA, 1995, ANNU REV MICROBIOL, V49, P175, DOI 10.1146/annurev.mi.49.100195.001135; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Buschiazzo A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002474; Caccia D, 2013, BBA-PROTEINS PROTEOM, V1834, P2442, DOI 10.1016/j.bbapap.2013.01.039; Camargo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095977; Caminha MA, 2019, J PROTEOMICS, V194, P179, DOI 10.1016/j.jprot.2018.11.019; Caradonna KL, 2013, CELL HOST MICROBE, V13, P108, DOI 10.1016/j.chom.2012.11.011; Cardillo F, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv082; Cestari I, 2012, J IMMUNOL, V188, P1942, DOI 10.4049/jimmunol.1102053; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221; Cuervo P, 2009, J PROTEOMICS, V73, P79, DOI 10.1016/j.jprot.2009.08.006; d'Avila-Levy Claudia M, 2014, Subcell Biochem, V74, P253, DOI 10.1007/978-94-007-7305-9_11; DA SILVA L. H. P., 1953, Folia Clinica et Biologica, V20, P191; dC-Rubin SSC, 2012, CELL MICROBIOL, V14, P1522, DOI 10.1111/j.1462-5822.2012.01831.x; dos Santos SL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001779; Ersfeld K, 2005, J MOL EVOL, V61, P742, DOI 10.1007/s00239-004-0272-8; Freire-de-Lima L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00698; Freire-De-Lima L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00356; Geiger A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-20; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Grebaut P, 2009, INT J PARASITOL, V39, P1137, DOI 10.1016/j.ijpara.2009.02.018; Hashimoto M, 2010, CELL MICROBIOL, V12, P19, DOI 10.1111/j.1462-5822.2009.01375.x; Hasslocher-Moreno AM, 2012, J ANTIMICROB CHEMOTH, V67, P1261, DOI 10.1093/jac/dks027; Henderson B, 2009, CELL STRESS CHAPERON, V14, P329, DOI 10.1007/s12192-008-0087-4; Hernandez-Osorio LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/283842; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kulkarni MM, 2009, INFECT IMMUN, V77, P2193, DOI 10.1128/IAI.01542-08; Kurup SP, 2014, CELL HOST MICROBE, V16, P439, DOI 10.1016/j.chom.2014.09.003; Belaunzaran ML, 2013, MOL BIOCHEM PARASIT, V187, P77, DOI 10.1016/j.molbiopara.2012.12.004; Li Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005511; Lippestad M, 2018, EXP EYE RES, V173, P64, DOI 10.1016/j.exer.2018.04.015; Ma LN, 2011, PARASITOL RES, V109, P1075, DOI 10.1007/s00436-011-2348-x; Martins VD, 2010, J BIOL CHEM, V285, P30906, DOI 10.1074/jbc.M110.142190; Munoz C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141526; Olivier M, 2012, MICROBES INFECT, V14, P1377, DOI 10.1016/j.micinf.2012.05.014; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Pech-Canul Angel de la Cruz, 2017, J Parasitol Res, V2017, P3751403, DOI 10.1155/2017/3751403; Queiroz RML, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00042; Queiroz RML, 2014, MOL CELL PROTEOMICS, V13, P3457, DOI 10.1074/mcp.M114.040329; Queiroz RML, 2014, J PROTEOME RES, V13, P3530, DOI 10.1021/pr401120y; Raimondo F, 2011, PROTEOMICS, V11, P709, DOI 10.1002/pmic.201000422; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Roca C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001135; Rubin-de-Celis SSC, 2006, CELL MICROBIOL, V8, P1888, DOI 10.1111/j.1462-5822.2006.00755.x; Shamaei-Tousi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001198; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; TOMLINSON S, 1995, PARASITOLOGY, V110, P547, DOI 10.1017/S0031182000065264; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Vanags D, 2006, LANCET, V368, P855, DOI 10.1016/S0140-6736(06)69210-6; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Wren KN, 2013, CURR BIOL, V23, P2463, DOI 10.1016/j.cub.2013.10.044; Yao CQ, 2010, INFECT IMMUN, V78, P22, DOI 10.1128/IAI.00776-09	71	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225386	10.1371/journal.pone.0225386	http://dx.doi.org/10.1371/journal.pone.0225386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756194	Green Published, gold			2022-12-26	WOS:000533889300023
J	Krysztofiak, H; Mlynczak, M; Malek, LA; Folga, A; Braksator, W				Krysztofiak, Hubert; Mlynczak, Marcel; Malek, Lukasz A.; Folga, Andrzej; Braksator, Wojciech			Left ventricular mass normalization for body size in children based on an allometrically adjusted ratio is as accurate as normalization based on the centile curves method	PLOS ONE			English	Article							ATHLETES HEART; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; HYPERTROPHY; ECHOCARDIOGRAPHY; GROWTH; ADULTS; RECOMMENDATIONS; QUANTIFICATION; METAANALYSIS	Background Normalization for body size is required for reliable left ventricular mass (LVM) evaluation, especially in children due to the large variability of body size. In clinical practice, the allometrically adjusted ratio of LVM to height raised to the power of 2.7 is often used. However, studies presenting normative LVM data for children recommend centile curves as optimal for the development of normative data. This study aimed to assess whether the allometrically adjusted LVM-to-height ratio can reliably reproduce the results of LVM normalization for height based on the centile curves method. Methods Left ventricular mass was computed for 464 boys and 327 girls, 5-18 years old, based on echocardiographic examination. Normalized data representing LVM for height were developed using the centile curves construction method and two variants of the allometrically adjusted ratio method: one variant with the allometric exponents specific to the study groups, and one variant with the universal exponent of 2.7. The agreement between the allometric methods and the centile curves method was analyzed using the concordance correlation coefficient, sensitivity, and specificity. Results For both the specific allometric variant and the universal variant, the analysis of concordance has indicated high reproducibility compared to the centile curves method. The respective coefficient values were 0.9917 and 0.9916 for girls, and 0.9886 and 0.9869 for boys. The sensitivity and specificity test has also shown high agreement. However, for girls, the sensitivity was higher for the specific variant (100% vs. 90.9%). Conclusion The results of the study show that allometric scaling of LVM for height can very reliably reproduce the results of LVM normalization for height based on the centile curves method. However, the analysis of sensitivity and specificity indicates greater agreement for the allometric normalization with the group-specific allometric exponents.	[Krysztofiak, Hubert] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland; [Krysztofiak, Hubert; Folga, Andrzej] Natl Ctr Sports Med, Warsaw, Poland; [Mlynczak, Marcel] Warsaw Univ Technol, Fac Mechatron, Inst Metrol & Biomed Engn, Warsaw, Poland; [Malek, Lukasz A.] Natl Inst Cardiol, Dept Epidemiol Cardiovasc Dis Prevent & Hlth Prom, Warsaw, Poland; [Braksator, Wojciech] Med Univ Warsaw, Dept Sports Cardiol & Noninvas Cardiovasc Imaging, Med Fac 2, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Warsaw University of Technology; Institute of Cardiology - Poland; Medical University of Warsaw	Krysztofiak, H (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland.; Krysztofiak, H (corresponding author), Natl Ctr Sports Med, Warsaw, Poland.	hkrysztofiak@imdik.pan.pl	Krysztofiak, Hubert/L-8083-2019; Młyńczak, Marcel/L-1509-2016; Braksator, Wojciech/N-2197-2018	Krysztofiak, Hubert/0000-0003-4567-1433; Młyńczak, Marcel/0000-0001-8549-7973; Braksator, Wojciech/0000-0003-2201-4887; Malek, Lukasz/0000-0002-9586-0163				ALBRECHT GH, 1993, AM J PHYS ANTHROPOL, V91, P441, DOI 10.1002/ajpa.1330910404; Armstrong AC, 2012, JACC-CARDIOVASC IMAG, V5, P837, DOI 10.1016/j.jcmg.2012.06.003; Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; Chinali M, 2016, J PEDIATR-US, V170, P193, DOI 10.1016/j.jpeds.2015.10.085; Chirinos JA, 2010, HYPERTENSION, V56, P91, DOI 10.1161/HYPERTENSIONAHA.110.150250; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; de Simone G, 2005, AM J HYPERTENS, V18, P191, DOI 10.1016/j.amjhyper.2004.08.032; de Simone G, 2008, EUR HEART J, V29, P741, DOI 10.1093/eurheartj/ehm605; de Simone G, 2010, HYPERTENSION, V56, pE177, DOI 10.1161/HYPERTENSIONAHA.110.163964; DESIMONE G, 1995, J AM COLL CARDIOL, V25, P1056, DOI 10.1016/0735-1097(94)00540-7; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Diaz A, 2019, PEDIATR CARDIOL, V40, P283, DOI 10.1007/s00246-018-2000-y; Foster BJ, 2008, CIRCULATION, V117, P2769, DOI 10.1161/CIRCULATIONAHA.107.741157; Foster BJ, 2016, J AM SOC ECHOCARDIOG, V29, P441, DOI 10.1016/j.echo.2015.12.011; Foster BJ, 2013, J AM SOC ECHOCARDIOG, V26, P410, DOI 10.1016/j.echo.2012.11.018; Galderisi M, 2015, EUR HEART J-CARD IMG, V16, P353, DOI 10.1093/ehjci/jeu323; GOULD SJ, 1971, AM NAT, V105, P113, DOI 10.1086/282710; GUTGESELL HP, 1990, AM J CARDIOL, V65, P662, DOI 10.1016/0002-9149(90)91048-B; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Krysztofiak H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217637; Krysztofiak H, 2016, KARDIOL POL, V74, P705, DOI 10.5603/KP.a2016.0084; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mawad W, 2013, J AM SOC ECHOCARDIOG, V26, P29, DOI 10.1016/j.echo.2012.09.021; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Pressler A, 2012, EUR J PREV CARDIOL, V19, P1194, DOI 10.1177/1741826711422455; Sharma S, 2002, J AM COLL CARDIOL, V40, P1431, DOI 10.1016/S0735-1097(02)02270-2; Sluysmans T, 2005, J APPL PHYSIOL, V99, P445, DOI 10.1152/japplphysiol.01144.2004; Utomi V, 2013, HEART, V99, P1727, DOI 10.1136/heartjnl-2012-303465; Whalley GA, 2004, J AM COLL CARDIOL, V44, P892, DOI 10.1016/j.jacc.2004.04.051; WHO, 2006, CHILD GROWTH STAND L; Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225287	10.1371/journal.pone.0225287	http://dx.doi.org/10.1371/journal.pone.0225287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751386	gold, Green Published			2022-12-26	WOS:000533886900044
J	Michalski, D; Heyer, R; Semmler, C				Michalski, Dana; Heyer, Rebecca; Semmler, Carolyn			The performance of practitioners conducting facial comparisons on images of children across age	PLOS ONE			English	Article							FACE; STRATEGY	Determining the identity of children is critical to aid in the fight against child exploitation, as well as for passport control and visa issuance purposes. Facial image comparison is one method that may be used to determine identity. Due to the substantial amount of facial growth that occurs in childhood, it is critical to understand facial image comparison performance across both chronological age (the age of the child), and age variation (the age difference between images). In this study we examined the performance of 120 facial comparison practitioners from a government agency on a dataset of 23,760 image pairs selected from the agency's own database of controlled, operational images. Each chronological age in childhood (0-17 years) and age variations ranging from 0-10 years were examined. Practitioner performance was found to vary considerably across childhood, and depended on whether the pairs were mated (same child) or non-mated (different child). Overall, practitioners were more accurate and confident with image pairs containing older children, and also more accurate and confident with smaller age variations. Chronological age impacted on accuracy with mated pairs, but age variation did not. In contrast, both age and age variation impacted on accuracy with non-mated pairs. These differences in performance show that changes in the face throughout childhood have a significant impact on practitioner performance. We propose that improvements in accuracy may be achievable with a better understanding of which facial features are most appropriate to compare across childhood, and adjusting training and development programs accordingly.	[Michalski, Dana; Heyer, Rebecca] Def Sci & Technol Grp, Edinburgh, SA, Australia; [Semmler, Carolyn] Univ Adelaide, Sch Psychol, Adelaide, SA, Australia	Defence Science & Technology; University of Adelaide	Michalski, D (corresponding author), Def Sci & Technol Grp, Edinburgh, SA, Australia.	dana.michalski@dst.defence.gov.au		Michalski, Dana/0000-0002-6585-1856; Heyer, Rebecca/0000-0002-1383-8705				[Anonymous], 2012, EXAMINE EMERGING POL; BRUCE V, 1994, Q J EXP PSYCHOL-A, V47, P5, DOI 10.1080/14640749408401141; Farkas Leslie G., 1994, P89; Ferguson EL, 2015, THESIS; FISWG, 2012, REC TRAIN PROGR FAC, P1; FISWG, 2012, GUID FAC COMP METH, P1; FISWG, 2019, PHYS STAB FAC FEAT A, P1; Grother P., 2014, 8009 NIST INT; Havard C., 2007, EYE MOVEMENT STRATEG; Heyer R, 2017, PROFILING FACIAL COM; Heyer R, 2018, J APPL RES MEM COGN, V7, P597; Hole M, 2015, DSTOGD0855; Kozak FK, 2015, CUMMINGS PEDIAT OTOL; Kramer RSS, 2018, PEERJ, V6, DOI 10.7717/peerj.5010; Megreya AM, 2007, PERCEPT PSYCHOPHYS, V69, P1175, DOI 10.3758/BF03193954; Megreya AM, 2018, PEERJ, V6, DOI 10.7717/peerj.4437; Megreya AM, 2013, APPL COGNITIVE PSYCH, V27, P700, DOI 10.1002/acp.2965; Michalski D, 2018, INT CONF BIOMETR, P217, DOI 10.1109/ICB2018.2018.00041; Michalski D., 2017, THESIS; Phillips P.J., 2018, P NATL ACAD SCI USA; Ricanek K, 2013, BOOK AGE FACTORS BIO; Stephens RG, 2017, J EXP PSYCHOL-APPL, V23, P336, DOI 10.1037/xap0000130; Towler A, 2017, J EXP PSYCHOL-APPL, V23, P47, DOI 10.1037/xap0000108; Towler A, 2014, PERCEPTION, V43, P214, DOI 10.1068/p7676; Vernon M. D., 1952, FURTHER STUDY VISUAL; White D, 2015, P ROY SOC B-BIOL SCI, V282, P73, DOI 10.1098/rspb.2015.1292; White D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139827; White D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103510; Wilkinson C, 2012, CRANIOFACIAL IDENTIFICATION, P254; Yadav D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112234; Zhang SX., 2007, SMUGGLING TRAFFICKIN	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225298	10.1371/journal.pone.0225298	http://dx.doi.org/10.1371/journal.pone.0225298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8LN	31743373	Green Published, gold			2022-12-26	WOS:000533877300025
J	Sunny, S; Baby, A; James, BL; Balaji, D; Aparna, NV; Rana, MH; Gurpur, P; Skandarajah, A; D'Ambrosio, M; Ramanjinappa, RD; Mohan, SP; Raghavan, N; Kandasarma, U; Sangeetha, N; Raghavan, S; Hedne, N; Koch, F; Fletcher, DA; Selvam, S; Kollegal, M; Birur, NP; Ladic, L; Suresh, A; Pandya, HJ; Kuriakose, MA				Sunny, Sumsum; Baby, Arun; James, Bonney Lee; Balaji, Dev; Aparna, N., V; Rana, Maitreya H.; Gurpur, Praveen; Skandarajah, Arunan; D'Ambrosio, Michael; Ramanjinappa, Ravindra Doddathimmasandra; Mohan, Sunil Paramel; Raghavan, Nisheena; Kandasarma, Uma; Sangeetha, N.; Raghavan, Subhasini; Hedne, Naveen; Koch, Felix; Fletcher, Daniel A.; Selvam, Sumithra; Kollegal, Manohar; Birur, Praveen N.; Ladic, Lance; Suresh, Amritha; Pandya, Hardik J.; Kuriakose, Moni Abraham			A smart tele-cytology point-of-care platform for oral cancer screening	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; CERVICAL SMEARS; TELECYTOLOGY DIAGNOSIS; EPITHELIAL DYSPLASIA; SAMPLE-SIZE; REPRODUCIBILITY; ACCURACY; INTRAOBSERVER; REQUIREMENTS; LESIONS	Early detection of oral cancer necessitates a minimally invasive, tissue-specific diagnostic tool that facilitates screening/surveillance. Brush biopsy, though minimally invasive, demands skilled cyto-pathologist expertise. In this study, we explored the clinical utility/efficacy of a tele-cytology system in combination with Artificial Neural Network (ANN) based risk-stratification model for early detection of oral potentially malignant (OPML)/malignant lesion. A portable, automated tablet-based tele-cytology platform capable of digitization of cytology slides was evaluated for its efficacy in the detection of OPML/malignant lesions (n = 82) in comparison with conventional cytology and histology. Then, an image pre-processing algorithm was established to segregate cells, ANN was trained with images (n = 11,981) and a risk-stratification model developed. The specificity, sensitivity and accuracy of platform/stratification model were computed, and agreement was examined using Kappa statistics. The tele-cytology platform, Cellscope, showed an overall accuracy of 84-86% with no difference between tele-cytology and conventional cytology in detection of oral lesions (kappa, 0.67-0.72). However, OPML could be detected with low sensitivity (18%) in accordance with the limitations of conventional cytology. The integration of image processing and development of an ANN-based risk stratification model improved the detection sensitivity of malignant lesions (93%) and high grade OPML (73%), thereby increasing the overall accuracy by 30%. Tele-cytology integrated with the risk stratification model, a novel strategy established in this study, can be an invaluable Point-of-Care (PoC) tool for early detection/screening in oral cancer. This study hence establishes the applicability of telecytology for accurate, remote diagnosis and use of automated ANN-based analysis in improving its efficacy.	[Sunny, Sumsum; Hedne, Naveen; Birur, Praveen N.; Suresh, Amritha; Kuriakose, Moni Abraham] NH Hlth City, Mazumdar Shaw Med Ctr, Head & Neck Oncol, Bangalore, Karnataka, India; [Sunny, Sumsum; James, Bonney Lee; Ramanjinappa, Ravindra Doddathimmasandra; Suresh, Amritha; Kuriakose, Moni Abraham] NH Hlth City, Mazumdar Shaw Med Fdn, Integrated Head & Neck Oncol Program DSRG 5, Bangalore, Karnataka, India; [Sunny, Sumsum] Manipal Acad Higher Educ, Manipal, Karnataka, India; [Sunny, Sumsum; Baby, Arun; Balaji, Dev; Aparna, N., V; Rana, Maitreya H.; Pandya, Hardik J.] Indian Inst Sci, Dept Elect Syst Engn, Biomed & Elect 106 109 Engn Syst Lab, Bangalore, Karnataka, India; [Gurpur, Praveen; Skandarajah, Arunan; Kollegal, Manohar] Siemens Healthcare Pvt Ltd, Bangalore, Karnataka, India; [D'Ambrosio, Michael; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [D'Ambrosio, Michael; Fletcher, Daniel A.] Univ Calif Berkeley, Biophys Program, Berkeley, CA 94720 USA; [Mohan, Sunil Paramel] Sree Anjaneya Dent Coll, Dept Oral & Maxillofacial pathol, Kozhikode, Kerala, India; [Raghavan, Nisheena] NH Hlth City, Mazumdar Shaw Med Ctr, Dept Pathol, Bangalore, Karnataka, India; [Kandasarma, Uma] KLE Soc Inst Dent Sci, Dept Oral & Maxillofacial Pathol, Bangalore, Karnataka, India; [Sangeetha, N.; Raghavan, Subhasini; Birur, Praveen N.] KLE Soc Inst Dent Sci, Dept Oral Med & Radiol, Bangalore, Karnataka, India; [Koch, Felix] Johannes Gutenberg Univ Mainz, D-55099 Mainz, Germany; [Selvam, Sumithra] St Johns Natl Acad Hlth Sci, St Johns Res Inst, Div Epidemiol & Biostat, Bangalore, Karnataka, India; [Ladic, Lance] Siemens Healthineers, Malvern, PA USA	Manipal Academy of Higher Education (MAHE); Indian Institute of Science (IISC) - Bangalore; Siemens AG; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Johannes Gutenberg University of Mainz; St. John's National Academy of Health Sciences; St. John's Research Institute; Siemens AG	Kuriakose, MA (corresponding author), NH Hlth City, Mazumdar Shaw Med Ctr, Head & Neck Oncol, Bangalore, Karnataka, India.; Kuriakose, MA (corresponding author), NH Hlth City, Mazumdar Shaw Med Fdn, Integrated Head & Neck Oncol Program DSRG 5, Bangalore, Karnataka, India.; Pandya, HJ (corresponding author), Indian Inst Sci, Dept Elect Syst Engn, Biomed & Elect 106 109 Engn Syst Lab, Bangalore, Karnataka, India.	hjpandya@iisc.ac.in; makuriakose@gmail.com	Raghavan, Shubhasini/AAT-2209-2020; N, Praveen Birur/J-5307-2019; PM, Sunil/AAK-5095-2021	Raghavan, Shubhasini/0000-0001-8385-4826; N, Praveen Birur/0000-0001-5287-8323; Kuriakose, Moni/0000-0003-4229-752X; Kollegal, Manohar/0000-0001-9023-1176; Baby, Arun/0000-0002-8109-5835	Wellcome Trust/DBT India Alliance Fellowship [IA/RTF/15/1/1017]	Wellcome Trust/DBT India Alliance Fellowship(Wellcome Trust DBT India Alliance)	This work was supported by the Wellcome Trust/DBT India Alliance Fellowship [IA/RTF/15/1/1017] awarded to Sumsum Sunny (https://www.indiaalliance.org/fellowsprofile/drsumsum-sunny-270).Additionally, funders provided support in the form of salaries for authors [DBT Alliance fellowship: SPS; Siemens Healthcare Pvt Ltd and Siemens Healthineers: LL, PG, MK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Afrogheh A, 2012, OR SURG OR MED OR PA, V113, P799, DOI 10.1016/j.oooo.2012.01.027; Alli PM, 2001, HUM PATHOL, V32, P1318, DOI 10.1053/hupa.2001.29651; Archondakis S, 2009, TELEMED J E-HEALTH, V15, P713, DOI 10.1089/tmj.2009.0037; Babshet M, 2011, J CYTOL, V28, P165, DOI 10.4103/0970-9371.86342; Bal MS, 2012, J CYTOL, V29, P45, DOI 10.4103/0970-9371.93222; Bott MJ, 2015, ANN THORAC SURG, V100, P201, DOI 10.1016/j.athoracsur.2015.02.090; Briscoe D, 2000, ACTA CYTOL, V44, P175, DOI 10.1159/000326357; Bujang MA, 2016, J CLIN DIAGN RES, V10, pYE1, DOI 10.7860/JCDR/2016/18129.8744; Chougrad H, 2018, COMPUT METH PROG BIO, V157, P19, DOI 10.1016/j.cmpb.2018.01.011; Erickson BJ, 2017, RADIOGRAPHICS, V37, P505, DOI 10.1148/rg.2017160130; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Galvez J, 1998, ACTA CYTOL, V42, P663, DOI 10.1159/000331823; Georgoulakis J, 2011, DIAGN CYTOPATHOL, V39, P495, DOI 10.1002/dc.21419; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Heimann A, 2012, DIAGN CYTOPATHOL, V40, P575, DOI 10.1002/dc.21582; Im H, 2018, NATURE BIOMEDICAL EN, P1, DOI [10.1038/s41551-018-0189-y, DOI 10.1038/S41551-018-0189-Y]; Joshi P, 2014, INDIAN J CANCER, V51, P95, DOI 10.4103/0019-509X.137934; Justel A, 1997, STAT PROBABIL LETT, V35, P251, DOI 10.1016/S0167-7152(97)00020-5; Kldiashvili E, 2011, TELEMED E-HEALTH, V17, P565, DOI 10.1089/tmj.2011.0016; Kudva V., 2018, CRITICAL REV BIOMEDI, V46; Kujan O, 2006, ORAL ONCOL, V42, P987, DOI 10.1016/j.oraloncology.2005.12.014; LeCun Y., 2010, 2010 IEEE INT S CIRC; Lee ES, 2003, AM J CLIN PATHOL, V119, P356, DOI 10.1309/7YTVAG4XNR48T75H; Lu Z, 2017, IEEE J BIOMED HEALTH, V21, P441, DOI 10.1109/JBHI.2016.2519686; Mignogna MD, 2004, EUR J CANCER PREV, V13, P139, DOI 10.1097/00008469-200404000-00008; Mun S K, 1995, J Med Syst, V19, P153, DOI 10.1007/BF02257066; Nosrati M. S., 2014, ISBI OVERLAPPING CER, P1; Ogden GR, 1997, ORAL ONCOL, V33B, P2, DOI 10.1016/S0964-1955(96)00047-4; Pouliakis A, 2016, BIOMEDICAL ENG COMPU, V7; Sekine J, 2017, DIAGN PATHOL, V12, DOI 10.1186/s13000-017-0618-3; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Shirani S, 2014, IRAN J MED SCI, V39, P406; Singh S, 2015, INT J PHARM PHYTOPHA, V4, P264; Skandarajah A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188440; Soille P., 1990, VISUAL COMMUNICATION; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Speight PM, 2007, HEAD NECK PATHOL, V1, P61, DOI 10.1007/s12105-007-0014-5; Srinath M. V., 2016, ICTACT J IMAGE VIDEO, V06, P1234; Subbaiah RM, 2014, DIAGN CYTOPATHOL, V42, P218, DOI 10.1002/dc.23026; Szegedy C, 2016, P IEEE C COMP VIS PA; Tsilalis T, 2012, TELEMED E-HEALTH, V18, P516, DOI 10.1089/tmj.2011.0167; Ushizima D.M., 2015, SEGMENTATION SUBCELL; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Weigum S. E., 2010, CANCER PREV RES, P1940; Weng S, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.10.106017; Yauney G, 2017, BIONF BIOENG BIBE 20; ZHOU YS, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0126760	47	20	20	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224885	10.1371/journal.pone.0224885	http://dx.doi.org/10.1371/journal.pone.0224885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730638	Green Accepted, gold, Green Published			2022-12-26	WOS:000532809500012
J	Wang, XW; Wang, YD; Li, L; Xue, XT; Xie, H; Shi, HX; Hu, Y				Wang, Xingwen; Wang, Yudong; Li, Li; Xue, Xuting; Xie, Hui; Shi, Huaxing; Hu, Ying			A lncRNA coordinates with Ezh2 to inhibit HIF-1 alpha transcription and suppress cancer cell adaption to hypoxia	ONCOGENE			English	Article							REPRESSIVE COMPLEX 2; LONG NONCODING RNAS; GROUP PROTEIN EZH2; INDUCIBLE FACTORS; DRUG-RESISTANCE; PROLIFERATION; PROGRESSION; EXPRESSION; PHOSPHORYLATION; INACTIVATION	Hypoxia is a salient feature of the tumor microenvironment. HIF-1 alpha is a master regulator of hypoxic adaption. The polycomb repressor complex 2 (PRC2) molecule Ezh2 is known to play roles in essential cellular processes of cell fate decisions. However, how PRC2-mediated epigenetic dynamic changes take part in hypoxic adaption is not completely understood. Recently, we identified a long non-coding RNA (lncRNA) named HITT (HIF-1 alpha inhibitor at translation levels) that plays roles in modulating hypoxia-mediated angiogenesis and tumor growth in vivo. In this study, we reveal an important activity of HITT in evading hypoxia-induced apoptosis by coordinating with PRC2 activity to regulate HIF-1 alpha transcription. Genetic or chemical inhibition of PRC2 significantly elevates HIF-1 alpha mRNA levels. The occupancy of Ezh2 and its substrate H3K27me3 on the HIF-1 alpha promoter is detected under normoxia, and is reduced by hypoxia. Restoring hypoxia-inhibited HITT expression rescues the association between Ezh2/H3K27me3 and the HIF-1 alpha promoter, which also simultaneously abrogates hypoxia-induced HIF-1 alpha mRNA transcription. Further mechanistic studies revealed that HITT inhibits HIF-1 alpha transcription by guiding Ezh2 through the formation of an RNA-DNA triplex with the HIF-1 alpha promoter. Importantly, HITT/Ezh2-regulated HIF-1 alpha transcription leads to alerted HIF-1 alpha protein output and elicits a significant effect to evade hypoxia-induced apoptosis. Importantly, a close association between HIF-1 alpha mRNA and HITT was further verified in human colon cancer tissues in vivo. Collectively, these findings suggest a model for the epigenetic regulation of hypoxia-induced HIF-1 alpha transcription modulated by lncRNA HITT, which provides important insights into how tumor cells sense and adapt to hypoxic stress.	[Wang, Xingwen; Wang, Yudong; Xue, Xuting; Hu, Ying] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China; [Li, Li] Harbin Med Univ, Affiliated Tumor Hosp, Harbin 150001, Heilongjiang, Peoples R China; [Xie, Hui] Harbin Inst Technol, State Key Lab Robot & Syst, 2 Yikuang, Harbin 150001, Peoples R China; [Shi, Huaxing] Harbin Inst Technol, Sch Comp Sci & Technol, 2 Yikuang, Harbin 150001, Peoples R China; [Hu, Ying] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China	Harbin Institute of Technology; Harbin Medical University; Harbin Institute of Technology; Harbin Institute of Technology; Harbin Institute of Technology; University Town of Shenzhen	Hu, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China.; Hu, Y (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China.	huying@hit.edu.cn	Hu, Ying/ABG-2935-2021; Xie, Hui/J-6999-2012; xuting, xue/ABD-5584-2020	Hu, Ying/0000-0003-2469-5604; Xie, Hui/0000-0003-4299-2776; xuting, xue/0000-0002-0654-3263; Wang, Xingwen/0000-0001-7416-142X	National Nature Science Foundation of China [31301131, 31741084, 31871389]; Basic Science Fundation of Science and technology innovation Commission in Shenzhen [JCYJ20170811154452255]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Science Fundation of Science and technology innovation Commission in Shenzhen	This work was funded by the National Nature Science Foundation of China (No. 31301131, 31741084 and 31871389) and Basic Science Fundation of Science and technology innovation Commission in Shenzhen (No. JCYJ20170811154452255).	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Battistelli C, 2017, ONCOGENE, V36, P942, DOI 10.1038/onc.2016.260; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Buske FA, 2012, GENOME RES, V22, P1372, DOI 10.1101/gr.130237.111; Cai BZ, 2020, CELL DEATH DIFFER, V27, P2158, DOI 10.1038/s41418-020-0492-5; Campbell S, 2013, CELL CYCLE, V12, P2675, DOI 10.4161/cc.25795; Chen S, 2016, CANCER LETT, V383, P73, DOI 10.1016/j.canlet.2016.09.027; Cheng YH, 2013, MOL CELL BIOL, V33, P3365, DOI 10.1128/MCB.00438-13; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Flavahan WA, 2017, SCIENCE, V357, DOI 10.1126/science.aal2380; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Holoch D, 2017, TRENDS BIOCHEM SCI, V42, P531, DOI 10.1016/j.tibs.2017.04.003; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kikuchi J, 2015, J CLIN INVEST, V125, P4375, DOI 10.1172/JCI80325; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; Li ZW, 2017, CELL DEATH DIFFER, V24, P59, DOI 10.1038/cdd.2016.95; Mahara S, 2016, P NATL ACAD SCI USA, V113, pE3735, DOI 10.1073/pnas.1602079113; Mahmoud F, 2016, CANCER BIOL THER, V17, P579, DOI 10.1080/15384047.2016.1167291; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pang B, 2016, ONCOTARGET, V7, P45134, DOI 10.18632/oncotarget.9761; Perez-Perri JI, 2011, INT J MOL SCI, V12, P4705, DOI 10.3390/ijms12074705; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Pruszko M, 2017, EMBO REP, V18, P1331, DOI 10.15252/embr.201643370; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sperandio S, 2009, MOL CARCINOGEN, V48, P38, DOI 10.1002/mc.20454; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Weikert S, 2005, INT J MOL MED, V16, P349; Wen Y, 2019, ONCOGENE, V38, P1845, DOI 10.1038/s41388-018-0552-1; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Zhang YY, 2016, NAT STRUCT MOL BIOL, V23, P522, DOI 10.1038/nsmb.3211; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	49	24	25	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1860	1874		10.1038/s41388-019-1123-9	http://dx.doi.org/10.1038/s41388-019-1123-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31784651				2022-12-26	WOS:000516579800003
J	Singh, S; Ng, J; Nayak, D; Sivaraman, J				Singh, Sunil; Ng, Joel; Nayak, Digant; Sivaraman, J.			Structural insights into a HECT-type E3 ligase AREL1 and its ubiquitination activities in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; E3 ubiquitin ligase; ubiquitylation (ubiquitination); crystal structure; structure-function; structural biology; protein degradation; post-translational modification (PTM); cancer; apoptosis-resistant E3 ligase 1 (AREL1); autopolyubiquitination; HECT domain; second mitochondria-derived activator of caspase (SMAC)	DOMAIN; ACTIVATION; REVEALS; APOPTOSIS; PROTEINS; AUTOUBIQUITINATION; POLYUBIQUITIN; OPTIMIZATION; RECOGNITION; ANTAGONISTS	The HECT E3 ligase family comprises three subfamilies: NEDD4 E3 ubiquitin protein ligase (NEDD4), HECT and RLD domain?containing E3 ubiquitin protein ligase (HERC), and ?other.? Most previous studies have focused on the NEDD4 subfamily. Apoptosis-resistant E3 ligase 1 (AREL1) belongs to ?other? subfamily HECT that inhibits apoptosis by ubiquitinating and degrading proapoptotic proteins. Here, we report the crystal structure of the extended HECT domain of AREL1 (amino acids (aa) 436?823) at 2.4 ? resolution and its ubiquitination of the proapoptotic protein second mitochondria-derived activator of caspase (SMAC). We found that the extended HECT domain adopts an inverted, T-shaped, bilobed conformation and harbors an additional loop (aa 567?573) absent in all other HECT members. We also show that the N-terminal extended region (aa 436?482) preceding the HECT domain is indispensable for its stability and activity and that without this region, the HECT domain becomes inactive. AREL1 ubiquitinated SMAC, primarily on Lys(62) and Lys(191). We solved the crystal structure of the tetrameric form of SMAC to 2.8 ? resolution, revealing the Lys(62) and Lys(191) locations. The AREL1 HECT domain assembled Lys(33)-, Lys(48)-, and Lys(63)-linked polyubiquitin chains. Moreover, E701A substitution in the AREL1 HECT domain substantially increased its autopolyubiquitination and SMAC ubiquitination activity, whereas deletion of the last three amino acids at the C terminus completely abrogated AREL1 autoubiquitination and reduced SMAC ubiquitination. Finally, an AREL1-specific ubiquitin variant inhibited SMAC ubiquitination in vitro. Our findings may assist in the development of AREL1 inhibitors that block its anti-apoptotic activity in cancer.	[Singh, Sunil; Ng, Joel; Nayak, Digant; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore	National University of Singapore	Sivaraman, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsjayar@nus.edu.sg	Nayak, Digant/AAJ-1823-2020; Singh, Sunil/AAC-6669-2022	Nayak, Digant/0000-0003-3680-0846; Singh, Sunil/0000-0002-2863-5492; Ng, Joel/0000-0003-1797-3071; J, Sivaraman/0000-0001-9781-5326	NIGMS, National Institutes of Health (NIH) [P41 GM103403]; NIH-ORIP HEI Grant [S10 RR029205]; United States Department of Energy User Facility [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI Grant; United States Department of Energy User Facility(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the beamline MX2 Australian Synchrotron, part of ANSTO, and NECAT beamline 24-ID-E at the Advanced Photon Source, Argonne National Laboratory. NECAT beamlines are funded by NIGMS, National Institutes of Health (NIH), Grant P41 GM103403. The Pilatus 6M detector on the 24-ID-E beamline is funded by NIH-ORIP HEI Grant S10 RR029205. The Advanced Photon Source is a United States Department of Energy User Facility operated by Argonne National Laboratory under Contract DE-AC02-06CH11357. We acknowledge the Protein and Proteomics center (NUS) for MS proteomics data acquisition and deposition.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chari A, 2015, NAT METHODS, V12, P859, DOI [10.1038/NMETH.3493, 10.1038/nmeth.3493]; Chew KCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019720; Corn JE, 2014, NAT STRUCT MOL BIOL, V21, P297, DOI 10.1038/nsmb.2808; Courivaud T, 2015, J BIOL CHEM, V290, P21007, DOI 10.1074/jbc.M115.642314; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Goka ET, 2015, ONCOGENE, V34, P5395, DOI 10.1038/onc.2014.468; Gong W, 2015, ACTA CRYSTALLOGR F, V71, P1251, DOI 10.1107/S2053230X1501554X; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kim JB, 2013, J BIOL CHEM, V288, P12014, DOI 10.1074/jbc.M112.436113; Kozak S, 2016, J BIOMOL NMR, V64, P281, DOI 10.1007/s10858-016-0027-z; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristariyanto YA, 2015, BIOCHEM J, V467, P345, DOI 10.1042/BJ20141502; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Kwon YT, 2017, TRENDS BIOCHEM SCI, V42, P873, DOI 10.1016/j.tibs.2017.09.002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Mannhold R, 2010, DRUG DISCOV TODAY, V15, P210, DOI 10.1016/j.drudis.2010.01.003; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Mastrangelo E, 2015, BIOPHYS J, V108, P714, DOI 10.1016/j.bpj.2014.11.3471; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Mukherjee M, 2014, J BIOL CHEM, V289, P25611, DOI 10.1074/jbc.M114.592840; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; Nayak D, 2018, J MOL BIOL, V430, P1173, DOI 10.1016/j.jmb.2018.02.016; Nayak D, 2015, ONCOTARGET, V6, P34342, DOI 10.18632/oncotarget.5326; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Prinz F, 2016, J BIOL CHEM, V291, P11252, DOI 10.1074/jbc.M115.702142; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Shaw N., 2007, PROTOC EXCHANGE, DOI [10.1038/nprot.2007.287, DOI 10.1038/NPROT.2007.287]; Sluimer J, 2018, CELL MOL LIFE SCI, V75, P3121, DOI 10.1007/s00018-018-2848-2; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Su V, 2012, ARCH BIOCHEM BIOPHYS, V524, P16, DOI 10.1016/j.abb.2011.12.027; Tan KM, 2014, METHODS MOL BIOL, V1140, P189, DOI 10.1007/978-1-4939-0354-2_15; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang D, 2017, CANCER METAST REV, V36, P683, DOI 10.1007/s10555-017-9703-z; Wei YB, 2008, ACTA BIOCH BIOPH SIN, V40, P278, DOI 10.1111/j.1745-7270.2008.00407.x; Yan S, 2014, ONCOGENE, V33, P5424, DOI 10.1038/onc.2013.494; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005	53	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19934	19949		10.1074/jbc.RA119.010327	http://dx.doi.org/10.1074/jbc.RA119.010327			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31732561	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000505005800010
J	Abraham, M; Kordatou, Z; Barriuso, J; Lamarca, A; Weaver, JMJ; Cipriano, C; Papaxoinis, G; Backen, A; Mansoor, W				Abraham, Marc; Kordatou, Zoe; Barriuso, Jorge; Lamarca, Angela; Weaver, Jamie M. J.; Cipriano, Claudia; Papaxoinis, George; Backen, Alison; Mansoor, Wasat			Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer	PLOS ONE			English	Article							WEIGHT-LOSS; CHEMOTHERAPY; CACHEXIA; CLASSIFICATION; CONSENSUS; THERAPY	Cancer cachexia is common in patients with oesophagogastric cancer (OG) and is linked to overall survival (OS). One of the key components of cachexia is anorexia; it is not known whether anorexia impacts on OS and there is no method of routine screening in current practice. Diagnosis relies on patients describing the symptoms, clinicians diagnosing anorexia and acting upon it. Patients with oesophageal/gastroesophageal junction or gastric cancer were assessed using the Functional Assessment of Anorexia Cachexia Therapy Anorexia/Cachexia Subscale (FAACT A/CS). FAACT A/CS includes 12 questions validated previously to diagnose anorexia in patients with cancer. Of the 182 patients included, 69% scored <= 37/48 and were considered to be anorexic; FAACT A/CS was a better predictor of OS in metastatic patients than body mass index or weight loss in the six months prior to cancer diagnosis. The median OS of patients with FAACT A/CS scores of >37 was longer than patients with scores of <= 37 (19.3 months vs 6.7 months, Hazard Ratio [HR] 2.9, 95% Confidence Interval [CI] 1.4-6.0, p< 0.0001). Patients with performance status (PS) 0-2 and FAACT A/CS >37 had substantially longer OS than those with PS 0-2 and FAACT A/CS.37 (18.7 months vs 7.9 months, HR 2.5 (95% CI 1.2-5.1, P<0.0001). The FAACT A/CS questionnaire allows clinicians to identify patients with anorexia who may benefit from early nutrition interventions. Importantly, this is the first study to show the association between anorexia and survival in patients with metastatic OG cancers. This will form the basis of future interventional studies to improve patient outcomes.	[Abraham, Marc] Christie NHS Fdn Trust, Dept Nutr & Dietet, Manchester, Lancs, England; [Kordatou, Zoe; Barriuso, Jorge; Lamarca, Angela; Weaver, Jamie M. J.; Cipriano, Claudia; Papaxoinis, George; Backen, Alison; Mansoor, Wasat] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England; [Barriuso, Jorge; Lamarca, Angela; Backen, Alison; Mansoor, Wasat] Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Canc Sci, Manchester, Lancs, England	Christie NHS Foundation Trust; Christie NHS Foundation Trust; University of Manchester	Mansoor, W (corresponding author), Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England.; Mansoor, W (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Div Canc Sci, Manchester, Lancs, England.	was.mansoor@christie.nhs.uk		Lamarca, Angela/0000-0001-9696-6122	Christie Charity	Christie Charity	We would like to thank the patients and their supporters for participating in this study. Assistance with data analysis and manuscript preparation was provided by The Systemic Therapy Research Group at The Christie NHS Foundation Trust. Dr Angela Lamarca was part-funded by The Christie Charity.	Aapro M, 2014, ANN ONCOL, V25, P1492, DOI 10.1093/annonc/mdu085; Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; Arends J, 2017, CLIN NUTR, V36, P11, DOI 10.1016/j.clnu.2016.07.015; Argiles JM, 2010, J AM MED DIR ASSOC, V11, P229, DOI 10.1016/j.jamda.2010.02.004; Blauwhoff-Buskermolen S, 2016, SUPPORT CARE CANCER, V24, P661, DOI 10.1007/s00520-015-2826-2; Blum D, 2014, ANN ONCOL, V25, P1635, DOI 10.1093/annonc/mdu086; Blum D, 2011, CRIT REV ONCOL HEMAT, V80, P114, DOI 10.1016/j.critrevonc.2010.10.004; Boshier PR, 2018, DIS ESOPHAGUS, V31, DOI 10.1093/dote/dox134; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fuchs CS, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.0013; Kamarajah SK, 2019, GASTRIC CANCER, V22, P10, DOI 10.1007/s10120-018-0882-2; Lis CG, 2009, SUPPORT CARE CANCER, V17, P129, DOI 10.1007/s00520-008-0447-8; Lu ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088553; Martin L, 2015, J CLIN ONCOL, V33, P90, DOI 10.1200/JCO.2014.56.1894; Muscaritoli M, 2017, ONCOTARGET, V8, P79884, DOI 10.18632/oncotarget.20168; Ock CY, 2016, GASTRIC CANCER, V19, P597, DOI 10.1007/s10120-015-0481-4; OROURKE IC, 1988, CANCER, V61, P2022, DOI 10.1002/1097-0142(19880515)61:10<2022::AID-CNCR2820611016>3.0.CO;2-0; Ribaudo JM, 2000, QUAL LIFE RES, V9, P1137, DOI 10.1023/A:1016670403148; Shen S, 2017, DIS ESOPHAGUS, V30, DOI 10.1093/dote/dox073; Solheim TS, 2018, BMJ SUPPORT PALLIAT, V8, P258, DOI 10.1136/bmjspcare-2017-001440; Temel JS, 2016, LANCET ONCOL, V17, P519, DOI 10.1016/S1470-2045(15)00558-6	23	5	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0224540	10.1371/journal.pone.0224540	http://dx.doi.org/10.1371/journal.pone.0224540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774822	gold, Green Published			2022-12-26	WOS:000533896400012
J	Kappen, C; Kruger, C; Jones, S; Herion, NJ; Salbaum, JM				Kappen, Claudia; Kruger, Claudia; Jones, Sydney; Herion, Nils J.; Salbaum, J. Michael			Maternal diet modulates placental nutrient transporter gene expression in a mouse model of diabetic pregnancy	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER; ACID TRANSPORTER; FETAL-GROWTH; OBESITY; ALTERS; INCREASES; GLUT8; RAT; GLUCOSE-TRANSPORTER-1; TERM	Diabetes in the mother during pregnancy is a risk factor for birth defects and perinatal complications and can affect long-term health of the offspring through developmental programming of susceptibility to metabolic disease. We previously showed that Streptozotocin-induced maternal diabetes in mice is associated with altered cell differentiation and with smaller size of the placenta. Placental size and fetal size were affected by maternal diet in this model, and maternal diet also modulated the risk for neural tube defects. In the present study, we sought to determine the extent to which these effects might be mediated through altered expression of nutrient transporters, specifically glucose and fatty acid transporters in the placenta. Our results demonstrate that expression of several transporters is modulated by both maternal diet and maternal diabetes. Diet was revealed as the more prominent determinant of nutrient transporter expression levels, even in pregnancies with uncontrolled diabetes, consistent with the role of diet in placental and fetal growth. Notably, the largest changes in nutrient transporter expression levels were detected around midgestation time points when the placenta is being formed. These findings place the critical time period for susceptibility to diet exposures earlier than previously appreciated, implying that mechanisms underlying developmental programming can act on placenta formation.	[Kappen, Claudia; Kruger, Claudia; Herion, Nils J.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Dev Biol, Baton Rouge, LA 70803 USA; [Jones, Sydney; Herion, Nils J.; Salbaum, J. Michael] Louisiana State Univ Syst, Regulat Gene Express Lab, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Herion, Nils J.] Heidelberg Univ, Med Sch, Heidelberg, Germany	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Ruprecht Karls University Heidelberg	Kappen, C (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Dev Biol, Baton Rouge, LA 70803 USA.	Claudia.Kappen@pbrc.edu	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680; Kappen, Claudia/0000-0002-1035-465X	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD37804, R01-HD086604, R01-HD055528, R01-HD085017]; Nutrition and Obesity Research Center from the National Institutes of Health [P30DK072476]; Center of Biomedical Research Excellence from the National Institutes of Health [P30-GM118430]; Peggy M. Pennington Cole Endowed Chair in Maternal Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD085017, R01HD086604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118430] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Nutrition and Obesity Research Center from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Biomedical Research Excellence from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peggy M. Pennington Cole Endowed Chair in Maternal Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development R01-HD37804 and R01-HD086604 to C. Kappen, and R01-HD055528 and R01-HD085017 to J. Michael Salbaum. The Cell Biology and Bioimaging Core and the Genomics Core at Pennington Biomedical Research Center are funded in part through the Nutrition and Obesity Research Center (P30DK072476) and Center of Biomedical Research Excellence (P30-GM118430) grants from the National Institutes of Health. Claudia Kappen was also supported by the Peggy M. Pennington Cole Endowed Chair in Maternal Biology.	Acosta O, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.009; Adastra KL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097675; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; BOILEAU P, 1995, J CLIN INVEST, V96, P309, DOI 10.1172/JCI118036; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Bozkurt L, 2016, HORM RES PAEDIAT, V86, P300, DOI 10.1159/000448076; Burton GJ, 2016, PHYSIOL REV, V96, P1509, DOI 10.1152/physrev.00029.2015; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Chassen SS, 2018, CLIN SCI, V132, P595, DOI 10.1042/CS20171340; Christians JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056260; Conover CA, 2011, ENDOCRINOLOGY, V152, P2837, DOI 10.1210/en.2011-0036; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Currie MJ, 1997, PLACENTA, V18, P393, DOI 10.1016/S0143-4004(97)80039-2; Das UG, 1998, AM J PHYSIOL-REG I, V274, pR339, DOI 10.1152/ajpregu.1998.274.2.R339; Dauber A, 2016, EMBO MOL MED, V8, P363, DOI 10.15252/emmm.201506106; Dawson PA, 2001, MOL GENET METAB, V74, P186, DOI 10.1006/mgme.2001.3212; DeBosch BJ, 2012, ENDOCRINOLOGY, V153, P4181, DOI 10.1210/en.2012-1541; DEVASKAR SU, 1994, AM J OBSTET GYNECOL, V171, P1316, DOI 10.1016/0002-9378(94)90154-6; Diaz P, 2015, AM J PHYSIOL-REG I, V309, pR1569, DOI 10.1152/ajpregu.00385.2015; Dimasuay KG, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00012; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; Ehrhardt RA, 1997, AM J PHYSIOL-REG I, V273, pR1132, DOI 10.1152/ajpregu.1997.273.3.R1132; Ericsson A, 2005, HUM REPROD, V20, P521, DOI 10.1093/humrep/deh596; Ericsson A, 2007, J PHYSIOL-LONDON, V581, P1323, DOI 10.1113/jphysiol.2007.131185; Gaccioli F, 2013, J DEV ORIG HLTH DIS, V4, P101, DOI 10.1017/S2040174412000529; Gaither K, 1999, J CLIN ENDOCR METAB, V84, P695, DOI 10.1210/jc.84.2.695; Ganguly A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1241, DOI 10.1152/ajpendo.00344.2006; Ganguly A, 2016, ENDOCRINOLOGY, V157, P4041, DOI 10.1210/en.2016-1259; Gawlik V, 2008, MOL MEMBR BIOL, V25, P224, DOI 10.1080/09687680701855405; Hahn T, 1996, Early Pregnancy, V2, P168; Ishida M, 2007, J REPROD DEVELOP, V53, P69, DOI 10.1262/jrd.18002; Jansson T, 2002, DIABETES, V51, P2214, DOI 10.2337/diabetes.51.7.2214; Jansson T, 1999, AM J OBSTET GYNECOL, V180, P163, DOI 10.1016/S0002-9378(99)70169-9; Jansson T, 2016, P NATL ACAD SCI USA, V113, P11066, DOI 10.1073/pnas.1613437113; Janzen C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193583; Kappen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038445; Kappen C, 2011, REPROD TOXICOL, V31, P41, DOI 10.1016/j.reprotox.2010.09.002; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010; Kevorkova O, 2007, BIOL REPROD, V76, P487, DOI 10.1095/biolreprod.106.055285; Konno T, 2011, PHYSIOL GENOMICS, V43, P930, DOI 10.1152/physiolgenomics.00069.2011; Korgun ET, 2011, FOLIA HISTOCHEM CYTO, V49, P325, DOI 10.5603/FHC.2011.0045; Korgun ET, 2001, BIOL REPROD, V65, P1364, DOI 10.1095/biolreprod65.5.1364; Kruger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008978; Kuhnel E, 2017, J CELL BIOCHEM, V118, P1316, DOI 10.1002/jcb.25789; KURUVILLA AG, 1994, J CLIN INVEST, V94, P689, DOI 10.1172/JCI117386; Lesage J, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740037; Limesand SW, 2004, PLACENTA, V25, P70, DOI 10.1016/j.placenta.2003.08.012; Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087; Lucy MC, 2012, J DAIRY SCI, V95, P5095, DOI 10.3168/jds.2012-5456; Ma Y, 2011, PLACENTA, V32, P255, DOI 10.1016/j.placenta.2011.01.007; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; Membrez M, 2006, MOL CELL BIOL, V26, P4268, DOI 10.1128/MCB.00081-06; Novakovic B, 2013, J NUTR BIOCHEM, V24, P282, DOI 10.1016/j.jnutbio.2012.06.006; Oey NA, 2003, J INHERIT METAB DIS, V26, P385, DOI 10.1023/A:1025163204165; Ogura K, 1999, J ENDOCRINOL, V160, P443, DOI 10.1677/joe.0.1600443; Pavlinkova G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-274; Plagemann A, 1997, INT J OBESITY, V21, P451, DOI 10.1038/sj.ijo.0800429; Preitner F, 2009, P NATL ACAD SCI USA, V106, P15501, DOI 10.1073/pnas.0904411106; Qia LP, 2015, DIABETES, V64, P3111, DOI 10.2337/db14-1627; Rijpert M, 2009, DIABETES CARE, V32, P2099, DOI 10.2337/dc09-0652; SAKATA M, 1995, EUR J ENDOCRINOL, V132, P206, DOI 10.1530/eje.0.1320206; Salbaum JM, 2011, DIABETOLOGIA, V54, P1909, DOI 10.1007/s00125-011-2132-6; Schmidt S, 2009, J ENDOCRINOL, V200, P23, DOI 10.1677/JOE-08-0262; Sciullo E, 1997, Early Pregnancy, V3, P172; Segura MT, 2017, PLACENTA, V57, P144, DOI 10.1016/j.placenta.2017.07.001; Sferruzzi-Perri AN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00033; Stanirowski PJ, 2017, ENDOCRINE, V55, P799, DOI 10.1007/s12020-016-1202-4; Vaughan OR, 2017, PROG MOL BIOL TRANSL, V145, P217, DOI 10.1016/bs.pmbts.2016.12.008; Vaughan OR, 2016, J PHYSIOL-LONDON, V594, P6407, DOI 10.1113/JP272301; Vlachova Z, 2015, DIABETOLOGIA, V58, P1454, DOI 10.1007/s00125-015-3589-5; Wali JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037899; Xing AY, 1998, J CLIN ENDOCR METAB, V83, P4097, DOI 10.1210/jc.83.11.4097; Yamaguchi M, 1996, J ENDOCRINOL INVEST, V19, P567, DOI 10.1007/BF03349018; Ye K, 2017, J CLIN RES PEDIATR E, V9, P300, DOI 10.4274/jcrpe.4510; Zhu MJ, 2010, AM J PHYSIOL-REG I, V299, pR1224, DOI 10.1152/ajpregu.00309.2010; Zohn IE, 2010, BIRTH DEFECTS RES A, V88, P593, DOI 10.1002/bdra.20705	78	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0224754	10.1371/journal.pone.0224754	http://dx.doi.org/10.1371/journal.pone.0224754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774824	Green Published, gold			2022-12-26	WOS:000533896400016
J	Wang, FJ; Chen, XB; Yuan, DP; Yi, YF; Luo, Y				Wang, Fengjie; Chen, Xianbing; Yuan, Depei; Yi, Yongfen; Luo, Yi			Golgi reassembly and stacking protein 65 downregulation is required for the anti-cancer effect of dihydromyricetin on human ovarian cancer cells	PLOS ONE			English	Article							POLO-LIKE KINASE; SIGNALING PATHWAY; APOPTOSIS; GRASP65; FRAGMENTATION; INHIBITION; TARGET; GROWTH; GOLPH3; ISCHEMIA/REPERFUSION	Golgi reassembly and stacking protein 65 (GRASP65), which has been involved in cancer progression, is associated with tumor growth and cell apoptosis. Dihydromyricetin (DHM) has demonstrated antitumor activity in different types of human cancers. However, the pharmacological effects of DHM on ovarian cancer (OC) and the molecular mechanisms that underlie these effects are largely unknown. The present study showed that DHM reduced cell migration and invasion in a concentration- and time-dependent manner and induced cell apoptosis primarily through upregulation of Cleaved-caspase-3 and the Bax/Bcl-2 ratio in OCs. To further clarify the cancer therapeutic target, we assessed the effect of DHM on the expression of GRASP65, which is overexpressed in human ovarian cancer tissues. DHM activated caspase-3 and decreased GRASP65 expression to promote cell apoptosis, implying that downregulation of GRASP65 was related to DHM-induced cell apoptosis. Additionally, the knockdown of GRASP65 by siRNA resulted in increased apoptosis after DHM treatment, while western blot and flow cytometry analysis demonstrated that overexpression of GRASP65 attenuated DHM-mediated apoptosis. In addition, the JNK/ERK pathway may be involved in DHM-mediated caspase-3 activation and GRASP65 downregulation. Taken together, these findings provide novel evidence of the anti-cancer properties of DHM in OCs, indicating that DHM is a potential therapeutic agent for ovarian cancer through the inhibition of GRASP65 expression and the regulation of JNK/ERK pathway.	[Wang, Fengjie; Yi, Yongfen; Luo, Yi] Chongqing Med Univ, Coll Basic Med, Dept Pathol, Chongqing, Peoples R China; [Wang, Fengjie; Chen, Xianbing; Yuan, Depei] Hubei Minzu Univ, Minda Hosp, Enshi, Hubei, Peoples R China; [Luo, Yi] Chongqing Med Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Chongqing, Peoples R China	Chongqing Medical University; Hubei Minzu University; Chongqing Medical University	Luo, Y (corresponding author), Chongqing Med Univ, Coll Basic Med, Dept Pathol, Chongqing, Peoples R China.; Luo, Y (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Chongqing, Peoples R China.	smileyi@163.com			Health and Family Planning Commission of Hubei Province [WJ2019M104]	Health and Family Planning Commission of Hubei Province	This work was supported by the Health and Family Planning Commission of Hubei Province (No. WJ2019M104).	Ahat E, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00131; Ahat E, 2019, MOL BIOL CELL, V30, P766, DOI 10.1091/mbc.E18-07-0462; AlAjmi MF, 2018, INT J BIOL MACROMOL, V116, P173, DOI 10.1016/j.ijbiomac.2018.05.023; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Cao Q, 2016, ONCOTARGET, V7, P77468, DOI 10.18632/oncotarget.12684; Cervigni RI, 2015, J CELL SCI, V128, P2249, DOI 10.1242/jcs.164871; Chang SH, 2012, MOL THER, V20, P2052, DOI 10.1038/mt.2012.125; Cheng JPX, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.59; Chiu KY, 2016, CANCER LETT, V373, P174, DOI 10.1016/j.canlet.2015.11.046; Collett NP, 2010, SEMIN ONCOL, V37, P258, DOI 10.1053/j.seminoncol.2010.06.014; El-Najjar N, 2010, APOPTOSIS, V15, P183, DOI 10.1007/s10495-009-0421-z; Feng YL, 2015, J CANCER, V6, P893, DOI 10.7150/jca.11865; Fleischer A, 2006, MOL IMMUNOL, V43, P1065, DOI 10.1016/j.molimm.2005.07.013; Goldsworthy TL, 1996, MUTAT RES-REV GENET, V365, P71, DOI 10.1016/S0165-1110(96)90013-5; Greenwell M, 2015, INT J PHARM SCI RES, V6, P4103, DOI 10.13040/IJPSR.0975-8232.6(10).4103-12; He SY, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0607-0; Hicks SW, 2005, BBA-MOL CELL RES, V1744, P406, DOI 10.1016/j.bbamcr.2005.03.002; Jaattela M, 2004, ONCOGENE, V23, P2746, DOI 10.1038/sj.onc.1207513; Ji FJ, 2015, GENET MOL RES, V14, P15564, DOI 10.4238/2015.December.1.7; Jiang LG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124994; Jiang Z, 2011, FREE RADICAL BIO MED, V50, P907, DOI 10.1016/j.freeradbiomed.2011.01.011; Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Li T, 2016, MOL NEUROBIOL, V53, P1377, DOI 10.1007/s12035-014-9083-0; Li T, 2014, MOL NEUROBIOL, V49, P1449, DOI 10.1007/s12035-013-8624-2; Bin L, 2016, MOL MED REP, V14, P4775, DOI 10.3892/mmr.2016.5816; Lin B, 2014, SCI REP-UK, V4, DOI 10.1038/srep07041; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; Nakagomi S, 2008, NEUROBIOL DIS, V29, P221, DOI 10.1016/j.nbd.2007.08.015; Petrosyan A, 2014, MOL CANCER RES, V12, P1704, DOI 10.1158/1541-7786.MCR-14-0291-T; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Rajamahanty S, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-5; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1; Sun JY, 2007, PHYTOMEDICINE, V14, P353, DOI 10.1016/j.phymed.2006.08.003; Sun J, 2017, CANCER MED-US, V6, P834, DOI 10.1002/cam4.1040; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; Sutterlin C, 2001, P NATL ACAD SCI USA, V98, P9128, DOI 10.1073/pnas.161283998; Tang DM, 2010, TRAFFIC, V11, P827, DOI 10.1111/j.1600-0854.2010.01055.x; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Veenendaal T, 2014, BIOL OPEN, V3, P431, DOI 10.1242/bio.20147757; Vinke FP, 2011, BIOCHEM J, V433, P423, DOI 10.1042/BJ20101540; VO A, 2015, AM J TRANSPLANT S3, V15; Walker A, 2004, BIOCHEM BIOPH RES CO, V316, P6, DOI 10.1016/j.bbrc.2004.02.015; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Wen XR, 2016, CELL MOL NEUROBIOL, V36, P1087, DOI 10.1007/s10571-015-0302-7; Woo HJ, 2012, ENZYME MICROB TECH, V51, P311, DOI 10.1016/j.enzmictec.2012.07.014; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132; Xu YQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46060; Yao Z, 2009, BIOFACTORS, V35, P407, DOI 10.1002/biof.52; Yoshimura S, 2005, J BIOL CHEM, V280, P23048, DOI 10.1074/jbc.M502442200; Zaid H, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/7952417; Zhang S, 2013, NEUROCHEM INT, V63, P522, DOI 10.1016/j.neuint.2013.08.008; Zhu BL, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/5701719	61	12	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225450	10.1371/journal.pone.0225450	http://dx.doi.org/10.1371/journal.pone.0225450			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770410	gold, Green Published			2022-12-26	WOS:000533892300019
J	Prober, SM; Raisbeck-Brown, N; Porter, NB; Williams, KJ; Leviston, Z; Dickson, F				Prober, Suzanne M.; Raisbeck-Brown, Nat; Porter, Natasha B.; Williams, Kristen J.; Leviston, Zoe; Dickson, Fiona			Recent climate-driven ecological change across a continent as perceived through local ecological knowledge	PLOS ONE			English	Article							ENVIRONMENTAL-CHANGE; RESPONSES; CONSERVATION; DROUGHT; TRAITS; FUTURE; ATTRIBUTION; FORESTS; DECLINE; PEOPLE	Documenting effects of climate change is an important step towards designing mitigation and adaptation responses. Impacts of climate change on terrestrial biodiversity and ecosystems have been well-documented in the Northern Hemisphere, but long-term data to detect change in the Southern Hemisphere are limited, and some types of change are generally difficult to measure. Here we present a novel approach using local ecological knowledge to facilitate a continent-scale view of climate change impacts on terrestrial biodiversity and ecosystems that people have perceived in Australia. We sought local knowledge using a national web-based survey, targeting respondents with close links to the environment (e.g. farmers, ecologists), and using a custom-built mapping tool to ask respondents to describe and attribute recent changes they had observed within an area they knew well. Results drawn from 326 respondents showed that people are already perceiving simple and complex climate change impacts on hundreds of species and ecosystems across Australia, significantly extending the detail previously reported for the continent. While most perceived trends and attributions remain unsubstantiated, > 35 reported anecdotes concurred with examples in the literature, and > 20 were reported more than once. More generally, anecdotes were compatible with expectations from global climate change impact frameworks, including examples across the spectrum from organisms (e.g. increased mortality in > 75 species), populations (e.g. changes in recruitment or abundance in > 100 species, phenological change in > 50 species), and species (e.g. > 80 species newly arriving or disappearing), to communities and landscapes (e.g. > 50 examples of altered ecological interactions). The overarching pattern indicated by the anecdotes suggests that people are more often noticing climate change losers (typically native species) than winners in their local areas, but with observations of potential 'adaptation in action' via compositional and phenological change and through arrivals and range shifts (particularly for native birds and exotic plants). A high proportion of climate change-related anecdotes also involved cumulative or interactive effects of land use. We conclude that targeted elicitation of local ecological knowledge about climate change impacts can provide a valuable complement to data-derived knowledge, substantially extending the volume of explicit examples and offering a foundation for further investigation.	[Prober, Suzanne M.; Raisbeck-Brown, Nat; Porter, Natasha B.] CSIRO Land & Water, Wembley, WA, Australia; [Williams, Kristen J.] CSIRO Land & Water, Canberra, ACT, Australia; [Leviston, Zoe] Edith Cowan Univ, Sch Arts & Humanities, Joondalup, WA, Australia; [Dickson, Fiona] Dept Environm & Energy, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Edith Cowan University	Prober, SM (corresponding author), CSIRO Land & Water, Wembley, WA, Australia.	Suzanne.Prober@csiro.au	Leviston, Zoe/G-5460-2010; Porter, Natasha B/A-2796-2011; Raisbeck-Brown, Nat/K-3546-2017; Williams, Kristen Jennifer/B-9941-2008; Prober, Suzanne/G-6465-2010	Leviston, Zoe/0000-0002-4969-7916; Porter, Natasha B/0000-0002-5125-3126; Raisbeck-Brown, Nat/0000-0001-8596-6258; Williams, Kristen Jennifer/0000-0002-7324-5880; Prober, Suzanne/0000-0002-6518-239X	Australian Government Department of the Environment and Energy; Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australia	Australian Government Department of the Environment and Energy(Australian Government); Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This study was funded by the Australian Government Department of the Environment and Energy, and the Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australia as part of its partnership on the Biodiversity Knowledge Projects series (https://research.csiro.au/biodiversity-knowledge/).These organisations collaborated on all aspects of this research.	Akerlof K, 2013, GLOBAL ENVIRON CHANG, V23, P81, DOI 10.1016/j.gloenvcha.2012.07.006; Albrecht Glenn, 2005, PAN PHILOS ACTIVISM, P41; Aswani S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195440; Australian Biological Resources Study (ABRS), 2019, AUSTR FAUN DIR; Australian Bureau of Statitstics (ABS), 2016, AUSTR POP GRID 2016; Beaumont LJ, 2006, GLOBAL CHANGE BIOL, V12, P1339, DOI 10.1111/j.1365-2486.2006.01171.x; Beaumont LJ, 2015, CLIM RES, V63, P203, DOI 10.3354/cr01294; Belisle AC, 2018, ECOL SOC, V23, DOI 10.5751/ES-09949-230214; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bice C, 2011, SARDI PUBLICATION; Bowman DMJS, 2010, AUSTRAL ECOL, V35, P898, DOI 10.1111/j.1442-9993.2009.02096.x; Bowman DMJS, 2010, LANDSCAPE ECOL, V25, P1247, DOI 10.1007/s10980-010-9496-8; Bradstock R, 2014, GLOBAL CHANGE BIOL, V20, P1412, DOI 10.1111/gcb.12449; Bureau of Meteorology and CSIRO, 2018, STAT CLIM; Challis A, 2016, PLANT SOIL, V404, P157, DOI 10.1007/s11104-016-2793-5; Chambers LE, 2014, INT J BIOMETEOROL, V58, P1147, DOI 10.1007/s00484-013-0707-2; Chambers LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075514; Cleverly J, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab33cb; Close D. C., 2004, Tasforests, V15, P1; Council of Heads of Australian Herbaria (CHAH), 2019, AUSTR PLANT CENSUS; Cresswell ID, AUSTR STATE ENV 2016; Cunsolo A, 2018, NAT CLIM CHANGE, V8, P275, DOI 10.1038/s41558-018-0092-2; Davis A, 2011, LANDSCAPE URBAN PLAN, V100, P295, DOI 10.1016/j.landurbplan.2010.12.017; Duke NC, 2017, MARINE FRESHWATER RE, V68; Ferrier S., 2017, GEO HDB BIODIVERSITY, P239, DOI DOI 10.1007/978-3-319-27288-7_10; Gardner JL, 2014, J AVIAN BIOL, V45, P529, DOI 10.1111/jav.00431; Guerin GR, 2012, BIOL LETTERS, V8, P882, DOI 10.1098/rsbl.2012.0458; Harris RMB, 2018, NAT CLIM CHANGE, V8, P579, DOI 10.1038/s41558-018-0187-9; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; Holleley CE, 2015, NATURE, V523, P79, DOI 10.1038/nature14574; Jaeschke A, 2014, NATURWISSENSCHAFTEN, V101, P1, DOI 10.1007/s00114-013-1132-4; Johnston A, 2018, METHODS ECOL EVOL, V9, P88, DOI 10.1111/2041-210X.12838; Kearney MR, 2010, BIOL LETTERS, V6, P674, DOI 10.1098/rsbl.2010.0053; Keatley MR, 2012, AUSTRAL ECOL, V37, P825, DOI 10.1111/j.1442-9993.2011.02344.x; Klamt M, 2011, GLOBAL CHANGE BIOL, V17, P3011, DOI 10.1111/j.1365-2486.2011.02472.x; Klunzinger MW, 2015, AUST J ZOOL, V63, P127, DOI 10.1071/ZO15002; Klunzinger MW, 2012, AUST J ZOOL, V60, P26, DOI 10.1071/ZO12022; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Leviston Z, 2015, AUSTR ATTITUDES CLIM; Mac Nally R, 2009, DIVERS DISTRIB, V15, P720, DOI 10.1111/j.1472-4642.2009.00578.x; Marin A, 2010, GLOBAL ENVIRON CHANG, V20, P162, DOI 10.1016/j.gloenvcha.2009.10.004; McFarlane R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028374; McLean EH, 2014, PLANT CELL ENVIRON, V37, P1440, DOI 10.1111/pce.12251; Mitchell PJ, 2014, ECOL EVOL, V4, P1088, DOI 10.1002/ece3.1008; National Climate Change Adaptation Research Facility (NCCARF), 2013, TERR REP CARD 2013 C; Newell BR, 2014, ANNU REV ENV RESOUR, V39, P443, DOI 10.1146/annurev-environ-010713-094623; Nicol S, 2018, J ENVIRON MANAGE, V215, P294, DOI 10.1016/j.jenvman.2018.03.068; Old JM, 2018, TRANSBOUND EMERG DIS, V65, P399, DOI 10.1111/tbed.12770; Oliver TH, 2014, WIRES CLIM CHANGE, V5, P317, DOI 10.1002/wcc.271; Paap T, 2017, ANN FOREST SCI, V74, DOI 10.1007/s13595-017-0658-6; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Parmesan C, 2011, NAT CLIM CHANGE, V1, P2, DOI 10.1038/nclimate1056; Pascual U, 2017, CURR OPIN ENV SUST, V26-27, P7, DOI 10.1016/j.cosust.2016.12.006; Pecl GT, 2017, SCIENCE, V355, DOI 10.1126/science.aai9214; Potts B. M., 2001, Papers and Proceedings of the Royal Society of Tasmania, V135, P57; PROBER SM, 2011, ECOL MANAG RESTOR, V12, P2, DOI DOI 10.1111/j.1442-8903.2011.00563.x; Prober SM, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1333; Prober SM, 2017, RANGELAND J, V39, P477, DOI [10.1071/RJ17069, 10.1071/rj17069]; Pyhala A, 2016, ECOL SOC, V21, DOI 10.5751/ES-08482-210325; Rawal DS, 2015, AGR FOREST METEOROL, V214, P231, DOI 10.1016/j.agrformet.2015.08.253; Reckless HJ, 2017, WILDLIFE RES, V44, P458, DOI 10.1071/WR16163; Reisinger A, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1371; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Roe J, 2009, NAT DISASTER RES PR, P175; Rogers R, 2017, J INTEGR ENVIRON SCI, V14, P1, DOI 10.1080/1943815X.2016.1268165; Scheffers BR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7671; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Searle K, 2010, INT J CLIM CHANG STR, V2, P362, DOI 10.1108/17568691011089891; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith SJ, 2015, NAT CLIM CHANGE, V5, P333, DOI 10.1038/nclimate2552; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorte CJB, 2013, ECOL LETT, V16, P261, DOI 10.1111/ele.12017; Steffen, 2009, AUSTR BIODIVERSITY C; Ujvari B, 2011, ECOLOGY, V92, P777, DOI 10.1890/10-1471.1; Vidler A., 2011, FARMONLINE NATL; Visoiu M, 2015, ECOL MANAG RESTOR, V16, P76, DOI 10.1111/emr.12146; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Whinam J, 2006, POLAR REC, V42, P43, DOI 10.1017/S0032247405004900; Williams K., 2014, IMPLICATIONS CLIMATE; Williamson GJ, 2011, REG ENVIRON CHANGE, V11, P19, DOI 10.1007/s10113-010-0109-5	83	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0224625	10.1371/journal.pone.0224625	http://dx.doi.org/10.1371/journal.pone.0224625			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LB9DB	31756177	Green Published, gold, Green Submitted			2022-12-26	WOS:000524928300001
J	Redmond, AM; Omarjee, S; Chernukhin, I; Le Romancer, M; Carroll, JS				Redmond, Aisling M.; Omarjee, Soleilmane; Chernukhin, Igor; Le Romancer, Muriel; Carroll, Jason S.			Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR; NUCLEAR-LOCALIZATION; TYROSINE KINASE; GROWTH; EXPRESSION; ERBB-2; TRANSCRIPTION; MECHANISM; TRANSPORT; PROMOTER	HER2 is a transmembrane receptor tyrosine kinase, which plays a key role in breast cancer due to a common genomic amplification. It is used as a marker to stratify patients in the clinic and is targeted by a number of drugs including Trastuzumab and Lapatinib. HER2 has previously been shown to translocate to the nucleus. In this study, we have explored the properties of nuclear HER2 by analysing the binding of this protein to the chromatin in two breast cancer cell lines. We find genome-wide re-programming of HER2 binding after treatment with the growth factor EGF and have identified a de novo motif at HER2 binding sites. Over 2,000 HER2 binding sites are found in both breast cancer cell lines after EGF treatment, and according to pathway analysis, these binding sites were enriched near genes involved in protein kinase activity and signal transduction. HER2 was shown to co-localise at a small subset of regions demarcated by H3K4me1, a hallmark of functional enhancer elements and HER2/H3K4me1 co-bound regions were enriched near EGF regulated genes providing evidence for their functional role as regulatory elements. A chromatin bound role for HER2 was verified by independent methods, including Proximity Ligation Assay (PLA), which confirmed a close association between HER2 and H3K4me1. Mass spectrometry analysis of the chromatin bound HER2 complex identified EGFR and STAT3 as interacting partners in the nucleus. These findings reveal a global role for HER2 as a chromatin-associated factor that binds to enhancer elements to elicit direct gene expression events in breast cancer cells.	[Redmond, Aisling M.; Omarjee, Soleilmane; Chernukhin, Igor; Carroll, Jason S.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Le Romancer, Muriel] Univ Lyon 1, Lyon, France; [Le Romancer, Muriel] Ctr Rech Cancerol Lyon, Inserm U1052, Lyon, France; [Le Romancer, Muriel] CNRS, UMR5286, Ctr Rech Cancerol Lyon, Lyon, France	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard	Redmond, AM; Carroll, JS (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.	amr75@mrc-cu.cam.ac.uk; jason.carroll@cruk.cam.ac.uk		Omarjee, Soleilmane/0000-0001-8686-7286; Redmond, Aisling/0000-0001-9070-1780; Carroll, Jason/0000-0003-3643-0080; Le Romancer, Muriel/0000-0002-8491-4015	Cancer Research UK; European Research Council [646876]; Fondation ARC Cancer; Region Rhone Alpes; La Ligue Contre le Cancer; University of Cambridge; Hutchison Whampoa Limited; ERC Consolidator grant	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Fondation ARC Cancer; Region Rhone Alpes(Region Auvergne-Rhone-Alpes); La Ligue Contre le Cancer(Ligue nationale contre le cancer); University of Cambridge(University of Cambridge); Hutchison Whampoa Limited; ERC Consolidator grant(European Research Council (ERC))	This work was funded by Cancer Research UK (JSC, Core funding), European Research Council (JSC, 646876) and Fondation ARC Cancer (MLR, Core Funding), Region Rhone Alpes (SO) and La Ligue Contre le Cancer (SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Aurelien Serandour for help with the ChIPexo method, the Genomics, Bioinformatics (Tom Carroll & Suraj Menon) and Proteomics core facilities at CRUK Cambridge Institute. We would like to acknowledge the support of the University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited. J.S.C. is supported by an ERC Consolidator grant. M.L.R is supported by a grant from Fondation ARC Cancer.	Andrique L, 2012, CELL SIGNAL, V24, P1074, DOI 10.1016/j.cellsig.2012.01.002; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beguelin W, 2010, MOL CELL BIOL, V30, P5456, DOI 10.1128/MCB.00012-10; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Russo RIC, 2015, ONCOGENE, V34, P3413, DOI 10.1038/onc.2014.272; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Flaque MCD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3587; Flaque MCD, 2013, STEROIDS, V78, P559, DOI 10.1016/j.steroids.2012.11.003; Dillon MF, 2008, ENDOCR-RELAT CANCER, V15, P745, DOI 10.1677/ERC-08-0009; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Krop IE, 2017, LANCET ONCOL, V18, P743, DOI 10.1016/S1470-2045(17)30313-3; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li LY, 2011, CANCER RES, V71, P4269, DOI 10.1158/0008-5472.CAN-10-3504; Li XF, 2012, J BIOL CHEM, V287, P23171, DOI 10.1074/jbc.M112.379412; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Poulard C, 2014, METHODS MOL BIOL, V1204, P135, DOI 10.1007/978-1-4939-1346-6_12; Ryan Q, 2008, ONCOLOGIST, V13, P1114, DOI 10.1634/theoncologist.2008-0816; Schillaci R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-74; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Serandour AA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r147; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Venturutti L, 2016, ONCOGENE, V35, P2208, DOI 10.1038/onc.2015.281; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang YN, 2012, J BIOL CHEM, V287, P16869, DOI 10.1074/jbc.M111.314799; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225180	10.1371/journal.pone.0225180	http://dx.doi.org/10.1371/journal.pone.0225180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747426	Green Published, gold			2022-12-26	WOS:000533881900026
J	Oh, H				Oh, HyungSeon			Analytical solution to swing equations in power grids	PLOS ONE			English	Article								Objective To derive a closed-form analytical solution to the swing equation describing the power system dynamics, which is a nonlinear second order differential equation. Existing challenges No analytical solution to the swing equation has been identified, due to the complex nature of power systems. Two major approaches are pursued for stability assessments on systems: (1) computationally simple models based on physically unacceptable assumptions, and (2) digital simulations with high computational costs. Motivation The motion of the rotor angle that the swing equation describes is a vector function. Often, a simple form of the physical laws is revealed by coordinate transformation. Methods The study included the formulation of the swing equation in the Cartesian coordinate system, which is different from conventional approaches that describe the equation in the polar coordinate system. Based on the properties and operational conditions of electric power grids referred to in the literature, we identified the swing equation in the Cartesian coordinate system and derived an analytical solution within a validity region. Results The estimated results from the analytical solution derived in this study agree with the results using conventional methods, which indicates the derived analytical solution is correct. Conclusion An analytical solution to the swing equation is derived without unphysical assumptions, and the closed-form solution correctly estimates the dynamics after a fault occurs.	[Oh, HyungSeon] US Naval Acad, Dept Elect & Comp Engn, Annapolis, MD 21402 USA	United States Department of Defense; United States Navy; United States Naval Academy	Oh, H (corresponding author), US Naval Acad, Dept Elect & Comp Engn, Annapolis, MD 21402 USA.	hoh@usna.edu	Oh, HyungSeon/AAE-5924-2019	Oh, HyungSeon/0000-0003-0271-072X				A Harris Williams & Co, 2010, TRANSM DISTR INFR WH; Anderson P. M., 2003, POWER SYSTEM CONTROL; [Anonymous], 2015, US EL IND PRIM, P94; Arif A, 2018, IEEE T SMART GRID, V9, P5986, DOI 10.1109/TSG.2017.2700436; Ascher UM, 1998, COMPUTER METHODS ORD; BARLOW JL, 1993, SIAM J MATRIX ANAL A, V14, P598, DOI 10.1137/0614042; BERZINS M, 1989, APPL NUMER MATH, V5, P375, DOI 10.1016/0168-9274(89)90038-X; Butcher J.C., 2008, NUMERICAL METHODS OR, DOI DOI 10.1002/9780470753767; Campbell S., 1989, IMACS T SCI COMPUTIN, V12, P555; CAMPBELL SL, 1986, FREQUENCY DOMAIN STA, P313; Chiang H. D., 2011, DIRECT METHODS STABI; CHIANG HD, 1989, IEEE T CIRCUITS SYST, V36, P1423, DOI 10.1109/31.41298; Dorfler F, 2013, P NATL ACAD SCI USA, V110, P2005, DOI 10.1073/pnas.1212134110; Filatrella G, 2008, EUR PHYS J B, V61, P485, DOI 10.1140/epjb/e2008-00098-8; Golub GH, 2013, MATRIX COMPUTATION, V4th; Grainger J. J., 1994, POWER SYSTEM ANAL; Hairer Ernst, 2000, SOLVING ORDINARY DIF, V1; HILL DJ, 1989, AUTOMATICA, V25, P453, DOI 10.1016/0005-1098(89)90015-0; Huang ZY, 2012, 2012 SC COMPANION: HIGH PERFORMANCE COMPUTING, NETWORKING, STORAGE AND ANALYSIS (SCC), P347, DOI 10.1109/SC.Companion.2012.54; Jereminov M, 2017, IEEE PES INNOV SMART; Karamata J., 1933, B SOC MATH FRANCE, V61, P55; KARLSSON D, 1994, IEEE T POWER SYST, V9, P157, DOI 10.1109/59.317546; Kosterev DN, 1999, IEEE T POWER SYST, V14, P967, DOI 10.1109/59.780909; KRONER A, 1992, COMPUT CHEM ENG, V16, pS131, DOI 10.1016/S0098-1354(09)80015-X; Kundur P., 2007, POWER SYSTEM STABILI, V10; Kuramoto, 1975, LECT NOTE PHYS, V30, P420, DOI DOI 10.1007/BFB0013365; Nagel I, 2013, IEEE T POWER SYST, V28, P4218, DOI 10.1109/TPWRS.2013.2259185; Oh H, 2019, ENERGIES, V12, DOI 10.3390/en12122425; Oh HS, 2018, METHODSX, V5, P103, DOI 10.1016/j.mex.2018.01.001; Overbye T., POWER SYSTEM ANAL LE; Pai M., 1981, IEEE POWER ENG REV, V100, P49; PANTELIDES CC, 1988, SIAM J SCI STAT COMP, V9, P213, DOI 10.1137/0909014; PANTELIDES CC, 1988, COMPUT CHEM ENG, V12, P745, DOI 10.1016/0098-1354(88)80012-7; Pauer, 2017, POWER SYSTEM DYNAMIC; Pfeifenberger JP., 2013, RESOURCE ADEQUACY RE; Rodrigues FA, 2016, PHYS REP, V610, P1, DOI 10.1016/j.physrep.2015.10.008; Runge C., 1895, MATH ANN, V46, P167, DOI DOI 10.1007/BF01446807; Song HA, 2017, JOINT EUR C MACH LEA; *US DOE, 2012, LARG POW TRANSF US E; Vu T, 2015, 2015 AM CONT C CHIC; Vu T, 2017, COMPUTERS, V6, DOI 10.3390/computers6010004; Weber J., 2015, DESCRIPTION MACHINE; Wilkinson JH, 1965, ALGEBRAIC EIGENVALUE; WILLEMS JL, 1970, IEEE T POWER AP SYST, VPA89, P795, DOI 10.1109/TPAS.1970.292636; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3	45	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225097	10.1371/journal.pone.0225097	http://dx.doi.org/10.1371/journal.pone.0225097			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743351	Green Submitted, Green Published, gold			2022-12-26	WOS:000533877300018
J	Galvin, HD; Husain, M				Galvin, Henry D.; Husain, Matloob			Influenza A virus-induced host caspase and viral PA-X antagonize the antiviral host factor, histone deacetylase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza virus; histone deacetylase 4 (HDAC4); innate immunity; host-pathogen interaction; signal transducers and activators of transcription 1 (STAT1); host defense; IFITM3; ISG15; PA; PA-X; viperin	CATHEPSIN-B CONTRIBUTES; PROTEIN ACETYLATION; MEDIATED DEGRADATION; SHUTOFF ACTIVITY; APOPTOSIS; INFECTION; RELEASE; EPIDEMIOLOGY; SUPPRESSION; RESISTANCE	Influenza A virus (IAV) effectively manipulates host machinery to replicate. There is a growing evidence that an optimal acetylation environment in the host cell is favorable to IAV proliferation and vice versa. The histone deacetylases (HDACs), a family of 18 host enzymes classified into four classes, are central to negatively regulating the acetylation level, hence the HDACs would not be favorable to IAV. Indeed, by using the RNAi and overexpression strategies, we found that human HDAC4, a class II member, possesses anti-IAV properties and is a component of host innate antiviral response. We discovered that IAV multiplication was augmented in HDAC4-depleted cells and abated in HDAC4-supplemented cells. Likewise, the expression of IFITM3, ISG15, and viperin, some of the critical markers of host anti-IAV response was abated in HDAC4-depleted cells and augmented in HDAC4-supplemented cells. In turn, IAV strongly antagonizes the HDAC4, by down-regulating its expression both at the mRNA level via viral RNA endonuclease PA-X and at the polypeptide level by inducing its cleavage via host caspase 3 in infected cells. Such HDAC4 polypeptide cleavage resulted in a ?30 kDa fragment that is also observed in some heterologous systems and may have a significant role in IAV replication.	[Galvin, Henry D.; Husain, Matloob] Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand	University of Otago	Husain, M (corresponding author), Univ Otago, Dunedin 9054, New Zealand.	matloob.husain@otago.ac.nz	Husain, Matloob/AAN-7649-2020	Husain, Matloob/0000-0002-4413-6220	H. S. and J. C. Anderson Charitable Trust; University of Otago; Department of Microbiology and Immunology; School of Biomedical Sciences	H. S. and J. C. Anderson Charitable Trust; University of Otago; Department of Microbiology and Immunology; School of Biomedical Sciences	This work was supported by the H. S. and J. C. Anderson Charitable Trust, a University of Otago Ph.D. scholarship (to H. D. G.), and the Department of Microbiology and Immunology and the School of Biomedical Sciences (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen DY, 2016, VIROLOGY, V497, P146, DOI 10.1016/j.virol.2016.07.017; Chen H, 2019, J VIROL, V93, DOI 10.1128/JVI.01896-18; Chen XY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00320; Conrad RJ, 2016, ACS CHEM BIOL, V11, P669, DOI 10.1021/acschembio.5b00999; Cook C, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt259; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Giese S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01112-3; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; Hatakeyama D, 2018, J BIOL CHEM, V293, P7126, DOI 10.1074/jbc.RA117.001683; Hayashi T, 2015, J VIROL, V89, P6442, DOI 10.1128/JVI.00319-15; Husain M, 2014, INFECT GENET EVOL, V28, P304, DOI 10.1016/j.meegid.2014.10.016; Husain M, 2014, J VIROL, V88, P11229, DOI 10.1128/JVI.00727-14; Husain M, 2009, FEBS LETT, V583, P2517, DOI 10.1016/j.febslet.2009.07.005; Hussain M, 2017, INFECT DRUG RESIST, V10, P121, DOI 10.2147/IDR.S105473; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jeng MY, 2015, CRIT REV BIOCHEM MOL, V50, P314, DOI 10.3109/10409238.2015.1061973; Khaperskyy DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005427; Kim H, 2018, VIRAL IMMUNOL, V31, P174, DOI 10.1089/vim.2017.0141; Koyuncu E, 2014, MBIO, V5, DOI 10.1128/mBio.02249-14; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Liu F, 2004, J BIOL CHEM, V279, P34537, DOI 10.1074/jbc.M402475200; Liu N, 2017, ONCOTARGET, V8, P89315, DOI 10.18632/oncotarget.19167; Moon J, 2016, BIOCHEM BIOPH RES CO, V474, P428, DOI 10.1016/j.bbrc.2016.05.005; Nagesh PT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01315; Nagesh PT, 2016, J VIROL, V90, P4614, DOI 10.1128/JVI.00126-16; Nutsford AN, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12989; Oishi K, 2018, CELL REP, V24, P851, DOI 10.1016/j.celrep.2018.06.078; Oishi K, 2018, VIROLOGY, V516, P71, DOI 10.1016/j.virol.2018.01.004; Ortiz JR, 2014, CRIT CARE MED, V42, P2325, DOI 10.1097/CCM.0000000000000545; Paroni G, 2004, MOL BIOL CELL, V15, P2804, DOI 10.1091/mbc.E03-08-0624; Paroni G, 2007, MOL CELL BIOL, V27, P6718, DOI 10.1128/MCB.00853-07; Petrie JG, 2016, CLIN INFECT DIS, V62, P448, DOI 10.1093/cid/civ952; Roberts LR, 1997, GASTROENTEROLOGY, V113, P1714, DOI 10.1053/gast.1997.v113.pm9352877; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Song GY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00421; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Webster RG, 2014, ANN NY ACAD SCI, V1323, P115, DOI 10.1111/nyas.12462; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Xue KS, 2018, TRENDS MICROBIOL, V26, P781, DOI 10.1016/j.tim.2018.02.007; Yang ZM, 2017, AM J PATHOL, V187, P781, DOI 10.1016/j.ajpath.2016.12.001; Zhou YL, 2017, EUR J IMMUNOL, V47, P1414, DOI 10.1002/eji.201746959	53	11	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20207	20221		10.1074/jbc.RA119.010650	http://dx.doi.org/10.1074/jbc.RA119.010650			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31757810	Green Published, hybrid			2022-12-26	WOS:000505005800031
J	Zhu, Y; Li, HJ; Su, Q; Wen, J; Wang, YF; Song, W; Xie, YP; He, WR; Yang, Z; Jiang, K; Guo, HW				Zhu, Ying; Li, Hong-jiang; Su, Qi; Wen, Jing; Wang, Yuefan; Song, Wen; Xie, Yinpeng; He, Wenrong; Yang, Zhen; Jiang, Kai; Guo, Hongwei			A phenotype-directed chemical screen identifies ponalrestat as an inhibitor of the plant flavin monooxygenase YUCCA in auxin biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemical biology; high-throughput screening (HTS); auxin; biosynthesis; enzyme inhibitor; ethylene; flavin-containing monooxygenase; ponalrestat; root growth regulator; YUCCA	ETHYLENE-INSENSITIVE MUTANTS; RESPONSE PATHWAY; SIGNALING PATHWAY; ARABIDOPSIS; TRYPTOPHAN; ACID; MECHANISM; GAS	Plant development is regulated by both synergistic and antagonistic interactions of different phytohormones, including a complex crosstalk between ethylene and auxin. For instance, auxin and ethylene synergistically control primary root elongation and root hair formation. However, a lack of chemical agents that specifically modulate ethylene or auxin production has precluded precise delineation of the contribution of each hormone to root development. Here, we performed a chemical genetic screen based on the recovery of root growth in ethylene-related Arabidopsis mutants with constitutive ?short root? phenotypes (eto1?2 and ctr1?1). We found that ponalrestat exposure recovers root elongation in these mutants in an ethylene signal?independent manner. Genetic and pharmacological investigations revealed that ponalrestat inhibits the enzymatic activity of the flavin-containing monooxygenase YUCCA, which catalyzes the rate-limiting step of the indole-3-pyruvic acid branch of the auxin biosynthesis pathway. In summary, our findings have identified a YUCCA inhibitor that may be useful as a chemical tool to dissect the distinct steps in auxin biosynthesis and in the regulation of root development.	[Zhu, Ying; Xie, Yinpeng; Jiang, Kai; Guo, Hongwei] Southern Univ Sci & Technol SUSTech, Inst Plant & Food Sci, Dept Biol, Shenzhen 518055, Guangdong, Peoples R China; [Li, Hong-jiang] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Su, Qi; Wang, Yuefan; Yang, Zhen] Peking Univ, Minist Educ, Key Lab Bioorgan Chem & Mol Engn, Beijing 100871, Peoples R China; [Su, Qi; Wang, Yuefan; Yang, Zhen] Peking Univ, BNLMS, Beijing 100871, Peoples R China; [Su, Qi; Wang, Yuefan; Yang, Zhen] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Wen, Jing; Song, Wen] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [He, Wenrong] Salk Inst Biol Studies, Plant Mol & Cellular Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Jiang, Kai] Southern Univ Sci & Technol SUSTech, SUSTech Acad Adv & Interdisciplinary Studies, Shenzhen 518055, Guangdong, Peoples R China; [Li, Hong-jiang] BioCentury Inc, Redwood City, CA 94065 USA; [Su, Qi] Johns Hopkins Univ, Dept Chem, 3400 N Charles St, Baltimore, MD 21218 USA; [Wen, Jing] North Sichuan Med Coll, Sch Pharm, Nanchong 637100, Peoples R China; [Wang, Yuefan] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Yang, Zhen] Peking Univ, State Key Lab Chem Oncogen, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China; [Yang, Zhen] Peking Univ, Key Lab Chem Genom, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China	Southern University of Science & Technology; Peking University; Peking University; Chinese Academy of Sciences; Peking University; Peking University; Max Planck Society; Salk Institute; Southern University of Science & Technology; Johns Hopkins University; North Sichuan Medical University; Johns Hopkins University; Peking University; University Town of Shenzhen; Peking University; University Town of Shenzhen	Jiang, K; Guo, HW (corresponding author), Southern Univ Sci & Technol SUSTech, Inst Plant & Food Sci, Dept Biol, Shenzhen 518055, Guangdong, Peoples R China.; Jiang, K (corresponding author), Southern Univ Sci & Technol SUSTech, SUSTech Acad Adv & Interdisciplinary Studies, Shenzhen 518055, Guangdong, Peoples R China.	jiangk@sustech.edu.cn; guohw@sustech.edu.cn	Wang, Yuefan/AGO-1425-2022	Song, Wen/0000-0002-9498-2409; Wang, Yuefan/0000-0001-5731-6143; Jiang, Kai/0000-0001-9901-5293	National Natural Science Foundation of China [31570286, 91740203, 21907049]; Guangdong Innovative and Entrepreneurial Research Team Program [2016ZT06S172]; Shenzhen Sci-Tech Fund [KYTDPT20181011104005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative and Entrepreneurial Research Team Program; Shenzhen Sci-Tech Fund	This work was supported by the National Natural Science Foundation of China Grants 31570286 and 91740203 (to H. G.) and Grant 21907049 (to K. J.), the Guangdong Innovative and Entrepreneurial Research Team Program Grant 2016ZT06S172 (to K. J.), and the Shenzhen Sci-Tech Fund Grant KYTDPT20181011104005 (to K. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abeles F.B., 1992, PLANT BIOL ETHYL, P1, DOI [DOI 10.1016/B978-0-08-091628-6.50001-1, 10.1016/b978-0-08-091628-6.50001-1, DOI 10.1016/C2009-0-03226-7]; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen QG, 2014, PLANT CELL PHYSIOL, V55, P1072, DOI 10.1093/pcp/pcu039; CHUNG S, 1989, J BIOL CHEM, V264, P14775; Dai XH, 2013, J BIOL CHEM, V288, P1448, DOI 10.1074/jbc.M112.424077; Dejonghe W, 2017, PLANT PHYSIOL, V174, P5, DOI 10.1104/pp.16.01805; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; EVANS ML, 1994, PLANTA, V194, P215, DOI 10.1007/BF01101680; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; He WR, 2011, PLANT CELL, V23, P3944, DOI 10.1105/tpc.111.089029; Hicks GR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00455; Jiang K, 2018, BIOSCI BIOTECH BIOCH, V82, P1265, DOI 10.1080/09168451.2018.1462693; Ju CL, 2015, PLANT PHYSIOL, V169, P85, DOI 10.1104/pp.15.00845; Kakei Y, 2015, PLANT J, V84, P827, DOI 10.1111/tpj.13032; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Kubo Y, 2015, CHEM COMMUN, V51, P2005, DOI 10.1039/c4cc07712a; Lindell SD, 2009, BIOORGAN MED CHEM, V17, P4035, DOI 10.1016/j.bmc.2009.03.027; Lomenick Brett, 2011, Curr Protoc Chem Biol, V3, P163; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Mao JL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005760; Martin YC, 2018, J COMPUT AID MOL DES, V32, P809, DOI 10.1007/s10822-018-0127-9; Mashiach E, 2010, PROTEINS, V78, P3197, DOI 10.1002/prot.22790; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Narukawa-Nara M, 2016, PLANT J, V87, P245, DOI 10.1111/tpj.13197; Nishimura T, 2014, PLANT J, V77, P352, DOI 10.1111/tpj.12399; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Sriram D, 2010, CHEM BIOL DRUG DES, V75, P381, DOI 10.1111/j.1747-0285.2010.00947.x; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Thimann KV, 1938, PLANT PHYSIOL, V13, P437, DOI 10.1104/pp.13.3.437; Tsugafune S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14332-w; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104	48	8	9	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19923	19933		10.1074/jbc.RA119.010480	http://dx.doi.org/10.1074/jbc.RA119.010480			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31732559	hybrid, Green Published			2022-12-26	WOS:000505005800009
J	Fumagalli, SE; Rice, SH				Fumagalli, Sarah E.; Rice, Sean H.			Stochasticity and non-additivity expose hidden evolutionary pathways to cooperation	PLOS ONE			English	Article							SOCIAL EVOLUTION; NATURAL-SELECTION; HAMILTONS RULE; ALTRUISM; FITNESS; ENHANCEMENT; COEVOLUTION; STRATEGIES; VARIANCE; CONFLICT	Cooperation is widespread across the tree of life, with examples ranging from vertebrates to lichens to multispecies biofilms. The initial evolution of such cooperation is likely to involve interactions that produce non-additive fitness effects among small groups of individuals in local populations. However, most models for the evolution of cooperation have focused on genealogically related individuals, assume that the factors influencing individual fitness are deterministic, that populations are very large, and that the benefits of cooperation increase linearly with the number of cooperative interactions. Here we show that stochasticity and non-additive interactions can facilitate the evolution of cooperation in small local groups. We derive a generalized model for the evolution of cooperation and show that if cooperation reduces the variance in individual fitness (separate from its effect on average fitness), this can aid in the evolution of cooperation through directional stochastic effects. In addition, we show that the potential for the evolution of cooperation is influenced by non-additivity in benefits with cooperation being more likely to evolve when the marginal benefit of a cooperative act increases with the number of such acts. Our model compliments traditional cooperation models (kin selection, reciprocal cooperation, green beard effect, etc.) and applies to a broad range of cooperative interactions seen in nature.	[Fumagalli, Sarah E.; Rice, Sean H.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Fumagalli, SE (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	sarah.e.fumagalli@ttu.edu		Fumagalli, Sarah/0000-0003-2469-4476	Texas Tech University	Texas Tech University	This work was supported by Texas Tech University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Armitage KB, 2000, P NATL ACAD SCI USA, V97, P12149, DOI 10.1073/pnas.200196097; Aviles L, 2002, AM NAT, V159, P115, DOI 10.1086/324792; Axelrod R, 2004, EVOLUTION, V58, P1833; Brockhurst MA, 2007, CURR BIOL, V17, P761, DOI 10.1016/j.cub.2007.02.057; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Colizzi ES, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0600-9; Connelly BD, 2017, J EVOLUTION BIOL, V30, P750, DOI 10.1111/jeb.13039; Covas R, 2008, BEHAV ECOL SOCIOBIOL, V63, P103, DOI 10.1007/s00265-008-0640-2; Damore JA, 2012, J THEOR BIOL, V299, P31, DOI 10.1016/j.jtbi.2011.03.008; DeLay LS, 1996, CONDOR, V98, P300, DOI 10.2307/1369148; Downing PA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1663; Dragos A, 2017, TRENDS MICROBIOL, V25, P257, DOI 10.1016/j.tim.2016.12.010; Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fletcher JA, 2006, AM NAT, V168, P252, DOI 10.1086/506529; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Foster KR, 2004, J EVOLUTION BIOL, V17, P1058, DOI 10.1111/j.1420-9101.2004.00747.x; FRANK SA, 1990, AM NAT, V136, P244, DOI 10.1086/285094; FRANK SA, 1994, J THEOR BIOL, V170, P393, DOI 10.1006/jtbi.1994.1200; Fromhage L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1410; Gardner A, 2011, J EVOLUTION BIOL, V24, P1020, DOI 10.1111/j.1420-9101.2011.02236.x; GILLESPIE JH, 1974, GENETICS, V76, P601; Gintis H, 2003, J THEOR BIOL, V220, P407, DOI 10.1006/jtbi.2003.3104; Grafen A, 2000, P ROY SOC B-BIOL SCI, V267, P1223, DOI 10.1098/rspb.2000.1131; Guindre-Parker S, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.172406; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARTL DL, 1973, THEOR POPUL BIOL, V4, P163, DOI 10.1016/0040-5809(73)90026-9; HEINSOHN RG, 1992, EVOL ECOL, V6, P97, DOI 10.1007/BF02270705; Huang RJ, 2011, VIRULENCE, V2, P435, DOI 10.4161/viru.2.5.16140; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Jungwirth A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1971; Kennedy P, 2018, NATURE, V555, P359, DOI 10.1038/nature25965; Kiaer LP, 2007, HEREDITY, V99, P112, DOI 10.1038/sj.hdy.6800973; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Kramer J, 2015, J EVOLUTION BIOL, V28, P1299, DOI 10.1111/jeb.12655; Lehmann L, 2002, AM NAT, V159, P451, DOI 10.1086/339458; Lewin-Epstein O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14040; Maccoll ADC, 2004, J ANIM ECOL, V73, P1137, DOI 10.1111/j.0021-8790.2004.00887.x; Marshall JAR, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00040; McLeod DV, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006739; Melbinger A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0171; Mitri S, 2011, P NATL ACAD SCI USA, V108, P10839, DOI 10.1073/pnas.1100292108; Mund A, 2017, MBIO, V8, DOI 10.1128/mBio.00353-17; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Orr HA, 2007, EVOLUTION, V61, P2997, DOI 10.1111/j.1558-5646.2007.00237.x; Paquet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059336; Piercey-Normore MD, 2017, BOTANY, V95, P1005, DOI 10.1139/cjb-2017-0037; Platt TG, 2012, P ROY SOC B-BIOL SCI, V279, P1691, DOI 10.1098/rspb.2011.2002; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Purswani J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00919; QUELLER DC, 1992, EVOLUTION, V46, P376, DOI 10.1111/j.1558-5646.1992.tb02045.x; QUELLER DC, 1985, NATURE, V318, P366, DOI 10.1038/318366a0; Reed JM, 1996, AUK, V113, P608, DOI 10.2307/4088981; Ren DW, 2015, ISME J, V9, P81, DOI 10.1038/ismej.2014.96; Rice SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007130; Rice SH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-262; Riehl C, 2011, P ROY SOC B-BIOL SCI, V278, P1728, DOI 10.1098/rspb.2010.1752; Rodrigues AMM, 2013, AM NAT, V181, P609, DOI 10.1086/670031; Rubenstein DR, 2011, P NATL ACAD SCI USA, V108, P10816, DOI 10.1073/pnas.1100303108; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Smith J, 2010, SCIENCE, V328, P1700, DOI 10.1126/science.1189675; Soucy SL, 2003, INSECT SOC, V50, P248, DOI 10.1007/s00040-003-0670-8; Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x; Taylor PD, 2000, EVOLUTION, V54, P1135; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Dyken JD, 2012, EVOLUTION, V66, P2498, DOI 10.1111/j.1558-5646.2012.01629.x; Van Dyken JD, 2012, AM NAT, V179, P436, DOI 10.1086/664609; van Gestel J, 2014, ISME J, V8, P2069, DOI 10.1038/ismej.2014.52; WALLACE B, 1963, GENETICS, V48, P633; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; WILSON DS, 1990, OIKOS, V59, P135, DOI 10.2307/3545133; Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; Zhang YL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02021	78	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0225517	10.1371/journal.pone.0225517	http://dx.doi.org/10.1371/journal.pone.0225517			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790440	gold, Green Published			2022-12-26	WOS:000533930800040
J	Zhao, XF; Li, YF; Du, K; Wu, YQ; Liu, L; Cui, S; Zhang, Y; Gao, J; Keep, RF; Xiang, JM				Zhao, Xiaofen; Li, Yangfang; Du, Kun; Wu, Yuqin; Liu, Ling; Cui, Shan; Zhang, Yan; Gao, Jin; Keep, Richard F.; Xiang, Jianming			Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CANCER RESISTANCE PROTEIN; BETA-LACTAM ANTIBIOTICS; ABC TRANSPORTERS; P-GLYCOPROTEIN; MULTIDRUG TRANSPORTER; EFFLUX; INHIBITORS; DRUGS; MODEL	The blood-brain barrier (BBB) is a dynamic and complex interface between blood and the central nervous system (CNS). It protects the brain by preventing toxic substances from entering the brain but also limits the entry of therapeutic agents. ATP-binding cassette (ABC) efflux transporters are critical for the functional barrier and present a formidable impediment to brain delivery of therapeutic agents including antibiotics. The aim of this study was to investigate the possible involvement of multidrug resistance-associated protein 1 and 4 (MRP1 and MRP4), two ABC transporters, in benzylpenicillin efflux transport using wild-type (WT) MDCKII cells and cells overexpressing those human transporters, as well as non-selective and selective inhibitors. We found that inhibiting MRP1 or MRP4 significantly increased [3 H]benzylpenicillin uptake in MDCKII-WT, -MRP1 or -MRP4 cells. Similar results were also found in HepG2 cells, which highly express MRP1 and MRP4, and hCMEC/D3 cells which express MRP1. The results indicate that human and canine MRP1 and MRP4 are involved in benzylpenicillin efflux transport. They could be potential therapeutic targets for improving the efficacy of benzylpenicillin for treating CNS infections since both MRP1 and MRP4 express at human blood-brain barrier.	[Zhao, Xiaofen; Li, Yangfang; Du, Kun; Wu, Yuqin; Liu, Ling; Cui, Shan; Zhang, Yan; Gao, Jin] Kunming Childrens Hosp, Dept Neonate, Kunming, Yunnan, Peoples R China; [Keep, Richard F.; Xiang, Jianming] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Xiang, JM (corresponding author), Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI 48109 USA.	jmxxdrnx@umich.edu			Programs of Scientific and Technological Talent Development/Ten-Hundred-Thousand Talent, Health Bureau of Kunming City [2016-SW-(G)-19]; Motor City Golf Classic grant from the Department of Neurosurgery, University of Michigan Medical School	Programs of Scientific and Technological Talent Development/Ten-Hundred-Thousand Talent, Health Bureau of Kunming City; Motor City Golf Classic grant from the Department of Neurosurgery, University of Michigan Medical School	Funded by YL: Programs of Scientific and Technological Talent Development/Ten-Hundred-Thousand Talent, Health Bureau of Kunming City, grant 2016-SW-(G)-19; JX: Motor City Golf Classic grant from the Department of Neurosurgery, University of Michigan Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Programs of Scientific and Technological Talent Development/Ten-Hundred-Thousand Talent, Health Bureau of Kunming City, grant 2016-SW-(G)-19 and by Motor City Golf Classic grant from the Department of Neurosurgery, University of Michigan Medical School.	Abbott NJ, STRUCTURE FUNCTION B; Acharya P, 2006, BIOCHEMISTRY-US, V45, P15505, DOI 10.1021/bi060593b; Agarwal S, 2011, CURR PHARM DESIGN, V17, P2793, DOI 10.2174/138161211797440186; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Azad TD, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2014.12.FOCUS14758; Borst P, 2013, J CLIN INVEST, V123, P4131, DOI 10.1172/JCI70430; Cheung L, 2014, BIOCHEM PHARMACOL, V91, P97, DOI 10.1016/j.bcp.2014.05.023; Choi MK, 2009, XENOBIOTICA, V39, P171, DOI 10.1080/00498250802642256; Dauchy S, 2009, BIOCHEM PHARMACOL, V77, P897, DOI 10.1016/j.bcp.2008.11.001; Eilers M, 2008, EXP BIOL MED, V233, P1149, DOI 10.3181/0802-RM-59; Fricker G, MODULATION DRUG TRAN; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Hartz AMS, 2010, MOL INTERV, V10, P293, DOI 10.1124/mi.10.5.6; Helms HC, 2014, AAPS J, V16, P1046, DOI 10.1208/s12248-014-9628-1; Iorio AL, 2015, ANTICANCER AGENTS ME, DOI [10.2174/, DOI 10.2174/]; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Li Y., 2016, EVID-BASED COMPL ALT, V2016, P11, DOI DOI 10.1155/2016/3965608; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Mahringer A, 2016, EXPERT OPIN DRUG MET, V12, P499, DOI 10.1517/17425255.2016.1168804; Miller DS, 2015, ADV CANCER RES, V125, P43, DOI 10.1016/bs.acr.2014.10.002; NORRBY SR, 1986, REV INFECT DIS, V8, pS35, DOI DOI 10.1093/CLINIDS/8.SUPPLEMENT_3.S358; Obermeier B, 2016, HAND CLINIC, V133, P39, DOI 10.1016/B978-0-444-63432-0.00003-7; Oberoi RK, 2016, NEURO-ONCOLOGY, V18, P27, DOI 10.1093/neuonc/nov164; Ohtsuki S, 2013, MOL PHARMACEUT, V10, P289, DOI 10.1021/mp3004308; Rigalli JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119502; Pardridge WM, 2015, EXPERT OPIN THER TAR, V19, P1059, DOI 10.1517/14728222.2015.1042364; Pascolo L, 2000, BIOCHEM BIOPH RES CO, V275, P466, DOI 10.1006/bbrc.2000.3339; Poelarends GJ, 2000, DRUG RESIST UPDATE, V3, P330, DOI 10.1054/drup.2000.0173; Potschka H, 2003, J PHARMACOL EXP THER, V306, P124, DOI 10.1124/jpet.103.049858; Ramos S R, 1992, Arq Neuropsiquiatr, V50, P289; Roberts JA, 2009, CRIT CARE MED, V37, P2071, DOI 10.1097/CCM.0b013e3181a0054d; Rousselle C, 2002, J DRUG TARGET, V10, P309, DOI 10.1080/10611860290031886; SCHLIAMSER SE, 1991, J ANTIMICROB CHEMOTH, V27, P405, DOI 10.1093/jac/27.4.405; SCHLIAMSER SE, 1988, SCAND J INFECT DIS, V20, P1, DOI 10.3109/00365548809117210; Seelig A, 1998, INT J CLIN PHARM TH, V36, P50; Serlin Y, 2015, SEMIN CELL DEV BIOL, V38, P2, DOI 10.1016/j.semcdb.2015.01.002; Shen SS, 2010, REV NEUROSCIENCE, V21, P29; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Sindac JA, 2013, J MED CHEM, V56, P9222, DOI 10.1021/jm401330r; Tivnan A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00218; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; Usuki F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09435-3; Zhu Min-Li, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P910	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225702	10.1371/journal.pone.0225702	http://dx.doi.org/10.1371/journal.pone.0225702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774876	gold, Green Published			2022-12-26	WOS:000533896400051
J	Demidenko, E; Miller, TW				Demidenko, Eugene; Miller, Todd W.			Statistical determination of synergy based on Bliss definition of drugs independence	PLOS ONE			English	Article							COMBINATION; DESIGN	Although synergy is a pillar of modern pharmacology, toxicology, and medicine, there is no consensus on its definition despite its nearly one hundred-year history. Moreover, methods for statistical determination of synergy that account for variation of response to treatment are underdeveloped and if exist are reduced to the traditional t-test, but do not comply with the normal distribution assumption. We offer statistical models for estimation of synergy using an established definition of Bliss drugs' independence. Although Bliss definition is well-known, it remains a theoretical concept and has never been applied for statistical determination of synergy with various forms of treatment outcome. We rigorously and consistently extend the Bliss definition to detect statistically significant synergy under various designs: (1) in vitro, when the outcome of a cell culture experiment with replicates is the proportion of surviving cells for a single dose or multiple doses, (2) dose-response methodology, (3) in vivo studies in organisms, when the outcome is a longitudinal measurement such as tumor volume, and (4) clinical studies, when the outcome of treatment is measured by survival. For each design, we developed a specific statistical model and demonstrated how to test for independence, synergy, and antagonism, and compute the associated p-value.	[Demidenko, Eugene] Geisel Sch Med Dartmouth, Biomed Data Sci, Hanover, NH 03755 USA; [Miller, Todd W.] Geisel Sch Med Dartmouth, Mol & Syst Biol, Hanover, NH USA	Dartmouth College; Dartmouth College	Demidenko, E (corresponding author), Geisel Sch Med Dartmouth, Biomed Data Sci, Hanover, NH 03755 USA.	eugened@dartmouth.edu			National Institutes of Health, Cancer Institute [P30 CA23108-37, 1U01CA196386-01, R01 LM012371-01A1, R01CA2000994]; NATIONAL CANCER INSTITUTE [P30CA023108, U01CA196386] Funding Source: NIH RePORTER	National Institutes of Health, Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health, Cancer Institute (P30 CA23108-37 and 1U01CA196386-01 to E.D.; R01 LM012371-01A1 and R01CA2000994 to T.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHFORD JR, 1970, BIOMETRICS, V26, P535, DOI 10.2307/2529107; Bijnsdorp IV, 2011, METHODS MOL BIOL, V731, P421, DOI 10.1007/978-1-61779-080-5_34; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Boik JC, 2010, J STAT SOFTW, V34, P1; CARTER WH, 1988, J AM COLL TOXICOL, V7, P963, DOI 10.3109/10915818809014527; CAUDLE RM, 1993, PAIN, V55, P313, DOI 10.1016/0304-3959(93)90006-B; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Chou TC, 2002, J VIROL, V76, P10577, DOI 10.1128/JVI.76.20.10577-10578.2002; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Demidenko E., 2013, MIXED MODELS THEORY; Demidenko E., 2019, ADV STAT APPL R; Demidenko E, 2017, TOXICOL APPL PHARM, V314, P12, DOI 10.1016/j.taap.2016.11.002; Demidenko E, 2016, AM STAT, V70, P33, DOI 10.1080/00031305.2015.1069760; Demidenko E, 2010, INT J RADIAT BIOL, V86, P164, DOI 10.3109/09553000903419304; Englehardt JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129042; Fedorov VV, 2014, CH CRC BIOSTAT SER, P1; FELLER W, 1971, INTRO PROBABILITY TH, V1; Finney D.J, 1952, STAT METHOD BIOL ASS; Flobak A, 2017, BIOINFORMATICS, V33, P2410, DOI 10.1093/bioinformatics/btx161; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; Geary N, 2013, AM J PHYSIOL-ENDOC M, V304, pE237, DOI 10.1152/ajpendo.00308.2012; Glaholt SP, 2012, SCI TOTAL ENVIRON, V432, P57, DOI 10.1016/j.scitotenv.2012.05.074; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hampsch RA, 2017, ONCOTARGET, V8, P21806, DOI 10.18632/oncotarget.15586; Hosford SR, 2017, CLIN CANCER RES, V23, P2795, DOI 10.1158/1078-0432.CCR-15-2764; Kashif M, 2017, ONCOTARGET, V8, P103952, DOI 10.18632/oncotarget.21895; Lederer S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00031; LESAFFRE E, 1991, STAT MED, V10, P1391, DOI 10.1002/sim.4780100907; Liu Q, 2018, STAT BIOPHARM RES, V10, P112, DOI 10.1080/19466315.2018.1437071; Loewe S., 1928, ERGEBN PHYSL, V27, P47, DOI [10.1007/BF02322290, DOI 10.1007/BF02322290]; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Nelsen R. B., 2016, INTRO COPULAS; Palmer AC, 2017, CELL, V171, P1678, DOI 10.1016/j.cell.2017.11.009; Rosner B., 2017, FUNDAMENTALS BIOSTAT; Saul A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000850; Searle S.R., 1971, LINEAR MODELS; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Straetemans Roel, 2010, Front Biosci (Elite Ed), V2, P266, DOI 10.2741/e89; Tallarida RJ, 2002, PAIN, V98, P163, DOI 10.1016/S0304-3959(02)00041-6; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Verrier F, 2001, J VIROL, V75, P9177, DOI 10.1128/JVI.75.19.9177-9186.2001; Wackerly D.D., 2008, MATH STAT APPL; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097414; Webb JL, 1963, ENZYME METABOLIC INH, VI; Yu D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16991; Zhao W, 2014, J BIOMOL SCREEN, V19, P817, DOI 10.1177/1087057114521867	50	47	47	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0224137	10.1371/journal.pone.0224137	http://dx.doi.org/10.1371/journal.pone.0224137			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765385	Green Published, Green Submitted, gold			2022-12-26	WOS:000533891000004
J	Pereira, MC; Guimaraes, ID; Acosta-Avalos, D; Antonialli, WF				Pereira, Marlon Cesar; Guimaraes, Ingrid de Carvalho; Acosta-Avalos, Daniel; Antonialli Junior, William Fernando			Can altered magnetic field affect the foraging behaviour of ants?	PLOS ONE			English	Article							GEOMAGNETIC-FIELD; ATTA-COLOMBICA; ORIENTATION; COMPASS; HYMENOPTERA; MAGNETORECEPTION; OPTIMIZATION; ANTENNAE; SYSTEM; SENSITIVITY	Social insects such as ants can use geomagnetic field information in orientation and navigation tasks. However, few studies have assessed the effect of magnetic fields on aspects such as orientation and decision making during foraging of ants. Therefore, the present study aims to test the hypothesis that foragers of different species of ants with different foraging strategies when under effect of applied magnetic field change the patterns of search for resources and recruitment of ants. We used two species with solitary foraging strategy, Ectatomma brunneum and Neoponera inversa, and another with mass recruitment, Pheidole sp. The experiments were performed in field and laboratory conditions. We used some parameters for comparison such as speed, distance and time during foraging in the field and laboratory experiments, under normal and applied magnetic field with the coils on and off. We also performed SQUID magnetometry analysis for all species. The results demonstrate that changes in normal values of magnetic field affect workers behaviour of the three species. Thus, we can conclude that ants under the effect of applied magnetic fields can suffer significant changes in their foraging activities decreasing the flow of workers, increasing the travelled distance from the nest to the resource and back to the nest, in addition to time and distance to fetch the resource and decision-making, in both types of species, those which have mass recruitment, or forage individually, and that the three species are magnetosensitive, being affected by changes of low intensity in the local magnetic field.	[Pereira, Marlon Cesar; Antonialli Junior, William Fernando] Fundacao Univ Fed Grande Dourados, Programa Posgrad Entomol & Conservacao Biodiversi, Dourados, MS, Brazil; [Pereira, Marlon Cesar; Guimaraes, Ingrid de Carvalho; Antonialli Junior, William Fernando] Univ Estadual Mato Grosso do Sul, Ctr Studies Nat Resources, Lab Ecol Comportamental, Dourados, MS, Brazil; [Guimaraes, Ingrid de Carvalho; Antonialli Junior, William Fernando] Univ Estadual Mato Grosso do Sul, Programa Posgrad Recursos Nat, Dourados, MS, Brazil; [Acosta-Avalos, Daniel] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, RJ, Brazil	Universidade Federal da Grande Dourados; Universidade Estadual de Mato Grosso do Sul; Universidade Estadual de Mato Grosso do Sul; Centro Brasileiro de Pesquisas Fisicas	Guimaraes, ID (corresponding author), Univ Estadual Mato Grosso do Sul, Ctr Studies Nat Resources, Lab Ecol Comportamental, Dourados, MS, Brazil.; Guimaraes, ID (corresponding author), Univ Estadual Mato Grosso do Sul, Programa Posgrad Recursos Nat, Dourados, MS, Brazil.	guimaraes_ingrid@yahoo.com.br	Acosta-Avalos, Daniel/M-3294-2019	Acosta-Avalos, Daniel/0000-0002-5784-754X; Guimaraes, Ingrid/0000-0001-8036-2703	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [307998/2014-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, http://www.capes.gov.br/, to MCP; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul, http://www.fundect.ms.gov.br/, to ICG; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://cnpq.br/, grant number 307998/2014-2, to WFAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA FJ, 1993, J THEOR BIOL, V160, P297, DOI 10.1006/jtbi.1993.1020; Acosta-Avalos D, 2001, NATURWISSENSCHAFTEN, V88, P343, DOI 10.1007/s001140100245; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ANDERSON JB, 1993, NATURWISSENSCHAFTEN, V80, P568, DOI 10.1007/BF01149274; Balmori A, 2015, SCI TOTAL ENVIRON, V518, P58, DOI 10.1016/j.scitotenv.2015.02.077; Banks AN, 2003, ETHOLOGY, V109, P835, DOI 10.1046/j.0179-1613.2003.00927.x; Bennet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101150; Berthouze L, 2008, LECT NOTES ARTIF INT, V5040, P113; Billen Johan, 2006, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V17, P9; Buehlmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033117; Buhl J, 2009, BEHAV ECOL SOCIOBIOL, V63, P451, DOI 10.1007/s00265-008-0680-7; Camlitepe Y, 2005, ACTA BIOL HUNG, V56, P215, DOI 10.1556/ABiol.56.2005.3-4.5; Cammaerts MC, 2012, BELG J ZOOL, V142, P147; de Oliveira JF, 2010, J R SOC INTERFACE, V7, P143, DOI 10.1098/rsif.2009.0102; Dunlop D. J., 2002, Journal of Geophysical Research, V107, pEPM5, DOI [10.1029/2001JB000486, 10.1029/2001JB000487]; Fleischmann PN, 2018, CURR BIOL, V28, P1440, DOI 10.1016/j.cub.2018.03.043; FRANKS NR, 1991, J INSECT BEHAV, V4, P583, DOI 10.1007/BF01048072; GOTTWALD WH, 1995, ARMY ANTS BIOL SOCIA; Gudmundsson GA, 2000, J EXP BIOL, V203, P3137; Hansen MF, 1999, J MAGN MAGN MATER, V203, P214, DOI 10.1016/S0304-8853(99)00238-3; Holldobler B., 1990, pi; Hsu CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000395; Jander R, 1998, ETHOLOGY, V104, P743, DOI 10.1111/j.1439-0310.1998.tb00108.x; Jardine M, 2010, SCIENCE, V327, P1206, DOI 10.1126/science.1187051; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; KALMIJN AJ, 1981, IEEE T MAGN, V17, P1113, DOI 10.1109/TMAG.1981.1061156; KERMARREC A, 1981, INSECT SOC, V28, P40, DOI 10.1007/BF02223621; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; Krylov VV, 2015, IZV ATMOS OCEAN PHY+, V51, P752, DOI 10.1134/S0001433815070051; Kumari M, 2015, GEOCHEM GEOPHY GEOSY, V16, P1739, DOI 10.1002/2015GC005744; Latty T, 2011, J R SOC INTERFACE, V8, P1298, DOI 10.1098/rsif.2010.0612; LOHMANN KJ, 1991, J EXP BIOL, V155, P37; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; Miguel TB, 2005, REV BRAS ZOO, V7, P285; Peck MA, 2011, J APPL PHYS, V109, DOI 10.1063/1.3556953; Pereira-Bomfim MGC, 2015, SOCIOBIOLOGY, V62, P99; Perna A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002592; PHILLIPS JB, 1986, SCIENCE, V233, P765, DOI 10.1126/science.3738508; Pie MR, 2002, J INSECT BEHAV, V15, P25, DOI 10.1023/A:1014475927822; Prozorov R, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.054406; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; Reid CR, 2011, J EXP BIOL, V214, P50, DOI 10.1242/jeb.048173; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Riveros A.J., 2010, ENCY ANIMAL BEHAV, V2, P305; Sandoval EL, 2012, J INSECT BEHAV, V25, P612, DOI 10.1007/s10905-012-9327-7; Sole RV, 2000, ARTIF LIFE, V6, P219, DOI 10.1162/106454600568843; Tomanova K, 2016, J EXP BIOL, V219, P1717, DOI 10.1242/jeb.132878; Traniello James F.A., 1995, P241; Vacha M, 1997, BIOLOGIA, V52, P629; Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612; Wajnberg E, 2004, BIOMETALS, V17, P467, DOI 10.1023/B:BIOM.0000029443.93732.62; Wajnberg E, 2017, BIOMETALS, V30, P541, DOI 10.1007/s10534-017-0024-z; Wajnberg E, 2010, J R SOC INTERFACE, V7, pS207, DOI 10.1098/rsif.2009.0526.focus; WALCOTT C, 1974, SCIENCE, V184, P180, DOI 10.1126/science.184.4133.180; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Walz F, 2002, J PHYS-CONDENS MAT, V14, pR285, DOI 10.1088/0953-8984/14/12/203; Weaver JC, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70016-X; Wiltschko R, 2007, HFSP J, V1, P41, DOI [10.2976/1.2714294, 10.2976/1.2714294/10.2976/1]; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Winklhofer M, 2010, J R SOC INTERFACE, V7, pS131, DOI 10.1098/rsif.2010.0010.focus; Wirth R, 1997, J TROP ECOL, V13, P741, DOI 10.1017/S0266467400010907; Woods HA, 2015, J THERM BIOL, V54, P86, DOI 10.1016/j.jtherbio.2014.10.002	62	4	4	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225507	10.1371/journal.pone.0225507	http://dx.doi.org/10.1371/journal.pone.0225507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765398	gold, Green Published			2022-12-26	WOS:000533891000032
J	Huang, CI; Wang, CC; Tai, TS; Hwang, TZ; Yang, CC; Hsu, CM; Su, YC				Huang, Chung-, I; Wang, Chih-Chun; Tai, Tzong-Shyuan; Hwang, Tzer-Zen; Yang, Chuan-Chien; Hsu, Chin-Mu; Su, Yu-Chieh			eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy	PLOS ONE			English	Article							CANCER; EXPRESSION; MTOR; PATHWAY; TARGETS; PROTEIN; GROWTH; RISK	There is high risk of metastasis and recurrence in head and neck squamous cell carcinoma (HNSCC) patients, especially for patient who received definitive surgery and adjuvant radiotherapy. Aberrant activation of PI3K/AKT/mTOR signaling occurs in approximately 80% of HNSCC, which has been indicated to serve as prognostic biomarkers for patients suffer from recurrence or metastasis. Therefore, in this study, we focus on the relationship between the expression level of signaling factors in PI3K/AKT/mTOR pathway and recurrence tumor from HNSCC patients. A tissue microarray (TMA) was constructed from 54 cases of HNSCC patients who received definitive surgery and adjuvant radiotherapy, are followed more than 5 years, and with no previous malignancy and synchronous tumor. Slides were scored and dichotomized by two pathologists and scores. Based on the TMA block with IHC staining, the results showed that PI3K/AKT/mTOR signaling was highly activated both in recurrence and non-recurrence patients. Particularly, in the recurrence population, the results showed the low expression phospho-eukaryotic initiation factor 4E (p-eIF4E) or high expression eIF4E, phospho-eIF4E binding protein 1 (p-4EBP1), phosphoribosomal protein S6 kinase beta-1 (p-S6K1) and phospho-40S ribosomal protein S6 (pS6R) exhibited worse overall survival. The expression level of eIF4E and p-4EBP1 were significantly associated with tumor recurrence and recurrence-free survival. Furthermore, high expression level of eIF4E and p-4EBP1 had worse recurrence-free survival. In conclusion, the expression of eIF4E and p-4EBP1 should be considered as predictive biomarkers for the HNSCC patients. This may contribute to potential predictive biomarkers for HNSCC patient who receive adjuvant radiotherapy.	[Huang, Chung-, I] E Da Canc Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Wang, Chih-Chun; Hwang, Tzer-Zen; Yang, Chuan-Chien] E Da Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Tai, Tzong-Shyuan] E Da Hosp, Dept Med Res, Kaohsiung, Taiwan; [Hsu, Chin-Mu; Su, Yu-Chieh] E Da Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan; [Su, Yu-Chieh] I Shou Univ, Sch Med, Kaohsiung, Taiwan	E-Da Hospital; E-Da Hospital; E-Da Hospital; E-Da Hospital; I Shou University	Su, YC (corresponding author), E Da Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan.; Su, YC (corresponding author), I Shou Univ, Sch Med, Kaohsiung, Taiwan.	hepatoma@gmail.com		Su, Yu-Chieh/0000-0002-1771-9017				Akhter M, 2011, J Oral Maxillofac Pathol, V15, P168, DOI 10.4103/0973-029X.84485; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Blatt S, 2016, CLIN ORAL INVEST, V20, P2097, DOI 10.1007/s00784-015-1699-6; Chin D, 2006, EXPERT REV ANTICANC, V6, P1111, DOI 10.1586/14737140.6.7.1111; Clark C, 2010, LARYNGOSCOPE, V120, P1159, DOI 10.1002/lary.20917; D'Abronzo LS, 2018, NEOPLASIA, V20, P563, DOI 10.1016/j.neo.2018.04.003; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fisher SB, 2012, HPB, V14, P514, DOI 10.1111/j.1477-2574.2012.00489.x; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Freudlsperger C, 2011, EXPERT OPIN THER TAR, V15, P63, DOI 10.1517/14728222.2011.541440; Garcia-Carracedo D, 2016, ONCOTARGET, V7, P29780, DOI 10.18632/oncotarget.8957; Geiger JL, 2016, HEAD NECK-J SCI SPEC, V38, P1759, DOI 10.1002/hed.24501; Georges P, 2014, WORLD J CLIN ONCOL, V5, P966, DOI 10.5306/wjco.v5.i5.966; Hildebrandt MAT, 2012, CLIN CANCER RES, V18, P3705, DOI 10.1158/1078-0432.CCR-11-3271; Hwang TZ, 2015, INT J CANCER, V137, P395, DOI 10.1002/ijc.29330; Jiang Y, 2002, CANCER RES, V62, P1910; Josse L, 2016, BIOCHEM J, V473, P4651, DOI 10.1042/BCJ20160845; Khan KH, 2013, CHIN J CANCER, V32, P253, DOI 10.5732/cjc.013.10057; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim YS, 2017, RADIAT ONCOL J, V35, P1, DOI 10.3857/roj.2017.00122; Kozakiewicz P, 2018, ONCOL LETT, V15, P7497, DOI 10.3892/ol.2018.8300; Lee CC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001114; Mazumdar T, 2014, MOL CANCER THER, V13, P2738, DOI 10.1158/1535-7163.MCT-13-1090; Millican-Slater RA, 2016, BRIT J CANCER, V115, P339, DOI 10.1038/bjc.2016.178; Ram H, 2011, J MAXILLOFAC ORAL SU, V10, P132, DOI 10.1007/s12663-011-0195-z; Ribeiro IP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14377-x; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sethi Kruttibas, 2011, J Exp Ther Oncol, V9, P187; Soni A, 2008, MOL CANCER THER, V7, P1782, DOI 10.1158/1535-7163.MCT-07-2357; Takes RP, 2010, HEAD NECK-J SCI SPEC, V32, P1693, DOI 10.1002/hed.21361; Worsham MJ, 2011, EXPERT REV ANTICANC, V11, P1321, DOI [10.1586/era.11.135, 10.1586/ERA.11.135]	34	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225537	10.1371/journal.pone.0225537	http://dx.doi.org/10.1371/journal.pone.0225537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756179	gold, Green Published			2022-12-26	WOS:000533889300036
J	Giordano, A; Liu, YY; Armeson, K; Park, Y; Ridinger, M; Erlander, M; Reuben, J; Britten, C; Kappler, C; Yeh, E; Ethier, S				Giordano, Antonio; Liu, Yueying; Armeson, Kent; Park, Yeonhee; Ridinger, Maya; Erlander, Mark; Reuben, James; Britten, Carolyn; Kappler, Christiana; Yeh, Elizabeth; Ethier, Stephen			Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer	PLOS ONE			English	Article							PHASE-II TRIAL; VOLASERTIB BI 6727; DOSE-ESCALATION; CELL-LINES; OPEN-LABEL; EXPERIMENTAL-DESIGN; ANTITUMOR-ACTIVITY; OVARIAN-CANCER; CHEMOTHERAPY; COMBINATION	Within triple negative breast cancer, several molecular subtypes have been identified, underlying the heterogeneity of such an aggressive disease. The basal-like subtype is characterized by mutations in the TP53 gene, and is associated with a low pathologic complete response rate following neoadjuvant chemotherapy. In a genome-scale short hairpin RNA (shRNA) screen of breast cancer cells, polo-like kinase 1 (Plk1) was a frequent and strong hit in the basal breast cancer cell lines indicating its importance for growth and survival of these breast cancer cells. Plk1 regulates progression of cells through the G2-M phase of the cell cycle. We assessed the activity of two ATP-competitive Plk1 inhibitors, GSK461364 and onvansertib, alone and with a taxane in a set of triple negative breast cancer cell lines and in vivo. GSK461364 showed synergism with docetaxel in SUM149 (Combination Index 0.70) and SUM159 (CI, 0.62). GSK461364 in combination with docetaxel decreased the clonogenic potential (interaction test for SUM149 and SUM159, p<0.001 and p = 0.01, respectively) and the tumorsphere formation of SUM149 and SUM159 (interaction test, p = 0.01 and p<0.001). In the SUM159 xenograft model, onvansertib plus paclitaxel significantly decreased tumor volume compared to single agent paclitaxel (p<0.0001). Inhibition of Plk1 in combination with taxanes shows promising results in a subset of triple negative breast cancer intrinsically resistant to chemotherapy. Onvansertib showed significant tumor volume shrinkage when combined with paclitaxel in vivo and should be considered in clinical trials for the treatment of triple negative cancers.	[Giordano, Antonio; Liu, Yueying; Britten, Carolyn] Med Univ South Carolina, Dept Med, Div Hematol & Oncol, Charleston, SC 29425 USA; [Armeson, Kent; Park, Yeonhee] Med Univ South Carolina, Hollings Canc Ctr, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Ridinger, Maya; Erlander, Mark] Trovagene Oncol, San Diego, CA USA; [Reuben, James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Kappler, Christiana; Ethier, Stephen] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Yeh, Elizabeth] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Medical University of South Carolina; Medical University of South Carolina; University of Texas System; UTMD Anderson Cancer Center; Medical University of South Carolina; Indiana University System; Indiana University Bloomington	Giordano, A (corresponding author), Med Univ South Carolina, Dept Med, Div Hematol & Oncol, Charleston, SC 29425 USA.	giordana@musc.edu	Park, Yeonhee/ABE-8543-2020	Giordano, Antonio/0000-0002-7760-9717	Paul Calabresi K12 funding, Hollings Cancer Center, Medical University of South Carolina [K12 CA157688]; Cell Evaluation & Therapy Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; Genomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; Biostatistics Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; NATIONAL CANCER INSTITUTE [K12CA157688, P30CA138313] Funding Source: NIH RePORTER	Paul Calabresi K12 funding, Hollings Cancer Center, Medical University of South Carolina; Cell Evaluation & Therapy Shared Resource, Hollings Cancer Center, Medical University of South Carolina; Genomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; Biostatistics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AG work was supported in part by the Paul Calabresi K12 funding, Hollings Cancer Center, Medical University of South Carolina (K12 CA157688); this work was supported in part by the Cell Evaluation & Therapy Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313); SE was supported in part by the Genomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; KA was supported in part by the Biostatistics Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313).	Archambault V, 2017, CELL CYCLE, V16, P1220, DOI 10.1080/15384101.2017.1325043; Awad MM, 2017, LUNG CANCER, V104, P126, DOI 10.1016/j.lungcan.2016.12.019; Awada A, 2015, INVEST NEW DRUG, V33, P611, DOI 10.1007/s10637-015-0223-9; Balic M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-358; Beria I, 2011, BIOORG MED CHEM LETT, V21, P2969, DOI 10.1016/j.bmcl.2011.03.054; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Casolaro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058424; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; de Braud F, 2015, ANN ONCOL, V26, P2341, DOI 10.1093/annonc/mdv354; Degenhardt Y, 2010, MOL CANCER THER, V9, P2079, DOI 10.1158/1535-7163.MCT-10-0095; Dibb M, 2012, BRIT J CANCER, V107, P1766, DOI 10.1038/bjc.2012.424; Ellis PM, 2015, CLIN LUNG CANCER, V16, P457, DOI 10.1016/j.cllc.2015.05.010; Ellis PM, 2013, CLIN LUNG CANCER, V14, P19, DOI 10.1016/j.cllc.2012.04.003; Ethier S., 2018, SUMLINEKNOWLEDGEBASE; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Frost A, 2012, CURR ONCOL, V19, pE28, DOI 10.3747/co.19.866; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Gilmartin AG, 2009, CANCER RES, V69, P6969, DOI 10.1158/0008-5472.CAN-09-0945; Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897; Hartsink-Segers SA, 2013, HAEMATOLOGICA, V98, P1539, DOI 10.3324/haematol.2013.084434; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hugle M, 2015, CELL DEATH DIFFER, V22, P1946, DOI 10.1038/cdd.2015.59; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kappler CS, 2015, MOL ONCOL, V9, P527, DOI 10.1016/j.molonc.2014.10.006; Korangath P, 2015, CLIN CANCER RES, V21, P3263, DOI 10.1158/1078-0432.CCR-14-1200; Lacerda L, 2014, STEM CELL TRANSL MED, V3, P849, DOI 10.5966/sctm.2013-0204; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lin CC, 2014, BRIT J CANCER, V110, P2434, DOI 10.1038/bjc.2014.195; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Machiels JP, 2015, CANCER CHEMOTH PHARM, V76, P843, DOI 10.1007/s00280-015-2860-2; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Mross K, 2012, BRIT J CANCER, V107, P280, DOI 10.1038/bjc.2012.257; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Mukhopadhyay NK, 2017, SCI REP-UK, V7, DOI 10.1038/srep46017; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nokihara H, 2016, INVEST NEW DRUG, V34, P66, DOI 10.1007/s10637-015-0300-0; Oliver PG, 2012, BREAST CANCER RES TR, V133, P417, DOI 10.1007/s10549-011-1755-0; Olmos D, 2011, CLIN CANCER RES, V17, P3420, DOI 10.1158/1078-0432.CCR-10-2946; Park Jung-Eun, 2017, F1000Res, V6, P1024, DOI 10.12688/f1000research.11398.1; Perez EA, 2001, J CLIN ONCOL, V19, P4216, DOI 10.1200/JCO.2001.19.22.4216; Posch C, 2015, J INVEST DERMATOL, V135, P2475, DOI 10.1038/jid.2015.198; Prat A, 2013, BREAST CANCER RES TR, V142, P237, DOI 10.1007/s10549-013-2743-3; Pujade-Lauraine E, 2016, J CLIN ONCOL, V34, P706, DOI 10.1200/JCO.2015.62.1474; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Schoffski P, 2012, EUR J CANCER, V48, P179, DOI 10.1016/j.ejca.2011.11.001; Schoffski P, 2010, EUR J CANCER, V46, P2206, DOI 10.1016/j.ejca.2010.03.039; Sebastian M, 2010, J THORAC ONCOL, V5, P1060, DOI 10.1097/JTO.0b013e3181d95dd4; Sero V, 2014, INVEST NEW DRUG, V32, P1167, DOI 10.1007/s10637-014-0158-6; Sharma P, 2018, CLIN CANCER RES, V24, P5820, DOI 10.1158/1078-0432.CCR-18-0585; Stadler WM, 2014, CANCER-AM CANCER SOC, V120, P976, DOI 10.1002/cncr.28519; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Streicher KL, 2007, MOL CANCER RES, V5, P847, DOI 10.1158/1541-7786.MCR-06-0427; TAIT L, 1990, CANCER RES, V50, P6087; Tan J, 2013, CANCER DISCOV, V3, P1156, DOI 10.1158/2159-8290.CD-12-0595; Team,R.C, 2018, R LANG ENV STAT COMP; Valsasina B, 2012, MOL CANCER THER, V11, P1006, DOI 10.1158/1535-7163.MCT-11-0765; Weiss GJ, 2018, INVEST NEW DRUG, V36, P85, DOI 10.1007/s10637-017-0491-7; Weiss LM, 2016, INT J CANCER, V138, P497, DOI 10.1002/ijc.29725; Yang AM, 2017, CANCER RES, V77, P6641, DOI 10.1158/0008-5472.CAN-16-3452; Zhang N, 2016, AM J CANCER RES, V6, P97; Zhang Z, 2016, ONCOL LETT, V11, P2685, DOI 10.3892/ol.2016.4228; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	69	21	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0224420	10.1371/journal.pone.0224420	http://dx.doi.org/10.1371/journal.pone.0224420			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751384	Green Published, gold			2022-12-26	WOS:000533886900011
J	Mat, S; Jaafar, MH; Ng, CT; Sockalingam, S; Raja, J; Kamaruzzaman, SB; Chin, AV; Abbas, AA; Chan, CK; Hairi, NN; Othman, S; Cumming, RG; Tey, NP; Tan, MP				Mat, Sumaiyah; Jaafar, Mohamad Hasif; Ng, Chin Teck; Sockalingam, Sargunan; Raja, Jasmin; Kamaruzzaman, Shahrul Bahyah; Chin, Ai-Vyrn; Abbas, Azlina Amir; Chan, Chee Ken; Hairi, Noran Naqiah; Othman, Sajaratulnisah; Cumming, Robert G.; Tey, Nai Peng; Tan, Maw Pin			Ethnic differences in the prevalence, socioeconomic and health related risk factors of knee pain and osteoarthritis symptoms in older Malaysians	PLOS ONE			English	Article							CHINESE POPULATION; UNITED-STATES; MANAGEMENT; IMPACT; HAND; HIP	Knee pain is often underreported, underestimated and undertreated. This study was conducted to estimate the prevalence, burden and further identify socioeconomic factors influencing ethnic differences in knee pain and symptoms of OA among older adults aged 55 years and over in Greater Kuala Lumpur (the capital city of Malaysia). The sample for the Malaysian Elders Longitudinal Research (MELoR) was selected using stratified random sampling, by age and ethnicity from the electoral rolls of three parliamentary constituencies. Information on knee pain was available in 1226 participants, mean age (SD) 68.96 (1.57) years (409 Malay, 416 Chinese, 401 Indian). The crude and weighted prevalence of knee pain and self-reported knee OA symptoms were 33.3% and 30.8% respectively. There were significant ethnic differences in knee pain (crude prevalence: Malays 44.6%, Chinese 23.5% and Indians 31.9%, p< 0.001). The presence of two or more non-communicable diseases (NCD) attenuated the increased risk of knee pain among the ethnic Indians compared to the ethnic Chinese. The prevalence of knee pain remained significantly higher among the ethnic Malays after adjustment for confounders. While the prevalence of knee pain in our older population appears similar to that reported in other published studies in Asia, the higher prevalence among the ethnic Malays has not previously been reported. Further research to determine potential genetic susceptibility to knee pain among the ethnic Malays is recommended.	[Mat, Sumaiyah; Jaafar, Mohamad Hasif; Tan, Maw Pin] Univ Malaya, Fac Med, Ageing & Age Associated Disorders Res Grp, Kuala Lumpur, Malaysia; [Jaafar, Mohamad Hasif] Perdana Univ, Res Management Ctr, Serdang, Selangor, Malaysia; [Ng, Chin Teck] Duke NUS Med Sch, Singapore, Singapore; [Ng, Chin Teck] Singapore Gen Hosp, Singapore, Singapore; [Sockalingam, Sargunan; Raja, Jasmin] Univ Malaya, Fac Med, Dept Rheumatol, Kuala Lumpur, Malaysia; [Kamaruzzaman, Shahrul Bahyah; Chin, Ai-Vyrn; Tan, Maw Pin] Univ Malaya, Fac Med, Dept Med, Geriatr Div, Kuala Lumpur, Malaysia; [Abbas, Azlina Amir; Chan, Chee Ken] Univ Malaya, Fac Med, Natl Orthopaed Ctr Excellence Res & Learning NOCE, Dept Orthopaed Surg, Kuala Lumpur, Malaysia; [Hairi, Noran Naqiah] Univ Malaya, Julius Ctr, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Othman, Sajaratulnisah] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Cumming, Robert G.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Tey, Nai Peng] Univ Malaya, Fac Econ & Adm, Kuala Lumpur, Malaysia; [Tan, Maw Pin] Univ Malaya, Ctr Innovat Med Engn, Kuala Lumpur, Malaysia; [Tan, Maw Pin] Sunway Univ, Sch Healthcare & Med Sci, Dept Med Sci, Bandar Sunway, Malaysia	Universiti Malaya; Perdana University; National University of Singapore; Singapore General Hospital; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; University of Sydney; Universiti Malaya; Universiti Malaya; Sunway University	Tan, MP (corresponding author), Univ Malaya, Fac Med, Ageing & Age Associated Disorders Res Grp, Kuala Lumpur, Malaysia.; Tan, MP (corresponding author), Univ Malaya, Fac Med, Dept Med, Geriatr Div, Kuala Lumpur, Malaysia.; Tan, MP (corresponding author), Univ Malaya, Ctr Innovat Med Engn, Kuala Lumpur, Malaysia.; Tan, MP (corresponding author), Sunway Univ, Sch Healthcare & Med Sci, Dept Med Sci, Bandar Sunway, Malaysia.	mptan@ummc.edu.my	HAIRI, NORAN/B-9339-2010; chan, chee ken/AAW-3676-2021; Ai-Vyrn, Chin/E-4237-2013; ABBAS, AZLINA AMIR/B-5405-2010; Mat, Sumaiyah/AFY-9404-2022; Mat, Sumaiyah/O-5610-2017; TEY, NAI PENG/B-5270-2010; SOCKALINGAM, SARGUNAN/B-9699-2010; Ng, Chin Teck/GRO-7239-2022; OTHMAN, SAJARATULNISAH/B-9673-2010; Tan, Maw Pin/G-6917-2011; Jaafar, Mohamad Hasif Hasif/AAX-3318-2021	HAIRI, NORAN/0000-0002-2692-9016; Ai-Vyrn, Chin/0000-0002-0332-0048; ABBAS, AZLINA AMIR/0000-0003-4423-4653; Mat, Sumaiyah/0000-0003-4973-6986; TEY, NAI PENG/0000-0003-3707-5033; SOCKALINGAM, SARGUNAN/0000-0002-7266-9526; Ng, Chin Teck/0000-0002-6396-1701; Tan, Maw Pin/0000-0002-3400-8540; Jaafar, Mohamad Hasif Hasif/0000-0002-8420-7580	Fundamental Research Grants Scheme from the Ministry of Education, Malaysia [FRGS/1/2019/SKK02/UM/01/1]; University of Malaya under the Wellness Research Centre (WRC) Impact-oriented Interdisciplinary Research Grant [IIRG024-2019]; Ministry of Education [UM.C/625/1/HIR/MOHE/ASH/02]; University of Malaya under the Wellness Research Centre (WRC) grant challenge grant [GC002A-HTM]	Fundamental Research Grants Scheme from the Ministry of Education, Malaysia; University of Malaya under the Wellness Research Centre (WRC) Impact-oriented Interdisciplinary Research Grant; Ministry of Education; University of Malaya under the Wellness Research Centre (WRC) grant challenge grant	This work was funded by the Fundamental Research Grants Scheme from the Ministry of Education, Malaysia ((FRGS/1/2019/SKK02/UM/01/1) and we would also like to acknowledge the financial support provided by University of Malaya under the Wellness Research Centre (WRC) Impact-oriented Interdisciplinary Research Grant (IIRG024-2019) and a High Impact Research Grant from the Ministry of Education (UM.C/625/1/HIR/MOHE/ASH/02) and University of Malaya under the Wellness Research Centre (WRC) grant challenge grant (GC002A-HTM). The funders of this study played no part in the design, data collection, data analysis or reporting of the study.	Barbour KE, 2017, MMWR-MORBID MORTAL W, V66, P246, DOI 10.15585/mmwr.mm6609e1; Barkin RL, 2007, RHEUM DIS CLIN N AM, V33, P1, DOI 10.1016/j.rdc.2006.12.001; Chia YC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011925; Cho HJ, 2015, CLIN ORTHOP RELAT R, V473, P3307, DOI 10.1007/s11999-015-4450-3; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Fransen M, 2011, INT J RHEUM DIS, V14, P113, DOI 10.1111/j.1756-185X.2011.01608.x; Gallup Healthways Well-being Index, 2016, GALLUP HEALTHWAYS WE; Ghoshal B, 2010, INDIA Q, V66, P69, DOI 10.1177/097492841006600105; Ho-Pham LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094563; Hodge WA, 2009, J ARTHROPLASTY, V24, P448, DOI 10.1016/j.arth.2007.12.012; Hong C. Y., 2004, SMJ Singapore Medical Journal, V45, P154; Jhun HJ, 2013, J KOREAN MED SCI, V28, P1807, DOI 10.3346/jkms.2013.28.12.1807; Kang XZ, 2009, ARTHRIT RHEUM-ARTHR, V61, P641, DOI 10.1002/art.24464; Khalaf H., CURIOUS CASE ARAB KN; King KB, 2015, OSTEOARTHR CARTILAGE, V23, P841, DOI 10.1016/j.joca.2015.03.031; Kirkman MS, 2015, OSTEOARTHR CARTILAGE, V23, P839, DOI 10.1016/j.joca.2015.03.030; Kraus VB, 2015, OSTEOARTHR CARTILAGE, V23, P1233, DOI 10.1016/j.joca.2015.03.036; Lian TC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157730; Lim LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173466; Liu Q, 2018, OSTEOARTHR CARTILAGE, V26, P1636, DOI 10.1016/j.joca.2018.07.019; Liu Y, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2782-x; Malaysia DoS, 2017, POP DISTR BAS DEM CH; Miranda H, 2002, OSTEOARTHR CARTILAGE, V10, P623, DOI 10.1053/joca.2002.0796; Muraki S, 2011, ARTHRIT CARE RES, V63, P1425, DOI 10.1002/acr.20562; National Institute on Aging, 2011, GLOB HLTH AG WORLD H; Nazaimoon WMW, 2013, DIABETIC MED, V30, P825, DOI 10.1111/dme.12161; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Silverwood V, 2015, OSTEOARTHR CARTILAGE, V23, P507, DOI 10.1016/j.joca.2014.11.019; Smith D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099048; Thiem U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060753; Thomas E, 2014, RHEUMATOLOGY, V53, P338, DOI 10.1093/rheumatology/ket346; Tormalehto S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219902; Turkiewicz A, 2015, RHEUMATOLOGY, V54, P827, DOI 10.1093/rheumatology/keu409; United Nations DoEaSA Population Division, 2019, WORLD POPPROSP 2019; van Schoor NM, 2016, QUAL LIFE RES, V25, P1423, DOI 10.1007/s11136-015-1171-8; Vaughn IA, 2019, J PAIN, V20, P629, DOI 10.1016/j.jpain.2018.11.012; Williams MF, 2016, J DIABETES COMPLICAT, V30, P944, DOI 10.1016/j.jdiacomp.2016.02.016; Zhang YQ, 2001, ARTHRITIS RHEUM, V44, P2065, DOI 10.1002/1529-0131(200109)44:9<2065::AID-ART356>3.0.CO;2-Z	39	8	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225075	10.1371/journal.pone.0225075	http://dx.doi.org/10.1371/journal.pone.0225075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751378	Green Published, gold			2022-12-26	WOS:000533886900028
J	Agarwal-Harding, KJ; Chokotho, L; Young, S; Mkandawire, N; Chawinga, M; Losina, E; Katz, JN				Agarwal-Harding, Kiran J.; Chokotho, Linda; Young, Sven; Mkandawire, Nyengo; Chawinga, Mabvuto; Losina, Elena; Katz, Jeffrey N.			Assessing the capacity of Malawi's district and central hospitals to manage traumatic diaphyseal femoral fractures in adults	PLOS ONE			English	Article							GLOBAL BURDEN; MUSCULOSKELETAL IMPAIRMENT; SYSTEMATIC ANALYSIS; CARE CAPACITY; INJURIES; DISEASE; SURGERY; CHALLENGES; HEALTH; EPIDEMIOLOGY	Background The burden of musculoskeletal trauma is growing worldwide, disproportionately affecting low-income countries like Malawi. However, resources required to manage musculoskeletal trauma remain inadequate. A detailed understanding of the current capacity of Malawian public hospitals to manage musculoskeletal trauma is unknown and necessary for effective trauma system development planning. Methods We developed a list of infrastructure, manpower, and material resources used during treatment of adult femoral shaft fractures-a representative injury managed non-operatively and operatively in Malawi. We identified, by consensus of at least 7 out of 10 experts, which items were essential at district and central hospitals. We surveyed orthopaedic providers in person at all 25 district and 4 central hospitals in Malawi on the presence, availability, and reasons for unavailability of essential resources. We validated survey responses by performing simultaneous independent on-site assessments of 25% of the hospitals. Results No district or central hospital in Malawi had available all the essential resources to adequately manage femoral fractures. On average, district hospitals had 71% (range 41-90%) of essential resources, with at least 15 of 25 reporting unavailability of inpatient ward nurses, x-ray, external fixators, gauze and bandages, and walking assistive devices. District hospitals offered only non-operative treatment, though 24/25 reported barriers to performing skeletal traction. Central hospitals reported an average of 76% (71-85%) of essential resources, with at least 2 of 4 hospitals reporting unavailability of full blood count, inpatient hospital beds, a procedure room, an operating room, casualty/A&E department clinicians, orthopaedic clinicians, a circulating nurse, inpatient ward nurses, electrocardiograms, x-ray, suture, and walking assistive devices. All four central hospitals reported barriers to performing skeletal traction. Operative treatment of femur fracture with a reliable supply of implants was available at 3/4 hospitals, though 2/3 were dependent entirely on foreign donations. Conclusion We identified critical deficiencies in infrastructure, manpower, and essential resources at district and central hospitals in Malawi. Our findings provide evidence-based guidance on how to improve the musculoskeletal trauma system in Malawi, by identifying where and why essential resources were unavailable when needed.	[Agarwal-Harding, Kiran J.] Harvard Combined Orthopaed Residency Program, Boston, MA 02114 USA; [Agarwal-Harding, Kiran J.; Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res, 75 Francis St, Boston, MA 02115 USA; [Chokotho, Linda; Mkandawire, Nyengo] Queen Elizabeth Cent Hosp, Dept Orthoped, Blantyre, Malawi; [Young, Sven] Haukeland Hosp, Dept Orthoped, Bergen, Norway; [Young, Sven; Chawinga, Mabvuto] Kamuzu Cent Hosp, Dept Orthoped, Lilongwe, Malawi; [Mkandawire, Nyengo] Univ Malawi, Coll Med, Blantyre, Malawi; [Chawinga, Mabvuto] Malawi Minist Hlth, Dept Clin Serv, Lilongwe, Malawi; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Katz, Jeffrey N.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Katz, Jeffrey N.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Malawi; University of Bergen; Haukeland University Hospital; University of Malawi; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Agarwal-Harding, KJ (corresponding author), Harvard Combined Orthopaed Residency Program, Boston, MA 02114 USA.; Agarwal-Harding, KJ (corresponding author), Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res, 75 Francis St, Boston, MA 02115 USA.	kagarwal-harding@partners.org		Agarwal-Harding, Kiran/0000-0003-1485-5950; Chokotho, Linda/0000-0003-1569-3885	Clinical Orthopedic and Musculoskeletal Education and Training Program at Brigham and Women's Hospital [NIH AR-T32-055885]; Global and Humanitarian Health Center of Excellence Travel Grant from Partners Healthcare; National Institutes of Health (NIH) [AR-P300072577, AR-K24-057827]; AO Alliance Foundation; COE Travel Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR072577, T32AR055885, K24AR057827] Funding Source: NIH RePORTER	Clinical Orthopedic and Musculoskeletal Education and Training Program at Brigham and Women's Hospital; Global and Humanitarian Health Center of Excellence Travel Grant from Partners Healthcare; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AO Alliance Foundation; COE Travel Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	One author (K.J.A.H.) was supported by the Clinical Orthopedic and Musculoskeletal Education and Training Program at Brigham and Women's Hospital (NIH AR-T32-055885), and a Global and Humanitarian Health Center of Excellence Travel Grant from Partners Healthcare. Two authors received funding from the National Institutes of Health (NIH) from grants AR-P300072577 (E.L. and J.N.K.) and AR-K24-057827 (E. L.). Two authors of this study (K.J.A.H. and L.C.) received grant support from the AO Alliance Foundation. Partners COE Travel Grant: https://www.partners.org/Graduate-Medical-Education/Centers-Of-Expertise/Global-And-HumanitarianHealth/Travel-Grant/Default.aspx.AO Alliance Foundation: https://ao-alliance.org/.All funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal-Harding KJ, 2019, J BONE JOINT SURG AM, V101, P920, DOI 10.2106/JBJS.18.00516; Agarwal-Harding KJ, 2015, J BONE JOINT SURG AM, V97A, DOI 10.2106/JBJS.N.00314; Agarwal-Harding KJ, 2019, MALAWI MED J; Alkire BC, 2015, LANCET GLOB HEALTH, V3, pE316, DOI 10.1016/S2214-109X(15)70115-4; Audige L, 2016, J SHOULDER ELB SURG, V25, P1907, DOI 10.1016/j.jse.2016.04.036; Chagomerana MB, 2017, INT J SURG, V39, P23, DOI 10.1016/j.ijsu.2017.01.047; Chokotho L, 2016, INJURY, V47, P1990, DOI 10.1016/j.injury.2015.10.036; Chokotho L, 2014, INJURY, V45, P2065, DOI 10.1016/j.injury.2014.10.001; Cornelissen D, 2018, WORLD J SURG, V42, P46, DOI 10.1007/s00268-017-4166-5; Eaton J, 2017, INJURY, V48, P1432, DOI 10.1016/j.injury.2017.05.023; Elliott IS, 2015, CLIN ORTHOP RELAT R, V473, P380, DOI 10.1007/s11999-014-4017-8; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Grimes CE, 2014, TROP DOCT, V44, P128, DOI 10.1177/0049475514535575; Jaffry Z, 2017, TROP DOCT, V47, P286, DOI 10.1177/0049475517690333; Kiser MM, 2012, INT J SURG, V10, P611, DOI 10.1016/j.ijsu.2012.10.004; Kotagal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091862; Lau BC, 2018, J ORTHOP TRAUMA, V32, pS52, DOI 10.1097/BOT.0000000000001299; Lavy C, 2007, ANN ROY COLL SURG, V89, P722, DOI 10.1308/003588407X209329; Linden AF, 2012, WORLD J SURG, V36, P1056, DOI 10.1007/s00268-012-1482-7; Alarcon MDL, 2019, J GERIATR ONCOL, V10, P643, DOI 10.1016/j.jgo.2019.03.012; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Matheson JIDM, 2011, WORLD J SURG, V35, P2635, DOI 10.1007/s00268-011-1293-2; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mkandawire N, 2008, CLIN ORTHOP RELAT R, V466, P2385, DOI 10.1007/s11999-008-0366-5; Mock C., 2004, GUIDELINES ESSENTIAL; Mock C, 2008, CLIN ORTHOP RELAT R, V466, P2306, DOI 10.1007/s11999-008-0416-z; Mulwafu W, 2017, MALAWI MED J, V29, P198, DOI 10.4314/mmj.v29i2.23; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Peden M., 2004, WORLD REPORT ROAD TR; Samuel JC, 2009, WORLD J SURG, V33, P1836, DOI 10.1007/s00268-009-0113-4; Shrime MG, 2015, SURGERY, V158, P27, DOI 10.1016/j.surg.2015.03.025; Spiegel DA, 2015, WORLD J SURG, V39, P1421, DOI 10.1007/s00268-015-2971-2; Spiegel DA, 2008, J BONE JOINT SURG AM, V90A, P915, DOI 10.2106/JBJS.G.00637; Stewart BT, 2015, WORLD J SURG, V39, P2428, DOI 10.1007/s00268-015-3132-3; Varela C, 2017, MALAWI MED J, V29, P231, DOI 10.4314/mmj.v29i3.1; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; World Health Organization, 2013, GLOB STAT REP ROAD S; Yoon RS, 2018, BULL HOSP JT DIS, V76, P9; Young S, 2016, ACTA ORTHOP, V87, P632, DOI 10.1080/17453674.2016.1228413; Yu A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1075-y	42	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225254	10.1371/journal.pone.0225254	http://dx.doi.org/10.1371/journal.pone.0225254			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747420	Green Published, gold			2022-12-26	WOS:000533881900029
J	Lee, CK; Tsai, CP; Liao, TL; Huang, WN; Chen, YH; Lin, CH; Chen, YM				Lee, Chun-Kang; Tsai, Ching-Pei; Liao, Tsai-Ling; Huang, Wen-Nan; Chen, Yi-Hsing; Lin, Ching-Heng; Chen, Yi-Ming			Overactive bladder and bladder pain syndrome/interstitial cystitis in primary Sjogren's syndrome patients: A nationwide population-based study	PLOS ONE			English	Article							INTERSTITIAL CYSTITIS; MAST-CELL; PATHOPHYSIOLOGY; SYMPTOMS; AUTOANTIBODIES; DYSFUNCTION; ETIOLOGY; RANTES	To investigate the risks of overactive bladder (OAB) and bladder pain syndrome/interstitial cystitis (BPS/IC) in primary Sjogren's syndrome (pSS) patients. A nationwide, population-based cohort study was conducted using data from Taiwan's National Health Insurance Research Database. From 2001 to 2010, participants with newly diagnosed pSS were recognized as the study group. In addition, a comparison cohort of non-pSS participants was matched for age, gender, and initial diagnosis date. Risks of developing OAB and BPS/IC in pSS patients of different age, sex, and various therapeutic strategies were calculated. Hazard ratios (HR) and a 95% confidence interval (CI) were analyzed by Cox proportional hazard model. In total, 11,526 pSS patients were recognized. The HRs of OAB and BPS/IC in pSS patients were 1.68 (95% C.I.: 1.48-1.91, p<0.01) and 2.34 (95% C.I.: 1.59-3.44, p<0.01), respectively. The risks of OAB and BPS/IC were significantly increased for pSS patients aged < 65 years (HR: 1.73 and 2.67), female patients (HR: 1.74 and 2.34), and patients requiring treatment for dry eyes and dry mouth (HR: 2.06 and 2.93). pSS patients exhibited an increased risk of OAB and BPS/IC. Female gender, younger age, and severe glandular dysfunction requiring treatments were potential risk factors.	[Lee, Chun-Kang; Chen, Yi-Hsing] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Tsai, Ching-Pei] Taichung Vet Gen Hosp, Dept Obstet Gynecol & Womens Hlth, Taichung, Taiwan; [Liao, Tsai-Ling; Lin, Ching-Heng; Chen, Yi-Ming] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Liao, Tsai-Ling; Chen, Yi-Ming] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Liao, Tsai-Ling; Chen, Yi-Ming] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Huang, Wen-Nan; Chen, Yi-Hsing; Chen, Yi-Ming] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Huang, Wen-Nan; Chen, Yi-Hsing; Chen, Yi-Ming] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Lin, Ching-Heng] Fu Jen Catholic Univ, Dept Publ Hlth, New Taipei, Taiwan; [Lin, Ching-Heng] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Lin, Ching-Heng] Tunghai Univ, Dept Ind Engn & Enterprise Informat, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Fu Jen Catholic University; National Taipei University of Nursing & Health Science (NTUNHS); Tunghai University	Chen, YM (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, YM (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, YM (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, YM (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, YM (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.	ymchen1@vghtc.gov.tw	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065	Taichung Veterans General Hospital, Taiwan [TCVGH-1087312C]	Taichung Veterans General Hospital, Taiwan	YMC received a grant (TCVGH-1087312C) from Taichung Veterans General Hospital, Taiwan (https://www.vghtc.gov.tw/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Bouchelouche K, 2006, UROLOGY, V67, P214, DOI 10.1016/j.urology.2005.07.049; Chen MC, 2007, AM J PHYSIOL-RENAL, V292, pF1372, DOI 10.1152/ajprenal.00472.2006; Chung KH, 2014, NEUROUROL URODYNAM, V33, P101, DOI 10.1002/nau.22382; Darrieutort-Laffite C, 2015, JOINT BONE SPINE, V82, P245, DOI 10.1016/j.jbspin.2014.12.007; Gao H, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011003; Gosens R, 2009, EUR RESPIR J, V34, P1436, DOI 10.1183/09031936.00045209; Kruize AA, 1997, BRIT J OPHTHALMOL, V81, P435, DOI 10.1136/bjo.81.6.435; Lee KL, 2011, NEUROUROL URODYNAM, V30, P97, DOI 10.1002/nau.20887; Patnaik SS, 2017, ARCH GYNECOL OBSTET, V295, P1341, DOI 10.1007/s00404-017-4364-2; Silva RPE, 2019, LUPUS, V28, P27, DOI 10.1177/0961203318811605; Pijpe J, 2007, ANN RHEUM DIS, V66, P107, DOI 10.1136/ard.2006.052647; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Stefanski AL, 2017, DTSCH ARZTEBL INT, V114, P354, DOI 10.3238/arztebl.2017.0354; Tarhan, 2013, WORLD J NEPHROL UROL, V2, P10, DOI [10.4021/wjnu85w, DOI 10.4021/WJNU85W]; Toker E, 2004, BRIT J OPHTHALMOL, V88, P384, DOI 10.1136/bjo.2003.028340; van de Merwe JP, 2007, NAT CLIN PRACT UROL, V4, P484, DOI 10.1038/ncpuro0874; Van De Merwe JP, 2000, BJU INT, V85, P995, DOI 10.1046/j.1464-410x.2000.00646.x; VANDEMERWE J, 1993, J RHEUMATOL, V20, P962; Vriezekolk JE, 2005, J RHEUMATOL, V32, P2351; Walker J, 2003, J RHEUMATOL, V30, P2406; Wang F, 2004, ARTHRITIS RHEUM-US, V50, P3637, DOI 10.1002/art.20625; Yamaguchi O, 1996, J UROLOGY, V156, P1208, DOI 10.1016/S0022-5347(01)65752-5; Zuo J, 2016, J IMMUNOL METHODS, V437, P28, DOI 10.1016/j.jim.2016.07.003	25	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225455	10.1371/journal.pone.0225455	http://dx.doi.org/10.1371/journal.pone.0225455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747429	gold, Green Published			2022-12-26	WOS:000533881900044
J	Konno, R; Tatebe, S; Sugimura, K; Satoh, K; Aoki, T; Miura, M; Suzuki, H; Yamamoto, S; Sato, H; Terui, Y; Miyata, S; Adachi, O; Kimura, M; Saiki, Y; Shimokawa, H				Konno, Ryo; Tatebe, Shunsuke; Sugimura, Koichiro; Satoh, Kimio; Aoki, Tatsuo; Miura, Masanobu; Suzuki, Hideaki; Yamamoto, Saori; Sato, Haruka; Terui, Yosuke; Miyata, Satoshi; Adachi, Osamu; Kimura, Masato; Saiki, Yoshikatsu; Shimokawa, Hiroaki			Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease	PLOS ONE			English	Article							HEPATIC-DYSFUNCTION; SURVIVAL; MORTALITY; TRANSPLANTATION; DEATH; PREDICTORS; REDUCTION; MORBIDITY; SYSTEM; IMPACT	Patients with adult congenital heart disease (ACHD) are at increased risk of developing late cardiovascular complication. However, little is known about the predictive factors for long-term outcome. The Model for End-Stage Liver Disease eXcluding INR (MELD-XI) score was originally developed to assess cirrhotic patients and has the prognostic value for heart failure (HF) patients. In the present study, we examined whether the score also has the prognostic value in this population. We retrospectively examined 637 ACHD patients (mean age 31.0 years) who visited our Tohoku University hospital from 1995 to 2015. MELD-XI score was calculated as follows; 11.76 x ln(serum creatinine) + 5.11 x ln(serum total bilirubin) + 9.44. We compared the long-term outcomes between the high (>= 10.4) and the low (<10.4) score groups. The cutoff value of MELD-XI score was determined based on the survival classification and regression tree (CART) analysis. The major adverse cardiac event (MACE) was defined as a composite of cardiac death, HF hospitalization, and lethal ventricular arrhythmias. During a mean follow-up period of 8.6 years (interquartile range 4.4-11.4 years), MACE was noted in 51 patients, including HF hospitalization in 37, cardiac death in 8, and lethal ventricular arrhythmias in 6. In Kaplan-Meier analysis, the high score group had significantly worse MACE-free survival compared with the low score group (log-rank, P<0.001). Multivariable Cox regression analysis showed that the MELD-XI score remained a significant predictor of MACE (hazard ratio 1.36, confidence interval 1.17-1.58, P< 0.001) even after adjusting for patient characteristics, such as sex, functional status, estimated glomerular filtration rate, and cardiac function. Furthermore, CART analysis revealed that the MELD-XI score was the most important variable for predicting MACE. These results demonstrate that the MELD-XI score can effectively predict MACE in ACHD patients, indicating that ACHD patients with high MELD-XI score need to be closely followed.	[Konno, Ryo; Tatebe, Shunsuke; Sugimura, Koichiro; Satoh, Kimio; Aoki, Tatsuo; Miura, Masanobu; Suzuki, Hideaki; Yamamoto, Saori; Sato, Haruka; Terui, Yosuke; Shimokawa, Hiroaki] Tohoku Univ, Dept Cardiovasc Med, Grad Sch Med, Sendai, Miyagi, Japan; [Miyata, Satoshi; Shimokawa, Hiroaki] Tohoku Univ, Dept Evidence Based Cardiovasc Med, Grad Sch Med, Sendai, Miyagi, Japan; [Adachi, Osamu; Saiki, Yoshikatsu] Tohoku Univ, Dept Cardiovasc Surg, Grad Sch Med, Sendai, Miyagi, Japan; [Kimura, Masato] Tohoku Univ, Dept Pediat, Grad Sch Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Shimokawa, H (corresponding author), Tohoku Univ, Dept Cardiovasc Med, Grad Sch Med, Sendai, Miyagi, Japan.; Shimokawa, H (corresponding author), Tohoku Univ, Dept Evidence Based Cardiovasc Med, Grad Sch Med, Sendai, Miyagi, Japan.	shimo@cardio.med.tohoku.ac.jp		Shimokawa, Hiroaki/0000-0001-7534-4826; Aoki, Tatsuo/0000-0002-6140-0417	Japan Agency for Medical Research and development, AMED [JP18ek0210068]	Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This research was supported by the Practical Research Project for Life-Style-related Diseases including Cardiovascular Diseases and Diabetes Mellitus from Japan Agency for Medical Research and development, AMED (JP18ek0210068). The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100618; Adams ED, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13257; Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Assenza GE, 2013, HEART, V99, P491, DOI 10.1136/heartjnl-2012-303347; Biegus J, 2016, EUR J HEART FAIL, V18, P1518, DOI 10.1002/ejhf.644; Chokshi A, 2012, J HEART LUNG TRANSPL, V31, P591, DOI 10.1016/j.healun.2012.02.008; De Caterina R, 2013, THROMB HAEMOSTASIS, V110, P1087, DOI 10.1160/TH13-06-0443; Diller GP, 2015, CIRCULATION, V132, P2118, DOI 10.1161/CIRCULATIONAHA.115.017202; Dimopoulos K, 2008, CIRCULATION, V117, P2320, DOI 10.1161/CIRCULATIONAHA.107.734921; Engelings CC, 2016, INT J CARDIOL, V211, P31, DOI 10.1016/j.ijcard.2016.02.133; Giannico S, 2006, J AM COLL CARDIOL, V47, P2065, DOI 10.1016/j.jacc.2005.12.065; Heuman DM, 2007, LIVER TRANSPLANT, V13, P30, DOI 10.1002/lt.20906; Hillege HL, 2000, CIRCULATION, V102, P203, DOI 10.1161/01.CIR.102.2.203; Inohara T, 2014, INT J CARDIOL, V176, P571, DOI 10.1016/j.ijcard.2014.08.052; Khairy P, 2008, CIRCULATION, V117, P85, DOI 10.1161/CIRCULATIONAHA.107.738559; Kim MS, 2013, J AM COLL CARDIOL, V61, P2253, DOI 10.1016/j.jacc.2012.12.056; Konno R, 2018, AM J CARDIOL, V122, P1965, DOI 10.1016/j.amjcard.2018.08.045; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Lewis M, 2016, J CARD FAIL, V22, P578, DOI 10.1016/j.cardfail.2015.09.002; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matthews JC, 2010, CIRCULATION, V121, P214, DOI 10.1161/CIRCULATIONAHA.108.838656; Moons P, 2010, CIRCULATION, V122, P2264, DOI 10.1161/CIRCULATIONAHA.110.946343; Mulder BJM, 2012, NETH HEART J, V20, P505, DOI 10.1007/s12471-012-0335-1; Naidu P, 2017, INT J CARDIOL, V245, P125, DOI 10.1016/j.ijcard.2017.05.132; Price S, 2007, INTENS CARE MED, V33, P652, DOI 10.1007/s00134-007-0544-z; Szygula-Jurkiewicz B, 2014, KARDIOCHIR TORAKOCHI, V11, P178, DOI 10.5114/kitp.2014.43847; van Deursen VM, 2014, HEART FAIL REV, V19, P163, DOI 10.1007/s10741-012-9370-7; Verheugt CL, 2010, EUR HEART J, V31, P1220, DOI 10.1093/eurheartj/ehq032; Wan D, 2017, CAN J CARDIOL, V33, P1597, DOI 10.1016/j.cjca.2017.08.009; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4	31	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225403	10.1371/journal.pone.0225403	http://dx.doi.org/10.1371/journal.pone.0225403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743362	Green Published, gold			2022-12-26	WOS:000533877300029
J	Pawluk, KA; Fox, CH; Service, CN; Stredulinsky, EH; Bryan, HM				Pawluk, Kylee A.; Fox, Caroline H.; Service, Christina N.; Stredulinsky, Eva H.; Bryan, Heather M.			Raising the bar: Recovery ambition for species at risk in Canada and the US	PLOS ONE			English	Article							ACT; CRITERIA; PROGRESS; THREATS; AGENCY	Routinely crossing international borders and/or persisting in populations across multiple countries, species are commonly subject to a patchwork of endangered species legislation. Canada and the United States share numerous endangered species; their respective acts, the Species at Risk Act (SARA) and the Endangered Species Act (ESA), require documents that outline requirements for species recovery. Although there are many priorities for improving endangered species legislation effectiveness, species recovery goals are a crucial component. We compared recovery goal quality, as measured by goal quantitativeness and ambition, for species listed under SARA and ESA. By comparing across ESA and SARA, the intent of the study was to identify differences and similarities that could support the development of stronger species' recovery goals under both legislations. Our results indicated that: (1) overall, only 38% of recovery goals were quantitative, 41% had high ambition, and 26% were both quantitative and with high ambition; (2) recovery goals had higher quantitativeness and ambition under ESA than SARA; (3) recovery goals for endangered species had higher ambition than threatened species under ESA and SARA, and; (4) no recovery goal aimed to restore populations to historic levels. Combined, these findings provide guidance to strengthen recovery goals and improve subsequent conservation outcomes. In particular, species at risk planners should seek to attain higher recovery goal ambition, particularly for SARA-listed species, and include quantitative recovery goals wherever possible.	[Pawluk, Kylee A.; Service, Christina N.; Stredulinsky, Eva H.; Bryan, Heather M.] Univ Victoria, Dept Geog, Victoria, BC, Canada; [Fox, Caroline H.] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Service, Christina N.; Bryan, Heather M.] Raincoast Conservat Fdn, Sidney, BC, Canada; [Service, Christina N.; Bryan, Heather M.] Hakai Inst, Heriot Bay, BC, Canada; [Bryan, Heather M.] Univ Northern British Columbia, Ecosyst Sci & Management Program, Prince George, BC, Canada	University of Victoria; Dalhousie University; Hakai Institute; University of Northern British Columbia	Pawluk, KA (corresponding author), Univ Victoria, Dept Geog, Victoria, BC, Canada.	kylee.pawluk@gmail.com		Pawluk, Kylee/0000-0002-4895-3164	Killam Postdoctoral Fellowship; Natural Sciences and Engineering Research Council of Canada (NSERC); Hakai Institute; Tula Foundation; MITACS; Raincoast Conservation Foundation	Killam Postdoctoral Fellowship; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hakai Institute; Tula Foundation; MITACS; Raincoast Conservation Foundation	The authors acknowledge support for this study: Killam Postdoctoral Fellowship (CHF), Natural Sciences and Engineering Research Council of Canada (NSERC) Vanier Fellowship (CNS), and Hakai Institute, Tula Foundation, MITACS, and Raincoast Conservation Foundation (HMB). We also thank Julian Ehlers for analytical assistance.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barnosky AD, 2010, HEATSTROKE NATURE AG; Bird SC, 2017, ENVIRON SCI POLICY, V71, P1, DOI 10.1016/j.envsci.2017.01.007; Boersma PD, 2001, BIOSCIENCE, V51, P643; Boor GKH, 2014, CONSERV BIOL, V28, P33, DOI 10.1111/cobi.12155; Carwardine J, 2009, CONSERV LETT, V2, P3, DOI 10.1111/j.1755-263X.2008.00042.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chutter RHB, 2004, RECOVERY STRATEGY NO; Darimont CT, 2015, SCIENCE, V349, P858, DOI 10.1126/science.aac4249; Department of Fisheries and Oceans, 2007, REC STRAT DWARF WEDG; Doak DF, 2015, BIOSCIENCE, V65, P189, DOI 10.1093/biosci/biu215; Environment and Climate Change Canada, 2019, REC STRAT KARN BLUE; Environment Canada, 2009, REC STRAT GRIZZL BEA; Environment Canada, 2014, REC STRAT MARBL MURR; Favaro B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113118; Findlay CS, 2009, CONSERV BIOL, V23, P1609, DOI 10.1111/j.1523-1739.2009.01255.x; Fisheries and Oceans Canada, 2011, REC STRAT NO SO RES; Gerber LR, 2002, ECOL APPL, V12, P668; Government of Canada, 2008, SPEC RISK ACT ANN RE; Government of Canada, 2002, SARA SPEC RISK ACT A; Government of Canada E and CC, COMM STAT END WILDL; Greenwald DN, 2005, ENDANGERED SPECIES A, P392; Gregr EJ, 2006, RECOVERY STRATEGY BL; Haines Aaron M., 2013, Animals, V3, P745, DOI 10.3390/ani3030745; Harvey E, 2002, ECOL APPL, V12, P682, DOI 10.1890/1051-0761(2002)012[0682:RPRPOD]2.0.CO;2; Hoekstra JM, 2002, ECOL APPL, V12, P630, DOI 10.1890/1051-0761(2002)012[0630:ACROES]2.0.CO;2; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; McCune JL, 2013, BIOL CONSERV, V166, P254, DOI 10.1016/j.biocon.2013.07.006; Miller JK, 2002, BIOSCIENCE, V52, P163, DOI 10.1641/0006-3568(2002)052[0163:TESADA]2.0.CO;2; Mooers AO, 2007, CONSERV BIOL, V21, P572, DOI 10.1111/j.1523-1739.2007.00689.x; Mooers AO, 2010, BIOSCIENCE, V60, P843, DOI 10.1525/bio.2010.60.10.11; National Marine Fisheries Service, 2011, FIN REC PLAN SEI WHA; National Marine Fisheries Service, 2008, REC PLAN SO RES KILL; Neel MC, 2012, BIOSCIENCE, V62, P646, DOI 10.1525/bio.2012.62.7.7; Newbold T, 2016, SCIENCE, V353, P288, DOI 10.1126/science.aaf2201; Olive A., 2014, LAND STEWARDSHIP LEG; Olive A, 2014, CAN GEOGR-GEOGR CAN, V58, P263, DOI 10.1111/cag.12090; Parks Canada Agency, 2011, REC STRAT LAK DAIS H; Parks Canada Agency, 2011, REC STRAT DWARF LAK; Puckett EE, 2016, BIOL CONSERV, V201, P220, DOI 10.1016/j.biocon.2016.07.005; Schultz CB, 2003, CONSERV BIOL, V17, P1372, DOI 10.1046/j.1523-1739.2003.02141.x; Taylor EB, 2013, ENVIRON REV, V21, P93, DOI 10.1139/er-2013-0002; Taylor MFJ, 2005, BIOSCIENCE, V55, P360, DOI 10.1641/0006-3568(2005)055[0360:TEOTES]2.0.CO;2; Tear TH, 2005, BIOSCIENCE, V55, P835, DOI 10.1641/0006-3568(2005)055[0835:HMIETR]2.0.CO;2; TEAR TH, 1993, SCIENCE, V262, P976, DOI 10.1126/science.262.5136.976; Troyer CM, 2015, CONSERV BIOL, V29, P1423, DOI 10.1111/cobi.12552; Tuckwell J, 2009, RECOVERY STRATEGY BL; U.S. Fish and Wildlife Service, 1997, REC PLAN THREAT MARR; U.S. Fish and Wildlife Service, 2007, FED STAT END THREAT; U.S. Fish and Wildlife Service, 1999, REC PLAN WHIT STURG; *US FISH WILDL SER, 2011, REV REC PLAN NO SPOT; Waples RS, 2013, BIOSCIENCE, V63, P723, DOI 10.1525/bio.2013.63.9.8; Wilson HB, 2011, ECOL LETT, V14, P886, DOI 10.1111/j.1461-0248.2011.01652.x	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0224021	10.1371/journal.pone.0224021	http://dx.doi.org/10.1371/journal.pone.0224021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743340	gold, Green Published			2022-12-26	WOS:000533877300004
J	Takahashi, K; Wakahara, T				Takahashi, Katsuki; Wakahara, Taku			Association between trunk and gluteus muscle size and long jump performance	PLOS ONE			English	Article							INTRAABDOMINAL PRESSURE; CORE STABILITY; HIP; MOVEMENT; MAXIMUS; TORQUE; PSOAS; SPINE	The present study aimed to examine the sizes of trunk and gluteus muscles in long jumpers and its relation to long jump performance. Twenty-three male long jumpers (personal best record in long jump: 653-788 cm) and 22 untrained men participated in the study. T1-weighted magnetic resonance images of the trunk and hip were obtained to determine the cross-sectional areas of the rectus abdominis, internal and external obliques and transversus abdominis, psoas major, quadratus lumborum, erector spinae and multifidus, iliacus, gluteus maximus, and gluteus medius and minimus. The cross-sectional areas of individual trunk and gluteus muscles relative to body mass were significantly larger in the long jumpers than in untrained men (P < 0.001, Cohen's d = 1.3-4.3) except for the gluteus medius and minimus. The relative cross-sectional area of the rectus abdominis of takeoff leg side was significantly correlated with their personal best record for the long jump (r = 0.674, corrected P = 0.004). Stepwise multiple regression analysis selected relative cross-sectional areas of the rectus abdominis and iliacus and the personal best record in 100-m sprint to predict the long jump distance (standard error of estimate = 22.6 cm, adjusted R-2 = 0.763). The results of the multiple regression analysis demonstrated that the rectus abdominis and iliacus size were associated with long jump performance independently of sprint running capacity, suggesting the importance of these muscles in achieving high performance in the long jump.	[Takahashi, Katsuki] Doshisha Univ, Grad Sch Hlth & Sports Sci, Kyoto, Japan; [Wakahara, Taku] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan; [Wakahara, Taku] Waseda Univ, Human Performance Lab, Saitama, Japan	Doshisha University; Doshisha University; Waseda University	Wakahara, T (corresponding author), Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan.; Wakahara, T (corresponding author), Waseda Univ, Human Performance Lab, Saitama, Japan.	twakahar@mail.doshisha.ac.jp		Takahashi, Katsuki/0000-0001-8534-0888; Wakahara, Taku/0000-0001-6864-7706				ALTMAN DG, 2011, BMJ-BRIT MED J, V343, DOI DOI 10.1136/BMJ.D2090; Andersson Eva, 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P10; Ben Kibler W, 2006, SPORTS MED, V36, P189, DOI 10.2165/00007256-200636030-00001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beres S, 2014, KINESIOLOGY, V46, P88; Copaver K, 2012, RES Q EXERCISE SPORT, V83, P160, DOI 10.1080/02701367.2012.10599846; CRESSWELL AG, 1993, EUR J APPL PHYSIOL O, V66, P315, DOI 10.1007/BF00237775; CRESSWELL AG, 1994, EXP BRAIN RES, V98, P336; Dorn TW, 2012, J EXP BIOL, V215, P1944, DOI 10.1242/jeb.064527; Fukunaga T, 2001, ACTA PHYSIOL SCAND, V172, P249, DOI 10.1046/j.1365-201x.2001.00867.x; Graham-Smith P, 2005, J SPORT SCI, V23, P891, DOI 10.1080/02640410400022169; Handsfield GG, 2014, J BIOMECH, V47, P631, DOI 10.1016/j.jbiomech.2013.12.002; HAY JG, 1986, J BIOMECH, V19, P855, DOI 10.1016/0021-9290(86)90136-3; HAY JG, 1993, J BIOMECH, V26, P7, DOI 10.1016/0021-9290(93)90076-Q; Hodges PW, 1997, PHYS THER, V77, P132, DOI 10.1093/ptj/77.2.132; IKAI MICHIO, 1968, INT Z ANGEW PHYSIOL ARBEITSPHYSIOL, V26, P26; Johnson MD, 2001, J SPORT SCI, V19, P263; Jorgensen MJ, 2001, CLIN BIOMECH, V16, P182, DOI 10.1016/S0268-0033(00)00087-5; LEES A, 1994, J APPL BIOMECH, V10, P61, DOI 10.1123/jab.10.1.61; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; Lieberman DE, 2006, J EXP BIOL, V209, P2143, DOI 10.1242/jeb.02255; Loenneke JP, 2019, SPORTS MED, V49, P987, DOI 10.1007/s40279-019-01106-9; MAUGHAN RJ, 1983, J PHYSIOL-LONDON, V338, P37, DOI 10.1113/jphysiol.1983.sp014658; Muraki Y., 2008, International Journal of Sport and Health Science, V6, P21, DOI 10.5432/ijshs.6.21; Nagahara R, 2014, BIOL OPEN, V3, P689, DOI 10.1242/bio.20148284; Slawinski J, 2017, SCAND J MED SCI SPOR, V27, P45, DOI 10.1111/sms.12627; Stefanyshyn DJ, 1998, J SPORT SCI, V16, P177; Sugisaki N, 2018, INT J SPORT PHYSIOL, V13, P214, DOI 10.1123/ijspp.2016-0703; Taber CB, 2019, SPORTS MED, V49, P993, DOI 10.1007/s40279-019-01107-8; Tayashiki K, 2017, EUR J APPL PHYSIOL, V117, P1267, DOI 10.1007/s00421-017-3617-x; Trezise J, 2016, EUR J APPL PHYSIOL, V116, P1159, DOI 10.1007/s00421-016-3352-8; Willson JD, 2005, J AM ACAD ORTHOP SUR, V13, P316, DOI 10.5435/00124635-200509000-00005	32	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225413	10.1371/journal.pone.0225413	http://dx.doi.org/10.1371/journal.pone.0225413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743360	Green Published, gold			2022-12-26	WOS:000533877300030
J	Benvenga, RM; De Rosa, R; Silverio, A; Matturro, R; Zambrano, C; Masullo, A; Mastrogiovanni, G; Soriente, L; Ascoli, R; Citro, R; Piscione, F; Galasso, G				Benvenga, Rossella M.; De Rosa, Roberta; Silverio, Angelo; Matturro, Rosanna; Zambrano, Cristina; Masullo, Alfonso; Mastrogiovanni, Generoso; Soriente, Lucia; Ascoli, Roberto; Citro, Rodolfo; Piscione, Federico; Galasso, Gennaro			Infective endocarditis and diabetes mellitus: Results from a single-center study from 1994 to 2017	PLOS ONE			English	Article							DIAGNOSIS; MANAGEMENT; CRITERIA; RISK; ECHOCARDIOGRAPHY; CHALLENGES; PREDICTORS; MORBIDITY; MORTALITY; ADULTS	Background To evaluate the prognostic impact of diabetes mellitus (DM) in patients with Infective Endocarditis (IE). Methods and results 375 patients with diagnosis of IE referred to our Hospital between 1994-2017 were retrospectively included; diabetes was reported in 129 (34.4%). Diabetic patients were older than non-diabetic (66 +/- 1 vs. 57 +/- 2 years, p<0.001) and showed a higher prevalence of comorbidities such as hypertension (75 vs. 54%, p<0.001), coronary artery disease (30 vs. 12%, p<0.001) and history of heart failure (HF; 24 vs. 13%, p = 0.021). Echocardiography showed a higher incidence of paravalvular complications (82 vs. 64%, p<0.001) and a lower left ventricular ejection fraction (LVEF; 52 +/- 11 vs. 55 +/- 10%, p = 0.001) in diabetic than in non-diabetic patients. In-hospital mortality was higher in diabetic patients (83 vs. 74%; p = 0.030). At logistic regression, history of HF (OR = 3.1, 95%CI: 1.87-5.29, p<0.001) resulted an independent predictor of in-hospital death. At long-term follow-up [median 24(7-84) months], the Kaplan-Meier analysis showed a significantly lower survival free from all-cause death in the group with diabetes (Log-rank<0.001). At the propensity score adjusted Cox multivariable analysis, DM (HR = 1.76, 95%CI: 1.18-2.6, p = 0.005), age (HR = 1.03, 95%CI: 1.02-1.05, p<0.001), intravenous drug users (HR = 5.42, 95%CI: 2.55-11.51, p<0.001) and low LVEF (HR = 0.98, 95%CI: 0.96-0.99, p = 0.013) were independently associated to a higher mortality. Conclusion In patients with IE, DM is associated to a higher prevalence of anatomic complications and a more impaired LVEF. Diabetic patients show a significantly lower survival both in hospital and during follow-up compared to the non-diabetic ones.	[Benvenga, Rossella M.; De Rosa, Roberta; Silverio, Angelo; Matturro, Rosanna; Zambrano, Cristina; Piscione, Federico; Galasso, Gennaro] Univ Salerno, Dept Med Surg & Dent, Salerno, Italy; [Masullo, Alfonso; Mastrogiovanni, Generoso; Soriente, Lucia; Ascoli, Roberto; Citro, Rodolfo] Univ Hosp San Giovanni Dio & Ruggi Aragona, Heart Dept, Salerno, Italy	University of Salerno	Galasso, G (corresponding author), Univ Salerno, Dept Med Surg & Dent, Salerno, Italy.	ggalasso@unisa.it	Silverio, Angelo/AAS-2810-2020; Soriente, Lucia/AAW-3784-2021; Citro, Rodolfo/Q-5242-2016	Soriente, Lucia/0000-0003-2717-7028; Citro, Rodolfo/0000-0002-7796-6298; GALASSO, Gennaro/0000-0002-7265-7613; Silverio, Angelo/0000-0001-9749-8092				Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Cahill TJ, 2017, J AM COLL CARDIOL, V69, P325, DOI 10.1016/j.jacc.2016.10.066; Cecchi E, 2015, INT J CARDIOL, V190, P151, DOI 10.1016/j.ijcard.2015.04.123; Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016; Chirillo F, 2005, HEART, V91, P329, DOI 10.1136/hrt.2003.031583; Chirillo F, 2010, J HEART VALVE DIS, V19, P312; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Duval X, 2007, EUR HEART J, V28, P59, DOI 10.1093/eurheartj/ehl318; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Habib G, 2006, HEART, V92, P124, DOI 10.1136/hrt.2005.063719; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Habib G, 2010, EUR J ECHOCARDIOGR, V11, P202, DOI 10.1093/ejechocard/jeq004; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hasbun R, 2003, JAMA-J AM MED ASSOC, V289, P1933, DOI 10.1001/jama.289.15.1933; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Kourany WM, 2006, SCAND J INFECT DIS, V38, P613, DOI 10.1080/00365540600617017; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lin CJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122248; Lockhart PB, 2007, J AM DENT ASSOC, V138, P458, DOI 10.14219/jada.archive.2007.0198; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Moreno R, 2002, J HEART VALVE DIS, V11, P651; Movahed MR, 2007, J DIABETES COMPLICAT, V21, P403, DOI 10.1016/j.jdiacomp.2007.07.003; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Netzer ROM, 2002, HEART, V88, P61, DOI 10.1136/heart.88.1.61; SANFILIPPO AJ, 1991, J AM COLL CARDIOL, V18, P1191, DOI 10.1016/0735-1097(91)90535-H; Thuny F, 2005, CIRCULATION, V112, P69, DOI 10.1161/CIRCULATIONAHA.104.493155; Thuny F, 2012, AM HEART J, V164, P94, DOI 10.1016/j.ahj.2012.04.003; Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1; VONREYN CF, 1994, CLIN INFECT DIS, V19, P368, DOI 10.1093/clinids/19.2.368; Wallace SM, 2002, HEART, V88, P53, DOI 10.1136/heart.88.1.53	33	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0223710	10.1371/journal.pone.0223710	http://dx.doi.org/10.1371/journal.pone.0223710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738753	Green Published, gold			2022-12-26	WOS:000532826300010
J	Kazazic, SP; Popovic, NT; Strunjak-Perovic, I; Babic, S; Florio, D; Fioravanti, M; Bojanic, K; Coz-Rakovac, R				Kazazic, Snjezana P.; Popovic, Natalija Topic; Strunjak-Perovic, Ivancica; Babic, Sanja; Florio, Daniela; Fioravanti, Marialetizia; Bojanic, Krunoslav; Coz-Rakovac, Rozelindra			Matrix-assisted laser desorption/ionization time of flight mass spectrometry identification of Vibrio (Listonella) anguillarum isolated from sea bass and sea bream	PLOS ONE			English	Article							MALDI-TOF MS; CULTURE-CONDITIONS; DIFFERENTIATION; DIAGNOSIS	Vibrio (Listonella) anguillarum is a pathogenic bacterium causing septicaemia in a wide range of marine organisms and inducing severe mortalities, thus it is crucial to conduct its accurate and rapid identification. The aim of this study was to assess MALDI-TOF MS as a method of choice for identification of clinical V. anguillarum isolates from affected marine fish. Since the method accuracy might be influenced by the type of the medium used, as well as by the incubation conditions, we tested V. anguillarum isolates grown on standard media with and without the addition of NaCl, cultured at three incubation temperatures, and at three incubation periods. The best scores were retrieved for V. anguillarum strains grown on NaCl-supplemented tryptone soy agar (TSA) at 22 degrees C and incubated for 48h (100% identification to species level; overall score 2.232), followed by incubation at 37 degrees C and 48h (100% to species level; score 2.192). The strains grown on non-supplemented TSA gave the best readings when incubated at 22 degrees C for 72h (100% identification to species level; overall score 2.182), followed by incubation at 15 degrees C for 72h (100% to species level; score 2.160). Unreliable identifications and no-identifications were growing with the incubation duration at 37 degrees C, on both media, amounting to 88.89% for 7d incubation on supplemented TSA, and 92.60% for 7d incubation on non-supplemented TSA. The age of the cultured strains and use of media significantly impacted the mass spectra, demonstrating that for reliable identification, MALDI-TOF MS protein fingerprinting with the on-target extraction should be performed on strains grown on a NaCl-supplemented medium at temperatures between 15 and 22 degrees C, incubated for 48-72 hours.	[Kazazic, Snjezana P.] Rudjer Boskovic Inst, Lab Mass Spectrometry & Funct Prote, Zagreb, Croatia; [Popovic, Natalija Topic; Strunjak-Perovic, Ivancica; Babic, Sanja; Bojanic, Krunoslav; Coz-Rakovac, Rozelindra] Rudjer Boskovic Inst, Lab Aquaculture Biotechnol, Zagreb, Croatia; [Popovic, Natalija Topic; Strunjak-Perovic, Ivancica; Babic, Sanja; Bojanic, Krunoslav; Coz-Rakovac, Rozelindra] Rudjer Boskovic Inst, Ctr Excellence Marine Bioprospecting BioProCro, Zagreb, Croatia; [Florio, Daniela; Fioravanti, Marialetizia] Univ Bologna, Alma Mater Studiorum, Dept Vet Med Sci, Ozzano Dell Emilia, Italy	Rudjer Boskovic Institute; Rudjer Boskovic Institute; Rudjer Boskovic Institute; University of Bologna	Popovic, NT (corresponding author), Rudjer Boskovic Inst, Lab Aquaculture Biotechnol, Zagreb, Croatia.; Popovic, NT (corresponding author), Rudjer Boskovic Inst, Ctr Excellence Marine Bioprospecting BioProCro, Zagreb, Croatia.	ntopic@irb.hr	Topic Popovic, Natalija/AAQ-9046-2020; Bojanić, Krunoslav/N-8930-2014; Babić, Sanja/AAU-6003-2020	Topic Popovic, Natalija/0000-0002-8897-0014; Bojanić, Krunoslav/0000-0002-4182-4685; FIORAVANTI, MARIALETIZIA/0000-0002-8234-432X	European Union [727610]; Scientific Centre of Excellence for Marine Bioprospecting - BioProCro; European Union through the European Regional Development Fund -the Competitiveness and Cohesion Operational Programme [KK.01.1.1.01]; Croatian Government	European Union(European Commission); Scientific Centre of Excellence for Marine Bioprospecting - BioProCro; European Union through the European Regional Development Fund -the Competitiveness and Cohesion Operational Programme; Croatian Government	This study has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 727610 (PerformFISH). This output reflects only the authors' view and the European Union cannot be held responsible for any use that may be made of the information contained therein. The study was also supported by the Scientific Centre of Excellence for Marine Bioprospecting - BioProCro, a project co-financed by the Croatian Government and the European Union through the European Regional Development Fund -the Competitiveness and Cohesion Operational Programme (KK.01.1.1.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSINA M, 1994, APPL ENVIRON MICROB, V60, P1681, DOI 10.1128/AEM.60.5.1681-1683.1994; Austin B, 2007, SPRINGER PRAXIS SERI; Azrad M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3709-9; Balazova T, 2014, FEMS MICROBIOL LETT, V353, P77, DOI 10.1111/1574-6968.12408; Crisafi F, 2015, J APPL MICROBIOL, V119, P1494, DOI 10.1111/jam.12957; Emami K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038515; Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x; Hickey ME, 2018, REV AQUACULT, V10, P585, DOI 10.1111/raq.12188; Lay JO, 2001, MASS SPECTROM REV, V20, P172, DOI 10.1002/mas.10003; Martinez-Picado J, 1996, APPL ENVIRON MICROB, V62, P443, DOI 10.1128/AEM.62.2.443-449.1996; Pedersen K, 1999, CURR MICROBIOL, V38, P183, DOI 10.1007/PL00006784; Perez-Sancho M, 2016, AQUACULTURE, V464, P159, DOI 10.1016/j.aquaculture.2016.06.024; Piccininno G, 1996, MICROBIOLOGICA, V19, P321; Popovic NT, 2007, VET MED-CZECH, V52, P49, DOI 10.17221/2058-VETMED; Popovic NT, 2017, ENVIRON RES, V152, P7, DOI 10.1016/j.envres.2016.09.020; Popovic NT, 2014, FRESEN ENVIRON BULL, V23, P151; Salplachta J, 2018, J CHROMATOGR A, V1532, P232, DOI 10.1016/j.chroma.2017.11.072; Valentine N, 2005, APPL ENVIRON MICROB, V71, P58, DOI 10.1128/AEM.71.1.58-64.2005; Veloo ACM, 2014, CLIN MICROBIOL INFEC, V20, pO1091, DOI 10.1111/1469-0691.12644; YANAGIHARA Y, 1984, MICROBIOL IMMUNOL, V28, P499, DOI 10.1111/j.1348-0421.1984.tb00701.x; Zhang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106185	21	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225343	10.1371/journal.pone.0225343	http://dx.doi.org/10.1371/journal.pone.0225343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KE5GF	31738803	Green Published, gold			2022-12-26	WOS:000508583200001
J	Lin, PY; Huang, CC; Chen, HH; Huang, BX; Lee, MS				Lin, Pin-Yao; Huang, Chun-Chia; Chen, Hsiu-Hui; Huang, Bo-Xuan; Lee, Maw-Sheng			Failed sperm retrieval from severely oligospermic or non-obstructive azoospermic patients on oocyte retrieval day: Emergent oocyte cryopreservation is a feasible strategy	PLOS ONE			English	Article							EXTRACTION MICRO-TESE; TESTICULAR SPERM; SURGICAL-MANAGEMENT; CONVENTIONAL TESE; INJECTION; FRESH; MEN; VITRIFICATION; PREGNANCY; OUTCOMES	Purpose Unexpected sperm retrieval failure on the day of oocyte retrieval is not common but frequently happened in patients with severe oligospermia or non-obstructive azoospermia (NOA). Oocyte cryopreservation is a common strategy after failed collection of sperm when concurrent ovarian stimulation is underwent. However, the use of oocyte vitrification in such male-infertility cases remains unclear. Objective To investigate the outcomes of emergent oocyte cryopreservation after failed sperm retrieval from severe oligospermic or non-obstructive azoospermic (NOA) patients on oocyte retrieval day. Methods Design: Retrospective cohort study Setting: Academic fertility center at Lee Women's Hospital, Taiwan, between March 2015 and August 2017. Patients: For 203 couples with NOA(n = 200) or severe oligospermia(n = 3), testicular spermatozoa (n = 67 cycles) or frozen donor sperm (n = 209 cycles) were injected into fresh or frozen-thawed oocytes via 276 intracytoplasmic sperm injection (ICSI) cycles. Main Outcome Measures: Clinical pregnancy and live-birth rates (LBRs). Results In the 67 cycles involving the use of fresh testicular spermatozoa, no significant differences were observed between fresh and warmed oocytes with respect to the fertilization rates 69.2% vs. 74.1%; p = 0.27), number of Day-3 embryos (8.6 +/- 4.4 vs. 6.4 +/- 3.4; p = 0.08), number of good-quality Day-3 embryos (4.5 +/- 3.9vs. 4.7 +/- 3.0; p = 0.45), implantation rates (29.1% vs. 17.8%; p = 0.21), clinical pregnancy rates (36.4% vs. 26.8.0%; p = 0.81), live birth rates (36.4% vs. 14.3%; p = 0.46), or perinatal outcomes. In the 209 cycles involving the use of frozen donor sperm, no significant differences were seen between the two groups, except that the mean birth weights were significantly lower with fresh oocyte pregnancies than with warmed oocytes (2952 +/- 196 gm vs 2643 +/- 700 gm; p = 0.006). Conclusions Emergent oocyte cryopreservation is a feasible strategy to manage unexpected sperm retrieval failure from severe oligospermic or NOA patients on the oocyte retrieval day. There is no detrimental effect on the live birth rate when testicular spermatozoa or frozen donor sperm are injected into the thawed oocytes compared with fresh oocytes.	[Lin, Pin-Yao; Huang, Chun-Chia; Chen, Hsiu-Hui; Lee, Maw-Sheng] Lee Womens Hosp, Div Infertil, Taichung, Taiwan; [Lin, Pin-Yao; Lee, Maw-Sheng] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Huang, Bo-Xuan] Puli Christian Hosp, Dept Urol, Nantou, Taiwan; [Lee, Maw-Sheng] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lee, MS (corresponding author), Lee Womens Hosp, Div Infertil, Taichung, Taiwan.; Lee, MS (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Lee, MS (corresponding author), Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan.	msleephd@gmail.com		Huang, Chun-Chia/0000-0003-2649-2384				Alrabeeah K, 2015, ANDROLOGY-US, V3, P462, DOI 10.1111/andr.12000; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P37, DOI 10.1016/j.fertnstert.2012.09.028; An G, 2018, MED SCI MONITOR, V24, P1379, DOI 10.12659/MSM.909026; Baert Y, 2013, HUM REPROD, V28, P1816, DOI 10.1093/humrep/det100; Chen HH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185747; Cobo A, 2008, FERTIL STERIL, V89, P1657, DOI 10.1016/j.fertnstert.2007.05.050; Cobo A, 2016, FERTIL STERIL, V105, P755, DOI 10.1016/j.fertnstert.2015.11.027; Cobo A, 2010, HUM REPROD, V25, P2239, DOI 10.1093/humrep/deq146; Colpi GM, 2009, REPROD BIOMED ONLINE, V18, P315, DOI 10.1016/S1472-6483(10)60087-9; Dabaja AA, 2013, ASIAN J ANDROL, V15, P35, DOI 10.1038/aja.2012.141; Dalzell LH, 2004, FERTIL STERIL, V82, P1443, DOI 10.1016/j.fertnstert.2004.04.053; Eken A, 2018, KAOHSIUNG J MED SCI, V34, P103, DOI 10.1016/j.kjms.2017.08.010; Esteves SC, 2015, ASIAN J ANDROL, V17, P459, DOI 10.4103/1008-682X.148719; Esteves Sandro C., 2013, Int. braz j urol., V39, P440, DOI 10.1590/S1677-5538.IBJU.2013.03.21; Gandhi G, 2017, METHODS MOL BIOL, V1568, P281, DOI 10.1007/978-1-4939-6828-2_21; Goncalves C, 2017, ASIAN J ANDROL, V19, P338, DOI 10.4103/1008-682X.172827; Grynberg M, 2011, J GYNECOL OBST BIO R, V40, P130, DOI 10.1016/j.jgyn.2010.11.003; Grynberg M, 2012, REPROD BIOMED ONLINE, V24, P611, DOI 10.1016/j.rbmo.2012.02.019; Janosek-Albright KJC, 2015, ASIAN J UROL, V2, P79, DOI 10.1016/j.ajur.2015.04.018; Kalsi J, 2012, BJU INT, V109, P418, DOI 10.1111/j.1464-410X.2011.10399.x; Karacan M, 2013, FERTIL STERIL, V100, P975, DOI 10.1016/j.fertnstert.2013.06.031; Kushnir VA, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-017-0378-4; Lee CI, 2019, TAIWAN J OBSTET GYNE, V58, P239, DOI 10.1016/j.tjog.2019.01.013; Lee CI, 2019, REPROD BIOMED ONLINE, V39, P569, DOI 10.1016/j.rbmo.2019.05.020; Lee CI, 2016, TAIWAN J OBSTET GYNE, V55, P558, DOI 10.1016/j.tjog.2016.06.005; Levin G, 2018, ACTA OBSTET GYN SCAN, V97, P1530, DOI 10.1111/aogs.13385; Lyrakou S, 2007, REPROD BIOMED ONLINE, V15, P99, DOI 10.1016/S1472-6483(10)60698-0; Moilanen JM, 1999, J ASSIST REPROD GEN, V16, P17, DOI 10.1023/A:1022589427805; Ohlander S, 2014, FERTIL STERIL, V101, P344, DOI 10.1016/j.fertnstert.2013.10.012; Onofre J, 2016, HUM REPROD UPDATE, V22, P744, DOI 10.1093/humupd/dmw029; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Park YS, 2014, J ASSIST REPROD GEN, V31, P1331, DOI 10.1007/s10815-014-0304-2; Ran RZ, 2016, INDIAN J UROL, V32, P15, DOI 10.4103/0970-1591.173103; Randolph L.M., 2013, PRINCIPLES CLIN CYTO; Ravizzini P, 2008, ANDROLOGIA, V40, P219, DOI 10.1111/j.1439-0272.2008.00846.x; Rienzi L, 2010, HUM REPROD, V25, P66, DOI 10.1093/humrep/dep346; Sakamoto H, 2008, INT J UROL, V15, P529, DOI 10.1111/j.1442-2042.2008.02071.x; Schachter-Safrai N, 2017, FERTIL STERIL, V107, P1148, DOI 10.1016/j.fertnstert.2017.03.009; Schlegel PN, 1999, HUM REPROD, V14, P131, DOI 10.1093/humrep/14.1.131; Schwarzer JU, 2016, ANDROLOGIA, V48, P402, DOI 10.1111/and.12460; Selman H, 2010, FERTIL STERIL, V94, P2927, DOI 10.1016/j.fertnstert.2010.06.080; Setti PEL, 2013, FERTIL STERIL, V100, P396, DOI 10.1016/j.fertnstert.2013.03.038; Shih YF, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1027158; Song WY, 2011, SYST BIOL REPROD MED, V57, P210, DOI 10.3109/19396368.2011.566666; Thompson-Cree M E M, 2003, Reprod Biomed Online, V7, P449; Tiseo BC, 2015, ASIAN J UROL, V2, P85, DOI 10.1016/j.ajur.2015.04.020; Verheyen G, 1997, FERTIL STERIL, V67, P74, DOI 10.1016/S0015-0282(97)81859-6; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343; Zeke J, 2012, SYST BIOL REPROD MED, V58, P165, DOI 10.3109/19396368.2012.656797	49	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0224919	10.1371/journal.pone.0224919	http://dx.doi.org/10.1371/journal.pone.0224919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738801	gold, Green Published			2022-12-26	WOS:000532826300024
J	Valencia-Sanchez, S; Nava-Castro, KE; Palacios-Arreola, MI; Prospero-Garcia, O; Morales-Montor, J; Drucker-Colin, R				Valencia-Sanchez, Salvador; Elizabeth Nava-Castro, Karen; Isabel Palacios-Arreola, Margarita; Prospero-Garcia, Oscar; Morales-Montor, Jorge; Drucker-Colin, Rene			Chronic exercise modulates the cellular immunity and its cannabinoid receptors expression	PLOS ONE			English	Article							MODERATE EXERCISE; CELLS; SUSCEPTIBILITY; SYSTEM	The impact of performing exercise on the immune system presents contrasting effects on health when performed at different intensities. In addition, the consequences of performing chronic exercise have not been sufficiently studied in contrast to the effects of acute bouts of exercise. The porpoise of this work was to determine the effect that a popular exercise regimen (chronic/moderate/aerobic exercise) has on the proportion of different immune cell subsets, their function and if it affects the cannabinoid system with potentially functional implications on the immune system. A marked increase in several immune cell subsets and their expression of cannabinoid receptors was expected, as well as an enhanced proliferative and cytotoxic activity by total splenocytes in exercised animals. For this study male Wistar rats performed treadmill running 5 times a week for a period of 10 weeks, at moderate intensity. Our results showed a significant decrease in lymphocyte subpopulations (CD4+, T gamma delta, and CD45 RA+ cells) and an increase in the cannabinoid receptors expression in those same cell. Although functional assays did not reveal any variation in total immunoglobulin production or NK cells cytotoxic activity, proliferative capability of total splenocytes increased in trained rats. Our results further support the notion that exercise affects the immunological system and extends the description of underlying mechanisms mediating such effects. Altogether, our results contribute to the understanding of the benefits of exercise on the practitioner's general health.	[Valencia-Sanchez, Salvador; Drucker-Colin, Rene] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neuropatol Mol, Circuito Exterior S-N,Ciudad Univ, Mexico City, DF, Mexico; [Elizabeth Nava-Castro, Karen; Isabel Palacios-Arreola, Margarita] Ctr Ciencias Atmosfera, Genotoxicol & Mutagenesis Ambientales, Ciencias Ambientales, Mexico City, DF, Mexico; [Prospero-Garcia, Oscar] Univ Nacl Autonoma Mexico, Lab Cannabinoides, Dept Fisiol, Fac Med, Circuito Exterior S-N,Ciudad Univ, Mexico City, DF, Mexico; [Morales-Montor, Jorge] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Morales-Montor, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico.	jmontor66@biomedicas.unam.mx	Montor, Jorge/B-1224-2012	Montor, Jorge/0000-0002-9461-610X; Palacios-Arreola, Margarita Isabel/0000-0001-8882-7544	Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA) [IN-209719]; Universidad Nacional Autonoma de Mexico (UNAM); Fronteras en la Ciencia, Consejo Nacional de Ciencia y Tecnologia (CONACYT) Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA) [FC-2016-2125]; Programa de Apoyo a Proyectos de Innovacio n Tecnolo gica (PAPIIT), Direccio n General de Asuntos del Personal Acade mico (DGAPA) [IA202919]	Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA); Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Fronteras en la Ciencia, Consejo Nacional de Ciencia y Tecnologia (CONACYT) Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA); Programa de Apoyo a Proyectos de Innovacio n Tecnolo gica (PAPIIT), Direccio n General de Asuntos del Personal Acade mico (DGAPA)	This work was supported by IN-209719 Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (UNAM) to JMM; Grant FC-2016-2125 from Fronteras en la Ciencia, Consejo Nacional de Ciencia y Tecnologia (CONACYT) Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (UNAM) to JMM; Grant IA202919 Programa de Apoyo a Proyectos de Innovacio n Tecnolo gica (PAPIIT), Direccio n General de Asuntos del Personal Acade mico (DGAPA), Universidad Nacional Autonoma de Mexico (UNAM) to KENC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amancio-Belmont O, 2019, BRAIN RES, V1725, DOI 10.1016/j.brainres.2019.146485; Blannin AK, 1996, BRIT J SPORT MED, V30, P125, DOI 10.1136/bjsm.30.2.125; BOUABOULA M, 1993, EUR J BIOCHEM, V214, P173, DOI 10.1111/j.1432-1033.1993.tb17910.x; Campbell JP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00648; Carvalho JF, 2005, COMP BIOCHEM PHYS A, V140, P409, DOI 10.1016/j.cbpb.2004.12.002; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Chiurchiu V, 2015, IMMUNOLOGY, V144, P352, DOI 10.1111/imm.12441; Cordova A, 2010, J PHYSIOL BIOCHEM, V66, P1, DOI 10.1007/s13105-010-0001-2; Davis JM, 2004, AM J PHYSIOL-REG I, V286, pR366, DOI 10.1152/ajpregu.00304.2003; Freidenreich DJ, 2013, NUTRITION AND ENHANCED SPORTS PERFORMANCE: MUSCLE BUILDING, ENDURANCE, AND STRENGTH, P95, DOI 10.1016/B978-0-12-396454-0.00009-6; Freidenreich DJ, 2012, EXERC IMMUNOL REV, V18, P8; Galdino G, 2014, NEUROPHARMACOLOGY, V77, P313, DOI 10.1016/j.neuropharm.2013.09.022; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Graham ES, 2010, INT J IMMUNOPATH PH, V23, P25, DOI 10.1177/039463201002300103; Greineisen WE, 2010, INT IMMUNOPHARMACOL, V10, P547, DOI 10.1016/j.intimp.2010.02.012; Gustafson MP, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0231-8; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Klein TW, 1998, IMMUNOL TODAY, V19, P373, DOI 10.1016/S0167-5699(98)01300-0; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lancaster GI, 2004, EXERC IMMUNOL REV, V10, P91; LaVoy EC, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13070; Lee SF, 2001, EUR J PHARMACOL, V423, P235, DOI 10.1016/S0014-2999(01)01122-0; LIN YS, 1993, INT J SPORTS MED, V14, P86, DOI 10.1055/s-2007-1021151; Mackinnon LT, 2000, IMMUNOL CELL BIOL, V78, P502, DOI 10.1046/j.1440-1711.2000.00955.x; Malek N, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/130639; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1242, DOI 10.1097/00005768-200208000-00003; Murphy EA, 2004, AM J PHYSIOL-REG I, V287, pR1354, DOI 10.1152/ajpregu.00274.2004; Noe SN, 2000, J NEUROIMMUNOL, V110, P161, DOI 10.1016/S0165-5728(00)00349-0; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Palmer CS, 2016, EBIOMEDICINE, V6, P31, DOI 10.1016/j.ebiom.2016.02.012; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Parsons LM, 2000, NEUROIMAGING EVIDENC, V97, DOI [10.1073/pnas.040555497, DOI 10.1073/PNAS.040555497]; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; PILIS W, 1993, COMP BIOCHEM PHYS A, V106, P285, DOI 10.1016/0300-9629(93)90513-4; Piszcz J A, 2007, Exp Oncol, V29, P221; Radom-Aizik S, 2013, J APPL PHYSIOL, V114, P628, DOI 10.1152/japplphysiol.01341.2012; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Saito Yukie, 2003, Environ Health Prev Med, V8, P18, DOI 10.1007/BF02897939; Sparling PB, 2003, NEUROREPORT, V14, P2209, DOI 10.1097/00001756-200312020-00015; SPARLING TM, 2017, MED SCI SPORTS EXERC; Sugiura H, 2001, J APPL PHYSIOL, V90, P789, DOI 10.1152/jappl.2001.90.3.789; Sugiura H, 2012, J APPL PHYSIOL, P789; Syu GD, 2012, MED SCI SPORT EXER, V44, P1021, DOI 10.1249/MSS.0b013e3182408639; Tanasescu R, 2010, IMMUNOBIOLOGY, V215, P588, DOI 10.1016/j.imbio.2009.12.005; Santos RVT, 2007, LIFE SCI, V80, P573, DOI 10.1016/j.lfs.2006.10.015; Wang J, 2012, SCAND J MED SCI SPOR, V22, P643, DOI 10.1111/j.1600-0838.2010.01288.x	48	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0220542	10.1371/journal.pone.0220542	http://dx.doi.org/10.1371/journal.pone.0220542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738771	gold, Green Published			2022-12-26	WOS:000532826300004
J	Hofman, ZLM; Clark, CC; Sanrattana, W; Nosairi, A; Parr, NMJ; Zivkovic, M; Krause, K; Mahnke, NA; Scheffel, J; Hack, CE; Maurer, M; de Maat, S; Maas, C				Hofman, Zonne L. M.; Clark, Chantal C.; Sanrattana, Wariya; Nosairi, Aziz; Parr, Naomi M. J.; Zivkovic, Minka; Krause, Karoline; Mahnke, Niklas A.; Scheffel, Joerg; Hack, C. Erik; Maurer, Marcus; de Maat, Steven; Maas, Coen			A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; serine protease; vascular biology; coagulation factor; enzyme mutation; autoinflammatory syndrome; bradykinin; factor XII; hereditary angioedema; kringle domain	HEREDITARY ANGIOEDEMA; ENHANCED SUSCEPTIBILITY; PLASMINOGEN-ACTIVATOR; PLASMA; GENE; AUTOACTIVATION; GENERATION; FIBRIN	Coagulation factor XII (FXII) drives production of the inflammatory peptide bradykinin. Pathological mutations in the F12 gene, which encodes FXII, provoke acute tissue swelling in hereditary angioedema (HAE). Interestingly, a recently identified F12 mutation, causing a W268R substitution, is not associated with HAE. Instead, FXII-W268R carriers experience cold-inducible urticarial rash, arthralgia, fever, and fatigue. Here, we aimed to investigate the molecular characteristics of the FXII-W268R variant. We expressed wild type FXII (FXII-WT), FXII-W268R, and FXII-T309R (which causes HAE), as well as other FXII variants in HEK293 freestyle cells. Using chromogenic substrate assays, immunoblotting, and ELISA, we analyzed expression media, cell lysates, and purified proteins for FXII activation. Recombinant FXII-W268R forms increased amounts of intracellular cleavage products that are also present in expression medium and display enzymatic activity. The active site?incapacitated variant FXII-W268R/S544A reveals that intracellular fragmentation is largely dependent on autoactivation. Purified FXII-W268R is highly sensitive to activation by plasma kallikrein and plasmin, compared with FXII-WT or FXII-T309R. Furthermore, binding studies indicated that the FXII-W268R variant leads to the exposure of a plasminogen-binding site that is cryptic in FXII-WT. In plasma, recombinant FXII-W268R spontaneously triggers high-molecular-weight kininogen cleavage. Our findings suggest that the W268R substitution influences FXII protein conformation and exposure of the activation loop, which is concealed in FXII-WT. This results in intracellular autoactivation and constitutive low-grade secretion of activated FXII. These findings help to explain the chronically increased contact activation in carriers of the FXII-W268R variant.	[Hofman, Zonne L. M.; Clark, Chantal C.; Sanrattana, Wariya; Nosairi, Aziz; Parr, Naomi M. J.; Zivkovic, Minka; de Maat, Steven; Maas, Coen] Univ Utrecht, Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, NL-3584 CX Utrecht, Netherlands; [Hack, C. Erik; Maurer, Marcus] Univ Med Ctr Utrecht, Lab Translat Immunol, NL-3584 CX Utrecht, Netherlands; [Krause, Karoline; Mahnke, Niklas A.; Scheffel, Joerg] Charite Univ Med Berlin, Dept Dermatol & Allergy, D-10117 Berlin, Germany	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Maas, C (corresponding author), Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	cmaas4@umcutrecht.nl	Maurer, Marcus/ABG-2174-2020; Levi, Marcel/AAZ-8559-2020; Krause, Karoline/G-5218-2018	Maurer, Marcus/0000-0002-4121-481X; Maas, Coen/0000-0003-4593-0976; Clark, Chantal/0000-0001-9614-7135; Sanrattana, Wariya/0000-0002-8731-8673; Zivkovic, Minka/0000-0003-4545-7939; Krause, Karoline/0000-0001-9711-9654; Mahnke, Niklas Amadeus/0000-0002-2520-2990	Landsteiner Foundation for Blood Transfusion Research Grant [LSBR 1520]; Netherlands Thrombosis Foundation [2017-03]; Thai government; Utrecht University Medical Center	Landsteiner Foundation for Blood Transfusion Research Grant; Netherlands Thrombosis Foundation; Thai government; Utrecht University Medical Center	This work was supported by funds from the Landsteiner Foundation for Blood Transfusion Research Grant LSBR 1520 (to C. M.), The Netherlands Thrombosis Foundation Grant 2017-03 (to C. M.), the Alexandre Suermann Grant from the Utrecht University Medical Center (to Z. L. M. H.), and a grant from the Thai government (to W. S.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], PEDIAT RHEUMATOLOGY; Beringer DX, 2013, ACTA CRYSTALLOGR F, V69, P94, DOI 10.1107/S1744309113000286; Bork K, 2011, CLIN IMMUNOL, V141, P31, DOI 10.1016/j.clim.2011.07.002; CASTELLINO FJ, 1987, J MOL EVOL, V26, P358, DOI 10.1007/BF02101155; Chinnaraj M, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00281; Citarella F, 2000, THROMB HAEMOSTASIS, V84, P1057; Citarella F, 1997, BRIT J HAEMATOL, V99, P197, DOI 10.1046/j.1365-2141.1997.3513165.x; Clark CC, 2018, THROMB HAEMOSTASIS, V118, P471, DOI 10.1055/s-0038-1627460; de Maat S, 2019, J THROMB HAEMOST, V17, P183, DOI 10.1111/jth.14325; De Maat S, 2018, J THROMB HAEMOST, V16, P1674, DOI 10.1111/jth.14209; de Maat S, 2016, J THROMB HAEMOST, V14, P1498, DOI 10.1111/jth.13383; de Maat S, 2016, J ALLERGY CLIN IMMUN, V138, P1414, DOI 10.1016/j.jaci.2016.02.021; de Maat S, 2013, THROMB HAEMOSTASIS, V110, P458, DOI 10.1160/TH12-11-0792; Dementiev A, 2018, BLOOD ADV, V2, P549, DOI 10.1182/bloodadvances.2018016337; Dewald G, 2006, BIOCHEM BIOPH RES CO, V343, P1286, DOI 10.1016/j.bbrc.2006.03.092; DORS DM, 1992, THROMB HAEMOSTASIS, V67, P644; Gelincik A, 2015, ANN ALLERG ASTHMA IM, V114, P154, DOI 10.1016/j.anai.2014.11.018; Hall SM, 2016, ACS CHEM NEUROSCI, V7, P1746, DOI 10.1021/acschemneuro.6b00258; Ivanov I, 2019, BLOOD, V133, P1152, DOI 10.1182/blood-2018-06-860270; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Kiss N, 2013, CLIN IMMUNOL, V149, P142, DOI 10.1016/j.clim.2013.08.001; Konings J, 2011, BLOOD, V118, P3942, DOI 10.1182/blood-2011-03-339572; Mahnke NA, 2018, EXP DERMATOL, V27, pE32; Mitchell JL, 2016, BLOOD, V128, P2834, DOI 10.1182/blood-2015-10-673285; Pathak M, 2015, J THROMB HAEMOST, V13, P580, DOI 10.1111/jth.12849; Pathak M, 2019, ACTA CRYSTALLOGR D, V75, P578, DOI 10.1107/S2059798319006910; RAVON DM, 1995, BLOOD, V86, P4134, DOI 10.1182/blood.V86.11.4134.bloodjournal86114134; Renne T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02011; SAMUEL M, 1992, J BIOL CHEM, V267, P19691; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; South K, 2014, P NATL ACAD SCI USA, V111, P18578, DOI 10.1073/pnas.1411979112; Stavrou EX, 2018, J CLIN INVEST, V128, P944, DOI 10.1172/JCI92880; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x	34	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					363	374		10.1074/jbc.RA119.009788	http://dx.doi.org/10.1074/jbc.RA119.009788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31771982	hybrid, Green Published			2022-12-26	WOS:000507373600009
J	Hsu, PJ; Shi, HL; Zhu, AC; Lu, ZK; Miller, N; Edens, BM; Ma, YC; He, C				Hsu, Phillip J.; Shi, Hailing; Zhu, Allen C.; Lu, Zhike; Miller, Nimrod; Edens, Brittany M.; Ma, Yongchao C.; He, Chuan			The RNA-binding protein FMRP facilitates the nuclear export of N-6-methyladenosine?containing mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA methylation; nuclear RNA; mouse; RNA metabolism; neurological disease; Fmr1 KO mice; FMRP; mouse brain; N6-methyladenosine (m6A); nuclear RNA export; fragile X mental retardation protein (FMRP); post-transcriptional modification; RNA-binding protein; gene regulation	MENTAL-RETARDATION PROTEIN; TRANSLATION	N-6-Methyladenosine (m(6)A) is the most abundant post-transcriptional mRNA modification in eukaryotes and exerts many of its effects on gene expression through reader proteins that bind specifically to m(6)A-containing transcripts. Fragile X mental retardation protein (FMRP), an RNA-binding protein, has previously been shown to affect the translation of target mRNAs and trafficking of mRNA granules. Loss of function of FMRP causes fragile X syndrome, the most common form of inherited intellectual disability in humans. Using HEK293T cells, siRNA-mediated gene knockdown, cytoplasmic and nuclear fractions, RNA-Seq, and LC-MS/MS analyses, we demonstrate here that FMRP binds directly to a collection of m(6)A sites on mRNAs. FMRP depletion increased mRNA m(6)A levels in the nucleus. Moreover, the abundance of FMRP targets in the cytoplasm relative to the nucleus was decreased in Fmr1-KO mice, an effect also observed in highly methylated genes. We conclude that FMRP may affect the nuclear export of m(6)A-modified RNA targets.	[Hsu, Phillip J.; Shi, Hailing; Zhu, Allen C.; Lu, Zhike; He, Chuan] Howard Hughes Med Inst, Dept Chem, Chevy Chase, MD 20815 USA; [Hsu, Phillip J.; Shi, Hailing; Zhu, Allen C.; Lu, Zhike; He, Chuan] Howard Hughes Med Inst, Inst Biophys Dynam, Chevy Chase, MD 20815 USA; [He, Chuan] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Hsu, Phillip J.] Univ Chicago, Med Scientist Training Program, Comm Immunol, Chicago, IL 60637 USA; [Zhu, Allen C.] Univ Chicago, Med Scientist Training Program, Comm Canc Biol, Chicago, IL 60637 USA; [Miller, Nimrod; Edens, Brittany M.; Ma, Yongchao C.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA; [Miller, Nimrod; Edens, Brittany M.; Ma, Yongchao C.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Neurol, Chicago, IL 60611 USA; [Miller, Nimrod; Edens, Brittany M.; Ma, Yongchao C.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Physiol, Chicago, IL 60611 USA; [He, Chuan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Howard Hughes Medical Institute	He, C (corresponding author), Howard Hughes Med Inst, Dept Chem, Chevy Chase, MD 20815 USA.; He, C (corresponding author), Howard Hughes Med Inst, Inst Biophys Dynam, Chevy Chase, MD 20815 USA.; He, C (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; He, C (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	ma@northwestern.edu; chuanhe@uchicago.edu	, WaNgtJ/AAR-7045-2020; Shi, Hailing/AAW-5351-2021	Shi, Hailing/0000-0001-7355-378X; Ma, Yongchao/0000-0002-2469-4356	Chicago Biomedical Consortium; National Institutes of Health Medical Scientist National Research Service Award [T32 GM007281]; National Institutes of Health [R01NS094564, R21NS106307]; Cure SMA; Hartwell Foundation	Chicago Biomedical Consortium; National Institutes of Health Medical Scientist National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure SMA; Hartwell Foundation	This work was supported by grants from the Chicago Biomedical Consortium (to Y. C. M. and C. H.). C. H. is a scientific founder of Accent Therapeutics, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Medical Scientist National Research Service Award T32 GM007281.; Supported by National Institutes of Health Grants R01NS094564 and R21NS106307, Cure SMA, and The Hartwell Foundation. To whom correspondence may be addressed. E-mail: ma@northwestern.edu.	Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; BAKKER CE, 1994, CELL, V78, P23; Bresson S, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.170270; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Edens BM, 2019, CELL REP, V28, P845, DOI 10.1016/j.celrep.2019.06.072; Edupuganti RR, 2017, NAT STRUCT MOL BIOL, V24, P870, DOI 10.1038/nsmb.3462; Feng Y, 1997, J NEUROSCI, V17, P1539; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Hsu PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1336-6; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lai DM, 2006, RNA, V12, P1446, DOI 10.1261/rna.94306; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Otero YD, 2002, MOL CELL BIOL, V22, P8332, DOI 10.1128/MCB.22.23.8332-8341.2002; Ries RJ, 2019, NATURE, V571, P424, DOI 10.1038/s41586-019-1374-1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Suhl JA, 2014, HUM MOL GENET, V23, P5479, DOI 10.1093/hmg/ddu272; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Williams T, 2018, SEMIN CELL DEV BIOL, V75, P70, DOI 10.1016/j.semcdb.2017.08.054; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Zhang FR, 2018, HUM MOL GENET, V27, P3936, DOI 10.1093/hmg/ddy292; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	32	53	57	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19889	19895		10.1074/jbc.AC119.010078	http://dx.doi.org/10.1074/jbc.AC119.010078			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31753916	hybrid, Green Published			2022-12-26	WOS:000505005800006
J	Helen; Jarzebski, MP; Gasparatos, A				Helen; Jarzebski, Marcin Pawel; Gasparatos, Alexandros			Land use change, carbon stocks and tree species diversity in green spaces of a secondary city in Myanmar, Pyin Oo Lwin	PLOS ONE			English	Article							ECOSYSTEM SERVICES; GAS EMISSIONS; KUALA-LUMPUR; COVER CHANGE; URBAN PARKS; SEQUESTRATION; BIODIVERSITY; IMPACTS; DENSITY; BANGKOK	Myanmar undergoes rapid urban expansion and experiences its negative impacts, often due to the loss of urban green spaces. National and local authorities lack sufficient knowledge, capacity and plans on how to preserve urban green spaces and benefit from their ecosystem services, with such gaps being particularly pronounced in the smaller secondary cities. This study focuses in such as secondary city, Pyin Oo Lwin, and analyzes land use and land cover (LULC) change, tree diversity and carbon stored in aboveground and belowground biomass, and soil. We focus on the main green spaces of the city, which contain different configurations of urban forest, grassland and agricultural land. Remote sensing analysis tracked LULC change between 1988 and 2018, and showed the extensive increase of built-up area, and the decline of urban forests and urban farms. Even though a substantial amount of green spaces has been converted to built-up land, the remaining urban green spaces are still serving as an important habitat for many different tree species, with a total of 82 species from 35 families observed in the different green spaces. Furthermore, these green spaces contain significant carbon stocks, which are, however, highly variable: botanical garden (383.67 t/ha), coffee farms (355.64 t/ha), monasteries (277.14 t/ha), golf course (208.45 t/ha), and seasonal farms (123.22 t/ha). Nevertheless, the extensive LULC change has reduced carbon stocks from 2.41 Mt (1988) to 1.65 Mt (2018). The findings of this study provide a better understanding of LULC change in secondary cities of Myanmar, and build an evidence base on how urban green spaces preservation and green infrastructure development can contribute to green economic transitions, and sustainable, resilient, and lowcarbon cities in the country.	[Helen] Univ Tokyo, Grad Sch Frontier Sci, Global Leadership Initiat, Grad Program Sustainabil Sci, Kashiwa, Chiba, Japan; [Jarzebski, Marcin Pawel; Gasparatos, Alexandros] Univ Tokyo, Inst Future Initiat, Tokyo, Japan	University of Tokyo; University of Tokyo	Helen (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Global Leadership Initiat, Grad Program Sustainabil Sci, Kashiwa, Chiba, Japan.	helen.helen.2010@gmail.com	Gasparatos, Alexandros/AAT-4403-2020	Gasparatos, Alexandros/0000-0001-9323-1366	Monbukagakusho scholarship	Monbukagakusho scholarship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Helen is supported by a Monbukagakusho scholarship offered by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) through the Graduate Program in Sustainability Science - Global Leadership Initiative (GPSS-GLI), at the University of Tokyo.	Agustin, 2012, CARBON SEQUESTRATION, P249, DOI [10.1007/978-94-007-2366-5_13, DOI 10.1007/978-94-007-2366-5_13]; Akinyemi FO, 2017, APPL GEOGR, V87, P127, DOI 10.1016/j.apgeog.2017.07.016; Ali G, 2018, LAND USE POLICY, V70, P471, DOI 10.1016/j.landusepol.2017.11.003; Anandan G, 2014, J BIODIVERS ENDANGER, V02, P1; [Anonymous], 2018, WORLD URB PROSP 2018; Apogbona, 2016, ENV ECOL RES, V4, P185, DOI [10.13189/eer.2016.040401, DOI 10.13189/EER.2016.040401]; Aung W-Y, 2018, ATMOS POLLUT RES, DOI [10.1016/tapr.2018.05.003, DOI 10.1016/TAPR.2018.05.003]; Aynekulu E., 2016, SOIL SAMPLING HOUSEH; Bae J, 2015, LANDSCAPE URBAN PLAN, V136, P57, DOI 10.1016/j.landurbplan.2014.11.015; Banko G., 1998, NEW SCI; Baro F, 2015, ECOL INDIC, V55, P146, DOI 10.1016/j.ecolind.2015.03.013; Bibi F, 2013, J ANIM PLANT SCI, V23, P469; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chen M, 2019, HABITAT INT; Chow WTL, 2006, INT J CLIMATOL, V26, P2243, DOI 10.1002/joc.1364; Deng L, 2018, ISPRS J PHOTOGRAMM, V144, P298, DOI 10.1016/j.isprsjprs.2018.08.002; Department Forest, 2017, PYIN OOLWIN UNPUB; Devi R., 2017, CARBON STORAGE TREES, V2, P250; Dobermann T., 2016, URBAN MYANMAR POLICY; Elmqvist T, 2015, CURR OPIN ENV SUST, V14, P101, DOI 10.1016/j.cosust.2015.05.001; Erdal Sakin, 2012, AFRICAN J BIOTECHNOL, V11; FAO (Food and Agriculture Organization), 2004, ASSESSING CARBON STO; Fox S, 2019, CITIES, V84, P83, DOI 10.1016/j.cities.2018.07.008; Freeman J, 2017, URBANIZATION CONFLIC; Sanchez FG, 2018, LAND USE POLICY, V79, P164, DOI 10.1016/j.landusepol.2018.08.010; Gasparatos A., 2015, BIODIVERSITY GREEN E; Gianna B.Y., 2015, CITIES CLIMATE DIPLO; Gilmore S., 2015, EFFECTIVENESS DOS DA; Global Green Growth Institute, 2017, GREEN GROWTH POT ASS; Global Green Growth Institute (GGGI), 2017, GREEN GROWTH POT ASS; Goldblatt R., 2018, DEV ENG, V3, P83, DOI [10.1016/j.deveng.2018.03.001, DOI 10.1016/J.DEVENG.2018.03.001]; Gomez-Baggethun Erik, 2013, P175; Government of Myanmar, 2016, EC POL UN MYANM; Govindarajulu D, 2014, URBAN CLIM, V10, P35, DOI 10.1016/j.uclim.2014.09.006; Gratani L, 2016, URBAN FOR URBAN GREE, V19, P184, DOI 10.1016/j.ufug.2016.07.007; Green Lotus, 2015, MYANM ACT PLAN GREEN; Hernandez-Guzman R, 2019, REMOTE SENS APPL, V13, P318, DOI 10.1016/j.rsase.2018.12.005; Hobbs ER, 1988, LANDSCAPE ECOLOGY, V1; Intasen M, 2017, J SUSTAIN FOREST, V36, P148, DOI 10.1080/10549811.2016.1265455; IPCC, 2003, INT PAN CLIM CHANG G; Kanniah KD, 2017, URBAN FOR URBAN GREE, V27, P287, DOI 10.1016/j.ufug.2017.08.016; Kavinchan N, 2015, KKU RES J, V20, P11; Khaing Lwin K, 2015, IJERD INT J ENV RURA; Khaing T., 2015, URBANIZATION STRUCTU; Kulak M, 2013, LANDSCAPE URBAN PLAN, V111, P68, DOI 10.1016/j.landurbplan.2012.11.007; Larondelle N, 2014, GLOBAL ENVIRON CHANG, V26, P119, DOI 10.1016/j.gloenvcha.2014.04.008; Lekha S.L.S., 2018, INT J APPL ENG RES, V13, P158; Lepczyk CA, 2017, BIOSCIENCE, V67, P799, DOI 10.1093/biosci/bix079; LI EJ, 2019, FRONT ECOL EVOL, V7, DOI DOI 10.3389/FEYO.2019.00277/FULL; Liu CF, 2012, URBAN FOR URBAN GREE, V11, P121, DOI 10.1016/j.ufug.2011.03.002; Mexia T, 2018, ENVIRON RES, V160, P469, DOI 10.1016/j.envres.2017.10.023; Ministry of Construction. National Habitat Report, 2016, NAT HAB REP PREP ANT; Ministry of Labour Immigration and Population, 2018, 2014 MYANM POP HOUS; Ministry of Labour Immigration and Population, 2015, 2014 MYANM POP HOUS, V3; Ministry of Natural Resources and Environmental Conservation, 2017, BUILD RES INCL SUST; Ministry of Transport and Communications, 2016, COUNTR REP SUST URB; Miyazawa I., 2013, ENHANCING READINESS; Muthulingam U, 2012, URBAN FOR URBAN GREE, V11, P450, DOI 10.1016/j.ufug.2012.08.003; Nagendra H, DIVERSITY DISTRIBUTI; Nath TK, 2018, URBAN FOR URBAN GREE, V36, P34, DOI 10.1016/j.ufug.2018.09.013; Ne Oo H, 2018, ANAL ENV CLIMATE CHA, V7; Nero BF, 2018, FORESTS, V9, DOI 10.3390/f9090519; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; Obodai J, 2019, REMOTE SENS APPL, V13, P247, DOI 10.1016/j.rsase.2018.10.007; Oxford Business Group, 2019, HAN ZAW MIN CONSTR I; Prakash A., 2013, EC TRANSITION MYANMA; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Prichett W.L., 1981, MANUAL LAB PROCEDURE; Richards DR, 2017, LANDSCAPE URBAN PLAN, V157, P553, DOI 10.1016/j.landurbplan.2016.09.005; Richards J.A, 2013, REMOTE SENSING DIGIT, P247, DOI [10.1007/978-3-642-30062-2, DOI 10.1007/978-3-642-30062-2]; Saksena S, 2014, APPL GEOGR, V50, P80, DOI 10.1016/j.apgeog.2014.02.010; Sikuzani YU, 2019, URBAN FOR URBAN GREE, V41, P67, DOI 10.1016/j.ufug.2019.03.008; Sisodia P.S., 2014, P INT C REC ADV INN, P1, DOI DOI 10.1109/ICRAIE.2014.6909319; Spellerberg IF, 2003, GLOBAL ECOLOGY BIOGE, V12; Strohbach MW, 2012, LANDSCAPE URBAN PLAN, V104, P220, DOI 10.1016/j.landurbplan.2011.10.013; TALAL ML, 2019, FRONT ECOL EVOL, V7, DOI DOI 10.3389/FEYO.2019.00201/FULL; Tang YJ, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00053; Taylor L, 2017, LANDSCAPE URBAN PLAN, V158, P25, DOI 10.1016/j.landurbplan.2016.09.024; Tidaker P, 2017, URBAN FOR URBAN GREE, V21, P80, DOI 10.1016/j.ufug.2016.11.009; Tor-ngern P, 2018, URBAN FOR URBAN GREE, V36, P76, DOI 10.1016/j.ufug.2018.10.010; U.S. Department of Housing and Urban Development, 2016, NEIGHBORHOODS VIOLEN; UN-Habitat, 2016, REP UN MYANM RAP URB; UN-Habitat, 2016, INT J; UNEP, 2011, PATHW SUST DEV POV E; UNEP, 2018, SUST URB INFR TRANS; UNEP-WCMC, 2014, REL BIOD CARB STOR P; USGS, 2017, LANDS COLL 1 LEV PRO; Velasco E, 2016, LANDSCAPE URBAN PLAN, V148, P99, DOI 10.1016/j.landurbplan.2015.12.003; Wai ATP, 2018, SUSTAIN CITIES SOC, V37, P323, DOI 10.1016/j.scs.2017.10.038; Wang YC, 2018, SCI TOTAL ENVIRON, V643, P738, DOI 10.1016/j.scitotenv.2018.06.209; Wang YC, 2015, AEROSOL AIR QUAL RES, V15, P1291, DOI 10.4209/aaqr.2015.02.0110; WILKES P, 2018, CARBON BAL MANAGE, V13, DOI DOI 10.1186/S13021.018-0098-0; Winston E, 2005, ARABICA COFFEE MANUA; World Bank Group, 2015, E ASIAS CHANGING URB; WWF, 2017, UNV GREEN EC MYANM; WWF, 2017, ASS CLIM RISK MYANM; Yilmaz H, 2010, INT J BIODIVERSITY S; Zaw M, 2011, STUDY EC CORRIDORS I; Zaw M., 2017, ASIA LEDS PARTNERSHI; Zomer RJ, 2016, NAT PUBL GR	100	6	6	8	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225331	10.1371/journal.pone.0225331	http://dx.doi.org/10.1371/journal.pone.0225331			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8RE	31770399	Green Published, gold			2022-12-26	WOS:000533892300015
J	Talabot-Ayer, D; Mermoud, L; Borowczyk, J; Drukala, J; Wolnicki, M; Modarressi, A; Boehncke, WH; Brembilla, N; Palmer, G				Talabot-Ayer, Dominique; Mermoud, Loic; Borowczyk, Julia; Drukala, Justyna; Wolnicki, Michal; Modarressi, Ali; Boehncke, Wolf-Henning; Brembilla, Nicolo; Palmer, Gaby			Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytes	PLOS ONE			English	Article							IL-1 RECEPTOR ANTAGONIST; GENE-COMPLEX MEMBERS; FAMILY CYTOKINES; ANKYLOSING-SPONDYLITIS; ASSOCIATION; EXPRESSION; CELLS; INFLAMMATION; IL-1-ALPHA; BINDING	Interleukin (IL)-38 is a member of the IL-1 family of cytokines, which was proposed to exert anti-inflammatory effects. IL-38 is constitutively expressed in the skin, where keratinocytes are the main producing cells. Little information is currently available concerning IL-38 biology. Here, we investigated the subcellular localization and interaction partners of the IL-38 protein in human keratinocytes. IL-38 expression was reduced in primary keratinocytes grown in monolayer (2D) cultures. We thus used IL-38 overexpressing immortalized normal human keratinocytes (NHK/38) to study this cytokine in cell monolayers. In parallel, differentiation of primary human keratinocytes in an in vitro reconstructed human epidermis (RHE) 3D model allowed us to restore endogenous IL-38 expression. In NHK/38 cells and in RHE, IL-38 was mainly cell-associated, rather than released into culture supernatants. Intracellular IL-38 was preferentially, although not exclusively, cytoplasmic. Similarly, in normal human skin sections, IL-38 was predominantly cytoplasmic in the epidermis and essentially excluded from keratinocyte nuclei. A yeast two-hybrid screen identified destrin/actin-depolymerizing factor (DSTN) as a potential IL-38-interacting molecule. Co-immunoprecipitation and proximity ligation assay confirmed this interaction. We further observed partial co-localization of IL-38 and DSTN in NHK/38 cells. Endogenous IL-38 and DSTN were also coexpressed in all epidermal layers in RHE and in normal human skin. Finally, IL-38 partially co-localized with F-actin in NHK/38 cells, in particular along the cortical actin network and in filopodia. In conclusion, IL-38 is found predominantly in the cytoplasm of human keratinocytes, where it interacts with DSTN. The functional relevance of this interaction remains to be investigated.	[Talabot-Ayer, Dominique; Mermoud, Loic; Borowczyk, Julia; Boehncke, Wolf-Henning; Brembilla, Nicolo; Palmer, Gaby] Univ Geneva, Sch Med, Dept Pathol Immunol, Geneva, Switzerland; [Talabot-Ayer, Dominique; Mermoud, Loic; Palmer, Gaby] Univ Hosp, Dept Internal Med Specialties, Div Rheumatol, Geneva, Switzerland; [Borowczyk, Julia; Boehncke, Wolf-Henning; Brembilla, Nicolo] Univ Hosp, Div Dermatol & Venereol, Geneva, Switzerland; [Drukala, Justyna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Cell Bank, Krakow, Poland; [Wolnicki, Michal] Jagiellonian Univ, Med Coll, Dept Pediat Urol, Krakow, Poland; [Modarressi, Ali] Univ Geneva, Sch Med, Univ Hosp Geneva, Dept Plast Reconstruct & Aesthet Surg, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Geneva	Palmer, G (corresponding author), Univ Geneva, Sch Med, Dept Pathol Immunol, Geneva, Switzerland.; Palmer, G (corresponding author), Univ Hosp, Dept Internal Med Specialties, Div Rheumatol, Geneva, Switzerland.	Gaby.Palmer@unige.ch	palmer, gaby/AAA-7117-2021	palmer, gaby/0000-0001-7567-1798; Borowczyk, Julia/0000-0002-4638-1596	Rheumasearch Foundation; Institute of Rheumatology Research	Rheumasearch Foundation; Institute of Rheumatology Research	This work was supported by grants from the Rheumasearch Foundation (http://www.rheumasearch.ch) and the Institute of Rheumatology Research (https://www.irr-research.org/home.html) to GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Banda NK, 2005, J IMMUNOL, V174, P3608, DOI 10.4049/jimmunol.174.6.3608; Boraschi D, 2018, IMMUNOL REV, V281, P197, DOI 10.1111/imr.12606; Boutet MA, 2016, CLIN EXP IMMUNOL, V184, P159, DOI 10.1111/cei.12761; Boutet MA, 2017, ANN RHEUM DIS, V76, P1300, DOI 10.1136/annrheumdis-2016-210630; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Chou CT, 2006, ANN RHEUM DIS, V65, P1106, DOI 10.1136/ard.2005.046847; Chu M, 2017, IMMUNOBIOLOGY, V222, P483, DOI 10.1016/j.imbio.2016.10.012; Ciccia F, 2015, CLIN EXP IMMUNOL, V181, P230, DOI 10.1111/cei.12644; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Fields JK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01412; Fonseca-Camarillo G, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5140691; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Garraud T, 2018, CYTOKINE GROWTH F R, V39, P26, DOI 10.1016/j.cytogfr.2018.01.001; Guo ZS, 2010, INT J IMMUNOGENET, V37, P33, DOI 10.1111/j.1744-313X.2009.00889.x; Han YY, 2019, CELL REP, V27, P835, DOI 10.1016/j.celrep.2019.03.082; HASKILL S, 1991, P NATL ACAD SCI USA, V88, P3681, DOI 10.1073/pnas.88.9.3681; Hessam S, 2018, BRIT J DERMATOL, V178, P761, DOI 10.1111/bjd.16019; Hu B, 2003, P NATL ACAD SCI USA, V100, P10008, DOI 10.1073/pnas.1737765100; Jung MY, 2010, SCAND J RHEUMATOL, V39, P190, DOI 10.3109/03009740903447028; Kanellos G, 2015, CELL REP, V13, P1949, DOI 10.1016/j.celrep.2015.10.056; Keermann M, 2015, J DERMATOL SCI, V80, P150, DOI 10.1016/j.jdermsci.2015.08.002; Lachner J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17782-4; Lee RT, 1997, J IMMUNOL, V159, P5084; Ligthart S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118859; Lin HS, 2001, J BIOL CHEM, V276, P20597, DOI 10.1074/jbc.M010095200; Mee JB, 2005, J INVEST DERMATOL, V124, P1267, DOI 10.1111/j.0022-202X.2005.23684.x; Mercurio L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1143-3; Monnet D, 2012, ANN RHEUM DIS, V71, P885, DOI 10.1136/annrheumdis-2011-200439; Mora J, 2016, J MOL CELL BIOL, V8, P426, DOI 10.1093/jmcb/mjw006; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Palomo J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194667; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; Rider P, 2017, J IMMUNOL, V198, P1395, DOI 10.4049/jimmunol.1601342; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Rudloff I, 2015, ARTHRITIS RHEUMATOL, V67, P3219, DOI 10.1002/art.39328; Lopez MES, 2013, J INTERF CYTOK RES, V33, P369, DOI 10.1089/jir.2012.0126; Steenbergen RDM, 1996, ONCOGENE, V13, P1249; Takenaka Shin-Ichi, 2015, Biochem Biophys Rep, V4, P386, DOI 10.1016/j.bbrep.2015.10.015; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Verdoni AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002701; Wang M, 2016, CELL MOL BIOL, V62, P31, DOI 10.14715/cmb/2016.62.4.6; Xu F, 2018, J INFECT DIS, V218, P1175, DOI 10.1093/infdis/jiy289; Xu KY, 2019, BIOCHEM BIOPH RES CO, V508, P198, DOI 10.1016/j.bbrc.2018.11.114; Xu WD, 2018, INT IMMUNOPHARMACOL, V65, P1, DOI 10.1016/j.intimp.2018.09.028; Yin HL, 2001, CYTOKINE, V15, P122, DOI 10.1006/cyto.2001.0891; Yuan XL, 2016, INT IMMUNOPHARMACOL, V40, P452, DOI 10.1016/j.intimp.2016.09.023	50	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225782	10.1371/journal.pone.0225782	http://dx.doi.org/10.1371/journal.pone.0225782			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770407	gold, Green Published			2022-12-26	WOS:000533892300039
J	Oldani, G; Peloso, A; Slits, F; Gex, Q; Delaune, V; Orci, LA; van de Looij, Y; Colin, DJ; Germain, S; de Vito, C; Rubbia-Brandt, L; Lacotte, S; Toso, C				Oldani, Graziano; Peloso, Andrea; Slits, Florence; Gex, Quentin; Delaune, Vaihere; Orci, Lorenzo A.; van de Looij, Yohan; Colin, Didier J.; Germain, Stephane; de Vito, Claudio; Rubbia-Brandt, Laura; Lacotte, Stephanie; Toso, Christian			The impact of short-term machine perfusion on the risk of cancer recurrence after rat liver transplantation with donors after circulatory death	PLOS ONE			English	Article							HYPOTHERMIC OXYGENATED PERFUSION; REPERFUSION INJURY; DONATION; GRAFTS; RESCUE; SYSTEM; MODEL	Hypothermic and normothermic ex vivo liver perfusions promote organ recovery after donation after circulatory death (DCD). We tested whether these perfusions can reduce the risk of hepatocellular carcinoma (HCC) recurrence in a 1h-DCD syngeneic transplantation model, using Fischer F344 rats. DCD grafts were machine perfused for 2h with hypothermic perfusion (HOPE) or normothermic perfusion (NORMO), and transplanted. After reperfusion, we injected HCC cells into the vena porta. On day 28 after transplantation, we assessed tumour volumes by MRI. Control rats included transplantations with Fresh and non-perfused DCD livers. We observed apoptotic-necrotic hepatocyte foci in all DCD grafts, which were more visible than in the Fresh liver grafts. Normothermic perfusion allowed a faster post-transplant recovery, with lower day 1 levels of transaminases compared with the other DCD. Overall, survival was similar in all four groups and all animals developed HCCs. Total tumor volume was lower in the Fresh liver recipients compared to the DCD and DCD+HOPE recipients. Volumes in DCD+NORMO recipients were not significantly different from those in the Fresh group. This experiment confirms that ischemia/reperfusion injury promotes HCC cell engraftment/growth after DCD liver transplantation. Using the present extreme 1h ischemia model, both hypothermic and normothermic perfusions were not effective in reducing this risk.	[Oldani, Graziano; Peloso, Andrea; Slits, Florence; Gex, Quentin; Delaune, Vaihere; Orci, Lorenzo A.; Lacotte, Stephanie; Toso, Christian] Univ Geneva, Fac Med, Dept Surg, Div Abdominal Surg, Geneva, Switzerland; [Oldani, Graziano; Peloso, Andrea; Delaune, Vaihere; Orci, Lorenzo A.; de Vito, Claudio; Rubbia-Brandt, Laura; Toso, Christian] Geneva Univ Hosp, Hepatopancreato Biliary Ctr, Geneva, Switzerland; [van de Looij, Yohan] Univ Childrens Hosp Geneva, Div Child Dev & Growth, Geneva, Switzerland; [van de Looij, Yohan] Univ Geneva, Inst Translat Mol Imaging, Geneva, Switzerland; [Colin, Didier J.; Germain, Stephane] Geneva Univ Hosp, Ctr BioMed Imaging, MicroPET SPECT CT Imaging Lab, Geneva, Switzerland; [Colin, Didier J.; Germain, Stephane; de Vito, Claudio; Rubbia-Brandt, Laura] Univ Geneva, Geneva, Switzerland; [de Vito, Claudio; Rubbia-Brandt, Laura] Geneva Univ Hosp, Dept Pathol & Immunol, Div Clin Pathol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Oldani, G (corresponding author), Univ Geneva, Fac Med, Dept Surg, Div Abdominal Surg, Geneva, Switzerland.; Oldani, G (corresponding author), Geneva Univ Hosp, Hepatopancreato Biliary Ctr, Geneva, Switzerland.	graziano.oldani@hcuge.ch	Delaune, Vaihere/GVT-9168-2022; Peloso, Andrea/K-4150-2016	Delaune, Vaihere/0000-0001-8931-0977; Peloso, Andrea/0000-0002-3089-0230; Oldani, Graziano/0000-0002-6637-0675; Lacotte, Stephanie/0000-0002-5921-6389; van de Looij, Yohan/0000-0003-2830-5482; Colin, Didier J./0000-0002-7067-8701	Swiss National Science Foundation [PP00P3_139021]; Geneva Cancer League [1509]; Minkoff Foundation; Arteres Foundation; Insuleman Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Geneva Cancer League; Minkoff Foundation; Arteres Foundation; Insuleman Foundation	This study was supported by grants from the Swiss National Science Foundation (PP00P3_139021), the Geneva Cancer League (ref 1509), the Minkoff Foundation, the Arteres Foundation, and the Insuleman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGMARK S, 1976, BRIT J SURG, V63, P268, DOI 10.1002/bjs.1800630405; Boteon YL, 2018, LIVER TRANSPLANT, V24, P1699, DOI 10.1002/lt.25315; Boteon Yuri L, 2018, Curr Transplant Rep, V5, P113, DOI 10.1007/s40472-018-0188-7; Compagnon P, 2017, TRANSPLANTATION, V101, pE205, DOI 10.1097/TP.0000000000001764; Croome KP, 2013, LIVER TRANSPLANT, V19, P1214, DOI 10.1002/lt.23715; Dutkowski P, 2015, ANN SURG, V262, P764, DOI 10.1097/SLA.0000000000001473; Dutkowski P, 2014, J HEPATOL, V60, P765, DOI 10.1016/j.jhep.2013.11.023; Dutkowski R, 2006, AM J TRANSPLANT, V6, P903, DOI 10.1111/j.1600-6143.2006.01264.x; Fransvea E, 2009, CELL ONCOL, V31, P227, DOI 10.3233/CLO-2009-0473; Grat M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27319-y; Guarrera JV, 2015, AM J TRANSPLANT, V15, P161, DOI 10.1111/ajt.12958; Guo Y, 2011, AM J TRANSL RES, V3, P114; Guo YJ, 2015, TRANSPLANT REV-ORLAN, V29, P127, DOI 10.1016/j.trre.2015.05.001; Ishii E, 2013, TRANSPL P, V45, P1748, DOI 10.1016/j.transproceed.2013.01.086; Izamis ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069758; Jayant K, 2018, EXPERT REV GASTROENT, V12, P1045, DOI 10.1080/17474124.2018.1505499; KAMADA N, 1983, SURGERY, V93, P64; Khorsandi SE, 2016, TRANSPLANTATION, V100, P1916, DOI 10.1097/TP.0000000000001150; Kobayashi Y, 1998, TRANSPLANTATION, V66, P708, DOI 10.1097/00007890-199809270-00004; Li CX, 2017, TRANSPLANTATION, V101, P2665, DOI 10.1097/TP.0000000000001844; Nasralla D, 2018, NATURE, V557, P50, DOI 10.1038/s41586-018-0047-9; NOVICKI DL, 1983, IN VITRO CELL DEV B, V19, P191; Oldani G, 2018, J HEPATOL, V69, P1025, DOI 10.1016/j.jhep.2018.07.008; Oldani G, 2016, LIVER TRANSPLANT, V22, P1688, DOI 10.1002/lt.24637; Oldani G, 2012, JOVE-J VIS EXP, DOI 10.3791/4143; Oldani G, 2014, J HEPATOL, V61, P278, DOI 10.1016/j.jhep.2014.03.036; Orci LA, 2018, J HEPATOL, V68, P978, DOI 10.1016/j.jhep.2017.12.025; Orci LA, 2014, DIGEST DIS SCI, V59, P2058, DOI 10.1007/s10620-014-3182-7; Prin M, 2015, WORLD J GASTROENTERO, V21, P2582, DOI 10.3748/wjg.v21.i9.2582; Richards JA, 2010, WORLD J GASTROENTERO, V16, P6068, DOI 10.3748/wjg.v16.i48.6068; Schlegel A, 2014, J HEPATOL, V61, P1267, DOI 10.1016/j.jhep.2014.07.023; Schlegel A, 2013, J HEPATOL, V59, P984, DOI 10.1016/j.jhep.2013.06.022; Schlegel A, 2013, J HEPATOL, V58, P278, DOI 10.1016/j.jhep.2012.10.004; SCHUMACKER PT, 1989, CRIT CARE CLIN, V5, P255; Selzner M, 2016, LIVER TRANSPLANT, V22, P1501, DOI 10.1002/lt.24499; Shapiro J., 2018, HPB SURG, V2018, P6360423, DOI [10.1155/2018/6360423, DOI 10.1155/2018/6360423]; Srivastava RM, 2008, J IMMUNOL, V180, P1117, DOI 10.4049/jimmunol.180.2.1117; Tolboom H, 2009, TRANSPLANTATION, V87, P170, DOI 10.1097/TP.0b013e318192df6b; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; van Rijn R, 2017, BRIT J SURG, V104, P907, DOI 10.1002/bjs.10515; Vendrell M, 2015, AM J TRANSPLANT, V15, P764, DOI 10.1111/ajt.13058	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0224890	10.1371/journal.pone.0224890	http://dx.doi.org/10.1371/journal.pone.0224890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765399	gold, Green Published			2022-12-26	WOS:000533891000012
J	David, I; Orboi, MD; Simandi, MD; Chirila, CA; Megyesi, CI; Radulescu, L; Draghia, LP; Lukinich-Gruia, AT; Muntean, C; Hadaruga, DI; Hadaruga, NG				David, Ioan; Orboi, Manuela D.; Simandi, Marius D.; Chirila, Cosmina A.; Megyesi, Corina I.; Radulescu, Laura; Draghia, Lavinia P.; Lukinich-Gruia, Alexandra T.; Muntean, Cornelia; Hadaruga, Daniel I.; Hadaruga, Nicoleta G.			Fatty acid profile of Romanian's common bean (Phaseolus vulgaris L.) lipid fractions and their complexation ability by beta-cyclodextrin	PLOS ONE			English	Article							ALPHA-CYCLODEXTRIN; INCLUSION; OIL; IMPROVEMENT	The goal of the present study was the evaluation of the fatty acid (FA) profile of lipid fraction from dry common beans (Phaseolus vulgaris L.) (CBO) harvested from North-East (NE) and South-West (SW) of Romania and to protect against thermal and oxidative degradation of the contained omega-3 and omega-6 polyunsaturated fatty acid (PUFA) glycerides by beta-cyclodextrin (beta-CD) nanoencapsulation, using kneading method. The most abundant FAs in the CBO samples were PUFAs, according to gas chromatography-mass spectrometry (GC-MS) analysis. Linoleic acid (methyl ester) was the main constituent, having relative concentrations of 43.4 (+/- 1.95)% and 35.23 (+/- 0.68) % for the lipid fractions separated from the common beans harvested from the NE and SW of Romania, respectively. Higher relative concentrations were obtained for the omega-3 alpha-linolenic acid methyl ester at values of 13.13 (+/- 0.59) % and 15.72 (+/- 0.30)% for NE and SW Romanian samples, respectively. The omega-3/omega-6 ratio consistently exceeds the lower limit value of 0.2, from where the PUFA glyceride mixture is valuable for the human health. This value was 0.32 (+/- 0.02) for the NE samples and significantly higher for the CBO-SW samples, 0.51 (+/- 0.01). These highly hydrophobic mixtures especially consisting of PUFA triglycerides provide beta-CD complexes having higher thermal and oxidative stability. Kneading method allowed obtaining beta-CD/CBO powder-like complexes with higher recovery yields of >70%. Thermal analyses of complexes revealed a lower content of hydration water (3.3-5.8% up to 110 degrees C in thermogravimetry (TG) analysis and 154-347 J/g endothermal effect in differential scanning calorimetry (DSC) analysis) in comparison with the beta-CD hydrate (12.1% and 479.5-480 J/g, respectively). These findings support the molecular inclusion process of FA moieties into the beta-CD cavity. Attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) analysis reveals the formation of the beta-CD/CBO inclusion complexes by restricting the vibration and bending of some bonds from the host and guest molecules. Moreover, powder X-ray diffractometry (PXRD) analysis confirm the formation of the host-guest complexes by modifying the diffractograms for beta-CD/CBO complexes in comparison with the beta-CD and beta-CD + CBO physical mixtures. A significant reduction of the level of crystallinity from 93.3 (+/- 5.3)% for beta-CD to 60-60.9% for the corresponding beta-CD/CBO complexes have been determined. The encapsulation efficiency (EE), the profile of FAs, as well as the controlled release of the encapsulated oil have also been evaluated. The EE was >40% in all cases, the highest value being obtained for beta-CD/CBO-SW complex. The SFA content increased, while the unsaturated FA glycerides had lower relative concentrations in the encapsulated CBO samples. It can be emphasized that the main omega-3 FA (namely alpha-linolenic acid glycerides) had close concentrations in the encapsulated and raw CBOs (13.13 (+/- 0.59) % and 14.04 (+/- 1.54) % for non-encapsulated and encapsulated CBO-NE samples, 15.72 (+/- 0.30) % and 12.41 (+/- 1.95)% for the corresponding CBO-SW samples, respectively). The overall unsaturated FA content significantly decreased after complexation (from 19.03-19.16% for the raw CBOs to 17.3-17.7% for encapsulated oils in the case of MUFAs, and from 55.7-58.8% to 35.13-43.36% for PUFAs). On the other hand, the omega-3/omega-6 ratio increased by beta-CD nanoencapsulation to 0.51 (+/- 0.07) and 0.76 (0.26) for beta-CD/CBO-NE and beta-CD/CBO-SW complexes, respectively. As a conclusion, the lipid fractions of the Romanian common beans are good candidates for beta-CD complexation and they can be protected against thermal and oxidative degradation in common beans based food products such as functional foods or food supplements using natural CDs.	[David, Ioan; Simandi, Marius D.; Chirila, Cosmina A.; Megyesi, Corina I.; Radulescu, Laura; Hadaruga, Nicoleta G.] Banats Univ Agr Sci & Vet Med King Michael I Roma, Dept Food Sci, Timisoara, Romania; [Orboi, Manuela D.] Banats Univ Agr Sci & Vet Med King Michael I Roma, Dept Econ & Co Financing, Timisoara, Romania; [Draghia, Lavinia P.; Lukinich-Gruia, Alexandra T.] Clin Cty Hosp Timisoara, Ctr Gene & Cellular Therapies Treatment Cancer On, Timisoara, Romania; [Muntean, Cornelia] Polytech Univ Timisoara, Dept Appl Chem & Engn Inorgan Cpds & Environm, Timisoara, Romania; [Muntean, Cornelia] Polytech Univ Timisoara, Res Inst Renewable Energy, Timisoara, Romania; [Hadaruga, Daniel I.] Polytech Univ Timisoara, Dept Appl Chem Organ & Nat Cpds Engn, Timisoara, Romania	Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; Polytechnic University of Timisoara; Polytechnic University of Timisoara; Polytechnic University of Timisoara	Hadaruga, NG (corresponding author), Banats Univ Agr Sci & Vet Med King Michael I Roma, Dept Food Sci, Timisoara, Romania.	nico_hadaruga@yahoo.com	LUKINICH-GRUIA, ALEXANDRA T/C-3329-2017; LUKINICH-GRUIA, ALEXANDRA/J-4281-2015; Muntean, Cornelia/HHN-5522-2022; Hadaruga, Daniel/ABG-6559-2021; Megyesi, Corina Iuliana/AAK-5508-2021; Draghia, Lavinia Paula/AAR-6851-2021	LUKINICH-GRUIA, ALEXANDRA T/0000-0002-5855-2276; LUKINICH-GRUIA, ALEXANDRA/0000-0002-5855-2276; Megyesi, Corina Iuliana/0000-0002-8863-3747; Draghia, Lavinia Paula/0000-0001-9129-8196	Ministry of Research and Innovation of Romania, Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI) [368]	Ministry of Research and Innovation of Romania, Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI)	This study was funded by: PNCDI III 2015-2020 -ID 368, Institutional development project "Ensuring excellence in R&D within USAMVBT", from the institutional performance subprogram 1.2, development of the R&D national system program 1 to NGH, Ministry of Research and Innovation of Romania, Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI). URL: https://uefiscdi.gov.ro/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin MA, 2010, WOODHEAD PUBL FOOD S, P479, DOI 10.1533/9780857090331.3.479; Belitz H. D., 2009, FOOD CHEM; Celmeli T, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8090166; Chew SC, 2018, J FOOD ENG, V237, P78, DOI 10.1016/j.jfoodeng.2018.05.016; Choi MJ, 2010, FOOD CHEM, V119, P1694, DOI 10.1016/j.foodchem.2009.09.052; Crini G, 2014, CHEM REV, V114, P10940, DOI 10.1021/cr500081p; Durante M, 2016, FOOD CHEM, V199, P684, DOI 10.1016/j.foodchem.2015.12.073; Gepts P, 2014, ENCY GLOBAL ARCHAEOL; HADARUGA DI, 2016, ORGANIC CHEM, V12, P179, DOI DOI 10.3762/BJOC.12.20; Hadaruga NG, 2018, ENV CHEM SUSTAIN WOR, P155, DOI 10.1007/978-3-319-76159-6_4; Jones A.L., 1999, PHASEOLUS BEAN POST; Kfoury M, 2015, CARBOHYD POLYM, V131, P264, DOI 10.1016/j.carbpol.2015.06.014; Khare AR, 2014, MICROENCAPSULATION IN THE FOOD INDUSTRY: A PRACTICAL IMPLEMENTATION GUIDE, P151, DOI 10.1016/B978-0-12-404568-2.00014-5; Kurkov SV, 2013, INT J PHARMACEUT, V453, P167, DOI 10.1016/j.ijpharm.2012.06.055; Lima PSS, 2016, CARBOHYD POLYM, V151, P965, DOI 10.1016/j.carbpol.2016.06.040; Luna-Vital DA, 2015, FOOD RES INT, V76, P39, DOI 10.1016/j.foodres.2014.11.024; Menezes PP, 2014, J THERM ANAL CALORIM, V115, P2429, DOI 10.1007/s10973-013-3367-x; Menezes PP, 2012, THERMOCHIM ACTA, V548, P45, DOI 10.1016/j.tca.2012.08.023; Mortensen A, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4628; Nickerson M, 2014, MICROENCAPSULATION IN THE FOOD INDUSTRY: A PRACTICAL IMPLEMENTATION GUIDE, P485, DOI 10.1016/B978-0-12-404568-2.00037-6; Nunes C, 2005, PHARM RES-DORDR, V22, P1942, DOI 10.1007/s11095-005-7626-9; Pathania A, 2014, BROADENING GENETIC B; Pirman T, 2003, EUR FOOD RES TECHNOL, V217, P498, DOI 10.1007/s00217-003-0784-2; Rodriguez-Carvajal J, 1998, INT UNION CRYSTALLOG; Roisnel T, 2001, MATER SCI FORUM, V378-3, P118, DOI 10.4028/www.scientific.net/MSF.378-381.118; Rubio-Rodriguez N, 2010, INNOV FOOD SCI EMERG, V11, P1, DOI 10.1016/j.ifset.2009.10.006; Quintans JDS, 2013, PHYTOMEDICINE, V20, P436, DOI 10.1016/j.phymed.2012.12.009; STEFANOV K, 1992, PHYTOCHEMISTRY, V31, P3745, DOI 10.1016/S0031-9422(00)97520-4; Szente L, 2017, STRUCT CHEM, V28, P479, DOI 10.1007/s11224-016-0884-9; Trichard L, 2011, J DRUG DELIV SCI TEC, V21, P189, DOI 10.1016/S1773-2247(11)50021-8; Yoshida H, 2005, EUR J LIPID SCI TECH, V107, P307, DOI 10.1002/ejlt.200401078; Yoshida H, 2005, J FOOD LIPIDS, V12, P169, DOI 10.1111/j.1745-4522.2005.00016.x; Zhang JX, 2013, ADV DRUG DELIVER REV, V65, P1215, DOI 10.1016/j.addr.2013.05.001	33	8	9	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225474	10.1371/journal.pone.0225474	http://dx.doi.org/10.1371/journal.pone.0225474			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KY0FP	31756198	Green Submitted, Green Published, gold			2022-12-26	WOS:000522250000001
J	Grazioli, S; Dunn-Siegrist, I; Pauchard, LA; Blot, M; Charles, PE; Pugin, J				Grazioli, Serge; Dunn-Siegrist, Irene; Pauchard, Laure-Anne; Blot, Mathieu; Charles, Pierre-Emmanuel; Pugin, Jerome			Mitochondrial alarmins are tissue mediators of ventilator-induced lung injury and ARDS	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; LOWER TIDAL VOLUMES; MECHANICAL VENTILATION; ACTIVATION; NEUTROPHILS; CELLS; DNA; INFLAMMASOME; CONTRIBUTES; MACROPHAGES	Rationale Endogenous tissue mediators inducing lung inflammation in the context of ventilator-induced lung injury (VILI) and acute respiratory distress syndrome (ARDS) are ill-defined. Objectives To test whether mitochondrial alarmins are released during VILI, and are associated with lung inflammation. Methods Release of mitochondrial DNA, adenosine triphosphate (ATP), and formyl-Met-Leu-Phe (fMLP) peptide-dependent neutrophil chemotaxis were measured in conditioned supernatants from human alveolar type II-like (A549) epithelial cells submitted to cyclic stretch in vitro. Similar measurements were performed in bronchoalveolar lavage fluids from rabbits submitted to an injurious ventilatory regimen, and from patients with ARDS. Measurements and main results Mitochondrial DNA was released by A549 cells during cell stretching, and was found elevated in BAL fluids from rabbits during VILI, and from ARDS patients. Cyclic stretch-induced interleukin-8 (IL-8) of A549 cells could be inhibited by Toll-like receptor 9 (TLR9) blockade. ATP concentrations were increased in conditioned supernatants from A549 cells, and in rabbit BAL fluids during VILI. Neutrophil chemotaxis induced by A549 cells conditioned supernatants was essentially dependent on fMLP rather than IL-8. A synergy between cyclic stretch-induced alarmins and lipopolysaccharide (LPS) was found in monocyte-derived macrophages in the production of IL-1 beta. Conclusions Mitochondrial alarmins are released during cyclic stretch of human epithelial cells, as well as in BAL fluids from rabbits ventilated with an injurious ventilatory regimen, and found in BAL fluids from ARDS patients, particularly in those with high alveolar inflammation. These alarmins are likely to represent the proximal endogenous mediators of VILI and ARDS, released by injured pulmonary cells.	[Grazioli, Serge; Dunn-Siegrist, Irene; Pugin, Jerome] Univ Hosp Geneva, Dept Microbiol & Mol Med, Intens Care Lab, Geneva, Switzerland; [Grazioli, Serge; Dunn-Siegrist, Irene; Pugin, Jerome] Fac Med, Geneva, Switzerland; [Grazioli, Serge] Univ Hosp Geneva, Dept Pediat, Div Neonatal & Pediat Intens Care, Geneva, Switzerland; [Pauchard, Laure-Anne; Charles, Pierre-Emmanuel] Univ Hosp Dijon, Intens Care Unit, Dijon, France; [Pauchard, Laure-Anne; Charles, Pierre-Emmanuel] Burgundy Univ, INSERM, UMR 1231, Dijon, France; [Blot, Mathieu] Univ Hosp Dijon, Dept Infect Dis, Dijon, France	University of Geneva; University of Geneva; University of Geneva; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne	Grazioli, S (corresponding author), Univ Hosp Geneva, Dept Microbiol & Mol Med, Intens Care Lab, Geneva, Switzerland.; Grazioli, S (corresponding author), Fac Med, Geneva, Switzerland.; Grazioli, S (corresponding author), Univ Hosp Geneva, Dept Pediat, Div Neonatal & Pediat Intens Care, Geneva, Switzerland.	serge.grazioli@hcuge.ch	Blot, Mathieu/D-4508-2019	Blot, Mathieu/0000-0001-6541-2434; Grazioli, Serge/0000-0002-5526-851X	Swiss National Foundation for Scientific Research [310030-141143]	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This study was supported by a grant from the Swiss National Foundation for Scientific Research (#310030-141143) to JP. http://www.snf.ch/en/Pages/default.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Ali MH, 2004, AM J PHYSIOL-LUNG C, V287, pL486, DOI 10.1152/ajplung.00389.2003; Blot M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30226-x; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Bregeon F, 2002, RESP PHYSIOL NEUROBI, V132, P191, DOI 10.1016/S1569-9048(02)00069-1; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Charles PE, 2004, INTENS CARE MED, V30, P2263, DOI 10.1007/s00134-004-2442-y; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Crouser ED, 2009, CRIT CARE MED, V37, P2000, DOI 10.1097/CCM.0b013e3181a001ae; Davidson BA, 2013, J IMMUNOL, V190, P1714, DOI 10.4049/jimmunol.1202410; Drifte G, 2013, CRIT CARE MED, V41, P820, DOI 10.1097/CCM.0b013e318274647d; Dunn I, 1999, CHEST, V116, p95S, DOI 10.1378/chest.116.suppl_1.95S; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Hajizadeh S, 2003, ARTHRITIS RES THER, V5, pR234, DOI 10.1186/ar787; KAWANO T, 1987, J APPL PHYSIOL, V62, P27, DOI 10.1152/jappl.1987.62.1.27; Kuipers MT, 2012, ANESTHESIOLOGY, V116, P1104, DOI 10.1097/ALN.0b013e3182518bc0; Kuipers MT, 2011, CRIT CARE, V15, DOI 10.1186/cc10437; Lin JY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01477; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matsuyama H, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-79; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McIlroy DJ, 2015, J TRAUMA ACUTE CARE, V78, P282, DOI 10.1097/TA.0000000000000519; McIlroy DJ, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.07.013; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Mortaz E, 2010, EUR RESPIR J, V36, P1143, DOI 10.1183/09031936.00062209; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; NARIMANBEKOV IO, 1995, EXP LUNG RES, V21, P239, DOI 10.3109/01902149509068830; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Oudin S, 2002, AM J RESP CELL MOL, V27, P107, DOI 10.1165/ajrcmb.27.1.4766; Panigrahi S, 2013, CIRC RES, V112, P103, DOI 10.1161/CIRCRESAHA.112.274241; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Pugin J, 2002, INTENS CARE MED, V28, P817, DOI 10.1007/s00134-002-1320-8; Pugin J, 1996, AM J RESP CRIT CARE, V153, P1850, DOI 10.1164/ajrccm.153.6.8665045; Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036; Pugin J, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-27; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Rich PB, 2003, J TRAUMA, V55, P290, DOI 10.1097/01.TA.0000078882.11919.AF; Sarma JV, 2011, COMPR PHYSIOL, V1, P1365, DOI 10.1002/cphy.c100068; Stroetz RW, 2001, J APPL PHYSIOL, V90, P2361, DOI 10.1152/jappl.2001.90.6.2361; Timmermans K, 2017, ANESTH ANALG, V124, P531, DOI 10.1213/ANE.0000000000001554; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Unuma K, 2015, AUTOPHAGY, V11, P1520, DOI 10.1080/15548627.2015.1063765; Vaneker M, 2007, ANESTHESIOLOGY, V107, P419, DOI 10.1097/01.anes.0000278908.22686.01; Vlahakis NE, 2000, J APPL PHYSIOL, V89, P2490, DOI 10.1152/jappl.2000.89.6.2490; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860; Yao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139416; Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	56	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225468	10.1371/journal.pone.0225468	http://dx.doi.org/10.1371/journal.pone.0225468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756204	Green Published, gold			2022-12-26	WOS:000533889300033
J	Saliba-Gustafsson, EA; Roing, M; Borg, MA; Rosales-Klintz, S; Lundborg, CS				Saliba-Gustafsson, Erika A.; Roing, Marta; Borg, Michael A.; Rosales-Klintz, Senia; Lundborg, Cecilia Stalsby			General practitioners' perceptions of delayed antibiotic prescription for respiratory tract infections: A phenomenographic study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED TRIAL; PRESCRIBING STRATEGIES; PRIMARY-CARE; PHYSICIANS; CHILDREN; RESISTANCE; EUROPE	Background Antibiotic use is a major driver of antibiotic resistance. Although delayed antibiotic prescription is a recommended strategy to reduce antibiotic use, practices vary; it appears less commonly used in southern European countries where antibiotic consumption is highest. Despite these variations, few qualitative studies have explored general practitioners' perceptions of delayed antibiotic prescription. We therefore aimed to explore and describe the perceptions of delayed antibiotic prescription for respiratory tract infections among general practitioners in Malta. Methods This qualitative phenomenographic study was conducted in Malta. A semi-structured interview guide was developed in English, pilot tested and revised accordingly. Interview topics included views on antibiotic resistance, antibiotic use and delayed antibiotic prescription for respiratory tract infections, and barriers and facilitators to antibiotic prescription. Individual, face-to-face interviews were held in 2014 with a quota sample of 20 general practitioners and transcribed verbatim. Data were subsequently analysed using a phenomenographic approach. Findings General practitioners perceived delayed antibiotic prescription in five qualitatively different ways: (A) "The Service Provider"-maintaining a good general practitioner-patient relationship to retain patients and avoid doctor-shopping, (B) "The Uncertainty Avoider"-reaching a compromise and providing treatment just in case, (C) "The Comforter"-providing the patient comfort and reassurance, (D) "The Conscientious Practitioner"-empowering and educating patients, and limiting antibiotic use, and (E) "The Holder of Professional Power"-retaining general practitioner responsibility by employing a wait-and-see approach. Although general practitioners were largely positive towards delayed antibiotic prescription, not all supported the strategy; some preferred a wait-and-see approach with follow-up. Many delayed antibiotic prescription users selectively practiced delayed prescription with patients they trusted or who they believed had a certain level of knowledge and understanding. They also preferred a patient-led approach with a one to three day delay; post-dating delayed antibiotic prescriptions was uncommon. Conclusions In this study we have shown that general practitioners hold varying perceptions about delayed antibiotic prescription and that there is variation in the way delayed antibiotic prescription is employed in Malta. Whilst delayed antibiotic prescription is utilised in Malta, not all general practitioners support the strategy, and motivations and practices differ. In high consumption settings, formal and standardised implementation of delayed antibiotic prescription could help curb antibiotic overuse. Diagnosis-specific delayed antibiotic prescription recommendations should also be incorporated into guidelines. Finally, further investigation into patients' and pharmacists' views on delayed antibiotic prescription is required.	[Saliba-Gustafsson, Erika A.; Rosales-Klintz, Senia; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Global Publ Hlth Hlth Syst & Policy Improvin, Stockholm, Sweden; [Roing, Marta] Uppsala Univ, Dept Publ Hlth & Caring Sci, Hlth Serv Res, Uppsala, Sweden; [Borg, Michael A.] Mater Dei Hosp, Dept Infect Prevent & Control, Msida, Malta; [Borg, Michael A.] Univ Malta, Fac Med & Surg, Msida, Malta; [Rosales-Klintz, Senia] European Ctr Dis Prevent & Control, Unit Surveillance & Response Support, Solna, Sweden	Karolinska Institutet; Uppsala University; University of Malta; European Centre for Disease Prevention & Control	Saliba-Gustafsson, EA (corresponding author), Karolinska Inst, Dept Global Publ Hlth Hlth Syst & Policy Improvin, Stockholm, Sweden.	erika.saliba@gmail.com	Gustafsson, Erika Saliba/AAR-7256-2021	Rosales Klintz, Senia/0000-0002-2897-6123; Saliba-Gustafsson, Erika A/0000-0003-1587-9591; Stalsby Lundborg, Cecilia/0000-0001-6525-1861	Karolinska Institutet [3-1233/2013]	Karolinska Institutet(Karolinska Institutet)	This work was supported by Karolinska Institutet funding for doctoral education (KIDfunding 3-1233/2013). It was also supported by funding available to CSL at Karolinska Institutet. This study received no other specific grant from any public, commercial or not-for-profit funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, TNS OP SOC SPEC EUR; Arroll B, 2003, BRIT J GEN PRACT, V53, P871; Arroll B, 2002, J FAM PRACTICE, V51, P954; Azzopardi-Muscat N, 2017, HEALT SYST TRANSIT, V19, P1; Bjorkman I, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.029199; Bjorkman I, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-1; Bjornsdottir I, 2002, Eur J Gen Pract, V8, P18, DOI DOI 10.3109/13814780209160824; Borg MA, 2002, INT J ANTIMICROB AG, V20, P253, DOI 10.1016/S0924-8579(02)00194-2; Borg MA, 2012, J ANTIMICROB CHEMOTH, V67, P763, DOI 10.1093/jac/dkr541; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cals JWL, 2010, ANN FAM MED, V8, P124, DOI 10.1370/afm.1090; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Cates C, 1999, BRIT MED J, V318, P715, DOI 10.1136/bmj.318.7185.715; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Dahlgren L.O., 1991, RES SOC ADMIN PHARM, V8, P150, DOI DOI 10.1080/17482620601068105; Abad MD, 2016, JAMA INTERN MED, V176, P21, DOI 10.1001/jamainternmed.2015.7088; Deschepper R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-123; Dowell J, 2001, BRIT J GEN PRACT, V51, P200; Dyar OJ, 2016, EXPERT REV ANTI-INFE, V14, P403, DOI 10.1586/14787210.2016.1151353; European Centre for Disease Prevention and Control, 2017, SUMM LAT DAT ANT CON; European Centre for Disease Prevention and Control European Medicines Agency, 2009, BACT CHALL TIM REACT; European Commission, 2017, EUR COMM LAST VISIT; Francis NA, 2012, BRIT J GEN PRACT, V62, DOI [10.3399/bjgp12X654614, 10.3399/bjgp12X653561]; Gaygisiz U, 2017, J INFECT PUBLIC HEAL, V10, P755, DOI 10.1016/j.jiph.2016.11.011; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hofstede G., 2010, CULTURES ORG SOFTWAR; Hoye S, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-34; Hoye S, 2010, BRIT J GEN PRACT, V60, P907, DOI 10.3399/bjgp10X544087; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1606; Llor C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572436; Lum EPM, 2018, INFECT DIS HEALTH, V23, P74, DOI 10.1016/j.idh.2017.12.002; Lundborg CS, 1999, SCAND J PRIM HEALTH, V17, P226; Marton F., 1986, J THOUGHT, V21, P28, DOI DOI 10.2307/42589189; Marton F., 1997, LEARNING AWARENESS; McDermott L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016903; Namey E, 2005, QUALITATIVE RES METH; National Institute for Health and Care Excellence, 2008, RESP TRACT INF SELF; Peters S, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593866; Petursson P, 2005, SCAND J PRIM HEALTH, V23, P120, DOI 10.1080/02813430510018491; PricewaterhouseCoopers, 2012, HEALTHC DEL MALT; Raft CF, 2017, EUR J GEN PRACT, V23, P191, DOI 10.1080/13814788.2017.1347628; Rahmner PB, 2010, ANN FAM MED, V8, P40, DOI 10.1370/afm.1074; Roing M, 2006, SUPPORT CARE CANCER, V14, P1046, DOI 10.1007/s00520-006-0043-8; Roing M, 2018, QUAL HEALTH RES, V28, P273, DOI 10.1177/1049732317719433; Ryves R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011882; Saliba-Gustafsson EA, 2019, J ANTIMICROB CHEMOTH, V74, P1116, DOI 10.1093/jac/dky544; Saliba-Gustafsson EA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017992; Sharland M, 2005, BMJ-BRIT MED J, V331, P328, DOI 10.1136/bmj.38503.706887.AE1; Spurling GKP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub4; Touboul-Lundgren P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2254-8; World Health Organization, 2015, GLOB ACT PLAN AN RES; Yates C., 2012, LIB INFORM RES, V36, P96, DOI DOI 10.29173/lirg496; [No title captured], DOI DOI 10.1136/BMJ.I3410	57	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225506	10.1371/journal.pone.0225506	http://dx.doi.org/10.1371/journal.pone.0225506			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756197	Green Published, gold			2022-12-26	WOS:000533889300034
J	Gudeta, TA; Regassa, TM; Belay, AS				Gudeta, Tesfaye Abera; Regassa, Tilahun Mekonnen; Belay, Alemayehu Sayih			Magnitude and factors associated with anemia among pregnant women attending antenatal care in Bench Maji, Keffa and Sheka zones of public hospitals, Southwest, Ethiopia, 2018: A cross-sectional study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; LOW-INCOME; PREVALENCE	Background Anemia during pregnancy is a common public health problem globally and it defined as the hemoglobin concentration of less than 11 g/dl. Anemia during pregnancy has maternal and perinatal diverse consequences and it increase the risk of maternal and perinatal mortality. The aim of this study is to assess magnitude and factors associated with anemia among pregnant women attending antenatal care in Bench Maji, Keffa and Sheka zones of public hospitals, South west, Ethiopia, 2018. Methods A cross-sectional study was employed on 1871 pregnant mothers from selected hospitals. All third trimester pregnant women attending antenatal care at Mizan-Tepi University Teaching Hospital, Tepi, Gebretsadik Shawo and Wacha public hospitals were included in the study. Data was entered to Epidata version 3.1 and exported to SPSS version 21 for analysis. Logistic regression analysis was carried out to identify independently associate factors at confidence interval of 95% and significance level of P-value <0.05. Result The magnitude of anemia in this study from the total study participant was 356 (19.0%). Among anemic pregnant women, 330 (92.7%), 21(5.9%) and 5(1.4%) were mild anemia, moderate anemia and severe anemia respectively. Age group 20-24 [AOR 6.28(2.40-16.42)], 25-29 [AOR = 6.38 (2.71-15.01)], 30-34 [AOR = 5.13 (2.27-11.58) and age >= 35 years [AOR = 2.53 (1.07-5.98)], educational status (read and write) [AOR 2.06, 95% CI (1.12-3.80)], gestational age(term)[AOR 1.94, 95% CI (1.27-2.96)], Caffeine (coffee and tea) and alcohol use occasionally [AOR 2.01, 95% CI (1.14-3.55)] and [AOR 2.59, 95% CI (1.49-4.52)] respectively, nutritional status (under nutrition) [AOR 3.00, 95% CI (2.22-3.97)] and family size (>6) [AOR 2.66, 95% CI (1.49-4.77)] were factors associated with anemia. Conclusion The magnitude of anemia found to be high. Age, educational status of the mother, gestational age, caffeine and alcohol use, Nutritional status and family size were factors significantly associated with anemia. To prevent adverse outcome of anemia, health care providers should work on these factors.	[Gudeta, Tesfaye Abera; Belay, Alemayehu Sayih] Mizan Tepi Univ, Coll Hlth Sci, Dept Nursing, Maternal Hlth Unit, Mizan Aman, Ethiopia; [Regassa, Tilahun Mekonnen] Mizan Tepi Univ, Dept Nursing, Adult Hlth Unit, Coll Hlth Sci, Mizan Aman, Ethiopia		Gudeta, TA (corresponding author), Mizan Tepi Univ, Coll Hlth Sci, Dept Nursing, Maternal Hlth Unit, Mizan Aman, Ethiopia.	tesfeabera2013@gmail.com	Belay, Alemayehu Sayih/AAT-1788-2021	Belay, Alemayehu Sayih/0000-0001-7039-6600	Mizan-Tepi University	Mizan-Tepi University	The budget of this study was funded by Mizan-Tepi University.	Abel G, J NUTR METABOLISM, V2015, DOI [10.1155/2015/165430, DOI 10.1155/2015/165430]; Abriha Abrehet, 2014, BMC Res Notes, V7, P888, DOI 10.1186/1756-0500-7-888; Acheampong K., 2018, GHANA INT J HLTH SCI, V8, P186; Adam I, 2016, ANEMIA PREGNANCY; Aghajanian Paola, 2007, CURRENT DIAGNOSIS TR; Akhtar M, 2012, SEVERE ANAEMIA LATE, V2012; Alene KA, 2014, ANEMIA, V2014, DOI 10.1155/2014/561567; [Anonymous], 2008, WORLDWIDE PREVALENCE; Argaw B, 2015, J COMMUNITY MED HLTH, V5, P2161, DOI DOI 10.4172/2161-0711.1000353; Baig-Ansari N, 2008, FOOD NUTR BULL, V29, P132, DOI 10.1177/156482650802900207; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bereka S., 2017, J PREG CHILD HLTH, V4, P2, DOI [10.4172/2376-127X.1000337, DOI 10.4172/2376-127X.1000337]; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; CSA I, 2012, ETH DEM HLTH SURV 20, P430; Ebrahim Mohammed, 2018, CENTRAL AFRICAN J PU, V4, P149, DOI [10.11648/j.cajph.20180405.14, DOI 10.11648/J.CAJPH.20180405.14]; Esmat Barooti, 2010, J Reprod Infertil, V11, P17; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; Karaoglu L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-329; Kefiyalew Filagot, 2014, BMC Res Notes, V7, P771, DOI 10.1186/1756-0500-7-771; Kenea A, 2018, ANEMIA, V2018, DOI 10.1155/2018/9201383; Lebso M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188783; Lee AI, 2011, HEMATOL ONCOL CLIN N, V25, P241, DOI 10.1016/j.hoc.2011.02.001; Levy A, 2005, EUR J OBSTET GYN R B, V122, P182, DOI 10.1016/j.ejogrb.2005.02.015; McClure EM, 2013, INT J GYNECOL OBSTET, V121, P103, DOI 10.1016/j.ijgo.2012.12.014; Mihiretie H., 2015, J MEDICAL MICROBIOLO, V4, P1, DOI DOI 10.4172/21610703.1000197; Negwo DT, 2018, J WOMENS HLTH CARE, V7, P443, DOI [10.4172/2167-0420.1000443, DOI 10.4172/2167-0420.1000443]; Organization WH, GLOB PREV AN 2011 GL; Rosas JP, 2009, COCHRANE DB SYST REV, V4; Salhan S, 2012, ANEMIA, V2012, DOI 10.1155/2012/608658; Shridevi, 2018, INT J REPROD CONTRAC, V7, P2612; Sifakis S, 2000, ANN NY ACAD SCI, V900, P125, DOI 10.1111/j.1749-6632.2000.tb06223.x; Soh KL., 2015, J BIOSCI MED, V3, P6, DOI [10.4236/jbm.2015.33002, DOI 10.4236/JBM.2015.33002]; Targets WGN, 2014, 2025 AN POL BRIEF; Viveki R. G., 2012, Al Ameen Journal of Medical Sciences, V5, P216; WHO, 2015, GLOB PREV AN 2011; Zekarias B., 2017, HLTH SCI J, V11, P529, DOI [DOI 10.21767/1791-809X.1000529, 10.21767/1791-809X.1000529]	37	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225148	10.1371/journal.pone.0225148	http://dx.doi.org/10.1371/journal.pone.0225148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751368	gold, Green Published			2022-12-26	WOS:000533886900032
J	Ljepoja, B; Schreiber, C; Gegenfurtner, FA; Garcia-Roman, J; Kohler, B; Zahler, S; Radler, JO; Wagner, E; Roidl, A				Ljepoja, Bojan; Schreiber, Christoph; Gegenfurtner, Florian A.; Garcia-Roman, Jonathan; Koehler, Bianca; Zahler, Stefan; Raedler, Joachim O.; Wagner, Ernst; Roidl, Andreas			Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; EXPRESSION; MIGRATION; MIR-200C; FAMILY; SRF; PROGRESSION; MORTALITY; PROMOTES; INVASION	Cancer progression and metastases are frequently related to changes of cell motility. Amongst others, the microRNA-200c (miR-200c) was shown to maintain the epithelial state of cells and to hamper migration. Here, we describe two miR-200c inducible breast cancer cell lines, derived from miR-200c knock-out MCF7 cells as well as from the miR-200c-negative MDA-MB-231 cells and report on the emerging phenotypic effects after miR-200s induction. The induction of miR-200c expression seems to effect a rapid reduction of cell motility, as determined by 1D microlane migration assays. Sustained expression of miR200c leads to a changed morphology and reveals a novel mechanism by which miR- 200c interferes with cytoskeletal components. We find that filamin A expression is attenuated by miRNA-200c induced downregulation of the transcription factors c-Jun and MRTF/SRF. This potentially novel pathway that is independent of the prominent ZEB axis could lead to a broader understanding of the role that miR200c plays in cancer metastasis.	[Ljepoja, Bojan; Garcia-Roman, Jonathan; Koehler, Bianca; Wagner, Ernst; Roidl, Andreas] Ludwig Maximilians Univ Munchen, Dept Pharm, Pharmaceut Biotechnol, Munich, Germany; [Schreiber, Christoph; Raedler, Joachim O.] Ludwig Maximilians Univ Munchen, Fac Phys, Munich, Germany; [Schreiber, Christoph; Raedler, Joachim O.] Ludwig Maximilians Univ Munchen, Ctr NanoSci, Munich, Germany; [Gegenfurtner, Florian A.; Zahler, Stefan] Ludwig Maximilians Univ Munchen, Dept Pharm, Pharmaceut Biol, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Roidl, A (corresponding author), Ludwig Maximilians Univ Munchen, Dept Pharm, Pharmaceut Biotechnol, Munich, Germany.	andreas.roidl@cup.uni-muenchen.de	Wagner, Ernst/ABB-5976-2020; Wagner, Ernst/A-7435-2012	Wagner, Ernst/0000-0001-8413-0934; Wagner, Ernst/0000-0001-8413-0934; Kohler, Bianca/0000-0002-9456-0302	German Research Foundation (DFG) [SFB 1032]; Cluster of Excellence NIM; Mexican government (CONACyT) [207973]	German Research Foundation (DFG)(German Research Foundation (DFG)); Cluster of Excellence NIM; Mexican government (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank the German Research Foundation (DFG) for financial support of SFB 1032 projects B01 (JOR), B04 (EW) and B08 (SZ), and Cluster of Excellence NIM (JOR, EW). JGR thanks the Mexican government for receiving a scholarship (CONACyT number 207973).	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Campbell K, 2016, DEVELOPMENT, V143, P4291, DOI 10.1242/dev.139071; Chang JTH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168284; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Damiano V, 2017, GENE CHROMOSOME CANC, V56, P147, DOI 10.1002/gcc.22422; DeSantis CE, 2017, CA-CANCER J CLIN, V67, P439, DOI 10.3322/caac.21412; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; Filios SR, 2015, DIABETES, V64, P3631, DOI 10.2337/db15-0831; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo JC, 2016, ONCOTARGET, V7, P62006, DOI 10.18632/oncotarget.11330; Hermann MR, 2016, J CELL SCI, V129, P1391, DOI 10.1242/jcs.177592; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kasza KE, 2009, BIOPHYS J, V96, P4326, DOI 10.1016/j.bpj.2009.02.035; Kircher P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad2959; Kopp F, 2014, ONCOTARGET, V5, P185, DOI 10.18632/oncotarget.1427; Kopp F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050469; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kumar S, 2015, CURR DRUG TARGETS, V16, P1381, DOI 10.2174/1389450116666150325231419; Ljepoja B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25240-y; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Maiuri P, 2012, CURR BIOL, V22, pR673, DOI 10.1016/j.cub.2012.07.052; Mariotto AB, 2017, CANCER EPIDEM BIOMAR, V26, P809, DOI [10.1158/1055-9965.EPI-16-0889, 10.1158/1055-9965.epi-16-0889]; Mutlu M, 2016, J MOL MED, V94, P629, DOI 10.1007/s00109-016-1420-5; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Sinh ND, 2017, CANCER SCI, V108, P952, DOI 10.1111/cas.13214; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Perdigao-Henriques R, 2016, ONCOGENE, V35, P158, DOI 10.1038/onc.2015.69; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Riggi N, 2018, ANNU REV PATHOL-MECH, V13, P117, DOI 10.1146/annurev-pathol-020117-044127; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Savoy RM, 2013, ENDOCR-RELAT CANCER, V20, pR341, DOI 10.1530/ERC-13-0364; Schaeffer D, 2014, MOL CELL BIOL, V34, P3486, DOI 10.1128/MCB.00694-14; Schreiber C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26858; Schwartz B, 2014, MECH DEVELOP, V133, P23, DOI 10.1016/j.mod.2014.07.001; Senfter Daniel, 2016, BioMolecular Concepts, V7, P311, DOI 10.1515/bmc-2016-0020; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; Soni A, 2015, AM J CLIN PATHOL, V143, P471, DOI 10.1309/AJCPYO5FSV3UPEXS; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Truong T, 2015, INTEGR BIOL-UK, V7, P1285, DOI 10.1039/c5ib00133a; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005	51	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0224314	10.1371/journal.pone.0224314	http://dx.doi.org/10.1371/journal.pone.0224314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747409	Green Published, gold			2022-12-26	WOS:000533881900008
J	Maassen, H; Hendriks, KDW; Venema, LH; Henning, RH; Hofker, SH; van Goor, H; Leuvenink, HGD; Coester, AM				Maassen, Hanno; Hendriks, Koen D. W.; Venema, Leonie H.; Henning, Rob H.; Hofker, Sijbrand H.; van Goor, Harry; Leuvenink, Henri G. D.; Coester, Annemieke M.			Hydrogen sulphide-induced hypometabolism in human-sized porcine kidneys	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE; H2S; PROTECTS; GASOTRANSMITTERS; TRANSPLANTATION; VASORELAXANT; PRESERVATION; APOPTOSIS; RECOVERY	Background Since the start of organ transplantation, hypothermia-forced hypometabolism has been the cornerstone in organ preservation. Cold preservation showed to protect against ischemia, although post-transplant injury still occurs and further improvement in preservation techniques is needed. We hypothesize that hydrogen sulphide can be used as such a new preservation method, by inducing a reversible hypometabolic state in human sized kidneys during normothermic machine perfusion. Methods Porcine kidneys were connected to an ex-vivo isolated, oxygen supplemented, normothermic blood perfusion set-up. Experimental kidneys (n = 5) received a 85mg NaHS infusion of 100 ppm and were compared to controls (n = 5). As a reflection of the cellular metabolism, oxygen consumption, mitochondrial activity and tissue ATP levels were measured. Kidney function was assessed by creatinine clearance and fractional excretion of sodium. To rule out potential structural and functional deterioration, kidneys were studied for biochemical markers and histology. Results Hydrogen sulphide strongly decreased oxygen consumption by 61%, which was associated with a marked decrease in mitochondrial activity/function, without directly affecting ATP levels. Renal biological markers, renal function and histology did not change after hydrogen sulphide treatment. Conclusion In conclusion, we showed that hydrogen sulphide can induce a controllable hypometabolic state in a human sized organ, without damaging the organ itself and could thereby be a promising therapeutic alternative for cold preservation under normothermic conditions in renal transplantation.	[Maassen, Hanno; Hendriks, Koen D. W.; Venema, Leonie H.; Hofker, Sijbrand H.; Leuvenink, Henri G. D.; Coester, Annemieke M.] Univ Groningen, Dept Surg, UMCG, Groningen, Netherlands; [Maassen, Hanno; van Goor, Harry] Univ Groningen, Dept Pathol & Med Biol, UMCG, Groningen, Netherlands; [Hendriks, Koen D. W.; Henning, Rob H.] Univ Groningen, Dept Clin Pharm & Pharmacol, UMCG, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Maassen, H (corresponding author), Univ Groningen, Dept Surg, UMCG, Groningen, Netherlands.; Maassen, H (corresponding author), Univ Groningen, Dept Pathol & Med Biol, UMCG, Groningen, Netherlands.	h.maassen@umcg.nl	van+Goor, Harry/AAS-7712-2020; Henning, Robert H/AAY-5222-2020; Venema, Leonie/T-3419-2019	Venema, Leonie/0000-0001-5556-6632; Leuvenink, Henri/0000-0001-5036-2999; Hendriks, Koen/0000-0002-1202-0389; Henning, Robert/0000-0002-5135-4621; van Goor, Harry/0000-0002-6670-1577	Tekke-Huizinga Grant, UMCG	Tekke-Huizinga Grant, UMCG	This study was financially supported by a Tekke-Huizinga Grant, UMCG. Received by Prof. Dr. H. van Goor. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anzell AR, 2018, MOL NEUROBIOL, V55, P2547, DOI 10.1007/s12035-017-0503-9; Baumgart K, 2009, CURR OPIN ANESTHESIO, V22, P168, DOI 10.1097/ACO.0b013e328328d22f; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Bon D, 2012, NAT REV NEPHROL, V8, P339, DOI 10.1038/nrneph.2012.83; Bos EM, 2009, J AM SOC NEPHROL, V20, P1901, DOI 10.1681/ASN.2008121269; Cavallo MG, 2014, TRANSPL P, V46, P3289, DOI 10.1016/j.transproceed.2014.09.146; Debout A, 2015, KIDNEY INT, V87, P343, DOI 10.1038/ki.2014.304; Dirkes MC, 2015, EUR SURG RES, V54, P178, DOI 10.1159/000369795; Dugbartey GJ, 2018, ANTIOXID REDOX SIGN, V28, P1503, DOI 10.1089/ars.2017.7127; Garonzik-Wang JM, 2019, AM J TRANSPLANT, V19, P585, DOI 10.1111/ajt.15174; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Haouzi P, 2008, RESP PHYSIOL NEUROBI, V160, P109, DOI 10.1016/j.resp.2007.09.001; Hendriks KDW, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2013-1; Hendriks KDW, 2019, CURR OPIN PHARMACOL, V45, P87, DOI 10.1016/j.coph.2019.07.001; Hendriks KDW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15606-z; Hosgood SA, 2010, BRIT J SURG, V97, P202, DOI 10.1002/bjs.6856; Jensen AR, 2017, AM J PHYSIOL-GASTR L, V312, pG450, DOI 10.1152/ajpgi.00444.2016; Juriasingani S, 2018, NITRIC OXIDE-BIOL CH, V81, P57, DOI 10.1016/j.niox.2018.10.004; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kashfi K, 2013, BIOCHEM PHARMACOL, V85, P689, DOI 10.1016/j.bcp.2012.10.019; KHAN AA, 1990, TOXICOL APPL PHARM, V103, P482, DOI 10.1016/0041-008X(90)90321-K; Kokkinos C, 2007, TRANSPLANTATION, V83, P1193, DOI 10.1097/01.tp.0000261710.53848.51; Koning AM, 2015, NITRIC OXIDE-BIOL CH, V46, P37, DOI 10.1016/j.niox.2015.01.005; Li HZ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0035-9; Lobb I, 2017, AM J TRANSPLANT, V17, P341, DOI 10.1111/ajt.14080; Lobb I, 2012, BJU INT, V110, pE1187, DOI 10.1111/j.1464-410X.2012.11526.x; Mahboub P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143859; Meng GL, 2015, J BIOMED RES, V29, P203, DOI 10.7555/JBR.28.20140037; Mooyaart EAQ, 2016, RESUSCITATION, V103, P1, DOI 10.1016/j.resuscitation.2016.03.012; Ojo AO, 2001, J AM SOC NEPHROL, V12, P589, DOI 10.1681/ASN.V123589; Sekijima M, 2017, J SURG RES, V219, P165, DOI 10.1016/j.jss.2017.05.123; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Slegtenhorst BR, 2014, TRANSPLANTATION, V97, P1091, DOI 10.1097/TP.0000000000000072; Snijder PM, 2013, AM J TRANSPLANT, V13, P3067, DOI 10.1111/ajt.12483; Snijder PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063291; Teng HJ, 2013, P NATL ACAD SCI USA, V110, P12679, DOI 10.1073/pnas.1308487110; Vinson AJ, 2018, TRANSPLANT DIRECT, V4, DOI 10.1097/TXD.0000000000000781; Wetzel MD, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-018-1753-7; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	40	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225152	10.1371/journal.pone.0225152	http://dx.doi.org/10.1371/journal.pone.0225152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743376	Green Published, gold			2022-12-26	WOS:000533877300019
J	Schuttevaer, R; Alsma, J; Brink, A; van Dijk, W; de Steenwinkel, JEM; Lingsma, HF; Melles, DC; Schuit, SCE				Schuttevaer, Romy; Alsma, Jelmer; Brink, Anniek; van Dijk, Willian; de Steenwinkel, Jurriaan E. M.; Lingsma, Hester F.; Melles, Damian C.; Schuit, Stephanie C. E.			Appropriate empirical antibiotic therapy and mortality: Conflicting data explained by residual confounding	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; PROPENSITY SCORES; BACTEREMIA; IMPACT; MULTICENTER; ILLNESS; SEPSIS	Objective Clinical practice universally assumes that appropriate empirical antibiotic therapy improves survival in patients with bloodstream infection. However, this is not generally supported by previous studies. We examined the association between appropriate therapy and 30-day mortality, while minimizing bias due to confounding by indication. Methods We conducted a retrospective cohort study between 2012 and 2017 at a tertiary university hospital in the Netherlands. Adult patients with bloodstream infection attending the emergency department were included. Based on in vitro susceptibility, antibiotic therapy was scored as appropriate or inappropriate. Primary outcome was 30-day mortality. To control for confounding, we performed conventional multivariable logistic regression and propensity score methods. Additionally, we performed an analysis in a more homogeneous subgroup (i.e. antibiotic monotherapy). Results We included 1.039 patients, 729 (70.2%) received appropriate therapy. Overall 30-day mortality was 10.4%. Appropriately treated patients had more unfavorable characteristics, indicating more severe illness. Despite adjustments, we found no association between appropriate therapy and mortality. For the antibiotic monotherapy subgroup (n = 449), patient characteristics were more homogeneous. Within this subgroup, appropriate therapy was associated with lower mortality (Odds Ratios [95% Confidence Intervals] ranging from: 0.31 [0.14; 0.67] to 0.40 [0.19; 0.85]). Conclusions Comparing heterogeneous treatment groups distorts associations despite use of common methods to prevent bias. Consequently, conclusions of such observational studies should be interpreted with care. If possible, future investigators should use our method of attempting to identify and analyze the most homogeneous treatment groups nested within their study objective, because this minimizes residual confounding.	[Schuttevaer, Romy; Alsma, Jelmer; Brink, Anniek; van Dijk, Willian; Schuit, Stephanie C. E.] Erasmus MC, Dept Internal Med, Sect Acute Med, Erasmus MC, Rotterdam, Netherlands; [de Steenwinkel, Jurriaan E. M.; Melles, Damian C.] Erasmus MC, Dept Med Microbiol & Infect Dis, Erasmus MC, Rotterdam, Netherlands; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Melles, Damian C.] Meander MC, Dept Med Microbiol & Immunol, Amersfoort, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Schuit, SCE (corresponding author), Erasmus MC, Dept Internal Med, Sect Acute Med, Erasmus MC, Rotterdam, Netherlands.	s.schuit@erasmusmc.nl	Alsma, Jelmer/O-7165-2019; van Dijk, Willian/ABB-4722-2020	Alsma, Jelmer/0000-0002-2808-1514; van Dijk, Willian/0000-0002-6314-9326; Schuttevaer, Romy/0000-0002-8589-4650				Alam N, 2018, LANCET RESP MED, V6, P40, DOI 10.1016/S2213-2600(17)30469-1; Anderson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091713; Austin PC, 2016, STAT MED, V35, P5642, DOI 10.1002/sim.7084; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bax HV N., 2018, SWAB ERASMUS MC; Brink A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211133; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Cain SE, 2015, ANTIMICROB AGENTS CH, V59, P245, DOI 10.1128/AAC.03935-14; Corona A, 2010, J ANTIMICROB CHEMOTH, V65, P1276, DOI 10.1093/jac/dkq088; Cross A, 2017, LANCET INFECT DIS, V17, P1005, DOI 10.1016/S1473-3099(17)30491-7; Dellinger RP, 2014, CLEV CLIN J MED, V82, P237, DOI 10.3949/ccjm.82gr.15001; Fitzpatrick JM, 2016, CLIN MICROBIOL INFEC, V22, P244, DOI 10.1016/j.cmi.2015.10.034; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Gradel KO, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2233-z; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Hernan Miguel A, 2019, CAUSAL INFERENCE WHA; Kollef MH, 2008, CLIN INFECT DIS, V47, pS55, DOI 10.1086/590937; Marquet Kristel, 2015, Crit Care, V19, P63, DOI 10.1186/s13054-015-0795-y; McGinley A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5310; McGregor JC, 2007, CLIN INFECT DIS, V45, P329, DOI 10.1086/519283; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P697, DOI 10.1002/pds.2256; Savage RD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154944; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Thom KA, 2008, INFECT CONT HOSP EP, V29, P1048, DOI 10.1086/591453; Trick WE, 2004, EMERG INFECT DIS, V10, P1612, DOI 10.3201/eid1009.030978; Verbrugh HA, 2003, NETH J MED, V61, P341; Zachariasse JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170811	31	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225478	10.1371/journal.pone.0225478	http://dx.doi.org/10.1371/journal.pone.0225478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743361	Green Published, gold			2022-12-26	WOS:000533877300033
J	Thielmann, A; Puth, MT; Kersting, C; Porz, J; Weltermann, B				Thielmann, Anika; Puth, Marie-Therese; Kersting, Christine; Porz, Johannes; Weltermann, Birgitta			Vaccine cold chain in general practices: A prospective study in 75 refrigerators (Keep Cool study)	PLOS ONE			English	Article							STORAGE; MEASLES; EFFICACY	Introduction Protecting vaccines from freeze damage is considered one of the most poorly addressed problems in vaccine management. Freezing may impair the potency especially of adsorbed vaccines. The Keep Cool study aims at ensuring optimal vaccine storage conditions in general practices. This publication analyses the baseline data using standardised temperature recordings. Methods This prospective study in German general practices analysed 7-day temperature recordings of refrigerators used for vaccine storage. Temperatures were recorded continuously using a standardised data logger with an accuracy of +/- 0.4 degrees C. The prevalence rates of refrigerators within the target range (2 to 8 degrees C) and of those reaching critically low temperatures (<= 0 degrees C) were calculated. In addition, the cumulative time and the duration of single episodes beyond the target range were computed. To assess for structural deficits, the prevalence of refrigerators with a cycling of >5 degrees C was determined. Generalised linear mixed models were applied to analyse correlating factors between the dependent variables 'within temperature range' and 'reaching critically low temperatures' with practice characteristics. Results The study included 64 of 168 practices (38.1% response rate) with 75 refrigerators. The prevalence of refrigerators with temperatures within the target range was 32.0% (n = 24), and 14.7% (n = 11) reached critically low temperatures <0 degrees C. 44.0% of refrigerators (n = 33) showed temperatures >8 degrees C and 28.0% (n = 21) <2 degrees C. Of the 168 hours recorded per refrigerator, the average cumulative time >8 degrees C was 49 hours, <2 degrees C 75 hours and <= 0 degrees C 74 hours. The longest consecutive period of critically low temperatures was 168 hours (mean: 39 +/- 53). The prevalence of refrigerators with a cycling range of >5 degrees C was 29.3%. Conclusion Given the importance of immunisation, the results of our study call for action, as two-thirds of the refrigerators exhibited cold chain breaches and 15% reached critically low temperatures threatening vaccine potency.	[Thielmann, Anika; Kersting, Christine; Weltermann, Birgitta] Univ Duisburg Essen, Univ Hosp Essen, Inst Gen Practice, Essen, Germany; [Thielmann, Anika; Puth, Marie-Therese; Porz, Johannes; Weltermann, Birgitta] Univ Bonn, Inst Gen Practice & Family Med, Bonn, Germany; [Puth, Marie-Therese] Univ Bonn, Fac Med, Dept Med Biometry Informat & Epidemiol, Bonn, Germany	University of Duisburg Essen; University of Bonn; University of Bonn	Thielmann, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Gen Practice, Essen, Germany.; Thielmann, A (corresponding author), Univ Bonn, Inst Gen Practice & Family Med, Bonn, Germany.	Anika.Thielmann@ukbonn.de		Schmitz, Marie-Therese/0000-0003-1351-9381; Kersting, Dr. Christine/0000-0001-9393-4766	Stiftung Universitatsmedizin Essen	Stiftung Universitatsmedizin Essen	The study received grants from Stiftung Universitatsmedizin Essen http://www.universitaetsmedizin.de/) to buy thermometers. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Z ALLG MED, DOI DOI 10.3238/ZFA.2014.0354-0359; Australian Government, 2013, NAT VACC STOR GUID S; Bell KN, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e100; Boros CA, 2001, VACCINE, V19, P3537, DOI 10.1016/S0264-410X(01)00063-9; Center for Disease Control. National Center for Immunization and Respiratory Diseases, 2018, VACC STOR HANDL TOOL; Chojnacky M, 2010, 7753 NISTIR; Chojnacky M, 2009, 7656 NISTIR; Davaalkham D, 2007, J EPIDEMIOL COMMUN H, V61, P578, DOI 10.1136/jech.2006.051375; Gazmararian JA, 2002, AM J PREV MED, V23, P246, DOI 10.1016/S0749-3797(02)00512-3; Gold MS, 1999, MED J AUSTRALIA, V171, P83, DOI 10.5694/j.1326-5377.1999.tb123528.x; Hanson CM, 2017, VACCINE, V35, P2127, DOI 10.1016/j.vaccine.2016.09.070; Lee Saerom, 2012, J Prev Med Public Health, V45, P78, DOI 10.3961/jpmph.2012.45.2.78; LERMAN SJ, 1971, J AMER MED ASSOC, V216, P1311, DOI 10.1001/jama.216.8.1311; Lewis PR, 2001, AUST NZ J PUBL HEAL, V25, P547, DOI 10.1111/j.1467-842X.2001.tb00322.x; Matthias DM, 2007, VACCINE, V25, P3980, DOI 10.1016/j.vaccine.2007.02.052; McColloster P, 2011, AM J PUBLIC HEALTH, V101, P46, DOI 10.2105/AJPH.2009.179853; MCINTYRE RC, 1982, B WORLD HEALTH ORGAN, V60, P767; ONOJA AL, 1992, VACCINE, V10, P49, DOI 10.1016/0264-410X(92)90419-K; Page SL, 2008, AUST FAM PHYSICIAN, V37, P892; Paul-Ehrlich-Institut, 2012, B ARZNEIMITTELSICHER, P12; Salisbury D, 2006, IMMUNISATION INFECT, V3rd; Thielmann A, 2015, GESUNDHEITSWESEN, V38, P1; Thielmann A, PLOS ONE; Thielmann A, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0824-9; Weltermann BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105119; World Health Organization, 2007, AID MEM PREV FREEZ D; World Health Organization, 2006, TRAD MED STRAT 2002, P1; World Health Organization Unicef, 2013, GLOB IMM DAT	28	10	10	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0224972	10.1371/journal.pone.0224972	http://dx.doi.org/10.1371/journal.pone.0224972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8LN	31743356	gold, Green Published			2022-12-26	WOS:000533877300012
J	Fang, Y; Han, SJ; Huang, C; Wu, RP				Fang, Yong; Han, Shengjun; Huang, Cheng; Wu, Runpu			TAP: A static analysis model for PHP vulnerabilities based on token and deep learning technology	PLOS ONE			English	Article								With the widespread usage of Web applications, the security issues of source code are increasing. The exposed vulnerabilities seriously endanger the interests of service providers and customers. There are some models for solving this problem. However, most of them rely on complex graphs generated from source code or regex patterns based on expert experience. In this paper, TAP, which is based on token mechanism and deep learning technology, was proposed as an analysis model to discover the vulnerabilities of PHP: Hypertext Preprocessor (PHP) Web programs conveniently and easily. Based on the token mechanism of PHP language, a custom tokenizer was designed, and it unifies tokens, supports some features of PHP and optimizes the parsing. Besides, the tokenizer also implements parameter iteration to achieve data flow analysis. On the Software Assurance Reference Dataset(SARD) and SQLI-LABS dataset, we trained the deep learning model of TAP by combining the word2vec model with Long Short-Term Memory (LSTM) network algorithm. According to the experiment on the dataset of CWE-89, TAP not only achieves the 0.9941 Area Under the Curve(AUC), which is better than other models, but also achieves the highest accuracy: 0.9787. Further, compared with RIPS, TAP shows much better in multiclass classification with 0.8319 Kappa and 0.0840 hamming distance.	[Fang, Yong; Han, Shengjun; Huang, Cheng] Sichuan Univ, Coll Cybersecur, Chengdu 610065, Peoples R China; [Wu, Runpu] China Informat Technol Secur Evaluat Ctr, Beijing 100085, Peoples R China	Sichuan University	Huang, C (corresponding author), Sichuan Univ, Coll Cybersecur, Chengdu 610065, Peoples R China.	opcodesec@gmail.com		Huang, Cheng/0000-0002-5871-946X	Key Research and Development Plan Project of Sichuan Province [2019YFG0407]; Sichuan University Postdoc Research Foundation [19XJ0002]	Key Research and Development Plan Project of Sichuan Province; Sichuan University Postdoc Research Foundation	This work is supported in part by Key Research and Development Plan Project of Sichuan Province (No.2019YFG0407), and Sichuan University Postdoc Research Foundation under Grant 19XJ0002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhuzali A, 2018, PROCEEDINGS OF THE 27TH USENIX SECURITY SYMPOSIUM, P377; [Anonymous], 2017, CVE20175223; [Anonymous], 2016, IEEE T BIG DATA, DOI DOI 10.1109/TBDATA.2016.2599928; [Anonymous], 2016, NVDCVE201610033; [Anonymous], 2019, USAGE CONTENT MANAGE; Backes M, 2017, 2017 IEEE EUROPEAN SYMPOSIUM ON SECURITY AND PRIVACY (EUROS&P), P334, DOI 10.1109/EuroSP.2017.14; Cheswick W. R., 2003, FIREWALLS INTERNET S; Dahse J, 2010, SEMINAR WORK SEMINER; Dahse J, 2014, CCS'14: PROCEEDINGS OF THE 21ST ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P42, DOI 10.1145/2660267.2660363; Doupe A, 2011, PROCEEDINGS OF THE 18TH ACM CONFERENCE ON COMPUTER & COMMUNICATIONS SECURITY (CCS 11), P251; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; jorkro/wirecaml, WEAKN ID RES EMPL CF; Jovanovic N, 2006, P IEEE S SECUR PRIV, P258, DOI 10.1109/SP.2006.29; KING JC, 1976, COMMUN ACM, V19, P385, DOI 10.1145/360248.360252; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li Z, 2018, 25TH ANNUAL NETWORK AND DISTRIBUTED SYSTEM SECURITY SYMPOSIUM (NDSS 2018), DOI 10.14722/ndss.2018.23158; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Pendleton M, 2017, ACM COMPUT SURV, V49, DOI 10.1145/3005714; PHP, TOK GET ALL MAN; PHP, LIST PARS TOK MAN; ripsscanner/rips, RIPS STAT SOURC COD; Russell RL, 2018, 2018 17TH IEEE INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), P757, DOI 10.1109/ICMLA.2018.00120; Shu JG, 2021, IEEE T SERV COMPUT, V14, P235, DOI 10.1109/TSC.2018.2791601; Son S., 2011, P ACM SIGPLAN 6 WORK, P1, DOI DOI 10.1145/2166956.2166964; Stivalet B, 2016, IEEE INT CONF SOFTW, P409, DOI 10.1109/ICST.2016.43; Tip F., 1994, SURVEY PROGRAM SLICI; Vranken H, 2018, P 13 IN TERNATIONAL, P1; Yamaguchi F, 2014, P IEEE S SECUR PRIV, P590, DOI 10.1109/SP.2014.44; Yamaguchi Y, 2011, 2011 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2011), P13, DOI 10.1109/ASONAM.2011.58; Zaremba Wojciech, 2014, ABS14092329 CORR	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225196	10.1371/journal.pone.0225196	http://dx.doi.org/10.1371/journal.pone.0225196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738786	gold, Green Published			2022-12-26	WOS:000532826300037
J	Guo, XY; Zhang, L; Wang, XZ; Zhang, MH; Xi, YX; Wang, AY; Zhu, JB				Guo, Xinyong; Zhang, Li; Wang, Xiaozhen; Zhang, Minhuan; Xi, Yuxin; Wang, Aiying; Zhu, Jianbo			Overexpression of Saussurea involucrata dehydrin gene SiDHN promotes cold and drought tolerance in transgenic tomato plants	PLOS ONE			English	Article							MULTIPLE ABIOTIC STRESSES; TIME QUANTITATIVE PCR; OXIDATIVE STRESS; GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; WATER-DEFICIT; METABOLISM; OXYGEN; PHOTOSYNTHESIS; EXPRESSION	Dehydrins are late embryogenesis abundant proteins that help regulate abiotic stress responses in plants. Overexpression of the Saussurea involucrata dehydrin gene SiDHN has previously been shown to improve water-use efficiency and enhance cold and drought tolerance of transgenic tobacco. To understand the mechanism by which SiDHN exerts its protective function, we transformed the SiDHN gene into tomato plants (Solanum lycopersicum L.) and assessed their response to abiotic stress. We observed that in response to stresses, the SiDHN transgenic tomato plants had increased contents of chlorophyll a and b, carotenoid and relative water content compared with wild-type plants. They also had higher maximal photochemical efficiency of photosystem II and accumulated more proline and soluble sugar. Compared to those wild-type plants, malondialdehyde content and relative electron leakage in transgenic plants were not significantly increased, and H2O2 and O-2-contents in transgenic tomato plants were significantly decreased. We further observed that the production of stress-related antioxidant enzymes, including superoxide dismutase, ascorbate peroxidase, peroxidase, and catalase, as well as pyrroline-5-carboxylate synthetase and lipid transfer protein 1, were up-regulated in the transgenic plants under cold and drought stress. Based on these observations, we conclude that overexpression of SiDHN gene can promote cold and drought tolerance of transgenic tomato plants by inhibiting cell membrane damage, protecting chloroplasts, and enhancing the reactive oxygen species scavenging capacity. The finding can be beneficial for the application of SiDHN gene in improving crop tolerance to abiotic stress and oxidative damage.	[Guo, Xinyong; Zhang, Li; Wang, Xiaozhen; Zhang, Minhuan; Xi, Yuxin; Wang, Aiying; Zhu, Jianbo] Shihezi Univ, Coll Life Sci, Key Lab Agr Biotechnol, Shihezi, Peoples R China	Shihezi University	Zhu, JB (corresponding author), Shihezi Univ, Coll Life Sci, Key Lab Agr Biotechnol, Shihezi, Peoples R China.	jianboz9@sina.com			National Science Foundation [31360053]; National transgenic major projects [2016ZX080005004-009]	National Science Foundation(National Science Foundation (NSF)); National transgenic major projects	This work was supported by the National Science Foundation Project grant no. 31360053 and the National transgenic major projects grant no. 2016ZX080005004-009 to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Benikhlef L, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-133; Brini F, 2007, PLANT SCI, V172, P20, DOI 10.1016/j.plantsci.2006.07.011; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Cao YX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00470; Chen RG, 2015, PLANT CELL REP, V34, P2189, DOI 10.1007/s00299-015-1862-1; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Doerge DR, 1997, ANAL BIOCHEM, V250, P10, DOI 10.1006/abio.1997.2191; DU ZY, 1992, J AGR FOOD CHEM, V40, P1566, DOI 10.1021/jf00021a018; Eriksson SK, 2011, ECOL STUD-ANAL SYNTH, V215, P289, DOI 10.1007/978-3-642-19106-0_14; Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183; FOYER C, 1991, PLANT PHYSIOL, V97, P863, DOI 10.1104/pp.97.3.863; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Gallois P, 1995, Methods Mol Biol, V49, P39; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Vendruscolo ECG, 2007, J PLANT PHYSIOL, V164, P1367, DOI 10.1016/j.jplph.2007.05.001; Guo L, 2013, J EXP BOT, V64, P1755, DOI 10.1093/jxb/ert040; Guo XY, 2017, PLANT SCI, V256, P160, DOI 10.1016/j.plantsci.2016.12.007; Halder T, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00136; Halder T, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00918; Halder T, 2016, PROTOPLASMA, V253, P1475, DOI 10.1007/s00709-015-0901-7; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hara M, 2003, PLANTA, V217, P290, DOI 10.1007/s00425-003-0986-7; Hara M, 2010, PLANT SIGNAL BEHAV, V5, P503, DOI 10.4161/psb.11085; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Hsieh AYY, 2016, J MOL DIAGN, V18, P425, DOI 10.1016/j.jmoldx.2016.01.004; Iturbe-Ormaetxe I, 1998, PLANT PHYSIOL, V116, P173, DOI 10.1104/pp.116.1.173; Jing H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161073; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khare N, 2010, PLANT CELL TISS ORG, V103, P267, DOI 10.1007/s11240-010-9776-7; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lara MV, 2003, PHOTOSYNTH RES, V77, P241, DOI 10.1023/A:1025834120499; Layton BE, 2010, AM J BOT, V97, P535, DOI 10.3732/ajb.0900285; Liu H, 2015, PLANT SCI, V231, P198, DOI 10.1016/j.plantsci.2014.12.006; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07852-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Lv AM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00748; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morsy MR, 2007, J PLANT PHYSIOL, V164, P157, DOI 10.1016/j.jplph.2005.12.004; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Pino LE, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-23; Pokorska B, 2009, BBA-BIOENERGETICS, V1787, P1161, DOI 10.1016/j.bbabio.2009.05.002; Rahman LN, 2013, BBA-BIOMEMBRANES, V1828, P967, DOI 10.1016/j.bbamem.2012.11.031; Safi H, 2015, PLANT PHYSIOL BIOCH, V89, P64, DOI 10.1016/j.plaphy.2015.02.008; Sarkar T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110507; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Shekhawat UKS, 2011, PLANTA, V234, P915, DOI 10.1007/s00425-011-1455-3; Sigrist C., 2012, NUCL ACIDS RES; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Wang HH, 2011, PLANT CELL REP, V30, P2037, DOI 10.1007/s00299-011-1111-1; Yordanov I, 2000, PHOTOSYNTHETICA, V38, P171, DOI 10.1023/A:1007201411474; Zhang YX, 2006, MOL BIOTECHNOL, V32, P205, DOI 10.1385/MB:32:3:205; Zhu JB, 2006, ACTA AGR BOREALI OCC; Zhu MK, 2013, PLANT CELL PHYSL	65	29	31	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225090	10.1371/journal.pone.0225090	http://dx.doi.org/10.1371/journal.pone.0225090			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738789	Green Published, gold			2022-12-26	WOS:000532826300030
J	Fukuda, A; Honda, S; Fujioka, N; Sekiguchi, Y; Mizuno, S; Miwa, Y; Sugiyama, F; Hayashi, Y; Nishimura, K; Hisatake, K				Fukuda, Aya; Honda, Shiho; Fujioka, Norie; Sekiguchi, Yuya; Mizuno, Seiya; Miwa, Yoshihiro; Sugiyama, Fumihiro; Hayashi, Yohei; Nishimura, Ken; Hisatake, Koji			Non-invasive in vivo imaging of UCP1 expression in live mice via near-infrared fluorescent protein iRFP720	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; DIET-INDUCED THERMOGENESIS; FUNCTIONAL-CHARACTERIZATION; BEIGE; COLD; FAT; ABLATION; MOUSE; RNA	Uncoupling protein 1 (UCP1) is a mitochondrial protein that is expressed in both brown and beige adipocytes. UCP1 uncouples the mitochondrial electron transport chain from ATP synthesis to produce heat via non-shivering thermogenesis. Due to their ability to dissipate energy as heat and ameliorate metabolic disorders, UCP1-expressing adipocytes are considered as a potential target for anti-obesity treatment. To monitor the expression of UCP1 in live mice in a non-invasive manner, we generated the Ucp1-iRFP720 knock-in (Ucp1-iRFP720 KI) mice, in which the gene encoding a near-infrared fluorescent protein iRFP720 is inserted into the Ucp1 gene locus. Using the heterozygous Ucp1-iRFP720 KI mice, we observed robust iRFP fluorescence in the interscapular region where brown adipose tissue is located. Moreover, the iRFP fluorescence was clearly observable in inguinal white adipose tissues in live mice administered with beta 3-adrenergic receptor agonist CL316,243. We also found that the homozygous Ucp1-iRFP720 KI mice, which are deficient in UCP1, displayed prominent iRFP fluorescence in the inguinal regions at the standard housing temperature. Consistent with this, the mice exhibited expanded populations of beige-like adipocytes in inguinal white adipose tissue, in which the Ucp1 promoter was dramatically activated. Thus, the Ucp1-iRFP720 KI mice provide a convenient model for non-invasive in vivo imaging of UCP1 expression in both brown and beige adipocytes in live mice.	[Fukuda, Aya; Honda, Shiho; Fujioka, Norie; Sekiguchi, Yuya; Hayashi, Yohei; Nishimura, Ken; Hisatake, Koji] Univ Tsukuba, Lab Gene Regulat, Tsukuba, Ibaraki, Japan; [Mizuno, Seiya; Sugiyama, Fumihiro] Univ Tsukuba, Lab Anim Sci, Tsukuba, Ibaraki, Japan; [Miwa, Yoshihiro] Univ Tsukuba, Lab Anat & Embryol, Tsukuba, Ibaraki, Japan; [Hayashi, Yohei] RIKEN BioResource Ctr, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; RIKEN	Fukuda, A; Hisatake, K (corresponding author), Univ Tsukuba, Lab Gene Regulat, Tsukuba, Ibaraki, Japan.	fukudaa@md.tsukuba.ac.jp; kojihisa@md.tsukuba.ac.jp	Nishimura, KEN/HGC-6147-2022	Hisatake, Koji/0000-0002-5795-3115; Nishimura, Ken/0000-0002-0716-4142; Fukuda, Aya/0000-0002-4960-7028	JSPS KAKENHI [JP16K08610, JP19K07343, JP16K07244, JP17H04036]; Nakanishi Foundation for Advancement of Measuring in Biomedical Engineering	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakanishi Foundation for Advancement of Measuring in Biomedical Engineering	This work was supported by JSPS KAKENHI Grant Numbers JP16K08610 and JP19K07343 (AF), JP16K07244 (KN) and JP17H04036 (KH) as well as by Nakanishi Foundation for Advancement of Measuring in Biomedical Engineering (KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldiss P, 2018, METABOLISM, V81, P63, DOI 10.1016/j.metabol.2017.11.009; Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Bertholet AM, 2017, CELL METAB, V25, P811, DOI 10.1016/j.cmet.2017.03.002; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Contreras GA, 2014, AM J PHYSIOL-ENDOC M, V307, pE793, DOI 10.1152/ajpendo.00033.2014; Croce AC, 2014, J BIOPHOTONICS, V7, P810, DOI 10.1002/jbio.201300039; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Galmozzi A, 2014, CELL REP, V9, P1584, DOI 10.1016/j.celrep.2014.10.066; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Hagberg CE, 2018, CELL REP, V24, P2746, DOI 10.1016/j.celrep.2018.08.006; Hanssen MJW, 2015, NAT MED, V21, P863, DOI 10.1038/nm.3891; HUANG MTF, 1990, NUCLEIC ACIDS RES, V18, P937, DOI 10.1093/nar/18.4.937; Ikeda K, 2018, TRENDS ENDOCRIN MET, V29, P191, DOI 10.1016/j.tem.2018.01.001; Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kazak L, 2017, CELL METAB, V26, P660, DOI 10.1016/j.cmet.2017.08.009; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Keipert S, 2015, MOL METAB, V4, P537, DOI 10.1016/j.molmet.2015.04.006; Kiefer FW, 2017, ENDOCR CONNECT, V6, pR70, DOI 10.1530/EC-17-0037; Kozak L, 2008, PSYCHOLINGUISTICS, V1; Lee P, 2011, ENDOCRINOLOGY, V152, P3597, DOI 10.1210/en.2011-1349; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XT, 2003, J CLIN INVEST, V111, P759, DOI 10.1172/JCI200315737E1; Liu ZQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02460-2; Maloney SK, 2014, PHYSIOLOGY, V29, P413, DOI 10.1152/physiol.00029.2014; Mao LF, 2017, DIABETES, V66, P407, DOI 10.2337/db16-0343; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nyman E, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/s41540-017-0027-y; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shcherbakova DM, 2015, CURR OPIN CHEM BIOL, V27, P52, DOI 10.1016/j.cbpa.2015.06.005; Shcherbakova DM, 2018, TRENDS BIOTECHNOL, V36, P1230, DOI 10.1016/j.tibtech.2018.06.011; Shemetov AA, 2017, CELL CHEM BIOL, V24, P758, DOI 10.1016/j.chembiol.2017.05.018; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Townsend KL, 2012, ADIPOCYTE, V1, P13, DOI 10.4161/adip.18951; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang H, 2019, MOL METAB, V20, P14, DOI 10.1016/j.molmet.2018.11.009; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125	54	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225213	10.1371/journal.pone.0225213	http://dx.doi.org/10.1371/journal.pone.0225213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730675	Green Published, Green Submitted, gold			2022-12-26	WOS:000532809500029
J	Takaoka, Y; Takeuchi, A; Sugano, A; Miura, K; Ohta, M; Suzuki, T; Kobayashi, D; Kimura, T; Sato, J; Ban, N; Nishio, H; Sakaeda, T				Takaoka, Yutaka; Takeuchi, Atsuko; Sugano, Aki; Miura, Kenji; Ohta, Mika; Suzuki, Takashi; Kobayashi, Daisuke; Kimura, Takuji; Sato, Juichi; Ban, Nobutaro; Nishio, Hisahide; Sakaeda, Toshiyuki			Establishment of the experimental procedure for prediction of conjugation capacity in mutant UGT1A1	PLOS ONE			English	Article							UDP-GLUCURONOSYLTRANSFERASE GENE; MOLECULAR-DYNAMICS; BILIRUBIN; GLUCURONIDATION; METABOLISM; MUTATIONS; POLYMORPHISMS; GILBERT; CYP3A; 1A1	UDP-glucuronosyltransferase 1A1 (UGT1A1) is an enzyme that is found in the endoplasmic reticulum membrane and can reportedly have a large number of amino acid substitutions that result in the reduction of glucuronidation capacity. For example, adverse drug reactions when patients receive CPT-11 (irinotecan) such as in cancer chemotherapy are caused by amino acid substitutions in UGT1A1. We previously found that the extent of the docking when the hydroxyl residue of bilirubin was oriented toward UDP-glucuronic acid correlated with in vitro conjugation capacity. In this study, we analyzed the conformation of mutant UGT1A1s by means of structural optimization with water and lipid bilayers instead of the optimization in vacuo that we used in our previous study. We then derived a mathematical model that can predict the conjugation capacities of mutant UGT1A1s by using results of substrate docking in silico and results of in vitro analysis of glucuronidation of acetaminophen and 17 beta-estradiol by UGT1A1s. This experimental procedure showed that the in silico conjugation capacities of other mutant UGT1A1s with bilirubin or SN-38 were similar to reported in vitro conjugation capacities. Our results suggest that this experimental procedure described herein can correctly predict the conjugation capacities of mutant UGT1A1s and any substrate.	[Takaoka, Yutaka; Sugano, Aki; Miura, Kenji; Ohta, Mika; Suzuki, Takashi] Kobe Univ Hosp, Div Med Informat & Bioinformat, Kobe, Hyogo, Japan; [Takeuchi, Atsuko] Kobe Pharmaceut Univ, Div Analyt Lab, Kobe, Hyogo, Japan; [Kobayashi, Daisuke] Kobe Univ, Healthcare Econ & Hosp Adm, Div Med & Healthcare Syst, Grad Sch Med, Kobe, Hyogo, Japan; [Kimura, Takuji; Sato, Juichi; Ban, Nobutaro] Nagoya Univ, Dept Gen Med Family & Community Med, Grad Sch Med, Nagoya, Aichi, Japan; [Ban, Nobutaro] Aichi Med Univ, Med Educ Ctr, Sch Med, Nagakute, Aichi, Japan; [Nishio, Hisahide] Kobe Univ, Dept Community Med & Social Healthcare Sci, Grad Sch Med, Kobe, Hyogo, Japan; [Sakaeda, Toshiyuki] Kyoto Pharmaceut Univ, Dept Pharmacokinet, Kyoto, Japan	Kobe University; Kobe Pharmaceutical University; Kobe University; Nagoya University; Aichi Medical University; Kobe University; Kyoto Pharmaceutical University	Takaoka, Y (corresponding author), Kobe Univ Hosp, Div Med Informat & Bioinformat, Kobe, Hyogo, Japan.	ytakaoka@ebraille.med.kobe-u.ac.jp		Takaoka, Yutaka/0000-0001-7568-8135	Japanese Ministry of Education, Culture, Sports, Science and Technology [18K07414, 19K12202, 19K07867]; Hyogo Science and Technology Association [27004]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association	This research was partially supported by Grants-in-Aid from Japanese Ministry of Education, Culture, Sports, Science and Technology (https://www.jsps.go.jp/english/index.html) No. 18K07414 (to Y.T.), No. 19K12202 (to A.S.), and No. 19K07867 (to M.O.), and Grants-in-Aid from Hyogo Science and Technology Association (http://hyogosta.jp) No. 27004 (to Y.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2000, CANCER RES, V60, P6921; [Anonymous], 2017, PYMOL MOL GRAPHICS S; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Canu G, 2013, BLOOD CELL MOL DIS, V50, P273, DOI 10.1016/j.bcmd.2013.01.003; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Ciotti M, 1998, BBA-MOL BASIS DIS, V1407, P40, DOI 10.1016/S0925-4439(98)00030-1; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; Hasegawa Y, 2006, EXPERT REV MOL DIAGN, V6, P527, DOI 10.1586/14737159.6.4.527; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Jeffery G.A., 1997, INTRO HYDROGEN BONDI; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaniwa N, 2005, DRUG METAB DISPOS, V33, P458, DOI 10.1124/dmd.104.001800; Kiang TKL, 2005, PHARMACOL THERAPEUT, V106, P97, DOI 10.1016/j.pharmthera.2004.10.013; Laakkonen L, 2010, MOL PHARMACOL, V77, P931, DOI 10.1124/mol.109.063289; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levesque E, 2007, HEPATOLOGY, V45, P128, DOI 10.1002/hep.21464; Locuson CW, 2007, XENOBIOTICA, V37, P155, DOI 10.1080/00498250601129109; Lusin TT, 2012, TOXICOLOGY, V292, P33, DOI 10.1016/j.tox.2011.11.015; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nagai H, 2017, J DERMATOL, V44, P1059, DOI 10.1111/1346-8138.13844; Nakamura Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188407; Nishimuta H, 2011, DRUG METAB PHARMACOK, V26, P592, DOI 10.2133/dmpk.DMPK-11-RG-034; Ogasawara M, 2016, CANCER CHEMOTH PHARM, V77, P1019, DOI 10.1007/s00280-016-3021-y; Ohta M, 2018, TRANSGENIC RES, V27, P15, DOI 10.1007/s11248-017-0054-x; Ohtsubo H, 2016, PEDIATR NEPHROL, V31, P1459, DOI 10.1007/s00467-016-3368-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakaeda T, 2018, INT J MED SCI, V15, P937, DOI 10.7150/ijms.22224; Soni Sangeeta, 2014, BMC Res Notes, V7, P446, DOI 10.1186/1756-0500-7-446; Sugawara K, 2019, J DIABETES INVEST, V10, P680, DOI 10.1111/jdi.12960; Takaoka Y, 2010, J BIOCHEM, V148, P25, DOI 10.1093/jb/mvq048; Tanaka Y, 2016, J PHARM SCI-US, V105, P431, DOI 10.1016/j.xphs.2015.11.005; Tripathi SP, 2013, DRUG METAB REV, V45, P231, DOI 10.3109/03602532.2013.767345; Udomuksorn W, 2007, PHARMACOGENET GENOM, V17, P1017, DOI 10.1097/FPC.0b013e328256b1b6; Vogelauer M, 2012, J BIOL CHEM, V287, P32006, DOI 10.1074/jbc.M112.362467; Wada K, 2006, J CHROMATOGR B, V838, P9, DOI 10.1016/j.jchromb.2006.01.030; Yamamoto K, 1998, BBA-MOL BASIS DIS, V1406, P267, DOI 10.1016/S0925-4439(98)00013-1	43	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225244	10.1371/journal.pone.0225244	http://dx.doi.org/10.1371/journal.pone.0225244			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730632	Green Published, gold			2022-12-26	WOS:000532809500030
J	Zhao, J; Hou, YR; Yin, C; Hu, J; Gao, T; Huang, XJ; Zhang, XH; Xing, JL; An, JZ; Wan, SG; Li, JB				Zhao, Jing; Hou, Yiran; Yin, Chun; Hu, Jing; Gao, Tian; Huang, Xiaojun; Zhang, Xiaohong; Xing, Jinliang; An, Jiaze; Wan, Shaogui; Li, Jibin			Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma	ONCOGENE			English	Article							NERVE GROWTH-FACTOR; H-1 RECEPTOR; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; ACTIVATION; ALLERGIES; CANCER; RISK; IDENTIFICATION; PROLIFERATION	H1 histamine receptor (H1HR) belongs to the family of rhodopsin-like G-protein-coupled receptors. Recent studies have shown that H1HR expression is increased in several types of cancer. However, its functional roles in tumor progression remain largely unknown, especially in hepatocellular carcinoma (HCC). We found that H1HR is frequently unregulated in HCC, which is significantly associated with both recurrence-free survival and overall survival in HCC patients. Functional experiments revealed that H1HR promoted both the growth and metastasis of HCC cells by inducing cell cycle progression, formation of lamellipodia, production of matrix metalloproteinase 2, and suppression of cell apoptosis. Activation of cyclic adenosine monophosphate-dependent protein kinase A was found to be involved in H1HR-mediated HCC cell growth and metastasis. In addition, we found that overexpression of H1HR was mainly due to the downregulation of miR-940 in HCC cells. Moreover, the H1HR inhibitor terfenadine significantly suppressed tumor growth and metastasis in an HCC xenograft nude mice model. Our findings demonstrate that H1HR plays a critical role in the growth and metastasis of HCC cells, which provides experimental evidence supporting H1HR as a potential drug target for the treatment of HCC.	[Zhao, Jing; Wan, Shaogui] Gannan Med Univ, Affiliated Hosp 1, Ctr Mol Pathol, Ganzhou 341000, Jiangxi, Peoples R China; [Zhao, Jing; Yin, Chun; Hu, Jing; Huang, Xiaojun; Xing, Jinliang; Li, Jibin] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Zhao, Jing; Yin, Chun; Hu, Jing; Huang, Xiaojun; Xing, Jinliang; Li, Jibin] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Peoples R China; [Hou, Yiran] Yanan Univ, Med Coll, Yanan 716000, Shaanxi, Peoples R China; [Gao, Tian; Zhang, Xiaohong] Fourth Mil Med Univ, Xijing Hosp, Dept Gynecol & Obstet, Xian 710032, Peoples R China; [An, Jiaze] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China	Gannan Medical University; Air Force Military Medical University; Air Force Military Medical University; Yanan University; Air Force Military Medical University; Air Force Military Medical University	Wan, SG (corresponding author), Gannan Med Univ, Affiliated Hosp 1, Ctr Mol Pathol, Ganzhou 341000, Jiangxi, Peoples R China.; Li, JB (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China.; Li, JB (corresponding author), Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Peoples R China.	wansg@gmu.edu.cn; lijibin2006@163.com		, Chun Yin/0000-0002-7299-1929	State Key Laboratory of Cancer Biology Project [CBSKL2017Z01]; National Natural Science Foundation of China [81472298, 81502085, U1604167]; Natural Science Basic Research Plan in Shaanxi Province of China [2018JM7018]	State Key Laboratory of Cancer Biology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China	This work was supported by the State Key Laboratory of Cancer Biology Project (CBSKL2017Z01), National Natural Science Foundation of China (grants 81472298, 81502085 and U1604167) and Natural Science Basic Research Plan in Shaanxi Province of China (Program no. 2018JM7018).	Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Beermann S, 2015, BIOCHEM PHARMACOL, V98, P432, DOI 10.1016/j.bcp.2015.09.011; Cai WK, 2014, EUR J CANCER, V50, P1195, DOI 10.1016/j.ejca.2013.12.025; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Cianchi F, 2005, CLIN CANCER RES, V11, P6807, DOI 10.1158/1078-0432.CCR-05-0675; Cotterchio M, 2014, CANCER EPIDEM BIOMAR, V23, P469, DOI 10.1158/1055-9965.EPI-13-0965; Das AK, 2007, J PHARMACOL SCI, V103, P374, DOI 10.1254/jphs.FP0061411; Davio C, 1995, Inflamm Res, V44 Suppl 1, pS70, DOI 10.1007/BF01674401; de Esch IJP, 2005, TRENDS PHARMACOL SCI, V26, P462, DOI 10.1016/j.tips.2005.07.002; Farso M, 2013, NEUROBIOL AGING, V34, P1971, DOI 10.1016/j.neurobiolaging.2013.02.008; Francis H, 2012, GUT, V61, P753, DOI 10.1136/gutjnl-2011-300007; Gandini S, 2005, CANCER EPIDEM BIOMAR, V14, P1908, DOI 10.1158/1055-9965.EPI-05-0119; GARCIACABALLERO M, 1994, SURG ONCOL, V3, P167, DOI 10.1016/0960-7404(94)90046-9; Hernandez-Angeles A, 2001, J NEURO-ONCOL, V55, P81, DOI 10.1023/A:1013338515229; Kim YS, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0227-1; Lieberman P, 2011, ANN ALLERG ASTHMA IM, V106, pS2, DOI 10.1016/j.anai.2010.08.005; Lin JJ, 2015, ONCOTARGET, V6, P17107, DOI 10.18632/oncotarget.3672; Lipnik-Stangelj M, 2006, BIOCHEM PHARMACOL, V72, P1375, DOI 10.1016/j.bcp.2006.06.028; Liu CJ, 2016, ACM T SENSOR NETWORK, V12, DOI 10.1145/2835180; Mahajan UM, 2018, GASTROENTEROLOGY, V155, P1625, DOI 10.1053/j.gastro.2018.08.009; Medina VA, 2010, BRIT J PHARMACOL, V161, P755, DOI 10.1111/j.1476-5381.2010.00961.x; Megson AC, 2001, MOL PHARMACOL, V59, P1012, DOI 10.1124/mol.59.5.1012; Meng FY, 2011, HEPATOLOGY, V54, P1718, DOI 10.1002/hep.24573; Mu H, 2014, WORLD J GASTROENTERO, V20, P5826, DOI 10.3748/wjg.v20.i19.5826; Ohtsu H, 2017, HANDB EXP PHARMACOL, V241, P333, DOI 10.1007/164_2016_9; Pelekanou V, 2018, CANCER RES, V78; Pino-Angeles A, 2012, J CELL MOL MED, V16, P1947, DOI 10.1111/j.1582-4934.2012.01566.x; Procopiou PA, 2017, BIOORG MED CHEM LETT, V27, P4914, DOI 10.1016/j.bmcl.2017.09.020; Rajendiran S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-250; Reynolds JL, 1996, MELANOMA RES, V6, P95, DOI 10.1097/00008390-199604000-00003; Schneider Elke, 2011, Front Biosci (Schol Ed), V3, P467, DOI 10.2741/s165; Shadman M, 2013, AM J HEMATOL, V88, P1050, DOI 10.1002/ajh.23564; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Shiroishi M, 2017, HANDB EXP PHARMACOL, V241, P21, DOI 10.1007/164_2016_10; Sieja K, 2005, BREAST, V14, P236, DOI 10.1016/j.breast.2004.06.012; Suzuki Y, 2011, BIOL PHARM BULL, V34, P507, DOI 10.1248/bpb.34.507; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Tomita Kazuyoshi, 2005, Inflammopharmacology, V13, P281, DOI 10.1163/156856005774423917; Wang MH, 2014, INT J MOL MED, V33, P1019, DOI 10.3892/ijmm.2014.1649; Wang ZY, 2010, MOL MED REP, V3, P103, DOI 10.3892/mmr_00000225; Wu XY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0755-y; Xu TY, 2019, AM J CANCER RES, V9, P250; Xue RD, 2019, CANCER CELL, V35, P932, DOI 10.1016/j.ccell.2019.04.007; Yang CG, 2019, INT J BIOL SCI, V15, P984, DOI 10.7150/ijbs.29836; Yuan B, 2015, CANCER SCI, V106, P819, DOI 10.1111/cas.12688	45	24	24	3	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1724	1738		10.1038/s41388-019-1093-y	http://dx.doi.org/10.1038/s41388-019-1093-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31740780	hybrid, Green Published			2022-12-26	WOS:000514923000008
J	Blackburn, DM; Lazure, F; Corchado, AH; Perkins, TJ; Najafabadi, HS; Soleimani, VD				Blackburn, Darren M.; Lazure, Felicia; Corchado, Aldo H.; Perkins, Theodore J.; Najafabadi, Hamed S.; Soleimani, Vahab D.			High-resolution genome-wide expression analysis of single myofibers using SMART-Seq	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						muscle; RNA; gene expression; molecular cell biology; molecular biology; SMART-Seq	MOUSE SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; STEM-CELLS; PROGENITORS; CHEMOKINE; EXERCISE; BINDING; NECDIN; RNA	Skeletal muscle is a heterogeneous tissue. Individual myofibers that make up muscle tissue exhibit variation in their metabolic and contractile properties. Although biochemical and histological assays are available to study myofiber heterogeneity, efficient methods to analyze the whole transcriptome of individual myofibers are lacking. Here, we report on a single-myofiber RNA-sequencing (smfRNA-Seq) approach to analyze the whole transcriptome of individual myofibers by combining single-fiber isolation with Switching Mechanism at 5? end of RNA Template (SMART) technology. Using smfRNA-Seq, we first determined the genes that are expressed in the whole muscle, including in nonmyogenic cells. We also analyzed the differences in the transcriptome of myofibers from young and old mice to validate the effectiveness of this new method. Our results suggest that aging leads to significant changes in the expression of metabolic genes, such as Nos1, and structural genes, such as Myl1, in myofibers. We conclude that smfRNA-Seq is a powerful tool to study developmental, disease-related, and age-related changes in the gene expression profile of skeletal muscle.	[Blackburn, Darren M.; Lazure, Felicia; Corchado, Aldo H.; Najafabadi, Hamed S.; Soleimani, Vahab D.] McGill Univ, Dept Human Genet, 3640 Rue Univ, Montreal, PQ H3A 0C7, Canada; [Blackburn, Darren M.; Lazure, Felicia; Najafabadi, Hamed S.] Jewish Gen Hosp, Lady Davis Inst Med Res, Mol & Regenerat Med Axis, Montreal, PQ H3T 1E2, Canada; [Perkins, Theodore J.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [Perkins, Theodore J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	McGill University; Lady Davis Institute; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Soleimani, VD (corresponding author), McGill Univ, Dept Human Genet, 3640 Rue Univ, Montreal, PQ H3A 0C7, Canada.	Vahab.soleimani@mcgill.ca			Canadian Institute of Health Research [PJT-15087]; Natural Sciences and Engineering Research Council	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institute of Health Research Grant PJT-15087 and a Natural Sciences and Engineering Research Council grant (to V. D. S.). We would like to acknowledge Compute Canada allocations (to H. S. N. and T. J. P.). The authors declare that they have no conflicts of interest with the contents of this article.	AbuSamra DB, 2017, BLOOD ADV, V1, P2799, DOI 10.1182/bloodadvances.2017004317; Alway SE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00246; Ancel S, 2019, AGING-US, V11, P7331, DOI 10.18632/aging.102304; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baghdadi MB, 2018, NATURE, V557, P714, DOI 10.1038/s41586-018-0144-9; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Bird L, 2016, NAT REV IMMUNOL, V16, P204, DOI 10.1038/nri.2016.30; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Cui CY, 2019, AGING CELL, V18, DOI 10.1111/acel.13032; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fernandez-Verdejo R, 2017, BIOCHEM BIOPH RES CO, V492, P249, DOI 10.1016/j.bbrc.2017.08.059; Fernandez-Verdejo R, 2017, FASEB J, V31, P840, DOI 10.1096/fj.201600987R; FERRERO E, 1995, FEBS LETT, V374, P323, DOI 10.1016/0014-5793(95)01110-Z; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Geng TT, 2018, DIABETES, V67, P2183, DOI 10.2337/db18-0370; Giordani L, 2019, MOL CELL, V74, P609, DOI 10.1016/j.molcel.2019.02.026; Guo QC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89206; HOOD DA, 1989, AM J PHYSIOL, V256, pC1092, DOI 10.1152/ajpcell.1989.256.5.C1092; Hwang AB, 2018, CURR TOP DEV BIOL, V126, P299, DOI 10.1016/bs.ctdb.2017.08.008; Ignatiadis N, 2016, NAT METHODS, V13, P577, DOI [10.1038/nmeth.3885, 10.1038/NMETH.3885]; Jiang DS, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00133; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinet C, 2016, DEVELOPMENT, V143, P962, DOI 10.1242/dev.131771; Nowak KJ, 2013, ACTA NEUROPATHOL, V125, P19, DOI 10.1007/s00401-012-1019-z; Nuss JE, 2009, AGING-US, V1, P557, DOI 10.18632/aging.100055; Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Pette D, 1999, ACTA PHYSIOL SCAND, V166, P261; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Ravenscroft G, 2018, HUM MOL GENET, V27, P4263, DOI 10.1093/hmg/ddy320; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sciorati C, 2009, J CELL SCI, V122, P1119, DOI 10.1242/jcs.041665; Sheng JJ, 2016, GENE, V576, P385, DOI 10.1016/j.gene.2015.10.052; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Thorley Matthew, 2015, J Neuromuscul Dis, V2, P205; Tomaru T, 2009, J BIOL CHEM, V284, P6116, DOI 10.1074/jbc.M808407200; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Waddell LA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02246; Wei B, 2016, GENE, V582, P1, DOI 10.1016/j.gene.2016.01.006; Yin J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04038-6; YOON SJ, 1992, P NATL ACAD SCI USA, V89, P12078, DOI 10.1073/pnas.89.24.12078	51	13	13	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20097	20108		10.1074/jbc.RA119.011506	http://dx.doi.org/10.1074/jbc.RA119.011506			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31753917	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000505005800022
J	Yoganand, KN; Muralidharan, M; Nimkar, S; Anand, B				Yoganand, Kakimani Nagarajan; Muralidharan, Manasasri; Nimkar, Siddharth; Anand, Baskaran			Fidelity of prespacer capture and processing is governed by the PAM-mediated interactions of Cas1-2 adaptation complex in CRISPR-Cas type I-E system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR-Cas; protein-nucleic acid interaction; protein-DNA interaction; Escherichia coli (E; coli); molecular biology; microbiology; bacterial immunity; Cas1-Cas2; exonuclease; prespacer processing; CRISPR adaptation; protospacer-adjacent motif (PAM); Cas1; Cas2; prespacer integration	SPACER ACQUISITION; HOST FACTOR; INTEGRATION; SEQUENCE; IMMUNITY; DEFENSE; TARGETS; GUIDE; ENDORIBONUCLEASE; CLASSIFICATION	Prokaryotes deploy CRISPR-Cas?based RNA-guided adaptive immunity to fend off mobile genetic elements such as phages and plasmids. During CRISPR adaptation, which is the first stage of CRISPR immunity, the Cas1-2 integrase complex captures invader-derived prespacer DNA and specifically integrates it at the leader-repeat junction as spacers. For this integration, several variants of CRISPR-Cas systems use Cas4 as an indispensable nuclease for selectively processing the protospacer adjacent motif (PAM) containing prespacers to a defined length. Surprisingly, however, a few CRISPR-Cas systems, such as type I-E, are bereft of Cas4. Despite the absence of Cas4, how the prespacers show impeccable conservation for length and PAM selection in type I-E remains intriguing. Here, using in vivo and in vitro integration assays, deep sequencing, and exonuclease footprinting, we show that Cas1-2/I-E?via the type I-E?specific extended C-terminal tail of Cas1?displays intrinsic affinity for PAM containing prespacers of variable length in Escherichia coli. Although Cas1-2/I-E does not prune the prespacers, its binding protects the prespacer boundaries from exonuclease action. This ensures the pruning of exposed ends by exonucleases to aptly sized substrates for integration into the CRISPR locus. In summary, our work reveals that in a few CRISPR-Cas variants, such as type I-E, the specificity of PAM selection resides with Cas1-2, whereas the prespacer processing is co-opted by cellular non-Cas exonucleases, thereby offsetting the need for Cas4.	[Yoganand, Kakimani Nagarajan; Muralidharan, Manasasri; Nimkar, Siddharth; Anand, Baskaran] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati 781039, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Anand, B (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati 781039, India.	banand@iitg.ac.in		KNR, Yoganand/0000-0001-8940-4084; , Anand/0000-0002-7125-4011	Department of Biotechnology (DBT) [BT/PR15925/NER/95/141/2015, BT/08/IYBA/2014/05]; Science and Engineering Research Board (SERB) [YSS/2014/000286]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Science and Engineering Research Board (SERB)	This work was supported by Department of Biotechnology (DBT) Grants BT/PR15925/NER/95/141/2015 and BT/08/IYBA/2014/05 and Science and Engineering Research Board (SERB) Grant YSS/2014/000286. The authors declare that they have no conflicts of interest with the contents of this article.	Almendros C, 2019, NUCLEIC ACIDS RES, V47, P5223, DOI 10.1093/nar/gkz217; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Drabavicius G, 2018, EMBO REP, V19, DOI 10.15252/embr.201745543; Fagerlund RD, 2017, P NATL ACAD SCI USA, V114, pE5122, DOI 10.1073/pnas.1618421114; Gleditzsch D, 2019, RNA BIOL, V16, P504, DOI 10.1080/15476286.2018.1504546; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goren MG, 2016, CELL REP, V16, P2811, DOI 10.1016/j.celrep.2016.08.043; Grainy J, 2019, NUCLEIC ACIDS RES, V47, P7518, DOI 10.1093/nar/gkz548; Guerrero F, 2015, PROTEIN EXPRES PURIF, V116, P42, DOI 10.1016/j.pep.2015.08.019; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Ivancic-Bace I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1213; Jackson SA, 2019, CELL HOST MICROBE, V25, P250, DOI 10.1016/j.chom.2018.12.014; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Ka D, 2018, NUCLEIC ACIDS RES, V46, P9805, DOI 10.1093/nar/gky702; Kieper SN, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz129; Kieper SN, 2018, CELL REP, V22, P3377, DOI 10.1016/j.celrep.2018.02.103; Kim JG, 2019, NUCLEIC ACIDS RES, V47, P8632, DOI 10.1093/nar/gkz677; Kim S., 2019, SELECTIVE PRESPACER, DOI [10.1101/608976, DOI 10.1101/608976]; Kim TY, 2013, BIOCHEM BIOPH RES CO, V441, P720, DOI 10.1016/j.bbrc.2013.10.122; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Lee H, 2019, ELIFE, V8, DOI 10.7554/eLife.44248; Lee H, 2018, MOL CELL, V70, P48, DOI 10.1016/j.molcel.2018.03.003; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2017, NUCLEIC ACIDS RES, V45, P4642, DOI 10.1093/nar/gkx229; Li M, 2014, NUCLEIC ACIDS RES, V42, P7226, DOI 10.1093/nar/gku389; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Liu T, 2017, NUCLEIC ACIDS RES, V45, P8978, DOI 10.1093/nar/gkx612; Makarova KS, 2018, CRISPR J, V1, P325, DOI 10.1089/crispr.2018.0033; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McGinn J, 2019, NAT REV MICROBIOL, V17, P7, DOI 10.1038/s41579-018-0071-7; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Moch C, 2017, NUCLEIC ACIDS RES, V45, P2714, DOI 10.1093/nar/gkw1309; Mohr G, 2018, MOL CELL, V72, P700, DOI 10.1016/j.molcel.2018.09.013; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Musharova O, 2019, MOL MICROBIOL, V111, P1558, DOI 10.1111/mmi.14237; Musharova O, 2018, MBIO, V9, DOI 10.1128/mBio.02169-18; Musharova O, 2017, NUCLEIC ACIDS RES, V45, P3297, DOI 10.1093/nar/gkx097; MUSKAVITCH KMT, 1982, J BIOL CHEM, V257, P2641; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Plateau P, 2019, J BIOL CHEM, V294, P11311, DOI 10.1074/jbc.RA119.007619; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Punetha A, 2018, P INDIAN NATL SCI AC, V84, P455, DOI 10.16943/ptinsa/2017/49241; Radovcic M, 2018, NUCLEIC ACIDS RES, V46, P10173, DOI 10.1093/nar/gky799; Rao CT, 2017, RNA, V23, P1525, DOI 10.1261/rna.062083.117; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rollie C, 2018, NUCLEIC ACIDS RES, V46, P1007, DOI 10.1093/nar/gkx1232; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Shiimori M, 2018, MOL CELL, V70, P814, DOI 10.1016/j.molcel.2018.05.002; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Wright AV, 2019, MOL CELL, V73, P727, DOI 10.1016/j.molcel.2018.12.015; Wright AV, 2017, SCIENCE, V357, P1113, DOI 10.1126/science.aao0679; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Xiao YB, 2017, NATURE, V550, P137, DOI 10.1038/nature24020; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZF, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00747-18	93	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20039	20053		10.1074/jbc.RA119.009438	http://dx.doi.org/10.1074/jbc.RA119.009438			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748409	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000505005800018
J	Dyer, JL; Milot, L				Dyer, Jessie L.; Milot, Lisa			Social vulnerability assessment of dog intake location data as a planning tool for community health program development: A case study in Athens-Clarke County, GA, 2014-2016	PLOS ONE			English	Article							ANIMAL SHELTERS; POPULATION-DYNAMICS; OVERPOPULATION; RISK; EUTHANASIA; ADOPTION; WELFARE	A retrospective spatial analysis of dog intake data from an open admission animal shelter in Georgia was conducted to explore patterns within dog demographics and outcomes by pickup location or by the home address of the person who transferred ownership rights of the dog to Athens-Clarke County Animal Control during the period 2014-2016. Spatial analysis found the relationship between these intake locations and the final disposition of the dogs to be non-random, suggesting social and environmental influences on distribution. Statistically significant clusters were identified using the Getis-Ord Gi* statistic. This study found statistically significant hot spots (i.e., areas with higher than expected values) and cold spots (i.e., areas with lower than expected values) for the intake of dogs with known health issues, physically neglected dogs, juveniles, and adults. Only statistically significant hot spots were found for socially neglected dogs and dogs whose final disposition was euthanasia due to severe health or behavioral issues. Given the close relationship between humans and dogs, this study explores the association of impounded dog clusters and a previously developed social vulnerability index. Social vulnerability is the product of social inequalities and inequalities related to the human-built environment. The social vulnerability index provides one tool for understanding the differences in characteristics of dogs from different intake locations. Results of this study indicate the utility of non-animal focused data as a planning tool for community programs and to allow for efficient allocation of limited resources for veterinary and other community outreach programs.	[Dyer, Jessie L.] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA 30602 USA; [Milot, Lisa] Athenspets Inc, Athens, GA USA; [Milot, Lisa] Univ Georgia, Sch Law, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dyer, JL (corresponding author), Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA 30602 USA.	Jessie.Dyer25@uga.edu		Dyer, Jessie/0000-0001-8931-7570				Am. Vet. Med. Assoc, 2012, US PET OWN DEM SOURC; [Anonymous], 2019, DOGS CATS RELEASED A; [Anonymous], 2019, OWN SURR RES LIF AN; Bizimana JP, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-2; Cope MR, 2017, POPUL ENVIRON, V38, P217, DOI 10.1007/s11111-016-0257-8; DeNavas-Walt C., 2013, CURRENT POPULATION R; Fidler M, 2000, ANTHROZOOS, V13, P48, DOI 10.2752/089279300786999978; Flanagan BE, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1792; Frank J, 2004, HUM ECOL, V32, P107, DOI 10.1023/B:HUEC.0000015213.66094.06; Frank JM, 2007, ECOL ECON, V62, P740, DOI 10.1016/j.ecolecon.2006.09.011; Gay JL, 2016, J PHYS ACT HEALTH, V13, P121, DOI 10.1123/jpah.2015-0042; GERSHMAN KA, 1994, PEDIATRICS, V93, P913; Hankin SJ, 2006, RUTGERS JL PUB POLY, V4, P314; Haraway D.J., 2013, ADA J GENDER NEW MED; Horowitz A, 2009, ANIM COGN, V12, P107, DOI 10.1007/s10071-008-0175-y; Kass P. H., 2001, Journal of Applied Animal Welfare Science, V4, P237, DOI 10.1207/S15327604JAWS0404_01; Landau RE, 2016, JAVMA-J AM VET MED A, V248, P681, DOI 10.2460/javma.248.6.681; OLSON PN, 1993, J REPROD FERTIL, P433; Patronek GJ, 2010, AM J VET RES, V71, P1321, DOI 10.2460/ajvr.71.11.1321; Patronek GJ, 2010, AM J VET RES, V71, P161, DOI 10.2460/ajvr.71.2.161; PATRONEK GJ, 1995, ANTHROZOOS, V8, P31, DOI 10.2752/089279395787156455; Pedraza DF, 2016, ACTA SCI-HEALTH SCI, V38, P81, DOI 10.4025/actascihealthsci.v38i1.29155; Rowan A., 2018, ANIMALS, V8, P5; ROWAN AN, 1992, ANTHROZOOS, V5, P140, DOI 10.2752/089279392787011430; Segurson SA, 2005, JAVMA-J AM VET MED A, V227, P1755, DOI 10.2460/javma.2005.227.1755; Siracusa C, 2017, J VET BEHAV, V22, P46, DOI 10.1016/j.jveb.2017.09.007; Turner P, 2012, CAN VET J, V53, P893; UNDP, 2004, GLOB REP RED DIS RIS; Waitman J, 2017, ENDOCRINOL DIAB NUTR, V64, P92, DOI 10.1016/j.endinu.2016.11.008; Weiss E, 2013, J APPL ANIM WELF SCI, V16, P221, DOI 10.1080/10888705.2013.803816; White SC, 2010, J APPL ANIM WELF SCI, V13, P191, DOI 10.1080/10888700903579903; Zahran S, 2011, RISK ANAL, V31, P1107, DOI 10.1111/j.1539-6924.2010.01580.x; Zawistowski S, 1998, J Appl Anim Welf Sci, V1, P193, DOI 10.1207/s15327604jaws0103_1	33	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0225282	10.1371/journal.pone.0225282	http://dx.doi.org/10.1371/journal.pone.0225282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO9FT	31790438	Green Published, gold			2022-12-26	WOS:000533930800027
J	Kavle, JA; Picolo, M; Buccini, G; Barros, I; Dillaway, CH; Perez-Escamilla, R				Kavle, Justine A.; Picolo, Melanie; Buccini, Gabriela; Barros, Iracema; Dillaway, Chloe H.; Perez-Escamilla, Rafael			Strengthening counseling on barriers to exclusive breastfeeding through use of job aids in Nampula, Mozambique	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; INFANT; RECOMMENDATIONS; INTELLIGENCE; IMPACT	Introduction While the Government of Mozambique has galvanized action around exclusive breast-feeding (EBF) as a national priority, only 43% of Mozambican children under six months of age are exclusively breastfed. In the absence of skilled lactation support, challenges mothers experience with breastfeeding may inhibit initiation, exclusivity and duration. There is insufficient evidence on how to strengthen health providers' competencies to address breastfeeding challenges in low-and middle-income countries. The objectives of this study were to 1) assess EBF challenges, from the perspectives of health providers and mothers; 2) ascertain the quality of health provider counseling to address EBF challenges; and 3) gain an understanding of the usefulness of job aids to improve counseling within routine health contact points in Nampula, Mozambique. Methods This implementation science study was conducted in Meconta and Mogovolas districts, Nampula province, Mozambique from July-November 2018. In Phase 1, 46 in-depth interviews with mothers and providers, and 11 observations of counseling sessions were conducted. In Phase 2, health providers were trained to use three job aids (i.e., facility, community or maternity contacts) to identify and address EBF problems during routine health services. In Phase 3, 30 in-depth interviews with mothers and providers were conducted to assess the experience with job aid use. In both Phase 1 and 3, we conducted a thematic analysis using a grounded theory approach involving a step-wise coding process. Results Poor latch and positioning, perceived insufficient breastmilk and breast engorgement emerged as barriers to EBF. Providers often lacked the knowledge, skillset, and self-efficacy to manage EBF problems, with little counseling provided at community or facility levels. Following job aid rollout, providers reported improved assessment of breastfeeding technique, and increased self-efficacy and motivation to identify and resolve EBF problems. Conclusions Integration of job aids, with clear lactation management guidance, into maternal and child health training curricula and supportive supervision is critical to building providers' skillsets and competencies to provide quality lactation counseling and support.	[Kavle, Justine A.; Dillaway, Chloe H.] US Agcy Int Dev USAID, Maternal & Child Survival Program MCSP PATH, Washington, DC 20523 USA; [Picolo, Melanie; Barros, Iracema] USAIDs Maternal & Child Survival Program MCSP PAT, Maputo, Mozambique; [Buccini, Gabriela; Perez-Escamilla, Rafael] Yale Univ, Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT USA	Yale University	Kavle, JA (corresponding author), US Agcy Int Dev USAID, Maternal & Child Survival Program MCSP PATH, Washington, DC 20523 USA.	justine@kavleconsulting.com		Kavle, Justine/0000-0003-0439-6308	United States Agency for International Development (USAID) [AID-OAA-A-14-00028]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of the Cooperative Agreement AID-OAA-A-14-00028. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. While USAID provided review of the manuscript; authors had intellectual freedom to include feedback, as needed.	Afiyanti Y., 2012, BRIT J MIDWIFERY, V20, P484, DOI [10.12968/bjom.2012.20.7.484, DOI 10.12968/BJOM.2012.20.7.484]; Aidam BA, 2005, J NUTR, V135, P1691, DOI 10.1093/jn/135.7.1691; [Anonymous], 2017, MCSP NUTR BRIEF ADDR; [Anonymous], 2018, IMPL GUID PROT PROM; Arts M, 2011, J HUM LACT, V27, P25, DOI 10.1177/0890334410390039; Aryeetey R, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0172-y; Babakazo P, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0044-7; Balaluka GB, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-2; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Bueno Lais Graci dos Santos, 2004, J. Pediatr. (Rio J.), V80, ps126, DOI 10.1590/S0021-75572004000700003; Chai Y, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001032; Chowdhury R, 2015, ACTA PAEDIATR, V104, P96, DOI 10.1111/apa.13102; Cooper CM, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12735; Damião Jorginete de Jesus, 2008, Rev. bras. epidemiol., V11, P442, DOI 10.1590/S1415-790X2008000300011; Engebretsen IM, 2010, INT BREASTFEED J, V5, DOI [10.1186/1746-4358-5-13, 10.1186/1746-4358-5-2]; Fanzo J, 2018, GLOBAL NUTR REPORT S; Global Breastfeeding Collective, 2019, ADV GUID TOOLS EN PA; Global Breastfeeding Collective, 2019, IMPR ACC SKILL BREAS; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Horta BL, 2015, ACTA PAEDIATR, V104, P14, DOI 10.1111/apa.13139; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Jennings L, 2015, MATERN CHILD HLTH J, V19, P557, DOI 10.1007/s10995-014-1537-5; Jennings L, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-75; Karkee R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-927; Kavle JA, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12725; Kavle JA, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12469; Kavle JA, 2017, PUBLIC HEALTH NUTR, V20, P3120, DOI 10.1017/S1368980017002531; Kavle JA, 2015, MATERN CHILD NUTR, V11, P346, DOI 10.1111/mcn.12165; Khan AI, 2017, ACTA PAEDIATR, V106, P49, DOI 10.1111/apa.13601; Kimani-Murage EW, 2015, MATERN CHILD NUTR, V11, P314, DOI 10.1111/mcn.12161; Leshabari S, 2007, GPHC00020000400 USAI; Lumbiganon P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006425.pub2; Mahmood SE, 2012, J FAM COMMUNITY MED, V19, P130, DOI 10.4103/2230-8229.98305; Maman S, 2012, AIDS CARE, V24, P259, DOI 10.1080/09540121.2011.597708; Mannan I, 2008, J PERINATOL, V28, P632, DOI 10.1038/jp.2008.64; Maternal and Child Survival Program. MCSP, 2016, MAT CHILD SURV PROGR; Ministry of Health National Directorate of Public Health, 2015, SOC BEH CHANG COMM S; Monteiro FR, 2017, J PEDIAT-BRAZIL, V93, P475, DOI 10.1016/j.jped.2016.11.016; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Nankunda J, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-16; Nguyen PH, 2014, J NUTR, V144, P1627, DOI 10.3945/jn.114.194464; Ostergaaard LR, 2010, AFR J REPROD HEALTH, V14, P10; Perez-Escamilla R, ADV NUTR; Perez-Escamilla R, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12596; Perez-Escamilla R, 2012, ADV NUTR, V3, P790, DOI 10.3945/an.112.002873; Picolo M., 2017, CULTURAL BELIEFS PRA; Piwoz EG, 2015, FOOD NUTR BULL, V36, P373, DOI 10.1177/0379572115602174; Robinson H, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12685; Suresh Sithara, 2014, Indian J Public Health, V58, P270, DOI 10.4103/0019-557X.146292; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; World Health Organization, 2008, IND ASS INF YOUNG CH; World Health Organization, 2018, GUID COUNS WOM IMPR; World Health Organization and the United Nations Children's Fund, 2009, BAB FRIENDL HOSP IN	54	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224939	10.1371/journal.pone.0224939	http://dx.doi.org/10.1371/journal.pone.0224939			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790430	Green Published, Green Submitted, gold			2022-12-26	WOS:000533930800018
J	Sartori, NS; Picon, P; Papke, A; Neyeloff, JL; Chakr, RMD				Sartori, Natalia Sarzi; Picon, Paulo; Papke, Afonso; Neyeloff, Jeruza Lavanholi; da Silva Chakr, Rafael Mendonca			A population-based study of tuberculosis incidence among rheumatic disease patients under anti-TNF treatment	PLOS ONE			English	Article							NECROSIS-FACTOR ANTAGONISTS; ARTHRITIS PATIENTS; POSTMARKETING SURVEILLANCE; FOLLOW-UP; RISK; INFECTIONS; AGENTS; THERAPY; INFLIXIMAB; SAFETY	Introduction Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. The advent of immunobiologic therapy with TNF inhibitors agents, has been associated with a significant increase in incident cases of tuberculosis in this population. Objective To estimate the incidence of tuberculosis in patients receiving TNF inhibitors therapy for rheumatic diseases. As secondary objectives, we sought to evaluate mortality and the clinical impact of screening for latent tuberculosis infection. Methods This retrospective study included patients with rheumatic diseases of Public Health System from the Brazilian state, a high TB incidence area, who received prescriptions of TNF inhibitors agents between 2006 and 2016. Results A total of 5853 rheumatic disease patients were included. Patients were predominantly women (68.7%) aged 49.5 (+/- 14.7) years old. Forty-three cases of TB were found (2.86 cases per 1000 person-years; 18 times higher than in the general population). Adalimumab and certolizumab users presented a higher risk for TB development compared to etanercept users (RR: 3.11, 95%CI 1.16-8.35; 7.47, 95%CI 1.39-40.0, respectively). In a subgroup of patients, screening for latent tuberculosis infection was performed in 86% of patients, and 30.2% had a positive tuberculin skin test. Despite latent TB treatment, TB was diagnosed in 2 out of 74 (2.7%) patients. Overall, TB diagnosis did not increase mortality. Conclusion In this population-based study of rheumatic disease patients from a high incident area, TNF inhibitor exposure was associated with an 18-time increased TB incidence. Adalimumab and certolizumab were associated with greater and earlier TB diagnosis compared to etanercept.	[Sartori, Natalia Sarzi; Papke, Afonso; da Silva Chakr, Rafael Mendonca] Univ Fed Rio Grande do Sul UFRGS, Hosp Clin Porto Alegre HCPA, Dept Rheumatol, Porto Alegre, RS, Brazil; [Picon, Paulo; da Silva Chakr, Rafael Mendonca] Univ Fed Rio Grande do Sul, Dept Internal Med, Porto Alegre, RS, Brazil; [Neyeloff, Jeruza Lavanholi] Hosp Clin Porto Alegre HCPA, Planning & Evaluat Advisory Off, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Sartori, NS (corresponding author), Univ Fed Rio Grande do Sul UFRGS, Hosp Clin Porto Alegre HCPA, Dept Rheumatol, Porto Alegre, RS, Brazil.	nataliasartori2007@yahoo.com.br			Graduate Program in Medical Sciences of the Federal University of Rio Grande do Sul, through the Research and Events Incentive Fund (FIPE) of the Hospital de Clinicas de Porto	Graduate Program in Medical Sciences of the Federal University of Rio Grande do Sul, through the Research and Events Incentive Fund (FIPE) of the Hospital de Clinicas de Porto	This work was funded by the Graduate Program in Medical Sciences of the Federal University of Rio Grande do Sul, through the Research and Events Incentive Fund (FIPE) of the Hospital de Clinicas de Porto, which provided financial support for the publication of this study. The funder had no role in study design, data collection and analysis, publication decision, or manuscript preparation.	Ai JW, 2015, J RHEUMATOL, V42, P2229, DOI 10.3899/jrheum.150057; Arkema EV, 2014, ANN RHEUM DIS, P1; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Baddley JW, 2018, CLIN MICROBIOL INFEC, V24, pS10, DOI 10.1016/j.cmi.2017.12.025; Bonfiglioli KR, 2014, INT J TUBERC LUNG D, V18, P905, DOI 10.5588/ijtld.13.0755; Brasil Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49, P18; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; Burmester GR, 2017, ANN RHEUM DIS, V76, P414, DOI 10.1136/annrheumdis-2016-209322; Cagatay T, 2018, CLIN RESPIR J, V12, P1668, DOI 10.1111/crj.12726; Cantini F, 2015, AUTOIMMUN REV, V14, P503, DOI 10.1016/j.autrev.2015.01.011; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Chiu YM, 2017, SCAND J RHEUMATOL, V46, P236, DOI 10.1080/03009742.2016.1202318; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Denis B, 2007, LONG TERM FOLLOW PAT, P183; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2896, DOI 10.1002/art.22808; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Ehlers S, 2003, ANN RHEUM DIS, V62, P37, DOI 10.1136/ard.62.suppl_2.ii37; Favalli EG, 2009, AUTOIMMUN REV, V8, P266, DOI 10.1016/j.autrev.2008.11.002; Furst DE, 2006, SEMIN ARTHRITIS RHEU, V36, P159, DOI 10.1016/j.semarthrit.2006.02.001; Garcia-Vidal C, 2009, EUR J CLIN MICROBIOL, V28, P331, DOI 10.1007/s10096-008-0628-x; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Garziera G, 2017, CLIN RHEUMATOL, V36, P1891, DOI 10.1007/s10067-017-3714-6; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gomez-Reino JJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P756, DOI 10.1002/art.22768; Perez-Sola MJ, 2011, MED CLIN-BARCELONA, V137, P533, DOI 10.1016/j.medcli.2010.11.032; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Ke WM, 2013, INT J TUBERC LUNG D, V17, P1590, DOI 10.5588/ijtld.13.0368; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; Kisacik B, 2016, J RHEUMATOL, V43, P524, DOI 10.3899/jrheum.150177; Koike T, 2012, MOD RHEUMATOL, V22, P498, DOI 10.1007/s10165-011-0541-5; Lahiri M, 2015, BEST PRACT RES CL RH, V29, P290, DOI 10.1016/j.berh.2015.05.009; Lee SK, 2013, LUNG, V191, P565, DOI 10.1007/s00408-013-9481-5; Liao HX, 2017, INT J RHEUM DIS, V20, P161, DOI 10.1111/1756-185X.12970; Maria L, 2012, REV BRAS REUMATOL, V52, P152; Mariette X, 2011, RHEUMATOLOGY, V50, P222, DOI 10.1093/rheumatology/keq368; Marques CDL, 2009, REV BRAS REUMATOL, V49; Ministerio da Saude Secretaria de Vigilancia^ em Saude Programa Nacional de Controle da Tuberculose, 2013, MAN REC TUB, P288; Nisar MK, 2015, CLIN RHEUMATOL, V34, P2141, DOI 10.1007/s10067-015-3099-3; Nobre CA, 2012, RHEUMATOL INT, V32, P2769, DOI 10.1007/s00296-011-2017-5; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Seong SS, 2007, J RHEUMATOL, V34, P706; Sichletidis L, 2006, INT J TUBERC LUNG D, V10, P1127; Silva DR, 2010, LUNG, V188, P33, DOI 10.1007/s00408-009-9224-9; Siqueira R., 2019, REV BRAS OFTALMOL, V78, P202, DOI [10.5935/0034-7280.201, DOI 10.5935/0034-7280.201]; Takeuchi T, 2008, ANN RHEUM DIS, V67, P189, DOI 10.1136/ard.2007.072967; Tarkiainen M, 2015, RHEUMATOLOGY, V54, P1170, DOI 10.1093/rheumatology/keu457; Titton DC, 2011, REV BRAS REUMATOL, V51, P145; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; Wang X, 2019, RHEUMATOLOGY, V58, P803, DOI 10.1093/rheumatology/key364; World Health Organization, 2017, GLOB ACT PLAN PUBL H, P1; Yeh JJ, 2014, PLOS ONE, V9; Yonekura CL, 2017, REV BRAS REUMATOL, V57, P477, DOI DOI 10.1016/j.rbr.2017.05.003	53	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224963	10.1371/journal.pone.0224963	http://dx.doi.org/10.1371/journal.pone.0224963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790428	Green Published, gold			2022-12-26	WOS:000533930800019
J	Tayyar, Y; Shiels, R; Bulmer, AC; Lam, AK; Clarke, D; Idris, A; McMillan, NA				Tayyar, Yaman; Shiels, Ryan; Bulmer, Andrew C.; Lam, Alfred K.; Clarke, Daniel; Idris, Adi; McMillan, Nigel A.			Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237	PLOS ONE			English	Article							HIV MICROBICIDE TMC120; VAGINAL RINGS; NONOXYNOL-9; PAPILLOMAVIRUS; RELEASE	Human papilloma virus (HPV) is the main culprit in cervical cancers. Although the HPV vaccine is now available, the slow and gradual process for HPV cancers to form means little will change, even for vaccinated individuals. This warrants the development of new therapeutic strategies in both the newly diagnosed and recurrent patients. We have previously shown that Alisertib (MLN8237), an Aurora A kinase inhibitor, potently and selectively kills HPVpositive cervical cancer cells. However, Alisertib is known for its unfavorable side effects when administered systemically. A targeted delivery approach is therefore warranted. The topical delivery of drugs to the cervix for the treatment of cervical cancer is an underexplored area of research that has the potential to significantly improve therapeutic outcome. Here, we design a novel topical drug delivery system for localized delivery in the vaginal tract using intravaginal silicone rings loaded with Alisertib. We assessed the suitability of the drug for the application and delivery method and develop a high-performance liquid chromatography method, then show that the vaginal rings were effective at releasing Alisertib over an extended period of time. Furthermore, we showed that Alisertib-loaded vaginal rings did not induce overt inflammation in the mouse vaginal tract. Our work has major translational implications for the future development of vaginal ring devices for the topical treatment of cervical cancer.	[Tayyar, Yaman; Shiels, Ryan; Bulmer, Andrew C.; Clarke, Daniel; Idris, Adi; McMillan, Nigel A.] Griffith Univ, Sch Med Sci, Southport, Qld, Australia; [Tayyar, Yaman; Lam, Alfred K.; Idris, Adi; McMillan, Nigel A.] Griffith Univ, Menzies Hlth Inst Queensland, Southport, Qld, Australia	Griffith University; Griffith University	Idris, A (corresponding author), Griffith Univ, Sch Med Sci, Southport, Qld, Australia.; Idris, A (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Southport, Qld, Australia.	a.idris@griffith.edu.au	Lam, Alfred/C-1652-2008; McMillan, Nigel/AAQ-5416-2021; Idris, Adi/N-3500-2016; Tayyar, Yaman/E-3896-2016	Lam, Alfred/0000-0003-2771-564X; Idris, Adi/0000-0002-0562-1549; Tayyar, Yaman/0000-0003-4385-0569; McMillan, Nigel/0000-0002-9471-1406	National Health and Medical Research Council [APP1104186]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (APP1104186). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, CANC CERVIX UTERI IN; Bell SEJ, 2007, J PHARM PHARMACOL, V59, P203, DOI 10.1211/jpp.59.2.0007; Dang TTN, 2014, POLYM MATRIX DEVICES; Fetherston SM, 2013, EUR J PHARM SCI, V48, P406, DOI 10.1016/j.ejps.2012.12.002; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gabrielli B, 2015, MOL CANCER THER, V14, P2753, DOI 10.1158/1535-7163.MCT-15-0506; Malcolm K, 2003, J CONTROL RELEASE, V91, P355, DOI 10.1016/S0168-3659(03)00260-8; Malcolm RK, 2016, ADV DRUG DELIVER REV, V103, P33, DOI 10.1016/j.addr.2016.01.015; Malcolm RK, 2010, ANTIVIR RES, V88, pS30, DOI 10.1016/j.antiviral.2010.09.003; Malcolm RK, 2005, J ANTIMICROB CHEMOTH, V56, P954, DOI 10.1093/jac/dki326; Martin D, 2017, MOL CANCER THER, V16, P1934, DOI 10.1158/1535-7163.MCT-17-0159; Morrow RJ, 2011, EUR J PHARM BIOPHARM, V77, P3, DOI 10.1016/j.ejpb.2010.10.010; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Pecorelli S, 2003, CANCER J, V9, P390, DOI 10.1097/00130404-200309000-00009; RADOMSKY ML, 1992, BIOL REPROD, V47, P133, DOI 10.1095/biolreprod47.1.133; Seiden MV, 2012, HARRISONS PRINCIPLES; Stafford MK, 1998, J ACQ IMMUN DEF SYND, V17, P327, DOI 10.1097/00042560-199804010-00006; Tayyar Y, 2017, CRIT REV ONCOL HEMAT, V119, P59, DOI 10.1016/j.critrevonc.2017.09.006; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Woolfson AD, 2006, INT J PHARMACEUT, V325, P82, DOI 10.1016/j.ijpharm.2006.06.026; Wyatt TL, 1998, J CONTROL RELEASE, V50, P93, DOI 10.1016/S0168-3659(97)00114-4; Yugaw T, 2013, MOL CELL BIOL, V33, P4434, DOI 10.1128/MCB.00577-13; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	23	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225774	10.1371/journal.pone.0225774	http://dx.doi.org/10.1371/journal.pone.0225774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774882	Green Published, gold			2022-12-26	WOS:000533896400061
J	Theinkom, F; Singer, L; Cieplik, F; Cantzler, S; Weilemann, H; Cantzler, M; Hiller, KA; Maisch, T; Zimmermann, JL				Theinkom, Felix; Singer, Larissa; Cieplik, Fabian; Cantzler, Sylvia; Weilemann, Hannes; Cantzler, Maximilian; Hiller, Karl-Anton; Maisch, Tim; Zimmermann, Julia L.			Antibacterial efficacy of cold atmospheric plasma against Enterococcus faecalis planktonic cultures and biofilms in vitro	PLOS ONE			English	Article							ANTIMICROBIAL PHOTODYNAMIC THERAPY; CONTACT-FREE INACTIVATION; PRESSURE PLASMA; DEINOCOCCUS-RADIODURANS; ARGON PLASMA; BACTERIA; JET; RESISTANCE; VIRULENCE; ESKAPE	Nosocomial infections have become a serious threat in our times and are getting more difficult to handle due to increasing development of resistances in bacteria. In this light, cold atmospheric plasma (CAP), which is known to effectively inactivate microorganisms, may be a promising alternative for application in the fields of dentistry and dermatology. CAPs are partly ionised gases, which operate at low temperature and are composed of electrons, ions, excited atoms and molecules, reactive oxygen and nitrogen species. In this study, the effect of CAP generated from ambient air was investigated against Enterococcus faecalis, grown on agar plates or as biofilms cultured for up to 72 h. CAP reduced the colony forming units (CFU) on agar plates by > 7 log(10) steps. Treatment of 24 h old biofilms of E. faecalis resulted in CFU-reductions by >= 3 log(10) steps after CAP treatment for 5 min and by. 5 log(10) steps after CAP treatment for 10 min. In biofilm experiments, chlorhexidine (CHX) and UVC radiation served as positive controls and were only slightly more effective than CAP. There was no damage of cytoplasmic membranes upon CAP treatment as shown by spectrometric measurements for release of nucleic acids. Thus, membrane damage seems not to be the primary mechanism of action for CAP towards E. faecalis. Overall, CAP showed pronounced antimicrobial efficacy against E. faecalis on agar plates as well as in biofilms similar to positive controls CHX or UVC.	[Theinkom, Felix; Singer, Larissa; Maisch, Tim] Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany; [Theinkom, Felix; Singer, Larissa; Cieplik, Fabian; Hiller, Karl-Anton] Univ Hosp Regensburg, Dept Conservat Dent & Periodontol, Regensburg, Germany; [Cantzler, Sylvia; Weilemann, Hannes; Cantzler, Maximilian] Terraplasma GmbH, Garching, Germany; [Zimmermann, Julia L.] Terraplasma Med GmbH, Garching, Germany	University of Regensburg; University of Regensburg	Maisch, T (corresponding author), Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany.	tim.maisch@ukr.de	Cieplik, Fabian/AFN-3560-2022	Cieplik, Fabian/0000-0002-1750-7380; Hiller, Karl-Anton/0000-0002-4726-9555	Bayern Innovativ GmbH, Germany [BayMed: 41-6618c/272/1-MED-1507-0004]; University Medical Center Regensburg (ReForM B program); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [CI 263/1-3]	Bayern Innovativ GmbH, Germany; University Medical Center Regensburg (ReForM B program); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	The authors Sylvia Cantzler, Hannes Weilemann, Maximilian Cantzler are employees from terraplasma GmbH (Garching, Germany), and Julia L. Zimmermann is anemployee from terraplasma medical GmbH (Garching, Germany), which have developed the plasma device used in this study. This study was funded by the grant "BayMed: 41-6618c/272/1-MED-1507-0004" (Bayern Innovativ GmbH, Germany). Furthermore, Fabian Cieplik thanks for funding by the University Medical Center Regensburg (ReForM B program) the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation; grant CI 263/1-3). Denise Muehler is gratefully acknowledged for her valuable help with the DNA release experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the grant "BayMed: 41-6618c/272/1-MED-1507-0004" (Bayern Innovativ GmbH, Germany). Furthermore, Fabian Cieplik thanks for funding by the University Medical Center Regensburg (ReForM B program) and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation; grant CI 263/1-3). Denise Muehler is gratefully acknowledged for her valuable help with the DNA release experiments.	Almeida A, 2018, NAT REV MICROBIOL, V16, P124, DOI 10.1038/nrmicro.2018.13; Arjunan KP, 2015, INT J MOL SCI, V16, P2971, DOI 10.3390/ijms16022971; Armand A, 2019, PHOTODIAGN PHOTODYN, V26, P327, DOI 10.1016/j.pdpdt.2019.04.023; Ballout H, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700186; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Becker S, 2019, AURIS NASUS LARYNX, V46, P294, DOI 10.1016/j.anl.2018.07.008; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Boxhammer V, 2013, MUTAT RES-GEN TOX EN, V753, P23, DOI 10.1016/j.mrgentox.2012.12.015; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Ch'ng JH, 2019, NAT REV MICROBIOL, V17, P82, DOI 10.1038/s41579-018-0107-z; Chen CZS, 2002, BIOMATERIALS, V23, P3359, DOI 10.1016/S0142-9612(02)00036-4; Cieplik F, 2018, CRIT REV MICROBIOL, V44, P571, DOI 10.1080/1040841X.2018.1467876; Cieplik F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00688; Cieplik F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00706; Cieplik F, 2013, FREE RADICAL BIO MED, V65, P477, DOI 10.1016/j.freeradbiomed.2013.07.031; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Dezest M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173618; Du T F, 2018, Zhonghua Kou Qiang Yi Xue Za Zhi, V53, P681, DOI 10.3760/cma.j.issn.1002-0098.2018.10.007; Duan YX, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2409624; Duggan JM, 2007, J ENDODONT, V33, P815, DOI 10.1016/j.joen.2007.02.016; Fernandes SC, 2013, INDIAN J MED RES, V137, P981; Flynn PB, 2015, INT J ANTIMICROB AG, V46, P101, DOI 10.1016/j.ijantimicag.2015.02.026; Gan L, 2018, J DTSCH DERMATOL GES, V16, P7, DOI 10.1111/ddg.13373; Guiton PS, 2010, INFECT IMMUN, V78, P4166, DOI 10.1128/IAI.00711-10; Habib M, 2014, CLIN PLASMA MED, V2, P17, DOI 10.1016/j.cpme.2014.07.002; Han L, 2016, APPL ENVIRON MICROB, V82, P450, DOI 10.1128/AEM.02660-15; Heinlin J, 2013, FUTURE MICROBIOL, V8, P1097, DOI 10.2217/fmb.13.86; Herbst SR, 2015, OPEN DENT J, V9, P486, DOI 10.2174/1874210601509010486; Hutner A, 2017, EFFECTS NONTHERMAL A, DOI [10.1002/ppap.201600064, DOI 10.1002/PPAP.201600064]; Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x; Jea O'Neill, 2016, TACKLING DRUG RESIST; Jiang Chunqi, 2012, ISRN Dent, V2012, P295736, DOI 10.5402/2012/295736; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Kajihara T, 2017, J INFECT CHEMOTHER, V23, P498, DOI 10.1016/j.jiac.2016.12.002; Kapoor Garima, 2017, J Anaesthesiol Clin Pharmacol, V33, P300, DOI 10.4103/joacp.JOACP_349_15; Kaya BU, 2014, LETT APPL MICROBIOL, V58, P8, DOI 10.1111/lam.12148; Kollmuss M, 2014, AM J DENT, V27, P134; Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220; Li YL, 2015, J ENDODONT, V41, P1325, DOI 10.1016/j.joen.2014.10.020; Lis KA, 2018, INT J ANTIMICROB AG, V52, P811, DOI 10.1016/j.ijantimicag.2018.08.023; Lis KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197773; Mai-Prochnow A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38610; Maisch T, 2017, ENVIRON MOL MUTAGEN, V58, P172, DOI 10.1002/em.22086; Maisch T, 2012, J IND MICROBIOL BIOT, V39, P1367, DOI 10.1007/s10295-012-1137-6; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Maisch T, 2012, APPL ENVIRON MICROB, V78, P4242, DOI 10.1128/AEM.07235-11; MARSH PD, 1995, J IND MICROBIOL, V15, P169, DOI 10.1007/BF01569822; Matthes R, 2014, GMS HYG INFECT CONTR, V9, DOI 10.3205/dgkh000237; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Modic M, 2017, INT J ANTIMICROB AG, V49, P375, DOI 10.1016/j.ijantimicag.2016.11.022; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pratten J, 1998, J APPL MICROBIOL, V84, P1149; Rehman MU, 2016, ARCH BIOCHEM BIOPHYS, V605, P19, DOI 10.1016/j.abb.2016.04.005; Rupf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025893; Shimizu T, 2017, SURFACE MICRODISCHAR, V7, P175, DOI [10.1615/PlasmaMed.2017019455, DOI 10.1615/PLASMAMED.2017019455]; Simoncicova J, 2019, APPL MICROBIOL BIOT, V103, P5117, DOI 10.1007/s00253-019-09877-x; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Walters J, 1993, Prof Nurse, V8, P788; Weiss M, 2017, J MED VIROL, V89, P952, DOI 10.1002/jmv.24701; Weiss M, 2019, ACS APPL MATER INTER, V11, P19841, DOI 10.1021/acsami.9b04803; Wende K, 2016, MUTAT RES-GEN TOX EN, V798, P48, DOI 10.1016/j.mrgentox.2016.02.003; Yang Y, 2018, DENT MATER J, V37, P157, DOI 10.4012/dmj.2017-030; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Ziuzina D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138209; Ziuzina D, 2015, INT J FOOD MICROBIOL, V210, P53, DOI 10.1016/j.ijfoodmicro.2015.05.019	67	24	24	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0223925	10.1371/journal.pone.0223925	http://dx.doi.org/10.1371/journal.pone.0223925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770390	Green Published, gold			2022-12-26	WOS:000533892300005
J	Maruta, T; Nemoto, T; Hidaka, K; Koshida, T; Shirasaka, T; Yanagita, T; Takeya, R; Tsuneyoshi, I				Maruta, Toyoaki; Nemoto, Takayuki; Hidaka, Koutaro; Koshida, Tomohiro; Shirasaka, Tetsuro; Yanagita, Toshihiko; Takeya, Ryu; Tsuneyoshi, Isao			Upregulation of ERK phosphorylation in rat dorsal root ganglion neurons contributes to oxaliplatin-induced chronic neuropathic pain	PLOS ONE			English	Article							MECHANICAL ALLODYNIA; INDUCED NEUROTOXICITY; ANTICANCER AGENT; HYPERSENSITIVITY; KINASE; HYPEREXCITABILITY; CHANNELS; MODEL; MOTOR; P38	Oxaliplatin is the first-line chemotherapy for metastatic colorectal cancer. Unlike other platinum anticancer agents, oxaliplatin does not result in significant renal impairment and ototoxicity. Oxaliplatin, however, has been associated with acute and chronic peripheral neuropathies. Despite the awareness of these side-effects, the underlying mechanisms are yet to be clearly established. Therefore, in this study, we aimed to understand the factors involved in the generation of chronic neuropathy elicited by oxaliplatin treatment. We established a rat model of oxaliplatin-induced neuropathic pain (4 mg kg(-1) intraperitoneally). The paw withdrawal thresholds were assessed at different time-points after the treatment, and a significant decrease was observed 3 and 4 weeks after oxaliplatin treatment as compared to the vehicle treatment (4.4 +/- 1.0 vs. 16.0 +/- 4.1 g; P < 0.05 and 4.4 +/- 0.7 vs. 14.8 +/- 3.1 g; P < 0.05, respectively). We further evaluated the role of different mitogen-activated protein kinases (MAPKs) pathways in the pathophysiology of neuropathic pain. Although the levels of total extracellular signal-regulated kinase (ERK) 1/2 in the dorsal root ganglia (DRG) were not different between oxaliplatin and vehicle treatment groups, phosphorylated ERK (pERK) 1/2 was up-regulated up to 4.5-fold in the oxaliplatin group. Administration of ERK inhibitor PD98059 (6 mu g day(-1) intrathecally) inhibited oxaliplatin-induced ERK phosphorylation and neuropathic pain. Therefore, upregulation of p-ERK by oxaliplatin in rat DRG and inhibition of mechanical allodynia by an ERK inhibitor in the present study may provide a better understanding of intracellular molecular alterations associated with oxaliplatin-induced neuropathic pain and help in the development of potential therapeutics.	[Maruta, Toyoaki; Hidaka, Koutaro; Koshida, Tomohiro; Shirasaka, Tetsuro; Tsuneyoshi, Isao] Univ Miyazaki, Fac Med, Dept Anesthesiol, Miyazaki, Japan; [Nemoto, Takayuki] Fukuoka Univ, Fac Med, Dept Pharmacol, Fukuoka, Japan; [Yanagita, Toshihiko] Univ Miyazaki, Fac Med, Sch Nursing, Dept Clin Pharmacol, Miyazaki, Japan; [Takeya, Ryu] Univ Miyazaki, Fac Med, Dept Pharmacol, Miyazaki, Japan	University of Miyazaki; Fukuoka University; University of Miyazaki; University of Miyazaki	Maruta, T (corresponding author), Univ Miyazaki, Fac Med, Dept Anesthesiol, Miyazaki, Japan.	mmctm2@yahoo.co.jp	Maruta, Toyoaki/J-1015-2019	Maruta, Toyoaki/0000-0002-2660-2179	University of Miyazaki Hospital	University of Miyazaki Hospital	This study was supported by a Grant for Clinical Research from University of Miyazaki Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelsberger H, 2000, EUR J PHARMACOL, V40, P685, DOI [10.1016/j.neuro.2009.04.010, DOI 10.1016/J.NEURO.2009.04.010]; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Benoit E, 2006, GEN PHYSIOL BIOPHYS, V25, P263; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Deuis JR, 2013, PAIN, V154, P1749, DOI 10.1016/j.pain.2013.05.032; Duan ZS, 2018, MOL PAIN, V14, DOI 10.1177/1744806918769426; Extra JM, 1998, SEMIN ONCOL, V25, P13; Gauchan P, 2009, NEUROSCI LETT, V458, P93, DOI 10.1016/j.neulet.2009.04.029; Grolleau F, 2001, J NEUROPHYSIOL, V85, P2293, DOI 10.1152/jn.2001.85.5.2293; Huang W, 2018, ANTI-CANCER AGENT ME, V18, P1197, DOI 10.2174/1871520618666180525091158; Illias AM, 2018, PAIN, V159, P1308, DOI 10.1097/j.pain.0000000000001212; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Kagiava A, 2008, NEUROTOXICOLOGY, V29, P1100, DOI 10.1016/j.neuro.2008.09.005; Kawashiri T, 2011, EUR J PAIN, V15, P344, DOI 10.1016/j.ejpain.2010.08.006; Kobayashi A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-12; Kono T, 2012, BRAIN BEHAV, V2, P68, DOI 10.1002/brb3.34; Lee Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-39; Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559; Li L, 2019, NEUROPHARMACOLOGY, V153, P111, DOI 10.1016/j.neuropharm.2019.04.024; Liu ZH, 2016, ANESTHESIOLOGY, V124, P934, DOI 10.1097/ALN.0000000000001010; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Nemoto T, 2010, EUR J PHARMACOL, V640, P20, DOI 10.1016/j.ejphar.2010.04.048; Obata K, 2004, LIFE SCI, V74, P2643, DOI 10.1016/j.lfs.2004.01.007; Park SB, 2009, J CLIN ONCOL, V27, P1243, DOI 10.1200/JCO.2008.19.3425; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scuteri A, 2010, NEUROSCI LETT, V486, P141, DOI 10.1016/j.neulet.2010.09.028; Scuteri A, 2009, NEUROTOXICOLOGY, V30, P312, DOI 10.1016/j.neuro.2009.01.003; Siniscalco D, 2011, CURR NEUROPHARMACOL, V9, P523, DOI 10.2174/157015911798376208; Sittl R, 2012, P NATL ACAD SCI USA, V109, P6704, DOI 10.1073/pnas.1118058109; Sittl R, 2010, NEUROTOXICOLOGY, V31, P694, DOI 10.1016/j.neuro.2010.07.006; Smith ES, 2018, J NEUROL, V265, P231, DOI 10.1007/s00415-017-8641-6; Stamboulian S, 2010, J NEUROSCI, V30, P1637, DOI 10.1523/JNEUROSCI.4872-09.2010; Tanaka N, 2010, ANESTH ANALG, V111, P784, DOI 10.1213/ANE.0b013e3181e9f62f; Tsubaki M, 2015, INT J CANCER, V137, P243, DOI 10.1002/ijc.29367; Wang J, 2017, MOL PAIN, V13, DOI 10.1177/1744806917726256; Wang YS, 2017, INFLAMMATION, V40, P2052, DOI 10.1007/s10753-017-0645-y; Webster RG, 2005, BRIT J PHARMACOL, V146, P1027, DOI 10.1038/sj.bjp.0706407; Wu SN, 2009, NEUROTOXICOLOGY, V30, P677, DOI 10.1016/j.neuro.2009.04.010; Xu DS, 2018, MOL PAIN, V14, DOI 10.1177/1744806918783535; Xu JT, 2007, EXP NEUROL, V204, P355, DOI 10.1016/j.expneurol.2006.11.016; Yeo JH, 2016, INT J CANCER, V138, P2466, DOI 10.1002/ijc.29980	43	17	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225586	10.1371/journal.pone.0225586	http://dx.doi.org/10.1371/journal.pone.0225586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765435	Green Published, gold			2022-12-26	WOS:000533891000038
J	Pereira, ASA; Silveira, GO; Amaral, MS; Almeida, SMV; Oliveira, JF; Lima, MCA; Verjovski-Almeida, S				Pereira, Adriana S. A.; Silveira, Gilbert O.; Amaral, Murilo S.; Almeida, Sinara M., V; Oliveira, Jamerson F.; Lima, Maria C. A.; Verjovski-Almeida, Sergio			In vitro activity of aryl-thiazole derivatives against Schistosoma mansoni schistosomula and adult worms	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; MEDICINAL CHEMISTRY; PRAZIQUANTEL; PARAMETERS; ANTIFUNGAL; MEFLOQUINE; APOPTOSIS; CALCIUM; PROTEIN; STRAIN	Schistosomiasis is caused by a trematode of the genus Schistosoma and affects over 200 million people worldwide. The only drug recommended by the World Health Organization for treatment and control of schistosomiasis is praziquantel. Development of new drugs is therefore of great importance. Thiazoles are regarded as privileged structures with a broad spectrum of activities and are potential sources of new drug prototypes, since they can act through interactions with DNA and inhibition of DNA synthesis. In this context, we report the synthesis of a series of thiazole derivatives and their in vitro schistosomicidal activity by testing eight molecules (NJ03-08; NJ11-12) containing thiazole structures. Parameters such as motility and mortality, egg laying, pairing and parasite viability by ATP quantification, which were influenced by these compounds, were evaluated during the assays. Scanning electron microscopy (SEM) was utilized for evaluation of morphological changes in the tegument. Schistosomula and adult worms were treated in vitro with different concentrations (6.25 to 50 mu M) of the thiazoles for up to 5 and 3 days, respectively. After in vitro treatment for five days with 6.25 mu M NJ05 or NJ07 separately, we observed a decrease of 30% in schistosomula viability, whilst treatment with NJ05+NJ07 lead to a reduction of 75% in viability measured by ATP quantitation and propidium iodide labeling. Adult worms' treatment with 50 mu M NJ05, NJ07 or NJ05 + NJ07 showed decreased motility to 30-50% compared with controls. Compound NJ05 was more effective than NJ07, and adult worm viability after three days was reduced to 25% in parasites treated with 50 mu M NJ05, compared with a viability reduction to 40% with 50 mu M NJ07. SEM analysis showed severe alterations in adult worms with formation of bulges and blisters throughout the dorsal region of parasites treated with NJ05 or NJ07. Oviposition was extremely affected by treatment with the NJ series compounds; at concentrations of 25 mu M and 50 mu M, oviposition reached almost zero with NJ05, NJ07 or NJ05 + NJ07 already at day one. Tested genes involved in egg biosynthesis were all confirmed by qPCR as downregulated in females treated with 25 mu M NJ05 for 2 days, with a significant reduction in expression of p14, Tyrosinase 2, p48 and fs800. NJ05, NJ07 or NJ05 +NJ07 treatment of HEK293 (human embryonic cell line) and HES (human epithelial cell line) showed EC50 in the range of 18.42 to 145.20 mu M. Overall, our results demonstrate that those molecules are suitable targets for further development into new drugs for schistosomiasis treatment, although progress is needed to lessen the cytotoxic effects on human cells. According to the present study, thiazole derivatives have schistosomicidal activities and may be part of a possible new arsenal of compounds against schistosomiasis.	[Pereira, Adriana S. A.; Silveira, Gilbert O.; Amaral, Murilo S.; Verjovski-Almeida, Sergio] Inst Butantan, Sao Paulo, Brazil; [Pereira, Adriana S. A.; Silveira, Gilbert O.; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Almeida, Sinara M., V; Oliveira, Jamerson F.; Lima, Maria C. A.] Univ Fed Pernambuco, Dept Antibiot, Recife, PE, Brazil; [Almeida, Sinara M., V] Univ Pernambuco, Campus Garanhuns, Garanhuns, PE, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade Federal de Pernambuco; Universidade de Pernambuco (UPE)	Verjovski-Almeida, S (corresponding author), Inst Butantan, Sao Paulo, Brazil.; Verjovski-Almeida, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.	verjo@iq.usp.br	Silveira, Gilbert/ABG-3618-2020; Amaral, Murilo S/G-5769-2013; Verjovski-Almeida, Sergio/E-4082-2012	Verjovski-Almeida, Sergio/0000-0002-6356-2401; Sena Amaral, Murilo/0000-0003-4999-5099; Silveira, Gilbert/0000-0003-2302-2520	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior (CAPES), Brazil [001]; FAPESP [016/100466, 2018/24015-0]; Fundacao Butantan; fellowship PNPD from CAPES [BCT-0149-4.03/17]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Butantan; fellowship PNPD from CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) to SVA. This study was financed in part by Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (CAPES), Brazil - Finance Code 001. Fellowships from FAPESP have supported ASAP (2016/100466) and GOS (2018/24015-0). MSA was supported by Fundacao Butantan. SMVA, JFO and MCAL were supported by fellowship PNPD from CAPES, process BCT-0149-4.03/17. SVA was also supported by institutional funds from Fundacao Butantan. SVA is the recipient of an established investigator fellowship award from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almeida GT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004086; Altintop MD, 2016, EUR J MED CHEM, V108, P406, DOI 10.1016/j.ejmech.2015.11.041; Anderson L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005539; Barreiro EJ, 2002, QUIM NOVA, V25, P129, DOI 10.1590/S0100-40422002000100022; Barreiro EJ, 2008, CURR DRUG THER, V3, P1, DOI 10.2174/157488508783331225; BASCH PF, 1981, J PARASITOL, V67, P179, DOI 10.2307/3280632; Bello ML, 2011, BIOORGAN MED CHEM, V19, P5046, DOI 10.1016/j.bmc.2011.06.023; Bertao HG, 2012, PARASITOL RES, V110, P2465, DOI 10.1007/s00436-011-2786-5; BOBEK LA, 1988, MOL CELL BIOL, V8, P3008, DOI 10.1128/MCB.8.8.3008; Bernardes LSC, 2006, BIOORGAN MED CHEM, V14, P7075, DOI 10.1016/j.bmc.2006.07.006; Carvalho OS, 2008, SCHISTOSOMA MANSONI, P822; CHEN LL, 1992, MOL BIOCHEM PARASIT, V52, P39, DOI 10.1016/0166-6851(92)90034-H; Cioli D, 2014, MOL BIOCHEM PARASIT, V195, P23, DOI 10.1016/j.molbiopara.2014.06.002; Cogswell AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001907; CRAIG PN, 1971, J MED CHEM, V14, P680, DOI 10.1021/jm00290a004; de Moraes J, 2011, EXP PARASITOL, V127, P357, DOI 10.1016/j.exppara.2010.08.021; de Oliveira GB, 2017, EUR J MED CHEM, V141, P346, DOI 10.1016/j.ejmech.2017.09.047; de Oliveira RN, 2012, EXP PARASITOL, V132, P135, DOI 10.1016/j.exppara.2012.06.005; de Oliveira SA, 2018, PARASITOL RES, V117, P2105, DOI 10.1007/s00436-018-5897-4; DESAI NN, 1994, FERTIL STERIL, V61, P760; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; DUVALL RH, 1967, AM J TROP MED HYG, V16, P483, DOI 10.4269/ajtmh.1967.16.483; Farias LP, 2011, PARASITOL RES, V108, P123, DOI 10.1007/s00436-010-2045-1; Fawzi S. M., 1999, J EGYPT SOC PARASITO, V33, P21; Fitzpatrick JM, 2007, FASEB J, V21, P823, DOI 10.1096/fj.06-7314com; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; Greenberg RM, 2005, INT J PARASITOL, V35, P1, DOI 10.1016/j.ijpara.2004.09.004; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; HARDER A, 1988, MOL BIOCHEM PARASIT, V29, P55, DOI 10.1016/0166-6851(88)90119-3; Horiuchi A, 2005, VET PARASITOL, V129, P83, DOI 10.1016/j.vetpar.2004.12.017; Katz N, 2008, ACTA TROP, V108, P72, DOI 10.1016/j.actatropica.2008.05.006; Keiser J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000350; Kubba AARM, 2018, RES J PHARM BIOL CHE, V9, P235; Kumar R, 2010, EUR J MED CHEM, V45, P5292, DOI 10.1016/j.ejmech.2010.08.049; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Lescano SZ, 2004, REV SAUDE PUBL, V38, P71, DOI 10.1590/S0034-89102004000100010; Lewis FA, 2014, ADV EXP MED BIOL, V766, P47, DOI 10.1007/978-1-4939-0915-5_3; LIMA SF, 1994, PARASITOLOGY, V109, P57, DOI 10.1017/S0031182000077763; Manneck T, 2010, PARASITOLOGY, V137, P85, DOI 10.1017/S0031182009990965; Marek M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003645; Marxer M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-165; MAZZONE G, 1992, PHARMAZIE, V47, P902; McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Mohamed S. H., 1997, QATAR UNIV SCI J, V17, P439; Mohareb RM, 2017, ACTA PHARMACEUT, V67, P495, DOI 10.1515/acph-2017-0040; NOLLEN PM, 1976, J PARASITOL, V62, P227, DOI 10.2307/3279273; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ouf SA, 2018, J HETEROCYCLIC CHEM, V55, P258, DOI 10.1002/jhet.3040; Palusiak M, 2002, J MOL STRUCT, V642, P97, DOI 10.1016/S0022-2860(02)00406-4; Panic G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1233-3; Papadopoulou MV, 2016, EUR J MED CHEM, V117, P179, DOI 10.1016/j.ejmech.2016.04.010; Paula FR, 2009, QUIM NOVA, V32, P1013, DOI 10.1590/S0100-40422009000400032; Peak E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000759; Pereira ASA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006873; Pereira RV, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0957-4; Pica-Mattoccia L, 2009, ACTA TROP, V111, P82, DOI 10.1016/j.actatropica.2009.01.012; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Popova ZI, 1985, FARMATSEVTICHNII ZH, V6, P41; Reddy GT, 2018, ADV SYNTH CATAL, V360, P995, DOI 10.1002/adsc.201701063; da Silva VBR, 2017, BIOORGAN MED CHEM, V25, P3259, DOI 10.1016/j.bmc.2017.04.031; Ribeiro-dos-Santos G, 2006, PARASITOL RES, V99, P505, DOI 10.1007/s00436-006-0175-2; Ross AGP, 2015, LANCET, V385, P2220, DOI 10.1016/S0140-6736(14)61417-3; Santiago EDF, 2014, ANTIMICROB AGENTS CH, V58, P352, DOI 10.1128/AAC.01900-13; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Siqueira LD, 2017, ACTA TROP, V176, P179, DOI 10.1016/j.actatropica.2017.08.002; Sovic I, 2019, CHEM RES TOXICOL, V32, P1880, DOI 10.1021/acs.chemrestox.9b00256; STOREY DM, 1991, ANN TROP MED PARASIT, V85, P111, DOI 10.1080/00034983.1991.11812537; Taha H. A., 2007, International Journal of Agriculture and Biology, V9, P87; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Wang JP, 2016, INT J PARASITOL, V46, P405, DOI 10.1016/j.ijpara.2016.03.004; Wang YY, 2007, P NATL ACAD SCI USA, V104, P5901, DOI 10.1073/pnas.0609708104; Wang YY, 2010, GENE DEV, V24, P2081, DOI 10.1101/gad.1951010; WHO, 2018, SCHIST FACT SHEET; Xiao SH, 2002, MEM I OSWALDO CRUZ, V97, P717, DOI 10.1590/S0074-02762002000500023; You H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003254	76	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225425	10.1371/journal.pone.0225425	http://dx.doi.org/10.1371/journal.pone.0225425			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765429	gold, Green Published, Green Submitted			2022-12-26	WOS:000533891000026
J	Van Geel, M; Yu, K; Peeters, G; van Acker, K; Ramos, M; Serafim, C; Kastendeuch, P; Najjar, G; Ameglio, T; Ngao, J; Saudreau, M; Castro, P; Ben Somers; Honnay, O				Van Geel, Maarten; Yu, Kang; Peeters, Gerrit; van Acker, Kasper; Ramos, Miguel; Serafim, Cindy; Kastendeuch, Pierre; Najjar, Georges; Ameglio, Thierry; Ngao, Jerome; Saudreau, Marc; Castro, Paula; Ben Somers; Honnay, Olivier			Soil organic matter rather than ectomycorrhizal diversity is related to urban tree health	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; STREET TREES; COMMUNITY; WATER; INDEXES; IMPACT; BIODIVERSITY; ACQUISITION; BENEFITS; AREA	Urban trees provide many ecosystem services, including carbon sequestration, air quality improvement, storm water attenuation and energy conservation, to people living in cities. Provisioning of ecosystem services by urban trees, however, may be jeopardized by the typically poor quality of the soils in urban areas. Given their well-known multifunctional role in forest ecosystems, ectomycorrhizal fungi (EcM) may also contribute to urban tree health and thus ecosystem service provisioning. Yet, no studies so far have directly related in situ EcM community composition to urban tree health indicators. Here, two previously collected datasets were combined: i) tree health data of 175 Tilia tomentosa trees from three European cities (Leuven, Strasbourg and Porto) estimated using a range of reflectance, chlorophyll fluorescence and physical leaf indicators, and ii) ectomycorrhizal diversity of these trees as characterized by next-generation sequencing. Tree health indicators were related to soil characteristics and EcM diversity using canonical redundancy analysis. Soil organic matter significantly explained variation in tree health indicators whereas no significant relation between mycorrhizal diversity variables and the tree health indicators was found. We conclude that mainly soil organic matter, through promoting soil aggregate formation and porosity, and thus indirectly tree water availability, positively affects the health of trees in urban areas. Our results suggest that urban planners should not overlook the importance of soil quality and its water holding capacity for the health of urban trees and potentially also for the ecosystem services they deliver. Further research should also study other soil microbiota which may independently, or in interaction with ectomycorrhiza, mediate tree performance in urban settings.	[Van Geel, Maarten; Peeters, Gerrit; van Acker, Kasper; Honnay, Olivier] Katholieke Univ Leuven, Dept Biol, Plant Conservat & Populat Biol, Kasteelpk Arenberg, Heverlee, Belgium; [Yu, Kang; Ben Somers] Katholieke Univ Leuven, Div Forest Nat & Landscape, Dept Earth & Environm Sci, Celestijnenlaan, Heverlee, Belgium; [Ramos, Miguel; Serafim, Cindy; Castro, Paula] Catholic Univ Portugal, Escola Super Biotecnol, Rua Arquiteto Lobao Vital, Porto, Portugal; [Kastendeuch, Pierre; Najjar, Georges] Strasbourg Univ, Lab Sci Ingenieur Informat & Imagerie, Illkirch Graffenstaden, France; [Ameglio, Thierry; Ngao, Jerome; Saudreau, Marc] Univ Clermont Auvergne, INRA, PIAF, Clermont Ferrand, France	KU Leuven; KU Leuven; Universidade Catolica Portuguesa; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; Universite Clermont Auvergne (UCA)	Van Geel, M (corresponding author), Katholieke Univ Leuven, Dept Biol, Plant Conservat & Populat Biol, Kasteelpk Arenberg, Heverlee, Belgium.	maarten.vangeel@kuleuven.be	Yu, Kang/G-8306-2011; NAJJAR, Georges/GWZ-4067-2022; Somers, Ben/ABG-2016-2020; Castro, Paula/M-8241-2013	Yu, Kang/0000-0002-0686-6783; Van Geel, Maarten/0000-0001-8688-6225; , Kastendeuch/0000-0002-5479-3136; Honnay, Olivier/0000-0002-4287-8511; Serafim, Cindy/0000-0002-7625-7131; Castro, Paula/0000-0001-8841-6606; Somers, Ben/0000-0002-7875-107X	FCT [SFRH/BD/111056/2015]; Belgian Science Policy (BelSPo); Research Foundation Flanders (FWO); Agence Nationale de la Recherche (ANR); Fundacao para a Ciencia e a Tecnologia (FCT) [BR/175/A1/URBANMYCOSERVE]; 2015-2016 BiodivERsA COFUND call for research proposals;  [BIODIVERS/0009/2015BI_I]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Belgian Science Policy (BelSPo)(Belgian Federal Science Policy Office); Research Foundation Flanders (FWO)(FWO); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); 2015-2016 BiodivERsA COFUND call for research proposals; 	CS and MR acknowledge BIODIVERS/0009/2015BI_I and FCT grand SFRH/BD/111056/2015, respectively. MVG and KY are supported by the 2015-2016 BiodivERsA COFUND call for research proposals, with the national funders: Belgian Science Policy (BelSPo), Research Foundation Flanders (FWO), Agence Nationale de la Recherche (ANR) and Fundacao para a Ciencia e a Tecnologia (FCT) (grant number BR/175/A1/URBANMYCOSERVE) (www.biodiversa.org; www.belspo.be).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the greenery services of Leuven, Strasbourg and Porto for providing a hydraulic ladder and assistance with fieldwork. Cindy Serafim and Miguel Ramos acknowledge BIODIVERS/0009/2015BI_I and FCT grand SFRH/BD/111056/2015, respectively. This work was supported by the 2015-2016 BiodivERsA COFUND call for research proposals, with the national funders: Belgian Science Policy (BelSPo), Research Foundation Flanders (FWO), Agence Nationale de la Recherche (ANR) and Fundacao para a Ciencia e a Tecnologia (FCT) (grant number BR/175/A1/URBANMYCOSERVE).	[Anonymous], 2014, J APPL ECOL, DOI [DOI 10.1111/1365-2664.12306, DOI 10.1016/S0167-8809(99)00024-9]; ATTIWILL PM, 1993, NEW PHYTOL, V124, P561, DOI 10.1111/j.1469-8137.1993.tb03847.x; Baxter JW, 2001, NEW PHYTOL, V152, P139, DOI 10.1046/j.0028-646x.2001.00245.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chalot M, 1998, FEMS MICROBIOL REV, V22, P21, DOI 10.1111/j.1574-6976.1998.tb00359.x; Chen DQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137026; Clark J. R., 1990, Journal of Arboriculture, V16, P203; Dale AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173844; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2016, SINTAZ SIMPLE NONBAY; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Egli S, 2011, ANN FOREST SCI, V68, P81, DOI 10.1007/s13595-010-0009-3; Eitel JUH, 2006, FOREST ECOL MANAG, V229, P170, DOI 10.1016/j.foreco.2006.03.027; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fenger J, 1999, ATMOS ENVIRON, V33, P4877, DOI 10.1016/S1352-2310(99)00290-3; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Groffman P.M., 1999, STANDARD SOIL METHOD, P272; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Itoo ZA, 2013, BOT REV, V79, P371, DOI 10.1007/s12229-013-9126-7; Jones MD, 2010, FUNCT ECOL, V24, P1139, DOI 10.1111/j.1365-2435.2010.01699.x; Jonsson L, 2000, FOREST ECOL MANAG, V132, P143, DOI 10.1016/S0378-1127(99)00220-0; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Kardan O, 2015, SCI REP-UK, V5, DOI 10.1038/srep11610; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kumar P, 2014, ENVIRON INT, V66, P1, DOI 10.1016/j.envint.2014.01.013; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; Layman RM, 2016, URBAN FOR URBAN GREE, V16, P25, DOI 10.1016/j.ufug.2016.01.004; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Lehto T, 2011, MYCORRHIZA, V21, P71, DOI 10.1007/s00572-010-0348-9; Lekberg Y, 2018, NEW PHYTOL, V220, P957, DOI 10.1111/nph.15064; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lu J.W.T., 2010, CITIES ENV, V3, P1; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; McNeeley S, 2007, CREATING A CLIMATE FOR CHANGE: COMMUNICATING CLIMATE CHANGE AND FACILITATING SOCIAL CHANGE, P139, DOI 10.1017/CBO9780511535871.011; Merzlyak MN, 1999, PHYSIOL PLANTARUM, V106, P135, DOI 10.1034/j.1399-3054.1999.106119.x; Mullaney J, 2015, LANDSCAPE URBAN PLAN, V134, P157, DOI 10.1016/j.landurbplan.2014.10.013; Murphy DV, 2011, SOIL RES, V49, P582, DOI 10.1071/SR11203; Ng E, 2012, BUILD ENVIRON, V47, P256, DOI 10.1016/j.buildenv.2011.07.014; Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006; Pandit R, 2013, LANDSCAPE URBAN PLAN, V110, P134, DOI 10.1016/j.landurbplan.2012.11.001; PENUELAS J, 1995, PHOTOSYNTHETICA, V31, P221; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; Roman LA, 2011, URBAN FOR URBAN GREE, V10, P269, DOI 10.1016/j.ufug.2011.05.008; Roy S, 2012, URBAN FOR URBAN GREE, V11, P351, DOI 10.1016/j.ufug.2012.06.006; Sanders JR, 2014, URBAN FOR URBAN GREE, V13, P295, DOI 10.1016/j.ufug.2013.12.006; Sapsford SJ, 2017, PLANT ECOL, V218, P1093, DOI 10.1007/s11258-017-0754-6; Seelig HD, 2008, REMOTE SENS ENVIRON, V112, P445, DOI 10.1016/j.rse.2007.05.002; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Sharma Y. P., 2014, Journal of Mycology and Plant Pathology, V44, P12; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Timonen Sari, 2008, Urban Forestry & Urban Greening, V7, P265, DOI 10.1016/j.ufug.2008.08.001; Tsirogiannis C, 2016, ECOGRAPHY, V39, P709, DOI 10.1111/ecog.01814; Van Geel M, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy207; Van Geel M, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0373-y; Vidal-Beaudet L, 2018, EUR J HORTIC SCI, V83, P173, DOI 10.17660/eJHS.2018/83.3.7; Waud M, 2014, MOL ECOL RESOUR, V14, P679, DOI 10.1111/1755-0998.12229; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Yu K, 2018, ECOL INDIC, V95, P895, DOI 10.1016/j.ecolind.2018.08.047; Zadeh ARK, 2013, ENVIRON POLLUT, V178, P7, DOI 10.1016/j.envpol.2013.02.021	66	4	4	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225714	10.1371/journal.pone.0225714	http://dx.doi.org/10.1371/journal.pone.0225714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QA	31756209	Green Published, gold			2022-12-26	WOS:000533889300053
J	Marszalek, J; Molik, B				Marszalek, Jolanta; Molik, Bartosz			Reliability of measurement of active trunk movement in wheelchair basketball players	PLOS ONE			English	Article							CLASSIFICATION-SYSTEM; PARALYMPIC CLASSIFICATION; SCIENTIFIC PRINCIPLES; FUNCTIONAL REACH; SEATED LIMITS; VALIDITY; STABILITY; KINECT; INDIVIDUALS; IMPAIRMENT	The study aim was to assess the reliability to active trunk movements measurement in four sitting positions in wheelchair basketball players and to check their trunk movements in these positions. Eighteen volunteer wheelchair basketball athletes, with a minimum of five years' training experience, were asked to perform the maximum range of active trunk movement in three planes in four sitting positions (in a sports wheelchair with straps, without straps, on a table with feet on the floor, on a table without foot support). The range of movement was measured by the Kinect for Windows V2 sensor twice (with one-week interval). To assess the reliability, different statistical methods were used for each movement: significance of differences between the results (p-value), interclass correlation coefficient (ICC) and minimal detectable change (MDC). The limits of agreement analysis (LOA) were calculated. Differences between trunk movements in four positions were checked by the MANOVA (Wilk's Lambda and ETA(2) were calculated if data were normally distributed). The significance level was set at alpha <.05. Friedman ANOVA and non-parametric Wilcoxon test with the Bonferroni correction were applied when data were not normally distributed. The significance level after Bonferroni correction was set at alpha <.013 (alpha = p/k, where p =.05, knumber of positions = 4). The measurement of active trunk movement in each plane was reliable (p >.05, no differences between the results, "very good"ICC, between.96-.99). In the position with straps, the trunk movement was significantly bigger than in other positions (p <.05), except for the position without straps (p >.05). The Kinect for Windows V2 sensor measured active trunk movement in a reliable manner and it can be recommended as a reliable tool for measuring trunk function. Utilizing straps by wheelchair basketball players increases their trunk movement.	[Marszalek, Jolanta; Molik, Bartosz] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Rehabil, Warsaw, Poland	Jozef Pilsudski University Physical Education in Warsaw	Marszalek, J (corresponding author), Jozef Pilsudski Univ Phys Educ Warsaw, Dept Rehabil, Warsaw, Poland.	marszalek.jolanta@gmail.com	Marszalek, Jolanta/E-6318-2018	Marszalek, Jolanta/0000-0003-1340-2263	Jozef Pilsudski University of Physical Educationin Warsaw, Poland; University of Illinois at Urbana-Champaign and Disability Resources & Educational Services (DRES)	Jozef Pilsudski University of Physical Educationin Warsaw, Poland; University of Illinois at Urbana-Champaign and Disability Resources & Educational Services (DRES)	The authors receive some funds from Jozef Pilsudski University of Physical Educationin Warsaw, Poland to conduct this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank The University of Illinois at Urbana-Champaign and Disability Resources & Educational Services (DRES) for the support in this study. They also thank the participants and the coaches for their engagement and help in this research.	Alm M, 2003, SPINAL CORD, V41, P563, DOI 10.1038/sj.sc.3101507; Altmann VC, 2013, SPINAL CORD, V51, P913, DOI 10.1038/sc.2013.109; Altmann VC, 2016, ARCH PHYS MED REHAB, V97, P437, DOI 10.1016/j.apmr.2015.10.096; Altmann VC, 2014, ADAPT PHYS ACT Q, V31, P377, DOI 10.1123/apaq.2013-0064; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonnechere B, 2014, GAIT POSTURE, V39, P593, DOI 10.1016/j.gaitpost.2013.09.018; Chen CL, 2003, ARCH PHYS MED REHAB, V84, P1276, DOI 10.1016/S0003-9993(03)00200-4; CURTIS KA, 1995, ARCH PHYS MED REHAB, V76, P360, DOI 10.1016/S0003-9993(95)80662-8; Domholdt E., 2005, REHABILITATION RES P; Fung Y., 2013, EUR J ADAPT PHYS ACT, V6, P17, DOI [10.5507/euj.2013.002, DOI 10.5507/EUJ.2013.002]; Gagnon D, 2008, CLIN BIOMECH, V23, P279, DOI 10.1016/j.clinbiomech.2007.09.017; Gagnon DH, 2016, REHABIL RES PRACT, V2016, DOI 10.1155/2016/6842324; Gao KL, 2015, J ORTHOP TRANSL, V3, P44, DOI 10.1016/j.jot.2014.07.003; Gauthier C, 2012, J SPINAL CORD MED, V35, P343, DOI 10.1179/2045772312Y.0000000039; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; Huber ME, 2015, PHYSIOTHERAPY, V101, P389, DOI 10.1016/j.physio.2015.02.002; International Wheelchair Basketball Federation (IWBF), 2014, OFF PLAYER CLASS MAN; Kinect, 2014, KIN US MAN; Kinetisense, 2017, WHAT IS KIN MOT CAPT; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lynch SM, 1998, PHYS THER, V78, P128, DOI 10.1093/ptj/78.2.128; Molik B, 2017, KINESIOLOGY, V49, P117, DOI 10.26582/k.49.1.1; Ozunlu N, 2012, TURK J PHYSIOTHER R, V23, P44; Pernot HFM, 2011, SPINAL CORD, V49, P935, DOI 10.1038/sc.2011.30; Ries JD, 2009, PHYS THER, V89, P569, DOI 10.2522/ptj.20080258; Rodgers MM, 2000, J REHABIL RES DEV, V37, P283; Rosso V, 2019, ADAPT PHYS ACT Q, V36, P61, DOI 10.1123/apaq.2017-0161; Rosso V, 2018, MECH MACH SCI, V49, P980, DOI 10.1007/978-3-319-61276-8_105; Saltan A, 2017, J SPORT REHABIL, V26, P287, DOI 10.1123/jsr.2016-0054; Santos PBR, 2017, SCAND J MED SCI SPOR, V27, P2019, DOI 10.1111/sms.12847; Santos SD, 2017, AM J PHYS MED REHAB, V96, P101, DOI 10.1097/PHM.0000000000000548; Stratford P. W., 2004, PHYSIOTHER CAN, V56, P27, DOI [10.2310/6640.2004.15377, DOI 10.2310/6640.2004.15377]; Tweedy SM, 2011, BRIT J SPORT MED, V45, P259, DOI 10.1136/bjsm.2009.065060; Tweedy SM, 2018, PHYS MED REH CLIN N, V29, P313, DOI 10.1016/j.pmr.2018.01.010; Tweedy SM, 2014, PM&R, V6, pS11, DOI 10.1016/j.pmrj.2014.04.013; Tweedy SM., 2010, POSTEP REHABIL, V3, P1, DOI DOI 10.2478/V10029-010-0001-8; van Diest M, 2014, J BIOMECH, V47, P2925, DOI 10.1016/j.jbiomech.2014.07.017; Vanlandewijck YC, 2011, MED SCI SPORT EXER, V43, P2344, DOI 10.1249/MSS.0b013e318223af14; Vanlandewijck YC, 2011, J SPORT SCI, V29, P1089, DOI 10.1080/02640414.2011.576694; Verheyden G, 2006, PHYS THER, V86, P66, DOI 10.1093/ptj/86.1.66; World Para Nordic Skiing, 2017, CLASS RUL REG 2017; Yeung LF, 2014, GAIT POSTURE, V40, P532, DOI 10.1016/j.gaitpost.2014.06.012; Yildirim NU, 2010, J BACK MUSCULOSKELET, V23, P55, DOI 10.3233/BMR-2010-0250	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225515	10.1371/journal.pone.0225515	http://dx.doi.org/10.1371/journal.pone.0225515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751434	Green Published, gold, Green Submitted			2022-12-26	WOS:000533886900075
J	Chirwa, GC; Mazalale, J; Likupe, G; Nkhoma, D; Chiwaula, L; Chintsanya, J				Chirwa, Gowokani Chijere; Mazalale, Jacob; Likupe, Gloria; Nkhoma, Dominic; Chiwaula, Levison; Chintsanya, Jesman			An evolution of socioeconomic related inequality in teenage pregnancy and childbearing in Malawi	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTENATAL CARE; HEALTH-CARE; ADOLESCENT; CHILDBIRTH; COUNTRIES; OUTCOMES; INDEXES; MOTHERS; ACCESS	Background Teenage pregnancies and childbearing are important health concerns in low-and middle-income countries (LMICs) including Malawi. Addressing these challenges requires, among other things, an understanding of the socioeconomic determinants of and contributors to the inequalities relating to these outcomes. This study investigated the trends of the inequalities and decomposed the underlying key socioeconomic factors which accounted for the inequalities in teenage pregnancy and childbearing in Malawi. Methods The study used the 2004, 2010 and 2015-16 series of nationally representative Malawi Demographic Health Survey covering 12,719 women. We used concentration curves to examine the existence of inequalities, and then quantified the extent of inequalities in teenage pregnancies and childbearing using the Erreygers concentration index. Finally, we decomposed concentration index to find out the contribution of the determinants to socioeconomic inequality in teenage pregnancy and childbearing. Results The teenage pregnancy and childbearing rate averaged 29% (p<0.01) between 2004 and 2015-16. Trends showed a "u-shape" in teenage pregnancy and childbearing rates, albeit a small one (34.1%; p<0.01) in 2004: (25.6%; p<0.01) in 2010, and (29%; p<0.01) in 2016. The calculated concentration indices-0.207 (p<0.01) in 2004,-0.133 (p<0.01) in 2010, and -0.217 (p<0.01) in 2015-16 indicated that inequality in teenage pregnancy and childbearing worsened to the disadvantage of the poor in the country. Additionally, the decomposition exercise suggested that the primary drivers to inequality in teenage pregnancy and child bearing were, early sexual debut (15.5%), being married (50%), and wealth status (13.8%). Conclusion The findings suggest that there is a need for sustained investment in the education of young women concerning the disadvantages of early sexual debut and early marriages, and in addressing the wealth inequalities in order to reduce the incidences of teenage pregnancies and childbearing.	[Chirwa, Gowokani Chijere; Mazalale, Jacob; Chiwaula, Levison] Univ Malawi, Chancellor Coll, Dept Econ, Zomba, Malawi; [Likupe, Gloria] Univ Hull, Hlth Nursing & Midwifery, Kingston Upon Hull, N Humberside, England; [Nkhoma, Dominic] Univ Malawi, Coll Med, Hlth Policy Unit, Lilongwe, Malawi; [Chintsanya, Jesman] Univ Malawi, Chancellor Coll, Dept Populat Studies, Zomba, Malawi; [Chirwa, Gowokani Chijere] Univ York, Ctr Hlth Econ, York, N Yorkshire, England	University of Malawi; University of Hull; University of Malawi; University of Malawi; University of York - UK	Chirwa, GC (corresponding author), Univ Malawi, Chancellor Coll, Dept Econ, Zomba, Malawi.	gowokani@gmail.com	Chirwa, Gowokani Chijere/AAB-3310-2020; Mazalale, Jacob/D-8972-2018; Mazalale, Jacob/AAE-3204-2022	Chirwa, Gowokani Chijere/0000-0003-0199-779X; Mazalale, Jacob/0000-0001-9856-1268; Mazalale, Jacob/0000-0001-9856-1268; Chintsanya, Jesman/0000-0002-0262-9668; Nkhoma, Dominic/0000-0001-6125-6630				Abdul-Rahman Lutuf, 2011, Afr J Reprod Health, V15, P45; Adeyanju O, 2017, HEALTH POLICY PLANN, V32, P1111, DOI 10.1093/heapol/czx049; African Health Observatory, 2016, MAL ISS CHALL OTH MD; Ahorlu CK, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0113-9; [Anonymous], 2017, WORLD DEV IND; [Anonymous], 2008, ANAL HLTH EQUITY USI; Atuyambe LM, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0026-7; Cavazos-Rehg PA, 2010, ARCH SEX BEHAV, V39, P664, DOI 10.1007/s10508-008-9397-y; Chikalipo MC, 2018, MALAWI MED J, V30, P25, DOI 10.4314/mmj.v30i1.6; de Azevedo WF, 2015, EINSTEIN-SAO PAULO, V13, P618, DOI 10.1590/S1679-45082015RW3127; Erreygers G, 2011, J HEALTH ECON, V30, P685, DOI 10.1016/j.jhealeco.2011.04.004; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Fall CHD, 2015, LANCET GLOB HEALTH, V3, pE366, DOI 10.1016/S2214-109X(15)00038-8; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Glynn JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196041; Gunawardena N, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001499; Heckley G, 2016, J HEALTH ECON, V48, P89, DOI 10.1016/j.jhealeco.2016.03.006; ICF, 2018, DEM HLTH SURV; Kaphagawani NC, 2017, GLOB PUBLIC HEALTH, V12, P694, DOI 10.1080/17441692.2016.1229354; Kjellsson G, 2013, J HEALTH ECON, V32, P659, DOI 10.1016/j.jhealeco.2012.10.012; Krugu JK, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0161-9; Machira Kennedy, 2017, Ghana Med J, V51, P88; Magadi MA, 2017, HEALTH PLACE, V46, P37, DOI 10.1016/j.healthplace.2017.04.006; Makate Marshall, 2017, Glob Health Res Policy, V2, P1, DOI 10.1186/s41256-016-0021-8; Mardh P A, 2000, Eur J Contracept Reprod Health Care, V5, P177, DOI 10.1080/13625180008500396; McConnell C, 2016, KEEPING GIRLS SCH SI; McNeish H, 2016, ALJAZEERA; Mussa R., 2015, DANGEROUS DIVIDE STA; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; National Statistical Office (NSO) [Malawi] and World Bank Poverty and Equity Global Practice, 2018, METH POV MEAS MAL 20; NSO, 2012, INT HOUS SURV IHS3 2; NSO, 2018, 2018 MAL POP HOUS CE; Odimegwu C, 2016, AFR J REPROD HEALTH, V20, P94, DOI 10.29063/ajrh2016/v20i3.14; Omani-Samani R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5515-5; Owolabi OO, 2017, LANCET CHILD ADOLESC, V1, P203, DOI 10.1016/S2352-4642(17)30025-1; Phillips SJ, 2016, INT J GYNECOL OBSTET, V132, P1, DOI 10.1016/j.ijgo.2015.10.005; Pulok MH, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0970-4; Rasch V, 2000, REPROD HEALTH MATTER, V8, P52, DOI 10.1016/S0968-8080(00)90006-5; Rutstein S. O., 2004, DHS WEALTH INDEX; UNDP, 2018, HUMAN DEV INDICES IN; UNDP, 2018, SUST DEV GOALS REP; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; WHO, 2017, GLOB ACC ACT HLTH AD; WHO, 2020, ADOLESCENT PREGNANCY; Yakubu I, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0460-4	47	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225374	10.1371/journal.pone.0225374	http://dx.doi.org/10.1371/journal.pone.0225374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8NF	31747437	gold, Green Published			2022-12-26	WOS:000533881900040
J	Fornillos, RJC; Sato, MO; Tabios, IKB; Sato, M; Leonardo, LR; Chigusa, Y; Minamoto, T; Kikuchi, M; Legaspi, ER; Fontanilla, IKC				Fornillos, Raffy Jay C.; Sato, Marcello Otake; Tabios, Ian Kim B.; Sato, Megumi; Leonardo, Lydia R.; Chigusa, Yuichi; Minamoto, Toshifumi; Kikuchi, Mihoko; Legaspi, Emelda R.; Fontanilla, Ian Kendrich C.			Detection of Schistosoma japonicum and Oncomelania hupensis quadrasi environmental DNA and its potential utility to schistosomiasis japonica surveillance in the Philippines	PLOS ONE			English	Article							WATER; HOST	In recent years, the prevalence and infection intensity of Schistosoma japonicum in endemic areas of the Philippines have significantly decreased due to yearly population-based treatment strategies, yet transmission rates remain high and uninterrupted. An important indicator of active disease transmission is the presence of Schistosoma japonicum and its snail intermediate host Oncomelania hupensis quadrasi in freshwater habitats. In this study, we sought to apply a species-specific real-time PCR (qPCR) assay for the detection of S. japonicum and O. hupensis quadrasi in freshwater samples using environmental DNA approach that can complement the commonly utilized malacological survey in determining potential transmission foci in order to have a more effective snail surveillance strategy for schistosomiasis japonica in endemic areas. The newly developed assay was specific to S. japonicum and O. hupensis quadrasi with no amplification detected against non-target trematode Fasciola spp. and snails such as Lymnaea spp., Pomacea canaliculata, and Melanoides spp. that typically co-exist in the same environment. The assay effectiveness was determined using 19 environmental water samples collected from Northern Samar (N = 5 sites), Leyte (N = 11 sites) and Compostela Valley (N = 3 sites) and compared to malacological survey for determining O. hupensis quadrasi snail colonies and snail crushing to visualize S. japonicum cercariae. TaqMan qPCR targeting a short fragment of the cytochrome c oxidase subunit 1 (cox1) gene was positive for S. japonicum in 9 sites, for O. hupensis quadrasi in 9 sites, and for both S. japonicum and O. hupensis quadrasi in 5 sampling sites. Moreover, it was able to detect O. hupensis quadrasi in 3 out of 12 sites found negative and 6 out of 7 sites found positive through malacological survey, and in 4 of the 5 snail sites positive for snails with cercariae. Overall, this method can complement malacological surveys for monitoring of schistosomes in endemic areas of the Philippines, especially those with high risk of human infection.	[Fornillos, Raffy Jay C.; Leonardo, Lydia R.; Fontanilla, Ian Kendrich C.] Univ Philippines Diliman, DNA Barcoding Lab, Coll Sci, Inst Biol, Quezon City, Philippines; [Fornillos, Raffy Jay C.; Fontanilla, Ian Kendrich C.] Univ Philippines Diliman, Nat Sci Res Inst, Velasquez St Diliman, Quezon City, Philippines; [Sato, Marcello Otake; Chigusa, Yuichi] Dokkyo Med Univ, Dept Trop Med & Parasitol, Mibu, Tochigi, Japan; [Tabios, Ian Kim B.] Univ Philippines Manila, Coll Med, Ermita Manilla, Philippines; [Sato, Megumi] Grad Sch Hlth Sci, Niigata, Japan; [Leonardo, Lydia R.] Univ East Ramon Magsaysay Mem Med Ctr, Grad Sch, Quezon City, Philippines; [Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo, Japan; [Kikuchi, Mihoko] Nagasaki Univ, Inst Trop Med, Dept Immunogenet, Nagasaki, Japan; [Legaspi, Emelda R.] Schistosomiasis Res & Training Ctr, Med Zool Lab, Palo Leyte, Philippines	University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Diliman; Dokkyo Medical University; UERM Memorial Medical Center; Kobe University; Nagasaki University	Fontanilla, IKC (corresponding author), Univ Philippines Diliman, DNA Barcoding Lab, Coll Sci, Inst Biol, Quezon City, Philippines.; Fontanilla, IKC (corresponding author), Univ Philippines Diliman, Nat Sci Res Inst, Velasquez St Diliman, Quezon City, Philippines.; Sato, MO (corresponding author), Dokkyo Med Univ, Dept Trop Med & Parasitol, Mibu, Tochigi, Japan.	marcello@dokkyomed.ac.jp; icfontanilla@up.edu.ph	Minamoto, Toshifumi/C-6453-2009; Sato, Marcello Otake/F-7674-2014	Minamoto, Toshifumi/0000-0002-5379-1622; Sato, Marcello Otake/0000-0002-9204-0602; Fornillos, Raffy Jay/0000-0002-3969-2660; SATO, Megumi/0000-0003-4374-8070; Tabios, Ian Kim/0000-0002-0956-334X	Department of Science and Technology - Philippine Council for Industry, Energy and Emerging Technology Research and Development [PCIEERD-BIO-17-02]; University of the Philippines Diliman-Natural Sciences Research Institute; University of the Philippines Diliman-Institute of Biology, College of Science	Department of Science and Technology - Philippine Council for Industry, Energy and Emerging Technology Research and Development; University of the Philippines Diliman-Natural Sciences Research Institute; University of the Philippines Diliman-Institute of Biology, College of Science	IKCF received grant from the Department of Science and Technology - Philippine Council for Industry, Energy and Emerging Technology Research and Development (Grant No. PCIEERD-BIO-17-02) in partnership with the University of the Philippines Diliman-Natural Sciences Research Institute and Institute of Biology, College of Science, http://pcieerd.dost.gov.ph/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bass D, 2015, TRENDS PARASITOL, V31, P499, DOI 10.1016/j.pt.2015.06.013; Blas BL, 2004, PARASITOL INT, V53, P127, DOI 10.1016/j.parint.2004.01.003; Blas BL, 1991, MONOGRAPH SCHISTOSOM; Blas BL, 1988, HDB CONTROL SCHISTOS, P22; Calata FIC, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040160; Chua JCC, 2017, SCI DILIMAN, V29, P32; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Conlan JV, 2011, VET PARASITOL, V182, P22, DOI 10.1016/j.vetpar.2011.07.013; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; Driscoll AJ, 2005, PARASITOLOGY, V131, P497, DOI 10.1017/S0031182005007961; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fornillos RJC, 2019, TROP BIOMED, V36, P402; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hashizume H, 2017, ACTA TROP, V169, P1, DOI 10.1016/j.actatropica.2017.01.008; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hung YW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000337; Jones RA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2928-z; Kachani M., 2013, EMERG INFECT DIS, V19; Leonardo LR, 2002, ACTA TROP, V82, P295, DOI 10.1016/S0001-706X(02)00022-0; Leonardo L, 2016, SE ASIAN J TROP MED, V47, P651; Leonardo L, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/936128; Leonardo L, 2015, ACTA TROP, V141, P354, DOI 10.1016/j.actatropica.2013.03.015; McCreesh N, 2013, TRENDS PARASITOL, V29, P548, DOI 10.1016/j.pt.2013.08.007; McManus DP, 2018, INT J INFECT DIS, V76, P128, DOI 10.1016/j.ijid.2018.09.022; MCMULLEN DB, 1947, AM J HYG, V45, P259, DOI 10.1093/oxfordjournals.aje.a119134; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Ohmae H, 2003, PARASITOL INT, V52, P409, DOI 10.1016/S1383-5769(03)00058-8; Olveda DU, 2014, INT J INFECT DIS, V18, P52, DOI 10.1016/j.ijid.2013.09.011; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Sato MO, 2018, INT J INFECT DIS, V76, P130, DOI 10.1016/j.ijid.2018.08.018; Shi YY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14090986; Staden R, 2000, Methods Mol Biol, V132, P115; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; TUBANGUI MARCOS A., 1932, PHILIPPINE JOUR SCI, V49, P295; Uchii K, 2016, MOL ECOL RESOUR, V16, P415, DOI 10.1111/1755-0998.12460; World Health Organization, 2017, EXP CONS ACC EL SCH; Worrell C, 2011, APPL ENVIRON MICROB, V77, P2192, DOI 10.1128/AEM.01561-10	41	12	12	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0224617	10.1371/journal.pone.0224617	http://dx.doi.org/10.1371/journal.pone.0224617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747401	Green Published, gold			2022-12-26	WOS:000533881900012
J	Lee, JW; Kim, NKD; Lee, SH; Cho, HW; Ma, Y; Ju, HY; Yoo, KH; Sung, KW; Koo, HH; Park, WY				Lee, Ji Won; Kim, Nayoung K. D.; Lee, Soo Hyun; Cho, Hee Won; Ma, Youngeun; Ju, Hee Young; Yoo, Keon Hee; Sung, Ki Woong; Koo, Hong Hoe; Park, Woong-Yang			Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors	PLOS ONE			English	Article							LARGE-CELL LYMPHOMA; CANCER; CRIZOTINIB; INHIBITOR; MUTATIONS; ALK; HETEROGENEITY; GENOMICS; GROWTH	Advances in genomic technologies and the development of targeted therapeutics are making the use of precision medicine increasingly possible. In this study, we explored whether precision medicine can be applied for the management of refractory/relapsed pediatric solid tumors by discovering actionable alterations using targeted panel sequencing. Samples of refractory/relapsed pediatric solid tumors were tested using a targeted sequencing panel covering the exonic DNA sequences of 381 cancer genes and introns across 22 genes to detect clinically significant genomic aberrations in tumors. The molecular targets were tiered from 1 to 5 based on the presence of actionable genetic alterations, strength of supporting evidence, and drug availability in the Republic of Korea. From January 2016 to October 2018, 55 patients were enrolled. The median time from tissue acquisition to drug selection was 29 d (range 14-39), and tumor profiling was successful in 53 (96.4%) patients. A total of 27 actionable alterations in tiers 1-4 were detected in 20 patients (36.4%), and the majority of actionable alterations were copy number variations. The tiers of molecular alterations were tier 1 (clinical evidence) in 4 variants, tier 2 (preclinical evidence) in 8 variants, tier 3 (consensus opinion) in 2 variants, and tier 4 (actionable variants with a drug that is available in other countries but not in the Republic of Korea) in 9 variants. In one patient with relapsed neuroblastoma with ALK F1174L mutation and ALK amplification, lorlatinib was used in a compassionate use program, and it showed some efficacy. In conclusion, using a targeted sequencing panel to discover actionable alterations in relapsed/refractory pediatric solid tumors was practical and feasible.	[Lee, Ji Won; Cho, Hee Won; Ma, Youngeun; Ju, Hee Young; Yoo, Keon Hee; Sung, Ki Woong; Koo, Hong Hoe] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pediat, Sch Med, Seoul, South Korea; [Kim, Nayoung K. D.; Park, Woong-Yang] Sungkyunkwan Univ, Samsung Med Ctr, Samsung Genome Inst, Sch Med, Seoul, South Korea; [Kim, Nayoung K. D.; Park, Woong-Yang] Geninus Inc, Seoul, South Korea; [Lee, Soo Hyun] Univ Texas Houston, MD Anderson Canc Ctr, Dept Translat Mol Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Park, Woong-Yang] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Seoul, South Korea; [Ma, Youngeun] Seoul Natl Univ, Dept Pediat, Bundang Hosp, Seongnam, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Seoul National University (SNU)	Sung, KW (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Pediat, Sch Med, Seoul, South Korea.; Park, WY (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Samsung Genome Inst, Sch Med, Seoul, South Korea.; Park, WY (corresponding author), Geninus Inc, Seoul, South Korea.; Park, WY (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea.; Park, WY (corresponding author), Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Seoul, South Korea.	kwsped@skku.edu; woongyang.park@samsung.com		Park, Woong-Yang/0000-0003-4234-0380; Sung, Ki Woong/0000-0001-5989-4772	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [1520210]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), Ministry of Health & Welfare, Republic of Korea [HI14C3418]	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (No. 1520210) and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), Ministry of Health & Welfare, Republic of Korea (HI14C3418). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cen L, 2012, NEURO-ONCOLOGY, V14, P870, DOI 10.1093/neuonc/nos114; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Chang W, 2016, CLIN CANC RES; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; del Bufalo F, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0356-1; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Harris M.H., 2016, JAMA ONCOL; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Infarinato NR, 2016, CANCER DISCOV, V6, P96, DOI 10.1158/2159-8290.CD-15-1056; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Kiessling MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147682; Kline CN, 2016, NEUROONCOL; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee B, 2018, TRANSL ONCOL, V11, P1390, DOI 10.1016/j.tranon.2018.08.013; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Mody RJ, 2015, JAMA-J AM MED ASSOC, V314, P913, DOI 10.1001/jama.2015.10080; Moreno L, 2017, NAT REV CLIN ONCOL; Mosse YP, 2017, J CLIN ONCOL, V35, P3215, DOI 10.1200/JCO.2017.73.4830; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Nakayama R, 2016, ONCOTARGET, V7, P16581, DOI 10.18632/oncotarget.7667; Newman WG, 2014, GENES-BASEL, V5, P1001, DOI 10.3390/genes5041001; Ortiz MV, 2016, PEDIATR BLOOD CANCER, V63, P1368, DOI 10.1002/pbc.26002; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Rao AAN, 2012, PEDIATR NEUROL, V46, P203, DOI 10.1016/j.pediatrneurol.2012.02.005; Robinson GW, 2015, J CLIN ONCOL, V33, P2646, DOI 10.1200/JCO.2014.60.1591; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Rosell R, 2013, LANCET, V382, P720, DOI 10.1016/S0140-6736(13)61715-8; Shin HY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15464; Tinsley S., ESTABLISH ROLE MUTAT; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Worst BC, 2016, EUR J CANCER, V65, P91, DOI 10.1016/j.ejca.2016.06.009; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	38	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0224227	10.1371/journal.pone.0224227	http://dx.doi.org/10.1371/journal.pone.0224227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747416	Green Published, gold			2022-12-26	WOS:000533881900005
J	Mackow, NA; Shen, J; Adnan, M; Khan, AS; Fries, BC; Diago-Navarro, E				Mackow, Natalie A.; Shen, Juntao; Adnan, Mutayyaba; Khan, Aisha S.; Fries, Bettina C.; Diago-Navarro, Elizabeth			CRISPR-Cas influences the acquisition of antibiotic resistance in Klebsiella pneumoniae	PLOS ONE			English	Article							REPEATS; SYSTEMS; VIRULENCE	In the US Carbapenem resistance in Klebsiella pneumoniae (Kp) is primarily attributed to the presence of the genes bla(KPC-2) and bla(KPC-3), which are transmitted via plasmids. Carbapenem-resistant Kp (CR-Kp) infections are associated with hospital outbreaks. They are difficult to treat, and associated with high mortality rates prompting studies of how resistance is obtained. In this study, we determined the presence of CRISPR-Cas in 304 clinical Kp strains. The CRISPR-Cas system has been found to prevent the spread of plasmids and bacteriophages, and therefore limits the horizontal gene transfer mediated by these mobile genetic elements. Here, we hypothesized that only those Kp strains that lack CRISPR-Cas can acquire CR plasmids, while those strains that have CRISPR-Cas are protected from gaining these plasmids and thus maintain sensitivity to antimicrobials. Our results show that CRISPR-Cas is absent in most clinical Kp strains including the clinically important ST258 clone. ST258 strains that continue to be sensitive to carbapenems also lack CRISPR-Cas. Interestingly, CRISPR-Cas positive strains, all non-ST258, exhibit lower resistance rates to antimicrobials than CRISPR-Cas negative strains. Importantly, we demonstrate that the presence of CRISPR-Cas appears to inhibit the acquisition of bla(KPC) plasmids in 7 Kp strains. Furthermore, we show that strains that are unable to acquire blaKPC plasmids contain CRISPR spacer sequences highly identical to those found in previously published multidrug-resistance-containing plasmids. Lastly, to our knowledge this is the first paper demonstrating that resistance to blaKPC plasmid invasion in a CRISPR-containing Kp strain can be reversed by deleting the CRISPR-cas cassette.	[Mackow, Natalie A.; Adnan, Mutayyaba; Khan, Aisha S.; Fries, Bettina C.; Diago-Navarro, Elizabeth] SUNY Stony Brook, Dept Med, Infect Dis Div, Stony Brook, NY 11794 USA; [Shen, Juntao] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China; [Fries, Bettina C.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Diago-Navarro, Elizabeth] Off Emergency Preparedness & Readiness, NYC Dept Hlth & Mental Hyg, New York, NY 10007 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Dalian University of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fries, BC; Diago-Navarro, E (corresponding author), SUNY Stony Brook, Dept Med, Infect Dis Div, Stony Brook, NY 11794 USA.; Fries, BC (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.; Diago-Navarro, E (corresponding author), Off Emergency Preparedness & Readiness, NYC Dept Hlth & Mental Hyg, New York, NY 10007 USA.	Bettina.fries@stonybrookmedicine.edu; elizabet.diagonavarro@stonybrookmedicine.edu	Shen, Juntao/AAL-5174-2020	Khan, Aisha/0000-0002-0914-5615; Diago Navarro, Elizabeth/0000-0001-7117-1796	Foundation for the National Institutes of Health [R21 AI114259]; Alpha Omega Foundation; Infectious Diseases Society of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114259] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha Omega Foundation; Infectious Diseases Society of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: 1. Foundation for the National Institutes of Health, Award Number: R21 AI114259, Recipient: Bettina C. Fries; 2. Alpha Omega Foundation, Award Number: Carolyn L. Kuckein Student Research Fellowship, Recipient: Natalie A. Mackow; and 3. Infectious Diseases Society of America, Award Number: Medical Scholars Program, Recipient: Natalie A. Mackow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Aydin S, 2017, J ANTIMICROB CHEMOTH, V72, P2213, DOI 10.1093/jac/dkx137; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bowers JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133727; Burley KM, 2012, J ENDODONT, V38, P1511, DOI 10.1016/j.joen.2012.07.004; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P165; Chen L, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00659-15; Chen L, 2014, TRENDS MICROBIOL, V22, P686, DOI 10.1016/j.tim.2014.09.003; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Diago-Navarro E, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00456-16; Diago-Navarro E, 2014, J INFECT DIS, V210, P803, DOI 10.1093/infdis/jiu157; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hargreaves KR, 2014, MBIO, V5, DOI 10.1128/mBio.01045-13; Hauck C, 2016, CLIN MICROBIOL INFEC, V22, P513, DOI 10.1016/j.cmi.2016.01.023; Hirsch EB, 2010, J ANTIMICROB CHEMOTH, V65, P1119, DOI 10.1093/jac/dkq108; Holt KE, 2015, P NATL ACAD SCI USA, V112, pE3574, DOI 10.1073/pnas.1501049112; Huang WH, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00076-17, 10.1128/aac.00076-17]; Li HY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01595; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Marsh JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144310; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Neuner EA, 2011, DIAGN MICR INFEC DIS, V69, P357, DOI 10.1016/j.diagmicrobio.2010.10.013; Ostria-Hernandez Martha Lorena, 2015, BMC Res Notes, V8, P332, DOI 10.1186/s13104-015-1285-7; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Park SO, 2016, OPEN FORUM INFECT DI, V3, DOI [10.1093/ofid/ofw222, DOI 10.1093/OFID/OFW222]; Porwollik S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099820; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Price VJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00064-16; Satlin MJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02349-16; Shen JT, 2017, J BASIC MICROB, V57, P325, DOI 10.1002/jobm.201600589; Touchon M, 2012, MICROBIOL-SGM, V158, P2997, DOI 10.1099/mic.0.060814-0; Wyres KL, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008114; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	36	20	21	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225131	10.1371/journal.pone.0225131	http://dx.doi.org/10.1371/journal.pone.0225131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747398	Green Published, gold			2022-12-26	WOS:000533881900022
J	Xue, H; Tian, XC; Zhang, KX; Li, WB; Qi, ZY; Fang, YL; Li, XY; Wang, Y; Song, J; Li, WX; Ning, HL				Xue, Hong; Tian, Xiaocui; Zhang, Kaixin; Li, Wenbin; Qi, Zhongying; Fang, Yanlong; Li, Xiyu; Wang, Yue; Song, Jie; Li, Wen-Xia; Ning, Hailong			Mapping developmental QTL for plant height in soybean [Glycine max (L.) Merr.] using a four-way recombinant inbred line population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TILLER NUMBER; MOLECULAR DISSECTION; AGRONOMIC TRAITS; CROSS POPULATION; GENETIC-ANALYSIS; GROWTH-STAGES; SEED WEIGHT; YIELD; BEHAVIOR	Plant height (PH) is an important trait in soybean, as taller plants may have higher yields but may also be at risk for lodging. Many genes act jointly to influence PH throughout development. To map the quantitative trait loci (QTL) controlling PH, we used the unconditional variable method (UVM) and conditional variable method (CVM) to analyze PH data for a fourway recombinant inbred line (FW-RIL) population derived from the cross of (Kenfeng14 x Kenfeng15) x (Heinong48 x Kenfeng19). We identified 7, 8, 16, 19, 15, 27, 17, 27, 22, and 24 QTL associated with PH at 10 developmental stages, respectively. These QTL mapped to 95 genomic regions. Among these QTL, 9 were detected using UVM and CVM, and 89 and 66 were only detected by UVM or CVM, respectively. In total, 36 QTL controlling PH were detected at multiple developmental stages and these made unequal contributions to genetic variation throughout development. Among 19 novel regions discovered in our study, 7 could explain over 10% of the phenotypic variation and contained only one single QTL. The unconditional and conditional QTL detected here could be used in molecular design breeding across the whole developmental procedure.	[Xue, Hong; Tian, Xiaocui; Zhang, Kaixin; Li, Wenbin; Qi, Zhongying; Fang, Yanlong; Li, Xiyu; Wang, Yue; Song, Jie; Li, Wen-Xia; Ning, Hailong] Minist Educ, Key Lab Soybean Biol, Harbin, Peoples R China; [Xue, Hong; Tian, Xiaocui; Zhang, Kaixin; Li, Wenbin; Qi, Zhongying; Fang, Yanlong; Li, Xiyu; Wang, Yue; Song, Jie; Li, Wen-Xia; Ning, Hailong] Minist Agr, Key Lab Soybean Biol & Breeding Genet, Harbin, Peoples R China; [Xue, Hong; Tian, Xiaocui; Zhang, Kaixin; Li, Wenbin; Qi, Zhongying; Fang, Yanlong; Li, Xiyu; Wang, Yue; Song, Jie; Li, Wen-Xia; Ning, Hailong] Northeast Agr Univ, Coll Crop Sci, Harbin, Heilongjiang, Peoples R China; [Xue, Hong] Heilongjiang Acad Agr Sci, Keshan Branch, Keshan, Heilongjiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China; Heilongjiang Academy of Agricultural Sciences	Li, WX; Ning, HL (corresponding author), Minist Educ, Key Lab Soybean Biol, Harbin, Peoples R China.; Li, WX; Ning, HL (corresponding author), Minist Agr, Key Lab Soybean Biol & Breeding Genet, Harbin, Peoples R China.; Li, WX; Ning, HL (corresponding author), Northeast Agr Univ, Coll Crop Sci, Harbin, Heilongjiang, Peoples R China.	liwenxianeau@126.com; ninghailongneau@126.com			National Key Research and Development Program of China [2017YFD0101303]; Scientific and Technological Foundation of Education Department of Heilongjiang Province [12541z001]	National Key Research and Development Program of China; Scientific and Technological Foundation of Education Department of Heilongjiang Province	D This study was supported by National Key Research and Development Program of China (2017YFD0101303) to W-X.L., Scientific and Technological Foundation of Education Department of Heilongjiang Province (12541z001) for H.Ning.	Alcivar A, 2007, J AGR FOOD ENV SCI, V1, P1; Atchley WR, 1997, GENETICS, V147, P765; Blanc G, 2006, THEOR APPL GENET, V113, P206, DOI 10.1007/s00122-006-0287-1; Bohlen MO, 2012, GENES BRAIN BEHAV, V11, P757, DOI 10.1111/j.1601-183X.2012.00802.x; Cao G, 2001, THEOR APPL GENET, V103, P153, DOI 10.1007/s001220100536; Chen QingShan, 2007, Agricultural Sciences in China, V6, P399, DOI 10.1016/S1671-2927(07)60062-5; Eskandari M, 2013, THEOR APPL GENET, V126, P1677, DOI 10.1007/s00122-013-2083-z; Guzman PS, 2007, CROP SCI, V47, P111, DOI 10.2135/cropsci2006.01.0003; Han YP, 2011, THEOR APPL GENET, V122, P1481, DOI 10.1007/s00122-011-1547-2; Han YP, 2008, GENET RES, V90, P481, DOI 10.1017/S0016672308009865; Harmegnies N, 2006, ANIM GENET, V37, P543, DOI 10.1111/j.1365-2052.2006.01523.x; Hayashi T, 2012, EUPHYTICA, V183, P277, DOI 10.1007/s10681-011-0345-x; Jiang ZF, 2013, EUPHYTICA, V189, P249, DOI 10.1007/s10681-012-0794-x; Jiang ZF, 2010, EUPHYTICA, V175, P227, DOI 10.1007/s10681-010-0172-5; Kabelka EA, 2004, CROP SCI, V44, P784, DOI 10.2135/cropsci2004.0784; Kim KS, 2012, THEOR APPL GENET, V125, P1353, DOI 10.1007/s00122-012-1944-1; Le BH, 2007, PLANT PHYSIOL, V144, P562, DOI 10.1104/pp.107.100362; Lee SH, 1996, CROP SCI, V36, P728, DOI 10.2135/cropsci1996.0011183X003600030035x; Lee S, 2015, EUPHYTICA, V203, P521, DOI 10.1007/s10681-014-1252-8; Li WB, 2007, GENOME, V50, P1067, DOI 10.1139/G07-080; Li WenXin, 2008, Journal of Crop Science and Biotechnology, V11, P171; Liu GF, 2009, THEOR APPL GENET, V118, P443, DOI 10.1007/s00122-008-0911-3; Liu SP, 2019, CROP J, V7, P694, DOI 10.1016/j.cj.2019.04.004; Liu WeiXian, 2011, Journal of Crop Science and Biotechnology, V14, P65, DOI 10.1007/s12892-010-0115-7; Liu ZongHua, 2007, Acta Agronomica Sinica, V33, P782; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; Muranty H, 1996, HEREDITY, V76, P156, DOI 10.1038/hdy.1996.23; Ning H, 2016, ACTA AGRONOMICA SINI, V42, P1609, DOI [10.3724/SP.J.1006.2016.01609, DOI 10.3724/SP.J.1006.2016.01609]; Orf JH, 1999, CROP SCI, V39, P1652, DOI 10.2135/cropsci1999.3961652x; Palomeque L, 2010, THEOR APPL GENET, V120, P997, DOI 10.1007/s00122-009-1227-7; Palomeque L, 2009, THEOR APPL GENET, V119, P429, DOI 10.1007/s00122-009-1048-8; Pathan SM, 2013, CROP SCI, V53, P765, DOI 10.2135/cropsci2012.03.0153; Paulo MJ, 2008, EUPHYTICA, V161, P107, DOI 10.1007/s10681-008-9665-x; PEAT WE, 1965, ANN BOT-LONDON, V29, P725, DOI 10.1093/oxfordjournals.aob.a083985; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; [秦鸿德 QIN Hongde], 2008, [南京农业大学学报, Journal of Nanjing Agricultural University], V31, P13; Rao SQ, 1998, HEREDITY, V81, P214, DOI 10.1038/sj.hdy.6883780; Reinprecht Y, 2006, GENOME, V49, P1510, DOI 10.1139/G06-112; Rossi ME, 2013, THEOR APPL GENET, V126, P1809, DOI 10.1007/s00122-013-2094-9; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; Sun DH, 2006, THEOR APPL GENET, V112, P665, DOI 10.1007/s00122-005-0169-y; Takavar S., 2010, Journal of Sciences-Islamic Republic of Iran, V21, P21; Teng W, 2009, HEREDITY, V102, P372, DOI 10.1038/hdy.2008.108; Wang D, 2004, THEOR APPL GENET, V108, P458, DOI 10.1007/s00122-003-1449-z; Wang Z, 2010, EUPHYTICA, V174, P447, DOI 10.1007/s10681-010-0166-3; Wu G., 1987, J ACTA GENET SIN, V14, P363; Wu WR, 1999, GENETICS, V151, P297; Wu XS, 2010, J EXP BOT, V61, P2923, DOI 10.1093/jxb/erq117; Xin DW, 2008, EUPHYTICA, V162, P155, DOI 10.1007/s10681-008-9652-2; Xu SZ, 1996, GENET RES, V68, P175, DOI 10.1017/S0016672300034066; XU YB, 1991, THEOR APPL GENET, V83, P243, DOI 10.1007/BF00226258; Xu YB, 1997, PL BRED RE, V15, P85; Yan JQ, 1998, THEOR APPL GENET, V97, P267, DOI 10.1007/s001220050895; Yan JQ, 1998, GENETICS, V150, P1257; Yang GH, 2006, HEREDITAS, V143, P236, DOI 10.1111/j.2006.0018-0661.01959.x; Yang JC, 2006, NEW PHYTOL, V171, P293, DOI 10.1111/j.1469-8137.2006.01753.x; Yao D, 2015, GENET MOL RES, V14, P6101, DOI 10.4238/2015.June.8.8; Ye ZH, 2003, EUPHYTICA, V129, P183, DOI 10.1023/A:1021974901501; Yuan J, 2002, CROP SCI, V42, P271, DOI 10.2135/cropsci2002.0271; Zhang S, 2017, HEREDITY, V119, P256, DOI 10.1038/hdy.2017.42; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; ZHU J, 1995, GENETICS, V141, P1633	63	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0224897	10.1371/journal.pone.0224897	http://dx.doi.org/10.1371/journal.pone.0224897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747415	Green Published, gold			2022-12-26	WOS:000533881900017
J	Machuki, JA; Aduda, DSO; Omondi, AB; Onono, MA				Machuki, Joel Amenya; Aduda, Dickens S. Omondi; Omondi, Abong'o B.; Onono, Maricianah Atieno			Patient-level cost of home- and facility-based child pneumonia treatment in Suba Sub County, Kenya	PLOS ONE			English	Article							COMMUNITY CASE-MANAGEMENT; MENINGITIS	Background Globally, pneumonia accounted for 16% of deaths among children under 5 years of age and was one of the major causes of death overall in 2018. Kenya is ranked among the top 15 countries with regard to pneumonia prevalence and contributed approximately 74% of the world's annual pneumonia cases in 2018. Unfortunately, less than 50% of children with pneumonia receive appropriate antibiotics for treatment. Homa-Bay County implemented pneumonia community case management utilizing community health workers, as recommended by the World Health Organization (WHO), in 2014. However, since implementation of the program, the relative patient-level cost of home-based and facility-based treatment of pneumonia, as well as the main drivers of these costs in Suba Subcounty, remain uncertain. Therefore, the main objective of this study was to compare the patient-level costs of home based treatment of pneumonia by a community health worker with those of health facility-based treatment. Methods and findings Using a cross-sectional study design, a structured questionnaire was used to collect quantitative data from 208 caregivers on the direct costs (consultation, medicine, transportation) and indirect costs (opportunity cost) of pneumonia treatment. The average household cost for the community managed patients was KSH 122.65 ($1.29) compared with KSh 447.46 ($4.71), a 4-fold difference, for those treated at the health facility. The largest cost drivers for home treatment and health facility treatment were opportunity costs (KSH 88.25 ($ 0.93)) and medicine costs (KSH 126.16 ($ 1.33)), respectively. Conclusion This study demonstrates that the costs incurred for home-based pneumonia management are considerably lower compared to those incurred for facility-based management. Opportunity costs (caregiver time and forgone wages) and the cost of medication were the key cost-drivers in the management of pneumonia at the health facility and at home, respectively. These findings emphasize the need to strengthen and scale community case management to overcome barriers and delays in accessing the correct treatment for pneumonia for sick children under 5 years of age.	[Machuki, Joel Amenya; Onono, Maricianah Atieno] Kenya Govt Med Res Ctr, Dept Res, Kisumu, Kenya; [Aduda, Dickens S. Omondi] Univ Kabianga, Dept Publ Hlth & Community Dev, Kericho, Kenya; [Omondi, Abong'o B.] Natl Univ Lesotho, Dept Biomed Sci & Technol, Maseru, Lesotho; [Omondi, Abong'o B.] Natl Univ Lesotho, Dept Biol, Lesotho, South Africa	Kenya Medical Research Institute	Machuki, JA (corresponding author), Kenya Govt Med Res Ctr, Dept Res, Kisumu, Kenya.	machukijoel2@gmail.com		MACHUKI, JOEL/0000-0002-2089-887X	Kenya Medical Research Institute	Kenya Medical Research Institute	We acknowledge financial support from Kenya Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayieko Philip, 2009, Cost Eff Resour Alloc, V7, P3, DOI 10.1186/1478-7547-7-3; Cupurdija V, 2015, J BRAS PNEUMOL, V41, P48, DOI [10.1590/S1806-37132015000100007, 10.1590/s1806-37132015000100007]; Dang DA, 2010, J HEALTH POPUL NUTR, V28, P436; Druetz T, 2015, HEALTH POLICY PLANN, V30, P253, DOI 10.1093/heapol/czt104; Ho Y-C, 2015, HUM VACC IMMUNOTHER, P11; Hussain H, 2006, INT J HEALTH PLAN M, V21, P229, DOI 10.1002/hpm.847; Ingram M, 2012, J COMMUN HEALTH, V37, P529, DOI 10.1007/s10900-011-9475-2; Kenya National Bureau of Statistics. UNICEF, 2013, UNICEF HOM BAY COUNT, P12; Krishnan Anand, 2005, Indian Journal of Pediatrics, V72, P657, DOI 10.1007/BF02724072; Madsen HO, 2009, TROP MED INT HEALTH, V14, P1315, DOI 10.1111/j.1365-3156.2009.02374.x; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Matovu F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-222; Munge K, 2014, HEALTH POLICY PLANN, V29, P912, DOI 10.1093/heapol/czt073; Onono M, 1992, ACTA PAEDIAT OS S471, V107, P44; Onono M, 2018, ACTA PAEDIATR, V107, P53, DOI 10.1111/apa.14662; Sadruddin S, 2012, AM J TROP MED HYG, V87, P137, DOI 10.4269/ajtmh.2012.12-0242; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Shaw BI, 2016, AM J TROP MED HYG, V94, P1170, DOI 10.4269/ajtmh.15-0784; World Health Organization, 2014, REV WHO CLASS TREATM	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225194	10.1371/journal.pone.0225194	http://dx.doi.org/10.1371/journal.pone.0225194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8LN	31743375	Green Published, gold			2022-12-26	WOS:000533877300022
J	Tian, QL; Gao, X; Sha, TT; Chen, C; Li, L; He, Q; Cheng, G; Wu, XL; Yang, F; Yan, Y				Tian, Qianling; Gao, Xiao; Sha, Tingting; Chen, Cheng; Li, Ling; He, Qiong; Cheng, Gang; Wu, Xialing; Yang, Fan; Yan, Yan			Effect of feeding patterns on growth and nutritional status of children aged 0-24 months: A Chinese cohort study	PLOS ONE			English	Article							CHILDHOOD OBESITY; BREAST; INFANT	Objective This study was aimed to examine the effect of feeding patterns on growth and nutritional status of children aged 0 similar to 24 months. Methods We conducted a cohort study with an initial sample of 927 children. Considering the follow-up losses, 903, 897, 895, 897, 883, 827 and 750 children were followed up at 1, 3, 6, 8, 12, 18 and 24 months, respectively. Children were grouped according to exclusive breastfeeding (EBF) duration in the first 6 months: (1) never EBF; (2) EBF <= 3 months: EBF <= 3 months and stopped BF after 3 months or EBF <= 3 months and BF = 6 months or EBF <= 3 months and BF after 3 months, had formula and/or solids; (3) EBF for 3 similar to 6 months: BF < 3 months and EBF for 3 similar to 6 months or EBF for 3 similar to 6 months and BF < 3 months, had formula and/or solids; (4) EBF = 6 months. We used Z-scores to evaluate the growth and nutritional status of children, used the generalized estimation equation to compare the difference between feeding patterns. Results The generalized estimation equation results showed that Weight-for-age Z-score (WAZ), Length-for-age Z-score (LAZ), and Weight-for-length Z-score (WLZ) in different feeding patterns had statistical significance. The WAZ in EBF for 6 months group was higher in the first 8 months, in never EBF group was higher after 12 months old; the LAZ in EBF for 6 month group was lower than other groups; the WLZ in EBF for 6 months group was higher than EBF for 3 similar to 6 months group. The EBF <= 3 months group had higher underweight, stunting, and wasting rates. The EBF for 6 months had a higher stunting rate; the never EBF and EBF for 6 months groups had higher overweight and obesity rates. Conclusions In conclusion, different feeding patterns affect growth and nutritional status in children, so proper guidelines should be implemented to improve nutritional status and promote the growth of children.	[Tian, Qianling; Gao, Xiao; Sha, Tingting; Chen, Cheng; Li, Ling; He, Qiong; Cheng, Gang; Wu, Xialing; Yang, Fan; Yan, Yan] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China	Central South University	Yan, Y (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	yanyan802394@126.com		Yan, Yan/0000-0001-7479-637X	National Natural Science Foundation of China [81673276, 81373101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China grant numbers 81673276 and 81373101 to YY. URL of funder website: http://www.nsfc.gov.cn/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland Margaret, 2005, Paediatr Child Health, V10, P148; Choi HJ, 2018, EARLY HUM DEV, V127, P42, DOI 10.1016/j.earlhumdev.2018.08.011; Gibbs BG, 2014, PEDIATR OBES, V9, P135, DOI 10.1111/j.2047-6310.2013.00155.x; Haschke F, 2019, NESTLE NUTR WORKS SE, V90, P107, DOI 10.1159/000490299; Hosseini SM, 2014, INT J PREVENTIVE MED, V5, P348; Kim JH, 2010, PAED CHILD HEALT-CAN, V15, P595, DOI 10.1093/pch/15.9.595; Lessen R, 2015, J ACAD NUTR DIET, V115, P444, DOI 10.1016/j.jand.2014.12.014; Natale V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003735; Ouyang FX, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1328-z; Prentice P, 2015, J PEDIATR-US, V166, P276, DOI 10.1016/j.jpeds.2014.10.021; Qu PF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171984; Roelants M, 2010, ANN HUM BIOL, V37, P2, DOI 10.3109/03014460903458080; Rossiter MD, 2015, MATERN CHILD HLTH J, V19, P2048, DOI 10.1007/s10995-015-1717-y; ROSTAMNEGAD M, 2004, J ARDABIL U MED SCI, V4, P30; Spatz DL, 2014, J PERINAT NEONAT NUR, V28, P41, DOI 10.1097/JPN.0000000000000009; Victora CG, 1998, AM J CLIN NUTR, V67, P452, DOI 10.1093/ajcn/67.3.452; Wallby T, 2017, BREASTFEED MED, V12, P48, DOI 10.1089/bfm.2016.0124; Wang L, 2017, CHILD OBES, V13, P197, DOI 10.1089/chi.2016.0210; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; WHO Multicentre Growth Reference Study Group, 1999, IMPL RES DEC INF YOU; WHO UNICEF, 2009, BAB FRIENDL HOSP IN; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Wu Yang-feng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P316; Wu YC, 2016, SOC WORK PUBLIC HLTH, V31, P574, DOI 10.1080/19371918.2015.1137524; Yan J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1267; Yarnoff BO, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00021; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569; Zongrone A, 2012, PUBLIC HEALTH NUTR, V15, P1697, DOI 10.1017/S1368980012001073	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0224968	10.1371/journal.pone.0224968	http://dx.doi.org/10.1371/journal.pone.0224968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743354	Green Published, gold			2022-12-26	WOS:000533877300011
J	Gul, M; Fakhar, M; Najumuddin; Rashid, S				Gul, Mehreen; Fakhar, Muhammad; Najumuddin; Rashid, Sajid			Phosphorylation-dependent activity-based conformational changes in P21-activated kinase family members and screening of novel ATP competitive inhibitors	PLOS ONE			English	Article							PROTEIN-KINASE; PAK1; ACTIVATION; SITE; IDENTIFICATION; OPTIMIZATION; SPECIFICITY; MECHANISM; DISCOVERY; GENOMICS	P21-activated kinases (PAKs) are serine/threonine protein kinases that are subdivided into two groups on the basis of their domain architecture: group-I (PAK1-3) and group-II (PAK4-6). PAKs are considered as attractive drug targets that play vital role in cell proliferation, survival, motility, angiogenesis and cytoskeletal dynamics. In current study, molecular dynamics simulation-based comparative residual contributions and differential transitions were monitored in both active and inactive states of human PAK homologs for therapeutic intervention. Due to their involvement in cancer, infectious diseases, and neurological disorders, it is inevitable to develop novel therapeutic strategies that specifically target PAKs on the basis of their activity pattern. In order to isolate novel inhibitors that are able to bind at the active sites of PAK1 and PAK4, high throughput structure-based virtual screening was performed. Multiple lead compounds were proposed on the basis of their binding potential and targeting region either phosphorylated (active) or unphosphorylated PAK isoform (inactive). Thus, ATP-competitive inhibitors may prove ideal therapeutic choice against PAK family members. The detailed conformational readjustements occurring in the PAKs upon phosphorylation-dephosphorylation events may serve as starting point for devising novel drug molecules that are able to target on activity basis. Overall, the observations of current study may add valuable contribution in the inventory of novel inhibitors that may serve as attractive lead compounds for targeting PAK family members on the basis of activity-based conformational changes.	[Gul, Mehreen; Fakhar, Muhammad; Najumuddin; Rashid, Sajid] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan	Quaid I Azam University	Rashid, S (corresponding author), Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan.	sajidrwp@yahoo.co.uk		Rashid, Sajid/0000-0003-2122-2799				Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aimes RT, 2000, BIOCHEMISTRY-US, V39, P8325, DOI 10.1021/bi992800w; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; BAXTER J, 1981, J OPER RES SOC, V32, P815, DOI 10.2307/2581397; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Blum C, 2008, STUD COMPUT INTELL, V114, P1, DOI 10.1007/978-3-540-78295-7; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Cai XZ, 2009, CANCER BIOL THER, V8, P1360, DOI 10.4161/cbt.8.14.8720; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ching YP, 2003, J BIOL CHEM, V278, P33621, DOI 10.1074/jbc.C300234200; Corvino A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112332; Cotteret S, 2006, MOL CELL BIOL, V26, P3215, DOI 10.1128/MCB.26.8.3215-3230.2006; Crawford JJ, 2015, J MED CHEM, V58, P5121, DOI 10.1021/acs.jmedchem.5b00572; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswaran J, 2007, STRUCTURE, V15, P201, DOI 10.1016/j.str.2007.01.001; Furnari MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061321; Gao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064704; Grant BD, 1996, PROTEIN SCI, V5, P1316, DOI 10.1002/pro.5560050710; Itakura A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073063; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Karpov AS, 2015, ACS MED CHEM LETT, V6, P776, DOI 10.1021/acsmedchemlett.5b00102; Kaur R, 2005, J BIOL CHEM, V280, P3323, DOI 10.1074/jbc.M406701200; Ke YB, 2014, FRONT MED-PRC, V8, P399, DOI 10.1007/s11684-014-0380-9; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kumar R, 2017, GENE, V605, P20, DOI 10.1016/j.gene.2016.12.014; Lee JH, 2013, MOL CELL, V49, P668, DOI 10.1016/j.molcel.2012.12.004; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Ma Qiu-Lan, 2012, Cell Logist, V2, P117; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McCoull W, 2016, ACS MED CHEM LETT, V7, P1118, DOI 10.1021/acsmedchemlett.6b00322; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Ndubaku CO, 2015, ACS MED CHEM LETT, V6, P1241, DOI 10.1021/acsmedchemlett.5b00398; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Ranjitkar P, 2010, CHEM BIOL, V17, P195, DOI 10.1016/j.chembiol.2010.01.008; Robinson R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001681; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Rudolph J, 2015, J MED CHEM, V58, P111, DOI 10.1021/jm501613q; Ryu BJ, 2014, CANCER LETT, V349, P45, DOI 10.1016/j.canlet.2014.03.024; Shao YG, 2016, WORLD J GASTROENTERO, V22, P1224, DOI 10.3748/wjg.v22.i3.1224; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Tariq S, 2018, ARCH PHARM, V351, DOI 10.1002/ardp.201700304; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vadlamudi RK, 2003, CANCER METAST REV, V22, P385, DOI 10.1023/A:1023729130497; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Wang J, 2011, STRUCTURE, V19, P1752, DOI 10.1016/j.str.2011.10.013; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wen YY, 2013, BIOORG MED CHEM LETT, V23, P6636, DOI 10.1016/j.bmcl.2013.10.051; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565	57	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225132	10.1371/journal.pone.0225132	http://dx.doi.org/10.1371/journal.pone.0225132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738805	Green Published, gold			2022-12-26	WOS:000532826300035
J	Vargas-Meza, J; Jauregui, A; Pacheco-Miranda, S; Contreras-Manzano, A; Barquera, S				Vargas-Meza, Jorge; Jauregui, Alejandra; Pacheco-Miranda, Selene; Contreras-Manzano, Alejandra; Barquera, Simon			Front-of-pack nutritional labels: Understanding by low- and middle-income Mexican consumers	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; OBESITY; INFORMATION; RESPONSES; WARNINGS; SYSTEMS; CHOICES; IMPACT	Front-of-pack labeling is a cost-effective strategy to decrease population consumption of sodium, sugar, saturated fat, total fat, and trans-fatty acids, considered critical nutrients for chronic disease. Our main objective was to explore the subjective understanding of labels that are currently used internationally among low- and middle-income Mexican consumers. We performed two phases of 10 focus groups with adolescents (13-15 y), young adults (21-23 y), mothers of children 3-12 y, fathers of children 3-12 y and older adults (55-70 y). Seven FOPL were evaluated: Guideline Daily Amounts, Multiple Traffic Light, Chilean Warning labels, Warning labels in Red, 5-Color Nutrition Label, Health Star Rating, and Healthy Choice label. Data was analyzed with a triangulation of researchers using a content analysis, based on three codes: 1) awareness and use of the Guideline Daily Amounts, 2) acceptability, and 3) subjective understanding of labels. Most participants were aware of the Guideline Daily Amounts, however they rarely used it because interpreting the information displayed on the label was too complicated. Health Star Rating, Warning labels, Multiple Traffic Light and the Healthy Choice logo labels were the most understandable, however the acceptability of the The Healthy Choice logo decreased as it did not provide information on specific ingredients. The Warning labels was the only label able to warn about critical nutrients that could represent a health risk. The Warning labels in red was more accepted compared to Warning labels in black. Results show that directive and semi-directive labels, such as Warning labels, Health Star Rating or Multiple Traffic Light, may be better at helping population of low- and middle income make healthier food choices, than non-directive FOPL such as the Guideline Daily Amounts implemented in Mexico. The study results highlight the potential of Warning labels to support decreases in the consumption of critical ingredients in low- and middle-income Mexican consumers.	[Vargas-Meza, Jorge; Jauregui, Alejandra; Pacheco-Miranda, Selene; Contreras-Manzano, Alejandra; Barquera, Simon] Natl Inst Publ Hlth, Ctr Hlth & Nutr Res, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica	Jauregui, A (corresponding author), Natl Inst Publ Hlth, Ctr Hlth & Nutr Res, Cuernavaca, Morelos, Mexico.	alejandra.jauregui@insp.mx		Vargas Meza, Jorge/0000-0002-6099-2895	Bloomberg Philantrophies	Bloomberg Philantrophies	This work was possible thanks to Bloomberg Philantrophies without restrictions.	Acton RB, 2018, OBESITY, V26, P1687, DOI 10.1002/oby.22311; Andreu J, 2002, FUNDACIN CTR ESTUDIO, V10, P1, DOI 10.2307/334486; [Anonymous], 2017, REV PANAM SALUD PUBL, DOI DOI 10.26633/RPSP.2017.54; Aqueveque Claudio, 2012, ESTUDIO EVALUACION M; Arrua A, 2017, PUBLIC HEALTH NUTR, V20, P2308, DOI 10.1017/S1368980017000866; Arrua A, 2017, APPETITE, V116, P139, DOI 10.1016/j.appet.2017.04.012; Barquera S, 2018, OBESITY, V26, P1530, DOI 10.1002/oby.22296; Becker MW, 2016, ASSESSING ATTENTIONA, P90; Cecchini M, 2016, OBES REV, V17, P201, DOI 10.1111/obr.12364; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chantal J, 2017, PUBLIC HLTH PANORAMA, V3, P712, DOI DOI 10.1016/S2468-2667(18)30009-4; Cho YJ, 2018, SOC SCI MED, V197, P226, DOI 10.1016/j.socscimed.2017.10.003; Corporate Research Associates Inc, 2005, CREAT CONC TEST HLTH; Cortes F, 2008, METODO CIENTIFICO PO; Corvalan C, 2019, OBES REV, V20, P367, DOI 10.1111/obr.12802; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]; DELACRUZGONGORA V, 2017, INT J BEHAV NUTR PHY, V14, DOI DOI 10.1186/S12966-016-0456-9; Diepeveen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-756; Ducrot P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140898; Ducrot P, 2015, NUTRIENTS, V7, P7106, DOI 10.3390/nu7085325; Egnell M, 2018, NUTRIENTS, P10; Freire Wilma B, 2017, Rev. perú. med. exp. salud publica, V34, P11, DOI 10.17843/rpmesp.2017.341.2762; Grunert KG, 2008, PROCESSING ACTING NU, V2030, P1; Grunert KG, 2007, J PUBLIC HEALTH-HEID, V15, P385, DOI 10.1007/s10389-007-0101-9; Hall MG, 2017, J BEHAV MED, V40, P520, DOI 10.1007/s10865-016-9821-z; Hawkes C, 2013, OBES REV, V14, P159, DOI 10.1111/obr.12098; Helfer P, 2014, ANN NY ACAD SCI, V1331, P174, DOI 10.1111/nyas.12461; Hersey JC, 2013, NUTR REV, V71, P1, DOI 10.1111/nure.12000; Julia C, 2017, ERNAHRUNGS UMSCHAU, V64, pM685, DOI 10.4455/eu.2017.048; Liamputtong P., 2016, QUALITATIVE RES METH, V4th; Mantzari Eleni, 2018, Prev Med Rep, V12, P259, DOI 10.1016/j.pmedr.2018.10.016; Maubach N, 2014, APPETITE, V82, P67, DOI 10.1016/j.appet.2014.07.006; Mazza MC, 2018, HEALTH PROMOT PRACT, V19, P925, DOI 10.1177/1524839917740119; Ministerio de Salud de Ecuador, 2014, ROT PROD AL; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Nathan R., 2012, ADV NUTR, V3, P332; Nielsen J., 1993, USABILITY ENG; Nieto C, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0842-1; Rivera JA, 2004, NUTR REV, V62, pS149, DOI 10.1111/j.1753-4887.2004.tb00086.x; Roodenburg AJC, 2011, EUR J CLIN NUTR, V65, P1190, DOI 10.1038/ejcn.2011.101; Sanchez K, 2018, ETIQUETADO ALIMENTOS; Secretaria de Salud, 2013, SECR SALUD, P105, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Stern D, 2011, I NAC SALUD PUBLICA; Strauss A., 2016, BASES INVESTIGACION; Talati Z, 2016, APPETITE, V101, P205, DOI 10.1016/j.appet.2016.03.009; *UK HLTH FOR, 2018, PUBL HLTH FOOD DRINK; van Trijp HCM, 2009, EUR J NUTR, V48, pS41, DOI 10.1007/s00394-009-0075-1; Vyth EL, 2012, NUTR REV, V70, P709, DOI 10.1111/j.1753-4887.2012.00535.x	48	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225268	10.1371/journal.pone.0225268	http://dx.doi.org/10.1371/journal.pone.0225268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN3EY	31738782	Green Published, gold			2022-12-26	WOS:000532826300042
J	Whitmarsh, SK; Amin, DB; Costi, JJ; Dennis, JD; Huveneers, C				Whitmarsh, Sasha K.; Amin, Dhara B.; Costi, John J.; Dennis, Joshua D.; Huveneers, Charlie			Effectiveness of novel fabrics to resist punctures and lacerations from white shark (Carcharodon carcharias): Implications to reduce injuries from shark bites	PLOS ONE			English	Article							FEEDING MECHANISM; MEDIA PORTRAYAL; FORCE; PERFORMANCE; ATTACK; TEETH; PENETRATION; COMPOSITES; BEHAVIOR; ISLAND	Increases in the number of shark bites, along with increased media attention on shark-human interactions has led to growing interest in preventing injuries from shark bites through the use of personal mitigation measures. The leading cause of fatality from shark bite victims is blood loss; thus reducing haemorrhaging may provide additional time for a shark bite victim to be attended to by emergency services. Despite previous shark-proof suits being bulky and cumbersome, new technological advances in fabric has allowed the development of lightweight alternatives that can be incorporated onto traditional wetsuits. The ability for these fabrics to withstand shark bites has not been scientifically tested. In this report, we compared two types of recently developed protective fabrics that incorporated ultra-high molecular weight polyethylene (UHMWPE) fibre onto neoprene (SharkStop and ActionTX) and compared them to standard neoprene alternatives. We tested nine different fabric variants using three different tests, laboratory-based puncture and laceration tests, along with field-based trials involving white sharks Carcharodon carcharias. Field-based trials consisted of measuring C. carcharias bite force and quantifying damages to the new fabrics following a bite from 3-4 m total length C. carcharias. We found that SharkStop and ActionTX fabric variants were more resistant to puncture, laceration, and bites from C. carcharias. More force was required to puncture the new fabrics compared to control fabrics (laboratory-based tests), and cuts made to the new fabrics were smaller and shallower than those on standard neoprene for both types of test, i.e. laboratory and field tests. Our results showed that UHMWPE fibre increased the resistance of neoprene to shark bites. Although the use of UHMWPE fibre (e.g. SharkStop and ActionTX) may therefore reduce blood loss resulting from a shark bite, research is needed to assess if the reduction in damages to the fabrics extends to human tissues and decreased injuries.	[Whitmarsh, Sasha K.; Amin, Dhara B.; Costi, John J.; Dennis, Joshua D.; Huveneers, Charlie] Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia	Flinders University South Australia	Huveneers, C (corresponding author), Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia.	charlie.huveneers@flinders.edu.au		Dennis, Joshua/0000-0002-7442-6667; Whitmarsh, Sasha/0000-0001-8934-2354; Huveneers, Charlie/0000-0001-8937-1358	New South Wales Department of Primary Industries Shark Management Strategy (SMS) Competitive Annual Grants Program	New South Wales Department of Primary Industries Shark Management Strategy (SMS) Competitive Annual Grants Program	This project was funded by the New South Wales Department of Primary Industries Shark Management Strategy (SMS) Competitive Annual Grants Program. The funding agency did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afonso AS, 2017, MAR FRESHWATER RES, V68, P1354, DOI 10.1071/MF16274; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Australian Bureau of Statistics, 2019, POP AUSTR AUSTR BUR; Australian Bureau of Statistics, 2019, MAN PEOPL LIV AUSTR; Ballas R, 2017, J TRAUMA ACUTE CARE, V82, P952, DOI 10.1097/TA.0000000000001399; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergman JN, 2017, J FISH BIOL, V91, P460, DOI 10.1111/jfb.13351; Breeze J, 2013, J FORENSIC LEG MED, V20, P296, DOI 10.1016/j.jflm.2012.12.007; Burgess GH, 2010, CRC MAR BIOL SER, P541; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chapman BK, 2016, OCEAN COAST MANAGE, V133, P72, DOI 10.1016/j.ocecoaman.2016.09.010; Colefax AP, 2019, OCEAN COAST MANAGE, V174, P108, DOI 10.1016/j.ocecoaman.2019.03.008; Crossley Roxanne, 2014, Human Dimensions of Wildlife, V19, P154; Curtis T, 2012, GLOBAL PERSPECTIVES, VFirst, P477; Ding BY, 2014, J DYN SYST-T ASME, V136, DOI 10.1115/1.4027945; Elvin A., 2018, IMPROVED WETSUIT DES; Engelbrecht T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185335; Ertekin M, 2016, J TEXT I, V107, P1276, DOI 10.1080/00405000.2015.1100820; Ferrara TL, 2011, J BIOMECH, V44, P430, DOI 10.1016/j.jbiomech.2010.09.028; Fox J., 2012, PACKAGE CAR; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Greenhalgh ES, 2013, COMPOS PART A-APPL S, V44, P51, DOI 10.1016/j.compositesa.2012.08.012; Habegger ML, 2012, ZOOLOGY, V115, P354, DOI 10.1016/j.zool.2012.04.007; Hart NS, 2015, INTEGR ZOOL, V10, P38, DOI 10.1111/1749-4877.12095; Hausmann JT., 2006, OSTEO TRAUMA CARE, V14, P259, DOI DOI 10.1055/S-2006-942333; Hazzard MK, 2017, INT J IMPACT ENG, V100, P35, DOI 10.1016/j.ijimpeng.2016.10.007; Huber DR, 2008, J R SOC INTERFACE, V5, P941, DOI 10.1098/rsif.2007.1325; Huber DR, 2006, ZOOLOGY, V109, P109, DOI 10.1016/j.zool.2005.12.002; Huber DR, 2009, PHYSIOL BIOCHEM ZOOL, V82, P20, DOI 10.1086/588177; Huber DR, 2005, J EXP BIOL, V208, P3553, DOI 10.1242/jeb.01816; Huber DR, 2004, J EXP ZOOL PART A, V301A, P26, DOI 10.1002/jez.a.20003; Huber DR, 2006, CRANIAL BIOMECHANICS; Huveneers C, 2018, PEERJ, V6, DOI 10.7717/peerj.5554; Huveneers C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062730; Jussila J, 2004, FORENSIC SCI INT, V141, P91, DOI 10.1016/j.forsciint.2003.11.036; Karbalaie M, 2012, J THERMOPLAST COMPOS, V25, P403, DOI 10.1177/0892705711411339; Kempster RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157717; Lemahieu A, 2017, OCEAN COAST MANAGE, V136, P73, DOI 10.1016/j.ocecoaman.2016.11.020; Lentz AK, 2010, AM SURGEON, V76, P101; Mara KR, 2010, EVOLUTION HAMMERHEAD; Mara KR, 2010, J EXP ZOOL PART A, V313A, P95, DOI 10.1002/jez.576; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; May C, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190456; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; McPhee D, 2014, COAST MANAGE, V42, P478, DOI 10.1080/08920753.2014.942046; Meyer CG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23006-0; Motta PJ, 1997, J EXP BIOL, V200, P2765; Motta PJ, 2001, ENVIRON BIOL FISH, V60, P131, DOI 10.1023/A:1007649900712; Moyer JK, 2017, ZOOLOGY, V120, P101, DOI 10.1016/j.zool.2016.05.007; Muter BA, 2013, CONSERV BIOL, V27, P187, DOI 10.1111/j.1523-1739.2012.01952.x; R Core Team, 2021, R LANG ENV STAT; Ritter E, 2004, J Forensic Odontostomatol, V22, P40; Sabatier E, 2018, CONSERV SOC, V16, P338, DOI 10.4103/cs.cs_18_5; Shishoo R., 2002, INT J CLOTH SCI TECH, V14, P201; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Utomo B.D.H., 2008, J SOLID MECH MAT ENG, V2, P707, DOI DOI 10.1299/JMMP.2.707; Van Dingenen J., 1989, MAT DES, V10, P101, DOI [DOI 10.1016/S0261-3069(89)80021-4, 10.1016/S0261-3069(89)80021-4]; Walley SM, 2009, DYMAT 2009: 9TH INTERNATIONAL CONFERENCE ON THE MECHANICAL AND PHYSICAL BEHAVIOUR OF MATERIALS UNDER DYNAMIC LOADING, VOL 2, P1133, DOI 10.1051/dymat/2009158; Wang HX, 2017, POLYM TEST, V61, P17, DOI 10.1016/j.polymertesting.2017.04.026; West JG, 2011, MAR FRESHWATER RES, V62, P744, DOI 10.1071/MF10181; Whitenack LB, 2011, J MORPHOL, V272, P169, DOI 10.1002/jmor.10903; Whitenack LB, 2010, BIOL J LINN SOC, V100, P271, DOI 10.1111/j.1095-8312.2010.01421.x; Woolgar JD, 2001, J TRAUMA, V50, P887, DOI 10.1097/00005373-200105000-00019; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x	64	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0224432	10.1371/journal.pone.0224432	http://dx.doi.org/10.1371/journal.pone.0224432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738770	Green Published, gold			2022-12-26	WOS:000532826300015
J	Bencardino, G; Spera, FR; Pinnacchio, G; Perna, F; Narducci, ML; Comerci, G; Pelargonio, G; Gabrielli, FA; La Rosa, G; Lanza, GA; Crea, F				Bencardino, Gianluigi; Spera, Francesco Raffaele; Pinnacchio, Gaetano; Perna, Francesco; Narducci, Maria Lucia; Comerci, Gianluca; Pelargonio, Gemma; Gabrielli, Francesca Augusta; La Rosa, Giulio; Lanza, Gaetano Antonio; Crea, Filippo			Prognostic significance of non-sustained ventricular tachycardia on stored electrograms in pacemaker recipients	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CLINICAL-SIGNIFICANCE; RECOMMENDATIONS; ARRHYTHMIAS	Background Little is known about the prognostic significance of non-sustained ventricular tachycardia (NS-VT) in outpatients scheduled for routine pacemaker controls. We therefore sought to investigate the prognostic significance of non-sustained ventricular tachycardia on stored electrograms in pacemaker recipients. Methods We enrolled patients implanted with dual chamber pacemaker for atrioventricular block or sinus node dysfunction from 2010 to 2016, with LVEF> 45%, older than 18 years, with at least 3 device interrogations at follow-up. Data were collected about medical history, pharmacological therapy at implantation, pacemaker programming, NS-VT occurrence, long-term survival. Results A total of 308 patients were included in the final analysis, with median follow-up time of 56 months. No ventricular arrhythmic episodes were documented in 221 patients (Group 1), whereas 87 had at least 1 episode of NS-VT during follow-up (Group 2). As a whole, 282 episodes of NS-VT were documented. There was a higher prevalence of previous myocardial infarction and slightly lower left ventricular ejection fraction (LVEF) in Group 2. The primary endpoint (all-cause mortality) occurred in 50 patients (22%) of Group 1 and 12 (14%) patients of Group 2 (p = 0.07). Clinical predictors of all-cause mortality at univariate analysis included age, LVEF and coronary artery disease (CAD). Only age and CAD, however, remained as predictors of mortality at multivariable analysis. A sizeable, but not statistically significant, portion of patients who died had a de novo occurrence of NS-VT at the last pacemaker check. Conclusion Our data do not support a prognostic role for the detection of NS-VT during pacemaker controls.	[Bencardino, Gianluigi; Spera, Francesco Raffaele; Pinnacchio, Gaetano; Perna, Francesco; Narducci, Maria Lucia; Comerci, Gianluca; Pelargonio, Gemma; Gabrielli, Francesca Augusta; La Rosa, Giulio; Lanza, Gaetano Antonio; Crea, Filippo] Fdn Policlin Univ Agostino Gemelli IRCC, Dipartimento Sci Cardiovasc & Toraciche, Rome, Italy; [Pelargonio, Gemma; Lanza, Gaetano Antonio; Crea, Filippo] Univ Cattolica Sacro Cuore, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Bencardino, G (corresponding author), Fdn Policlin Univ Agostino Gemelli IRCC, Dipartimento Sci Cardiovasc & Toraciche, Rome, Italy.	gl.bencardino@libero.it	; Perna, Francesco/K-4813-2018	La Rosa, Giulio/0000-0001-7360-1999; BENCARDINO, GIANLUIGI/0000-0003-4737-1143; Perna, Francesco/0000-0002-9019-9492				Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; BUXTON AE, 1993, PROG CARDIOVASC DIS, V36, P215, DOI 10.1016/0033-0620(93)90015-6; Cheema AN, 1998, CIRCULATION, V98, P2030, DOI 10.1161/01.CIR.98.19.2030; Engstrom G, 1999, J INTERN MED, V246, P363, DOI 10.1046/j.1365-2796.1999.00509.x; Gabriels J, 2016, PACE, V39, P1335, DOI 10.1111/pace.12968; Haqeel AJ, 2019, AM J CARDIOL, V123, P409, DOI [10.1016/j.amjcard.2018.10.040, DOI 10.1016/J.AMJCARD.2018.10.040]; Katritsis DG, 2004, EUR HEART J, V25, P1093, DOI 10.1016/j.ehj.2004.03.022; Larsson B, 2003, PACE, V26, P114, DOI 10.1046/j.1460-9592.2003.00162.x; Lin CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160181; Mammarella A, 2000, ADV THER, V17, P222, DOI 10.1007/BF02853161; Mittal S, 2002, J CARDIOVASC ELECTR, V13, P342, DOI 10.1046/j.1540-8167.2002.00342.x; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Senges JC, 2002, PACE, V25, P183, DOI 10.1046/j.1460-9592.2002.00183.x; Seth N, 2015, PACE, V38, P980, DOI 10.1111/pace.12632; Zhou XH, 2004, J CARDIOVASC ELECTR, V15, P14, DOI 10.1046/j.1540-8167.2004.03154.x; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	16	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225059	10.1371/journal.pone.0225059	http://dx.doi.org/10.1371/journal.pone.0225059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730671	gold, Green Published			2022-12-26	WOS:000532809500022
J	Takayanagi, H; Hayase, J; Kamakura, S; Miyano, K; Chishiki, K; Yuzawa, S; Sumimoto, H				Takayanagi, Hiroki; Hayase, Junya; Kamakura, Sachiko; Miyano, Kei; Chishiki, Kanako; Yuzawa, Satoru; Sumimoto, Hideki			Intramolecular interaction in LGN, an adaptor protein that regulates mitotic spindle orientation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; cell division; cytoskeleton; G protein; mitosis; protein conformation; protein domain; protein motif; protein-protein interaction; nuclear mitotic apparatus protein (NuMA)	ASYMMETRIC CELL-DIVISION; STRUCTURAL BASIS; CORTICAL DYNEIN; GOLOCO MOTIF; NUMA; POLARITY; BINDING; CHROMOSOME; POSITION; MITOSIS	Proper mitotic spindle orientation requires that astral microtubules are connected to the cell cortex by the microtubule-binding protein NuMA, which is recruited from the cytoplasm. Cortical recruitment of NuMA is at least partially mediated via direct binding to the adaptor protein LGN. LGN normally adopts a closed conformation via an intramolecular interaction between its N-terminal NuMA-binding domain and its C-terminal region that contains four GoLoco (GL) motifs, each capable of binding to the membrane-anchored G?(i) subunit of heterotrimeric G protein. Here we show that the intramolecular association with the N-terminal domain in LGN involves GL3, GL4, and a region between GL2 and GL3, whereas GL1 and GL2 do not play a major role. This conformation renders GL1 but not the other GL motifs in a state easily accessible to G?(i). To interact with full-length LGN in a closed state, NuMA requires the presence of G?(i); both NuMA and G?(i) are essential for cortical recruitment of LGN in mitotic cells. In contrast, mInsc, a protein that competes with NuMA for binding to LGN and regulates mitotic spindle orientation in asymmetric cell division, efficiently binds to full-length LGN without G?(i) and induces its conformational change, enhancing its association with G?(i). In nonpolarized symmetrically dividing HeLa cells, disruption of the LGN?NuMA interaction by ectopic expression of mInsc results in a loss of cortical localization of NuMA during metaphase and anaphase and promotes mitotic spindle misorientation and a delayed anaphase progression. These findings highlight a specific role for LGN-mediated cell cortex recruitment of NuMA.	[Takayanagi, Hiroki; Hayase, Junya; Kamakura, Sachiko; Miyano, Kei; Chishiki, Kanako; Yuzawa, Satoru; Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka, Fukuoka 8128582, Japan	Kyushu University	Sumimoto, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka, Fukuoka 8128582, Japan.	hsumi@med.kyushu-u.ac.jp		Yuzawa, Satoru/0000-0002-1031-5781	Ministry of Education, Culture, Sports, Science and Technology [JP26111009]; Japan Society for the Promotion of Science KAKENHI [JP18K06934]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" JP26111009 (to H. S.); and Japan Society for the Promotion of Science KAKENHI Grant JP18K06934 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bergstralh DT, 2017, DEVELOPMENT, V144, P1137, DOI 10.1242/dev.140764; Chapard C, 2014, J CELL SCI, V127, P5149, DOI 10.1242/jcs.152579; Chishiki K, 2017, GENES CELLS, V22, P293, DOI 10.1111/gtc.12477; Chishiki K, 2013, BIOCHEM BIOPH RES CO, V435, P414, DOI 10.1016/j.bbrc.2013.04.103; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Culurgioni S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03343-4; Culurgioni S, 2011, P NATL ACAD SCI USA, V108, P20998, DOI 10.1073/pnas.1113077108; di Pietro F, 2016, EMBO REP, V17, P1106, DOI 10.15252/embr.201642292; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Hayase J, 2013, J CELL BIOL, V200, P635, DOI 10.1083/jcb.201208150; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Iwakiri Y, 2013, BIOCHEM J, V451, P195, DOI 10.1042/BJ20121447; Izaki T, 2006, BIOCHEM BIOPH RES CO, V341, P1001, DOI 10.1016/j.bbrc.2006.01.050; Jia M, 2012, J BIOL CHEM, V287, P36766, DOI 10.1074/jbc.M112.391607; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kiyomitsu T, 2015, TRENDS CELL BIOL, V25, P286, DOI 10.1016/j.tcb.2014.12.003; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kotak S, 2014, EMBO J, V33, P1815, DOI 10.15252/embj.201488147; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; Larson ME, 2017, MOL BIOL CELL, V28, P746, DOI 10.1091/mbc.E16-06-0355; Lazaro-Dieguez F, 2015, MOL BIOL CELL, V26, P1286, DOI 10.1091/mbc.E14-08-1330; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Matsumura S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1634; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Pan Z, 2013, STRUCTURE, V21, P1007, DOI 10.1016/j.str.2013.04.005; Pirovano L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09999-w; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; Seldin L, 2013, MOL BIOL CELL, V24, P3651, DOI 10.1091/mbc.E13-05-0277; Takayanagi H, 2015, ACTA CRYSTALLOGR F, V71, P175, DOI 10.1107/S2053230X14028143; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tuncay H, 2016, CELL MOL LIFE SCI, V73, P1195, DOI 10.1007/s00018-015-2116-7; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Williams SE, 2014, NAT CELL BIOL, V16, P758, DOI 10.1038/ncb3001; Williams SE, 2013, CURR OPIN CELL BIOL, V25, P749, DOI 10.1016/j.ceb.2013.08.003; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yasumi M, 2005, J BIOL CHEM, V280, P6761, DOI 10.1074/jbc.C400440200; Yuzawa S, 2011, P NATL ACAD SCI USA, V108, P19210, DOI 10.1073/pnas.1110951108; Zheng Z, 2014, MOL BIOL CELL, V25, P606, DOI 10.1091/mbc.E13-08-0474; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011	55	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19655	19666		10.1074/jbc.RA119.011457	http://dx.doi.org/10.1074/jbc.RA119.011457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31732560	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000504093200017
J	Salas-Martinez, MG; Saldana-Alvarez, Y; Cordova, EJ; Mendiola-Soto, DK; Cid-Soto, MA; Luckie-Duque, A; Vicenteno-Ayala, H; Barajas-Olmos, F; Contreras-Cubas, C; Garcia-Ortiz, H; Jimenez-Ruiz, JL; Centeno-Cruz, F; Martinez-Hernandez, A; Mendoza-Caamal, EC; Mirzaeicheshmeh, E; Orozco, L				Guadalupe Salas-Martinez, Maria; Saldana-Alvarez, Yolanda; Cordova, Emilio J.; Karen Mendiola-Soto, Diana; Cid-Soto, Miguel A.; Luckie-Duque, Angelica; Vicenteno-Ayala, Hermenegildo; Barajas-Olmos, Francisco; Contreras-Cubas, Cecilia; Garcia-Ortiz, Humberto; Jimenez-Ruiz, Juan L.; Centeno-Cruz, Federico; Martinez-Hernandez, Angelica; Mendoza-Caamal, Elvia C.; Mirzaeicheshmeh, Elaheh; Orozco, Lorena			Genetic variability of five ADRB2 polymorphisms among Mexican Amerindian ethnicities and the Mestizo population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MYOCARDIAL-INFARCTION; ASSOCIATION; RISK; SUSCEPTIBILITY; HYPERTENSION; ASTHMA; COMMON; PHARMACOGENETICS; HAPLOTYPES	The Mexican population is characterized by high and particular admixture, and the picture of variants associated with disease remains unclear. Here we investigated the distribution of single nucleotide polymorphisms (SNPs) in the Mexican population. We focused on two nonsynonymous and three synonymous SNPs in the beta-2 adrenergic receptor gene (ADRB2), which plays key roles in energy balance regulation. These SNPs were genotyped in 2,011 Mexican Amerindians (MAs) belonging to 62 ethnic groups and in 1,980 geographically matched Mexican Mestizos (MEZs). The frequency distribution of all five ADRB2 variants significantly differed between MAs, MEZs, and other continental populations (CPs) from the 1000 Genomes database. Allele frequencies of the three synonymous SNPs rs1042717A, rs1042718A, and rs1042719C were significantly higher in Mexican individuals, particularly among MAs, compared to in the other analyzed populations (P<0.05). The non-synonymous ADRB2 Glu27 allele (rs1042714G), which is associated with several common conditions, showed the lowest frequency in MAs (0.03) compared to other populations worldwide. Among MEZs, this allele showed a frequency of 0.15, intermediate between that in MAs and in Iberians (0.43). Moreover, Glu27 was the only SNP exhibiting a geographic gradient within the MEZ population (from 0.22 to 0.11), reflecting admixed mestizo ancestry across the country. Population differentiation analysis demonstrated that Glu27 had the highest F-ST value in MAs compared with Europeans (CEU) (0.71), and the lowest between MAs and Japanese (JPT) (0.01), even lower than that observed between MAs and MEZs (0.08). This analysis demonstrated the genetic diversity among Amerindian ethnicities, with the most extreme FST value (0.34) found between the Nahuatls from Morelos and the Seris. This is the first study of ADRB2 genetic variants among MA ethnicities. Our findings add to our understanding of the genetic contribution to variability in disease susceptibility in admixed populations.	[Guadalupe Salas-Martinez, Maria; Saldana-Alvarez, Yolanda; Cordova, Emilio J.; Karen Mendiola-Soto, Diana; Cid-Soto, Miguel A.; Barajas-Olmos, Francisco; Contreras-Cubas, Cecilia; Garcia-Ortiz, Humberto; Jimenez-Ruiz, Juan L.; Centeno-Cruz, Federico; Martinez-Hernandez, Angelica; Mirzaeicheshmeh, Elaheh; Orozco, Lorena] Secretaria Salud Mexico, Immunogen & Metab Dis Lab, Inst Nacl Med Genom, Mexico City, DF, Mexico; [Guadalupe Salas-Martinez, Maria; Orozco, Lorena] Univ Autonoma Ciudad Mexico, Genom Sci Program, Mexico City, DF, Mexico; [Luckie-Duque, Angelica] ISSSTE, Hosp Reg 1 Octubre, Mexico City, DF, Mexico; [Vicenteno-Ayala, Hermenegildo] ISSSTE, Hosp Reg Adolfo Lopez Mateos, Mexico City, DF, Mexico; [Mendoza-Caamal, Elvia C.] Secretaria Salud Mexico, Inst Nacl Med Genom, Clin Area, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica	Orozco, L (corresponding author), Secretaria Salud Mexico, Immunogen & Metab Dis Lab, Inst Nacl Med Genom, Mexico City, DF, Mexico.; Orozco, L (corresponding author), Univ Autonoma Ciudad Mexico, Genom Sci Program, Mexico City, DF, Mexico.	lorozco@inmegen.gob.mx	Barajas, Francisco/GLV-6617-2022	Orozco, Lorena/0000-0002-5801-9180; Centeno Cruz, Federico/0000-0002-3512-4519	Consejo Nacional de Ciencia y Tecnologia Mexico, (CONACyT) [S008-2014-1-233970]	Consejo Nacional de Ciencia y Tecnologia Mexico, (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the Consejo Nacional de Ciencia y Tecnologia Mexico, (CONACyT) grant numbers: S008-2014-1-233970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anwar MS, 2015, PHARMACOGENOMICS, V16, P1817, DOI 10.2217/pgs.15.120; Cagliani R, 2009, AM J HUM GENET, V85, P64, DOI 10.1016/j.ajhg.2009.06.005; Contreras-Cubas C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163248; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Gorlov IP, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005371; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Kidd JR, 2011, AM J PHYS ANTHROPOL, V146, P495, DOI 10.1002/ajpa.21560; Klimentidis YC, 2011, HUM GENET, V129, P407, DOI 10.1007/s00439-010-0935-z; Kulminski AM, 2010, MECH AGEING DEV, V131, P338, DOI 10.1016/j.mad.2010.04.001; Larocca N, 2013, BIOMED PAP, V157, P374, DOI 10.5507/bp.2012.084; Liang SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104488; Litonjua AA, 2010, PHARMACOGENET GENOM, V20, P64, DOI 10.1097/FPC.0b013e328333dae6; Mansley MK, 2016, KIDNEY INT REP, V1, P197, DOI 10.1016/j.ekir.2016.08.003; Valencia DM, 2013, BIOMEDICA, V33, P598, DOI 10.7705/biomedica.v33i4.1489; Martinez-Aguilar NE, 2015, J ASTHMA, V52, P232, DOI 10.3109/02770903.2014.966913; Masuo K, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/832821; Baas OM, 2014, CURR EYE RES, V39, P1076, DOI 10.3109/02713683.2014.900807; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; Ordonez G, 2015, CLIN NEUROL NEUROSUR, V130, P55, DOI 10.1016/j.clineuro.2014.11.026; Ortega VE, 2014, J ALLERGY CLIN IMMUN, V133, P16, DOI 10.1016/j.jaci.2013.10.040; Pickrell JK, 2014, TRENDS GENET, V30, P377, DOI 10.1016/j.tig.2014.07.007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saadi AV, 2013, INFECT GENET EVOL, V20, P140, DOI 10.1016/j.meegid.2013.08.026; Takenaka A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043461; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Tomar A, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0268-y; Vargas-Alarcon G, 2009, ARTHRITIS RHEUM-US, V60, P2169, DOI 10.1002/art.24655; Wang DW, 2015, GENET MOL BIOL, V38, P433, DOI 10.1590/S1415-475738420140234; Wechsler ME, 2011, AM J RESP CRIT CARE, V184, P1247, DOI 10.1164/rccm.201103-0514OC; Xia K, 2017, GENE, V624, P43, DOI 10.1016/j.gene.2017.04.045; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Zhang H.Z., 2014, AREAL RES DEV, V2, P16, DOI DOI 10.1371/J0URNAL.P0NE.0100489; Zhao L, 2012, AGING CELL, V11, P1094, DOI 10.1111/acel.12011	40	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0225030	10.1371/journal.pone.0225030	http://dx.doi.org/10.1371/journal.pone.0225030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790415	gold, Green Published			2022-12-26	WOS:000533930800022
J	Santaus, TM; Greenberg, K; Suri, P; Geddes, CD				Santaus, Tonya M.; Greenberg, Ken; Suri, Prabhdeep; Geddes, Chris D.			Elucidation of a non-thermal mechanism for DNA/RNA fragmentation and protein degradation when using Lyse-It	PLOS ONE			English	Article							METAL-ENHANCED FLUORESCENCE; MICROWAVE-TRIGGERED CHEMILUMINESCENCE; DNA; PROBES; EXTRACTION; CELLS; ASSAY; ROS	Rapid sample preparation is one of the leading bottlenecks to low-cost and efficient sample component detection. To overcome this setback, a technology known as Lyse-It has been developed to rapidly (less than 60 seconds) lyse Gram-positive and-negative bacteria alike, while simultaneously fragmenting DNA/RNA and proteins into tunable sizes. This technology has been used with a variety of organisms, but the underlying mechanism behind how the technology actually works to fragment DNA/RNA and proteins has hitherto been studied. It is generally understood how temperature affects cellular lysing, but for DNA/RNA and protein degradation, the temperature and amount of energy introduced by microwave irradiation of the sample, cannot explain the degradation of the biomolecules to the extent that was being observed. Thus, an investigation into the microwave generation of reactive oxygen species, in particular singlet oxygen, hydroxyl radicals, and superoxide anion radicals, was undertaken. Herein, we probe one aspect, the generation of reactive oxygen species (ROS), which is thought to contribute to a non-thermal mechanism behind biomolecule fragmentation with the Lyse-It technology. By utilizing off/on (Photoinduced electron transfer) PET fluorescent-based probes highly specific for reactive oxygen species, it was found that as oxygen concentration in the sample and/or microwave irradiation power increases, more reactive oxygen species are generated and ultimately, more oxidation and biomolecule fragmentation occurs within the microwave cavity.	[Santaus, Tonya M.; Greenberg, Ken; Suri, Prabhdeep; Geddes, Chris D.] Univ Maryland Baltimore Cty, Chem & Biochem Dept, Baltimore, MD 21228 USA; [Santaus, Tonya M.; Geddes, Chris D.] Univ Maryland Baltimore Cty, Inst Fluorescence, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County	Geddes, CD (corresponding author), Univ Maryland Baltimore Cty, Chem & Biochem Dept, Baltimore, MD 21228 USA.; Geddes, CD (corresponding author), Univ Maryland Baltimore Cty, Inst Fluorescence, Baltimore, MD 21228 USA.	geddes@umbc.edu		Geddes, Chris/0000-0002-9110-6374; Santaus, Tonya/0000-0002-8643-2343	National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship [T32GM066706-15]	National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship	This work is supported by the National Institutes of Health UMBC Graduate Training Chemistry Biology Interface Fellowship (T32GM066706-15) to TMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan K, 2005, ANAL CHEM, V77, P8057, DOI 10.1021/ac0516077; Aslan K, 2008, ANALYST, V133, P1469, DOI 10.1039/b808292h; Aslan K, 2008, ANAL CHEM, V80, P4125, DOI 10.1021/ac800519r; Aslan K, 2007, ANALYST, V132, P1130, DOI 10.1039/b707876e; Aslan K, 2006, PLASMONICS, V1, P53, DOI 10.1007/s11468-006-9006-7; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Dragan AI, 2012, ANAL BIOCHEM, V425, P54, DOI 10.1016/j.ab.2012.02.040; Garcia-Diaz M, 2016, METHODS, V109, P158, DOI 10.1016/j.ymeth.2016.06.025; Kim S, 2013, PHOTOCHEMISTRY SINGL, P13985; KNIGHT JA, 1995, ANN CLIN LAB SCI, V25, P111; Krumova K, 2016, OVERVIEW REACTIVE OX, P3; Lunec J, 2002, FREE RADICAL BIO MED, V33, P875, DOI 10.1016/S0891-5849(02)00882-1; Melendez JH, 2016, ANAL BIOCHEM, V510, P33, DOI 10.1016/j.ab.2016.06.017; Melendez JH, 2013, J CLIN MICROBIOL, V51, P2913, DOI 10.1128/JCM.00980-13; Pannunzio NR, 2017, MOL CELL, V68, P901, DOI 10.1016/j.molcel.2017.11.011; Previte MJR, 2007, ANAL CHEM, V79, P7042, DOI 10.1021/ac071042+; Previte MJR, 2007, J FLUORESC, V17, P279, DOI 10.1007/s10895-007-0170-8; Ragas X, 2009, CHEM COMMUN, P2920, DOI 10.1039/b822776d; Ray RS, 2013, TOXICOLOGY, V314, P229, DOI 10.1016/j.tox.2013.10.002; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Santaus T., 2019, FOCUSED MICROW UNPUB; Santaus T, 2019, EFFECTS LYSE I UNPUB; Santaus T.M., 2017, MICROWAVE EFFECTS DN, P275, DOI [10.1007/978-3-319-50289-2_8, DOI 10.1007/978-3-319-50289-2_8]; Santaus TM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201070; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Sugiyama I, 2010, COLLOID POLYM SCI, V288, P1293, DOI 10.1007/s00396-010-2256-0; Tripathy S, 2017, INT J PHARM SCI RES, V8, P1, DOI 10.13040/IJPSR.0975-8232.8(1).1-16; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Waris G, 1998, ATTENUATED ANTIGENIC, P33; Zhang YX, 2011, IEEE T BIO-MED ENG, V58, P781, DOI 10.1109/TBME.2010.2066275	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0225475	10.1371/journal.pone.0225475	http://dx.doi.org/10.1371/journal.pone.0225475			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LC2NX	31790434	Green Published, gold			2022-12-26	WOS:000525164900001
J	Banos, G; Clark, EL; Bush, SJ; Dutta, P; Bramis, G; Arsenos, G; Hume, DA; Psifidi, A				Banos, Georgios; Clark, Emily L.; Bush, Stephen J.; Dutta, Prasun; Bramis, Georgios; Arsenos, Georgios; Hume, David A.; Psifidi, Androniki			Genetic and genomic analyses underpin the feasibility of concomitant genetic improvement of milk yield and mastitis resistance in dairy sheep	PLOS ONE			English	Article							SOMATIC-CELL SCORE; CHIOS SHEEP; ASSOCIATION; TRAITS; EXPRESSION; PARAMETERS; DISCOVERY; APOPTOSIS; UDDER; GHR	Milk yield is the most important dairy sheep trait and constitutes the key genetic improvement goal via selective breeding. Mastitis is one of the most prevalent diseases, significantly impacting on animal welfare, milk yield and quality, while incurring substantial costs. Our objectives were to determine the feasibility of a concomitant genetic improvement programme for enhanced milk production and resistance to mastitis. Individual records for milk yield, and four mastitis-related traits (milk somatic cell count, California Mastitis Test score, total viable bacterial count in milk and clinical mastitis presence) were collected monthly throughout lactation for 609 ewes of the Chios breed. All ewes were genotyped with a mastitis specific custom-made 960 single nucleotide polymorphism (SNP) array. We performed targeted genomic association studies, (co)variance component estimation and pathway enrichment analysis, and characterised gene expression levels and the extent of allelic expression imbalance. Presence of heritable variation for milk yield was confirmed. There was no significant genetic correlation between milk yield and mastitis traits. Environmental factors appeared to favour both milk production and udder health. There were no overlapping of SNPs associated with mastitis resistance and milk yield in Chios sheep. Furthermore, four distinct Quantitative Trait Loci (QTLs) affecting milk yield were detected on chromosomes 2, 12, 16 and 19, in locations other than those previously identified to affect mastitis resistance. Five genes (DNAJA1, GHR, LYPLA1, NUP35 and OXCT1) located within the QTL regions were highly expressed in both the mammary gland and milk transcriptome, suggesting involvement in milk synthesis and production. Furthermore, the expression of two of these genes (NUP35 and OXCT1) was enriched in immune tissues implying a potentially pleiotropic effect or likely role in milk production during udder infection, which needs to be further elucidated in future studies. In conclusion, the absence of genetic antagonism between milk yield and mastitis resistance suggests that simultaneous genetic improvement of both traits be achievable.	[Banos, Georgios] Scotlands Rural Coll, Edinburgh, Midlothian, Scotland; [Banos, Georgios; Clark, Emily L.; Bush, Stephen J.; Dutta, Prasun; Hume, David A.; Psifidi, Androniki] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Banos, Georgios; Bramis, Georgios; Arsenos, Georgios] Aristotle Univ Thessaloniki, Sch Vet Med, Thessaloniki, Greece; [Bush, Stephen J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford, England; [Hume, David A.] Univ Queensland, Translat Res Inst, Mater Res Inst, Woolloongabba, Qld, Australia; [Psifidi, Androniki] Univ London, Royal Vet Coll, Hatfield, Herts, England	Scotland's Rural College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Aristotle University of Thessaloniki; University of Oxford; Mater Research; University of Queensland; University of London; University of London Royal Veterinary College	Psifidi, A (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.; Psifidi, A (corresponding author), Univ London, Royal Vet Coll, Hatfield, Herts, England.	apsifidi@rvc.ac.uk	Bush, Stephen/GQO-9103-2022; Bush, Stephen/J-7405-2019; Bush, Stephen/GPX-3353-2022; Arsenos, Georgios/AAO-7147-2021; Dutta, Prasun/AFQ-8429-2022; Clark, Emily/GVR-7159-2022	Bush, Stephen/0000-0001-9341-2562; Bush, Stephen/0000-0001-9341-2562; Bush, Stephen/0000-0001-9341-2562; Arsenos, Georgios/0000-0003-3224-5128; Bramis, Georgios/0000-0001-7271-7180; Hume, David/0000-0002-2615-1478; Clark, Emily/0000-0002-9550-7407; Banos, Georgios/0000-0002-7674-858X	Seven Framework Program of the European Commission (project: '3SR: Sustainable Solutions for Small Ruminants'); Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L001209/1, BB/J004235/1, BBS/E/D/20211550, BB/P013732/1, BB/P013759/1]; Laboratory of Animal Production, School of Veterinary Medicine, Aristotle University of Thessaloniki, Greece; Rural & Environment Science & Analytical Services Division of the Scottish Government; BBSRC [BBS/E/D/20211550, BB/L001209/1] Funding Source: UKRI	Seven Framework Program of the European Commission (project: '3SR: Sustainable Solutions for Small Ruminants'); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Laboratory of Animal Production, School of Veterinary Medicine, Aristotle University of Thessaloniki, Greece; Rural & Environment Science & Analytical Services Division of the Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was partly supported by the Seven Framework Program of the European Commission (project: '3SR: Sustainable Solutions for Small Ruminants'), a Biotechnology and Biological Sciences Research Council (BBSRC) Grant 'Functional Annotation of the Sheep Genome' ref.: BB/L001209/1 and BBSRC Institute Strategic Programme Grants 'Analysis and Prediction in Complex Animal Systems' ref.: BB/J004235/1 and Farm animal genomics ref: BBS/E/D/20211550, 'Blue Prints for Healthy Animals' ref.: BB/P013732/1 and 'Improving Animal Production & Welfare' ref.: BB/P013759/1 as well as the Laboratory of Animal Production, School of Veterinary Medicine, Aristotle University of Thessaloniki, Greece. The contribution of G. Banos was also supported by the Rural & Environment Science & Analytical Services Division of the Scottish Government.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Authority EFS., 2014, EFSA J, V12; Banos G, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3982-1; Barillet F, 2007, SMALL RUMINANT RES, V70, P60, DOI 10.1016/j.smallrumres.2007.01.004; Baro J, 1995, BREEDING PROGRAMME S, P81, DOI [10.1016/S0301-6226(00)00187-1, DOI 10.1016/S0301-6226(00)00187-1]; Barrett JA, 2004, AGE AGEING, V33, P502, DOI 10.1093/ageing/afh139; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Bishop SC, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P1, DOI 10.1079/9781845935559.0000; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Bush SJ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4972-7; Bush SJ, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1714-9; Chamberlain AJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2174-0; Chatziplis DG, 2012, SMALL RUMINANT RES, V105, P61, DOI 10.1016/j.smallrumres.2011.12.009; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark EL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006997; Davies G, 2009, ANIMAL, V3, P415, DOI 10.1017/S1751731108003522; Garcia-Gamez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047782; Gilmour AR, 2009, ASREML USER GUIDE RE; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Gutierrez-Gil B G-GE, 2013, EAAP 64 ANN M NANT; Gutierrez-Gil B, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00167; Gutierrez-Gil B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094623; Hagnestam-Nielsen C, 2009, J DAIRY SCI, V92, P3124, DOI 10.3168/jds.2008-1719; Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806; Juan Jose Arranz BGr-G, 2012, ADV GENETIC TRAITS C; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lahens NF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r86; Legarra A, 2005, J DAIRY SCI, V88, P2238, DOI 10.3168/jds.S0022-0302(05)72899-X; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Ligda C, 2003, OPTIONS MEDITERRAN A, V55, P55; Mateescu RG, 2010, ANIM GENET, V41, P460, DOI 10.1111/j.1365-2052.2010.02045.x; Mavrogenis AP, 2000, LIVEST PROD SCI, V67, P81, DOI 10.1016/S0301-6226(00)00187-1; Mayba O, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0405-3; Merz A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00319; Miltiadou D, 2017, J DAIRY SCI, V100, P6285, DOI 10.3168/jds.2016-12326; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Ogorevc J, 2009, ANIM GENET, V40, P832, DOI 10.1111/j.1365-2052.2009.01921.x; Psifidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115960; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahmatalla SA, 2011, J APPL GENET, V52, P459, DOI 10.1007/s13353-011-0051-3; Raven LA, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-29; Rupp R, 2003, VET RES, V34, P671, DOI 10.1051/vetres:2003020; Rupp R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005629; Sechi S CS, 2013, EAAP 64 ANN M NANT 2; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Stefanon B, 2002, J DAIRY RES, V69, P37, DOI 10.1017/S0022029901005246; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Suarez-Vega A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3581-1; Suarez-Vega A, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.51; Suarez-Vega A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18399; Sun D, 2009, ANIM GENET, V40, P997, DOI 10.1111/j.1365-2052.2009.01945.x; Tiezzi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114919; Tolone M, 2013, LIVEST SCI, V151, P134, DOI 10.1016/j.livsci.2012.11.014; Zarrin M, 2014, J DAIRY SCI, V97, P3531, DOI 10.3168/jds.2013-7480; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]	60	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0214346	10.1371/journal.pone.0214346	http://dx.doi.org/10.1371/journal.pone.0214346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765378	Green Published, gold, Green Submitted			2022-12-26	WOS:000533891000001
J	Chen, AT; Brady, L; Bulman, DE; Sundaram, ANE; Rodriguez, AR; Margolin, E; Waye, JS; Tarnopolsky, MA				Chen, Andrew T.; Brady, Lauren; Bulman, Dennis E.; Sundaram, Arun N. E.; Rodriguez, Amadeo R.; Margolin, Edward; Waye, John S.; Tarnopolsky, Mark A.			An evaluation of genetic causes and environmental risks for bilateral optic atrophy	PLOS ONE			English	Article							CLINICAL-FEATURES; MUTATIONS; OPA1; NEUROPATHY; WFS1; PATHOPHYSIOLOGY; DEGENERATION; ACONITASE	Purpose To assess the clinical utility of next-generation sequencing (NGS) for the diagnosis of patients with optic atrophy (OA). Design Retrospective cohort study. Methods 97 patients were referred to the McMaster University Medical Center (Hamilton, Ontario) for evaluation of bilateral OA. All patients were sent for NGS including a 22 nuclear gene panel and/or complete mitochondrial DNA (mtDNA) sequencing. Positive genetic test results and abnormal vibration sensation were compared in patients +/- environmental exposures or a family history. Results 19/94 (20.2%) had a positive nuclear variant, of which 15/19 (78.9%) were in the OPA1 gene. No positive mtDNA variants were identified. The detection of a positive genetic variant was significantly different in patients who reported excessive ethanol use, but not in patients who smoke (0/19 (0%) vs. 19/78 (24.4%), P = 0.0164 and 4/22 (18.2%) vs. 15/74 (20.3%), P = 0.829, respectively). Patients with a positive family history were more likely to have a positive genetic variant compared to patients with a negative family history (P = 0.0112). There were significantly more excessive drinkers with an abnormal vibration sensation (P = 0.026), and with a similar trend in smokers (P = 0.074). Conclusions All positive genetic variants were identified in nuclear genes. We identified a potential independent pathophysiological link between a history of excessive ethanol consumption and bilateral OA. Further investigations should evaluate and identify potential environmental risk factors for OA.	[Chen, Andrew T.; Brady, Lauren; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Bulman, Dennis E.] Univ Ottawa, Eastern Ontario Res Inst, Childrens Hosp, Ottawa, ON, Canada; [Sundaram, Arun N. E.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Rodriguez, Amadeo R.] McMaster Univ, Dept Ophthalmol, Hamilton, ON, Canada; [Margolin, Edward] Univ Toronto, Mt Sinai Hosp, Dept Ophthalmol & Visual Sci, Toronto, ON, Canada; [Waye, John S.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McMaster University	Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.	tarnopol@mcmaster.ca		Chen, Andrew/0000-0003-0396-9960	Canadian Institute for Health Research [143325]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Dr. Tarnopolsky's (MT) work on mitochondrial disorders is supported by kind donations from Mr. Warren Lammert and family, Mr. Dan Wright and family and MitoCanada (https://mitocanada.org/).Dr.Tarnopolsky's research into genetic disorders is supported by a grant from the Canadian Institute for Health Research Grant Number 143325 (http://www.cihrirsc.gc.ca/e/193.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2005, BRIT J OPHTHALMOL, V89, P1380, DOI 10.1136/bjo.2005.072819; Ahuja S, 2016, BMJ OPEN OPHTHALMOL, V1, DOI 10.1136/bmjophth-2016-000003; Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012; Astuti D, 2017, HUM MUTAT, V38, P764, DOI 10.1002/humu.23233; Avino J, 2002, Arch Soc Esp Oftalmol, V77, P263; Bajracharya K., 2016, J UNIVERS COLL MED S, V3, P26, DOI 10.3126/jucms.v3i2.14287; Bansal V, 2018, DIABETOLOGIA, V61, P2180, DOI 10.1007/s00125-018-4690-3; Bargiela D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.051; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Brooks PJ, 1997, ALCOHOL CLIN EXP RES, V21, P1073, DOI 10.1111/j.1530-0277.1997.tb04256.x; Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2; CARELLI V, 2016, BRAIN 3, V139, DOI DOI 10.1093/BRAIN/AWV339; CARELLI V, 2004, INVEST OPHTH VIS S1, V45, P31419; Chan C, 1996, AUST NZ J OPHTHALMOL, V24, P7, DOI 10.1111/j.1442-9071.1996.tb01545.x; Chun BY, 2016, CURR OPIN OPHTHALMOL, V27, P475, DOI 10.1097/ICU.0000000000000314; Del Dotto V, 2017, CELL REP, V19, P2557, DOI 10.1016/j.celrep.2017.05.073; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre-Cribaillet C, 1993, GENEREVIEWS INGTON; Ferre M, 2015, HUM MUTAT, V36, P20, DOI 10.1002/humu.22703; Gasparin MRR, 2009, EUR J ENDOCRINOL, V160, P309, DOI 10.1530/EJE-08-0698; Giordano L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.364; Grenier J, 2016, OPHTHALMOLOGY, V123, P1989, DOI 10.1016/j.ophtha.2016.05.036; Grzybowski A, 2015, ACTA OPHTHALMOL, V93, P402, DOI 10.1111/aos.12515; Gunay-Aygun M, 1993, OPA3 RELATED 3 METHY; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; Jurkute N, 2019, EUR J HUM GENET, V27, P494, DOI 10.1038/s41431-018-0235-y; Kelman JC, 2018, OPHTHALMIC GENET, V39, P648, DOI 10.1080/13816810.2018.1509353; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Lenaers G, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-46; Ly TBN, 2003, HUM MUTAT, V21, P401, DOI 10.1002/humu.10202; Maass J, 2018, DOC OPHTHALMOL, V136, P145, DOI 10.1007/s10633-018-9622-5; Majander A, 2017, BRIT J OPHTHALMOL, V101, P1505, DOI 10.1136/bjophthalmol-2016-310072; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; Manickam AH, 2017, INDIAN J OPHTHALMOL, V65, P1087, DOI 10.4103/ijo.IJO_358_17; Marelli C, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000225; Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532; Morris B, 2014, ACTA OPHTHALMOL, V92, pE77, DOI 10.1111/aos.12100; Morris Brid, 2012, Acta Ophthalmol, V90, pe568, DOI 10.1111/j.1755-3768.2012.02387.x; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; Schenkel LC, 2016, J MOL DIAGN, V18, P657, DOI 10.1016/j.jmoldx.2016.04.002; SCRIMGEOUR EM, 1982, MED J AUSTRALIA, V2, P481, DOI 10.5694/j.1326-5377.1982.tb132529.x; Services UD of H and H, 2017, DIET GUID AM 2015 20; Sharkia R, 2019, J INHERIT METAB DIS, V42, P264, DOI 10.1002/jimd.12022; Shimozono M, 1998, J Am Optom Assoc, V69, P293; Spiegel K, 2012, AM J HUM GENET, V90, P518, DOI 10.1016/j.ajhg.2012.01.009; Srivastava S, 2017, J CHILD NEUROL, V32, P840, DOI 10.1177/0883073817711527; Sullivan-Mee M, 1998, J Am Optom Assoc, V69, P57; Urano F, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0702-6; Verma IC, 2018, INDIAN J PEDIATR, V85, P228, DOI 10.1007/s12098-017-2453-7; Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007; Yu-Wai-Man P, 2016, ACTA NEUROPATHOL, V132, P789, DOI 10.1007/s00401-016-1625-2; Yu-Wai-Man P, 2016, ANN CLIN TRANSL NEUR, V3, P723, DOI 10.1002/acn3.323; Yu-Wai-Man P, 2013, OPHTHALMOLOGY, V120, P1712, DOI 10.1016/j.ophtha.2013.04.022; YUWAIMAN P, 2011, BRAIN 4, V134, P31419, DOI DOI 10.1093/BRAIN/AWQ288; Zalloua P, 2008, HUM MOL GENET, V17, P4012, DOI 10.1093/hmg/ddn304; Zen PRG, J PEDIAT RIO J, V78, P529	58	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225656	10.1371/journal.pone.0225656	http://dx.doi.org/10.1371/journal.pone.0225656			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765440	gold, Green Published			2022-12-26	WOS:000533891000041
J	Nakamura, S; Igaki, H; Ito, M; Okamoto, H; Nishioka, S; Iijima, K; Nakayama, H; Takemori, M; Imamichi, S; Kashihara, T; Takahashi, K; Inaba, K; Okuma, K; Murakami, N; Abe, Y; Nakayama, Y; Masutani, M; Nishio, T; Itami, J				Nakamura, Satoshi; Igaki, Hiroshi; Ito, Masashi; Okamoto, Hiroyuki; Nishioka, Shie; Iijima, Kotaro; Nakayama, Hiroki; Takemori, Mihiro; Imamichi, Shoji; Kashihara, Tairo; Takahashi, Kana; Inaba, Koji; Okuma, Kae; Murakami, Naoya; Abe, Yoshihisa; Nakayama, Yuko; Masutani, Mitsuko; Nishio, Teiji; Itami, Jun			Characterization of the relationship between neutron production and thermal load on a target material in an accelerator-based boron neutron capture therapy system employing a solid-state Li target	PLOS ONE			English	Article							NEAR-THRESHOLD; RECURRENT HEAD; BNCT; BEAM; ENERGY; IRRADIATION; THICKNESS; DESIGN; LI-7(P	An accelerator-based boron neutron capture therapy (BNCT) system that employs a solid-state Li target can achieve sufficient neutron flux derived from the Li-7(p,n) reaction. However, neutron production is complicated by the large thermal load expected on the target. The relationship between neutron production and thermal load was examined under various conditions. A target structure for neutron production consists of a Li target and a target basement. Four proton beam profiles were examined to vary the local thermal load on the target structure while maintaining a constant total thermal load. The efficiency of neutron production was evaluated with respect to the total number of protons delivered to the target structure. The target structure was also evaluated by observing its surface after certain numbers of protons were delivered. The yield of the sputtering effect was calculated via a Monte Carlo simulation to investigate whether it caused complications in neutron production. The efficiency of neutron production and the amount of damage done depended on the proton profile. A more focused proton profile resulted in greater damage. The efficiency decreased as the total number of protons delivered to the target structure increased, and the rate of decrease depended on the proton profile. The sputtering effect was not sufficiently large to be a main factor in the reduction in neutron production. The proton beam profile on the target structure was found to be important to the stable operation of the system with a solid-state Li target. The main factor in the rate of reduction in neutron production was found to be the local thermal load induced by proton irradiation of the target.	[Nakamura, Satoshi; Okamoto, Hiroyuki; Nishioka, Shie; Iijima, Kotaro; Nakayama, Hiroki; Takemori, Mihiro; Itami, Jun] Natl Canc Ctr, Dept Med Phys, Chuo Ku, Tokyo, Japan; [Nakamura, Satoshi; Igaki, Hiroshi; Okamoto, Hiroyuki; Nishioka, Shie; Imamichi, Shoji; Abe, Yoshihisa; Masutani, Mitsuko; Itami, Jun] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Chuo Ku, Tokyo, Japan; [Igaki, Hiroshi; Kashihara, Tairo; Takahashi, Kana; Inaba, Koji; Okuma, Kae; Murakami, Naoya; Nakayama, Yuko; Itami, Jun] Natl Canc Ctr, Dept Radiat Oncol, Chuo Ku, Tokyo, Japan; [Ito, Masashi] Natl Ctr Global Hlth & Med, Dept Radiol, Shinjuku Ku, Tokyo, Japan; [Nakayama, Hiroki; Takemori, Mihiro] Grad Sch Human Hlth Sci, Dept Radiol Sci, Arakawa Ku, Tokyo, Japan; [Imamichi, Shoji; Masutani, Mitsuko] Natl Canc Ctr, Div Cellular Signaling, Lab Collaborat Res, Res Inst,Chuo Ku, Tokyo, Japan; [Abe, Yoshihisa] Natl Canc Ctr, Dept Radiol Technol, Chuo Ku, Tokyo, Japan; [Masutani, Mitsuko] Nagasaki Univ, Ctr Bioinformat & Mol Med, Dept Frontier Life Sci, Grad Sch Biomed Sci, Nagasaki, Japan; [Nishio, Teiji] Tokyo Womens Med Univ, Grad Sch Med, Dept Med Phys, Shinjuku Ku, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Center for Global Health & Medicine - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Nagasaki University; Tokyo Women's Medical University	Igaki, H (corresponding author), Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Chuo Ku, Tokyo, Japan.; Igaki, H (corresponding author), Natl Canc Ctr, Dept Radiat Oncol, Chuo Ku, Tokyo, Japan.	hirigaki@ncc.go.jp	Igaki, Hiroshi/GOH-1916-2022; Itami, Jun/AAB-1380-2022; Murakami, Naoya/J-7671-2019	Igaki, Hiroshi/0000-0001-7817-624X; Murakami, Naoya/0000-0003-0660-9987	JSPS [16K10410, 19K17218, 15H04912, 26860410]; National Cancer Center Research and Development Fund [29-A-8, 26-A-18, 23-A-46]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was supported by a JSPS Grant-in-Aid for Young Scientists (Grant Number 19K17218), and JSPS Grant-in-Aid for Young Scientists (B) (Grant Number 26860410), partially supported by a JSPS Grant-in-Aid for Scientific Research (B) (Grant Number 15H0491215H04912), by a JSPS Grant-in-Aid for Scientific Research (C) (Grant Number 16K10410), and by the National Cancer Center Research and Development Fund (29-A-8), (26-A-18), and (23-A-46). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Aihara T, 2014, APPL RADIAT ISOTOPES, V88, P12, DOI 10.1016/j.apradiso.2014.04.007; ALLEN DA, 1995, PHYS MED BIOL, V40, P807, DOI 10.1088/0031-9155/40/5/007; Astrelin VT, 2010, J NUCL MATER, V396, P43, DOI 10.1016/j.jnucmat.2009.10.051; Chiappiniello A, 2018, CURR RADIOPHARM, V11, P92, DOI 10.2174/1874471011666180412170219; Dahl K, 2017, J LABELLED COMPD RAD, V60, P624, DOI 10.1002/jlcr.3561; Hirota Y, 2014, J RADIAT RES, V55, P75, DOI 10.1093/jrr/rrt095; Inoue R, 2014, APPL RADIAT ISOTOPES, V88, P225, DOI 10.1016/j.apradiso.2013.12.017; Kamada S, 2014, APPL RADIAT ISOTOPES, V88, P195, DOI 10.1016/j.apradiso.2014.03.015; Kato I, 2004, APPL RADIAT ISOTOPES, V61, P1069, DOI 10.1016/j.apradiso.2004.05.059; Kobayashi T, 2007, PHYS MED BIOL, V52, P645, DOI 10.1088/0031-9155/52/3/008; Kudriavtsev Y, 2005, APPL SURF SCI, V239, P273, DOI 10.1016/j.apsusc.2004.06.014; Kumada H, 2014, APPL RADIAT ISOTOPES, V88, P211, DOI 10.1016/j.apradiso.2014.02.018; Lee CL, 1999, NUCL INSTRUM METH B, V152, P1, DOI 10.1016/S0168-583X(99)00026-9; Lee CL, 2000, MED PHYS, V27, P192, DOI 10.1118/1.598884; Loeffler MJ, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3079612; Masunaga S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-128; Minsky DM, 2011, APPL RADIAT ISOTOPES, V69, P1668, DOI 10.1016/j.apradiso.2011.02.047; Nakai K, 2011, APPL RADIAT ISOTOPES, V69, P1790, DOI 10.1016/j.apradiso.2011.03.049; Nakamura S, 2017, P JPN B, V93, P1; Nakamura S, 2019, PHYS MEDICA, V58, P121, DOI 10.1016/j.ejmp.2019.02.010; Nakamura S, 2017, APPL RADIAT ISOTOPES, V125, P80, DOI 10.1016/j.apradiso.2017.03.027; Nakamura S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2329-7; NICKLES RJ, 1980, NUCL INSTRUM METHODS, V177, P593, DOI 10.1016/0029-554X(80)90077-4; Randers-Pehrson G, 1998, MED PHYS, V25, P894, DOI 10.1118/1.598266; Sun T, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-195; Suzuki M, 2000, JPN J CANCER RES, V91, P1058, DOI 10.1111/j.1349-7006.2000.tb00885.x; Takada M, 2012, NUCL INSTRUM METH A, V689, P22, DOI 10.1016/j.nima.2012.06.019; Tanaka H, 2011, APPL RADIAT ISOTOPES, V69, P1642, DOI 10.1016/j.apradiso.2011.03.020	29	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225587	10.1371/journal.pone.0225587	http://dx.doi.org/10.1371/journal.pone.0225587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756237	Green Published, gold			2022-12-26	WOS:000533889300043
J	Onandia, G; Schittko, C; Ryo, M; Bernard-Verdier, M; Heger, T; Joshi, J; Kowarik, I; Gessler, A				Onandia, Gabriela; Schittko, Conrad; Ryo, Masahiro; Bernard-Verdier, Maud; Heger, Tina; Joshi, Jasmin; Kowarik, Ingo; Gessler, Arthur			Ecosystem functioning in urban grasslands: The role of biodiversity, plant invasions and urbanization	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; WATER-USE EFFICIENCY; CHLOROPHYLL FLUORESCENCE; SPECIES RICHNESS; ALIEN PLANTS; DIVERSITY; PRODUCTIVITY; CONSERVATION; PATTERNS; FLUXES	Urbanization is driving the transformation of natural and rural ecosystems worldwide by affecting both the abiotic environment and the biota. This raises the question whether urban ecosystems are able to provide services in a comparable way to their non-urban counterparts. In urban grasslands, the effects of urbanization-driven ecological novelty and the role of plant diversity in modulating ecosystem functioning have received little attention. In this study, we assessed the influence of biodiversity, abiotic and biotic novelty on ecosystem functioning based on in situ measurements in non-manipulated grasslands along an urbanization gradient in Berlin (Germany). We focused on plant aboveground biomass (AGB), intrinsic water-use efficiency (iWUE) and N-15 enrichment factor (Delta delta N-15) as proxies for biomass production, water and N cycling, respectively, within grassland communities, and tested how they change with plant biogeographic status (native vs alien), functional group and species identity. Approximately one third of the forb species were alien to Berlin and they were responsible for 13.1% of community AGB. Community AGB was positively correlated with plant-species richness. In contrast, iWUE and Delta delta N-15 were mostly determined by light availability (depicted by sky view factor) and urban parameters like the percentage of impervious surface or human population density. We found that abiotic novelty potentially favors aliens in Berlin, mainly by enhancing their dispersal and fitness under drought. Mainly urban parameters indicating abiotic novelty were significantly correlated to both alien and native Delta delta N-15, but to AGB and iWUE of alien plants only, pointing to a stronger impact of abiotic novelty on N cycling compared to C and water cycling. At the species level, sky view factor appeared to be the prevailing driver of photosynthetic performance and resource-use efficiency. Although we identified a significant impact of abiotic novelty on AGB, iWUE and Delta delta N-15 at different levels, the relationship between species richness and community AGB found in the urban grasslands studied in Berlin was comparable to that described in non-urban experimental grasslands in Europe. Hence, our results indicate that conserving and enhancing biodiversity in urban ecosystems is essential to preserve ecosystem services related to AGB production. For ensuring the provision of ecosystem services associated to water and N use, however, changes in urban abiotic parameters seem necessary.	[Onandia, Gabriela] Leibniz Ctr Agr Landscape Res ZALF, Res Platform Data, Muncheberg, Germany; [Onandia, Gabriela; Schittko, Conrad; Ryo, Masahiro; Bernard-Verdier, Maud; Heger, Tina; Joshi, Jasmin; Kowarik, Ingo; Gessler, Arthur] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Schittko, Conrad; Heger, Tina; Joshi, Jasmin] Univ Potsdam, Biodivers Res & Systemat Bot, Potsdam, Germany; [Ryo, Masahiro] Free Univ Berlin, Inst Biol, Berlin, Germany; [Bernard-Verdier, Maud] Free Univ Berlin, Div Zool, Berlin, Germany; [Heger, Tina] Tech Univ Munich, Restorat Ecol, Freising Weihenstephan, Germany; [Joshi, Jasmin] HSR Hsch Tech, Inst Landscape & Open Space, Rapperswil, Switzerland; [Kowarik, Ingo] Tech Univ Berlin, Dept Ecol Ecosyst Sci & Plant Ecol, Berlin, Germany; [Gessler, Arthur] Swiss Fed Res Inst Forest Snow & Landscape Res WS, Dept Forest Dynam, Birmensdorf, Switzerland; [Gessler, Arthur] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland	Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); University of Potsdam; Free University of Berlin; Free University of Berlin; Technical University of Munich; Technical University of Berlin; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich	Onandia, G (corresponding author), Leibniz Ctr Agr Landscape Res ZALF, Res Platform Data, Muncheberg, Germany.; Onandia, G (corresponding author), Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany.	gabriela.onandia@zalf.de	Ryo, Masahiro/AAL-7294-2020; Gessler, Arthur/C-7121-2008; Heger, Tina/AAH-4802-2019	Ryo, Masahiro/0000-0002-5271-3446; Gessler, Arthur/0000-0002-1910-9589; Heger, Tina/0000-0002-5522-5632; Schittko, Conrad/0000-0002-2200-8762; Bernard-Verdier, Maud/0000-0003-4240-9560; ONANDIA, GABRIELA/0000-0001-9597-1923	German Federal Ministry of Education and Research BMBF within the Collaborative Project "Bridging in Biodiversity Science -BIBS" [01LC1501A-H]	German Federal Ministry of Education and Research BMBF within the Collaborative Project "Bridging in Biodiversity Science -BIBS"	This work was funded by the German Federal Ministry of Education and Research BMBF (https://www.bmbf.de/) within the Collaborative Project "Bridging in Biodiversity Science -BIBS" (funding number 01LC1501A-H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, 138781998 DIN ISO; [Anonymous], 2008, 197302008 DIN ISO; Ansong M, 2015, AUSTRAL ECOL, V40, P765, DOI 10.1111/aec.12251; Antrop M, 2004, LANDSCAPE URBAN PLAN, V67, P9, DOI 10.1016/S0169-2046(03)00026-4; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Bachmann D, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0116367, 10.1371/journal.pone.0124250]; Bernard J, 2018, CLIMATE, V6, DOI 10.3390/cli6030060; Betts RA, 2016, NAT CLIM CHANGE, V6, P806, DOI 10.1038/nclimate3063; Bischl B, 2016, J MACH LEARN RES, V17; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Bradter U, 2013, METHODS ECOL EVOL, V4, P167, DOI 10.1111/j.2041-210x.2012.00253.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brunzel S, 2009, J BIOGEOGR, V36, P835, DOI 10.1111/j.1365-2699.2008.02044.x; Bullock JM, 2018, TRENDS ECOL EVOL; Caldeira MC, 2001, ECOL LETT, V4, P439, DOI 10.1046/j.1461-0248.2001.00238.x; Carthey AJR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031804; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapin III F.S., 2007, TERRESTRIAL ECOSYSTE, P81, DOI DOI 10.1007/978-3-540-32730-1_7; Chollet S, 2018, LANDSCAPE URBAN PLAN, V180, P121, DOI 10.1016/j.landurbplan.2018.08.009; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Craine JM, 2015, PLANT SOIL, V396, P1, DOI 10.1007/s11104-015-2542-1; Craven D, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0277; De Boeck HJ, 2006, PLANT SOIL, V288, P249, DOI 10.1007/s11104-006-9112-5; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Duncan RP, 2011, GLOBAL ECOL BIOGEOGR, V20, P509, DOI 10.1111/j.1466-8238.2010.00633.x; Ehleringer J. R., 1993, Stable isotopes and plant carbon-water relations., P155; Ellis EC, 2015, ECOL MONOGR, V85, P287, DOI 10.1890/14-2274.1; Farquhar G. D., 1993, Stable isotopes and plant carbon-water relations., P47; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Fenn ME, 2005, CAN J FOREST RES, V35, P1464, DOI 10.1139/X05-068; Fischer LK, 2018, GLOBAL ENVIRON CHANG, V49, P35, DOI 10.1016/j.gloenvcha.2018.02.001; Fischer LK, 2013, URBAN FOR URBAN GREE, V12, P263, DOI 10.1016/j.ufug.2013.03.009; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Golubiewski NE, 2006, ECOL APPL, V16, P555, DOI 10.1890/1051-0761(2006)016[0555:UIGCPE]2.0.CO;2; Gornall JL, 2011, OECOLOGIA, V166, P769, DOI 10.1007/s00442-011-1911-6; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Groffman PM, 2014, FRONT ECOL ENVIRON, V12, P74, DOI 10.1890/120374; Grossiord C, 2013, METHODS ECOL EVOL, V4, P954, DOI 10.1111/2041-210X.12090; Guderle M, 2018, FUNCT ECOL, V32, P214, DOI 10.1111/1365-2435.12948; Guerrero-Ramirez NR, 2017, NAT ECOL EVOL, V1, P1639, DOI 10.1038/s41559-017-0325-1; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; Hapfelmeier A, 2013, COMPUT STAT DATA AN, V60, P50, DOI 10.1016/j.csda.2012.09.020; Hapfelmeier A, 2014, STAT COMPUT, V24, P21, DOI 10.1007/s11222-012-9349-1; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Heger T, 2019, BIOSCIENCE, V69, P888, DOI 10.1093/biosci/biz095; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Ingerpuu N, 2005, PLANT ECOL, V180, P69, DOI 10.1007/s11258-005-2508-0; Jager E, 2011, ROTHMALER EXKURSIONS; Jeffery Simon, 2010, Acta Societatis Zoologicae Bohemicae, V74, P7; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kaye JP, 2005, GLOBAL CHANGE BIOL, V11, P575, DOI 10.1111/j.1365-2486.2005.00921.x; Klaus VH, 2013, RESTOR ECOL, V21, P665, DOI 10.1111/rec.12051; Kleinebecker T, 2014, J ECOL, V102, P456, DOI 10.1111/1365-2745.12202; Klotz S, 2002, DTSCH BUNDESAMT NATU, P38; Kowarik I, 2008, PATHWAYS PLANT INVAS, P29; Kowarik I, 2018, J APPL ECOL, V55, P2354, DOI 10.1111/1365-2664.13144; Kowarik I, 2011, ENVIRON POLLUT, V159, P1974, DOI 10.1016/j.envpol.2011.02.022; Kuhn I, 2004, EVOL ECOL RES, V6, P749; Leimer S, 2018, ECOHYDROLOGY, V11, DOI 10.1002/eco.1945; Lindberg F, 2008, INT J BIOMETEOROL, V52, P697, DOI 10.1007/s00484-008-0162-7; Lindberg F, 2011, URBAN ECOSYST, V14, P617, DOI 10.1007/s11252-011-0184-5; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; LUA. Brandenburg State Environmental Office, 2002, CAT NAT HAB SPEC APP; Madrid L, 2002, CHEMOSPHERE, V49, P1301, DOI 10.1016/S0045-6535(02)00530-1; Malone ET, 2018, ECOSYSTEMS, V21, P1659, DOI 10.1007/s10021-018-0245-1; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McDonnell MJ, 2015, ANNU REV ECOL EVOL S, V46, P261, DOI 10.1146/annurev-ecolsys-112414-054258; Nicodemus KK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-110; Niemela J, 2010, BIODIVERS CONSERV, V19, P3225, DOI 10.1007/s10531-010-9888-8; OKE TR, 1995, NATO ADV SCI INST SE, V277, P81; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Pearse IS, 2013, OIKOS, V122, P1554, DOI 10.1111/j.1600-0706.2013.00527.x; Pereira P, 2015, HYDROL EARTH SYST SC, V12; Planchuelo G, 2019, LANDSCAPE URBAN PLAN, V189, P320, DOI 10.1016/j.landurbplan.2019.05.007; Prasse R, 2001, LISTE WILDWACHSENDEN; QGIS Development Team, 2018, QGIS GEOGR INF SYST; Quanz JA, 2018, CLIMATE, V6, DOI 10.3390/cli6010005; Quinet M, 2015, INT J PLANT SCI, V176, P848, DOI 10.1086/683276; R Core Team, 2021, R LANGUAGE ENV STAT; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Rao P, 2014, BIOGEOCHEMISTRY, V121, P229, DOI 10.1007/s10533-013-9861-1; Rascher U, 2000, PLANT CELL ENVIRON, V23, P1397, DOI 10.1046/j.1365-3040.2000.00650.x; Rebele F, 2001, FLORA, V196, P325, DOI 10.1016/S0367-2530(17)30069-5; Roscher C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0204715; Rudolph M, 2017, APPL VEG SCI, V20, P18, DOI 10.1111/avsc.12267; Ryo M, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1976; Scherling C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012569; Schirmel J, 2016, GLOBAL CHANGE BIOL, V22, P594, DOI 10.1111/gcb.13093; Schittko C, 2019, BIORXIV; Schittko C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099065; Schreiber U., 1993, Progress in Botany, V54, P151; Scolozzi R, 2012, ENVIRON IMPACT ASSES, V36, P9, DOI 10.1016/j.eiar.2012.03.001; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Seitz B, 2018, ROTE LISTE GESAMTART; Shields EJ, 2006, WEED SCI, V54, P1063, DOI 10.1614/WS-06-097R1.1; Sikorski P, 2018, URBAN FOR URBAN GREE, V35, P148, DOI 10.1016/j.ufug.2018.08.017; SMEDLEY MP, 1991, OECOLOGIA, V85, P314, DOI 10.1007/BF00320605; Southon GE, 2017, LANDSCAPE URBAN PLAN, V158, P105, DOI 10.1016/j.landurbplan.2016.08.003; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Strauss Sharon Y, 2006, Ecol Lett, V9, P357, DOI 10.1111/j.1461-0248.2005.00874.x; Strobl C., 2009, 050 U MUN DEP STAT, P1; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Thompson GL, 2017, CROP SCI, V57, pS238, DOI 10.2135/cropsci2016.05.0433; Thompson GL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155986; Thompson K, 2004, J VEG SCI, V15, P373, DOI 10.1111/j.1654-1103.2004.tb02274.x; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tsialtas JT, 2001, FUNCT ECOL, V15, P605, DOI 10.1046/j.0269-8463.2001.00555.x; United Nations, 2014, WORLD URB PROSP 2014, P32, DOI DOI 10.18356/527E5125-EN; van der Walt L, 2015, URBAN ECOSYST, V18, P87, DOI 10.1007/s11252-014-0393-9; Verheyen K, 2008, OECOLOGIA, V156, P351, DOI 10.1007/s00442-008-0998-x; Verhoeven KJF, 2009, ECOL LETT, V12, P107, DOI 10.1111/j.1461-0248.2008.01248.x; Vila M, 2017, INVAD NAT SPRING SER, V12, P1, DOI 10.1007/978-3-319-45121-3_1; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; Walter J., 2005, NEOBIOTA, V6, P13; Wang ME, 2018, J ENVIRON SCI-CHINA, V64, P328, DOI 10.1016/j.jes.2016.11.026; Wania A, 2006, LANDSCAPE URBAN PLAN, V75, P97, DOI 10.1016/j.landurbplan.2004.12.006; Warwick SI, 2006, CAN J PLANT SCI, V86, P1297, DOI 10.4141/P06-030; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Weisser WW, 2017, BASIC APPL ECOL, V23, P1, DOI 10.1016/j.baae.2017.06.002; Weiwei LU, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18694-z; Zavalloni C, 2009, PHYSIOL PLANTARUM, V136, P57, DOI 10.1111/j.1399-3054.2009.01214.x; Zeeman BJ, 2017, J VEG SCI, V28, P550, DOI 10.1111/jvs.12507	129	15	15	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225438	10.1371/journal.pone.0225438	http://dx.doi.org/10.1371/journal.pone.0225438			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QA	31756202	Green Published, gold			2022-12-26	WOS:000533889300029
J	Satirapod, C; Sukprasert, M; Panthan, B; Charoenyingwattana, A; Chitayanan, P; Chantratita, W; Choktanasiri, W; Trachoo, O; Hongeng, S				Satirapod, Chonthicha; Sukprasert, Matchuporn; Panthan, Bhakbhoom; Charoenyingwattana, Angkana; Chitayanan, Pawares; Chantratita, Wasun; Choktanasiri, Wicharn; Trachoo, Objoon; Hongeng, Suradej			Clinical utility of combined preimplantation genetic testing methods in couples at risk of passing on beta thalassemia/hemoglobin E disease: A retrospective review from a single center	PLOS ONE			English	Review							STEM-CELL TRANSPLANTATION; PRACTICE GUIDELINES; PRENATAL-DIAGNOSIS; HEALTHY-CHILDREN; ESHRE PGD; BIRTH; ENDOMETRIOSIS; PRECONCEPTION; CONSORTIUM; EXPERIENCE	Thalassemia and hemoglobinopathy is a group of hereditary blood disorder with diverse clinical manifestation inherited by autosomal recessive manner. The Beta thalassemia/Hemoglobin E disease (HbE/beta thal) causes a variable degree of hemolysis and the most severe form of HbE/beta thal disease develop a lifelong transfusion-dependent anemia. Preimplantation genetic testing (PGT) is an established procedure of embryo genetic analysis to avoid the risk of passing on this particular condition from the carrier parents to their offspring. Preimplantation genetic testing for chromosomal aneuploidy (PGT-A) also facilitates the selection of embryos without chromosomal aberration resulting in the successful embryo implantation rate. Herein, we study the clinical outcome of using combined PGT-M and PGT-A in couples at risk of passing on HbE/beta thal disease. The study was performed from January 2016 to December 2017. PGT-M was developed using short tandem repeat linkage analysis around the beta globin gene cluster and direct mutation testing using primer extension-based mini-sequencing. Thereafter, we recruited 15 couples at risk of passing on HbE/beta thal disease who underwent a combined total of 22 IVF cycles. PGT was performed in 106 embryos with a 3.89% allele drop-out rate. Using combined PGT-M and PGT-A methods, 80% of women obtained satisfactory genetic testing results and were able to undergo embryo transfer within the first two cycles. The successful implantation rate was 64.29%. PGT accuracy was evaluated by prenatal and postnatal genetic confirmation and 100% had a genetic status consistent with PGT results. The overall clinical outcome of successful live birth for couples at risk of producing offspring with HbE/beta thal was 53.33%. Conclusively, combined PGT-M and PGT-A is a useful technology to prevent HbE/beta thal disease in the offspring of recessive carriers.	[Satirapod, Chonthicha; Sukprasert, Matchuporn; Choktanasiri, Wicharn] Mahidol Univ, Fac Med, Dept Obstet & Gynecol, Ramathibodi Hosp, Bangkok, Thailand; [Panthan, Bhakbhoom; Charoenyingwattana, Angkana; Chantratita, Wasun; Trachoo, Objoon] Mahidol Univ, Fac Med, Ctr Med Genom, Ramathibodi Hosp, Bangkok, Thailand; [Chitayanan, Pawares] Panthupk Genet Clin, Bangkok, Thailand; [Trachoo, Objoon] Mahidol Univ, Fac Med, Dept Med, Ramathibodi Hosp, Bangkok, Thailand; [Hongeng, Suradej] Mahidol Univ, Fac Med, Dept Pediat, Ramathibodi Hosp, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Trachoo, O (corresponding author), Mahidol Univ, Fac Med, Ctr Med Genom, Ramathibodi Hosp, Bangkok, Thailand.; Trachoo, O (corresponding author), Mahidol Univ, Fac Med, Dept Med, Ramathibodi Hosp, Bangkok, Thailand.	objoon.tra@mahidol.ac.th	Trachoo, Objoon/AGW-0098-2022; Charoenyingwattana, Angkana/ABH-1818-2021	Hongeng, Suradej/0000-0002-7376-9393; Trachoo, Objoon/0000-0001-7867-3238	Thailand Research Fund; Center for Medical Genomics; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Thailand Center of Excellence for Life Science (TCELS), Ministry of Science, Thailand	Thailand Research Fund(Thailand Research Fund (TRF)); Center for Medical Genomics; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Thailand Center of Excellence for Life Science (TCELS), Ministry of Science, Thailand	The research was supported in grants to the sub-project `Search the molecular basis of rare genetic disorders as a model for disease prevention using preimplantation blastocyst technology' (to O. Trachoo) and `Preimplantation genetic diagnosis for rare genetic disorders' (to W. Choktanasiri) by the Thailand Research Fund. The grants for next-generation sequencing were partially supported by the Center for Medical Genomics in collaboration with the Faculty of Medicine, Ramathibodi Hospital, Mahidol University and the Thailand Center of Excellence for Life Science (TCELS), Ministry of Science, Thailand (to W. Chantratita).	[Anonymous], GENEREVIEWS R; Ben-Nagi J, 2017, REPROD BIOMED ONLINE, V35, P264, DOI 10.1016/j.rbmo.2017.06.004; Cao A, 1998, BAILLIERE CLIN HAEM, V11, P215, DOI 10.1016/S0950-3536(98)80076-0; Chamayou S, 2002, HUM REPROD, V17, P1158, DOI 10.1093/humrep/17.5.1158; Chiamchanya Charoenchai, 2008, Journal of the Medical Association of Thailand, V91, P1644; Cimadomo D, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00327; Corveleyn A, 2008, EUR J HUM GENET, V16, P290, DOI 10.1038/sj.ejhg.5201976; Darras B. T., 1993, GENEREVIEWS R; De Rycke M, 2001, PRENATAL DIAG, V21, P214, DOI 10.1002/1097-0223(200103)21:3<214::AID-PD51>3.0.CO;2-4; Demko ZP, 2016, FERTIL STERIL, V105, P1307, DOI 10.1016/j.fertnstert.2016.01.025; Elborai Y, 2012, IMMUNOTHERAPY-UK, V4, P947, DOI [10.2217/IMT.12.95, 10.2217/imt.12.95]; Friedenthal J, 2018, FERTIL STERIL, V109, P627, DOI 10.1016/j.fertnstert.2017.12.017; Fritz R, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0438-4; Fucharoen S, 1987, Birth Defects Orig Artic Ser, V23, P241; Fucharoen S, 2000, CURR OPIN HEMATOL, V7, P106, DOI 10.1097/00062752-200003000-00006; Fucharoen S, 2000, J PEDIAT HEMATOL ONC, V22, P552, DOI 10.1097/00043426-200011000-00022; Girardet A, 2016, EUR J HUM GENET, V24, P469, DOI 10.1038/ejhg.2015.99; Gould RL, 2017, EXPERT REV MOL DIAGN, V17, P611, DOI 10.1080/14737159.2017.1325736; Griffin DK, 2018, REPRODUCTION, V156, pF29, DOI 10.1530/REP-17-0683; Harton GL, 2011, HUM REPROD, V26, P33, DOI 10.1093/humrep/deq231; Ioannides AS, 2017, BEST PRACT RES CL OB, V42, P2, DOI 10.1016/j.bpobgyn.2017.04.003; Jiao ZX, 2003, PRENATAL DIAG, V23, P646, DOI 10.1002/pd.659; Kekre N, 2014, BLOOD, V124, P334, DOI 10.1182/blood-2014-02-514760; Kokkali G, 2007, HUM REPROD, V22, P1443, DOI 10.1093/humrep/del506; Kubikova N, 2018, REPROD BIOMED ONLINE, V37, P136, DOI 10.1016/j.rbmo.2018.05.005; Kuliev A, 1998, J ASSIST REPROD GEN, V15, P219, DOI 10.1023/A:1022571822585; Kuliev A, 1999, J ASSIST REPROD GEN, V16, P207, DOI 10.1023/A:1020316924064; Lamb B, 2018, J ASSIST REPROD GEN, V35, P1605, DOI 10.1007/s10815-018-1278-2; Limwongse C, 2017, CURR OPIN PEDIATR, V29, P634, DOI 10.1097/MOP.0000000000000544; Lucarelli G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011825; Origa R., 1993, GENEREVIEWS R; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; Ozekinci M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0223-0; Palmer GA, 2002, HUM REPROD, V17, P25, DOI 10.1093/humrep/17.1.25; Panich V, 1992, Southeast Asian J Trop Med Public Health, V23 Suppl 2, P1; Rafati M, 2018, BIOL BLOOD MARROW TR, V24, P1575, DOI 10.1016/j.bbmt.2018.03.024; Seyhan A, 2015, SEMIN REPROD MED, V33, P422, DOI 10.1055/s-0035-1567820; Smith WM, 1998, GENET TEST, V2, P43, DOI 10.1089/gte.1998.2.43; Thein SL, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011700; Thornhill AR, 2005, HUM REPROD, V20, P35, DOI 10.1093/humrep/deh579; Tongsong T, 2013, PRENATAL DIAG, V33, P477, DOI 10.1002/pd.4095; Trachoo O, 2017, J ASSIST REPROD GEN, V34, P109, DOI 10.1007/s10815-016-0833-y; TRAEGER J, 1980, NATURE, V288, P497, DOI 10.1038/288497a0; Traeger-Synodinos J, 2017, EXPERT REV MOL DIAGN, V17, P281, DOI 10.1080/14737159.2017.1285701; Weatherall DJ, 2010, HEMATOL ONCOL CLIN N, V24, P1021, DOI 10.1016/j.hoc.2010.08.010; Weatherall DJ, 2018, HEMATOL ONCOL CLIN N, V32, P165, DOI 10.1016/j.hoc.2017.11.008; Yamsri S, 2010, PRENATAL DIAG, V30, P540, DOI 10.1002/pd.2514; Zeng C, 2014, GYNECOL OBSTET INVES, V77, P180, DOI 10.1159/000358390	48	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225457	10.1371/journal.pone.0225457	http://dx.doi.org/10.1371/journal.pone.0225457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751397	gold, Green Published			2022-12-26	WOS:000533886900065
J	Li, SZ; Bronnimann, MP; Williams, SJ; Campos, SK				Li, Shuaizhi; Bronnimann, Matthew P.; Williams, Spencer J.; Campos, Samuel K.			Glutathione contributes to efficient post-Golgi trafficking of incoming HPV16 genome	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; MINOR CAPSID PROTEIN; CYSTEINE RESIDUES; OXIDATIVE STRESS; L2; ENTRY; COLOCALIZATION; INHIBITION; SYNTHETASE; ACCUMULATION	Human papillomavirus (HPV) is the most common sexually transmitted pathogen in the United States, causing 99% of cervical cancers and 5% of all human cancers worldwide. HPV infection requires transport of the viral genome (vDNA) into the nucleus of basal keratinocytes. During this process, minor capsid protein L2 facilitates subcellular retrograde trafficking of the vDNA from endosomes to the Golgi, and accumulation at host chromosomes during mitosis for nuclear retention and localization during interphase. Here we investigated the relationship between cellular glutathione (GSH) and HPV16 infection. siRNA knockdown of GSH biosynthetic enzymes results in a partial decrease of HPV16 infection. Likewise, infection of HPV16 in GSH depleted keratinocytes is inefficient, an effect that was not seen with adenoviral vectors. Analysis of trafficking revealed no defects in cellular binding, entry, furin cleavage of L2, or retrograde trafficking of HPV16, but GSH depletion hindered postGolgi trafficking and translocation, decreasing nuclear accumulation of vDNA. Although precise mechanisms have yet to be defined, this work suggests that GSH is required for a specific post-Golgi trafficking step in HPV16 infection.	[Li, Shuaizhi; Bronnimann, Matthew P.; Campos, Samuel K.] Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA; [Williams, Spencer J.; Campos, Samuel K.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Campos, Samuel K.] Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA; [Campos, Samuel K.] Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA; [Bronnimann, Matthew P.] Roche Tissue Diagnost, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Campos, SK (corresponding author), Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA.; Campos, SK (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.; Campos, SK (corresponding author), Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA.; Campos, SK (corresponding author), Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA.	skcampos@email.arizona.edu	Campos, Samuel K/H-8998-2019	Campos, Samuel K/0000-0003-1540-9821; Williams, Spencer/0000-0003-4601-9201	National Institute for Allergy and Infectious Diseases [1R01AI108751-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108751] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SKC is supported by grant 1R01AI108751-01 from the National Institute for Allergy and Infectious Diseases, https://www.niaid.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Aydin I. A, 2017, CENTRAL REGION MINOR; Becker M, 2018, J VIROL, V92, DOI 10.1128/JVI.02106-17; Biryukov J, 2015, VIRUSES-BASEL, V7, P4303, DOI 10.3390/v7082823; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Braaten Kari P, 2008, Rev Obstet Gynecol, V1, P2; Bronnimann M. P., 2016, J VIROL, V301, DOI [10.1080/10715760000300291, DOI 10.1080/10715760000300291]; Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Buck CB, 2013, VIROLOGY, V445, P169, DOI 10.1016/j.virol.2013.05.038; Calton C. M., 2017, TRANSLOCATION PAPILL; Calton CM, 2013, J GEN VIROL, V94, P1865, DOI 10.1099/vir.0.053694-0; Campos SK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120370; Campos SK, 2012, J VIROL, V86, P4169, DOI 10.1128/JVI.05493-11; Campos SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004463; Cardone G, 2014, MBIO, V5, DOI 10.1128/mBio.01104-14; Cerqueira C, 2015, J VIROL, V89, P7038, DOI 10.1128/JVI.00234-15; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; Day PM, 2013, J VIROL, V87, P3862, DOI 10.1128/JVI.03222-12; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; DiGiuseppe S, 2016, P NATL ACAD SCI USA, V113, P6289, DOI 10.1073/pnas.1600638113; DiGiuseppe S, 2014, VIROLOGY, V458, P93, DOI 10.1016/j.virol.2014.04.024; Doorbar J, 2016, J PATHOL, V238, P166, DOI 10.1002/path.4656; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Guion L, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007590; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Inoue T, 2018, J CELL BIOL, V217, P3545, DOI 10.1083/jcb.201804171; KINSELLA BT, 1991, J BIOL CHEM, V266, P8540; LASH LH, 1984, BIOCHIM BIOPHYS ACTA, V779, P191, DOI 10.1016/0304-4157(84)90008-X; Lipovsky A, 2013, P NATL ACAD SCI USA, V110, P7452, DOI 10.1073/pnas.1302164110; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Lowenstein CJ, 2006, BIOL CHEM, V387, P1377, DOI 10.1515/BC.2006.173; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Markovic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006413; Marusic MB, 2012, TRAFFIC, V13, P455, DOI 10.1111/j.1600-0854.2011.01320.x; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Mikulicic S, 2019, PAPILLOMAVIRUS RES, V7, P135, DOI 10.1016/j.pvr.2019.03.004; Njalssson R, 2005, ACTA PAEDIATR, V94, P132, DOI 10.1080/08035250410025285; Ozbun MA, 2019, PAPILLOMAVIRUS RES, V7, P188, DOI 10.1016/j.pvr.2019.04.009; Padmanabhan S, 2010, NAT BIOTECHNOL, V28, P671, DOI 10.1038/nbt0710-671; Popa A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004699; Pyeon D, 2005, P NATL ACAD SCI USA, V102, P9311, DOI 10.1073/pnas.0504020102; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Ristoff E, 2002, J INHERIT METAB DIS, V25, P577, DOI 10.1023/A:1022095324407; SAPP M, 1994, J GEN VIROL, V75, P3375, DOI 10.1099/0022-1317-75-12-3375; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657; Schiffman M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.86; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Smith AD, 2006, VIROLOGY, V353, P258, DOI 10.1016/j.virol.2006.06.012; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; TOMODA H, 1989, J BIOL CHEM, V264, P15445; Vahrmeijer AL, 1999, BIOCHEM PHARMACOL, V58, P655, DOI 10.1016/S0006-2952(99)00130-6; Van Doorslaer K, 2017, NUCLEIC ACIDS RES, V45, pD499, DOI 10.1093/nar/gkw879; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang JW, 2013, VIROLOGY, V445, P175, DOI 10.1016/j.virol.2013.04.017; Washbourne P, 2001, BIOCHEM J, V357, P625, DOI 10.1042/0264-6021:3570625; Wild AC, 2000, FREE RADICAL RES, V32, P281, DOI 10.1080/10715760000300291; Xiao ZG, 2019, J MOL BIOL, V431, P158, DOI 10.1016/j.jmb.2018.12.006; Yamaguchi T, 1998, J BIOCHEM-TOKYO, V124, P1229, DOI 10.1093/oxfordjournals.jbchem.a022242; Zhang P, 2018, CELL, V174, P1450, DOI 10.1016/j.cell.2018.07.002; Zhang W, 2014, MBIO, V5, DOI 10.1128/mBio.01777-14; Zhao Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P56, DOI 10.1016/j.abb.2009.03.001; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	78	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225496	10.1371/journal.pone.0225496	http://dx.doi.org/10.1371/journal.pone.0225496			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743367	Green Submitted, gold, Green Published			2022-12-26	WOS:000533877300034
J	Chobrutskiy, BI; Yeagley, M; Tipping, P; Zaman, S; Diviney, A; Patel, DN; Falasiri, S; Uversky, VN; Blanck, G				Chobrutskiy, Boris, I; Yeagley, Michelle; Tipping, Price; Zaman, Saif; Diviney, Andrea; Patel, Dhruv N.; Falasiri, Shayan; Uversky, Vladimir N.; Blanck, George			Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma	ONCOGENE			English	Article							PERIPHERAL-BLOOD; DISTINCT; SEQUENCE; IDENTIFICATION; LYMPHOCYTES; MECHANISMS; MELANOMA; DATASETS; GENES	Focusing on highly specific aspects of the immune response is likely to answer a number of basic questions, and in some cases even resolve basic contradictions, in cancer immunology. For example, there are many cases, where chronic inflammation is associated with cancer development, and many other cases where an immune response represents an anticancer process. In this study, using bioinformatics algorithms, we examined the chemical relationships between the amino acid sequences of the complementarity-determining region-3 (CDR3) represented by immune receptors associated with lower grade glioma and isocitrate dehydrogenase-1 (IDH1) mutants. In particular, we developed a chemical complementarity scoring approach to classify tumors based on the complementarity of CDR3s and mutant IDH1 amino acids, relying on net charge per residue and hydropathy parameters. There was a strong correlation between the increased survival in low-grade glioma (LGG) and complementarity of IDH1 mutants to the CDR3 domain of the T-cell receptor beta chain (TRB). Similar results were obtained for TRB CDR3s and NRAS mutants in melanoma. Furthermore, the clear connection between increased survival rates and immune receptor-IDH1 mutant complementarities may also, partially, explain the better LGG prognosis for patients with IDH1 mutants.	[Chobrutskiy, Boris, I; Yeagley, Michelle; Tipping, Price; Zaman, Saif; Diviney, Andrea; Patel, Dhruv N.; Falasiri, Shayan; Uversky, Vladimir N.; Blanck, George] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Zaman, Saif; Blanck, George] H Lee Moffitt Canc Ctr & Res Inst, Immunol Program, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Blanck, G (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA.; Blanck, G (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Immunol Program, Tampa, FL 33612 USA.	gblanck@health.usf.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857; Patel, Dhruv/0000-0002-9888-7783; Falasiri, Seyed Shayan/0000-0002-8701-5146	USF Morsani College of Medicine RISE fellowships	USF Morsani College of Medicine RISE fellowships	Authors thank USF research computing and the taxpayers of the State of Florida. BIC, SZ, SF, MY and AD were recipients of USF Morsani College of Medicine RISE fellowships.	[Anonymous], 2014, Cancer Discov, V4, pOF13, DOI 10.1158/2159-8290.CD-RW2014-145; Berghoff AS, 2017, NEURO-ONCOLOGY, V19, P1460, DOI 10.1093/neuonc/nox054; Chen G, 2017, CELL REP, V19, P569, DOI 10.1016/j.celrep.2017.03.072; Chen WW, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.28; Chobrutskiy BI, 2019, J CANCER RES CLIN, V145, P615, DOI 10.1007/s00432-018-2815-1; Chobrutskiy BI, 2018, J NEURO-ONCOL, V140, P697, DOI 10.1007/s11060-018-03001-1; Cohen AL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0345-4; Davidson TB, 2019, CLIN CANCER RES, V25, P1913, DOI 10.1158/1078-0432.CCR-18-1176; Dutoit V, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1391972; Fisler DA, 2018, ONCOL LETT, V16, P2757, DOI 10.3892/ol.2018.8957; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Han S, 2014, BRIT J CANCER, V110, P2560, DOI 10.1038/bjc.2014.162; Holehouse AS, 2017, BIOPHYS J, V112, P16, DOI 10.1016/j.bpj.2016.11.3200; KIMURA H, 1988, J IMMUNOL, V140, P1212; Kiviniemi A, 2015, J NEURO-ONCOL, V124, P237, DOI 10.1007/s11060-015-1829-7; Leu S, 2013, NEURO-ONCOLOGY, V15, P469, DOI 10.1093/neuonc/nos317; Mauro JA, 2017, GENE, V614, P37, DOI 10.1016/j.gene.2017.02.026; Mauro JA, 2015, GENE, V554, P50, DOI 10.1016/j.gene.2014.10.021; Mauro JA, 2014, GENE, V536, P398, DOI 10.1016/j.gene.2013.11.013; Metellus P, 2010, ACTA NEUROPATHOL, V120, P719, DOI 10.1007/s00401-010-0777-8; Roca AM, 2019, HUM IMMUNOL, V80, P237, DOI 10.1016/j.humimm.2019.01.005; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Sikaria D, 2018, J CANCER RES CLIN, V144, P459, DOI 10.1007/s00432-017-2569-1; Syed P, 2015, SCI REP-UK, V5, DOI 10.1038/srep13895; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Tong WL, 2019, BREAST CANCER RES TR, V173, P167, DOI 10.1007/s10549-018-4961-1; Tsuchiya Y, 2018, IMMUNOLOGY, V153, P466, DOI 10.1111/imm.12849; Yin QS, 2010, HEMATOLOGY, V15, P48, DOI 10.1179/102453310X12583347009694; You ZB, 2006, CANCER RES, V66, P175, DOI 10.1158/0008-5472.CAN-05-1130; Zaman S, 2019, ONCOL REP, V41, P1359, DOI 10.3892/or.2018.6896; Zaman S, 2019, CLIN BIOCHEM, V63, P85, DOI 10.1016/j.clinbiochem.2018.11.004; Zaman S, 2018, BIOCHEM BIOPH RES CO, V503, P2218, DOI 10.1016/j.bbrc.2018.06.141; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099255; Zhou CY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00983	34	16	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1773	1783		10.1038/s41388-019-1101-2	http://dx.doi.org/10.1038/s41388-019-1101-2			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31740784				2022-12-26	WOS:000514923000011
J	Maity, S; Muhamed, J; Sarikhani, M; Kumar, S; Ahamed, F; Spurthi, KM; Ravi, V; Jain, A; Khan, D; Arathi, BP; Desingu, PA; Sundaresan, NR				Maity, Sangeeta; Muhamed, Jaseer; Sarikhani, Mohsen; Kumar, Shweta; Ahamed, Faiz; Spurthi, Kondapalli Mrudula; Ravi, Venkatraman; Jain, Aditi; Khan, Danish; Arathi, Bangalore Prabhashankar; Desingu, Perumal Arumugam; Sundaresan, Nagalingam R.			Sirtuin 6 deficiency transcriptionally up-regulates TGF-? signaling and induces fibrosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sirtuin; transforming growth factor beta (TGF-beta); fibrosis; aging; SMAD transcription factor; aging; aging-associated fibrosis; SIRT6 deacetylase; TGF-beta signaling; SMAD3; caloric restriction; cardiac disease; extracellular matrix (ECM)	GROWTH-FACTOR-BETA; CALORIE RESTRICTION; CELLULAR SENESCENCE; HEART-FAILURE; SMAD3; ACTIVATION; MECHANISMS; EXPRESSION; TGF-BETA-1; INFLAMMATION	Caloric restriction has been associated with increased life span and reduced aging-related disorders and reduces fibrosis in several diseases. Fibrosis is characterized by deposition of excess fibrous material in tissues and organs and is caused by aging, chronic stress, injury, or disease. Myofibroblasts are fibroblast-like cells that secrete high levels of extracellular matrix proteins, resulting in fibrosis. Histological studies have identified many-fold increases of myofibroblasts in aged organs where myofibroblasts are constantly generated from resident tissue fibroblasts and other cell types. However, it remains unclear how aging increases the generation of myofibroblasts. Here, using mouse models and biochemical assays, we show that sirtuin 6 (SIRT6) deficiency plays a major role in aging-associated transformation of fibroblasts to myofibroblasts, resulting in tissue fibrosis. Our findings suggest that SIRT6-deficient fibroblasts transform spontaneously to myofibroblasts through hyperactivation of transforming growth factor ? (TGF-?) signaling in a cell-autonomous manner. Importantly, we noted that SIRT6 haploinsufficiency is sufficient for enhancing myofibroblast generation, leading to multiorgan fibrosis and cardiac dysfunction in mice during aging. Mechanistically, SIRT6 bound to and repressed the expression of key TGF-? signaling genes by deacetylating SMAD family member 3 (SMAD3) and Lys-9 and Lys-56 in histone 3. SIRT6 binding to the promoters of genes in the TGF-? signaling pathway decreased significantly with age and was accompanied by increased binding of SMAD3 to these promoters. Our findings reveal that SIRT6 may be a potential candidate for modulating TGF-? signaling to reduce multiorgan fibrosis during aging and fibrosis-associated diseases.	[Maity, Sangeeta; Muhamed, Jaseer; Sarikhani, Mohsen; Kumar, Shweta; Ahamed, Faiz; Spurthi, Kondapalli Mrudula; Ravi, Venkatraman; Khan, Danish; Arathi, Bangalore Prabhashankar; Desingu, Perumal Arumugam; Sundaresan, Nagalingam R.] Indian Inst Sci, Div Biol Sci, Dept Microbiol & Cell Biol, Lab SB 02, Bengaluru 560012, Karnataka, India; [Jain, Aditi] Indian Inst Sci, Ctr BioSyst Sci & Engn, Bengaluru 560012, Karnataka, India; [Muhamed, Jaseer] Indian Council Med Res, Reg Occupat Hlth Ctr Southern, Bengaluru 562110, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Council of Medical Research (ICMR); ICMR - National Institute of Occupational Health (NIOH)	Sundaresan, NR (corresponding author), Indian Inst Sci, Div Biol Sci, Dept Microbiol & Cell Biol, Lab SB 02, Bengaluru 560012, Karnataka, India.	rsundaresan@iisc.ac.in	Desingu, P./AGM-5446-2022; Desingu, Perumal/AGH-9777-2022; Ravi, Venkatraman/C-7967-2014	Desingu, P./0000-0003-4395-4472; Muhamed, Jaseer/0000-0001-5046-9438; Ravi, Venkatraman/0000-0002-1409-682X; Maity, Sangeeta/0000-0003-4426-1715	Department of Science and Technology (DST)-Science and Engineering Research Board (SERB)-National Post-Doctoral Fellowship (N-PDF); Department of Biotechnology Research Associateship; Dr. D. S. Kothari Postdoctoral fellowship (DKPDF); Ramalingaswami Re-entry Fellowship; Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India; Department of Science and Technology [EMR/2014/000065]; Department of Biotechnology [BRB/10/1294/2014, MED/30/1454/2014]; Council for Scientific and Industrial Research [37(1646)/15/EMR-II]; Department of Biotechnology-Indian Institute of Science partnership program for advanced research	Department of Science and Technology (DST)-Science and Engineering Research Board (SERB)-National Post-Doctoral Fellowship (N-PDF)(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); Department of Biotechnology Research Associateship; Dr. D. S. Kothari Postdoctoral fellowship (DKPDF); Ramalingaswami Re-entry Fellowship; Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India; Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology-Indian Institute of Science partnership program for advanced research	Supported by the Department of Science and Technology (DST)-Science and Engineering Research Board (SERB)-National Post-Doctoral Fellowship (N-PDF).; Supported by a Department of Biotechnology Research Associateship.; Supported by a Dr. D. S. Kothari Postdoctoral fellowship (DKPDF).; Recipient of the Ramalingaswami Re-entry Fellowship and the Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India. This author's laboratory is supported by research funding from the Department of Science and Technology (Grant EMR/2014/000065), the Department of Biotechnology (Grants BRB/10/1294/2014 and MED/30/1454/2014), the Council for Scientific and Industrial Research (Grant 37(1646)/15/EMR-II), and the Department of Biotechnology-Indian Institute of Science partnership program for advanced research.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Araki S, 2015, CIRCULATION, V132, P1081, DOI 10.1161/CIRCULATIONAHA.114.014821; Arteaga M, 2016, AM J PHYSIOL-GASTR L, V310, pG1155, DOI 10.1152/ajpgi.00271.2015; Bhardwaj A, 2016, P NATL ACAD SCI USA, V113, pE538, DOI 10.1073/pnas.1520045113; Biernacka A, 2011, AGING DIS, V2, P158; Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93; Cappetta D, 2016, INT J CARDIOL, V205, P99, DOI 10.1016/j.ijcard.2015.12.008; Chalkiadaki A, 2015, NAT REV CANCER, V15, DOI 10.1038/nrc3985; Cho JS, 2012, CLIN EXP ALLERGY, V42, P872, DOI 10.1111/j.1365-2222.2011.03931.x; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Davis J, 2014, J MOL CELL CARDIOL, V70, P9, DOI 10.1016/j.yjmcc.2013.10.019; Diez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Dolinsky VW, 2011, BBA-MOL BASIS DIS, V1812, P1477, DOI 10.1016/j.bbadis.2011.06.010; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Edgley AJ, 2012, CARDIOVASC THER, V30, pe30, DOI 10.1111/j.1755-5922.2010.00228.x; Feng XX, 2015, CANCER SCI, V106, P559, DOI 10.1111/cas.12632; GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Harvey AE, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094151, 10.1371/journal.pone.0101803]; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Huang XZ, 2014, J CELL BIOCHEM, V115, P996, DOI 10.1002/jcb.24748; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kashiwagi I, 2015, IMMUNITY, V43, P65, DOI 10.1016/j.immuni.2015.06.010; Khan Shaukat A, 2012, BMC Res Notes, V5, P636, DOI 10.1186/1756-0500-5-636; Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6; Kim S, 2013, AM J PATHOL, V183, P1758, DOI 10.1016/j.ajpath.2013.08.014; Knaapen P, 2006, RADIOLOGY, V240, P380, DOI 10.1148/radiol.2402051038; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; LAURENT GJ, 1993, THORAX, V48, P953, DOI 10.1136/thx.48.10.953; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li Rujun, 2017, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V33, P67; Li ZY, 2016, AGING-US, V8, P2337, DOI 10.18632/aging.101050; Luo YX, 2017, EUR HEART J, V38, P1389, DOI 10.1093/eurheartj/ehw138; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Massague J, 2000, GENE DEV, V14, P627; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Neveu WA, 2015, AM J PHYSIOL-CELL PH, V309, pC616, DOI 10.1152/ajpcell.00086.2015; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Rapisarda V, 2017, CELL REP, V18, P2480, DOI 10.1016/j.celrep.2017.02.012; Ravi V, 2019, NUCLEIC ACIDS RES, V47, P9115, DOI 10.1093/nar/gkz648; Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057; Ruiz-Torres MP, 1998, J AM SOC NEPHROL, V9, P782; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Sarikhani M, 2018, ELIFE, V7, DOI 10.7554/eLife.32952; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Sharma A, 2013, J BIOL CHEM, V288, P18439, DOI 10.1074/jbc.M112.405928; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Tan KM, 2015, TRANSL RES, V165, P374, DOI 10.1016/j.trsl.2014.08.008; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Tasselli L, 2016, NAT STRUCT MOL BIOL, V23, P434, DOI 10.1038/nsmb.3202; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Weigert C, 2000, J AM SOC NEPHROL, V11, P2007, DOI 10.1681/ASN.V11112007; Xiao CY, 2012, J BIOL CHEM, V287, P41903, DOI 10.1074/jbc.M112.415182; Yamamoto T, 1999, CLIN IMMUNOL, V92, P6, DOI 10.1006/clim.1999.4720; Yan L, 2013, AGE, V35, P2177, DOI 10.1007/s11357-012-9508-5; Yang BH, 2012, CELL BIOL INT, V36, P105, DOI 10.1042/CBI20110268; Yao QP, 2014, INT J BIOCHEM CELL B, V49, P98, DOI 10.1016/j.biocel.2014.01.016; Zerr P, 2016, ANN RHEUM DIS, V75, P226, DOI 10.1136/annrheumdis-2014-205740; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003; Zhao GY, 2016, AGING-US, V8, P2308, DOI 10.18632/aging.101038; Zorrilla-Zubilete MA, 2018, J NEUROCHEM, V144, P128, DOI 10.1111/jnc.14243	69	33	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					415	434		10.1074/jbc.RA118.007212	http://dx.doi.org/10.1074/jbc.RA118.007212			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31744885	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000507373600013
J	Frinder, J; Kahloon, MA; Zhang, YQ; Ahmed, YL; Sinning, I; Jaschke, A				Frinder, Jens; Kahloon, Masroor Ahmad; Zhang, Yaqing; Ahmed, Yasar Luqman; Sinning, Irmgard; Jaeschke, Andres			YvcI from Bacillus subtilis has in vitro RNA pyrophosphohydrolase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA degradation; RNA processing; RNA turnover; nucleic acid enzymology; metalloenzyme; manganese; Nudix hydrolase; pyrophosphohydrolase; ribonucleolytic decay; YvcI	MESSENGER-RNA; ESCHERICHIA-COLI; NUDIX HYDROLASES; DEGRADATION; SPECIFICITY; GENE; VERSATILE; PROTEINS; STATE; DAPF	RNA degradation is one of several ways for organisms to regulate gene expression. In bacteria, the removal of two terminal phosphate moieties as orthophosphate (Bacillus subtilis) or pyrophosphate (Escherichia coli) triggers ribonucleolytic decay of primary transcripts by 5?-monophosphate?dependent ribonucleases. In the soil-dwelling firmicute species B. subtilis, the RNA pyrophosphohydrolase BsRppH, a member of the Nudix family, triggers RNA turnover by converting primary transcripts to 5?-monophospate RNA. In addition to BsRppH, a source of redundant activity in B. subtilis has been proposed. Here, using recombinant protein expression and in vitro enzyme assays, we provide evidence for several additional RNA pyrophosphohydrolases, among them MutT, NudF, YmaB, and YvcI in B. subtilis. We found that in vitro, YvcI converts RNA 5?-di- and triphosphates into monophosphates in the presence of manganese at neutral to slightly acidic pH. It preferred G-initiating RNAs and required at least one unpaired nucleotide at the 5?-end of its substrates, with the 5?-terminal nucleotide determining whether primarily ortho- or pyrophosphate is released. Exchanges of catalytically important glutamate residues in the Nudix motif impaired or abolished the enzymatic activity of YvcI. In summary, the results of our extensive in vitro biochemical characterization raise the possibility that YvcI is an additional RNA pyrophosphohydrolase in B. subtilis.	[Frinder, Jens; Kahloon, Masroor Ahmad; Zhang, Yaqing; Jaeschke, Andres] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; [Ahmed, Yasar Luqman; Sinning, Irmgard] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Jaschke, A (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany.	jaeschke@uni-hd.de			Baden-Wurttemberg Stiftung Grant [BWST_NCRNA_045]; Deutsche Forschungsgemeinschaft [SPP 1784, Ja794/10-1]	Baden-Wurttemberg Stiftung Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Baden-Wurttemberg Stiftung Grant BWST_NCRNA_045] and in part by Deutsche Forschungsgemeinschaft Priority Program SPP 1784 Grant Ja794/10-1. The authors declare that they have no conflicts of interest with the contents of this article.	Akbar S, 1999, MICROBIOL-UK, V145, P1069, DOI 10.1099/13500872-145-5-1069; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Cahova H, 2015, NATURE, V519, P374, DOI 10.1038/nature14020; Celesnik H, 2008, METHOD ENZYMOL, V447, P83, DOI 10.1016/S0076-6879(08)02205-2; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Dorleans A, 2011, STRUCTURE, V19, P1252, DOI 10.1016/j.str.2011.06.018; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002520; Foley PL, 2015, J BIOL CHEM, V290, P9478, DOI 10.1074/jbc.M114.634659; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Frindert J, 2018, CELL REP, V24, P1890, DOI 10.1016/j.celrep.2018.07.047; Fukushima T, 2003, J BIOCHEM, V133, P475, DOI 10.1093/jb/mvg062; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; Hofer K, 2016, NAT CHEM BIOL, V12, P730, DOI 10.1038/nchembio.2132; Hsieh PK, 2013, P NATL ACAD SCI USA, V110, P8864, DOI 10.1073/pnas.1222670110; Huang FQ, 1997, P NATL ACAD SCI USA, V94, P8965, DOI 10.1073/pnas.94.17.8965; Hui MP, 2014, ANNU REV GENET, V48, P537, DOI 10.1146/annurev-genet-120213-092340; Hwang J, 2001, J BIOL CHEM, V276, P31415, DOI 10.1074/jbc.M104455200; Lee CR, 2014, NUCLEIC ACIDS RES, V42, P12746, DOI 10.1093/nar/gku926; Lehnik-Habrink M, 2012, MOL MICROBIOL, V84, P1005, DOI 10.1111/j.1365-2958.2012.08072.x; Liu SW, 2008, METHOD ENZYMOL, V448, P3, DOI 10.1016/S0076-6879(08)02601-3; Luciano DJ, 2017, MOL CELL, V67, P44, DOI 10.1016/j.molcel.2017.05.035; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; McLennan AG, 2013, CELL MOL LIFE SCI, V70, P373, DOI 10.1007/s00018-012-1210-3; Piccirillo C, 2003, RNA, V9, P1138, DOI 10.1261/rna.5690503; Piton J, 2013, P NATL ACAD SCI USA, V110, P8858, DOI 10.1073/pnas.1221510110; Presecan E, 1997, MICROBIOL-SGM, V143, P3313, DOI 10.1099/00221287-143-10-3313; REDDY PS, 1994, EUR J BIOCHEM, V225, P737, DOI 10.1111/j.1432-1033.1994.00737.x; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; RICHAUD C, 1987, J BACTERIOL, V169, P1454, DOI 10.1128/jb.169.4.1454-1459.1987; Schwartz D, 2003, RNA, V9, P239, DOI 10.1261/rna.2171203; Vasilyev N, 2015, J BIOL CHEM, V290, P9487, DOI 10.1074/jbc.M114.634824; Xu WL, 2004, J BACTERIOL, V186, P8380, DOI 10.1128/JB.186.24.8380-8384.2004	34	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19967	19977		10.1074/jbc.RA119.011485	http://dx.doi.org/10.1074/jbc.RA119.011485			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31740579	Green Published, hybrid			2022-12-26	WOS:000505005800012
J	Richards, P; Mokuwa, E; Welmers, P; Maat, H; Beisel, U				Richards, Paul; Mokuwa, Esther; Welmers, Pleun; Maat, Harro; Beisel, Ulrike			Trust, and distrust, of Ebola Treatment Centers: A case-study from Sierra Leone	PLOS ONE			English	Article								The paper considers local responses to the introduction of an Ebola Treatment Centre in eastern Sierra Leone during the West African epidemic of 2014-15. Our study used qualitative methods consisting of focus groups and interviews, to gather responses from patients, members of the families of survivors and deceased victims of the disease, social liaison workers from the centre, and members of the general public. The data indicate that scepticism and resistance were widespread at the outset, but that misconceptions were replaced, in the minds of those directly affected by the disease, by more positive later assessments. Social workers, and social contacts of families with workers in the centre, helped reshape these perceptions, but a major factor was direct experience of the disease. This is apparent in the positive endorsements by survivors and families who had members taken to the facility. Even relatives of deceased victims agreed that the case-handling centre was valuable. However, we also present evidence of continuing scepticism in the minds of members of the general public, who continue to suspect that Ebola was a crisis manufactured for external benefit. Our conclusions stress the importance of better connectivity between communities and Ebola facilities to facilitate experiential learning. There is also a need to address the wider cognitive shock caused by a well-funded Ebola health initiative arriving in communities with a long history of inadequate health care. Restoring trust in medicine requires Ebola Virus Disease to be re-contextualized within a broader framework of concern for the health of all citizens.	[Richards, Paul] Njala Univ, Directorate Res & Planning, Makonde, Sierra Leone; [Mokuwa, Esther] Wageningen Univ, Dev Econ Grp, Wageningen, Netherlands; [Welmers, Pleun; Maat, Harro] Wageningen Univ, Knowledge Technol & Innovat Grp, Wageningen, Netherlands; [Beisel, Ulrike] Univ Bayreuth, Dept Anthropol, Bayreuth, Germany	Njala University; Wageningen University & Research; Wageningen University & Research; University of Bayreuth	Richards, P (corresponding author), Njala Univ, Directorate Res & Planning, Makonde, Sierra Leone.	paul.richards1945@gmail.com	Maat, Harro/D-2142-2012	Maat, Harro/0000-0001-7338-7910; Richards, Paul/0000-0001-5813-0228	German Research Foundation Program "Infectious Diseases in Africa" [BE5682 4-1]; German Research Foundation as part of the project "Trust in Medicine after the EVD epidemic: Street-level health bureaucrats, the institutionalization of care, and the creation of preparedness in Sierra Leone, Uganda, and Ghana"; DFG	German Research Foundation Program "Infectious Diseases in Africa"; German Research Foundation as part of the project "Trust in Medicine after the EVD epidemic: Street-level health bureaucrats, the institutionalization of care, and the creation of preparedness in Sierra Leone, Uganda, and Ghana"; DFG(German Research Foundation (DFG))	This research was funded under the German Research Foundation Program "Infectious Diseases in Africa"with the grant number BE5682 4-1 (Grant holders: Beisel and Mokuwa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; First and foremost our heartfelt thanks go to our team of research assistants: Baigeh Johnson, Fomba Kanneh, Musa Konneh, Philip Lahai and Sao Bockarie. This study was funded by the German Research Foundation as part of the project "Trust in Medicine after the EVD epidemic: Street-level health bureaucrats, the institutionalization of care, and the creation of preparedness in Sierra Leone, Uganda, and Ghana", we thank the DFG for the support. We also thank our collaborators in the project for intellectual companionship: Sung-Joon Park, Grace Akello, John Kuumuori Ganle, and Sylvanus Spencer. We thank Frederic Le Marcis for insightful comments as well as the two reviewers and editors of PLOS ONE for their constructive and helpful feedback.	Abramowitz S, 2017, J HEALTH COMMUN, V22, P59, DOI 10.1080/10810730.2016.1209599; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Bardosh K., 2019, SOCIAL SCI BEHAV DAT; Bonwitt J, 2018, SOC SCI MED, V200, P166, DOI 10.1016/j.socscimed.2017.12.028; Boozary AS, 2014, JAMA-J AM MED ASSOC, V312, P1859, DOI 10.1001/jama.2014.14387; Fairhead J, 2016, AFR STUD REV, V59, P7, DOI 10.1017/asr.2016.87; Freudenthal E, 2019, TELEGRAPH; Lave Jean., 1998, SITUATED LEARNING LE; Lave Jean., 2011, APPRENTICESHIP CRITI; Mas L., 2019, FRANCE 24 OBSERV MAR; Richards P, 2015, VILLAGE RESPONSES EB; Richards P., 2016, EBOLA PEOPLES SCI HE; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Nguyen VK, 2019, NEW ENGL J MED, V380, P1298, DOI 10.1056/NEJMp1902682; White Louise, 2000, SPEAKING VAMPIRES RU; Wilson D, 2015, AM J NURS, V115, P28, DOI 10.1097/01.NAJ.0000475288.30664.70	16	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224511	10.1371/journal.pone.0224511	http://dx.doi.org/10.1371/journal.pone.0224511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO9FT	31790420	Green Published, gold			2022-12-26	WOS:000533930800007
J	Jiang, Y; Jiang, YF; Zhang, HH; Mei, MR; Song, HL; Ma, XH; Jiang, L; Yu, ZQ; Zhang, Q; Ding, XD				Jiang, Yao; Jiang, Yifan; Zhang, Haihan; Mei, Mengran; Song, Hailiang; Ma, Xianghui; Jiang, Li; Yu, Zhenquan; Zhang, Qin; Ding, Xiangdong			A mutation in MAP2 is associated with prenatal hair follicle density	FASEB JOURNAL			English	Article						pig; hairless; morphogenesis; embryonic period	ECTODERMAL DYSPLASIA; BETA-CATENIN; MODEL; MORPHOGENESIS; GENE; MICE; PIG; DIFFERENTIATION; IDENTIFICATION; POPULATION	Hairlessness is usually a rare trait in pigs; however, in this study, we found hairless (HR) pigs at a relatively high frequency in 1 pig herd. We observed that, the lower hair shaft density of HR pigs could be mainly attributed to the lower hair follicle density, and during the embryonic period, d 39-45 were a critical stage for the formation of the hair follicle. In this regard, d 41 during gestation was a particularly important point. Hair follicle morphogenesis occurring at an early stage of embryo development is similar to humans and mice. Further analyses of association studies based on single-nucleotide polymorphism chip as well as sequence data, mRNA sequencing, immunohistochemistry, and comparative genomics demonstrated that microtubule-associated protein 2 (MAP2) is a key gene responsible for hair follicle density and 1 missense mutation of A-to-G at rs328005415 in MAP2, causing a valine-to-methionine substitution leads to the HR phenotype. Considering the high homology between pigs and humans, our research has some significance for the study of the mechanisms of skin development, hair morphogenesis, and hair loss in humans by showing that the pig may be a more appropriate model in which to study these processes.	[Jiang, Yao; Jiang, Yifan; Zhang, Haihan; Mei, Mengran; Song, Hailiang; Jiang, Li; Zhang, Qin; Ding, Xiangdong] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Lab Anim Genet Breeding & Reprod,Minist Agr, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China; [Ma, Xianghui; Yu, Zhenquan] China Agr Univ, Coll Biol Sci, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, State Key Lab Agrobiotechnol, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Ding, XD (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Lab Anim Genet Breeding & Reprod,Minist Agr, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	xding@cau.edu.cn	jiang, yifan/GQH-5044-2022	Jiang, Li/0000-0002-0648-2173	National Natural Science Foundation of China [31671327]; earmarked fund for China Agriculture Research System [CARS-35]; Changjiang Scholars Program and Innovative Research Team in University [IRT_15R621]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for China Agriculture Research System; Changjiang Scholars Program and Innovative Research Team in University	This study was supported by grants from the National Natural Science Foundation of China (31671327), the earmarked fund for China Agriculture Research System (CARS-35), the Changjiang Scholars Program and Innovative Research Team in University (IRT_15R621). The authors declare no conflicts of interest.	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Bastakoty D, 2015, FASEB J, V29, P4881, DOI 10.1096/fj.15-275941; Bianco E, 2015, MOL ECOL, V24, P2364, DOI 10.1111/mec.13182; Bourneuf E, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00146; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Calvo-Sanchez MI, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39992-8; Calvo-Sanchez MI, 2019, J MOL CELL BIOL, V11, P39, DOI 10.1093/jmcb/mjy051; Choi BY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092703; Collins KJ, 2014, STRUCTURE, V22, P70, DOI 10.1016/j.str.2013.10.010; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Duverger O, 2014, SEMIN CELL DEV BIOL, V25, P22, DOI 10.1016/j.semcdb.2013.12.006; Duverger O, 2009, BIRTH DEFECTS RES C, V87, P263, DOI 10.1002/bdrc.20158; Esteve-Codina A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-148; Fliniaux I, 2008, DEV BIOL, V320, P60, DOI 10.1016/j.ydbio.2008.04.023; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Fu J, 2013, J INVEST DERMATOL, V133, P890, DOI 10.1038/jid.2012.407; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Fuchs E, 2016, CURR TOP DEV BIOL, V116, P357, DOI 10.1016/bs.ctdb.2015.11.033; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Gao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151118; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Griaud F, 2017, MABS-AUSTIN, V9, P1337, DOI 10.1080/19420862.2017.1366395; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gutleb DR, 2018, GENES BRAIN BEHAV, V17, DOI 10.1111/gbb.12443; Han K, 2017, HUM MOL GENET, V26, P184, DOI 10.1093/hmg/ddw378; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kobayashi T, 2017, NATURE, V546, P416, DOI 10.1038/nature22812; Ladrech S, 2002, J COMP NEUROL, V451, P70, DOI 10.1002/cne.10334; Lichtenberger BM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10537; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Malhotra H, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00245; Nguyen MB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04399-y; Mokabber H, 2019, J CELL PHYSIOL, V234, P8941, DOI 10.1002/jcp.27563; Motlik J, 2007, THERIOGENOLOGY, V67, P105, DOI 10.1016/j.theriogenology.2006.09.018; Mundlapati VR, 2015, J PHYS CHEM LETT, V6, P1385, DOI 10.1021/acs.jpclett.5b00491; Neumann C, 2014, BIOMETRICAL J, V56, P1076, DOI 10.1002/bimj.201300148; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Patel S, 2018, J BIOL CHEM, V293, P12149, DOI 10.1074/jbc.RA118.002918; Perez-Enciso M, 2017, HEREDITY, V118, P160, DOI 10.1038/hdy.2016.78; Pissarenko A, 2019, ACTA BIOMATER, V86, P77, DOI 10.1016/j.actbio.2019.01.023; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Plikus MV, 2009, INT J DEV BIOL, V53, P857, DOI 10.1387/ijdb.072564mp; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sahoo S, 2017, J SURG RES, V210, P115, DOI 10.1016/j.jss.2016.10.026; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sardella C, 2018, J INVEST DERMATOL, V138, P500, DOI 10.1016/j.jid.2017.09.024; Schlechter N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01624; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sprecher E, 1999, J INVEST DERMATOL, V113, P687, DOI 10.1046/j.1523-1747.1999.00723.x; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; Susin C, 2017, J CLIN PERIODONTOL, V44, P1059, DOI 10.1111/jcpe.12766; Takeo M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023267; Tomann P, 2016, DEVELOPMENT, V143, P1512, DOI 10.1242/dev.130898; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112	67	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14479	14490		10.1096/fj.201901187R	http://dx.doi.org/10.1096/fj.201901187R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31751154	Bronze			2022-12-26	WOS:000507466100109
J	Chaganti, S; Welty, VF; Taylor, W; Albert, K; Failla, MD; Cascio, C; Smith, S; Mawn, L; Resnick, SM; Beason-Held, LL; Bagnato, F; Lasko, T; Blume, JD; Landman, BA				Chaganti, Shikha; Welty, Valerie F.; Taylor, Warren; Albert, Kimberly; Failla, Michelle D.; Cascio, Carissa; Smith, Seth; Mawn, Louise; Resnick, Susan M.; Beason-Held, Lori L.; Bagnato, Francesca; Lasko, Thomas; Blume, Jeffrey D.; Landman, Bennett A.			Discovering novel disease comorbidities using electronic medical records	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; OPTIC NEURITIS; ASSOCIATION; RISK; INFLAMMATION; ALZHEIMERS; RECOVERY; SYSTEM; FALLS; TEXT	Increasing reliance on electronic medical records at large medical centers provides unique opportunities to perform population level analyses exploring disease progression and etiology. The massive accumulation of diagnostic, procedure, and laboratory codes in one place has enabled the exploration of co-occurring conditions, their risk factors, and potential prognostic factors. While most of the readily identifiable associations in medical records are (now) well known to the scientific community, there is no doubt many more relationships are still to be uncovered in EMR data. In this paper, we introduce a novel finding index to help with that task. This new index uses data mined from real-time PubMed abstracts to indicate the extent to which empirically discovered associations are already known (i.e., present in the scientific literature). Our methods leverage second-generation p-values, which better identify associations that are truly clinically meaningful. We illustrate our new method with three examples: Autism Spectrum Disorder, Alzheimer's Disease, and Optic Neuritis. Our results demonstrate wide utility for identifying new associations in EMR data that have the highest priority among the complex web of correlations and causalities. Data scientists and clinicians can work together more effectively to discover novel associations that are both empirically reliable and clinically understudied.	[Chaganti, Shikha; Landman, Bennett A.] Vanderbilt Univ, Dept Elect Engn & Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Welty, Valerie F.; Blume, Jeffrey D.] Vanderbilt Univ, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Taylor, Warren; Albert, Kimberly; Failla, Michelle D.; Cascio, Carissa] Vanderbilt Univ, Med Ctr, Dept Psychiat & Behav Sci, Nashville, TN USA; [Smith, Seth] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Mawn, Louise] Vanderbilt Univ, Med Ctr, Dept Ophthalmol & Visual Sci, Nashville, TN USA; [Resnick, Susan M.; Beason-Held, Lori L.] NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA; [Bagnato, Francesca] Vanderbilt Univ, Dept Neurol, Med Ctr, Nashville, TN USA; [Lasko, Thomas] Vanderbilt Univ, Dept Biomed Informat, Med Ctr, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Vanderbilt University; Vanderbilt University	Chaganti, S (corresponding author), Vanderbilt Univ, Dept Elect Engn & Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	cshikha@gmail.com	Landman, Bennett A/A-2343-2009; Failla, Michelle/AAI-3788-2021; Mawn, Louise/DSQ-6331-2022	Landman, Bennett A/0000-0001-5733-2127; Failla, Michelle/0000-0001-9734-3373; 	Research to Prevent Blindness, New York, NY; Vanderbilt CTSA from NCATS/NIH [ULTR000445]; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; NSF CAREER [1452485]; NIH [5R21EY024036]; ViSE/VICTR; Intramural Research Program, National Institute on Aging, NIH; National Institute of Health [K24 MH110598]; Alzheimer's Association award [SAGA-18-418231]; National Institute of Biomedical Imaging and Bioengineering training grant [T32-EB021937]; NIMH training grant [T32-MH18921]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB021937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018921, K24MH110598] Funding Source: NIH RePORTER	Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Vanderbilt CTSA from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ViSE/VICTR; Intramural Research Program, National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association award; National Institute of Biomedical Imaging and Bioengineering training grant; NIMH training grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	LAM: Supported in part by an unrestricted grant to the Vanderbilt Eye Institute and Physician Scientist Award from Research to Prevent Blindness, New York, NY. A dataset used for the analyses described were obtained from Vanderbilt University Medical Center's Synthetic Derivative which is supported by institutional funding and by the Vanderbilt CTSA grant ULTR000445 from NCATS/NIH. BAL: This project was supported National Center for Research Resources, Grant UL1 RR024975-01 (now at the National Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06). This work was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University, Nashville, TN. This research was supported by NSF CAREER 1452485 and NIH grants 5R21EY024036. This project was supported in part by ViSE/VICTR. BAL, SR, LBH: This research was conducted with the support from Intramural Research Program, National Institute on Aging, NIH WT: National Institute of Health grant K24 MH110598 and Alzheimer's Association award SAGA-18-418231. SC: National Institute of Biomedical Imaging and Bioengineering training grant T32-EB021937 MF: NIMH training grant T32-MH18921.	Ahmad NA, 2002, GASTROINTEST ENDOSC, V55, P390, DOI 10.1067/mge.2002.121881; Aldinger KA, 2009, NAT GENET, V41, P1037, DOI 10.1038/ng.422; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Bazelier MT, 2011, J BONE MINER RES, V26, P2271, DOI 10.1002/jbmr.418; BECK RW, 1994, OPHTHALMOLOGY, V101, P1771; Blume JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188299; Brodsky M, 1997, NEUROLOGY, V49, P1404; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Browning BL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-309; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Careaga M, 2017, BIOL PSYCHIAT, V81, P434, DOI 10.1016/j.biopsych.2015.08.036; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Engels EA, 2016, CANC EPIDEMIOL PREV; Fiorini N, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005343; Gu Y, 2019, NEUROL-NEUROIMMUNOL, V6, DOI 10.1212/NXI.0000000000000521; Hanauer DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005203; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hill K, 2004, INTERN MED J, V34, P557, DOI 10.1111/j.1445-5994.2004.00668.x; Holmes AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021132; Hood DC, 2000, INVEST OPHTH VIS SCI, V41, P4032; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kellogg TA, 2009, SURG OBES RELAT DIS, V5, P416, DOI 10.1016/j.soard.2009.01.008; King E, 2018, J NEUROL NEUROSUR PS, V89, P339, DOI 10.1136/jnnp-2017-317134; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; McCarthy MM, 2017, BIOL PSYCHIAT, V81, P402, DOI 10.1016/j.biopsych.2016.10.004; Mead J, 2015, IMMUNOL LETT, V163, P49, DOI 10.1016/j.imlet.2014.11.006; Meltzer A, 2017, NEUROPSYCHOPHARMACOL, V42, P284, DOI 10.1038/npp.2016.158; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reed-Jones RJ, 2013, MATURITAS, V75, P22, DOI 10.1016/j.maturitas.2013.01.019; Resnick SM, 2003, J NEUROSCI, V23, P3295; Richesson RL, 2013, J AM MED INFORM ASSN, V20, pE319, DOI 10.1136/amiajnl-2013-001952; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586	39	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225495	10.1371/journal.pone.0225495	http://dx.doi.org/10.1371/journal.pone.0225495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774837	gold, Green Published			2022-12-26	WOS:000533896400034
J	Qi, L; Su, K; Xia, Y; Tang, WG; Shen, T; Li, Q				Qi, Li; Su, Kun; Xia, Yu; Tang, Wenge; Shen, Tao; Li, Qin			Enterovirus 71 vaccine acceptance among parents of children < 5 years old and their knowledge of hand, foot and mouth disease, Chongqing, China, 2017	PLOS ONE			English	Article							SEASONAL INFLUENZA VACCINATION; HEALTH-CARE WORKERS; ATTITUDES; BELIEFS; IMMUNIZATION	Background Enterovirus 71 (EV71) vaccine, which was put into market in China in 2016, has been viewed as a promising prevention measure against severe and fatal hand, foot and mouth disease (HFMD). This study aimed to investigate the knowledge of HFMD and acceptability of EV71 vaccine among parents of under-five in Chongqing, China. Methodology/Principal findings A cross-sectional survey was conducted in 2017. A validated questionnaire consisting of three sections including demographic information, knowledge of HFMD, acceptability and reasons for declining vaccination was developed based on literature review. Factors associated with unwillingness to receive EV71 vaccine were explored using multivariate logistic regression. A total of 992 parents finished the questionnaire with a response rate of 91.9%. Awareness of HFMD and EV71 vaccine were reported by 823 (83.0%) parents and 386 (38.9%) parents respectively. Knowledge about HFMD was with a mean score of 5.0 (standard deviation = 3.5) out of a total score of 12. Only 369 (37.2%) participants were classified as with good knowledge level about HFMD. 279 (28.1%) participants had their children received EV71 vaccine and 271 (27.3%) expressed willingness to vaccinate their children after a short-time education about EV71 vaccine. Acceptability of EV71 vaccine increased along with parents' education level (p = 0.008) and HFMD knowledge level (p< 0.001). Parents of scattered children had higher acceptability than those of preschool children (p = 0.002). 442 (44.6%) of participants were unwilling to have their children vaccinated with EV71 vaccine. The most common reasons for declining EV71 vaccine were doubts about its safety (56.6%) and efficacy (48.3%), and the necessity of vaccination (38.3%). Physicians and vaccination certificate were the parents' most trusted sources of vaccine information. Conclusions Parents' knowledge about HFMD was not sufficient, and nearly half of the parents expressed unwillingness to vaccinate their children with EV71 vaccine. Our findings stress that more efforts by health authorities in Chongqing are needed to increase the acceptability of EV71 vaccine, especially among parents of preschool children with lower education level.	[Qi, Li; Su, Kun; Xia, Yu; Tang, Wenge; Li, Qin] Chongqing Municipal Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Shen, Tao] Chinese Hosp Assoc, Beijing, Peoples R China		Tang, WG (corresponding author), Chongqing Municipal Ctr Dis Control & Prevent, Chongqing, Peoples R China.	wengetang@163.com			Highlevel Medical Reserved Personnel Training Project of Chongqing, Chongqing Health Commission [2019GDRC014]; National Key R&D Program of China [2017YFC0907303]	Highlevel Medical Reserved Personnel Training Project of Chongqing, Chongqing Health Commission; National Key R&D Program of China	This project was supported by the Highlevel Medical Reserved Personnel Training Project of Chongqing, Chongqing Health Commission [grant number 2019GDRC014] and the National Key R&D Program of China [grant number 2017YFC0907303]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUIDELINE DIAGNOSIS; Chen B, 2015, VACCINE, V33, P1780, DOI 10.1016/j.vaccine.2015.02.046; Cvjetkovic SJ, 2017, J INFECT PUBLIC HEAL, V10, P649, DOI 10.1016/j.jiph.2017.05.008; Gao LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100003; Goksugur Nadir, 2010, N Engl J Med, V362, pe49, DOI 10.1056/NEJMicm0910628; Li HX, 2016, J PUBLIC HLTH PREVEN, V27, P25; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Ma T, 2016, MODERN PREVENTIVE ME, V43, P18; Ma Tao, 2016, Modern Preventive Medicine, V43, P4310; Mao QY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.73; Olatunbosun OD, 2017, VACCINE, V35, P6375, DOI 10.1016/j.vaccine.2017.10.006; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Rehmani R, 2010, VACCINE, V28, P4283, DOI 10.1016/j.vaccine.2010.04.031; Rosenthal SL, 2008, J ADOLESCENT HEALTH, V43, P239, DOI 10.1016/j.jadohealth.2008.06.009; Smailbegovic MS, 2003, CHILD CARE HLTH DEV, V29, P303, DOI 10.1046/j.1365-2214.2003.00347.x; Song Y, 2017, VACCINE, V35, P4060, DOI 10.1016/j.vaccine.2017.06.054; Wodi AP, 2005, INFECT CONT HOSP EP, V26, P867, DOI 10.1086/502510; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wu JT, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001975; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu Y, 2016, 2016 13TH CHINA INTERNATIONAL FORUM ON SOLID STATE LIGHTING: INTERNATIONAL FORUM ON WIDE BANDGAP SEMICONDUCTORS CHINA (SSLCHINA: IFWS), P97, DOI 10.1109/IFWS.2016.7803766; YAN CY, 2013, CHINESE J HLTH ED, V29, P605; Zhang J, 2012, EPIDEMIOL INFECT, V140, P1569, DOI 10.1017/S0950268811002214; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	25	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225569	10.1371/journal.pone.0225569	http://dx.doi.org/10.1371/journal.pone.0225569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774839	Green Published, gold			2022-12-26	WOS:000533896400040
J	Venier, LA; Swystun, T; Mazerolle, MJ; Kreutzweiser, DP; Wainio-Keizer, KL; McIlwrick, KA; Woods, ME; Wang, XL				Venier, Lisa A.; Swystun, Tom; Mazerolle, Marc J.; Kreutzweiser, David P.; Wainio-Keizer, Kerrie L.; McIlwrick, Ken A.; Woods, Murray E.; Wang, Xianli			Modelling vegetation understory cover using LiDAR metrics	PLOS ONE			English	Article							AIRBORNE LIDAR; FOREST STRUCTURE; SPECIES RICHNESS; STAND VARIABLES; DENSITY; INVENTORY; CLASSIFICATION; ECOSYSTEMS; PREDICTION; REGRESSION	Forest understory vegetation is an important characteristic of the forest. Predicting and mapping understory is a critical need for forest management and conservation planning, but it has proved difficult with available methods to date. LiDAR has the potential to generate remotely sensed forest understory structure data, but this potential has yet to be fully validated. Our objective was to examine the capacity of LiDAR point cloud data to predict forest understory cover. We modeled ground-based observations of understory structure in three vertical strata (0.5 m to < 1.5 m, 1.5 m to < 2.5 m, 2.5 m to < 3.5 m) as a function of a variety of LiDAR metrics using both mixed-effects and Random Forest models. We compared four understory LiDAR metrics designed to control for the spatial heterogeneity of sampling density. The four metrics were highly correlated and they all produced high values of variance explained in mixed-effects models. The top-ranked model used a voxel-based understory metric along with vertical stratum (Akaike weight = 1, explained variance = 87%, cross-validation error = 15.6%). We found evidence of occlusion of LiDAR pulses in the lowest stratum but no evidence that the occlusion influenced the predictability of understory structure. The Random Forest model results were consistent with those of the mixed-effects models, in that all four understory LiDAR metrics were identified as important, along with vertical stratum. The Random Forest model explained 74.4% of the variance, but had a lower cross-validation error of 12.9%. We conclude that the best approach to predict understory structure is using the mixed-effects model with the voxel-based understory LiDAR metric along with vertical stratum, because it yielded the highest explained variance with the fewest number of variables. However, results show that other understory LiDAR metrics (fractional cover, normalized cover and leaf area density) would still be effective in mixed-effects and Random Forest modelling approaches.	[Venier, Lisa A.; Swystun, Tom; Kreutzweiser, David P.; Wainio-Keizer, Kerrie L.; McIlwrick, Ken A.; Wang, Xianli] Nat Resources Canada, Great Lakes Forestry Ctr, Canadian Forest Serv, Saul St Marie, ON, Canada; [Mazerolle, Marc J.] Univ Laval, Ctr Forest Res, Dept Wood & Forest Sci, Quebec City, PQ, Canada; [Woods, Murray E.] Ontario Minist Nat Resources & Forestry, North Bay, ON, Canada	Natural Resources Canada; Canadian Forest Service; Laval University; Ministry of Natural Resources & Forestry	Venier, LA (corresponding author), Nat Resources Canada, Great Lakes Forestry Ctr, Canadian Forest Serv, Saul St Marie, ON, Canada.	lisa.venier@canada.ca	Venier, Lisa/GYU-3566-2022	Mazerolle, Marc/0000-0002-0486-0310	Canadian Wood Fibre Centre, Natural Resources Canada	Canadian Wood Fibre Centre, Natural Resources Canada(Natural Resources CanadaCanadian Forest Service)	This study was funded by the Canadian Wood Fibre Centre, Natural Resources Canada to LV. (https://www.nrcan.gc.ca/forests/resources/research-centres-and-forests/canadian-wood-fibrecentre/13457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2008, P NATL ACAD SCI USA, V105, P4519, DOI 10.1073/pnas.0710811105; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Bouvier M, 2015, REMOTE SENS ENVIRON, V156, P322, DOI 10.1016/j.rse.2014.10.004; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Call PT, 1997, INT J WILDLAND FIRE, V7, P259, DOI 10.1071/WF9970259; Campbell MJ, 2018, REMOTE SENS ENVIRON, V215, P330, DOI 10.1016/j.rse.2018.06.023; Clawges R, 2008, REMOTE SENS ENVIRON, V112, P2064, DOI 10.1016/j.rse.2007.08.023; Coops NC, 2016, ECOL INDIC, V67, P346, DOI 10.1016/j.ecolind.2016.02.057; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davies AB, 2014, TRENDS ECOL EVOL, V29, P681, DOI 10.1016/j.tree.2014.10.005; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Eskelson BNI, 2011, FOREST SCI, V57, P212; Gneiting T, 2011, J AM STAT ASSOC, V106, P746, DOI 10.1198/jasa.2011.r10138; Gonzalez-Ferreiro E, 2012, FORESTRY, V85, P281, DOI 10.1093/forestry/cps002; Goodwin NR, 2006, REMOTE SENS ENVIRON, V103, P140, DOI 10.1016/j.rse.2006.03.003; Hely C, 2000, J VEG SCI, V11, P813, DOI 10.2307/3236551; Hill RA, 2009, ISPRS J PHOTOGRAMM, V64, P223, DOI 10.1016/j.isprsjprs.2008.12.004; Hyde P, 2006, REMOTE SENS ENVIRON, V102, P63, DOI 10.1016/j.rse.2006.01.021; Jakubowski MK, 2013, REMOTE SENS ENVIRON, V130, P245, DOI 10.1016/j.rse.2012.11.024; Kerns BK, 2004, ECOL INDIC, V4, P83, DOI 10.1016/j.ecolind.2003.12.002; Kim E, 2016, FORESTS, V7, DOI 10.3390/f7110259; Latifi H, 2017, FORESTRY, V90, P496, DOI 10.1093/forestry/cpw066; Latifi H, 2016, FORESTRY, V89, P69, DOI 10.1093/forestry/cpv032; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; Lesak AA, 2011, REMOTE SENS ENVIRON, V115, P2823, DOI 10.1016/j.rse.2011.01.025; Lim K, 2003, CAN J REMOTE SENS, V29, P658, DOI 10.5589/m03-025; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Martinuzzi S, 2009, REMOTE SENS ENVIRON, V124, P730; Melin M, 2016, FOREST ECOL MANAG, V380, P202, DOI 10.1016/j.foreco.2016.09.007; Morsdorf F, 2010, REMOTE SENS ENVIRON, V114, P1403, DOI 10.1016/j.rse.2010.01.023; Muller J, 2010, REMOTE SENS ENVIRON, V114, P490, DOI 10.1016/j.rse.2009.10.006; Naesset E, 2004, SCAND J FOREST RES, V19, P164, DOI 10.1080/02827580310019257; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Penner M, 2013, CAN J REMOTE SENS, V39, P426, DOI 10.5589/m13-049; Pinheiro J, 2018, R PACKAGE VERSION 3; R Core Team, 2018, R LANG ENV STAT COMP; Rechsteiner C, 2017, REMOTE SENS ECOL CON, V3, P247, DOI 10.1002/rse2.46; Roxburgh SH, 2019, FOREST ECOL MANAG, V432, P264, DOI 10.1016/j.foreco.2018.09.011; Ruiz LA, 2014, FORESTS, V5, P936, DOI 10.3390/f5050936; Suchar VA, 2010, ECOL INDIC, V10, P602, DOI 10.1016/j.ecolind.2009.10.004; Thomas V, 2006, CAN J FOREST RES, V36, P34, DOI [10.1139/x05-230, 10.1139/X05-230]; Venier LA, 2007, CAN J FOREST RES, V37, P1214, DOI 10.1139/X07-025; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Vierling LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080988; Vogeler JC, 2014, REMOTE SENS ENVIRON, V147, P13, DOI 10.1016/j.rse.2014.02.006; Wing BM, 2012, REMOTE SENS ENVIRON, V124, P730, DOI 10.1016/j.rse.2012.06.024; Woods M, 2008, FOREST CHRON, V84, P827, DOI 10.5558/tfc84827-6; YARIE J, 1980, ECOLOGY, V61, P1498, DOI 10.2307/1939057	52	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0220096	10.1371/journal.pone.0220096	http://dx.doi.org/10.1371/journal.pone.0220096			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774813	Green Submitted, Green Published, gold			2022-12-26	WOS:000533896400005
J	Fischer-Rasokat, U; Renker, M; Liebetrau, C; Weferling, M; Rolf, A; Doss, M; Mollmann, H; Walther, T; Hamm, CW; Kim, WK				Fischer-Rasokat, Ulrich; Renker, Matthias; Liebetrau, Christoph; Weferling, Maren; Rolf, Andreas; Doss, Mirko; Moellmann, Helge; Walther, Thomas; Hamm, Christian W.; Kim, Won-Keun			Outcome of patients with heart failure after transcatheter aortic valve implantation	PLOS ONE			English	Article							REDUCED EJECTION FRACTION; LOW-GRADIENT; LOW-FLOW; EUROPEAN ASSOCIATION; NATRIURETIC PEPTIDE; PROGNOSTIC VALUE; STENOSIS; REPLACEMENT; TAVI; IMPACT	Aims Patients with aortic stenosis (AS) may have concomitant heart failure (HF) that determines prognosis despite successful transcatheter aortic valve implantation (TAVI). We compared outcomes of TAVI patients with low stroke volume index (SVI)<= 35 ml/m(2) body surface area in different HF classes. Methods and results Patients treated by transfemoral TAVI at our center (n = 1822) were classified as 1) 'HF with preserved ejection fraction (EF)' (HFpEF, EF.50%), 2) 'HF with mid-range EF' (HFmrEF, EF 40-49%), or 3) 'HF with reduced EF' (HFrEF, EF <40%). Patients with SVI >35 ml/m(2) served as controls. The prevalence of cardiovascular disease and symptoms increased stepwise from controls (n = 968) to patients with HFpEF (n = 591), HFmrEF (n = 97), and HFrEF (n = 166). Mortality tended to be highest in HFrEF patients 30 days post-procedure, and it became significant after one year: 10.2% (controls), 13.5% (HFpEF), 13.4% (HFmrEF), and 23.5% (HFrEF). However, symptomatic improvement in survivors of all groups was achieved in the majority of patients without differences among groups. Conclusions Patients with AS and HF benefit from TAVI with respect to symptom alleviation. TAVI in patients with HFpEF and HFmrEF led to an identical, favorable post-procedural prognosis that was significantly better than that of patients with HFrEF, which remains a high-risk population.	[Fischer-Rasokat, Ulrich; Renker, Matthias; Liebetrau, Christoph; Weferling, Maren; Rolf, Andreas; Hamm, Christian W.; Kim, Won-Keun] Kerckhoff Heart Ctr, Dept Cardiol, Bad Nauheim, Germany; [Fischer-Rasokat, Ulrich; Liebetrau, Christoph; Rolf, Andreas; Hamm, Christian W.; Kim, Won-Keun] Univ Hosp Giessen, Dept Cardiol & Angiol, Med Clin 1, Giessen, Germany; [Renker, Matthias; Doss, Mirko; Walther, Thomas; Kim, Won-Keun] Kerckhoff Heart Ctr, Dept Cardiac Surg, Bad Nauheim, Germany; [Renker, Matthias; Liebetrau, Christoph; Rolf, Andreas; Walther, Thomas; Hamm, Christian W.] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Bad Nauheim, Germany; [Moellmann, Helge] St Johannes Hosp, Dept Cardiol, Med Clin 1, Dortmund, Germany; [Walther, Thomas] Goethe Univ, Dept Cardiac Thorac & Thorac Vasc Surg, Univ Hosp, Frankfurt, Germany	Kerckhoff Clinic; University Hospital of Giessen & Marburg; Kerckhoff Clinic; German Centre for Cardiovascular Research; St. Johannes Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Fischer-Rasokat, U (corresponding author), Kerckhoff Heart Ctr, Dept Cardiol, Bad Nauheim, Germany.; Fischer-Rasokat, U (corresponding author), Univ Hosp Giessen, Dept Cardiol & Angiol, Med Clin 1, Giessen, Germany.	u.fischer-rasokat@kerckhoff-klinik.de	Renker, Matthias/GWG-8992-2022; Kim, Won-Keun/AAS-8945-2021; Rolf, Andreas/ABH-4255-2020	Kim, Won-Keun/0000-0002-0799-7478; Renker, Matthias/0000-0002-4756-5397; Fischer-Rasokat, Ulrich/0000-0002-7825-2799				Altaie S, 2018, ESC HEART FAIL, V5, P1008, DOI 10.1002/ehf2.12353; Amabile N, 2014, EUROINTERVENTION, V10, P842, DOI 10.4244/EIJV10I7A144; Arsalan M, 2016, CLIN RES CARDIOL, V105, P1042, DOI 10.1007/s00392-016-1027-4; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Beach JM, 2014, J THORAC CARDIOV SUR, V147, P362, DOI 10.1016/j.jtcvs.2012.12.016; Bhambhani V, 2018, EUR J HEART FAIL, V20, P651, DOI 10.1002/ejhf.1091; Clavel MA, 2013, J AM COLL CARDIOL, V62, P2329, DOI 10.1016/j.jacc.2013.08.1621; Conrotto F, 2017, CATHETER CARDIO INTE, V89, P1100, DOI 10.1002/ccd.26839; Diez JD, 2013, INT J CHRONIC OBSTR, V8, P305, DOI 10.2147/COPD.S31236; Eleid MF, 2015, AM J CARDIOL, V116, P989, DOI 10.1016/j.amjcard.2015.06.027; Gotzmann M, 2020, CLIN CARDIOL, V43, P508, DOI 10.1002/clc.23338; Guazzi M, 2018, HEART FAIL CLIN, V14, P297, DOI 10.1016/j.hfc.2018.02.006; Kaneko H, 2018, HEART VESSELS; Koh AS, 2017, EUR J HEART FAIL, V19, P1624, DOI 10.1002/ejhf.945; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lauritsen J, 2018, ESC HEART FAIL, V5, P685, DOI 10.1002/ehf2.12283; Lauten A, 2014, EUROINTERVENTION, V10, P850, DOI 10.4244/EIJV10I7A145; Liebetrau C, 2018, INT J CARDIOL, V265, P40, DOI 10.1016/j.ijcard.2018.02.037; Luo X, 2015, HERZ, V40, P168, DOI 10.1007/s00059-014-4193-z; Nauta JF, 2017, EUR J HEART FAIL, V19, P1569, DOI 10.1002/ejhf.1058; Pibarot P, 2019, JACC-CARDIOVASC IMAG, V12, P172, DOI 10.1016/j.jcmg.2018.10.021; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Puls M, 2017, EUROINTERVENTION, V13, P286, DOI 10.4244/EIJ-D-16-00801; Ribeiro HB, 2014, AM J CARDIOL, V113, P851, DOI 10.1016/j.amjcard.2013.11.038; Ribeiro HB, 2018, J AM COLL CARDIOL, V71, P1297, DOI 10.1016/j.jacc.2018.01.054; Rodriguez-Gabella T, 2019, J AM COLL CARDIOL, V74, P631, DOI 10.1016/j.jacc.2019.05.055; Rodriguez-Gabella T, 2018, AM J CARDIOL, V122, P625, DOI 10.1016/j.amjcard.2018.04.044; Schmidt T, 2018, CLIN RES CARDIOL; Spitzer E, 2016, AM HEART J, V182, P80, DOI 10.1016/j.ahj.2016.08.009; Steiner J, 2017, J AM COLL CARDIOL, V70, P3026, DOI 10.1016/j.jacc.2017.10.040; Tschope C, 2018, CLIN RES CARDIOL, V107, P1, DOI 10.1007/s00392-017-1170-6; Voros G, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.118.004953; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	33	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225473	10.1371/journal.pone.0225473	http://dx.doi.org/10.1371/journal.pone.0225473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770401	Green Published, Green Submitted, gold			2022-12-26	WOS:000533892300021
J	Fleming, I; Cavalcanti, ARO				Fleming, Ira; Cavalcanti, Andre R. O.			Selection for tandem stop codons in ciliate species with reassigned stop codons	PLOS ONE			English	Article							TRANSLATION TERMINATION; MESSENGER-RNAS; ERF1; READTHROUGH; DEGRADATION; DOWNSTREAM; EFFICIENCY; PROTEIN	The failure of mRNA translation machinery to recognize a stop codon as a termination signal and subsequent translation of the 3' untranslated region (UTR) is referred to as stop codon readthrough, the frequency of which is related to the length, composition, and structure of mRNA sequences downstream of end-of-gene stop codons. Secondary in-frame stop codons within a few positions downstream of the primary stop codons, so-called tandem stop codons (TSCs), serve as backup termination signals, which limit the effects of readthrough: polypeptide product degradation, mislocalization, and aggregation. In this study, ciliate species with UAA and UAG stop codons reassigned to code for glutamine are found to possess statistical excesses of TSCs at the beginning of their 3' UTRs. The overrepresentation of TSCs in these species is greater than that observed in standard code organisms. Though the overall numbers of TSCs are lower in most species with alternative stop codons because they use fewer than three unique stop codons, the relatively great overrepresentation of TSCs in alternative-code ciliate species suggests that there exist stronger selective pressures to maintain TSCs in these organisms compared to standard code organisms.	[Fleming, Ira; Cavalcanti, Andre R. O.] Pomona Coll, Dept Mol Biol, Claremont, CA 91711 USA; [Fleming, Ira; Cavalcanti, Andre R. O.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Claremont Colleges; Pomona College; Massachusetts Institute of Technology (MIT)	Cavalcanti, ARO (corresponding author), Pomona Coll, Dept Mol Biol, Claremont, CA 91711 USA.	aroc@pomona.edu		Fleming, Ira/0000-0002-4691-6933				Adachi M, 2009, J MOL EVOL, V68, P424, DOI 10.1007/s00239-009-9220-y; Arribere JA, 2016, NATURE, V534, P719, DOI 10.1038/nature18308; Bachvaroff TR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212912; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Conard SE, 2012, RNA, V18, P1210, DOI 10.1261/rna.031997.111; Csibra E, 2014, J VIROL, V88, P10364, DOI 10.1128/JVI.00898-14; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Eliseev BD, 2011, MOL BIOL+, V45, P614, DOI 10.1134/S0026893311040030; Fort P, 2015, GENOME BIOL EVOL, V7, P1363, DOI 10.1093/gbe/evv068; Fu CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-208; Hollingsworth TJ, 2013, J BIOL CHEM, V288, P29047, DOI 10.1074/jbc.M113.495184; Hou J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8214; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Klauer AA, 2012, WIRES RNA, V3, P649, DOI 10.1002/wrna.1124; Kochetov AV, 2011, GENE, V481, P1, DOI 10.1016/j.gene.2011.04.002; Korostelev AA, 2011, RNA, V17, P1409, DOI 10.1261/rna.2733411; Lekomtsev S, 2007, P NATL ACAD SCI USA, V104, P10824, DOI 10.1073/pnas.0703887104; Liang H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r31; LIEBMAN SW, 1976, GENETICS, V82, P233; Lozupone CA, 2001, CURR BIOL, V11, P65, DOI 10.1016/S0960-9822(01)00028-8; LU P, 1971, J MOL BIOL, V58, P513, DOI 10.1016/0022-2836(71)90368-8; Merritt GH, 2010, NUCLEIC ACIDS RES, V38, P5479, DOI 10.1093/nar/gkq338; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; Namy O, 2010, NUCLEIC ACIDS MOL BI, V24, P79, DOI 10.1007/978-0-387-89382-2_4; NICHOLS JL, 1970, NATURE, V225, P147, DOI 10.1038/225147a0; Plant EP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000517; Salas-Marco J, 2006, MOL CELL BIOL, V26, P438, DOI 10.1128/MCB.26.2.438-447.2006; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shibata N, 2015, J BIOL CHEM, V290, P28428, DOI 10.1074/jbc.M115.670901; Slabodnick MM, 2017, CURR BIOL, V27, P569, DOI 10.1016/j.cub.2016.12.057; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; Stover NA, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas007; Swart EC, 2016, CELL, V166, P691, DOI 10.1016/j.cell.2016.06.020; Templeton TJ, 2004, GENOME RES, V14, P1686, DOI 10.1101/gr.2615304; Vidal R, 1999, NATURE, V399, P776; Wang RL, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4445-z	38	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225804	10.1371/journal.pone.0225804	http://dx.doi.org/10.1371/journal.pone.0225804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770405	gold, Green Published			2022-12-26	WOS:000533892300040
J	Ho, CH; Chang, TS; Chien, RN				Ho, Cheng-Hsun; Chang, Ting-Tsung; Chien, Rong-Nan			Telbivudine on IgG-associated hypergammaglobulinemia and TGF-beta 1 hyperactivity in hepatitis B virus-related liver cirrhosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; E-ANTIGEN SEROCONVERSION; TRANSFORMING GROWTH-FACTOR-BETA-1; N-GLYCOME; ENTECAVIR; GALACTOSYLTRANSFERASE; EFFICACY; CELLS; IMMUNOGLOBULINS; EXPRESSION	As debate rumbles on about whether anti-hepatitis B virus (HBV) nucleos(t)ide analogue treatments modulate host immune system during end-stage liver diseases, we studied effects of two potent anti-HBV agents, telbivudine or entecavir, on humoral immune activities including cytokine secretion, immunoglobulin production, and IgG-Fc agalactosylation, which is known to induce proinflammatory responses, in liver cirrhosis. Serum IgG-Fc N-glycan structures in patients with HBV-related liver cirrhosis, who had received either telbivudine treatment or entecavir treatment for at least 48 weeks were analyzed using liquid chromatography tandem-mass spectrometry. Levels of cytokines and each immunoglobulin isotype were measured using enzyme-linked immunosorbent assays. Results showed that 48 weeks of entecavir treatment caused HBV DNA loss, alanine aminotransferase normalization, and an amelioration of hypergammaglobulinemia in cirrhotic patients; however, telbivudine treatment, though possessing similar efficacies on HBV suppression and an improvement in liver inflammation to entecavir treatment, did not mitigate IgG-related hypergammaglobulinemia. Levels of IgG and transforming growth factor (TGF)-beta 1 in sera of the cirrhotic patients before and during treatment were positively correlated. In vitro assays revealed that telbivudine treatment induced TGF-beta 1 expression in human macrophagic cells. Moreover, recombinant TGF-beta 1 treatment stimulated cell proliferation and IgG overproduction in human IgG-producing B cell lines. Finally, we found that telbivudine treatment enhanced the proportion of serum IgG-Fc agalactosylation in cirrhotic patients, which was associated with enhanced levels of TGF-beta 1 and IgG. In conclusion, telbivudine therapy was associated with TGF-beta 1 hyperactivity, IgG-related hypergammaglobulinemia, and IgG-Fc agalactosylation in HBV-related liver cirrhosis.	[Ho, Cheng-Hsun] I Shou Univ, Coll Med, Dept Med Lab Sci, Kaohsiung, Taiwan; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan, Taiwan; [Chien, Rong-Nan] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Linkou, Taiwan	I Shou University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Chang Gung Memorial Hospital	Chien, RN (corresponding author), Chang Gung Mem Hosp, Dept Hepatogastroenterol, Linkou, Taiwan.	ronald@adm.cgmh.org.tw			Ministry of Science and Technology, Taiwan [1002314-B-006-024-MY3, 103-2314-B-006-013-MY3, 107-2314-B-214-009, 108-2314-B-214-003MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant 1002314-B-006-024-MY3, 103-2314-B-006-013-MY3, 107-2314-B-214-009, and 108-2314-B-214-003MY2 from Ministry of Science and Technology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Borzio M, 2001, DIGEST LIVER DIS, V33, P41, DOI 10.1016/S1590-8658(01)80134-1; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; Dispenzieri A, 2001, MAYO CLIN PROC, V76, P476, DOI 10.4065/76.5.476; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Fallatah HI, 2010, LIBYAN J MED, V5, DOI 10.3402/ljm.v5i0.4857; FEIZI T, 1968, GUT, V9, P193, DOI 10.1136/gut.9.2.193; FURUKAWA K, 1990, INT IMMUNOL, V2, P105, DOI 10.1093/intimm/2.1.105; Gotte M, 2008, HUM MOL GENET, V17, P996, DOI 10.1093/hmg/ddm372; Ho CH, 2015, J INFECT DIS, V211, P115, DOI 10.1093/infdis/jiu388; Ho CH, 2014, ANTIVIR RES, V111, P121, DOI 10.1016/j.antiviral.2014.09.011; KEKOW J, 1988, CANCER DETECT PREV, V12, P211; KEUSCH J, 1995, GLYCOBIOLOGY, V5, P365, DOI 10.1093/glycob/5.4.365; Keusch J, 1998, GLYCOCONJUGATE J, V15, P1093, DOI 10.1023/A:1006957711557; Kim HR, 2015, LIVER INT, V35, P860, DOI 10.1111/liv.12605; KIM PH, 1990, J IMMUNOL, V145, P3773; Kirmaz C, 2004, EUR CYTOKINE NETW, V15, P112; Klein A, 2010, PROTEOM CLIN APPL, V4, P379, DOI 10.1002/prca.200900133; LEBMAN DA, 1990, J IMMUNOL, V144, P952; Liang J, 2013, HEPAT MON, V13, DOI [10.5812/hepatmon.7862, 10.7862/hepatmon.7862]; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Punnoose Ann R, 2012, JAMA, V307, P874, DOI 10.1001/jama.2012.82; RATH S, 1988, CLIN EXP IMMUNOL, V72, P164; Rizzetto M, 2012, HEPAT MON, V12, P309, DOI 10.5812/hepatmon.6113; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shen H, 2005, DIGEST DIS SCI, V50, P181, DOI 10.1007/s10620-005-1298-5; STOBO JD, 1979, DIGEST DIS SCI, V24, P737, DOI 10.1007/BF01317204; Tanaka S, 2007, HEPATO-GASTROENTEROL, V54, P2301; Tsai MC, 2012, J ANTIMICROB CHEMOTH, V67, P696, DOI 10.1093/jac/dkr495; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; VANVLASSELAER P, 1992, J IMMUNOL, V148, P2062; Wang GQ, 2013, J VIRAL HEPATITIS, V20, P9, DOI 10.1111/jvh.12059; Wang N, 2013, TURK J GASTROENTEROL, V24, P230, DOI 10.4318/tjg.2013.0680; Wu ZG, 2010, J VIRAL HEPATITIS, V17, P24, DOI 10.1111/j.1365-2893.2010.01268.x; Zhou H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.186	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225482	10.1371/journal.pone.0225482	http://dx.doi.org/10.1371/journal.pone.0225482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770396	gold, Green Published			2022-12-26	WOS:000533892300022
J	Perroni, F; Fittipaldi, S; Falcioni, L; Ghizzoni, L; Borrione, P; Vetrano, M; Del Vescovo, R; Migliaccio, S; Guidetti, L; Baldari, C				Perroni, Fabrizio; Fittipaldi, Simona; Falcioni, Lavinia; Ghizzoni, Lucia; Borrione, Paolo; Vetrano, Mario; Del Vescovo, Riccardo; Migliaccio, Silvia; Guidetti, Laura; Baldari, Carlo			Effect of pre-season training phase on anthropometric, hormonal and fitness parameters in young soccer players	PLOS ONE			English	Article							INTERMITTENT RECOVERY TEST; PHYSICAL PERFORMANCE; MATCH-PLAY; TESTOSTERONE; RESPONSES; RELIABILITY; POWER; CORTISOL; HEIGHT; MUSCLE	The aims of the study were to investigate 1) the effect of 8 weeks of PSP training on anthropometrics, salivary hormones and fitness parameters in youth soccer players, 2) the correlations between fitness and hormonal parameters, and 3) the impact of the experience of the coach and his methodology of training on these parameters. Weight, height, BMI, pubertal development (PDS), salivary Cortisol (sC), salivary Testosterone (sT), salivary sDHEAS, intermittent tests (VO2max), and countermovement jump test (CMJ) modifications of 35 youth soccer players (age: 14 +/- 0 yrs; BMI: 20.8 +/- 1.8 k/m(2)) from two Italian clubs ("Lupa Frascati" -LF-; "Albalonga" -AL) were analysed. A significant (p<0.05) time by club effect was observed in sC (F-(1,F-31) = 9.7, ES = 1.13), sT (F-(1,F-31) = 4.2, ES = 0.74), CMJ (F-(1,F-28) = 26.5, ES = 1.94), and VO2max (F-(1,F-28) = 8.5, ES = 1.10). Statistical differences (p<0.05) in weight (F-(1,F-32) = 25.5, ES = 0.11), sC (F-(1,F-31) = 32.1, ES = 1.43), sT/sC ratio (F-(1,F-31) = 10.1, ES = 0.97), sDHEAS/sC ratio (F-(1,F-31) = 6.3, ES = 0.70), and VO2max (F-(1,F-28) = 64.3, ES = 1.74) were found within time factor. Between clubs, differences (p<0.05) in sC (F-(1,F-32) = 8.5, ES = 1.17), sT (F-(1,F-31) = 4.2, ES = 0.74), CMJ (F-(1,F-28) = 26.5, ES = 1.50), and VO2max (F-(1,F-28) = 8.5, ES = 1.10) were found. CMJ was inversely correlated with sDHEAS (r = -0.38) before PSP, while Delta of CMJ showed significant correlations with Delta of sC (r = 0.43) and Delta VO2max was inversely correlated with Delta BMI (r = -0.54) and Delta sC (r = -0.37) in all subjects. Considering each single club, Delta VO2max showed correlations with Delta BMI (r = -0.45) in AL, while CMJ showed correlations with Delta PDS (r = 0.72) in LF club. Since the PSP is often limited training time to simultaneously develop physical, technical and tactical qualities, an efficient method to distribute the training load is important in youth soccer players to increase the performance and to avoid injuries.	[Perroni, Fabrizio; Baldari, Carlo] eCampus Univ, Fac Psychol, Novedrate, Como, Italy; [Fittipaldi, Simona] IRCCS, SDN, Naples, Italy; [Falcioni, Lavinia; Borrione, Paolo; Migliaccio, Silvia; Guidetti, Laura] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Ghizzoni, Lucia] Univ Turin, Dept Med Sci, Turin, Italy; [Vetrano, Mario] Sapienza Univ Rome, St Andrea Hosp, Phys Med & Rehabil Unit, Rome, Italy; [Del Vescovo, Riccardo] AS Roma Soccer Team, Rome, Italy	Universita Ecampus; IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Foro Italico University of Rome; University of Turin; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Baldari, C (corresponding author), eCampus Univ, Fac Psychol, Novedrate, Como, Italy.	carlo.baldari@uniecampus.it	Vetrano, Mario/ABE-5885-2020; Baldari, Carlo/N-6756-2014	Vetrano, Mario/0000-0002-8680-4004; Fittipaldi, Simona/0000-0001-7578-395X; Guidetti, Laura/0000-0002-1419-4550; Falcioni, Lavinia/0000-0001-8704-7044; Borrione, Paolo/0000-0003-0506-169X; Migliaccio, Silvia/0000-0002-4563-6630; Baldari, Carlo/0000-0001-6227-3571				Akubat I, 2014, FITNESS SOCCER SCI P, P167; [Anonymous], 2016, LUCCIA USE TESTOSTER, V9, P104; Baldari C, 2009, BRIT J SPORT MED, V43, P191, DOI 10.1136/bjsm.2007.040386; Bangsbo J., 2000, SOCCER SCI IN INTERD; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; CARLI G, 1982, J SPORT MED PHYS FIT, V22, P489; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Casto KV, 2016, HORM BEHAV, V82, P21, DOI 10.1016/j.yhbeh.2016.04.004; Chatzinikolaou A, 2010, J STRENGTH COND RES, V24, P1389, DOI 10.1519/JSC.0b013e3181d1d318; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Daly RM, 1998, EUR J APPL PHYSIOL, V79, P74, DOI 10.1007/s004210050476; Di Blasio A, 2015, SPORT MED, V2; Di Luigi L, 2006, INT J SPORTS MED, V27, P709, DOI 10.1055/s-2005-872931; Dragijsky M, 2017, SPORTS, V5, DOI 10.3390/sports5010012; Duke SA, 2014, J ADOLESCENT HEALTH, V55, P315, DOI 10.1016/j.jadohealth.2014.05.007; Dvorak Jiri, 2004, Am J Sports Med, V32, p3S, DOI 10.1177/0363546503262283; Fanchini M, 2014, J SPORT SCI, V32, P1950, DOI 10.1080/02640414.2014.969295; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gatti R, 2011, SCAND J MED SCI SPOR, V21, P157, DOI 10.1111/j.1600-0838.2010.01252.x; Gil SM, 2007, J STRENGTH COND RES, V21, P438; Gravina L, 2008, J STRENGTH COND RES, V22, P1308, DOI 10.1519/JSC.0b013e31816a5c8e; Hammami MA, 2018, J SPORT SCI MED, V17, P455; Handziski Z, 2006, Bratisl Lek Listy, V107, P259; Hopkins WG, 2013, NEW VIEW STAT; Iuliano-Burns S, 2001, AM J HUM BIOL, V13, P1; Jeong TS, 2011, J SPORT SCI, V29, P1161, DOI 10.1080/02640414.2011.583671; Kadi F, 2008, BRIT J PHARMACOL, V154, P522, DOI 10.1038/bjp.2008.118; Kalapotharakos VI, 2011, J STRENGTH COND RES, V25, P1502, DOI 10.1519/JSC.0b013e3181da85a9; Klipker K, 2017, HORM BEHAV, V95, P22, DOI 10.1016/j.yhbeh.2017.07.012; KOMI PV, 1978, MED SCI SPORT EXER, V10, P261; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Lewis John G, 2006, Clin Biochem Rev, V27, P139; Malina RM, 2005, J SPORT SCI, V23, P515, DOI 10.1080/02640410410001729928; Markovic G, 2011, J STRENGTH COND RES, V25, P2931, DOI 10.1519/JSC.0b013e318207ed8c; Markovic G, 2010, SPORTS MED, V40, P859, DOI 10.2165/11318370-000000000-00000; Mendez-Villanueva A, 2013, INT J SPORTS MED, V34, P101, DOI 10.1055/s-0032-1306323; Moreira A, 2013, PEDIATR EXERC SCI, V25, P186, DOI 10.1123/pes.25.2.186; Morgan CA, 2004, ARCH GEN PSYCHIAT, V61, P819, DOI 10.1001/archpsyc.61.8.819; Mujika I, 1996, EUR J APPL PHYSIOL, V74, P361, DOI 10.1007/BF02226933; Mujika I, 2009, J SPORT SCI, V27, P107, DOI 10.1080/02640410802428071; Noda Y, 2000, NEUROPSYCHOPHARMACOL, V23, P276, DOI 10.1016/S0893-133X(00)00103-2; Perroni F, 2017, OPEN SPORTS SCI J, V10, P122, DOI [10.2174/1875399x01710010122, DOI 10.2174/1875399X01710010122]; Perroni F., 2014, SPORT SCI HLTH, V10, P67, DOI [https://doi.org/10.1007/s11332-014-0175-z, DOI 10.1007/s11332-014-0175-z]; Perroni F, 2015, J STRENGTH COND RES, V29, P2097, DOI 10.1519/JSC.0000000000000881; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Reilly TH, 2014, TAIPING HEAVENLY KINGDOM: REBELLION AND THE BLASPHEMY OF EMPIRE, P1; Slimani M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186100; Slinde F, 2008, J STRENGTH COND RES, V22, P640, DOI 10.1519/JSC.0b013e3181660475; Spiering BA, 2008, MED SCI SPORT EXER, V40, P1039, DOI 10.1249/MSS.0b013e31816722bd; Tessitore A, 2012, J STRENGTH COND RES, V26, P106, DOI 10.1519/JSC.0b013e31821854f2; Tofas T, 2008, J STRENGTH COND RES, V22, P490, DOI 10.1519/JSC.0b013e31816605a0; Wisloff U, 2004, BRIT J SPORT MED, V38, P285, DOI 10.1136/bjsm.2002.002071	54	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225471	10.1371/journal.pone.0225471	http://dx.doi.org/10.1371/journal.pone.0225471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QR	31765396	gold, Green Published			2022-12-26	WOS:000533891000031
J	Berardi, A; Sforza, F; Baroni, L; Spada, C; Ambretti, S; Biasucci, G; Bolognesi, S; Capretti, M; Carrette, E; Ciccia, M; Lanari, M; Pedna, MF; Rizzo, V; Venturelli, C; Tzialla, C; Lucaccioni, L; Reggiani, MLB				Berardi, Alberto; Sforza, Francesca; Baroni, Lorenza; Spada, Catarina; Ambretti, Simone; Biasucci, Giacomo; Bolognesi, Serenella; Capretti, Mariagrazia; Carrette, Edoardo; Ciccia, Matilde; Lanari, Marcello; Pedna, Maria Federica; Rizzo, Vittoria; Venturelli, Claudia; Tzialla, Crisoula; Lucaccioni, Laura; Reggiani, Maria Letizia Bacchi			Epidemiology and complications of late-onset sepsis: an Italian area-based study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; BIRTH-WEIGHT INFANTS; GROUP-B STREPTOCOCCUS; NEONATAL SEPSIS; RISK-FACTORS	Background Most studies regarding late-onset sepsis (LOS) address selected populations (i.e., neonates with low birth weight or extremely preterm neonates). Studying all age groups is more suitable to assess the burden of single pathogens and their clinical relevance. Methods This is a retrospective regional study involving paediatric departments and NICUs in EmiliaRomagna (Italy). Regional laboratory databases were searched from 2009 to 2012. Records of infants (aged 4 to 90 days) with a positive blood or cerebrospinal fluid (CSF) culture were retrospectively reviewed and analysed according to acquisition mode (whether hospital-or community-acquired). Results During the study period, there were 146,682 live births (LBs), with 296 patients experiencing 331 episodes of LOS (incidence rate: 2.3/1000 LBs). Brain lesions upon discharge from the hospital were found in 12.3% (40/296) of cases, with death occurring in 7.1% (23/296; 0.14/1000 LBs). With respect to full-term neonates, extremely preterm or extremely low birth weight neonates had very high risk of LOS and related mortality (> 100- and > 800-fold higher respectively). Hospital-acquired LOS (n = 209) was significantly associated with very low birth weight, extremely preterm birth, pneumonia, mechanical ventilation, and death (p< 0.01). At multivariate logistic regression analysis, catecholamine support (OR = 3.2), central venous line before LOS (OR = 14.9), and meningitis (OR = 44.7) were associated with brain lesions or death in hospital-acquired LOS (area under the ROC curve 0.81, H-L p = 0.41). Commonly identified pathogens included coagulase-negative staphylococci (CoNS n = 71, 21.4%), Escherichia coli (n = 50, 15.1%), Staphylococcus aureus (n = 41, 12.4%) and Enterobacteriaceae (n = 41, 12.4%). Group B streptococcus was the predominant cause of meningitis (16 of 38 cases, 42%). Most pathogens were sensitive to first line antibiotics. Conclusions This study provides the first Italian data regarding late-onset sepsis (LOS) in all gestational age groups. Compared to full-term neonates, very high rates of LOS and mortality occurred in neonates with a lower birth weight and gestational age. Group B streptococcus was the leading cause of meningitis. Excluding CoNS, the predominant pathogens were Escherichia coli and Staphylococcus aureus. Neonates with hospital-acquired LOS had a worse outcome. Antibiotic associations, recommended for empirical treatment of hospital-or community-acquired LOS, were adequate.	[Berardi, Alberto; Lucaccioni, Laura] Azienda Osped Univ Policlin, Unita Operat Terapia Intens Neonatale, Dipartimento Integrato Materno Infantile, Modena, Italy; [Sforza, Francesca; Spada, Catarina] Univ Modena & Reggio Emilia, Scuola Specializzaz Pediat, Med Formaz, Modena, Italy; [Baroni, Lorenza] Ist Ricovero & Cura Carattere Sci IRCCS, Arcispedale Santa Maria Nuova, Terapia Intens Neonatale, Dipartimento Ostetr & Pediatr, Reggio Emilia, Italy; [Ambretti, Simone] Azienda Osped Univ S Orsola Malpighi, Unita Operat Microbiol, Bologna, Italy; [Biasucci, Giacomo] Osped G Saliceto, Unita Operat Pediat, Piacenza, Italy; [Bolognesi, Serenella] Osped Infermi, Unita Operat Terapia Intens Neonatale, Rimini, Italy; [Capretti, Mariagrazia] Azienda Osped Univ St Orsola Malpighi, Unita Operat Neonatol, Dipartimento Bambino Donna & Malattie Urol, Bologna, Italy; [Carrette, Edoardo] Ist Ricovero & Cura Carattere Sci IRCCS, Dipartimento Interaziendale Diagnost Immagini & M, Lab Microbiol, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; [Ciccia, Matilde] Osped Maggiore Bologna, Unita Operat Terapia Intens Neonatale, Dipartimento Materno Infantile, Bologna, Italy; [Lanari, Marcello] Azienda Osped Univ St Orsola Malpighi, Unita Operat Pediat, Dipartimento Bambino Donna & Malattie, Bologna, Italy; [Pedna, Maria Federica] Lab Unico Ausl Romagna, Unita Operat Microbiol, Pievesestina Cesena, Italy; [Rizzo, Vittoria] Osped Civile M Bufalini, Unita Operat Terapia Intens Neonatale & Pediat, Cesena, Italy; [Venturelli, Claudia] Azienda Ospedal Univ Policlin, Struttura Complessa Microbiol & Virol, Modena, Italy; [Tzialla, Crisoula] Fdn IRCCS Policlin San Matteo, Neonatol Patol Neonatale & Terapia Intens Neonata, Pavia, Italy; [Reggiani, Maria Letizia Bacchi] Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Azienda Osped Univ S Orsola Malpighi, Bologna, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Arcispedale S. Maria Nuova; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Hospital of Rimini; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Arcispedale S. Maria Nuova; AUSL di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; AUSL della Romagna; IRCCS Fondazione San Matteo; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Berardi, A (corresponding author), Azienda Osped Univ Policlin, Unita Operat Terapia Intens Neonatale, Dipartimento Integrato Materno Infantile, Modena, Italy.	berardi.alberto@unimore.it	Biasucci, Giacomo/X-9186-2018; Lucaccioni, Laura/K-4469-2018; Tzialla, Chryssoula/GYU-0266-2022; Carretto, Edoardo/A-2506-2013; Berardi, Alberto/A-5889-2015	Biasucci, Giacomo/0000-0002-7441-9248; Carretto, Edoardo/0000-0001-6521-5887; Berardi, Alberto/0000-0002-3534-7499; Tzialla, Chryssoula/0000-0002-6040-2381	European Community [HEALTH-F7-2007-200481 DEVANI]	European Community(European Commission)	AB Part of the research leading to these results has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement n degrees HEALTH-F7-2007-200481 DEVANI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, VERM OXF NETW DAT 2; Berardi A, 2017, MED BAMBINO, P493; Berardi A, 2017, J MATERN-FETAL NEO M, V30, P1739, DOI 10.1080/14767058.2016.1224832; Berardi A, 2016, J MATERN-FETAL NEO M, V29, P3126, DOI 10.3109/14767058.2015.1114093; Berardi A, 2015, EXPERT REV ANTI-INFE, V13, P1387, DOI 10.1586/14787210.2015.1079126; Berardi A, 2013, PEDIATR INFECT DIS J, V32, pE265, DOI 10.1097/INF.0b013e31828b0884; Berardi A, 2011, J MED SCREEN, V18, P60, DOI 10.1258/jms.2011.011023; Bizzarro MJ, 2015, J PEDIATR-US, V166, P1193, DOI 10.1016/j.jpeds.2015.02.009; Bizzarro MJ, 2005, PEDIATRICS, V116, P595, DOI 10.1542/peds.2005-0552; Boghossian NS, 2013, J PEDIATR-US, V162, P1120, DOI 10.1016/j.jpeds.2012.11.089; Brodie SB, 2000, PEDIATR INFECT DIS J, V19, P56, DOI 10.1097/00006454-200001000-00012; Cailes B, 2018, ARCH DIS CHILD-FETAL, V103, pF547, DOI 10.1136/archdischild-2017-313203; Didier C, 2012, EUR J PEDIATR, V171, P681, DOI 10.1007/s00431-011-1639-7; Dong Y, 2015, ARCH DIS CHILD-FETAL, V100, pF257, DOI 10.1136/archdischild-2014-306213; Giannoni E, 2018, J PEDIATR-US, V201, P106, DOI 10.1016/j.jpeds.2018.05.048; Gkentzi D, 2019, ARCH DIS CHILD-FETAL, V104, pF293, DOI 10.1136/archdischild-2018-315024; Gowda H, 2017, PEDIATR INFECT DIS J, V36, P883, DOI 10.1097/INF.0000000000001568; Greenberg RG, 2017, PEDIATR INFECT DIS J, V36, P774, DOI [10.1097/INF.0000000000001570, 10.1097/inf.0000000000001570]; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; Jiang Jia-Horng, 2004, Journal of Microbiology Immunology and Infection, V37, P301; Ku LC, 2015, CLIN PERINATOL, V42, P29, DOI 10.1016/j.clp.2014.10.004; Payne NR, 2004, PEDIATRICS, V114, P348, DOI 10.1542/peds.114.2.348; Perlman SE, 2007, AM J INFECT CONTROL, V35, P177, DOI 10.1016/j.ajic.2006.01.002; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1; Shah BA, 2014, VIRULENCE, V5, P170, DOI 10.4161/viru.26906; Shah J, 2015, AM J PERINAT, V32, P675, DOI 10.1055/s-0034-1393936; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Tsai MH, 2014, PEDIATR INFECT DIS J, V33, pE7, DOI 10.1097/INF.0b013e3182a72ee0; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Vergnano S, 2011, ARCH DIS CHILD-FETAL, V96, pF9, DOI 10.1136/adc.2009.178798	32	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225407	10.1371/journal.pone.0225407	http://dx.doi.org/10.1371/journal.pone.0225407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756213	Green Published, gold			2022-12-26	WOS:000533889300027
J	Lucas, PJ; Uddin, MR; Khisa, N; Akter, SMS; Unicomb, L; Nahar, P; Islam, MA; Nizame, FA; Rousham, EK				Lucas, Patricia Jane; Uddin, Mohammad Rofi; Khisa, Nirnita; Akter, S. M. Salim; Unicomb, Leanne; Nahar, Papreen; Islam, Mohammad Aminul; Nizame, Fosiul Alam; Rousham, Emily K.			Pathways to antibiotics in Bangladesh: A qualitative study investigating how and when households access medicine including antibiotics for humans or animals when they are ill	PLOS ONE			English	Article							RISK-FACTORS; HEALTH; CHILDREN; ILLNESS; DHAKA; POOR	Background To understand how to reduce antibiotic use, greater knowledge is needed about the complexities of access in countries with loose regulation or enforcement. This study aimed to explore how households in Bangladesh were accessing antimicrobials for themselves and their domestic animals. Methods In-depth interviews were conducted with 48 households in one urban and one rural area. Households were purposively sampled from two lower income strata, prioritising those with under 5-year olds, older adults, household animals and minority groups. Households where someone was currently ill with a suspected infection (13 households) were invited for a follow-up interview. Framework analysis was used to explore access to healthcare and medicines. Findings People accessed medicines for themselves through five pathways: drugs shops, private clinics, government/charitable hospitals, community/family planning clinics, and specialised/private hospitals. Drug shops provided direct access to medicines for common, less serious and acute illnesses. For persistent or serious illnesses, the healthcare pathway may include contacts with several of these settings, but often relied on medicines provided by drug shops. In the 13 households with an unwell family member, most received at least one course of antibiotics for this illness. Multiple and incomplete dosing were common even when prescribed by a qualified doctor. Antibiotics were identified by their high cost compared to other medicines. Cost was a reported barrier to purchasing full courses of antibiotics. Few households in the urban area kept household animals. In this rural area, government animal health workers provided most care for large household animals (cows), but drug shops were also important. Conclusions In Bangladesh, unregulated drug shops provide an essential route to medicines including those prescribed in the formal sector. Wherever licensed suppliers are scarce and expensive, regulations which prohibit this supply risk removing access entirely for many people.	[Lucas, Patricia Jane] Univ Bristol, Sch Policy Studies, Bristol, Avon, England; [Uddin, Mohammad Rofi; Khisa, Nirnita; Akter, S. M. Salim; Unicomb, Leanne; Islam, Mohammad Aminul; Nizame, Fosiul Alam] Int Ctr Diarrhoea Dis Res, Icddr B, Dhaka, Bangladesh; [Nahar, Papreen] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Islam, Mohammad Aminul] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Rousham, Emily K.] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Ctr Global Hlth & Human Dev, Loughborough, Leics, England; [Khisa, Nirnita] Univ Technol Sydney, Fac Hlth, Sydney, NSW, Australia	University of Bristol; International Centre for Diarrhoeal Disease Research (ICDDR); University of Brighton; University of Sussex; Washington State University; Loughborough University; University of Technology Sydney	Lucas, PJ (corresponding author), Univ Bristol, Sch Policy Studies, Bristol, Avon, England.	Patricia.lucas@bristol.ac.uk	Unicomb, Leanne Elizabeth/AAW-4900-2021	Unicomb, Leanne Elizabeth/0000-0002-7757-5641; Nahar, Papreen/0000-0002-5817-8093; Lucas, Patricia Jane/0000-0002-0469-8085; Rousham, Emily/0000-0001-5654-9279	Antimicrobial Resistance Cross-Council Initiative; Department of Health; UK Department of Environment Food and Rural Affairs; Global Challenges Research Fund (Economic and Social Research Council) [ES/P004563/1]; ESRC [ES/P004563/1] Funding Source: UKRI	Antimicrobial Resistance Cross-Council Initiative; Department of Health; UK Department of Environment Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Global Challenges Research Fund (Economic and Social Research Council); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Antimicrobial Resistance Cross-Council Initiative supported by the seven UK research councils in partnership with the Department of Health, the UK Department of Environment Food and Rural Affairs and the Global Challenges Research Fund (Economic and Social Research Council grant ES/P004563/1 awarded to Dr Emily Rousham). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2015, HEALTH POLICY PLANN, V30, pi32, DOI 10.1093/heapol/czu094; Ahmed S, 2018, AM J TROP MED HYG, V98, P1571, DOI 10.4269/ajtmh.17-0988; Ahmed Syed Masud, 2017, J Pharm Policy Pract, V10, P21, DOI 10.1186/s40545-017-0108-8; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Bangladesh Bureau of Statistics Ministry of Planning, 2011, REP HOUS INC EXP SUR; Bloom G, 2015, 16 STEPS CTR I DEV; Charani E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209847; Chowdhury F, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3486-y; Chowdhury F, 2017, PATIENT PREFER ADHER, V11, P479, DOI 10.2147/PPA.S121800; Correspondent Staff, 2019, DAILY STAR; Directorate General of Drug Administration, 2016, STAND EST OP MOD PHA; Directorate General of Drug Administration, 2018, LIST MOD PHARM; Dyar OJ, 2017, CLIN MICROBIOL INFEC, V23, P793, DOI 10.1016/j.cmi.2017.08.026; Faiz M. A., 2011, Regional Health Forum, V15, P1; Founou RC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189621; Harris AR, 2016, ENVIRON SCI TECHNOL, V50, P4642, DOI 10.1021/acs.est.5b06282; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Laxminarayan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001974; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Le Doare K, 2015, BRIT J CLIN PHARMACO, V79, P446, DOI 10.1111/bcp.12320; Mahmood SS, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-18; Miller R, 2016, HEALTH POLICY PLANN, V31, P940, DOI 10.1093/heapol/czw007; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nahar P, 2017, SOCIOL HEALTH ILL, V39, P614, DOI 10.1111/1467-9566.12521; Roess AA, 2015, ZOONOSES PUBLIC HLTH, V62, P569, DOI 10.1111/zph.12186; Rousham EK, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028215; Rousham EK, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0332; Rutta E., 2014, MED HLTH SYSTEMS ADV; Saha S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2072-z; SIAPS, 2015, BAS STUD PRIV DRUG S; Sirinavin Sayomporn, 2004, Semin Pediatr Infect Dis, V15, P94, DOI 10.1053/j.spid.2004.01.012; Spencer L., 2014, QUALITATIVE RES PRAC, V2, P269; Sultana J., 2018, BANGLADESH PHARM J, V21, P47, DOI [10.3329/bpj.v21i1.37906, DOI 10.3329/BPJ.V21I1.37906]; Wardrop NA, 2018, INT J HYG ENVIR HEAL, V221, P33, DOI 10.1016/j.ijheh.2017.09.014; WHO, 2001, WHO GLOB STRAT CONT; WHO, 2015, GLOB ACT PLAN AMR; WHO, ANT US UND; World Health Organization Food and Agriculture Organization of the United Nations Health WOfA, 2016, ANT RES MAN DEV NAT	38	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225270	10.1371/journal.pone.0225270	http://dx.doi.org/10.1371/journal.pone.0225270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756224	Green Published, Green Accepted, gold			2022-12-26	WOS:000533889300015
J	Anand-Ivell, R; Byrne, CJ; Arnecke, J; Fair, S; Lonergan, P; Kenny, DA; Ivell, R				Anand-Ivell, Ravinder; Byrne, Colin J.; Arnecke, Jonas; Fair, Sean; Lonergan, Pat; Kenny, David A.; Ivell, Richard			Prepubertal nutrition alters Leydig cell functional capacity and timing of puberty	PLOS ONE			English	Article							INSULIN-LIKE FACTOR-3; PEPTIDE 3; PLASMA-CONCENTRATIONS; GENE-EXPRESSION; HEALTHY BOYS; INSL3; HORMONE; TESTOSTERONE; BULLS; AGE	Leydig cell functional capacity reflects the numbers and differentiation status of the steroidogenic Leydig cells in the testes and becomes more or less fixed in early adulthood with the final establishment of the hypothalamo-pituitary-gonadal (HPG) axis after puberty. Factors influencing Leydig cell functional capacity and its role in puberty are poorly understood. Using a bovine model of dairy bulls fed four different nutritional regimes from 1 month to 12 months, and applying circulating Insulin-like peptide 3 (INSL3) as an accurate biomarker of Leydig cell functional capacity, showed that a high plane of nutrition in the first 6 months of life, but not later, significantly increased INSL3 in young adulthood. Moreover, INSL3 concentration at 4 months indicated a marked differential in early feeding regime and correlated well (negatively) with the timing of puberty, as reflected by the age in days for the first production of an ejaculate with >50 million sperm and >10% forward motility, as well as with testis size at 18 months. Reversing the diet at 6 months was unable to rectify the trend in either parameter, unlike for other parameters such as testosterone, body weight, and scrotal circumference. This study has shown that early prepubertal nutrition is a key factor in the development of Leydig cell functional capacity in early adulthood and appears to be a key driver in the dynamic progression of puberty.	[Anand-Ivell, Ravinder; Arnecke, Jonas; Ivell, Richard] Univ Nottingham, Sch Biosci, Loughborough, England; [Byrne, Colin J.; Kenny, David A.] TEAGASC, Anim & Biosci Dept, Dunsany, Meath, Ireland; [Byrne, Colin J.; Lonergan, Pat] Univ Coll Dublin, Sch Agr & Food Sci, Dublin, Ireland; [Fair, Sean] Univ Limerick, Dept Biol Sci, Lab Anim Reprod, Limerick, Ireland	University of Nottingham; Teagasc; University College Dublin; University of Limerick	Anand-Ivell, R (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, England.	ravinder.anand-ivell@nottingham.ac.uk	Byrne, Colin/ABA-7674-2021; sean, fair/R-6330-2016	Byrne, Colin/0000-0002-5202-216X; Anand-Ivell, Ravinder/0000-0002-4976-4314; sean, fair/0000-0003-0085-1537	Irish Department of Agriculture, Food and Marine Research Stimulus Fund [11/S/116]	Irish Department of Agriculture, Food and Marine Research Stimulus Fund	This work was funded by the Irish Department of Agriculture, Food and Marine Research Stimulus Fund (Project 11/S/116) to PL and DAK, https://www.agriculture.gov.ie/research/competitivenationalprogrammes/researchstimulusfundrsf/.	ABBITT B, 1995, J AM VET MED ASSOC, V207, P753; Amory JK, 2007, J ANDROL, V28, P548, DOI 10.2164/jandrol.106.002345; Anand-Ivell R, 2006, INT J ANDROL, V29, P618, DOI 10.1111/j.1365-2605.2006.00714.x; Anand-Ivell R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019821; Anand-Ivell R, 2009, BIOL REPROD, V81, P480, DOI 10.1095/biolreprod.109.077552; Anand-Ivell RJK, 2006, BIOL REPROD, V74, P945, DOI 10.1095/biolreprod.105.048165; Barth AD, 2018, ANIMAL, V12, pS158, DOI [10.1017/s1751731118000538, 10.1017/S1751731118000538]; Bathgate R, 1996, BIOL REPROD, V55, P1452, DOI 10.1095/biolreprod55.6.1452; Beltman ME, 2010, REPROD FERT DEVELOP, V22, P987, DOI 10.1071/RD09302; Brito LFC, 2004, THERIOGENOLOGY, V62, P1198, DOI 10.1016/j.theriogenology.2004.01.006; Byrne CJ, 2018, J DAIRY SCI, V101, P3447, DOI 10.3168/jds.2017-13719; Byrne CJ, 2018, J DAIRY SCI, V101, P3460, DOI 10.3168/jds.2017-13720; Castilla-Cortazar I, 2015, UROLOGY, V86, DOI 10.1016/j.urology.2015.09.012; Chong YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133637; Collodel G, 2014, SYST BIOL REPROD MED, V60, P217, DOI 10.3109/19396368.2014.911392; Cooke DJ, 1997, J REPROD FERTIL, V110, P339, DOI 10.1530/jrf.0.1100339; Crowe MA, 1997, ANIM REPROD SCI, V48, P123, DOI 10.1016/S0378-4320(97)00022-5; Del Borgo MP, 2006, J BIOL CHEM, V281, P13068, DOI 10.1074/jbc.M600472200; English AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34611-4; Ferlin A, 2006, J CLIN ENDOCR METAB, V91, P3426, DOI 10.1210/jc.2006-0821; Hannan MA, 2017, THERIOGENOLOGY, V92, P51, DOI 10.1016/j.theriogenology.2017.01.009; Hannan MA, 2015, THERIOGENOLOGY, V84, P1530, DOI 10.1016/j.theriogenology.2015.07.039; Heng K, 2012, INT J ANDROL, V35, P353, DOI 10.1111/j.1365-2605.2011.01231.x; Hombach-Klonisch S, 2004, BIOL REPROD, V71, P1079, DOI 10.1095/biolreprod.103.024752; Ivell R, 2002, E SCHERING RES FDN W, P99; Ivell R, 2017, BRIT J PHARMACOL, V174, P990, DOI 10.1111/bph.13689; Ivell R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00006; Ivell R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108969; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Johansen ML, 2014, REPRODUCTION, V147, P529, DOI 10.1530/REP-13-0435; Kawate N, 2011, THERIOGENOLOGY, V76, P1632, DOI 10.1016/j.theriogenology.2011.07.011; Kenny DA, 2018, REPROD FERT DEVELOP, V30, P101, DOI 10.1071/RD17376; McGowan M, 2018, ANIMAL, V12, pS19, DOI [10.1017/S1751731118000460, 10.1017/s1751731118000460]; Minagawa I, 2018, ANDROLOGIA, V50, DOI 10.1111/and.13010; Minagawa I, 2014, J ENDOCRINOL, V220, P247, DOI 10.1530/JOE-13-0430; Murphy EM, 2018, J ANIM SCI, V96, P2408, DOI 10.1093/jas/sky130; Pitia AM, 2017, ANIM SCI J, V88, P678, DOI 10.1111/asj.12694; Plant TM, 2015, J ENDOCRINOL, V226, pT41, DOI 10.1530/JOE-15-0113; Rawlings N, 2008, REPROD DOMEST ANIM, V43, P295, DOI 10.1111/j.1439-0531.2008.01177.x; Sadeghian H, 2005, MOL CELL ENDOCRINOL, V241, P10, DOI 10.1016/j.mce.2005.03.017; Sakase M, 2018, J REPROD DEVELOP, V64, P401, DOI 10.1262/jrd.2018-034; Satchell L, 2013, ENDOCRINOLOGY, V154, P1897, DOI 10.1210/en.2012-2232; Teerds KJ, 2015, HUM REPROD UPDATE, V21, P310, DOI 10.1093/humupd/dmv008; Weerakoon WWPN, 2018, THERIOGENOLOGY, V114, P54, DOI 10.1016/j.theriogenology.2018.03.006; Wikstrom AM, 2006, J CLIN ENDOCR METAB, V91, P4705, DOI 10.1210/jc.2006-0669; WOLF FR, 1965, J ANIM SCI, V24, P761, DOI 10.2527/jas1965.243761x	46	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225465	10.1371/journal.pone.0225465	http://dx.doi.org/10.1371/journal.pone.0225465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751436	Green Published, Green Submitted, gold			2022-12-26	WOS:000533886900068
J	Lamsal, A; Devkota, MP; Shrestha, DS; Joshi, S; Shrestha, A				Lamsal, Anju; Devkota, Mohan P.; Shrestha, Deepa S.; Joshi, Srijana; Shrestha, Anil			Seed germination ecology of Ageratum houstonianum: A major invasive weed in Nepal	PLOS ONE			English	Article							CONYZA-BONARIENSIS; LIGHT; PERSISTENCE; ASTERACEAE; EMERGENCE; BANK	In recent years, spread of invasive alien plant species (IAPS) has been a major concern in Nepal. One such IAPS is Ageratum houstonianum, an Asteraceae, that is a prolific seed producer and difficult-to-control in farmland and various ecological regions causing crop yield and biodiversity losses. However, very little information is available on the germination biology and ecology of this species. Therefore, experiments were conducted to assess the effect of water stress, pH level, and light requirement on seed germination, and the effect of seed burial depth on seedling emergence. Water stress was simulated by polyethylene glycol solutions ranging from 0-5.56 MPa and pH solutions ranging from 4 to 9 were prepared using hydrochloric acid and sodium hydroxide. Germination tests were conducted in petri dishes lined with filter paper and placed in a controlled environment chamber set at 20 degrees C. Light requirement comparisons were made by having petri dishes wrapped with aluminum foil or left unwrapped. Seedling emergence was evaluated by placing seeds at depths ranging from 0 to 20 mm in the soil. Results indicated that this species was moderately drought-tolerant because germination ceased beyond 0.51 MPa. Greater germination occurred at neutral to acidic than at alkaline pH levels. The seeds were positively photoblastic because no germination occurred under dark condition. No seedlings emerged from seeds placed more than 2 mm deep in the soil, indicating that this is a primarily surface germinating species. These findings will help predict future invasions and in development of management strategies for this IAPS.	[Lamsal, Anju; Devkota, Mohan P.] Tribhuvan Univ, Dept Bot, Amrit Campus, Kathmandu, Nepal; [Shrestha, Deepa S.] Nepal Agr Res Council, Natl Gene Bank, Lalitpur, Nepal; [Joshi, Srijana] Int Ctr Integrated Mt Dev, Lalitpur, Nepal; [Shrestha, Anil] Calif State Univ Fresno, Dept Viticulture & Enol, Fresno, CA 93740 USA	Tribhuvan University; California State University System; California State University Fresno	Shrestha, A (corresponding author), Calif State Univ Fresno, Dept Viticulture & Enol, Fresno, CA 93740 USA.	ashrestha@mail.fresnostate.edu		Singh Shrestha, Deepa/0000-0001-9771-6299; Shrestha, Anil/0000-0001-7709-6344				Barua IC, 2013, P 24 AS PAC WEED SCI, V24, P166; Benvenuti S, 1998, WEED RES, V38, P199, DOI 10.1046/j.1365-3180.1998.00086.x; Burnham KM, 2010, BIOL INVASIONS, V12, P1509, DOI 10.1007/s10530-009-9563-8; Chachalis D, 2000, WEED SCI, V48, P212, DOI 10.1614/0043-1745(2000)048[0212:FACRSG]2.0.CO;2; Downey PO, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw047; Egley G. H., 1986, WEED SCI, V2, P67; EVETTS LL, 1972, WEED SCI, V20, P371, DOI 10.1017/S004317450003589X; Fenner M, 1985, SEED ECOLOGY; HARDEGREE SP, 1994, SEED SCI TECHNOL, V22, P1; Holmes TP, 2009, ANN NY ACAD SCI, V1162, P18, DOI 10.1111/j.1749-6632.2009.04446.x; Honda Y, 2008, PLANT ECOL, V196, P301, DOI 10.1007/s11258-007-9360-3; JOHNSON MF, 1971, ANN MO BOT GARD, V58, P6, DOI 10.2307/2394925; Karel N, 2007, J PLANT DIS PROTECT, V21, P271; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kettenring KM, 2006, ANN BOT-LONDON, V98, P869, DOI 10.1093/aob/mcl170; KIVILAAN A, 1981, AM J BOT, V68, P1290, DOI 10.2307/2443054; LAVOREL S, 1994, OIKOS, V71, P75, DOI 10.2307/3546174; MARKS MK, 1986, WEED RES, V26, P151, DOI 10.1111/j.1365-3180.1986.tb00690.x; Michael, 1977, P 6 AS PAC WEED SCI, P87; Nandula VK, 2006, WEED SCI, V54, P898, DOI 10.1614/WS-06-006R2.1; PLUMMER JA, 1995, AUST J BOT, V43, P93, DOI 10.1071/BT9950093; Saure HI, 2013, J VEG SCI, V24, P744, DOI 10.1111/jvs.12010; Schutz W, 2002, ANN BOT-LONDON, V90, P707, DOI 10.1093/aob/mcf250; SHOEMAKER CA, 1990, HORTSCIENCE, V25, P762, DOI 10.21273/HORTSCI.25.7.762; Shrestha A, 2018, WEED SCI, V66, P340, DOI 10.1017/wsc.2017.79; Shrestha BB, 2019, J ENVIRON MANAGE, V229, P38, DOI 10.1016/j.jenvman.2018.06.034; TAYLORSON R B, 1987, Reviews of Weed Science, V3, P135; THILL DC, 1979, AGRON J, V71, P105, DOI 10.2134/agronj1979.00021962007100010027x; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Tobe K, 2006, SEED SCI RES, V16, P61, DOI 10.1079/SSR2005230; WOOLLEY JT, 1978, PLANT PHYSIOL, V61, P597, DOI 10.1104/pp.61.4.597; Wu H, 2007, WEED BIOL MANAG, V7, P192, DOI 10.1111/j.1445-6664.2007.00256.x; Wu LM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214480; Yuan X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191710; ZINZOLKER A, 1985, PHYTOPARASITICA, V13, P229	35	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225430	10.1371/journal.pone.0225430	http://dx.doi.org/10.1371/journal.pone.0225430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751412	Green Published, gold			2022-12-26	WOS:000533886900061
J	Takeuchi, R; Katagiri, W; Endo, S; Kobayashi, T				Takeuchi, Ryoko; Katagiri, Wataru; Endo, Satoshi; Kobayashi, Tadaharu			Exosomes from conditioned media of bone marrow-derived mesenchymal stem cells promote bone regeneration by enhancing angiogenesis	PLOS ONE			English	Article							STROMAL CELLS; EXTRACELLULAR VESICLES; FUNCTIONAL RECOVERY; TISSUE; SECRETOMES; VEGF; MICE	Growth factors in serum-free conditioned media from human bone marrow-derived mesenchymal stem cells (MSC-CM) are known to be effective in bone regeneration. However, the secretomes in MSC-CM that act as active ingredients for bone regeneration, as well as their mechanisms, remains unclear. Exosomes, components of MSC-CM, provide the recipient cells with genetic information and enhance the recipient cellular paracrine stimulation, which contributes to tissue regeneration. We hypothesized that MSC-CM-derived exosomes (MSC-Exo) promoted bone regeneration, and that angiogenesis was a key step. Here, we prepared an MSC-Exo group, MSC-CM group, and Exo-antiVEGF group (MSC-Exo with angiogenesis inhibitor), and examined the osteogenic and angiogenic potential in MSCs. Furthermore, we used a rat model of calvaria bone defect and implanted each sample to evaluate bone formation weekly, until week 4 after treatment. Results showed that MSC-Exo enhanced cellular migration and osteogenic and angiogenic gene expression in MSCs compared to that in other groups. In vivo, early bone formation by MSC-Exo was also confirmed. Two weeks after implantation, the newly formed bone area was 31.5 +/- 6.5% in the MSC-Exo group while those in the control and Exo-antiVEGF groups were 15.4 +/- 4.4% and 8.7 +/- 1.1%, respectively. Four weeks after implantation, differences in the area between the MSC-Exo group and the Exo-antiVEGF or control groups were further broadened. Histologically, notable accumulation of osteoblast-like cells and vascular endothelial cells was observed in the MSC-Exo group; however, fewer cells were found in the Exo-antiVEGF and control groups. In conclusion, MSC-Exo promoted bone regeneration during early stages, as well as enhanced angiogenesis. Considering the tissue regeneration with transplanted cells and their secretomes, this study suggests that exosomes might play an important role, especially in angiogenesis.	[Takeuchi, Ryoko; Katagiri, Wataru; Endo, Satoshi; Kobayashi, Tadaharu] Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Reconstruct Surg Oral & Maxillofacial Reg, Niigata, Japan	Niigata University	Katagiri, W (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Reconstruct Surg Oral & Maxillofacial Reg, Niigata, Japan.	w-kat@dent.niigata-u.ac.jp			Ministry of Health, Labor and Welfare of Japan [15K112123, 18K09785]; Japan Agency for Medical Research and Development [J17J0138]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by Grants-in-Aid for Scientific Research (B) from the Ministry of Health, Labor and Welfare of Japan (Nos. 15K112123 and 18K09785) to WK and TK and Research project for practical applications of regenerative medicine from Japan Agency for Medical Research and Development (No. J17J0138) to WK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen S, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12669; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dalirfardouei R, 2019, J TISSUE ENG REGEN M, V13, P555, DOI 10.1002/term.2799; Dicarlo M, 2015, CELLS TISSUES ORGANS, V201, P333, DOI 10.1159/000445346; Duan XC, 2016, MATRIX BIOL, V52-54, P127, DOI 10.1016/j.matbio.2016.02.005; Fennema EM, 2018, J TISSUE ENG REGEN M, V12, pE150, DOI 10.1002/term.2453; Fleury A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00370; Furuta T, 2016, STEM CELL TRANSL MED, V5, P1620, DOI 10.5966/sctm.2015-0285; Gangadaran P, 2017, J CONTROL RELEASE, V264, P112, DOI 10.1016/j.jconrel.2017.08.022; Granero-Molto F, 2011, STEM CELLS, V29, P1537, DOI 10.1002/stem.697; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Gruber R, 2017, CLIN ORAL IMPLAN RES, V28, P1139, DOI 10.1111/clr.12929; Guiducci S, 2011, ANN RHEUM DIS, V70, P2011, DOI 10.1136/ard.2011.150607; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Jafarian M, 2008, ORAL SURG ORAL MED O, V105, pE14, DOI 10.1016/j.tripleo.2008.01.010; Kaigler D, 2013, CELL TRANSPLANT, V22, P767, DOI 10.3727/096368912X652968; Katagiri W, 2017, IMPLANT DENT, V26, P607, DOI 10.1097/ID.0000000000000618; Katagiri W, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12333; Katagiri W, 2017, MAX PLAST RECONSTR S, V39, DOI 10.1186/s40902-017-0106-4; Katagiri W, 2016, HEAD FACE MED, V12, DOI 10.1186/s13005-016-0101-5; Katagiri W, 2013, INT J ORAL MAX IMPL, V28, P1009, DOI 10.11607/jomi.3036; Kawai T, 2015, CYTOTHERAPY, V17, P369, DOI 10.1016/j.jcyt.2014.11.009; Kodama A, 2012, J BONE JOINT SURG BR, V94B, P998, DOI 10.1302/0301-620X.94B7.28521; Krankel N, 2011, PHARMACOL THERAPEUT, V129, P62, DOI 10.1016/j.pharmthera.2010.10.002; Kumar S, 2010, MOL THER, V18, P1026, DOI 10.1038/mt.2009.315; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Liu S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060982; Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nishida S, 1999, J BONE MINER METAB, V17, P171, DOI 10.1007/s007740050081; Ogata K, 2018, J ORAL MAX SURG MED, V30, P445, DOI 10.1016/j.ajoms.2018.04.002; Osugi M, 2012, TISSUE ENG PT A, V18, P1479, DOI [10.1089/ten.tea.2011.0325, 10.1089/ten.TEA.2011.0325]; Pacelli S, 2017, ADV DRUG DELIVER REV, V120, P50, DOI 10.1016/j.addr.2017.07.011; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Pelegrine AA, 2010, CLIN ORAL IMPLAN RES, V21, P535, DOI 10.1111/j.1600-0501.2009.01891.x; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Qin YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21961; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rashed MH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030538; Rickert D, 2011, CLIN ORAL IMPLAN RES, V22, P251, DOI 10.1111/j.1600-0501.2010.01981.x; Robey PG, 2011, TISSUE ENG PART B-RE, V17, P423, DOI 10.1089/ten.teb.2011.0199; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Samsonraj RM, 2017, STEM CELL TRANSL MED, V6, P2173, DOI 10.1002/sctm.17-0129; Saran U, 2014, ARCH BIOCHEM BIOPHYS, V561, P109, DOI 10.1016/j.abb.2014.07.006; Schorn L, 2017, HEAD FACE MED, V13, DOI 10.1186/s13005-017-0146-0; Sun GD, 2018, MAT SCI ENG C-MATER, V89, P194, DOI 10.1016/j.msec.2018.04.006; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang XQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193059; Watson L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt439; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zhang B, 2018, ANAL CELL PATHOL, V2018, DOI 10.1155/2018/8402390; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770	54	84	89	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225472	10.1371/journal.pone.0225472	http://dx.doi.org/10.1371/journal.pone.0225472			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751396	Green Published, gold			2022-12-26	WOS:000533886900069
J	Montoya-Zumaeta, J; Rojas, E; Wunder, S				Montoya-Zumaeta, Javier; Rojas, Eduardo; Wunder, Sven			Adding rewards to regulation: The impacts of watershed conservation on land cover and household wellbeing in Moyobamba, Peru	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES HELP; FOREST CONSERVATION; ECOSYSTEM SERVICES; POLICY INSTRUMENTS; PROTECTED AREAS; PAYMENTS; INCENTIVES; POVERTY; DEFORESTATION; PERFORMANCE	We estimate the effects of Peru's oldest watershed payments for environmental services (PES) initiative in Moyobamba (Andes-Amazon transition zone) and disentangle the complex intervention into its two main forest conservation treatments. First, a state-managed protected area (PA) was established, allowing sustainable use but drastically limiting de facto land use and land rights of households in the upper watershed through command-andcontrol interventions. Second, a subset of those environmentally regulated households also received incentives: PES-like voluntary contracts with conditional in-kind rewards, combined with access to participation in sustainable income-generating activities of the integrated conservation and development project (ICDP) type. To evaluate impacts, we perform matching procedures and adjustment regressions to obtain the average treatment effect on the treated (ATT) of each intervention. We investigate impacts on plot-level forest cover and household welfare for the period 2010-2016. We find that both treatments-command-and-control restrictions and the incentive package-modestly but significantly mitigated primary forest loss. Incentive-induced conservation gains came at elevated per-hectare implementation costs. We also find positive effects on incentive-treated households' incomes and assets; however, their self-perceived wellbeing counterintuitively declined. We hypothesise that locally frustrated beneficiary expectations vis-a-vis the ambitiously designed PES-cum-ICDP intervention help explain this surprising finding. We finalise with some recommendations for watershed incentives and policy mix design in Moyobamba and beyond.	[Montoya-Zumaeta, Javier] Australian Natl Univ, Crawford Sch Publ Policy, Canberra, ACT, Australia; [Montoya-Zumaeta, Javier; Wunder, Sven] Ctr Int Forestry Res CIFOR, Bogor, Indonesia; [Rojas, Eduardo] Univ Barcelona, Fac Geog & Hist, Barcelona, Spain; [Wunder, Sven] European Forest Inst EFI, Barcelona, Spain	Australian National University; CGIAR; Center for International Forestry Research (CIFOR); University of Barcelona	Montoya-Zumaeta, J (corresponding author), Australian Natl Univ, Crawford Sch Publ Policy, Canberra, ACT, Australia.; Montoya-Zumaeta, J (corresponding author), Ctr Int Forestry Res CIFOR, Bogor, Indonesia.	jmontoya.iq@gmail.com	Wunder, Sven/ABE-7773-2020; ZUMAETA, JAVIER MONTOYA/ABD-2964-2020	Wunder, Sven/0000-0002-9422-0260; ZUMAETA, JAVIER MONTOYA/0000-0001-5059-4036; Rojas Baez, Eduardo/0000-0003-1574-0485	International Development Research Centre, Ottawa, Canada; Fondo Nacional de Desarrollo Cientifico, Tecnologico y de Innovacion Tecnologica (FONDECYT), an initiative of the Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC-Peru); European Commission (SINCERE) [H2020 GA 773702]; CGIAR's Forest, Trees and Agroforestry programme	International Development Research Centre, Ottawa, Canada(CGIAR); Fondo Nacional de Desarrollo Cientifico, Tecnologico y de Innovacion Tecnologica (FONDECYT), an initiative of the Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC-Peru); European Commission (SINCERE)(European Commission); CGIAR's Forest, Trees and Agroforestry programme(CGIAR)	This work was carried out with the aid of a grant from the International Development Research Centre, Ottawa, Canada through Project entitled "Using an Environmental Economics Perspective to Influence Policies in Latin America and the Caribbean -Latin American and Caribbean Environmental Economics Program (LACEEP)". Additional funds to the first author were provided by the Fondo Nacional de Desarrollo Cientifico, Tecnologico y de Innovacion Tecnologica (FONDECYT), an initiative of the Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC-Peru). We also acknowledge funding from the European Commission (SINCERE, H2020 GA 773702) and the CGIAR's Forest, Trees and Agroforestry programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Garcia JM, 2015, AM ECON J-ECON POLIC, V7, P1, DOI 10.1257/pol.20130139; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Arriagada RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131544; Arriagada R, 2018, ECOSYST SERV, V29, P116, DOI 10.1016/j.ecoser.2017.12.007; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Aspajo F, 2006, MECANISMO PAGO SERVI; Asquith N. M., 2002, Mitigation and Adaptation Strategies for Global Change, V7, P323, DOI 10.1023/A:1024712424319; Bartels WL, 2010, PAYMENTS FOR ENVIRONMENTAL SERVICES, FOREST CONSERVATION AND CLIMATE CHANGE: LIVELIHOODS IN THE REDD, P82; Baylis K, 2016, CONSERV LETT, V9, P58, DOI 10.1111/conl.12180; Blackman A, 2017, P NATL ACAD SCI USA, V114, P4123, DOI 10.1073/pnas.1603290114; Borner J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159152; Borner J, 2016, ENVIRON CONSERV, V43, P407, DOI 10.1017/S0376892916000229; Borner J., 2013, PROMOTING FOREST STE; Chiarella J, 2015, SISTEMATIZACION APRE; Clements T, 2015, CONSERV BIOL, V29, P78, DOI 10.1111/cobi.12423; Comite Gestor M, 2013, ACUERDOS CONSERVACIO, P83; Cook CN, 2010, FRONT ECOL ENVIRON, V8, P181, DOI 10.1890/090020; Costedoat S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119881; Cuenca P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203545; de Koning F, 2011, ENVIRON SCI POLICY, V14, P531, DOI 10.1016/j.envsci.2011.04.007; DPA-DRASAM, 2016, DIAGN CAD VAL CULT C; EPS-Moyobamba, 2016, PROYECTO INVERSION P; Ferraro PJ, 2015, P NATL ACAD SCI USA, V112, P7420, DOI 10.1073/pnas.1406487112; Ferraro PJ, 2014, ANNU REV ENV RESOUR, V39, P495, DOI 10.1146/annurev-environ-101813-013230; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Ferraro PJ, 2002, LAND ECON, V78, P339, DOI 10.2307/3146894; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; Ferraro PJ, 2001, CONSERV BIOL, V15, P990, DOI 10.1046/j.1523-1739.2001.015004990.x; Finer M, 2015, IMPORTANCIA AREAS NA; Fu GL, 2019, J ENVIRON ECON POLIC, V8, P231, DOI 10.1080/21606544.2018.1552626; Giudice R, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aafc83; GORESAM, 2013, PLAN GEST PRED EST D; GORESAM-IIAP, 2007, ZONIFICACION ECOLOGI; Grieg-Gran M, 2005, WORLD DEV, V33, P1511, DOI 10.1016/j.worlddev.2005.05.002; Honey-Roses J, 2009, ENVIRON CONSERV, V36, P120, DOI 10.1017/S0376892909990063; Hughes R., 2001, INTEGRATING CONSERVA; INEI, 2018, CENS NAC 2017 12 POB; Jayachandran S, 2017, SCIENCE, V357, P267, DOI 10.1126/science.aan0568; Jones KW, 2018, ECOSYST SERV, V31, P208, DOI 10.1016/j.ecoser.2018.04.008; Jones KW, 2017, ENVIRON CONSERV, V44, P56, DOI 10.1017/S0376892916000308; Kowler L.F., 2016, ANAL MULTILEVEL GOVE; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Landell-Mills N, 2002, SILVER BULLET FOOLS; Le Velly G, 2017, LAND ECON, V93, P230, DOI 10.3368/le.93.2.230; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; McShane T.O., 2004, GETTING BIODIVERSITY, P49; Mesia Vasquez J, 2016, MECANISMO RETRIBUCIO; MINAGRI, 2016, AN EST PROD AGR GAN; MINAM, 2018, FICHA MRSEH RETR SER; MINAM, 2010, COMP SERV EC GUEA MO; MINAM, 2010, COMP SERV EC LECC EX; MINAM, 2016, PRER MEC RETR SERV E; Miranda JJ, 2016, WORLD DEV, V78, P288, DOI 10.1016/j.worlddev.2015.10.026; Miteva DA, 2012, OXFORD REV ECON POL, V28, P69, DOI 10.1093/oxrep/grs009; Naeem S, 2015, SCIENCE, V347, P1206, DOI 10.1126/science.aaa1403; Pagiola S, 2005, WORLD DEV, V33, P237, DOI 10.1016/j.worlddev.2004.07.011; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Pfaff A., 2017, ANN REV RESOURCE EC, V9; Porras I.T, 2008, ALL GLITTERS REV PAY; Potapov PV, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/12/124012; Quintero M, 2009, FOREST ECOL MANAG, V258, P1871, DOI 10.1016/j.foreco.2009.04.032; Quintero M, 2015, ESTADO AVANCE CUELLO, P40; Robalino J, 2013, LAND ECON, V89, P432, DOI 10.3368/le.89.3.432; Rodriguez D, 2007, GESTION INTEGRAL CUE, P78; Rosenbaum P.R, 2002, OBSERVATIONAL STUDIE, P105, DOI DOI 10.1007/978-1-4757-3692-2_4; RUBIN DB, 1979, J AM STAT ASSOC, V74, P318, DOI 10.2307/2286330; Salzman J, 2018, NAT SUSTAIN, V1, P136, DOI 10.1038/s41893-018-0033-0; Samii C., 2014, Campbell Systematic Reviews, V10; Schleicher J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10736-w; Shanee N, 2016, TROP CONSERV SCI, V9, DOI 10.1177/1940082916682957; Simonet G, 2019, AM J AGR ECON, V101, P211, DOI 10.1093/ajae/aay028; Sims KRE, 2017, J ENVIRON ECON MANAG, V86, P8, DOI 10.1016/j.jeem.2016.11.010; Sommerville MM, 2009, ECOL SOC, V14; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; SUNASS, 2015, DIAGN HIDR RAP DHR; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Suyanto S, 2007, INSIGHTS NOTES FIELD, V2, P29; Tiburcio J, 2007, ABSTR PAP AM CHEM S, V234; Uchida E, 2009, AM J AGR ECON, V91, P70, DOI 10.1111/j.1467-8276.2008.01184.x; van Noordwijk M, 2012, ANNU REV ENV RESOUR, V37, P389, DOI 10.1146/annurev-environ-042511-150526; Wunder S, 2018, NAT SUSTAIN, V1, P145, DOI 10.1038/s41893-018-0036-x; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x; Wunder S, 2015, ECOL ECON, V117, P234, DOI 10.1016/j.ecolecon.2014.08.016; Zheng H, 2013, P NATL ACAD SCI USA, V110, P16681, DOI 10.1073/pnas.1312324110	85	9	9	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225367	10.1371/journal.pone.0225367	http://dx.doi.org/10.1371/journal.pone.0225367			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8NF	31747419	Green Published, gold			2022-12-26	WOS:000533881900038
J	Wong, ELY; Xu, RH; Cheung, AWL				Wong, Eliza Lai Yi; Xu, Richard Huan; Cheung, Annie Wai Ling			Measuring the impact of chronic conditions and associated multimorbidity on health-related quality of life in the general population in Hong Kong SAR, China: A cross-sectional study	PLOS ONE			English	Article							MINIMALLY IMPORTANT DIFFERENCE; EQ-5D INDEX; NORMS; CARE; FUTURE; ADULTS	Objectives The aims of this study were to 1) evaluate the impact of eight common chronic conditions and multimorbidity on preference-based health-related quality of life (HRQoL), and 2) estimate the minimally important difference (MID) in the general population of Hong Kong (HK). Design Data were analyzed using secondary data analysis based on a cross-sectional, population-based validation study of HK's general population. Participants A representative sample was recruited across eighteen geographical districts in HK, and 1,014 HK Chinese residents aged 18 years and older participated in the survey. The prevalence of chronic conditions among the respondents was 30.3%. Interventions The HRQoL was assessed using the locally validated version of EQ-5D-5L. The five-dimension descriptive system, and the utility scores of EQ-5D-5L were used as the dependent variable in the study. Eight common chronic conditions, multimorbidity, and demographic characteristics were defined as predictors in the analysis. Chi-squared test, analysis of variance (ANOVA), logistic regression, and Tobit regression models were used to analyze the data. A simulation-based approach was used to calculate the MID based on instrument-defined single level transitions. Results The findings indicated that respondents with physical disabilities were more likely to report problems on all five dimensions of the EQ-5D-5L than those with other chronic conditions. In addition, respondents with multiple chronic conditions were more likely to report health problems and lower utility scores of EQ-5D-5L. The mean of MID estimates among the respondents in HK was 0.093 (standard deviation = 0.001), which is higher than in other Asian countries. Conclusions The findings suggest that having more chronic conditions is strongly associated with a lower HRQoL. Healthcare reforms to address foreseeable challenges arising as more patients live with chronic conditions and multimorbidity could improve the HRQoL of HK citizens.	[Wong, Eliza Lai Yi; Xu, Richard Huan; Cheung, Annie Wai Ling] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China	Chinese University of Hong Kong	Wong, ELY; Xu, RH (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.	lywong@cuhk.edu.hk; richardhxu@cuhk.edu.hk	Wong, Eliza Lai-Yi/ABI-2092-2020; Xu, Richard Huan/AAB-5449-2021	Xu, Richard Huan/0000-0002-4720-5172; Wong, Eliza/0000-0001-9983-6219	Health and Medical Research Fund from the Food and Health Bureau of Hong Kong, Hong Kong Special Administrative Region (SAR) [HMRF11120491]	Health and Medical Research Fund from the Food and Health Bureau of Hong Kong, Hong Kong Special Administrative Region (SAR)	The EQ-5D HK valuation study was supported by the Health and Medical Research Fund from the Food and Health Bureau of Hong Kong, Hong Kong Special Administrative Region (SAR) (Grant number: HMRF11120491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdin E, 2015, QUAL LIFE RES, V24, P1545, DOI 10.1007/s11136-014-0859-5; Abdin E, 2013, QUAL LIFE RES, V22, P2983, DOI 10.1007/s11136-013-0405-x; [Anonymous], 2018, LANCET, V391, P1637, DOI 10.1016/S0140-6736(18)30941-3; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Brazier J, 2007, MEASURING VALUING HL; Brazier JE, 2019, VALUE HEALTH, V22, P62, DOI 10.1016/j.jval.2018.12.001; Chin WY, 2016, FAM PRACT, V33, P61, DOI 10.1093/fampra/cmv090; Chung RY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140040; Coretti S, 2014, EXPERT REV PHARM OUT, V14, P221, DOI 10.1586/14737167.2014.894462; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; Epping-Jordan J., 2002, INNOVATIVE CARE CHRO; Gheshlagh RG, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.38562; Hong Kong Census and Statistics Department, 2011, HONG KONG CENSUS STA; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Lakdawalla DN, 2018, VALUE HEALTH, V21, P131, DOI 10.1016/j.jval.2017.12.007; Lawson KD, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-67; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P319, DOI 10.1016/j.jamda.2013.01.001; Lo RSK, 2002, J PAIN SYMPTOM MANAG, V24, P388, DOI 10.1016/S0885-3924(02)00504-3; Mair FS, 2017, BRIT J GEN PRACT, V67, P248, DOI 10.3399/bjgp17X690965; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; McClure NS, 2018, VALUE HEALTH, V21, P1090, DOI 10.1016/j.jval.2018.02.007; McClure NS, 2017, VALUE HEALTH, V20, P644, DOI 10.1016/j.jval.2016.11.015; Mielck A, 2013, EUR J PUBLIC HEALTH, V23, P45, DOI 10.1093/eurpub/ckr206; Mouthon L, 2010, ANN RHEUM DIS, V69, P214, DOI 10.1136/ard.2008.094193; O'Brien R, 2011, CHRONIC ILLN, V7, P45, DOI 10.1177/1742395310382461; Oppe M, 2014, VALUE HEALTH, V17, P445, DOI 10.1016/j.jval.2014.04.002; Park B, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-1016-6; Parker L, 2014, FAM PRACT, V31, P557, DOI 10.1093/fampra/cmu035; Pati S, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1180-3; Pickard AS, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-4; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Salisbury C, 2018, LANCET, V392, P41, DOI 10.1016/S0140-6736(18)31308-4; Schandl AR, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020702; Shiroiwa T, 2016, QUAL LIFE RES, V25, P707, DOI 10.1007/s11136-015-1108-2; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Tollisen A, 2018, ARTHRIT CARE RES, V70, P741, DOI 10.1002/acr.23327; Ullrich A, 2017, BMC PALLIAT CARE, V16, DOI 10.1186/s12904-017-0206-z; Walker V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169282; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Wang LL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-016-0580-x; Wassenaar MJE, 2010, GROWTH HORM IGF RES, V20, P226, DOI 10.1016/j.ghir.2010.02.003; Williams JS, 2016, AM J MED SCI, V352, P45, DOI 10.1016/j.amjms.2016.03.004; Wong ELY, 2018, PATIENT, V11, P235, DOI 10.1007/s40271-017-0278-0; Wong ELY, 2019, VALUE HEALTH, V22, P916, DOI 10.1016/j.jval.2019.02.014; Xu RH, 2017, PATIENT PREFER ADHER, V11, P1565, DOI 10.2147/PPA.S143944	45	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0224970	10.1371/journal.pone.0224970	http://dx.doi.org/10.1371/journal.pone.0224970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8NF	31747393	Green Published, gold			2022-12-26	WOS:000533881900019
J	Pechlivanis, S; Heilmann-Heimbach, S; Erbel, R; Mahabadi, AA; Hochfeld, LM; Jockel, KH; Nothen, MM; Moebus, S				Pechlivanis, Sonali; Heilmann-Heimbach, Stefanie; Erbel, Raimund; Mahabadi, Amir A.; Hochfeld, Lara M.; Joeckel, Karl-Heinz; Noethen, Markus M.; Moebus, Susanne			Male-pattern baldness and incident coronary heart disease and risk factors in the Heinz Nixdorf Recall Study	PLOS ONE			English	Article							ANDROGENETIC ALOPECIA; MYOCARDIAL-INFARCTION; ARTERY CALCIFICATION; CARDIOVASCULAR RISK; EARLY-ONSET; ASSOCIATION; ATHEROSCLEROSIS; HAIR; MEN; PROGRESSION	Male-pattern baldness (MPB) is characterized by a progressive hair loss from the frontal and vertex scalp that affects about 80% of men at the age of 80 years. Epidemiological studies show positive associations between MPB and coronary heart disease (CHD) and CHD related risk factors such as blood pressure (BP), diabetes mellitus (DM) or elevated blood lipid levels. The results however vary with regard to the pattern of hair loss (i.e. moderate, severe, frontal or vertex). Further, no study has investigated for a shared genetic determinant between MPB and CHD as well as CHD related risk factors. Using the longitudinal data from the population-based Heinz Nixdorf Recall study we aimed to systematically investigate the association between MPB and incident CHD and CHD risk factors on (i) an epidemiological (N = 1,673 males) and (ii) a genetic (N = 1,357 males) level. The prevalence of any baldness in our study population was 88% (mean age +/- SD: 64 +/- 7.5 years). Compared to men with 'no baldness', in men with any kind of baldness a slightly increased risk for CHD (Hazard ratio [95% confidence interval (95%CI)] = 1.2 [0.8; 1.9]), a slightly higher extend of coronary artery calcification (CAC) (Beta [95%CI] = 0.2 [-0.1; 0.6]), a moderately increased risk for DM (prevalence ratio [95%CI] = 1.4 [0.9; 2.0]) and higher body mass index (BMI) (Beta [95%CI] = 0.6 [0.00003; 1.2]) seem to be indicated in the adjusted model. In contrast, the MPB genetic risk score did not show any association with CHD or CHD risk factors. Taken together, the results of our study suggest a weak association between MPB and a few CHD risk factors (CAC, DM and BMI) but do not point to MPB as a strong surrogate measure for CHD and CHD risk factors in general.	[Pechlivanis, Sonali; Erbel, Raimund; Joeckel, Karl-Heinz; Moebus, Susanne] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Heilmann-Heimbach, Stefanie; Hochfeld, Lara M.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Heilmann-Heimbach, Stefanie; Hochfeld, Lara M.; Noethen, Markus M.] Univ Bonn, Life & Brain GmbH, Dept Genom, Bonn, Germany; [Mahabadi, Amir A.] Univ Hosp Essen, West German Heart & Vasc Ctr, Dept Cardiol & Vasc Med, Essen, Germany; [Moebus, Susanne] Univ Hosp Essen, Ctr Urbane Epidemiol, Essen, Germany; [Pechlivanis, Sonali] Witten Herdecke Univ, Ctr Biomed Educ & Res, Inst Pharmacol & Toxicol, Witten, Germany	University of Duisburg Essen; University of Bonn; University of Bonn; University of Duisburg Essen; University of Duisburg Essen	Pechlivanis, S (corresponding author), Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany.; Heilmann-Heimbach, S (corresponding author), Univ Bonn, Inst Human Genet, Bonn, Germany.; Heilmann-Heimbach, S (corresponding author), Univ Bonn, Life & Brain GmbH, Dept Genom, Bonn, Germany.; Pechlivanis, S (corresponding author), Witten Herdecke Univ, Ctr Biomed Educ & Res, Inst Pharmacol & Toxicol, Witten, Germany.	sonali.pechlivanis@uk-essen.de; sheilman@uni-bonn.de	Mahabadi, Amir/ABE-6057-2020	Moebus, Susanne/0000-0002-0072-5410; Pechlivanis, Sonali/0000-0002-6181-7044	Heinz Nixdorf Foundation; Deutsche Forschungsgemeinschaft [ER 155/6-1, ER 155/6-2]; Bundesministerium fur Bildung und Forschung; Ministry of Innovation, Science and Research, Nordrhine Westfalia; GE Imatron Inc., South San Francisco, CA; Sarstedt AG & Co. (Numbrecht, Germany)	Heinz Nixdorf Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Ministry of Innovation, Science and Research, Nordrhine Westfalia; GE Imatron Inc., South San Francisco, CA; Sarstedt AG & Co. (Numbrecht, Germany)	Financial support for the Heinz Nixdorf Recall Study was received from the Heinz Nixdorf Foundation [Chairman: M. Nixdorf; Past Chairman: G. Schmidt], the "Deutsche Forschungsgemeinschaft" (Project numbers: ER 155/6-1 and ER 155/6-2) and the "Bundesministerium fur Bildung und Forschung." We thank the Ministry of Innovation, Science and Research, Nordrhine Westfalia for the generous support for the genotyping of the Heinz Nixdorf Recall study participants. GE Imatron Inc., South San Francisco, CA and Sarstedt AG & Co. (Numbrecht, Germany) provided financial support for EBCT scanners and laboratory equipment. The funders had no role in study design, data analysis or interpretation for the present study.	Arias-Santiago S, 2012, J AM ACAD DERMATOL, V66, P401, DOI 10.1016/j.jaad.2010.12.023; Dogramaci AC, 2009, J EUR ACAD DERMATOL, V23, P673, DOI 10.1111/j.1468-3083.2009.03137.x; Erbel R, 2014, EUR HEART J, V35, P2960, DOI 10.1093/eurheartj/ehu288; Erbel R, 2013, ATHEROSCLEROSIS, V229, P531, DOI 10.1016/j.atherosclerosis.2013.04.015; Erbel R, 2012, HYPERTENSION, V59, P44, DOI 10.1161/HYPERTENSIONAHA.111.180489; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; Ford ES, 1996, AM J EPIDEMIOL, V143, P651; Geisel MH, 2016, ATHEROSCLEROSIS, V249, P83, DOI 10.1016/j.atherosclerosis.2016.03.042; Hagenaars SP, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006594; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; Heilmann-Heimbach S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14694; HERRERA CR, 1995, AM J EPIDEMIOL, V142, P828, DOI 10.1093/oxfordjournals.aje.a117722; Hirsso Paivi, 2006, Central European Journal of Public Health, V14, P78; Hirsso P, 2007, DERMATOLOGY, V214, P125, DOI 10.1159/000098570; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Lehmann N, 2018, CIRCULATION, V137, P665, DOI 10.1161/CIRCULATIONAHA.116.027034; Lehmann N, 2014, ATHEROSCLEROSIS, V232, P339, DOI 10.1016/j.atherosclerosis.2013.11.045; LESKO SM, 1993, JAMA-J AM MED ASSOC, V269, P998, DOI 10.1001/jama.269.8.998; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Lotufo PA, 2000, ARCH INTERN MED, V160, P165, DOI 10.1001/archinte.160.2.165; Matilainen V, 2000, LANCET, V356, P1165, DOI 10.1016/S0140-6736(00)02763-X; Matilainen VA, 2001, J CARDIOVASC RISK, V8, P147, DOI 10.1097/00043798-200106000-00005; Moebus S, 2009, DIABETOLOGIA, V52, P81, DOI 10.1007/s00125-008-1173-y; Pechlivanis S, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-23; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sari I, 2015, NETH HEART J, V23, P265, DOI 10.1007/s12471-015-0688-3; Schmermund A, 2006, ATHEROSCLEROSIS, V185, P177, DOI 10.1016/j.atherosclerosis.2005.06.003; SCHNOHR P, 1995, AM HEART J, V130, P1003, DOI 10.1016/0002-8703(95)90201-5; Shahar E, 2008, AM J EPIDEMIOL, V167, P676, DOI 10.1093/aje/kwm365; Sharma S, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON COMPUTING, COMMUNICATION AND AUTOMATION (ICCCA), P283; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stang A, 2005, EUR J EPIDEMIOL, V20, P489, DOI 10.1007/s10654-005-5529-z; Stang A, 2006, AM J EPIDEMIOL, V164, P85, DOI 10.1093/aje/kwj160; Su LH, 2013, JAMA DERMATOL, V149, P601, DOI 10.1001/jamadermatol.2013.130; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Trieu N, 2014, INT J CARDIOL, V176, P687, DOI 10.1016/j.ijcard.2014.07.079; Yamada T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002537; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	38	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225521	10.1371/journal.pone.0225521	http://dx.doi.org/10.1371/journal.pone.0225521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743359	Green Published, gold			2022-12-26	WOS:000533877300035
J	Bang, SP; Yeon, CY; Adhikari, N; Neupane, S; Kim, H; Lee, DC; Son, MJ; Lee, HG; Kim, JY; Jun, JH				Bang, Seung Pil; Yeon, Chang Yeor; Adhikari, Nirpesh; Neupane, Sanjiv; Kim, Harim; Lee, Dong Cheol; Son, Myeong Jin; Lee, Hyun Gyo; Kim, Jae-Young; Jun, Jong Hwa			Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY CYTOKINES; SQUAMOUS METAPLASIA; OPHTHALMIC EMULSION; SIGNALING PATHWAYS; T-CELLS; ACTIVATION; EXPRESSION; SJOGRENS; TEAR	Purpose We aimed to compare the physicochemical properties and in vivo efficacy of commercially available nanoemulsion cyclosporine A (CsA) eyedrops in benzalkonium chloride (BAC)induced dry eye disease (DED). Methods Particle size analysis was performed on conventional 0.05% CsA (Restasis, C-CsA) and two new types of 0.05% CsA eyedrops based on a self-nanoemulsifying drug delivery system (SNEDDS, SNEDDS-N and -T). Turbidometry, pH measurements and instability indices of each CsA solution were measured. DED was induced with BAC, and animals were treated with vehicle or CsA preparations. Tear volume and fluorescein staining scores were evaluated on days 7 and 14. Eyes were enucleated and subjected to IHC, TUNEL staining, periodic acid-Schiff (PAS) staining, real-time PCR and western blotting. Results Both SNEDDSs had lower and more uniform particle size distribution than C-CsA, and a similar optical density to phosphate-buffered saline and stable pH, in contrast to the high turbidity and unstable pH of C-CsA. Aqueous tear volume and fluorescein staining scores were improved in C-CsA- and SNEDDS-treated mice. Numbers of PAS-positive goblet cells and levels of inflammatory mediators were decreased by both C-CsA and SNEDDS, although SNEDDS resolved inflammation more effectively than C-CsA. Conclusions Cyclosporine A eyedrops with SNEDDS have improved physicochemical properties and treatment efficacy in BAC-induced DED.	[Bang, Seung Pil; Kim, Harim; Lee, Dong Cheol; Son, Myeong Jin; Lee, Hyun Gyo; Jun, Jong Hwa] Keimyung Univ, Dept Ophthalmol, Dongsan Med Ctr, Sch Med, Daegu, South Korea; [Bang, Seung Pil] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Yeon, Chang Yeor; Adhikari, Nirpesh; Neupane, Sanjiv; Kim, Jae-Young] Kyungpook Natl Univ, Sch Dent, Dept Biochem, IHBR, Daegu, South Korea	Keimyung University; University of Rochester; Kyungpook National University	Jun, JH (corresponding author), Keimyung Univ, Dept Ophthalmol, Dongsan Med Ctr, Sch Med, Daegu, South Korea.	junjonghwa@gmail.com		ADHIKARI, NIRPESH/0000-0002-8922-2114; Bang, Seung Pil/0000-0002-7521-544X; Neupane, Sanjiv/0000-0003-2051-9865	National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2014R1A5A2010008, NRF-2018R1D1A1B07045362]	National Research Foundation of Korea (NRF) - Korea Government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea Government (MSIP) (No.2014R1A5A2010008) and NRF-2018R1D1A1B07045362. This funding body had no role in the design of the study, in the collection, analysis and interpretation of data, or in the preparation of the manuscript.	Agarwal P, 2016, DRUG DISCOV TODAY, V21, P977, DOI 10.1016/j.drudis.2016.04.002; Anton N, 2011, PHARM RES-DORDR, V28, P978, DOI 10.1007/s11095-010-0309-1; Barbosa FL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050978; Barnadas-Rodriguez R, 2001, INT J PHARMACEUT, V213, P175, DOI 10.1016/S0378-5173(00)00661-X; Bron AJ, 2017, OCUL SURF, V15, P438, DOI 10.1016/j.jtos.2017.05.011; Chen M, 2010, EXP EYE RES, V90, P437, DOI 10.1016/j.exer.2009.12.004; Chen MK, 2011, INT IMMUNOPHARMACOL, V11, P549, DOI 10.1016/j.intimp.2010.11.025; Chen YT, 2009, MOL VIS, V15, P563; Coursey TG, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.5.24; Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008; Dogru M, 2006, INVEST OPHTH VIS SCI, V47, P1895, DOI 10.1167/iovs.05-0802; Einhorn-Stoll U, 2002, NAHRUNG, V46, P294, DOI [10.1002/1521-3803(20020701)46:4<294::AID-FOOD294>3.0.CO;2-2, 10.1002/1521-3803(20020701)46:4&lt;294::AID-FOOD294&gt;3.0.CO;2-2]; Farkouh A, 2016, CLIN OPHTHALMOL, V10, P2433, DOI 10.2147/OPTH.S118409; Galooyak SS, 2015, J FOOD SCI TECH MYS, V52, P2558, DOI 10.1007/s13197-014-1363-1; Gao JP, 2013, INVEST OPHTH VIS SCI, V54, P4717, DOI 10.1167/iovs.13-11681; Kim H, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01820; Kunert KS, 2000, ARCH OPHTHALMOL-CHIC, V118, P1489; Lallemand F, 2003, EUR J PHARM BIOPHARM, V56, P307, DOI 10.1016/S0939-6411(03)00138-3; Lallemand F, 2017, EUR J PHARM BIOPHARM, V117, P14, DOI 10.1016/j.ejpb.2017.03.006; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Li S, 2008, INVEST OPHTH VIS SCI, V49, P34, DOI 10.1167/iovs.07-0685; Lin ZR, 2011, MOL VIS, V17, P257; Liu XF, 2015, EXP CELL RES, V331, P223, DOI 10.1016/j.yexcr.2014.08.040; Liu Y, 2008, INVEST OPHTH VIS SCI, V49, P3336, DOI 10.1167/iovs.07-0972; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Mah F, 2012, CLIN OPHTHALMOL, V6, P1971, DOI 10.2147/OPTH.S30261; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MEHTA RC, 1992, AM J HOSP PHARM, V49, P2749, DOI 10.1093/ajhp/49.11.2749; Murube J, 2003, EUR J OPHTHALMOL, V13, P115, DOI 10.1177/112067210301300201; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Orita T, 2010, INVEST OPHTH VIS SCI, V51, P5556, DOI 10.1167/iovs.09-4909; Pflugfelder SC, 2008, CORNEA, V27, P64, DOI 10.1097/ICO.0b013e318158f6dc; Pflugfelder SC, 2015, INVEST OPHTH VIS SCI, V56, P7545, DOI 10.1167/iovs.15-17627; POWER WJ, 1993, CORNEA, V12, P507, DOI 10.1097/00003226-199311000-00008; Rao SN, 2011, J OCUL PHARMACOL TH, V27, P603, DOI 10.1089/jop.2011.0073; Rehman FU, 2017, EXPERT OPIN DRUG DEL, V14, P1325, DOI 10.1080/17425247.2016.1218462; Saheki A, 2012, INT J PHARMACEUT, V422, P489, DOI 10.1016/j.ijpharm.2011.10.060; Sall K, 2000, OPHTHALMOLOGY, V107, P631, DOI 10.1016/S0161-6420(99)00176-1; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seo MJ, 2010, CURR EYE RES, V35, P165, DOI 10.3109/02713680903453494; Shahba AAW, 2012, AAPS PHARMSCITECH, V13, P967, DOI 10.1208/s12249-012-9821-4; Shetty R, 2015, INVEST OPHTH VIS SCI, V56, P738, DOI 10.1167/iovs.14-14831; Stern ME, 2002, INVEST OPHTH VIS SCI, V43, P2609; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023; Tang SY, 2013, ULTRASON SONOCHEM, V20, P485, DOI 10.1016/j.ultsonch.2012.04.005; Turner K, 2000, CORNEA, V19, P492, DOI 10.1097/00003226-200007000-00018; Utine CA, 2010, OCUL IMMUNOL INFLAMM, V18, P352, DOI 10.3109/09273948.2010.498657; Wan KH, 2015, OCUL SURF, V13, P213, DOI 10.1016/j.jtos.2014.12.006; Wang Z, 2011, MOL VIS, V17, P3137; Wu H, 2011, MOL VIS, V17, P3364; Xiao XY, 2012, INVEST OPHTH VIS SCI, V53, P191, DOI 10.1167/iovs.11-8553; Xie YF, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0038-z; Zhang WW, 2018, MOL MED REP, V17, P1913, DOI 10.3892/mmr.2017.8073; Zhang XB, 2011, AM J PATHOL, V179, P1807, DOI 10.1016/j.ajpath.2011.06.030; Zhang Z, 2014, INVEST OPHTH VIS SCI, V55, P2963, DOI 10.1167/iovs.13-13577; Zhu SP, 2017, EXP EYE RES, V164, P109, DOI 10.1016/j.exer.2017.07.017	56	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0224805	10.1371/journal.pone.0224805	http://dx.doi.org/10.1371/journal.pone.0224805			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738791	Green Published, gold			2022-12-26	WOS:000532826300022
J	Brucher, VC; Heiduschka, P; Grenzebach, U; Eter, N; Biermann, J				Bruecher, Viktoria C.; Heiduschka, Peter; Grenzebach, Ulrike; Eter, Nicole; Biermann, Julia			Distribution of macular ganglion cell layer thickness in foveal hypoplasia: A new diagnostic criterion for ocular albinism	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY	Background/Aims To analyse the distribution of macular ganglion cell layer thickness (GCLT) in patients with foveal hypoplasia (FH) with or without albinism to obtain new insights into visual pathway anomalies in albinos. Methods Patients with FH who presented at our institution between 2013 and 2018 were retrospectively drawn for analysis. Mean GCLT was calculated after automated segmentation of spectral domain-optical coherence tomography (SD-OCT) scans. Patients with FH due to albinism (n = 13, termed 'albinism FH') or other kinds (n = 10, termed 'non-albinism FH') were compared with control subjects (n = 15). The areas: fovea (central), parafovea (nasal I, temporal I) and perifovea (nasal II, temporal II) along the horizontal meridian were of particular interest. Primary endpoints of this study were the ratios (GCLT-I- and GCLT-II-Quotient) between the GCLT measured in the temporal I or II and nasal I or II areas. Results There was a significant difference between the GCLT-I-Quotient of healthy controls and albinism FH (p < 0.001), as well as between non-albinism FH and albinism FH (p = 0.004). GCLT-II-Quotient showed significant differences between healthy controls and albinism FH (p < 0.001) and between non-albinism FH and albinism FH (p = 0.006). The best measure for distinguishing between non-albinism FH and albinism FH was the calculation of GCLT-II-Quotient (area temporal II divided by area nasal II), indicating albinism at a cut-off of < 0.7169. The estimated specificity and sensitivity for this cut-off were 84.6% and 100.0%, respectively. The estimated area under the curve (AUC) was 0.892 [95%CI: 0.743-1.000, p = 0.002]. Conclusion Macular GCLT-distribution showed a characteristic temporal to central shift in patients with FH due to albinism. Calculation of the GCLT-II-Quotient at a cut-off of < 0.7169 presents a new diagnostic criterion for identification of ocular albinism.	[Bruecher, Viktoria C.; Heiduschka, Peter; Grenzebach, Ulrike; Eter, Nicole; Biermann, Julia] Univ Munster, Dept Ophthalmol, Med Ctr, Munster, Germany	University of Munster	Biermann, J (corresponding author), Univ Munster, Dept Ophthalmol, Med Ctr, Munster, Germany.	julia.biermann@ukmuenster.de	Heiduschka, Peter/AAX-3882-2021		Deanship of the University of Munster, North Rhine-Westphalia in Germany	Deanship of the University of Munster, North Rhine-Westphalia in Germany	VB acknowledges support from the Deanship of the University of Munster, North Rhine-Westphalia in Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian P, 1996, EYE, V10, P222, DOI 10.1038/eye.1996.50; APKARIAN P, 1983, ELECTROEN CLIN NEURO, V55, P513, DOI 10.1016/0013-4694(83)90162-1; Cifuentes-Canorea P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196112; COLEMAN J, 1979, EXP NEUROL, V65, P667, DOI 10.1016/0014-4886(79)90052-9; Garvin MK, 2008, IEEE T MED IMAGING, V27, P1495, DOI 10.1109/TMI.2008.923966; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; GUILLERY RW, 1985, DEV BRAIN RES, V20, P221, DOI 10.1016/0165-3806(85)90109-9; HENDRICKSON AE, 1984, OPHTHALMOLOGY, V91, P603; Hoffmann MB, 2005, INVEST OPHTH VIS SCI, V46, P3892, DOI 10.1167/iovs.05-0491; Hoffmann MB, 2007, BRIT J OPHTHALMOL, V91, P509, DOI 10.1136/bjo.2006.094854; Invernizzi A, 2018, OPHTHALMOL RETINA, V2, P808, DOI 10.1016/j.oret.2017.12.012; Kruijt CC, 2018, OPHTHALMOLOGY, V125, P1953, DOI 10.1016/j.ophtha.2018.08.003; McCafferty BK, 2015, J PEDIAT OPHTH STRAB, V52, P167, DOI 10.3928/01913913-20150427-06; Noyal S, 2014, J AAPOS, V18, P471, DOI 10.1016/j.jaapos.2014.07.157; Oki R, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20612; Prieur DS, 2017, DEV NEUROBIOL, V77, P844, DOI 10.1002/dneu.22473; Rossi S, 2012, CASE REP OPHTHALM, V3, P113, DOI 10.1159/000337489; Thomas MG, 2011, OPHTHALMOLOGY, V118, P1653, DOI 10.1016/j.ophtha.2011.01.028; Welton T, 2017, HUM BRAIN MAPP, V38, P740, DOI 10.1002/hbm.23414; Yamashita T, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/2394957	20	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0224410	10.1371/journal.pone.0224410	http://dx.doi.org/10.1371/journal.pone.0224410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738774	Green Published, gold			2022-12-26	WOS:000532826300014
J	Robertson, J; Lin, J; Wren-Hedgus, A; Arya, G; Carrillo, C; Nash, JHE				Robertson, James; Lin, Janet; Wren-Hedgus, Amie; Arya, Gitanjali; Carrillo, Catherine; Nash, John H. E.			Development of a multi-locus typing scheme for an Enterobacteriaceae linear plasmid that mediates inter-species transfer of flagella	PLOS ONE			English	Article							GENETIC-ANALYSIS; PHASE VARIATION; SALMONELLA; GENOME; SEROTYPE; ANTIGEN; BIOSYNTHESIS; STRAINS	Due to the public health importance of flagellar genes for typing, it is important to understand mechanisms that could alter their expression or presence. Phenotypic novelty in flagellar genes arise predominately through accumulation of mutations but horizontal transfer is known to occur. A linear plasmid termed pBSSB1 previously identified in Salmonella Typhi, was found to encode a flagellar operon that can mediate phase variation, which results in the rare z66 flagella phenotype. The identification and tracking of homologs of pBSSB1 is limited because it falls outside the normal replicon typing schemes for plasmids. Here we report the generation of nine new pBSSB1-family sequences using Illumina and Nanopore sequence data. Homologs of pBSSB1 were identified in 154 genomes representing 25 distinct serotypes from 67,758 Salmonella public genomes. Pangenome analysis of pBSSB1-family contigs was performed using roary and we identified three core genes amenable to a minimal pMLST scheme. Population structure analysis based on the newly developed pMLST scheme identified three major lineages representing 35 sequence types, and the distribution of these sequence types was found to span multiple serovars across the globe. This in silico pMLST scheme has shown utility in tracking and subtyping pBSSB1-family plasmids and it has been incorporated into the plasmid MLST database under the name "pBSSB1-family".	[Robertson, James; Lin, Janet; Wren-Hedgus, Amie; Arya, Gitanjali] Publ Hlth Agcy Canada, Natl Microbiol Lab, Guelph, ON, Canada; [Carrillo, Catherine] Canadian Food Inspect Agcy, Ottawa Lab Carling, Ottawa, ON, Canada; [Nash, John H. E.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Toronto, ON, Canada; [Lin, Janet] Agr & Agri Food Canada, Guelph Res & Dev Ctr, Guelph, ON, Canada	Public Health Agency of Canada; Canadian Food Inspection Agency; Public Health Agency of Canada; Agriculture & Agri Food Canada	Nash, JHE (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Toronto, ON, Canada.	james.robertson@canada.ca	Nash, John/P-2384-2017	Nash, John/0000-0003-2925-8710; Robertson, James/0000-0002-8534-5694; Carrillo, Catherine/0000-0002-2334-8718; Lin, Janet/0000-0003-0117-2915	Public Health Agency of Canada; Government of Canada's Genomics R&D Initiative Phase VI Shared Priority Project Management Plan on Antimicrobial Resistance	Public Health Agency of Canada; Government of Canada's Genomics R&D Initiative Phase VI Shared Priority Project Management Plan on Antimicrobial Resistance	This work was funded by the Public Health Agency of Canada and the Government of Canada's Genomics R&D Initiative Phase VI Shared Priority Project Management Plan on Antimicrobial Resistance.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Alikhan NF, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007261; Baker S, 2007, PLOS PATHOG, V3, P605, DOI 10.1371/journal.ppat.0030059; BELTRAN P, 1988, P NATL ACAD SCI USA, V85, P7753, DOI 10.1073/pnas.85.20.7753; Broadbent SE, 2010, MOL MICROBIOL, V77, P337, DOI 10.1111/j.1365-2958.2010.07203.x; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; de Been M, 2015, J CLIN MICROBIOL, V53, P3788, DOI 10.1128/JCM.01946-15; Everest P, 2001, TRENDS MICROBIOL, V9, P316, DOI 10.1016/S0966-842X(01)02067-4; Franklin K, 2011, J CLIN MICROBIOL, V49, P2954, DOI 10.1128/JCM.02347-10; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Garcia-Fernandez A, 2011, J ANTIMICROB CHEMOTH, V66, P1987, DOI 10.1093/jac/dkr225; Garcia-Fernandez A, 2010, J ANTIMICROB CHEMOTH, V65, P1155, DOI 10.1093/jac/dkq101; Ghurye J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3879-z; GUINEE PAM, 1981, ANN INST PASTEUR MIC, VA132, P331; Hancock SJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01740-16; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keenleyside WJ, 1996, J BIOL CHEM, V271, P28581, DOI 10.1074/jbc.271.45.28581; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kropinski AM, 2007, VIROLOGY, V369, P234, DOI 10.1016/j.virol.2007.07.027; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Maiden MCJ., 2018, WELLCOME OPEN RES, P3, DOI [10.12688/wellcomeopenres.14826.130345391, DOI 10.12688/WELLCOMEOPENRES.14826.130345391]; Nair S, 2016, J ANTIMICROB CHEMOTH; Nutrition C for FS and A, WHOL GEN SEQ WGS PRO; Pa G, 1980, ANN MICROBIOL, V132, P331; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; ROBERTSON J, 2018, MICROB GENOMICS, V4, DOI DOI 10.1099/MGEN.0.000206; Robertson J, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000151; ROWE B, 1976, J HYG-CAMBRIDGE, V77, P355, DOI 10.1017/S0022172400055728; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SILVERMAN M, 1979, P NATL ACAD SCI USA, V76, P391, DOI 10.1073/pnas.76.1.391; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; WRIGHT A, 1971, J BACTERIOL, V105, P927, DOI 10.1128/JB.105.3.927-936.1971; Wyres KL, 2014, PATHOGENS, V3, P437, DOI 10.3390/pathogens3020437; Yachison CA, 2017, FRONT MICROBIOL, P8, DOI [10.3389/fmicb.2017.01044/full, DOI 10.3389/FMICB.2017.01044/FULL]; Yoshida C, 2016, J CLIN MICROBIOL; Yoshida CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147101; Zhang HL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050676; Zhang SK, 2015, J CLIN MICROBIOL, V53, P1685, DOI 10.1128/JCM.00323-15; Zhou Z, 2018, GENOME RES	44	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0218638	10.1371/journal.pone.0218638	http://dx.doi.org/10.1371/journal.pone.0218638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738764	Green Published, gold			2022-12-26	WOS:000532826300002
J	Hillert, LK; Ivanisenko, NV; Espe, J; Konig, C; Ivanisenko, VA; Kahne, T; Lavrik, IN				Hillert, Laura K.; Ivanisenko, Nikita, V; Espe, Johannes; Koenig, Corinna; Ivanisenko, Vladimir A.; Kaehne, Thilo; Lavrik, Inna N.			Long and short isoforms of c-FLIP act as control checkpoints of DED filament assembly	ONCOGENE			English	Article							KAPPA-B ACTIVATION; CELL-DEATH; CASPASE-8; REVEALS; PROCASPASE-8; MECHANISM; QUANTIFICATION; REGULATOR; APOPTOSIS; SKYLINE	The assembly of the death-inducing signaling complex (DISC) and death effector domain (DED) filaments at CD95/Fas initiates extrinsic apoptosis. Procaspase-8 activation at the DED filaments is controlled by short and long c-FLIP isoforms. Despite apparent progress in understanding the assembly of CD95-activated platforms and DED filaments, the detailed molecular mechanism of c-FLIP action remains elusive. Here, we further addressed the mechanisms of c-FLIP action at the DISC using biochemical assays, quantitative mass spectrometry, and structural modeling. Our data strongly indicate that c-FLIP can bind to both FADD and procaspase-8 at the DED filament. Moreover, the constructed in silico model shows that c-FLIP proteins can lead to the formation of the DISCs comprising short DED filaments as well as serve as bridging motifs for building a cooperative DISC network, in which adjacent CD95 DISCs are connected by DED filaments. This network is based on selective interactions of FADD with both c-FLIP and procaspase-8. Hence, c-FLIP proteins at the DISC control initiation, elongation, and composition of DED filaments, playing the role of control checkpoints. These findings provide new insights into DISC and DED filament regulation and open innovative possibilities for targeting the extrinsic apoptosis pathway.	[Hillert, Laura K.; Espe, Johannes; Koenig, Corinna; Lavrik, Inna N.] Otto von Guericke Univ, Ctr Dynam Syst, Med Fac, Translat Inflammat Res, D-39106 Magdeburg, Germany; [Ivanisenko, Nikita, V; Ivanisenko, Vladimir A.] SB RAS, Inst Cytol & Genet, Fed Res Ctr, Novosibirsk 630090, Russia; [Kaehne, Thilo] Otto von Guericke Univ, Med Fac, Inst Internal Expt Med, D-39120 Magdeburg, Germany	Otto von Guericke University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Otto von Guericke University	Lavrik, IN (corresponding author), Otto von Guericke Univ, Ctr Dynam Syst, Med Fac, Translat Inflammat Res, D-39106 Magdeburg, Germany.	inna.lavrik@med.ovgu.de	Lavrik, Inna N/C-1700-2009; Ivanisenko, Vladimir/J-7832-2018; Ivanisenko, Nikita/AAO-1621-2020	Lavrik, Inna N/0000-0002-9324-309X; Ivanisenko, Vladimir/0000-0002-1859-4631	Volkswagen Foundation [VW 90315]; Wilhelm Sander-Stiftung [2017.008.01]; Center of dynamic systems (CDS) - EU-program ERDF (European Regional Development Fund); DFG [LA 2386]	Volkswagen Foundation(Volkswagen); Wilhelm Sander-Stiftung; Center of dynamic systems (CDS) - EU-program ERDF (European Regional Development Fund); DFG(German Research Foundation (DFG))	We acknowledge Volkswagen Foundation (VW 90315), Wilhelm Sander-Stiftung (2017.008.01), Center of dynamic systems (CDS), funded by the EU-program ERDF (European Regional Development Fund) and DFG (LA 2386) for supporting our work.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Algeciras-Schimnich A, 2003, FEBS LETT, V546, P185, DOI 10.1016/S0014-5793(03)00558-1; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Fu TM, 2016, MOL CELL, V64, P236, DOI 10.1016/j.molcel.2016.09.009; Golks A, 2006, CELL DEATH DIFFER, V13, P489, DOI 10.1038/sj.cdd.4401766; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Hoffmann JC, 2009, MOL CELL BIOL, V29, P4431, DOI 10.1128/MCB.02261-07; Horn S, 2017, CELL REP, V19, P785, DOI 10.1016/j.celrep.2017.04.010; Hughes MA, 2016, MOL CELL, V61, P834, DOI 10.1016/j.molcel.2016.02.023; Hwang EY, 2014, BMB REP, V47, P488, DOI 10.5483/BMBRep.2014.47.9.239; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lavrik IN, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.160; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Majkut J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4350; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Peter Marcus E, 2004, Biochem J, V382, pe1; Pietkiewicz S, 2015, EXP CELL RES, V339, P1, DOI 10.1016/j.yexcr.2015.10.005; Pietkiewicz S, 2015, J IMMUNOL METHODS, V423, P99, DOI 10.1016/j.jim.2015.04.025; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schleich K, 2016, CELL DEATH DIFFER, V23, P681, DOI 10.1038/cdd.2015.137; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Schmidt JH, 2015, J IMMUNOL METHODS, V423, P12, DOI 10.1016/j.jim.2015.04.026; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Ueffing N, 2008, CELL DEATH DIFFER, V15, P773, DOI 10.1038/sj.cdd.4402314; Warnken Uwe, 2013, Cells, V2, P476, DOI 10.3390/cells2030476; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106	37	16	18	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1756	1772		10.1038/s41388-019-1100-3	http://dx.doi.org/10.1038/s41388-019-1100-3			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31740779				2022-12-26	WOS:000514923000010
J	Park, KC; Geleta, B; Leck, LYW; Paluncic, J; Chiang, SN; Jansson, PJ; Kovacevic, Z; Richardson, DR				Park, Kyung Chan; Geleta, Bekesho; Leck, Lionel Yi Wen; Paluncic, Jasmina; Chiang, Shannon; Jansson, Patric J.; Kovacevic, Zaklina; Richardson, Des R.			Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; cancer biology; molecular pharmacology; receptor tyrosine kinase; hepatocyte growth factor (HGF); c-Met; hepatocyte growth factor receptor; MET proto-oncogene receptor tyrosine kinase (MET); N-myc downstream-regulated gene-1 (NDRG1); thiosemicarbazone	HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; SELECTIVE ANTITUMOR-ACTIVITY; MITOGEN-INDUCIBLE GENE-6; RECEPTOR TYROSINE KINASE; IRON CHELATORS; METASTASIS SUPPRESSOR; REGULATED GENE-1; DOWN-REGULATION; UP-REGULATION	Considering the role of proto-oncogene c-Met (c-Met) in oncogenesis, we examined the effects of the metastasis suppressor, N-myc downstream-regulated gene-1 (NDRG1), and two NDRG1-inducing thiosemicarbazone-based agents, Dp44mT and DpC, on c-Met expression in DU145 and Huh7 cells. NDRG1 silencing without Dp44mT and DpC up-regulated c-Met expression, demonstrating that NDRG1 modulates c-Met levels. Dp44mT and DpC up-regulated NDRG1 by an iron-dependent mechanism and decreased c-Met levels, c-Met phosphorylation, and phosphorylation of its downstream effector, GRB2-associated binding protein 1 (GAB1). However, incubation with Dp44mT and DpC after NDRG1 silencing or silencing of the receptor tyrosine kinase inhibitor, mitogen-inducible gene 6 (MIG6), decreased c-Met and its phosphorylation, suggesting NDRG1- and MIG6-independent mechanism(s). Lysosomal inhibitors rescued the Dp44mT- and DpC-mediated c-Met down-regulation in DU145 cells. Confocal microscopy revealed that lysosomotropic agents and the thiosemicarbazones significantly increased co-localization between c-Met and lysosomal-associated membrane protein 2 (LAMP2). Moreover, generation of c-Met C-terminal fragment (CTF) and its intracellular domain (ICD) suggested metalloprotease-mediated cleavage. In fact, Dp44mT increased c-Met CTF while decreasing the ICD. Dp44mT and a ?-secretase inhibitor increased cellular c-Met CTF levels, suggesting that Dp44mT induces c-Met CTF levels by increasing metalloprotease activity. The broad metalloprotease inhibitors, EDTA and batimastat, partially prevented Dp44mT-mediated down-regulation of c-Met. In contrast, the ADAM inhibitor, TIMP metallopeptidase inhibitor 3 (TIMP-3), had no such effect, suggesting c-Met cleavage by another metalloprotease. Notably, Dp44mT did not induce extracellular c-Met shedding that could decrease c-Met levels. In summary, the thiosemicarbazones Dp44mT and DpC effectively inhibit oncogenic c-Met through lysosomal degradation and metalloprotease-mediated cleavage.	[Park, Kyung Chan; Geleta, Bekesho; Leck, Lionel Yi Wen; Paluncic, Jasmina; Chiang, Shannon; Jansson, Patric J.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Med Fdn Bldg K25, Sydney, NSW 2006, Australia; [Park, Kyung Chan; Geleta, Bekesho; Leck, Lionel Yi Wen; Paluncic, Jasmina; Chiang, Shannon; Jansson, Patric J.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Bosch Inst, Med Fdn Bldg K25, Sydney, NSW 2006, Australia; [Richardson, Des R.] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4668550, Japan	University of Sydney; University of Sydney; Nagoya University	Kovacevic, Z; Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Med Fdn Bldg K25, Sydney, NSW 2006, Australia.; Kovacevic, Z; Richardson, DR (corresponding author), Univ Sydney, Bosch Inst, Med Fdn Bldg K25, Sydney, NSW 2006, Australia.	zaklina.kovacevic@sydney.edu.au; d.richardson@med.usyd.edu.au	Geleta, Bekesho/AAC-5785-2022; Kovacevic, Zaklina/ABD-9581-2021; Jansson, Patric/AAC-4221-2022	Kovacevic, Zaklina/0000-0002-4742-4690; Jansson, Patric/0000-0002-9322-653X; Leck Yi Wen, Lionel/0000-0001-7589-6735; Wendimu, Bekesho Geleta/0000-0002-4546-9692; Chiang, Shannon/0000-0002-5043-9586; Richardson, Des/0000-0002-5506-3274	National Health and Medical Research Council of Australia (NHMRC) [1060482]; Priority-driven Collaborative Cancer Research Scheme Grant - Cure Cancer Australia Foundation of Australia [1086449]; Cancer Australia; NHMRC/PdCCRS Cancer Australia Project Grant - NBCF [NHMRC APP1146599]; National Breast Cancer Foundation (NBCF) [IIRS-19-048]; Research Training Program Scholarship from the University of Sydney; Cancer Institute of New South Wales Career Development Fellowship [CDF171147]; NHMRC Peter Doherty Early Career Fellowship [1037323]; Cancer Institute New South Wales Early Career Fellowship [12-ECF2-17]; NHMRC RD Wright Fellowship [APP1140447]; Cancer Institute New South Wales Career Development Fellowship [CDF171126]; NHMRC Senior Principal Research Fellowship [1062607]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Priority-driven Collaborative Cancer Research Scheme Grant - Cure Cancer Australia Foundation of Australia; Cancer Australia; NHMRC/PdCCRS Cancer Australia Project Grant - NBCF; National Breast Cancer Foundation (NBCF); Research Training Program Scholarship from the University of Sydney; Cancer Institute of New South Wales Career Development Fellowship; NHMRC Peter Doherty Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Early Career Fellowship; NHMRC RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Career Development Fellowship; NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grant 1060482 (to D. R. R. and Z. K.) and Priority-driven Collaborative Cancer Research Scheme Grant 1086449 co-funded by the Cure Cancer Australia Foundation of Australia and Cancer Australia) (to Z. K.). This research was also supported by NHMRC/PdCCRS Cancer Australia Project Grant co-Funded by NBCF (NHMRC APP1146599) and National Breast Cancer Foundation (NBCF) grant support IIRS-19-048 (to D. R. R. and P. J. J.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Research Training Program Scholarship from the University of Sydney.; Recipient of Cancer Institute of New South Wales Career Development Fellowship CDF171147.; Supported by NHMRC Peter Doherty Early Career Fellowship 1037323, Cancer Institute New South Wales Early Career Fellowship 12-ECF2-17, NHMRC RD Wright Fellowship APP1140447, and Cancer Institute New South Wales Career Development Fellowship CDF171126. To whom correspondence may be addressed: Molecular Pharmacology and Pathology Program, Dept. of Pathology and Bosch Institute, Medical Foundation Bldg. (K25), University of Sydney, Sydney, New South Wales 2006, Australia. Tel.: 6129036-3026; E-mail: zaklina.kovacevic@sydney.edu.au.; Supported by NHMRC Senior Principal Research Fellowship 1062607. To whom correspondence may be addressed: Molecular Pharmacology and Pathology Program, Dept. of Pathology and Bosch Institute, Medical Foundation Bldg. (K25), University of Sydney, Sydney, New South Wales 2006, Australia. Tel.: 612-9036-3026; E-mail: d.richardson@med.usyd.edu.au.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Al-Akra L, 2018, J BIOL CHEM, V293, P3562, DOI 10.1074/jbc.M116.772699; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Ancot F, 2012, TRAFFIC, V13, P1261, DOI 10.1111/j.1600-0854.2012.01384.x; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bachleitner-Hofmann T, 2011, CLIN CANCER RES, V17, P122, DOI 10.1158/1078-0432.CCR-10-0253; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Ceci A, 2003, EXPERT OPIN PHARMACO, V4, P1763, DOI 10.1517/14656566.4.10.1763; Chalupsky K, 2013, FOLIA BIOL-PRAGUE, V59, P76; Chaston TB, 2003, CLIN CANCER RES, V9, P402; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Codony-Servat J, 1999, CANCER RES, V59, P1196; Copin MC, 2016, LUNG CANCER, V101, P59, DOI 10.1016/j.lungcan.2016.09.009; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fan SJ, 2001, MOL CELL BIOL, V21, P4968, DOI 10.1128/MCB.21.15.4968-4984.2001; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; GALVANI AP, 1995, BIOCHEM PHARMACOL, V50, P959, DOI 10.1016/0006-2952(95)00219-P; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Ghalayini MK, 2013, BIOSCIENCE REP, V33, P451, DOI 10.1042/BSR20130042; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; GIORDANO S, 1989, ONCOGENE, V4, P1383; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; Guo ZL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0330-x; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; HUMPHREY PA, 1995, AM J PATHOL, V147, P386; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jansson PJ, 2015, PHARMACOL RES, V100, P255, DOI 10.1016/j.phrs.2015.08.013; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; Kovacevic Z, 2008, BBA-MOL CELL RES, V1783, P1981, DOI 10.1016/j.bbamcr.2008.05.016; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Krishan S, 2016, BBA-MOL CELL RES, V1863, P2916, DOI 10.1016/j.bbamcr.2016.09.011; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lefebvre J, 2012, FASEB J, V26, P1387, DOI 10.1096/fj.11-197723; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li PC, 2016, AM J TRANSL RES, V8, P5370; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Liu WS, 2015, ONCOTARGET, V6, P8851, DOI 10.18632/oncotarget.3316; Lohi J, 2001, J BIOL CHEM, V276, P10134, DOI 10.1074/jbc.M001599200; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Lui GYL, 2015, MOL PHARMACOL, V87, P543, DOI 10.1124/mol.114.096529; Menezes SV, 2019, J BIOL CHEM, V294, P4045, DOI 10.1074/jbc.RA118.006279; Menezes SV, 2019, CARCINOGENESIS, V40, P805, DOI 10.1093/carcin/bgy178; MORGAN EH, 1981, BIOCHIM BIOPHYS ACTA, V642, P119, DOI 10.1016/0005-2736(81)90143-7; Mueller KL, 2008, CANCER RES, V68, P3314, DOI 10.1158/0008-5472.CAN-08-0132; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nabeshima K, 1998, INT J CANCER, V78, P750, DOI 10.1002/(SICI)1097-0215(19981209)78:6<750::AID-IJC13>3.0.CO;2-#; Ogunwobi OO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063765; Pante G, 2005, J CELL BIOL, V171, P337, DOI 10.1083/jcb.200502013; Park KC, 2020, FREE RADICAL BIO MED, V157, P154, DOI 10.1016/j.freeradbiomed.2019.05.020; Park KC, 2018, BBA-MOL BASIS DIS, V1864, P2644, DOI 10.1016/j.bbadis.2018.04.011; Peng M, 2010, IMMUNOLOGY, V130, P83, DOI 10.1111/j.1365-2567.2009.03215.x; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; RICHARDSON DR, 1994, J CELL PHYSIOL, V161, P160, DOI 10.1002/jcp.1041610119; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Sahni S, 2019, BBA-MOL BASIS DIS, V1865, P1361, DOI 10.1016/j.bbadis.2019.02.008; Sahni S, 2014, J BIOL CHEM, V289, P9692, DOI 10.1074/jbc.M113.529511; Schelter F, 2010, J BIOL CHEM, V285, P26335, DOI 10.1074/jbc.M110.106435; Seebacher NA, 2016, J BIOL CHEM, V291, P3796, DOI 10.1074/jbc.M115.682450; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Sidarovich V, 2015, MOL PHARMACOL, V87, P513, DOI 10.1124/mol.114.095729; Stacy AE, 2016, J MED CHEM, V59, P8601, DOI 10.1021/acs.jmedchem.6b01050; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; WojtowiczPraga SM, 1997, INVEST NEW DRUG, V15, P61, DOI 10.1023/A:1005722729132; Xi RX, 2017, MOL PHARMACOL, V91, P499, DOI 10.1124/mol.116.107870; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Xu YX, 2018, ONCOL LETT, V15, P7999, DOI 10.3892/ol.2018.8279; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790	87	14	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					481	503		10.1074/jbc.RA119.011341	http://dx.doi.org/10.1074/jbc.RA119.011341			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31744884	Green Published, hybrid			2022-12-26	WOS:000507373600018
J	Johnston, JR; Landim-Vieira, M; Marques, MA; de Oliveira, GAP; Gonzalez-Martinez, D; Moraes, AH; He, H; Iqbal, A; Wilnai, Y; Birk, E; Zucker, N; Silva, JL; Chase, PB; Pinto, JR				Johnston, Jamie R.; Landim-Vieira, Maicon; Marques, Mayra A.; de Oliveira, Guilherme A. P.; Gonzalez-Martinez, David; Moraes, Adolfo H.; He, Huan; Iqbal, Anwar; Wilnai, Yael; Birk, Einat; Zucker, Nili; Silva, Jerson L.; Chase, P. Bryant; Pinto, Jose Renato			The intrinsically disordered C terminus of troponin T binds to troponin C to modulate myocardial force generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac muscle; contractile protein; protein dynamic; structure?function; cardiovascular disease; cardiac muscle; cardiomyopathy; cross-bridges; NMR; troponin	FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HUMAN CARDIAC TROPONIN; DILATED CARDIOMYOPATHY; THIN FILAMENT; FUNCTIONAL-CHARACTERIZATION; TENSION DEVELOPMENT; CA2+ SENSITIVITY; ATPASE ACTIVITY; NMR RELAXATION; RARE VARIANTS	Aberrant regulation of myocardial force production represents an early biomechanical defect associated with sarcomeric cardiomyopathies, but the molecular mechanisms remain poorly defined. Here, we evaluated the pathogenicity of a previously unreported sarcomeric gene variant identified in a pediatric patient with sporadic dilated cardiomyopathy, and we determined a molecular mechanism. Trio whole-exome sequencing revealed a de novo missense variant in TNNC1 that encodes a p.I4M substitution in the N-terminal helix of cardiac troponin C (cTnC). Reconstitution of this human cTnC variant into permeabilized porcine cardiac muscle preparations significantly decreases the magnitude and rate of isometric force generation at physiological Ca2+-activation levels. Computational modeling suggests that this inhibitory effect can be explained by a decrease in the rates of cross-bridge attachment and detachment. For the first time, we show that cardiac troponin T (cTnT), in part through its intrinsically disordered C terminus, directly binds to WT cTnC, and we find that this cardiomyopathic variant displays tighter binding to cTnT. Steady-state fluorescence and NMR spectroscopy studies suggest that this variant propagates perturbations in cTnC structural dynamics to distal regions of the molecule. We propose that the intrinsically disordered C terminus of cTnT directly interacts with the regulatory N-domain of cTnC to allosterically modulate Ca2+ activation of force, perhaps by controlling the troponin I switching mechanism of striated muscle contraction. Alterations in cTnC?cTnT binding may compromise contractile performance and trigger pathological remodeling of the myocardium.	[Johnston, Jamie R.; Landim-Vieira, Maicon; Gonzalez-Martinez, David; He, Huan; Pinto, Jose Renato] Florida State Univ, Coll Med, Dept Biomed Sci, 1115 West Call St, Tallahassee, FL 32306 USA; [Marques, Mayra A.; de Oliveira, Guilherme A. P.; Iqbal, Anwar; Silva, Jerson L.] Univ Fed Rio Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med, Programa Biol Estrutural,Inst Nacl Biol Estrutura, BR-21941902 Rio De Janeiro, Brazil; [Moraes, Adolfo H.] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Quim, BR-31270901 Belo Horizonte, MG, Brazil; [Chase, P. Bryant] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [He, Huan] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Wilnai, Yael] Dana Dwek Children COs Hosp, Tel Aviv Sourasky Med Ctr, Dept Pediat, IL-6423906 Israel, Israel; [Birk, Einat; Zucker, Nili] Tel Aviv Univ, Schneider Childrens Med Ctr, Dept Cardiol, IL-4920235 Petah Tiqwa, Israel	State University System of Florida; Florida State University; Universidade Federal de Minas Gerais; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University	Pinto, JR (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, 1115 West Call St, Tallahassee, FL 32306 USA.	jose.pinto@med.fsu.edu	Marques, Mayra/AAN-3130-2021; Silva, Jerson/J-8984-2014; SILVA, JERSON Lima/GRF-1442-2022; de Oliveira, Guilherme A. P./O-1192-2013; Pinto, Jose R/H-2631-2017	Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441; de Oliveira, Guilherme A. P./0000-0002-0063-5888; Landim-Vieira, Maicon/0000-0002-6696-8888; Gonzalez-Martinez, David/0000-0003-1782-9133; Pinto, Jose R/0000-0001-9092-4976	American Heart Association [19PRE34380628]; National Institutes of Health from NHLBI [HL128683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128683] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 19PRE34380628 (to J. R. J.) and National Institutes of Health Grant HL128683 from NHLBI (to J. R. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alves ML, 2017, CARDIOVASC RES, V113, P915, DOI 10.1093/cvr/cvx068; Baker AJ, 1998, AM J PHYSIOL-HEART C, V275, pH744, DOI 10.1152/ajpheart.1998.275.3.H744; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bing W, 1997, BIOCHEM J, V327, P335, DOI 10.1042/bj3270335; Blumenschein TMA, 2001, J BIOL CHEM, V276, P36606, DOI 10.1074/jbc.M105130200; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Brunet NM, 2014, ARCH BIOCHEM BIOPHYS, V552, P11, DOI 10.1016/j.abb.2013.12.021; Burke MA, 2016, J AM COLL CARDIOL, V68, P2871, DOI 10.1016/j.jacc.2016.08.079; Cannata' A, 2019, EUR HEART J SUPPL, V21, pB90, DOI 10.1093/eurheartj/suz033; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; CHASE PB, 1988, BIOPHYS J, V53, P935, DOI 10.1016/S0006-3495(88)83174-6; Chung JH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00562; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Deranek AE, 2019, PFLUG ARCH EUR J PHY, V471, P661, DOI 10.1007/s00424-019-02269-0; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Filatov VL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P969; Franklin AJ, 2012, BIOPHYS J, V102, P2536, DOI 10.1016/j.bpj.2012.04.037; Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Gonzalez-Martinez D, 2018, J MOL CELL CARDIOL, V123, P26, DOI 10.1016/j.yjmcc.2018.08.015; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Johnson D, 2018, BIOPHYS J, V115, P702, DOI 10.1016/j.bpj.2018.06.028; Johnston JR, 2018, ONCOTARGET, V9, P1461, DOI 10.18632/oncotarget.22879; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kawai M, 2017, BIOPHYS J, V112, P1726, DOI 10.1016/j.bpj.2017.02.045; Khush K, 2018, J HEART LUNG TRANSPL, V37, pS341, DOI 10.1016/j.healun.2018.01.874; Kim G, 2014, BBA-GEN SUBJECTS, V1840, P901, DOI 10.1016/j.bbagen.2013.04.038; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 1999, BIOCHEMISTRY-US, V38, P5386, DOI 10.1021/bi981320m; Kowlessur D, 2012, J BIOL CHEM, V287, P42299, DOI 10.1074/jbc.M112.423459; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LANDESBERG A, 1994, AM J PHYSIOL, V266, pH1260, DOI 10.1152/ajpheart.1994.266.3.H1260; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Li MX, 2015, GENE, V571, P153, DOI 10.1016/j.gene.2015.07.074; LIPARI G, 1982, NATURE, V300, P197, DOI 10.1038/300197a0; Lipshultz SE, 2019, CIRCULATION, V140, pE9, DOI 10.1161/CIR.0000000000000682; Loong CKP, 2013, CELL MOL BIOENG, V6, P183, DOI 10.1007/s12195-013-0269-8; Malnic B, 1998, J BIOL CHEM, V273, P10594, DOI 10.1074/jbc.273.17.10594; Marques MA, 2019, ARCH BIOCHEM BIOPHYS, V663, P95, DOI 10.1016/j.abb.2018.12.026; Marques MD, 2017, J BIOL CHEM, V292, P2379, DOI 10.1074/jbc.M116.765362; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; Morin S, 2011, PROG NUCL MAG RES SP, V59, P245, DOI 10.1016/j.pnmrs.2010.12.003; Na I, 2016, BIOL CHEM, V397, P731, DOI 10.1515/hsz-2015-0303; Norton N, 2012, CIRC-CARDIOVASC GENE, V5, P167, DOI 10.1161/CIRCGENETICS.111.961805; Parvatiyar MS, 2012, J BIOL CHEM, V287, P31845, DOI 10.1074/jbc.M112.377713; Pejaver V, 2017, BIORXIV, DOI [10.1101/134981, DOI 10.1101/134981]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Pinto JR, 2011, J BIOL CHEM, V286, P34404, DOI 10.1074/jbc.M111.267211; Pinto JR, 2011, J BIOL CHEM, V286, P1005, DOI 10.1074/jbc.M110.168583; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; Regnier M, 1999, BIOPHYS J, V76, P2664, DOI 10.1016/S0006-3495(99)77418-7; Repetti GG, 2019, CIRC RES, V124, P1536, DOI 10.1161/CIRCRESAHA.119.313569; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ripoll-Vera T, 2016, REV ESP CARDIOL, V69, P149, DOI 10.1016/j.rec.2015.06.025; Risi C, 2017, P NATL ACAD SCI USA, V114, P6782, DOI 10.1073/pnas.1700868114; Rossano JW, 2018, J HEART LUNG TRANSPL, V37, P1184, DOI 10.1016/j.healun.2018.07.018; Schmidt C, 2014, NAT PROTOC, V9, P2224, DOI 10.1038/nprot.2014.144; Schultheiss HP, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0084-1; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shettigar V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10794; Solis C, 2018, BIOPHYS J, V115, P1762, DOI 10.1016/j.bpj.2018.08.033; Stehle R, 2010, J MOL CELL CARDIOL, V48, P843, DOI 10.1016/j.yjmcc.2009.12.020; Stevens CM, 2017, J BIOL CHEM, V292, P11915, DOI 10.1074/jbc.M116.770776; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; van der Velden J, 2019, PHYSIOL REV, V99, P381, DOI 10.1152/physrev.00040.2017; Veltri T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00777-6; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; Wei B, 2016, GENE, V582, P1, DOI 10.1016/j.gene.2016.01.006; Williams MR, 2016, P NATL ACAD SCI USA, V113, P3257, DOI 10.1073/pnas.1519541113; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; WOLFF MR, 1995, CIRC RES, V76, P154, DOI 10.1161/01.RES.76.1.154; Zamora JE, 2016, PHYS CHEM CHEM PHYS, V18, P20691, DOI 10.1039/c6cp02610a	90	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20054	20069		10.1074/jbc.RA119.011177	http://dx.doi.org/10.1074/jbc.RA119.011177			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748410	Green Published, hybrid			2022-12-26	WOS:000505005800019
J	Gietel-Basten, S; Scherbov, S				Gietel-Basten, Stuart; Scherbov, Sergei			Is half the world's population really below 'replacement-rate'?	PLOS ONE			English	Article							FERTILITY	A perennial activity of demographers is to estimate the percentage of the world's population which is above or below the 'replacement rate of fertility' [RRF]. However, most attempts to do so have been based upon, at best, oversimplified, or at worst, simply incorrect assumptions about what RRF actually is. The objective of this paper is to calculate the proportion of the world's population living in countries with observed period total fertility rates [TFR] below the respective calculated RRF, rather than the commonly used measure of 2.1. While the differences between comparing TFR to 2.1 or RRF are relatively modest in many periods when considering populations at the national level, a significant difference can be observed in the near future based upon India's fertility and mortality trajectories. Our exercise represents a means of 'correcting the record' using the most up-to-date evidence and using the correct protocol.	[Gietel-Basten, Stuart] Hong Kong Univ Sci & Technol, Div Social Sci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China; [Scherbov, Sergei] Int Inst Appl Syst Anal, World Populat Program, Laxenburg, Austria	Hong Kong University of Science & Technology; International Institute for Applied Systems Analysis (IIASA)	Gietel-Basten, S (corresponding author), Hong Kong Univ Sci & Technol, Div Social Sci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China.	sgb@ust.hk		Scherbov, Sergei/0000-0002-0881-1073				Chamie J., 2018, REPLACEMENT FERTILIT; Dorling S, 2018, WHY DEMOGRAPHY MATTE; Espenshade TJ, 2004, POPULATION RES POLIC, V22, P575; Frejka T, 2017, HALF WORLDS POPULATI; Gallagher J, 2018, BBC NEWS        1109; Gietel-Basten S., 2019, POPULATION PROBLEM P; Govt. of India, 2017, STAT UT WIS AADH SAT; James KS, 2011, SCIENCE, V333, P576, DOI 10.1126/science.1207969; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; Murray CJL, 2018, LANCET, V392, P1995, DOI [10.1016/S0140-6736(18)32278-5, 10.1016/s0140-6736(18)32278-5]; Myrskyla M, 2009, NATURE, V460, P741, DOI 10.1038/nature08230; ORGCC, 2017, SAMPL REG SYST STAT; ORGCC, 2017, SRS BAS LIF TABL 201; Smallwood Steve, 2005, Popul Trends, P16; Striessnig E, 2013, EMPIRICA, V40, P409, DOI 10.1007/s10663-013-9213-3; UNPD, 2017, 20173 UNPD; UNPD, 2017, ESAPWP248 UNOD; UNPD, 2017, WORLD POP PROSP 2017; Wilson, 2004, POPULATION SOC, V405, P1; Wilson C, 2004, SCIENCE, V304, P207; Wu PK, 2018, SOC INDIC RES, V135, P751, DOI 10.1007/s11205-016-1503-2	21	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224985	10.1371/journal.pone.0224985	http://dx.doi.org/10.1371/journal.pone.0224985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790416	gold, Green Published, Green Accepted			2022-12-26	WOS:000533930800020
J	Laporte, C; Lambert, C; Pereira, B; Blanc, O; Authier, N; Balayssac, D; Brousse, G; Vorilhon, P				Laporte, Catherine; Lambert, Celine; Pereira, Bruno; Blanc, Olivier; Authier, Nicolas; Balayssac, David; Brousse, Georges; Vorilhon, Philippe			Cannabis users: Screen systematically, treat individually. A descriptive study of participants in a randomized trial in primary care	PLOS ONE			English	Article							BRIEF INTERVENTION	Purpose The aim of the present study was to describe the profiles of a sample of young cannabis users not seeking care, for use in general practice in France. Methods In this cross-sectional study, baseline data were used from a previous clinical randomized trial, in which a brief intervention was tested. The participants were 262 cannabis users aged 15 to 25 years who smoked at least one joint per month. Assessment was undertaken both by the GP and via an anonymous self-reporting questionnaire. All statistical analyses were performed using Stata software and R. We used multiple correspondence analysis to determine the profiles of users. Results Among the 262 patients, 46.2% were daily users (more than 30 joints per month), 25.6% were regular users (from 10 to 29 joints per month), and 28.2% were recent users (fewer than 10 joints per month). The higher the frequency of use, the greater the incidence of unaccompanied use, daily use and week use (p from <0.001 to 0.01). The motivations of daily users were mostly self-treatment and habit (p < 0.05). The cannabis abuse screening trial score revealed risky use for 87.5% of daily users and 34.4% for recent users. Factorial analysis identified 5 profiles according to age, risk, and motive for use. The reasons for consultation were equally distributed among users regardless of their level of use or their profile (p > 0.05). Conclusions The results provide support for the practice of asking young patients systematically about their cannabis use, allowing GPs to identify users who require medical care. GPs should consider the differences between participants according to their profile in order to determine the appropriate type of care.	[Laporte, Catherine] Univ Clermont Auvergne, Unite Format & Rech Med, Dept Med Gen, Equipe Accueil 7280, Clermont Ferrand, France; [Lambert, Celine; Pereira, Bruno] Ctr Hosp Univ Clermont Ferrand, Delegat Rech Clin & Innovat, Clermont Ferrand, France; [Blanc, Olivier; Brousse, Georges] Univ Clermont Auvergne, Unite Format & Rech Med, Equipe Accueil 7280, Clermont Ferrand, France; [Blanc, Olivier; Brousse, Georges] Ctr Hosp Univ Clermont Ferrand, Serv Psychiat B & Addictol, Clermont Ferrand, France; [Authier, Nicolas] Univ Clermont Auvergne, Neuro Dol, INSERM, Clermont Ferrand, France; [Authier, Nicolas] Ctr Hosp Univ Clermont Ferrand, Ctr Addictovigilance Pharmacovigilance, Ctr Evaluat & Traitement Douleur, Serv Pharmacol Med, Clermont Ferrand, France; [Balayssac, David] Univ Clermont Auvergne, Unite Format & Rech Pharm, NEURO DOL, Inserm,U1107, Clermont Ferrand, France; [Balayssac, David] Ctr Hosp Univ Clermont Ferrand, Lab Toxicol, Delegat Rech Clin & Innovat, Clermont Ferrand, France; [Vorilhon, Philippe] Univ Clermont Auvergne, Inst Pascal, SIGMA Clermont, CNRS, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Laporte, C (corresponding author), Univ Clermont Auvergne, Unite Format & Rech Med, Dept Med Gen, Equipe Accueil 7280, Clermont Ferrand, France.	Catherine.laporte2@uca.fr	Balayssac, David/AAZ-3007-2020	Balayssac, David/0000-0002-6126-6588; laporte, catherine/0000-0001-9890-489X	French Ministry of Health (PHRC-Hospital Program of Clinical Research) [0505]	French Ministry of Health (PHRC-Hospital Program of Clinical Research)	This study was supported by a grant from the French Ministry of Health (PHRC-Hospital Program of Clinical Research; no 0505, 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2015, EUR DRUG REP TRENDS; [Anonymous], 2010, BAR SANT 2010; [Anonymous], 2018, GLOBAL OVERVIEW DRUG; [Anonymous], 2014, BAR SANT 2014; Bahadoor K, 2011, EUR J GEN PRACT, V17, P35; Beck F, 2011, REV EPIDEMIOL SANTE, V59, P285, DOI 10.1016/j.respe.2011.03.059; Benard V, 2015, PRESSE MED, V44, P707, DOI 10.1016/j.lpm.2014.11.014; Castellanos-Ryan N, 2017, DEV PSYCHOPATHOL, V29, P1253, DOI 10.1017/S0954579416001280; Copeland J, 2001, J SUBST ABUSE TREAT, V20, P45, DOI 10.1016/S0740-5472(00)00148-3; Day S., 1994, STATISTICIAN, V43, P608, DOI [10.2307/2348155, DOI 10.2307/2348155]; Erlbaum L., 1988, STAT POWER ANAL BEHA; Esmaeelzadeh S, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120543; Gilchrist G, 2011, ADDICTION, V106, P1114, DOI 10.1111/j.1360-0443.2011.03407.x; Gobbi G, 2019, JAMA PSYCHIAT, V76, P426, DOI 10.1001/jamapsychiatry.2018.4500; Goodhines PA, 2019, BEHAV SLEEP MED, V17, P327, DOI 10.1080/15402002.2017.1357119; Haller DM, 2008, J ADOLESCENT HEALTH, V43, P517, DOI 10.1016/j.jadohealth.2008.03.006; Laporte C, 2017, ANN FAM MED, V15, P131, DOI 10.1370/afm.2003; Laporte C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-40; Legleye S, 2011, DRUG ALCOHOL DEPEN, V113, P229, DOI 10.1016/j.drugalcdep.2010.08.011; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Marconi A, 2016, SCHIZOPHRENIA BULL, V42, P1262, DOI 10.1093/schbul/sbw003; McCambridge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023748; Miller WR, 1993, MOTIVATING YOUNG ADU, P55; Obradovic I, OFDT 2013; Orr C, 2019, J NEUROSCI, V39, P1817, DOI 10.1523/JNEUROSCI.3375-17.2018; Pouchain D, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-318; Richmond-Rakerd LS, 2017, PSYCHOL ADDICT BEHAV, V31, P664, DOI 10.1037/adb0000304; Smelt AFH, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514819; Solowij N, 2011, PSYCHOPHARMACOLOGY, V216, P131, DOI 10.1007/s00213-011-2203-x; Spilka S, 2018, DROGUES 17 ANS ANAL; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tims FM, 2002, ADDICTION, V97, P46, DOI 10.1046/j.1360-0443.97.s01.7.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Vorilhon P, 2014, FAM PRACT, V31, P585, DOI 10.1093/fampra/cmu030	35	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224867	10.1371/journal.pone.0224867	http://dx.doi.org/10.1371/journal.pone.0224867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO9FT	31790425	Green Published, gold, Green Submitted			2022-12-26	WOS:000533930800014
J	Yolken, R; Stallings, C; Origoni, A; Katsafanas, E; Sweeney, K; Squire, A; Dickerson, F				Yolken, Robert; Stallings, Cassie; Origoni, Andrea; Katsafanas, Emily; Sweeney, Kevin; Squire, Amalia; Dickerson, Faith			Exposure to household pet cats and dogs in childhood and risk of subsequent diagnosis of schizophrenia or bipolar disorder	PLOS ONE			English	Article							COGNITIVE DEFICITS; OWNERSHIP; ASSOCIATIONS; INDIVIDUALS; ANTIBODIES; SYMPTOMS; STRESS; HEALTH	Background Serious psychiatric disorders such as schizophrenia and bipolar disorder have been associated with environmental exposures in early life. Contact with household pets such as cats and dogs can serve as a source of environmental exposure during these time periods. Methods We investigated the relationship between exposure to a household pet cat or dog during the first 12 years of life and having a subsequent diagnosis of schizophrenia or bipolar disorder. These studies were performed in a cohort of 396 individuals with schizophrenia, 381 with bipolar disorder, and 594 controls. The hazards of developing schizophrenia or bipolar disorder associated with first exposure to a household pet cat or dog were calculated using Cox Proportional Hazard and multivariate logistic regression models including socio-demographic covariates. Results We found that exposure to a household pet dog was associated with a significantly decreased hazard of having a subsequent diagnosis of schizophrenia (Hazard Ratio.75, p <.002) Furthermore, a significant decreased relative risk of schizophrenia was detected following exposure at birth and during the first years of life. There was no significant relationship between household exposure to a pet dog and bipolar disorder. There were no significant associations between exposure to a household pet cat and subsequent risk of either a schizophrenia or bipolar disorder diagnosis. However, there were trends towards an increased risk of both disorders at defined periods of exposure. Conclusions Exposure to household pets during infancy and childhood may be associated with altered rates of development of psychiatric disorders in later life.	[Yolken, Robert] Johns Hopkins Sch Med, Stanley Div Dev Neurovirol, Baltimore, MD 21205 USA; [Stallings, Cassie; Origoni, Andrea; Katsafanas, Emily; Sweeney, Kevin; Squire, Amalia; Dickerson, Faith] Sheppard Pratt Hlth Syst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Yolken, R (corresponding author), Johns Hopkins Sch Med, Stanley Div Dev Neurovirol, Baltimore, MD 21205 USA.	rhyolken@gmail.com	yolken, robert/AAW-2556-2021	Yolken, Robert/0000-0001-9902-1554	Stanley Medical Research Institute; NIMH P50 Silvio O. Conte Center at Johns Hopkins [MH-94268]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER	Stanley Medical Research Institute; NIMH P50 Silvio O. Conte Center at Johns Hopkins; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Stanley Medical Research Institute and by the NIMH P50 Silvio O. Conte Center at Johns Hopkins (grant#MH-94268). Dr. Yolken is a paid Scientific Adviser to the Stanley Medical Research Institute and to the Astellas Research Institute of America and is on the Board of the Treatment Advocacy Center.; This work was supported by grants from the Stanley Medical Research Institute. The authors thank Dr. E Fuller Torrey for his careful reading of the manuscript.	Aichbhaumik N, 2008, CLIN EXP ALLERGY, V38, P1787, DOI 10.1111/j.1365-2222.2008.03079.x; [Anonymous], 2019, JAMA PSYCHIAT; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Bufford JD, 2008, CLIN EXP ALLERGY, V38, P1635, DOI 10.1111/j.1365-2222.2008.03018.x; Cruz-Mejia S, 2018, NUTR HOSP, V35, P841, DOI 10.20960/nh.1614; Dickerson F, 2017, BRAIN BEHAV IMMUN, V62, P46, DOI 10.1016/j.bbi.2016.12.010; Dickerson F, 2014, J NERV MENT DIS, V202, P589, DOI 10.1097/NMD.0000000000000166; Dickerson F, 2013, J AFFECT DISORDERS, V150, P456, DOI 10.1016/j.jad.2013.04.039; Dickerson FB, 2003, ARCH GEN PSYCHIAT, V60, P466, DOI 10.1001/archpsyc.60.5.466; Ezell JM, 2014, ETHNIC DIS, V24, P104; Fall T, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.3219; Fecteau SM, 2017, BIOL PSYCHOL, V123, P187, DOI 10.1016/j.biopsycho.2016.12.008; Flegr J, 2017, SCHIZOPHR RES, V189, P219, DOI 10.1016/j.schres.2017.02.007; Gadomski AM, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150204; Guma E, 2019, NEUROSCI BIOBEHAV R, V104, P141, DOI 10.1016/j.neubiorev.2019.06.020; HAUSER RM, 1994, CHILD DEV, V65, P1541, DOI 10.2307/1131279; Husted JA, 2012, SCHIZOPHR RES, V137, P166, DOI 10.1016/j.schres.2012.02.009; Jhun Iny, 2016, Evid Based Med, V21, P80, DOI 10.1136/ebmed-2015-110373; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Kohler-Forsberg O, 2019, JAMA PSYCHIAT, V76, P271, DOI 10.1001/jamapsychiatry.2018.3428; Kolpakova J, 2013, SCHIZOPHR RES, V146, P370, DOI 10.1016/j.schres.2013.02.039; Konya T, 2014, ENVIRON RES, V131, P25, DOI 10.1016/j.envres.2014.02.005; Meyer U, 2013, PROG NEURO-PSYCHOPH, V42, P20, DOI 10.1016/j.pnpbp.2011.11.003; Nathans-Barel I, 2005, PSYCHOTHER PSYCHOSOM, V74, P31, DOI 10.1159/000082024; Nicholas C, 2009, AM J EPIDEMIOL, V170, P388, DOI 10.1093/aje/kwp139; Nieto M, 2019, J CLIN PSYCHOL, V75, P1011, DOI 10.1002/jclp.22746; Ohi K, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.260; Palomaki J, 2019, SCHIZOPHR RES, V206, P444, DOI 10.1016/j.schres.2018.12.020; Pintar KDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144976; Severance EG, 2016, CURR PHARM DESIGN, V22, P6076, DOI 10.2174/1381612822666160914183804; Solmi F, 2017, PSYCHOL MED, V47, P1659, DOI 10.1017/S0033291717000125; Stapelberg NJC, 2018, NEUROSCI BIOBEHAV R, V90, P1, DOI 10.1016/j.neubiorev.2018.03.005; Torrey EF, 2019, PSYCHIAT RES, V278, P146, DOI 10.1016/j.psychres.2019.06.006; Torrey EF, 2015, SCHIZOPHR RES, V165, P1, DOI 10.1016/j.schres.2015.03.036; TORREY EF, 1995, SCHIZOPHRENIA BULL, V21, P167, DOI 10.1093/schbul/21.2.167; Torrey EF, 2000, SCHIZOPHR RES, V46, P17, DOI 10.1016/S0920-9964(99)00237-6; Westgarth C, 2010, INT J ENV RES PUB HE, V7, P3704, DOI 10.3390/ijerph7103704; Yuksel P, 2010, FOLIA PARASIT, V57, P121, DOI 10.14411/fp.2010.015	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0225320	10.1371/journal.pone.0225320	http://dx.doi.org/10.1371/journal.pone.0225320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO9FT	31790431	gold, Green Published			2022-12-26	WOS:000533930800029
J	Dunn, LK; Taylor, DG; Smith, SJ; Skojec, AJ; Wang, TR; Chung, J; Hanak, MF; Lacomis, CD; Palmer, JD; Ruminski, C; Fang, SH; Tsang, S; Spangler, SN; Durieux, ME; Naik, BI				Dunn, Lauren K.; Taylor, Davis G.; Smith, Samantha J.; Skojec, Alexander J.; Wang, Tony R.; Chung, Joyce; Hanak, Mark F.; Lacomis, Christopher D.; Palmer, Justin D.; Ruminski, Caroline; Fang, Shenghao; Tsang, Siny; Spangler, Sarah N.; Durieux, Marcel E.; Naik, Bhiken, I			Persistent post-discharge opioid prescribing after traumatic brain injury requiring intensive care unit admission: A cross-sectional study with longitudinal outcome	PLOS ONE			English	Article							PRESSURE	Traumatic brain injury (TBI) is associated with increased risk for psychological and substance use disorders. The study aim is to determine incidence and risk factors for persistent opioid prescription after hospitalization for TBI. Electronic medical records of patients age. 18 admitted to a neuroscience intensive care unit between January 2013 and February 2017 for an intracranial injury were retrospectively reviewed. Primary outcome was opioid use through 12 months post-hospital discharge. A total of 298 patients with complete data were included in the analysis. The prevalence of opioid use among preadmission opioid users was 48 (87%), 36 (69%) and 22 (56%) at 1, 6 and 12-months post-discharge, respectively. In the opioid naive group, 69 (41%), 24 (23%) and 17 (19%) were prescribed opioids at 1, 6 and 12 months, respectively. Preadmission opioid use (OR 324.8, 95% CI 23.116907.5, p = 0.0004) and higher opioid requirements during hospitalization (OR 4.5, 95% CI 1.8-16.3, p = 0.006) were independently associated with an increased risk of being prescribed opioids 12 months post-discharge. These factors may be used to identify and target at-risk patients for intervention.	[Dunn, Lauren K.; Smith, Samantha J.; Skojec, Alexander J.; Chung, Joyce; Hanak, Mark F.; Lacomis, Christopher D.; Palmer, Justin D.; Ruminski, Caroline; Fang, Shenghao; Spangler, Sarah N.; Durieux, Marcel E.; Naik, Bhiken, I] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22903 USA; [Taylor, Davis G.; Wang, Tony R.; Durieux, Marcel E.; Naik, Bhiken, I] Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA USA; [Tsang, Siny] Washington State Univ, Nutr & Exercise Physiol, Spokane, WA USA	University of Virginia; University of Virginia; Washington State University	Dunn, LK (corresponding author), Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22903 USA.	lak3r@virginia.edu		Skojec, Alexander/0000-0002-9400-9916; Tsang, Siny/0000-0001-5076-5587				Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; [Anonymous], 2015, R LANG ENV STAT COMP; Brummett CM, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2017.0504; Camps AS, 2000, CRIT CARE MED, V28, P3612, DOI 10.1097/00003246-200011000-00009; Colton K, 2016, J INTENSIVE CARE MED, V31, P263, DOI 10.1177/0885066614555692; Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI [10.1097/CCM.0000000000003259, 10.1097/CCM.0000000000003299]; Dunn LK, 2018, ANESTH ANALG; Harbaugh CM, 2018, JAMA-J AM MED ASSOC, V320, P504, DOI 10.1001/jama.2018.9023; Hudson TJ, 2018, PAIN MED, V19, P774, DOI 10.1093/pm/pnx208; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Portenoy R. K., 2017, CANC PAIN MANAGEMENT; Shehabi Y, 2019, NEW ENGL J MED, V380, P2506, DOI 10.1056/NEJMoa1904710; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sun YX, 2012, DIS COLON RECTUM, V55, P1183, DOI 10.1097/DCR.0b013e318259bcd8; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vaughn MG, 2019, PSYCHIAT QUART, V90, P151, DOI 10.1007/s11126-018-9617-0; Wang HT, 2018, CRIT CARE MED, V46, P1934, DOI 10.1097/CCM.0000000000003401; Wiener J, 2019, BRAIN INJURY, V33, P559, DOI 10.1080/02699052.2019.1574328; Zhao HY, 2019, J CRIT CARE, V54, P136, DOI 10.1016/j.jcrc.2019.08.022	21	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225787	10.1371/journal.pone.0225787	http://dx.doi.org/10.1371/journal.pone.0225787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774864	Green Published, gold			2022-12-26	WOS:000533896400063
J	Fu, CP; Ali, H; Rachakonda, VP; Oczypok, EA; DeLany, JP; Kershaw, EE				Fu, Chia-Po; Ali, Hira; Rachakonda, Vikrant P.; Oczypok, Elizabeth A.; DeLany, James P.; Kershaw, Erin E.			The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women	PLOS ONE			English	Article							FATTY LIVER-DISEASE; WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; DIAGNOSIS; RISK; MANAGEMENT; ADIPOSITY; FIBROSIS	Introduction Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the western world and is highly associated with multiple cardiometabolic complications. The Zhejiang University (ZJU) index was first developed to predict NAFLD in Chinese populations, where it was shown to have better predictive value than other currently used indices. The aims of the present study were to 1) determine the diagnostic accuracy of ZJU index in identifying NAFLD in a well-phenotyped cohort of obese middle-aged American women and 2) compare its performance with other non-invasive indices for NAFLD identification. Methods To achieve this goal, we performed a retrospective analysis of a prospectively-collected cohort of participants enrolled in a weight loss trial for severe obesity (RENEW, clinical-trials. gov identifier: NCT00712127). One hundred and seven women between the age of 30 and 55 with obesity class II (BMI 35-39.9 kg/m(2)) or class III (BMI >= 40 kg/m(2)) were recruited for analyses. Hepatic steatosis was measured using liver/spleen attenuation ratio (L/S ratio) from unenhanced abdominal computed tomography. Beside ZJU index, hepatic steatosis index (HSI), lipid accumulation production index (LAPI), and visceral adiposity index (VAI) were also determined and to compare their performance in predicting NAFLD. Results Of 107 obese women in the study, 40 (37.4%) met imaging criteria for NAFLD using cut-off value of L/S ratio < 1.1. The ZJU index was positively correlated with HIS, LAPI, but not VAI. The area under the curve was highest for the ZJU index (AUC = 0.742, 95% CI:0.647-0.837), followed by HSI (AUC = 0.728, 95% CI:0.631-0.825), LAPI (AUC = 0.682, CI:0.583-0.781), and VAI (AUC = 0.621, 95% CI:0.518-0.725), respectively, using the Youden method. Conclusion The ZJU index is a powerful surrogate marker for NAFLD in severely obese western females and its predictive value was better than that of other commonly used indices for predicting NAFLD. Our study is the first to suggest that the ZJU index could be a promising model for use in western as well as Chinese populations.	[Fu, Chia-Po] Taichung Vet Gen Hosp, Dept Med, Div Endocrinol & Metab, Taichung, Taiwan; [Fu, Chia-Po] Chung Shan Med Univ, Dept Med, Taichung, Taiwan; [Fu, Chia-Po] Natl Taiwan Univ, Coll Elect Engn & Comp Sci, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan; [Ali, Hira; Oczypok, Elizabeth A.; Kershaw, Erin E.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA; [Rachakonda, Vikrant P.] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [DeLany, James P.] Florida Hosp, Translat Res Inst Metab & Diabet, Orlando, FL USA	Taichung Veterans General Hospital; Chung Shan Medical University; National Taiwan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Adventist Health Services; AdventHealth	Kershaw, EE (corresponding author), Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA.	kershawee@upmc.edu	Kershaw, Erin E/G-9587-2013	Kershaw, Erin E/0000-0002-3887-4868; Fu, Chia-Po/0000-0001-5210-9444	NIH [T32 DK007052, T32 DK063922]; National institutes of Health (NIH) [T32 DK007052]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK120531, T32DK007052, T32DK063922] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following: NIH T32 DK007052 (HA) NIH T32 DK063922 (VPR).; This work was supported by grants from National institutes of Health (NIH) T32 DK007052 (HA) and NIH T32 DK063922 (VPR).	Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bedogni G, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-98; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Goodpaster BH, 1999, DIABETES, V48, P839, DOI 10.2337/diabetes.48.4.839; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Li LM, 2017, ACTA DIABETOL, V54, P905, DOI 10.1007/s00592-017-1024-8; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Rachakonda V, 2017, OBESITY, V25, P1360, DOI 10.1002/oby.21890; Rachakonda VP, 2015, OBESITY, V23, P965, DOI 10.1002/oby.20960; RATZIU V, 2005, COMP HEPATOL, V42, P12, DOI DOI 10.1186/1476-5926-4-10; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Rocha PM, 2011, J LIPIDS, V2011, DOI 10.1155/2011/154672; Sattar N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4596; Siddiqui MS, 2015, CLIN GASTROENTEROL H, V13, P1000, DOI 10.1016/j.cgh.2014.10.008; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wang JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16494	28	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0224942	10.1371/journal.pone.0224942	http://dx.doi.org/10.1371/journal.pone.0224942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770380	Green Published, gold			2022-12-26	WOS:000533892300010
J	Lee, SY; Mac Aogain, M; Fam, KD; Chia, KL; Ali, NABM; Yap, MMC; Yap, EPH; Chotirmall, SH; Lim, CL				Lee, Shuen Yee; Mac Aogain, Micheal; Fam, Kai Deng; Chia, Kar Ling; Ali, Nur A'tikah Binte Mohamed; Yap, Margaret M. C.; Yap, Eric P. H.; Chotirmall, Sanjay H.; Lim, Chin Leong			Airway microbiome composition correlates with lung function and arterial stiffness in an age-dependent manner	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PULSE-WAVE VELOCITY; CARDIOVASCULAR RISK; GUT MICROBIOTA; PRESSURE; PATHOGENESIS; INFLAMMATION; INFECTIONS; REFLECTION; UPDATE	Objective To investigate age-associated changes in airway microbiome composition and their relationships with lung function and arterial stiffness among genetically matched young and elderly pairs. Methods Twenty-four genetically linked family pairs comprised of younger (<= 40 years) and older (>= 60 years) healthy participants were recruited (Total n = 48). Lung function and arterial stiffness (carotid-femoral pulse wave velocity (PWV) and augmentation index (AIx)) were assessed. Sputum samples were collected for targeted 16S rRNA gene amplicon sequencing and correlations between microbiome composition, lung function and arterial stiffness were investigated. Results Elderly participants exhibited reductions in lung function (FEV1 (p<0.001), FVC (p< 0.001) and percentage FEV1/FVC (p = 0.003)) and a 1.3-3.9-fold increase in arterial stiffness (p< 0.001) relative to genetically related younger adults. Elderly adults had a higher relative abundance of Firmicutes (p = 0.035) and lower relative abundance of Proteobacteria (p = 0.014), including specific genera Haemophilus (p = 0.024) and Lautropia (p = 0.020) which were enriched in the younger adults. Alpha diversity was comparable between young and elderly pairs (p> 0.05) but was inversely associated with lung function (FEV1%Predicted and FVC %Predicted) in the young (p = 0.006 and p = 0.003) though not the elderly (p = 0.481 and p = 0.696). Conversely, alpha diversity was negatively associated with PWV in the elderly (p = 0.01) but not the young (p = 0.569). Specifically, phylum Firmicutes including the genus Gemella were correlated with lung function (FVC %Predicted) in the young group (p = 0.047 and p = 0.040), while Fusobacteria and Leptotrichia were associated with arterial stiffness (PWV) in the elderly (both p = 0.004). Conclusion Ageing is associated with increased Firmicutes and decreased Proteobacteria representation in the airway microbiome among a healthy Asian cohort. The diversity and composition of the airway microbiome is independently associated with lung function and arterial stiffness in the young and elderly groups respectively. This suggests differential microbial associations with these phenotypes at specific stages of life with potential prognostic implications.	[Lee, Shuen Yee; Mac Aogain, Micheal; Fam, Kai Deng; Chia, Kar Ling; Ali, Nur A'tikah Binte Mohamed; Yap, Margaret M. C.; Yap, Eric P. H.; Chotirmall, Sanjay H.; Lim, Chin Leong] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lim, CL (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.	fabianlim@ntu.edu.sg	Aogáin, Micheál Mac/M-6782-2013; Lim, Chin L/H-8687-2013; Lee, Shuen Yee/AAA-2790-2022; Chotirmall, Sanjay Haresh/K-4127-2015	Aogáin, Micheál Mac/0000-0002-1726-7700; Lim, Chin L/0000-0002-3863-0994; Lee, Shuen Yee/0000-0001-5271-5794; Chotirmall, Sanjay Haresh/0000-0003-0417-7607	Ageing Research Institute for Society and Education (ARISE), Nanyang Technological University, Singapore [ARISE/2017/6]	Ageing Research Institute for Society and Education (ARISE), Nanyang Technological University, Singapore(Nanyang Technological University)	This work received a grant award by Ageing Research Institute for Society and Education (ARISE), Nanyang Technological University, Singapore, ARISE/2017/6 (http://arise.ntu.edu.sg) to SHC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amplicon PCR Clean-up P.C.R. & Index P.C.R, 16S MET SEQ LIB PREP; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bolton CE, 2009, INT J EPIDEMIOL, V38, P867, DOI 10.1093/ije/dyn374; BUDDEN K, 2019, LANCET RESP MED; Budinger GRS, 2017, J GERONTOL A-BIOL, V72, P1492, DOI 10.1093/gerona/glx090; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Chotirmall SH, 2015, EXPERT REV RESP MED, V9, P125, DOI 10.1586/17476348.2015.1002473; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Coburn B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10241; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; El Assar M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00132; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fan XZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194729; Flight WG, 2015, J CLIN MICROBIOL, V53, P2022, DOI 10.1128/JCM.00432-15; Garcia-Nunez M, 2014, J CLIN MICROBIOL, V52, P4217, DOI 10.1128/JCM.01967-14; Gursli S, 2017, SAGE OPEN MED, V5, DOI 10.1177/2050312117697505; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hosgood HD, 2019, ENVIRON MOL MUTAGEN, V60, P617, DOI 10.1002/em.22291; Huang YJ, 2015, ANN AM THORAC SOC, V12, pS176, DOI 10.1513/AnnalsATS.201506-319AW; Jacobs DR, 2012, HYPERTENSION, V59, P219, DOI 10.1161/HYPERTENSIONAHA.111.184101; Jankowich MD, 2010, AM J HYPERTENS, V23, P614, DOI 10.1038/ajh.2010.37; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Jorth P, 2019, CELL REP, V27, P1190, DOI 10.1016/j.celrep.2019.03.086; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Leung JM, 2017, RESPIROLOGY, V22, P634, DOI 10.1111/resp.13032; Liu HY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00038; Ma WY, 2013, DIABETES CARE, V36, P1660, DOI 10.2337/dc12-1452; Mac Aogain M, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00766-2018; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mills NL, 2008, THORAX, V63, P306, DOI 10.1136/thx.2007.083493; Mitchell GF, 2005, CIRCULATION, V112, P194, DOI 10.1161/CIRCULATIONAHA.104.530675; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Murray MA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/692546; Nakagomi A, 2018, HYPERTENS RES, V41, P27, DOI 10.1038/hr.2017.81; O'Dwyer DN, 2016, J IMMUNOL, V196, P4839, DOI 10.4049/jimmunol.1600279; O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Polverino F, 2018, PULM CIRC, V8, DOI 10.1177/2045894018758528; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Qvist L, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.27023; Sharma G, 2006, CLIN INTERV AGING, V1, P253, DOI 10.2147/ciia.2006.1.3.253; Steinmann M, 2015, EUR J PEDIATR, V174, P519, DOI 10.1007/s00431-014-2423-2; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Sze MA, 2015, AM J RESP CRIT CARE, V192, P438, DOI 10.1164/rccm.201502-0223OC; Takahashi Y, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0736-9; Tuleta I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186820; Valenzano DR, 2018, F1000RESEARCH, V7, P1480, DOI [10.12688/e00630-19f1000research.15121.1, DOI 10.12688/E00630-19F1000RESEARCH.15121.1]; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; van Rooyen Y, 2016, LUNG, V194, P107, DOI 10.1007/s00408-015-9804-9; Wang Z, 2016, EUR RESPIR J, V47, P1082, DOI 10.1183/13993003.01406-2015; Zureik M, 2001, AM J RESP CRIT CARE, V164, P2181, DOI 10.1164/ajrccm.164.12.2107137; Zureik M, 2001, ARCH INTERN MED, V161, P1669, DOI 10.1001/archinte.161.13.1669	58	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225636	10.1371/journal.pone.0225636	http://dx.doi.org/10.1371/journal.pone.0225636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770392	gold, Green Published			2022-12-26	WOS:000533892300031
J	Yapuncich, GS; Kemp, AD; Griffith, DM; Gladman, JT; Ehmke, E; Boyer, DM				Yapuncich, Gabriel S.; Kemp, Addison D.; Griffith, Darbi M.; Gladman, Justin T.; Ehmke, Erin; Boyer, Doug M.			A digital collection of rare and endangered lemurs and other primates from the Duke Lemur Center	PLOS ONE			English	Article							HIGH-RESOLUTION; IMAGE; MORPHOSOURCE; TOOL	Scientific study of lemurs, a group of primates found only on Madagascar, is crucial for understanding primate evolution. Unfortunately, lemurs are among the most endangered animals in the world, so there is a strong impetus to maximize as much scientific data as possible from available physical specimens. MicroCT scanning efforts at Duke University have resulted in scans of more than 100 strepsirrhine cadavers representing 18 species from the Duke Lemur Center. An error study of the microCT scanner recovered less than 0.3% error at multiple resolution levels. Scans include specimen overviews and focused, high-resolution selections of complex anatomical regions (e.g., cranium, hands, feet). Scans have been uploaded to MorphoSource, an online digital repository for 3D data. As captive (but free ranging) individuals, these specimens have a wealth of associated information that is largely unavailable for wild populations, including detailed life history data. This digital collection maximizes the information obtained from rare and endangered animals with minimal degradation of the original specimens.	[Yapuncich, Gabriel S.; Kemp, Addison D.; Griffith, Darbi M.; Boyer, Doug M.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27706 USA; [Kemp, Addison D.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Gladman, Justin T.] Duke Univ, SMIF, Durham, NC USA; [Ehmke, Erin] Duke Univ, Duke Lemur Ctr, Durham, NC USA	Duke University; University of Texas System; University of Texas Austin; Duke University; Duke University	Yapuncich, GS (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27706 USA.	gabriel.yapuncich@duke.edu		Boyer, Douglas/0000-0002-8697-2999	National Science Foundation [NSF BCS 1540421, NSF BCS 1552848, NSF DBI 1759839, NSF DBI 1701714, NSF DBI 1661386, NSF BCS 1650734, NSF DBI 1661132, NSF SBR 9617286]; Duke University; Mount Holyoke Alumnae Association	National Science Foundation(National Science Foundation (NSF)); Duke University; Mount Holyoke Alumnae Association	This work was funded by grants from the National Science Foundation, including NSF BCS 1540421 to GSY and DMB; NSF BCS 1552848 to DMB; NSF DBI 1759839 to DMB; NSF DBI 1701714 to David Blackburn, Gavin Naylor, and Jonathan Bloch and DMB; NSF DBI 1661386 to DMB, Gregg Gunnell, Sayan Mukherjee, and Timothy McGeary; to NSF BCS 1650734 to ADK and Chris Kirk; NSF DBI 1661132 to Timothy Ryan, Kathleen Hill, and Annmarie Ward; and NSF SBR 9617286 to Liza Shapiro. This work was also funded by internal grants from Duke University to DMB and a grant from the Mount Holyoke Alumnae Association to ADK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139800; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Bornbusch SL, 2019, AM J PRIMATOL, V13; Boyer Doug M., 2016, Paleontological Society Papers, V22, P157; BUETTNER.J, 1965, SCIENCE, V147, P836, DOI 10.1126/science.147.3660.836; Burrows AM, 2019, JOVE-J VIS EXP, DOI 10.3791/58394; Cartmill M., 1974, P45; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; Copes LE, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.1; Fabre AC, 2018, AM J PHYS ANTHROPOL, V167, P602, DOI 10.1002/ajpa.23688; Gignac PM, 2016, J ANAT, V228, P889, DOI 10.1111/joa.12449; Gordon AD, 2013, AM J PHYS ANTHROPOL, V152, P2, DOI 10.1002/ajpa.22391; Gunnell GF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05648-w; Huq E, 2018, AM J PHYS ANTHROPOL, V166, P95, DOI 10.1002/ajpa.23405; HYLANDER WL, 1977, AM J PHYS ANTHROPOL, V46, P309, DOI 10.1002/ajpa.1330460212; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; Kemp AD, 2019, THESIS; KLOPFER PH, 1970, FOLIA PRIMATOL, V12, P199, DOI 10.1159/000155289; Larsen PA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0439-6; Maclean EL, 2008, ANIM BEHAV, V76, P479, DOI 10.1016/j.anbehav.2008.01.025; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Mittermeier RA, 1973, LAB PRIM NEWS, V12, P1; Mizutani R, 2012, MICRON, V43, P104, DOI 10.1016/j.micron.2011.10.002; Nishimura AC, 2017, AM J PHYS ANTHROPOL, V162, P757, DOI 10.1002/ajpa.23167; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Samson DR, 2019, ANIM COGN, V22, P697, DOI 10.1007/s10071-019-01266-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Schwitzer C., 2013, LEMURS MADAGASCAR ST; Shi JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203022; Smith TD, 2016, ANAT REC, V299, P1492, DOI 10.1002/ar.23465; TATTERSALL I, 1973, ANTHROPOL PAP AM MUS, V52, P1; Teichroeb JA, 2019, ANIM COGN, V22, P343, DOI 10.1007/s10071-019-01247-4; Yapuncich G. S., 2017, THESIS; Yapuncich GS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48651-x; Zehr SM, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.19	39	4	4	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0219411	10.1371/journal.pone.0219411	http://dx.doi.org/10.1371/journal.pone.0219411			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8RE	31770383	Green Published, Green Submitted, gold			2022-12-26	WOS:000533892300001
J	Gupta, V; Cadieux, CL; McMenamin, D; Medina-Jaszek, CA; Arif, M; Ahonkhai, O; Wielechowski, E; Taheri, M; Che, Y; Goode, T; Limberis, MP; Li, MY; Cerasoli, DM; Tretiakova, AP; Wilson, JM				Gupta, Vibhor; Cadieux, C. Linn; McMenamin, Deirdre; Medina-Jaszek, C. Angelica; Arif, Muhammad; Ahonkhai, Omua; Wielechowski, Erik; Taheri, Maryam; Che, Yan; Goode, Tamara; Limberis, Maria P.; Li, Mingyao; Cerasoli, Douglas M.; Tretiakova, Anna P.; Wilson, James M.			Adeno-associated virus-mediated expression of human butyrylcholinesterase to treat organophosphate poisoning	PLOS ONE			English	Article							POMPE DISEASE; RICH PEPTIDES; GENE-TRANSFER; ACETYLCHOLINESTERASE; THERAPY; TOXICITY; VECTORS; SAFETY; MOUSE	Rare diseases defined by genetic mutations are classic targets for gene therapy. More recently, researchers expanded the use of gene therapy in non-clinical studies to infectious diseases through the delivery of vectorized antibodies to well-defined antigens. Here, we further extend the utility of gene therapy beyond the "accepted" indications to include organophosphate poisoning. There are no approved preventives for the multi-organ damage resulting from acute or chronic exposure to organophosphates. We show that a single intramuscular injection of adeno-associated virus vector produces peak expression (similar to 0.5 mg/ml) of active human butyrylcholinesterase (hBChE) in mice serum within 3-4 weeks post-treatment. This expression is sustained for up to 140 days post-injection with no silencing. Sustained expression of hBChE provided dose-dependent protection against VX in male and female mice despite detectable antibodies to hBChE in some mice, thereby demonstrating that expression of hBChE in vivo in mouse muscle is an effective prophylactic against organophosphate poisoning.	[Gupta, Vibhor; McMenamin, Deirdre; Medina-Jaszek, C. Angelica; Arif, Muhammad; Ahonkhai, Omua; Wielechowski, Erik; Taheri, Maryam; Che, Yan; Goode, Tamara; Limberis, Maria P.; Li, Mingyao; Tretiakova, Anna P.; Wilson, James M.] Univ Penn, Dept Med, Gene Therapy Program, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cadieux, C. Linn; Cerasoli, Douglas M.] US Army Med Res Inst Chem Def, Gunpowder, MD USA; [Li, Mingyao] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Tretiakova, Anna P.] Pfizer Inc, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pfizer	Wilson, JM (corresponding author), Univ Penn, Dept Med, Gene Therapy Program, Perelman Sch Med, Philadelphia, PA 19104 USA.	wilsonjm@upenn.edu	Wilson, James/F-9220-2011	Wilson, James/0000-0002-9630-3131	Defense Threat Reduction Agency [HDTRA1-15-C-0023]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by Grant HDTRA1-15-C-0023 from the Defense Threat Reduction Agency to University of Pennsylvania; PI: Dr. James M. Wilson.	Bird Steven B, 2010, Front Biosci (Schol Ed), V2, P209; Chilukuri N, 2008, CHEM-BIOL INTERACT, V175, P327, DOI 10.1016/j.cbi.2008.04.009; Chilukuri N, 2009, MOL PHARMACOL, V76, P612, DOI 10.1124/mol.109.055665; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Dunn EN, 2018, TOXICOL MECH METHOD, V28, P563, DOI 10.1080/15376516.2018.1476637; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Gao GP, 2006, MOL THER, V13, P77, DOI 10.1016/j.ymthe.2005.08.017; Geyer BC, 2010, P NATL ACAD SCI USA, V107, P20251, DOI 10.1073/pnas.1009021107; Greig JA, 2016, VACCINE, V34, P6323, DOI 10.1016/j.vaccine.2016.10.053; Greig JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112268; Gupta RC, 2009, HANDBOOK OF TOXICOLOGY OF CHEMICAL WARFARE AGENTS, P1; Han SO, 2019, MOL THER-METH CLIN D, V13, P431, DOI 10.1016/j.omtm.2019.04.005; Han SO, 2017, MOL THER-METH CLIN D, V4, P126, DOI 10.1016/j.omtm.2016.12.010; Hrabovska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012892; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P13603, DOI 10.1073/pnas.0702756104; John H, 2018, FORENSIC TOXICOL, V36, P61, DOI 10.1007/s11419-017-0376-7; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Lenz DE, 2007, TOXICOLOGY, V233, P31, DOI 10.1016/j.tox.2006.11.066; Li B, 2008, J PHARMACOL EXP THER, V324, P1146, DOI 10.1124/jpet.107.133330; Li H, 2008, BIOCHEM J, V411, P425, DOI 10.1042/BJ20071551; Lockridge O, 2016, CHEM RES TOXICOL, V29, P1381, DOI 10.1021/acs.chemrestox.6b00228; Murthy V, 2014, VACCINE, V32, P4155, DOI 10.1016/j.vaccine.2014.05.067; Nachon F, 2002, EUR J BIOCHEM, V269, P630, DOI 10.1046/j.0014-2956.2001.02692.x; Nachon F, 2013, CHEM-BIOL INTERACT, V206, P536, DOI 10.1016/j.cbi.2013.06.012; Naughton SX, 2018, TOXICOLOGY, V408, P101, DOI 10.1016/j.tox.2018.08.011; Onder S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00117; Parikh K, 2011, J PHARMACOL EXP THER, V337, P92, DOI 10.1124/jpet.110.175646; Peng H, 2016, CHEM-BIOL INTERACT, V259, P63, DOI 10.1016/j.cbi.2016.02.007; Salmon F, 2014, EXPERT REV CLIN PHAR, V7, P53, DOI 10.1586/17512433.2014.852065; Solberg Yoram, 1998, Harefuah, V135, P268; Sun B, 2007, AM J HUM GENET, V81, P1042, DOI 10.1086/522236	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225188	10.1371/journal.pone.0225188	http://dx.doi.org/10.1371/journal.pone.0225188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765413	gold, Green Published			2022-12-26	WOS:000533891000017
J	Jorde, R; Stunes, AK; Kubiak, J; Grimnes, G; Thorsby, PM; Syversen, U				Jorde, Rolf; Stunes, Astrid Kamilla; Kubiak, Julia; Grimnes, Guri; Thorsby, Per Medboe; Syversen, Unni			Smoking and other determinants of bone turnover	PLOS ONE			English	Article							INSULIN-RESISTANCE; DIABETES-MELLITUS; RENAL-FUNCTION; SERUM LEPTIN; OSTEOPROTEGERIN; SCLEROSTIN; MARKERS; WOMEN; AGE; OSTEOBLASTS	The balance between bone resorption and formation may be assessed by measurement of bone turnover markers (BTMs), like carboxyl-terminal cross-linked telopeptide of type 1 collagen (CTX-1) and procollagen type 1 amino-terminal propeptide (P1NP). Smoking has been shown to influence bone turnover and to reduce bone mass density (BMD), the exact mechanism for this is, however, not settled. In this post-hoc study including 406 subjects (mean age 51.9 years), we aimed to study the impact of smoking on bone turnover. Moreover, we wanted to assess the inter-correlation between substances regulating bone metabolism and BTMs, as well as tracking over time. BMD measurements and serum analyses of CTX-1, P1NP, osteoprotegerin (OPG), receptor activator of nuclear factor.B ligand (RANKL), Dickkopf-1 (DKK1), sclerostin, tumor necrosis factor-a (TNF-a), and leptin were performed. Repeated serum measurements were made in 195 subjects after four months. Adjustments were made for sex, age, body mass index (BMI), smoking status, insulin resistance, serum calcium, parathyroid hormone, 25-hydroxyvitamin D and creatinine. Smokers had higher levels of DKK1 and OPG, and lower levels of RANKL, as reflected in lower BTMs and BMD compared to non-smokers. There were strong and predominantly positive intercorrelations between BTMs and the other substances, and there was a high degree of tracking with Spearman's rho from 0.72 to 0.92 (P < 0.001) between measurements four months apart. In conclusion, smokers exhibited higher levels of DKK1 and OPG and a lower bone turnover than did non-smokers. The strong inter-correlations between the serum parameters illustrate the coupling between bone resorption and formation and crosstalk between cells.	[Jorde, Rolf; Kubiak, Julia; Grimnes, Guri] Arctic Univ Norway, Dept Clin Med, UiT, Tromso Endocrine Res Grp, Tromso, Norway; [Jorde, Rolf; Grimnes, Guri] Univ Hosp North Norway, Div Internal Med, Tromso, Norway; [Stunes, Astrid Kamilla; Syversen, Unni] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Clin & Mol Med, Trondheim, Norway; [Stunes, Astrid Kamilla] Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Med, Trondheim, Norway; [Thorsby, Per Medboe] Oslo Univ Hosp, Aker Hosp, Dept Med Biochem, Hormone Lab, Oslo, Norway; [Syversen, Unni] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Endocrinol, Clin Med, Trondheim, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; Norwegian University of Science & Technology (NTNU)	Jorde, R (corresponding author), Arctic Univ Norway, Dept Clin Med, UiT, Tromso Endocrine Res Grp, Tromso, Norway.; Jorde, R (corresponding author), Univ Hosp North Norway, Div Internal Med, Tromso, Norway.	rolf.jorde@unn.no	Stunes, Astrid Kamilla/B-9901-2008; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Thorsby, Per Medboe/A-1268-2017	Stunes, Astrid Kamilla/0000-0003-1074-5199; Thorsby, Per Medboe/0000-0002-9615-1035	North Norway Regional Health Authorities [SFP1277-16]; UiT The Arctic University of Norway; Central Norway Regional Health Authority; Norwegian University of Science and Technology	North Norway Regional Health Authorities; UiT The Arctic University of Norway; Central Norway Regional Health Authority; Norwegian University of Science and Technology	The study was supported by grants from the North Norway Regional Health Authorities (https://helse-nord.no) (RJ) grant number SFP1277-16; UiT The Arctic University of Norway (https://uit.no) (RJ) grant number na; and the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (https://helse-midt.no) (US) grant number na. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bashaireh AM, 2018, J OSTEOPOROS, V2018, DOI 10.1155/2018/1206235; Altinova AE, 2011, SCAND J CLIN LAB INV, V71, P340, DOI 10.3109/00365513.2011.570868; Amrein K, 2012, J CLIN ENDOCR METAB, V97, P148, DOI 10.1210/jc.2011-2152; Bauer S, 2013, EPILEPSY RES, V106, P417, DOI 10.1016/j.eplepsyres.2013.06.020; Baumgartner RN, 1999, OBES RES, V7, P141, DOI 10.1002/j.1550-8528.1999.tb00695.x; Bjarnason NH, 2002, BONE, V30, P307, DOI 10.1016/S8756-3282(01)00662-7; Caruso RV, 2014, INT J ENV RES PUB HE, V11, P202, DOI 10.3390/ijerph110100202; Chang MC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124071; Compston J, 2018, J INTERN MED, V283, P140, DOI 10.1111/joim.12725; Degens H, 2015, AM J RESP CRIT CARE, V191, P620, DOI 10.1164/rccm.201410-1830PP; Delgado-Calle J, 2017, BONE, V96, P29, DOI 10.1016/j.bone.2016.10.007; Duan P, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/8724869; Eastell R, 2018, EUR J ENDOCRINOL, V178, pR19, DOI 10.1530/EJE-17-0585; Farr JN, 2014, J BONE MINER RES, V29, P787, DOI 10.1002/jbmr.2106; Fernandes TAP, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/9021314; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fujiyoshi Akira, 2016, Bone Rep, V5, P104; Ganji V, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-3; Goltzman D, 2018, HISTOCHEM CELL BIOL, V149, P305, DOI 10.1007/s00418-018-1648-y; Gruszfeld D, 2016, CHILD OBES, V12, P179, DOI 10.1089/chi.2015.0245; Halimi JM, 2000, KIDNEY INT, V58, P1285, DOI 10.1046/j.1523-1755.2000.00284.x; Hipmair G, 2010, NEUROENDOCRINOL LETT, V31, P155; Holloway-Kew KL, 2019, CALCIFIED TISSUE INT, V104, P599, DOI 10.1007/s00223-019-00527-y; Ibrahim Khadiga S, 2016, Open Access Maced J Med Sci, V4, P302, DOI 10.3889/oamjms.2016.042; Ikeda Kyoji, 2014, J Bone Metab, V21, P163, DOI 10.11005/jbm.2014.21.3.163; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Jorde R, 2005, EUR J ENDOCRINOL, V152, P39, DOI 10.1530/eje.1.01816; Jorde R, 2019, BONE, V124, P7, DOI 10.1016/j.bone.2019.04.002; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kalkwarf HJ, 2010, J CLIN ENDOCR METAB, V95, P1690, DOI 10.1210/jc.2009-2319; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Khan TS, 2015, J OSTEOPOROS, V2015, DOI 10.1155/2015/174186; Kiechl S, 2013, NAT MED, V19, P358, DOI 10.1038/nm.3084; Komori T, 2016, HORM METAB RES, V48, P755, DOI 10.1055/s-0042-110571; Kotlinska-Hasiec E, 2017, ANN AGR ENV MED, V24, P181, DOI [10.5604/12321966.1232762, 10.5604/12321966.1232767]; Kubiak J, 2018, ENDOCR CONNECT, V7, P840, DOI 10.1530/EC-18-0144; Li LJ, 2019, METABOLISM, V91, P30, DOI 10.1016/j.metabol.2018.11.003; Martin TJ, 2015, REV ENDOCR METAB DIS, V16, P131, DOI 10.1007/s11154-014-9308-6; Miyazaki Y, 2003, INT J OBESITY, V27, P88, DOI 10.1038/sj.ijo.0802187; Mohamed HG, 2016, INT J DENT, V2016, DOI 10.1155/2016/6296854; Redmond J, 2016, J CLIN ENDOCR METAB, V101, P3222, DOI 10.1210/jc.2016-1183; Register TC, 2014, J CLIN ENDOCR METAB, V99, P315, DOI 10.1210/jc.2013-3168; Reseland JE, 2005, PROSTAG LEUKOTR ESS, V73, P43, DOI 10.1016/j.plefa.2005.04.006; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; Rodriguez J, 2018, J TOXICOL-US, V2018, DOI 10.1155/2018/4854152; Secchiero P, 2006, AM J PATHOL, V169, P2236, DOI 10.2353/ajpath.2006.060398; Shao JJ, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/573071; Shinkov AD, 2014, CLIN MED INSIGHTS-EN, V7, P19, DOI [10.4137/CMEDED.S15466, 10.4137/CMED.S15466]; Steptoe A, 2006, INT J PSYCHOPHYSIOL, V59, P228, DOI 10.1016/j.ijpsycho.2005.10.011; Tanaka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059402; Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Viljakainen H, 2014, J CLIN ENDOCR METAB, V99, P2155, DOI 10.1210/jc.2013-3097; Voronov I, 2008, BIOCHEM PHARMACOL, V75, P2034, DOI 10.1016/j.bcp.2008.02.025; Yoon V, 2012, OSTEOPOROSIS INT, V23, P2081, DOI 10.1007/s00198-012-1940-y; Yun Chawon, 2017, Bone Rep, V6, P51, DOI 10.1016/j.bonr.2017.02.003; Zhao BH, 2017, CURR OSTEOPOROS REP, V15, P126, DOI 10.1007/s11914-017-0358-z; Zuo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054615	58	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225539	10.1371/journal.pone.0225539	http://dx.doi.org/10.1371/journal.pone.0225539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765401	Green Published, gold			2022-12-26	WOS:000533891000034
J	Reckman, GAR; Navis, GJ; Krijnen, WP; Vonk, RJ; Jager-Wittenaar, H; van der Schans, CP				Reckman, Gerlof A. R.; Navis, Gerjan J.; Krijnen, Wim P.; Vonk, Roel J.; Jager-Wittenaar, Harriet; van der Schans, Cees P.			Aerobic exercise increases post-exercise exogenous protein oxidation in healthy young males	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; PHYSICAL-ACTIVITY; AMINO-ACID; MUSCLE; METABOLISM; INTENSITY; OLDER; PRESCRIPTION; MEN	The capacity to utilize ingested protein for optimal support of protein synthesis and lean body mass is described within the paradigm of anabolic competence. Protein synthesis can be stimulated by physical exercise, however, it is not known if physical exercise affects post-exercise protein oxidation. Characterization of the driving forces behind protein oxidation, such as exercise, can contribute to improved understanding of whole body protein metabolism. The purpose of this study is to determine the effect of two levels of aerobic exercise intensity on immediate post-exercise exogenous protein oxidation. Sixteen healthy males with a mean (SD) age of 24 (4) years participated. The subjects' VO2-max was estimated with the Astrand cycling test. Habitual dietary intake was assessed with a three-day food diary. Exogenous protein oxidation was measured by isotope ratio mass spectrometry. These measurements were initiated after the ingestion of a 30 g C-13-milk protein test drink that was followed by 330 minutes breath sample collection. On three different days with at least one week in between, exogenous protein oxidation was measured: 1) during rest, 2) after 15 minutes of aerobic exercise at 30% of VO2-max (moderate intensity), and 3) after 15 minutes of aerobic exercise at 60% of VO2-max (vigorous intensity). After vigorous intensity aerobic exercise, 31.8%+/- 8.0 of the 30 g C-13-milk protein was oxidized compared to 26.2%+/- 7.1 during resting condition (p = 0.012), and 25.4%+/- 7.6 after moderate intensity aerobic exercise compared to resting (p = 0.711). In conclusion, exogenous protein oxidation is increased after vigorous intensity aerobic exercise which could be the result of an increased protein turnover rate.	[Reckman, Gerlof A. R.; Navis, Gerjan J.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Reckman, Gerlof A. R.; Krijnen, Wim P.; Jager-Wittenaar, Harriet; van der Schans, Cees P.] Hanze Univ Appl Sci, Ctr Expertise Hlth Ageing, Res Grp Hlth Ageing Allied Hlth Care & Nursing, Groningen, Netherlands; [Vonk, Roel J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Jager-Wittenaar, Harriet] Univ Groningen, Univ Med Ctr Groningen, Dept Maxillofacial Surg, Groningen, Netherlands; [van der Schans, Cees P.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil, Groningen, Netherlands; [van der Schans, Cees P.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Reckman, GAR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands.; Reckman, GAR (corresponding author), Hanze Univ Appl Sci, Ctr Expertise Hlth Ageing, Res Grp Hlth Ageing Allied Hlth Care & Nursing, Groningen, Netherlands.	g.a.r.reckman@pl.hanze.nl		van der Schans, Cees P/0000-0003-4728-4082				[Anonymous], 2016, J BIOMED SCI ENG, DOI DOI 10.4236/JBISE.2016.93012; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; [Anonymous], 2017, ACSMS GUIDELINES EXE; Arts FJP, 1994, INT J SPORTS MED; Astrand PO., 1986, TXB WORK PHYSL, P391; Astrand PO, 1954, J APPL PHYSL; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Biolo G., 2012, Nutrition in intensive care medicine: beyond physiology, P12; Broer S, 2017, BIOCHEM J, V474, P1935, DOI 10.1042/BCJ20160822; Carraro F, 2017, AM J PHYSL METAB, V259, pE470; Cederholm T, 2017, CLIN NUTR, V36, P49, DOI 10.1016/j.clnu.2016.09.004; Coyle EF, 2000, AM J CLIN NUTR, V72, p512S, DOI 10.1093/ajcn/72.2.512S; Di Donato DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1025, DOI 10.1152/ajpendo.00487.2013; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Ebeling P, 2001, DIABETES OBES METAB, V3, P113, DOI 10.1046/j.1463-1326.2001.00122.x; Evenepoel P, 1998, J NUTR, V128, P1716, DOI 10.1093/jn/128.10.1716; Fox J., 2019, R COMPANION APPL REG, V.; GHOOS YF, 1993, GASTROENTEROLOGY, V104, P1640, DOI 10.1016/0016-5085(93)90640-X; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Grazzi G, 1999, MED SCI SPORT EXER, V31, P1478, DOI 10.1097/00005768-199910000-00019; Harber MP, 2012, J APPL PHYSIOL, V113, P1495, DOI 10.1152/japplphysiol.00786.2012; Harber MP, 2010, AM J PHYSIOL-REG I, V299, pR1254, DOI 10.1152/ajpregu.00348.2010; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; LEFEBVRE P, 1975, DIABETES, V24, P185, DOI 10.2337/diabetes.24.2.185; Lindner MC, 1991, NUTR BIOCH METABOLIS, V2nd, P87; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; Millward DJ, 1982, FED P; Moore DR, 2009, AM J CLIN NUTR, V89, P161, DOI 10.3945/ajcn.2008.26401; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Reckman GAR, 2019, NUTRITION; Reckman GAR, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010115; Rennie MJ, 2006, J NUTR, V136, p264S, DOI 10.1093/jn/136.1.264S; RIVM, 2013, NEVO ONL VERS 2013 4; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Sanaka M, 2006, EUR J CLIN INVEST, V36, P574, DOI 10.1111/j.1365-2362.2006.01674.x; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Satterthwaite FE, 1946, BIOMETRICS B; Shad BJ, 2016, MATURITAS, V93, P78, DOI 10.1016/j.maturitas.2016.05.016; Sheffield-Moore M, 2004, AM J PHYSIOL-ENDOC M, V287, pE513, DOI 10.1152/ajpendo.00334.2003; Smiles WJ, 2016, J EXP BIOL, V219, P214, DOI 10.1242/jeb.125104; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Walsh PJ, 1995, NITROGEN METABOLISM; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0591-0; Weisberg S, 2014, APPL LINEAR REGRESSI, V4th; WELLE S, 1990, AM J PHYSIOL, V258, pE990, DOI 10.1152/ajpendo.1990.258.6.E990; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wilkinson DJ, 2013, J PHYSIOL-LONDON, V591, P2911, DOI 10.1113/jphysiol.2013.253203; Wu GY, 2016, FOOD FUNCT, V7, P1251, DOI 10.1039/c5fo01530h	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225803	10.1371/journal.pone.0225803	http://dx.doi.org/10.1371/journal.pone.0225803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765432	Green Published, gold			2022-12-26	WOS:000533891000048
J	Abbas, M; Matta, J; Le, T; Bensmail, H; Obafemi-Ajayi, T; Honavar, V; EL-Manzalawy, Y				Abbas, Mostafa; Matta, John; Thanh Le; Bensmail, Halima; Obafemi-Ajayi, Tayo; Honavar, Vasant; EL-Manzalawy, Yasser			Biomarker discovery in inflammatory bowel diseases using network-based feature selection	PLOS ONE			English	Article							HIGH-DIMENSIONAL COVARIANCE; MICROBIOME; ACCURACY	Reliable identification of Inflammatory biomarkers from metagenomics data is a promising direction for developing non-invasive, cost-effective, and rapid clinical tests for early diagnosis of IBD. We present an integrative approach to Network-Based Biomarker Discovery (NBBD) which integrates network analyses methods for prioritizing potential biomarkers and machine learning techniques for assessing the discriminative power of the prioritized biomarkers. Using a large dataset of new-onset pediatric IBD metagenomics biopsy samples, we compare the performance of Random Forest (RF) classifiers trained on features selected using a representative set of traditional feature selection methods against NBBD framework, configured using five different tools for inferring networks from metagenomics data, and nine different methods for prioritizing biomarkers as well as a hybrid approach combining best traditional and NBBD based feature selection. We also examine how the performance of the predictive models for IBD diagnosis varies as a function of the size of the data used for biomarker identification. Our results show that (i) NBBD is competitive with some of the state-of-the-art feature selection methods including Random Forest Feature Importance (RFFI) scores; and (ii) NBBD is especially effective in reliably identifying IBD biomarkers when the number of data samples available for biomarker discovery is small.	[Abbas, Mostafa; Bensmail, Halima] Hamad Bin Khalifa Univ, Qatar Comp Res Inst, Doha, Qatar; [Matta, John] Southern Illinois Univ Edwardsville, Dept Comp Sci, Edwardsville, IL USA; [Thanh Le; Obafemi-Ajayi, Tayo] Missouri State Univ, Engn Program, Springfield, MO 65897 USA; [Honavar, Vasant; EL-Manzalawy, Yasser] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [EL-Manzalawy, Yasser] Geisinger Hlth Syst, Danville, PA 17822 USA	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; Southern Illinois University System; Southern Illinois University Edwardsville; Missouri State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Geisinger Health System	Obafemi-Ajayi, T (corresponding author), Missouri State Univ, Engn Program, Springfield, MO 65897 USA.; EL-Manzalawy, Y (corresponding author), Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA.; EL-Manzalawy, Y (corresponding author), Geisinger Hlth Syst, Danville, PA 17822 USA.	TayoObafemiAjayi@missouristate.edu; yelmanzalawi@geeisinger.edu	El-Manzalawy, Yasser/ABE-3489-2020; Bensmail, Halima/AAT-7858-2020; Honavar, Vasant/K-9835-2015	El-Manzalawy, Yasser/0000-0002-4681-7994; Honavar, Vasant/0000-0001-5399-3489	National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000127, TR002014]; National Science Foundation [1518732, 1640834, 1636795]; Penn State Center for Big Data Analytics and Discovery Informatics; Penn State Institute for Cyberscience; Edward Frymoyer Endowed Professorship in Information Sciences and Technology at Penn State; Pratiksha Trust, through the Sudha Murty Distinguished Visiting Chair in Neurocomputing and Data Sciences at the Indian Institute of Science; Center for Big Data Analytics and Discovery Informatics at the Pennsylvania State University; Penn State Clinical and Translational Sciences Institute; Biomedical Data Sciences from the National Library of Medicine, National Institutes of Health [T32-LM012415]; NATIONAL LIBRARY OF MEDICINE [T32LM012415] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Science Foundation(National Science Foundation (NSF)); Penn State Center for Big Data Analytics and Discovery Informatics; Penn State Institute for Cyberscience; Edward Frymoyer Endowed Professorship in Information Sciences and Technology at Penn State; Pratiksha Trust, through the Sudha Murty Distinguished Visiting Chair in Neurocomputing and Data Sciences at the Indian Institute of Science; Center for Big Data Analytics and Discovery Informatics at the Pennsylvania State University; Penn State Clinical and Translational Sciences Institute; Biomedical Data Sciences from the National Library of Medicine, National Institutes of Health; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	V.H. was supported in part by the National Center for Advancing Translational Sciences, National Institutes of Health, through the Grant UL1 TR000127 and TR002014 in support of the Penn State Clinical and Translational Sciences Institute, by the National Science Foundation, through the grants 1518732, 1640834, and 1636795; the Penn State Center for Big Data Analytics and Discovery Informatics, the Penn State Institute for Cyberscience, the Edward Frymoyer Endowed Professorship in Information Sciences and Technology at Penn State, and the Pratiksha Trust, through the Sudha Murty Distinguished Visiting Chair in Neurocomputing and Data Sciences at the Indian Institute of Science. Y.E. was supported in part by the Center for Big Data Analytics and Discovery Informatics at the Pennsylvania State University and the Penn State Clinical and Translational Sciences Institute. The work of T.L was supported in part by the institutional match on the Predoctoral Training Grant T32-LM012415 in Biomedical Data Sciences from the National Library of Medicine, National Institutes of Health. The publication costs were covered by Qatar Computing Research Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas MM, 2017, ACM-BCB' 2017: PROCEEDINGS OF THE 8TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY,AND HEALTH INFORMATICS, P313, DOI 10.1145/3107411.3107472; Abbas Z, 2018, INT ARAB CONF INF TE, P173; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Avella-Medina M, 2018, BIOMETRIKA, V105, P271, DOI 10.1093/biomet/asy011; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barefoot C., 1987, J COMBIN MATH COMBIN, V1, P13; Bickel PJ, 2008, ANN STAT, V36, P199, DOI 10.1214/009053607000000758; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cozzens M., 1995, P 7 INT C THEOR APPL, P1111; Debelius JW, 2016, J MICROBIOL BIOL EDU, V17, P46, DOI 10.1128/jmbe.v17i1.1034; Delday M, 2019, INFLAMM BOWEL DIS, V25, P85, DOI 10.1093/ibd/izy281; Ditzler G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0793-8; Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8; El-Manzalawy Y., 2018, BIORXIV; El-Manzalawy Y, 2018, 2018 IEEE CONFERENCE ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (CIBCB), P67; EL-Manzalawy Y, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0388-0; Ercal G., 2014, ARXIV14092172; Fan JQ, 2008, J ECONOMETRICS, V147, P186, DOI 10.1016/j.jeconom.2008.09.017; Faust K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01200; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Flemer B, 2018, GUT, V67, P1454, DOI 10.1136/gutjnl-2017-314814; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Goenawan IH, 2016, BIOINFORMATICS, V32, P2713, DOI 10.1093/bioinformatics/btw187; Goldstein M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152173; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Hiippala K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01706; Holtman GA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2126; Hung-Hsuan Chen, 2013, 2013 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), P442; Jeh G., 2002, P 8 ACM SIGKDD INT C, P538; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Konikoff T, 2016, TRENDS MICROBIOL, V24, P523, DOI 10.1016/j.tim.2016.02.015; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Koutra D., 2013, P 2013 SIAM INT C DA, P162, DOI DOI 10.1137/1.9781611972832.18; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Kyrpides NC, 2016, TRENDS MICROBIOL, V24, P425, DOI 10.1016/j.tim.2016.02.011; Lavelle A, 2015, GUT, V64, P1553, DOI 10.1136/gutjnl-2014-307873; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; MANDAL S, 2015, MICROB ECOL HEALTH D, V26, DOI DOI 10.3402/MEHD.V26.27663; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Matta J., 2017, INT C COMPLEX NETWOR, P3, DOI [10.1007/978-3-319-72150-7_1, DOI 10.1007/978-3-319-72150-7_1]; Matta J, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8081307; Matta J, 2017, RAIRO-OPER RES, V51, P1055, DOI 10.1051/ro/2017008; Matta J, 2016, IEEE DATA MINING, P320, DOI [10.1109/ICDM.2016.85, 10.1109/ICDM.2016.0043]; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Menon R, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005939; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027076; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Pascal V, 2017, GUT, V66, P813, DOI 10.1136/gutjnl-2016-313235; Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ravikumar P, 2011, ELECTRON J STAT, V5, P935, DOI 10.1214/11-EJS631; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruemmele FM, 1998, GASTROENTEROLOGY, V115, P822, DOI 10.1016/S0016-5085(98)70252-5; Schmidt C, 2005, Minerva Gastroenterol Dietol, V51, P127; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shanahan F, 2014, GASTROENTEROLOGY, V146, P1554, DOI 10.1053/j.gastro.2014.01.050; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Sun YW, 2018, INT CONF DAT MIN WOR, P1006, DOI 10.1109/ICDMW.2018.00145; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Tye H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06125-0; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; van Dam S, 2018, BRIEF BIOINFORM, V19, P575, DOI 10.1093/bib/bbw139; Viennois E, 2015, INFLAMM BOWEL DIS, V21, P2467, DOI 10.1097/MIB.0000000000000444; Waldor MK, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002050; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; Wang XF, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-18, 10.1186/1471-2105-13-113]; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235	78	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225382	10.1371/journal.pone.0225382	http://dx.doi.org/10.1371/journal.pone.0225382			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756219	Green Published, gold, Green Submitted			2022-12-26	WOS:000533889300021
J	Figueiredo, MGOP; Takita, SY; Douradol, BMR; Mendes, HD; Terakado, EO; Nunes, HRD; da Fonseca, CRB				Otsuka Padovan Figueiredo, Marina Guim; Takita, Stefanie Yaemi; Ramos Douradol, Bianca Maria; Mendes, Helderjan de Souza; Terakado, Erick Olsen; de Carvalho Nunes, Helio Rubens; Branco da Fonseca, Catia Regina			Periodontal disease: Repercussions in pregnant woman and newborn health-A cohort study	PLOS ONE			English	Article							ORAL-HEALTH; DENTAL-CARE; OUTCOMES	The periodontal disease during pregnancy triggers an exacerbated immune response with high local and systemic concentrations of inflammatory markers. Objective To investigate the repercussion of periodontal disease (PD) in the pregnant woman health and the complications during pregnancy and delivery, as well as negative outcomes for the newborn (as infections, prematurity, low birth weight and fetal growth restriction). Method Retrospective cohort study, based on medical records of 142 pregnant women assisted at a prenatal service of usual risk between 2012-2014, with a dental evaluation for PD. Maternal variables, along with labor and newborn variables, were analyzed. The newborns were stratified into two groups: offspring of mothers with PD (subdivided into Severe Periodontal Disease-SPD) and offspring of mothers without PD. Each outcome was adjusted by a multiple logistic regression model, with significance for p-value < 0.05, considering all potential confounding factors. Results Among women diagnosed with SPD, the odds ratio for vulvovaginitis was 3.45 times greater (OR = 3.45, p-value = 0.050) and 5.59 times higher for premature rupture of membranes (OR = 5.59; p-value = 0.017). For neonates, the chance of fetal growth restriction was 11.53 times higher for pregnant women with SPD (OR = 11.53, p = 0.041). Conclusion The periodontal disease increased the chance of neonatal and maternal negative outcomes, being the fetal growth restriction, vulvovaginitis and premature rupture of the membrane (PROM) the main results driven by the presence of Severe Periodontal Disease.	[Otsuka Padovan Figueiredo, Marina Guim; Takita, Stefanie Yaemi; Ramos Douradol, Bianca Maria; de Carvalho Nunes, Helio Rubens; Branco da Fonseca, Catia Regina] Sao Paulo State Univ UNESP, Botucatu Med Sch, Pediat Dept, Botucatu, SP, Brazil; [Mendes, Helderjan de Souza] Botucatu Clin Hosp, Botucatu, SP, Brazil; [Terakado, Erick Olsen] Paulista Univ Nip, Psychol Dept, Sao Paulo, SP, Brazil	Universidade Estadual Paulista	da Fonseca, CRB (corresponding author), Sao Paulo State Univ UNESP, Botucatu Med Sch, Pediat Dept, Botucatu, SP, Brazil.	catia.fonseca@unesp.br	Fonseca, Catia Regina Branco da/AAA-5931-2022	Fonseca, Catia Regina Branco da/0000-0001-7067-3209; Takita, Stefanie Yaemi/0000-0003-1387-4631	FAPESP Sao Paulo Research Foundation [2015/23304-0, 2015/23313-0, 2013/12053-1]	FAPESP Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP Sao Paulo Research Foundation grants 2015/23304-0, 2015/23313-0, and 2013/12053-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Habashneh R, 2005, J CLIN PERIODONTOL, V32, P815, DOI 10.1111/j.1600-051X.2005.00739.x; Ananth CV, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0623-2; [Anonymous], 2012, REV BRAS ENFERM, V62, P387, DOI [10.1590/s0034-71672009000300009, DOI 10.1590/S0034-71672009000300009]; Baldani Márcia Helena, 2010, Rev. bras. epidemiol., V13, P150, DOI 10.1590/S1415-790X2010000100014; Beune IM, 2018, J PEDIATR-US, V196, P71, DOI 10.1016/j.jpeds.2017.12.059; Boggess KA, 2010, J AM DENT ASSOC, V141, P553, DOI 10.14219/jada.archive.2010.0228; Brasil. Ministerio da Saude, 2009, PESQ NAC DEM SAUD CR, P151; Chanomethaporn A, 2019, J PERIODONTOL, V90, P381, DOI 10.1002/JPER.18-0174; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Fisher L, 1993, BIOSTATISTICS METHOD; George A, 2013, HEALTH PROMOT J AUST, V24, P178, DOI 10.1071/HE13040; Gonzalez-Jaranay M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178234; Gupta S, 2018, J NEPAL MED ASSOC, V56, P565, DOI 10.31729/jnma.3513; Keirse MJNC, 2010, J PERINAT MED, V38, P3, DOI [10.1515/JPM.2010.007, 10.1515/jpm.2010.007]; Khan Najia Sajjad, 2016, J Ayub Med Coll Abbottabad, V28, P120; Laine MA, 2002, ACTA ODONTOL SCAND, V60, P257, DOI 10.1080/00016350260248210; Louro P M, 2001, J Pediatr (Rio J), V77, P23; Mendes HS, 2014, THESIS; Nascimento LFC, 1997, 5 C BRAS SAUD COL GU, P271; Nunes RD, 2018, ARQ CATARIN MED, V47, P121; Offenbacher S, 1998, Ann Periodontol, V3, P233, DOI 10.1902/annals.1998.3.1.233; Offenbacher S, 2010, J CLIN PERIODONTOL, V37, P324, DOI 10.1111/j.1600-051X.2010.01543.x; Passini R, 2007, REV BRAS GINECOL OBS, V29, P370, DOI 10.1590/S0100-72032007000700008; Schwendicke F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129060; Sharif S, 2016, MALAYS J MED SCI, V23, P63; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Soucy-Giguere L, 2016, J OBSTET GYNAECOL CA, V38, P346, DOI 10.1016/j.jogc.2016.02.012; SOUSA Luciana Luz Araújo de, 2016, RGO, Rev. Gaúch. Odontol., V64, P154, DOI 10.1590/1981-863720160002000053036; Teshome A, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.215.8727; Tettamanti L, 2017, Oral Implantol (Rome), V10, P112, DOI 10.11138/orl/2017.10.2.112; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Xiong X, 2006, BJOG-INT J OBSTET GY, V113, P135, DOI 10.1111/j.1471-0528.2005.00827.x	33	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225036	10.1371/journal.pone.0225036	http://dx.doi.org/10.1371/journal.pone.0225036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756178	gold, Green Submitted, Green Published			2022-12-26	WOS:000533889300007
J	Kim, RJY; Benic, GI; Park, JM				Kim, Ryan Jin-Young; Benic, Goran I.; Park, Ji-Man			Trueness of digital intraoral impression in reproducing multiple implant position	PLOS ONE			English	Article							ACCURACY; TECHNOLOGY	The aim of this study was to evaluate the trueness of 5 intraoral scanners (IOSs) for digital impression of simulated implant scan bodies in a partially edentulous model. A 3D printed partially edentulous mandible model made of Co-Cr with a total of 6 bilaterally positioned cylinders in the canine, second premolar, and second molar area served as the study model. Digital scans of the model were made with a reference scanner (steroSCAN neo) and 5 IOSs (CEREC Omnicam, CS3600, i500, iTero Element, and TRIOS 3) (n = 10). For each IOS's dataset, the XYZ coordinates of the cylinders were obtained from the reference point and the deviations from the reference scanner were calculated using a 3D reverse engineering program (Rapidform). The trueness values were analyzed by Kruskal-Wallis test and Mann-Whitney post hoc test. Direction and amount of deviation differed among cylinder position and among IOSs. Regardless of the IOS type, the cylinders positioned on the left second molar, nearest to the scanning start point, showed the smallest deviation. The deviation generally increased further away from scanning start point towards the right second molar. TRIOS 3 and i500 outperformed the other IOSs for partially edentulous digital impression. The accuracy of the CEREC Omnicam, CS3600, and iTero Element were similar on the left side, but they showed more deviations on the right side of the arch when compared to the other IOSs. The accuracy of IOS is still an area that needs to be improved.	[Kim, Ryan Jin-Young] Seoul Natl Univ, Dent Res Inst, Sch Dent, Seoul, South Korea; [Benic, Goran I.] Univ Zurich, Ctr Dent Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Zurich, Switzerland; [Park, Ji-Man] Yonsei Univ, Dept Prosthodont, Coll Dent, Seoul, South Korea	Seoul National University (SNU); University of Zurich; Yonsei University; Yonsei University Health System	Park, JM (corresponding author), Yonsei Univ, Dept Prosthodont, Coll Dent, Seoul, South Korea.	jimarn@yuhs.ac	Park, Ji-Man/O-9279-2019; Park, Ji-Man/GXZ-6936-2022; Park, Ji-Man/J-3284-2015	Park, Ji-Man/0000-0003-0018-1166; Park, Ji-Man/0000-0003-0018-1166; Park, Ji-Man/0000-0003-0018-1166; Kim, Ryan Jin Young/0000-0002-7132-8180	Korea Health Technology R&D Project from Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare [HI18C0435]	Korea Health Technology R&D Project from Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare	This work received a grant of the Korea Health Technology R&D Project from Korea Health Industry Development Institute (KHIDI) (https://www.khidi.or.kr/eps), funded by the Ministry of Health & Welfare (HI18C0435) to JMP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajioka H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164048; Alikhasi M, 2018, INT J DENT, V2018, DOI 10.1155/2018/3761750; Alsharbaty MHM, 2019, J PROSTHODONT, V28, pE902, DOI 10.1111/jopr.12764; Andriessen FS, 2014, J PROSTHET DENT, V111, P186, DOI 10.1016/j.prosdent.2013.07.010; Basaki K, 2017, INT J ORAL MAX IMPL, V32, P792, DOI 10.11607/jomi.5431; Chew AA, 2017, INT J ORAL MAX IMPL, V32, P70, DOI 10.11607/jomi.4942; Flugge TV, 2016, INT J PROSTHODONT, V29, P277, DOI 10.11607/ijp.4417; Gimenez B, 2015, IMPLANT DENT, V24, P498, DOI 10.1097/ID.0000000000000283; Gimenez B, 2015, INT J ORAL MAX IMPL, V30, P56, DOI 10.11607/jomi.3689; Gimenez B, 2014, INT J ORAL MAX IMPL, V29, P853, DOI 10.11607/jomi.3343; Gjelvold B, 2016, J PROSTHODONT, V25, P282, DOI 10.1111/jopr.12410; Imburgia M, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0383-4; Joda T, 2017, CLIN ORAL IMPLAN RES, V28, P1318, DOI 10.1111/clr.12982; Katsoulis J, 2017, EUR J ORAL IMPLANTOL, V10, P121; Kim RJY, 2018, J PROSTHET DENT, V120, P895, DOI 10.1016/j.prosdent.2018.01.035; Lee SJ, 2015, CLIN ORAL IMPLAN RES, V26, P715, DOI 10.1111/clr.12375; Lin WS, 2015, INT J ORAL MAX IMPL, V30, P102, DOI 10.11607/jomi.3592; Mangano F, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0442-x; Mangano FG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163107; Marghalani A, 2018, J PROSTHET DENT, V119, P574, DOI 10.1016/j.prosdent.2017.07.002; Menini M, 2018, CLIN ORAL INVEST, V22, P1253, DOI 10.1007/s00784-017-2217-9; Papaspyridakos P, 2016, CLIN ORAL IMPLAN RES, V27, P465, DOI 10.1111/clr.12567; Papaspyridakos P, 2014, INT J ORAL MAX IMPL, V29, P836, DOI 10.11607/jomi.3625; Park JM, 2019, JOVE-J VIS EXP, DOI 10.3791/59261; Rhee YK, 2015, J ADV PROSTHODONT, V7, P460, DOI 10.4047/jap.2015.7.6.460; Rutkunas V, 2017, EUR J ORAL IMPLANTOL, V10, P101; Tan MY, 2019, INT J ORAL MAX IMPL, V34, P366, DOI 10.11607/jomi.6855; van der Meer WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043312; Vandeweghe S, 2017, CLIN ORAL IMPLAN RES, V28, P648, DOI 10.1111/clr.12853; Wismeijer D, 2014, CLIN ORAL IMPLAN RES, V25, P1113, DOI 10.1111/clr.12234	30	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0222070	10.1371/journal.pone.0222070	http://dx.doi.org/10.1371/journal.pone.0222070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS6WP	31743331	Green Submitted, Green Published, gold			2022-12-26	WOS:000518448200001
J	Bazan, EL; Ruan, L; Zhou, C				Bazan, Elias L.; Ruan, Lin; Zhou, Cheng			Improving the antimicrobial efficacy against resistant Staphylococcus aureus by a combined use of conjugated oligoelectrolytes	PLOS ONE			English	Article								Two membrane-intercalating conjugated oligoelectrolytes (COEs), namely COE-D8 and COE-S6, were combined to achieve enhanced antimicrobial efficacy. COE-D8 has a shorter molecular length than COE-S6 and is typical of effective antimicrobial COE molecules, presumably due to its prominent membrane disrupting function. In contrast, COE-D6 exhibits lower efficacy against bacteria and lower toxicity toward mammalian cells. Surprisingly, after supplementing 8 mu M COE-S6, the minimum inhibitory concentration (MIC) of COE-D8 against methicillin-resistant Staphylococcus aureus (MRSA) was improved 8-fold, from 0.5 mu M to 0.063 mu M (0.050 mu g mL(-1)). No increased toxicity toward mammalian cells was observed by the combination of COEs, as indicated by cytotoxicity measurements using the 3T3 cell line. Indeed, there is an extended ratio between the half maximal inhibitory concentration based on 3T3 cells to MIC against MRSA from 12 to greater than 256. Biophysical experiments using liposome models suggest that COE-S6 promotes the interactions between COE-D8 and lipid bilayers, which is in agreement with damages of cellular permeability and morphology, as observed by confocal microscopy and scanning electron microscopy. The application of a combined mixture of COEs further demonstrates their promising potential as a new class of antimicrobial agents with high efficacy and selectivity.	[Bazan, Elias L.; Ruan, Lin; Zhou, Cheng] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore; [Zhou, Cheng] Nanyang Technol Univ, SCELSE, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhou, C (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.; Zhou, C (corresponding author), Nanyang Technol Univ, SCELSE, Singapore, Singapore.	zhoucheng@ntu.edu.sg	zhou, cheng/ABE-9093-2020	ZHOU, CHENG/0000-0003-0770-2649	Singapore Ministry of Education [M4360005]; Nanyang Technological University [M4081984.120]	Singapore Ministry of Education(Ministry of Education, Singapore); Nanyang Technological University(Nanyang Technological University)	Cheng Zhou received the grants that supported this work. Cheng Zhou thanks Nanyang Technological University start up grant M4081984.120 (http://www.ntu.edu.sg).Cheng Zhou thanks the Singapore Ministry of Education through grant M4360005 (www.moe.gov.sg).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Nanyang Technological University start up grant M4081984.120. Work at SCELSE was supported by the Singapore Ministry of Education through grant M4360005.	Antonoplis A, 2018, J AM CHEM SOC, V140, P16140, DOI 10.1021/jacs.8b08711; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Chang JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186120; Chen CH, 2019, J AM CHEM SOC, V141, P4839, DOI 10.1021/jacs.8b11939; Chen YY, 2018, ANGEW CHEM INT EDIT, V57, P8806, DOI 10.1002/anie.201806260; Chin W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03325-6; Choi H, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006481; Cuthbert TJ, 2018, ANGEW CHEM INT EDIT, V57, P12707, DOI 10.1002/anie.201806412; Demetzos C, 2008, J LIPOSOME RES, V18, P159, DOI [10.1080/08982100802310261, 10.1080/08982100802310261 ]; Enright MC, 2003, CURR OPIN PHARMACOL, V3, P474, DOI 10.1016/S1471-4892(03)00109-7; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Ergene C, 2018, POLYM CHEM-UK, V9, P2407, DOI 10.1039/c8py00012c; Ergene C, 2018, CURR PHARM DESIGN, V24, P855, DOI 10.2174/1381612824666180213140732; Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068024; Foster TJ, 2017, FEMS MICROBIOL REV, V41, P430, DOI 10.1093/femsre/fux007; Garner LE, 2010, J AM CHEM SOC, V132, P10042, DOI 10.1021/ja1016156; Guo JN, 2018, POLYM CHEM-UK, V9, P4611, DOI 10.1039/c8py00665b; Hinks J, 2014, LANGMUIR, V30, P2429, DOI 10.1021/la403409t; Hofer Ursula, 2019, Nat Rev Microbiol, V17, P3, DOI 10.1038/s41579-018-0125-x; Ito Teruyo, 2007, V391, P87; Judzewitsch PR, 2018, ANGEW CHEM INT EDIT, V57, P4559, DOI 10.1002/anie.201713036; Landy M, 1943, SCIENCE, V97, P265, DOI 10.1126/science.97.2516.265; Lazar V, 2018, NAT MICROBIOL, V3, P718, DOI 10.1038/s41564-018-0164-0; Lee AS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.33; Li JH, 2018, NANO LETT, V18, P4180, DOI 10.1021/acs.nanolett.8b01000; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Miguel CPV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212029; Namivandi-Zangeneh R, 2018, POLYM CHEM-UK, V9, P1735, DOI 10.1039/c7py01069a; Narayanaswamy VP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191522; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; OAKBERG EF, 1947, GENETICS, V32, P249; Shen W, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800354; Siriwardena TN, 2018, ANGEW CHEM INT EDIT, V57, P8483, DOI 10.1002/anie.201802837; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; Stiefel P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0376-x; Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069; Stokes JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.28; Stryjewski ME, 2014, CLIN INFECT DIS, V58, pS10, DOI 10.1093/cid/cit613; Turner NA, 2019, NAT REV MICROBIOL, V17, P203, DOI 10.1038/s41579-018-0147-4; Wang B, 2019, ADV MATER, V31, DOI 10.1002/adma.201806701; Wang B, 2017, ANGEW CHEM INT EDIT, V56, P16063, DOI 10.1002/anie.201709887; Wang B, 2017, ANGEW CHEM INT EDIT, V56, P5031, DOI 10.1002/anie.201701146; Wu X, 2017, ANNU REV CHEM BIOMOL, V8, P87, DOI 10.1146/annurev-chembioeng-060816-101612; Xiao FF, 2019, ACS NANO, V13, P1511, DOI 10.1021/acsnano.8b07251; Yan HJ, 2016, CHEM SCI, V7, P5714, DOI 10.1039/c6sc00630b; Yang YC, 2018, POLYM J, V50, P33, DOI 10.1038/pj.2017.72; Yazawa H, 2005, J PERIODONTOL, V76, P295, DOI 10.1902/jop.2005.76.2.295; Zhang L, 2016, ANAL BIOCHEM, V514, P55, DOI 10.1016/j.ab.2016.09.001; Zheng LY, 2003, CARBOHYD POLYM, V54, P527, DOI 10.1016/j.carbpol.2003.07.009; Zhou C, 2019, ADV MATER, V31, DOI 10.1002/adma.201808021	51	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224816	10.1371/journal.pone.0224816	http://dx.doi.org/10.1371/journal.pone.0224816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730663	Green Published, gold			2022-12-26	WOS:000532809500009
J	Thomsen, MK; Skouboe, MK; Boularan, C; Vernejoul, F; Lioux, T; Leknes, SL; Berthelsen, MF; Riedel, M; Cai, HQ; Joseph, JV; Perouzel, E; Tiraby, M; Vendelbo, MH; Paludan, SR				Thomsen, Martin K.; Skouboe, Morten K.; Boularan, Cedric; Vernejoul, Fabienne; Lioux, Thierry; Leknes, Siv L.; Berthelsen, Martin F.; Riedel, Maria; Cai, Huiqiang; Joseph, Justin, V; Perouzel, Eric; Tiraby, Michele; Vendelbo, Mikkel H.; Paludan, Soren R.			The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma	ONCOGENE			English	Article							INTERFERON-ALPHA; CANCER; DNA; ACTIVATION; INFLAMMATION; IMMUNITY; CELLS; HEPATOCYTES; CONTRIBUTES; REGRESSION	Hepatocellular carcinoma (HCC) is the most common primary liver cancer, and the incidence of HCC is increasing. Recently, cancer immunotherapy has emerged as an efficient treatment against some cancers. Here we have used a mouse model of mutagen-induced HCC to explore the therapeutic usefulness of targeting the DNA-activated STING pathway in HCC. STING-deficient mice exhibited unaltered initial development of HCC, but had higher number of large tumors at late stages of disease. In the liver of STING-deficient HCC mice, we observed reduced levels of phospho-STAT1, autophagy, and cleaved caspase3. These responses were activated in the liver by treatment with a cyclic dinucleotide (CDN) STING agonist. Importantly, CDN treatment of mice after HCC development efficiently reduced tumor size. Initiation of CDN treatment at an even later stage of disease to allow HCC detection by MR scanning revealed that the majority of tumors regressed in response to CDN, but new tumors were also detected, which were unresponsive to CDN treatment. Overall, the modulation of the STING pathway affects the development of HCC, and holds promise for a use as a treatment of this disease, most likely in combination with other immunomodulatory treatments such as PD1 inhibitors or with standard of care.	[Thomsen, Martin K.; Skouboe, Morten K.; Vendelbo, Mikkel H.; Paludan, Soren R.] Univ Aarhus, Dept Biomed, Hoegh Guldberg Gade 10, Aarhus C, Denmark; [Thomsen, Martin K.; Leknes, Siv L.; Berthelsen, Martin F.; Riedel, Maria; Cai, Huiqiang; Joseph, Justin, V] Univ Aarhus, Dept Clin Med, Palle Juul Jensens Blvd 82, DK-8200 Aarhus N, Denmark; [Boularan, Cedric; Vernejoul, Fabienne; Lioux, Thierry; Perouzel, Eric; Tiraby, Michele] InvivoGen, Toulouse, France; [Vendelbo, Mikkel H.] Aarhus Univ Hosp, Dept Nucl Med, Aarhus, Denmark; [Vendelbo, Mikkel H.] Aarhus Univ Hosp, PET Ctr, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Thomsen, MK; Paludan, SR (corresponding author), Univ Aarhus, Dept Biomed, Hoegh Guldberg Gade 10, Aarhus C, Denmark.; Thomsen, MK (corresponding author), Univ Aarhus, Dept Clin Med, Palle Juul Jensens Blvd 82, DK-8200 Aarhus N, Denmark.	mkt@clin.au.dk; srp@biomed.au.dk	Thomsen, Martin/AAU-5014-2021	Thomsen, Martin/0000-0002-5055-7531; Riedel, Maria/0000-0002-6545-0243; Skouboe, Morten Kelder/0000-0001-9358-5500; Vendelbo, Mikkel Holm/0000-0003-0431-2522	Danish Medical Research Council [12-124330, DFF-6110-00068]; Lundbeck Foundation [R198-2015-171]; InvivoGen; Danish Cancer Society [R146-A9394-16-S2, R204-A12490]; Ministry of health [4-1612-236/7]; AUFF NOVA [E-2o15-FLS-9-8]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); InvivoGen; Danish Cancer Society(Danish Cancer Society); Ministry of health; AUFF NOVA	We thank Mette Simonsen for assistant with scanning, Latifa Bakiri for thoroughly reading and comments on the manuscript, and Kirsten S Petersen for technical assistance. This work was funded by the Danish Medical Research Council (grants nos: 12-124330 and DFF-6110-00068), the Lundbeck Foundation (grant no R198-2015-171), and an unrestricted research grant from InvivoGen (all to SRP). MKT was funded by a fellowship sponsored by InvivoGen, Danish Cancer Society (R146-A9394-16-S2 and R204-A12490), Ministry of health (4-1612-236/7), and AUFF NOVA (E-2o15-FLS-9-8).	Ahn J, 2015, ONCOGENE, V34, P5302, DOI 10.1038/onc.2014.457; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4723; Ariff B, 2009, WORLD J GASTROENTERO, V15, P1289, DOI 10.3748/wjg.15.1289; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Chen DS, 2018, P NATL ACAD SCI USA, V115, P3930, DOI 10.1073/pnas.1717190115; Cheon H, 2014, SEMIN ONCOL, V41, P156, DOI 10.1053/j.seminoncol.2014.02.002; Corrales L, 2015, CLIN CANCER RES, V21, P4774, DOI 10.1158/1078-0432.CCR-15-1362; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gao P, 2014, CELL REP, V8, P1668, DOI 10.1016/j.celrep.2014.08.010; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Haanen JBAG, 2015, PROG TUMOR RES, V42, P55, DOI 10.1159/000437178; Hou J, 2014, CANCER CELL, V25, P49, DOI 10.1016/j.ccr.2013.11.011; Iurescia S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00711; Jessy Thomas, 2011, J Nat Sci Biol Med, V2, P43, DOI 10.4103/0976-9668.82318; Larkin B, 2017, J IMMUNOL, V199, P397, DOI 10.4049/jimmunol.1601999; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Li K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020404; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Lucas ED, 2018, J IMMUNOL, V45, P520; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Ohkuri T, 2014, CANCER IMMUNOL RES, V2, P1199, DOI 10.1158/2326-6066.CIR-14-0099; Paludan SR, 2019, NAT REV IMMUNOL, V19, P141, DOI 10.1038/s41577-018-0117-0; Paludan SR, 2015, MICROBIOL MOL BIOL R, V79, P225, DOI 10.1128/MMBR.00061-14; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; Sakamaki A, 2017, WORLD J GASTROENTERO, V23, P3797, DOI 10.3748/wjg.v23.i21.3797; Schlageter M, 2014, WORLD J GASTROENTERO, V20, P15955, DOI 10.3748/wjg.v20.i43.15955; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Skouboe MK, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006976; Sokolowska O, 2018, ARCH IMMUNOL THER EX, V66, P125, DOI 10.1007/s00005-017-0481-7; Sze A, 2013, CELL HOST MICROBE, V14, P422, DOI 10.1016/j.chom.2013.09.009; Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8; Thomsen MK, 2016, HEPATOLOGY, V64, P746, DOI 10.1002/hep.28685; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yeung JT, 2013, CLIN CANCER RES, V19, P1816, DOI 10.1158/1078-0432.CCR-12-2861; Young A, 2018, CANCER IMMUNOL RES, V6, P1445, DOI 10.1158/2326-6066.CIR-18-0487; Yu YS, 2019, J CLIN INVEST, V129, P546, DOI 10.1172/JCI121842; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang CX, 2019, CELL DEATH DIFFER, V26, P2314, DOI 10.1038/s41418-019-0302-0; Zhong ZY, 2016, CELL, V166, P288, DOI 10.1016/j.cell.2016.05.051; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051	47	27	27	3	31	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1652	1664		10.1038/s41388-019-1108-8	http://dx.doi.org/10.1038/s41388-019-1108-8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31740782				2022-12-26	WOS:000514923000003
J	Anderson, EM; Sychantha, D; Brewer, D; Clarke, AJ; Geddes-McAlister, J; Khursigara, CM				Anderson, Erin M.; Sychantha, David; Brewer, Dyanne; Clarke, Anthony J.; Geddes-McAlister, Jennifer; Khursigara, Cezar M.			Peptidoglycomics reveals compositional changes in peptidoglycan between biofilm- and planktonic-derived Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptidoglycan; Pseudomonas aeruginosa (P; aeruginosa); biofilm; microbiology; mass spectrometry (MS); bacterial cell wall; murine; peptidoglycomics; planktonic; sacculi	D-AMINO ACIDS; BETA-LACTAM RESISTANCE; BACTERIAL-CELL-WALL; LYTIC TRANSGLYCOSYLASES; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN RESISTANCE; VI SECRETION; CLONING; MUREIN; GROWTH	Peptidoglycan (PG) is a critical component of the bacterial cell wall and is composed of a repeating ?-1,4?linked disaccharide of N-acetylglucosamine and N-acetylmuramic acid appended with a highly conserved stem peptide. In Gram-negative bacteria, PG is assembled in the cytoplasm and exported into the periplasm where it undergoes considerable maturation, modification, or degradation depending on the growth phase or presence of environmental stressors. These modifications serve important functions in diverse processes, including PG turnover, cell elongation/division, and antibiotic resistance. Conventional methods for analyzing PG composition are complex and time-consuming. We present here a streamlined MS-based method that combines differential analysis with statistical 1D annotation approaches to quantitatively compare PGs produced in planktonic- and biofilm-cultured Pseudomonas aeruginosa. We identified a core assembly of PG that is present in high abundance and that does not significantly differ between the two growth states. We also identified an adaptive PG assembly that is present in smaller amounts and fluctuates considerably between growth states in response to physiological changes. Biofilm-derived adaptive PG exhibited significant changes compared with planktonic-derived PG, including amino acid substitutions of the stem peptide and modifications that indicate changes in the activity of amidases, deacetylases, and lytic transglycosylases. The results of this work also provide first evidence of de-N-acetylated muropeptides from P. aeruginosa. The method developed here offers a robust and reproducible workflow for accurately determining PG composition in samples that can be used to assess global PG fluctuations in response to changing growth conditions or external stimuli.	[Anderson, Erin M.; Sychantha, David; Clarke, Anthony J.; Geddes-McAlister, Jennifer; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Brewer, Dyanne; Geddes-McAlister, Jennifer; Khursigara, Cezar M.] Univ Guelph, Mass Spectrometry Facil, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Geddes-McAlister, J; Khursigara, CM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	jgeddesm@uoguelph.ca; ckhursig@uoguelph.ca		Khursigara, Cezar/0000-0001-9263-7604	Canadian Institutes of Health Research Operating Grants [PJT 156111, PJT 156353]; Alexander Graham Bell Canada Graduate Scholarships Doctoral Program of the Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research Operating Grants(Canadian Institutes of Health Research (CIHR)); Alexander Graham Bell Canada Graduate Scholarships Doctoral Program of the Natural Sciences and Engineering Research Council of Canada	This work was supported by Canadian Institutes of Health Research Operating Grants PJT 156111 (to C. M. K.) and PJT 156353 (to A. J. C.) and a scholarship from the Alexander Graham Bell Canada Graduate Scholarships Doctoral Program of the Natural Sciences and Engineering Research Council of Canada (to E. M. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Asmar AT, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny199; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bern M, 2017, ANAL BIOANAL CHEM, V409, P551, DOI 10.1007/s00216-016-9857-5; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; BRAUN V, 1972, EUR J BIOCHEM, V28, P51, DOI 10.1111/j.1432-1033.1972.tb01883.x; Brott AS, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8030094; CAPARROS M, 1992, J BACTERIOL, V174, P5549; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Chang JD, 2018, BIOCHEMISTRY-US, V57, P1274, DOI 10.1021/acs.biochem.7b01207; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; Clarke CA, 2010, J BIOL CHEM, V285, P14843, DOI 10.1074/jbc.C110.120931; Costa K, 1999, J BACTERIOL, V181, P3710, DOI 10.1128/JB.181.12.3710-3715.1999; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Crepin S, 2018, MOL MICROBIOL, V109, P745, DOI 10.1111/mmi.14000; de Jonge BLM, 2002, ANTIMICROB AGENTS CH, V46, P3151, DOI 10.1128/AAC.46.10.3151-3155.2002; deJonge BLM, 1996, ANTIMICROB AGENTS CH, V40, P1498, DOI 10.1128/AAC.40.6.1498; Dhar S, 2018, J MED MICROBIOL, V67, P1, DOI 10.1099/jmm.0.000636; Dik DA, 2017, CRIT REV BIOCHEM MOL, V52, P503, DOI 10.1080/10409238.2017.1337705; DUCHENE M, 1989, J BACTERIOL, V171, P4130; Espaillat A, 2016, J AM CHEM SOC, V138, P9193, DOI 10.1021/jacs.6b04430; Fisher JF, 2014, BIOORG CHEM, V56, P41, DOI 10.1016/j.bioorg.2014.05.011; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Grohs P, 2000, J BACTERIOL, V182, P6228, DOI 10.1128/JB.182.21.6228-6232.2000; HAMMES W, 1973, J BACTERIOL, V116, P1029, DOI 10.1128/JB.116.2.1029-1053.1973; Herlihey Francesca A, 2017, Adv Exp Med Biol, V925, P41, DOI 10.1007/5584_2016_52; Hochbaum AI, 2011, J BACTERIOL, V193, P5616, DOI 10.1128/JB.05534-11; Hugonnet JE, 2016, ELIFE, V5, DOI 10.7554/eLife.19469; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lee M, 2017, ANGEW CHEM INT EDIT, V56, P2735, DOI 10.1002/anie.201611279; Lee M, 2016, ANGEW CHEM INT EDIT, V55, P6882, DOI [10.1002/anie.201601693, 10.1002/anie.201608482]; Legaree BA, 2007, J ANTIMICROB CHEMOTH, V59, P411, DOI 10.1093/jac/dkl536; LIAO XW, 1995, ANTIMICROB AGENTS CH, V39, P1871, DOI 10.1128/AAC.39.8.1871; Liao XW, 1997, J BACTERIOL, V179, P1490, DOI 10.1128/jb.179.5.1490-1496.1997; Lupoli TJ, 2011, J AM CHEM SOC, V133, P10748, DOI 10.1021/ja2040656; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Meirelles LA, 2018, MOL MICROBIOL, V110, P995, DOI 10.1111/mmi.14132; Monteiro C, 2011, J BACTERIOL, V193, P6443, DOI 10.1128/JB.00425-11; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Moya B, 2008, ANTIMICROB AGENTS CH, V52, P3694, DOI 10.1128/AAC.00172-08; Neudorf KD, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx035; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Park AJ, 2015, J PROTEOME RES, V14, P4524, DOI 10.1021/acs.jproteome.5b00262; Park AJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00464; Park AJ, 2014, MOL CELL PROTEOMICS, V13, P1095, DOI 10.1074/mcp.M113.033985; Peters K, 2018, P NATL ACAD SCI USA, V115, P10786, DOI 10.1073/pnas.1809285115; Pomin V. H., 2012, J GLYCOMICS LIPIDOMI, V2, p1000e102, DOI [10.4172/2153-0637.1000e102, DOI 10.4172/2153-0637.1000E102]; Priyadarshini R, 2007, J BACTERIOL, V189, P5334, DOI 10.1128/JB.00415-07; Putty S, 2013, ANAL BIOCHEM, V442, P166, DOI 10.1016/j.ab.2013.07.045; QUINTELA JC, 1995, FEMS MICROBIOL LETT, V125, P95, DOI 10.1016/0378-1097(94)00479-B; Ramon-Perez ML, 2014, J MED MICROBIOL, V63, P1369, DOI 10.1099/jmm.0.075796-0; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; Rivera I, 2016, MICROB DRUG RESIST, V22, P470, DOI 10.1089/mdr.2016.0083; Ropy A, 2015, ANTIMICROB AGENTS CH, V59, P3925, DOI 10.1128/AAC.05150-14; Rusconi F, 2001, ANAL BIOCHEM, V295, P31, DOI 10.1006/abio.2001.5164; Sanchez CJ, 2014, ANTIMICROB AGENTS CH, V58, P4353, DOI 10.1128/AAC.02468-14; Schaub RE, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2438; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; She PF, 2015, MICROB PATHOGENESIS, V86, P38, DOI 10.1016/j.micpath.2015.07.009; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Sychantha D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02332; Takacs CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057579; Teo ACK, 2015, ANTIBIOTICS-BASEL, V4, P495, DOI 10.3390/antibiotics4040495; Tolker-Nielsen T, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0001-2014; Torrens G, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01868; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van der Aart LT, 2018, J BACTERIOL, V200, DOI [10.1128/JB.0020-18, 10.1128/JB.00290-18]; Vermassen A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00331; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; Weatherspoon-Griffin N, 2011, J BIOL CHEM, V286, P5529, DOI 10.1074/jbc.M110.200352; Werner E, 2004, APPL ENVIRON MICROB, V70, P6188, DOI 10.1128/AEM.70.10.6188-6196.2004; Wheeler R, 2014, CELL MICROBIOL, V16, P1014, DOI 10.1111/cmi.12304; WIENTJES FB, 1991, J BACTERIOL, V173, P7684, DOI 10.1128/jb.173.23.7684-7691.1991; Yadav AK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02064; Yakhnina AA, 2015, MOL MICROBIOL, V97, P957, DOI 10.1111/mmi.13077; Zhang L, 2011, J BACTERIOL, V193, P5510, DOI 10.1128/JB.00268-11; Zhang WL, 2013, J AM CHEM SOC, V135, P4950, DOI 10.1021/ja400970n	90	11	11	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					504	516		10.1074/jbc.RA119.010505	http://dx.doi.org/10.1074/jbc.RA119.010505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31771981	Green Published, hybrid			2022-12-26	WOS:000507373600019
J	Sian, TCCLK; Indumathy, S; Halim, H; Greule, A; Cryle, MJ; Bowness, P; Rossjohn, J; Gras, S; Purcell, AW; Schittenhelm, RB				Sian, Terry C. C. Lim Kam; Indumathy, Saranjah; Halim, Hanim; Greule, Anja; Cryle, Max J.; Bowness, Paul; Rossjohn, Jamie; Gras, Stephanie; Purcell, Anthony W.; Schittenhelm, Ralf B.			Allelic association with ankylosing spondylitis fails to correlate with human leukocyte antigen B27 homodimer formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; major histocompatibility complex (MHC); crystallography; arthritis; single-nucleotide polymorphism (SNP); Ankylosing spondylitis; HLA heavy chain homodimers; HLA-B*27; 03; HLA-B27; X-ray crystallography	HLA CLASS-I; HLA-B-ASTERISK-27 SUBTYPES; MONOCLONAL-ANTIBODIES; IMGT/HLA DATABASE; HLA-B27; SUSCEPTIBILITY; RECOGNITION; KIR3DL2; CELLS; EXPRESSION	Expression of human leukocyte antigen (HLA)-B27 is strongly associated with predisposition toward ankylosing spondylitis (AS) and other spondyloarthropathies. However, the exact involvement of HLA-B27 in disease initiation and progression remains unclear. The homodimer theory, which proposes that HLA-B27 heavy chains aberrantly form homodimers, is a central hypothesis that attempts to explain the role of HLA-B27 in disease pathogenesis. Here, we examined the ability of the eight most prevalent HLA-B27 allotypes (HLA-B*27:02 to HLA-B*27:09) to form homodimers. We observed that HLA-B*27:03, a disease-associated HLA-B27 subtype, showed a significantly reduced ability to form homodimers compared with all other allotypes, including the non-disease-associated/protective allotypes HLA-B*27:06 and HLA-B*27:09. We used X-ray crystallography and site-directed mutagenesis to unravel the molecular and structural mechanisms in HLA-B*27:03 that are responsible for its compromised ability to form homodimers. We show that polymorphism at position 59, which differentiates HLA-B*27:03 from all other allotypes, is responsible for its compromised ability to form homodimers. Indeed, histidine 59 in HLA-B*27:03 leads to a series of local conformational changes that act in concert to reduce the accessibility of the nearby cysteine 67, an essential amino acid residue for the formation of HLA-B27 homodimers. Considered together, the ability of both protective and disease-associated HLA-B27 allotypes to form homodimers and the failure of HLA-B*27:03 to form homodimers challenge the role of HLA-B27 homodimers in AS pathoetiology. Rather, this work implicates other features, such as peptide binding and antigen presentation, as pivotal mechanisms for disease pathogenesis.	[Sian, Terry C. C. Lim Kam; Indumathy, Saranjah; Halim, Hanim; Greule, Anja; Cryle, Max J.; Rossjohn, Jamie; Gras, Stephanie; Purcell, Anthony W.; Schittenhelm, Ralf B.] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Sian, Terry C. C. Lim Kam; Indumathy, Saranjah; Halim, Hanim; Greule, Anja; Cryle, Max J.; Rossjohn, Jamie; Gras, Stephanie; Purcell, Anthony W.; Schittenhelm, Ralf B.] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Greule, Anja; Cryle, Max J.] Monash Univ, EMBL Australia, Clayton, Vic 3800, Australia; [Rossjohn, Jamie; Gras, Stephanie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Monash Univ, Monash Prote & Metabol Facil, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Bowness, Paul] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Windmill Rd, Oxford OX3 7LD, England; [Schittenhelm, Ralf B.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; European Molecular Biology Laboratory (EMBL); Monash University; Monash University; Monash University; Nuffield Orthopaedic Centre; University of Oxford; Cardiff University	Gras, S; Purcell, AW (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia.; Schittenhelm, RB (corresponding author), Monash Univ, Monash Prote & Metabol Facil, Biomed Discovery Inst, Clayton, Vic 3800, Australia.	Stephanie.gras@monash.edu; anthony.purcell@monash.edu; ralf.schittenhelm@monash.edu	Bowness, Paul/AAH-2484-2019; Purcell, Anthony/AAH-1942-2019; Cryle, Max/H-7656-2017; Rossjohn, Jamie/F-9032-2013	Purcell, Anthony/0000-0003-0532-8331; Schittenhelm, Ralf/0000-0001-8738-1878; Abd Halim, Noor Hanim/0000-0002-3502-9351; Cryle, Max/0000-0002-9739-6157; Rossjohn, Jamie/0000-0002-2020-7522; Lim Kam Sian, Terry/0000-0001-7038-1214	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC) [1085017]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC) Project 1085017. The authors declare that they have no conflicts of interest with the contents of this article.	Allen RL, 1999, J IMMUNOL, V162, P5045; Antoniou AN, 2004, J BIOL CHEM, V279, P8895, DOI 10.1074/jbc.M311757200; Armas JB, 1999, TISSUE ANTIGENS, V53, P237, DOI 10.1034/j.1399-0039.1999.530303.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Ben Radhia K, 2008, JOINT BONE SPINE, V75, P172, DOI 10.1016/j.jbspin.2007.05.020; Bird LA, 2003, EUR J IMMUNOL, V33, P748, DOI 10.1002/eji.200323678; Bowness P, 2015, ANNU REV IMMUNOL, V33, P29, DOI 10.1146/annurev-immunol-032414-112110; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Bricogne G., 2017, BUSTER VERSION 1 7 6; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Brown MA, 2011, BRIEF FUNCT GENOMICS, V10, P249, DOI 10.1093/bfgp/elr023; Cauli A, 2013, RHEUMATOLOGY, V52, P1952, DOI 10.1093/rheumatology/ket219; Chan AT, 2005, ARTHRITIS RHEUM, V52, P3586, DOI 10.1002/art.21395; Colbert RA, 2004, CURR MOL MED, V4, P21, DOI 10.2174/1566524043479293; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; EDWARDS PAW, 1982, EUR J IMMUNOL, V12, P641, DOI 10.1002/eji.1830120804; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giquel B, 2007, ARTHRITIS RHEUM, V56, P2232, DOI 10.1002/art.22725; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; GonzalezRoces S, 1997, TISSUE ANTIGENS, V49, P116, DOI 10.1111/j.1399-0039.1997.tb02724.x; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karnes JH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8708; Khan MA, 2000, CURR OPIN RHEUMATOL, V12, P235, DOI 10.1097/00002281-200007000-00001; Khan MA, 2007, AUTOIMMUN REV, V6, P183, DOI 10.1016/j.autrev.2006.11.003; Khan Muhammad Asim, 2010, Curr Rheumatol Rep, V12, P337, DOI 10.1007/s11926-010-0126-x; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Ladell K, 2013, IMMUNITY, V38, P425, DOI 10.1016/j.immuni.2012.11.021; Lin H, 2017, RHEUMATOL INT, V37, P1267, DOI 10.1007/s00296-017-3741-2; Liu X, 2010, RHEUMATOL INT, V30, P587, DOI 10.1007/s00296-009-1018-0; Mage MG, 2012, J IMMUNOL, V189, P1391, DOI 10.4049/jimmunol.1200831; Makhadiyeva D, 2012, IMMUNOLOGY, V135, P133, DOI 10.1111/j.1365-2567.2011.03518.x; McHugh K, 2014, ANN RHEUM DIS, V73, P763, DOI 10.1136/annrheumdis-2012-203080; Perosa F, 2003, J IMMUNOL, V171, P1918, DOI 10.4049/jimmunol.171.4.1918; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reveille JD, 2011, AM J MED SCI, V341, P284, DOI 10.1097/MAJ.0b013e31820f8c99; Reveille JD, 2009, ADV EXP MED BIOL, V649, P159; Robinson J, 2016, HUM IMMUNOL, V77, P233, DOI 10.1016/j.humimm.2016.01.020; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Santos SG, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2492; Schittenhelm RB, 2014, TISSUE ANTIGENS, V83, P174, DOI 10.1111/tan.12282; Schittenhelm RB, 2015, ARTHRITIS RHEUMATOL, V67, P702, DOI 10.1002/art.38963; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; VANDERLINDEN SM, 1984, ARTHRITIS RHEUM, V27, P241; Wong-Baeza I, 2013, J IMMUNOL, V190, P3216, DOI 10.4049/jimmunol.1202926; Yu HC, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4016802; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; Ziegler A, 2009, ADV EXP MED BIOL, V649, P177	57	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20185	20195		10.1074/jbc.RA119.010257	http://dx.doi.org/10.1074/jbc.RA119.010257			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31740583	Green Published, hybrid			2022-12-26	WOS:000505005800029
J	Bai, ZP; Li, YF; Zhao, YH				Bai, Z. P.; Li, Y. F.; Zhao, Y. H.			Study on characteristics of fire plume in building facade window under lateral blow	PLOS ONE			English	Article							FLAME HEIGHT; POOL FIRE; COMPARTMENT; PHYSICS	The overflow of the flame plume from the window is the main cause of the vertical spread of the fire on the facade of the building. This paper considers the geometry of the window by taking measures to prevent the flame from propagating along the vertical wall. In this paper, a residential building is taken as an example to evaluate the flame plume characteristics through experimental tests and numerical simulations. The objective of the present study is to study the flame plume characteristics under the air blow on the outer window side of the building. The theoretical equations of the flame tilt angle, non-dimensional temperature and non-dimensional velocity are derived. A series of experimental tests were carried out in a reduced-scale building model corresponding to the changes of lateral blow ventilation velocity. Reduced scale numerical simulations were conducted to verify the experiments. Results showed that the flame tilt angle increases with ventilation velocity increases. Meanwhile, the experimental results were compared with the reduced-scale tests and numerical simulations. These showed a good agreement between experimental results and numerical simulations. All these findings provide theoretical basis for building fire prevention outside window.	[Bai, Z. P.; Zhao, Y. H.] Beijing Univ Technol, Beijing Key Lab Green Built Environm & Energy Eff, Beijing, Peoples R China; [Bai, Z. P.; Li, Y. F.] Beijing Univ Technol, Coll Architecture & Civil Engn, Beijing, Peoples R China	Beijing University of Technology; Beijing University of Technology	Bai, ZP (corresponding author), Beijing Univ Technol, Beijing Key Lab Green Built Environm & Energy Eff, Beijing, Peoples R China.; Bai, ZP (corresponding author), Beijing Univ Technol, Coll Architecture & Civil Engn, Beijing, Peoples R China.	baiyi1056@126.com			Beijing Municipal Natural Science Foundation [8172006]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Beijing Municipal Natural Science Foundation Project No. 8172006.; This work was supported by "Beijing Municipal Natural Science Foundation(Project No. 8172006)".	Arteta A, 2017, INT J EDUC INF TECH, V11, P153; Asimakopoulou EK, 2017, FIRE SAFETY J, V91, P451, DOI 10.1016/j.firesaf.2017.03.075; DEFAVERI DM, 1989, J HAZARD MATER, V22, P85, DOI 10.1016/0304-3894(89)85030-7; Harrison R., 2006, SMOKE MANAGEMENT ISS; Hu LH, 2019, P COMBUST INST, V37, P3859, DOI 10.1016/j.proci.2018.06.201; Hu LH, 2017, FIRE SAFETY J, V91, P41, DOI 10.1016/j.firesaf.2017.05.008; Jiang Y-X, 2006, FIRE SAFETY SCI, V2; Konno Y, 2019, P COMBUST INST, V37, P3817, DOI 10.1016/j.proci.2018.05.074; Lam CS, 2015, FIRE SAFETY J, V75, P1, DOI 10.1016/j.firesaf.2015.04.009; Lee YP, 2012, FIRE SAFETY J, V49, P82, DOI 10.1016/j.firesaf.2012.01.001; Li J-M, 2017, DESTECH T MATERIALS, DOI [10.12783/dtmse/icmsea/mce2017/10856, DOI 10.12783/DTMSE/ICMSEA/MCE2017/10856]; Li Y-Z, 2007, J CATASTROPHOLOGY, V4; Livkiss K, 2018, FIRE TECHNOL, V54, P689, DOI 10.1007/s10694-018-0706-2; Ma TG, 2003, FIRE SAFETY J, V38, P467, DOI 10.1016/S0379-7112(02)00082-6; McGrattan K., 2019, NIST SPECIAL PUBLICA, V1019, DOI 10.6028/NIST.SP.1019; Miao L, 2019, FIRE SAFETY J, V109, DOI 10.1016/j.firesaf.2019.102864; Morgan HP, 1999, DESIGN METHODOLOGIES; Oleszkiewicz I, 1990, FIRE TECHNOL, V26, P357, DOI DOI 10.1007/BF01293079; Oleszkiewicz I., 1989, IRCP1662 NAT RES COU, DOI [10.4224/40001813, DOI 10.4224/40001813]; QUINTIERE JG, 1981, COMBUST SCI TECHNOL, V26, P193, DOI 10.1080/00102208108946960; Quintiere JG, 1994, FIRE TECHNOL, V30, P209, DOI DOI 10.1007/BF01040003; Ren F, 2019, FIRE TECHNOL, V55, P903, DOI 10.1007/s10694-018-0809-9; Su SC, 2018, AIP CONF PROC, V1971, DOI 10.1063/1.5041130; Sun XP, 2019, P COMBUST INST, V37, P3869, DOI 10.1016/j.proci.2018.05.161; Suzuki T, 2000, P 4 ASIA OCEANIA S F, P363; Tang F, 2012, INT J HEAT MASS TRAN, V55, P93, DOI 10.1016/j.ijheatmasstransfer.2011.08.045; THOMAS PH, 1967, FORESTRY, V40, P139, DOI 10.1093/forestry/40.2.139; Thomas PH, 1972, FIRE SAF SCI, V921, P1; Yamaguchi J-i, 2005, FIRE SCI TECHNOL, V24, P17, DOI [10.3210/fst.24.17, DOI 10.3210/FST.24.17]; Yokoi S., 1960, BRI REPORT, P34	30	5	5	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225120	10.1371/journal.pone.0225120	http://dx.doi.org/10.1371/journal.pone.0225120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774848	gold, Green Published			2022-12-26	WOS:000533896400025
J	Krueger, KL; Willman, JC; Matthews, GJ; Hublin, JJ; Perez-Perez, A				Krueger, Kristin L.; Willman, John C.; Matthews, Gregory J.; Hublin, Jean-Jacques; Perez-Perez, Alejandro			Anterior tooth-use behaviors among early modern humans and Neandertals	PLOS ONE			English	Article							MICROWEAR TEXTURE ANALYSIS; SKELETAL ISOTOPE CHEMISTRY; DENTAL WEAR PATTERNS; DIVISION-OF-LABOR; PESTERA CU OASE; ANATOMICAL EVIDENCE; MASTICATORY SYSTEM; LATE PLEISTOCENE; HUMAN FOOTWEAR; HUMAN REMAINS	Early modern humans (EMH) are often touted as behaviorally advanced to Neandertals, with more sophisticated technologies, expanded resource exploitation, and more complex clothing production. However, recent analyses have indicated that Neandertals were more nuanced in their behavioral adaptations, with the production of the Cha<^> telperronian technocomplex, the processing and cooking of plant foods, and differences in behavioral adaptations according to habitat. This study adds to this debate by addressing the behavioral strategies of EMH (n = 30) within the context of non-dietary anterior tooth-use behaviors to glean possible differences between them and their Neandertal (n = 45) counterparts. Highresolution casts of permanent anterior teeth were used to collect microwear textures of fossil and comparative bioarchaeological samples using a Sensofar white-light confocal profiler with a 100x objective lens. Labial surfaces were scanned, totaling a work envelope of 204 x 276 mu m for each individual. The microwear textures were examined for post-mortem damage and uploaded to SSFA software packages for surface characterization. Statistical analyses were performed to examine differences in central tendencies and distributions of anisotropy and textural fill volume variables among the EMH sample itself by habitat, location, and time interval, and between the EMH and Neandertal samples by habitat and location. Descriptive statistics for the EMH sample were compared to seven bioarchaeological samples (n = 156) that utilized different tooth-use behaviors to better elucidate specific activities that may have been performed by EMH. Results show no significant differences between the means within the EMH sample by habitat, location, or time interval. Furthermore, there are no significant differences found here between EMH and Neandertals. Comparisons to the bioarchaeological samples suggest both fossil groups participated in clamping and grasping activities. These results indicate that EMH and Neandertals were similar in their non-dietary anterior tooth-use behaviors and provide additional evidence for overlapping behavioral strategies employed by these two hominins.	[Krueger, Kristin L.] Loyola Univ, Dept Anthropol, Chicago, IL 60611 USA; [Willman, John C.] Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona, Spain; [Willman, John C.] Univ Rovira & Virgili URV, Area Prehist, Tarragona, Spain; [Matthews, Gregory J.] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Perez-Perez, Alejandro] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain	Loyola University Chicago; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Loyola University Chicago; Max Planck Society; University of Barcelona	Krueger, KL (corresponding author), Loyola Univ, Dept Anthropol, Chicago, IL 60611 USA.	kkrueger4@luc.edu	Willman, John/J-7948-2018; Perez-Perez, Alejandro/K-6715-2014	Willman, John/0000-0001-7143-4533; Perez-Perez, Alejandro/0000-0002-1442-1397; Krueger, Kristin/0000-0002-8132-7675	National Science Foundation [BCS-0925818]; Marie Sklodowska-Curie Actions (H2020-MSCA-IF-2016) [749188]; AGAUR [2017SGR1040]; URV [2017PFR-URV-B2-91, MICINN/FEDER: PGC2018-093925-B-C32]	National Science Foundation(National Science Foundation (NSF)); Marie Sklodowska-Curie Actions (H2020-MSCA-IF-2016); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); URV	This study was funded by the National Science Foundation (BCS-0925818) to KLK. JCW is supported by funding from the Marie Sklodowska-Curie Actions (H2020-MSCA-IF-2016 No. 749188), AGAUR (Ref. 2017SGR1040) and URV (Ref. 2017PFR-URV-B2-91) Projects, and MICINN/FEDER: PGC2018-093925-B-C32.	Alvarez-Fernandez E, 2011, J ANTHROPOL ARCHAEOL, V30, P327, DOI 10.1016/j.jaa.2011.05.005; [Anonymous], 2006, EARLY MODERN HUMAN E; [Anonymous], 1994, HUMAN EVOLUTION, DOI DOI 10.1007/BF02437262; Anton S.C., 1994, INTEGRATIVE PATHS PA, P677; Anton S.C., 1990, KROEBER ANTHR SOC PA, V71, P67; Anton SC, 1996, J HUM EVOL, V31, P391, DOI 10.1006/jhev.1996.0068; Aranguren B, 2007, ANTIQUITY, V81, P845, DOI 10.1017/S0003598X00095946; Arman SD, 2016, SURF TOPOGR-METROL, V4, DOI 10.1088/2051-672X/4/2/024007; Arsuaga JL, 2001, NEANDERTALES CROMANO, P327; Bailey S, 2006, PERIOD BIOL, V108, P253; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Beechey Frederick William, 1831, NARRATIVE VOYAGE PAC; Berbesque JC, 2012, HUM NATURE-INT BIOS, V23, P270, DOI 10.1007/s12110-012-9145-9; BRACE CL, 1981, CURR ANTHROPOL, V22, P549, DOI 10.1086/202726; BRACE CL, 1967, J DENT RES, V46, P809, DOI 10.1177/00220345670460053501; BRACE CL, 1995, AM ANTHROPOL, V97, P711, DOI 10.1525/aa.1995.97.4.02a00130; BRACE CL, 1975, CURR ANTHROPOL, V16, P396; Burch E. S., 1981, TRADITIONAL ESKIMO H; Clement AF, 2012, J HUM EVOL, V62, P367, DOI 10.1016/j.jhevol.2011.11.014; Collard M, 2016, J ANTHROPOL ARCHAEOL, V44, P235, DOI 10.1016/j.jaa.2016.07.010; Coltrain JB, 2004, J ARCHAEOL SCI, V31, P39, DOI 10.1016/j.jas.2003.06.003; Coltrain JB, 2009, J ARCHAEOL SCI, V36, P764, DOI 10.1016/j.jas.2008.10.022; Compton Tim, 2012, P118; Crevecoeur I, 2009, AM J PHYS ANTHROPOL, V140, P347, DOI 10.1002/ajpa.21080; CYBULSKI J S, 1974, Syesis, V7, P31; Dabbs GR, 2009, THESIS; de Lumley M.A., 1973, ANTENEANDERTALIENS N; DEMES B, 1987, J HUM EVOL, V16, P297, DOI 10.1016/0047-2484(87)90005-4; Dobos A., 2010, PREHISTORY PALEONTOL; El Zaatari S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153277; El Zaatari S, 2011, J HUM EVOL, V61, P411, DOI 10.1016/j.jhevol.2011.05.004; Estalrrich A, 2015, J HUM EVOL, V80, P51, DOI 10.1016/j.jhevol.2014.07.007; Estalrrich A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062797; Fiore Ivana, 2015, Paleoanthropology, P19; Fiorenza L., 2015, J ANTHROPOL SCI, V93, P1, DOI DOI 10.4436/JASS.93006; Fiorenza L, 2019, J HUM EVOL, V132, P174, DOI 10.1016/j.jhevol.2019.05.005; Fiorenza L, 2015, HOMO, V66, P414, DOI 10.1016/j.jchb.2015.04.002; Fiorenza L, 2015, AM J PHYS ANTHROPOL, V156, P43, DOI 10.1002/ajpa.22659; Fiorenza L, 2013, AM J PHYS ANTHROPOL, V152, P107, DOI 10.1002/ajpa.22335; Fiorenza L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014769; Fiorenza L, 2010, AM J PHYS ANTHROPOL, V143, P306, DOI 10.1002/ajpa.21311; Foote BA, 1992, TIGARA ESKIMOS THEIR; Fox CL, 1997, INT J OSTEOARCHAEOL, V7, P133, DOI 10.1002/(SICI)1099-1212(199703)7:2<133::AID-OA326>3.0.CO;2-4; Franciscus RG, 2003, J HUM EVOL, V44, P701, DOI 10.1016/S0047-2484(03)00062-9; Frayer DW, 2006, EARLY MODERN HUMANS AT THE MORAVIAN GATE: THE MLADEC CAVES AND THEIR REMAINS, P185, DOI 10.1007/978-3-211-49294-9_9; Frayer DW, 2010, J ANTHROPOL SCI, V88, P113; Gilligan I, 2007, WORLD ARCHAEOL, V39, P499, DOI 10.1080/00438240701680492; Hardy BL, 2013, QUATERNARY SCI REV, V82, P23, DOI 10.1016/j.quascirev.2013.09.028; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Henry AG, 2014, J HUM EVOL, V69, P44, DOI 10.1016/j.jhevol.2013.12.014; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Hlusko LJ, 2013, AM J PHYS ANTHROPOL, V151, P477, DOI 10.1002/ajpa.22291; Hoffmann DL, 2018, SCIENCE, V359, P912, DOI 10.1126/science.aap7778; Hoffmann DL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5255; Holton NE, 2011, J HUM EVOL, V61, P624, DOI 10.1016/j.jhevol.2011.08.001; Holton NE, 2008, J HUM EVOL, V55, P942, DOI 10.1016/j.jhevol.2008.07.001; Hu YW, 2009, P NATL ACAD SCI USA, V106, P10971, DOI 10.1073/pnas.0904826106; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Jaubert J, 2016, NATURE, V534, P111, DOI 10.1038/nature18291; Koby F. E., 1956, Verhandlungen der Naturforschenden Gesellschaft in Basel, V67, P1; Krueger KL, 2010, INT J OSTEOARCHAEOL, V20, P549, DOI 10.1002/oa.1093; Krueger KL, 2017, J HUM EVOL, V105, P13, DOI 10.1016/j.jhevol.2017.01.004; Krueger KL, 2015, J ARCHAEOL SCI-REP, V1, P29, DOI 10.1016/j.jasrep.2014.10.002; Krueger KL, 2012, CENT EUR J GEOSCI, V4, P651, DOI 10.2478/s13533-012-0111-1; Kuhn SL, 2006, CURR ANTHROPOL, V47, P953, DOI 10.1086/507197; Kullmer O, 2009, AM J PHYS ANTHROPOL, V139, P600, DOI 10.1002/ajpa.21086; Le Cabec A, 2013, J HUM EVOL, V64, P169, DOI 10.1016/j.jhevol.2012.08.011; Lippi MM, 2015, P NATL ACAD SCI USA, V112, P12075, DOI 10.1073/pnas.1505213112; Lowe J, 2012, P NATL ACAD SCI USA, V109, P13532, DOI 10.1073/pnas.1204579109; Lozano M, 2017, EVOL ANTHROPOL, V26, P313, DOI 10.1002/evan.21554; LUKACS JR, 1988, AM J PHYS ANTHROPOL, V76, P377, DOI 10.1002/ajpa.1330760310; Man Edward Horace, 1883, J ANTHR I GREAT BRIT, Vxii, P327, DOI [DOI 10.2307/2841948, 10.2307/2841948]; Man EH, 1885, J ROYAL ANTHR I, V14, P253; Marean CW, 2015, ANNU REV ANTHROPOL, V44, P533, DOI 10.1146/annurev-anthro-102313-025954; Marean CW, 1999, EVOL ANTHROPOL, V8, P22, DOI 10.1002/(SICI)1520-6505(1999)8:1<22::AID-EVAN7>3.0.CO;2-F; Marshall J, 1957, HUNTERS KUNG SERIES; Martin H, 1923, HOMME FOSSILE QUINA; Mathiassen T., 1927, REPORT 5 THULE EXPED; Mayes AT, 2001, THESIS; MCCARTNEY AP., 1977, THULE ESKIMO PREHIST; Mellars P, 1999, CURR ANTHROPOL, V40, P341, DOI 10.1086/200024; Merbs C. F., 1983, NATL MUSEUM MAN ARCH; MOLNAR S, 1972, CURR ANTHROPOL, V13, P511, DOI 10.1086/201284; O'Connor CF, 2005, AM J PHYS ANTHROPOL, V127, P129, DOI 10.1002/ajpa.20025; O'Connor S, 2011, SCIENCE, V334, P1117, DOI 10.1126/science.1207703; Portman MV, 1899, HIST OUR RELATIONS A; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Power RC, 2018, J PALEOLITH ARCHAEOL, V1, P281, DOI 10.1007/s41982-018-0014-x; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Puech P-F, 1978, RECHERCHE, V94, P1029; PUECH PF, 1981, CURR ANTHROPOL, V22, P424, DOI 10.1086/202699; PUECH PF, 1979, CURR ANTHROPOL, V20, P590, DOI 10.1086/202335; R Core Team, 2018, R LANG ENV STAT COMP; Radini A, 2016, ANTIQUITY, V90, P290, DOI 10.15184/aqy.2016.21; Rae TC, 2011, J HUM EVOL, V60, P234, DOI 10.1016/j.jhevol.2010.10.003; RAK Y, 1986, J HUM EVOL, V15, P151, DOI 10.1016/S0047-2484(86)80042-2; Revedin A, 2015, QUATERN INT, V359, P77, DOI 10.1016/j.quaint.2014.09.066; Revedin A, 2010, P NATL ACAD SCI USA, V107, P18815, DOI 10.1073/pnas.1006993107; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Roebroeks W, 2016, P NATL ACAD SCI USA, V113, P6372, DOI 10.1073/pnas.1521269113; Rozzi FVR, 2009, J ANTHROPOL SCI, V87, P153; Ruebens K, 2015, J HUM EVOL, V86, P55, DOI 10.1016/j.jhevol.2015.06.011; Ryan A, 1980, THESIS; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Shea J.J., 2010, PALAEOANTHROPOLOGY, V2010, P100; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; Simpson J., 1875, OBSERVATIONS W ESKIM; Smith F.H., 1989, EMERGENCE MODERN HUM, P181; Smith F.H., 1983, BAR INT SERIES, V164, P141; SMITH FH, 1976, CURR ANTHROPOL, V17, P167; Soffer O, 2000, CURR ANTHROPOL, V41, P511, DOI 10.1086/317381; Soficaru A, 2006, P NATL ACAD SCI USA, V103, P17196, DOI 10.1073/pnas.0608443103; Sollas WJ, 1908, PHILOS T R SOC LON B, V199, P281, DOI 10.1098/rstb.1908.0007; SPENCER MA, 1993, AM J PHYS ANTHROPOL, V91, P1, DOI 10.1002/ajpa.1330910102; Staab ML, 1979, THULE ESKIMO CULTURE, V88, P349; Stiner MC, 2000, CURR ANTHROPOL, V41, P39, DOI 10.1086/300102; Trinkaus, 2014, SHANIDAR NEANDERTALS; Trinkaus E, 2005, J ARCHAEOL SCI, V32, P1515, DOI 10.1016/j.jas.2005.04.006; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; TRINKAUS E, 1987, J HUM EVOL, V16, P429, DOI 10.1016/0047-2484(87)90071-6; Trinkaus E., 2014, PEOPLE SUNGHIR BURIA; Trinkaus E., 1992, EVOLUTION DISPERSAL, P277; TRINKAUS E, 2004, MISCELANEA HOMENAJE, P393; Trinkaus E, 2008, J ARCHAEOL SCI, V35, P1928, DOI 10.1016/j.jas.2007.12.002; Trinkaus E, 2018, ANTIQUITY, V92, P7, DOI 10.15184/aqy.2017.223; TURNER CG, 1969, AM J PHYS ANTHROPOL, V31, P303, DOI 10.1002/ajpa.1330310305; Verna C, 2012, J HUM EVOL, V62, P605, DOI 10.1016/j.jhevol.2012.02.001; Villa P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096424; Villa P, 2010, J ANTHROPOL RES, V66, P5, DOI 10.3998/jar.0521004.0066.102; VLCEK E., 1997, DOLNI VESTONICE STUD, V4, P53; Volpato V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043949; Wales N, 2012, J HUM EVOL, V63, P781, DOI 10.1016/j.jhevol.2012.08.006; WALLACE JA, 1975, CURR ANTHROPOL, V16, P393, DOI 10.1086/201570; Weaver TD, 2007, J HUM EVOL, V53, P135, DOI 10.1016/j.jhevol.2007.03.001; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P16028, DOI 10.1073/pnas.0903864106; Welker F, 2016, P NATL ACAD SCI USA, V113, P11162, DOI 10.1073/pnas.1605834113; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Williams FL, 2018, CR PALEVOL, V17, P545, DOI 10.1016/j.crpv.2018.04.003; Willman J. C., 2016, DOLNI VESTONICE STUD, V21, P353; Willman JC, 2017, PEOPLE PALOMAS NEAND, P155; Willman JC, 2016, THESIS; Wood SR, 1992, THESIS; Wroe S, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0085; Zapata J., 2017, NEANDERTALS SIMA PAL, P52; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103	149	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0224573	10.1371/journal.pone.0224573	http://dx.doi.org/10.1371/journal.pone.0224573			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8SS	31774826	Green Published, gold			2022-12-26	WOS:000533896400014
J	Rivera, J; Isidro, RA; Loucil-Alicea, RY; Cruz, ML; Appleyard, CB; Isidro, AA; Chompre, G; Colon-Rivera, K; Noel, RJ				Rivera, Jocelyn; Isidro, Raymond A.; Loucil-Alicea, Raisa Y.; Cruz, Myrella L.; Appleyard, Caroline B.; Isidro, Angel A.; Chompre, Gladys; Colon-Rivera, Krystal; Noel, Richard J., Jr.			Infusion of HIV-1 Nef-expressing astrocytes into the rat hippocampus induces enteropathy and interstitial pneumonitis and increases blood-brain-barrier permeability	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CENTRAL-NERVOUS-SYSTEM; PULMONARY-HYPERTENSION; INFLAMMATORY RESPONSE; VASCULAR-LESIONS; DOWN-REGULATION; CROSS-TALK; IN-VIVO; INFECTION; ACTIVATION	Even though HIV-1 replication can be suppressed by combination antiretroviral therapy (cART) inflammatory processes still occur, contributing to comorbidities. Comorbidities are attributed to variety of factors, including HIV-1 mediated inflammation. Several HIV-1 proteins mediate central nervous system (CNS) inflammation, including Nef. Nef is an early HIV-1 protein, toxic to neurons and glia and is sufficient to cause learning impairment similar to some deficits observed in HIV-1 associated neurocognitive disorders. To determine whether hippocampal Nef expression by astrocytes contributes to comorbidities, specifically peripheral inflammation, we infused Sprague Dawley rats with GFP- (control) or Nef-transfected astrocytes into the right hippocampus. Brain, lung, and ileum were collected postmortem for the measurement of inflammatory markers. Increased blood-brain-barrier permeability and serum IL-1 beta levels were detected in the Nef-treated rats. The lungs of Neftreated rats demonstrated leukocyte infiltration, macrophage upregulation, and enhanced vascular permeability. Ileal tissue showed reactive follicular lymphoid hyperplasia, increased permeability and macrophage infiltration. The intracerebroventricular application of IL-1 receptor antagonist reduced infiltration of immune cells into ileum and lung, indicating the important role of IL-1 beta in mediating the spread of inflammation from the brain to other tissues. This suggests that localized expression of a single viral protein, HIV-1 Nef, can contribute to a broader inflammatory response by upregulation of IL-1 beta. Further, these results suggest that Nef contributes to the chronic inflammation seen in HIV patients, even in those whose viremia is controlled by cART.	[Rivera, Jocelyn; Colon-Rivera, Krystal] Wistar Inst Anat & Biol, HIV 1 Immunopathogenesis Lab, 3601 Spruce St, Philadelphia, PA 19104 USA; [Isidro, Raymond A.; Loucil-Alicea, Raisa Y.; Cruz, Myrella L.; Appleyard, Caroline B.; Isidro, Angel A.; Noel, Richard J., Jr.] Ponce Hlth Sci Univ, Dept Basic Sci, Ponce Res Inst, Ponce, PR 00716 USA; [Chompre, Gladys] Pontifical Catholic Univ Puerto Rico, Dept Biol, Ponce, PR USA	The Wistar Institute; Ponce Health Sciences University; Pontifical Catholic University of Puerto Rico	Noel, RJ (corresponding author), Ponce Hlth Sci Univ, Dept Basic Sci, Ponce Res Inst, Ponce, PR 00716 USA.	rnoel@psm.edu		Chompre, Gladys/0000-0002-4529-6752; Isidro, Raymond/0000-0002-1774-8643; Appleyard, Caroline/0000-0002-1211-4246; Rivera-Ortiz, Jocelyn/0000-0002-6229-1523	National Institutes of Health [GM106970, DA026722, MD007579, MD007587]; NIH [GM082406]; William Townsend Porter Predoctoral Fellowship from the American Physiological Society; Molecular and Genomics Core [MD007579]; Behavioral Research and Integrative Neuroscience core [MD007579]; Translational Resources for Core Laboratories component of the PRCTRC [MD007587]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM082406] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579, U54MD007579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Townsend Porter Predoctoral Fellowship from the American Physiological Society; Molecular and Genomics Core; Behavioral Research and Integrative Neuroscience core; Translational Resources for Core Laboratories component of the PRCTRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	These studies were supported by National Institutes of Health grants GM106970 (RJN), DA026722 (RJN), MD007579 (RJN), MD007587. R. Loucil, J. Rivera, G. Chompre, and R. Isidro were supported by NIH training grant GM082406 (CBA). R. Isidro was supported by a William Townsend Porter Predoctoral Fellowship from the American Physiological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For their help with the Ussing chamber assay, we would like to thank Antonio Rami ' rez-Capo ' and Siomara Herna ' ndez; for his help with the surgeries, we would like to thank Eliezer Ruiz; for her help with tissue preparation, we would like to thank Alcira Beni ' tez. Critical review and advice for the development of the manuscript was kindly provided by Dr. Kim E. Barrett (University of California San Diego School of Medicine) through the American Physiological Society course Writing and Reviewing for Scientific Journals. We acknowledge the support of the Molecular and Genomics Core (MD007579), the Behavioral Research and Integrative Neuroscience core (MD007579), and the Translational Resources for Core Laboratories component of the PRCTRC (MD007587). R. Loucil, J. Rivera, G. Chompre, and R. Isidro were supported by NIH training grant GM082406. Finally, we are grateful to Bob Ritchie of the Publications Office of Ponce Health Sciences University for his help in the final preparation of this manuscript and to Carlos J. Carmona, MPH at the Wistar Institute, HIV-1 Immunopathogenesis Laboratory for critical revision and editing of the manuscrip.	Acharjee S, 2014, BRAIN BEHAV IMMUN, V40, P74, DOI 10.1016/j.bbi.2014.02.016; Acheampong EA, 2005, J VIROL, V79, P4257, DOI 10.1128/JVI.79.7.4257-4269.2005; Akay C, 2012, NEUROPATH APPL NEURO, V38, P175, DOI 10.1111/j.1365-2990.2011.01215.x; Al-Harthi L, 2019, J NEUROIMMUNE PHARM, V14, P6, DOI 10.1007/s11481-018-09827-w; Almodovar Sharilyn, 2011, Proc Am Thorac Soc, V8, P308, DOI 10.1513/pats.201006-046WR; Appleyard CB, 2006, DIGEST DIS SCI, V51, P506, DOI 10.1007/s10620-006-3163-6; Appleyard CB, 2002, DIGEST DIS SCI, V47, P2007, DOI 10.1023/A:1019660526241; Asahchop EL, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0370-5; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Barat C, 2018, GLIA, V66, P1363, DOI 10.1002/glia.23310; Blamire AM, 2000, J NEUROSCI, V20, P8153; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; BRACKWERNER R, 1992, AIDS, V6, P273, DOI 10.1097/00002030-199203000-00003; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Choe EY, 2002, J BIOL CHEM, V277, P46079, DOI 10.1074/jbc.M204698200; Chompre G, 2013, NEUROBIOL DIS, V49, P128, DOI 10.1016/j.nbd.2012.08.007; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; CONANT K, 1994, ADV NEUROIMMUNOL, V4, P287, DOI 10.1016/S0960-5428(06)80269-X; Crothers Kristina, 2011, Proc Am Thorac Soc, V8, P275, DOI 10.1513/pats.201009-059WR; DeVries HE, 1997, PHARMACOL REV, V49, P143; Dominkus PP, 2017, J NEUROVIROL, V23, P713, DOI 10.1007/s13365-017-0552-x; Elices MJ, 2008, CURR OPIN INVEST DR, V9, P1149; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007; Eugenin EA, 2011, J NEUROSCI, V31, P9456, DOI 10.1523/JNEUROSCI.1460-11.2011; Ferdin J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191613; GALLO P, 1989, J NEUROIMMUNOL, V23, P109, DOI 10.1016/0165-5728(89)90029-5; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Gasbarrini G, ITALIAN J GASTROENTE, V31, P481; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gray LR, 2014, CURR OPIN HIV AIDS, V9, P552, DOI 10.1097/COH.0000000000000108; Gupta RK, 2013, J INFECT DIS, V207, pS101, DOI 10.1093/infdis/jit108; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Henderson LJ, 2012, J VIROL, V86, P9495, DOI 10.1128/JVI.00486-12; Hoxie JA, 1998, J REPROD IMMUNOL, V41, P197, DOI 10.1016/S0165-0378(98)00059-X; Huang ZH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06269-x; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Isidro RA, 2015, HISTOCHEM CELL BIOL, V144, P613, DOI 10.1007/s00418-015-1364-9; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Keely S, 2012, MUCOSAL IMMUNOL, V5, P7, DOI 10.1038/mi.2011.55; Khan MB, 2016, J NEUROVIROL, V22, P179, DOI 10.1007/s13365-015-0383-6; KOTLER DP, 1984, ANN INTERN MED, V101, P421, DOI 10.7326/0003-4819-101-4-421; Kotler DP, 1998, AIDS, V12, P597, DOI 10.1097/00002030-199806000-00008; Lamers SL, 2018, J NEUROVIROL, V24, P1, DOI 10.1007/s13365-017-0586-0; Lamers SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016659; Lampa J, 2012, P NATL ACAD SCI USA, V109, P12728, DOI 10.1073/pnas.1118748109; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; LEPEZUNIGA JL, 1987, J CLIN MICROBIOL, V25, P1695, DOI 10.1128/JCM.25.9.1695-1700.1987; Li GH, 2016, CURR HIV RES, V14, P373, DOI 10.2174/1570162X14666161006121455; Li GH, 2015, AIDS, V29, P755, DOI 10.1097/QAD.0000000000000605; Li Hongyu, 2004, J Cyst Fibros, V3 Suppl 2, P123, DOI 10.1016/j.jcf.2004.05.026; Liu X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09867; Liu Xun, 2014, Sci Rep, V4, P4450, DOI 10.1038/srep04450; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI [10.2735/3489, 10.2741/3489]; Luo XY, 2015, J NEUROVIROL, V21, P66, DOI 10.1007/s13365-014-0304-0; Machowska A., 2008, Inflammopharmacology, V16, P40, DOI 10.1007/s10787-007-1600-6; Marecki JC, 2006, AM J RESP CRIT CARE, V174, P437, DOI 10.1164/rccm.200601-005OC; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Mediouni S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01164; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mordelet E, 2004, FASEB J, V18, P1851, DOI 10.1096/fj.04-2308com; Narasipura SD, 2014, J VIROL, V88, P3031, DOI 10.1128/JVI.03333-13; Nitkiewicz J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0794-9; Nobile C, 2010, J VIROL, V84, P2282, DOI 10.1128/JVI.02230-09; Oliveira SHP, 2008, INFLAMMATION, V31, P36, DOI 10.1007/s10753-007-9047-x; Park IW, 2009, J LEUKOCYTE BIOL, V86, P1171, DOI 10.1189/jlb.0409261; Parnet P, 2002, J NEUROIMMUNOL, V125, P5, DOI 10.1016/S0165-5728(02)00022-X; Pelosi P, 2011, CRIT CARE, V15, DOI 10.1186/cc10259; PLATASALAMAN CR, 1992, PHYSIOL BEHAV, V51, P1277, DOI 10.1016/0031-9384(92)90321-R; Prevedel Lisa, 2019, Curr Protoc Cell Biol, V82, pe64, DOI 10.1002/cpcb.64; Quaranta MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023442; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Rao VR, 2016, METHODS MOL BIOL, V1354, P367, DOI 10.1007/978-1-4939-3046-3_25; Raymond AD, 2016, J NEUROVIROL, V22, P129, DOI 10.1007/s13365-015-0397-0; Russell RA, 2017, CELL REP, V18, P1473, DOI 10.1016/j.celrep.2017.01.027; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; Saribas AS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.467; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schenk M, 2014, IMMUNOLOGY, V141, P174, DOI 10.1111/imm.12167; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sehgal PB, 2009, AM J PHYSIOL-LUNG C, V297, pL729, DOI 10.1152/ajplung.00087.2009; Speth C, 2002, J VIROL, V76, P3179, DOI 10.1128/JVI.76.7.3179-3188.2002; Spindler-Vesel A, 2006, J INTERF CYTOK RES, V26, P771, DOI 10.1089/jir.2006.26.771; Sporer B, 2000, J NEUROIMMUNOL, V102, P125, DOI 10.1016/S0165-5728(99)00170-8; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Ton Hoai, 2013, J AIDS Clin Res, V4, P255; Torres-Munoz J, 2001, J NEUROPATH EXP NEUR, V60, P885, DOI 10.1093/jnen/60.9.885; Trillo-Pazos G, 2000, BRAIN RES, V864, P315, DOI 10.1016/S0006-8993(00)02213-7; Uhl J, 2019, J CELL COMMUN SIGNAL, V13, P209, DOI 10.1007/s12079-018-0493-z; van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024; Verollet C, 2015, BLOOD, V125, P1611, DOI 10.1182/blood-2014-08-596775; Vitkovic L, 2000, MOL PSYCHIATR, V5, P604, DOI 10.1038/sj.mp.4000813; Wang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091063; WERNER T, 1991, AIDS, V5, P1301, DOI 10.1097/00002030-199111000-00003; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753	100	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225760	10.1371/journal.pone.0225760	http://dx.doi.org/10.1371/journal.pone.0225760			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774879	Green Published, gold			2022-12-26	WOS:000533896400057
J	Shridhar, PB; Worley, JN; Gao, X; Yang, X; Noll, LW; Shi, XR; Bai, JF; Meng, JH; Nagaraja, TG				Shridhar, Pragathi B.; Worley, Jay N.; Gao, Xin; Yang, Xun; Noll, Lance W.; Shi, Xiaorong; Bai, Jianfa; Meng, Jianghong; Nagaraja, T. G.			Analysis of virulence potential of Escherichia coli O145 isolated from cattle feces and hide samples based on whole genome sequencing	PLOS ONE			English	Article							UNITED-STATES; BEEF-CATTLE; INFECTIONS; O157; OUTBREAK; GENES; SURVEILLANCE; ASSOCIATION; SEROGROUPS; VARIANTS	Escherichia coli O145 serogroup is one of the big six non-O157 Shiga toxin producing E. coli (STEC) that causes foodborne illnesses in the United States and other countries. Cattle are a major reservoir of STEC, which harbor them in their hindgut and shed in the feces. Cattle feces is the main source of hide and subsequent carcass contaminations during harvest leading to foodborne illnesses in humans. The objective of our study was to determine the virulence potential of STEC O145 strains isolated from cattle feces and hide samples. A total of 71 STEC O145 strains isolated from cattle feces (n = 16), hide (n = 53), and human clinical samples (n = 2) were used in the study. The strains were subjected to whole genome sequencing using Illumina MiSeq platform. The average draft genome size of the fecal, hide, and human clinical strains were 5.41, 5.28, and 5.29 Mb, respectively. The average number of genes associated with mobile genetic elements was 260, 238, and 259, in cattle fecal, hide, and human clinical strains, respectively. All strains belonged to O145:H28 serotype and carried eae subtype gamma. Shiga toxin 1a was the most common Shiga toxin gene subtype among the strains, followed by stx2a and stx2c. The strains also carried genes encoding type III secretory system proteins, nle, and plasmid-encoded virulence genes. Phylogenetic analysis revealed clustering of cattle fecal strains separately from hide strains, and the human clinical strains were more closely related to the hide strains. All the strains belonged to sequence type (ST)-32. The virulence gene profile of STEC O145 strains isolated from cattle sources was similar to that of human clinical strains and were phylogenetically closely related to human clinical strains. The genetic analysis suggests the potential of cattle STEC O145 strains to cause human illnesses. Inclusion of more strains from cattle and their environment in the analysis will help in further elucidation of the genetic diversity and virulence potential of cattle O145 strains.	[Shridhar, Pragathi B.; Shi, Xiaorong; Nagaraja, T. G.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Worley, Jay N.; Gao, Xin; Yang, Xun; Meng, Jianghong] Univ Maryland, Joint Inst Food Safety & Appl Nutr, College Pk, MD 20742 USA; [Worley, Jay N.; Gao, Xin; Yang, Xun; Meng, Jianghong] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Noll, Lance W.; Bai, Jianfa] Kansas State Univ, Vet Diagnost Lab, Manhattan, KS 66506 USA	Kansas State University; University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park; Kansas State University	Nagaraja, TG (corresponding author), Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	tnagaraj@vet-state.edu	Bai, Jianfa/M-7830-2019	Bai, Jianfa/0000-0002-0021-3036; Worley, Jay/0000-0002-5923-1159; Nagaraja, T. G./0000-0002-0899-878X	National Institute of Food and Agriculture, U.S. Department of Agriculture [2012-68003-30155]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2012-68003-30155. The funder had no role in the study design, data collection and analyses, preparation of the manuscript or decision to publish.	Rivero MA, 2010, J MED MICROBIOL, V59, P345, DOI 10.1099/jmm.0.015560-0; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082; Bankevich A, 2012, JCOMPUTBIOL, V19; Beutin L, 1998, EMERG INFECT DIS, V4, P635, DOI 10.3201/eid0404.980415; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Bugarel M, 2010, APPL ENVIRON MICROB, V76, P203, DOI 10.1128/AEM.01921-09; Carter MQ, 2016, APPL ENVIRON MICROB, V82, P1090, DOI 10.1128/AEM.03172-15; Cooper KK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-17; Cull CA, 2017, FOODBORNE PATHOG DIS, V14, P309, DOI 10.1089/fpd.2016.2227; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Fan RY, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1582-8; Folster JP, 2011, ANTIMICROB AGENTS CH, V55, P5955, DOI 10.1128/AAC.05545-11; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Iyoda S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu061; Jacob ME, 2010, J FOOD PROTECT, V73, P1030, DOI 10.4315/0362-028X-73.6.1030; Jajarmi M, 2017, MICROB PATHOGENESIS, V109, P274, DOI 10.1016/j.micpath.2017.05.041; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kozyreva VK, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00344-16; Lorenz SC, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1094-3; Luna R., 2010, NONO157 SHIGA TOXIN; Lyimo Beatus, 2016, Int J Microbiol, V2016, P3103672, DOI 10.1155/2016/3103672; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mshana SE, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-97; Noll LW, 2018, J FOOD PROTECT, V81, P1236, DOI 10.4315/0362-028X.JFP-17-497; Noll LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135446; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Oswald E, 2000, INFECT IMMUN, V68, P64, DOI [10.1128/IAI.68.1.64-71.2000, 10.1128/IAI.68.11.6402-6410.2000]; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schmidt H, 1996, J CLIN MICROBIOL, V34, P2364, DOI 10.1128/JCM.34.10.2364-2367.1996; Silva LEP, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-135; Taylor EV, 2013, J FOOD PROTECT, V76, P939, DOI 10.4315/0362-028X.JFP-12-503; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; USDA-FSIS, 2011, SHIG TOX PROD E COL, V75; VANGASSE B, 2007, EUROSURVEILLANCE, P13; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yoder Jonathan, 2008, MMWR Surveill Summ, V57, P39; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang Q, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1512-4; Zhang XA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050288	47	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225057	10.1371/journal.pone.0225057	http://dx.doi.org/10.1371/journal.pone.0225057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774847	Green Published, gold			2022-12-26	WOS:000533896400022
J	Wang, J; Wong, AWK; Tsang, YK; Wang, SP; Chen, HC				Wang, Jie; Wong, Andus Wing-Kuen; Tsang, Yiu-Kei; Wang, Suiping; Chen, Hsuan-Chih			Behavioural evidence for segments as subordinate units in Chinese spoken word production: The form-preparation paradigm revisited	PLOS ONE			English	Article							PHONOLOGICAL PREPARATION UNIT; TIME-COURSE; PROSODIC INFORMATION; LANGUAGE PRODUCTION; SPEECH PRODUCTION; MANDARIN CHINESE; ORTHOGRAPHY; RETRIEVAL	It is widely acknowledged that phonemic segments are primary phonological units, processed serially, in spoken word production of Germanic languages. However, evidence for a behavioural effect of single-segment overlap on Chinese spoken word production is lacking. The current study adopted the form-preparation paradigm to investigate the effects of segment predictability and segment repetition separately, which were mixed in previous studies. Native Mandarin Chinese speakers named pictures in the following conditions: predictable, unpredictable, and no segment repetition. Different positions in words (i.e., the onset and the rhyme) were examined at the same time. Results revealed a facilitation effect of onset predictability masked by an inhibition tendency of onset repetition, indicating Chinese speakers' ability to prepare the predictable onset. In contrast, rhyme predictability showed a non-significant effect. This pattern of results did not change no matter whether the conditions of unpredictable onset repetition and unpredictable rhyme repetition were mixed in the same context (Experiment 1) or extracted from different blocked contexts (Experiment 2). The finding provides essential support to the claim that phonemic segments are functionally engaged in Chinese spoken word production, and thus adds original evidence to the universal aspect of spoken word production.	[Wang, Jie] Educ Univ Hong Kong, Dept Psychol, Hong Kong, Peoples R China; [Wong, Andus Wing-Kuen] City Univ Hong Kong, Dept Social & Behav Sci, Nam Shan Psychol Lab, Hong Kong, Peoples R China; [Tsang, Yiu-Kei] Hong Kong Baptist Univ, Dept Educ Studies, Hong Kong, Peoples R China; [Wang, Suiping] South China Normal Univ, Sch Psychol, Guangzhou, Peoples R China; [Chen, Hsuan-Chih] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Peoples R China	Education University of Hong Kong (EdUHK); City University of Hong Kong; Hong Kong Baptist University; South China Normal University; Chinese University of Hong Kong	Wang, J (corresponding author), Educ Univ Hong Kong, Dept Psychol, Hong Kong, Peoples R China.	jwang@eduhk.hk	Wang, Jie/L-3215-2019	Wang, Jie/0000-0001-6423-826X; Wang, Suiping/0000-0001-8726-169X; Tsang, Yiu Kei/0000-0002-4978-1333	Direct Grant for Research from The Chinese University of Hong Kong [4052098]; Key Project of National Social Science Foundation of China [15AZD048]	Direct Grant for Research from The Chinese University of Hong Kong; Key Project of National Social Science Foundation of China	This work was supported by a Direct Grant for Research from The Chinese University of Hong Kong [grant number 4052098] to HsuanChih Chen; and a grant from Key Project of National Social Science Foundation of China [grant number 15AZD048] to Suiping Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 2007, COGNITION, V102, P464, DOI 10.1016/j.cognition.2006.02.002; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belke E, 2005, Q J EXP PSYCHOL-A, V58, P667, DOI 10.1080/02724980443000142; Breining B, 2016, PSYCHON B REV, V23, P500, DOI 10.3758/s13423-015-0900-x; Chen JY, 2002, J MEM LANG, V46, P751, DOI 10.1006/jmla.2001.2825; Costa A, 2009, P NATL ACAD SCI USA, V106, P21442, DOI 10.1073/pnas.0908921106; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Damian MF, 2009, LANG COGNITIVE PROC, V24, P685, DOI 10.1080/01690960802351260; Damian MF, 2003, J MEM LANG, V49, P119, DOI 10.1016/S0749-596X(03)00008-1; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Howard D, 2006, COGNITION, V100, P464, DOI 10.1016/j.cognition.2005.02.006; Kureta Y, 2006, J EXP PSYCHOL LEARN, V32, P1102, DOI 10.1037/0278-7393.32.5.1102; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 1999, TRENDS COGN SCI, V3, P223, DOI 10.1016/S1364-6613(99)01319-4; Li CC, 2017, BILING-LANG COGN, V20, P351, DOI 10.1017/S1366728915000711; Li CC, 2015, MEM COGNITION, V43, P563, DOI 10.3758/s13421-014-0484-0; MEYER AS, 1991, J MEM LANG, V30, P69, DOI 10.1016/0749-596X(91)90011-8; MEYER AS, 1990, J MEM LANG, V29, P524, DOI 10.1016/0749-596X(90)90050-A; O'Seaghdha PG, 2014, J EXP PSYCHOL LEARN, V40, P797, DOI 10.1037/a0035576; O'Seaghdha PG, 2010, COGNITION, V115, P282, DOI 10.1016/j.cognition.2010.01.001; Oppenheim GM, 2010, COGNITION, V114, P227, DOI 10.1016/j.cognition.2009.09.007; Qu QQ, 2012, P NATL ACAD SCI USA, V109, P14265, DOI 10.1073/pnas.1200632109; R Core Team, 2021, R LANGUAGE ENV STAT; Roelofs A, 1997, COGNITION, V64, P249, DOI 10.1016/S0010-0277(97)00027-9; Roelofs A, 2015, JPN PSYCHOL RES, V57, P22, DOI 10.1111/jpr.12050; Schiller NO, 2008, COGNITION, V106, P952, DOI 10.1016/j.cognition.2007.03.007; Sulpizio S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01612; Verdonschot RG, 2015, JPN PSYCHOL RES, V57, P61, DOI 10.1111/jpr.12064; Wang J, 2018, PSYCHON B REV, V25, P1147, DOI 10.3758/s13423-017-1325-5; Wang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05661-x; Wong AWK, 2008, J EXP PSYCHOL LEARN, V34, P1172, DOI 10.1037/a0013000; Wong AWK, 2019, LANG COGN NEUROSCI, V34, P677, DOI 10.1080/23273798.2018.1562559; Wong AWK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207617; Wong AWK, 2015, JPN PSYCHOL RES, V57, P69, DOI 10.1111/jpr.12054; Wong AWK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048776; Wong AWK, 2009, PSYCHON B REV, V16, P888, DOI 10.3758/PBR.16.5.888; Yu MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106486; Zhang QF, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13317; [张清芳 ZHANG QingFang], 2008, [心理学报, Acta Psychologica Sinica], V40, P253	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225718	10.1371/journal.pone.0225718	http://dx.doi.org/10.1371/journal.pone.0225718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8SS	31774874	Green Published, gold			2022-12-26	WOS:000533896400053
J	Kwong, YD; Chen, S; Bouajram, R; Li, F; Matthay, MA; Mehta, KM; Glidden, DV; Liu, KD				Kwong, Yuenting D.; Chen, Sheldon; Bouajram, Rima; Li, Fanny; Matthay, Michael A.; Mehta, Kala M.; Glidden, David, V; Liu, Kathleen D.			The value of kinetic glomerular filtration rate estimation on medication dosing in acute kidney injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; CREATININE CLEARANCE; FLUID-MANAGEMENT; GFR; RECOMMENDATIONS; PREDICTION; EQUATION; EGFR	Background In acute kidney injury (AKI), medication dosing based on Cockcroft-Gault creatinine clearance (CrCl) or Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimated glomerular filtration rates (eGFR) are not valid when serum creatinine (SCr) is not in steady state. The aim of this study was to determine the impact of a kinetic estimating equation that incorporates fluctuations in SCrs on drug dosing in critically ill patients. Methods We used data from participants enrolled in the NIH Acute Respiratory Distress Syndrome Network Fluid and Catheters Treatment Trial to simulate drug dosing category changes with the application of the kinetic estimating equation developed by Chen. We evaluated whether kinetic estimation of renal function would change medication dosing categories (>= 60, 30-59, 15-29, and < 15mL/min) compared with the use of CrCl or CKD-EPI eGFR. Results The use of kinetic CrCl and CKD-EPI eGFR resulted in a large enough change in estimated renal function to require medication dosing recategorization in 19.3% [95 CI 16.8%-21.9%] and 23.4% [95% CI 20.7%-26.1%] of participants, respectively. As expected, recategorization occurred more frequently in those with AKI. When we examined individual days for those with AKI, dosing discordance was observed in 8.5% of total days using the CG CrCl and 10.2% of total days using the CKD-EPI equation compared with the kinetic counterparts. Conclusion In a critically ill population, use of kinetic estimates of renal function impacted medication dosing in a substantial proportion of AKI participants. Use of kinetic estimates in clinical practice should lower the incidence of medication toxicity as well as avoid subtherapeutic dosing during renal recovery.	[Kwong, Yuenting D.; Liu, Kathleen D.] Univ Calif San Francisco, Sch Med, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Chen, Sheldon] MD Anderson, Div Nephrol, Dept Med, Houston, TX USA; [Bouajram, Rima; Li, Fanny] Univ Calif San Francisco, Med Ctr, Dept Pharmaceut Serv, San Francisco, CA USA; [Matthay, Michael A.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, Sch Med, San Francisco, CA USA; [Mehta, Kala M.; Glidden, David, V] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA; [Liu, Kathleen D.] Univ Calif San Francisco, Sch Med, Dept Anesthesia, Div Crit Care Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kwong, YD (corresponding author), Univ Calif San Francisco, Sch Med, Dept Med, Div Nephrol, San Francisco, CA 94143 USA.	Diana.kwong@ucsf.edu	Bouajram, Rima H./ABH-6028-2020; Glidden, David/AAD-4730-2020	Glidden, David/0000-0001-5888-1419; Chen, Sheldon/0000-0002-5427-4969	National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) of the National Institutes of Health (NIH) [T32 DK007219, F32DK118870, 1K24DK113381]; American Society of Nephrology Donald E. Wesson Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK113381, T32DK007219, F32DK118870] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) of the National Institutes of Health (NIH); American Society of Nephrology Donald E. Wesson Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) of the National Institutes of Health (NIH grants T32 DK007219 and F32DK118870 to Dr Kwong and 1K24DK113381 to Dr. Liu) and the American Society of Nephrology Donald E. Wesson Fellowship to Dr. Kwong. The funders of this study had no role in study design, collection, analysis, and interpretation of data.	Bouchard J, 2010, NEPHROL DIAL TRANSPL, V25, P102, DOI 10.1093/ndt/gfp392; Bragadottir G, 2013, CRIT CARE, V17, DOI 10.1186/cc12777; Carrie C, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2117-7; Chawla LS, 2017, NAT REV NEPHROL, V13, P241, DOI 10.1038/nrneph.2017.2; Chen S, 2018, ADV CHRONIC KIDNEY D, V25, P105, DOI 10.1053/j.ackd.2017.10.013; Chen S, 2013, J AM SOC NEPHROL, V24, P877, DOI 10.1681/ASN.2012070653; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; CHIOU WL, 1975, RES COMMUN CHEM PATH, V10, P315; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dewitte A, 2015, CLIN J AM SOC NEPHRO, V10, P1900, DOI 10.2215/CJN.12651214; Endre ZH, 2016, NEPHRON, V132, P312, DOI 10.1159/000444456; Gill J, 2007, NEPHROL DIAL TRANSPL, V22, P2894, DOI 10.1093/ndt/gfm289; Golik MV, 2008, PHARMACOTHERAPY, V28, P1125, DOI 10.1592/phco.28.9.1125; Grissom CK, 2015, CRIT CARE MED, V43, P288, DOI 10.1097/CCM.0000000000000715; Harada D, 2018, INT J CLIN PHARM TH, V56, P612, DOI 10.5414/CP203266; Hekmat R, 2017, EXP CLIN TRANSPLANT, V15, P104, DOI 10.6002/ect.mesot2016.O104; Jelliffe R, 2002, AM J NEPHROL, V22, P320, DOI 10.1159/000065221; JELLIFFE R W, 1972, Mathematical Biosciences, V14, P17, DOI 10.1016/0025-5564(72)90003-X; Jones Graham Rd, 2011, Clin Biochem Rev, V32, P81; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu KD, 2011, CRIT CARE MED, V39, P2665, DOI 10.1097/CCM.0b013e318228234b; Macedo E, 2010, CRIT CARE, V14, DOI 10.1186/cc9004; Marques FD, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1873-0; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; MORAN SM, 1985, KIDNEY INT, V27, P928, DOI 10.1038/ki.1985.101; O'Sullivan ED, 2017, CLIN KIDNEY J, V10, P202, DOI 10.1093/ckj/sfw108; Pianta TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125669; Pickkers P, 2017, INTENS CARE MED, V43, P1198, DOI 10.1007/s00134-017-4687-2; Seelhammer TG, 2016, J CRIT CARE, V31, P249, DOI 10.1016/j.jcrc.2015.11.006; Stevens LA, 2009, AM J KIDNEY DIS, V54, P33, DOI 10.1053/j.ajkd.2009.03.008; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; US Department of Health and Humans Services.Food and Drug Administration & Center for Drug Evaluation and Research (CDER), 2010, GUID IND PHARM PAT I; Weinberg L, 2017, BRIT J ANAESTH, V119, P606, DOI 10.1093/bja/aex163; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Yashiro M, 2012, CLIN EXP NEPHROL, V16, P570, DOI 10.1007/s10157-012-0602-x; Yasuhara M, 1998, THER DRUG MONIT, V20, P139, DOI 10.1097/00007691-199804000-00003	38	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225601	10.1371/journal.pone.0225601	http://dx.doi.org/10.1371/journal.pone.0225601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770424	Green Published, gold			2022-12-26	WOS:000533892300028
J	Dignam, C; Thomas, J; Brown, M; Thompson, CH				Dignam, Colette; Thomas, Josephine; Brown, Margaret; Thompson, Campbell H.			The impact of language on the interpretation of resuscitation clinical care plans by doctors. A mixed methods study	PLOS ONE			English	Article							ORDERS	Introduction Resuscitation clinical care plans (resuscitation plans) are gradually replacing 'Not for Cardiopulmonary Resuscitation' orders in the hospital setting. The 7-Step Pathway Resuscitation Plan and Alert form (7-Step form) is one example of a resuscitation plan. Treatment recommendations in resuscitation plans currently lack standardised language, creating potential for misinterpretation and patient harm. Aims To explore how terminology used in resuscitation plans is interpreted and applied by clinicians. Method A mixed methods study surveyed 50 general medical doctors, who were required to interpret and apply a 7-Step form in three case vignettes and define seven key terms. Statistical analysis on multiple choice and thematic analysis on free-text responses was performed. Results Terminology was inconsistently interpreted and inconsistently applied, resulting in clinically significant differences in treatment choices. Three key themes influenced the application of a resuscitation plan: in-depth discussion, precise documentation and personal experience of the bedside deciding doctor. Discussion This study highlights persistent communication deficiencies in resuscitation plan documentation and how this may adversely affect patient care; findings unlikely to be unique to Australia or South Australia. Conclusion Removing ambiguity by standardising and defining the terminology in resuscitation plans will improve bedside decision-making, while also supporting the rights of the patient to receive appropriate and desired care.	[Dignam, Colette; Thompson, Campbell H.] Univ Adelaide, Fac Hlth & Med Sci, Div Med, Adelaide, SA, Australia; [Dignam, Colette; Thompson, Campbell H.] Royal Adelaide Hosp, Div Med, Adelaide, SA, Australia; [Thomas, Josephine] Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Adelaide, SA, Australia; [Brown, Margaret] Univ South Australia, Sch Psychol Social Work & Social Policy, Div Educ Arts & Social Sci, Adelaide, SA, Australia	University of Adelaide; Royal Adelaide Hospital; University of Adelaide; University of South Australia	Dignam, C (corresponding author), Univ Adelaide, Fac Hlth & Med Sci, Div Med, Adelaide, SA, Australia.; Dignam, C (corresponding author), Royal Adelaide Hosp, Div Med, Adelaide, SA, Australia.	colette.dignam@sa.gov.au	Thompson, Campbell/E-2885-2010	Thompson, Campbell/0000-0002-5164-3327; Thomas, Josephine/0000-0001-8124-5920; Brown, Margaret/0000-0001-8127-8669; Dignam, Colette/0000-0003-3319-1037				Akhunbay-Fudge CY, 2014, BMJ QUAL IMPROV REP, P3; Australian Commission on Safety and Quality in Health Care, 2015, NATL CONS STAT ESS E; Beach MC, 2002, J AM GERIATR SOC, V50, P2057, DOI 10.1046/j.1532-5415.2002.50620.x; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Citko J, 2011, J PALLIAT MED, V14, P241, DOI 10.1089/jpm.2010.9730; Dignam C, 2019, AUSTRALAS J AGEING, V38, P28, DOI 10.1111/ajag.12587; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Fadel Michael G, 2018, BMJ Open Qual, V7, pe000268, DOI 10.1136/bmjoq-2017-000268; Fritz Z, 2017, BMJ, V356, P1; Fritz Z, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2213; Health SA, 2014, RES PLAN 7 STEP PATH; Hui D, 2013, SUPPORT CARE CANCER, V21, P659, DOI 10.1007/s00520-012-1564-y; Patient Care Quality Office, MED ORD SCOP TREATM; Schmidt TA, 2014, RESUSCITATION, V85, P480, DOI 10.1016/j.resuscitation.2013.11.027; Shermon E., 2017, BMJ OPEN QUAL, V6, DOI [10.1136/bmjoq-2017-000011, DOI 10.1136/BMJOQ-2017-000011]; The National POLST Paradigm, NAT POLST FORM PORT; Zanartu C, 2013, AM J HOSP PALLIAT ME, V30, P35, DOI 10.1177/1049909112440740	17	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225338	10.1371/journal.pone.0225338	http://dx.doi.org/10.1371/journal.pone.0225338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765418	Green Published, gold, Green Accepted			2022-12-26	WOS:000533891000022
J	Kuo, LT; Chen, HM; Yu, PA; Chen, CL; Hsu, WH; Tsai, YH; Chen, KJ; Chen, VCH				Kuo, Liang-Tseng; Chen, Hong-Ming; Yu, Pei-An; Chen, Chi-Lung; Hsu, Wei-Hsiu; Tsai, Yao-Hung; Chen, Ko-Jung; Chen, Vincent Chin-Hung			Depression increases the risk of rotator cuff tear and rotator cuff repair surgery: A nationwide population-based study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INFLAMMATION; DEGENERATION; ASSOCIATION; DISEASE; COPD	Background Chronic inflammation is known to be associated with both rotator cuff tears (RCTs) and depression. However, no epidemiological studies with a longitudinal follow-up have been performed to prove this association. We aimed to investigate whether depressed patients had an elevated risk of RCT and subsequent repair surgery compared with those without depression. Methods This retrospective cohort study comprised of patients diagnosed with depression between 2000 and 2010 (depression cohort) and patients without depression (non-depression cohort, 1:2 age and sex matched). The risk of RCT and rotator cuff repair surgery were determined during a 13-year follow-up (2000-2013) between these two cohorts. Results This study included 26,868 patients with depression and 53,736 patients without depression. The incidence of RCT was 648 and 438 per 100,000 person-years in the depression and non-depression cohorts, respectively. The adjusted hazard ratio (HR) was 1.46 (95% confidence interval [CI], 1.36-1.57) for depressed patients. The incidence of rotator cuff repair surgery was 28 and 18 per 100,000 person-years in the depression and non-depression cohorts, respectively. Depressed patients also had a significantly increased risk of subsequent rotator cuff repair surgery (adjusted HR = 1.46; 95% CI, 1.04-2.06). Conclusion The present study showed that depression was associated with an increased risk of rotator cuff tear and rotator cuff repair surgery.	[Kuo, Liang-Tseng; Yu, Pei-An; Chen, Chi-Lung; Hsu, Wei-Hsiu; Tsai, Yao-Hung] Chang Gung Mem Hosp, Dept Orthopaed Surg, Div Sports Med, Chiayi, Taiwan; [Kuo, Liang-Tseng; Hsu, Wei-Hsiu; Chen, Vincent Chin-Hung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chen, Hong-Ming; Chen, Vincent Chin-Hung] Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan; [Chen, Ko-Jung] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, VCH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Chen, VCH (corresponding author), Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan.	hjcch@yahoo.com.tw	Kuo, Liang-Tseng/AAA-5890-2019	Kuo, Liang-Tseng/0000-0002-5507-8396	 [CLRPG6G0041]		The authors would like to thank the Health Information and Epidemiology Laboratory (CLRPG6G0041) for their comments and assistance in data analysis.	Abraham AC, 2017, TECH SHOULDER ELBOW, V18, P84, DOI 10.1097/BTE.0000000000000124; Bennett S, 2014, MATURITAS, V79, P184, DOI 10.1016/j.maturitas.2014.05.009; Boettger MK, 2008, ARTHRITIS RHEUM-US, V58, P2368, DOI 10.1002/art.23608; Chaudhury S, 2012, ARTHRIT CARE RES, V64, P76, DOI 10.1002/acr.20552; Chhana A, 2014, ANN RHEUM DIS, V73, P1737, DOI 10.1136/annrheumdis-2013-204657; Chung SW, 2012, AM J SPORT MED, V40, P631, DOI 10.1177/0363546511430309; Ford DE, 1998, ARCH INTERN MED, V158, P1422, DOI 10.1001/archinte.158.13.1422; Franceschi C., 2014, J GERONTOL A BIOL S1, V69, P4, DOI [DOI 10.1093/GER0NA/GLU057, 10.1093/gerona/glu057, DOI 10.1093/GERONA/GLU057]; Hashimoto T, 2003, CLIN ORTHOP RELAT R, P111, DOI 10.1097/01/blo.0000092974.12414.22; Jiang XZ, 2018, INT J CARDIOL, V271, P8, DOI 10.1016/j.ijcard.2018.05.085; Jordan N, 2007, J GEN INTERN MED, V22, P1447, DOI 10.1007/s11606-007-0328-8; Leonard BE, 2015, MOD TR PHARMACOPSYCH, V30, P22, DOI 10.1159/000435930; Lewinson RT, 2017, J INVEST DERMATOL, V137, P828, DOI 10.1016/j.jid.2016.11.032; Lin TTL, 2015, AM J SPORT MED, V43, P2126, DOI 10.1177/0363546515588173; Lipscomb H, 2008, AM J IND MED, V51, P24, DOI 10.1002/ajim.20527; Rivera CM, 2016, LUNG, V194, P335, DOI 10.1007/s00408-016-9862-7; Mikova O, 2001, EUR NEUROPSYCHOPHARM, V11, P203, DOI 10.1016/S0924-977X(01)00081-5; Nho SJ, 2008, AM J SPORT MED, V36, P987, DOI 10.1177/0363546508317344; Pasic J, 2003, PSYCHOSOM MED, V65, P181, DOI 10.1097/01.PSY.0000058372.50240.38; Ranger TA, 2016, BRIT J SPORT MED, V50, P982, DOI 10.1136/bjsports-2015-094735; Rees JD, 2014, BRIT J SPORT MED, V48, P1553, DOI 10.1136/bjsports-2012-091957; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Sasaki K, 2012, J ELECTRON MICROSC, V61, P327, DOI 10.1093/jmicro/dfs057; Schubert TEO, 2005, ANN RHEUM DIS, V64, P1083, DOI 10.1136/ard.2004.029876; Schweyer S, 2000, VIRCHOWS ARCH, V437, P534, DOI 10.1007/s004280000282; Tsouli SG, 2005, EUR J CLIN INVEST, V35, P236, DOI 10.1111/j.1365-2362.2005.01484.x; Wani Z, 2016, TRAUMA, V18, P190, DOI 10.1177/1460408615596770; Wassertheil-Smoller S, 2004, ARCH INTERN MED, V164, P289, DOI 10.1001/archinte.164.3.289; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yoshimura R, 2009, PROG NEURO-PSYCHOPH, V33, P722, DOI 10.1016/j.pnpbp.2009.03.020; Zakaria MHB, 2014, DIABETIC MED, V31, P425, DOI 10.1111/dme.12344; Zunszain Patricia A, 2013, Curr Top Behav Neurosci, V14, P135, DOI 10.1007/7854_2012_211	32	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225778	10.1371/journal.pone.0225778	http://dx.doi.org/10.1371/journal.pone.0225778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765424	Green Published, gold			2022-12-26	WOS:000533891000046
J	Berendes, D; Knee, J; Sumner, T; Capone, D; Lai, A; Wood, A; Patel, S; Nala, R; Cumming, O; Brown, J				Berendes, David; Knee, Jackie; Sumner, Trent; Capone, Drew; Lai, Amanda; Wood, Anna; Patel, Siddhartha; Nala, Rassul; Cumming, Oliver; Brown, Joe			Gut carriage of antimicrobial resistance genes among young children in urban Maputo, Mozambique: Associations with enteric pathogen carriage and environmental risk factors	PLOS ONE			English	Article							FECAL SLUDGE MANAGEMENT; ANTIBIOTIC-RESISTANCE; TETRACYCLINE RESISTANCE; ESCHERICHIA-COLI; RESISTOME; INFECTION; PANEL; SANITATION; BACTERIA; MECHANISMS	Because poor sanitation is hypothesized as a major direct and indirect pathway of exposure to antimicrobial resistance genes (ARGs), we sought to determine a) the prevalence of and b) environmental risk factors for gut carriage of key ARGs in a pediatric cohort at high risk of enteric infections due to poor water, sanitation, and hygiene (WASH) conditions. We investigated ARGs in stool from young children in crowded, low-income settlements of Maputo, Mozambique, and explored potential associations with concurrent enteric pathogen carriage, diarrhea, and environmental risk factors, including WASH. We collected stool from 120 children <14 months old and tested specimens via quantal, multiplex molecular assays for common bacterial, viral, and protozoan enteric pathogens and 84 ARGs encoding potential resistance to 7 antibiotic classes. We estimated associations between ARG detection (number and diversity detected) and concurrently-measured enteric pathogen carriage, recently-reported diarrhea, and risk factors in the child's living environment. The most commonly-detected ARGs encoded resistance to macrolides, lincosamides, and streptogramins (100% of children); tetracyclines (98%); beta-lactams (94%), aminoglycosides (84%); fluoroquinolones (48%); and vancomycin (38%). Neither concurrent diarrhea nor measured environmental (including WASH) conditions were associated with ARG detection in adjusted models. Enteric pathogen carriage and ARG detection were associated: on average, 18% more ARGs were detected in stool from children carrying bacterial pathogens than those without (adjusted risk ratio (RR): 1.18, 95% confidence interval (CI): 1.02, 1.37), with 16% fewer ARGs detected in children carrying parasitic pathogens (protozoans, adjusted RR: 0.84, 95% CI: 0.71, 0.99). We observed gut ARGs conferring potential resistance to a range of antibiotics in this at-risk cohort that had high rates of enteric infection, even among children <14 months-old. Gut ARGs did not appear closely correlated with WASH, though environmental conditions were generally poor. ARG carriage may be associated with concurrent carriage of bacterial enteric pathogens, suggesting indirect linkages to WASH that merit further investigation.	[Berendes, David] US Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA; [Berendes, David; Knee, Jackie; Sumner, Trent; Capone, Drew; Lai, Amanda; Patel, Siddhartha; Brown, Joe] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Wood, Anna] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Nala, Rassul] Natl Inst Hlth, Maputo, Mozambique; [Cumming, Oliver] London Sch Trop Med & Hyg, Dept Dis Control, London, England	Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia Institute of Technology; Emory University; Rollins School Public Health; University of London; London School of Hygiene & Tropical Medicine	Berendes, D (corresponding author), US Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA.; Berendes, D (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.	dberendes@cdc.gov	Knee, Jackie/AAB-4434-2021; Capone, Drew/ABC-4505-2021; Brown, Joe/ABF-8201-2020	Knee, Jackie/0000-0002-0834-8488; Capone, Drew/0000-0002-2138-6382; Brown, Joe/0000-0002-5200-4148; Cumming, Oliver/0000-0002-5074-8709; Wood, Anna/0000-0002-5033-4629; Lai, Amanda/0000-0002-3768-7294	United States Agency for International Development under Translating Research to Action [GHS-A-00-09-0001500]; Bill and Melinda Gates Foundation [OPP1137224]; Emory HERCULES center [T846289, NIH/NIEHS/5P50ES026071-02]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES026071, P30ES019776] Funding Source: NIH RePORTER	United States Agency for International Development under Translating Research to Action; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Emory HERCULES center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this study came from the United States Agency for International Development under Translating Research to Action (Cooperative Agreement #GHS-A-00-09-0001500, usaid.gov), the Bill and Melinda Gates Foundation (OPP1137224, gatesfoundation.org), and subaward T846289 from the Emory HERCULES center (prime award: NIH/NIEHS/5P50ES026071-02, niehs.nih.gov). JB and OC obtained all funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agga GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132586; Alicea-Serrano AM, 2013, ARCH MICROBIOL, V195, P447, DOI 10.1007/s00203-012-0864-4; Arango-Argoty GA, 2017, BIORXIV; Ashbolt NJ, 2013, ENVIRON HEALTH PERSP, V121, P993, DOI 10.1289/ehp.1206316; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baum R, 2013, ENVIRON SCI TECHNOL, V47, P1994, DOI 10.1021/es304284f; Berendes D, 2017, TROP MED INT HEALTH, P1; Berendes D, 2017, AM J TROP MED HYG, V96, P1404, DOI 10.4269/ajtmh.16-0170; Berendes DM, 2018, NAT SUSTAIN, V1, P679, DOI 10.1038/s41893-018-0167-0; Berendes DM, 2017, ENVIRON SCI TECHNOL, V51, P3074, DOI 10.1021/acs.est.6b06019; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Bouki C, 2013, ECOTOX ENVIRON SAFE, V91, P1, DOI 10.1016/j.ecoenv.2013.01.016; Brown J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008215; Calero-Caceres W, 2014, ENVIRON SCI TECHNOL, V48, P7602, DOI 10.1021/es501851s; Center for Disease Dynamics and Policy, 2015, STAT WORLDS ANT 2015; Chirindze LM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3154-1; Collignon P, 2018, LANCET PLANET HEALTH, V2, pE398, DOI 10.1016/S2542-5196(18)30186-4; Cotton JA, 2015, PATHOGENS, V4, P764, DOI 10.3390/pathogens4040764; Cotton JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109087; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; Deng JK, 2015, DIAGN MICR INFEC DIS, V83, P325, DOI 10.1016/j.diagmicrobio.2015.07.024; Eibach D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1481-7; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Fisher JC, 2015, APPL ENVIRON MICROB, V81, P7023, DOI 10.1128/AEM.01524-15; Fletcher S, 2015, ENVIRON HEALTH PREV, V20, P243, DOI 10.1007/s12199-015-0468-0; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Global Antibiotic Resistance Partnership Mozambican Ministry of Health Centro de investigacao em saude de manhica, 2015, CTR INV SAUD MANH SI; Gosalbes MJ, 2016, J DEV ORIG HLTH DIS, V7, P35, DOI 10.1017/S2040174415001506; Graham DW, 2014, ENVIRON SCI TECHNOL, V48, P11746, DOI 10.1021/es504206x; Graham DW, 2018, WATER, V11; Han XM, 2016, ENVIRON POLLUT, V211, P48, DOI 10.1016/j.envpol.2015.12.033; Hu HW, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv169; Huddleston JR, 2014, INFECT DRUG RESIST, V7, P167, DOI 10.2147/IDR.S48820; Igbokwe H, 2015, EPIDEMIOL INFECT, V143, P494, DOI 10.1017/S0950268814001046; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jouhten H, 2016, CLIN INFECT DIS, V63, P710, DOI 10.1093/cid/ciw390; Kao SJ, 2000, ANTIMICROB AGENTS CH, V44, P2876, DOI 10.1128/AAC.44.10.2876-2879.2000; Karami N, 2006, ANTIMICROB AGENTS CH, V50, P156, DOI 10.1128/AAC.50.1.156-161.2006; Karanika S, 2016, CLIN INFECT DIS, V63, P195, DOI 10.1093/cid/ciw240; Keenan JD, 2018, NEW ENGL J MED, V378, P1583, DOI [10.1056/nejmoa1715474, 10.1056/NEJMoa1715474]; Knee J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006956; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Ma YJ, 2011, ENVIRON SCI TECHNOL, V45, P7855, DOI 10.1021/es200827t; Mandomando I, 2009, ANTIMICROB AGENTS CH, V53, P2450, DOI 10.1128/AAC.01282-08; Mandomando IM, 2007, AM J TROP MED HYG, V76, P522, DOI 10.4269/ajtmh.2007.76.522; Manko A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178647; McLain JE, 2016, J ENV QUAL; Montealegre MC, 2018, APPL ENV MICROBIOL; Moore AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0090-9; Moore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078822; Mshana SE, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-28; Navidad JF, 2013, J CLIN MICROBIOL, V51, P3018, DOI 10.1128/JCM.00896-13; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Organization W.H., 2017, PROGR DRINKING WATER; Pal C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0199-5; Parnanen K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06393-w; Patel A, 2014, J CLIN MICROBIOL, V52, P3068, DOI 10.1128/JCM.01393-14; Perry MD, 2014, J MED MICROBIOL, V63, P1419, DOI 10.1099/jmm.0.074773-0; PIELOU EC, 1966, AM NAT, V100, P463, DOI 10.1086/282439; R Core Team, 2021, R LANGUAGE ENV STAT; Rogawski ET, 2017, B WORLD HEALTH ORGAN, V95, P49, DOI 10.2471/BLT.16.176123; Rolain JM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00173; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SUTCLIFFE JG, 1978, P NATL ACAD SCI USA, V75, P3737, DOI 10.1073/pnas.75.8.3737; Suzuki S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6792; Talukdar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061090; Vikesland PJ, 2017, ENVIRON SCI TECHNOL, V51, P13061, DOI 10.1021/acs.est.7b03623; Vikram A, 2017, APPL ENVIRON MICROB, V83, P1; von Wintersdorff CJH, 2016, FUTURE MICROBIOL, V11, P501, DOI 10.2217/fmb.15.154; Duong VT, 2016, J CLIN MICROBIOL, V54, P1094, DOI 10.1128/JCM.03321-15; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614	74	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225464	10.1371/journal.pone.0225464	http://dx.doi.org/10.1371/journal.pone.0225464			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756196	Green Accepted, Green Published, gold			2022-12-26	WOS:000533889300032
J	Felker-Kantor, EA; Cunningham-Myrie, C; Greene, LG; Lyew-Ayee, P; Atkinson, U; Abel, W; Clarke, P; Anderson, SG; Theall, KP				Felker-Kantor, Erica Ann; Cunningham-Myrie, Colette; Greene, Lisa-Gaye; Lyew-Ayee, Parris; Atkinson, Uki; Abel, Wendel; Clarke, Pernell; Anderson, Simon G.; Theall, Katherine P.			Neighborhood crime, disorder and substance use in the Caribbean context: Jamaica National Drug Use Prevalence Survey 2016	PLOS ONE			English	Article							GENDER-DIFFERENCES; ALCOHOL; SMOKING; URBAN; STRESS; SAFETY; DISADVANTAGE; ASSOCIATIONS; DEPRIVATION; PERCEPTIONS	The purpose of the study was to examine the role of objective and subjective measures of neighborhood crime and disorder on substance use among a nationally representative sample of 4525 Jamaicans aged 12-65 years. Log-Poisson models with generalized estimating equations were used to estimate relative risks (RR) and 95% confidence intervals (CI). A test of interaction was used to determine presence of effect modification by sex. Approximately 39% of the study population reported past-month alcohol use; 10% past-month tobacco use; and 15% past-month marijuana use. In fully adjusted models, past-month alcohol and tobacco use were associated with perceived neighborhood disorder (p< 0.05). The likelihood of alcohol use was 1.12 (95%CI:1.04, 1.20) times greater among participants who perceived higher neighborhood disorder. The likelihood of tobacco use was 1.22 (95%CI: 1.01, 1.46) times greater among participants who perceived higher neighborhood disorder. A significant test for interaction in adjusted models (P< 0.2) suggested that the associations between substance use and perceived neighborhood disorder varied by sex. Examination of stratified models indicated that the role of perceived neighborhood disorder on alcohol and tobacco consumption varied among females, but not males. Females who perceived higher levels of neighborhood disorder had an increased likelihood of past-month alcohol and tobacco use (RRa:1.25 95%CI:1,07, 1.45; RRa:1.73 95%CI: 1.10, 2.67). Objective neighborhood crime measures were not associated with alcohol, tobacco, or marijuana use. The study findings provide evidence for the importance of considering subjective and objective neighborhood measures when examining relations with health outcome and demonstrate that perceptions of context and contextual exposures are not uniform across populations within neighborhoods. Interventions focused on building community trust and social cohesion (e.g. neighborhood community watch groups) and greening of blighted or abandoned spaces may help increase the sense of safety and order, reducing stress and maladaptive coping such as substance use.	[Felker-Kantor, Erica Ann; Theall, Katherine P.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA; [Cunningham-Myrie, Colette; Abel, Wendel] Univ West Indies, Dept Community Hlth & Psychiat, Kingston, Jamaica; [Greene, Lisa-Gaye; Lyew-Ayee, Parris] Univ West Indies, Mona GeoInformat Inst, Jamaica, NY USA; [Atkinson, Uki] Minist Hlth, Natl Council Drug Abuse, Jamaica, NY USA; [Clarke, Pernell] Interamer Drug Abuse Control Commiss, Org Amer States, Washington, DC USA; [Anderson, Simon G.] Univ West Indies, Caribbean Inst Hlth Res, George Alleyne Chron Dis Res Ctr, Cave Hill, Barbados	Tulane University; University West Indies Mona Jamaica; University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Cunningham-Myrie, C (corresponding author), Univ West Indies, Dept Community Hlth & Psychiat, Kingston, Jamaica.	colette.cunninghammyrie@uwimona.edu.jm	Anderson, Simon G/AGM-2359-2022	Anderson, Simon G/0000-0002-8896-073X				Aiken L. S., 1991, MULTIPLE REGRESSION; Ambrey CL, 2014, SOC INDIC RES, V119, P877, DOI 10.1007/s11205-013-0521-6; Andrews JO, 2014, J URBAN HEALTH, V91, P1158, DOI 10.1007/s11524-014-9911-6; [Anonymous], 2014, PUBLIC HLTH REV; Baldock KL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201336; Boardman JD, 2001, J HEALTH SOC BEHAV, V42, P151, DOI 10.2307/3090175; Bryant KJ, 1997, SCI PREVENTION METHO; Bryden A, 2013, HEALTH PLACE, V21, P70, DOI 10.1016/j.healthplace.2013.01.012; Burdette HL, 2005, PEDIATRICS, V116, P657, DOI 10.1542/peds.2004-2443; Byrnes HF, 2017, HEALTH PLACE, V43, P151, DOI 10.1016/j.healthplace.2016.12.004; Centers for Disease Control and Prevention [CDC], ALC REL DIS IMP ARDI; Clavel T., 2018, 2017 HOMICIDE RATES; Degenhardt L, 2018, LANCET PSYCHIAT, V5, P987, DOI 10.1016/S2215-0366(18)30337-7; Ellaway A, 2009, J EPIDEMIOL COMMUN H, V63, P78, DOI 10.1136/jech.2007.068767; ELLAWAY A, 2001, GEOGRAPHIES WOMENS H; Fagan AA, 2015, SOC SCI RES, V49, P314, DOI 10.1016/j.ssresearch.2014.08.015; Felker-Kantor E, 2017, HEALTH PLACE, V46, P130, DOI 10.1016/j.healthplace.2017.05.011; French Michael T., 2000, Subst Abus, V21, P95, DOI 10.1023/A:1007763129628; Furr-Holden CDM, 2011, J STUD ALCOHOL DRUGS, V72, P371, DOI 10.15288/jsad.2011.72.371; Galaviz KI, 2016, J PHYS ACT HEALTH, V13, P1110, DOI 10.1123/jpah.2015-0557; Galea S, 2002, PUBLIC HEALTH REP, V117, pS135; Galea S, 2007, AM J PREV MED, V32, pS195, DOI 10.1016/j.amepre.2007.04.003; Ganz ML, 2000, AM J PUBLIC HEALTH, V90, P367, DOI 10.2105/AJPH.90.3.367; Harriott A., 2016, CRIME VIOLENCE JAMAI; HARRISON L, 1992, CRIME DELINQUENCY, V38, P422, DOI 10.1177/0011128792038004002; Hart T, 2014, POLICING, V37, P305, DOI 10.1108/PIJPSM-04-2013-0039; Hawkins JD, 2004, PREV SCI, V5, P213, DOI 10.1023/B:PREV.0000045355.53137.45; Hill TD, 2005, J HEALTH SOC BEHAV, V46, P170, DOI 10.1177/002214650504600204; Jitnarin N, 2015, INT J ENV RES PUB HE, V12, P784, DOI 10.3390/ijerph120100784; Karriker-Jaffe KJ, 2011, DRUG ALCOHOL REV, V30, P84, DOI 10.1111/j.1465-3362.2010.00191.x; Kawachi I., 2003, NEIGHBORHOODS HLTH; King TL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137402; Kulis S, 2007, SOCIOL PERSPECT, V50, P273, DOI 10.1525/sop.2007.50.2.273; Lambert SF, 2004, AM J COMMUN PSYCHOL, V34, P205, DOI 10.1007/s10464-004-7415-3; Latkin CA, 2003, J HEALTH SOC BEHAV, V44, P34, DOI 10.2307/1519814; Latkin CA, 2007, AM J PREV MED, V32, pS234, DOI 10.1016/j.amepre.2007.02.023; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Mason MJ, 2010, HEALTH PLACE, V16, P926, DOI 10.1016/j.healthplace.2010.05.004; Matheson FI, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112441; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Merline AC, 2004, AM J PUBLIC HEALTH, V94, P96, DOI 10.2105/AJPH.94.1.96; Messer LC, 2006, ANN EPIDEMIOL, V16, P455, DOI 10.1016/j.annepidem.2005.08.006; Messer Lynne C, 2006, Int J Health Geogr, V5, P22, DOI 10.1186/1476-072X-5-22; Miles R, 2006, SOC SCI MED, V63, P2464, DOI 10.1016/j.socscimed.2006.06.011; Mueller MAE, 2019, HEALTH PLACE, V58, DOI 10.1016/j.healthplace.2019.102153; Mujahid MS, 2008, EPIDEMIOLOGY, V19, P590, DOI 10.1097/EDE.0b013e3181772cb2; Mujahid MS, 2008, AM J EPIDEMIOL, V167, P1349, DOI 10.1093/aje/kwn047; NATHAN PE, 1991, J ABNORM PSYCHOL, V100, P356, DOI 10.1037/0021-843X.100.3.356; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; OAS, 2015, REP DRUG US AM 2015; Orstad SL, 2017, ENVIRON BEHAV, V49, P904, DOI 10.1177/0013916516670982; Patterson F, 2012, ADDICT BEHAV, V37, P1132, DOI 10.1016/j.addbeh.2012.05.011; Patton GC, 2007, ADDICTION, V102, P607, DOI 10.1111/j.1360-0443.2006.01728.x; Peacock A, 2018, ADDICTION, V113, P1905, DOI 10.1111/add.14234; Pollack CE, 2005, INT J EPIDEMIOL, V34, P772, DOI 10.1093/ije/dyi026; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Ross CE, 2001, J HEALTH SOC BEHAV, V42, P258, DOI 10.2307/3090214; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schafer JA, 2006, J CRIM JUST, V34, P285, DOI 10.1016/j.jcrimjus.2006.03.003; Schulden JD, 2009, CURR PSYCHIAT REP, V11, P353, DOI 10.1007/s11920-009-0053-6; Shareck M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-930; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Stockdale SE, 2007, SOC SCI MED, V65, P1867, DOI 10.1016/j.socscimed.2007.05.045; Theall KP, 2009, HEALTH PLACE, V15, P323, DOI 10.1016/j.healthplace.2008.06.001; Theall KP, 2009, AM J HEALTH BEHAV, V33, P353, DOI 10.5993/AJHB.33.4.2; Tucker JS, 2013, DRUG ALCOHOL DEPEN, V128, P83, DOI 10.1016/j.drugalcdep.2012.08.006; Whitesell M., 2013, J ADDICT, DOI 10.1155/2013/579310; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Younger-Coleman N, 2016, 2016 NATL DRUG USE P	72	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0224516	10.1371/journal.pone.0224516	http://dx.doi.org/10.1371/journal.pone.0224516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QA	31756190	Green Published, gold			2022-12-26	WOS:000533889300005
J	Beierfu, A; Hunjadi, M; Ritsch, A; Kremser, C; Thome, C; Mern, DS				Beierfu, Anja; Hunjadi, Monika; Ritsch, Andreas; Kremser, Christian; Thome, Claudius; Mern, Demissew Shenegelegn			APOE-knockout in rabbits causes loss of cells in nucleus pulposus and enhances the levels of inflammatory catabolic cytokines damaging the intervertebral disc matrix	PLOS ONE			English	Article							LOW-BACK-PAIN; APOLIPOPROTEIN-E; AGGRECAN DEGRADATION; SERUM-LIPIDS; TNF-ALPHA; SPINE; DEGENERATION; DIFFUSION; ATHEROSCLEROSIS; CLASSIFICATION	Rabbits with naturally high levels of cholesterol ester transfer protein (CETP), unlike rodents, have become an interesting animal model for the study of lipid metabolism and atherosclerosis, as they have similarities to humans in lipid metabolism, cardiovascular physiology and susceptibility to develop atherosclerosis. Rodents, such as mice, are not prone to atherosclerosis as they lack the mass and activity of CETP, as a key player in lipoprotein metabolism. Recently, APOE-knockout in rabbits has been shown to promote atherosclerosis and associated premature IVD degeneration that mimic the symptoms of atherosclerosis and structural changes of IVDs in humans. Here we examined whether APOE-knockout promoted IVD degeneration in rabbits is associated with imbalanced inflammatory catabolic activities, as the underlying problem of biological deterioration that mimic the symptoms of advanced IVD degeneration in humans. We analysed in lumbar nucleus pulposus (NP) of APOE-knockout rabbits the cell viabilities and the intracellular levels of inflammatory, catabolic, anti-catabolic and anabolic proteins derogating IVD matrix. Grades of IVD degeneration were evaluated by magnetic resonance imaging. NP cells were isolated from homozygous APOE-knockout and wild-type New Zealand White rabbits of similar age. Three-dimensional cell culture with low-glucose was completed in alginate hydrogel. Cell proliferation and intracellular levels of target proteins were examined by MTT and ELISA assays. Alike human NP cells of different disc degeneration grades, NP cells of APOE-knockout and wild-type rabbits showed significantly different in vivo cell population densities (p<0.0001) and similar in vitro proliferation rates. Furthermore, they showed differences in overexpression of selective inflammatory and catabolic proteins (p<0.0001) similar to those found in human NP cells of different disc degeneration grades, such as IL-1 beta, TNF-alpha, ADAMTS-4, ADAMTS-5 and MMP-3. This study showed that premature IVD degeneration in APOE-knockout rabbits was promoted by the accumulation of selective inflammatory catabolic factors that enhanced imbalances between catabolic and anabolic factors mimicking the symptoms of advanced IVD degeneration in humans. Thus, APOE-knockout rabbits could be used as a promising model for therapeutic approaches of degenerative disc disorders.	[Beierfu, Anja] Med Univ Innsbruck, Lab Anim Facil, Innsbruck, Austria; [Hunjadi, Monika; Ritsch, Andreas] Med Univ Innsbruck, Dept Internal Med 1, Innsbruck, Austria; [Kremser, Christian] Med Univ Innsbruck, Dept Radiol, Innsbruck, Austria; [Thome, Claudius; Mern, Demissew Shenegelegn] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Mern, DS (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria.	demissew.shenegelegn@i-med.ac.at	Hunjadi, Monika/ABG-5791-2021; Kremser, Christian/A-5031-2008	Hunjadi, Monika/0000-0003-4285-2925; Shenegelegn Mern, Demissew/0000-0001-5893-981X; Ritsch, Andreas/0000-0002-0417-5161; Kremser, Christian/0000-0002-6953-935X	Austrian Science Fund FWF [P 27116] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Adams MA, 2000, SPINE, V25, P1625, DOI 10.1097/00007632-200007010-00005; Battie MC, 2009, SPINE J, V9, P47, DOI 10.1016/j.spinee.2008.11.011; Beierfuss A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187564; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; CHIRAS J, 1979, J NEURORADIOLOGY, V6, P169; CROCK HV, 1976, CLIN ORTHOP RELAT R, P6; De Geer CM, 2018, J CHIROPR MED, V17, P54, DOI 10.1016/j.jcm.2017.09.003; Grunhagen T, 2011, ORTHOP CLIN N AM, V42, P465, DOI 10.1016/j.ocl.2011.07.010; Ji DN, 2015, TRANSGENIC RES, V24, P227, DOI 10.1007/s11248-014-9834-8; Johnson ZI, 2015, EUR CELLS MATER, V30, P104, DOI 10.22203/eCM.v030a08; Kalb S, 2012, WORLD NEUROSURG, V77, P491, DOI 10.1016/j.wneu.2011.07.014; Kanayama M, 2009, J NEUROSURG-SPINE, V11, P501, DOI 10.3171/2009.5.SPINE08675; KAUPPILA LI, 1994, ACTA RADIOL, V35, P541; KAUPPILA LI, 1993, J SPINAL DISORD, V6, P124; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Leino-Arjas P, 2006, SPINE, V31, P1032, DOI 10.1097/01.brs.0000214889.31505.08; Leino-Arjas P, 2008, ATHEROSCLEROSIS, V197, P43, DOI 10.1016/j.atherosclerosis.2007.07.035; Liebscher T, 2011, SPINE, V36, P153, DOI 10.1097/BRS.0b013e3181cd588c; MABUCHI H, 1989, METABOLISM, V38, P115, DOI 10.1016/0026-0495(89)90249-7; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Mahley RW, 1999, J LIPID RES, V40, P1; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Mern DS, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0799-4; Mern DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096870; Mern DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081467; Mern DS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172181; Mern DS, 2014, J TISSUE ENG REGEN M, V8, P925, DOI 10.1002/term.1583; Niimi M, 2016, ATHEROSCLEROSIS, V245, P187, DOI 10.1016/j.atherosclerosis.2015.12.002; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rajasekaran S, 2008, EUR SPINE J, V17, P626, DOI 10.1007/s00586-008-0645-6; Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; SOLBERG LA, 1983, ARTERIOSCLEROSIS, V3, P187, DOI 10.1161/01.ATV.3.3.187; Soukane DM, 2007, J BIOMECH, V40, P2645, DOI 10.1016/j.jbiomech.2007.01.003; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Vo NV, 2013, SPINE J, V13, P331, DOI 10.1016/j.spinee.2012.02.027; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003; Wang D, 2012, OSTEOARTHR CARTILAGE, V20, P896, DOI 10.1016/j.joca.2012.04.010; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wang ZH, 2010, BIOTECHNOL BIOENG, V107, P730, DOI 10.1002/bit.22862; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001; Zhdanov VS, 1999, INT J CARDIOL, V68, P95, DOI 10.1016/S0167-5273(98)00339-8	51	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225527	10.1371/journal.pone.0225527	http://dx.doi.org/10.1371/journal.pone.0225527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751427	Green Published, Green Submitted, gold			2022-12-26	WOS:000533886900077
J	Zhang, LL; Li, Y; Lin, XY; Jia, CS; Yu, XW				Zhang, Lili; Li, Ying; Lin, Xiuying; Jia, Chunshu; Yu, Xiaowei			Liquid Chromatography/Mass Spectrometry based serum metabolomics study on recurrent abortion women with antiphospholipid syndrome	PLOS ONE			English	Article							NEWBORN SPINY MOUSE; INTERNATIONAL CONSENSUS STATEMENT; MID-PREGNANCY PROTECTS; CLASSIFICATION CRITERIA; CREATINE	Objective The antiphospholipid syndrome (APS) is an important cause of acquired thromboembolic complications and pregnancy morbidity. The pathogenic mechanisms that damage the fetal-maternal unit and cause abnormal placental development are incompletely understood in APS patients. Liquid Chromatography/Mass Spectrometry (LC/MS) based metabolomics are applied for the mechanism of disease and further supporting the research of diagnosis and management in recent years. The aim of this research was to investigate the difference of serum metabolic profiles in recurrent abortion women with APS and healthy women to explore the mechanism of this disease. Methods Serum samples of 25 recurrent abortion women with APS and 25 healthy women were collected and analyzed by LC/MS in this study. Potential biomarkers were discovered by multivariate statistical analysis and then identified based on analysis results. Results Totally, we identified five biomarkers that involved in different metabolic pathway such as purine metabolism, amino acid metabolism and tyrosine metabolism. These biomarkers showed different roles in disease development. Conclusion Metabolomics was proved as a powerful tool in understanding the mechanism of recurrent abortion caused by APS.	[Zhang, Lili] First Hosp Jilin Univ, Dept Ultrasonog, Changchun, Peoples R China; [Li, Ying] First Hosp Jilin Univ, Dept Neonatol, Changchun, Peoples R China; [Lin, Xiuying] Jilin Prov Peoples Hosp, Ctr Reprod Med, Changchun, Peoples R China; [Jia, Chunshu; Yu, Xiaowei] First Hosp Jilin Univ, Ctr Prenatal Diag, Ctr Reprod Med, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University	Jia, CS; Yu, XW (corresponding author), First Hosp Jilin Univ, Ctr Prenatal Diag, Ctr Reprod Med, Changchun, Peoples R China.	jiacs08@mails.jlu.edu.cn; csrichard@163.com			First Hospital of Jilin University [JDYY82017012]	First Hospital of Jilin University	This study was funded by the First Hospital of Jilin University, grant number: JDYY82017012 to XY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Angela M, 2017, J Hum Reprod Sci, V10, P10, DOI 10.4103/0974-1208.204018; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cannata DJ, 2010, PEDIATR RES, V68, P393, DOI 10.1203/PDR.0b013e3181f1c048; Clowse MEB, 2013, ANN RHEUM DIS, V72, P1536, DOI 10.1136/annrheumdis-2012-202449; Ellery SJ, 2013, PEDIATR RES, V73, P201, DOI 10.1038/pr.2012.174; Fiehn O, 2003, PHYTOCHEMISTRY, V62, P875, DOI 10.1016/S0031-9422(02)00715-X; HUGHES GRV, 1983, BRIT MED J, V287, P1088, DOI 10.1136/bmj.287.6399.1088; HUGHES GRV, 1993, LANCET, V342, P341, DOI 10.1016/0140-6736(93)91477-4; Ireland Z, 2011, NEUROSCIENCE, V194, P372, DOI 10.1016/j.neuroscience.2011.05.012; Levine AB, 2014, CONTRACEPTION PREGNA; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mulla MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065237; Niu J, 2012, J CHROMATOGR B, V907, P7, DOI 10.1016/j.jchromb.2012.08.012; Palisi A, 2017, J PHARMACEUT BIOMED, V133, P90, DOI 10.1016/j.jpba.2016.11.002; Springer D, 2017, CRIT REV CL LAB SCI, V54, P102, DOI 10.1080/10408363.2016.1269309; Tincani A, 1998, CLIN EXP RHEUMATOL, V16, P396; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; YAO SK, 1992, CIRCULATION, V86, P1302, DOI 10.1161/01.CIR.86.4.1302	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225463	10.1371/journal.pone.0225463	http://dx.doi.org/10.1371/journal.pone.0225463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751406	gold, Green Published			2022-12-26	WOS:000533886900067
J	Fong, PY; Tan, SH; Lim, DWT; Tan, EH; Ng, QS; Sommat, K; Tan, DSW; Ang, MK				Fong, Pei Yuan; Tan, Sze Huey; Lim, Darren Wan Teck; Tan, Eng Huat; Ng, Quan Sing; Sommat, Kiattisa; Tan, Daniel Shao Weng; Ang, Mei Kim			Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC)	PLOS ONE			English	Article							CHARLSON COMORBIDITY INDEX; LOCALLY ADVANCED HEAD; LONG-TERM OUTCOMES; NECK-CANCER; CONCURRENT CHEMORADIOTHERAPY; ADJUVANT RADIOTHERAPY; COMPETING CAUSES; CHEMOTHERAPY; SURGERY; IMPACT	Aim Treatment strategies in laryngeal squamous cell cancer (LSCC) straddle the need for long term survival and tumor control as well as preservation of laryngeal function as far as possible. We sought to identify prognostic factors affecting LSCC outcomes in our population. Methods Clinical characteristics, treatments and survival outcomes of patients with LSCC were analysed. Baseline comorbidity data was collected and age-adjusted Charlson Comorbidity Index (aCCI) was calculated. Outcomes of overall survival (OS), progression-free survival (PFS) and laryngectomy-free survival (LFS) were evaluated. Results Two hundred and fifteen patients were included, 170 (79%) underwent primary radiation/chemoradiation and the remainder upfront surgery with adjuvant therapy where indicated. The majority of patients were male, Chinese and current/ex-smokers. Presence of comorbidity was common with median aCCI of 3. Median OS was 5.8 years. On multivariable analyses, high aCCI and advanced nodal status were associated with inferior OS (HR 1.24 per one point increase in aCCI, P<0.001 and HR 3.52; p<0.001 respectively), inferior PFS (HR 1.14; p = 0.007 and HR 3.23; p<0.001 respectively) and poorer LFS (HR 1.19; p = 0.001 and HR 2.95; p<0.001 respectively). Higher tumor (T) stage was associated with inferior OS and LFS (HR 1.61; p = 0.02 and HR 1.91; p = 0.01 respectively). Conclusion In our Asian population, the presence of comorbidities and high nodal status were associated with inferior OS, PFS and LFS whilst high T stage was associated with inferior LFS and OS.	[Fong, Pei Yuan; Lim, Darren Wan Teck; Tan, Eng Huat; Ng, Quan Sing; Tan, Daniel Shao Weng; Ang, Mei Kim] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore; [Tan, Sze Huey] Natl Canc Ctr, Div Clin Trials & Epidemiol Sci, Singapore, Singapore; [Sommat, Kiattisa] Natl Canc Ctr, Div Radiat Oncol, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS)	Ang, MK (corresponding author), Natl Canc Ctr, Div Med Oncol, Singapore, Singapore.	Ang.mei.kim@singhealth.com.sg	Lim, Darren Wan-Teck/V-8435-2019; Lim, Darren Wan Teck/L-2007-2016	Lim, Darren Wan-Teck/0000-0002-4655-0206; Lim, Darren Wan Teck/0000-0002-4655-0206; Tan, Sze Huey/0000-0002-3089-7379; Ang, Mei-Kim/0000-0003-3209-864X				Argiris A, 2004, CLIN CANCER RES, V10, P1956, DOI 10.1158/1078-0432.CCR-03-1077; Baijal G, 2012, HEAD NECK-J SCI SPEC, V34, P1251, DOI 10.1002/hed.21897; Baxi SS, 2014, CANCER-AM CANCER SOC, V120, P1507, DOI 10.1002/cncr.28588; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Boje CR, 2013, ACTA ONCOL, V52, P285, DOI 10.3109/0284186X.2012.742964; Brandstorp-Boesen J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179371; Chang JH, 2017, ONCOTARGET, V8, P55600, DOI 10.18632/oncotarget.16340; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen AY, 2001, HEAD NECK-J SCI SPEC, V23, P566, DOI 10.1002/hed.1079; Choi YS, 2016, HEAD NECK-J SCI SPEC, V38, P1271, DOI 10.1002/hed.24438; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Cosetti M, 2008, ARCH OTOLARYNGOL, V134, P370, DOI 10.1001/archotol.134.4.370; Datema FR, 2010, HEAD NECK-J SCI SPEC, V32, P728, DOI 10.1002/hed.21245; Dronkers EAC, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1523-3; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Forastiere AA, 2013, J CLIN ONCOL, V31, P845, DOI 10.1200/JCO.2012.43.6097; Fuller CD, 2016, HEAD NECK-J SCI SPEC, V38, P1739, DOI 10.1002/hed.24532; Genther DJ, 2015, HEAD NECK-J SCI SPEC, V37, P685, DOI 10.1002/hed.23651; Gollnitz I, 2016, CANCER MED-US, V5, P3260, DOI 10.1002/cam4.882; Gourin CG, 2009, LARYNGOSCOPE, V119, P1312, DOI 10.1002/lary.20477; Grover S, 2015, INT J RADIAT ONCOL, V92, P594, DOI 10.1016/j.ijrobp.2015.03.004; Habbous S, 2013, ORAL ONCOL, V49, P407, DOI 10.1016/j.oraloncology.2012.11.010; Harris BN, 2016, HEAD NECK-J SCI SPEC, V38, P1380, DOI 10.1002/hed.24443; Hartl DM, 2015, OTOLARYNG CLIN N AM, V48, P611, DOI 10.1016/j.otc.2015.04.007; Hu M, 2012, LARYNGOSCOPE, V122, P565, DOI 10.1002/lary.22489; Iyer NG, 2015, CANCER-AM CANCER SOC, V121, P1599, DOI 10.1002/cncr.29251; Massa ST, 2017, ORAL ONCOL, V65, P8, DOI 10.1016/j.oraloncology.2016.12.006; Mell LK, 2010, J CLIN ONCOL, V28, P15, DOI 10.1200/JCO.2008.20.9288; Mulcahy CF, 2018, HEAD NECK-J SCI SPEC, V40, P2060, DOI 10.1002/hed.25200; Paleri V, 2010, ORAL ONCOL, V46, P712, DOI 10.1016/j.oraloncology.2010.07.008; Piccirillo JF, 2000, LARYNGOSCOPE, V110, P593, DOI 10.1097/00005537-200004000-00011; Rosenthal DI, 2015, CANCER-AM CANCER SOC, V121, P1608, DOI 10.1002/cncr.29241; Sanabria A, 2007, LARYNGOSCOPE, V117, P835, DOI 10.1097/MLG.0b013e3180337827; Sanabria A, 2007, ANN SURG ONCOL, V14, P1449, DOI 10.1245/s10434-006-9296-1; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh B, 1998, HEAD NECK-J SCI SPEC, V20, P1; Singh B, 1997, LARYNGOSCOPE, V107, P1469, DOI 10.1097/00005537-199711000-00009; Soo KC, 2005, BRIT J CANCER, V93, P279, DOI 10.1038/sj.bjc.6602696; Talamini R, 2002, CANCER CAUSE CONTROL, V13, P957, DOI 10.1023/A:1021944123914; Wang JR, 2016, HEAD NECK-J SCI SPEC, V38, P736, DOI 10.1002/hed.23947; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402	44	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0224665	10.1371/journal.pone.0224665	http://dx.doi.org/10.1371/journal.pone.0224665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747406	Green Published, gold			2022-12-26	WOS:000533881900013
J	Jiang, N; Li, M; Zhang, M; Xu, J; Jiang, L; Gong, L; Wu, F; Gu, J; Zhao, J; Xiang, Y; Wang, Z; Zhao, Y; Zeng, X				Jiang, N.; Li, M.; Zhang, M.; Xu, J.; Jiang, L.; Gong, L.; Wu, F.; Gu, J.; Zhao, J.; Xiang, Y.; Wang, Z.; Zhao, Y.; Zeng, X.		CSTAR Co-authors	Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus	PLOS ONE			English	Article							PREVALENCE; MANIFESTATIONS; MORTALITY; SUBSETS; COLLEGE; DISEASE; COHORT; DAMAGE; INDEX	Objectives To investigate the prevalence, clinical characteristics, and prognosis of thrombocytopenia (TP) in Chinese patients with systemic lupus erythematosus (SLE). Methods The study was conducted based on the Chinese SLE Treatment and Research group (CSTAR) registry. Thrombocytopenia was defined as the platelet count<100,000/mm(3) at enrollment. Severe thrombocytopenia was defined as the platelet count<50,000/mm(3). The prevalence of SLE-related TP, the associations of thrombocytopenia with demographic data, organ involvements, laboratory findings, disease activity, damage, and mortality were investigated. Results Of 2104 patients with SLE, 342 patients (16.3%) were diagnosed with thrombocytopenia. The prevalence of neuropsychiatric SLE, vasculitis, myositis, nephritis, mucocutaneous lesions, pleuritis, fever, leukocytopenia and hypocomplementemia were significantly higher in patients with thrombocytopenia (p<0.05). SLE disease activity index (SLEDAI) was significantly higher in patients with thrombocytopenia (p<0.05). Multivariate analysis showed that leukocytopenia (OR = 2.644), lupus nephritis (OR = 1.539), hypocomplementemia (OR = 1.497) and elevated SLEDAI (OR = 1.318) were independently associated with thrombocytopenia (p<0.05). Long disease duration (OR = 1.006) was an independent risk factor of severe thrombocytopenia, while anti-rRNP (OR = 0.208) was an independent protective factor of severe thrombocytopenia (p<0.05). Long disease duration was an independent risk factor of mortality in patients with thrombocytopenia (RR = 1.006). The 6-year survival of patients with thrombocytopenia was significantly lower than patients without thrombocytopenia (88.2% vs. 95.5%). Conclusions Thrombocytopenia was a common manifestation of SLE and was associated with leukocytopenia, nephritis and severe disease activity. Severe thrombocytopenia tended to occur in long-term and relatively inactive SLE. Patients with SLE-related thrombocytopenia has a decreased long-term survival rate. Long disease duration was an independent risk factor of mortality in patients with thrombocytopenia.	[Jiang, N.; Li, M.; Zhao, J.; Xiang, Y.; Wang, Z.; Zhao, Y.; Zeng, X.] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Minist Educ, Dept Rheumatol,Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China; [Zhang, M.] Jiangsu Prov Peoples Hosp, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China; [Xu, J.] Anhui Med Univ, Affiliated Hosp 1, Dept Rheumatol, Hefei, Anhui, Peoples R China; [Jiang, L.] Fudan Univ, Zhongshan Hosp, Dept Rheumatol, Shanghai, Peoples R China; [Gong, L.] Tianjin Med Univ, Gen Hosp, Dept Rheumatol, Tianjin, Peoples R China; [Wu, F.] Capital Inst Pediat, Dept Rheumatol, Beijing, Peoples R China; [Gu, J.] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Anhui Medical University; Fudan University; Tianjin Medical University; Capital Institute of Pediatrics (CIP); Sun Yat Sen University	Li, M; Zeng, X (corresponding author), Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Minist Educ, Dept Rheumatol,Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China.	mengtao.li@cstar.org.cn; zengxfpumc@163.com	Jiuliang, Zhao/AAW-5669-2020	Jiuliang, Zhao/0000-0001-9308-2858	Chinese National Key Technology R&D Program, Chinese National High Technology Research and Development Program, Ministry of Science and Technology of People's Republic of China [2017YFC0907601, 2017YFC0907602, 2017YFC0907603, 2008BAI59B02, 2012AA02A513]	Chinese National Key Technology R&D Program, Chinese National High Technology Research and Development Program, Ministry of Science and Technology of People's Republic of China	This study was supported by grant numbers: 2017YFC0907601, 2017YFC0907602, 2017YFC0907603, 2008BAI59B02, 2012AA02A513, to Dr X Zeng, from Chinese National Key Technology R&D Program, Chinese National High Technology Research and Development Program, Ministry of Science and Technology of People's Republic of China, http://www.most.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGER M, 1977, J RHEUMATOL, V4, P351; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Fayyaz A, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000078; Fernandez M, 2007, ARTHRITIS RHEUM, V56, P614, DOI 10.1002/art.22376; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gladman DD, 2000, J RHEUMATOL, V27, P373; Gonzalez-Naranjo LA, 2016, SEMIN ARTHRITIS RHEU, V45, P675, DOI 10.1016/j.semarthrit.2015.11.003; HARRIS EN, 1985, BRIT J HAEMATOL, V59, P227, DOI 10.1111/j.1365-2141.1985.tb02988.x; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jung JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002818; KEELING DM, 1993, BLOOD REV, V7, P199, DOI 10.1016/0268-960X(93)90006-P; Li M, 2014, LUPUS, V23, P1085, DOI 10.1177/0961203314527366; Li M, 2013, LUPUS, V22, P1192, DOI 10.1177/0961203313499086; Patel N, 2014, LUPUS, V23, P204, DOI 10.1177/0961203313512009; Sultan SM, 2003, RHEUMATOLOGY, V42, P230, DOI 10.1093/rheumatology/keg069; To CH, 2005, ARTHRITIS RHEUM-US, V52, P4003, DOI 10.1002/art.21414; Zhao J, 2016, LUPUS, V25, P652, DOI 10.1177/0961203315625460	17	9	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225516	10.1371/journal.pone.0225516	http://dx.doi.org/10.1371/journal.pone.0225516			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747435	gold, Green Published			2022-12-26	WOS:000533881900048
J	Nyberg, E; O'Sullivan, A; Grayson, W				Nyberg, Ethan; O'Sullivan, Aine; Grayson, Warren			scafSLICR: A MATLAB-based slicing algorithm to enable 3D-printing of tissue engineering scaffolds with heterogeneous porous microarchitecture	PLOS ONE			English	Article							CALCIUM-PHOSPHATE; PORE-SIZE; BONE; DIFFERENTIATION; POROSITY; DIAMETER; GRADIENT; QUALITY; DESIGN; CELLS	3D-printing is a powerful manufacturing tool that can create precise microscale architectures across macroscale geometries. Within biomedical research, 3D-printing of various materials has been used to fabricate rigid scaffolds for cell and tissue engineering constructs with precise microarchitecture to direct cell behavior and macroscale geometry provides patient specificity. While 3D-printing hardware has become low-cost due to modeling and rapid prototyping applications, there is no common paradigm or platform for the controlled design and manufacture of 3D-printed constructs for tissue engineering. Specifically, controlling the tissue engineering features of pore size, porosity, and pore arrangement is difficult using currently available software. We have developed a MATLAB approach termed scafSLICR to design and manufacture tissue-engineered scaffolds with precise microarchitecture and with simple options to enable spatially patterned pore properties. Using scafSLICR, we designed, manufactured, and characterized porous scaffolds in acrylonitrile butadiene styrene with a variety of pore sizes, porosities, and gradients. We found that transitions between different porous regions maintained an open, connected porous network without compromising mechanical integrity. Further, we demonstrated the usefulness of scafSLICR in patterning different porous designs throughout large anatomic shapes and in preparing craniofacial tissue engineering bone scaffolds. Finally, scafSLICR is distributed as opensource MATLAB scripts and as a stand-alone graphical interface.	[Nyberg, Ethan; O'Sullivan, Aine; Grayson, Warren] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD 21205 USA; [Nyberg, Ethan; O'Sullivan, Aine; Grayson, Warren] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Grayson, Warren] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Grayson, Warren] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Grayson, W (corresponding author), Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD 21205 USA.; Grayson, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.; Grayson, W (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.; Grayson, W (corresponding author), Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA.	wgrayson@jhmi.edu	Nyberg, Ethan/AAG-8436-2020		Office of the Assistant Secretary of Defense for Health Affairs, through the Vision Research Program Technology/Therapeutic Development Award [W81XWH-16-1-0758]	Office of the Assistant Secretary of Defense for Health Affairs, through the Vision Research Program Technology/Therapeutic Development Award	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Vision Research Program Technology/Therapeutic Development Award under Award No. W81XWH-15-VRP-TTDA (W.G). Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense (W81XWH-16-1-0758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2018, VIRTUAL PHYS PROTOTY, V13, P2, DOI 10.1080/17452759.2017.1392684; Aitkenhead AH, 2013, MATLAB STL IMPORT; Amini AR, 2008, NIH PUBLIC ACCESS, V42, P157; Bandyopadhyay A, 2015, MRS BULL, V40, P108, DOI 10.1557/mrs.2015.3; Barui S, 2017, MAT SCI ENG C-MATER, V70, P812, DOI 10.1016/j.msec.2016.09.040; Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017; Challis VJ, 2012, INT J SOLIDS STRUCT, V49, P3397, DOI 10.1016/j.ijsolstr.2012.07.019; Cheah CM, 2004, TISSUE ENG, V10, P595, DOI 10.1089/107632704323061951; Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4; Chua CK, 2003, INT J ADV MANUF TECH, V21, P291, DOI 10.1007/s001700300034; Cox SC, 2015, MAT SCI ENG C-MATER, V47, P237, DOI 10.1016/j.msec.2014.11.024; Di Luca A., 2016, BIOFABRICATION, V8; Di Luca A, 2016, ADV HEALTHC MATER, V5, P1753, DOI 10.1002/adhm.201600083; Di Luca A, 2016, ACTA BIOMATER, V36, P210, DOI 10.1016/j.actbio.2016.03.014; Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4; Gibson I, 2015, ADDITIVE MANUFACTURI, V2nd, P293; Gleadall A, 2018, BURNS TRAUMA, P1; Hasiuk F, 2018, VALIDATING 3D PRINTE; Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5; Hotaling NA, 2015, BIOMATERIALS, V61, P327, DOI 10.1016/j.biomaterials.2015.05.015; Hung BP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt158; Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064; Jammalamadaka U, 2018, J FUNCT BIOMATER, V9, DOI 10.3390/jfb9010022; Kang H, 2010, STRUCT MULTIDISCIP O, V42, P633, DOI 10.1007/s00158-010-0508-8; Kang HW, 2016, NAT BIOTECHNOL, V34, P312, DOI 10.1038/nbt.3413; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017; Kelly CN, 2018, ADV HEALTHC MATER, V7, P1; Kengla C, 2017, 3D PRINT ADDIT MANUF, V4, P239, DOI 10.1089/3dp.2017.0075; Kim J, 2018, COMPUT MATH METHOD M, V2018, DOI 10.1155/2018/8652034; Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93; Lepowsky E, 2018, INT J BIOPRINTING, V4, DOI 10.18063/IJB.v4i1.119; Liu K, 2016, MATLAB 3D PLOT; Markl D, 2017, ANAL 3D PRINTS XRAY, P1037; Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023; Ranellucci A., 2011, SLIC3R; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sears NA, 2016, TISSUE ENG PART B-RE, V22, P298, DOI [10.1089/ten.teb.2015.0464, 10.1089/ten.TEB.2015.0464]; Shao HF, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa663c; Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003; Sun Q, 2008, RAPID PROTOTYPING J, V14, P72, DOI 10.1108/13552540810862028; Szojka Alexander, 2017, Bioprinting, V8, P1, DOI 10.1016/j.bprint.2017.08.001; Tamburrino F, 2019, VIRTUAL PHYS PROTOTY, V14, P316, DOI 10.1080/17452759.2019.1607758; Tan C, 2018, INT J BIOPRINTING, V4, DOI 10.18063/IJB.v4i2.143; Temple JP, 2014, J BIOMED MATER RES, P1; Trachtenberg JE, 2014, J BIOMED MAT RES A; Trombetta R, 2017, ANN BIOMED ENG, V45, P23, DOI 10.1007/s10439-016-1678-3; Tseng TLB, 2014, J COMPUT DES ENG, V1, P194, DOI 10.7315/JCDE.2014.019; Voon SL, 2019, VIRTUAL PHYS PROTOTY, V14, P203, DOI 10.1080/17452759.2019.1603508; Wang MO, 2015, ADV MATER, V27, P138, DOI 10.1002/adma.201403943; Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297; Yang YW, 2019, INT J BIOPRINTING, V5, DOI 10.18063/IJB.v5i1.148	52	8	8	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225007	10.1371/journal.pone.0225007	http://dx.doi.org/10.1371/journal.pone.0225007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KC0QO	31743350	Green Published, gold			2022-12-26	WOS:000506892800001
J	Rodriguez-Martinez, M; Lopez-Rodriguez, JF; Flores-Sandoval, O; Calvo-Turrubiartes, MZ; Sanchez-Briones, ME; Silva-Ramirez, AS; Guerreo-Ojeda, V				Rodriguez-Martinez, Manuel; Francisco Lopez-Rodriguez, Juan; Flores-Sandoval, Omar; Zarahi Calvo-Turrubiartes, Miriam; Eugenia Sanchez-Briones, Maria; Sonia Silva-Ramirez, Ana; Guerreo-Ojeda, Vianney			Additional evidence that the rat renal interstitium contracts in vivo	PLOS ONE			English	Article							ALPHA-TRINOSITOL; SODIUM-EXCRETION; FLUID PRESSURE; INFLAMMATION; CELLS	We recently provided highly suggestive preliminary evidence that the renal interstitium contracts reactively in vivo. We demonstrated that renal medullary direct interstitial volume expansion (rmDIVE = 100 mu l bolus infusion of 0.9% saline (SS)/30 s) brought about a biphasic renal interstitial hydrostatic pressure (RIHP) response which was abolished when dibutyryl-cAMP was concomitant and interstitially infused. To assess more deeply the feasibility of the concept that the renal interstitium contracts in vivo, two experimental series (S1, S2) were performed in hydropenic rats subjected to acute left renal-denervation, hormonal clamping, and control of renal arterial pressure. In S1, RIHP and renal outer medullary blood flow (RoMBF) were continuously measured before and after a sudden micro-bolus (5 mu l) injection, into the renal medullary interstitium, of SS containing alpha-trinositol (alpha-TNS, antiinflammatory drug) to either two doses 2 or 4 mM (SS + 2 alpha-TNS and SS + 4 alpha-TNS groups). No overall differences between groups in either Delta RIHP or% Delta RoMBF time courses were found; however, in the SS + 2 a-TNS group the data were less scattered and the Delta RIHP time course tended to peak faster and then persisted there, so that, this alpha-TNS dose was selected for S2. In S2, RIHP and RoMBF were similarly measured in rats randomly assigned to three groups: the CTR group (sham time-control), SS group (SS alone), and SS + alpha-TNS group. The micro-bolus injection of SS alone (SS group) was unable to increase Delta RIHP. The group with no micro-bolus injection (CTR group) experienced a decrease in Delta RIHP. The micro-bolus injection of SS + 2 alpha-TNS was accompanied by a differential increase in.RIHP (vs. CTR and SS groups). These responses were not associated with differential changes among groups in% Delta RoMBF or hemodilution parameters. These results provide additional evidence that the renal interstitium contracts in vivo.	[Rodriguez-Martinez, Manuel; Francisco Lopez-Rodriguez, Juan; Flores-Sandoval, Omar; Zarahi Calvo-Turrubiartes, Miriam; Eugenia Sanchez-Briones, Maria; Sonia Silva-Ramirez, Ana; Guerreo-Ojeda, Vianney] Autonomous Univ San Luis Potosi, Fac Med, Dept Physiol & Biophys, Integrat Physiol Lab, San Luis Potosi, San Luis Potosi, Mexico	Universidad Autonoma de San Luis Potosi	Rodriguez-Martinez, M (corresponding author), Autonomous Univ San Luis Potosi, Fac Med, Dept Physiol & Biophys, Integrat Physiol Lab, San Luis Potosi, San Luis Potosi, Mexico.	rodrigum@uaslp.mx		Sanchez-Briones, Maria E./0000-0001-9968-0322; Silva-Ramirez, Ana Sonia/0000-0003-0390-9618	 [C15-FAI-04-96.6/UASLP]		This work was supported by Universidad Autonoma de San Luis Potosi, C15-FAI-04-96.6/UASLP (http://a.uaslp.mx/eG5cSwpd) to MRM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen K, 1998, CELL ADHES COMMUN, V5, P461, DOI 10.3109/15419069809005604; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Berg A, 2001, AM J PHYSIOL-HEART C, V281, pH7, DOI 10.1152/ajpheart.2001.281.1.H7; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; COOK NR, 1983, ANNU REV PUBL HEALTH, V4, P1, DOI 10.1146/annurev.pu.04.050183.000245; Flores-Sandoval O, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13328; GARCIAESTAN J, 1989, AM J PHYSIOL, V256, pF63, DOI 10.1152/ajprenal.1989.256.1.F63; GARDINER SM, 1994, BRIT J PHARMACOL, V113, P129, DOI 10.1111/j.1476-5381.1994.tb16184.x; Heiberger RM, 2015, SPRINGER TEXTS STAT, P263, DOI 10.1007/978-1-4939-2122-5_9; HUGHES AK, 1995, J CLIN INVEST, V96, P411, DOI 10.1172/JCI118050; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Kaissling B, 1996, ANAT EMBRYOL, V193, P303; KAPANCI Y, 1974, J CELL BIOL, V60, P375, DOI 10.1083/jcb.60.2.375; KHRAIBI AA, 1992, AM J PHYSIOL, V263, pR1182, DOI 10.1152/ajpregu.1992.263.6.R1182; LARSON M, 1984, ACTA PHYSIOL SCAND, V120, P297, DOI 10.1111/j.1748-1716.1984.tb00137.x; LEMLEY KV, 1991, KIDNEY INT, V39, P370, DOI 10.1038/ki.1991.49; Lennernas H, 1997, EUR J PHARM SCI, V5, P267, DOI 10.1016/S0928-0987(97)00019-5; Lingnau W, 1997, SHOCK, V8, P179, DOI 10.1097/00024382-199709000-00005; LUND T, 1994, J TRAUMA, V36, P761, DOI 10.1097/00005373-199406000-00001; Mattson DL, 2003, AM J PHYSIOL-REG I, V284, pR13, DOI 10.1152/ajpregu.00321.2002; NAKAMURA T, 1993, HYPERTENSION, V21, P956, DOI 10.1161/01.HYP.21.6.956; NILSSON GE, 1984, MED BIOL ENG COMPUT, V22, P343, DOI 10.1007/BF02442104; Pruitt MEC, 2006, AM J PHYSIOL-RENAL, V290, pF892, DOI 10.1152/ajprenal.00323.2005; RODT SA, 1994, CIRC RES, V75, P942, DOI 10.1161/01.RES.75.5.942; SCHMIDTNIELSEN B, 1987, KIDNEY INT, V31, P621, DOI 10.1038/ki.1987.43; SIMCHON S, 1990, P SOC EXP BIOL MED, V195, P114; Smith LR, 2018, PHYSIOLOGY, V33, P16, DOI 10.1152/physiol.00026.2017; Stridh S, 2012, AM J PHYSIOL-REG I, V302, pR1235, DOI 10.1152/ajpregu.00332.2011; Weinfurt KP, 2000, READING UNDERSTANDIN, P245; WILCOX CS, 1984, AM J PHYSIOL, V247, pF344, DOI 10.1152/ajprenal.1984.247.2.F344; Williams JM, 2007, HYPERTENSION, V49, P687, DOI 10.1161/01.HYP.0000255753.89363.47; WOIE K, 1994, AM J RESP CRIT CARE, V150, P924, DOI 10.1164/ajrccm.150.4.7921464; YOO HY, 1994, EUR J PHARM-MOLEC PH, V268, P55, DOI 10.1016/0922-4106(94)90119-8	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225640	10.1371/journal.pone.0225640	http://dx.doi.org/10.1371/journal.pone.0225640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774858	Green Published, gold			2022-12-26	WOS:000533896400046
J	Ogata, T; Makino, H; Ishizuka, N; Iwamoto, E; Masaki, T; Ikuta, K; Kim, YH; Sato, S				Ogata, Toru; Makino, Hiroki; Ishizuka, Naoki; Iwamoto, Eiji; Masaki, Tatsunori; Ikuta, Kentaro; Kim, Yo-Han; Sato, Shigeru			Long-term high-grain diet altered the ruminal pH, fermentation, and composition and functions of the rumen bacterial community, leading to enhanced lactic acid production in Japanese Black beef cattle during fattening	PLOS ONE			English	Article							SARA ADAPTATION; SEQUENCE DATA; DAIRY-COWS; VITAMIN-A; GEN. NOV.; IMPACT; DIVERSITY; QUALITY	To increase intramuscular fat accumulation, Japanese Black cattle are commonly fed a high-grain diet from 10 to 30 months of age although it can result in the abnormal accumulation of organic acids in the rumen. We explored the effect of long-term high-concentrate diet feeding on ruminal pH and fermentation, and its effect on the rumen bacterial community in Japanese Black beef cattle during a 20-month fattening period. Nine castrated and fistulated Japanese Black beef cattle were housed with free access to food and water throughout the study period (10-30 months of age). The fattening stages included Early, Middle, and Late stages (10-14, 15-22, and 23-30 months of age, respectively). Cattle were fed high-concentrate diets for the experimental cattle during fattening. The body weight of the cattle was 439 7.6, 561 11.6, and 712 18.5 kg (mean SE) during the Early, Middle, and Late stages, respectively. Ruminal pH was measured continuously during the final 7 days of each stage, and rumen fluid and blood samples were collected on day 4 (fourth day during the final 7 days of the pH measurements). The 24-h mean ruminal pH during the Late stage was significantly lower than that during the Early stage. Total volatile fatty acid (VFA) during the Late stage was significantly lower than during the Early and Middle stages, but no changes were noted in individual VFA components. The lactic acid concentration during the Late stage was significantly higher than that during the Early and Middle stages. The bacterial richness indices decreased significantly during the Late stage in accordance with the 24h mean ruminal pH. Among the 35 bacterial operational taxonomic units (OTUs) shared by all samples, the relative abundances of OTU8 (Family Ruminococcaceae) and OTU26 (Genus Butyrivibrio) were positively correlated with the 24-h mean ruminal pH. Total VFA concentration was negatively correlated with OTU167 (Genus Intestinimonas), and lactic acid concentration was correlated positively with OTU167 and OTU238 (Family Lachnospiraceae). These results suggested that long-term high-grain diet feeding gradually lowers ruminal pH and total VFA production during the Late fattening stage. However, the ruminal bacterial community adapted to feeding management and the lower pH during the Late stage by preserving their diversity or altering their richness, composition, and function, to enhance lactic acid production in Japanese Black beef cattle.	[Ogata, Toru; Sato, Shigeru] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Ogata, Toru; Makino, Hiroki; Ishizuka, Naoki; Kim, Yo-Han; Sato, Shigeru] Iwate Univ, Cooperat Dept Vet Med, Fac Agr, Morioka, Iwate, Japan; [Iwamoto, Eiji; Masaki, Tatsunori] Hyogo Prefectural Technol Ctr Agr Forestry & Fish, Kasai, Hyogo, Japan; [Ikuta, Kentaro] Awaji Agr Technol Ctr, Minami Awaji, Hyogo, Japan	Gifu University; Iwate University	Sato, S (corresponding author), Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan.; Kim, YH; Sato, S (corresponding author), Iwate Univ, Cooperat Dept Vet Med, Fac Agr, Morioka, Iwate, Japan.	haneey@iwate-u.ac.jp; sshigeru@iwate-u.ac.jp						Abaker JA, 2017, J DAIRY SCI, V100, P666, DOI 10.3168/jds.2016-10871; Aikman PC, 2008, J DAIRY SCI, V91, P1103, DOI 10.3168/jds.2007-0724; Allen MS, 1997, J DAIRY SCI, V80, P1447, DOI 10.3168/jds.S0022-0302(97)76074-0; [Anonymous], 2013, 16S METAGENOMIC SEQU; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; CAMERON PJ, 1994, MEAT SCI, V38, P361, DOI 10.1016/0309-1740(94)90125-2; Golder HM, 2014, J DAIRY SCI, V97, P5131, DOI 10.3168/jds.2014-8003; Guo JF, 2017, ONCOTARGET, V8, P46769, DOI 10.18632/oncotarget.18151; Hirabayashi H, 2017, ANIM SCI J, V88, P1162, DOI 10.1111/asj.12743; Hook SE, 2011, FEMS MICROBIOL ECOL, V78, P275, DOI 10.1111/j.1574-6941.2011.01154.x; Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8; Iwai S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166104; Katamoto H, 2003, J VET MED SCI, V65, P1001, DOI 10.1292/jvms.65.1001; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kim YH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01575; Kim YH, 2016, PHYSIOL GENOMICS, V48, P803, DOI 10.1152/physiolgenomics.00086.2016; Kimura A, 2012, J VET MED SCI, V74, P1023, DOI 10.1292/jvms.12-0084; Klaring K, 2013, INT J SYST EVOL MICR, V63, P4606, DOI 10.1099/ijs.0.051441-0; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Mao SY, 2013, ANAEROBE, V24, P12, DOI 10.1016/j.anaerobe.2013.08.003; Ministry of Agriculture Forestry and Fisheries (MAFF), 2008, EST METH AN FEEDS FE; Nagaraja TG, 2007, J DAIRY SCI, V90, pE17, DOI 10.3168/jds.2006-478; Nagata R, 2018, J DAIRY SCI, V101, P4424, DOI 10.3168/jds.2017-13859; National Agricalture and Feed Reserch Organization (NARO), 2009, JAP FEED STAND BEEF; Neubauer V, 2018, J DAIRY SCI, V101, P2335, DOI 10.3168/jds.2017-13565; Ogata T, 2019, J VET MED SCI, V81, P968, DOI 10.1292/jvms.19-0077; Oka A, 1998, MEAT SCI, V48, P159, DOI 10.1016/S0309-1740(97)00086-7; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Plaizier JC, 2008, VET J, V176, P21, DOI 10.1016/j.tvjl.2007.12.016; Plaizier Jan C, 2016, Front Microbiol, V7, P2128, DOI 10.3389/fmicb.2016.02128; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Roche JF, 2006, ANIM REPROD SCI, V96, P282, DOI 10.1016/j.anireprosci.2006.08.007; Sato S, 2012, VET RES COMMUN, V36, P85, DOI 10.1007/s11259-012-9518-x; Schlau N, 2012, J DAIRY SCI, V95, P5866, DOI 10.3168/jds.2011-5167; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seo B, 2017, INT J SYST EVOL MICR, V67, P2430, DOI 10.1099/ijsem.0.001977; Takemura K, 2019, J ANIM SCI, V97, P2220, DOI 10.1093/jas/skz088; Watanabe Y, 2019, J DAIRY SCI, V102, P6518, DOI 10.3168/jds.2018-15871; Zhang RY, 2018, ANIMAL, V12, P2511, DOI [10.1017/S175173111800040X, 10.1017/s175173111800040x]	40	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225448	10.1371/journal.pone.0225448	http://dx.doi.org/10.1371/journal.pone.0225448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX5TV	31770419	Green Published, gold			2022-12-26	WOS:000521943900001
J	Flegr, J; Preiss, M				Flegr, Jaroslav; Preiss, Marek			Friends with malefit. The effects of keeping dogs and cats, sustaining animal-related injuries and Toxoplasma infection on health and quality of life	PLOS ONE			English	Article							PET OWNERSHIP; RISK-FACTORS; GONDII INFECTION; SCRATCH DISEASE; SCHIZOPHRENIA; ASSOCIATIONS; DEPRESSION; SURVIVAL; CONSEQUENCES; DISORDERS	Many studies show that keeping cats and dogs has a positive impact on humans' physical and mental health and quality of life. The existence of this "pet phenomenon" is now widely discussed because other studies performed recently have demonstrated a negative impact of owning pets or no impact at all. The main problem of many studies was the autoselection-participants were informed about the aims of the study during recruitment and later likely described their health and wellbeing according to their personal beliefs and wishes, not according to their real status. To avoid this source of bias, we did not mention pets during participant recruitment and hid the pet-related questions among many hundreds of questions in an 80-minute Internet questionnaire. Results of our explorative study performed on a sample of 10,858 subjects showed that liking dogs has a weak positive association with quality of life. However, keeping pets, especially cats, and even more being injured by pets, were strongly negatively associated with many facets of quality of life. Our data also confirmed that infection by the cat parasite Toxoplasma had a very strong negative effect on quality of life, especially on mental health. However, the infection was not responsible for the observed negative effects of keeping pets, as these effects were much stronger in 1,527 Toxoplasma-free subjects than in the whole population. Any cross-sectional study cannot discriminate between a cause and an effect. However, because of the large and still growing popularity of keeping pets, the existence and nature of the reverse pet phenomenon deserve the outmost attention.	[Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Div Biol, Prague, Czech Republic; [Flegr, Jaroslav; Preiss, Marek] Natl Inst Mental Hlth, Klecany, Czech Republic	Charles University Prague; National Institute of Mental Health - Czech Republic	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Div Biol, Prague, Czech Republic.; Flegr, J (corresponding author), Natl Inst Mental Hlth, Klecany, Czech Republic.	flegr@cesnet.cz	Flegr, Jaroslav/A-1564-2008; Preiss, Marek/AAG-9405-2020; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126; Preiss, Marek/0000-0002-4463-6313	Czech Science Foundation [P407/16/20958, 18-13692S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by: JF, MP: P407/16/20958, and JF: 18-13692S, Czech Science Foundation, https://gacr.cz/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2001, HYPERTENSION, V38, P815, DOI 10.1161/hyp.38.4.815; Antonacopoulos NMD, 2017, SOC ANIM, V25, P319, DOI 10.1163/15685306-12341449; Bao KJ, 2016, ANTHROZOOS, V29, P283, DOI 10.1080/08927936.2016.1152721; Barker SB, 2008, J VET MED EDUC, V35, P487, DOI 10.3138/jvme.35.4.487; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett PC, 2015, ANTHROZOOS, V28, P403, DOI 10.1080/08927936.2015.1052266; Black K, 2012, J PEDIATR NURS, V27, P103, DOI 10.1016/j.pedn.2010.11.009; Breitschwerdt EB, 2008, J CLIN MICROBIOL, V46, P2856, DOI 10.1128/JCM.00832-08; Brown CM, 2016, ANTHROZOOS, V29, P47, DOI 10.1080/20414005.2015.1067958; Chang CC, 2016, PAEDIATR INT CHILD H, V36, P232, DOI 10.1179/2046905515Y.0000000005; Chowdhury EK, 2017, J HYPERTENS, V35, P769, DOI 10.1097/HJH.0000000000001214; Dragomirecka E., 2006, PSYCHIATRIE, V10, P68; Enmarker I, 2015, AGING MENT HEALTH, V19, P347, DOI 10.1080/13607863.2014.933310; Flegr J, 1996, PARASITOLOGY, V113, P49, DOI 10.1017/S0031182000066269; Flegr J, 2017, EPIDEMIOL INFECT, V145, P1351, DOI 10.1017/S095026881700019X; Flegr J, 2016, PARASITOLOGY, V143, P1974, DOI 10.1017/S0031182016001785; Flegr J, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00314; Flegr J, 2018, SCHIZOPHR RES, V197, P603, DOI 10.1016/j.schres.2018.02.008; Flegr J, 2017, SCHIZOPHR RES, V189, P219, DOI 10.1016/j.schres.2017.02.007; Flegr J, 2015, CURR CLIN MICROBIOL, V2, P163, DOI 10.1007/s40588-015-0024-0; Flegr J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-015-1290-7; Flegr J, 2015, EXPERT REV ANTI-INFE, V13, P817, DOI 10.1586/14787210.2015.1051033; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; FRIEDMANN E, 1995, AM J CARDIOL, V76, P1213, DOI 10.1016/S0002-9149(99)80343-9; Gillum RF, 2010, INT J ENV RES PUB HE, V7, P2452, DOI 10.3390/ijerph7062452; Hanauer DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070585; Herzog H, 2011, CURR DIR PSYCHOL SCI, V20, P236, DOI 10.1177/0963721411415220; Hill AB, 2015, J ROY SOC MED, V108, P32, DOI 10.1177/0141076814562718; Hinkert C., 2013, INFLUENCE DOGS CATS; Kankova Sarka, 2015, Folia Parasitol (Praha), V62, DOI 10.14411/fp.2015.041; Kim S, 2015, COMMUN STAT APPL MET, V22, P665, DOI 10.5351/CSAM.2015.22.6.665; Koivusilta LK, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000109; Kolbekova P, 2007, CLIN MICROBIOL INFEC, V13, P1012, DOI 10.1111/j.1469-0691.2007.01771.x; Kolpakova J, 2013, SCHIZOPHR RES, V146, P370, DOI 10.1016/j.schres.2013.02.039; Lindova J, 2006, INT J PARASITOL, V36, P1485, DOI 10.1016/j.ijpara.2006.07.008; Lindsay DS, 1997, VET PARASITOL, V73, P27, DOI 10.1016/S0304-4017(97)00048-4; Mazur-Melewska K, 2015, POSTEP DERM ALERGOL, V32, P216, DOI 10.5114/pdia.2014.44014; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Miltiades H, 2011, ANTHROZOOS, V24, P147, DOI 10.2752/175303711X12998632257585; Mubanga M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16118-6; Mullersdorf M, 2010, SCAND J PUBLIC HEALT, V38, P53, DOI 10.1177/1403494809344358; Niebuhr DW, 2007, SCHIZOPHRENIA BULL, V33, P243; Nimer J, 2007, ANTHROZOOS, V20, P225, DOI 10.2752/089279307X224773; Orley J, 1997, QUAL LIFE RES, V6, P273; Parker GB, 2010, ACTA PSYCHIAT SCAND, V121, P65, DOI 10.1111/j.1600-0447.2009.01410.x; Parslow RA, 2005, GERONTOLOGY, V51, P40, DOI 10.1159/000081433; Parslow RA, 2003, MED J AUSTRALIA, V179, P466, DOI 10.5694/j.1326-5377.2003.tb05649.x; Pikhartova J, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-106; Qureshi Adnan I, 2009, J Vasc Interv Neurol, V2, P132; R Core Team, 2018, R LANG ENV STAT COMP; Rijken M, 2011, SOC INDIC RES, V102, P373, DOI 10.1007/s11205-010-9690-8; Rodi H., 2000, AUSTRALAS J AGEING, V19, P143, DOI 10.1111/j.1741-6612.2000.tb00167.x; Rondet B, 2012, ARCH PEDIATRIE, V19, P823, DOI 10.1016/j.arcped.2012.05.011; Sebankova B, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00144; Souter MA, 2007, ANTHROZOOS, V20, P167, DOI 10.2752/175303707X207954; Sterneberg-van der Maaten T, 2016, J Comp Pathol, V155, pS8, DOI 10.1016/j.jcpa.2015.06.007; STRAEDE CM, 1993, ANTHROZOOS, V6, P30, DOI 10.2752/089279393787002385; Sutterland AL, 2015, ACTA PSYCHIAT SCAND, V132, P161, DOI 10.1111/acps.12423; Toohey AM, 2018, CAN J AGING, V37, P200, DOI 10.1017/S0714980818000107; Torrey EF, 2017, SCHIZOPHRENIA BULL, V43, P247, DOI 10.1093/schbul/sbw113; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Walster D., 1997, J DEMENTIA CARE, V5, P20; Wells DL, 2009, J SOC ISSUES, V65, P523, DOI 10.1111/j.1540-4560.2009.01612.x; Wells DL, 2009, J ALTERN COMPLEM MED, V15, P407, DOI 10.1089/acm.2008.0496; Westgarth Carri, 2007, BMC Vet Res, V3, P5, DOI 10.1186/1746-6148-3-5; Wood L, 2005, SOC SCI MED, V61, P1159, DOI 10.1016/j.socscimed.2005.01.017	68	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0221988	10.1371/journal.pone.0221988	http://dx.doi.org/10.1371/journal.pone.0221988			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QA	31756184	Green Published, gold, Green Submitted			2022-12-26	WOS:000533889300003
J	Konig, S; Boudriot, E; Arya, A; Lurz, JA; Sandri, M; Erbs, S; Thiele, H; Hindricks, G; Dinov, B				Koenig, Sebastian; Boudriot, Enno; Arya, Arash; Lurz, Julia Anna; Sandri, Marcus; Erbs, Sandra; Thiele, Holger; Hindricks, Gerhard; Dinov, Borislav			Incidence and characteristics of ventricular tachycardia in patients after percutaneous coronary revascularization of chronic total occlusions	PLOS ONE			English	Article							CARDIOVERTER-DEFIBRILLATOR RECIPIENTS; ELEVATION MYOCARDIAL-INFARCTION; PROCEDURAL COMPLICATIONS; HIBERNATING MYOCARDIUM; WEIGHTED METAANALYSIS; ANGIOGRAPHIC SUCCESS; ARRHYTHMIA BURSTS; HYBRID APPROACH; IMPACT; REPERFUSION	Objectives This study sought to investigate the prevalence of ventricular tachycardia after percutaneous coronary intervention (PCI) of chronic total occlusion (CTO). Background PCI of a CTO is associated with improvement of the left ventricular ejection fraction and possibly associated with reduced mortality. However, benefits of CTO-PCI must be weighed against a higher risk of procedure-related complications. The incidence of new-onset ventricular tachycardia after a successful CTO-PCI has not been investigated so far. In this retrospective registry we seek to describe characteristics and predictors of occurrence of post-procedural ventricular tachycardias. Methods and results Between 2010 and 2015, 485 patients underwent successful CTO-PCI at Heart Center Leipzig. Of them, 342 had complete follow-up and were further analyzed. Ventricular tachycardias were detected in 9 (2.6%) patients. All of them were monomorphic ventricular tachycardias occurring in median 1 day (interquartile range [IQR] 0.25-4.75 days) after PCI and caused prolongation of the hospital stay. Patients with ventricular tachycardia were older, had worse left ventricular ejection fraction (mean 33.1%, SD 5.9%) and more frequently a CTO of an infarct-related artery. The target vessel was not associated with the occurrence of ventricular arrhythmias. In multivariable analysis, only impaired left ventricular systolic function was an independent predictor for procedure-related ventricular tachycardia. Mortality rates were not different between patients with or without ventricular tachycardia. Conclusion Ventricular tachycardia can occur early after CTO-PCI as possible reperfusion arrhythmia and poorer left ventricular ejection fraction is the only independent predictor for onset. Although the occurrence of ventricular tachycardia after CTO-PCI seems not to influence mortality, awareness of this possible complication and longer monitoring may be recommended.	[Koenig, Sebastian; Arya, Arash; Lurz, Julia Anna; Hindricks, Gerhard; Dinov, Borislav] Univ Leipzig, Heart Ctr Leipzig, Dept Electrophysiol, Leipzig, Sachsen, Germany; [Boudriot, Enno; Sandri, Marcus; Erbs, Sandra; Thiele, Holger] Univ Leipzig, Dept Cardiol, Heart Ctr Leipzig, Leipzig, Sachsen, Germany; [Hindricks, Gerhard] Leipzig Heart Inst, Leipzig, Sachsen, Germany	Heart Center Leipzig GMBH; Leipzig University; Heart Center Leipzig GMBH; Leipzig University; Heart Center Leipzig GMBH	Konig, S (corresponding author), Univ Leipzig, Heart Ctr Leipzig, Dept Electrophysiol, Leipzig, Sachsen, Germany.	sebastian.koenig@helios-gesundheit.de	Thiele, Holger/ABE-6792-2020	Thiele, Holger/0000-0002-0169-998X; Nombela Franco, Luis/0000-0003-3438-8907				Abe M, 2019, CATHETER CARDIO INTE, V93, P1025, DOI 10.1002/ccd.28104; Brilakis ES, 2015, JACC-CARDIOVASC INTE, V8, P245, DOI 10.1016/j.jcin.2014.08.014; Canty JM, 2004, CIRC RES, V94, P1142, DOI 10.1161/01.RES.0000125628.57672.CF; Christofferson RD, 2005, AM J CARDIOL, V95, P1088, DOI 10.1016/j.amjcard.2004.12.065; Christopoulos G, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002171; Christopoulos G, 2014, J INVASIVE CARDIOL, V26, P427; Di Marco A, 2017, EUROPACE, V19, P267, DOI 10.1093/europace/euw009; Di Marco A, 2015, J CARDIOVASC ELECTR, V26, P532, DOI 10.1111/jce.12622; Dinov B, 2014, CIRCULATION, V129, P728, DOI 10.1161/CIRCULATIONAHA.113.003063; El Sabbagh A, 2014, INT J CARDIOL, V174, P243, DOI 10.1016/j.ijcard.2014.04.004; Fefer P, 2012, J AM COLL CARDIOL, V59, P991, DOI 10.1016/j.jacc.2011.12.007; Fernandez SF, 2013, AM J PHYSIOL-HEART C, V304, pH318, DOI 10.1152/ajpheart.00810.2011; Hoebers LP, 2015, INT J CARDIOL, V187, P90, DOI 10.1016/j.ijcard.2015.03.164; Ilia R, 2007, ISR MED ASSOC J, V9, P21; Jeroudi OM, 2014, CATHETER CARDIO INTE, V84, P637, DOI 10.1002/ccd.25264; Joyal D, 2010, AM HEART J, V160, P179, DOI 10.1016/j.ahj.2010.04.015; Jurkovicova O, 1998, Bratisl Lek Listy, V99, P162; Khan MF, 2015, CATHETER CARDIO INTE, V85, P781, DOI 10.1002/ccd.25712; Koenig Sebastian, 2016, HeartRhythm Case Rep, V2, P462, DOI 10.1016/j.hrcr.2016.04.008; Ma JY, 2013, CHINESE MED J-PEKING, V126, P1086, DOI 10.3760/cma.j.issn.0366-6999.20123435; Majidi M, 2008, EUROPACE, V10, P988, DOI 10.1093/europace/eun123; Majidi M, 2015, EUR HEART J-ACUTE CA, V4, P51, DOI 10.1177/2048872614532414; Nombela-Franco L, 2017, JACC-CARDIOVASC INTE, V10, P879, DOI 10.1016/j.jcin.2017.02.008; Nombela-Franco L, 2012, CIRC-ARRHYTHMIA ELEC, V5, P147, DOI 10.1161/CIRCEP.111.968008; Patel VG, 2014, J INVASIVE CARDIOL, V26, P100; Patel VG, 2013, JACC-CARDIOVASC INTE, V6, P128, DOI 10.1016/j.jcin.2012.10.011; Ramunddal T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103850; Solhjoo S, 2015, J MOL CELL CARDIOL, V78, P90, DOI 10.1016/j.yjmcc.2014.09.024; Sotomi Y, 2017, INT J CARDIOVAS IMAG, V33, P815, DOI 10.1007/s10554-017-1064-8; Stone GW, 2005, CIRCULATION, V112, P2364, DOI 10.1161/CIRCULATIONAHA.104.481283; Suero JA, 2001, J AM COLL CARDIOL, V38, P409, DOI 10.1016/S0735-1097(01)01349-3; Werner GS, 2009, CLIN RES CARDIOL, V98, P435, DOI 10.1007/s00392-009-0013-5; Wilson WM, 2016, HEART, V102, P1486, DOI 10.1136/heartjnl-2015-308891; Xiang SQ, 1996, CHINESE MED J-PEKING, V109, P282	34	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225580	10.1371/journal.pone.0225580	http://dx.doi.org/10.1371/journal.pone.0225580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756220	Green Published, gold			2022-12-26	WOS:000533889300040
J	Aboulwafa, M; Zhang, ZG; Saier, MH				Aboulwafa, Mohammad; Zhang, Zhongge; Saier, Milton H., Jr.			Protein:Protein interactions in the cytoplasmic membrane apparently influencing sugar transport and phosphorylation activities of the e. coli phosphotransferase system	PLOS ONE			English	Article							ENZYME-II COMPLEXES; ESCHERICHIA-COLI; BACTERIAL PHOSPHOENOLPYRUVATE; CRYSTAL-STRUCTURE; CATABOLITE REPRESSION; PTS; PROTEINS; PERMEASE; TRANSPHOSPHORYLATION; PHOSPHATE	The multicomponent phosphoenolpyruvate (PEP)-dependent sugar-transporting phosphotransferase system (PTS) in Escherichia coli takes up sugar substrates from the medium and concomitantly phosphorylates them, releasing sugar phosphates into the cytoplasm. We have recently provided evidence that many of the integral membrane PTS permeases interact with the fructose PTS (FruA/FruB) [1]. However, the biochemical and physiological significance of this finding was not known. We have carried out molecular genetic/biochemical/physiological studies that show that interactions of the fructose PTS often enhance, but sometimes inhibit the activities of other PTS transporters many fold, depending on the target PTS system under study. Thus, the glucose (Glc), mannose (Man), mannitol (Mtl) and N-acetylglucosamine (NAG) permeases exhibit enhanced in vivo sugar transport and sometimes in vitro PEP-dependent sugar phosphorylation activities while the galactitol (Gat) and trehalose (Tre) systems show inhibited activities. This is observed when the fructose system is induced to high levels and prevented when the fruA/fruB genes are deleted. Overexpression of the fruA and/or fruB genes in the absence of fructose induction during growth also enhances the rates of uptake of other hexoses. The beta-galactosidase activities of man, mtl, and gat-lacZ transcriptional fusions and the sugar-specific transphosphorylation activities of these enzyme transporters were not affected either by frustose induction or by fruAB overexpression, showing that the rates of synthesis of the target PTS permeases were not altered. We thus suggest that specific protein-protein interactions within the cytoplasmic membrane regulate transport in vivo (and sometimes the PEP-dependent phosphorylation activities in vitro) of PTS permeases in a physiologically meaningful way that may help to provide a hierarchy of preferred PTS sugars. These observations appear to be applicable in principle to other types of transport systems as well.	[Aboulwafa, Mohammad; Zhang, Zhongge; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Aboulwafa, Mohammad] Ain Shams Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt	University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); Ain Shams University	Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	msaier@ucsd.edu	Aboulwafa, Mohammad/V-5498-2018	Aboulwafa, Mohammad/0000-0002-0828-1420; Saier, Milton/0000-0001-5530-0017	U.S. National Institutes of Health [MS - GM077402]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health, MS - GM077402, https://www.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulwafa M, 2003, MOL MICROBIOL, V48, P131, DOI 10.1046/j.1365-2958.2003.03394.x; Aboulwafa M, 2002, RES MICROBIOL, V153, P667, DOI 10.1016/S0923-2508(02)01376-1; Aboulwafa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024088; [Anonymous], 1972, EXPT MOL GENETICS; Babu M, 2018, NAT BIOTECHNOL, V36, P103, DOI 10.1038/nbt.4024; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Bogdanov M, 2013, J MOL MICROB BIOTECH, V23, P24, DOI 10.1159/000346517; Charbit A, 1996, J BIOL CHEM, V271, P9997, DOI 10.1074/jbc.271.17.9997; Chen JS, 2011, J MOL MICROB BIOTECH, V21, P83, DOI 10.1159/000334611; Clore GM, 2013, TRENDS BIOCHEM SCI, V38, P515, DOI 10.1016/j.tibs.2013.08.003; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; FEUCHT BU, 1980, J BACTERIOL, V141, P603, DOI 10.1128/JB.141.2.603-610.1980; Gabor E, 2011, EUR J CELL BIOL, V90, P711, DOI 10.1016/j.ejcb.2011.04.002; Garrity LF, 1998, J BACTERIOL, V180, P4475, DOI 10.1128/JB.180.17.4475-4480.1998; Higgins MA, 2017, PROTEINS, V85, P963, DOI 10.1002/prot.25264; Hvorup R, 2003, J MOL MICROB BIOTECH, V6, P191, DOI 10.1159/000077250; Kalbermatter D, 2015, J STRUCT BIOL, V191, P376, DOI 10.1016/j.jsb.2015.08.003; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kotrba P, 2001, J BIOSCI BIOENG, V92, P502, DOI 10.1263/jbb.92.502; Lengeler JW, 2015, J MOL MICROB BIOTECH, V25, P79, DOI 10.1159/000369809; Luo P, 2015, NAT STRUCT MOL BIOL, V22, P238, DOI 10.1038/nsmb.2975; LUX R, 1995, P NATL ACAD SCI USA, V92, P11583, DOI 10.1073/pnas.92.25.11583; MANAYAN R, 1988, J BACTERIOL, V170, P1290, DOI 10.1128/jb.170.3.1290-1296.1988; Mccoy JG, 2015, BBA-GEN SUBJECTS, V1850, P577, DOI 10.1016/j.bbagen.2014.03.013; Neumann S, 2012, P NATL ACAD SCI USA, V109, P12159, DOI 10.1073/pnas.1205307109; Orriss GL, 2003, J MOL BIOL, V327, P1111, DOI 10.1016/S0022-2836(03)00215-8; Park J, 2016, MOL CELLS, V39, P495, DOI 10.14348/molcells.2016.0055; POSTMA PW, 1981, J BACTERIOL, V147, P382, DOI 10.1128/JB.147.2.382-389.1981; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Ramadurai S, 2009, J AM CHEM SOC, V131, P12650, DOI 10.1021/ja902853g; REPHAELI AW, 1978, J BIOL CHEM, V253, P7595; Rodionova IA, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00691-17; Rodionova IA, 2017, J BIOL CHEM, V292, P14250, DOI 10.1074/jbc.M117.795294; Saier MH, 2005, BIOCHEM SOC T, V33, P220, DOI 10.1042/BST0330220; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; SAIER MH, 1994, MOL MICROBIOL, V13, P755; SAIER MH, 1976, J BIOL CHEM, V251, P3834; SAIER MH, 1977, J BIOL CHEM, V252, P8908; SAIER MH, 1977, J BIOL CHEM, V252, P8899; Saier MH, 1996, MICROBIOL-UK, V142, P217, DOI 10.1099/13500872-142-2-217; SAIER MH, 1993, J CELL BIOCHEM, V51, P62, DOI 10.1002/jcb.240510112; SAIER MH, 1985, J CELL BIOCHEM, V27, P43, DOI 10.1002/jcb.240270106; SAIER MH, 1977, J BIOL CHEM, V252, P8890; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Schneider D, 2008, BBA-BIOENERGETICS, V1777, P735, DOI 10.1016/j.bbabio.2008.03.003; Shepherd VA, 2006, CURR TOP DEV BIOL, V75, P171, DOI 10.1016/S0070-2153(06)75006-2; Shimizu K, 2014, METABOLITES, V4, P1, DOI 10.3390/metabo4010001; Somavanshi R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000074; Tchieu JH, 2001, J MOL MICROB BIOTECH, V3, P329; Tian Z, 2015, B ENVIRON CONTAM TOX, V94, P370, DOI 10.1007/s00128-014-1445-9; Woronowicz K, 2011, METALLOMICS, V3, P765, DOI 10.1039/c1mt00034a; WU LF, 1990, J MOL BIOL, V213, P687, DOI 10.1016/S0022-2836(05)80256-6; Yoo W, 2017, SCI REP-UK, V7, DOI 10.1038/srep44827	57	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0219332	10.1371/journal.pone.0219332	http://dx.doi.org/10.1371/journal.pone.0219332			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751341	Green Published, gold, Green Submitted			2022-12-26	WOS:000533886900002
J	Khor, NWM; Swarbrick, MM; Gunton, JE				Khor, Nicole Wen Mun; Swarbrick, Michael M.; Gunton, Jenny E.			Inducible UCP1 silencing: A lentiviral RNA-interference approach to quantify the contribution of beige fat to energy homeostasis	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; WHITE; THERMOGENESIS; ADIPOCYTES; DYSFUNCTION; PHENOTYPE; AGONIST; MOUSE	Energy consuming, heat-producing beige adipocytes, located in classic white adipose tissue (WAT), hold promise for the treatment of obesity. Few reports have quantitatively assessed the contribution of browned 'WAT' to energy expenditure. There is a need for methods to examine beige-fat thermogenesis, independently of classical brown fat. The aim of this study is to optimize an inducible lentiviral shRNA to conditionally knock-down Ucp1 and assess the effects on 'browned' WAT. Primary adipocytes from mouse inguinal WAT converted into thermogenic adipocytes when stimulated with beta-adrenergic agonist and thiazolidinedione. There was increased UCP1 protein and importantly increases in various indicators of mitochondrial bioenergetics. Next, we determined optimal transfection conditions for the UCP1-shRNA lentiviral system and subsequently applied this to 'browned' WAT. UCP1 knockdown decreased the brown/beige-fat gene profile and decreased mitochondrial respiration. In summary, this study optimizes lentiviral UCP1-shRNA technology in vitro. This technique could be applied to inguinal fat depots in vivo. This would allow investigation of contribution of depots to whole-body metabolism to help elucidate the physiological relevance of beige fat.	[Khor, Nicole Wen Mun; Swarbrick, Michael M.; Gunton, Jenny E.] Westmead Inst Med Res, Sydney, NSW, Australia; [Khor, Nicole Wen Mun; Swarbrick, Michael M.; Gunton, Jenny E.] Garvan Inst Med Res, Sydney, NSW, Australia; [Khor, Nicole Wen Mun; Swarbrick, Michael M.; Gunton, Jenny E.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Khor, Nicole Wen Mun; Swarbrick, Michael M.; Gunton, Jenny E.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney	Gunton, JE (corresponding author), Westmead Inst Med Res, Sydney, NSW, Australia.; Gunton, JE (corresponding author), Garvan Inst Med Res, Sydney, NSW, Australia.; Gunton, JE (corresponding author), Univ New South Wales, Fac Med, Sydney, NSW, Australia.; Gunton, JE (corresponding author), Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia.	jenny.gunton@sydney.edu.au	Gunton, Jenny E/AAH-7719-2021	Swarbrick, Michael/0000-0003-2838-8548; Khor, Nicole/0000-0002-0183-3528	NHMRC [1078707]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by NHMRC project grant 1078707.	Bartesaghi S, 2015, MOL ENDOCRINOL, V29, P130, DOI 10.1210/me.2014-1295; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Betz MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038997; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bugge A, 2014, METHOD ENZYMOL, V538, P233, DOI 10.1016/B978-0-12-800280-3.00013-X; CAWTHORNE MA, 1992, AM J CLIN NUTR, V55, P252; Clarke KJ, 2012, BBA-BIOENERGETICS, V1817, P1759, DOI 10.1016/j.bbabio.2012.03.035; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Emanuelli B, 2015, J CLIN INVEST, V125, P458, DOI 10.1172/JCI80223; GEHealthcare, 2014, SMARTVECTOR LENT SHR; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Larsen TM, 2002, AM J CLIN NUTR, V76, P780, DOI 10.1093/ajcn/76.4.780; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Lee P, 2015, CELL METAB, V21, P795, DOI 10.1016/j.cmet.2015.05.018; Lee P, 2013, ENDOCR REV, V34, P413, DOI 10.1210/er.2012-1081; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lidell ME, 2014, J INTERN MED, V276, P364, DOI 10.1111/joim.12255; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P609, DOI 10.1139/y86-101; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; Pfeifer A, 2015, ANNU REV PHARMACOL, V55, P207, DOI 10.1146/annurev-pharmtox-010814-124346; Redman LM, 2007, J CLIN ENDOCRINOLOGY, V92; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QA, 2014, J LIPID RES, V55, P605, DOI 10.1194/jlr.R046441; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555; World Health Organisation, 2015, OB SIT TRENDS; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yang T, 2014, PLASMID, V72, P29, DOI 10.1016/j.plasmid.2014.04.001; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0223987	10.1371/journal.pone.0223987	http://dx.doi.org/10.1371/journal.pone.0223987			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751350	Green Published, gold			2022-12-26	WOS:000533886900006
J	Kocnar, T; Saribay, SA; Kleisner, K				Kocnar, Tomas; Saribay, S. Adil; Kleisner, Karel			Perceived attractiveness of Czech faces across 10 cultures: Associations with sexual shape dimorphism, averageness, fluctuating asymmetry, and eye color	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; HAIR COLOR; HUMAN PREFERENCES; MATE PREFERENCES; EVOLUTIONARY PSYCHOLOGY; WOMENS PREFERENCES; HOMO-SAPIENS; MENS FACES; BODY-SIZE; SYMMETRY	Research on the perception of faces typically assumes that there are some universal values of attractiveness which are shared across individuals and cultures. The perception of attractiveness may, however, vary across cultures due to local differences in both facial morphology and standards of beauty. To examine cross-cultural consensus in the ratings of attractiveness, we presented a set of 120 non-manipulated photographs of Czech faces to ten samples of raters from both European (Czech Republic, Estonia, Sweden, Romania, Turkey, Portugal) and non-European countries (Brazil, India, Cameroon, Namibia). We examined the relative contribution of three facial markers (sexual shape dimorphism, averageness, fluctuating asymmetry) to the perception of attractiveness as well as the possible influence of eye color, which is a locally specific trait. In general, we found that both male and female faces which were closer to the average and more feminine in shape were regarded as more attractive, while fluctuating asymmetry had no effect. Despite a high cross-cultural consensus on attractiveness standards, significant differences in the perception of attractiveness seem to be related to the level of socio-economic development (as measured by the Human Development Index, HDI). Attractiveness ratings by raters from low-HDI countries (India, Cameroon, Namibia) converged less with ratings from Czech Republic than ratings from high-HDI countries (European countries and Brazil). With respect to eye color, some local patterns emerged which we discuss as a consequence of negative frequency-dependent selection.	[Kocnar, Tomas; Kleisner, Karel] Charles Univ Prague, Dept Philosophy & Hist Sci, Prague, Czech Republic; [Saribay, S. Adil] Bogazici Univ, Dept Psychol, Istanbul, Turkey	Charles University Prague; Bogazici University	Kocnar, T (corresponding author), Charles Univ Prague, Dept Philosophy & Hist Sci, Prague, Czech Republic.	tomas.kocnar@gmail.com	Kleisner, Karel/M-2718-2017	Kleisner, Karel/0000-0002-3277-8365; Kocnar, Tomas/0000-0002-6724-0389	Czech Science Foundation [18-10298S]	Czech Science Foundation(Grant Agency of the Czech Republic)	The research was supported by the Czech Science Foundation project reg. no 18-10298S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend P, 2015, EVOL HUM BEHAV, V36, P174, DOI 10.1016/j.evolhumbehav.2014.10.004; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; ALLEY TR, 1991, PSYCHOL SCI, V2, P123, DOI 10.1111/j.1467-9280.1991.tb00113.x; Andersson Malte, 1994; Munoz-Reyes JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132979; Apicella CL, 2007, PERCEPTION, V36, P1813, DOI 10.1068/p5601; Augood C, 2004, OPHTHAL EPIDEMIOL, V11, P117, DOI 10.1076/opep.11.2.117.28160; Balaresque P, 2016, CURR TOP DEV BIOL, V119, P349, DOI 10.1016/bs.ctdb.2016.02.001; Banfai Z, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00558; Banks GC, 2010, INTELLIGENCE, V38, P393, DOI 10.1016/j.intell.2010.04.003; Basu J, 2001, PSYCHOLOGIA, V44, P281, DOI 10.2117/psysoc.2001.281; Batres C, 2017, HUM NATURE-INT BIOS, V28, P344, DOI 10.1007/s12110-017-9289-8; Batres C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100966; Baudouin JY, 2004, ACTA PSYCHOL, V117, P313, DOI 10.1016/j.actpsy.2004.07.002; Beals R. L., 1965, INTRO ANTHR; Bejanyan K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01355; Boothroyd LG, 2008, EVOL HUM BEHAV, V29, P211, DOI 10.1016/j.evolhumbehav.2007.12.009; Bovet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049791; Bressan P, 2018, SCI REP, V8, P1, DOI [10.1038/3668587, DOI 10.1038/3668587]; Bronstad PM, 2007, PERCEPTION, V36, P1674, DOI 10.1068/p5793; Brooks R, 2011, P ROY SOC B-BIOL SCI, V278, P810, DOI 10.1098/rspb.2010.0964; Bugay A, 2010, PROCD SOC BEHV, V5, P1464, DOI 10.1016/j.sbspro.2010.07.309; Carrito MD, 2016, EVOL HUM BEHAV, V37, P125, DOI 10.1016/j.evolhumbehav.2015.09.006; Coetzee V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099629; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Danel DP, 2016, HOMO, V67, P337, DOI 10.1016/j.jchb.2016.05.002; Danel DP, 2012, ETHOLOGY, V118, P1173, DOI 10.1111/eth.12022; Davidjants B, 2017, MUSIC SCI, V21, P430, DOI 10.1177/1029864916662904; DeBruine LM, 2007, J EXP PSYCHOL HUMAN, V33, P1420, DOI 10.1037/0096-1523.33.6.1420; DeBruine LM, 2012, BEHAV BRAIN SCI, V35, P86, DOI 10.1017/S0140525X11000987; DeBruine LM, 2011, P ROY SOC B-BIOL SCI, V278, P813, DOI 10.1098/rspb.2010.2200; DeBruine LM, 2010, P ROY SOC B-BIOL SCI, V277, P2405, DOI 10.1098/rspb.2009.2184; Deniz A, 2014, ANTALYADAKI RUS GELI, V3, P175; Dixson BJW, 2017, BEHAV ECOL, V28, P1217, DOI 10.1093/beheco/arx067; Edwards M, 2016, PIGM CELL MELANOMA R, V29, P141, DOI 10.1111/pcmr.12435; Farrera A, 2015, AM J HUM BIOL, V27, P387, DOI 10.1002/ajhb.22657; Fink B, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01893; FINK M, 2011, J EUR ACAD DERMATOL, V26, DOI DOI 10.1111/J.1468-3083.2011.04316.X; Foo YZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39731; Frost P, 2006, EVOL HUM BEHAV, V27, P85, DOI 10.1016/j.evolhumbehav.2005.07.002; Frost P., 2014, ADV ANTHR, V4, P78, DOI [10.4236/aa.2014.42011, DOI 10.4236/AA.2014.42011]; Frost P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190238; Gelles Rebecca, 2011, INDEPENDENT STUDY PR, V1145; Germine L, 2015, CURR BIOL, V25, P2684, DOI 10.1016/j.cub.2015.08.048; Graham JH, 2016, SYMMETRY-BASEL, V8, DOI 10.3390/sym8120154; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Gray PB, 2012, EVOL PSYCHOL-US, V10, P631, DOI 10.1177/147470491201000319; Henderson AJ, 2016, PHILOS T R SOC LON B, P371; Hinsz VB, 2013, CURR PSYCHOL, V32, P136, DOI 10.1007/s12144-013-9169-2; Honekopp J, 2006, J EXP PSYCHOL HUMAN, V32, P199, DOI 10.1037/0096-1523.32.2.199; Iyigun M, 2013, ECON DEV CULT CHANGE, V61, P693, DOI 10.1086/670376; Jablonski NG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0349; Janif ZJ, 2015, ADAPT HUM BEHAV PHYS, V1, P54, DOI 10.1007/s40750-014-0008-y; Janif ZJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0958; JOHNSTON VS, 2000, PRAGMAT COGN, V8, P107, DOI DOI 10.1075/PC.8.1.06JOH; Jokela M, 2009, EVOL HUM BEHAV, V30, P342, DOI 10.1016/j.evolhumbehav.2009.03.006; Jones AL, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11020279; Jones BC, 2001, EVOL HUM BEHAV, V22, P417, DOI 10.1016/S1090-5138(01)00083-6; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; Jones D., 1995, SEXUAL SELECTION PHY, V36; Karandashev V, 2016, CROSS-CULT RES, V50, P478, DOI 10.1177/1069397116674446; Kavas S, 2013, J FAM HIST, V38, P223, DOI 10.1177/0363199013482263; Keating C. F., 2002, FACIAL ATTRACTIVENES, P153; KEATING CF, 1985, SOC PSYCHOL QUART, V48, P61, DOI 10.2307/3033782; Klein KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080661; Kleisner K, 2017, EVOL HUM BEHAV, V38, P744, DOI 10.1016/j.evolhumbehav.2017.07.002; Kleisner K, 2010, PERS INDIV DIFFER, V49, P59, DOI 10.1016/j.paid.2010.03.011; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Komori M, 2009, ACTA PSYCHOL, V131, P136, DOI 10.1016/j.actpsy.2009.03.008; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Laeng B, 2007, BEHAV ECOL SOCIOBIOL, V61, P371, DOI 10.1007/s00265-006-0266-1; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; LAWSON ED, 1971, PSYCHOL REP, V28, P311, DOI 10.2466/pr0.1971.28.1.311; Lee AJ, 2016, EVOL HUM BEHAV, V37, P61, DOI 10.1016/j.evolhumbehav.2015.08.003; Lefevre CE, 2015, Q J EXP PSYCHOL, V68, P284, DOI 10.1080/17470218.2014.944194; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Little AC, 2003, EVOL HUM BEHAV, V24, P43, DOI 10.1016/S1090-5138(02)00119-8; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; Little AC, 2007, P ROY SOC B-BIOL SCI, V274, P3113, DOI 10.1098/rspb.2007.0895; Little AC, 2007, BEHAV ECOL SOCIOBIOL, V61, P967, DOI 10.1007/s00265-006-0325-7; Little AC, 2006, ANIM BEHAV, V72, P981, DOI 10.1016/j.anbehav.2006.01.026; Little AC, 2014, LEADERSHIP QUART, V25, P865, DOI 10.1016/j.leaqua.2014.04.002; Little AC, 2014, BRIT J PSYCHOL, V105, P364, DOI 10.1111/bjop.12043; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Lu H. J., 2015, EVOL BEHAV SCI, V9, P215, DOI DOI 10.1037/EBS0000048; Lyons M, 2016, PERS INDIV DIFFER, V95, P25, DOI 10.1016/j.paid.2016.02.025; Manzakoglu BT, 2016, TURK ONLINE J DES AR, V6, P193, DOI 10.7456/10602100/013; Marcinkowska UM, 2014, BIOL LETT, V10, P2013; Marcinkowska UM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39350-8; Mardia KV, 2005, BIOMETRIKA, V92, P249, DOI 10.1093/biomet/92.1.249-a; Mitra S., 2018, CELEBRITY STUDIES, V10, P228; Mitteroecker P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118374; Mo JJY, 2014, CROSS-CULT RES, V48, P78, DOI 10.1177/1069397113510272; Mogilski JK, 2017, HUM NATURE-INT BIOS, V28, P53, DOI 10.1007/s12110-016-9277-4; Mueller U, 1997, BEHAV ECOL, V8, P569; Muggleton NK, 2017, PERS INDIV DIFFER, V111, P169, DOI 10.1016/j.paid.2017.01.054; Ozener B, 2010, EVOL HUM BEHAV, V31, P436, DOI 10.1016/j.evolhumbehav.2010.06.003; Ozgur E.M., 2010, EGE DERGISI, V19, P13; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P355, DOI 10.1016/j.evolhumbehav.2004.06.002; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Perrett DI, 2002, P ROY SOC B-BIOL SCI, V269, P873, DOI 10.1098/rspb.2002.1971; Pisanski K, 2013, CROSS-CULT RES, V47, P162, DOI 10.1177/1069397112471806; Pollet TV, 2014, HUM NATURE-INT BIOS, V25, P410, DOI 10.1007/s12110-014-9206-3; Pound N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1639; Prokop P, 2011, J ETHOL, V29, P453, DOI 10.1007/s10164-011-0274-0; Prokop P, 2010, ACTA ETHOL, V13, P101, DOI 10.1007/s10211-010-0079-0; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rantala MJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P859, DOI 10.1007/s00265-011-1145-y; Rennels JL, 2008, J EXP PSYCHOL HUMAN, V34, P884, DOI 10.1037/0096-1523.34.4.884; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rhodes G, 2001, PERCEPTION, V30, P611, DOI 10.1068/p3123; Rhodes G, 1999, PSYCHOL SCI, V10, P52, DOI 10.1111/1467-9280.00106; Rhodes G., 2007, OXFORD HDB EVOLUTION, P333; RHODES G, 1994, VIS COGN, V1, P275, DOI DOI 10.1080/13506289408402303; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Roberts SC, 2005, BIOL LETT-UK, V1, P400, DOI 10.1098/rsbl.2005.0343; Said CP, 2011, PSYCHOL SCI, V22, P1183, DOI 10.1177/0956797611419169; Sakalli-Ugurlu N, 2016, SEX ROLES, V75, P535, DOI 10.1007/s11199-016-0689-8; Salter F, 1996, ETHOL SOCIOBIOL, V17, P211, DOI 10.1016/0162-3095(96)00036-2; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schneider TM, 2013, PERS INDIV DIFFER, V55, P356, DOI 10.1016/j.paid.2013.03.022; Scott IM, 2014, P NATL ACAD SCI USA, V111, P14388, DOI 10.1073/pnas.1409643111; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Soler C, 2012, PERCEPTION, V41, P1234, DOI 10.1068/p7214; Sorokowski P, 2008, PERCEPT MOTOR SKILL, V106, P737, DOI 10.2466/PMS.106.3.737-744; Sorokowski P, 2013, EVOL PSYCHOL-US, V11, P907, DOI 10.1177/147470491301100414; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Swaddle JP, 2002, P ROY SOC B-BIOL SCI, V269, P2285, DOI 10.1098/rspb.2002.2165; Swami V., 2008, J EVOLUTIONARY PSYCH, V6, P321, DOI DOI 10.1556/JEP.6.2008.4.4; Swami V, 2015, EUR PSYCHOL, V20, P44, DOI 10.1027/1016-9040/a000150; Swami V, 2011, SCAND J PSYCHOL, V52, P595, DOI 10.1111/j.1467-9450.2011.00911.x; Thayer ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060681; THELEN TH, 1983, SOC BIOL, V30, P162; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; THORNHILL R, 1994, PSYCHOL SCI, V5, P297, DOI 10.1111/j.1467-9280.1994.tb00629.x; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; United Nations Development Programme, 2015, HUM DEV REP 2015; Van Dongen S, 2014, ANN HUM BIOL, V41, P205, DOI 10.3109/03014460.2013.847120; Van Dongen S, 2012, ARCH SEX BEHAV, V41, P1453, DOI 10.1007/s10508-012-9917-7; Van Dongen S, 2011, EVOL HUM BEHAV, V32, P380, DOI 10.1016/j.evolhumbehav.2011.03.002; Van Dongen S, 2011, ANN HUM BIOL, V38, P317, DOI 10.3109/03014460.2010.544676; Walsh S, 2012, FORENSIC SCI INT-GEN, V6, P330, DOI 10.1016/j.fsigen.2011.07.009; Wehr P, 2001, HUM NATURE-INT BIOS, V12, P383, DOI 10.1007/s12110-001-1004-z; WILSON GD, 1987, J BIOSOC SCI, V19, P157; Young SG, 2012, PERS SOC PSYCHOL REV, V16, P116, DOI 10.1177/1088868311418987; Yuksel-Kaptanoglu I, 2014, J FAM ISSUES, V35, P1707, DOI 10.1177/0192513X14538025; Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P1633, DOI 10.1073/pnas.1808659116	159	10	10	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225549	10.1371/journal.pone.0225549	http://dx.doi.org/10.1371/journal.pone.0225549			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KB0IC	31751432	gold, Green Published			2022-12-26	WOS:000506181600001
J	Chen, GW; Yue, YZ; Hua, YJ; Hu, D; Shi, TT; Chang, ZJ; Yang, XL; Wang, LG				Chen, Gongwei; Yue, Yuanzheng; Hua, Yajie; Hu, Die; Shi, Tingting; Chang, Zhaojing; Yang, Xiulian; Wang, Lianggui			SSR marker development in Clerodendrum trichotomum using transcriptome sequencing	PLOS ONE			English	Article							GENETIC DIVERSITY; ABIETANE DITERPENOIDS; LEAVES; LENGTH; AFLP	Clerodendrum trichotomum, a member of the Lamiaceae (Verbenaceae) family, is an ornamental plant widely distributed in South Asia. Previous studies have focused primarily on its growth characteristics, stress resistance, and pharmacological applications; however, molecular investigations remain limited. Considering germplasm conservation and the extensive applications of this plant, it is necessary to explore transcriptome resources and SSR makers for C. trichotomum. In the present study, RNA sequencing was used to determine the transcriptome of C. trichotomum. Subsequently, unigene annotations and classifications were obtained, and SSRs were mined with MIcroSAtellite. Finally, primer pairs designed with Oligo 6.0 were selected for polymorphism validation. In total, 127,325,666 high-quality reads were obtained, and 58,345 non-redundant unigenes were generated, of which 36,900 (63.24%) were annotated. Among the annotated unigenes, 35,980 (97.51%) had significant similarity to 607 species in Nr databases. In addition, a total of 6,444 SSRs were identified in 5,530 unigenes, and 200 random primer pairs were designed for polymorphism validation. Furthermore, after primary polymorphism identification, 30 polymorphic primer pairs were selected for the further polymorphism screening, and 200 alleles were identified, 197 of which showed polymorphism. In this work, a large number of unigenes were generated, and numerous SSRs were detected. These findings should be beneficial for further investigations into germplasm conservation and various applications of C. trichotomum. These results should also provide a solid foundation for future molecular biology studies in C. trichotomum.	[Chen, Gongwei; Yue, Yuanzheng; Hua, Yajie; Hu, Die; Shi, Tingting; Chang, Zhaojing; Yang, Xiulian; Wang, Lianggui] Nanjing Forestry Univ, Coll Landscape Architecture, Nanjing, Jiangsu, Peoples R China; [Wang, Lianggui] Nanjing Forestry Univ, Coll Forestry, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University; Nanjing Forestry University	Yang, XL; Wang, LG (corresponding author), Nanjing Forestry Univ, Coll Landscape Architecture, Nanjing, Jiangsu, Peoples R China.; Wang, LG (corresponding author), Nanjing Forestry Univ, Coll Forestry, Nanjing, Jiangsu, Peoples R China.	yangxl339@sina.com; wlg@njfu.com.cn	Yue, Yuanzheng/H-1313-2011	Yue, Yuanzheng/0000-0002-6048-5236	Natural Science Research of Jiangsu Higher Education Institutions of China [PPZY2015A063]; Special Fund for Forest Scientific Research in the Public Welfare [201404109]	Natural Science Research of Jiangsu Higher Education Institutions of China; Special Fund for Forest Scientific Research in the Public Welfare	This study was supported by Natural Science Research of Jiangsu Higher Education Institutions of China (PPZY2015A063) and Special Fund for Forest Scientific Research in the Public Welfare (201404109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arokiyaraj S., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS601; Carver M, 2014, AUSTRAL ENTOMOLOGY, V42, P109, DOI [10.1046/j.1440-6055.2003.00339.x, DOI 10.1046/J.1440-6055.2003.00339.X]; Chae Sungwook, 2007, Journal of Applied Biological Chemistry, V50, P270; Chen CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187738; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; Choi Ji Won, 2012, Journal of Applied Biological Chemistry, V55, P169, DOI 10.3839/jabc.2012.026; Dang M, 2016, FORESTS, V7, DOI 10.3390/f7100247; Fan L, 2018, PLANT MOL BIOL REP, V116, P52, DOI [10.1016/j.sajb.2018.02.408, DOI 10.1016/J.SAJB.2018.02.408]; Gang Q, 2011, J MOL BIOL, V25, P66; [王亮 Wang Liang], 2017, [核农学报, Journal of Nuclear Agricultural Sciences], V31, P2087; Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo LN, 2016, BIOCHEM SYST ECOL, V68, P36, DOI 10.1016/j.bse.2016.06.010; Huang HaiYan, 2013, Scientia Silvae Sinicae, V49, P176; Kaur S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-104; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li LZ, 2014, BIOCHEM SYST ECOL, V56, P218, DOI 10.1016/j.bse.2014.06.002; Miyake T, 2003, PLANT SYST EVOL, V243, P31, DOI 10.1007/s00606-003-0059-1; Mizusawa L, 2011, AM J BOT, V98, pE333, DOI 10.3732/ajb.1100155; Muthu C, 2012, PARASITOL RES, V111, P1059, DOI 10.1007/s00436-012-2932-8; Niemandt M, 2018, S AFR J BOT, V116, P52, DOI 10.1016/j.sajb.2018.02.408; Ono M, 2013, J NAT MED-TOKYO, V67, P404, DOI 10.1007/s11418-012-0690-7; Pan LM, 2017, SCI HORTIC-AMSTERDAM, V225, P171, DOI 10.1016/j.scienta.2017.06.053; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Ronoh R, 2018, SCI HORTIC-AMSTERDAM, V235, P152, DOI 10.1016/j.scienta.2018.03.003; Sakamoto RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033803; Singh RK, 2010, GENET MOL BIOL, V33, P319, DOI 10.1590/S1415-47572010005000024; Soriano JM, 2005, GENOME, V48, P108, DOI 10.1139/G04-101; Thitilertdecha P, 2014, J ETHNOPHARMACOL, V154, P400, DOI 10.1016/j.jep.2014.04.021; Tian J, 1997, J NAT PROD, V60, P766, DOI 10.1021/np9606759; Wahba HM, 2011, PHARM BIOL, V49, P66, DOI 10.3109/13880209.2010.494674; Wang Jin-Hui, 2018, J Tradit Complement Med, V8, P24, DOI 10.1016/j.jtcme.2017.04.001; Wang WX, 2013, PHYTOCHEMISTRY, V89, P89, DOI 10.1016/j.phytochem.2013.01.008; Wang Y, 2017, PEERJ, V5, DOI 10.7717/peerj.3422; Xu M, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-016-0613-5; Xu RL, 2015, CHEM NAT COMPD+, V51, P999, DOI 10.1007/s10600-015-1477-3; Xu RL, 2014, PHYTOCHEM LETT, V7, P111, DOI 10.1016/j.phytol.2013.10.010; Yoder AD, 2018, MOL BIOL EVOL, V35, P1322, DOI 10.1093/molbev/msy076; Yuan YW, 2010, TAXON, V59, P125, DOI 10.1002/tax.591013; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zhang R, 2010, PLANT MOL BIOL REP, V28, P646, DOI 10.1007/s11105-010-0192-2	41	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225451	10.1371/journal.pone.0225451	http://dx.doi.org/10.1371/journal.pone.0225451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747430	gold, Green Published			2022-12-26	WOS:000533881900043
J	Huang, V; Yu, M; Carleton, RN; Beshai, S				Huang, Vivian; Yu, Mabel; Carleton, R. Nicholas; Beshai, Shadi			Intolerance of uncertainty fuels depressive symptoms through rumination: Cross-sectional and longitudinal studies	PLOS ONE			English	Article							ANXIETY DISORDERS; MEDIATION; REFLECTION; SUBTYPES; PHQ-9; ADOLESCENCE; STRATEGIES; RESPONSES; DURATION; STYLES	The current study replicated and extended previous studies by examining the mediating and moderating role of rumination in the relationship between intolerance of uncertainty (IU) and depression in a community sample using both cross-sectional (n = 494; 56.9% female) and a two-months longitudinal (n = 321; 48.4% female) designs. Participants in each study were recruited through online crowdsourcing websites and completed study questionnaires. Results from Study 1 suggested that, while rumination did not appear to moderate the relationship between IU and depression, rumination appeared to partially mediates such relationship. Results from Study 2 supported rumination as fully mediating the relationship between IU and depression over two months. The brooding and reflection rumination subtypes exerted a significant indirect, but not moderating, effect on the relationship between IU and depression. Brooding exhibited a stronger mediation effect than did reflection. Overall, current results suggest that high levels of IU fuel the development of depression symptoms over time through engagement in heightened rumination. The IU-depression association appeared fully explained through rumination as it is a passive and contextually-dependent coping response that may enhance individuals' emotion and facilitate the development of depressive symptoms.	[Huang, Vivian] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Yu, Mabel; Carleton, R. Nicholas; Beshai, Shadi] Univ Regina, Dept Psychol, Regina, SK, Canada	Toronto Metropolitan University; University of Regina	Huang, V (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	vivian.huang@psych.ryerson.ca	Beshai, Shadi/C-7287-2016	Beshai, Shadi/0000-0001-7119-0129; Huang, Vivian/0000-0001-7232-124X				Abela JRZ, 2011, J ABNORM PSYCHOL, V120, P259, DOI 10.1037/a0022796; Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Bagby RM, 2001, COGNITIVE THER RES, V25, P91, DOI 10.1023/A:1026430900363; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Burwell RA, 2007, J CLIN CHILD ADOLESC, V36, P56, DOI 10.1207/s15374424jccp3601_6; Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014; Carleton RN, 2016, J ANXIETY DISORD, V41, P5, DOI 10.1016/j.janxdis.2016.03.011; Carleton RN, 2016, J ANXIETY DISORD, V39, P30, DOI 10.1016/j.janxdis.2016.02.007; Carleton RN, 2012, EXPERT REV NEUROTHER, V12, P937, DOI 10.1586/ERN.12.82; Carleton RN, 2012, J ANXIETY DISORD, V26, P468, DOI 10.1016/j.janxdis.2012.01.011; Chandler J, 2016, ANNU REV CLIN PSYCHO, V12, P53, DOI 10.1146/annurev-clinpsy-021815-093623; Ciesla JA, 2007, EMOTION, V7, P555, DOI 10.1037/1528-3542.7.3.555; Cox S, 2012, COGNITIVE THER RES, V36, P290, DOI 10.1007/s10608-011-9373-z; Crane C, 2007, BRIT J CLIN PSYCHOL, V46, P497, DOI 10.1348/014466507X230895; de Jong-Meyer R, 2009, PERS INDIV DIFFER, V46, P547, DOI 10.1016/j.paid.2008.12.010; Dickson KS, 2012, BEHAV THER, V43, P629, DOI 10.1016/j.beth.2011.11.002; Dugas MJ, 2005, COGNITIVE THER RES, V29, P57, DOI 10.1007/s10608-005-1648-9; Dugas MJ, 2004, COGNITIVE THER RES, V28, P835, DOI 10.1007/s10608-004-0669-0; FREESTON MH, 1994, PERS INDIV DIFFER, V17, P791, DOI 10.1016/0191-8869(94)90048-5; Friedrich M J, 2017, JAMA, V317, P1517, DOI 10.1001/jama.2017.3826; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hong RY, 2013, J PSYCHOPATHOL BEHAV, V35, P407, DOI 10.1007/s10862-013-9350-9; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Khawaja NG, 2010, CLIN PSYCHOL-UK, V14, P97, DOI 10.1080/13284207.2010.502542; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kung S, 2013, J AFFECT DISORDERS, V145, P341, DOI 10.1016/j.jad.2012.08.017; Kuyken W, 2006, J AFFECT DISORDERS, V96, P39, DOI 10.1016/j.jad.2006.05.017; Le J., 2010, P SIGIR 2010 WORKSH, P22; Lee PW, 2007, J AFFECT DISORDERS, V99, P139, DOI 10.1016/j.jad.2006.09.002; Liao KYH, 2011, J CLIN PSYCHOL, V67, P1220, DOI 10.1002/jclp.20846; Lo CSL, 2008, BEHAV RES THER, V46, P487, DOI 10.1016/j.brat.2008.01.013; Long J.A., 2019, INTERACTIONS COMPREH; LYUBOMIRSKY S, 1993, J PERS SOC PSYCHOL, V65, P339, DOI 10.1037/0022-3514.65.2.339; LYUBOMIRSKY S, 1995, J PERS SOC PSYCHOL, V69, P176, DOI 10.1037/0022-3514.69.1.176; Lyubomirsky S., 2004, RUMINATION NATURE TH, P21, DOI 10.1002/9780470713853.ch2; Mahoney Alison E. J., 2012, Cognitive Behaviour Therapy, V41, P212, DOI 10.1080/16506073.2011.622130; Marroquin BM, 2010, COGNITION EMOTION, V24, P1446, DOI 10.1080/02699930903510212; Maxwell SE, 2011, MULTIVAR BEHAV RES, V46, P816, DOI 10.1080/00273171.2011.606716; McEvoy PM, 2012, BEHAV THER, V43, P533, DOI 10.1016/j.beth.2011.02.007; McIntosh W. D., 1992, REV PERSONALITY SOCI, V14, P222; Mezulis A, 2011, COGNITION EMOTION, V25, P1460, DOI 10.1080/02699931.2010.543642; Nakai Y, 2014, J AFFECT DISORDERS, V158, P101, DOI 10.1016/j.jad.2014.02.004; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NOLENHOEKSEMA S, 1993, J ABNORM PSYCHOL, V102, P20, DOI 10.1037/0021-843X.102.1.20; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; O'Laughlin KD, 2018, MULTIVAR BEHAV RES, V53, P375, DOI 10.1080/00273171.2018.1454822; Olatunji BO, 2013, CLIN PSYCHOL-SCI PR, V20, P225, DOI 10.1111/cpsp.12037; Pilkonis PA, 2014, J PSYCHIATR RES, V56, P112, DOI 10.1016/j.jpsychires.2014.05.010; Pinheiro J, 2020, R PACKAGE VERSION 31; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; R Core Team, 2021, R LANGUAGE ENV STAT; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raes F, 2008, DEPRESS ANXIETY, V25, P1067, DOI 10.1002/da.20447; Schoofs H, 2010, J PSYCHOPATHOL BEHAV, V32, P609, DOI 10.1007/s10862-010-9182-9; Spasojevic J, 2001, EMOTION, V1, P25, DOI 10.1037/1528-3542.1.1.25; Takano K, 2009, BEHAV RES THER, V47, P260, DOI 10.1016/j.brat.2008.12.008; Thoemmes F, 2015, BASIC APPL SOC PSYCH, V37, P226, DOI 10.1080/01973533.2015.1049351; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; van Randenborgh A, 2010, CLIN PSYCHOL PSYCHOT, V17, P285, DOI 10.1002/cpp.651; Ward A, 2003, PERS SOC PSYCHOL B, V29, P96, DOI 10.1177/0146167202238375; Watkins E, 2002, J NEUROL NEUROSUR PS, V72, P400, DOI 10.1136/jnnp.72.3.400; Watkins E, 2001, J ABNORM PSYCHOL, V110, P353, DOI 10.1037/0021-843X.110.2.333; Watkins E, 2004, PERS INDIV DIFFER, V37, P679, DOI 10.1016/j.paid.2003.10.002; Watkins E, 2002, BEHAV RES THER, V40, P1179, DOI 10.1016/S0005-7967(01)00098-5; Yook K, 2010, J ANXIETY DISORD, V24, P623, DOI 10.1016/j.janxdis.2010.04.003	69	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0224865	10.1371/journal.pone.0224865	http://dx.doi.org/10.1371/journal.pone.0224865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8LN	31743357	Green Published, gold			2022-12-26	WOS:000533877300008
J	Oh, JW; Park, CW; Moon, KC; Park, JS; Jun, JK				Oh, Jeong-Won; Park, Chan-Wook; Moon, Kyung Chul; Park, Joong Shin; Jun, Jong Kwan			The relationship among the progression of inflammation in umbilical cord, fetal inflammatory response, early-onset neonatal sepsis, and chorioamnionitis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-CELL COUNT; AMNIOTIC-FLUID; INTRAUTERINE INFECTION; GESTATIONAL-AGE; PLACENTAL INFLAMMATION; PREMATURE RUPTURE; HYRTL ANASTOMOSIS; LEVELS CORRELATE; PRETERM	Objectives No information exists about whether fetal inflammatory-response(FIR), early-onset neonatal sepsis(EONS) and chorioamnionitis(an advanced-stage of maternal inflammatory-response in extraplacental membranes) continuously increase according to the progression of inflammation in umbilical-cord(UC). The objective of current-study is to examine this-issue. Methods Study-population included 239 singleton pregnant-women(gestational-age[GA] at delivery: 21.6 similar to 36weeks) who had inflammation in extraplacental membranes or chorionic plate (CP) and either preterm-labor or preterm-PROM. We examined FIR, and the frequency of fetal inflammatory-responses syndrome(FIRS), proven-EONS, suspected-EONS and chorioamnionitis according to the progression of inflammation in UC. The progression of inflammation in UC was divided with a slight-modification from previously reported-criteria as follows: stage0, inflammation-free UC; stage-1: umbilical phlebitis only; stage-2: involvement of at least one UA and either the other UA or UV without extension into WJ; stage-3: the extension of inflammation into WJ. FIR was gauged by umbilical-cord-plasma(UCP) CRP concentration(ng/ml) at birth, and FIRS was defined as an elevated UCP CRP concentration at birth(>= 200ng/ml). Results Stage-0, stage-1, stage-2 and stage-3 of inflammation in UC were present in 48.1%, 15.5%, 6.7%, and 29.7% of cases. FIR continuously increased according to the progression of inflammation in UC(Kruskal-Wallis test, P<0.001; Spearman-rank-correlation test, P<0.000001, r = 0.546). Moreover, there was a significant and stepwise increase in the frequency of FIRS, proven-EONS, suspected-EONS and chorioamnionitis according to the progression of inflammation in UC(each for P<0.000005 in both chi-square test and linear-by-linear-association). Multiple logistic-regression analysis demonstrated that the more advanced-stage in the progression of inflammation in UC(i.e., stage-1 vs. stage-2 vs. stage-3), the better predictor of suspected-EONS (Odds-ratio[OR]3.358, 95%confidence-interval [CI]:1.020-11.057 vs. OR5.147, 95%CI:1.189-22.275 vs. OR11.040, 95%CI:4.118-29.592) and chorioamnionitis(OR6.593, 95%CI:2.717-15.999 vs. OR16.508, 95% CI:3.916-69.596 vs. OR20.167, 95%CI:8.629-47.137). Conclusion FIR, EONS and chorioamnionitis continuously increase according to the progression of inflammation in UC among preterm-gestations with inflammation in extraplacental membranes or CP. This finding may suggest that funisitis(inflammation in UC) is both qualitatively and quantitatively histologic-counterpart of FIRS, and a surrogate-marker for chorioamnionitis.	[Oh, Jeong-Won; Park, Chan-Wook; Park, Joong Shin; Jun, Jong Kwan] Seoul Natl Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Coll Med, Seoul, South Korea; [Moon, Kyung Chul] Seoul Natl Univ, Dept Pathol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Park, CW (corresponding author), Seoul Natl Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Coll Med, Seoul, South Korea.	hwpark0803@gmail.com			SNUH Research Fund (CW PARK) [03-2015-0220]; SNUH Research Fund [03-2015-0220]	SNUH Research Fund (CW PARK); SNUH Research Fund	This study was supported by the grant no. 03-2015-0220 from the SNUH Research Fund (CW PARK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript..; This study was supported by the grant no. 03-2015-0220 from the SNUH Research Fund.	Amarilyo G, 2011, J PERINATOL, V31, P30, DOI 10.1038/jp.2010.53; BENIRSCHKE K, 1962, AM J OBSTET GYNECOL, V84, P1595, DOI 10.1016/0002-9378(62)90005-4; Blanc W A, 1981, Monogr Pathol, P67; Burton GJ, 2014, PLACENTA, V35, P9, DOI 10.1016/j.placenta.2013.11.005; CHELLAM VG, 1985, BRIT J OBSTET GYNAEC, V92, P808, DOI 10.1111/j.1471-0528.1985.tb03050.x; Dexter SC, 2000, OBSTET GYNECOL, V96, P172, DOI 10.1016/S0029-7844(00)00886-3; Dong YF, 2009, REPROD SCI, V16, P650, DOI 10.1177/1933719109333662; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Gordon Z, 2007, AM J PHYSIOL-REG I, V292, pR977, DOI 10.1152/ajpregu.00410.2006; Guo R, 2010, REPROD SCI, V17, P540, DOI 10.1177/1933719110364061; Katzman PJ, 2010, PEDIATR DEVEL PATHOL, V13, P265, DOI 10.2350/09-02-0604-OA.1; Khong TY, 2001, PATHOLOGY, V33, P174; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Kim CJ, 2001, HUM PATHOL, V32, P623, DOI 10.1053/hupa.2001.24992; Kim CJ, 2001, AM J OBSTET GYNECOL, V185, P496, DOI 10.1067/mob.2001.116689; Lee J, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.10.009; Lee Y, 2015, J PERINAT MED, V43, P259, DOI 10.1515/jpm-2014-0035; Miranda RN, 2006, ARCH PATHOL LAB MED, V130, P1786; Naccasha N, 2001, OBSTET GYNECOL, V97, P220, DOI 10.1016/S0029-7844(00)01149-2; Park CW, 2014, J MATERN-FETAL NEO M, V27, P98, DOI 10.3109/14767058.2013.806898; Park CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017; Raio L, 1999, HUM REPROD, V14, P1890, DOI 10.1093/humrep/14.7.1890; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Redline RW, 2000, PEDIATR RES, V47, P721, DOI 10.1203/00006450-200006000-00007; Rogers BB, 2002, HUM PATHOL, V33, P335, DOI 10.1053/hupa.2002.32214; ROMERO R, 1988, CLIN OBSTET GYNECOL, V31, P553, DOI 10.1097/00003081-198809000-00006; Romero R, 2016, J PERINAT MED, V44, P33, DOI 10.1515/jpm-2015-0119; Salafia CM, 1997, AM J PERINAT, V14, P419, DOI 10.1055/s-2007-994172; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Trevisanuto D, 2007, NEONATOLOGY, V91, P186, DOI 10.1159/000097451; Tsiartas P, 2013, J MATERN-FETAL NEO M, V26, P1332, DOI 10.3109/14767058.2013.784741; vanHoeven KH, 1996, PEDIATR PATHOL LAB M, V16, P731; VINTZILEOS AM, 1985, AM J OBSTET GYNECOL, V152, P510, DOI 10.1016/0002-9378(85)90617-9; Visentin S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/401595; Wharton KN, 2004, EARLY HUM DEV, V77, P77, DOI 10.1016/j.earlhumdev.2004.02.001; Yoon B H, 2003, J Matern Fetal Neonatal Med, V14, P85; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035; Yoon BH, 1996, OBSTET GYNECOL, V87, P231, DOI 10.1016/0029-7844(95)00380-0; Yoon BH, 1996, OBSTET GYNECOL, V88, P1034	43	17	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225328	10.1371/journal.pone.0225328	http://dx.doi.org/10.1371/journal.pone.0225328			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743377	gold, Green Published			2022-12-26	WOS:000533877300027
J	Hayashi, K; Motoishi, M; Sawai, S; Horimoto, K; Hanaoka, J				Hayashi, Kazuki; Motoishi, Makoto; Sawai, Satoru; Horimoto, Kanna; Hanaoka, Jun			Postoperative delirium after lung resection for primary lung cancer: Risk factors, risk scoring system, and prognosis	PLOS ONE			English	Article							SURGERY; ASSOCIATION	Delirium is a common post-surgical complication, but few studies have examined postoperative delirium following lung cancer surgery. The purpose of this study was to clarify the risk factors of postoperative delirium, to construct a useful scoring system, and to clarify the relationship between delirium and prognosis after lung cancer surgery. We retrospectively analyzed data from 570 patients who underwent surgery for primary lung cancer. Logistic regression analysis was used to determine the effects of various factors on the onset of delirium. Kaplan-Meier analysis was performed to determine the relationship between delirium and prognosis. Postoperative delirium occurred in 6.7% of the patients. Three risk factors were identified, and the risk scores were determined as follows: 2x(cerebrovascular disease history) + 1x(squamous cell carcinoma) + 1x(age older than 75 years). Scores 0-1 denoted low risk, 2 denoted intermediate risk, and 3-4 denoted high risk. Additionally, we found that patients who developed delirium had significantly shorter overall survival. However, there was no difference in the frequency between cancer-related death and non-cancer related death when comparing the delirium and non-delirium groups. We identified the risk factors, i.e., cerebrovascular disease history, squamous cell carcinoma, and age older than 75 years, that determine the onset of delirium after lung cancer surgery and constructed a useful scoring system. In addition, although the prognosis of the delirium group was poor, the factor that determines prognosis may not be cancer per se but vulnerability in the patient background.	[Hayashi, Kazuki; Hanaoka, Jun] Shiga Univ Med Sci, Div Gen Thorac Surg, Dept Surg, Otsu, Shiga, Japan; [Motoishi, Makoto] Mitsubishikyoto Hosp, Dept Thorac Surg, Kyoto, Japan; [Sawai, Satoru; Horimoto, Kanna] Natl Hosp Org Kyoto Med Ctr, Dept Thorac Surg, Kyoto, Japan	Shiga University of Medical Science	Hayashi, K (corresponding author), Shiga Univ Med Sci, Div Gen Thorac Surg, Dept Surg, Otsu, Shiga, Japan.	hayashik@belle.shiga-med.ac.jp						AAKERLUND LP, 1994, BRIT J ANAESTH, V72, P286, DOI 10.1093/bja/72.3.286; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, P596, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Gallagher TK, 2014, HPB, V16, P864, DOI 10.1111/hpb.12266; Galyfos GC, 2017, J VASC SURG, V66, P937, DOI 10.1016/j.jvs.2017.03.439; Gusmao-Flores D, 2012, CRIT CARE, V16, DOI 10.1186/cc11407; Kawase A, 2012, JPN J CLIN ONCOL, V42, P189, DOI 10.1093/jjco/hyr188; Koebrugge B, 2009, DIGEST SURG, V26, P63, DOI 10.1159/000194947; Luetz A, 2010, CRIT CARE MED, V38, P409, DOI 10.1097/CCM.0b013e3181cabb42; Lynch EP, 1998, ANESTH ANALG, V86, P781; Marcantonio ER, 2017, NEW ENGL J MED, V377, P1456, DOI 10.1056/NEJMcp1605501; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Marcantonio ER, 1998, AM J MED, V105, P380, DOI 10.1016/S0002-9343(98)00292-7; Martin BJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9273; Murakawa K, 2015, J PHARM HEALTH CARE, V1, DOI 10.1186/s40780-014-0002-3; Ozyurtkan MO, 2010, EUR J CARDIO-THORAC, V37, P1152, DOI 10.1016/j.ejcts.2009.11.047; Pandharipande PP, 2017, INTENS CARE MED, V43, P1329, DOI 10.1007/s00134-017-4860-7; Park SA, 2017, WORLD J SURG, V41, P2847, DOI 10.1007/s00268-017-4079-3; Root JC, 2013, PSYCHO-ONCOLOGY, V22, P2087, DOI 10.1002/pon.3262; Rudolph JL, 2007, AM J MED, V120, P807, DOI 10.1016/j.amjmed.2007.02.026; Sakaguchi T, 2018, J CARDIOL, V71, P564, DOI 10.1016/j.jjcc.2017.11.011; Shah S, 2012, ARCH OTOLARYNGOL, V138, P266, DOI 10.1001/archoto.2011.1456; Takeuchi M, 2012, ANN SURG ONCOL, V19, P3963, DOI 10.1245/s10434-012-2432-1; Tei M, 2016, INT J COLORECTAL DIS, V31, P67, DOI 10.1007/s00384-015-2335-2; TRZEPACZ PT, 1994, PSYCHOSOMATICS, V35, P374, DOI 10.1016/S0033-3182(94)71759-X; Vasunilashorn SM, 2017, J AM GERIATR SOC, V65, pE109, DOI 10.1111/jgs.14913; Veiga D, 2012, REV BRAS ANESTESIOL, V62, P469, DOI 10.1016/S0034-7094(12)70146-0; Winawer N, 2001, MED CLIN N AM, V85, P1229, DOI 10.1016/S0025-7125(05)70374-6	28	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0223917	10.1371/journal.pone.0223917	http://dx.doi.org/10.1371/journal.pone.0223917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738751	gold, Green Published			2022-12-26	WOS:000532826300011
J	Jasinska, M; Jasek-Gajda, E; Woznicka, O; Lis, GJ; Pyza, E; Litwin, JA				Jasinska, Malgorzata; Jasek-Gajda, Ewa; Woznicka, Olga; Lis, Grzegorz J.; Pyza, Elzbieta; Litwin, Jan A.			Circadian clock regulates the shape and content of dendritic spines in mouse barrel cortex	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PREFRONTAL CORTEX; SYNAPSE FORMATION; PLASTICITY; SYNAPTOPODIN; APPARATUS; CA1; GLUCOCORTICOIDS; SYNAPTOGENESIS; CALCIUM	Circadian rhythmicity affects neuronal activity induced changes in the density of synaptic contacts and dendritic spines, the most common location of synapses, in mouse somatosensory cortex. In the present study we analyzed morphology of single- and double-synapse spines under light/dark (12:12) and constant darkness conditions. Using serial electron micrographs we examined the shape of spines (stubby, thin, mushroom) and their content (smooth endoplasmic reticulum, spine apparatus), because these features are related to the maturation and stabilization of spines. We observed significant diurnal and circadian changes in the shape of spines that are differentially regulated: single-synapse spines remain under circadian clock regulation, while changes of double-synapse spines are driven by light. The thin and mushroom single-synapse spines, regardless of their content, are more stable comparing with the stubby single-synapse spines that show the greatest diversity. All types of double-synapse spines demonstrate a similar level of stability. In light/dark regime, formation of new mushroom single-synapse spines occurs, while under constant darkness new stubby single-synapse spines are formed. There are no shape preferences for new double-synapse spines. Diurnal and circadian alterations also concern spine content: both light exposure and the clock influence translocation of smooth endoplasmic reticulum from dendritic shaft to the spine. The increasing number of mushroom single-synapse spines and the presence of only those mushroom double-synapse spines that contain spine apparatus in the light phase indicates that the exposure to light, a stress factor for nocturnal animals, promotes enlargement and maturation of spines to increase synaptic strength and to enhance the effectiveness of neurotransmission.	[Jasinska, Malgorzata; Jasek-Gajda, Ewa; Lis, Grzegorz J.; Litwin, Jan A.] Jagiellonian Univ Med Coll, Dept Histol, Krakow, Poland; [Woznicka, Olga; Pyza, Elzbieta] Jagiellonian Univ, Dept Cell Biol & Imaging, Inst Zool & Biomed Res, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University	Jasinska, M (corresponding author), Jagiellonian Univ Med Coll, Dept Histol, Krakow, Poland.	malgorzata.m.jasinska@uj.edu.pl			Jagiellonian University Medical College [N41/DBS/000064]	Jagiellonian University Medical College	The research was supported by statutory grant (N41/DBS/000064) from the Jagiellonian University Medical College to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardo A, 2015, NATURE, V523, P592, DOI 10.1038/nature14467; Bellot A, 2014, BRAIN RES, V1573, P1, DOI 10.1016/j.brainres.2014.05.024; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Buijs RM, 2003, J ENDOCRINOL, V177, P17, DOI 10.1677/joe.0.1770017; CHEIFETZ PN, 1971, J ENDOCRINOL, V49, pR11; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Chirillo MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40520-x; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; de Vivo L, 2017, SCIENCE, V355, P507, DOI 10.1126/science.aah5982; DEHAY C, 1991, J PHYSIOL-LONDON, V440, P723, DOI 10.1113/jphysiol.1991.sp018732; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Deller T, 2007, ANN ANAT, V189, P5, DOI 10.1016/j.aanat.2006.06.013; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1983, BRAIN RES, V266, P163, DOI 10.1016/0006-8993(83)91322-7; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Foster RG, 2002, PROG RETIN EYE RES, V21, P507, DOI 10.1016/S1350-9462(02)00036-8; Frank MG, 2014, TRENDS NEUROSCI, V37, P491, DOI 10.1016/j.tins.2014.06.005; Geinisman Y, 2000, J COMP NEUROL, V417, P49; Gonzalez-Tapia D, 2016, BEHAV BRAIN RES, V298, P261, DOI 10.1016/j.bbr.2015.11.013; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hasegawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07707; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Havekes R, 2016, ELIFE, V5, DOI 10.7554/eLife.13424; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Ikeda M, 2015, J ENDOCRINOL, V226, pM13, DOI 10.1530/JOE-15-0078; Ikeno T, 2013, CHRONOBIOL INT, V30, P1089, DOI 10.3109/07420528.2013.800090; Jasinska M, 2006, ACTA NEUROBIOL EXP, V66, P99; Jasinska M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9828517; Jasinska M, 2015, EUR J NEUROSCI, V42, P2585, DOI 10.1111/ejn.13045; Jasinska M, 2010, J NEUROSCI, V30, P1176, DOI 10.1523/JNEUROSCI.2970-09.2010; Jedlicka P, 2017, NEUROBIOL LEARN MEM, V138, P21, DOI 10.1016/j.nlm.2016.07.023; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Koch CE, 2017, NEUROBIOL STRESS, V6, P57, DOI 10.1016/j.ynstr.2016.09.001; Korkotian E, 2014, J NEUROSCI, V34, P11641, DOI 10.1523/JNEUROSCI.0381-14.2014; Korkotian E, 2011, J PHYSIOL-LONDON, V589, P5987, DOI 10.1113/jphysiol.2011.217315; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Liu S, 2007, CHRONOBIOL INT, V24, P793, DOI 10.1080/07420520701672556; Lu J, 2017, BRAIN RES BULL, V129, P18, DOI 10.1016/j.brainresbull.2016.09.008; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Okubo-Suzuki R, 2008, MOL CELL NEUROSCI, V38, P266, DOI 10.1016/j.mcn.2008.03.001; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Ostroff LE, 2010, P NATL ACAD SCI USA, V107, P9418, DOI 10.1073/pnas.0913384107; Parajuli LK, 2017, BRAIN RES BULL, V129, P3, DOI 10.1016/j.brainresbull.2016.07.014; Perez-Cruz C, 2009, BEHAV BRAIN RES, V205, P406, DOI 10.1016/j.bbr.2009.07.021; Pierce JP, 2000, NAT NEUROSCI, V3, P311, DOI 10.1038/73868; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; van der Zee EA, 2015, NEUROSCI BIOBEHAV R, V50, P77, DOI 10.1016/j.neubiorev.2014.06.012; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; Vlachos A, 2009, J NEUROSCI, V29, P1017, DOI 10.1523/JNEUROSCI.5528-08.2009; Wang LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148310; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yadav A, 2012, J COMP NEUROL, V520, P2888, DOI 10.1002/cne.23070; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	75	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225394	10.1371/journal.pone.0225394	http://dx.doi.org/10.1371/journal.pone.0225394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730670	Green Published, gold			2022-12-26	WOS:000532809500038
J	Lohofer, FK; Kaissis, GA; Muller-Leisse, C; Franz, D; Katemann, C; Hock, A; Peeters, JM; Rummeny, EJ; Karampinos, D; Braren, RF				Lohoefer, Fabian K.; Kaissis, Georgios A.; Mueller-Leisse, Christina; Franz, Daniela; Katemann, Christoph; Hock, Andreas; Peeters, Johannes M.; Rummeny, Ernst J.; Karampinos, Dimitrios; Braren, Rickmer F.			Acceleration of chemical shift encoding-based water fat MRI for liver proton density fat fraction and T2*mapping using compressed sensing	PLOS ONE			English	Article							IRON OVERLOAD; QUANTIFICATION; DISEASE; VALIDATION; DIAGNOSIS; ACCURACY; BIOPSY; TISSUE	Objectives To evaluate proton density fat fraction (PDFF) and T2* measurements of the liver with combined parallel imaging (sensitivity encoding, SENSE) and compressed sensing (CS) accelerated chemical shift encoding-based water-fat separation. Methods Six-echo Dixon imaging was performed in the liver of 89 subjects. The first acquisition variant used acceleration based on SENSE with a total acceleration factor equal to 2.64 (acquisition labeled as SENSE). The second acquisition variant used acceleration based on a combination of CS with SENSE with a total acceleration factor equal to 4 (acquisition labeled as CS +SENSE). Acquisition times were compared between acquisitions and proton density fat fraction (PDFF) and T2*-values were measured and compared separately for each liver segment. Results Total scan duration was 14.5 sec for the SENSE accelerated image acquisition and 9.3 sec for the CS+SENSE accelerated image acquisition. PDFF and T2* values did not differ significantly between the two acquisitions (paired Mann-Whitney and paired t-test P>0.05 in all cases). CS+SENSE accelerated acquisition showed reduced motion artifacts (1.1%) compared to SENSE acquisition (12.3%). Conclusion CS+SENSE accelerates liver PDFF and T2*mapping while retaining the same quantitative values as an acquisition using only SENSE and reduces motion artifacts.	[Lohoefer, Fabian K.; Kaissis, Georgios A.; Mueller-Leisse, Christina; Franz, Daniela; Rummeny, Ernst J.; Karampinos, Dimitrios; Braren, Rickmer F.] Tech Univ Munich, Inst Diagnost & Intervent Radiol, Klinikum Rechts Isar, Ismaninger Str, Munich, Germany; [Katemann, Christoph; Hock, Andreas] Philips Healthcare, Hamburg, Germany; [Peeters, Johannes M.] Philips Healthcare, Best, Netherlands	Technical University of Munich; Philips; Philips Healthcare; Philips; Philips Healthcare	Braren, RF (corresponding author), Tech Univ Munich, Inst Diagnost & Intervent Radiol, Klinikum Rechts Isar, Ismaninger Str, Munich, Germany.	rbraren@tum.de	Karampinos, Dimitrios C/A-5994-2011; Peeters, Hans/AAB-3735-2019; Braren, Rickmer/U-3254-2018	Karampinos, Dimitrios C/0000-0003-4922-3662; Braren, Rickmer/0000-0001-6039-6957; Junker, Daniela/0000-0002-7598-8485	German Research Foundation [SFB 824/A9]; Philips Healthcare	German Research Foundation(German Research Foundation (DFG)); Philips Healthcare	The present work was supported by the German Research Foundation (SFB 824/A9) and Philips Healthcare. Philips Healthcare provided support in the form of salaries for authors [AH, JP, CK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Bian H, 2018, DIGEST LIVER DIS, V50, P168, DOI 10.1016/j.dld.2017.08.030; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Dehkordy SF, 2019, EUR RADIOL, V29, P2474, DOI 10.1007/s00330-018-5894-0; Doneva M, 2010, MAGN RESON MED, V64, P1749, DOI 10.1002/mrm.22563; Feng L, 2017, J MAGN RESON IMAGING, V45, P966, DOI 10.1002/jmri.25547; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Fushimi Y, 2016, INVEST RADIOL, V51, P228, DOI 10.1097/RLI.0000000000000226; Hernando D, 2014, J MAGN RESON IMAGING, V40, P1003, DOI 10.1002/jmri.24584; Hollingsworth KG, 2014, MAGN RESON MED, V72, P1610, DOI 10.1002/mrm.25072; Hu HH, 2013, NMR BIOMED, V26, P1609, DOI 10.1002/nbm.3025; Idilman IS, 2013, RADIOLOGY, V267, P767, DOI 10.1148/radiol.13121360; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Mann LW, 2016, RADIOLOGY, V278, P247, DOI 10.1148/radiol.2015150320; Nash S, 2002, AM J CLIN PATHOL, V118, P73; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Reeder SB, 2010, MAGN RESON IMAGING C, V18, P337, DOI 10.1016/j.mric.2010.08.013; Ren JM, 2008, J LIPID RES, V49, P2055, DOI 10.1194/jlr.D800010-JLR200; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sarigianni M, 2015, CLIN GASTROENTEROL H, V13, P55, DOI 10.1016/j.cgh.2014.05.027; Serai SD, 2018, PEDIATR RADIOL, V48, P94, DOI 10.1007/s00247-017-3990-y; Sharma SD, 2013, J MAGN RESON IMAGING, V38, P1267, DOI 10.1002/jmri.24034; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Tang A, 2013, RADIOLOGY, V267, P422, DOI 10.1148/radiol.12120896; Urru SAM, 2015, AM J HEMATOL, V90, P87, DOI 10.1002/ajh.23878; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; Wiens CN, 2014, MAGN RESON MED, V71, P608, DOI 10.1002/mrm.24699; Yokoo T, 2009, RADIOLOGY, V251, P67, DOI 10.1148/radiol.2511080666; Zelber-Sagi S, 2006, LIVER INT, V26, P856, DOI 10.1111/j.1478-3231.2006.01311.x; Zhang Y, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170587; Zhu L, 2018, INVEST RADIOL, V53, P150, DOI 10.1097/RLI.0000000000000421	34	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224988	10.1371/journal.pone.0224988	http://dx.doi.org/10.1371/journal.pone.0224988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730658	Green Submitted, Green Published, gold			2022-12-26	WOS:000532809500019
J	Rao, DM; Shackleford, MT; Bordeaux, EK; Sottnik, JL; Ferguson, RL; Yamamoto, TM; Wellberg, EA; Bitler, BG; Sikora, MJ				Rao, Deviyani M.; Shackleford, Madeleine T.; Bordeaux, Evelyn K.; Sottnik, Joseph L.; Ferguson, Rebecca L.; Yamamoto, Tomomi M.; Wellberg, Elizabeth A.; Bitler, Benjamin G.; Sikora, Matthew J.			Wnt family member 4 (WNT4) and WNT3A activate cell-autonomous Wnt signaling independent of porcupine O-acyltransferase or Wnt secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt signaling; Wnt pathway; protein secretion; cancer biology; cell signaling; cell growth; glycoprotein secretion; breast cancer; ovarian cancer; PORCN; WNT3A; WNT4	BETA-CATENIN; LOBULAR CARCINOMA; STEM-CELLS; PROTEINS; PATHWAY; PROGESTERONE; IDENTIFICATION; ENDOMETRIOSIS; INHIBITION; EXPRESSION	Porcupine O-acyltransferase (PORCN) is considered essential for Wnt secretion and signaling. However, we observed that PORCN inhibition does not phenocopy the effects of WNT4 knockdown in WNT4-dependent breast cancer cells. This suggests a unique relationship between PORCN and WNT4 signaling. To examine the role of PORCN in WNT4 signaling, here we overexpressed WNT4 or WNT3A in breast cancer, ovarian cancer, and fibrosarcoma cell lines. Conditioned media from these lines and co-culture systems were used to assess the dependence of Wnt secretion and activity on the critical Wnt secretion proteins PORCN and Wnt ligand secretion (WLS) mediator. We observed that WLS is universally required for Wnt secretion and paracrine signaling. In contrast, the dependence of WNT3A secretion and activity on PORCN varied across the cell lines, and WNT4 secretion was PORCN-independent in all models. Surprisingly, WNT4 did not exhibit paracrine activity in any tested context. Absent the expected paracrine activity of secreted WNT4, we identified cell-autonomous Wnt signaling activation by WNT4 and WNT3A, independent of PORCN or Wnt secretion. The PORCN-independent, cell-autonomous Wnt signaling demonstrated here may be critical in WNT4-driven cellular contexts or in those that are considered to have dysfunctional Wnt signaling.	[Rao, Deviyani M.; Shackleford, Madeleine T.; Bordeaux, Evelyn K.; Sottnik, Joseph L.; Ferguson, Rebecca L.; Wellberg, Elizabeth A.; Sikora, Matthew J.] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA; [Yamamoto, Tomomi M.; Bitler, Benjamin G.] Univ Colorado, Dept Obstet & Gynecol, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Sikora, MJ (corresponding author), Mail Stop 8104,Res Complex 1 South,Rm 5117, Aurora, CO 80045 USA.	matthew.sikora@cuanschutz.edu	Wellberg, Elizabeth/AFQ-6450-2022	Shackleford, Madeleine/0000-0003-2599-1747; Bordeaux, Evelyn/0000-0001-9264-0205; Sottnik, Joseph/0000-0002-0263-3608; Sikora, Matthew/0000-0003-2915-7442; Bitler, Benjamin/0000-0002-5809-5271; Rao, Deviyani/0000-0002-6923-4492	National Institutes of Health [T32 GM007635, R00 CA193734, R00 CA194318]; Cancer League of Colorado, Inc.; NATIONAL CANCER INSTITUTE [K99CA193734, R00CA193734, R00CA194318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R00 CA193734 (to M. J. S.) and R00 CA194318 (to B. G. B.), a grant from the Cancer League of Colorado, Inc. (to M. J. S.), and by National Institutes of Health Grant T32 GM007635 (to E. K. B.). This manuscript was posted as a pre-print on bioRxiv (73). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal P, 2017, BLOOD, V129, P1008, DOI 10.1182/blood-2016-05-714089; Alexander CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008037; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brisken C, 2000, GENE DEV, V14, P650; Brisken C, 2015, ENDOCRINOLOGY, V156, P3442, DOI 10.1210/en.2015-1392; Caprioli A, 2015, DEV BIOL, V406, P222, DOI 10.1016/j.ydbio.2015.08.017; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Chen QH, 2012, J CELL SCI, V125, P2224, DOI 10.1242/jcs.098368; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Dissanayake Samudra K., 2008, V468, P157, DOI 10.1007/978-1-59745-249-6_12; Galli LM, 2018, DEV BIOL, V439, P53, DOI 10.1016/j.ydbio.2018.04.025; Galli LM, 2016, EXP CELL RES, V347, P171, DOI 10.1016/j.yexcr.2016.07.028; Glaeser K, 2018, EMBO J, V37, DOI 10.15252/embj.201797311; Hayashi M, 2017, ONCOTARGET, V8, P78265, DOI 10.18632/oncotarget.19432; Itaranta P, 2006, DEV BIOL, V293, P473, DOI 10.1016/j.ydbio.2006.02.019; Jordan BK, 2003, P NATL ACAD SCI USA, V100, P10866, DOI 10.1073/pnas.1834480100; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kim YC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-55; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Kurita Yayoi, 2019, Kurume Med J, V65, P55, DOI 10.2739/kurumemedj.MS652008; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Loh KM, 2016, DEV CELL, V38, P643, DOI 10.1016/j.devcel.2016.08.011; Louis I, 2008, IMMUNITY, V29, P57, DOI 10.1016/j.immuni.2008.04.023; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; Mafra F, 2015, J ASSIST REPROD GEN, V32, P1359, DOI 10.1007/s10815-015-0523-1; Meier-Abt F, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3419; Miranda M, 2014, FEBS LETT, V588, P4815, DOI 10.1016/j.febslet.2014.11.016; Moti N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212711; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Philibert P, 2008, J CLIN ENDOCR METAB, V93, P895, DOI 10.1210/jc.2007-2023; Powell JE, 2016, HUM MOL GENET, V25, P5046, DOI 10.1093/hmg/ddw320; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Prunskaite-Hyyrylainen R, 2016, HUM MOL GENET, V25, P1059, DOI 10.1093/hmg/ddv621; Pryde JG, 1998, METH MOL B, V88, P23; Rahmioglu N, 2015, HUM MOL GENET, V24, P1185, DOI 10.1093/hmg/ddu516; Rajaram RD, 2015, EMBO J, V34, P641, DOI 10.15252/embj.201490434; Rao D. M., 2019, ESTROGEN CONTROLS MT, DOI [10.1101/684530, DOI 10.1101/684530]; Rao DM, 2018, WNT4 WNT3A ACTIVATE, DOI [10.1101/333906, DOI 10.1101/333906]; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Richards MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092159; Schackmann RCJ, 2011, J CLIN INVEST, V121, P3176, DOI 10.1172/JCI41695; Sikora MJ, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0748-7; Sikora MJ, 2014, CANCER RES, V74, P1463, DOI 10.1158/0008-5472.CAN-13-2779; Speer KF, 2019, CELL REP, V26, P875, DOI 10.1016/j.celrep.2018.12.104; Strochlic L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029976; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Yamamoto H, 2013, J CELL SCI, V126, P2931, DOI 10.1242/jcs.126052; Yamamoto T. M., 2018, TARGETING WNT SIGNAL, DOI [10.1101/378463, DOI 10.1101/378463]; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Zhang G, 2017, NEW ENGL J MED, V377, P1156, DOI 10.1056/NEJMoa1612665; Zheng Y, 2016, OSTEOPOROSIS INT, V27, P1805, DOI 10.1007/s00198-015-3457-7; Zmuda JM, 2011, OSTEOPOROSIS INT, V22, P1079, DOI 10.1007/s00198-010-1296-0	72	12	14	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19950	19966		10.1074/jbc.RA119.009615	http://dx.doi.org/10.1074/jbc.RA119.009615			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31740580	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000505005800011
J	Yoon, JY; Sy, K; Brezden-Masley, C; Streutker, CJ				Yoon, Ju-Yoon; Sy, Keiyan; Brezden-Masley, Christine; Streutker, Catherine J.			Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study	PLOS ONE			English	Article							EXPRESSION-BASED CLASSIFICATION; MICROSATELLITE INSTABILITY; CANCER; PROTEIN	Gastric cancers comprise molecularly heterogeneous diseases; four molecular subtypes were identified in the cancer genome atlas (TCGA) study, with implications in patient management. In our efforts to devise a clinically feasible means of subtyping, we devised an algorithm based on histology and five stains available in most academic pathology laboratories. This algorithm was used to subtype our cohort of 107 gastric cancer patients from a single institution (St. Michael's Hospital, Toronto, Canada), which was divided into 3 cases of EBV-positive, 23 of MSI, 27 of GS and 54 of CIN tumours. 87% of the tumours with diffuse histology were classified as GS subtype, which was notable for younger age. Examining for characteristic molecular features, aberrant p53 immunostaining was seen most frequently in the CIN subtype (43% in CIN vs. 6% in others), whereas ARID1A loss was rarely seen (6% vs. 35% in others). HER2 overexpression was seen exclusively in CIN tumours (17% of CIN tumours). PD-L1 positivity was seen predominantly in the EBV and MSI tumours. As with the TCGA study, no survival differences were seen between the subtypes. A similar strategy was employed to approximate the Asian Cancer Research Group (ACRG) molecular subtyping, with the addition of p53 IHC to the algorithm. We observed rates of ARID1A loss and HER2 overexpression that were comparable to the ACRG study. In summary, our algorithm allowed for clinically feasible means of subtyping gastric carcinoma that recapitulated the key molecular features reported in the large scale studies.	[Yoon, Ju-Yoon; Streutker, Catherine J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Sy, Keiyan; Streutker, Catherine J.] St Michaels Hosp, Dept Pathol, Toronto, ON, Canada; [Brezden-Masley, Christine] St Michaels Hosp, Dept Hematol Oncol, Toronto, ON, Canada; [Yoon, Ju-Yoon] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Pennsylvania; Pennsylvania Medicine	Streutker, CJ (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Streutker, CJ (corresponding author), St Michaels Hosp, Dept Pathol, Toronto, ON, Canada.	streutkerc@smh.ca		Yoon, Ju-Yoon/0000-0003-4632-0045				Ahn S, 2017, AM J SURG PATHOL, V41, P106, DOI 10.1097/PAS.0000000000000756; Bae YS, 2015, GUT LIVER, V9, P629, DOI 10.5009/gnl15133; Bartley AN, 2016, ARCH PATHOL LAB MED, V140, P1345, DOI 10.5858/arpa.2016-0331-CP; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Birkman EM, 2018, VIRCHOWS ARCH, V472, P369, DOI 10.1007/s00428-017-2240-x; Camargo MC, 2014, GUT, V63, P236, DOI 10.1136/gutjnl-2013-304531; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Giunchi F, 2018, APPL IMMUNOHISTO M M, V26, P489, DOI 10.1097/PAI.0000000000000458; Gonzalez RS, 2016, HUM PATHOL, V56, P16, DOI 10.1016/j.humpath.2016.06.003; Kim HS, 2016, ONCOTARGET, V7, P44608, DOI 10.18632/oncotarget.10115; Kulangara K, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.e14589; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Liu L, 2013, ANTI-CANCER AGENT ME, V13, P227, DOI 10.2174/1871520611313020007; Mathiak M, 2017, APPL IMMUNOHISTO M M, V25, P12, DOI 10.1097/PAI.0000000000000264; Parra ER, 2018, APPL IMMUNOHISTO M M, V26, P83, DOI 10.1097/PAI.0000000000000531; Petrelli F, 2017, J GASTROINTEST ONCOL, V8, P148, DOI 10.21037/jgo.2017.01.10; Setia N, 2016, MODERN PATHOL, V29, P772, DOI 10.1038/modpathol.2016.55; Shia J, 2008, J MOL DIAGN, V10, P293, DOI 10.2353/jmoldx.2008.080031; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Truong CD, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-14; Wang HH, 1999, HEPATO-GASTROENTEROL, V46, P1214; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wiegand KC, 2014, HUM PATHOL, V45, P1258, DOI 10.1016/j.humpath.2014.02.006; Zhu L, 2015, MOL CLIN ONCOL, V3, P699, DOI 10.3892/mco.2015.506	25	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224812	10.1371/journal.pone.0224812	http://dx.doi.org/10.1371/journal.pone.0224812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790410	gold, Green Published			2022-12-26	WOS:000533930800012
J	Carranza, NL; Carlson, SJ				Carranza, Natalia Lopez; Carlson, Sandra J.			Testing Species Assignments in Extant Terebratulide Brachiopods: A Threedimensional Geometric Morphometric Analysis of Long-Looped Brachidia	PLOS ONE			English	Article							FOSSIL; TOMOGRAPHY; LOPHOPHORE; TOLERANCE; EVOLUTION; ORIGIN	Species of terebratulide brachiopods have been largely characterized qualitatively on the basis of morphology. Furthermore, species-level morphological variability has rarely been analyzed within a quantitative framework. The objective of our research is to quantify morphological variation to test the validity of extant named species of terebratulide brachiopods, focusing on the lophophore-supporting structures-the "long loops." Long loops are the most distinctive and complex morphological feature in terebratellidine brachiopods and are considered to be phylogenetically and taxonomically informative. We studied eight species with problematic species identities in three genera distributed in the North Pacific: Laqueus, Terebratalia, and Dallinella. Given how geometrically complex long loops are, we generated 3D models from computed tomography (CT) scans of specimens of these eight species and analyzed them using 3D geometric morphometrics. Our goal was to determine ranges of variation and to test whether species are clearly distinguishable from one another in morphospace and statistically. Previous studies have suggested that some species might be overly split and are indistinguishable. Our results show that these extant species of terebratellidines can be reliably distinguished on the basis of quantitative loop morphometrics. Using 3D geometric morphometric methods, we demonstrate the utility of CT beyond purely descriptive imaging purposes in testing the morphometric validity of named species. It is crucial to treat species described and named from qualitative morphology as working hypotheses to be tested; many macroevolutionary studies depend upon the accurate assessment of species in order to identify and seek to explain macroevolutionary patterns. Our results provide quantitative documentation of the distinction of these species and thus engender greater confidence in their use to characterize macroevolutionary patterns among extant terebratellidine brachiopods. These methods, however, require further testing in extinct terebratellidines, which only rarely preserve the delicate long loop in three dimensions. In addition, molecular analyses of extant terebratellidines will test the species delimitations supported by the morphometric analyses presented in this study. [Species determination; morphological variability; 3D geometric morphometrics; terebratulide brachiopods; long loops.]	[Carranza, Natalia Lopez; Carlson, Sandra J.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Carranza, NL (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	nlopezc@ucdavis.edu		Lopez Carranza, Natalia/0000-0002-1393-2902	National Science Foundation [EAR 1147537, DEB 1747704]; University of California, Davis Department of Earth and Planetary Sciences; Cordell Durrell Funds; Consejo Nacional de Ciencia y Tecnologia (CONACYT); University of California Institute for Mexico; United States (UCMEXUS); Secretaria de Educacion Publica (SEP, Mexico)	National Science Foundation(National Science Foundation (NSF)); University of California, Davis Department of Earth and Planetary Sciences(University of California System); Cordell Durrell Funds; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California Institute for Mexico; United States (UCMEXUS); Secretaria de Educacion Publica (SEP, Mexico)	This work was partially supported by grants from the National Science Foundation (EAR 1147537 and DEB 1747704) to S.J. Carlson and the University of California, Davis Department of Earth and Planetary Sciences and Cordell Durrell Funds to N. Lopez Carranza. N. Lopez Carranza gratefully acknowledges support from Consejo Nacional de Ciencia y Tecnologia (CONACYT), the University of California Institute for Mexico and the United States (UCMEXUS), and Secretaria de Educacion Publica (SEP, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A., 1850, ZOOLOGY VOYAGE HMS S, P1; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; BEECHER CE, 1893, T CONNECTICUT ACADEM, V9, P376; Bitner MA, 2005, CRETACEOUS RES, V26, P525, DOI 10.1016/j.cretres.2005.02.008; Blazejowski B, 2011, ACTA PALAEONTOL POL, V56, P439, DOI 10.4202/app.2010.0114; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bose R, 2012, HIST BIOL, V24, P655, DOI 10.1080/08912963.2012.658568; Bose R, 2011, PALAEOGEOGR PALAEOCL, V310, P427, DOI 10.1016/j.palaeo.2011.08.004; Buckman S. S., 1901, Proceedings of the Cotteswold Club, Vxiii, P231; Carlson SJ, 2008, EARTH ENV SCI T R SO, V98, P311, DOI 10.1017/S1755691007078437; Carlson SJ, 2016, ANNU REV EARTH PL SC, V44, P409, DOI 10.1146/annurev-earth-060115-012348; Cloud PE, 1941, AM J SCI, V239, P899, DOI 10.2475/ajs.239.12.899; Cooper G.A., 1972, Smithsonian Contributions to Paleobiology, VNo. 11, P1; Cooper G.A., 1983, SMITHSONIAN CONTRIBU, V50, P1, DOI DOI 10.5479/SI.00810266.50.1; Cunningham JA, 2014, TRENDS ECOL EVOL, V29, P347, DOI 10.1016/j.tree.2014.04.004; Dall, 1870, AM J CONCHOLOGY, V6, P88; Dall W. H., 1920, Proceedings of the United States National Museum, V57; Dall WH, 1871, AM NAT, V5, P1; Davidson T., 1887, MONOGRAPH RECENT BRA, V4, P74; Du Bois H. M., 1916, Puget Sound Marine Station Publication, V1; Dunker W.B.R.H., 1882, INDEX MOLLUSCORUM MA; EMIG CC, 1976, ZOOL SCR, V5, P133, DOI 10.1111/j.1463-6409.1976.tb00690.x; Emig CC, 2018, BRACHIOPODA DATABASE; Gaspard D, 2013, CR PALEVOL, V12, P149, DOI 10.1016/j.crpv.2013.01.005; GILMOUR THJ, 1981, CAN J ZOOL, V59, P1539, DOI 10.1139/z81-209; Haney RA, 2001, PALAIOS, V16, P115, DOI 10.2307/3515524; Hatai K., 1936, Venus Kyoto, V6, P146; Hatai KM, 1940, GEOLOGY, V20, P1; HATAI KOTORA M., 1938, AMER MIDL NAT, V19, P706, DOI 10.2307/2420485; Hendricks JR, 2014, PALEOBIOLOGY, V40, P511, DOI 10.1666/13076; Hertlein LG, 1944, GRANT US CENOZOIC BR; Hochberg FG, 1997, SANTA BARBARA MUSEUM, V14, P1; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Krause RA, 2004, PALAIOS, V19, P460, DOI 10.1669/0883-1351(2004)019<0460:AAOMFI>2.0.CO;2; Laumer CE, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0831; Lee DE, 2006, TREATISE INVERTEBR H, V5; Lee S, 2018, LETHAIA, V51, P1, DOI 10.1111/let.12217; Lee SH, 2017, PATTERN RECOGN, V71, P1, DOI 10.1016/j.patcog.2017.05.015; Light SF, 2007, LIGHT SMITH MANUAL I; Logan W, 2007, TLS-TIMES LIT SUPPL, P6; Mackinnon D.I., 2000, Bulletin of the Natural History Museum Geology Series, V56, P85; MacKinnon DI, 2006, TREATISE INVERTEBR H, V5; Motchurova-Dekova Neda, 2010, Geoloshki Anali Balkanskoga Poluostrva, V71, P109; Muir-Wood H.M., 1955, HIST CLASSIFICATION; Muir-Wood HM, 1934, PHILOS T R SOC LON B, V223, P511, DOI 10.1098/rstb.1934.0012; Oldroyd I.S., 1924, MARINE SHELLS W COAS; PAINE RT, 1969, PAC SCI, V23, P337; Pakhnevich AV, 2010, PALEONTOL J+, V44, P1217, DOI 10.1134/S0031030110090066; Pakhnevich A, 2018, J IMAGING, V4, DOI 10.3390/jimaging4080103; Pennington JT, 1999, BIOL BULL-US, V196, P245, DOI 10.2307/1542949; R Core Team, 2013, R LANG ENV STAT COMP; Radulovic V, 2006, GEOL CARPATH, V57, P269; REED CG, 1977, CELL TISSUE RES, V185, P17; ROWELL AJ, 1982, LETHAIA, V15, P299, DOI 10.1111/j.1502-3931.1982.tb01695.x; Rudwick M. J. S., 1962, Journal of the Linnean Society London Zoology, V44, P592; Rudwick M.J.S., 1970, LIVING FOSSIL BRACHI; Ruggiero ET, 2008, FOSS STRATA, P209; Saito M, 2000, MOL PHYLOGENET EVOL, V15, P331, DOI 10.1006/mpev.2000.0773; Saito Michiko, 2001, Paleontological Research, V5, P87; Schlager S., 2017, STAT SHAPE DEFORMATI, P217; Schreiber HA, 2014, PALEOBIOLOGY, V40, P640, DOI 10.1666/13042; Schumann D., 1991, BRACH TIM P 2 INT BR; Seidel R, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0065-x; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Smirnova TN, 2008, PALEONTOL J+, V42, P805, DOI 10.1134/S0031030108080054; Sowerby GB., 1846, P ZOOL SOC LOND, V14, P91; Sperling EA, 2011, EVOL DEV, V13, P290, DOI 10.1111/j.1525-142X.2011.00480.x; STEHLI FG, 1956, EVOLUTION, V10, P187, DOI 10.2307/2405893; Stehli FG, 1965, TREATISE INVERTEBR H; Temereva EN, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1029-5; Thomson J. A., 1915, Geological Magazine London Dec 6, V2; Topper TP, 2017, PALAEONTOLOGY, V60, P269, DOI 10.1111/pala.12281; Tort A, 2001, J PALEONTOL, V75, P261, DOI 10.1666/0022-3360(2001)075<0261:IAIVII>2.0.CO;2; TUNNICLIFFE V, 1988, MAR ECOL PROG SER, V47, P117, DOI 10.3354/meps047117; Waagen W.H., 1883, GEOLOGICAL SURVEY 13, V4, P391; Watanabe A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198341; Williams A, 1997, TREATISE INVERTEBR H, V1; World Register of Marine Species (WoRMS), 1870, LAQ DALL; Yabe H., 1934, Proceedings of the Imperial Academy Tokyo, V10, P661; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; Zezina ON, 2010, PALEONTOL J+, V44, P1176, DOI 10.1134/S0031030110090030	81	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225528	10.1371/journal.pone.0225528	http://dx.doi.org/10.1371/journal.pone.0225528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774831	Green Published, gold			2022-12-26	WOS:000533896400037
J	Nantha, YS; Haque, S; Chelliah, AAP				Nantha, Yogarabindranath Swarna; Haque, Shamsul; Chelliah, Azriel Abisheg Paul			The internal realities of individuals with type 2 diabetes - a functional framework of self-management practices via Grounded Theory approach	PLOS ONE			English	Article							METASYNTHESIS; BARRIERS	Background An upward trend is observed in the prevalence of Type 2 diabetes (T2D) in South-East Asian and Western Pacific regions. These patterns incur a costly health burden to developing nations around the world. A clear understanding of the mechanics behind self-management practices of T2D patients might help overcome this impasse. This information can help unlock specific problem areas that warrant specific intervention. We aim to uncover prevailing T2D self-management habits and its deviations from optimal behaviour. Methods We adopted a Grounded Theory approach to guide in-depth interviews (IDI) with T2D patients and healthcare providers (HCP) at a regional primary care clinic in Malaysia. Twenty-four T2D patients and 10 HCPs were recruited through purposive sampling to examine their inner psychological narratives related to self-management practices. 2 focus group discussions (FGD) were conducted as a part of the data triangulation process. Results A functional framework for self-management practices in T2D patients was developed. Selfmanagement behavior was characterized by 2 major processes- 1) helpful and, 2) unhelpful practices. Self-efficacy, taking responsibility and being rational define helpful behaviour in these patients. On the other hand, unhelpful traits (neglect, poor restraint, and experimentation) often trigger violations with regards to medication compliance and therapeutic lifestyle changes. Conclusions We outlined a roadmap that navigates through the positive and negative mindset in relation to self-management practices of T2D patients. These results highlight the importance of devising individualized strategies by taking into account the personal challenges, emotions, and motivations that define the inner self of the patient.	[Nantha, Yogarabindranath Swarna; Chelliah, Azriel Abisheg Paul] Seremban Primary Hlth Care Clin, Primary Care Res Initiat & Methods Educ Dept PRIM, Seremban, Malaysia; [Nantha, Yogarabindranath Swarna; Chelliah, Azriel Abisheg Paul] Seremban Primary Hlth Care Clin, Noncommunicable Dis Dept, Seremban, Malaysia; [Nantha, Yogarabindranath Swarna; Haque, Shamsul] Monash Univ Malaysia, Dept Psychol, Subang Jaya, Malaysia	Monash University; Monash University Sunway	Nantha, YS (corresponding author), Seremban Primary Hlth Care Clin, Primary Care Res Initiat & Methods Educ Dept PRIM, Seremban, Malaysia.; Nantha, YS (corresponding author), Seremban Primary Hlth Care Clin, Noncommunicable Dis Dept, Seremban, Malaysia.; Nantha, YS (corresponding author), Monash Univ Malaysia, Dept Psychol, Subang Jaya, Malaysia.	yogarabin@gmail.com			MOH-NIH grant [:91000440]; Ministry of Health Malaysia	MOH-NIH grant; Ministry of Health Malaysia	This study was funded by the MOH-NIH grant (Grant No.:91000440) received from the Ministry of Health Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu MD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217771; American Association of Diabetes Educators, 2008, AADE7 SELF CAR BEH D, V34, P445, DOI [10.1177/0145721708316625, DOI 10.1177/0145721708316625]; Beverly EA, 2012, J GEN INTERN MED, V27, P1180, DOI 10.1007/s11606-012-2070-0; Bloom BR, 2000, LANCET, V356, pS50, DOI 10.1016/S0140-6736(00)92036-1; Burt RS, 2005, BROKERAGE CLOSURE IN; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Coyle ME, 2013, AUST HEALTH REV, V37, P513, DOI 10.1071/AH13060; Glanz K., 2015, HLTH BEHAV THEORY RE; Gomersall T, 2011, QUAL HEALTH RES, V21, P853, DOI 10.1177/1049732311402096; Livingston JA., 2003, METACOGNITION OVERVI; Nagelkerk J, 2006, J ADV NURS, V54, P151, DOI 10.1111/j.1365-2648.2006.03799.x; Narayan K M, 1999, Health Care Manag Sci, V2, P223, DOI 10.1023/A:1019048114376; Newton P, 2015, J DIABETES RES, V2015, P1; Rakel D., 2018, INTEGRATIVE MED; Rushforth B, 2016, BRIT J GEN PRACT, V66, pE114, DOI 10.3399/bjgp16X683509; Schulman-Green D, 2016, J ADV NURS, V72, P1469, DOI 10.1111/jan.12902; Sevick MA, 2007, J GEN INTERN MED, V22, P438, DOI 10.1007/s11606-007-0316-z; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Strauss, 2015, BASICS QUALITATIVE R; Swarna Nantha Y, 2018, FAM PRACT, P1, DOI [10.1093/fampra/cmx129, DOI 10.1093/FAMPRA/CMX129]; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zimmet Paul Z, 2017, Clin Diabetes Endocrinol, V3, P1, DOI 10.1186/s40842-016-0039-3	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225534	10.1371/journal.pone.0225534	http://dx.doi.org/10.1371/journal.pone.0225534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8RE	31770421	Green Published, gold			2022-12-26	WOS:000533892300026
J	Cobb, LH; Park, J; Swanson, EA; Beard, MC; McCabe, EM; Rourke, AS; Seo, KS; Olivier, AK; Priddy, LB				Cobb, Leah H.; Park, JooYoun; Swanson, Elizabeth A.; Beard, Mary Catherine; McCabe, Emily M.; Rourke, Anna S.; Seo, Keun Seok; Olivier, Alicia K.; Priddy, Lauren B.			CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection	PLOS ONE			English	Article							VANCOMYCIN; DELIVERY; FOSFOMYCIN; DIAGNOSIS	Osteomyelitis, or bone infection, is often induced by antibiotic resistant Staphylococcus aureus strains of bacteria. Although debridement and long-term administration of antibiotics are the gold standard for osteomyelitis treatment, the increase in prevalence of antibiotic resistant bacterial strains limits the ability of clinicians to effectively treat infection. Bacteriophages (phages), viruses that in a lytic state can effectively kill bacteria, have gained recent attention for their high specificity, abundance in nature, and minimal risk of host toxicity. Previously, we have shown that CRISPR-Cas9 genomic editing techniques could be utilized to expand temperate bacteriophage host range and enhance bactericidal activity through modification of the tail fiber protein. In a dermal infection study, these CRISPR-Cas9 phages reduced bacterial load relative to unmodified phage. Thus we hypothesized this temperate bacteriophage, equipped with the CRISPR-Cas9 bactericidal machinery, would be effective at mitigating infection from a biofilm forming S. aureus strain in vitro and in vivo. In vitro, qualitative fluorescent imaging demonstrated superiority of phage to conventional vancomycin and fosfomycin antibiotics against S. aureus biofilm. Quantitative antibiofilm effects increased over time, at least partially, for all fosfomycin, phage, and fosfomycin-phage (dual) therapeutics delivered via alginate hydrogel. We developed an in vivo rat model of osteomyelitis and soft tissue infection that was reproducible and challenging and enabled longitudinal monitoring of infection progression. Using this model, phage (with and without fosfomycin) delivered via alginate hydrogel were successful in reducing soft tissue infection but not bone infection, based on bacteriological, histological, and scanning electron microscopy analyses. Notably, the efficacy of phage at mitigating soft tissue infection was equal to that of high dose fosfomycin. Future research may utilize this model as a platform for evaluation of therapeutic type and dose, and alternate delivery vehicles for osteomyelitis mitigation.	[Cobb, Leah H.; Beard, Mary Catherine; McCabe, Emily M.; Rourke, Anna S.; Priddy, Lauren B.] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA; [Park, JooYoun; Seo, Keun Seok] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Swanson, Elizabeth A.] Mississippi State Univ, Coll Vet Med, Dept Clin Sci, Mississippi State, MS 39762 USA; [Olivier, Alicia K.] Mississippi State Univ, Coll Vet Med, Dept Pathobiol & Populat Med, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University	Priddy, LB (corresponding author), Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA.	lbpriddy@abe.msstate.edu		Rourke, Anna/0000-0002-7043-1370; (Horstemeyer) Cobb, Leah/0000-0002-0018-4618; Priddy, Lauren/0000-0002-4156-7586	NIH Center of Biomedical Research Excellence in Pathogen-Host Interactions [2P20GM103646]; Office of Research and Economic Development at Mississippi State University; USDA-ARS Biophotonics Initiative [58-6402-3-018]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103646] Funding Source: NIH RePORTER	NIH Center of Biomedical Research Excellence in Pathogen-Host Interactions; Office of Research and Economic Development at Mississippi State University; USDA-ARS Biophotonics Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH Center of Biomedical Research Excellence in Pathogen-Host Interactions (2P20GM103646) and the Office of Research and Economic Development at Mississippi State University. The authors would like to thank Dr. Jean Feugang, Dr. Seongbin Park, and the USDA-ARS Biophotonics Initiative (58-6402-3-018) for supporting our use of the IVIS Lumina XR system.; This research was supported by the NIH Center of Biomedical Research Excellence in Pathogen-Host Interactions (2P20GM103646) and the Office of Research and Economic Development at Mississippi State University. The authors would like to thank Dr. Jean Feugang, Dr. Seongbin Park, and the USDA-ARS Biophotonics Initiative (58-6402-3-018) for supporting our use of the IVIS Lumina XR system, Dr. Robert Wills for statistical analyses, and Dr. Lucy Senter and Dr. Bridget Willeford for veterinary care. Thanks also to Jamie Walker, Delisa Pennell, Dr. Hayley Gallaher, Weitong Chen, Kali Sebastian, Kristen Lacy, Christine Grant, Drew Moran, Ryan Yingling, Alex Feaster, Hannah Bostick, Christina Moffett, Sonja Jensen, Anna Marie Dulaney, and Luke Tucker for assistance with surgeries.	Abatangelo V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181671; Alves DR, 2014, APPL ENVIRON MICROB, V80, P6694, DOI 10.1128/AEM.01789-14; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bean JE, 2014, CHEM MATER, V26, P7201, DOI 10.1021/cm503974g; Bentley KLD, 2017, J BONE MINER RES, V32, P985, DOI 10.1002/jbmr.3055; Berbari EF, 2015, CLIN INFECT DIS, V61, P859, DOI 10.1093/cid/civ633; CDC, 2017, ANT US US PROGR OPP; de Jong NWM, 2017, SCI REP-UK, V7, DOI 10.1038/srep43889; Dijkmans AC, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6040024; Fabijan AP, 2019, BIORXIV, DOI [10.1101/619999, DOI 10.1101/619999]; Fish R, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7040087; Fridkin SK, 2001, CLIN INFECT DIS, V32, P108, DOI 10.1086/317542; Frieden Tom, 2013, CS239559B; Furfaro LL, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00376; Geraghty T, 2019, EXPERT REV PHARM OUT, V19, P279, DOI 10.1080/14737167.2019.1567337; IBRAHIM OMS, 2016, ADV ANIM VET SCI, V4, P593, DOI DOI 10.14737/JOURNAL.AAVS/2016/4.11.593.603; Johnson C, 2014, IGARSS; Johnson CT, 2018, P NATL ACAD SCI USA, V115, pE4960, DOI 10.1073/pnas.1801013115; Karnovsky MJ, 1965, AM SOC CELL BIOL SOU; Kishor C, 2016, INDIAN J MED RES, V143, P87, DOI 10.4103/0971-5916.178615; Koo V, 2006, CELLULAR ONCOLOGY; Krishnan L, 2017, ACTA BIOMATER, V49, P101, DOI 10.1016/j.actbio.2016.12.012; Krishnan L, 2015, CLIN ORTHOP RELAT R, V473, P2885, DOI 10.1007/s11999-015-4312-z; KRISTENSEN HK, 1948, STAIN TECHNOL, V23, P151, DOI 10.3109/10520294809106242; Leitner L, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0283-6; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P1330, DOI 10.1128/AAC.01602-07; Lopes A, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6040125; neill J, 2014, REV ANTIMICROB RESIS; Nelson CL, 2002, J ORTHOP RES, V20, P643, DOI 10.1016/S0736-0266(01)00133-4; Park JY, 2017, SCI REP-UK, V7, DOI 10.1038/srep44929; Pincus NB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124280; Poeppl W, 2014, ANTIMICROB AGENTS CH, V58, P5111, DOI 10.1128/AAC.02720-13; Priddy LB, 2014, ACTA BIOMATER, V10, P4390, DOI 10.1016/j.actbio.2014.06.015; Rowley WR, 2017, POPUL HEALTH MANAG, V20, P6, DOI 10.1089/pop.2015.0181; Souza GR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002242; Tagliaferri TL, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00022; Takahata S, 2010, INT J ANTIMICROB AG, V35, P333, DOI 10.1016/j.ijantimicag.2009.11.011; Taki H, 2016, BRIT J HOSP MED, V77, pC161, DOI 10.12968/hmed.2016.77.10.C161; Tang ZX, 2015, LWT-FOOD SCI TECHNOL, V60, P263, DOI 10.1016/j.lwt.2014.08.012; Thorpe KE, 2018, HEALTH AFFAIR, V37, P662, DOI 10.1377/hlthaff.2017.1153; TRAUTMANN M, 1992, INFECTION, V20, P350, DOI 10.1007/BF01710683; VOELKER R, 2019, JAMA-J AM MED ASSOC, V321, P638, DOI DOI 10.1001/JAMA.2019.0510; Wang F, 2018, ACS OMEGA, V3, P37, DOI 10.1021/acsomega.7b01483; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x	45	45	50	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0220421	10.1371/journal.pone.0220421	http://dx.doi.org/10.1371/journal.pone.0220421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756187	Green Published, gold, Green Submitted			2022-12-26	WOS:000533889300002
J	D'Alberto, BM; Carlson, JK; Pardo, SA; Simpfendorfer, CA				D'Alberto, Brooke M.; Carlson, John K.; Pardo, Sebastian A.; Simpfendorfer, Colin A.			Population productivity of shovelnose rays: Inferring the potential for recovery	PLOS ONE			English	Article							GUITARFISH RHINOBATOS-RHINOBATOS; APTYCHOTREMA-ROSTRATA SHAW; LIFE-HISTORY; REPRODUCTIVE-BIOLOGY; NATURAL MORTALITY; EXTINCTION RISK; COMMON GUITARFISH; INTRINSIC RATE; MORETON BAY; GROWTH	There is recent evidence of widespread declines of shovelnose ray populations (Order Rhinopristiformes) in heavily fished regions. These declines, which are likely driven by high demand for their fins in Asian markets, raises concern about their risk of over-exploitation and extinction. Using life-history theory and incorporating uncertainty into a modified Euler-Lotka model, the maximum intrinsic rates of population increase (r(max)) were estimated for nine species from four families of Rhinopristiformes, using four different natural mortality estimators. Estimates of mean r(max), across the different natural mortality methods, varied from 0.03 to 0.59 year(-1) among the nine species, but generally increased with increasing maximum size. Comparing these estimates to r(max) values for other species of chondrichthyans, the species Rhynchobatus australiae, Glaucostegus typus, and Glaucostegus cemiculus were relatively productive, while most species from Rhinobatidae and Trygonorrhinidae had relatively low r(max) values. If the demand for their high-value products can be addressed then population recovery for some species is likely possible, but will vary depending on the species.	[D'Alberto, Brooke M.; Simpfendorfer, Colin A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [D'Alberto, Brooke M.; Simpfendorfer, Colin A.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [D'Alberto, Brooke M.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Carlson, John K.] Natl Marine Fisheries Serv, NOAA, Southeast Fisheries Sci Ctr, Panama City, FL USA; [Pardo, Sebastian A.] Dalhousie Univ, Biol Dept, Halifax, NS, Canada	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Oceanic Atmospheric Admin (NOAA) - USA; Dalhousie University	D'Alberto, BM (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia.; D'Alberto, BM (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.; D'Alberto, BM (corresponding author), CSIRO Oceans & Atmosphere, Hobart, Tas, Australia.	brooke.dalberto@my.jcu.edu.au	D'Alberto, Brooke/ABD-1775-2021; Simpfendorfer, Colin/G-9681-2011	D'Alberto, Brooke/0000-0002-7834-0211; Pardo, Sebastian A./0000-0002-4147-5796; Simpfendorfer, Colin/0000-0002-0295-2238	Shark Conservation Fund (Small Grant Program 2018); Australian Government Research Training Program Scholarship (RTPS)	Shark Conservation Fund (Small Grant Program 2018); Australian Government Research Training Program Scholarship (RTPS)(Australian Government)	This project was funded by the Shark Conservation Fund (Small Grant Program 2018 to BMD), a philanthropic collaborative pooling expertise and resources to meet the threats facing the world's sharks and rays. The Shark Conservation Fund is a project of Rockefeller Philanthropy Advisors. The corresponding author (BMD) is supported through an Australian Government Research Training Program Scholarship (RTPS). The scientific results and conclusions, as well as any views or opinions expressed herein, are those of the author(s) and do not necessarily reflect those of NOAA or the Department of Commerce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAZIZ SH, 1993, AUST J MAR FRESH RES, V44, P507; Adams KR, 2018, BIOL CONSERV, V217, P11, DOI 10.1016/j.biocon.2017.10.010; Ali M, 2008, ANN AGR SCI, V46, P21; [Anonymous], 2018, MARINE FRESHWATER RE, V69, DOI [10.1071/mf16403, DOI 10.1071/MF16403]; [Anonymous], 2009, J MAR BIOL ASSOC UK, V89, DOI [10.1017/s0025315409990348, DOI 10.1017/S0025315409990348]; [Anonymous], 2011, EXTERNAL ACTORS HIGH; Au DW, 2015, CAN J FISH AQUAT SCI, V72, P767, DOI 10.1139/cjfas-2014-0360; Au DW, 1997, CAN J FISH AQUAT SCI, V54, P415, DOI 10.1139/cjfas-54-2-415; Barbini SA, 2011, MAR BIOL RES, V7, P365, DOI 10.1080/17451000.2010.515229; Basusta N, 2008, J MAR BIOL ASSOC UK, V88, P837, DOI 10.1017/S0025315408001124; Beddington JR, 2005, PHILOS T R SOC B, V360, P163, DOI 10.1098/rstb.2004.1582; Bizzarro JJ, 2009, STATUS SHARK RAY FIS; Bizzarro JJ, 2009, FISH RES, V97, P103, DOI 10.1016/j.fishres.2009.01.009; Blanco-Parra Maria Del Pilar, 2009, Pan-American Journal of Aquatic Sciences, V4, P456; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Cailliet GM, 2015, J FISH BIOL, V87, P1271, DOI 10.1111/jfb.12829; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; CAPAPE C, 1994, AUST J MAR FRESH RES, V45, P551, DOI 10.1071/MF9940551; Capape C., 1997, ICTHYOPHYSIOL ACTA, V20, P113; Cardenosa D, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12457; Carlson JK, 2015, AQUAT CONSERV, V25, P187, DOI 10.1002/aqc.2434; Carmo WPD, 2018, NEOTROP ICHTHYOL, V16, DOI 10.1590/1982-0224-20170005; Casselberry GA, 2015, ENDANGERED SPECIES A, P15; Caswell, 2000, MATRIX POPULATION MO; CHARNOV EL, 1973, AM NAT, V107, P791, DOI 10.1086/282877; Charnov EL, 2011, EVOL ECOL RES, V13, P431; Chin A, 2013, MAR FRESHWATER RES, V64, P965, DOI 10.1071/MF13017; CITES, 2019, SHARKS MANT RAYS GEN; CITES, 2019, PROP AM APP 1 2; Clarke S, 2007, MAR RESOUR ECON, V22, P305, DOI 10.1086/mre.22.3.42629561; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; CMS, 2018, CMSSHARKSMOS3DECISIO; CMS, 12 M CONV PART MAN P; Colonello JC, 2011, J FISH BIOL, V78, P287, DOI 10.1111/j.1095-8649.2010.02864.x; Compagno Leonard J.V., 2008, CSIRO Marine and Atmospheric Research Paper, V022, P227; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Cortes E, 2016, METHODS ECOL EVOL, V7, P1136, DOI 10.1111/2041-210X.12592; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; CUSHING DH, 1975, J CONSEIL, V36, P150; D'Alberto B. M., 2019, UNTANGLING INDONESIA; Dillingham PW, 2010, ECOL MODEL, V221, P895, DOI 10.1016/j.ecolmodel.2009.12.008; DIOP M, 2011, 30 YEARS SHARK FISHI; Downton-Hoffman C., 1856, BIOL PEZ GUITARRA RH; Dulvy NK, 2017, CURR BIOL, V27, pR565, DOI 10.1016/j.cub.2017.04.038; Dulvy NK, 2016, AQUAT CONSERV, V26, P134, DOI 10.1002/aqc.2525; Dulvy NK, 2014, PEERJ, V2, DOI 10.7717/peerj.400; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dulvy NK, 2010, CRC MAR BIOL SER, P639; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Dulvy NK, 2004, FISH FISH, V5, P255, DOI 10.1111/j.1467-2679.2004.00158.x; Enajjar S, CAHIERS BIOL; FABENS AJ, 1965, GROWTH, V29, P265; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fields AT, 2018, CONSERV BIOL, V32, P376, DOI 10.1111/cobi.13043; Fowler S. L., 1997, P INT SEM WORKSH SAB; Frisk MG, 2001, CAN J FISH AQUAT SCI, V58, P969, DOI 10.1139/cjfas-58-5-969; Garcia VB, 2008, P ROY SOC B-BIOL SCI, V275, P83, DOI 10.1098/rspb.2007.1295; Gedamke T, 2007, N AM J FISH MANAGE, V27, P605, DOI 10.1577/M05-157.1; Gonzalez Manoel M. B., 2004, Rev. Bras. Zool., V21, P785, DOI 10.1590/S0101-81752004000400010; Harrison LR., 2014, SAWFISH GLOBAL STRAT; Harry AV, 2018, FISH FISH, V19, P185, DOI 10.1111/faf.12243; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Hewitt DA, 2005, FISH B-NOAA, V103, P433; Hoenig JM, 2016, ICES J MAR SCI, V73, P2453, DOI 10.1093/icesjms/fsw089; HOLDEN M J, 1973, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V164, P360; Holden M.J., 1974, P117; Hutchings JA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0693; Ismen A, 2007, FISH RES, V84, P263, DOI 10.1016/j.fishres.2006.12.002; Jabado RW, 2018, FISH RES, V204, P448, DOI 10.1016/j.fishres.2018.03.022; Jabado R.W., 2019, WEDGEFISHES GIANT GU; Jabado RW, 2017, FISH FISH, V18, P1096, DOI 10.1111/faf.12227; Jensen AL, 1996, CAN J FISH AQUAT SCI, V53, P820, DOI 10.1139/cjfas-53-4-820; Kenchington TJ, 2014, FISH FISH, V15, P533, DOI 10.1111/faf.12027; Keong CH, 1996, INDONESIA; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Kyne P. M., 2019, BIORXIV, DOI [10.1101/595462, DOI 10.1101/595462]; Kyne PM, 2002, MAR FRESHWATER RES, V53, P583, DOI 10.1071/MF01063; Kyne PM, 2002, MAR FRESHWATER RES, V53, P679, DOI 10.1071/MF01040; Lack M., 2009, TRENDS GLOBAL SHARK; Last P. R., 2016, P1; Lawson JM, 2018, SHARKS AHEAD REALIZI; Lessa R.P., 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T41064A103933918.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T41064A103933918.EN]; Lteif M, 2016, J FISH BIOL, V88, P1441, DOI 10.1111/jfb.12921; Lteif Myriam, 2016, Egyptian Journal of Aquatic Research, V42, P475; Marquez-Farias JF, 2007, MAR BIOL, V151, P1445, DOI 10.1007/s00227-006-0599-3; Marshall LJ, 2007, MAR FRESHWATER RES, V58, P104, DOI 10.1071/MF05165; Mohanraj G., 2009, Asian Fisheries Science, V22, P607; Moore ABM, 2017, ENDANGER SPECIES RES, V34, P75, DOI 10.3354/esr00830; Myers RA, 1998, ECOL APPL, V8, pS165, DOI 10.1890/1051-0761(1998)8[S165:TLOEAP]2.0.CO;2; Myers RA, 1997, FISH B-NOAA, V95, P762; Natanson LJ, 2018, MAR FRESHWATER RES, V69, P1440, DOI 10.1071/MF17279; Newell B., STATUS REV REPORT 2, P1; Niel C, 2005, CONSERV BIOL, V19, P826, DOI 10.1111/j.1523-1739.2005.00310.x; Oliver S, 2015, MAR POLICY, V54, P86, DOI 10.1016/j.marpol.2014.12.017; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Pardo SA, 2018, ICES J MAR SCI, V75, P953, DOI 10.1093/icesjms/fsx220; Pardo SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33745; Pardo SA, 2016, CAN J FISH AQUAT SCI, V73, P1159, DOI 10.1139/cjfas-2016-0069; Pardo SA, 2013, METHODS ECOL EVOL, V4, P353, DOI 10.1111/2041-210x.12020; Pierce SJ, 2008, SHARK FISHING MOZAMB, P1; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; ROSSOUW GJ, 1984, J FISH BIOL, V25, P213, DOI 10.1111/j.1095-8649.1984.tb04868.x; Schaeffer D., 2004, ASSESSMENT ARTISANAL, P536; Seck A.A., 2004, Scientia Gerundensis, V27, P19; SIMPFENDORFER CA, 1992, AUST J MAR FRESH RES, V43, P67, DOI 10.1071/MF9920067; Simpfendorfer CA, 2005, ENVIRON BIOL FISH, V73, P20, DOI 10.1007/s10641-004-4174-9; Simpfendorfer CA, 2005, FAO FISH TECH PAP, V474, P143; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Smart JJ, 2015, AFR J MAR SCI, V37, P177, DOI 10.2989/1814232X.2015.1025428; Smart JJ, 2016, FISH FISH, V17, P955, DOI 10.1111/faf.12154; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Smith WD, 2008, MAR FRESHWATER RES, V59, P575, DOI 10.1071/MF07020; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevens John D., 2005, P48; Stobutzki IC, 2002, FISH B-NOAA, V100, P800; Team RC, 2016, R LANG ENV STAT COMP; Then AY, 2015, ICES J MAR SCI, V72, P82, DOI 10.1093/icesjms/fsu136; Thorburn DC, 2008, ENVIRON BIOL FISH, V83, P139, DOI 10.1007/s10641-007-9306-6; THORSON TB, 1982, FISHERIES, V7, P2, DOI 10.1577/1548-8446(1982)007<0002:TIOCEO>2.0.CO;2; Timmons M, 1998, OCEANOGRAPHIC LIT RE, V1, P148; VILLAVICENCIOGARAYZAR CJ, 1995, CIENC MAR, V21, P141, DOI 10.7773/cm.v21i2.991; Vincent ACJ, 2014, FISH FISH, V15, P563, DOI 10.1111/faf.12035; Vooren, 2003, FRENTE MARITIMO, V19, P217; Vooren CM, 2006, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2006.RLTS.T61419A12478303.en, DOI 10.2305/IUCN.UK.2006.RLTS.T61419A12478303.EN]; Wainwright BJ, 2018, CONSERV GENET, P1; White J, 2014, ENVIRON BIOL FISH, V97, P773, DOI 10.1007/s10641-013-0178-7; White J, 2014, J FISH BIOL, V84, P1340, DOI 10.1111/jfb.12359; White J, 2013, J EXP MAR BIOL ECOL, V448, P281, DOI 10.1016/j.jembe.2013.08.004; White WT, 2007, J FISH BIOL, V70, P1809, DOI 10.1111/j.1095-8649.2007.01458.x; White WT, 2010, J FISH BIOL, V76, P2090, DOI 10.1111/j.1095-8649.2010.02654.x; White WT, 2010, CRC MAR BIOL SER, P159; Ya BP, 2017, SHARK RAY TRADE SING	134	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225183	10.1371/journal.pone.0225183	http://dx.doi.org/10.1371/journal.pone.0225183			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751369	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000533886900034
J	Guillemin, A; Duchesne, R; Crauste, F; Gonin-Giraud, S; Gandrillon, O				Guillemin, Anissa; Duchesne, Ronan; Crauste, Fabien; Gonin-Giraud, Sandrine; Gandrillon, Olivier			Drugs modulating stochastic gene expression affect the erythroid differentiation process	PLOS ONE			English	Article							CELL FATE; NOISE; PROTEIN; HETEROGENEITY; MECHANISMS; ENTROPY; MODELS; MEMORY	To better understand the mechanisms behind cells decision-making to differentiate, we assessed the influence of stochastic gene expression (SGE) modulation on the erythroid differentiation process. It has been suggested that stochastic gene expression has a role in cell fate decision-making which is revealed by single-cell analyses but studies dedicated to demonstrate the consistency of this link are still lacking. Recent observations showed that SGE significantly increased during differentiation and a few showed that an increase of the level of SGE is accompanied by an increase in the differentiation process. However, a consistent relation in both increasing and decreasing directions has never been shown in the same cellular system. Such demonstration would require to be able to experimentally manipulate simultaneously the level of SGE and cell differentiation in order to observe if cell behavior matches with the current theory. We identified three drugs that modulate SGE in primary erythroid progenitor cells. Both Artemisinin and Indomethacin decreased SGE and reduced the amount of differentiated cells. On the contrary, a third component called MB-3 simultaneously increased the level of SGE and the amount of differentiated cells. We then used a dynamical modelling approach which confirmed that differentiation rates were indeed affected by the drug treatment. Using single-cell analysis and modeling tools, we provide experimental evidence that, in a physiologically relevant cellular system, SGE is linked to differentiation.	[Guillemin, Anissa; Duchesne, Ronan; Gonin-Giraud, Sandrine; Gandrillon, Olivier] Univ Claude Bernard Lyon 1, Lab Biol & Modelisat Cellule, LBMC Ecole Normale Super Lyon,Ecole Normale Super, Ctr Natl Rech Sci UMR5239,Inst Natl Sante & Rech, F-69007 Lyon, France; [Duchesne, Ronan; Crauste, Fabien; Gandrillon, Olivier] Inria Dracula, Villeurbanne, France; [Crauste, Fabien] Univ Bordeaux, CNRS, Bordeaux INP, IMB,UMR 5251, F-33400 Talence, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite de Bordeaux	Gandrillon, O (corresponding author), Univ Claude Bernard Lyon 1, Lab Biol & Modelisat Cellule, LBMC Ecole Normale Super Lyon,Ecole Normale Super, Ctr Natl Rech Sci UMR5239,Inst Natl Sante & Rech, F-69007 Lyon, France.; Gandrillon, O (corresponding author), Inria Dracula, Villeurbanne, France.	olivier.gandrillon@ens-lyon.fr		Crauste, Fabien/0000-0002-9979-9638	French agency ANR (SinCity) [ANR-17CE12-0031]; La Ligue Contre le Cancer (Comite de Haute Savoie) [LS 136994]	French agency ANR (SinCity)(French National Research Agency (ANR)); La Ligue Contre le Cancer (Comite de Haute Savoie)	This work was supported by funding from the French agency ANR (SinCity; ANR-17CE12-0031) and La Ligue Contre le Cancer (Comite de Haute Savoie; LS 136994). There was no additional external funding received for this study. All these funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, SCIPY OPEN SOURCE SC; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; BENZER S, 1953, BIOCHIM BIOPHYS ACTA, V11, P383, DOI 10.1016/0006-3002(53)90057-2; Bertaux F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003893; Bossone K, 2018, BIORXIV; Braun E, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/3/036602; Brock A, 2015, NAT REV CANCER, V15, P499, DOI 10.1038/nrc3959; Burnham K.P., 2010, MODEL SELECTION MULT; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Chubb JR, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.284; Dar RD, 2018, APL BIOENG, V2, DOI 10.1063/1.5025033; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; Dixit PD, 2013, BIOPHYS J, V104, P2743, DOI 10.1016/j.bpj.2013.05.010; Duchesne R, 2019, SILICO BIOL, P1; Eisenberg DTA, 2015, AM J HUM BIOL, V27, P570, DOI 10.1002/ajhb.22690; Eling N, 2019, NAT REV GENET, V20, P536, DOI 10.1038/s41576-019-0130-6; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Gandrillon O, 1999, EMBO J, V18, P2764, DOI 10.1093/emboj/18.10.2764; Ganguli A, 2014, BIOCHIMIE, V107, P338, DOI 10.1016/j.biochi.2014.10.001; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hansen MMK, 2018, CELL SYST, V7, P384, DOI 10.1016/j.cels.2018.08.002; HART FD, 1963, BMJ-BRIT MED J, P965, DOI 10.1136/bmj.2.5363.965; Heller LE, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4020089; Herbach U, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0487-0; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Johnston RJ, 2014, SCIENCE, V343, P661, DOI 10.1126/science.1243039; Keegstra JM, 2017, ELIFE, V6, DOI 10.7554/eLife.27455; Kubota Y, 2016, J BIOL CHEM, V291, P20516, DOI 10.1074/jbc.M116.719161; Kupiec J, 1997, MOL GEN GENET, V255, P201, DOI 10.1007/s004380050490; Liu CG, 1998, GENOMICS, V50, P206, DOI 10.1006/geno.1998.5328; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MacArthur BD, 2013, CELL, V154, P484, DOI 10.1016/j.cell.2013.07.024; Megaridis MR, 2018, APL BIOENG, V2, DOI 10.1063/1.5021183; Mojtahedi M, 2016, CELL FATE DECISION H, DOI [10.1101/041541, DOI 10.1101/041541]; Moris N, 2018, STEM CELLS, V36, P1828, DOI 10.1002/stem.2919; Moris N, 2016, NAT REV GENET, V17, P693, DOI 10.1038/nrg.2016.98; Murakami A, 2018, J CLIN BIOCHEM NUTR, V62, P115, DOI 10.3164/jcbn.17-113; NASH SG, 1984, SIAM J NUMER ANAL, V21, P770, DOI 10.1137/0721052; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Richard A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002585; Semrau S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01076-4; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Slentz-Kesler K, 2000, GENOMICS, V69, P63, DOI 10.1006/geno.2000.6299; Stumpf PS, 2017, CELL SYST, V5, P268, DOI 10.1016/j.cels.2017.08.009; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Symmons O, 2016, MOL CELL, V62, P788, DOI 10.1016/j.molcel.2016.05.023; Teschendorff AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15599; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Viney M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1104; Vu TM, 2017, NATURE, V550, P524, DOI 10.1038/nature24053; Waddington C., 1957, STRATEGY GENES; Wang J, 2015, ONCOTARGET, V6, P16527, DOI 10.18632/oncotarget.4113; Wang Kai, 2015, BMC Res Notes, V8, P832, DOI 10.1186/s13104-015-1786-4; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wong VC, 2018, CELL REP, V22, P585, DOI 10.1016/j.celrep.2017.12.080; Wu YN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.465; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yan MD, 2018, GENE, V648, P54, DOI 10.1016/j.gene.2018.01.040	71	10	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225166	10.1371/journal.pone.0225166	http://dx.doi.org/10.1371/journal.pone.0225166			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751364	Green Submitted, gold, Green Published			2022-12-26	WOS:000533886900033
J	Schellen, C; Posekany, A; Ferrari, J; Krebs, S; Lang, W; Brainin, M; Staykov, D; Sykora, M				Schellen, Christoph; Posekany, Alexandra; Ferrari, Julia; Krebs, Stefan; Lang, Wilfried; Brainin, Michael; Staykov, Dimitre; Sykora, Marek		Austrian Stroke Unit Registry Coll	Temporal trends in intracerebral hemorrhage: Evidence from the Austrian Stroke Unit Registry	PLOS ONE			English	Article							CASE-FATALITY; TIME TRENDS; MORTALITY; SUPPORT; RISK	Background To assess changes in frequency, severity, complications, therapy and outcome of intracerebral hemorrhage in patients treated in stroke units in Austria, we evaluated data from the Austrian Stroke Unit Registry between 2008 and 2016. Methods and findings Data of 6707 cases of ICH covering a time span of 9 years and including information on age, risk factors, pre-stroke modified Rankin Score (mRS), baseline stroke severity (NIHSS), complications, therapy, functional outcome, and mortality were extracted from the Austrian Stroke Unit Registry. A multivariate regularized logistic regression model and linear models for temporal dependence were computed for analyzing statistical inference and time trends. Bonferroni correction was applied to correct for multiple testing. Between 2008 and 2016, the proportion of ICH admissions to stroke units in Austria declined, with a shift among patients towards older age (> 70 years, p = 0.04) and lower admission NIHSS scores. While no significant time trends in risk factors, pre-stroke mRS and medical complications were observed, therapeutic interventions declined significantly (p<0.001). Three-month mortality increased over the years independently (p = 0.003). Conclusions Despite declining incidence and clinical severity of ICH we observed a clear increase in three-month mortality. This effect seems to be independent of predictors including age, admission NIHSS, pre-morbid MRS, or medical complications. The observations from this large retrospective database cohort study underline an urgent call for action in the therapy of ICH.	[Schellen, Christoph] Rudolf Fdn Hosp Krankenanstalt Rudolfstiftung, Dept Radiol, Vienna, Austria; [Posekany, Alexandra; Brainin, Michael] Danube Univ, Dept Clin Neurosci & Prevent Med, Krems, Austria; [Ferrari, Julia; Krebs, Stefan; Lang, Wilfried; Sykora, Marek] St Johns Hosp, Dept Neurol, Vienna, Austria; [Lang, Wilfried; Sykora, Marek] Sigmund Freud Univ, Med Fac, Vienna, Austria; [Staykov, Dimitre] St Johns Hosp, Dept Neurol, Eisenstadt, Austria; [Sykora, Marek] Comenius Univ, Dept Neurol 1, Bratislava, Slovakia	Danube University Krems; Comenius University Bratislava	Sykora, M (corresponding author), St Johns Hosp, Dept Neurol, Vienna, Austria.; Sykora, M (corresponding author), Sigmund Freud Univ, Med Fac, Vienna, Austria.; Sykora, M (corresponding author), Comenius Univ, Dept Neurol 1, Bratislava, Slovakia.	mareksykora@yahoo.com	Sykora, Marek/ACM-5186-2022	Sykora, Marek/0000-0003-3508-2176				Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bejot Y, 2017, NEUROLOGY, V88, P985, DOI 10.1212/WNL.0000000000003681; Bejot Y, 2013, BRAIN, V136, P658, DOI 10.1093/brain/aws349; Brainin M, 2008, WIEN MED WOCHENSCHR, V158, P407, DOI 10.1007/s10354-008-0562-7; Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b; Gattellari M, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001161; Geurts M, 2017, EUR STROKE J, V2, P244, DOI 10.1177/2396987317704546; Gueniat J, 2018, NEUROEPIDEMIOLOGY, V50, P47, DOI 10.1159/000486397; Hofer C, 2008, WIEN MED WOCHENSCHR, V158, P411, DOI 10.1007/s10354-008-0563-6; Islam SM, 2008, STROKE, V39, P776, DOI 10.1161/STROKEAHA.107.493643; Jolink WMT, 2015, NEUROLOGY, V85, P1318, DOI 10.1212/WNL.0000000000002015; Kleindorfer DO, 2010, STROKE, V41, P1326, DOI 10.1161/STROKEAHA.109.575043; Knoflach M, 2012, NEUROLOGY, V78, P279, DOI 10.1212/WNL.0b013e31824367ab; Langhorne P, 2013, STROKE, V44, P3044, DOI 10.1161/STROKEAHA.113.001564; Morgenstern LB, 2015, NEUROLOGY, V84, P1739, DOI 10.1212/WNL.0000000000001525; Otite FO, 2017, STROKE, V48, P596, DOI 10.1161/STROKEAHA.116.015746; R Core Team, 2018, R LANG ENV STAT COMP; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Siddiqui AA, 2013, INT J STAT MED RES, V2, P23; Silvennoinen K, 2014, INT J STROKE, V9, P53, DOI 10.1111/ijs.12161; Teuschl Y, 2013, STROKE, V44, P1070, DOI 10.1161/STROKEAHA.111.676114; Tsivgoulis G, 2018, STROKE, V49, P288, DOI 10.1161/STROKEAHA.117.019524; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wasay M, 2012, J STROKE CEREBROVASC, V21, P289, DOI 10.1016/j.jstrokecerebrovasdis.2010.09.001; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72; Zahuranec DB, 2014, NEUROLOGY, V82, P2180, DOI 10.1212/WNL.0000000000000519	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225378	10.1371/journal.pone.0225378	http://dx.doi.org/10.1371/journal.pone.0225378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747428	Green Published, gold			2022-12-26	WOS:000533881900041
J	Schubert, RS; Jung, ML; Helmert, JR; Velichkovsky, BM; Pannasch, S				Schubert, Rebekka S.; Jung, Maarten L.; Helmert, Jens R.; Velichkovsky, Boris M.; Pannasch, Sebastian			Size matters: How reaching and vergence movements are influenced by the familiar size of stereoscopically presented objects	PLOS ONE			English	Article							LEARNED PERCEPTUAL ASSOCIATIONS; EYE-MOVEMENTS; LIMITED CONDITIONS; OCULAR VERGENCE; DISTANCE; DEPTH; CUES; PERSPECTIVE; COMPONENTS; RESPONSES	The knowledge about the usual size of objects-familiar size-is known to be a taken into account for distance perception. The influence of familiar size on action programming is less clear and has not yet been tested with regard to vergence eye movements. In two experiments, we stereoscopically presented everyday objects, such as a credit card or a package of paper tissues, and varied the distance as specified by binocular disparity and the distance as specified by familiar size. Participants had to fixate the shown object and subsequently reach towards it either with open or with closed eyes. When binocular disparity and familiar size were in conflict, reaching movements revealed a combination of the two depth cues with individually different weights. The influence of familiar size was larger when no visual feedback was available during the reaching movement. Vergence movements closely followed binocular disparity and were largely unaffected by familiar size. In sum, the results suggest that in this experimental setting familiar size is taken into account for programming and executing reaching movements while vergence movements are primarily based on binocular disparity.	[Schubert, Rebekka S.; Jung, Maarten L.; Helmert, Jens R.; Velichkovsky, Boris M.; Pannasch, Sebastian] Tech Univ Dresden, Fac Psychol, Dresden, Germany; [Velichkovsky, Boris M.] Natl Res Ctr, Kurchatov Inst, Moscow, Russia; [Velichkovsky, Boris M.] Moscow Inst Phys & Technol, Moscow, Russia; [Velichkovsky, Boris M.] Russian State Univ Humanities, Moscow, Russia	Technische Universitat Dresden; National Research Centre - Kurchatov Institute; Moscow Institute of Physics & Technology; Russian State University for the Humanities	Pannasch, S (corresponding author), Tech Univ Dresden, Fac Psychol, Dresden, Germany.	Sebastian.Pannasch@tu-dresden.de		Jung, Maarten/0000-0003-0514-6706; Helmert, Jens R./0000-0003-1000-1915	German Research Council (Deutsche Forschungsgemeinschaft, DFG) [VE 192/17-1]; NRC "Kurchatov Institute" [1361/25.06.2019]	German Research Council (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); NRC "Kurchatov Institute"	R.S.S. and J.R.H. were supported by a grant from the German Research Council (Deutsche Forschungsgemeinschaft, DFG; https://www.dfg.de/; grant number: VE 192/17-1). B.M. V.'s work has been supported by the NRC "Kurchatov Institute", grant number: 1361/25.06.2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LIMESURVEY OPEN SOUR; Baayen H., 2015, REPSYCHLING DATA SET; Baayen HR, 2007, J MEM LANG, V59, P390, DOI [DOI 10.1016/J.JML.2007.12.005, 10.1016/j.jml.2007.12.005]; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barton K., 2016, MUMIN MULTIMODEL INF; Bates D, 2015, PARSIMONIOUS MIXED M, DOI DOI 10.1177/0146167220913363; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Borchers S, 2012, VISION RES, V67, P8, DOI 10.1016/j.visres.2012.06.019; Borchers S, 2011, NEUROPSYCHOLOGIA, V49, P556, DOI 10.1016/j.neuropsychologia.2010.12.018; Bozzacchi C, 2015, J NEUROPHYSIOL, V114, P2242, DOI 10.1152/jn.00350.2015; Campagnoli C, 2017, J VISION, V17, DOI 10.1167/17.9.21; Chen YF, 2010, J MED BIOL ENG, V30, P1; Christensen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054230; Cutting J.E., 1995, PERCEPTION SPACE MOT, P69, DOI 10.1016/B978-012240530-3/50005-5; Ebrahimi E, 2016, ACM T APPL PERCEPT, V13, DOI 10.1145/2947617; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; ENRIGHT JT, 1987, VISION RES, V27, P1513, DOI 10.1016/0042-6989(87)90160-X; Erkelens CJ, 2011, J VISION, V11, DOI 10.1167/11.10.21; ERKELENS CJ, 1986, J PHYSIOL-LONDON, V379, P145, DOI 10.1113/jphysiol.1986.sp016245; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P417, DOI 10.1098/rspb.1989.0030; Erkelens IM, 2018, VISION RES, V149, P66, DOI 10.1016/j.visres.2018.06.006; FOLEY JM, 1980, PSYCHOL REV, V87, P411, DOI 10.1037/0033-295X.87.5.411; Frey J, 2011, J NEUROSCI, V31, P17069, DOI 10.1523/JNEUROSCI.2192-11.2011; GOGEL WC, 1969, Q J EXP PSYCHOL, V21, P239, DOI 10.1080/14640746908400218; Gonzalez EG, 2010, VISION RES, V50, P136, DOI 10.1016/j.visres.2009.11.005; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodale MA, 2006, 1 HALF 2 MICROGENESI, P51; Green P, 2016, METHODS ECOL EVOL, V7, P493, DOI 10.1111/2041-210X.12504; Grosjean M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044706; Haffenden AM, 2002, EXP BRAIN RES, V147, P473, DOI 10.1007/s00221-002-1249-8; Haffenden AM, 2002, EXP BRAIN RES, V147, P485, DOI 10.1007/s00221-002-1250-2; Haffenden AM, 2000, J COGNITIVE NEUROSCI, V12, P950, DOI 10.1162/08989290051137495; Heath M, 2004, MOTOR CONTROL, V8, P76, DOI 10.1123/mcj.8.1.76; Hoffmann J, 2007, PERCEPTION, V36, P461, DOI 10.1068/p5549; Holway AH, 1941, AM J PSYCHOL, V54, P21, DOI 10.2307/1417790; Hooge ITC, 2019, VISION RES, V156, P1, DOI 10.1016/j.visres.2019.01.004; IBM Corp, 2011, IBM SPSS STAT WIND V; Iijima A, 2007, P 1 INT S VIS IND MO, P59; Jaeger B., 2017, R2GLMM COMPUTES R SQ; Jainta S, 2007, VISION RES, V47, P3238, DOI 10.1016/j.visres.2007.05.006; Jaschinski W., 2008, J EYE MOVEMENT RES, V1, P1, DOI DOI 10.16910/JEMR.1.2.5; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Keefe BD, 2009, EXP BRAIN RES, V194, P435, DOI 10.1007/s00221-009-1718-4; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kopiske KK, 2019, PSYCHOL RES-PSYCH FO, V83, P147, DOI 10.1007/s00426-018-1101-9; Lenth R., 2018, EMMEANS ESTIMATED MA; Lin CJ, 2018, APPL ERGON, V69, P10, DOI 10.1016/j.apergo.2017.12.020; Liversedge SP, 2006, CURR BIOL, V16, P1726, DOI 10.1016/j.cub.2006.07.051; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; Marotta JJ, 2001, J COGNITIVE NEUROSCI, V13, P8, DOI 10.1162/089892901564135; Matuschek H, 2017, J MEM LANG, V94, P305, DOI 10.1016/j.jml.2017.01.001; McIntosh RD, 2008, NEUROPSYCHOLOGIA, V46, P2441, DOI 10.1016/j.neuropsychologia.2008.03.003; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neely KA, 2008, EXP BRAIN RES, V186, P375, DOI 10.1007/s00221-007-1238-z; Neveu P, 2015, CLIN EXP OPTOM, V98, P435, DOI 10.1111/cxo.12311; Nuthmann A, 2009, J VISION, V9, DOI 10.1167/9.5.31; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OLEARY A, 1980, PERCEPT PSYCHOPHYS, V27, P131, DOI 10.3758/BF03204300; ONO H, 1969, J EXP PSYCHOL, V79, P109, DOI 10.1037/h0026879; Proffitt Dennis R., 2002, HDB PSYCHOL EXPT PSY, V4, P213; Rambold H, 2002, J NEUROPHYSIOL, V88, P1220, DOI 10.1152/jn.2002.88.3.1220; RCore Team, 2020, R LANG ENV STAT COMP; Renner R. S., 2013, P ACM S APPL PERC, P130; Renner RS, 2015, ACM T APPL PERCEPT, V12, DOI 10.1145/2724716; Ringach DL, 1996, VISION RES, V36, P1479, DOI 10.1016/0042-6989(95)00285-5; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schubert RS, 2016, 22ND ACM CONFERENCE ON VIRTUAL REALITY SOFTWARE AND TECHNOLOGY (VRST 2016), P307, DOI 10.1145/2993369.2996334; Schubert RS, 2016, 22ND ACM CONFERENCE ON VIRTUAL REALITY SOFTWARE AND TECHNOLOGY (VRST 2016), P233, DOI 10.1145/2993369.2993408; Schubert RS, 2019, SIZE MATTERS DATA AN; SEMMLOW JL, 1986, INVEST OPHTH VIS SCI, V27, P558; Sheliga BM, 2003, J VISION, V3, P654, DOI 10.1167/3.11.2; Singmann H, 2018, AFEX ANAL FACTORIAL; Sousa R, 2013, J VISION, V13, DOI 10.1167/13.2.2; Sousa R, 2012, J VISION, V12, DOI 10.1167/12.10.6; Sousa R, 2011, J VISION, V11, DOI 10.1167/11.9.10; Stilling J, 2011, TAFELN PRUFUNG FARBE; Svede A, 2015, PERCEPTION, V44, P1110, DOI 10.1177/0301006615596886; Wagner M, 2009, NEUROSCI LETT, V449, P142, DOI 10.1016/j.neulet.2008.10.093; Weber S, 2017, BEHAV RES METHODS, P1; Westwood DA, 2003, J MOTOR BEHAV, V35, P127, DOI 10.1080/00222890309602128; Westwood DA, 2001, CAN J EXP PSYCHOL, V55, P304, DOI 10.1037/h0087377; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wismeijer DA, 2008, EXP BRAIN RES, V184, P61, DOI 10.1007/s00221-007-1081-2; Wismeijer DA, 2010, J VISION, V10, DOI 10.1167/10.6.25; Wismeijer DA, 2009, J VISION, V9, DOI 10.1167/9.13.12; Woldegiorgis BH, 2017, J SOC INF DISPLAY, V25, P701, DOI 10.1002/jsid.618; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zeileis A, 2005, J STAT SOFTW, V14, P1, DOI [10.18637/jss.v014.i06, DOI 10.18637/JSS.V014.I06]	93	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225311	10.1371/journal.pone.0225311	http://dx.doi.org/10.1371/journal.pone.0225311			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8NF	31747431	Green Published, gold			2022-12-26	WOS:000533881900032
J	Tomazevic, M; Kaiba, T; Kurent, U; Trebse, R; Cimerman, M; Kralj-Iglic, V				Tomazevic, Matevz; Kaiba, Tina; Kurent, Urban; Trebse, Rihard; Cimerman, Matej; Kralj-Iglic, Veronika			Hip stress distribution - Predictor of dislocation in hip arthroplasties. A retrospective study of 149 arthroplasties	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; CONTACT STRESS; VOLUMETRIC WEAR; HEAD DIAMETER; ASSOCIATION; IMPINGEMENT; DESIGN; RISK	Dislocation after hip arthroplasty is still a major concern. Recent study of the volumetric wear of the cup has suggested that stresses studied in a one-legged stance model could predispose arthroplasty dislocation. The aim of this work was to study whether biomechanical parameters of contact stress distribution in total hip arthroplasty during a neutral hip position can predict a higher possibility of the arthroplasty dislocating. Biomechanical parameters were determined using 3-dimensional mathematical models of the one-legged stance within the HIPSTRESS method. Geometrical parameters were measured from standard anteroposterior X-ray images of the pelvis and proximal femora. Fifty-five patients subjected to total hip arthroplasty that later suffered dislocation of the head and, for comparison, ninety-four total hip arthroplasties that were functional at least 10 years after the implantation, were included in the study. Arthroplasties that suffered dislocation had on average a 6% higher resultant hip force than the control group (p = 0.004), 11% higher peak stress on the load-bearing area (p = 0.001) and a 50% more laterally positioned stress pole (p = 0.026), all parameters being less favorable in the group of unstable arthroplasties. There was no statistically significant difference in the gradient index or in the functional angle of the weight bearing. Our study showed that arthroplasties that show a tendency to push the head out of the cup in the representative body position-the one-legged stance-are prone to dislocation. An unfavorable resultant hip force, peak stress on the load bearing and laterally positioned stress pole are predictors of arthroplasty dislocation.	[Tomazevic, Matevz; Kaiba, Tina; Kralj-Iglic, Veronika] Univ Ljubljana, Fac Hlth Sci, Lab Clin Biophys, Ljubljana, Slovenia; [Tomazevic, Matevz; Kurent, Urban; Cimerman, Matej] Univ Med Ctr Ljubljana, Dept Traumatol, Div Surg, Ljubljana, Slovenia; [Trebse, Rihard] Orthopaed Hosp Valdoltra, Ankaran, Slovenia	University of Ljubljana; University Medical Centre Ljubljana	Tomazevic, M (corresponding author), Univ Ljubljana, Fac Hlth Sci, Lab Clin Biophys, Ljubljana, Slovenia.; Tomazevic, M (corresponding author), Univ Med Ctr Ljubljana, Dept Traumatol, Div Surg, Ljubljana, Slovenia.	matevz.tomazevic@kclj.si	Trebše, Rihard/I-1482-2019	Trebše, Rihard/0000-0002-1075-3351; Tomazevic, Matevz/0000-0003-0744-1012	Slovenian Research Agency [P3-0388]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The study was funded by the Slovenian Research Agency grant P3-0388 to VK-I. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel MP, 2016, CLIN ORTHOP RELAT R, V474, P386, DOI 10.1007/s11999-015-4432-5; Badarudeen S, 2017, J ARTHROPLASTY, V32, P1954, DOI 10.1016/j.arth.2017.01.037; Berry DJ, 2005, J BONE JOINT SURG AM, V87A, P2456, DOI 10.2106/JBJS.D.02860; Brennan SA, 2012, HIP INT, V22, P500, DOI 10.5301/HIP.2012.9747; Brown Thomas D, 2014, Iowa Orthop J, V34, P1; Bunn A, 2014, J ORTHOP RES, V32, P1525, DOI 10.1002/jor.22659; Dargel J, 2014, DTSCH ARZTEBL INT, V111, P884, DOI 10.3238/arztebl.2014.0884; Debevec H, 2010, J APPL BIOMECH, V26, P522, DOI 10.1123/jab.26.4.522; Eggli S, 1998, J BONE JOINT SURG BR, V80B, P382, DOI 10.1302/0301-620X.80B3.7764; Elkins JM, 2012, J ORTHOP RES, V30, P169, DOI 10.1002/jor.21524; Ferguson RJ, 2018, LANCET, V392, P1662, DOI 10.1016/S0140-6736(18)31777-X; Forde B, 2018, J ORTHOP, V15, P131, DOI 10.1016/j.jor.2018.01.026; Goel A, 2015, J ARTHROPLASTY, V30, P743, DOI 10.1016/j.arth.2014.11.012; Heckmann N, 2018, J BONE JOINT SURG AM, V100, DOI 10.2106/JBJS.18.00078; IGLIC A, 1993, CLIN BIOMECH, V8, P223, DOI 10.1016/0268-0033(93)90019-E; Iglic A., 1990, ACTA ORTHOP IUGOSL, V20, P35; Iglic Ales, 2002, Comput Methods Biomech Biomed Engin, V5, P185, DOI 10.1080/10255840290010300; Ike H, 2018, J BONE JOINT SURG AM, V100, P1606, DOI 10.2106/JBJS.17.00403; Ipavec M, 1999, J BIOMECH, V32, P1229, DOI 10.1016/S0021-9290(99)00119-0; Kim YH, 2009, J ARTHROPLASTY, V24, P1258, DOI 10.1016/j.arth.2009.03.017; Kluess D, 2007, MED ENG PHYS, V29, P465, DOI 10.1016/j.medengphy.2006.07.001; Kosak R, 2003, SKELETAL RADIOL, V32, P679, DOI 10.1007/s00256-003-0685-2; Kosak R, 2011, CLIN ORTHOP RELAT R, V469, P3415, DOI 10.1007/s11999-011-2078-5; Kralj M, 2005, ACTA ORTHOP, V76, P833, DOI 10.1080/17453670510045453; Kralj-Iglic V, 2015, OSTEOARTHRITIS PROGR; Kralj-Iglic V, 2012, APPL BIOL ENG PRINCI; KREIN S W, 1984, Journal of Orthopaedic Research, V2, P356, DOI 10.1002/jor.1100020408; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217, DOI 10.2106/00004623-197860020-00014; Mavcic B, 2002, J ORTHOP RES, V20, P1025, DOI 10.1016/S0736-0266(02)00014-1; Mavcic B, 2008, CLIN ORTHOP RELAT R, V466, P884, DOI 10.1007/s11999-008-0145-3; Moriarity Andrew, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-210282; Nadzadi ME, 2003, J BIOMECH, V36, P577, DOI 10.1016/S0021-9290(02)00232-4; NHS Digital, FIN PAT REP OUTC MEA; Parvizi J, 2006, CLIN ORTHOP RELAT R, P66, DOI 10.1097/01.blo.0000218751.14989.a6; Pompe B, 2003, MED ENG PHYS, V25, P379, DOI 10.1016/S1350-4533(03)00014-6; Pompe B, 2002, CELL MOL BIOL LETT, V7, P144; Recnik G, 2007, CLIN BIOMECH, V22, P1119, DOI 10.1016/j.clinbiomech.2007.08.002; Recnik G, 2009, J INT MED RES, V37, P1620, DOI 10.1177/147323000903700541; Rijavec B, 2015, COMPUT METHOD BIOMEC, V18, P1468, DOI 10.1080/10255842.2014.916700; Rowan FE, 2018, J ARTHROPLASTY, V33, P1316, DOI 10.1016/j.arth.2018.01.047; Scifert CF, 1999, CLIN BIOMECH, V14, P697, DOI 10.1016/S0268-0033(99)00054-6; Sikes C Van, 2008, J Arthroplasty, V23, P59, DOI 10.1016/j.arth.2008.06.032; Soong M, 2004, J AM ACAD ORTHOP SUR, V12, P314, DOI 10.5435/00124635-200409000-00006; Tanino H, 2007, J ORTHOP RES, V25, P1401, DOI 10.1002/jor.20410; Yoon YS, 2008, CLIN BIOMECH, V23, P253, DOI 10.1016/j.clinbiomech.2007.10.014	45	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225459	10.1371/journal.pone.0225459	http://dx.doi.org/10.1371/journal.pone.0225459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747433	Green Published, gold			2022-12-26	WOS:000533881900045
J	Harvey, NR; Albury, CL; Stuart, S; Benton, MC; Eccles, DA; Connell, JR; Sutherland, HG; Allcock, RJN; Lea, RA; Haupt, LM; Griffiths, R				Harvey, N. R.; Albury, C. L.; Stuart, S.; Benton, M. C.; Eccles, D. A.; Connell, J. R.; Sutherland, H. G.; Allcock, R. J. N.; Lea, R. A.; Haupt, L. M.; Griffiths, R.			Ion torrent high throughput mitochondrial genome sequencing (HTMGS)	PLOS ONE			English	Article							GUIDELINES; DISCOVERY; LINKAGE	The implementation and popularity of next generation sequencing (NGS) has led to the development of various rapid whole mitochondrial genome sequencing techniques. We summarise an efficient and cost-effective NGS approach for mitochondrial genomic DNA in humans using the Ion Torrent platform, and further discuss our bioinformatics pipeline for streamlined variant calling. Ion 316 chips were utilised with the Ion Torrent semi-conductor platform Personal Genome Machine (PGM) to perform tandem sequencing of mitochondrial genomes from the core pedigree (n = 315) of the Norfolk Island Health Study. Key improvements from commercial methods focus on the initial PCR step, which currently requires extensive optimisation to ensure the accurate and reproducible elongation of each section of the complete mitochondrial genome. Dual-platform barcodes were incorporated into our protocol thereby extending its potential application onto Illumina-based systems. Our bioinformatics pipeline consists of a modified version of GATK best practices tailored for mitochondrial genomic data. When compared with current commercial methods, our method, termed high throughput mitochondrial genome sequencing (HTMGS), allows high multiplexing of samples and the use of alternate library preparation reagents at a lower cost per sample (similar to 1.7 times) when compared to current commercial methodologies. Our HTMGS methodology also provides robust mitochondrial sequencing data (>450X average coverage) that can be applied and modified to suit various study designs. On average, we were able to identify similar to 30 variants per sample with 572 variants observed across 315 samples. We have developed a high throughput sequencing and analysis method targeting complete mitochondrial genomes; with the potential to be platform agnostic with analysis options that adhere to current best practices.	[Harvey, N. R.; Albury, C. L.; Stuart, S.; Benton, M. C.; Eccles, D. A.; Connell, J. R.; Sutherland, H. G.; Lea, R. A.; Haupt, L. M.; Griffiths, R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Biomed Sci, Genom Res Ctr, Brisbane, Qld, Australia; [Harvey, N. R.] Bond Univ, Hlth Sci & Med Fac, Robina, Qld, Australia; [Allcock, R. J. N.] Univ Western Australia M504, Sch Biomed Sci, Crawley, WA, Australia; [Stuart, S.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Benton, M. C.] Inst Environm Sci & Res, Human Genom Hlth & Environm Grp, Wellington, New Zealand	Queensland University of Technology (QUT); Bond University; University of Western Australia; Peter Maccallum Cancer Center; Institute of Environmental Science & Research (ESR) - New Zealand	Griffiths, R (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Biomed Sci, Genom Res Ctr, Brisbane, Qld, Australia.	lyn.griffiths@qut.edu.au	Connell, Jasmine/AAY-7288-2020; Harvey, Nicholas/ABF-6795-2021	Connell, Jasmine/0000-0003-4155-5750; Harvey, Nicholas/0000-0003-2035-8475; Haupt, Larisa/0000-0002-7735-8110; Lea, Rodney/0000-0002-1148-5862; Sutherland, Heidi/0000-0002-8512-1498	Australian National Health and Medical Research Council (NHMRC) [APP1083450]; Australian International Science Linkages grant; National Collaborative Research Infrastructure Strategy (NCRIS) government funding; Bond University; Corbett Postgraduate Research Grant	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian International Science Linkages grant(Australian GovernmentDepartment of Industry, Innovation and Science); National Collaborative Research Infrastructure Strategy (NCRIS) government funding; Bond University; Corbett Postgraduate Research Grant	This work was supported by funding from the Australian National Health and Medical Research Council (NHMRC) project grant [APP1083450 to LRG] and by an Australian International Science Linkages grant and by infrastructure purchased with Australian Government EIF Super Science Funds as part of the Therapeutic Innovation Australia - Queensland Node project with equipment, staff and reagents supported by National Collaborative Research Infrastructure Strategy (NCRIS) government funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge the Norfolk Island individuals who have generously donated their DNA samples and time to participate in this research study and for the ongoing community support which aids our work. NRH was the recipient of a Bond University postgraduate student scholarship for tuition fees and living allowance. MCB was supported by a Corbett Postgraduate Research Grant.	Abicht A, 2018, MOL GENET GENOM MED, V6, P1188, DOI 10.1002/mgg3.500; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ballard D, 2016, METHODS MOL BIOL, V1420, P143, DOI 10.1007/978-1-4939-3597-0_12; Barshad G, 2018, TRENDS GENET; Bellis C, 2005, HUM HERED, V60, P211, DOI 10.1159/000090545; Benton MC, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0029-8; Benton MC, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0028-9; Benton MC, 2013, AM J HUM GENET, V93, P1087, DOI 10.1016/j.ajhg.2013.11.004; Cox HC, 2009, HUM HERED, V68, P55, DOI 10.1159/000210449; De Fanti S, 2016, MITOCHONDRIAL DNA A, P1; Deiner Kristy, 2017, Methods in Ecology and Evolution, V8, P1888; Diroma MA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S3-S2; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Holland MM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030124; Jennings LJ, 2017, J MOL DIAGN, V19, P341, DOI 10.1016/j.jmoldx.2017.01.011; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matthijs G, 2016, EUR J HUM GENET, V24, P2, DOI 10.1038/ejhg.2015.226; Parson W, 2013, FORENSIC SCI INT-GEN, V7, P632, DOI 10.1016/j.fsigen.2013.09.007; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rocha AD, 2018, J FORENSIC SCI, V63, P536, DOI 10.1111/1556-4029.13552; Seo SB, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S1-S4; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Stenton SL, 2018, ESSAYS BIOCH; Theunissen TEJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00400; Wang J, 2012, GENET MED, V14, P620, DOI 10.1038/gim.2012.4; Zascavage RR, 2019, ELECTROPHORESIS, V40, P272, DOI 10.1002/elps.201800083; Zole E, 2018, MITOCHONDRIAL DNA A, V29, P431, DOI 10.1080/24701394.2017.1303490	30	9	9	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224847	10.1371/journal.pone.0224847	http://dx.doi.org/10.1371/journal.pone.0224847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730669	Green Published, gold			2022-12-26	WOS:000532809500010
J	Ito, H; Tsunoda, T; Riku, M; Inaguma, S; Inoko, A; Murakami, H; Ikeda, H; Matsuda, M; Kasai, K				Ito, Hideaki; Tsunoda, Takumi; Riku, Miho; Inaguma, Shingo; Inoko, Akihito; Murakami, Hideki; Ikeda, Hiroshi; Matsuda, Michiyuki; Kasai, Kenji			Indispensable role of STIL in the regulation of cancer cell motility through the lamellipodial accumulation of ARHGEF7-PAK1 complex	ONCOGENE			English	Article							CENTRIOLE DUPLICATION; PAK; MEMBRANE; MIGRATION; CDC42; PROMOTES; RAC1; PLK4; CENTROSOME; ACTIVATION	Cell motility is a tightly regulated phenomenon that supports the accurate formation of organ structure during development and homeostasis, including wound healing and inflammation. Meanwhile, cancer cells exhibit dysregulated motility, which causes spreading and invasion. The Dbl family RhoGEF ARHGEF7/beta-PIX and its binding partner p21-activated kinase PAK1 are overexpressed in a variety of cancers and have been shown to be responsible for cancer cell migration. A key step in motility is the intracellular transport of ARHGEF7-PAK1 complex to the migrating front of cells, where lamellipodia protrusion and cytoskeletal remodeling efficiently occur. However, the molecular mechanisms of the intracellular transport of this complex are not fully understood. Here we revealed that SCL/TAL1-interrupting locus (STIL) is indispensable for the efficient migration of cancer cells. STIL forms a ternary complex with ARHGEF7 and PAK1 and accumulates with those proteins at the lamellipodia protrusion of motile cells. Knockdown of STIL impedes the accumulation of ARHGEF7-PAK1 complex within membrane ruffles and attenuates the phosphorylation of PAK1 substrates and cortical actin remodeling at the migrating front. Intriguingly, ARHGEF7 knockdown also diminishes STIL and PAK1 accumulation in membrane ruffles. Either STIL or ARHGEF7 knockdown impedes cell migration and Rac1 activity at the migrating front of cells. These results indicate that STIL is involved in the ARHGEF7-mediated positive-feedback activation of cytoskeletal remodeling through accumulating the ARHGEF7-PAK1 complex in lamellipodia. We conclude that its involvement is crucial for the polarized formation of Rac1-mediated leading edge, which supports the efficient migration of cancer cells.	[Ito, Hideaki; Tsunoda, Takumi; Riku, Miho; Inaguma, Shingo; Inoko, Akihito; Murakami, Hideki; Ikeda, Hiroshi; Kasai, Kenji] Aichi Med Univ, Dept Pathol, Sch Med, Nagakute, Aichi, Japan; [Matsuda, Michiyuki] Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Kyoto, Japan	Aichi Medical University; Kyoto University	Kasai, K (corresponding author), Aichi Med Univ, Dept Pathol, Sch Med, Nagakute, Aichi, Japan.	kkasai@aichi-med-u.ac.jp	Riku, Miho/GPP-3435-2022	Riku, Miho/0000-0002-1799-5839; Kasai, Kenji/0000-0001-6566-9483	JSPS KAKENHI [16K19091, 17K08706, 19K06671, 18K07031, 16H06280, 15H05949, 24590456, 19K07449]; Pancreas Research Foundation of Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan)	We thank Norika Yamada, Kazuko Tanimizu, and Minako Suzuki for their excellent technical assistance and Tatsuhito Miyake and Yuji Nakagomi for laser confocal microscope. We also thank Yukiko Kuru (Faculty of Foreign Languages, Aichi Medical University School of Medicine) for English editing. This study was supported in part by JSPS KAKENHI Grant Number 16K19091 (HI), 17K08706 (SI), 19K06671 (AI), 18K07031 (HM), 16H06280 "ABiS" (MM), 15H05949 "Resonance Bio" (MM), 24590456 and 19K07449 (KK); Pancreas Research Foundation of Japan (HI).	APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; Arquint C, 2012, J CELL SCI, V125, P1342, DOI 10.1242/jcs.099887; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Bustelo Xose R, 2012, Small GTPases, V3, P60, DOI 10.4161/sgtp.19111; Byrne KM, 2016, CELL SYST, V2, P38, DOI 10.1016/j.cels.2016.01.003; Castro-Castro A, 2011, EMBO J, V30, P3913, DOI 10.1038/emboj.2011.310; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; Erez A, 2004, ONCOGENE, V23, P5371, DOI 10.1038/sj.onc.1207685; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kasai K, 2008, CANCER RES, V68, P7723, DOI 10.1158/0008-5472.CAN-07-6661; Kazazian K, 2017, CANCER RES, V77, P434, DOI 10.1158/0008-5472.CAN-16-2060; Koh CG, 2001, J CELL SCI, V114, P4239; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Kumar R, 2017, GENE, V605, P20, DOI 10.1016/j.gene.2016.12.014; Kunida K, 2012, J CELL SCI, V125, P2381, DOI 10.1242/jcs.096859; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; Li F, 2002, EMBO REP, V3, P767, DOI 10.1093/embo-reports/kvf157; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Nigg EA, 2018, NAT REV MOL CELL BIO, V19, P297, DOI 10.1038/nrm.2017.127; Nola S, 2008, HUM MOL GENET, V17, P3552, DOI 10.1093/hmg/ddn248; Ohta M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6267; Omelchenko T, 2014, GENE DEV, V28, P2764, DOI 10.1101/gad.251371.114; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Patwardhan D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0101-9; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Rabinowicz N, 2017, ONCOTARGET, V8, P27380, DOI 10.18632/oncotarget.16068; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rane CK, 2019, SEMIN CANCER BIOL, V54, P40, DOI 10.1016/j.semcancer.2018.01.006; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rosario CO, 2015, ONCOGENE, V34, P3441, DOI 10.1038/onc.2014.275; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schnoor M, 2018, TRENDS CELL BIOL, V28, P79, DOI 10.1016/j.tcb.2017.10.009; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Stevens NR, 2010, J CELL BIOL, V188, P313, DOI 10.1083/jcb.200910016; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; Wu XC, 2019, GENE, V686, P220, DOI 10.1016/j.gene.2018.11.048; Yamao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17527; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	44	8	8	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1931	1943		10.1038/s41388-019-1115-9	http://dx.doi.org/10.1038/s41388-019-1115-9			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31754215				2022-12-26	WOS:000516579800008
J	Salimi, H; Johnson, J; Flores, MG; Zhang, MS; O'Malley, Y; Houtman, JC; Schlievert, PM; Haim, H				Salimi, Hamid; Johnson, Jacklyn; Flores, Manuel G.; Zhang, Michael S.; O'Malley, Yunxia; Houtman, Jon C.; Schlievert, Patrick M.; Haim, Hillel			The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); virus entry; membrane lipid; antibody; protein conformation; protein stability; cholesterol; vaccine development; lipid raft; envelope glycoproteins; surface-acting agent	IMMUNODEFICIENCY-VIRUS TYPE-1; VIRION-ASSOCIATED CHOLESTEROL; HUMAN MONOCLONAL-ANTIBODY; GP41 CYTOPLASMIC TAIL; CD4-BOUND CONFORMATION; VAGINAL TRANSMISSION; PLASMA-MEMBRANE; CRAC SEGMENT; GP120; PROTEIN	The envelope glycoproteins (Envs) of HIV-1 are embedded in the cholesterol-rich lipid membrane of the virus. Chemical depletion of cholesterol from HIV-1 particles inactivates their infectivity. We observed that diverse HIV-1 strains exhibit a range of sensitivities to such treatment. Differences in sensitivity to cholesterol depletion could not be explained by variation in Env components known to interact with cholesterol, including the cholesterol-recognition motif and cytoplasmic tail of gp41. Using antibody-binding assays, measurements of virus infectivity, and analyses of lipid membrane order, we found that depletion of cholesterol from HIV-1 particles decreases the conformational stability of Env. It enhances exposure of partially cryptic epitopes on the trimer and increases sensitivity to structure-perturbing treatments such as antibodies and cold denaturation. Substitutions in the cholesterol-interacting motif of gp41 induced similar effects as depletion of cholesterol. Surface-acting agents, which are incorporated into the virus lipid membrane, caused similar effects as disruption of the Env-cholesterol interaction. Furthermore, substitutions in gp120 that increased structural stability of Env (i.e. induced a ?closed? conformation of the trimer) increased virus resistance to cholesterol depletion and to the surface-acting agents. Collectively, these results indicate a critical contribution of the viral membrane to the stability of the Env trimer and to neutralization resistance against antibodies. Our findings suggest that the potency of poorly neutralizing antibodies, which are commonly elicited in vaccinated individuals, may be markedly enhanced by altering the lipid composition of the viral membrane.	[Salimi, Hamid; Johnson, Jacklyn; Flores, Manuel G.; Zhang, Michael S.; O'Malley, Yunxia; Houtman, Jon C.; Schlievert, Patrick M.; Haim, Hillel] Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA	University of Iowa	Haim, H (corresponding author), Univ Iowa, Dept Microbiol & Immunol, 51 Newton Rd,3-770 BSB, Iowa City, IA 52242 USA.	Hillel-haim@uiowa.edu		Haim, Hillel/0000-0002-6071-5089; Houtman, Jon/0000-0002-5307-9854	University of Iowa Research Foundation (UIRF) Iowa Centers for Enterprise (ICE) Fund Award; Department of Microbiology and Immunology, the University of Iowa	University of Iowa Research Foundation (UIRF) Iowa Centers for Enterprise (ICE) Fund Award; Department of Microbiology and Immunology, the University of Iowa	This work was supported by the University of Iowa Research Foundation (UIRF) Iowa Centers for Enterprise (ICE) Fund Award (to H. H.) as well as a Development Grant from the Department of Microbiology and Immunology, the University of Iowa (to H. H.). Dr. Schlievert is co-founder of a small business, Hennepin Life Sciences, which has licensed a patent awarded to the University of Minnesota for the development of glycerol monolaurate (GML) to treat vaginal bacterial infections. Dr. Schlievert receives no salary or consulting support from Hennepin Life Sciences, although he does have stock in the company. Dr. Schlievert is a co-inventor on the above GML patent awarded to the University of Minnesota. The title of this patent is Compositions and Methods for Controlling Infections (US 8796332 B2). The authors confirm that the patent and stock do not alter adherence to all Journal of Biological Chemistry policies on sharing data and materials. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablan S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-104; Affranchino JL, 2006, VIROLOGY, V347, P217, DOI 10.1016/j.virol.2005.11.032; Alexandre KB, 2016, VIROLOGY, V497, P69, DOI 10.1016/j.virol.2016.07.004; Ali A, 2000, VIROLOGY, V276, P289, DOI 10.1006/viro.2000.0556; Ambrose Z, 2008, J VIROL, V82, P6591, DOI 10.1128/JVI.02730-07; [Anonymous], 1998, NUMBERING POSITIONS; Apel-Paz M, 2003, LANGMUIR, V19, P591, DOI 10.1021/la020723r; Arriaga LR, 2017, ADV COLLOID INTERFAC, V247, P514, DOI 10.1016/j.cis.2017.07.007; Ball C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049792; Beer BE, 2006, ANTIMICROB AGENTS CH, V50, P713, DOI 10.1128/AAC.50.2.713-723.2006; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Bourinbaiar AS, 1996, AIDS, V10, P558, DOI 10.1097/00002030-199605000-00024; Brandano L, 2012, J VIROL, V86, P2347, DOI 10.1128/JVI.06047-11; Bromfield EG, 2014, REPRODUCTION, V147, P153, DOI 10.1530/REP-13-0393; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Chen SSL, 2009, J VIROL, V83, P870, DOI 10.1128/JVI.01088-08; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; DeLeon O, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001549; Dinic J, 2011, BBA-BIOMEMBRANES, V1808, P298, DOI 10.1016/j.bbamem.2010.10.002; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RF, 2005, BIOCHEMISTRY-US, V44, P5525, DOI 10.1021/bi0500224; Etemad-Moghadam B, 2000, J VIROL, V74, P4433, DOI 10.1128/JVI.74.9.4433-4440.2000; Etemad-Moghadam B, 2002, VACCINE, V20, P1934, DOI 10.1016/S0264-410X(02)00072-5; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Freitas MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015756; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Greenwood AI, 2008, BBA-BIOMEMBRANES, V1778, P1120, DOI 10.1016/j.bbamem.2008.01.008; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; HAFFAR OK, 1991, VIROLOGY, V180, P439, DOI 10.1016/0042-6822(91)90054-F; Haim H, 2013, CELL HOST MICROBE, V14, P547, DOI 10.1016/j.chom.2013.10.006; Haim H, 2013, J VIROL, V87, P1884, DOI 10.1128/JVI.02765-12; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Hammonds J, 2003, VIROLOGY, V314, P636, DOI 10.1016/S0042-6822(03)00467-7; HATCH WC, 1992, J IMMUNOL, V148, P3055; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jin L, 2005, BIOPHYS J, V89, pL4, DOI 10.1529/biophysj.105.064816; Johnson J, 2017, J VIROL, V91, DOI 10.1128/JVI.00174-17; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kassa A, 2009, J VIROL, V83, P4476, DOI 10.1128/JVI.02110-08; Kawano N, 2011, J LIPIDS, V2011, DOI 10.1155/2011/264706; Khanna KV, 2002, J CLIN INVEST, V109, P205; Kim IS, 2017, P NATL ACAD SCI USA, V114, pE28, DOI 10.1073/pnas.1618883114; Kirtane AR, 2017, J PHARM SCI-US, V106, P1821, DOI 10.1016/j.xphs.2017.03.030; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Mayr LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01590; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; McGee K, 2014, J VIROL, V88, P21, DOI 10.1128/JVI.01558-13; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Munro JB, 2015, J VIROL, V89, P5752, DOI 10.1128/JVI.03187-14; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nieto-Garai JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01983; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Owen DM, 2006, BIOPHYS J, V90, pL80, DOI 10.1529/biophysj.106.084673; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Paladino S, 2002, INT J MED MICROBIOL, V291, P439; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Schwarzer R, 2014, CELL MICROBIOL, V16, P1565, DOI 10.1111/cmi.12314; Sezgin E, 2014, LANGMUIR, V30, P8160, DOI 10.1021/la501226v; Shadan S, 2004, BIOL REPROD, V71, P253, DOI 10.1095/biolreprod.103.026435; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Simon JHM, 1997, J VIROL, V71, P5259, DOI 10.1128/JVI.71.7.5259-5267.1997; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; SULLIVAN N, 1995, J VIROL, V69, P4413, DOI 10.1128/JVI.69.7.4413-4422.1995; Sundaram RVK, 2016, BIOCHEMISTRY-US, V55, P447, DOI 10.1021/acs.biochem.5b00936; Tedbury PR, 2014, TRENDS MICROBIOL, V22, P372, DOI 10.1016/j.tim.2014.04.012; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Viard M, 2008, BIOCHEMISTRY-US, V47, P1977, DOI 10.1021/bi701920f; Vincent N, 2002, BBA-BIOMEMBRANES, V1567, P157, DOI 10.1016/S0005-2736(02)00611-9; Vincent S, 2000, J VIROL, V74, P9911, DOI 10.1128/JVI.74.21.9911-9915.2000; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P11869, DOI 10.1021/bi8014828; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P124, DOI 10.1021/bi7018892; Waheed AA, 2007, P NATL ACAD SCI USA, V104, P8467, DOI 10.1073/pnas.0701443104; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Wilen CB, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006866; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Yang PL, 2010, J VIROL, V84, P59, DOI 10.1128/JVI.00899-09; Yang ST, 2016, CHEM PHYS LIPIDS, V199, P136, DOI 10.1016/j.chemphyslip.2016.05.003; Ye L, 2004, J VIROL, V78, P13409, DOI 10.1128/JVI.78.24.13409-13419.2004; Yuan W, 2006, J VIROL, V80, P6725, DOI 10.1128/JVI.00118-06; Zhang MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30225	115	25	26	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					348	362		10.1074/jbc.RA119.009481	http://dx.doi.org/10.1074/jbc.RA119.009481			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31757809	Green Published, hybrid			2022-12-26	WOS:000507373600008
J	Shi, JF; Hu, XY; Guo, Y; Wang, LH; Ji, J; Li, JQ; Zhang, ZR				Shi, Junfen; Hu, Xianyan; Guo, Yuan; Wang, Linhan; Ji, Jia; Li, Jiqiang; Zhang, Zai-Rong			A technique for delineating the unfolding requirements for substrate entry into retrotranslocons during endoplasmic reticulum?associated degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ER-associated degradation; ER quality control; E3 ubiquitin ligase; protein misfolding; ubiquitylation (ubiquitination); membrane enzyme; dihydrofolate reductase; ER-to-cytosol transport; retrotranslocation; tunable folding domain; unfolded substrate	DIHYDROFOLATE-REDUCTASE; PROTEIN-DEGRADATION; UBIQUITIN; RETICULUM; PROTEASOME; ERAD; COMPLEX; BINDING; IMPORT; DOMAIN	The endoplasmic reticulum?associated degradation (ERAD) pathway mediates the endoplasmic reticulum?to?cytosol retrotranslocation of defective proteins through protein complexes called retrotranslocons. Defective proteins usually have complex conformations and topologies, and it is unclear how ERAD can thread these conformationally diverse protein substrates through the retrotranslocons. Here, we investigated the substrate conformation flexibility necessary for transport via retrotranslocons on the ERAD-L, ERAD-M, and HIV-encoded protein Vpu-hijacked ERAD branches. To this end, we appended various ERAD substrates with specific domains whose conformations were tunable in flexibility or tightness by binding to appropriate ligands. With this technique, we could define the capacity of specific retrotranslocons in disentangling very tight, less tight but well-folded, and unstructured conformations. The Hrd1 complex, the retrotranslocon on the ERAD-L branch, permitted the passage of substrates with a proteinase K?resistant tight conformation, whereas the E3 ligase gp78-mediated ERAD-M allowed passage only of nearly completely disordered but not well-folded substrates and thus may have the least unfoldase activity. Vpu-mediated ERAD, containing a potential retrotranslocon, could unfold well-folded substrates for successful retrotranslocation. However, substrate retrotranslocation in Vpu-mediated ERAD was blocked by enhanced conformational tightness of the substrate. On the basis of these findings, we propose a mechanism underlying polypeptide movement through the endoplasmic reticulum membrane. We anticipate that our biochemical system paves the way for identifying the factors necessary for the retrotranslocation of membrane proteins.	[Shi, Junfen; Hu, Xianyan; Guo, Yuan; Wang, Linhan; Ji, Jia; Li, Jiqiang; Zhang, Zai-Rong] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 201210, Peoples R China; [Shi, Junfen; Hu, Xianyan; Guo, Yuan; Wang, Linhan; Ji, Jia; Li, Jiqiang; Zhang, Zai-Rong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, ZR (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 201210, Peoples R China.	zrzhang@sioc.ac.cn		ZHANG, ZAIRONG/0000-0001-9768-0548	National Key RAMP;D Program of China [2016YFA0501903]; National Natural Science Foundation of China [31670780]	National Key RAMP;D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China Grant 2016YFA0501903 and National Natural Science Foundation of China Grant 31670780. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; [Anonymous], 2019, SCIENCE; ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; Baldridge RD, 2016, CELL, V166, P394, DOI 10.1016/j.cell.2016.05.048; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Berner N, 2018, ANNU REV BIOCHEM, V87, P751, DOI 10.1146/annurev-biochem-062917-012749; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHEN MY, 1993, J VIROL, V67, P3877, DOI 10.1128/JVI.67.7.3877-3884.1993; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Cooney I, 2019, SCIENCE, V365, P502, DOI 10.1126/science.aax0486; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Emerman AB, 2010, MOL BIOL CELL, V21, P4325, DOI 10.1091/mbc.E10-09-0742; ENDO T, 1994, EUR J BIOCHEM, V225, P403, DOI 10.1111/j.1432-1033.1994.00403.x; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ganesan I, 2018, PLANT CELL, V30, P2161, DOI 10.1105/tpc.18.00427; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Jain P, 2018, CELL REP, V22, P2493, DOI 10.1016/j.celrep.2018.01.091; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Keusekotten K, 2006, J BIOL CHEM, V281, P17545, DOI 10.1074/jbc.M602360200; Liu Y, 2019, NAT MICROBIOL, V4, P813, DOI 10.1038/s41564-019-0372-2; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mehrtash AB, 2019, SEMIN CELL DEV BIOL, V93, P111, DOI 10.1016/j.semcdb.2018.09.013; Morito D, 2015, MOL CELL, V59, P335, DOI 10.1016/j.molcel.2015.06.010; Needham PG, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033928; Nery FC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1383; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Petris G, 2014, J BIOL CHEM, V289, P1, DOI 10.1074/jbc.M113.512368; Plumb R, 2015, ELIFE, V4, DOI 10.7554/eLife.07426; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salvador N, 2000, J BIOL CHEM, V275, P27447; SASSO SP, 1994, BBA-PROTEIN STRUCT M, V1207, P74, DOI 10.1016/0167-4838(94)90053-1; Schoebel S, 2017, NATURE, V548, P352, DOI 10.1038/nature23314; Sellmyer MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043297; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wu XD, 2018, CURR OPIN CELL BIOL, V53, P22, DOI 10.1016/j.ceb.2018.04.004; Zhang ZR, 2013, CELL, V154, P609, DOI 10.1016/j.cell.2013.06.038; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104; Zhou HJ, 2015, J MED CHEM, V58, P9480, DOI 10.1021/acs.jmedchem.5b01346	55	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20084	20096		10.1074/jbc.RA119.010019	http://dx.doi.org/10.1074/jbc.RA119.010019			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748412	Green Published, hybrid			2022-12-26	WOS:000505005800021
J	Jiang, MH; Li, PC; You, JHS; Zheng, XL; Deng, JZ; Zhao, MY; Feng, LX; Fang, Y				Jiang, Minghuan; Li, Pengchao; You, Joyce Hoi-sze; Zheng, Xinglong; Deng, Jizhao; Zhao, Mingyue; Feng, Liuxin; Fang, Yu			Cost-effectiveness analysis of aspirin for primary prevention of cardiovascular events among patients with type 2 diabetes in China	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; BENEFIT; DISEASE; CLOPIDOGREL; THERAPY	The use of aspirin for primary prevention of cardiovascular disease (CVD) in patients with diabetes mellitus (DM) is associated with lower rates of cardiovascular events but increased risks of bleeding complications. We aimed to examine the cost-effectiveness of aspirin therapy for primary prevention of CVD in Chinese DM patients. A life-long Markov model was developed to compare aspirin therapy (100mg daily) versus no use of aspirin in DM patients with no history of CVD. Model validation was conducted by comparing the simulated event rates with data reported in a clinical trial. Direct medical costs and quality-adjusted life-years gained (QALYs) were the primary outcomes from the perspective of healthcare system in China. Sensitivity analyses were performed to examine the uncertainty of model inputs. Base-case analysis showed aspirin therapy was more costly (USD1,086 versus USD819) with higher QALYs gained (11.94 versus 11.86 QALYs) compared to no use of aspirin. The base-case results were sensitive to the odds ratio of all-cause death in aspirin therapy versus no use of aspirin. Probabilistic sensitivity analysis found that aspirin therapy gained an additional 0.066 QALYs (95% CI: -0.167 QALYs-0.286 QALYs) at higher cost by USD352 (95% CI: USD130-644)). Using 30,000 USD/QALY as willingness-to-pay threshold, aspirin therapy and no use of aspirin were the preferred option in 68.71% and 31.29% of 10,000 Monte Carlo simulations, respectively. In conclusion, aspirin therapy appears to be cost-effective compared with no use of aspirin in primary prevention of CVD in Chinese DM patients.	[Jiang, Minghuan; Li, Pengchao; Zhao, Mingyue; Fang, Yu] Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Peoples R China; [Jiang, Minghuan; Li, Pengchao; Zhao, Mingyue; Fang, Yu] Xi An Jiao Tong Univ, Ctr Drug Safety & Policy Res, Xian, Peoples R China; [You, Joyce Hoi-sze] Chinese Univ Hong Kong, Fac Med, Sch Pharm, Shatin, Hong Kong, Peoples R China; [Zheng, Xinglong] Xi An Jiao Tong Univ, Dept Cardiovasc Surg, Affiliated Hosp 1, Xian, Peoples R China; [Deng, Jizhao] Shaanxi Prov Peoples Hosp, Dept Cardiovasc Med, Xian, Peoples R China; [Feng, Liuxin] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Pharm, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Chinese University of Hong Kong; Xi'an Jiaotong University; Xi'an Medical University; Xi'an Jiaotong University	Fang, Y (corresponding author), Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Peoples R China.; Fang, Y (corresponding author), Xi An Jiao Tong Univ, Ctr Drug Safety & Policy Res, Xian, Peoples R China.	yufang@xjtu.edu.cn	You, Joyce H. S./C-2984-2008	You, Joyce H. S./0000-0002-5763-7403	China Postdoctoral Science Foundation [2018M631179]; Central University Basic Research Fund [2015qngz05]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Central University Basic Research Fund	This work was supported by the China Postdoctoral Science Foundation (http://www.chinapostdoctor.org.cn/WebSite/program/Default.aspx) under award number 2018M631179 [PI M Jiang] and supported by the Central University Basic Research Fund (http://www.xjtu.edu.cn/) under award number 2015qngz05 [PI Y Fang]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the funding support from the China Postdoctoral Science Foundation (2018M631179) and the Central University Basic Research Fund (2015qngz05).	Annemans Lieven, 2010, J Med Econ, V13, P418, DOI 10.3111/13696998.2010.499731; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.010]; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Bonaventura A, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.13001; Bowman L, 2018, NEW ENGL J MED, V379, P1529, DOI 10.1056/NEJMoa1804988; Briggs A, 2008, DECISION MODELLING H; Chang San-Shuai, 2018, Chronic Dis Transl Med, V4, P127, DOI 10.1016/j.cdtm.2018.01.001; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Dehmer SP, 2017, ANN FAM MED, V15, P23, DOI 10.1370/afm.2015; Gaziano JM, 2018, LANCET, V392, P1036, DOI 10.1016/S0140-6736(18)31924-X; Greving JP, 2008, CIRCULATION, V117, P2875, DOI 10.1161/CIRCULATIONAHA.107.735340; Guzauskas GF, 2012, CLIN PHARMACOL THER, V91, P829, DOI 10.1038/clpt.2011.303; International Monetary Fund. People's Republic of China, 2019, COUNRT NEWS GLANC; Ito K, 2015, CIRC-CARDIOVASC QUAL, V8, P252, DOI 10.1161/CIRCOUTCOMES.114.001330; Kunutsor SK, 2017, DIABETIC MED, V34, P316, DOI 10.1111/dme.13133; Lamotte M, 2006, PHARMACOECONOMICS, V24, P155, DOI 10.2165/00019053-200624020-00005; Leggio M, 2018, DIABETES METAB, V44, P217, DOI 10.1016/j.diabet.2017.11.002; Li T, 2018, ADV THER, V35, P2214, DOI 10.1007/s12325-018-0823-9; Mahmoud AN, 2019, EUR HEART J, V40, P607, DOI 10.1093/eurheartj/ehy813; Main C, 2004, HEALTH TECHNOL ASSES, V8, P1; McNeil JJ, 2018, NEW ENGL J MED, V379, P1509, DOI 10.1056/NEJMoa1805819; Michaud TL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002321; National Health Commission of the People's Republic of China, 2018, CHIN HLTH STAT YB 20; Nikolic E, 2013, EUR HEART J, V34, P220, DOI 10.1093/eurheartj/ehs149; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Pan CW, 2016, MED DECIS MAKING, V36, P234, DOI 10.1177/0272989X15606903; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Pignone M, 2013, J GEN INTERN MED, V28, P1483, DOI 10.1007/s11606-013-2465-6; Pignone M, 2010, CIRCULATION, V121, P2694, DOI 10.1161/CIR.0b013e3181e3b133; Shen XH, 2016, ENDOCR PRACT, V22, P1119, DOI 10.4158/EP161199.RA; Shiffman D, 2012, CLIN THER, V34, P1387, DOI 10.1016/j.clinthera.2012.04.004; Tolla MT, 2016, COST EFFECT RESOUR A, V14, DOI 10.1186/s12962-016-0059-y; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056459; Weng JP, 2016, DIABETES-METAB RES, V32, P442, DOI 10.1002/dmrr.2827; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	35	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224580	10.1371/journal.pone.0224580	http://dx.doi.org/10.1371/journal.pone.0224580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790409	Green Published, gold			2022-12-26	WOS:000533930800009
J	Peixoto, LAW; Datovo, A; Campos-da-Paz, R; de Santana, CD; Menezes, NA				Peixoto, Luiz A. W.; Datovo, Alessio; Campos-da-Paz, Ricardo; de Santana, Carlos D.; Menezes, Naercio A.			Anatomical, taxonomic, and phylogenetic reappraisal of a poorly known ghost knifefish, Tembeassu marauna (Ostariophysi: Gymnotiformes), using X-ray microcomputed tomography	PLOS ONE			English	Article							ELECTRIC KNIFEFISHES; SEXUAL-DIMORPHISM; APTERONOTIDAE; GENUS; TELEOSTEI; FISHES; DIVERSITY; ECOLOGY; BASIN	A detailed osteological study of the poorly known and critical endangered ghost knifefish, Tembeassu marauna, from the rio Parana, Brazil, was conducted using X-ray microcomputed tomography (mu CT scan). A redescription of the external anatomy was performed, including the unusual presence of a rostral patch of extra teeth on the region of the upper lip anterior to the premaxilla and the prominent anterior fleshy expansions in both upper and lower lips. The newly surveyed characters were included and analyzed in light of a recent morphological data matrix for Gymnotiformes. In spite of some uncertainties that remains as to phylogenetic allocation of the genus, the most probable hypothesis is that Tembeassu is the sister group of a clade that includes Megadontognathus and Apteronotus sensu stricto. The phylogenetic analysis also supports that Tembeassu is considered a valid genus of Apteronotidae. An amended diagnosis for the genus is also provided.	[Peixoto, Luiz A. W.; Datovo, Alessio; Menezes, Naercio A.] Univ Sao Paulo, Seca Peixes, Museu Zool, Sao Paulo, SP, Brazil; [Campos-da-Paz, Ricardo] Univ Fed Estado Rio de Janeiro, Ctr Ciencias Biol & Saude, Inst Biociencias, Rio De Janeiro, RJ, Brazil; [de Santana, Carlos D.] Smithsonian Inst, Natl Museum Nat Hist, Div Fishes, Dept Vertebrate Zool, Washington, DC 20560 USA	Universidade de Sao Paulo; Universidade Federal do Estado do Rio de Janeiro; Smithsonian Institution; Smithsonian National Museum of Natural History	Peixoto, LAW (corresponding author), Univ Sao Paulo, Seca Peixes, Museu Zool, Sao Paulo, SP, Brazil.	luizwp@yahoo.com.br	Menezes, Naercio A./K-8763-2013; Datovo, Alessio/ABA-1945-2021	Menezes, Naercio A./0000-0002-9634-6051; Datovo, Alessio/0000-0001-9117-7343; Peixoto, Luiz/0000-0002-7262-0239	Sao Paulo Research Foundation (FAPESP grants) [2018/05084-1, 2016/19075-9]	Sao Paulo Research Foundation (FAPESP grants)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by the Sao Paulo Research Foundation (FAPESP grants): 2018/05084-1 to LAWP, 2016/19075-9 to AD, CDS and NAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT J, 2003, CHECK LIST FRESHWATE, V2598, P1; Albert JS, 2006, ICHTHYOL EXPLOR FRES, V17, P267; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert JS, 2009, SYST BIODIVERS, V7, P81, DOI 10.1017/S1477200008002934; Albert JS, 2001, MISC PUBL MUS ZOOL U; Bernt MJ, 2019, MOL PHYLOGENET EVOL, V135, P297, DOI 10.1016/j.ympev.2019.02.019; Campos-da-Paz R, 1999, COPEIA, P1041; Campos-da-Paz Ricardo, 2005, Neotrop. ichthyol., V3, P395, DOI 10.1590/S1679-62252005000300007; CARR CE, 1982, J COMP NEUROL, V211, P139, DOI 10.1002/cne.902110204; Crampton W.G.R., 2006, COMMUNICATION FISHES, P647; Crampton W.G.R., 2007, FISH LIFE SPECIAL EN, P283; Crampton WG, 2013, PEIXES RIO MADEIRA, VIII, P257; Crampton WGR, 2019, AN ACAD BRA CIENC, V70, P805; Crampton WGR, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P165; Datovo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060846; Santana CD, 2013, ZOOL J LINN SOC-LOND, V168, P564, DOI 10.1111/zoj.12022; de Santana CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068719; De Santana CD, 2010, ZOOL J LINN SOC-LOND, V159, P223, DOI 10.1111/j.1096-3642.2009.00588.x; de Santana CD, 2009, COPEIA, P233, DOI 10.1643/CI-08-082; Fernandes CC, 2004, SCIENCE, V305, P1960, DOI 10.1126/science.1101240; Fernandes CC, 2002, COPEIA, P52, DOI 10.1643/0045-8511(2002)002[0052:LOAEFS]2.0.CO;2; Ferraris CJ, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20160067; Fink Sara V., 1996, P209, DOI 10.1016/B978-012670950-6/50012-6; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Franchina CR, 1996, BRAIN BEHAV EVOLUT, V47, P165, DOI 10.1159/000113236; Fricke R, 2020, ESCHMEYERS CATALOG F; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Hilton EJ, 2006, COPEIA, P826, DOI 10.1643/0045-8511(2006)6[826:SDIABG]2.0.CO;2; Hilton EL, 2007, P ACAD NAT SCI PHILA, V156, P1, DOI 10.1635/0097-3157(2007)156[1:ROOTBG]2.0.CO;2; HOPKINS CD, 1991, COPEIA, P151; ICMBIO-INSTITUTO CHICO MENDES DE CONSERVACAO DA BIODIVERSIDADE, 2018, LIVRO VERMELHO FAUNA, VIII; Ivanyisky SJ, 2014, NEOTROP ICHTHYOL, V12, P565, DOI 10.1590/1982-0224-20130159; Keeffe R, 2019, ZOOTAXA, V4555, P101, DOI 10.11646/zootaxa.4555.1.8; Kirschbaum F., 1995, ELECT FISHES HIST BE, P446; LOPEZ-ROJAS H, 1984, North American Journal of Fisheries Management, V4, P331, DOI 10.1577/1548-8659(1984)4<331:DAOOAS>2.0.CO;2; Lundberg JG, 1996, COPEIA, P657; Mago-Leccia F., 1985, CONTRIB SCI NAT HIST, V358, P1; Mago-Leccia F, 1994, BIBLIOTECA ACAD CIEN, V29, P1; MARRERO C, 1987, Revue d'Hydrobiologie Tropicale, V20, P57; MARRERO C, 1993, ENVIRON BIOL FISH, V38, P299, DOI 10.1007/BF00007523; Marrero C., 1991, BIOLLAN, V8, P123; Moller P., 1995, ELECT FISHES HIST BE; Py-Daniel Lúcia H. Rapp, 2005, Acta Amaz., V35, P97, DOI 10.1590/S0044-59672005000100015; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Tagliacollo VA, 2016, MOL PHYLOGENET EVOL, V95, P20, DOI 10.1016/j.ympev.2015.11.007; Triques Mauro L., 2005, Lundiana, V6, P121; Triques ML, 2011, VERTEBR ZOOL, V61, P299; Triques Mauro Luis, 1998, Revue Francaise d'Aquariologie Herpetologie, V25, P5; Triques Mauro Luis, 1993, Comunicacoes do Museu de Ciencias da PUCRS Serie Zoologia, V6, P85; Turner CR, 2007, J EXP BIOL, V210, P4104, DOI 10.1242/jeb.007930; Vari RP, 2012, ZOOL J LINN SOC-LOND, V165, P670, DOI 10.1111/j.1096-3642.2012.00827.x; VISCHER HA, 1989, J COMP NEUROL, V290, P16, DOI 10.1002/cne.902900103; Peixoto LAW, 2015, ZOOL J LINN SOC-LOND, V175, P384, DOI 10.1111/zoj.12274; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225	55	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225342	10.1371/journal.pone.0225342	http://dx.doi.org/10.1371/journal.pone.0225342			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774853	Green Published, gold			2022-12-26	WOS:000533896400031
J	Rozing, MP; Moller, A; Aabenhus, R; Siersma, V; Rasmussen, K; Koster-Rasmussen, R				Rozing, Maarten P.; Moller, Anne; Aabenhus, Rune; Siersma, Volkert; Rasmussen, Katja; Koster-Rasmussen, Rasmus			Changes in HbA(1c) during the first six years after the diagnosis of Type 2 diabetes mellitus predict long-term microvascular outcomes	PLOS ONE			English	Article							STRUCTURED PERSONAL CARE; FOLLOW-UP; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; RISK; MORTALITY; COMPLICATIONS; DYSGLYCAEMIA; COHORT	To analyze the association between change in HbA(1c) during the first 6 years after diagnosis of Type 2 diabetes mellitus (Type 2 DM) and incident micro- and macrovascular morbidity and mortality during 13 years thereafter. This is an observational study of the participants in the intervention arm of the randomized controlled trial Diabetes Care in General Practice (DCGP) in Denmark. 494 newly diagnosed persons with Type 2 DM aged 40 years and over with three or more measurements of HbA(1c) during six years of intervention were included in the analyses. Based on a regression line, fitted through the HbA(1c)-measurements from 1 to 6 years after diabetes diagnosis, glycaemic control was characterized by the one-year level of HbA(1c) after diagnosis, and the slope of the regression line. Outcomes were incident diabetes-related morbidity and mortality from 6 to 19 years after diabetes diagnosis. The association between change in HbA(1c) (the slope of the regression line) and clinical outcomes were assessed in adjusted Cox regression models. The median HbA(1c) level at year one was 60 (IQR: 52-71) mmol/mol or (7.65 (IQR: 6.91-8.62) %). Higher HbA(1c) levels one year after diagnosis were associated with a higher risk of later diabetes-related morbidity and mortality. An increase in HbA(1c) during the first 6 years after diabetes diagnosis was associated with later microvascular complications (HR per 1.1 mmol/mol or 0.1% point increase in HbA(1c) per year; 95% CI) = 1.14; 1.05-1.24). Change in HbA(1c) did not predict the aggregate outcome 'any diabetes-related endpoint, all-cause mortality, diabetes-related mortality, myocardial infarction, stroke, or peripheral vascular diseases. We conclude that suboptimal development of glycaemic control during the first 6 years after diabetes diagnosis was an independent risk factor for microvascular complications during the succeeding 13-year follow-up, but not for mortality or macrovascular complications.	[Rozing, Maarten P.; Moller, Anne; Aabenhus, Rune; Siersma, Volkert; Rasmussen, Katja; Koster-Rasmussen, Rasmus] Univ Copenhagen, Res Unit Gen Practice, Dept Publ Hlth, Copenhagen, Denmark; [Rozing, Maarten P.; Moller, Anne; Aabenhus, Rune; Siersma, Volkert; Rasmussen, Katja; Koster-Rasmussen, Rasmus] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Rozing, MP (corresponding author), Univ Copenhagen, Res Unit Gen Practice, Dept Publ Hlth, Copenhagen, Denmark.	mroz@sund.ku.dk	Rozing, Maarten/AHC-7454-2022; Siersma, Volkert/G-6867-2016	Moller, Anne/0000-0003-0179-4108; Koster-Rasmussen, Rasmus/0000-0002-6452-1839; Siersma, Volkert/0000-0003-1941-2681	Danish Medical Research Council; Danish Research Foundation for General Practice; Health Insurance Foundation; Danish Ministry of Health; Pharmacy Foundation; commercial source Novo Nordisk Farmaka Denmark Ltd.	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Research Foundation for General Practice; Health Insurance Foundation; Danish Ministry of Health; Pharmacy Foundation; commercial source Novo Nordisk Farmaka Denmark Ltd.	Major funding for this study was received from The Danish Medical Research Council, The Danish Research Foundation for General Practice, The Health Insurance Foundation, The Danish Ministry of Health and The Pharmacy Foundation. Additionally, funding was received from the commercial source Novo Nordisk Farmaka Denmark Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Cavero-Redondo I, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015949; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2010, DIABETOLOGIA, V53, P2509, DOI 10.1007/s00125-010-1871-0; Gerstein HC, 2005, DIABETOLOGIA, V48, P1749, DOI 10.1007/s00125-005-1858-4; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goff DC, 2007, AM J CARDIOL, V99, p4I, DOI 10.1016/j.amjcard.2007.03.002; Hansen LJ, 2013, DIABETOLOGIA, V56, P1243, DOI 10.1007/s00125-013-2893-1; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Krag MO, 2016, DIABETOLOGIA, V59, P275, DOI 10.1007/s00125-015-3804-4; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Olivarius ND, 2009, SCAND J CLIN LAB INV, V69, P851, DOI 10.3109/00365510903323191; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pedersen CB, 2006, DAN MED BULL, V53, P441; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Skrha J, 2016, REV ENDOCR METAB DIS, V17, P103, DOI 10.1007/s11154-016-9347-2; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Svensson E, 2017, DIABETES CARE, V40, P800, DOI 10.2337/dc16-2271; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Veloso AG, 2013, PRIM CARE DIABETES, V7, P33, DOI 10.1016/j.pcd.2012.09.001	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225230	10.1371/journal.pone.0225230	http://dx.doi.org/10.1371/journal.pone.0225230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774849	Green Published, gold			2022-12-26	WOS:000533896400029
J	Liu, X; Mawolo, JB; Du, XH; Zhou, YJ; Wang, HF; Liu, FY; He, ZQ; Marela, HA				Liu, Xia; Mawolo, James Blackar; Du, Xiaohua; Zhou, Yingjie; Wang, Haifang; Liu, Fayang; He, Zhiqing; Marela, Haqi Astika			Investigation of biochemical and physiological parameters of the newborn Saiga antelope (Saiga tatarica) in Gansu Province, China	PLOS ONE			English	Article							HEMATOLOGY; STRESS; PRZEWALSKI; PYRENAICA; TRANSPORT; VALUES	Background The Saiga antelope (Saiga tatarica) is a critically endangered species, and there has been limited success in restoring the population by captive breeding. This study assessed the biochemical and physiological parameters of newborn Saiga antelope to provide reference information that can be used to evaluate their health. Comparisons have been made with parameters for horses and closely related members of the Bovidae family but there are no reference values for the newborn Saiga antelope. Methods Biochemical and physiological parameters were measured in 61 animals. An automatic analyzer (Hitachi Ltd. 7180 Serial, Tokyo, Japan) was used to analyze the biochemical parameters, while the Coulter counter (Model ZK) was used to analyze the physiological parameters. Results The results showed that the biochemical and physiological parameters differ considerably in range. The evaluation of parameters stratified by sex showed differences. Triglyceride and LDL cholesterol concentrations among male animals were significantly higher than those in female animals, while the creatine kinase concentrations were significantly higher in females than in males. Comparing this study's results with published data for horses showed many similarities and some differences. Cholesterol, magnesium and glucose levels were similar between Saiga antelope and horses, while albumin and hematocrit levels in Saiga antelope differed from the reference values in horses. Conclusion The study has shown that horses and even closely related members of the Bovidae family are not suitable references when evaluating the biochemical and physiological properties of newborn Saiga antelope. These animals have unique stressors and warrant further study to inform efforts pertaining to their care and the future sustainability of the species.	[Liu, Xia; Mawolo, James Blackar; Wang, Haifang; Liu, Fayang; Marela, Haqi Astika] Gansu Agr Univ, Coll Life Sci & Technol, Dept Anim Biotechnol, Lanzhou, Gansu, Peoples R China; [Du, Xiaohua] Gansu Agr Univ, Coll Vet Med, Dept Basic Vet Med, Lanzhou, Gansu, Peoples R China; [Zhou, Yingjie; He, Zhiqing] Gansu Endangered Anim Protect Ctr State Forestry, Wuwei Town, Gansu, Peoples R China	Gansu Agricultural University; Gansu Agricultural University	Du, XH (corresponding author), Gansu Agr Univ, Coll Vet Med, Dept Basic Vet Med, Lanzhou, Gansu, Peoples R China.	drdugau2019@gmail.com	Mawolo, James/AAA-1589-2021	Xiaohua, Du/0000-0001-9604-6860	Key Research and Development program of Gansu province	Key Research and Development program of Gansu province	In order to enhance the ability of scientific and technological innovation, accelerate the transformation of scientific and technological achievements, and promote scientific research in universities, the Key Research and Development program of Gansu province provides fund for projects. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadi F, 2006, VET CLIN PATH, V35, P332, DOI 10.1111/j.1939-165X.2006.tb00142.x; Baronetzky-Mercier A., 1992, THESIS, P235; CHAPPLE RS, 1991, J WILDLIFE DIS, V27, P396, DOI 10.7589/0090-3558-27.3.396; Dey A, 2008, SMALL RUMINANT RES, V75, P105, DOI 10.1016/j.smallrumres.2007.06.013; Finco D. R., 1997, Clinical biochemistry of domestic animals., P441, DOI 10.1016/B978-012396305-5/50018-X; Gupta AK, 2005, INDIAN VET J, V82, P604; Hawkey CM, 1975, COMP MAMMALIAN HAEMA, P310; Kaneko J. J., 1997, Clinical biochemistry of domestic animals., P117, DOI 10.1016/B978-012396305-5/50006-3; Kannan G, 2000, J ANIM SCI, V78, P1450; Karesh W, 1997, J ZOO WILDLIFE MED, P316; Knowles T. G., 2000, Livestock handling and transport., P385, DOI 10.1079/9780851994093.0385; KUTTNER C, 1987, J ZOO WILDLIFE MED, V18, P144, DOI 10.2307/20094827; Lopez-Olvera JR, 2006, VET J, V172, P347, DOI 10.1016/j.tvjl.2005.06.007; LUMSDEN JH, 1980, CAN J COMP MED, V44, P32; MITCHELL G, 1988, VET REC, V123, P201, DOI 10.1136/vr.123.8.201; Nicholls H., 2015, NAT NEWS, V12, DOI 10.1038/nature.2015.17675; PEINADO VI, 1993, VET REC, V132, P580, DOI 10.1136/vr.132.23.580; Perez JM, 2003, J WILDLIFE DIS, V39, P209, DOI 10.7589/0090-3558-39.1.209; PLOTKA ED, 1988, J WILDLIFE DIS, V24, P231, DOI 10.7589/0090-3558-24.2.231; Pritchard JC, 2009, RES VET SCI, V87, P389, DOI 10.1016/j.rvsc.2009.05.003; Tomenendalova J, 2014, VET MED-CZECH, V59, P11, DOI 10.17221/7242-VETMED; WARRISS PD, 1989, BRIT VET J, V145, P242, DOI 10.1016/0007-1935(89)90076-6	22	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0224822	10.1371/journal.pone.0224822	http://dx.doi.org/10.1371/journal.pone.0224822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770378	Green Published, gold, Green Submitted			2022-12-26	WOS:000533892300008
J	Asaf, S; Khan, A; Khan, AL; Al-Harrasi, A; Al-Rawahi, A				Asaf, Sajjad; Khan, Arif; Khan, Abdul Latif; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed			Complete Chloroplast Genomes of Vachellia nilotica and Senegalia senegal: Comparative Genomics and Phylogenomic Placement in a New Generic System	PLOS ONE			English	Article							PLASTID GENOMES; ACACIA-S.L.; EVOLUTIONARY; SEQUENCE; SOFTWARE; REPEAT; DNA; L.; IDENTIFICATION; MITOCHONDRIAL	Vachellia and Senegalia are the most important genera in the subfamily Mimosoideae (Fabaceae). Recently, species from both genera were separated from the long-characterized Acacia due to their macro-morphological characteristics. However, this morpho-taxonomic differentiation struggles to discriminate some species, for example, Vachellia nilotica and Senegalia senegal. Therefore, sequencing the chloroplast (cp) genomes of these species and determining their phylogenetic placement via conserved genes may help to validate the taxonomy. Hence, we sequenced the cp genomes of V. nilotica and S. senegal, and the results showed that the sizes of the genomes are 165.3 and 162.7 kb, respectively. The cp genomes of both species comprised large single-copy regions (93,849 similar to 91,791 bp) and pairs of inverted repeats (IR; 26,093 similar to 26,008 bp). The total numbers of genes found in the V. nilotica and S. senegal cp genomes were 135 and 132, respectively. Approximately 123:130 repeats and 290:281 simple sequence repeats were found in the S. senegal and V. nilotica cp genomes, respectively. Genomic characterization was undertaken by comparing these genomes with those of 17 species belonging to related genera in Fabaceae. A phylogenetic analysis of the whole genome dataset and 56 shared genes was undertaken by generating cladograms with the same topologies and placing both species in a new generic system. These results support the likelihood of identifying segregate genera from Acacia with phylogenomic disposition of both V. nilotica and S. senegal in the subfamily Mimosoideae. The current study is the first to obtain complete genomic information on both species and may help to elucidate the genome architecture of these species and evaluate the genetic diversity among species.	[Asaf, Sajjad; Khan, Arif; Khan, Abdul Latif; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed] Univ Nizwa, Nat & Med Sci Res Ctr, Nizwa, Oman; [Khan, Arif] Nord Univ, Fac Biosci & Aquaculture, Genom Grp, Bodo, Norway	University of Nizwa; Nord University	Khan, AL; Al-Harrasi, A (corresponding author), Univ Nizwa, Nat & Med Sci Res Ctr, Nizwa, Oman.	latifepm78@yahoo.co.uk; aharrasi@unizwa.edu.com	Lee, In-Jung/GLS-0432-2022; Asaf, Sajjad/ABA-3647-2021	Lee, In-Jung/0000-0001-7154-4820; asaf, sajjad/0000-0001-8216-7549	Research Council, Oman	Research Council, Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	The authors are thankful to The Research Council, Oman for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, MOL ECOL RESOUR, V13, P929, DOI 10.1111/1755-0998.12128; Al-Assaf S, 2007, FOOD HYDROCOLLOID, V21, P319, DOI 10.1016/j.foodhyd.2006.04.011; Arce LR, 2001, BOT J LINN SOC, V135, P263, DOI 10.1111/j.1095-8339.2001.tb01095.x; Asaf S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07891-5; Asaf S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00304; Bargali K, 2009, NATURE SCI, V7, P11; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BESHAI AA, 1984, OXFORD B ECON STAT, V46, P371, DOI 10.1111/j.1468-0084.1984.mp46004006.x; Bouchenak-Khelladi Y, 2010, MOL PHYLOGENET EVOL, V57, P495, DOI 10.1016/j.ympev.2010.07.019; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Donalisio M, 2018, J ETHNOPHARMACOL, V213, P403, DOI 10.1016/j.jep.2017.11.039; Dong WL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030716; Downie SR, 2015, SYST BOT, V40, P336, DOI 10.1600/036364415X686620; Dugas DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16958; Firetti F, 2017, AM J BOT, V104, P1493, DOI 10.3732/ajb.1700302; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Givnish TJ, 2015, P ROY SOC B-BIOL SCI, V282, P171, DOI 10.1098/rspb.2015.1553; Good A, 2018, SCIENCE, V359, P869, DOI 10.1126/science.aas8737; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Haque A, 2015, THESIS; Henry R. J., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, DOI 10.1079/9780851999043.0000; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jeon JH, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010023; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan I. A., 2011, LEUNGS ENCY COMMON N; Khandoker AH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168584; Kim K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117159; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kraemer L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-41; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Kyalangalilwa B, 2013, BOT J LINN SOC, V172, P500, DOI 10.1111/boj.12047; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; LUCKOW M, 2003, ADV LEGUME SYSTEMATI, V10, P197; Miller JT, 2012, AUST SYST BOT, V25, P217, DOI 10.1071/SB11042; Miller JT, 2003, AUST SYST BOT, V16, P27, DOI 10.1071/SB01035; Mitchell R.L., 2017, PHYSL CROP PLANTS; Motlagh S, 2006, FOOD HYDROCOLLOID, V20, P848, DOI 10.1016/j.foodhyd.2005.08.007; Orchard AE, 2005, TAXON, V54, P509, DOI 10.2307/25065384; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Raddad EY, 2005, PLANT SOIL, V275, P261, DOI 10.1007/s11104-005-2152-4; Raj A., 2015, S INDIAN J BIOL SCI, V1, P66, DOI [10.22205/sijbs/2015/v1/i2/100421, DOI 10.22205/SIJBS/2015/V1/I2/100421]; Rather LJ, 2015, SUSTAIN CHEM PHARM, V2, P12, DOI 10.1016/j.scp.2015.08.002; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross JH, CONSPECTUS AFRICAN A; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Taylor DBJ, 2019, ANN APPL BIOL, V174, P238, DOI 10.1111/aab.12499; Wang YH, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1124-1; Weng ML, 2014, MOL BIOL EVOL, V31, P645, DOI 10.1093/molbev/mst257; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Wysocki WP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0321-5; Xue JH, 2012, AM J BOT, V99, pE240, DOI 10.3732/ajb.1100547; Yang J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00816; Yang JB, 2014, MOL ECOL RESOUR, V14, P1024, DOI 10.1111/1755-0998.12251; Ye X, 2019, BIORXIV; Zhang SD, 2017, NEW PHYTOL, V214, P1355, DOI 10.1111/nph.14461	67	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225469	10.1371/journal.pone.0225469	http://dx.doi.org/10.1371/journal.pone.0225469			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765416	Green Submitted, Green Published, gold			2022-12-26	WOS:000533891000030
J	Chun, YJ; Choi, JW; Hong, MH; Jung, D; Son, H; Cho, EK; Min, YJ; Kim, SW; Park, K; Lee, SS; Kim, S; Kim, HR; Cho, BC				Chun, You Jin; Choi, Jae Woo; Hong, Min Hee; Jung, Dongmin; Son, Hyeonju; Cho, Eun Kyung; Min, Young Joo; Kim, Sang-We; Park, Keunchil; Lee, Sung Sook; Kim, Sangwoo; Kim, Hye Ryun; Cho, Byoung Chul		Korean Lung Canc Consortium	Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing	PLOS ONE			English	Article							CLINICAL INTERPRETATION; TARGETED THERAPY; CANCER; MUTATIONS; VARIANTS; PATHWAYS	The treatment of Lung adenocarcinoma (LUAD) could benefit from the incorporation of precision medicine. This study was to identify cancer-related genetic alterations by next generation sequencing (NGS) in resected LUAD samples from Korean patients and to determine their associations with clinical features. A total of 201 tumors and their matched peripheral blood samples were analyzed using targeted sequencing via the Illumina HiSeq 2500 platform of 242 genes with a median depth of coverage greater than 500X. One hundred ninetytwo tumors were amenable to data analysis. EGFR was the most frequently mutated gene, occurring in 106 (55%) patients, followed by TP53 (n = 67, 35%) and KRAS (n = 11, 6%). EGFR mutations were strongly increased in patients that were female and never-smokers. Smokers had a significantly higher tumor mutational burden (TMB) than never-smokers (average 4.84 non-synonymous mutations/megabase [mt/Mb] vs. 2.84 mt/Mb, p = 0.019). Somatic mutations of APC, CTNNB1, and AMER1 in the WNT signaling pathway were highly associated with shortened disease-free survival (DFS) compared to others (median DFS of 89 vs. 27 months, p = 0.018). Patients with low TMB, annotated as less than 2 mt/Mb, had longer DFS than those with high TMB (p = 0.041). A higher frequency of EGFR mutations and a lower of KRAS mutations were observed in Korean LUAD patients. Profiles of 242 genes mapped in this study were compared with whole exome sequencing genetic profiles generated in The Cancer Genome Atlas Lung Adenocarcinoma. NGS-based diagnostics can provide clinically relevant information such as mutations or TMB from readily available formalin-fixed paraffin-embedded tissue.	[Chun, You Jin; Hong, Min Hee; Kim, Hye Ryun; Cho, Byoung Chul] Yonsei Univ, Yonsei Canc Ctr, Dept Internal Med, Div Med Oncol,Coll Med, Seoul, South Korea; [Choi, Jae Woo; Jung, Dongmin] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea; [Choi, Jae Woo] Yonsei Univ, Dept Pharmacol, Coll Med, Seoul, South Korea; [Son, Hyeonju; Kim, Sangwoo] Yonsei Univ, Coll Med, Brain Korea 21 Plus Project Med Sci, Dept Biomed Syst Informat, Seoul, South Korea; [Cho, Eun Kyung] Gil Med Ctr, Gachon Med Sch, Dept Internal Med, Div Hematol Oncol, Incheon, South Korea; [Min, Young Joo] Univ Ulsan, Ulsan Univ Hosp, Dept Internal Med, Div Hematol & Oncol,Coll Med, Ulsan, South Korea; [Kim, Sang-We] Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea; [Park, Keunchil] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, Seoul, South Korea; [Lee, Sung Sook] Inje Univ, Dept Hematol Oncol, Haeundae Paik Hosp, Busan, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Gachon University; University of Ulsan; Ulsan University Hospital; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Inje University	Kim, HR; Cho, BC (corresponding author), Yonsei Univ, Yonsei Canc Ctr, Dept Internal Med, Div Med Oncol,Coll Med, Seoul, South Korea.; Kim, S (corresponding author), Yonsei Univ, Coll Med, Brain Korea 21 Plus Project Med Sci, Dept Biomed Syst Informat, Seoul, South Korea.	SWKIM@yuhs.ac; nobelg@yuhs.ac; cbc1971@yuhs.ac	Park, Keunchil/ABD-5852-2021; Park, Keunchil/ABD-7072-2021	Park, Keunchil/0000-0002-4846-7449; Kim, Sangwoo/0000-0001-5356-0827; Choi, Jae Woo/0000-0001-5741-8748; Hong, Min Hee/0000-0003-3490-2195; Cho, Byoung Chul/0000-0002-5562-270X	Korean Lung Cancer Consortium (KLCC); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2016R1A2B3016282]	Korean Lung Cancer Consortium (KLCC); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This study was supported in part by Korean Lung Cancer Consortium (KLCC) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016R1A2B3016282 to B.C. Cho). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JW, 2014, GENOME MED, V6, DOI 10.1186/gm535; Bahceci I, 2017, BIOINFORMATICS, V33, P2238, DOI 10.1093/bioinformatics/btx149; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; Choi YW, 2018, AM J CLIN ONCOL-CANC, V41, P385, DOI 10.1097/COC.0000000000000282; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Consonni D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203539; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Devarakonda S, 2018, J CLIN ONCOL, V36, P2995, DOI 10.1200/JCO.2018.78.1963; Douville C, 2013, BIOINFORMATICS, V29, P647, DOI 10.1093/bioinformatics/btt017; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Griffith M, 2017, NAT GENET, V49, P170, DOI 10.1038/ng.3774; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102685; Joshi N. A., 2011, SICKLE SLIDING WINDO; LACKNER N, 2018, ARCHAEA, V2018, DOI DOI 10.1101/366856; Lamichhane DK, 2017, YONSEI MED J, V58, P1111, DOI [10.3349/ymj.2017.5, 10.3349/ymj.2017.58.6.1111]; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SY, 2016, J THORAC ONCOL, V11, P2129, DOI 10.1016/j.jtho.2016.08.142; Lim SM, 2016, ONCOTARGET, V7, P36311, DOI 10.18632/oncotarget.8904; Luo WX, 2018, INT J CANCER, V143, P1696, DOI 10.1002/ijc.31542; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mayakonda A, 2018, GENOME RES, V28, P1747, DOI 10.1101/gr.239244.118; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Narzisi G, 2014, NAT METHODS, V11, P1033, DOI [10.1038/NMETH.3069, 10.1038/nmeth.3069]; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Owada-Ozaki Y, 2018, J THORAC ONCOL, V13, P1217, DOI 10.1016/j.jtho.2018.04.003; Rapp J, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0650-6; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Soo RA, 2012, FUTURE ONCOL, V8, P451, DOI [10.2217/FON.12.25, 10.2217/fon.12.25]; Stewart DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt356; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Tamborero D, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0531-8; Tsimberidou AM, 2015, CANCER CHEMOTH PHARM, V76, P1113, DOI 10.1007/s00280-015-2861-1; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	40	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0224379	10.1371/journal.pone.0224379	http://dx.doi.org/10.1371/journal.pone.0224379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765373	Green Published, gold			2022-12-26	WOS:000533891000008
J	Khattar, M; Baum, CE; Schroder, P; Breidenbach, JD; Haller, ST; Chen, WH; Stepkowski, S				Khattar, Mithun; Baum, Caitlin E.; Schroder, Paul; Breidenbach, Joshua D.; Haller, Steven T.; Chen, Wenhao; Stepkowski, Stanislaw			Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection	PLOS ONE			English	Article							T-CELL DIFFERENTIATION; FACTOR BATF CONTROLS; INTERNATIONAL-SOCIETY; LUNG-TRANSPLANTATION; B-CELLS; GENERATION; PATHWAY	IL-21 is the most recently discovered common gamma-chain cytokine that promotes persistent T-cell responses in chronic infections, autoimmunity and cancer. However, the therapeutic potential of inhibiting the IL-21-BATF signaling axis, particularly in transplant rejection, remains unclear. We used heart transplant models to examine the effects of IL-21 blockade in prevention of chronic cardiac allograft vasculopathy (CAV) using genetic knockout and therapeutic approaches. Both wild-type C57BL/6 and IL-21-/- strains acutely rejected Balb/c skin grafts and once immunized with this skin graft, rejected Balb/c heart allografts in an accelerated fashion. However, when transplanted with heart grafts from the class-II major histocompatibility complex mutant, B6(bm12) mice; wild-type recipients developed CAV, while IL-21(-/-) recipients were protected, even at day 100 post-transplant. Similarly, BATF-/-recipients, lacking the transcription factor BATF responsible for IL-21 production, did not develop CAV in B6-bm12 heart allografts. Strikingly, in a transient treatment protocol, the development of CAV in wild-type recipients of B6-bm12 hearts allografts was blocked by the administration of IL-21 receptor fusion protein (R-Fc). Thus, we demonstrate that CAV is regulated at least in part by IL-21 signaling and its blockade by genetic approaches or therapy with IL-21R-Fc prevents CAV in mice.	[Khattar, Mithun; Baum, Caitlin E.; Breidenbach, Joshua D.; Chen, Wenhao; Stepkowski, Stanislaw] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Schroder, Paul] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Haller, Steven T.] Univ Toledo, Dept Med, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; Duke University; University System of Ohio; University of Toledo	Stepkowski, S (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	Stanislaw.Stepkowski@utoledo.edu		Breidenbach, Joshua/0000-0002-5892-1879	University of Toledo Medical Microbiology and Immunology department	University of Toledo Medical Microbiology and Immunology department	This work was funded by The University of Toledo Medical Microbiology and Immunology department. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baan CC, 2007, TRANSPLANTATION, V83, P1485, DOI 10.1097/01.tp.0000264998.23349.54; Cherkassky L, 2011, AM J TRANSPLANT, V11, P1388, DOI 10.1111/j.1600-6143.2011.03540.x; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Djamali A, 2014, AM J TRANSPLANT, V14, P255, DOI 10.1111/ajt.12589; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Fischbein MP, 2003, J THORAC CARDIOV SUR, V126, P216, DOI 10.1016/S0022-5223(03)00026-6; Garrod Kym R, 2008, J Vis Exp, DOI 10.3791/634; Gu-Trantien C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91487; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Itoh S, 2010, J CLIN IMMUNOL, V30, P235, DOI 10.1007/s10875-009-9366-9; Jane-wit D, 2013, CIRCULATION, V128, P2504, DOI 10.1161/CIRCULATIONAHA.113.002972; Khattar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085882; Kwun J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02323; Laschinger M, 2012, POTENTIAL HETEROTOPI; Lindemann M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123945; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; McGuire HM, 2011, DIABETES, V60, P867, DOI 10.2337/db10-1157; MCKENZIE IFC, 1979, J EXP MED, V150, P1323, DOI 10.1084/jem.150.6.1323; Mehra MR, 2010, J HEART LUNG TRANSPL, V29, P717, DOI 10.1016/j.healun.2010.05.017; Mehra MR, 2006, AM J TRANSPLANT, V6, P1248, DOI 10.1111/j.1600-6143.2006.01314.x; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Pethig K, 2000, CIRCULATION, V102, P233; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schroder PM, 2013, TARGETING SIGNAL 1 T; Shi XY, 2016, TRANSPLANT REV-ORLAN, V30, P27, DOI 10.1016/j.trre.2015.06.003; Sutherland APR, 2013, J IMMUNOL, V190, P3977, DOI 10.4049/jimmunol.1201730; Taylor DO, 2004, J HEART LUNG TRANSPL, V23, P796, DOI 10.1016/j.healun.2004.05.004; Thaunat O, 2005, P NATL ACAD SCI USA, V102, P14723, DOI 10.1073/pnas.0507223102; Tian Y, 2016, TRENDS IMMUNOL, V37, P557, DOI 10.1016/j.it.2016.06.001; Vassalli G, 2003, EUR HEART J, V24, P1180, DOI 10.1016/S0195-668X(03)00237-9; Win TS, 2009, CIRC-HEART FAIL, V2, P361, DOI 10.1161/CIRCHEARTFAILURE.108.827139; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zeng Q, 2014, J CLIN INVEST, V124, P1052, DOI 10.1172/JCI70084; Zhang RB, 2018, CLIN J AM SOC NEPHRO, V13, P182, DOI 10.2215/CJN.00700117	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225624	10.1371/journal.pone.0225624	http://dx.doi.org/10.1371/journal.pone.0225624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756235	Green Published, gold			2022-12-26	WOS:000533889300049
J	Liu, ZW; Yu, Y; Fang, L; Hu, M; Zhou, L; Xiao, SY				Liu, Zi-Wei; Yu, Yu; Fang, Liang; Hu, Mi; Zhou, Liang; Xiao, Shui-Yuan			Willingness to receive institutional and community-based eldercare among the rural elderly in China	PLOS ONE			English	Article							PEOPLE	Studies on the willingness to receive institutional eldercare among the rural elderly are scarce. This study aims to explore factors associated with the willingness to receive institutional eldercare and community-based eldercare among the rural elderly. A cross-sectional study was conducted in three rural villages of Changde City, Hunan Province, China. A total of 517 elderly were recruited through multistage sampling from these villages. The dependent variable is the willingness to receive eldercare from family (as reference), institution, and community. The independent variables includes sociodemographic characteristics: having physical disease, depression, anxiety, and daily living activities, and concerns toward home-based, institutional, and community-based care, respectively. Results show that 78.3% of the elderly are willing to receive home-based eldercare, 10.8% institutional eldercare, and 8.5% community-based eldercare. The factors associated with the willingness to receive institutional eldercare are having concerns toward home-based (OR = 4.85, P<0.001) and institutional eldercare (OR = 5.51, P<0.001). The factors associated with community-based care is living alone (OR = 2.18, P = 0.034). Finally, the major concerns toward home-based eldercare are lack of care ability and separation of family members, whereas those toward institutional eldercare are unaffordable services and fear of being abandoned by the children. The major concerns toward community-based eldercare includes affordability and lack of necessary services. In summary, elderly having concerns toward home-based care and having no concerns about institutional care are willing to accept institutional eldercare. Elderly who are living alone is tend to accept community-based care. Unaffordable services and loss of contact with family members are the major concerns of institutional eldercare. Aside from the cost, the lack of necessary care services is also a serious concern of community-based eldercare.	[Liu, Zi-Wei; Fang, Liang; Hu, Mi; Xiao, Shui-Yuan] Cent South Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China; [Liu, Zi-Wei] Cent South Univ, Xiangya Hosp 2, Natl Clin Res Ctr Mental Disorders, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Liu, Zi-Wei] Natl Technol Inst Mental Disorders, Hunan Key Lab Psychiat & Mental Hlth, Changsha, Hunan, Peoples R China; [Yu, Yu] Cent South Univ, Hosp Evaluat Off, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Zhou, Liang] Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Peoples R China	Central South University; Central South University; Central South University; Guangzhou Medical University	Xiao, SY (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China.	xiaosy@csu.edu.cn	ZHOU, LIANG/AAG-7587-2020	ZHOU, LIANG/0000-0003-3207-7419				BJELKEVIG C, 2010, SHANGHAI ARCH PSYCHI, V22, DOI DOI 10.1088/0953-8984/22/30/302002; Chen L, 2016, J AGING SOC POLICY, V28, P292, DOI 10.1080/08959420.2016.1151310; Gong X., 2012, QIU YI WEN YAO, V10, P852; [黄晓玲 Huang Xiaoling], 2017, [中国卫生统计, Chinese Journal of Health Statistics], V34, P729; Keimig R, 2017, J AGING SOC POLICY, V29, P461, DOI 10.1080/08959420.2017.1364082; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Li H, 2017, J AGING SOC POLICY, V29, P182, DOI 10.1080/08959420.2016.1220229; [李振华 Li Zhenhua], 2011, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V19, P171; Luo MY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021741; Martikainen P, 2009, GERONTOLOGIST, V49, P34, DOI 10.1093/geront/gnp013; Ministry of Civil Affairs of the People's Republic of China, 2016, 4 SAMPL SURV LIV CON; Ministry of Civil Affairs of the People's Republic of China, 2006, 5 GUARANT GRANT FARM; Mo Y, 2017, J EDUC EVAL HEALTH P, V14, DOI 10.3352/jeehp.2017.14.22; National Bureau of Statistics of the People's Republic of China, 2014, STAT B NAT EC SOC DE; National Health Commission of the People's Repulic of China, 2015, REP FAM DEV CHIN; Peng H., 2007, RES DUALISTIC STRUCT; State Council of the People's Republic of China, 2009, GID STAT COUNC LAUNC; Wild B, 2014, AM J GERIAT PSYCHIAT, V22, P1029, DOI 10.1016/j.jagp.2013.01.076; Xing YA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020225; Zeng Y, 2012, CHINA ECON J, V5, P131, DOI 10.1080/17538963.2013.764677; Zhan Heying J, 2006, J Aging Soc Policy, V18, P85, DOI 10.1300/J031v18n02_06	21	10	10	13	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225314	10.1371/journal.pone.0225314	http://dx.doi.org/10.1371/journal.pone.0225314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756228	Green Published, gold			2022-12-26	WOS:000533889300018
J	Spengler, S; Kuritz, A; Rabel, M; Mess, F				Spengler, Sarah; Kuritz, Arvid; Rabel, Matthias; Mess, Filip			Are primary school children attending full-day school still engaged in sports clubs?	PLOS ONE			English	Article							MEASURED PHYSICAL-ACTIVITY; TIME; ADOLESCENTS; CHILDHOOD; PATTERNS; TRACKING	Purpose Schools and organized sports both offer great chances to promote physical activity among children. Full-day schools particularly allow for extensive participation in extra-curricular physical activities. However, due to time reasons, full-day schools may also prevent children from engagement in organized sports outside school. There is only little national and international research addressing the possible competition of full-day schools and providers of organized sports outside school and the potential effects on children's physical activity behavior. In Germany's educational system, a transformation towards more full-day schools is currently taking place. The existence of both, half-day and full-day schools, gave occasion to the following research question: Do students attending half-day and full-day school differ with respect to a) sports club membership rate and b) weekly amount of sports club training? Methods Data were collected in eleven German primary schools. Selected schools offered both half-day and full-day (minimum three days/week with at least seven hours) care. 372 students' data (grades 1-4; N = 153 half-day, N = 219 full-day; 47.4% male, 8.8 +/- 1.2y) were eligible for analyses. We assessed sports club membership and weekly training duration via questionnaire. Statistical analyses included Chi-square and Mann-Whitney-U-Tests. Results 83% of half-day school students and 67% of full-day school students were sports club members (chi(2) (1) = 12.31, p<.001). Weekly duration of training in sports clubs among sports club members (N = 266) also differed between the groups (mdn = 150 min in half-day, mdn = 120 min in full-day school students; z = -2.37, p = .018). Additional analyses stratified for age and gender showed similar results. Conclusion Primary school students attending full-day schools engage less in organized sports outside school than half-day school students, regardless of age and gender. Future studies should examine if the detected lower engagement in sports club physical activity is compensated by physical activities in other settings such as school or non-organized leisure time.	[Spengler, Sarah; Rabel, Matthias; Mess, Filip] Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany; [Kuritz, Arvid] Univ Konstanz, Dept Sports Sci, Constance, Germany	Technical University of Munich; University of Konstanz	Spengler, S (corresponding author), Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany.	sarah.spengler@tum.de	Mess, Filip/J-7090-2016	Mess, Filip/0000-0002-9506-524X	Ministry of Education, Youth and Sports Baden-Wuerttemberg; German Research Foundation (DFG); Technical University of Munich	Ministry of Education, Youth and Sports Baden-Wuerttemberg; German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich	This study was supported by funding from the Ministry of Education, Youth and Sports Baden-Wuerttemberg, https://km-bw.de/Lde/Startseite.This work was also supported by the German Research Foundation (DFG) and the Technical University of Munich within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aznar S, 2011, CHILD CARE HLTH DEV, V37, P322, DOI 10.1111/j.1365-2214.2010.01175.x; Baur J, 2002, BISP JB 2001, P219; Berger M, 2017, STRUKTURANALYSE PERS; Bewegung Naul R., 2011, BEWEGUNG SPIEL SPORT; Brettschneider W.-D., 2002, JUGENDARBEIT SPORTVE; Breuer C, 2014, HDB SPORTENTWICKLUNG, P225; Breuer C., 2015, SPORT CLUBS EUROPE C, P187; Breuer C., 2015, SPORTENTWICKLUNGSBER; Brooke Hannah L, 2016, Prev Med Rep, V4, P585; Brooke HL, 2016, J SCI MED SPORT, V19, P29, DOI 10.1016/j.jsams.2014.10.003; CDU CSU & SPD, 2018, NEUER AUFBR EUR NEUE; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Field SC, 2017, SPORTS, V5, DOI 10.3390/sports5020043; Guinhouya BC, 2009, J PHYS ACT HEALTH, V6, P510, DOI 10.1123/jpah.6.4.510; Heim C, KORPER BEWEGUNG SCHU; Heinemann K, 2007, EINFUHRUNG SOZIOLOGI; Heinemann K., 1981, SPORTWISSENSCHAFT, V11, P123, DOI [10.1007/BF03177039, DOI 10.1007/BF03177039]; Holtappels HG, 2007, GANZTAGSSCHULE DEUTS, P186; Howie EK, 2016, MED SCI SPORT EXER, V48, P1331, DOI 10.1249/MSS.0000000000000894; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jauregui A, 2011, SALUD PUBLICA MEXICO, V53, P228; Jekauc D, 2013, DIAGNOSTICA, V59, P100, DOI 10.1026/0012-1924/a000083; Kalman M, 2015, CENT EUR J PUBL HEAL, V23, pS78; Kamette F., 2011, EUROPEAN ISSUES, P212; Klemm K, 2017, GUTE GANZTAGSSCHULE; Kokko S, 2019, SCAND J PUBLIC HEALT, V47, P851, DOI 10.1177/1403494818786110; Krimmer H, 2013, ZIVIZ SURVEY 2012 ZI; Kuritz A, 2016, GER J EXERC SPORT RE, V46, P162, DOI 10.1007/s12662-016-0406-3; Manz K, 2014, BUNDESGESUNDHEITSBLA, V57, P840, DOI 10.1007/s00103-014-1986-4; Marcus J., 2013, DIW WOCHENBERICHT, V80, P11; Marques A, 2016, J SCI MED SPORT, V19, P154, DOI 10.1016/j.jsams.2015.02.007; Mess F, 2012, Z SOZIOL ERZIEH SOZI, V32, P358; Moller NC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0121-0; Mota J, 2005, J SPORT SCI, V23, P269, DOI 10.1080/02640410410001730124; Pau M, 2017, J PHYS ACT HEALTH, V14, P501, DOI 10.1123/jpah.2016-0492; Petry K., 2013, COMP SPORT DEV, P75; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Rutten A, 2017, BUNDES ZENTRALE GESU; Schmidt S, 2016, KIT SCI WORKING PAPE, P53; Schmidt SCE, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111375; Sekretariat der Standigen Konferenz der Kultusminister der Lander in der Bundesrepublik Deutschland, 2018, ALLG SCHUL GANZT LAN; Silva P, 2011, J SPORT SCI MED, V10, P66; Suenbach J, 2013, EVALUATION BEWEGUNGS; Thieme L., 2013, SPORTUNTERRICHT, V62, P142; Trudeau F, 2004, MED SCI SPORT EXER, V36, P1937, DOI 10.1249/01.MSS.0000145525.29140.3B; Vella SA, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-62; Walk L., 2011, DIE Z ERWACHSENENBIL, V1, P27, DOI [10.3278/DIE1101W027, DOI 10.3278/DIE1101W027]; Wolfert S, 2018, KINDER DEUTSCHLAND 2, P54; World Health Organisation, 2010, GLOB REC PHYS ACT HL; Zuchner I., 2013, JUGEND HILFE FORSCHU, P45; Zuchner I, 2012, SPORTPADAGOGIK HEUTE, V3, P1	51	3	3	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225220	10.1371/journal.pone.0225220	http://dx.doi.org/10.1371/journal.pone.0225220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QA	31756210	gold, Green Published			2022-12-26	WOS:000533889300011
J	Chang, WJ; Lo, SY; Kuo, CL; Wang, YL; Hsiao, HC				Chang, Wen-Jen; Lo, Shih-Yin; Kuo, Chen-Li; Wang, Yen-Li; Hsiao, Hsu-Chuan			Development of an intervention tool for precision oral self-care: Personalized and evidence-based practice for patients with periodontal disease	PLOS ONE			English	Article							BEHAVIOR-CHANGE; GLOBAL BURDEN; HEALTH; HYGIENE; POPULATION; PREVENTION; CONSENSUS; MODELS; SYSTEM; IMPACT	Background Oral self-care plays an important role in maintaining oral health and preventing the occurrence of oral diseases. The association between good oral care and good oral hygiene is well known. However, the adherence to a proper daily oral hygiene regimen generally remains poor, so the prevalence of oral diseases remains high. Periodontal disease is the most common oral disease in the population. To enhance the adherence to good oral hygiene behaviors for patients with periodontal disease, we developed a personalized and evidence-based mobile application as an intervention tool for the purpose of initiating and improving good oral self-care. Objective The objective of this study was to demonstrate the systematic development process and content of the oral self-care mobile application, OSCA. Methods The systematic development process of OSCA consists of three phases: behavioral diagnosis, intervention design, and assessment of OSCA. Firstly, behavioral problem of oral self-care was identified by the experts in periodontics care. Secondly, the intervention functions and the mode of delivery were designed based on the capability-opportunity-motivation behavioral model, which is the underpinning model behind the behavior change wheel framework. Thirdly, the developed app was evaluated by the experts through a heuristics evaluation checklist by adopting Morville's Honeycomb model, and the final version of OSCA was assessed by the patients with periodontal disease using the System Usability Scale (SUS). Results The problems of target behavior were identified and incorporated into the design of intervention functions. For the beta version of the OSCA, experts proposed four main suggestions to improve the usefulness. Experts evaluated the beta and final versions of the app using a heuristics evaluation checklist, providing mean scores of 4.38 and 4.62, respectively. For usability testing, 87 participants completed both the specified tasks and the SUS questionnaire, providing an SUS median score of 77.5 (IQR = 12.5) and an overall mean completion time of 12.22 minutes for the specified tasks. The mean scores of the intervention functions for capability establishment, motivation enhancement, and opportunity creation were 6.13, 5.88, and 6.06, respectively. Conclusions The study presents a rigorous design process of developing an evidence-based and personalized mobile application for oral self-care. The results of the expert evaluation confirmed the validated design and the participants were satisfied with the designed app.	[Chang, Wen-Jen; Kuo, Chen-Li] Chang Gung Univ, Dept Informat Management, Taoyuan, Taiwan; [Chang, Wen-Jen] Chang Gung Mem Hosp, Dept Dent, Taoyuan, Taiwan; [Lo, Shih-Yin; Wang, Yen-Li] Chang Gung Mem Hosp, Dept Periodont, Taoyuan, Taiwan; [Kuo, Chen-Li; Hsiao, Hsu-Chuan] Chang Gung Mem Hosp, Dept Nursing, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chang, WJ (corresponding author), Chang Gung Univ, Dept Informat Management, Taoyuan, Taiwan.; Chang, WJ (corresponding author), Chang Gung Mem Hosp, Dept Dent, Taoyuan, Taiwan.	wjchang@gap.cgu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 107-2221-E-182-057]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grant MOST 107-2221-E-182-057 from the Ministry of Science and Technology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arweiler NB, 2018, PERIODONTOL 2000, V76, P164, DOI 10.1111/prd.12152; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Beatty Alexis L, 2018, JMIR Hum Factors, V5, pe3, DOI 10.2196/humanfactors.8017; Boulos Maged N Kamel, 2014, Online J Public Health Inform, V5, P229, DOI 10.5210/ojphi.v5i3.4814; Brooke J., 1996, USABILITY EVALUATION, V189, P4; Brown W, 2013, J BIOMED INFORM, V46, P1080, DOI 10.1016/j.jbi.2013.08.001; Clemens C, 1980, Dent Hyg (Chic), V54, P125; Dorfer C, 2017, INT DENT J, V67, P14, DOI 10.1111/idj.12360; Dugdale S, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0069-y; Edwards EA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012447; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Fulton EA, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4020031; Godha S, 2015, INT J ORAL HLTH MED, V2, P105; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Hagger M.S., 2014, EUROPEAN HLTH PSYCHO, V16, P206; Hoj TH, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7206; Jepsen S, 2017, J CLIN PERIODONTOL, V44, pS85, DOI 10.1111/jcpe.12687; Jin LJ, 2016, ORAL DIS, V22, P609, DOI 10.1111/odi.12428; JOHANSSON I, 1994, COMMUNITY DENT ORAL, V22, P431, DOI 10.1111/j.1600-0528.1994.tb00792.x; Johnston M., 2016, EUR HLTH PSYCHOL, V16, P181; Kao CK, 2017, PM&R, V9, pS106, DOI 10.1016/j.pmrj.2017.02.018; Kassebaum NJ, 2014, J DENT RES, V93, P20, DOI 10.1177/0022034514537828; Lewis JR, 2018, INT J HUMAN COMPUTER, DOI [10.1080/10447318.2018.1550177, DOI 10.1080/10447318.2018.1550177]; Listl S, 2015, J DENT RES, V94, P1355, DOI 10.1177/0022034515602879; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Misra S, 2013, PATIENT PREFER ADHER, V7, P543, DOI 10.2147/PPA.S43255; Morville P., 2004, USER EXPERIENCE HONE; Newton JT, 2017, BRIT DENT J, V223, P147, DOI 10.1038/sj.bdj.2017.659; Newton JT, 2015, J CLIN PERIODONTOL, V42, pS36, DOI 10.1111/jcpe.12356; Newton JT, 2018, PERIODONTOL 2000, V78, P201, DOI 10.1111/prd.12236; Nielsen J., 1992, P ACM CHI 92, P372; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Righolt AJ, 2018, J DENT RES, V97, P501, DOI 10.1177/0022034517750572; Schnall R, 2016, J BIOMED INFORM, V60, P243, DOI 10.1016/j.jbi.2016.02.002; Schuz B, 2006, J CLIN PERIODONTOL, V33, P612, DOI 10.1111/j.1600-051X.2006.00967.x; Thevissen E, 2017, INT J DENT HYG, V15, P261, DOI 10.1111/idh.12211; Tonetti MS, 2017, J CLIN PERIODONTOL, V44, P456, DOI 10.1111/jcpe.12732; U. S. Department of Health and Human Services, 2000, OR HLTH AM REP SURG; Underwood B, 2015, BRIT DENT J, V219, DOI 10.1038/sj.bdj.2015.660; van der Weijden F, 2011, PERIODONTOL 2000, V55, P104, DOI 10.1111/j.1600-0757.2009.00337.x; Vatne JF, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0037-3; Williams Kristin A, 2018, Dent J (Basel), V6, DOI 10.3390/dj6010002; Yevlahova D, 2009, AUST DENT J, V54, P190, DOI 10.1111/j.1834-7819.2009.01118.x; Zhou GY, 2015, HEALTH EDUC RES, V30, P671, DOI 10.1093/her/cyv032	45	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225453	10.1371/journal.pone.0225453	http://dx.doi.org/10.1371/journal.pone.0225453			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8PC	31751411	Green Published, gold			2022-12-26	WOS:000533886900063
J	Widjaja, E; Papastavros, T; Sander, B; Snead, C; Pechlivanoglou, P				Widjaja, Elysa; Papastavros, Tina; Sander, Beate; Snead, Carter; Pechlivanoglou, Petros			Early economic evaluation of MRI-guided laser interstitial thermal therapy (MRgLITT) and epilepsy surgery for mesial temporal lobe epilepsy	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; AMYGDALOHIPPOCAMPOTOMY; COMPLICATIONS; REOPERATION; RESECTIONS; ABLATION; FAILURE	Background MRI-guided laser interstitial thermal therapy (MRgLITT) is a new minimally invasive treatment for temporal lobe epilepsy (TLE), with limited effectiveness data. It is unknown if the cost savings associated with shorter hospitalization could offset the high equipment cost of MRgLITT. We examined the cost-utility of MRgLITT versus surgery for TLE from healthcare payer perspective, and the value of additional research to inform policy decision on MRgLITT. Methods We developed a microsimulation model to evaluate quality adjusted life years (QALYs), costs, and incremental cost-effectiveness ratio (ICER) of MRgLITT versus surgery in TLE, assuming life-time horizon and 1.5% discount rate. Model inputs were derived from the literature. We conducted threshold and sensitivity analyses to examine parameter uncertainties, and expected value of partial perfect information analyses to evaluate the expected monetary benefit of eliminating uncertainty on probabilities associated with MRgLITT. Results MRgLITT yielded 0.08 more QALYs and cost $7,821 higher than surgery, with ICER of $94,350/QALY. Influential parameters that could change model outcomes include probabilities of becoming seizure-free from disabling seizures state and returning to disabling seizures from seizure-free state 5 years after surgery and MRgLITT, cost of MRgLITT disposable equipment, and utilities of disabling seizures and seizure-free states of surgery and MRgLITT. The cost-effectiveness acceptability curve showed surgery was preferred in more than 50% of iterations. The expected monetary benefit of eliminating uncertainty for probabilities associated with MRgLITT was higher than for utilities associated with MRgLITT. Conclusions MRgLITT resulted in more QALYs gained and higher costs compared to surgery in the base-case. The model was sensitive to variations in the cost of MRgLITT disposable equipment. There is value in conducting more research to reduce uncertainty on the probabilities and utilities of MRgLITT, but priority should be given to research focusing on improving the precision of estimates on effectiveness of MRgLITT.	[Widjaja, Elysa; Sander, Beate; Pechlivanoglou, Petros] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Widjaja, Elysa] Hosp Sick Children, Diagnost Imaging, Toronto, ON, Canada; [Widjaja, Elysa; Snead, Carter] Hosp Sick Children, Div Neurol, Toronto, ON, Canada; [Papastavros, Tina] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Sander, Beate] Univ Hlth Network, Toronto Hlth Econ Technol Assessment, Toronto, ON, Canada; [Sander, Beate] Inst Clin Evaluat Sci Ices, Toronto, ON, Canada; [Sander, Beate] Publ Hlth Ontario, Toronto, ON, Canada; [Pechlivanoglou, Petros] Hosp Sick Children, Child Hlth Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Widjaja, E (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Widjaja, E (corresponding author), Hosp Sick Children, Diagnost Imaging, Toronto, ON, Canada.; Widjaja, E (corresponding author), Hosp Sick Children, Div Neurol, Toronto, ON, Canada.	Elysa.Widjaja@sickkids.ca		Widjaja, Elysa/0000-0003-0986-5476; Pechlivanoglou, Petros/0000-0001-5090-7936				[Anonymous], 2017, CADTH METHODS GUIDEL, V4th ed; [Anonymous], 2015, BRAIN DISORDERS ONTA; Bowen James M, 2012, Ont Health Technol Assess Ser, V12, P1; Burneo JG, 2016, NEUROLOGY, V86, P72, DOI 10.1212/WNL.0000000000002249; Choi H, 2008, JAMA-J AM MED ASSOC, V300, P2497, DOI 10.1001/jama.2008.771; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Drane DL, 2015, EPILEPSIA, V56, P101, DOI 10.1111/epi.12860; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Georgiadis Iordanis, 2013, Epilepsy Res Treat, V2013, P752195, DOI 10.1155/2013/752195; GERMANO IM, 1994, J NEUROSURG, V81, P31, DOI 10.3171/jns.1994.81.1.0031; Goellner E, 2013, EPILEPSIA, V54, P1933, DOI 10.1111/epi.12389; Gross RE, 2018, ANN NEUROL, V83, P575, DOI 10.1002/ana.25180; Hader WJ, 2013, EPILEPSIA, V54, P840, DOI 10.1111/epi.12161; Hinde S, 2014, EPILEPSY RES, V108, P775, DOI 10.1016/j.eplepsyres.2014.02.002; Ibrahim GM, 2014, CAN MED ASSOC J, V186, P973, DOI 10.1503/cmaj.140427; Jain P, 2018, J NEUROL NEUROSUR PS, V89, P1138, DOI 10.1136/jnnp-2017-317783; Jung R, 2013, SEIZURE-EUR J EPILEP, V22, P502, DOI 10.1016/j.seizure.2012.11.011; Kang JY, 2017, NEUROTHERAPEUTICS, V14, P176, DOI 10.1007/s13311-016-0498-3; Kang JY, 2016, EPILEPSIA, V57, P325, DOI 10.1111/epi.13284; King JT, 1997, J NEUROSURG, V87, P20, DOI 10.3171/jns.1997.87.1.0020; Krucoff MO, 2017, EPILEPSIA, V58, P2133, DOI 10.1111/epi.13920; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Langfitt JT, 2007, NEUROLOGY, V68, P1290, DOI 10.1212/01.wnl.0000259550.87773.3d; Lim ME, 2013, EPILEPSY RES, V107, P286, DOI 10.1016/j.eplepsyres.2013.08.010; Manjunath R, 2012, NEUROLOGY, V79, P1908, DOI 10.1212/WNL.0b013e318271f77e; Micieli A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001031; Ontario Case Costing Initiative (OCCI), HLTH DAT BRANCH WEB; Ontario Ministry of Finance, ONT POP PROJ UPD 201; Oostenbrink JB, 2008, VALUE HEALTH, V11, P1070, DOI 10.1111/j.1524-4733.2008.00389.x; Picot MC, 2016, EPILEPSIA, V57, P1669, DOI 10.1111/epi.13492; Salanova V, 2005, ACTA NEUROL SCAND, V111, P126, DOI 10.1111/j.1600-0404.2005.00371.x; Sperling MR, 2004, CNS SPECTRUMS, V9, P98, DOI 10.1017/S1092852900008464; Tao JX, 2018, J NEUROL NEUROSUR PS, V89, P542, DOI 10.1136/jnnp-2017-316833; Vakharia VN, 2018, EPILEPSIA, V59, P814, DOI 10.1111/epi.14034; Waseem H, 2017, J CLIN NEUROSCI, V38, P1, DOI 10.1016/j.jocn.2016.12.002; Waseem H, 2015, EPILEPSY BEHAV, V51, P152, DOI 10.1016/j.yebeh.2015.07.022; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Willie JT, 2014, NEUROSURGERY, V74, P569, DOI 10.1227/NEU.0000000000000343; Wu CY, 2019, EPILEPSIA, V60, P1171, DOI 10.1111/epi.15565; Youngerman BE, 2018, EPILEPSIA, V59, P595, DOI 10.1111/epi.14004	41	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0224571	10.1371/journal.pone.0224571	http://dx.doi.org/10.1371/journal.pone.0224571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747402	gold, Green Published			2022-12-26	WOS:000533881900011
J	Bajehson, M; Musa, BM; Gidado, M; Nsa, B; Sani, U; Habibu, AT; Aliyu, I; Hussaini, T; Yusuf, A; Gida, Y				Bajehson, Mamman; Musa, Baba Maiyaki; Gidado, Mustapha; Nsa, Bassey; Sani, Useni; Habibu, Ahmad T.; Aliyu, Ibrahim; Hussaini, Tijjani; Yusuf, AbdulRasheed; Gida, Yakubu			Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria	PLOS ONE			English	Article							RISK-FACTORS; SURVIVAL; OUTCOMES; DEATH; TB	Background Drug-Resistant tuberculosis (DR-TB) is estimated to cause about 10% of all TB related deaths. There is dearth of data on determinants of DR-TB mortality in Nigeria. Death among DR-TB treated cohorts in Nigeria from 2010 to 2013 was 30%, 29%, 15% and 13% respectively. Our objective was to identify factors affecting survival among DR-TB patients in northern Nigeria. Methods Demographic and clinical data of all DR-TB patients enrolled in Kano, Katsina and Bauchi states of Nigeria between 1st February 2015 and 30th November 2016 was used. Survival analysis was done using Kaplan-Meier and multiple regression with Cox proportional hazard modeling. Results Mean time to death during treatment is 19.2 weeks and 3.9 weeks among those awaiting treatment. Death was recorded among 38 of the 147 DR-TB patients assessed. HIV co-infection significantly increased probability of mortality, with an adjusted hazard ratio (aHR) of 2.35, 95% CI: 1.05-5.29, p = 0.038. Treatment delay showed significant negative association with survival (p = 0.000), not starting treatment significantly reduced probability of survival with an aHR of 7.98, 95% CI: 2.83-22.51, p = 0.000. Adjusted hazard ratios for patients started on treatment more than eight weeks after detection or within two to four weeks after detection, was beneficial though not statistically significant with respective p-values of 0.056 and 0.092. The model of care (facility vs. community-based) did not significantly influence survival. Conclusion Both HIV co-infected DR-TB patients and DR-TB patients that fail to start treatment immediately after diagnosis are at significant risk of mortality. Our study showed no significant difference in mortality based on models of care. The study highlights the need to address programmatic and operational issues pertaining to treatment delays and strengthening DR-TB/HIV co-management as key strategies to reduce mortality.	[Bajehson, Mamman; Habibu, Ahmad T.] KNCV Challenge TB, Kano Reg Off, Kano, Nigeria; [Musa, Baba Maiyaki] Bayero Univ, Dept Med, Kano, Nigeria; [Gidado, Mustapha] KNCV TB Fdn, The Hague, Netherlands; [Nsa, Bassey; Sani, Useni] KNCV Nigeria Challenge TB, Country Off, Abuja, Nigeria; [Aliyu, Ibrahim] Kano State TB & Leprosy Control Program, Kano, Nigeria; [Hussaini, Tijjani] State Minist Hlth, Kano, Nigeria; [Yusuf, AbdulRasheed] Katsina State TB & Leprosy Control Program, Katsina, Nigeria; [Gida, Yakubu] Bauchi State TB & Leprosy Control Program, Bauchi, Nigeria	Bayero University; KNCV Tuberculosis Foundation	Bajehson, M (corresponding author), KNCV Challenge TB, Kano Reg Off, Kano, Nigeria.	Mamman.Bajehson@kncvtbc.org		Bajehson, Mamman/0000-0002-5499-5635	United States Agency for International Development for supporting the Programmatic Management of Drug-Resistant Tuberculosis through the Challenge TB project in Nigeria	United States Agency for International Development for supporting the Programmatic Management of Drug-Resistant Tuberculosis through the Challenge TB project in Nigeria	We wish to acknowledge the United States Agency for International Development for supporting the Programmatic Management of Drug-Resistant Tuberculosis through the Challenge TB project in Nigeria.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Alavi-Naini R, 2013, J RES MED SCI, V18, P52; All party Parliamentary group on global Tuberculosis, 2013, DRUG RES TUB OLD DIS; Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Balabanova Y, 2016, THORAX, V71, P854, DOI 10.1136/thoraxjnl-2015-207638; Balabanova Y, 2011, BMJ OPEN, V1, DOI [10.1136/bmjopen-2011-0003511, 10.1136/bmjopen-2011-000351]; Chung-Delgado K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119332; Fantaw D, 2018, ADV PHARMACOEPIDEMIO, V7, P220, DOI [DOI 10.4172/2167-1052.1000222, 10.4172/2167-1052.1000222]; Farmer P, 1998, BRIT MED J, V317, P671, DOI 10.1136/bmj.317.7159.671; Global TB Caucus, 2017, PRIC PAND 2017; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mollel EW, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/9241238; Olaleye AO, 2016, INFECT DIS-NOR, V48, P422, DOI 10.3109/23744235.2016.1153806; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Tang SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082943; TURETT GS, 1995, CLIN INFECT DIS, V21, P1238, DOI 10.1093/clinids/21.5.1238; Umanah T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1214-3; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; WHO, GLOB TB REP 2017; World Health Organization, 2014, COMP HDB WHO GUID PR	22	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225165	10.1371/journal.pone.0225165	http://dx.doi.org/10.1371/journal.pone.0225165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743358	Green Published, Green Submitted, gold			2022-12-26	WOS:000533877300021
J	Yang, HC; Chen, Y; Zhang, FH				Yang, Haichang; Chen, Yun; Zhang, Fenghua			Evaluation of comprehensive improvement for mild and moderate soil salinization in arid zone	PLOS ONE			English	Article							CROP PRODUCTION; SALT TOLERANCE; SALINITY; IRRIGATION; WATER; DRAINAGE; PADDY	Sustainable development of agricultural lands in arid environments is limited by soil salinization. Comprehensive measures were conducted to completely improve soil salinization in this study. For the purpose of assessing the effect of comprehensive improvement in salinized farmland in arid zone, soil salinity at a range of soil depths, EC of subsurface pipe drainage and crop yield during crop growth period in Xinjiang, China were investigated. The results show that soil salinity decreased significantly on mildly (1-3 dS m(-1)) and moderately (3-6 dS m(-1)) salinized farmlands. The improvement in moderately salinized soil was better than that in mildly salinized soil. The average desalinization rate of mildly and moderately salinized farmland was 15% and -15.8%, respectively. The more irrigation times were, the better desalinization effect became. The EC of drainage water varied in the range of 7.53-11.16 dS m(-1) and was greater than the EC of irrigation water, which showed that subsurface pipe drainage can remove soil salinity from salinized farmlands. The crop yield using comprehensive improvement increased significantly compared with the control check. The outcome of this study suggests that comprehensive measures on salinized farmland are conductive to the decrease of soil salinity and the increase of crop yield.	[Yang, Haichang; Zhang, Fenghua] Shihezi Univ, Agr Coll, Shihezi City, Xinjiang, Peoples R China; [Chen, Yun] Commonwealth Sci & Ind Res Org, Land & Water, Canberra, ACT, Australia	Shihezi University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zhang, FH (corresponding author), Shihezi Univ, Agr Coll, Shihezi City, Xinjiang, Peoples R China.	zhangfenghua6088@126.com	Chen, Yun/C-8672-2011; Haichang, Yang/GXF-8063-2022	Chen, Yun/0000-0001-6819-6562; Zhang, Fenghua/0000-0002-1666-9548	National Key Research and Development Program of China [2016YFC0501406]; China Postdoctoral Science Foundation [2018M643823XB]; Youth Innovation Talent Program of Shihezi University [CXPY201910]; Science and Technology Project of Xinjiang Production and Construction Corps [2019AB038]; Startup Foundation for Advanced Talents of Shihezi University [RCSX2018B08]	National Key Research and Development Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Youth Innovation Talent Program of Shihezi University; Science and Technology Project of Xinjiang Production and Construction Corps; Startup Foundation for Advanced Talents of Shihezi University	This research was supported by grants from The National Key Research and Development Program of China (No. 2016YFC0501406), China Postdoctoral Science Foundation funded project (2018M643823XB), The Youth Innovation Talent Program of Shihezi University (CXPY201910), Science and Technology Project of Xinjiang Production and Construction Corps (2019AB038) and Startup Foundation for Advanced Talents of Shihezi University (RCSX2018B08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter J, 2004, PLANT SOIL, V258, P207, DOI 10.1023/B:PLSO.0000016551.08880.6b; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Badalucco L, 2010, BIOL FERT SOILS, V46, P481, DOI 10.1007/s00374-010-0455-y; Bouksila F, 2013, ENVIRON EXP BOT, V92, P176, DOI 10.1016/j.envexpbot.2012.06.002; Chaganti VN, 2015, AGR WATER MANAGE, V158, P255, DOI 10.1016/j.agwat.2015.05.016; Egamberdieva D., 2014, USE MICROBES ALLEVIA, P73, DOI DOI 10.1007/978-1-4614-9466-9_4; FAO-UNESCO, 1988, SOIL MAP WORLD REV L; Gong SW, 2015, SOIL RES, V53, P242, DOI 10.1071/SR14140; Gong Z. T., 1988, ARID ZONE RES, V2, P1; Herrero J, 2014, PADDY WATER ENVIRON, V12, P263, DOI 10.1007/s10333-013-0371-5; Howell TA, 2001, AGRON J, V93, P281, DOI 10.2134/agronj2001.932281x; Kladivko EJ, 2004, J ENVIRON QUAL, V33, P1803, DOI 10.2134/jeq2004.1803; Klimanov AV, 2014, EURASIAN SOIL SCI+, V47, P266, DOI 10.1134/S1064229314040036; Kushiev H., 2005, International Journal of Agricultural Sustainability, V3, P102, DOI 10.1080/14735903.2005.9684748; Li XM, 2012, J INTEGR AGR, V11, P1365, DOI 10.1016/S2095-3119(12)60135-X; Lv ZZ, 2013, PLANT BIOSYST, V147, P1201, DOI 10.1080/11263504.2013.861531; Mkadam KM, 2006, GEOCHEM J, V40, P333, DOI 10.2343/geochemj.40.333; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R., 2009, V44, P99; Ok YS, 2011, CHEMOSPHERE, V85, P677, DOI 10.1016/j.chemosphere.2011.06.073; PASTERNAK D, 1987, ANNU REV PHYTOPATHOL, V25, P271; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Ritzema HP, 2008, AGR WATER MANAGE, V95, P179, DOI 10.1016/j.agwat.2007.09.012; Schultz B, 2002, IRRIG DRAIN, V51, P311, DOI 10.1002/ird.67; Tomar OS, 2003, J ARID ENVIRON, V55, P533, DOI 10.1016/S0140-1963(02)00285-9; Wang SL, 2007, IRRIGATION DRAINAGE, V56; Yan L, 2014, INFORM SYST FRONT, V16, P543, DOI 10.1007/s10796-012-9359-8; Yang CW, 2008, PLANT GROWTH REGUL, V56, P179, DOI 10.1007/s10725-008-9299-y; Yang HC, 2016, SOIL RES, V54, P869, DOI 10.1071/SR15169; Yuan BC, 2007, SOIL BIOL BIOCHEM, V39, P3004, DOI 10.1016/j.soilbio.2007.05.034; Zhao YG, 2016, SOIL TILL RES, V155, P363, DOI 10.1016/j.still.2015.08.019	31	6	8	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0224790	10.1371/journal.pone.0224790	http://dx.doi.org/10.1371/journal.pone.0224790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LE6FL	31743344	Green Published, gold			2022-12-26	WOS:000526819200001
J	Zheng, S; Jiang, SQ; Chen, ZL; Huang, ZC; Shi, WZ; Liu, BQ; Xu, Y; Guo, YN; Yang, HJ; Li, MQ				Zheng, Song; Jiang, Shaoqin; Chen, Zhenlin; Huang, Zhangcheng; Shi, Wenzhen; Liu, Bingqiao; Xu, Yue; Guo, Yinan; Yang, Huijie; Li, Mengqiang			The roles of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen concentrations in predicting prostate cancer and high-risk prostate cancer	PLOS ONE			English	Article							PSA DENSITY; TRANSITION ZONE; ACCURACY	Prostate biopsies are frequently performed to screen for prostate cancer (PCa) with complications such as infections and bleeding. To reduce unnecessary biopsies, here we designed an improved predictive model of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen (PSA) concentrations for diagnosing PCa and risk stratification. Multiparametric MRI administered to 422 consecutive patients before initial transrectal ultrasonography-guided 13-core prostate biopsies from January 2012 to March 2018 at Fujian Medical University Union Hospital. Univariate and multivariate logistic regression analyses and determination of the area under the curve (AUC) of the receiver operating characteristic (ROC) curve was performed to evaluate and integrate the predictors of PCa and high-risk prostate cancer (HR-PCa). The detection rates of PCa was 43.84% (185/422). And the detection rates of HR-PCa was 71.35% (132/185) in PCa patients. Multivariate analysis revealed that prostate volume(PV), PSA density(PSAD), transitional zone volume(TZV), PSA density of the transitional zone(PSADTZ), and MR were independent predictors of PCa and HR-PCa. PSA, peripheral zone volume(PZV) and PSA density of the peripheral zone(PSADPZ) were independent predictors of PCa but not HR-PCa. The AUC of our best predictive model including PSA + PV + PSAD + MR + TZV or PSA + PV + PSAD + MR + PZV was 0.906 for PCa. The AUC of the best predictive model of PV + PSAD + MR + TZV was 0.893 for HR-PCa. In conclusion, our results will likely improve the detection rate of prostate cancer, avoiding unnecessary prostate biopsies, and for evaluating risk stratification.	[Zheng, Song; Jiang, Shaoqin; Chen, Zhenlin; Huang, Zhangcheng; Shi, Wenzhen; Liu, Bingqiao; Xu, Yue; Yang, Huijie; Li, Mengqiang] Fujian Med Univ, Fujian Union Hosp, Dept Urol, Lab Urol, Fuzhou, Fujian, Peoples R China; [Guo, Yinan] Fujian Med Univ, Fujian Union Hosp, Dept Nursing, Lab Urol,Dept Urol, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Li, MQ (corresponding author), Fujian Med Univ, Fujian Union Hosp, Dept Urol, Lab Urol, Fuzhou, Fujian, Peoples R China.	limengqiang1976@163.com			Startup Fund for scientific research, Fujian Medical University [2016QH032]; Fujian Natural Sciences Foundation [2017J01203]; Joint Funds for the innovation of science and Technology, Fujian province [2017Y9023]	Startup Fund for scientific research, Fujian Medical University; Fujian Natural Sciences Foundation; Joint Funds for the innovation of science and Technology, Fujian province	This work was supported by Startup Fund for scientific research, Fujian Medical University (Grant number: 2016QH032), Fujian Natural Sciences Foundation (Grant number: 2017J01203) and Joint Funds for the innovation of science and Technology, Fujian province (Grant number: 2017Y9023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IEEE ACM T COMPUT BI; BENSON MC, 1992, J UROLOGY, V147, P815, DOI 10.1016/S0022-5347(17)37393-7; Chang YF, 2017, ONCOTARGET, V8, P34836, DOI 10.18632/oncotarget.16753; Cronin KA, 2018, CANCER-AM CANCER SOC, V124, P2785, DOI [10.1002/cncr.31551, 10.1002/cncr.32802]; Erbersdobler A, 2004, BJU INT; Fedorov A, 2017, INVEST RADIOL, V52, P538, DOI 10.1097/RLI.0000000000000382; Fu Qiang, 2002, Zhonghua Nan Ke Xue, V8, P411; Giannarini G, 2008, UROL ONCOL-SEMIN ORI, V26, P353, DOI 10.1016/j.urolonc.2007.04.002; Huang Y, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-8; Jeong IG, 2013, PROSTATE INT, V1, P69, DOI 10.12954/PI.12008; Koie T, 2015, INT J CLIN ONCOL, V20, P176, DOI 10.1007/s10147-014-0696-0; MacAskill F, 2017, INT UROL NEPHROL, V49, P1335, DOI 10.1007/s11255-017-1609-8; Nathan MS, 1996, BRIT J UROL, V77, P401, DOI 10.1046/j.1464-410X.1996.90214.x; Nowroozi Mohammadreza, 2015, Nephrourol Mon, V7, pe26752, DOI 10.5812/numonthly.26752; O'Mahoney PRA, 2015, J LAPAROENDOSC ADV S, V25, P737, DOI 10.1089/lap.2014.0603; RAHMOUNI A, 1992, J COMPUT ASSIST TOMO, V16, P935, DOI 10.1097/00004728-199211000-00020; Shen P, 2017, ANDROLOGY-US, V5, P548, DOI 10.1111/andr.12322; Smith RA, 2016, CA-CANCER J CLIN, V66, P96, DOI 10.3322/caac.21336; Castro HAS, 2018, INT BRAZ J UROL, V44, P709, DOI [10.1590/S1677-5538.IBJU.2017.0506, 10.1590/s1677-5538.ibju.2017.0506]; Tanaka N, 2007, PROSTATE CANCER P D, V10, P274, DOI 10.1038/sj.pcan.4500957; Tang P, 2013, UROL ONCOL-SEMIN ORI, V31, P744, DOI 10.1016/j.urolonc.2011.06.012; Ujike T, 2018, ENDOCR-RELAT CANCER, V25, P59, DOI 10.1530/ERC-17-0134; van den Bergh R.C.N., 2018, EAU ESTRO ESUR SIOG; Xie SW, 2018, J CANCER, V9, P4382, DOI 10.7150/jca.27344; Yacoub JH, 2018, RADIOL CLIN N AM, V56, P197, DOI 10.1016/j.rcl.2017.10.003; Zhuo CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002285	26	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0218645	10.1371/journal.pone.0218645	http://dx.doi.org/10.1371/journal.pone.0218645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743339	Green Published, gold			2022-12-26	WOS:000533877300001
J	Jordan, S; Davies, GI; Thayer, DS; Tucker, D; Humphreys, I				Jordan, Sue; Davies, Gareth I.; Thayer, Daniel S.; Tucker, David; Humphreys, Ioan			Antidepressant prescriptions, discontinuation, depression and perinatal outcomes, including breastfeeding: A population cohort analysis	PLOS ONE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; PERSISTENT PULMONARY-HYPERTENSION; LOW-BIRTH-WEIGHT; PRETERM BIRTH; MATERNAL DEPRESSION; PREGNANCY; RISK; EXPOSURE; METAANALYSIS; WOMEN	Objectives To explore associations between exposure to antidepressants, their discontinuation, depression [medicated or unmediated] and preterm birth [< 37 and < 32 weeks], small for gestational age (SGA) [< 10th and < 3rd centiles], breastfeeding [any] at 6-8 weeks. Methods Design: A population-based cohort study. Setting: The Secure Anonymised Information Linkage [SAIL] databank in Wales, linking maternal primary care data with infant outcomes. Participants: 107,573, 105,331, and 38,725 infants born 2000-2010 with information on prematurity, SGA and breastfeeding respectively, after exclusions. Exposures: Maternal antidepressant prescriptions in trimesters 2 or 3, discontinuation after trimester 1, recorded diagnosis of depression [medicated or unmediated] in pregnancy. Methods: Odds ratios for adverse pregnancy outcomes were calculated, adjusted for smoking, parity, socio-economic status, and depression. Results Exclusive formula feeding at 6-8 weeks was associated with prescriptions in trimesters 2 or 3 for any antidepressants (adjusted odds ratio [aOR] 0.81, 95% confidence intervals 0.67-0.98), SSRIs [aOR 0.77, 0.62-0.95], particularly higher doses [aOR 0.45, 0.23-0.86], discontinuation of antidepressants or SSRIs after trimester 1 (aOR 0.70, 0.57-0.83 and 0.66, 0.51-0.87), diagnosis of depression aOR 0.76 [0.70-0.82), particularly if medicated (aOR 0.70, 0.58-0.85), rather than unmedicated (aOR 0.87, 0.82-0.92). Preterm birth at < 37 and < 32 weeks' gestation was associated with diagnosis of depression (aOR 1.27, 1.17-1.38, and 1.33, 1.09-1.62), particularly if medicated (aOR 1.56, 1.23-1.96, and 1.63, 0.94-2.84); birth at < 37 weeks was associated with antidepressants, (aOR 1.24, 1.04-1.49]. SGA < 3rd centile was associated with antidepressants (aOR 1.43, 1.07-1.90), and SSRIs (aOR 1.46, 1.06-2.00], particularly higher doses [aOR 2.10, 1.32-3.34]. All adverse outcomes were associated with socio-economic status and smoking.	[Jordan, Sue; Tucker, David; Humphreys, Ioan] Swansea Univ, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Davies, Gareth I.; Thayer, Daniel S.] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Tucker, David] Publ Hlth Wales, Cardiff, Wales	Swansea University; Swansea University	Jordan, S (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Swansea, W Glam, Wales.	s.e.jordan@swansea.ac.uk		Thayer, Dan/0000-0003-1847-4362; Davies, Gareth/0000-0001-9005-1618; jordan, sue/0000-0002-5691-2987	European Union [HEALTH-F5-2011-260598]; UK Research and Innovation funding through an Administrative Data Research Centre grant (2018-2921) [ES/S007393/1]	European Union(European Commission); UK Research and Innovation funding through an Administrative Data Research Centre grant (2018-2921)	This paper was developed from the EUROmediCAT project, and uses the cohort identified in that project. The analyses presented here were completed outside the funded period. Financial support for the EUROmediCAT study was provided by the European Union under the 7th Framework Program [grant agreement HEALTH-F5-2011-260598]. Start date: 1 March 2011. Duration: 48 months. Coordinator Prof. Helen Dolk, University of Ulster. Further information can be found at www.euromedicat.eu The paper is based on data in the all-Wales SAIL databank, which is supported by UK Research and Innovation funding to Swansea University through an Administrative Data Research Centre grant (2018-2921), project reference: ES/S007393/1, Principal Investigator: Professor David Ford.; This study uses anonymised data held in the Secure Anonymised Information Linkage [SAIL] system, which is part of the national e-health records research infrastructure for Wales. We should like to acknowledge all the data providers who make anonymised data available for research. Data held in SAIL databases are anonymised and aggregated and have been obtained with permission of relevant Data Protection Officers, as approved by the National Research Ethics Service, Wales. Under this agreement, disclosure of numbers <5 is not permitted. The project was approved by the SAIL Information Governance Review Panel [IGFRP] on 24th March 2011. Since the project uses only anonymised data, ethical review was deemed unnecessary.	Alwan S, 2016, CNS DRUGS, V30, P499, DOI 10.1007/s40263-016-0338-3; Amick HR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6019; Angermeyer MC, 2014, SOC SCI MED, V103, P60, DOI 10.1016/j.socscimed.2013.11.014; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Bogen DL, 2010, J CLIN PSYCHIAT, V71, P1069, DOI 10.4088/JCP.09m05383blu; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; Charlton RA, 2015, BJOG-INT J OBSTET GY, V122, P1010, DOI 10.1111/1471-0528.13143; Christiaens I, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0353-0; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cooper DL, 2013, J EPIDEMIOL COMMUN H, V67, P821, DOI 10.1136/jech-2012-202303; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Daws LC, 2011, PHARMACOL THERAPEUT, V131, P61, DOI 10.1016/j.pharmthera.2011.03.013; De Vera MA, 2012, BRIT J CLIN PHARMACO, V74, P362, DOI 10.1111/j.1365-2125.2012.04196.x; Delpisheh A, 2007, PUBLIC HEALTH, V121, P861, DOI 10.1016/j.puhe.2007.03.015; Eke AC, 2016, BJOG-INT J OBSTET GY, V123, P1900, DOI 10.1111/1471-0528.14144; EUROCAT EUROCAT, 2013, GUID 1 4 EUROCAT CEN; EUROmediCAT. [EMC], 2015, SEL SER REUPT INH SS; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Galbally M, 2019, J HUM LACT, V35, P127, DOI 10.1177/0890334418758658; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gemmel M, 2018, NEUROSCI BIOBEHAV R, V85, P102, DOI 10.1016/j.neubiorev.2017.04.023; Gentile S, 2017, J MATERN-FETAL NEO M, V30, P1189, DOI 10.1080/14767058.2016.1209184; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Handal M, 2016, BJOG-INT J OBSTET GY, V123, P1908, DOI 10.1111/1471-0528.13582; Hannerfors AK, TREATMENT SEROTONIN; Hendrick V, 2003, AM J PSYCHIAT, V160, P993, DOI 10.1176/appi.ajp.160.5.993; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; Hilli J, 2009, EUR NEUROPSYCHOPHARM, V19, P363, DOI 10.1016/j.euroneuro.2009.01.006; Huang H, 2014, GEN HOSP PSYCHIAT, V36, P13, DOI 10.1016/j.genhosppsych.2013.08.002; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V314, P1294, DOI 10.1001/jama.2015.10048; IBM Corp, 2011, IBM SPSS STAT WIND V; ICH, 1996, ICH HARM TRIP GUID G; Jefferies AL, 2011, PAED CHILD HEALT-CAN, V16, P562, DOI 10.1093/pch/16.9.562; Jordan S, 2005, BJOG-INT J OBSTET GY, V112, P927, DOI 10.1111/j.1471-0528.2005.00548.x; Jordan S, 2009, BJOG-INT J OBSTET GY, V116, P1622, DOI 10.1111/j.1471-0528.2009.02256.x; Jordan S., 2015, ARCH WOMEN MENT HLTH, V18, P269, DOI [10.1007/S00737-014-0488-6, DOI 10.1007/S00737-014-0488-6]; Jordan S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165122; Jordan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067912; Kaihola H, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00160; Kendall-Tackett K, 2010, J HUM LACT, V26, P187, DOI 10.1177/0890334409342071; Kendrick T, 2005, BRIT J GEN PRACT, V55, P280; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Leggett C, 2017, J HUM LACT, V33, P701, DOI 10.1177/0890334416678209; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Malin GL, 2015, BJOG-INT J OBSTET GY, V122, P634, DOI 10.1111/1471-0528.13282; Malm H, 2015, AM J PSYCHIAT, V172, P1224, DOI 10.1176/appi.ajp.2015.14121575; Marshall AM, 2010, J CLIN ENDOCR METAB, V95, P837, DOI 10.1210/jc.2009-1575; Martins ACM, 2014, J CLIN PHARM THER, V39, P609, DOI 10.1111/jcpt.12204; Maschi S, 2008, BJOG-INT J OBSTET GY, V115, P283, DOI 10.1111/j.1471-0528.2007.01518.x; McAndrew F, 2012, INFANT FEEDING SURVE; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; McManus S, ADULT PSYCHIAT 2009; Merlob P., 2015, DRUGS PREGNANCY, VLactation, P743, DOI [10.1016/B978-0-12-408078-2.00034-2, DOI 10.1016/B978-0-12-408078-2.00034-2]; Miquel-Verges F, 2015, J PERINATOL, V35, P198, DOI 10.1038/jp.2014.180; Mitchell J, 2018, ARCH WOMEN MENT HLTH, V21, P505, DOI 10.1007/s00737-018-0844-z; Molenaar NM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0752-6; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; NCCMH. [National Collaborating Centre for Mental Health] Antenatal and postnatal mental health: Clinical management and service guidance updated edition, 2014, ANT POSTN MENT HLTH; Nikfar S, 2012, DARU, V20, DOI 10.1186/2008-2231-20-75; Olivier JDA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00073; Pearlstein T, 2015, BEST PRACT RES CL OB, V29, P754, DOI 10.1016/j.bpobgyn.2015.04.004; Purisch SE, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.089; Ray S, 2014, BEST PRACT RES CL OB, V28, P71, DOI 10.1016/j.bpobgyn.2013.09.005; Reefhuis J, 2006, NEW ENGL J MED, V354, P2188; Robinson D, 1997, J AM MED INFORM ASSN, V4, P465, DOI 10.1136/jamia.1997.0040465; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Saha MR, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0053-6; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Salisbury AL, 2009, CLIN PERINATOL, V36, P595, DOI 10.1016/j.clp.2009.06.002; Sillesen M, 2011, EUR J CARDIO-THORAC, V40, P448, DOI 10.1016/j.ejcts.2010.12.011; Sockol LE, 2015, J AFFECT DISORDERS, V177, P7, DOI 10.1016/j.jad.2015.01.052; Statistics Wales Birth Statistics from the National Community Child Health Database [NCCHD], 2013, QUAL REP; 't Jong GW, 2012, REPROD TOXICOL, V34, P293, DOI 10.1016/j.reprotox.2012.04.015; Tak CR, 2017, EUR J CLIN PHARMACOL, V73, P1055, DOI 10.1007/s00228-017-2269-4; Taylor D, 2015, FROM THE CAM TO THE ZAMBEZI: COLONIAL SERVICE AND THE PATH TO THE NEW ZAMBIA, P1; The European Network for Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), EMA950982010; Toh S, 2009, J CLIN PSYCHOPHARM, V29, P555, DOI 10.1097/JCP.0b013e3181bf344c; Toh S, 2009, AM J PSYCHIAT, V166, P320, DOI 10.1176/appi.ajp.2008.08060817; Townsend PP., 1988, HLTH DEPRIVATION INE; Velasquez JC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00047; Venkatesh KK, 2017, J PERINATOL, V37, P1003, DOI 10.1038/jp.2017.92; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Viktorin A, 2016, AM J PSYCHIAT, V173, P158, DOI 10.1176/appi.ajp.2015.15010085; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; Weightman AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000964; Willner P, 2013, NEUROSCI BIOBEHAV R, V37, P2331, DOI 10.1016/j.neubiorev.2012.12.007; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]; Zhao XF, 2018, J AFFECT DISORDERS, V241, P563, DOI 10.1016/j.jad.2018.08.061	97	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225133	10.1371/journal.pone.0225133	http://dx.doi.org/10.1371/journal.pone.0225133			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN3EY	31738813	gold, Green Published			2022-12-26	WOS:000532826300036
J	Cho, SB; Choi, HC; Lee, SM; Na, JB; Park, MJ; Shin, HS; Won, JH; Lee, CE; Park, SE				Cho, Soo Buem; Choi, Ho Cheol; Lee, Sang Min; Na, Jae Boem; Park, Mi Jung; Shin, Hwa Seon; Won, Jung Ho; Lee, Chung Eun; Park, Sung Eun			Combined treatment (image-guided thrombectomy and endovascular therapy with open femoral access) for acute lower limb ischemia: Clinical efficacy and outcomes	PLOS ONE			English	Article							LOWER-EXTREMITY; SURGICAL REVASCULARIZATION; ARTERY OCCLUSIONS; INITIAL TREATMENT; STENT PLACEMENT; THROMBOLYSIS; ANGIOPLASTY; SURGERY; METAANALYSIS; GUIDELINES	Objectives To evaluate the effectiveness and safety of combined treatment (image guided thrombectomy and endovascular therapy with open femoral access) for acute lower limb ischemia. Methods From 2009 to 2017, 52 patients (44 men, eight women, mean 67.2 years) underwent combined treatment for acute thrombotic occlusion of lower extremity arteries. The patients presented with acute limb ischemia and we selectively perform combined treatment in the cases with challenging clinical considerations (e.g. various spectrum of thrombus, underlying atherosclerotic lesions). Combined treatment included cutdown of common femoral artery, thrombectomy using a Fogarty balloon catheter, balloon angioplasty, stenting, and catheter-introduced thrombus fragmentation and aspiration. Patients' medical records were retrospectively reviewed and follow-up data were collected. The technical and clinical success rates and limb salvage were assessed. The Kaplan-Meier method was used to analyze primary patency rates and overall survival rates. Univariate analyses were performed to determine the factors related to clinical outcomes. Results Technical and clinical success rate was 90.4% and 80.8%, respectively. The mean follow-up duration was 26.5 +/- 25.8 months. Primary patency was 91.4%, 86.1%, and 74.6% at six months, 1-, and 2-year, respectively. Limb salvage without amputation was 88.5% (46/52). The overall survival rates at six months, 1-, and 3-year were 82.6%, 80.2, and 56.9%, respectively. The 30-day mortality was 5.8% (3/52). Univariate analysis showed that percutaneous transluminal angioplasty (PTA) type (balloon versus stent) was related to clinical failure. Conclusions Combined treatment can be effective and safe for ALI patients even under challenging clinical conditions.	[Cho, Soo Buem] Ewha Womans Univ, Seoul Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Choi, Ho Cheol; Lee, Sang Min; Na, Jae Boem; Park, Mi Jung; Shin, Hwa Seon; Won, Jung Ho] Gyeongsang Natl Univ, Dept Radiol, Sch Med, Jinju, South Korea; [Choi, Ho Cheol; Lee, Sang Min; Na, Jae Boem; Park, Mi Jung; Shin, Hwa Seon; Won, Jung Ho; Lee, Chung Eun] Gyeonsang Natl Univ Hosp, Jinju, South Korea; [Lee, Chung Eun] Gyeongsang Natl Univ, Thorac & Cardiovasc Surg, Sch Med, Jinju, South Korea; [Park, Sung Eun] Gyeongsang Natl Univ, Dept Radiol, Sch Med, Chang Won, South Korea; [Park, Sung Eun] Gyeonsang Natl Univ, Changwon Hosp, Chang Won, South Korea	Ewha Womans University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University	Lee, SM (corresponding author), Gyeongsang Natl Univ, Dept Radiol, Sch Med, Jinju, South Korea.; Lee, SM (corresponding author), Gyeonsang Natl Univ Hosp, Jinju, South Korea.	lsmd10@naver.com	Park, Mi Jung/GRN-9597-2022; Park, Mi Jung/GRO-0133-2022	Park, Mi Jung/0000-0002-1136-1763; Park, Mi Jung/0000-0002-1136-1763				Bosch JL, 1997, RADIOLOGY, V204, P87, DOI 10.1148/radiology.204.1.9205227; Campbell WB, 1998, BRIT J SURG, V85, P1498; Cardella JF, 2009, J VASC INTERV RADIOL, V20, pS189, DOI 10.1016/j.jvir.2009.04.035; Chowdhury MM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006767.pub3; Davies MG, 2008, J VASC SURG, V48, P619, DOI 10.1016/j.jvs.2008.04.013; de Donato G, 2014, J VASC SURG, V59, P729, DOI 10.1016/j.jvs.2013.09.016; FOGARTY TJ, 1989, J VASC SURG, V10, P530, DOI 10.1067/mva.1989.15454; Fusaro M, 2013, JACC-CARDIOVASC INTE, V6, P1284, DOI 10.1016/j.jcin.2013.08.007; Goode SD, 2013, BRIT J SURG, V100, P1148, DOI 10.1002/bjs.9197; GRAOR RA, 1994, ANN SURG, V220, P251; Kashyap VS, 2011, J VASC SURG, V53, P340, DOI 10.1016/j.jvs.2010.08.064; KUUKASJARVI P, 1994, EUR J VASCULAR SURG, V8, P578, DOI 10.1016/S0950-821X(05)80594-8; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; OURIEL K, 1994, J VASC SURG, V19, P1021, DOI 10.1016/S0741-5214(94)70214-4; Ouriel K, 1996, J VASC SURG, V23, P64, DOI 10.1016/S0741-5214(05)80036-9; Ouriel K, 1998, NEW ENGL J MED, V338, P1105, DOI 10.1056/NEJM199804163381603; Parsons RE, 1996, ANN VASC SURG, V10, P201, DOI 10.1007/BF02001883; PLECHA FR, 1972, ARCH SURG-CHICAGO, V105, P902; Rastan A, 2013, CIRCULATION, V127, P2535, DOI 10.1161/CIRCULATIONAHA.113.001849; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Rutherford RB, 2009, SEMIN VASC SURG, V22, P5, DOI 10.1053/j.semvascsurg.2008.12.003; Taha AG, 2015, J VASC SURG, V61, P147, DOI 10.1016/j.jvs.2014.06.109; Vedantham S, 2014, J VASC INTERV RADIOL, V25, P1317, DOI 10.1016/j.jvir.2014.04.019; Weaver FA, 1996, J VASC SURG, V24, P513, DOI 10.1016/S0741-5214(96)70067-8; YEAGER RA, 1992, J VASC SURG, V15, P385, DOI 10.1016/0741-5214(92)90260-F	25	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225136	10.1371/journal.pone.0225136	http://dx.doi.org/10.1371/journal.pone.0225136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730625	Green Published, gold			2022-12-26	WOS:000532809500026
J	Kato, S; Iwasaki, A; Kurita, Y; Arimoto, J; Yamamoto, T; Hasegawa, S; Sato, T; Imajo, K; Hosono, K; Kobayashi, N; Yoneda, M; Higurashi, T; Kubota, K; Utsunomiya, D; Nakajima, A				Kato, Shingo; Iwasaki, Akito; Kurita, Yusuke; Arimoto, Jun; Yamamoto, Toh; Hasegawa, Sho; Sato, Takamitsu; Imajo, Kento; Hosono, Kunihiro; Kobayashi, Noritoshi; Yoneda, Masato; Higurashi, Takuma; Kubota, Kensuke; Utsunomiya, Daisuke; Nakajima, Atsushi			Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility	PLOS ONE			English	Article							LIVER-DISEASE; FIBROSIS; MRI; QUANTIFICATION; CHOLESTEROL; AUTOPSY	Background Since pancreatic steatosis is reported as a possible risk factor for pancreatic cancer, the development of a non-invasive method to quantify pancreatic steatosis is needed. Proton density fat fraction (PDFF) measurement is a magnetic resonance imaging (MRI) based method for quantitatively assessing the steatosis of a region of interest (ROI). Although it is commonly used for quantification of hepatic steatosis, pancreatic PDFF can greatly vary depending on the ROI's location because of the patchy nature of pancreatic fat accumulation. In this study, we attempted to quantify pancreatic steatosis by fat-water MRI with improved reproducibility. Methods Using the MRI images of 159 patients with nonalcoholic fatty liver disease, we attempted to calculate the average PDFF of whole pancreas. We set ROIs covering the entire area of the pancreas appearing in every slice and calculated the average PDFF from all the voxels included in the pancreas. We named this average value as whole-pancreatic PDFF and evaluated the reproducibility of the measured values. In addition to whole-pancreatic PDFF, we measured the average PDFF of the pancreatic head (head-PDFF) and that of the pancreatic body plus tail separately and analyzed their correlation with the clinical characteristics of the patients. Results The mean inter-examiner coefficient of variation of the whole-pancreatic PDFF was 11.39%. The whole-pancreatic PDFF was correlated with age (p = 0.039), body mass index (p = 0.0093) and presence/absence of diabetes (p = 0.0055). The serum level of low-density lipoprotein cholesterol was inversely correlated with the head-PDFF. Conclusion We developed a new measurement method of the pancreatic PDFF with greater reproducibility. Using this method, we characterized pancreatic steatosis in detail. This novel measurement method allows accurate estimation of the severity of pancreatic steatosis and is therefore useful for the detailed characterization of pancreatic steatosis.	[Kato, Shingo; Iwasaki, Akito; Kurita, Yusuke; Arimoto, Jun; Hasegawa, Sho; Sato, Takamitsu; Imajo, Kento; Hosono, Kunihiro; Yoneda, Masato; Higurashi, Takuma; Kubota, Kensuke; Nakajima, Atsushi] Yokohama City Univ, Dept Gastroenterol & Hepatol, Sch Med, Yokohama, Kanagawa, Japan; [Yamamoto, Toh; Utsunomiya, Daisuke] Yokohama City Univ, Diagnost Radiol, Grad Sch Med, Yokohama, Kanagawa, Japan; [Kobayashi, Noritoshi] Yokohama City Univ Med, Dept Oncol, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Yokohama City University	Nakajima, A (corresponding author), Yokohama City Univ, Dept Gastroenterol & Hepatol, Sch Med, Yokohama, Kanagawa, Japan.	nakajima-tky@umin.ac.jp	Higurashi, Takuma/AAD-7747-2022; Kurita, Yusuke/GPK-7068-2022					Biswas N, 2016, Mymensingh Med J, V25, P425; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1; Hori M, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.5; Hu HH, 2010, OBESITY, V18, P841, DOI 10.1038/oby.2009.352; Idilman IS, 2015, ABDOM IMAGING, V40, P1512, DOI 10.1007/s00261-015-0385-0; Imajo K, 2016, GASTROENTEROLOGY, V150, P626, DOI 10.1053/j.gastro.2015.11.048; Jennings RE, 2015, DEVELOPMENT, V142, P3126, DOI 10.1242/dev.120063; Kuhn JP, 2015, RADIOLOGY, V276, P129, DOI 10.1148/radiol.15140446; Marz W, 2016, AM J CARDIOVASC DRUG, V16, P323, DOI 10.1007/s40256-016-0179-y; MATSUMOTO S, 1995, RADIOLOGY, V194, P453, DOI 10.1148/radiology.194.2.7824726; OLSEN TS, 1978, ACTA PATH MICRO IM A, V86, P367; Ou HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062561; Patel NS, 2013, ALIMENT PHARM THER, V37, P630, DOI 10.1111/apt.12237; Smits MM, 2011, NAT REV GASTRO HEPAT, V8, P169, DOI 10.1038/nrgastro.2011.4; STAMM BH, 1984, HUM PATHOL, V15, P677, DOI 10.1016/S0046-8177(84)80294-4; Sun DQ, 2016, ONCOTARGET, V7, P5728, DOI 10.18632/oncotarget.6799; Takahashi M, 2018, CANCER SCI, V109, P3013, DOI 10.1111/cas.13766; van Geenen EJM, 2010, PANCREAS, V39, P1185, DOI 10.1097/MPA.0b013e3181f6fce2; Wong VWS, 2014, AM J GASTROENTEROL, V109, P589, DOI 10.1038/ajg.2014.1; Yoon JH, 2016, RADIOLOGY, V279, P140, DOI 10.1148/radiol.2015142254; Yu HZ, 2011, MAGN RESON MED, V66, P199, DOI 10.1002/mrm.22840	21	17	17	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224921	10.1371/journal.pone.0224921	http://dx.doi.org/10.1371/journal.pone.0224921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790429	Green Published, gold			2022-12-26	WOS:000533930800017
J	Ramirez-Bello, J; Sun, CL; Valencia-Pacheco, G; Singh, B; Barbosa-Cobos, RE; Saavedra, MA; Lopez-Villanueva, RF; Nath, SK				Ramirez-Bello, Julian; Sun, Celi; Valencia-Pacheco, Guillermo; Singh, Bhupinder; Elda Barbosa-Cobos, Rosa; Saavedra, Miguel A.; Lopez-Villanueva, Ricardo F.; Nath, Swapan K.			ITGAM is a risk factor to systemic lupus erythematosus and possibly a protection factor to rheumatoid arthritis in patients from Mexico	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NECROSIS-FACTOR-ALPHA; GENETIC ASSOCIATION; FUNCTIONAL VARIANT; RS1143679 R77H; DISEASE; SUSCEPTIBILITY; POLYMORPHISM; ADMIXTURE; LOCI	Introduction ITGAM has consistently been associated with susceptibility to systemic lupus erythematosus (SLE) in many ethnically diverse populations. However, in populations with higher Amerindian ancestry (like Yucatan) or highly admixed population (like Mexican), ITGAM has seldom been evaluated (except few studies where patients with childhood-onset SLE were included). In addition, ITGAM has seldom been evaluated in patients with rheumatoid arthritis (RA). Here, we evaluated whether four single nucleotide polymorphisms (SNPs), located within ITGAM, were associated with SLE and RA susceptibility in patients from Mexico. Methods Our study consisted of 1,462 individuals, which included 363 patients with SLE (292 from Central Mexico and 71 from Yucatan), and 621 healthy controls (504 from Central Mexico and 117 from Yucatan). Our study also included 478 patients with RA from Central Mexico. TaqMan assays were used to obtain the genotypes of the four SNPs: rs34572943 (G/A), rs1143679 (G/A), rs9888739 (C/T), and rs1143683 (C/T). We also verified the genotypes by Sanger sequencing. Fisher's exact test and permutation test were employed to evaluate the distribution of genotype, allele, and haplotype between patients and controls. Results Our data show that all four ITGAM SNPs are significantly associated with susceptibility to SLE using both genotypic and allelic association tests (corrected for multiple testing, but not for population stratification). A second study carried out in patients from Yucatan, a southeastern part of Mexico (with a high Amerindian ancestry), also replicated SLE association with all four SNPs, including the functional SNP, rs1143679 (OR = 24.6 and p = 9.3X10(-6)). On the other hand, none of the four SNPs are significant in RA after multiple testing. Interestingly, the GACC haplotype, which carries the ITGAM rs1143679 (A) minor allele, showed an association with protection against RA (OR = 0.14 and p = 3.0x10(-4)). Conclusion Our data displayed that ITGAM is a risk factor to SLE in individuals of Mexican population. Concurrently, a risk haplotype in ITGAM confers protection against RA.	[Ramirez-Bello, Julian] Hosp Juarez Mexico, Res Unit, Mexico City, DF, Mexico; [Sun, Celi; Singh, Bhupinder; Nath, Swapan K.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Valencia-Pacheco, Guillermo] Autonomous Univ Yucatan, Reg Res Ctr, Hematol Lab, Merida, Yucatan, Mexico; [Elda Barbosa-Cobos, Rosa] Hosp Juarez Mexico, Rheumatol Dept, Mexico City, DF, Mexico; [Saavedra, Miguel A.] Ctr Med Nacl La Raza, Rheumatol Dept, Mexico City, DF, Mexico; [Lopez-Villanueva, Ricardo F.] Reg Hosp Gen ISSSTE, Rheumatol Dept, Hlth Serv Yucatan, Merida, Yucatan, Mexico	Oklahoma Medical Research Foundation; Universidad Autonoma de Yucatan; Instituto Mexicano del Seguro Social	Nath, SK (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Swapan-Nath@omrf.org	Pacheco, Guillermo Valencia/AAU-5220-2020; Saavedra, Miguel/AAK-7278-2021; Pacheco, Guillermo Valencia/AAU-5864-2020; Ramírez-Bello, Julian/AAR-1308-2020	Pacheco, Guillermo Valencia/0000-0002-6633-130X; Ramírez-Bello, Julian/0000-0002-4153-9315; nath, swapan/0000-0001-6013-9328; Singh, Bhupinder/0000-0002-9185-7944; LOPEZ VILLANUEVA, RICARDO/0000-0002-8697-2112	National Institute of Health [AR60366, MD007909]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Health grants (AR60366, MD007909). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Riquelme ME, 2016, ARTHRITIS RHEUMATOL, V68, P932, DOI 10.1002/art.39504; Anaya JM, 2012, AUTOIMMUN REV, V11, P276, DOI 10.1016/j.autrev.2011.07.007; Baca V, 2006, GENES IMMUN, V7, P693, DOI 10.1038/sj.gene.6364350; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Deng Y, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0695-z; Deshmukh HA, 2011, J RHEUMATOL, V38, P1866, DOI 10.3899/jrheum.110199; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Gupta V, 2018, LUPUS, V27, P1973, DOI 10.1177/0961203318786432; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jimenez-Morales S, 2009, HUM IMMUNOL, V70, P251, DOI 10.1016/j.humimm.2009.01.027; Lopez-Cano DJ, 2017, INFLAMM RES, V66, P775, DOI 10.1007/s00011-017-1056-0; Khan SQ, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00052; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Li CM, 2018, J INT MED RES, V46, P1008, DOI 10.1177/0300060517719210; Maiti AK, 2014, HUM MOL GENET, V23, P4161, DOI 10.1093/hmg/ddu106; Martinez-Cortes G, 2012, J HUM GENET, V57, P568, DOI 10.1038/jhg.2012.67; Martinez-Marignac VL, 2007, HUM GENET, V120, P807, DOI 10.1007/s00439-006-0273-3; Rincon JFM, 2016, CLIN RHEUMATOL, V35, P1457, DOI 10.1007/s10067-016-3223-z; Molineros JE, 2009, GENES IMMUN, V10, P539, DOI 10.1038/gene.2009.30; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Orozco G, 2011, ANN RHEUM DIS, V70, P463, DOI 10.1136/ard.2010.137174; Pelaez-Ballestas I, 2011, J RHEUMATOL, V38, P3, DOI 10.3899/jrheum.100951; Phipps-Green AJ, 2009, RHEUMATOLOGY, V48, P1614, DOI 10.1093/rheumatology/kep254; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez-Bello J, 2018, IMMUNOL RES, V66, P348, DOI 10.1007/s12026-018-8993-8; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Machado-Contreras JR, 2016, CLIN EXP MED, V16, P399, DOI 10.1007/s10238-015-0359-0; Rhodes B, 2012, ANN RHEUM DIS, V71, P2028, DOI 10.1136/annrheumdis-2012-201390; Roberts AL, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4566; Ruiz-Larranaga O, 2016, CLIN RHEUMATOL, V35, P1161, DOI 10.1007/s10067-016-3235-8; Sanchez E, 2011, ARTHRITIS RHEUM-US, V63, P3493, DOI 10.1002/art.30563; Sanchez E, 2010, ARTHRITIS RHEUM-US, V62, P3722, DOI 10.1002/art.27753; Suarez-Gestal M, 2009, ARTHRITIS RHEUM-US, V60, P2558, DOI 10.1002/art.24748; Suarez-Gestal M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2698; Viatte S, 2017, SEMIN IMMUNOPATHOL, V39, P395, DOI 10.1007/s00281-017-0630-4; Yang WL, 2009, HUM MOL GENET, V18, P2063, DOI 10.1093/hmg/ddp118; Zuniga J, 2001, GENES IMMUN, V2, P363, DOI 10.1038/sj.gene.6363793	40	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0224543	10.1371/journal.pone.0224543	http://dx.doi.org/10.1371/journal.pone.0224543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774828	gold, Green Published			2022-12-26	WOS:000533896400013
J	Vaesen, K; Scherjon, F; Hemerik, L; Verpoorte, A				Vaesen, Krist; Scherjon, Fulco; Hemerik, Lia; Verpoorte, Alexander			Inbreeding, Allee effects and stochasticity might be sufficient to account for Neanderthal extinction	PLOS ONE			English	Article							MODERN HUMANS; MODEL; MIDDLE; EVOLUTION; DYNAMICS; SURVIVAL; BEHAVIOR; ORIGINS; HISTORY; CLIMATE	The replacement of Neanderthals by Anatomically Modern Humans has typically been attributed to environmental pressure or a superiority of modern humans with respect to competition for resources. Here we present two independent models that suggest that no such heatedly debated factors might be needed to account for the demise of Neanderthals. Starting from the observation that Neanderthal populations already were small before the arrival of modern humans, the models implement three factors that conservation biology identifies as critical for a small population's persistence, namely inbreeding, Allee effects and stochasticity. Our results indicate that the disappearance of Neanderthals might have resided in the smallness of their population(s) alone: even if they had been identical to modern humans in their cognitive, social and cultural traits, and even in the absence of inter-specific competition, Neanderthals faced a considerable risk of extinction. Furthermore, we suggest that if modern humans contributed to the demise of Neanderthals, that contribution might have had nothing to do with resource competition, but rather with how the incoming populations geographically restructured the resident populations, in a way that reinforced Allee effects, and the effects of inbreeding and stochasticity.	[Vaesen, Krist] Eindhoven Univ Technol, Sch Innovat Sci, Eindhoven, Netherlands; [Vaesen, Krist; Scherjon, Fulco; Verpoorte, Alexander] Leiden Univ, Fac Archaeol, Human Origins Grp, Leiden, Netherlands; [Hemerik, Lia] Wageningen Univ, Biometris Math & Stat Methods, Wageningen, Netherlands	Eindhoven University of Technology; Leiden University; Leiden University - Excl LUMC; Wageningen University & Research	Vaesen, K (corresponding author), Eindhoven Univ Technol, Sch Innovat Sci, Eindhoven, Netherlands.; Vaesen, K (corresponding author), Leiden Univ, Fac Archaeol, Human Origins Grp, Leiden, Netherlands.	k.vaesen@tue.nl		Vaesen, Krist/0000-0002-7496-7463; Hemerik, Lia/0000-0002-6892-2840; Scherjon, Fulco/0000-0002-5859-8813	Netherlands Organisation for Scientific Research (NWO) [276-20-021]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Research by KV was supported by the Netherlands Organisation for Scientific Research (NWO) (grant 276-20-021).	[Anonymous], 2004, INTERDISCIP APPL MAT; [Anonymous], 1983, REGIONAL MODEL LIFE; Banks WE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003972; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Bocquet-Appel JP, 2013, CURR ANTHROPOL, V54, pS202, DOI 10.1086/673725; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Caswell, 2000, MATRIX POPULATION MO; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; CHAKRABORTY R, 1977, HUM GENET, V36, P47, DOI 10.1007/BF00390435; Chamberlain A.T., 2006, DEMOGRAPHY ARCHAEOLO; Churchill SE, 2014, THIN ON THE GROUND: NEANDERTAL BIOLOGY, ARCHEOLOGY, AND ECOLOGY, P1, DOI 10.1002/9781118590836; Courchamp F, 2000, ANIM CONSERV, V3, P277, DOI 10.1017/S1367943000001001; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Finlayson C., 2004, NEANDERTHALS MODERN; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Finlayson C, 2008, QUATERNARY SCI REV, V27, P2246, DOI 10.1016/j.quascirev.2008.08.033; Flores JC, 2011, J THEOR BIOL, V280, P189, DOI 10.1016/j.jtbi.2011.04.008; Flores JC, 1998, J THEOR BIOL, V191, P295, DOI 10.1006/jtbi.1997.0581; French JC, 2016, J ARCHAEOL METHOD TH, V23, P150, DOI 10.1007/s10816-014-9237-4; Gao ZY, 2015, GENETICS, V199, P1243, DOI 10.1534/genetics.114.173351; Gilpin W, 2016, P NATL ACAD SCI USA, V113, P2134, DOI 10.1073/pnas.1524861113; Goldfield AE, 2018, J HUM EVOL, V124, P91, DOI 10.1016/j.jhevol.2018.07.006; Golovanova LV, 2010, CURR ANTHROPOL, V51, P655, DOI 10.1086/656185; Hajdinjak M, 2018, NATURE, V555, P652, DOI 10.1038/nature26151; Harris K, 2016, GENETICS, V203, P881, DOI 10.1534/genetics.116.186890; Hershkovitz I, 2018, SCIENCE, V359, P456, DOI 10.1126/science.aap8369; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; Horan RD, 2005, J ECON BEHAV ORGAN, V58, P1, DOI 10.1016/j.jebo.2004.03.009; Hrdy SB, 2009, MOTHER OTHERS EVOLUT; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Hublin JJ, 2009, CR PALEVOL, V8, P503, DOI 10.1016/j.crpv.2009.04.001; Jimenez-Espejo FJ, 2007, QUATERNARY SCI REV, V26, P836, DOI 10.1016/j.quascirev.2006.12.013; Kelly Robert L, 2013, LIFEWAYS HUNTER GATH; Klein RG, 2008, EVOL ANTHROPOL, V17, P267, DOI 10.1002/evan.20181; Kolodny O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01043-z; Kuhlwilm M, 2016, NATURE, V530, P429, DOI 10.1038/nature16544; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Lacy RC, 2014, STOCHASTIC SIMULATIO; Lacy Robert C., 2000, Ecological Bulletins, V48, P191; Lalueza-Fox C, P NAT ACAD SC, V108, P250, DOI [10.1038/s41467-017-01043-z, DOI 10.1038/S41467-017-01043-Z]; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Mafessoni F, 2017, P NAT AC SC, V114, P16918; Marean C.W., 2005, TOOLS SYMBOLS EARLY, P333; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Molnar PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085410; Muller UC, 2011, QUATERNARY SCI REV, V30, P273, DOI 10.1016/j.quascirev.2010.11.016; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Nash DJ, 2013, J HUM EVOL, V64, P280, DOI 10.1016/j.jhevol.2013.01.010; Pennington R, 2001, BIOSOCIAL S, V13, P170; Pettit P.B., 1999, OXFORD J ARCHAEOL, V18, P217; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Rios L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136550; Rogers AR, 2017, P NATL ACAD SCI USA, V114, P9859, DOI 10.1073/pnas.1706426114; Shea J.J., 2010, PALAEOANTHROPOLOGY, V2010, P100; Shea JJ, 2009, VERTEBR PALEOBIOL PA, P189, DOI 10.1007/978-1-4020-9699-0_14; Sikora M, 2017, SCIENCE, V358, P659, DOI 10.1126/science.aao1807; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; Sorensen B, 2011, J ANTHROPOL ARCHAEOL, V30, P17, DOI 10.1016/j.jaa.2010.12.003; Soule M., 1987, VIABLE POPULATIONS C; Stringer C, 2003, NATURE, V423, P692, DOI 10.1038/423692a; TULJAPURKAR SD, 1980, THEOR POPUL BIOL, V18, P314, DOI 10.1016/0040-5809(80)90057-X; Tzedakis PC, 2007, NATURE, V449, P206, DOI 10.1038/nature06117; Underdown S, 2008, MED HYPOTHESES, V71, P4, DOI 10.1016/j.mehy.2007.12.014; Villa P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096424; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wolff H, 2010, MED HYPOTHESES, V75, P99, DOI 10.1016/j.mehy.2010.01.048; Wynn Thomas, 2011, Int J Evol Biol, V2011, P741357, DOI 10.4061/2011/741357; Wynn T, 2009, P NATL ACAD SCI USA, V106, P9544, DOI 10.1073/pnas.0904369106; ZUBROW E, 1989, HUMAN REVOLUTION, P212	78	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225117	10.1371/journal.pone.0225117	http://dx.doi.org/10.1371/journal.pone.0225117			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8SS	31774843	Green Published, gold			2022-12-26	WOS:000533896400024
J	Choi, SB; Kim, J; Ahn, I				Choi, Soo Beom; Kim, Juhyeon; Ahn, Insung			Forecasting type-specific seasonal influenza after 26 weeks in the United States using influenza activities in other countries	PLOS ONE			English	Article							EPIDEMIOLOGY; PREDICTION; EVOLUTION; AUSTRALIA; PATTERNS; VIRUSES	To identify countries that have seasonal patterns similar to the time series of influenza surveillance data in the United States and other countries, and to forecast the 2018-2019 seasonal influenza outbreak in the U.S., we collected the surveillance data of 164 countries using the FluNet database, search queries from Google Trends, and temperature from 2010 to 2018. Data for influenza-like illness (ILI) in the U.S. were collected from the Fluview database. We identified the time lag between two time-series which were weekly surveillances for ILI, total influenza (Total INF), influenza A (INF A), and influenza B (INF B) viruses between two countries using cross-correlation analysis. In order to forecast ILI, Total INF, INF A, and INF B of next season (after 26 weeks) in the U.S., we developed prediction models using linear regression, auto regressive integrated moving average, and an artificial neural network (ANN). As a result of cross-correlation analysis between the countries located in northern and southern hemisphere, the seasonal influenza patterns in Australia and Chile showed a high correlation with those of the U.S. 22 weeks and 28 weeks earlier, respectively. The R-2 score of ANN models for ILI for validation set in 2015-2019 was 0.758 despite how hard it is to forecast 26 weeks ahead. Our prediction models forecast that the ILI for the U.S. in 2018-2019 may be later and less severe than those in 2017-2018, judging from the influenza activity for Australia and Chile in 2018. It allows to estimate peak timing, peak intensity, and type-specific influenza activities for next season at 40th week. The correlation between seasonal influenza patterns in the U.S., Australia, and Chile could be used to forecast the next seasonal influenza pattern, which can help to determine influenza vaccine strategy approximately six months ahead in the U.S.	[Choi, Soo Beom; Kim, Juhyeon; Ahn, Insung] Korea Inst Sci & Technol Informat, Dept Data Centr Problem Solving Res, Daejeon, South Korea; [Choi, Soo Beom; Kim, Juhyeon; Ahn, Insung] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon, South Korea	Korea Institute of Science & Technology Information (KISTI); Korea Research Institute of Chemical Technology (KRICT)	Ahn, I (corresponding author), Korea Inst Sci & Technol Informat, Dept Data Centr Problem Solving Res, Daejeon, South Korea.; Ahn, I (corresponding author), Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon, South Korea.	isahn@kisti.re.kr			National Research Council of Science and Technology grant from the Korean government (MSIP) [CRC-16-01-KRICT]	National Research Council of Science and Technology grant from the Korean government (MSIP)	This work was supported by a National Research Council of Science and Technology grant from the Korean government (MSIP) (no. CRC-16-01-KRICT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agor JK, 2018, HUM VACC IMMUNOTHER, V14, P678, DOI 10.1080/21645515.2017.1423152; Alonso WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17214; Arora VS, 2019, HEALTH POLICY, V123, P338, DOI 10.1016/j.healthpol.2019.01.001; Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Caini S, 2017, EUROSURVEILLANCE, V22, P7, DOI [10.2807/1560-7917.ES.2017.22.35.30606, 10.2807/1560-7917.es.2017.22.35.30606]; Centers for Disease Control and Prevention, OV INFL SURV US; Chattopadhyay I, 2018, ELIFE, V7, DOI 10.7554/eLife.30756; Cho S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081422; Chretien JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094130, 10.1371/currents.outbreaks.3408774290b1a0f2dd7cae877c8b8ff6]; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; Du X, 2018, PLOS CURR, V10; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hickmann KS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004239; Hu HP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23075-1; Kandula S, 2017, AM J EPIDEMIOL, V185, P395, DOI 10.1093/aje/kww211; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Moa AM, 2017, INFLUENZA OTHER RESP, V11, P102, DOI 10.1111/irv.12432; Newman LP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193263; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Pascoa R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192681; Paul Susannah, 2017, Online J Public Health Inform, V9, pe187, DOI 10.5210/ojphi.v9i2.8004; Petrova VN, 2018, NAT REV MICROBIOL, V16, P47, DOI 10.1038/nrmicro.2017.118; Polgreen PM, 2007, CLIN INFECT DIS, V44, P272, DOI 10.1086/510427; Poonia P, 2016, INT J COMPUT SCI MAT, V5, P43; Saha S, 2016, INFLUENZA OTHER RESP, V10, P176, DOI 10.1111/irv.12372; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Viboud C, 2019, P NATL ACAD SCI USA, V116, P2802, DOI 10.1073/pnas.1822167116; Won M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005330; Xi GK, 2018, PROCEEDINGS OF THE 2ND ACM SIGSPATIAL INTERNATIONAL WORKSHOP ON AI FOR GEOGRAPHIC KNOWLEDGE DISCOVERY (GEOAI 2018), P19, DOI 10.1145/3281548.3281558; Xu CL, 2015, AM J EPIDEMIOL, V182, P705, DOI 10.1093/aje/kwv110; Yang W, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005201; Zhang J, 2018, EPIDEMIOL INFECT, V146, P809, DOI 10.1017/S0950268818000705; Zou Jinming, 2008, V458, P15	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0220423	10.1371/journal.pone.0220423	http://dx.doi.org/10.1371/journal.pone.0220423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765386	Green Published, Green Submitted, gold			2022-12-26	WOS:000533891000003
J	Kovtun, O; Tomlinson, ID; Ferguson, RS; Rosenthal, SJ				Kovtun, Oleg; Tomlinson, Ian D.; Ferguson, Riley S.; Rosenthal, Sandra J.			Quantum dots reveal heterogeneous membrane diffusivity and dynamic surface density polarization of dopamine transporter	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; LATERAL DIFFUSION; TRAFFICKING; INTERNALIZATION; VISUALIZATION; LOCALIZATION; ENDOCYTOSIS; CURVATURE; RECEPTORS; DOMAINS	The presynaptic dopamine transporter mediates rapid reuptake of synaptic dopamine. Although cell surface DAT trafficking recently emerged as an important component of DAT regulation, it has not been systematically investigated. Here, we apply our single quantum dot (Qdot) tracking approach to monitor DAT plasma membrane dynamics in several heterologous expression cell hosts with nanometer localization accuracy. We demonstrate that Qdot-tagged DAT proteins exhibited highly heterogeneous membrane diffusivity dependent on the local membrane topography. We also show that Qdot-tagged DATs were localized away from the flat membrane regions and were dynamically retained in the membrane protrusions and cell edges for the duration of imaging. Single quantum dot tracking of wildtype DAT and its conformation-defective coding variants (R60A and W63A) revealed a significantly accelerated rate of dysfunctional DAT membrane diffusion. We believe our results warrant an in-depth investigation as to whether compromised membrane dynamics is a common feature of brain disorder-derived DAT mutants.	[Kovtun, Oleg; Tomlinson, Ian D.; Ferguson, Riley S.; Rosenthal, Sandra J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Kovtun, Oleg; Tomlinson, Ian D.; Rosenthal, Sandra J.] Vanderbilt Univ, Vanderbilt Inst Nanoscale Sci & Engn, Nashville, TN 37235 USA; [Rosenthal, Sandra J.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Rosenthal, Sandra J.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [Rosenthal, Sandra J.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Rosenthal, Sandra J.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Rosenthal, SJ (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA.; Rosenthal, SJ (corresponding author), Vanderbilt Univ, Vanderbilt Inst Nanoscale Sci & Engn, Nashville, TN 37235 USA.; Rosenthal, SJ (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA.; Rosenthal, SJ (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA.; Rosenthal, SJ (corresponding author), Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.; Rosenthal, SJ (corresponding author), Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA.	sandra.j.rosenthal@vanderbilt.edu		Ferguson, Riley/0000-0001-5782-4906; Rosenthal, Sandra/0000-0002-4576-5854; Kovtun, Oleg/0000-0001-6809-9332	NIH [CA68485, DK20593, DK58404, DK59637, EY08126]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Imaging experiments were performed in part through the use of the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, DK59637 and EY08126).	Adkins EM, 2017, BIOCHEMISTRY-US, V46, P10484; Arizono M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002498; Bailey DM, 2018, ACS CHEM NEUROSCI, V9, P2534, DOI 10.1021/acschemneuro.8b00214; Caltagarone J, 2015, MOL CELL NEUROSCI, V68, P120, DOI 10.1016/j.mcn.2015.04.005; Chang JC, 2012, J NEUROSCI, V32, P8919, DOI 10.1523/JNEUROSCI.0048-12.2012; Chaudhuri A, 2011, P NATL ACAD SCI USA, V108, P14825, DOI 10.1073/pnas.1100007108; COWAN AE, 1987, J CELL BIOL, V104, P917, DOI 10.1083/jcb.104.4.917; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Gabriel LR, 2013, J NEUROSCI, V33, P17836, DOI 10.1523/JNEUROSCI.3284-13.2013; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Girault JA, 2004, ARCH NEUROL-CHICAGO, V61, P641, DOI 10.1001/archneur.61.5.641; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Gowrishankar R, 2014, NEUROCHEM INT, V73, P42, DOI 10.1016/j.neuint.2013.10.016; Greenwood TA, 2001, AM J MED GENET, V105, P145, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1161>3.0.CO;2-8; Gussin HA, 2006, J AM CHEM SOC, V128, P15701, DOI 10.1021/ja064324k; Gussin HA, 2013, ACS CHEM NEUROSCI, V4, P435, DOI 10.1021/cn300144v; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kaya C, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0298-17.2017; Kirley A, 2003, AM J MED GENET B, V121B, P50, DOI 10.1002/ajmg.b.20071; Kovtun O, 2018, CHEM PHYS LETT, V706, P741, DOI 10.1016/j.cplett.2018.06.019; Kovtun O, 2015, ACS CHEM NEUROSCI, V6, P526, DOI 10.1021/cn500202c; Kovtun O, 2011, ACS CHEM NEUROSCI, V2, P370, DOI 10.1021/cn200032r; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Liu JJ, 2018, NEUROPSYCHOPHARMACOL, V43, P2165, DOI 10.1038/s41386-018-0133-6; Ma S, 2017, SCI REP, V14, P5339; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Monnier N, 2015, NAT METHODS, V12, P838, DOI [10.1038/NMETH.3483, 10.1038/nmeth.3483]; Murphy-Royal C, 2015, NAT NEUROSCI, V18, P219, DOI 10.1038/nn.3901; Nirenberg MJ, 1997, J NEUROSCI, V17, P5255; Orndorff RL, 2009, NANO LETT, V9, P2589, DOI 10.1021/nl900789e; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/nmeth.1444, 10.1038/NMETH.1444]; Rahbek-Clemmensen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00790-3; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rosenthal SJ, 2011, CHEM BIOL, V18, P10, DOI 10.1016/j.chembiol.2010.11.013; Rosenthal SJ, 2002, J AM CHEM SOC, V124, P4586, DOI 10.1021/ja003486s; Rosholm KR, 2017, NAT CHEM BIOL, V13, P724, DOI 10.1038/nchembio.2372; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Swanson JM, 2000, NEUROSCI BIOBEHAV R, V24, P21, DOI 10.1016/S0149-7634(99)00062-7; Tomlinson ID, 2019, BIOORG MED CHEM LETT, V29, P959, DOI 10.1016/j.bmcl.2019.02.024; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Vuorenpaa A, 2016, J BIOL CHEM, V291, P5634, DOI 10.1074/jbc.M115.702050; Wheeler DS, 2015, P NATL ACAD SCI USA, V112, pE7138, DOI 10.1073/pnas.1511670112; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Wu SJ, 2017, J NEUROSCI, V37, P9438, DOI 10.1523/JNEUROSCI.3885-16.2017; Zeppelin T, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005907	57	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225339	10.1371/journal.pone.0225339	http://dx.doi.org/10.1371/journal.pone.0225339			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751387	Green Published, gold			2022-12-26	WOS:000533886900051
J	Tuells, J; Echaniz-Martinez, B				Tuells, Jose; Echaniz-Martinez, Berta			The fight against polio through the NO-DO newsreels during the Francoism period in Spain	PLOS ONE			English	Article							POLIOMYELITIS	The weekly NO-DO newsreels, official and of obligatory projection in cinemas, held an information monopoly during the Francoist dictatorship (1943-1975) in Spain. The NO-DO was used as an instrument of indoctrination and legitimation, building a discourse based on the regime's needs and interests. In this study, we examined newsreels on medical subjects related to vaccine-preventable diseases. A majority of reports centred on poliomyelitis, and two differentiated periods could be defined, coinciding with the evolution of the Franco regime's foreign policy. The first period reflected the regime's era of isolation and referred to polio as a foreign disease, with the NO-DO showing the US initiatives to fight against it, as it had become the scientific model to follow. Subsequently, the ambiguities of the news related to the disease reflected the dictatorship's refusal to confront the epidemic suffered by the Spanish population until the vaccination campaigns began in 1963. Even then, the consequences that the negligent management of the disease had for many families were concealed. Meanwhile, the image of a modernized country concerned about national public health was legitimized.	[Tuells, Jose; Echaniz-Martinez, Berta] Univ Alicante, Catedra Balmis Vacunol, Alicante, Spain	Universitat d'Alacant	Tuells, J (corresponding author), Univ Alicante, Catedra Balmis Vacunol, Alicante, Spain.	tuells@ua.es	Tuells, José/G-1015-2013	Tuells, José/0000-0003-1159-429X; Echaniz Martinez, Berta/0000-0001-7489-0876				Ballester Anon R, 2009, ASCLEPIO, V61, P55; Ballester Anon R, 2015, HYGIEA INT INTERDISC, V11, P71; BENISON S, 1982, B HIST MED, V56, P460; Black K., 1996, SHADOW POLIO PERSONA; Dawson Liza, 2004, Clin Trials, V1, P122, DOI 10.1191/1740774504cn010xx; Day Alison, 2009, Health History, V11, P42; Blanco MAD, 2006, PASADO MEM, V5, P241; DELGADO GOMEZ-ESCALONILLA L., 2003, STUDIA HIST HIST CON, V21, P231; Diez Puertas Emeterio, 2003, HIST SOCIAL CINE ESP; Eiroa San Francisco M, 2001, HIST COMUN SOC, V6, P203; ELLWOOD SM, 1987, HIST J FILM RADIO TV, V7, P225, DOI 10.1080/01439688700260321; Fernandez Fernandez-Cuesta J. M., 2013, REV INT HIST COMUN, V1, P132, DOI [10.12795/RiHC.2013.i01.07, DOI 10.12795/RIHC.2013.I01.07]; Garrido F., 1993, FILMHISTORIA, V3, P321; Gould A., 1995, SUMMER PLAGUE POLIO; Hampton L, 2009, AM J PUBLIC HEALTH, V99, P34, DOI 10.2105/AJPH.2007.117952; Porras MI, 2010, DYNAMIS, V30, P91, DOI 10.4321/s0211-95362010000100004; Jimenez Lucena I., 1994, DYNAMIS, V14, P131; LUCENA IJ, 2002, ASCLEPIO, V54, P201; Marin Martinez P, 1990, Dynamis, V10, P275; Markel H, 2005, NEW ENGL J MED, V352, P1408, DOI 10.1056/NEJMp048250; Medina-Domenech RM, 2005, PUBLIC UNDERST SCI, V14, P393, DOI 10.1177/0963662505056692; Menendez Navarro A., 2009, QUADERNS CINE, V4, P47; Menendez -Navarro A, 2003, 10 C INT AEIHM MADR, P395; Molero Mesa J, 1994, Dynamis, V14, P199; Montero M, 2012, HISPANIA, V72, P205, DOI 10.3989/hispania.2012.v72.i240.369; NATHANSON N, 1995, AM J EPIDEMIOL, V142, P109, DOI 10.1093/oxfordjournals.aje.a117611; Offit Paul A., 2005, CUTTER INCIDENT AM F; Ordonez Rodriguez J, 2008, CIEN ANOS POLITICA C, P257; Oshinsky DM., 2005, POLIO AM STORY; Pardo Sanz R., 1999, FRANQUISMO VISIONES, P93; Pardo-Sanz R., 2016, APERTURA INT ESPANA, P263; Paul R, 1971, HIST POLIOMYELITIS; Pulpillo Leiva C., 2016, ACT 5 C INT HIST NUE, P215; Ramirez Martinez F., 2008, ACTES HIST CIENCIA T, V1, P253; Rodriguez Mateos A., 2008, FRANQUISMO CINE IMAG; Sanchez JAR, 2012, DYNAMIS, V32, P391; Rodriguez Tranche R., 2001, IMAGEN MEMORIA FASCI; Rodriguez Tranche R, 1997, HIST CONT ESPANA CIN, P115; Rogers N., 1992, DIRT DIS POLIO FDR; Laffond JCR, 2010, HIST CRITICA, P170; Sanchez Biosca V., 2009, ARTCULTURA, V11, P95; Sanchez J, 2010, ASSETS 2010: PROCEEDINGS OF THE 12TH INTERNATIONAL ACM SIGACCESS CONFERENCE ON COMPUTERS AND ACCESSIBILITY, P195; Sass EJ., 1996, POLIOS LEGACY ORAL H; Shell M., 2005, POLIO ITS AFTERMATH; Smallman-Raynor M., 2006, POLIOMYELITIS WORLD; Tabernero C, 2018, SCI CONTEXT, V31, P61, DOI 10.1017/S0269889718000066; TRANCHE R., 2001, TIEMPO MEMORIA; Tuells J, 2019, GAC SANIT, V33, P480, DOI 10.1016/j.gaceta.2018.05.005; Tusell Gomez J., 1994, ESPACIO TIEMPO FORMA, V7, P323; Wilson D., 1988, B HIST MED, V72, P464	50	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225324	10.1371/journal.pone.0225324	http://dx.doi.org/10.1371/journal.pone.0225324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751398	gold, Green Published			2022-12-26	WOS:000533886900049
J	Hammad, SM; Hardin, JR; Wilson, DA; Twal, WO; Nietert, PJ; Oates, JC				Hammad, Samar M.; Hardin, Jasmyn R.; Wilson, Dulaney A.; Twal, Waleed O.; Nietert, Paul J.; Oates, James C.			Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity	PLOS ONE			English	Article							PLASMA SPHINGOMYELIN; REVISED CRITERIA; DISEASE; ATHEROSCLEROSIS; CLASSIFICATION; PATHOGENESIS; MECHANISMS; RISK	Systemic lupus erythematous (SLE) is a chronic multi-organ autoimmune disease. Genetic and environmental factors contribute to disease onset and severity. Sphingolipids are signaling molecules involved in regulating cell functions and have been associated with multiple genetic disease processes. African-Americans are more likely to suffer from SLE morbidity than Whites. The Medical University of South Carolina has banked plasma samples from a well-characterized lupus cohort that includes African-Americans and Whites. This study examined the influence of race on plasma sphingolipid profiles in SLE patients and association of sphingolipid levels with comorbid atherosclerosis and SLE disease activity. Mass spectrometry revealed that healthy African-Americans had higher sphingomyelin levels and lower lactosylcermide levels compared to healthy Whites. SLE patients, irrespective of race, had higher levels of ceramides, and sphingoid bases (sphingosine and dihydrosphingosine) and their phosphates compared to healthy subjects. Compared to African-American controls, African-American SLE patients had higher levels of ceramides, hexosylceramides, sphingosine and dihydrosphingosine 1-phosphate. Compared to White controls, White SLE patients exhibited higher levels of sphingoid bases and their phosphates, but lower ratios of C16:0 ceramide/sphingosine 1-phosphate and C24:1 ceramide/sphingosine 1-phosphate. White SLE patients with atherosclerosis exhibited lower levels of sphingoid bases compared to White SLE patients without atherosclerosis. In contrast, African-American SLE patients with atherosclerosis had higher levels of sphingoid bases and sphingomyelins compared to African-American SLE patients without atherosclerosis. Compared to White SLE patients with atherosclerosis, African-American SLE patients with atherosclerosis had higher levels of select sphingolipids. Plasma levels of sphingosine, C16:0 ceramide/sphingosine 1-phosphate ratio and C24:1 ceramide/sphingosine 1-phosphate ratio significantly correlated with SLEDAI in the African-American but not White SLE patients. The C16:0 ceramide/sphingosine 1-phosphate ratio in SLE patients, and levels of C18:1 and C26:1 lactosylcermides, C20:0 hexosylceramide, and sphingoid bases in SLE patients with atherosclerosis could be dependent on race. Further ethnic studies in SLE cohorts are necessary to verify use of sphingolipidomics as complementary diagnostic tool.	[Hammad, Samar M.; Twal, Waleed O.] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Hardin, Jasmyn R.] Med Univ South Carolina, Coll Grad Studies, Summer Undergrad Res Program, Charleston, SC 29425 USA; [Wilson, Dulaney A.; Nietert, Paul J.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Oates, James C.] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Hammad, SM (corresponding author), Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	hammadsm@musc.edu	Wilson, Dulaney/AHE-8372-2022	Nietert, Paul/0000-0002-3933-4986; Hammad, Samar/0000-0002-1313-2542; Oates, Jim/0000-0002-5426-1359	South Carolina Clinical & Translational Research (SCTR) Institute; MUSC through NIH/NCATS [UL1 TR001450]; Clinical and Community Resource Core within Rheumatology and Immunology P30 Core Center for Clinical Research (CCCR) [P60 AR062755, P30 AR072582]; Lipidomics Shared Resource, Hollings Cancer Center, MUSC [P30 CA138313, P30 GM103339]; College of Graduate Studies/Summer Undergraduate Research Program [R25HL092611-11]; CCCR Methodologic Core;  [K23 AR052364];  [M01 RR001070]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001450] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR062755, P30AR072582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103339] Funding Source: NIH RePORTER	South Carolina Clinical & Translational Research (SCTR) Institute; MUSC through NIH/NCATS; Clinical and Community Resource Core within Rheumatology and Immunology P30 Core Center for Clinical Research (CCCR); Lipidomics Shared Resource, Hollings Cancer Center, MUSC; College of Graduate Studies/Summer Undergraduate Research Program; CCCR Methodologic Core; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by a Discovery Grant to SMH from the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at MUSC through NIH/NCATS Grant Number UL1 TR001450. SLE cohort is within the MUSC Multidisciplinary Clinical Research Center (MCRC) for Rheumatic Diseases in African-Americans (now the Clinical and Community Resource Core contained within the Rheumatology and Immunology P30 Core Center for Clinical Research (CCCR) (P60 AR062755 & P30 AR072582). Samples collected before April 2013 were under K23 AR052364 & M01 RR001070. Sphingolipidomics analyses supported in part by the Lipidomics Shared Resource, Hollings Cancer Center, MUSC (P30 CA138313 and P30 GM103339). Statistical analysis by PJN & DAW was supported by the CCCR Methodologic Core. JRH funded by the College of Graduate Studies/Summer Undergraduate Research Program (R25HL092611-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Gadban MM, 2015, CLIN IMMUNOL, V157, P133, DOI 10.1016/j.clim.2015.01.008; Al Gadban MM, 2012, CELL IMMUNOL, V276, P42, DOI 10.1016/j.cellimm.2012.03.007; Bentley AR, 2017, GLOB HEART, V12, P141, DOI 10.1016/j.gheart.2017.01.011; Borodzicz S, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0053-y; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Buie JNJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216213; Checa A, 2017, LUPUS, V26, P1023, DOI 10.1177/0961203316686707; Deutschman DH, 2003, AM HEART J, V146, P62, DOI 10.1016/S0002-8703(03)00118-2; Hammad SM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/180705; Hammad Samar M, 2012, Neurobiol Lipids, V10, P2; Hammad SM, 2011, ADV EXP MED BIOL, V721, P57, DOI 10.1007/978-1-4614-0650-1_4; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Karlson Elizabeth W., 1995, Annals of Epidemiology, V5, P297, DOI 10.1016/1047-2797(94)00096-C; Klein RL, 2014, METABOLISM, V63, P1287, DOI 10.1016/j.metabol.2014.07.001; Liu F, 2017, SCAND J IMMUNOL, V86, P377, DOI 10.1111/sji.12611; Lopes-Virella MF, 2019, J CLIN LIPIDOL, V13, P481, DOI 10.1016/j.jacl.2019.03.005; Lu L, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040105; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Matanes F, 2019, ADV EXP MED BIOL, V1159, P109, DOI 10.1007/978-3-030-21162-2_7; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McDonald G, 2014, J CLIN INVEST, V124, P712, DOI 10.1172/JCI69571; Meikle PJ, 2017, NAT REV ENDOCRINOL, V13, P79, DOI 10.1038/nrendo.2016.169; Mikdashi J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0702-6; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Nowling TK, 2015, J AM SOC NEPHROL, V26, P1402, DOI 10.1681/ASN.2014050508; Patyna S, 2019, PROSTAG OTH LIPID M, V144, DOI 10.1016/j.prostaglandins.2019.106348; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Sherer Y, 2006, NAT CLIN PRACT RHEUM, V2, P99, DOI 10.1038/ncprheum0092; Skaggs BJ, 2012, NAT REV RHEUMATOL, V8, P214, DOI 10.1038/nrrheum.2012.14; Summers SA, 2018, CELL METAB, V27, P276, DOI 10.1016/j.cmet.2017.12.003; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; The Lupus Foundation of America, LUP FACTS STAT 2017; Vaclavkova A, 2014, LANCET, V384, P2036, DOI 10.1016/S0140-6736(14)60803-5	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0224496	10.1371/journal.pone.0224496	http://dx.doi.org/10.1371/journal.pone.0224496			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT8LX	31747417	gold, Green Published			2022-12-26	WOS:000501236200001
J	Kamm, JL; Parlane, NA; Riley, CB; Gee, EK; Dittmer, KE; Mcllwraith, CW				Kamm, J. Lacy; Parlane, Natalie A.; Riley, Christopher B.; Gee, Erica K.; Dittmer, Keren E.; Mcllwraith, C. Wayne			Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression	PLOS ONE			English	Article							STROMAL CELLS; IN-VITRO; DIFFERENTIATION; IMMUNOPHENOTYPE; IMMUNOGENICITY; PROLIFERATION; ENVIRONMENT; IMMUNOLOGY; SENESCENCE; REJECTION	Background As the search for an immune privileged allogeneic donor mesenchymal stem cell (MSC) line continues in equine medicine, the characterization of the cells between different sources becomes important. Our research seeks to more clearly define the MSC marker expression of different equine MSC donors. Methods The bone marrow-derived MSCs from two equine breeds and different blood donor-types were compared over successive culture passages to determine the differential expression of important antigens. Eighteen Thoroughbreds and 18 Standardbreds, including 8 blood donor (erythrocyte Aa, Ca, and Qa antigen negative) horses, were evaluated. Bone marrow was taken from each horse for isolation and culture of MSCs. Samples from passages 2, 4, 6, and 8 were labelled and evaluated by flow cytometry. The cell surface expression of CD11a/18, CD44, CD90 and MHC class II antigens were assessed. Trilineage assays for differentiation into adipogenic, chondrogenic and osteogenic lines were performed to verify characterization of the cells as MSCs. Findings There were significant differences in mesenchymal stem cell marker expression between breeds and blood antigen-type groups over time. Standardbred horses showed a significantly lower expression of MHC class II than did Thoroughbred horses at passages 2, 4 and 6. CD90 was significantly higher in universal blood donor Standardbreds as compared to non-blood donor Standardbreds over all time points. All MSC samples showed high expression of CD44 and low expression of CD11a/18. Conclusions Universal blood donor-type Standardbred MSCs from passages 2-4 show the most ideal antigen expression pattern of the horses and passages that we characterized for use as a single treatment of donor bone marrow-derived MSCs. Further work is needed to determine the significance of this differential expression along with the effect of the expression of MHC I on equine bone marrow-derived MSCs.	[Kamm, J. Lacy; Riley, Christopher B.; Gee, Erica K.; Dittmer, Keren E.; Mcllwraith, C. Wayne] Massey Univ, Sch Vet Sci, Palmerston North, New Zealand; [Kamm, J. Lacy] Vet Associates, Auckland, New Zealand; [Parlane, Natalie A.] Massey Univ, Hopkirk Res Inst, AgRes, Palmerston North, New Zealand; [Mcllwraith, C. Wayne] Colorado State Univ, Orthopaed Res Ctr, Ft Collins, CO 80523 USA	Massey University; AgResearch - New Zealand; Massey University; Colorado State University	Kamm, JL (corresponding author), Massey Univ, Sch Vet Sci, Palmerston North, New Zealand.; Kamm, JL (corresponding author), Vet Associates, Auckland, New Zealand.	lacykamm@gmail.com	Dittmer, Keren/AAR-3148-2021; Gee, Erica/Y-1999-2018	Dittmer, Keren/0000-0002-1813-2197; Riley, Christopher/0000-0001-8679-7986; Gee, Erica/0000-0001-5218-6589	C. Wayne and Nancy Goodman McIlwraith Equine Orthopaedic Scholarship Fund [18131]; New Zealand Equine Trust [18131]	C. Wayne and Nancy Goodman McIlwraith Equine Orthopaedic Scholarship Fund; New Zealand Equine Trust	Funding was provided by the C. Wayne and Nancy Goodman McIlwraith Equine Orthopaedic Scholarship Fund and the New Zealand Equine Trust (equinetrust.co.nz). Grant number 18131 was given to JLK and CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the New Zealand Equine Trust and the C. Wayne and Nancy Goodman McIlwraith Equine Orthopaedic Scholarship Fund. Joanna Roberts of AgResearch, Palmerston North, New Zealand is thanked for her assistance with the flow cytometry assay. Tristan Wade, Woodland's Stud, Alabar Stud, and Holilio Polo Club are thanked for the use of their animals for this project.	Arias RA, 2012, ADV EXP MED BIOL, V741, P27, DOI 10.1007/978-1-4614-2098-9_3; ANGELOS J, 1988, ANIM GENET, V19, P417, DOI 10.1111/j.1365-2052.1988.tb00833.x; Barrachina L, 2016, VET IMMUNOL IMMUNOP, V171, P57, DOI 10.1016/j.vetimm.2016.02.007; BECHT JL, 1985, VET CLIN N AM-EQUINE, V1, P91, DOI 10.1016/S0749-0739(17)30771-X; Benichou G, 2011, IMMUNOTHERAPY-UK, V3, P757, DOI [10.2217/IMT.11.2, 10.2217/imt.11.2]; Berglund AK, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0742-8; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Campioni D, 2008, CYTOTHERAPY, V10, P69, DOI 10.1080/14653240701762364; Colbath AC, 2017, STEM CELLS DEV, V26, P503, DOI 10.1089/scd.2016.0266; Consentius C, 2015, REGEN MED, V10, P305, DOI [10.2217/rme.15.14, 10.2217/RME.15.14]; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; De Schauwer C, 2012, CYTOM PART A, V81A, P312, DOI 10.1002/cyto.a.22026; Dvorakova J, 2008, CELL BIOL INT, V32, P1116, DOI 10.1016/j.cellbi.2008.04.024; Esteves CL, 2017, STEM CELLS DEV, V26, P964, DOI 10.1089/scd.2017.0017; Favi PM, 2013, MAT SCI ENG C-MATER, V33, P1935, DOI 10.1016/j.msec.2012.12.100; Ferris DJ, 2014, VET SURG, V43, P255, DOI 10.1111/j.1532-950X.2014.12100.x; Garvican ER, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt483; Gibco, 2014, STEMPRO DIFF KIT PRO; Godwin EE, 2012, EQUINE VET J, V44, P25, DOI 10.1111/j.2042-3306.2011.00363.x; Griffin MD, 2013, IMMUNOL CELL BIOL, V91, P40, DOI 10.1038/icb.2012.67; Hardy J., 2009, EQUINE ANESTHESIA MO; He X, 2017, HEREDITY, V119, P117, DOI 10.1038/hdy.2017.24; Huang XP, 2016, FASEB J, V30, P3069, DOI 10.1096/fj.201600331R; Joswig AJ, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0503-8; Kisiday JD, 2008, J ORTHOP RES, V26, P322, DOI 10.1002/jor.20508; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Kundrotas G, 2016, ONCOTARGET, V7, P10788, DOI 10.18632/oncotarget.7456; Lacitignola L, 2008, VET RES COMMUN, V32, pS33, DOI 10.1007/s11259-008-9085-3; Maecker HT, 2004, CYTOM PART A, V62A, P169, DOI 10.1002/cyto.a.20092; McIlwraith CW, 2011, ARTHROSCOPY, V27, P1552, DOI 10.1016/j.arthro.2011.06.002; Mei L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176107; Moraes DA, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0359-3; Ogawa M, 2010, INT J HEMATOL, V91, P353, DOI 10.1007/s12185-010-0554-4; Paebst F, 2014, CYTOM PART A, V85A, P678, DOI 10.1002/cyto.a.22491; Pezzanite LM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0053-x; Portalska KJ, 2013, TISSUE ENG PT A, V19, P2318, DOI [10.1089/ten.TEA.2012.0646, 10.1089/ten.tea.2012.0646]; Radcliffe CH, 2010, STEM CELLS DEV, V19, P269, DOI 10.1089/scd.2009.0091; Ranera B, 2011, VET IMMUNOL IMMUNOP, V144, P147, DOI 10.1016/j.vetimm.2011.06.033; Richardson SM, 2016, METHODS, V99, P69, DOI 10.1016/j.ymeth.2015.09.015; Schnabel LV, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt402; Snyder L., 2012, CLIN VET ADVISOR HOR; Song XH, 2017, IN VITRO CELL DEV-AN, V53, P77, DOI 10.1007/s11626-016-0081-6; Talbot B, 2017, J HERED, V108, P207, DOI 10.1093/jhered/esw077; Tomlinson JE, 2015, J VET INTERN MED, V29, P1683, DOI 10.1111/jvim.13627; VANKOOYK Y, 1993, CELL ADHES COMMUN, V1, P21, DOI 10.3109/15419069309095679; Waselau M, 2008, JAVMA-J AM VET MED A, V232, P1515, DOI 10.2460/javma.232.10.1515; Whittington NC, CURR PROTOC NEUROSCI, V81; Zahedi M, 2017, INT J STEM CELLS, V10, P93, DOI 10.15283/ijsc16036; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217; Zhao YF, 2014, MOL MED REP, V9, P1583, DOI 10.3892/mmr.2014.1988	50	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225161	10.1371/journal.pone.0225161	http://dx.doi.org/10.1371/journal.pone.0225161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747418	Green Published, gold			2022-12-26	WOS:000533881900025
J	Yin, N; Koide, RT				Yin, Na; Koide, Roger T.			The role of resource transfer in positive, non-additive litter decomposition	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; LEAF-LITTER; DYNAMICS; NITROGEN; CARBON; MIXTURES; NEEDLE; PINE; STABILIZATION; BIODIVERSITY	Naturally occurring, mixed litter decomposes at unpredictable rates when individual components do not decompose in mixtures as they do individually. Consequently, nutrient, carbon and energy fluxes associated with decomposition may be difficult to predict. However, predictability is improved when we understand the mechanisms responsible for such non-additive decomposition. In this study, we explored mechanisms to explain our previous observation that an approximately 30% increase in oat straw decomposition due to the presence of clover litter is associated with a significant increase in the activity of cellobiohydrolase, an enzyme involved in litter decomposition. We hypothesized that resources limiting decomposer microbe enzyme activity in oat straw can be supplied by clover litter. Amendment of oat straw with water, NH4Cl, glucose, or NH4Cl combined with glucose did not account for the significant, positive effect of clover litter on oat straw decomposition and cellobiohydrolase activity. However, amendment of oat straw with a complete set of mineral nutrients for plant growth did account for the entire effect of clover litter, and the addition of the complete set of mineral nutrients without N accounted for the majority of the clover effect. In our system, therefore, the majority of the positive effect of clover litter on oat straw decomposition and cellobiohydrolase activity was unexpectedly not attributable to the transfer from clover to oat straw of labile N. We found that mineral soil could substitute for the mineral nutrients other than N. This highlights the role of soil as a potential source of limiting resources for microbes decomposing litter. It may also explain why positive, non-additive decomposition has been observed in some previous studies but not in others depending on whether the soil supplied a resource that limited decomposer activity.	[Yin, Na; Koide, Roger T.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Brigham Young University	Koide, RT (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	rogerkoide@byu.edu	Koide, Roger/I-4033-2012; Koide, Roger/AAE-7763-2020	Koide, Roger/0000-0002-5209-5422; Koide, Roger/0000-0002-5209-5422	Brigham Young University; Office of Research and Creative Activities, Brigham Young University; Sustainable Bioenergy Research Program of the USDA National Institute of Food and Agriculture [2011-67009-20072]	Brigham Young University; Office of Research and Creative Activities, Brigham Young University; Sustainable Bioenergy Research Program of the USDA National Institute of Food and Agriculture	We gratefully acknowledge the financial support provided by Brigham Young University to RTK, the Office of Research and Creative Activities, Brigham Young University to NY, and by the Sustainable Bioenergy Research Program of the USDA National Institute of Food and Agriculture (#2011-67009-20072) to RTK.	Agren GI, 2001, OECOLOGIA, V128, P94, DOI 10.1007/s004420100646; [Anonymous], 2010, ACTA ECOL SIN, DOI DOI 10.1016/J.CHNAES.2010.06.006; Bird JA, 2008, ORG GEOCHEM, V39, P465, DOI 10.1016/j.orggeochem.2007.12.003; Boberg J, 2008, SOIL BIOL BIOCHEM, V40, P995, DOI 10.1016/j.soilbio.2007.11.005; Butenschoen O, 2014, SOIL BIOL BIOCHEM, V77, P121, DOI 10.1016/j.soilbio.2014.06.019; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chen BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066289; Chigineva NI, 2009, APPL SOIL ECOL, V42, P264, DOI 10.1016/j.apsoil.2009.05.001; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; Dijkstra FA, 2006, SOIL BIOL BIOCHEM, V38, P2519, DOI 10.1016/j.soilbio.2006.02.020; FYLES JW, 1993, CAN J FOREST RES, V23, P358, DOI 10.1139/x93-052; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Ghasemi-Aghbash F, 2016, ANN FOR RES, V59, P21, DOI 10.15287/afr.2015.475; Hattenschwiler S, 2010, J ECOL, V98, P754, DOI 10.1111/j.1365-2745.2010.01671.x; Hamer U, 2005, GEODERMA, V128, P38, DOI 10.1016/j.geoderma.2004.12.014; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P747, DOI 10.1016/j.soilbio.2005.06.025; Li W, 2009, ECOL RES, V24, P761, DOI 10.1007/s11284-008-0546-5; Liu P, 2007, BIOL FERT SOILS, V44, P211, DOI 10.1007/s00374-007-0195-9; Lodge DJ, 2014, FOREST ECOL MANAG, V332, P11, DOI 10.1016/j.foreco.2014.03.002; Makkonen M, 2013, OIKOS, V122, P987, DOI 10.1111/j.1600-0706.2012.20750.x; Mambelli S, 2011, ORG GEOCHEM, V42, P1099, DOI 10.1016/j.orggeochem.2011.06.008; McTiernan KB, 1997, OIKOS, V78, P527, DOI 10.2307/3545614; Montane F, 2013, PLANT SOIL, V368, P459, DOI 10.1007/s11104-012-1533-8; Montane F, 2010, PLANT SOIL, V337, P151, DOI 10.1007/s11104-010-0512-1; Peoples MS, 2012, APPL SOIL ECOL, V62, P98, DOI 10.1016/j.apsoil.2012.08.002; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; R Core Team, 2021, R LANGUAGE ENV STAT; Salamanca EF, 1998, ECOL ENG, V10, P53, DOI 10.1016/S0925-8574(97)10020-9; Smith VC, 2003, OIKOS, V102, P235, DOI 10.1034/j.1600-0706.2003.12503.x; STOTT DE, 1986, SOIL BIOL BIOCHEM, V18, P577, DOI 10.1016/0038-0717(86)90078-7; Swift M.J., 1979, DECOMPOSITION TERRES, V5; TAYLOR BR, 1989, CAN J FOREST RES, V19, P674, DOI 10.1139/x89-104; Vestgarden LS, 2001, SOIL BIOL BIOCHEM, V33, P465, DOI 10.1016/S0038-0717(00)00187-5; Vivanco L, 2011, GLOBAL CHANGE BIOL, V17, P1963, DOI 10.1111/j.1365-2486.2010.02344.x; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Yin N, 2019, PEDOBIOLOGIA, V76, DOI 10.1016/j.pedobi.2019.150570	39	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225337	10.1371/journal.pone.0225337	http://dx.doi.org/10.1371/journal.pone.0225337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738799	gold, Green Published			2022-12-26	WOS:000532826300045
J	Song, YL; Sackey, EA; Wang, H; Wang, H				Song, Yali; Sackey, Ebenezer Ampofo; Wang, He; Wang, Hua			Adsorption of oxytetracycline on kaolinite	PLOS ONE			English	Article							AQUATIC ENVIRONMENTS; RISK-ASSESSMENT; ANTIBIOTICS; TETRACYCLINE; WATER; SORPTION; CONTAMINATION; STRAW	As antibiotic contamination increases in wastewater and aqueous environments, the reduction of antibiotics has become a pertinent topic of research regarding water treatment. Clay minerals, such as smectite or kaolinite, are important adsorbents used in water treatment, and sufficient removal of antibiotics by clay minerals is expected. In this study, the adsorption of oxytetracycline (OTC) on kaolinite was investigated. The experimental data of OTC adsorption on kaolinite fit the pseudo-second-order kinetics model well (R-2>0.98). After 24 h, adsorption equilibrium of OTC on kaolinite was reached. The Langmuir model was better fitting with the adsorption isotherms generated from experimental data and OTC adsorption occurred on the external surface of kaolinite. The analysis of several thermodynamic parameters indicated that the adsorption of OTC on kaolinite was spontaneous and thermodynamically favorable. With the increase of the pH of a solution, the adsorption capacity increased and then decreased. The adsorption coefficient (K-d) of 10(2)-10(3) were obtained for adsorption process of OTC on kaolinite.	[Song, Yali; Sackey, Ebenezer Ampofo; Wang, He; Wang, Hua] Zhejiang Univ Sci & Technol, Sch Civil Engn & Architecture, Hangzhou, Zhejiang, Peoples R China; [Song, Yali; Wang, Hua] Zhejiang Univ Sci & Technol, Key Lab Recycling & Ecotreatment Waste Biomass Zh, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Science & Technology; Zhejiang University of Science & Technology	Wang, H (corresponding author), Zhejiang Univ Sci & Technol, Sch Civil Engn & Architecture, Hangzhou, Zhejiang, Peoples R China.; Wang, H (corresponding author), Zhejiang Univ Sci & Technol, Key Lab Recycling & Ecotreatment Waste Biomass Zh, Hangzhou, Zhejiang, Peoples R China.	wangh08@hotmail.com	Sackey, Ebenezer Ampofo/AAT-3485-2020	Sackey, Ebenezer Ampofo/0000-0002-2713-3458	Zhejiang Provincial Natural Science Foundation of China [LY16E080007]; Public Welfare Technology Application Research Project of Zhejiang Province [2016C33102]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Public Welfare Technology Application Research Project of Zhejiang Province	This study was financially supported by the Zhejiang Provincial Natural Science Foundation of China (No. LY16E080007) to YS and the Public Welfare Technology Application Research Project of Zhejiang Province (No. 2016C33102) to HW.	Acosta R, 2016, CHEMOSPHERE, V149, P168, DOI 10.1016/j.chemosphere.2016.01.093; Charuaud L, 2019, J HAZARD MATER, V361, P169, DOI 10.1016/j.jhazmat.2018.08.075; Ding HJ, 2017, CHEMOSPHERE, V184, P137, DOI 10.1016/j.chemosphere.2017.05.148; Figueroa RA, 2004, ENVIRON SCI TECHNOL, V38, P476, DOI 10.1021/es0342087; Harja M, 2018, SCI TOTAL ENVIRON, V628-629, P36, DOI 10.1016/j.scitotenv.2018.02.027; Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043; Huang YH, 2019, SCI TOTAL ENVIRON, V670, P170, DOI 10.1016/j.scitotenv.2019.03.168; Huijbers PMC, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.05.074; Iakovides IC, 2019, WATER RES, V159, P333, DOI 10.1016/j.watres.2019.05.025; Jia J, 2018, SCI TOTAL ENVIRON, V642, P1136, DOI 10.1016/j.scitotenv.2018.06.149; Jia MY, 2013, BIORESOURCE TECHNOL, V136, P87, DOI 10.1016/j.biortech.2013.02.098; Li N, 2019, J HAZARD MATER, V366, P563, DOI 10.1016/j.jhazmat.2018.12.047; Li S, 2019, ENVIRON POLLUT, V246, P435, DOI 10.1016/j.envpol.2018.12.038; Li ZH, 2010, J COLLOID INTERF SCI, V351, P254, DOI 10.1016/j.jcis.2010.07.034; Li ZH, 2010, J COLLOID INTERF SCI, V341, P311, DOI 10.1016/j.jcis.2009.09.054; Liu XH, 2018, SCI TOTAL ENVIRON, V627, P1195, DOI 10.1016/j.scitotenv.2018.01.271; Ma C, 1999, CLAY CLAY MINER, V47, P174, DOI 10.1346/CCMN.1999.0470207; Ma JZ, 2019, INT J BIOL MACROMOL, V124, P557, DOI 10.1016/j.ijbiomac.2018.11.235; ParoloM E, 2010, APPL CLAY SCI, V49, P194, DOI [10.1016/j.clay.2010.05.005, DOI 10.1016/J.CLAY.2010.05.005]; ParoloM E, 2008, APPL CLAY SCI, V40, P179, DOI [10.1016/j.clay.2007.08.003, DOI 10.1016/J.CLAY.2007.08.003]; Phan TPH, 2011, SCI TOTAL ENVIRON, V409, P2894, DOI 10.1016/j.scitotenv.2011.04.030; Wang H, 2018, RSC ADV, V8, P16260, DOI 10.1039/c8ra01454j; Wang JT, 2010, J COLLOID INTERF SCI, V349, P578, DOI 10.1016/j.jcis.2010.04.081; Wang XC, 2019, WATER RES, V161, P308, DOI 10.1016/j.watres.2019.06.014; Wu QF, 2013, APPL CLAY SCI, V74, P66, DOI 10.1016/j.clay.2012.09.026; Zhang FL, 2017, CHEMOSPHERE, V182, P483, DOI 10.1016/j.chemosphere.2017.05.058; Zhao FK, 2019, J ENVIRON SCI, V79, P200, DOI 10.1016/j.jes.2018.11.024; Zhao YP, 2011, J COLLOID INTERF SCI, V361, P247, DOI 10.1016/j.jcis.2011.05.051; Zhao YP, 2011, ECOTOXICOLOGY, V20, P1141, DOI 10.1007/s10646-011-0665-6	29	12	13	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225335	10.1371/journal.pone.0225335	http://dx.doi.org/10.1371/journal.pone.0225335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS2WO	31730641	gold, Green Published			2022-12-26	WOS:000518171000001
J	Liao, YJ; Duan, B; Zhang, YF; Zhang, XM; Xia, B				Liao, Yangjie; Duan, Bo; Zhang, Yufei; Zhang, Xinmin; Xia, Bin			Excessive ER-phagy mediated by the autophagy receptor FAM134B results in ER stress, the unfolded protein response, and cell death in HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; cell death; endoplasmic reticulum stress (ER stress); unfolded protein response (UPR); endoplasmic reticulum (ER); Bcl-xL inhibitor; ER-phagy; FAM134B; reticulophagy regulator 1 (RETREG1); Z36	DIFFERENTIAL EXPRESSION ANALYSIS; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; DEGRADATION; DISCOVERY	Autophagy is typically a prosurvival cellular process that promotes the turnover of long-lived proteins and damaged organelles, but it can also induce cell death. We have previously reported that the small molecule Z36 induces autophagy along with autophagic cell death in HeLa cells. In this study, we analyzed differential gene expression in Z36-treated HeLa cells and found that Z36-induced endoplasmic reticulum?specific autophagy (ER-phagy) results in ER stress and the unfolded protein response (UPR). This result is in contrast to the common notion that autophagy is generally activated in response to ER stress and the UPR. We demonstrate that Z36 up-regulates the expression levels of FAM134B, LC3, and Atg9, which together mediate excessive ER-phagy, characterized by forming increased numbers of autophagosomes with larger sizes. We noted that the excessive ER-phagy accelerates ER degradation and impairs ER homeostasis and thereby triggers ER stress and the UPR as well as ER-phagy?dependent cell death. Interestingly, overexpression of FAM134B alone in HeLa cells is sufficient to impair ER homeostasis and cause ER stress and cell death. These findings suggest a mechanism involving FAM134B activity for ER-phagy to promote cell death.	[Liao, Yangjie; Duan, Bo; Zhang, Yufei; Xia, Bin] Peking Univ, Coll Chem & Mol Engn, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Zhang, Xinmin] BioInfoRx Inc, Madison, WI 53719 USA	Peking University	Xia, B (corresponding author), Peking Univ, Coll Chem & Mol Engn, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	binxia@pku.edu.cn	Xia, Bin/O-1160-2016; Zhang, yufei/HHC-7375-2022	Xia, Bin/0000-0002-2197-6403; Duan, Bo/0000-0003-0018-4092	Ministry of Science and Technology of China [2016YFA0501200, 2012CB910703]; National Natural Science Foundation of China [91013011]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grants 2016YFA0501200 and 2012CB910703 (to B. X.) and National Natural Science Foundation of China Grant 91013011 (to B. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chen N, 2009, BBA-MOL CELL RES, V1793, P1516, DOI 10.1016/j.bbamcr.2008.12.013; Das G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008813; Deegan S, 2014, BIOCHEM BIOPH RES CO, V451, P367, DOI 10.1016/j.bbrc.2014.07.111; Denton D, 2015, IMMUNOL CELL BIOL, V93, P35, DOI 10.1038/icb.2014.85; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Fregno Ilaria, 2018, F1000Res, V7, P454, DOI 10.12688/f1000research.13968.1; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hiramatsu N, 2015, AM J PATHOL, V185, P1800, DOI 10.1016/j.ajpath.2015.03.009; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Islam F, 2018, J CELL PHYSIOL, V233, P4479, DOI 10.1002/jcp.26384; Iurlaro R, 2016, FEBS J, V283, P2640, DOI 10.1111/febs.13598; Jager R, 2012, BIOL CELL, V104, P259, DOI 10.1111/boc.201100055; Jin MY, 2014, FEBS LETT, V588, P2457, DOI 10.1016/j.febslet.2014.06.015; Jin MY, 2014, CURR BIOL, V24, P1314, DOI 10.1016/j.cub.2014.04.048; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kuang Y, 2016, AUTOPHAGY, V12, P2363, DOI 10.1080/15548627.2016.1238552; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin J, 2009, AUTOPHAGY, V5, P314, DOI 10.4161/auto.5.3.7888; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Liu Z, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.183; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Svenning S, 2013, ESSAYS BIOCHEM, V55, P79, DOI [10.1042/bse0550079, 10.1042/BSE0550079]; Tian SH, 2010, AUTOPHAGY, V6, P1032, DOI 10.4161/auto.6.8.13336; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamamoto A, 2011, NEUROBIOL DIS, V43, P17, DOI 10.1016/j.nbd.2010.08.015; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	49	32	33	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20009	20023		10.1074/jbc.RA119.008709	http://dx.doi.org/10.1074/jbc.RA119.008709			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31748416	hybrid, Green Published			2022-12-26	WOS:000505005800016
J	Bolla, AC; Valente, T; Miguez, A; Brito, V; Gines, S; Sol, C; Straccia, M; Canals, JM				Bolla, Andrea Comella; Valente, Tony; Miguez, Andres; Brito, Veronica; Gines, Silvia; Sol, Carme; Straccia, Marco; Canals, Josep M.			CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease	PLOS ONE			English	Article							INDUCED COGNITIVE IMPAIRMENT; MICROGLIAL ACTIVATION; INHIBITORY MOLECULES; CD200-DEFICIENT MICE; IMMUNE ACTIVATION; CAG REPEAT; EXPRESSION; RECEPTOR; NEUROINFLAMMATION; HIPPOCAMPUS	In Huntington's disease (HD), striatal medium spiny neurons (MSNs) are particularly sensitive to the presence of a CAG repeat in the huntingtin (HTT) gene. However, there are many evidences that cells from the peripheral immune system and central nervous system (CNS) immune cells, namely microglia, play an important role in the etiology and the progression of HD. However, it remains unclear whether MSNs neurodegeneration is mediated by a noncell autonomous mechanism. The homeostasis in the healthy CNS is maintained by several mechanisms of interaction between all brain cells. Neurons can control microglia activation through several inhibitory mechanisms, such as the CD200-CD200R1 interaction. Due to the complete lack of knowledge about the CD200-CD200R1 system in HD, we determined the temporal patterns of CD200 and CD200R1 expression in the neocortex, hippocampus and striatum in the HD mouse models R6/1 and HdhQ111/7 from pre-symptomatic to manifest stages. In order to explore any alteration in the peripheral immune system, we also studied the levels of expression of CD200 and CD200R1 in whole blood. Although CD200R1 expression was not altered, we observed and increase in CD200 gene expression and protein levels in the brain parenchyma of all the regions we examined, along with HD pathogenesis in R6/1 mice. Interestingly, the expression of CD200 mRNA was also up-regulated in blood following a similar temporal pattern. These results suggest that canonical neuronalmicroglial communication through CD200-CD200R1 interaction is not compromised, and CD200 up-regulation in R6/1 brain parenchyma could represent a neurotrophic signal to sustain or extend neuronal function in the latest stages of HD as pro-survival mechanism.	[Bolla, Andrea Comella; Miguez, Andres; Straccia, Marco; Canals, Josep M.] Univ Barcelona, Stem Cells & Regenerat Med Lab, Prod & Validat Ctr Adv Therapies Creatio, Dept Biomed,Fac Med & Hlth Sci, Barcelona, Spain; [Bolla, Andrea Comella; Miguez, Andres; Brito, Veronica; Gines, Silvia; Straccia, Marco; Canals, Josep M.] Univ Barcelona, Neurosci Inst, Barcelona, Spain; [Bolla, Andrea Comella; Valente, Tony; Miguez, Andres; Brito, Veronica; Gines, Silvia; Sol, Carme; Straccia, Marco; Canals, Josep M.] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Bolla, Andrea Comella; Miguez, Andres; Straccia, Marco; Canals, Josep M.] Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain; [Valente, Tony; Sol, Carme] Consejo Super Invest Cient & IBB CSIC, Dept Cerebral Ischem & Neurodegenerat, Inst Invest Biomed Barcelona, Barcelona, Spain; [Brito, Veronica; Gines, Silvia] Univ Barcelona, Fac Med & Hlth Sci, Dept Biomed, Barcelona, Spain; [Straccia, Marco] FRESCI, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; University of Barcelona	Straccia, M; Canals, JM (corresponding author), Univ Barcelona, Stem Cells & Regenerat Med Lab, Prod & Validat Ctr Adv Therapies Creatio, Dept Biomed,Fac Med & Hlth Sci, Barcelona, Spain.; Straccia, M; Canals, JM (corresponding author), Univ Barcelona, Neurosci Inst, Barcelona, Spain.; Straccia, M; Canals, JM (corresponding author), August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain.; Straccia, M; Canals, JM (corresponding author), Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain.; Straccia, M (corresponding author), FRESCI, Barcelona, Spain.	marco.straccia@fre-sci.info; jmcanals@ub.edu	Valente, Tony/M-3097-2014; Brito, Verónica/M-2112-2015; Straccia, Marco/L-8048-2014; Canals, Josep M./M-3846-2014; Gines Padros, Silvia/L-1943-2015	Valente, Tony/0000-0002-2697-8184; Brito, Verónica/0000-0002-4137-0708; Straccia, Marco/0000-0003-3903-4163; Canals, Josep M./0000-0001-6829-7670; Miguez, Andres/0000-0001-6014-3685; Sola, Carme/0000-0002-4012-816X; Gines Padros, Silvia/0000-0002-9479-8185	Ministerio de Ciencia, Innovacion y Universidades (Spain) [RTI2018-099001-B-I00]; Instituto de Salud Carlos III, Ministerio de Ciencia, Innovacion y Universidades, Spain; Generalitat de Catalunya, Spain [2017SGR-1408]; CHDI Foundation, USA [A12076]; ADVANCE (CAT), Spain; ACCIO (Catalonia Trade Investment; Generalitat de Catalunya), Spain; European Community under the Catalonian ERDF operational program 2014-2020, Spain; European Regional Development Fund (ERDF) [CIBERNED], Spain; European Regional Development Fund (ERDF) [RETICS (Red de Terapia Celular)], Spain [RD16/0011/0012]	Ministerio de Ciencia, Innovacion y Universidades (Spain); Instituto de Salud Carlos III, Ministerio de Ciencia, Innovacion y Universidades, Spain; Generalitat de Catalunya, Spain(Generalitat de Catalunya); CHDI Foundation, USA; ADVANCE (CAT), Spain; ACCIO (Catalonia Trade Investment; Generalitat de Catalunya), Spain; European Community under the Catalonian ERDF operational program 2014-2020, Spain; European Regional Development Fund (ERDF) [CIBERNED], Spain; European Regional Development Fund (ERDF) [RETICS (Red de Terapia Celular)], Spain	This study was supported by grants from the Ministerio de Ciencia, Innovacion y Universidades (Spain), (RTI2018-099001-B-I00 to JMC); Instituto de Salud Carlos III, Ministerio de Ciencia, Innovacion y Universidades and European Regional Development Fund (ERDF) [CIBERNED and RETICS (Red de Terapia Celular, RD16/0011/0012 to JMC)], Spain; Generalitat de Catalunya (2017SGR-1408 to J. M. C.), Spain; the CHDI Foundation (A12076 to JMC), USA; and ADVANCE (CAT) with the support of ACCIO (Catalonia Trade & Investment; Generalitat de Catalunya) and the European Community under the Catalonian ERDF operational program 2014-2020], Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay AN., 1981, IMMUNOLOGY; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Blandino P, 2009, BRAIN BEHAV IMMUN, V23, P958, DOI 10.1016/j.bbi.2009.04.013; Brito V, 2014, J CLIN INVEST, V124, P4411, DOI 10.1172/JCI74809; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Chen ZQ, 2008, TRANSPLANTATION, V86, P1116, DOI 10.1097/TP.0b013e318186fec2; Chen ZQ, 2010, NUCLEIC ACIDS RES, V38, P6684, DOI 10.1093/nar/gkq554; Chitnis T, 2007, AM J PATHOL, V170, P1695, DOI 10.2353/ajpath.2007.060677; Costello DA, 2011, J BIOL CHEM, V286, P34722, DOI 10.1074/jbc.M111.280826; Cox FF, 2012, BRAIN BEHAV IMMUN, V26, P789, DOI 10.1016/j.bbi.2011.10.004; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Deckert M, 2006, ACTA NEUROPATHOL, V111, P548, DOI 10.1007/s00401-006-0062-z; Denieffe S, 2013, BRAIN BEHAV IMMUN, V34, P86, DOI 10.1016/j.bbi.2013.07.174; Dentesano G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-165; Elmore MRP, 2014, J NEUROSCI, V34, P2120, DOI 10.1523/JNEUROSCI.2180-13.2014; Epping EA, 2011, NEURODEGENER DIS MAN, V1, P407, DOI 10.2217/NMT.11.45; Estrada-Sanchez AM, 2015, J NEUROSCI, V35, P4440, DOI 10.1523/JNEUROSCI.2812-14.2015; Estrada-Sanchez AM, 2009, NEUROBIOL DIS, V34, P78, DOI 10.1016/j.nbd.2008.12.017; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Gil JMAC, 2005, NEUROBIOL DIS, V20, P744, DOI 10.1016/j.nbd.2005.05.006; Giralt A, 2009, NEUROSCIENCE, V158, P1234, DOI 10.1016/j.neuroscience.2008.11.024; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Hernangomez M, 2012, GLIA, V60, P1437, DOI 10.1002/glia.22366; Holmannova Drahomira, 2012, Acta Medica (Hradec Kralove), V55, P59; Holmannova Drahomira, 2012, Acta Medica (Hradec Kralove), V55, P12; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Jurgens HA, 2012, BRAIN BEHAV IMMUN, V26, P1006, DOI 10.1016/j.bbi.2012.05.015; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Koning N, 2007, ANN NEUROL, V62, P504, DOI 10.1002/ana.21220; Koning N, 2009, J NEUROPATH EXP NEUR, V68, P159, DOI 10.1097/NEN.0b013e3181964113; Kwan W, 2012, J CLIN INVEST, V122, P4737, DOI 10.1172/JCI64484; Li Z, 2017, BRAIN RES, V1665, P65, DOI 10.1016/j.brainres.2017.04.004; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Lyons A, 2017, MOL NEUROBIOL, V54, P5730, DOI 10.1007/s12035-016-0223-6; Lyons A, 2009, BRAIN BEHAV IMMUN, V23, P1020, DOI 10.1016/j.bbi.2009.05.060; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin DSD, 2009, NEUROIMMUNOMODULAT, V16, P400, DOI 10.1159/000228915; Masgrau R, 2017, TRENDS MOL MED, V23, P486, DOI 10.1016/j.molmed.2017.04.005; Masocha W, 2010, J NEUROIMMUNOL, V226, P59, DOI 10.1016/j.jneuroim.2010.05.033; Masocha W, 2009, J NEUROIMMUNOL, V214, P78, DOI 10.1016/j.jneuroim.2009.06.022; Miguez A, 2015, HUM MOL GENET, V24, P4958, DOI 10.1093/hmg/ddv218; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Montiel Milagros, 2015, Antiviral Chemistry & Chemotherapy, V24, P99, DOI 10.1177/2040206616660851; Murray C, 2012, NEUROBIOL AGING, V33, P603, DOI 10.1016/j.neurobiolaging.2010.04.002; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ojo B, 2012, BRAIN BEHAV IMMUN, V26, P778, DOI 10.1016/j.bbi.2011.09.013; Paixao S, 2010, CURR OPIN NEUROBIOL, V20, P466, DOI 10.1016/j.conb.2010.04.008; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Pankratova S, 2016, MOL NEUROBIOL, V53, P584, DOI 10.1007/s12035-014-9037-6; Paoletti P, 2008, J NEUROSCI, V28, P10090, DOI 10.1523/JNEUROSCI.3237-08.2008; Paoli RA, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7060067; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Puigdellivol M, 2015, HUM MOL GENET, V24, P7265, DOI 10.1093/hmg/ddv426; Reiner A, 1988, P NATL ACAD SCI US; Ren Y, 2016, MED SCI MONITOR, V22, P1733, DOI 10.12659/MSM.898400; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shrivastava K, 2012, J COMP NEUROL, V520, P2657, DOI 10.1002/cne.23062; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Sorrells SF, 2014, NEUROENDOCRINOLOGY, V100, P129, DOI 10.1159/000367849; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Straccia M, 2013, GLIA, V61, P1607, DOI 10.1002/glia.22542; Stubelius A, 2017, IMMUNOBIOLOGY, V222, P878, DOI 10.1016/j.imbio.2017.05.007; Sun FJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0546-2; Sung YH, 2012, LIFE SCI, V91, P1309, DOI 10.1016/j.lfs.2012.10.003; Valente T, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00129; Vieites JM, 2003, GENE, V311, P99, DOI 10.1016/S0378-1119(03)00562-6; Walker DG, 2017, NEUROBIOL AGING, V54, P175, DOI 10.1016/j.neurobiolaging.2017.03.007; Walker DG, 2009, EXP NEUROL, V215, P5, DOI 10.1016/j.expneurol.2008.09.003; Wang CY, 2016, J NEUROSCI RES, V94, P1460, DOI 10.1002/jnr.23922; Wang HT, 2017, NEUROTOX RES, V31, P505, DOI 10.1007/s12640-016-9696-3; Wang XJ, 2011, FREE RADICAL BIO MED, V50, P1094, DOI 10.1016/j.freeradbiomed.2011.01.032; Wang YX, 2016, BRAIN RES, V1648, P380, DOI 10.1016/j.brainres.2016.07.045; WEBB M, 1984, J NEUROCHEM, V43, P1061, DOI 10.1111/j.1471-4159.1984.tb12844.x; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x; Xie X, 2017, J NEUROCHEM, V141, P222, DOI 10.1111/jnc.13972; Yi MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34901; Yi MH, 2012, BRAIN RES, V1481, P90, DOI 10.1016/j.brainres.2012.08.053; Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	89	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224901	10.1371/journal.pone.0224901	http://dx.doi.org/10.1371/journal.pone.0224901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790427	Green Published, Green Submitted, gold			2022-12-26	WOS:000533930800016
J	Haley, NJ; Merrett, K; Stein, AB; Simpson, D; Carlson, A; Mitchell, G; Staskevicius, A; Nichols, T; Lehmkuhl, AD; Thomsen, BV				Haley, Nicholas J.; Merrett, Kahla; Stein, Amy Buros; Simpson, Dennis; Carlson, Andrew; Mitchell, Gordon; Staskevicius, Antanas; Nichols, Tracy; Lehmkuhl, Aaron D.; Thomsen, Bruce, V			Estimating relative CWD susceptibility and disease progression in farmed white-tailed deer with rare PRNP alleles	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; PRION PROTEIN; CLASSICAL SCRAPIE; INFECTIOUS PRIONS; MULE DEER; TRANSMISSION; ELK; GENETICS; POLYMORPHISMS; SHEEP	Chronic wasting disease is a prion disease affecting both free-ranging and farmed cervids in North America and Scandinavia. A range of cervid species have been found to be susceptible, each with variations in the gene for the normal prion protein, PRNP, reportedly influencing both disease susceptibility and progression in the respective hosts. Despite the finding of several different PRNP alleles in white-tailed deer, the majority of past research has focused on two of the more common alleles identified-the 96G and 96S alleles. In the present study, we evaluate both infection status and disease stage in nearly 2100 farmed deer depopulated in the United States and Canada, including 714 CWD-positive deer and correlate our findings with PRNP genotype, including the more rare 95H, 116G, and 226K alleles. We found significant differences in either likelihood of being found infected or disease stage (and in many cases both) at the time of depopulation in all genotypes present, relative to the most common 96GG genotype. Despite high prevalence in many of the herds examined, infection was not found in several of the reported genotypes. These findings suggest that additional research is necessary to more properly define the role that these genotypes may play in managing CWD in both farmed and free-ranging white-tailed deer, with consideration for factors including relative fitness levels, incubation periods, and the kinetics of shedding in animals with these rare genotypes.	[Haley, Nicholas J.; Merrett, Kahla] Midwestern Univ, Coll Grad Studies, Dept Microbiol & Immunol, Glendale, AZ 85308 USA; [Stein, Amy Buros] Midwestern Univ, Off Res & Sponsored Programs, Glendale, AZ USA; [Simpson, Dennis; Carlson, Andrew] Simpson Whitetails Genet Testing, Belleville, MI USA; [Mitchell, Gordon; Staskevicius, Antanas] Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Natl & OIE Reference Lab Scrapie & CWD, Ottawa, ON, Canada; [Nichols, Tracy] USDA, APHIS, Vet Serv, Cervid Hlth Program, Ft Collins, CO USA; [Lehmkuhl, Aaron D.; Thomsen, Bruce, V] USDA, APHIS, Vet Serv, Natl Vet Serv Labs, Ames, IA USA; [Thomsen, Bruce, V] USDA, APHIS, Vet Serv, Ctr Vet Biol, Ames, IA USA	Midwestern University; Midwestern University; Canadian Food Inspection Agency; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Haley, NJ (corresponding author), Midwestern Univ, Coll Grad Studies, Dept Microbiol & Immunol, Glendale, AZ 85308 USA.	NHaley@midwestern.edu			North American Deer Farmers Association; Whitetails of Wisconsin	North American Deer Farmers Association; Whitetails of Wisconsin	This work was supported by the North American Deer Farmers Association (https://nadefa.org/) to NH and Whitetails of Wisconsin (https://www.whitetailsofwisconsin.com/) to NH. Simpson Whitetails Genetic Testing provided support in the form of salaries for authors (DS and AC), as well as genotypic data from a subset of CWD negative herds, representing approximately 50% of the healthy herds reported. These authors had no role in study design or data analysis. The specific roles of these authors are further articulated in the "author contributions" section.; This study was funded in large part by the North American Deer Farmers Association and Whitetails of Wisconsin. The authors would like to thank all of the deer farmers who were involved in the depopulation events, which formed the basis for the present study. We are also thankful for the support personnel working with the United States Department of Agriculture, the National Veterinary Services Laboratory, and the Canadian Food Inspection Agency who helped facilitate post-mortem sample collection and processing for this study.	Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Arnold M, 2014, PREV VET MED, V117, P242, DOI 10.1016/j.prevetmed.2014.07.015; Asante EA, 2015, NATURE, V522, P478, DOI 10.1038/nature14510; Baylis M, 2004, CURR MOL MED, V4, P385, DOI 10.2174/1566524043360672; Belay ED, 2004, EMERG INFECT DIS, V10, P977, DOI 10.3201/eid1006.031082; Benestad Sylvie L, 2018, Handb Clin Neurol, V153, P135, DOI 10.1016/B978-0-444-63945-5.00008-8; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Brandt AL, 2018, PRION, V12, P204, DOI 10.1080/19336896.2018.1474671; Burkner PC, 2018, R J, V10, P395; Davenport KA, 2018, J CLIN MICROBIOL, V56; DeArmond SJ, 2004, NEUROCHEM RES, V29, P1979, DOI 10.1007/s11064-004-6872-2; Dormont D, 2002, FEBS LETT, V529, P17, DOI 10.1016/S0014-5793(02)03268-4; Fast C, 2017, VET RES, V48, DOI 10.1186/s13567-017-0455-0; Haley N, MANAGEMENT CHRONIC W; Haley NJ, 2017, J GEN VIROL, V98, P2882, DOI 10.1099/jgv.0.000952; Haley NJ, 2016, J CLIN MICROBIOL, V54, P1108, DOI 10.1128/JCM.02699-15; Haley NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081488; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Haley NJ, 2015, ANN REV ANIM BIOSCI; Hamir AN, 2011, CAN J VET RES, V75, P152; Henderson DM, 2017, J GEN VIROL, V98, P1953, DOI 10.1099/jgv.0.000844; Henderson DM, 2015, J VIROL, V89, P9338, DOI 10.1128/JVI.01118-15; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Jeffrey M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091026; Jewell JE, 2005, J GEN VIROL, V86, P2127, DOI 10.1099/vir.0.81077-0; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Johnson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017450; Keane DP, 2008, J VET DIAGN INVEST, V20, P698, DOI 10.1177/104063870802000534; Kelly AC, 2008, PRION, V2, P28, DOI 10.4161/pri.2.1.6321; Knowles JE, MERTOOLS TOOLS ANALY; Lacroux C, 2017, J GEN VIROL, V98, P2200, DOI 10.1099/jgv.0.000861; Laurent M, 1998, BIOPHYS CHEM, V72, P211, DOI 10.1016/S0301-4622(98)00135-5; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Lloyd SE, 2013, CURR OPIN GENET DEV, V23, P345, DOI 10.1016/j.gde.2013.02.012; Mahal SP, 2010, P NATL ACAD SCI USA, V107, P22653, DOI 10.1073/pnas.1013014108; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; MaWhinney S, 2006, EMERG INFECT DIS, V12, P1527, DOI 10.3201/eid1210.060019; Miller MW, 2004, J WILDLIFE DIS, V40, P320, DOI 10.7589/0090-3558-40.2.320; Mitchell GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039055; Murdoch BM, 2015, BIOINFORM BIOL INSIG, V9, P1, DOI [10.4137/BBi.s29678, 10.4137/BBI.S29678]; Niedermeyer S, 2016, VET RES, V47, DOI 10.1186/s13567-016-0379-0; Nodelijk G, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-5; O'Rourke KI, 1999, J GEN VIROL, V80, P2765, DOI 10.1099/0022-1317-80-10-2765; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Otero A, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1794-z; Pastore A, 2007, PRION, V1, P185, DOI 10.4161/pri.1.3.5281; Pinheiro J., 2019, NLME LINEAR NONLINEA; Plummer IH, 2017, J GEN VIROL, V98, P1932, DOI 10.1099/jgv.0.000845; ProMED-Mail, 2018, CHRONIC WASTING DIS; ProMED-Mail, 2019, CHRONIC WASTING DIS; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race B, 2009, J VIROL, V83, P9608, DOI 10.1128/JVI.01127-09; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Raymond GJ, 2007, J VIROL, V81, P4305, DOI 10.1128/JVI.02474-06; Richt JA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000156; Robinson SJ, 2012, PRION, V6, P153, DOI 10.4161/pri.19640; Robinson SJ, 2012, ECOL APPL, V22, P1050, DOI 10.1890/11-0907.1; Samuel MD, 2016, ECOLOGY, V97, P3195, DOI 10.1002/ecy.1538; Smith PG, 2003, BRIT MED BULL, V66, P185, DOI 10.1093/bmb/66.1.185; Sohn HJ, 2002, J VET MED SCI, V64, P855, DOI 10.1292/jvms.64.855; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; Sutton D., 2015, USDA APHIS SCRAPIE P, P342; Thomsen BV, 2012, J VET DIAGN INVEST, V24, P878, DOI 10.1177/1040638712453582; Vouraki S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198819; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204; Wolfe LL, 2014, J WILDLIFE DIS, V50, P660, DOI 10.7589/2013-10-274; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831	74	19	19	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224342	10.1371/journal.pone.0224342	http://dx.doi.org/10.1371/journal.pone.0224342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790424	Green Submitted, gold, Green Published			2022-12-26	WOS:000533930800004
J	Li, J; Yang, YD; Iqbal, A; Qadri, R; Shi, P; Wang, Y; Wu, Y; Fan, HK; Wu, GJ				Li, Jing; Yang, Yaodong; Iqbal, Amjad; Qadri, Rashad; Shi, Peng; Wang, Yong; Wu, Yi; Fan, Haikuo; Wu, Guojiang			Correlation analysis of cold-related gene expression with physiological and biochemical indicators under cold stress in oil palm	PLOS ONE			English	Article							FREEZING TOLERANCE; CBF3/DREB1A EXPRESSION; LOW-TEMPERATURE; SOLUBLE SUGARS; WINTER-WHEAT; ACCLIMATION; DROUGHT; RESPONSES; RESISTANCE; STABILITY	Oil palm (Elaeis guineensis Jacq.) is a representative tropical oil crop that is sensitive to low temperature. Oil palm can experience cold damage when exposed to low temperatures for a long period. During these unfavorable conditions, a series of gene induction/repression and physico-chemical changes occur in oil palm. To better understand the link between these events, we investigated the expression levels of various genes (including COR410, COR413, CBF1, CBF2, CBF3, ICE1-1, ICE1-2, ICE1-4, SIZ1-1, SIZ1-2, ZAT10, ZAT12) and the accumulation of osmolytes (proline, malondialdehyde and sucrose). Likewise, the activity of superoxide dismutase (SOD) in oil palm under cold stress (4 degrees C, 8 degrees C and 12 degrees C) was examined. The results showed a clear link among the expression of CBFs (especially CBF1 and CBF3) and the all genes examined under cold stress (12 degrees C). The expression of CBF1 and CBF2 also exhibited a positive link with the accumulation of sucrose and proline under cold stress in oil palm. At 4 degrees C, the proline content exhibited a very significant correlation with electrolyte leakage in oil palm. The results of this study provide necessary information regarding the mechanism of the response and adaption of oil palm to cold stress. Additionally, they offer clues for the selection or development of cold-tolerant cultivars from the available germplasms of oil palm.	[Li, Jing; Yang, Yaodong; Iqbal, Amjad; Qadri, Rashad; Shi, Peng; Wang, Yong; Wu, Yi; Fan, Haikuo] Chinese Acad Trop Agr Sci, Coconut Res Inst, Hainan Key Lab Trop Oil Crops Biol, Wenchang, Hainan, Peoples R China; [Wu, Guojiang] Chinese Acad Sci, Key Lab Plant Resource Conservat & Sustainable Ut, South China Bot Garden, Guangzhou, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Sciences; South China Botanical Garden, CAS	Yang, YD (corresponding author), Chinese Acad Trop Agr Sci, Coconut Res Inst, Hainan Key Lab Trop Oil Crops Biol, Wenchang, Hainan, Peoples R China.	yyang@catas.cn	Iqbal, Amjad/E-2010-2014; Qadri, Rashad Waseem Khan/AAX-6327-2020; Wang, Yong/GPW-9194-2022	Iqbal, Amjad/0000-0001-6141-8337; Qadri, Rashad Waseem Khan/0000-0002-0241-6048; Yang, Yaodong/0000-0002-6599-5665	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [PCU201402]; Natural Science Foundation of China [31870670]; "948" projects for Ministry of Agriculture of China [2015-Z25]; Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences [1630152017009, 17CXTD-28]; Central Public-interest Scientific Institution Basal Research Fund of the Chinese Academy of Tropical Agricultural Sciences [1630152017009, 17CXTD-28]	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "948" projects for Ministry of Agriculture of China; Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences; Central Public-interest Scientific Institution Basal Research Fund of the Chinese Academy of Tropical Agricultural Sciences	This work was supported by Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences funds (PCU201402) (to YY), the Natural Science Foundation of China (No. 31870670) (to YY). "948" projects for Ministry of Agriculture of China (2015-Z25) and the Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences (No. 1630152017009 and 17CXTD-28) (to YW).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other modifications were done in the manuscript.; This work was supported by the Key Laboratory of Plant Resource Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences funds (PCU201402), the Natural Science Foundation of China (No. 31870670), the "948" projects of the Ministry of Agriculture of China (2015-Z25) and the Central Public-interest Scientific Institution Basal Research Fund of the Chinese Academy of Tropical Agricultural Sciences (No. 1630152017009 and 17CXTD-28).	Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Alvim PdT, 2013, ECOPHYSIOLOGY TROPIC; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Bajji M, 2002, CAN J BOT, V80, P297, DOI [10.1139/B02-008, 10.1139/b02-008]; Balakhnina T, 2013, INT AGROPHYS, V27, P225, DOI 10.2478/v10247-012-0089-4; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Byun MY, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00601; Chatgilialoglu C, 2008, CHIMIA, V62, P713, DOI 10.2533/chimia.2008.713; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Corley RHV, 2009, ENVIRON SCI POLICY, V12, P134, DOI 10.1016/j.envsci.2008.10.011; Corley RHV, 2003, OIL PALM, P201; CRESPI MD, 1991, PLANT PHYSIOL, V96, P887, DOI 10.1104/pp.96.3.887; Ding YL, 2015, DEV CELL, V32, P278, DOI 10.1016/j.devcel.2014.12.023; Dominguez T, 2010, PLANT PHYSIOL, V153, P655, DOI 10.1104/pp.110.154815; Feng ZZ, 2011, GLOBAL CHANGE BIOL, V17, P580, DOI 10.1111/j.1365-2486.2010.02184.x; Fu JJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3222-0; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Janmohammadi M., 2012, CURR OPIN AGRIC, V1, P1; Jiang JL, 2013, BIOLOGIA, V68, P231, DOI 10.2478/s11756-013-0003-y; Karimi M, 2015, SCI HORTIC-AMSTERDAM, V197, P521, DOI 10.1016/j.scienta.2015.10.011; Kaur S, 2009, J AGRON CROP SCI, V195, P393, DOI 10.1111/j.1439-037X.2009.00383.x; Kim YS, 2015, PLANT MOL BIOL, V89, P187, DOI 10.1007/s11103-015-0365-3; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Lei XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114482; Li KW, 2013, WOR CONG SOFTW ENG, P131, DOI 10.1109/WCSE.2013.25; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu YK, 2019, PLANT CELL REP, V38, P511, DOI 10.1007/s00299-019-02376-3; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Ma YY, 2009, AFR J BIOTECHNOL, V8, P2004; Marchi S, 2012, J SIGNAL TRANSDUCTIO, V2011; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Miura K, 2013, INT J MOL SCI, V14, P5312, DOI 10.3390/ijms14035312; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Pamplona R, 2011, CHEM-BIOL INTERACT, V192, P14, DOI 10.1016/j.cbi.2011.01.007; Pasquali G, 2008, PLANT CELL REP, V27, P1677, DOI 10.1007/s00299-008-0587-9; RUTTEN D, 1992, OECOLOGIA, V91, P260, DOI 10.1007/BF00317794; Savitch LV, 2000, PHYSIOL PLANTARUM, V108, P270, DOI 10.1034/j.1399-3054.2000.108003270.x; Shah K, 1998, BIOL PLANTARUM, V40, P121, DOI 10.1023/A:1000956803911; Shan DP, 2007, NEW PHYTOL, V176, P70, DOI 10.1111/j.1469-8137.2007.02160.x; Shi YT, 2018, TRENDS PLANT SCI, V23, P623, DOI 10.1016/j.tplants.2018.04.002; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Spinner JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009279; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Verheye W., 2010, LAND USE; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Xiao Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189224; Xiao Y, 2012, PLANT OMICS, V5, P584; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yoon YE, 2017, FOOD CHEM, V215, P185, DOI 10.1016/j.foodchem.2016.07.167; Zhang Q, 2014, RICE, V7, DOI 10.1186/s12284-014-0024-3	60	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225768	10.1371/journal.pone.0225768	http://dx.doi.org/10.1371/journal.pone.0225768			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774880	Green Published, gold			2022-12-26	WOS:000533896400058
J	Kalilani, L; Friesen, D; Boudiaf, N; Asgharnejad, M				Kalilani, Linda; Friesen, David; Boudiaf, Nada; Asgharnejad, Mahnaz			The characteristics and treatment patterns of patients with Parkinson's disease in the United States and United Kingdom: A retrospective cohort study	PLOS ONE			English	Article							SYMPTOMS	Objectives The objective of the study was to describe treatment patterns in patients newly diagnosed with Parkinson's disease (PD) in the United States (US) and the United Kingdom (UK). Methods This retrospective cohort study used the US IBM MarketScan database (2012-2017) and the UK Clinical Practice Research Datalink (CPRD) (2004-2015) database to describe treatment patterns in incident PD cases. Patients fulfilling the case definition of PD,.30 years, with a 2-year baseline period prior to the index date (date of PD diagnosis), and.90 days of follow-up were included in the study. Treatment was classified as monotherapy (one PD medication for.60 continuous days), polytherapy (at least two PD medications concurrently for.60 days), or untreated (no PD medication prescription). Treatment patterns described included type of medication, duration and outcome of treatment. Results There were 11,280 patients in IBM MarketScan and 7775 patients in CPRD who fulfilled the study criteria. The proportion of treated patients was 62.4% (US) and 78.6% (UK). The majority of patients were prescribed monotherapy as first-line treatment (US: 85.2%, UK: 68.5%). Levodopa was the most frequently prescribed first-line medication (US: 70.1%, UK: 29.0%). There were 57.9% in the US and 23.8% in the UK who remained on the first monotherapy treatment till the end of the study. Conclusion The study has highlighted the current treatment practices in the US and UK, and underscored differences in the two regions impacted by treatment policies and guidelines.	[Kalilani, Linda; Asgharnejad, Mahnaz] UCB Pharma, Raleigh, NC 27617 USA; [Friesen, David; Boudiaf, Nada] UCB Pharma, Slough, Berks, England	UCB Pharma SA; UCB Pharma SA	Kalilani, L (corresponding author), UCB Pharma, Raleigh, NC 27617 USA.	linda.kalilani@ucb.com			UCB Pharma, Brussels, Belgium; UCB Pharma	UCB Pharma, Brussels, Belgium(UCB Pharma SA); UCB Pharma(UCB Pharma SA)	This study was supported by UCB Pharma, Brussels, Belgium. Linda Kalilani is an employee of UCB Pharma. David Friesen (Friesen Limited, Ascot, UK) and Nada Boudiaf (Chiltern International, Slough, UK) were paid consultants for UCB Pharma on this study. Mahnaz Asgharnejad is a former employee of UDCB Pharma. The funder provided support in the form of salaries or consultancy fees for authors [LK, MA, DF, NB], who designed the retrospective analysis ('study'), performed the statistical analysis, and decided to publish. The specific roles of these authors are articulated in the 'author contributions' section.; The authors thank the patients whose data contributed to this research. The authors acknowledge the contribution of Knut Mueller (previous employee of UCB Pharma) for statistical programming, and Helen Ysak PhD (UCB Pharma, Atlanta, GA, USA) and Nicole Meinel PhD (Evidence Scientific Solutions, London, UK) for coordination of publication and editorial assistance, funded by UCB Pharma.	Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Crispo JAG, 2015, EUR J CLIN PHARMACOL, V71, P1011, DOI 10.1007/s00228-015-1881-4; Dahodwala N, 2017, MOV DISORD CLIN PRAC, V4, P335, DOI 10.1002/mdc3.12422; Machado-Alba JE, 2018, BIOMEDICA, V38, P417, DOI 10.7705/biomedica.v38i4.3781; Fayard C, 2011, PARKINSONISM RELAT D, V17, P543, DOI 10.1016/j.parkreldis.2011.04.020; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Liu WM, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/1859321; Nakaoka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099021; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Xia RP, 2012, NEUROSCI BULL, V28, P39, DOI 10.1007/s12264-012-1050-z	10	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225723	10.1371/journal.pone.0225723	http://dx.doi.org/10.1371/journal.pone.0225723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756215	Green Published, gold			2022-12-26	WOS:000533889300054
J	Senefeld, JW; Clayburn, AJ; Baker, SE; Carter, RE; Johnson, PW; Joyner, MJ				Senefeld, Jonathon W.; Clayburn, Andrew J.; Baker, Sarah E.; Carter, Rickey E.; Johnson, Patrick W.; Joyner, Michael J.			Sex differences in youth elite swimming	PLOS ONE			English	Article							ENDURANCE EXERCISE PERFORMANCE; TESTOSTERONE; AGE; PHYSIOLOGY; SERUM	Background The timing and magnitude of sex differences in athletic performance during early human development, prior to adulthood, is unknown. Objective To compare swimming velocity of boys and girls for all Olympic-length freestyle swimming events to determine the age of divergence in swimming performance. Methods We collected the all-time top 100 U.S. freestyle swimming performance times of boys and girls age 5 to 18 years for the 50m to 1500m events. Results Swimming performance improved with increasing age for boys and girls (p< 0.001) until reaching a plateau, which initiated at a younger age for girls (15 years) than boys (17 years; sexxage; p<0.001). Prior to age 10, the top 5 swimming records for girls were 3% faster than the top boys (p< 0.001). For the 10th-50th places, however, there were no sex-related differences in swimming performance prior to age 10 (p = 0.227). For both the top 5 and 10th-50th places, the sex difference in performance increased from age 10 (top 5, 2.5%; 10th-50th places, 1.0%) until age 17 (top 5, 7.6%; 10th-50th places, 8.0%). For all places, the sex difference in performance at age 18 was larger for sprint events (9.6%; 50-200m) than endurance events (7.1%; 400-1500m; p<0.001). Additionally, the sex-related difference in performance increased across age and US ranking from 2.4% for 1st place to 4.3% for 100th place (p<0.001), indicating less depth of performance in girls than boys. However, annual participation was similar to 20% higher in girls than boys for all ages (p<0.001). Conclusion The top 5 girls demonstrated faster swimming velocities and the 10th-50th place girls demonstrated similar swimming velocities than boys (until similar to 10 years). After age 10, however, boys demonstrated increasingly faster swimming velocities than girls until 17 years. Collectively, these data suggest girls are faster, or at least not slower, than boys prior to the performance-enhancing effects of puberty.	[Senefeld, Jonathon W.; Clayburn, Andrew J.; Baker, Sarah E.; Joyner, Michael J.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN 55905 USA; [Carter, Rickey E.; Johnson, Patrick W.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic	Senefeld, JW (corresponding author), Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN 55905 USA.	senefeld.jonathon@mayo.edu	Johnson, Patrick/ABE-9597-2020; Senefeld, Jack/ABF-1286-2020; Carter, Rickey/A-1594-2012	Johnson, Patrick/0000-0001-8365-1375; Clayburn, Andrew/0000-0001-8729-1805; Senefeld, Jonathon/0000-0001-8116-3538; Carter, Rickey/0000-0002-0818-273X; Baker, Sarah/0000-0001-9647-7660				Abbassi V, 1998, PEDIATRICS, V102, P507; [Anonymous], 2018, 2018O5794 CAS; Araujo FC, 2015, PHYSIOL GENOMICS, V47, P177, DOI 10.1152/physiolgenomics.00138.2014; Buttler RM, 2016, CLIN CHIM ACTA, V456, P15, DOI 10.1016/j.cca.2016.02.015; Cheuvront SN, 2005, SPORTS MED, V35, P1017, DOI 10.2165/00007256-200535120-00002; Dukes Richard L., 2002, FREE INQUIRY CREATIV, V30, P185; Franke WW, 1997, CLIN CHEM, V43, P1262; Handelsman DJ, 2018, ENDOCR REV, V39, P803, DOI 10.1210/er.2018-00020; Handelsman DJ, 2017, CLIN ENDOCRINOL, V87, P68, DOI 10.1111/cen.13350; Handelsman DJ, 2016, ANN CLIN BIOCHEM, V53, P377, DOI 10.1177/0004563215610589; HAWKINS WW, 1950, BLOOD, V5, P278, DOI 10.1182/blood.V5.3.278.278; Hunter SK, 2013, MED SCI SPORT EXER, V45, P148, DOI 10.1249/MSS.0b013e31826900f6; Hunter SK, 2011, MED SCI SPORT EXER, V43, P656, DOI 10.1249/MSS.0b013e3181fb4e00; Joyner M J, 1993, Exerc Sport Sci Rev, V21, P103; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Keenan KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191504; Saudan C, 2006, BRIT J SPORT MED, V40, P21, DOI 10.1136/bjsm.2006.027482; Senefeld J, 2016, SCAND J MED SCI SPOR, V26, P17, DOI 10.1111/sms.12412; Senefeld J, 2016, INT J SPORT PHYSIOL, V11, P635, DOI 10.1123/ijspp.2015-0418; Tanaka H, 1997, J APPL PHYSIOL, V82, P846, DOI 10.1152/jappl.1997.82.3.846; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; Tonnessen E, 2015, PLOS ONE, V10, DOI [10.18632/oncotarget.25214, DOI 10.18632/ONCOTARGET.25214]; Vesper HW, 2015, CLIN CHEM, V61, P1495, DOI 10.1373/clinchem.2015.245969; Wood RI, 2012, HORM BEHAV, V61, P147, DOI 10.1016/j.yhbeh.2011.09.010; Zhou H, 2017, ANAL BIOANAL CHEM, V409, P5943, DOI 10.1007/s00216-017-0529-x	25	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225724	10.1371/journal.pone.0225724	http://dx.doi.org/10.1371/journal.pone.0225724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756208	Green Published, gold			2022-12-26	WOS:000533889300055
J	Lee, IP; Walker, RM				Lee, Ivan P.; Walker, Richard M.			Does source credibility matter for point-of-decision prompts? A quasi-experimental field study to increase stair use	PLOS ONE			English	Article							CHOICE PROMPTS; INTERVENTIONS; WORKPLACE; HABITS; CONSERVATION; VALIDATION; ATTITUDES; BREAKING; BEHAVIOR; ABSENCE	A quasi-experimental field study was undertaken to examine whether the source credibility of point-of-decision (POD) prompts would affect their effectiveness in increasing stair use. POD prompts attributed either to a more credible source, a less credible source, or nothing were randomly installed in three student halls of residence at a public university in Hong Kong (plus a control). The stair and elevator use of residents were recorded by view-from-top surveillance cameras and counted using motion-detection software, resulting in 14,189 observations. The findings show that all the POD prompts can yield, as hypothesized, a significant positive effect on stair use. The relative increase in stair use was 2.49% on average. However, contrary to our second hypothesis, the POD prompt attributed to the more credible source was not the most effective intervention. The implications of these findings are discussed in conclusion.	[Lee, Ivan P.] Rutgers Univ Newark, Ctr Expt & Behav Publ Adm, Sch Publ Affairs & Adm, Newark, NJ 07102 USA; [Walker, Richard M.] City Univ Hong Kong, Dept Publ Policy, Lab Publ Management & Policy, Behav & Policy Sci, Hong Kong, Peoples R China	Rutgers State University Newark; City University of Hong Kong	Lee, IP (corresponding author), Rutgers Univ Newark, Ctr Expt & Behav Publ Adm, Sch Publ Affairs & Adm, Newark, NJ 07102 USA.	ivan.lee@rutgers.edu	Walker, Richard Mark/A-4139-2010	Walker, Richard Mark/0000-0003-1503-1814; Lee, Ivan P./0000-0002-7226-2929	City University of Hong Kong [9610318]; Student Residence Office of the City University of Hong Kong	City University of Hong Kong(City University of Hong Kong); Student Residence Office of the City University of Hong Kong	The authors acknowledge support from the City University of Hong Kong (URL: www.cityu.edu.hk; Grant #9610318). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Student Residence Office of the City University of Hong Kong for their administrative support. The authors thank the support from Dr. Jeff Hager, who is the developer of SmartMotion. The authors also thank Professors Samuel Ho, Sebastian Jilke and Gregg Van Ryzin for their comments. Finally, the authors thank Melody Calkins, Keith Choi, Jane Ma, Joyce Ho, Kristy Luk, Danni Man, Evelyn Man, Kari Wong, and Kerry Wong for their research assistance.	Aarts H, 2000, J PERS SOC PSYCHOL, V78, P53, DOI 10.1037/0022-3514.78.1.53; Adriaanse MA, 2011, PERS SOC PSYCHOL B, V37, P502, DOI 10.1177/0146167211399102; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albarracin D, 2004, ADV EXP SOC PSYCHOL, V36, P251, DOI 10.1016/S0065-2601(04)36005-3; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; BARGH JA, 1994, NEBR SYM MOTIV, V41, P71; Bassett DR, 1997, MED SCI SPORT EXER, V29, P1250, DOI 10.1097/00005768-199709000-00019; Bellicha A, 2015, PREV MED, V70, P3, DOI 10.1016/j.ypmed.2014.11.001; Boreham CAG, 2005, BRIT J SPORT MED, V39, P590, DOI 10.1136/bjsm.2002.001131; Care UDoHaS, 2011, START ACT STAY ACT R; CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752; CHAIKEN S, 1994, J PERS SOC PSYCHOL, V66, P460, DOI 10.1037/0022-3514.66.3.460; Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; CIALDINI RB, 1991, ADV EXP SOC PSYCHOL, V24, P201; Cohen DA, 2016, OBES REV, V17, P389, DOI 10.1111/obr.12387; Cooley PD, 2008, HEALTH PROMOT J AUST, V19, P64; Eagly A. H., 1993, PSYCHOL ATTITUDES; Edwards NC, 2018, AM J PREV MED, V54, P323, DOI 10.1016/j.amepre.2017.07.011; Eves F F, 2008, Hong Kong Med J, V14, P36; Fazio RH, 2000, WHY WE EVALUATE: FUNCTIONS OF ATTITUDES, P1; Fricke H, 2017, OXFORD B ECON STAT, V79, P426, DOI 10.1111/obes.12178; Frolich M, 2004, J ECON SURV, V18, P181, DOI 10.1111/j.0950-0804.2004.00001.x; Gneezy A, 2010, SCIENCE, V329, P325, DOI 10.1126/science.1186744; Gockeritz S, 2010, EUR J SOC PSYCHOL, V40, P514, DOI 10.1002/ejsp.643; Griskevicius V., 2008, INT J SUSTAIN COMMUN, V3, P5, DOI DOI 10.1007/S13398-014-0173-7.2; Gustafson CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207792; Hellmueller L., 2012, P WAPOR 65 ANN C; Holland RW, 2006, J EXP SOC PSYCHOL, V42, P776, DOI 10.1016/j.jesp.2005.11.006; Hovland C.I., 1953, COMMUN PERSUATION; Hovland CI, 1951, PUBLIC OPIN QUART, V15, P635, DOI 10.1086/266350; Jennings CA, 2017, AM J PREV MED, V52, P106, DOI 10.1016/j.amepre.2016.08.014; Kerr J, 2001, PREV MED, V33, P422, DOI 10.1006/pmed.2001.0908; KRUGLANSKI AW, 1993, J PERS SOC PSYCHOL, V65, P861, DOI 10.1037/0022-3514.65.5.861; Kumkale GT, 2010, J APPL SOC PSYCHOL, V40, P1325, DOI 10.1111/j.1559-1816.2010.00620.x; Latimer AE, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-36; Lewis AL, 2012, PSYCHOL SPORT EXERC, V13, P126, DOI 10.1016/j.psychsport.2011.10.001; Lewis AL, 2012, J PHYS ACT HEALTH, V9, P954, DOI 10.1123/jpah.9.7.954; LOY SF, 1994, MED SCI SPORT EXER, V26, P241, DOI 10.1249/00005768-199402000-00016; MACKIE DM, 1989, J PERS SOC PSYCHOL, V57, P27, DOI 10.1037/0022-3514.57.1.27; MCCRACKEN G, 1989, J CONSUM RES, V16, P310, DOI 10.1086/209217; Meyer P, 2010, EUR J CARDIOV PREV R, V17, P569, DOI 10.1097/HJR.0b013e328338a4dd; Milne S, 2002, BRIT J HEALTH PSYCH, V7, P163, DOI 10.1348/135910702169420; Nocon M, 2010, SCAND J PUBLIC HEALT, V38, P633, DOI 10.1177/1403494810375865; OHANIAN R, 1991, J ADVERTISING RES, V31, P46; OHANIAN R, 1990, J ADVERTISING, V19, P39, DOI 10.1080/00913367.1990.10673191; Olander EK, 2011, J ENVIRON PSYCHOL, V31, P200, DOI 10.1016/j.jenvp.2011.03.001; Pearson JC, 1988, UNDERSTANDING SHARIN; PETTY BG, 1986, NEW ENGL J MED, V315, P399; Petty R.E., 1986, COMMUN PERSUATION, P123; Pornpitakpan C, 2004, J APPL SOC PSYCHOL, V34, P243, DOI 10.1111/j.1559-1816.2004.tb02547.x; Pratkanis A.R., 1989, ADV EXPT SOCIAL PSYC, VVol. 22, P245, DOI [DOI 10.1016/S0065-2601(08)60310-X, 10.1016/S0065-2601(08)60310-X*]; Russell WD, 2000, PERCEPT MOTOR SKILL, V91, P55, DOI 10.2466/PMS.91.5.55-61; SANBONMATSU DM, 1990, J PERS SOC PSYCHOL, V59, P614, DOI 10.1037/0022-3514.59.4.614; Schultz PW, 2016, ENVIRON BEHAV, V48, P686, DOI 10.1177/0013916514553835; Schultz PW, 2008, SOC INFLUENCE, V3, P4, DOI 10.1080/15534510701755614; Schultz PW, 1999, BASIC APPL SOC PSYCH, V21, P25, DOI 10.1207/s15324834basp2101_3; Scotland NH, 2004, PRET STAIR CLIMB RES; Sheeran P, 2003, SOC SCI MED, V56, P2153, DOI 10.1016/S0277-9536(02)00220-4; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [DOI 10.1080/14792772143000003, 10.1080/14792772143000003]; Silva SA, 2016, WILEY BLACK HB ORG P, P61; Soler RE, 2010, AM J PREV MED, V38, pS292, DOI 10.1016/j.amepre.2009.10.028; Soler RE, 2010, AM J PREV MED, V38, pS290, DOI 10.1016/j.amepre.2009.10.031; van Nieuw-Amerongen ME, 2011, ENVIRON BEHAV, V43, P131, DOI 10.1177/0013916509341242; Verplanken B, 2006, BRIT J SOC PSYCHOL, V45, P639, DOI 10.1348/014466605X49122; Webb OJ, 2007, HEALTH EDUC RES, V22, P49, DOI 10.1093/her/cyl045; Werner CM, 2002, BASIC APPL SOC PSYCH, V24, P185, DOI 10.1207/S15324834BASP2403_2; Wood W, 2009, J CONSUM PSYCHOL, V19, P579, DOI 10.1016/j.jcps.2009.08.003	68	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225520	10.1371/journal.pone.0225520	http://dx.doi.org/10.1371/journal.pone.0225520			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8PC	31751401	Green Published, gold, Green Submitted			2022-12-26	WOS:000533886900076
J	Nyato, D; Nnko, S; Komba, A; Kuringe, E; Plotkin, M; Mbita, G; Shao, A; Changalucha, J; Wambura, M				Nyato, Daniel; Nnko, Soori; Komba, Albert; Kuringe, Evodius; Plotkin, Marya; Mbita, Gaspar; Shao, Amani; Changalucha, John; Wambura, Mwita			Facilitators and barriers to linkage to HIV care and treatment among female sex workers in a community-based HIV prevention intervention in Tanzania: A qualitative study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; COUNTRIES; STIGMA; HEALTH	Background HIV-infected female sex workers (FSWs) have poor linkage to HIV care in sub-Sahara Africa. Methods We conducted 21 participatory group discussions (PGDs) to explore factors influencing linkage to HIV care among FSWs tested for HIV through a comprehensive community-based HIV prevention project in Tanzania. Results Influences on linkage to care were present at the system, societal and individual levels. System-level factors included unfriendly service delivery environment, including lengthy preenrolment sessions, concerns about confidentiality, stigmatising attitudes of health providers. Societal-level factors included myths and misconceptions about ART and stigma. On the individual level, most notable was fear of not being able to continue to have a livelihood if one's status were to be known. Facilitators were noted, including the availability of transport to services, friendly health care providers and peer-support referral and networks. Conclusion Findings of this study underscore the importance of peer-supported linkages to HIV care and the need for respectful, high-quality care.	[Nyato, Daniel; Nnko, Soori; Kuringe, Evodius; Shao, Amani; Changalucha, John; Wambura, Mwita] Natl Inst Med Res, Dept Sexual & Reprod Hlth, Mwanza Ctr, Mwanza, Tanzania; [Komba, Albert; Plotkin, Marya; Mbita, Gaspar] Jhpiego Tanzania, Dar Es Salaam, Tanzania	National Institute of Medical Research; Jhpiego	Nyato, D (corresponding author), Natl Inst Med Res, Dept Sexual & Reprod Hlth, Mwanza Ctr, Mwanza, Tanzania.	dnyato2000@gmail.com	Nyato, Daniel/J-1682-2019	Nyato, Daniel/0000-0002-2397-1390; Shao, Anwen/0000-0001-9986-6290; Shao, Amani/0000-0003-1995-3031	USAID [AID-621-A-15-00003]	USAID(United States Agency for International Development (USAID))	This study was funded by USAID under Cooperative Agreement No: AID-621-A-15-00003 to MW. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CLIN GUIDELINES CONT; Ao T, 2003, INT J STD AIDS, V14, P688, DOI 10.1258/095646203322387956; Apinundecha C, 2007, AIDS CARE, V19, P1157, DOI 10.1080/09540120701335204; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Braunstein SL, 2011, JAIDS-J ACQ IMM DEF, V57, pE70, DOI 10.1097/QAI.0b013e3182170fd3; Catz SL, 2000, HEALTH PSYCHOL, V19, P124, DOI 10.1037/0278-6133.19.2.124; Chanda MM, 2017, AIDS PATIENT CARE ST, V31, P290, DOI 10.1089/apc.2017.0016; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Chimukangara B, 2017, AIDS RES HUM RETROV, V33, P1185, DOI 10.1089/aid.2017.0029; Cluver L, 2009, AIDS CARE, V21, P732, DOI 10.1080/09540120802511885; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corbie-Smith G, 2010, AIDS EDUC PREV, V22, P184, DOI 10.1521/aeap.2010.22.3.184; Deacon H., 2005, UNDERSTANDING HIV AI; Dutta A., 2014, CONSENSUS ESTIMATES; Edhlund B, 2017, NVIVO 11 ESSENTIALS; Eshleman SH, 2017, JAIDS-J ACQ IMM DEF, V74, P112, DOI 10.1097/QAI.0000000000001158; Hargreaves JR, 2017, AIDS CARE, V29, P675, DOI 10.1080/09540121.2016.1268673; Hennink M, 2010, QUALITATIVE RES METH, DOI [10.1016/j.ymeth.2009.12.006, DOI 10.1016/J.YMETH.2009.12.006]; Kerrigan D, 2017, JAIDS-J ACQ IMM DEF, V74, pS60, DOI 10.1097/qai.0000000000001203; Lankowski AJ, 2014, AIDS BEHAV, V18, P1199, DOI 10.1007/s10461-014-0729-8; Mburu G, 2013, J INT AIDS SOC, V16; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Ministry of Health CD Gender Elderly Children-MoHCDGEC/Tanzania Mainland Ministry of Health-MoH/Zanzibar National Bureau of Statistics-NBS/Tanzania Office of Chief Government Statistician-OCGS/Zanzibar ICF, 2016, TANZ DEM HLTH SURV M; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; NACP, 2013, WELFARE MOHAS; NACP M, 2015, NAT GUID MAN HIV AID; NACP. NATIONAL GUIDELINE FOR COMPREHENSIVE PACKAGE OF HIV INTERVENTIONS FOR KEY POPULATIONS, 2017, DAR SALAAM NATL AIDS; Naidoo Sarita, 2013, S. Afr. j. sci., V109, P01; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Nakanwagi S., 2016, J SEXUALLY TRANSMITT; Nglazi MD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1275-3; Ngugi EN, 2012, SAHARA J-J SOC ASP H, V9, P148, DOI 10.1080/17290376.2012.743825; Nyblade L, 2017, CULT HEALTH SEX, V19, P1092, DOI 10.1080/13691058.2017.1293844; Ozanne JL, 2008, J CONSUM RES, V35, P423, DOI 10.1086/586911; Phrasisombath K, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-37; Sanga ES, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013733; Scheibe A, 2012, SAHARA J-J SOC ASP H, V9, P167, DOI 10.1080/17290376.2012.743809; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Scorgie F, 2011, FINAL REPORT AFRICAN; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; TACAIDS, 2017, TANZANIA HIV IMPACT; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; van Rensburg DHCJ, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-15; Wanyenze RK, 2011, AIDS BEHAV, V15, P751, DOI 10.1007/s10461-010-9704-1; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	45	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0219032	10.1371/journal.pone.0219032	http://dx.doi.org/10.1371/journal.pone.0219032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8LN	31743336	Green Published, gold, Green Submitted			2022-12-26	WOS:000533877300002
J	Bommi, PV; Chand, V; Mukhopadhyay, NK; Raychaudhuri, P; Bagchi, S				Bommi, Prashant, V; Chand, Vaibhav; Mukhopadhyay, Nishit K.; Raychaudhuri, Pradip; Bagchi, Srilata			NER-factor DDB2 regulates HIF1 alpha and hypoxia-response genes in HNSCC	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; NF-KAPPA-B; LYSYL OXIDASE; NECK-CANCER; HEAD; PROTEIN; EXPRESSION; CARCINOMA; THROMBOSPONDIN-1; METASTASIS	Cancers in the oral/head & neck region (HNSCC) are aggressive due to high incidence of recurrence and distant metastasis. One prominent feature of aggressive HNSCC is the presence of severely hypoxic regions in tumors and activation of hypoxia-inducible factors (HIFs). In this study, we report that the XPE gene product DDB2 (damaged DNA binding protein 2), a nucleotide excision repair protein, is upregulated by hypoxia. Moreover, DDB2 inhibits HIF1 alpha in HNSCC cells. It inhibits HIF1 alpha in both normoxia and hypoxia by reducing mRNA expression. Knockdown of DDB2 enhances the expression of angiogenic markers and promotes tumor growth in a xenograft model. We show that DDB2 binds to an upstream promoter element in the HIF1 Alpha gene and promotes histone H3K9 trimethylation around the binding site by recruiting Suv39h1. Also, we provide evidence that DDB2 has a significant suppressive effect on expression of the endogenous markers of hypoxia that are also prognostic indicators in HNSCC. Together, these results describe a new mechanism of hypoxia regulation that opposes expression of HIF1 Alpha mRNA and the hypoxia-response genes.	[Bommi, Prashant, V; Bagchi, Srilata] Univ Illinois, Coll Dent, Dept Oral Biol, 801 S Paulina St, Chicago, IL 60612 USA; [Chand, Vaibhav; Mukhopadhyay, Nishit K.; Raychaudhuri, Pradip] Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA; [Bommi, Prashant, V] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Biol Sci Res Bldg,6767 Bertner Ave, Houston, TX 77030 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; UTMD Anderson Cancer Center	Bagchi, S (corresponding author), Univ Illinois, Coll Dent, Dept Oral Biol, 801 S Paulina St, Chicago, IL 60612 USA.; Raychaudhuri, P (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.	pradip@uic.edu; sbagchi@uic.edu		Bommi, Prashant/0000-0002-9457-1730	National Cancer Institute (NCI) [R01CA156164]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the grants from National Cancer Institute (NCI) to SB (R03CA227308) and the multi-PI grant from the National Cancer Institute (NCI) to PR and SB (R01CA156164).	Albinger-Hegyi A, 2010, INT J CANCER, V126, P2653, DOI 10.1002/ijc.24948; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Berra E, 2001, FEBS LETT, V491, P85, DOI 10.1016/S0014-5793(01)02159-7; Bommi Prashant V, 2018, Oncotarget, V9, P34708, DOI 10.18632/oncotarget.26168; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Ennen M, 2013, CANCER RES, V73, P5040, DOI 10.1158/0008-5472.CAN-12-3655; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Firlej V, 2011, CANCER RES, V71, P7649, DOI 10.1158/0008-5472.CAN-11-0833; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Han CH, 2014, MOL CANCER RES, V12, P784, DOI 10.1158/1541-7786.MCR-13-0638; Hayashido Y, 2003, INT J MOL MED, V12, P447; Horiguchi Hidehisa, 2013, J Med Invest, V60, P91; Hoskin PJ, 2003, BRIT J CANCER, V89, P1290, DOI 10.1038/sj.bjc.6601260; Huang S, 2017, CANCER RES, V77, P6562, DOI 10.1158/0008-5472.CAN-17-1570; Iyer AK, 2013, ADV DRUG DELIVER REV, V65, P1784, DOI 10.1016/j.addr.2013.07.012; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jayachandran A, 2014, ONCOTARGET, V5, P5782, DOI 10.18632/oncotarget.2164; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Koumenis C, 2014, ADV EXP MED BIOL, V772, pV; Le QT, 2009, J CLIN ONCOL, V27, P4281, DOI 10.1200/JCO.2008.20.6003; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; McDonald PC, 2014, SUBCELL BIOCHEM, V75, P255, DOI 10.1007/978-94-007-7359-2_13; Minig V, 2009, J BIOL CHEM, V284, P14165, DOI 10.1074/jbc.M808208200; Nowrousian MR, 2008, RECOMBINANT HUMAN ER; Overgaard J, 2005, LANCET ONCOL, V6, P757, DOI 10.1016/S1470-2045(05)70292-8; Pal SK, 2016, J ORAL PATHOL MED, V45, P730, DOI 10.1111/jop.12430; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perez-Sayans M, 2013, J ORAL PATHOL MED, V42, P1, DOI 10.1111/j.1600-0714.2012.01144.x; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Roy N, 2013, CANCER RES, V73, P3771, DOI 10.1158/0008-5472.CAN-12-4069; Roy N, 2013, CANCER BIOL THER, V14, P108, DOI 10.4161/cbt.22631; Roy N, 2012, INT J MOL SCI, V13, P11012, DOI 10.3390/ijms130911012; Ryu JH, 2011, J BIOL CHEM, V286, P6963, DOI 10.1074/jbc.M110.188706; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sorensen BS, 2015, RADIOTHER ONCOL, V116, P346, DOI 10.1016/j.radonc.2015.06.028; Stoyanova T, 2012, J BIOL CHEM, V287, P3019, DOI 10.1074/jbc.M111.295816; Stoyanova T, 2009, CELL CYCLE, V8, P4067, DOI 10.4161/cc.8.24.10109; Sui H, 2014, ONCOL RES TREAT, V37, P584, DOI 10.1159/000367802; Toustrup K, 2016, ACTA ONCOL, V55, P1091, DOI 10.3109/0284186X.2016.1167959; Toustrup K, 2011, CANCER RES, V71, P5923, DOI 10.1158/0008-5472.CAN-11-1182; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2002, Wien Med Wochenschr, V152, P334; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Waypa GB, 2016, MOL ASPECTS MED, V47-48, P76, DOI 10.1016/j.mam.2016.01.002; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Wittschieben BO, 2003, DNA REPAIR, V2, P1065, DOI 10.1016/S1568-7864(03)00113-7; Wykoff CC, 2000, CANCER RES, V60, P7075; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Zhang S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2408-9; Zhao R, 2015, NUCLEIC ACIDS RES, V43, P7838, DOI 10.1093/nar/gkv667; Zhao R, 2014, MOL CANCER RES, V12, P370, DOI 10.1158/1541-7786.MCR-13-0281	64	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1784	1796		10.1038/s41388-019-1105-y	http://dx.doi.org/10.1038/s41388-019-1105-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31740787				2022-12-26	WOS:000514923000012
J	Hu, LY; Sun, Y; Luo, J; He, X; Ye, MH; Li, GH; Zhang, Y; Bai, J; Zhang, DH; Chang, CS				Hu, Linyi; Sun, Yin; Luo, Jie; He, Xiang; Ye, Meihua; Li, Gonghui; Zhang, Yong; Bai, Jian; Zhang, Dahong; Chang, Chawnshang			Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression	ONCOGENE			English	Article							LINCRNA-P21; MECHANISMS; APOPTOSIS; ROLES; CELLS	Prostate cancer (PCa) is the second leading cause of cancer death in men in America, and there are no curative options for metastatic castration-resistant prostate cancer (mCRPC). Docetaxel (DTX) has been used as a standard chemotherapy for the mCRPC. However, resistance to DTX is a significant clinical problem as half of patients fail to respond to therapy. The TR4 nuclear receptor has been reported to play an important role in PCa progression, however, its linkage to the DTX resistance remains unclear. Here we found that TR4 was upregulated after DTX chemotherapy in the mCRPC cells and patients, and TR4 expression is correlated with DTX sensitivity with a higher level conferring chemo-resistance. Targeting TR4 with an antagonist bexarotene (Bex, a derivative of retinoid) suppressed the TR4 transactivation with increased DTX chemo-sensitivity. Mechanism dissection studies revealed that TR4 might alter the DTX chemo-sensitivity via modulating the TR4/lincRNA-p21/HIF-1 alpha/VEGF-A signaling. Together, these results suggest that targeting this newly identified TR4/lincRNA-p21/HIF-1 alpha/VEGF-A signaling with Bex, an FDA-approved drug, may increase the DTX chemo-sensitivity to better suppress the mCRPC progression.	[Hu, Linyi; He, Xiang; Ye, Meihua; Zhang, Dahong] Zhejiang Prov Peoples Hosp, Dept Urol, Hangzhou 310014, Peoples R China; [Hu, Linyi; Sun, Yin; Luo, Jie; Li, Gonghui; Bai, Jian; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA; [Hu, Linyi; Sun, Yin; Luo, Jie; Li, Gonghui; Bai, Jian; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA; [Hu, Linyi; Sun, Yin; Luo, Jie; Li, Gonghui; Bai, Jian; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA; [Zhang, Yong] Hebei Med Univ, Hosp 2, Dept Urol, Shijiazhuang 050000, Hebei, Peoples R China; [Chang, Chawnshang] China Med Univ & Hosp, Dept Urol, Sex Hormone Res Ctr, Taichung 404, Taiwan	Zhejiang Provincial People's Hospital; University of Rochester; University of Rochester; University of Rochester; Hebei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Zhang, DH (corresponding author), Zhejiang Prov Peoples Hosp, Dept Urol, Hangzhou 310014, Peoples R China.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA.; Chang, CS (corresponding author), China Med Univ & Hosp, Dept Urol, Sex Hormone Res Ctr, Taichung 404, Taiwan.	zhangdahongzhj@163.co; chang@urmc.rochester.edu	Luo, Jie/AAG-3091-2019	Chang, Chawnshang/0000-0001-8510-3516	NIH [CA155477, CA156700]; George Whipple Professorship Endowment; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Whipple Professorship Endowment; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This work was supported by NIH grants (CA155477 and CA156700), George Whipple Professorship Endowment and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002). We thank Karen Wolf for help preparing the manuscript.	Bos TJ, 2009, CURR GENE THER, V9, P192, DOI 10.2174/156652309788488578; CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040; Chen B, 2014, CANCER GENE THER, V21, P411, DOI 10.1038/cgt.2014.41; Chen SY, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0959-5; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Chen YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27301; Corcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999; Ding XF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0281-1; Ding XF, 2015, INT J CANCER, V136, P955, DOI 10.1002/ijc.29049; Fayda M, 2016, TUMOR BIOL, V37, P3969, DOI 10.1007/s13277-015-4189-1; Fenner Annette, 2015, Nat Rev Urol, V12, P361, DOI 10.1038/nrurol.2015.135; Galletti G, 2017, CANCER TREAT REV, V57, P16, DOI 10.1016/j.ctrv.2017.04.008; Isin M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00168; Lee YF, 2004, BIOCHEM BIOPH RES CO, V323, P876, DOI 10.1016/j.bbrc.2004.08.176; Lin SJ, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-43; Liu S, 2014, ENDOCR-RELAT CANCER, V21, pR279, DOI 10.1530/ERC-13-0529; O'Neill AJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-126; Obasaju C, 2001, HEMATOL ONCOL CLIN N, V15, P525, DOI 10.1016/S0889-8588(05)70230-6; Pan Y, 2016, CELL PHYSIOL BIOCHEM, V40, P219, DOI 10.1159/000452539; Pileri A, 2013, IMMUNOTHERAPY-UK, V5, P427, DOI [10.2217/IMT.13.15, 10.2217/imt.13.15]; Qiu XF, 2015, ONCOTARGET, V6, P15397, DOI 10.18632/oncotarget.3778; Saad F, 2018, CUAJ-CAN UROL ASSOC, V12, pE415, DOI 10.5489/cuaj.5154; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; Shen YM, 2017, EXP CELL RES, V358, P188, DOI 10.1016/j.yexcr.2017.06.016; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Wang GY, 2014, ONCOL REP, V31, P1839, DOI 10.3892/or.2014.3047; Wang XH, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12395; Wang XH, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12318; Wu GZ, 2014, CIRCULATION, V130, P1452, DOI 10.1161/CIRCULATIONAHA.114.011675; Yang DR, 2013, J BIOL CHEM, V288, P16476, DOI 10.1074/jbc.M112.448142; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Yu SC, 2015, PROSTATE, V75, P1632, DOI 10.1002/pros.23044; Zhou XE, 2011, J BIOL CHEM, V286, P2877, DOI 10.1074/jbc.M110.168740	35	6	6	2	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1891	1903		10.1038/s41388-019-1070-5	http://dx.doi.org/10.1038/s41388-019-1070-5			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31748715	Green Published, hybrid			2022-12-26	WOS:000516579800005
J	Lefort, S; Tan, S; Balani, S; Rafn, B; Pellacani, D; Hirst, M; Sorensen, PH; Eaves, CJ				Lefort, Sylvain; Tan, Susanna; Balani, Sneha; Rafn, Bo; Pellacani, Davide; Hirst, Martin; Sorensen, Poul H.; Eaves, Connie J.			Initiation of human mammary cell tumorigenesis by mutant KRAS requires YAP inactivation	ONCOGENE			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; HIPPO PATHWAY; BREAST; GROWTH; YAP/TAZ; DIFFERENTIATION; LOCALIZATION; CROSSTALK; MUTATION; COMPLEX	High YAP activity is associated with poor prognosis human breast cancers, but its role during the initial stage of mammary cell transformation is unknown. To address this question, we designed experiments that exploit the ability of KRAS(G12D)-transduced subsets of freshly isolated normal human mammary cells to form invasive tumors rapidly and efficiently when transplanted into immunodeficient mice. Initial examination of the newly developing tumors thus generated revealed a consistent marked loss of nuclear YAP, independent of the initial primary human mammary cell type transduced. Conversely, co-transduction of the same subsets of primary human mammary cells with KRAS(G12D) plus the constitutively active YAP(S127A) prevented tumor formation. These findings contrast with the enhanced display of transformed properties obtained when the immortalized, but non-tumorigenic MCF10A cells are transduced just with YAP(S127A). In addition, we show that YAP(S127A)-transduction of the human MDA-MB-231 breast cancer cell line (that carry a similar KRAS mutation) enhances their metastatic activity in vivo. We also discover that the KRAS(G12D)-induced early loss of YAP in primary human mammary cells is associated with their induced secretion of amphiregulin. Collectively, these findings suggest that YAP can differentially affect the acquisition of malignant properties by human mammary cells at different stages of their transformation.	[Lefort, Sylvain; Tan, Susanna; Balani, Sneha; Pellacani, Davide; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Rafn, Bo; Sorensen, Poul H.] British Columbia Canc Agcy, Dept Mol Oncol, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Hirst, Martin] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Hirst, Martin] Univ British Columbia, Dept Microbiol & Immunol, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia	Lefort, S (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	sylvain.lefort@lyon.unicancer.fr		Lefort, Sylvain/0000-0001-7320-4256; Eaves, Connie/0000-0002-3452-1926	Canadian Cancer Society Research Institute; Cancer Research Society; Cancer Institute for Health Research [CRP-154482]; University of British Columbia Graduate Studentship; Canadian Institute of Health Research Banting and Best Studentship	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research Society; Cancer Institute for Health Research; University of British Columbia Graduate Studentship; Canadian Institute of Health Research Banting and Best Studentship(Canadian Institutes of Health Research (CIHR))	The authors thank D. Wilkinson, G. Edin, and M. Hale for excellent technical support; Drs J. Cheng and P. Hoodless for their help with data interpretation; and Drs E. Bovill, J. Boyle, S. Bristol, P. Gdalevitch, A. Seal, J. Sproul, and N. van Laeken for access to discarded reduction human mammoplasty tissue. This work was supported by grants from the Canadian Cancer Society Research Institute, the Cancer Research Society, and the Cancer Institute for Health Research (grant CRP-154482). The authors declare no conflict of interest. SB was a recipient of a University of British Columbia Graduate Studentship and ST was a recipient of a Canadian Institute of Health Research Banting and Best Studentship.	Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Balani S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15422; Bartucci M, 2015, ONCOGENE, V34, P681, DOI 10.1038/onc.2014.5; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Britschgi A, 2017, NATURE, V541, P541, DOI 10.1038/nature20829; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Grannas K, 2015, J MOL BIOL, V427, P3407, DOI 10.1016/j.jmb.2015.04.015; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Kannan N, 2014, P NATL ACAD SCI USA, V111, P7789, DOI 10.1073/pnas.1403813111; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Marella NV, 2009, CANCER RES, V69, P5946, DOI 10.1158/0008-5472.CAN-09-0420; Morel AP, 2017, NAT MED, V23, P568, DOI 10.1038/nm.4323; Nguyen LV, 2015, NATURE, V528, P267, DOI 10.1038/nature15742; Nguyen LV, 2014, CELL STEM CELL, V14, P253, DOI 10.1016/j.stem.2013.12.011; Pellacani D, 2016, CELL REP, V17, P2060, DOI 10.1016/j.celrep.2016.10.058; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vlug EJ, 2013, CELL ONCOL, V36, P375, DOI 10.1007/s13402-013-0143-7; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	34	12	12	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1957	1968		10.1038/s41388-019-1111-0	http://dx.doi.org/10.1038/s41388-019-1111-0			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31772328	Green Published, hybrid			2022-12-26	WOS:000516579800010
J	McRae, TD; Oleksyn, D; Miller, J; Gao, YR				McRae, Tristan D.; Oleksyn, David; Miller, Jim; Gao, Yu-Rong			Robust blind spectral unmixing for fluorescence microscopy using unsupervised learning	PLOS ONE			English	Article							EXCITATION CROSS-SECTIONS; COMPONENT ANALYSIS; COLOCALIZATION; PROTEIN; CELL; FLUOROPHORES; TOMOGRAPHY; ABSORPTION; SEPARATION; WHOLE	Due to the overlapping emission spectra of fluorophores, fluorescence microscopy images often have bleed-through problems, leading to a false positive detection. This problem is almost unavoidable when the samples are labeled with three or more fluorophores, and the situation is complicated even further when imaged under a multiphoton microscope. Several methods have been developed and commonly used by biologists for fluorescence microscopy spectral unmixing, such as linear unmixing, non-negative matrix factorization, deconvolution, and principal component analysis. However, they either require pre-knowledge of emission spectra or restrict the number of fluorophores to be the same as detection channels, which highly limits the real-world applications of those spectral unmixing methods. In this paper, we developed a robust and flexible spectral unmixing method: Learning Unsupervised Means of Spectra (LUMoS), which uses an unsupervised machine learning clustering method to learn individual fluorophores' spectral signatures from mixed images, and blindly separate channels without restrictions on the number of fluorophores that can be imaged. This method highly expands the hardware capability of two-photon microscopy to simultaneously image more fluorophores than is possible with instrumentation alone. Experimental and simulated results demonstrated the robustness of LUMoS in multi-channel separations of two-photon microscopy images. We also extended the application of this method to background/autofluorescence removal and colocalization analysis. Lastly, we integrated this tool into ImageJ to offer an easy to use spectral unmixing tool for fluorescence imaging. LUMoS allows us to gain a higher spectral resolution and obtain a cleaner image without the need to upgrade the imaging hardware capabilities.	[McRae, Tristan D.; Gao, Yu-Rong] Univ Rochester, Med Ctr, Multiphoton Res Core Facil, Shared Resource Labs, Rochester, NY 14642 USA; [McRae, Tristan D.; Gao, Yu-Rong] Univ Rochester, Dept Neurosci, Med Ctr, Rochester, NY 14642 USA; [Oleksyn, David; Miller, Jim] Univ Rochester, Ctr Vaccine Biol & Immunol, Med Ctr, Rochester, NY 14642 USA; [Oleksyn, David; Miller, Jim] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Gao, YR (corresponding author), Univ Rochester, Med Ctr, Multiphoton Res Core Facil, Shared Resource Labs, Rochester, NY 14642 USA.; Gao, YR (corresponding author), Univ Rochester, Dept Neurosci, Med Ctr, Rochester, NY 14642 USA.	yurong_gao@urmc.rochester.edu		McRae, Tristan/0000-0002-1823-1451	University of Rochester Health Sciences Center for Computational Innovation under the Support Health Sciences Research Using High Performance Computational Resources grant [OP211341]; National Institutes of Health [5PO1-AI102851]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102851] Funding Source: NIH RePORTER	University of Rochester Health Sciences Center for Computational Innovation under the Support Health Sciences Research Using High Performance Computational Resources grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	YRG received funding from the University of Rochester Health Sciences Center for Computational Innovation (https://www.rochester.edu/hscci/) under the Support Health Sciences Research Using High Performance Computational Resources grant NO: OP211341. DO, JM, and YRG received funding from National Institutes of Health (https://www.nih.gov/) grant NO: 5PO1-AI102851.	Akemann W, 2013, SCI REP-UK, V3, DOI 10.1038/srep02231; Albota MA, 1998, APPL OPTICS, V37, P7352, DOI 10.1364/AO.37.007352; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Benninger R.K.P., 2013, CURR PROTOC CELL BIO, P1; Bestvater F, 2002, J MICROSC-OXFORD, V208, P108, DOI 10.1046/j.1365-2818.2002.01074.x; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Bunting P, 2010, REMOTE SENS ENVIRON, V114, P2536, DOI 10.1016/j.rse.2010.05.030; Coates Adam, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P561, DOI 10.1007/978-3-642-35289-8_30; Croce AC, 2014, EUR J HISTOCHEM, V58, P320, DOI 10.4081/ejh.2014.2461; Dao L, 2014, J MICROSC-OXFORD, V256, P133, DOI 10.1111/jmi.12167; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dickinson ME, 2001, BIOTECHNIQUES, V31, P1272, DOI 10.2144/01316bt01; Drobizhev M, 2009, J PHYS CHEM B, V113, P855, DOI 10.1021/jp8087379; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Dunn KW, 2002, AM J PHYSIOL-CELL PH, V283, pC905, DOI 10.1152/ajpcell.00159.2002; Ecker RC, 2004, CYTOM PART A, V59A, P172, DOI 10.1002/cyto.a.20053; Gammon STM, 2006, ANAL CHEM, V78, P1520, DOI 10.1021/ac051999h; Gao YR, 2016, J NEUROSCI, V36, P2503, DOI 10.1523/JNEUROSCI.3665-15.2016; Gao YR, 2015, NEUROIMAGE, V115, P162, DOI 10.1016/j.neuroimage.2015.04.054; Glatz J, 2011, OPT EXPRESS, V19, P3175, DOI 10.1364/OE.19.003175; Gobinet Cyril, 2004, 2004 12th European Signal Processing Conference (EUSIPCO), P1095; Hinton G. E., 1999, UNSUPERVISED LEARNIN; Huang HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20887; Huang S, 2015, BIOMED ENG ONLINE, V14, P1, DOI [10.1186/1475-925X-14-1, DOI 10.1186/1475-925X-14-1]; Iordache MD, 2012, IEEE T GEOSCI REMOTE, V50, P4484, DOI 10.1109/TGRS.2012.2191590; Ishidoshiro N, 2016, INT ARCH PHOTOGRAMME, P431, DOI [10.5194/isprs-archives-XLI-B8-431-2016, DOI 10.5194/ISPRS-ARCHIVES-XLI-B8-431-2016]; Kapoor J, 2017, 2017 INTERNATIONAL CONFERENCE ON EMERGING TRENDS IN COMPUTING AND COMMUNICATION TECHNOLOGIES (ICETCCT), P1; Keshava N, 2002, IEEE SIGNAL PROC MAG, V19, P44, DOI 10.1109/79.974727; Keshava N, 2003, LINCOLN LAB J, V14, P44; Khanmohammadi S, 2017, EXPERT SYST APPL, V67, P12, DOI 10.1016/j.eswa.2016.09.025; Kwong Justin D., 2009, Proceedings of the SPIE - The International Society for Optical Engineering, V7457, DOI 10.1117/12.826354; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, P63; Lansford R, 2001, J BIOMED OPT, V6, P311, DOI 10.1117/1.1383780; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Luker KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep10332; Mahou P, 2012, NAT METHODS, V9, P815, DOI [10.1038/NMETH.2098, 10.1038/nmeth.2098]; Megjhani M, 2017, BIOINFORMATICS, V33, P2182, DOI 10.1093/bioinformatics/btx108; Mohamad I.B., 2013, RES J APPL SCI ENG T, V6, P3299; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Montcuquet AS, 2011, IEEE T BIO-MED ENG, V58, P2554, DOI 10.1109/TBME.2011.2159382; Nadrigny F, 2006, EUR BIOPHYS J BIOPHY, V35, P533, DOI 10.1007/s00249-005-0040-8; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Neher RA, 2009, BIOPHYS J, V96, P3791, DOI 10.1016/j.bpj.2008.10.068; Palsson B, 2018, IEEE ACCESS, V6, P25646, DOI 10.1109/ACCESS.2018.2818280; Pengo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078504; Pu HS, 2014, PHYS MED BIOL, V59, P5025, DOI 10.1088/0031-9155/59/17/5025; Pu HS, 2013, BIOMED OPT EXPRESS, V4, P1829, DOI 10.1364/BOE.4.001829; Qin BJ, 2016, IEEE T INSTRUM MEAS, V65, P874, DOI 10.1109/TIM.2016.2516318; Rakhymzhan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07165-0; Ricard C, 2018, BRAIN STRUCT FUNCT, V223, P3011, DOI 10.1007/s00429-018-1678-1; Ricard C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00057; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sanchez-Lockhart M, 2008, J IMMUNOL, V181, P7639, DOI 10.4049/jimmunol.181.11.7639; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sladitschek HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124958; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Torrecilla E, 2011, REMOTE SENS ENVIRON, V115, P2578, DOI 10.1016/j.rse.2011.05.014; Tsurui H, 2000, J HISTOCHEM CYTOCHEM, V48, P653, DOI 10.1177/002215540004800509; Valm AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158495; Walter J, 2004, SPECTRAL UNMIXING PL; Xenaki SD, 2016, IEEE T FUZZY SYST, V24, P791, DOI 10.1109/TFUZZ.2015.2486806; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Zare A, 2011, IEEE INT CONF FUZZY, P741; Zhao WZ, 2019, IEEE T IMAGE PROCESS, V28, DOI 10.1109/TIP.2019.2916976; Zimmermann T, 2005, ADV BIOCHEM ENG BIOT, V95, P245, DOI 10.1007/b102216; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0; Zimmermann T, 2014, METHODS MOL BIOL, V1075, P129, DOI 10.1007/978-1-60761-847-8_5	71	26	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0225410	10.1371/journal.pone.0225410	http://dx.doi.org/10.1371/journal.pone.0225410			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790435	Green Published, Green Submitted, gold			2022-12-26	WOS:000533930800032
J	Senpuku, H; Tuna, EB; Nagasawa, R; Nakao, R; Ohnishi, M				Senpuku, Hidenobu; Tuna, Elif Bahar; Nagasawa, Ryo; Nakao, Ryoma; Ohnishi, Makoto			The inhibitory effects of polypyrrole on the biofilm formation of Streptococcus mutans	PLOS ONE			English	Article							MOLECULAR-GENETIC-ANALYSIS; SURFACE PROTEIN ANTIGEN; EXTRACELLULAR DNA; BACTERIAL DIVERSITY; CONDUCTING POLYMERS; LOW PH; ADSORPTION; ACID; BINDING; SYSTEM	Streptococcus mutans primary thrives on the biofilm formation on the tooth surface in sticky biofilms and under certain conditions can lead to carious lesions on the tooth surface. To search for a new preventive material for oral biofilm-associated diseases, including dental caries, we investigated the effects of polypyrrole, which contains an electrochemical polymer and causes protonation and incorporation of anion under low pH condition, on the biofilm formation of S. mutans and other streptococci. In this study, polypyrrole was applied in biofilm formation assays with the S. mutans strains UA159 and its gtfB and gtfC double mutant (gtfBC mutant), S. sanguinis, S. mitis and S. gordonii on human saliva and bovine serum albumin-coated 96-well microtiter plates in tryptic soy broth supplemented with 0.25% sucrose. The effects of polypyrrole on biofilm formation were quantitatively and qualitatively observed. High concentrations of polypyrrole significantly inhibited the biofilm formation of S. mutans UA159 and S. sanguinis. As an inhibition mechanism, polypyrrole attached to the surface of bacterial cells, increased chains and aggregates, and incorporated proteins involving GTF-I and GTF-SI produced by S. mutans. In contrast, the biofilm formation of gtfBC mutant, S. sanguinis, S. mitis and S. gordonii was temporarily induced by the addition of low polypyrrole concentrations on human saliva-coated plate but not on the uncoated and bovine serum albumin-coated plates. Moreover, biofilm formation depended on live cells and, likewise, specific interaction between cells and binding components in saliva. However, these biofilms were easily removed by increased frequency of water washing. In this regard, the physical and electrochemical properties in polypyrrole worked effectively in the removal of streptococci biofilms. Polypyrrole may have the potential to alter the development of biofilms associated with dental diseases.	[Senpuku, Hidenobu; Nagasawa, Ryo; Nakao, Ryoma; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan; [Tuna, Elif Bahar] Istanbul Univ, Fac Dent, Dept Pediat Dent, Istanbul, Turkey; [Nagasawa, Ryo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Infectious Diseases (NIID); Istanbul University; University of Tsukuba	Senpuku, H (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan.	hsenpuku@nih.go.jp	Nagasawa, Ryo/AAM-4882-2021; SENPUKU, HIDENOBU/ABC-6160-2021	Nagasawa, Ryo/0000-0002-3106-7916; 	Ministry of Education, Science and Culture of Japan [21390506, 24659821, 16K11537]; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED [40105502]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	The work was supported in-part by Grants-in-Aid for the Development of Scientific Research (21390506, 24659821 and 16K11537) from the Ministry of Education, Science and Culture of Japan and by the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED(40105502).	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abel ML, 2002, J CHROMATOGR A, V969, P273, DOI 10.1016/S0021-9673(02)00894-4; Arrigucci R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176117; Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141; Azioune A, 2004, LANGMUIR, V20, P3350, DOI 10.1021/la030407s; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; Bidan G., 1995, POLYM FILMS SENSOR A, P206; Biswas S, 2005, INFECT IMMUN, V73, P6923, DOI 10.1128/IAI.73.10.6923-6934.2005; Bitoun JP, 2012, APPL ENVIRON MICROB, V78, P2914, DOI 10.1128/AEM.07823-11; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Burne RA, 1998, J DENT RES, V77, P445, DOI 10.1177/00220345980770030301; Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I; Das T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091935; Das T, 2013, ENV MICROBIOL REP, V5, P778, DOI 10.1111/1758-2229.12085; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; FREEDMAN ML, 1982, INFECT IMMUN, V35, P476, DOI 10.1128/IAI.35.2.476-482.1982; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HAMADA S, 1989, J GEN MICROBIOL, V135, P335; Hwang JH, 2006, B KOREAN CHEM SOC, V27, P2067; Jang J, 2005, SMALL, V1, P1195, DOI 10.1002/smll.200500237; KATO C, 1992, BIOCHEM BIOPH RES CO, V189, P1184, DOI 10.1016/0006-291X(92)92329-V; Kawarai T, 2016, J ORAL BIOSCI, V58, P55, DOI 10.1016/j.job.2015.12.004; Ke KM, 2015, CHEM COMMUN, V51, P6800, DOI 10.1039/c5cc01129a; Kim S, 2018, ACTA BIOMATER, V80, P258, DOI 10.1016/j.actbio.2018.09.035; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Kuramitsu HK, 2003, CRIT REV ORAL BIOL M, V14, P331, DOI 10.1177/154411130301400504; Lambert RJ, 1999, J APPL MICROBIOL, V86, P157, DOI 10.1046/j.1365-2672.1999.00646.x; LI YF, 1988, SYNTHETIC MET, V26, P139, DOI 10.1016/0379-6779(88)90341-4; Li YL, 2005, LANGMUIR, V21, P10702, DOI 10.1021/la0514314; Liao SM, 2014, J BACTERIOL, V196, P2355, DOI 10.1128/JB.01493-14; Liu Y, 2001, J BACTERIOL, V193, P2826; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MIKSA B, 1995, J BIOMAT SCI-POLYM E, V7, P77; Molino PJ, 2013, BIOFOULING, V29, P1155, DOI 10.1080/08927014.2013.830110; MOOSER G, 1991, J BIOL CHEM, V266, P8916; Motegi M, 2006, APPL ENVIRON MICROB, V72, P6277, DOI 10.1128/AEM.00614-06; Nalwa H. S., 1997, HDB ORGANIC CONDUCTI, V2; Necas J, 2008, VET MED-CZECH, V53, P397, DOI 10.17221/1930-VETMED; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; OHTA H, 1989, J GEN MICROBIOL, V135, P981; Ouyang J, 2010, ANTIMICROB AGENTS CH, V54, P3895, DOI 10.1128/AAC.01802-09; Pande R, 1998, BIOMATERIALS, V19, P1657, DOI 10.1016/S0142-9612(98)00043-X; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; PEI Q, 1991, SYNTHETIC MET, V45, P35, DOI 10.1016/0379-6779(91)91845-2; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Postollec F, 2003, J MICROBIOL METH, V55, P241, DOI 10.1016/S0167-7012(03)00145-3; Ravichandran R, 2010, J R SOC INTERFACE, V7, pS559, DOI 10.1098/rsif.2010.0120.focus; Reck M, 2011, J BACTERIOL, V193, P5692, DOI 10.1128/JB.05424-11; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; RUSSELL JB, 1992, J APPL BACTERIOL, V73, P363, DOI 10.1111/j.1365-2672.1992.tb04990.x; Saoudi B, 1997, J COLLOID INTERF SCI, V192, P269, DOI 10.1006/jcis.1997.5000; Sato Y, 2002, ORAL MICROBIOL IMMUN, V17, P252, DOI 10.1034/j.1399-302X.2002.170408.x; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; Senpuku H, 1997, IMMUNOL INVEST, V26, P531, DOI 10.3109/08820139709088538; Skotheim T. A., 1998, HDB CONDUCTING POLYM; Suzuki Y, 2017, J INFECT CHEMOTHER, V23, P634, DOI 10.1016/j.jiac.2017.06.006; Thompson BC, 2006, J CONTROL RELEASE, V116, P285, DOI 10.1016/j.jconrel.2006.09.004; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200; Zhang K, 2009, BIOCHEM BIOPH RES CO, V379, P933, DOI 10.1016/j.bbrc.2008.12.175	62	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225584	10.1371/journal.pone.0225584	http://dx.doi.org/10.1371/journal.pone.0225584			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774855	Green Published, gold			2022-12-26	WOS:000533896400042
J	Kirtania, P; Hodi, B; Mallick, I; Vass, IZ; Feher, T; Vass, I; Kos, PB				Kirtania, Prithwiraj; Hodi, Barbara; Mallick, Ivy; Vass, Istvan Zoltan; Feher, Tamas; Vass, Imre; Kos, Peter B.			A single plasmid based CRISPR interference in Synechocystis 6803-A proof of concept	PLOS ONE			English	Article							PHOTOSYSTEM-II; D1 PROTEIN; PSBA GENE; CYANOBACTERIA; EXPRESSION; REPRESSION; CLONING; GENOME; MUTANT; CAS	We developed a simple method to apply CRISPR interference by modifying an existing plasmid pCRISPathBrick containing the native S. pyogenes CRISPR assembly for Synechocystis PCC6803 and named it pCRPB1010. The technique presented here using deadCas9 is easier to implement for gene silencing in Synechocystis PCC6803 than other existing techniques as it circumvents the genome integration and segregation steps thereby significantly shortens the construction of the mutant strains. We executed CRISPR interference against well characterized photosynthetic genes to get a clear phenotype to validate the potential of pCRPB1010 and presented the work as a "proof of concept". Targeting the non-template strand of psbO gene resulted in decreased amount of PsbO and 50% decrease in oxygen evolution rate. Targeting the template strand of psbA2 and psbA3 genes encoding the D1 subunit of photosystem II (PSII) using a single spacer against the common sequence span of the two genes, resulted in full inhibition of both genes, complete abolition of D1 protein synthesis, complete loss of oxygen evolution as well as photoautotrophic growth arrest. This is the first report of a single plasmid based, completely lesion free and episomal expression and execution of CRISPR interference in Synechocystis PCC6803.	[Kirtania, Prithwiraj; Hodi, Barbara; Mallick, Ivy; Vass, Istvan Zoltan; Vass, Imre; Kos, Peter B.] Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, Szeged, Hungary; [Kirtania, Prithwiraj; Hodi, Barbara] Univ Szeged, Doctoral Sch Biol, Szeged, Hungary; [Feher, Tamas] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Szeged, Hungary; [Kos, Peter B.] Univ Szeged, Fac Sci & Informat, Dept Biotechnol, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University	Kos, PB (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, Szeged, Hungary.; Kos, PB (corresponding author), Univ Szeged, Fac Sci & Informat, Dept Biotechnol, Szeged, Hungary.	kos.peter@brc.hu	Feher, Tamas/AAH-4479-2019; Vass, Imre/AAS-6171-2021	Feher, Tamas/0000-0001-9318-3640; Vass, Imre/0000-0003-4987-7842; Kos, Peter/0000-0001-7443-9671	Hungarian National Research, Development and Innovation Office [NKFIH K-116016]; Hungarian Ministry for National Economy [GINOP-2.3.2-15-2016-00001]	Hungarian National Research, Development and Innovation Office; Hungarian Ministry for National Economy	The work was supported by grants of I.V. from the Hungarian National Research, Development and Innovation Office (NKFIH K-116016) and from the Hungarian Ministry for National Economy GINOP-2.3.2-15-2016-00001.	Al-Haj Lamya, 2016, Life-Basel, V6, P42, DOI 10.3390/life6040042; BARBATO R, 1991, BIOCHEMISTRY-US, V30, P10220, DOI 10.1021/bi00106a021; Behler J, 2018, TRENDS BIOTECHNOL, V36, P996, DOI 10.1016/j.tibtech.2018.05.011; Bikard David, 2013, F1000Prime Rep, V5, P47, DOI 10.12703/P5-47; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Cleto S, 2016, ACS SYNTH BIOL, V5, P375, DOI 10.1021/acssynbio.5b00216; Cress BF, 2015, ACS SYNTH BIOL, V4, P987, DOI 10.1021/acssynbio.5b00012; Didovyk A, 2016, CURR OPIN BIOTECH, V40, P177, DOI 10.1016/j.copbio.2016.06.003; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; Guerrero F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050470; Higo A, 2018, PLANT CELL PHYSIOL, V59, P119, DOI 10.1093/pcp/pcx166; JANSSON C, 1987, PLANT PHYSIOL, V85, P1021, DOI 10.1104/pp.85.4.1021; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaczmarzyk D, 2018, METAB ENG, V45, P59, DOI 10.1016/j.ymben.2017.11.014; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; KOMENDA J, 1995, BIOCHEMISTRY-US, V34, P9625, DOI 10.1021/bi00029a040; LABARRE J, 1989, J BACTERIOL, V171, P3449, DOI 10.1128/jb.171.6.3449-3457.1989; Li H, 2016, METAB ENG, V38, P293, DOI 10.1016/j.ymben.2016.09.006; Liang FY, 2016, METAB ENG, V38, P56, DOI 10.1016/j.ymben.2016.06.005; Mate Z, 1998, J BIOL CHEM, V273, P17439, DOI 10.1074/jbc.273.28.17439; Mougiakos L, 2018, CURR OPIN BIOTECH, V50, P146, DOI [10.1016/j.copbio.2018.01.002, 10.1016/j.cophio.2018.01.002]; Naduthodi MIS, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700591; NIXON PJ, 1991, PLANT CELL, V3, P383, DOI 10.1105/tpc.3.4.383; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Nyerges A, 2019, SYNTHETIC BIOL, P4, DOI [10.1101/428029%JbioRxiv, DOI 10.1101/428029%JBIORXIV]; POWELL B, 1989, FEMS MICROBIOL LETT, V59, P269, DOI 10.1111/j.1574-6968.1989.tb03123.x; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Shabestary K, 2018, ACS SYNTH BIOL, V7, P1669, DOI 10.1021/acssynbio.8b00056; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Ungerer J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39681; van der Oost J, 2014, MICROB CELL, V1, P158, DOI 10.15698/mic2014.05.144; VASS I, 1992, BIOCHIM BIOPHYS ACTA, V1102, P195, DOI 10.1016/0005-2728(92)90100-G; Wendt KE, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0514-7; Xu XS, 2019, J MOL BIOL, V431, P34, DOI 10.1016/j.jmb.2018.06.037; Yao L, 2016, ACS SYNTH BIOL, V5, P207, DOI 10.1021/acssynbio.5b00264; Zerulla K, 2016, MICROBIOL-SGM, V162, P730, DOI 10.1099/mic.0.000264	37	8	8	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225375	10.1371/journal.pone.0225375	http://dx.doi.org/10.1371/journal.pone.0225375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770415	Green Published, Green Accepted, gold			2022-12-26	WOS:000533892300016
J	Sebastiao, CS; Neto, Z; de Jesus, CS; Mirandela, M; Jandondo, D; Couto-Fernandez, JC; Tanuri, A; Morais, J; Brito, M				Sebastiao, Cruz S.; Neto, Zoraima; de Jesus, Carlos S.; Mirandela, Marinela; Jandondo, Domingos; Couto-Fernandez, Jose C.; Tanuri, Amilcar; Morais, Joana; Brito, Miguel			Genetic diversity and drug resistance of HIV-1 among infected pregnant women newly diagnosed in Luanda, Angola	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VARIABILITY; MUTATIONS	Monitoring genetic diversity and drug resistance mutations (DRMs) is critical for understanding HIV epidemiology. Here, we report HIV-1 genetic diversity and DRMs in blood samples from 42 HIV-positive pregnant women naive to antiretroviral therapy (ART), in Luanda. The samples were subjected to nested-PCR, followed by sequencing of HIV-1 pol gene, targeting the protease and reverse transcriptase fragments. HIV-1 diversity was analyzed using the REGA HIV-1 subtyping tool and DRMs were identified using the Calibrated Population Resistance tool. A total of 34 sequences were obtained. The data revealed wide HIV-1 subtypes heterogeneity, with subtype C (38%, 13/34) the most frequent, followed by the subtypes F1 (18%, 6/34), A1 (9%, 3/34), G (9%, 3/34), D (6%, 2/34) and H (3%, 1/34). In addition, recombinants strains were detected, with CRF02_AG (6%, 2/34) the most frequent, followed by CRF37_cpx, F1/C, A1/G and H/G, all with 3% (1/34). A total of 6/34 (18%) of the sequences presented DRMs. The non-nucleoside reverse transcriptase inhibitors presented 15% (5/34) of resistance. Moreover, 1/34 (3%) sequence presented resistance against both non-nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors, simultaneously. Despite the small sample size, our results suggest the need to update currently used ART regimens. Surveillance of HIV-1 subtypes and DRMs are necessary to understand HIV epidemiology and to guide modification of ART guidelines in Angola.	[Sebastiao, Cruz S.] Univ Nova Lisboa, Fac Ciencias Med, NOVA Med Sch, Lisbon, Portugal; [Sebastiao, Cruz S.; Neto, Zoraima; Mirandela, Marinela; Jandondo, Domingos; Morais, Joana] Inst Nacl Invest Saude, Lab Biol Mol, Luanda, Angola; [Sebastiao, Cruz S.] Univ Agostinho Neto, Inst Super Ciencias Saude, Luanda, Angola; [Sebastiao, Cruz S.; Morais, Joana; Brito, Miguel] Ctr Invest Saude Angola, Luanda, Angola; [de Jesus, Carlos S.; Couto-Fernandez, Jose C.] Inst Oswaldo Cruz, Lab AIDS & Munol Mol, Rio De Janeiro, Brazil; [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil; [Morais, Joana] Univ Agostinho Neto, Fac Med, Luanda, Angola; [Brito, Miguel] Inst Politecn Lisboa, Hlth & Technol Res Ctr, Escola Super Tecnol Saude Lisboa, Lisbon, Portugal	Universidade Nova de Lisboa; University Agostinho Neto; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; University Agostinho Neto; Polytechnic Institute of Lisbon; Universidade de Lisboa	Brito, M (corresponding author), Ctr Invest Saude Angola, Luanda, Angola.; Brito, M (corresponding author), Inst Politecn Lisboa, Hlth & Technol Res Ctr, Escola Super Tecnol Saude Lisboa, Lisbon, Portugal.	miguel.brito@estesl.ipl.pt	Brito, Miguel/A-7970-2016; Tanuri, Amilcar/AAM-8601-2021	Brito, Miguel/0000-0001-6394-658X; Neto, Zoraima/0000-0003-1606-9996; Soares, Helena/0000-0002-5881-3843; Machado de Morais, Joana Filipa/0000-0002-4524-4055; Sebastiao, Cruz/0000-0003-1232-0119	FCT [SFRH/BD/135296/2017]; project Pro-Africa CNPq, Brazil [440145/2015-5]; Foundation for Science and Technology (FCT) [SFRH/BD/135296/2017]; project Pro-Africa [CNPq: 440145/2015-5]; Postgraduate Science for Development Program (PGCD) [SFRH/BD/135296/2017]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); project Pro-Africa CNPq, Brazil; Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); project Pro-Africa; Postgraduate Science for Development Program (PGCD)	This work was supported by a PhD grant (FCT) (SFRH/BD/135296/2017) to CSS and a grant from project Pro-Africa CNPq no 440145/2015-5, Brazil to JCC and AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to pregnant women who participated in this study. To thank the Postgraduate Science for Development Program (PGCD) and the Foundation for Science and Technology (FCT), by the PhD scholarship awarded to Cruz Sebastiao (SFRH/BD/135296/2017), and the project Pro-Africa (CNPq: 440145/2015-5) for supporting some analysis. Moreover, thanks to INIS, CISA, INLS, FIOCRUZ, NOVA Medical School/Faculdade de Ciencias Medicas, ISCISA/Agostinho Neto University, and Lucrecia Paim Maternity clinic, for institutional support. Thanks to Valter Nuaila, Marcio Sitoe, Fredilson Melo and Sarah Hill, for scientific support.	Abecasis A., 2005, Infection Genetics and Evolution, V5, P231, DOI 10.1016/j.meegid.2004.07.007; Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; Alcaro S, 2011, CHEMMEDCHEM, V6, P2203, DOI 10.1002/cmdc.201100362; Castelbranco EPAF, 2010, AIDS RES HUM RETROV, V26, P1313, DOI 10.1089/aid.2010.0111; Bartolo I, 2005, AIDS RES HUM RETROV, V21, P306, DOI 10.1089/aid.2005.21.306; Bartolo I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113626; Bartolo I, 2009, INFECT GENET EVOL, V9, P672, DOI 10.1016/j.meegid.2008.05.003; Bbosa N, 2019, CURR OPIN HIV AIDS, V14, P153, DOI 10.1097/COH.0000000000000534; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Delatorre E, 2017, AIDS RES HUM RETROV, V33, P68, DOI [10.1089/aid.2016.0159, 10.1089/AID.2016.0159]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Inzaule SC, 2019, LANCET INFECT DIS, V19, pE246, DOI 10.1016/S1473-3099(18)30710-2; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leitner T, 2015, HIV SEQUENCE COMPEND; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; National Institute of Fighting Against AIDS, 2006, PLAN ESTR NAC CONTR; National Institute of Fighting Against AIDS, 2015, NORM TRAT ANT, P159; Perrin L, 2003, LANCET INFECT DIS, V3, P22, DOI 10.1016/S1473-3099(03)00484-5; Pineda-pena A, 2013, INFECT GENETICS EVOL; Rhee SY, 2010, ANTIMICROB AGENTS CH, V54, P4253, DOI 10.1128/AAC.00574-10; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shahriar R, 2009, ANTIMICROB AGENTS CH, V53, P4869, DOI 10.1128/AAC.00592-09; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Ssemwanga D, 2015, AIDS REV, V17, P3; Tamura K, 1993, ESTIMATION NUMBER NU, P10; Unaids, 2018, UN DAT 2018; United Nations, 2016, POL DECL HIV AIDS FA, V17020, P1; Van de Vijver D, 2006, EPIDEMIOLOGY TRANSMI, V2007, P17; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; World Health Organization, 2016, US ANT DRUGS TREAT P	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225251	10.1371/journal.pone.0225251	http://dx.doi.org/10.1371/journal.pone.0225251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770425	Green Published, gold			2022-12-26	WOS:000533892300012
J	Garrett, SM; Hsu, E; Thomas, JM; Pilewski, JM; Feghali-Bostwick, C				Garrett, Sara M.; Hsu, Eileen; Thomas, Justin M.; Pilewski, Joseph M.; Feghali-Bostwick, Carol			Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; FACTOR-II; IGF-II; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; FIBROBLAST PROLIFERATION; SYSTEMIC-SCLEROSIS; HYBRID RECEPTORS; EXPRESSION; BINDING	Type 2 insulin-like growth factor (IGF-II) levels are increased in fibrosing lung diseases such as idiopathic pulmonary fibrosis (IPF) and scleroderma/ systemic sclerosis-associated pulmonary fibrosis (SSc). Our goal was to investigate the contribution of IGF receptors to IGFII-mediated fibrosis in these diseases and identify other potential mechanisms key to the fibrotic process. Cognate receptor gene and protein expression were analyzed with qRTPCR and immunoblot in primary fibroblasts derived from lung tissues of normal donors (NL) and patients with IPF or SSc. Compared to NL, steady-state receptor gene expression was decreased in SSc but not in IPF. IGF-II stimulation differentially decreased receptor mRNA and protein levels in NL, IPF, and SSc fibroblasts. Neutralizing antibody, siRNA, and receptor inhibition targeting endogenous IGF-II and its primary receptors, type 1 IGF receptor (IGF1R), IGF2R, and insulin receptor (IR) resulted in loss of the IGF-II response. IGF-II tipped the TIMP:MMP balance, promoting a fibrotic environment both intracellularly and extracellularly. Differentiation of fibroblasts into myofibroblasts by IGF-II was blocked with a TGF beta 1 receptor inhibitor. IGF-II also increased TGF beta 2 and TGF beta 3 expression, with subsequent activation of canonical SMAD2/3 signaling. Therefore, IGF-II promoted fibrosis through IGF1R, IR, and IGF1R/IR, differentiated fibroblasts into myofibroblasts, decreased protease production and extracellular matrix degradation, and stimulated expression of two TGF beta isoforms, suggesting that IGF-II exerts pro-fibrotic effects via multiple mechanisms.	[Garrett, Sara M.; Feghali-Bostwick, Carol] Med Univ South Carolina MUSC, Dept Med, Div Rheumatol, Charleston, SC 29425 USA; [Hsu, Eileen] Mid Atlantic Permanente Med Grp, Mclean, VA USA; [Thomas, Justin M.] Eisenhower Med Ctr, Rancho Mirage, CA USA; [Pilewski, Joseph M.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Medical University of South Carolina; Permanente Medical Groups; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Feghali-Bostwick, C (corresponding author), Med Univ South Carolina MUSC, Dept Med, Div Rheumatol, Charleston, SC 29425 USA.	feghalib@musc.edu	Pilewski, Joseph/AAF-5149-2021	Garrett, Sara/0000-0001-9220-0947	SmartState(R); Kitty Trask Holt Endowment; NIH [K24 AR060297, R01 HL121262, NIH 5T32AR050958]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR060297, T32AR050958] Funding Source: NIH RePORTER	SmartState(R); Kitty Trask Holt Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	CFB received funding from the SmartState (R) and Kitty Trask Holt Endowment and the NIH (K24 AR060297; R01 HL121262; https://www.nih.gov/) and SMG received funding from the NIH (NIH 5T32AR050958; https://www.nih.gov/).The sponsors/funders did not contribute to study design, data collection/analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL EXTRAC, DOI [10.1016/0955-2235(95)00017-8, DOI 10.1016/0955-2235(95)00017-8]; Alvino CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027488; [Anonymous], 2016, DIS MARKERS; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Back K, 2011, MOL CELL ENDOCRINOL, V339, P130, DOI 10.1016/j.mce.2011.04.005; Bergman D, 2013, GERONTOLOGY, V59, P240, DOI 10.1159/000343995; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Brown J, 2009, VITAM HORM, V80, P699, DOI 10.1016/S0083-6729(08)00625-0; Bukowska J, 2018, CELL TISSUE RES, V374, P149, DOI 10.1007/s00441-018-2836-8; Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017; Bullard KM, 1999, J SURG RES, V84, P31, DOI 10.1006/jsre.1999.5599; Choi JE, 2009, AM J RESP CRIT CARE, V179, P212, DOI 10.1164/rccm.200802-228OC; Chung B, 2012, AM J MED GENET A, V158A, P2373, DOI 10.1002/ajmg.a.35570; Craig VJ, 2015, AM J RESP CELL MOL, V53, P585, DOI 10.1165/rcmb.2015-0020TR; Fowlkes John L., 1995, Progress in Growth Factor Research, V6, P255, DOI 10.1016/0955-2235(95)00017-8; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Garrett SM, 2019, METHOD PROTOCOL, V2, DOI 10.3390/mps2020045; Garrett SM, 2017, J SCLERODERMA RELAT, V2, P100, DOI 10.5301/jsrd.5000240; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Halje M, 2012, IN VIVO, V26, P519; HARRISON NK, 1994, CLIN SCI, V86, P141, DOI 10.1042/cs0860141; Herzog EL, 2014, ARTHRITIS RHEUMATOL, V66, P1967, DOI 10.1002/art.38702; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Hsu E, 2008, AM J PATHOL, V172, P1580, DOI 10.2353/ajpath.2008.071021; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Jelaska A, 2000, ARTHRITIS RHEUM-US, V43, P2230, DOI 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8; Keppler S, 2016, ONCOTARGET, V7, P38762, DOI 10.18632/oncotarget.9607; KHALIL N, 1991, CHEST, V99, pS65, DOI 10.1378/chest.99.3_Supplement.65S-a; Kim SY, 2012, AM J PHYSIOL-LUNG C, V302, pL891, DOI 10.1152/ajplung.00288.2011; Krizkova K, 2016, BIOCHEMISTRY-US, V55, P2903, DOI 10.1021/acs.biochem.6b00140; Kubo H, 2018, CHEST, V153, P210, DOI 10.1016/j.chest.2017.06.026; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; Li Y, 2009, HUM PATHOL, V40, P1441, DOI 10.1016/j.humpath.2009.03.003; Liu TC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050763; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Madtes DK, 2001, AM J RESP CELL MOL, V24, P599, DOI 10.1165/ajrcmb.24.5.4192; Martyanov V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187580; Melendez-Zajgla J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-85; Menou A, 2018, MATRIX BIOL, V68-69, P382, DOI 10.1016/j.matbio.2018.03.001; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; Nielsen Finn Cilius, 1992, Progress in Growth Factor Research, V4, P257, DOI 10.1016/0955-2235(92)90023-B; O'Dwyer DN, 2016, AM J PHYSIOL-LUNG C, V311, pL590, DOI 10.1152/ajplung.00221.2016; Osipo C, 2001, EXP CELL RES, V264, P388, DOI 10.1006/excr.2000.5121; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Park AM, 2012, ARCH BIOCHEM BIOPHYS, V518, P133, DOI 10.1016/j.abb.2011.12.012; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Pineiro-Hermida S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04561-4; Raghu G, 2016, EUR RESPIR J, V48, P179, DOI 10.1183/13993003.01653-2015; Rogers MA, 2016, TUMOR BIOL, V37, P12485, DOI 10.1007/s13277-016-5115-x; Scott CD, 2015, BEST PRACT RES CL EN, V29, P723, DOI 10.1016/j.beem.2015.08.001; Shin JY, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw0790; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; Susol E, 2000, RHEUMATOLOGY, V39, P1332, DOI 10.1093/rheumatology/39.12.1332; Talior-Volodarsky I, 2015, J CELL PHYSIOL, V230, P327, DOI 10.1002/jcp.24708; Tarrago D, 1999, IMMUNOLOGY, V98, P652, DOI 10.1046/j.1365-2567.1999.00889.x; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Yamashita CM, 2014, EXPERT REV RESP MED, V8, P411, DOI 10.1586/17476348.2014.909288; Yasuoka H, 2006, AM J PATHOL, V169, P1633, DOI 10.2353/ajpath.2006.060501; Yasuoka H, 2006, ARTHRITIS RHEUM-US, V54, P3001, DOI 10.1002/art.22084; Yasuoka H, 2019, AM J PHYSIOL-LUNG C, V316, pL644, DOI 10.1152/ajplung.00106.2018; Zaina S, 1998, ENDOCRINOLOGY, V139, P3886, DOI 10.1210/en.139.9.3886; Zhang QR, 2015, MOL MED REP, V12, P3855, DOI 10.3892/mmr.2015.3810	70	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225422	10.1371/journal.pone.0225422	http://dx.doi.org/10.1371/journal.pone.0225422			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765403	Green Published, gold			2022-12-26	WOS:000533891000025
J	Kamau, M; Mirie, W; Kimani, S; Mugoya, I				Kamau, Mary; Mirie, Waithira; Kimani, Samuel; Mugoya, Isaac			Effect of community based health education on knowledge and attitude towards iron and folic acid supplementation among pregnant women in Kiambu County, Kenya: A quasi experimental study	PLOS ONE			English	Article							SERVICES; MOTHERS; INDIA	Introduction Iron and Folic Acid Supplementation (IFAS) services are currently provided free of charge to pregnant women in Kenya during antenatal care (ANC) but compliance remains low. Poor awareness is an important factor contributing to low utilization of IFAS. Inadequate counselling is one of the key factors associated with poor awareness on IFAS. Community based health education is a promising diversification strategy for IFAS health education to curb this problem. Objectives To determine effect of community based IFAS health education, utilizing CHVs, on IFAS knowledge, levels of counselling on various IFAS topics and attitude towards IFAS among pregnant women in Kiambu County. Methodology A Pretest-Posttest Quasi-Experimental study design, consisting of intervention and control group, was applied among 340 pregnant women 18-49 years, in five health facilities, selected using two stage sampling in Lari Sub-County, Kiambu County, Kenya. Community health volunteers provided IFAS health education with weekly supplements and follow-ups to pregnant women in intervention group, while control group received the same from health care providers. Baseline and endline data were collected during ANC and compared. Quantitative data was analyzed using STATA version 14. Analysis of effect of intervention was done using Difference-In-Difference approach. Results There was an effect difference in maternal IFAS knowledge of 13%, with intervention group levels increasing most by 35 percentage points. The odds of being knowledgeable were 3 times more at endline than baseline. There was significant (p<0.001) change in proportion with positive attitude towards IFAS: the odds of having positive attitude at endline was 9 times that of baseline (OR = 9.2:95%CI 3.1, 27.2). Conclusion Implementation of community based health education improved maternal knowledge, positive attitude and proportion of pregnant women counselled on IFAS, better improvement being recorded in intervention group. Hence, there is need to integrate community based approach with antenatal IFAS distribution to improve supplementation.	[Kamau, Mary; Mirie, Waithira; Kimani, Samuel] Univ Nairobi, Sch Nursing Sci, Nairobi, Kenya; [Mugoya, Isaac] John Snow Inc, Nairobi, Kenya	University of Nairobi	Kamau, M (corresponding author), Univ Nairobi, Sch Nursing Sci, Nairobi, Kenya.	kwanjira@uonbi.ac.ke	Kamau, Mary/ABF-7607-2020	Kamau, Mary/0000-0002-4167-3549; kimani, Samuel/0000-0003-1537-6804	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; DELTAS Africa Initiative [107768/Z/15/Z]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK) [107768/Z/15/Z]; UK government	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No--B 8606.R02), Sida (Grant No:54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK government, "The statements made and views expressed are solely the responsibility of the fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in form of research materials to carry out the study. The funder (CARTA) did not provide support in the form of salaries for authors and John Snow Inc. had no role to play in this study.	Abdullahi Hala, 2014, BMC Res Notes, V7, P498, DOI 10.1186/1756-0500-7-498; Aguayo VM, 2005, PUBLIC HEALTH NUTR, V8, P33, DOI 10.1079/PHN2004664; Al-Akhfash AA, 2013, SAUDI MED J, V34, P1173; Al-Hossani H., 2010, Eastern Mediterranean Health Journal, V16, P402; Alam A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1697-2; [Anonymous], 2012, GUID DAIL IR FOL AC; Bilimale A, 2010, AUSTRALAS MED J, V3, P281, DOI 10.4066/AMJ.2010.291; Bin Nisar Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-305; Birhanu Z, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12424; Bruce Martha L, 2002, Ment Health Serv Res, V4, P205, DOI 10.1023/A:1020912531637; Demidenko E, 2008, STAT MED, V27, P36, DOI 10.1002/sim.2980; Galloway R, 1994, SOC SCI MED, P39, DOI [10.1016/0277-9536(94)90164-3, DOI 10.1016/0277-9536(94)90164-3]; Gebreamlak B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169415; Gebremariam AD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210086; Gebremedhin S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-607; Getachew M, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1716-2; Ilmas T., 2018, THESIS; Kamau M, 2018, AAS OPEN RES, V1; Kamau MW, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5437-2; Klassen TP, 2000, FUTURE CHILD, V10, P83, DOI 10.2307/1602826; Kothari CR, 2014, REMETHODOLOGY METH, V3rd ed; Lee JH, 2007, ADDICT BEHAV, V32, P187, DOI 10.1016/j.addbeh.2006.03.030; Liu N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-45; Mahmoud A-HAW, 2007, IRON DEFICIENCY ANEM; Maina-Gathigi L, 2013, MATERN CHILD HLTH J, V17, P1236, DOI 10.1007/s10995-012-1120-x; Matiri E, 2017, IMPROVING IRON FOLIC; MCHIP, 2014, COMM BAS DISTR ROUT; MCSP. MCSP Nutrition Brief, 2017, COMM BAS DISTR IR FO; Muro Grace S., 1999, Food and Nutrition Bulletin, V20, P435; Nadia H., 2018, IOSR J NURS HLTH SCI, V7, P49; Nairobi, 2012, ACC RED IR DEF AN PR; Nairobi, 2013, NAT POL GUID COMB IR; Nairobi, 2012, IFAS DIAL GUID HLTH; Nairobi, 2013, NAT IR FOL AC SUPPL; NISAR N, 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0112446; Nuno L, 2008, ADEQUACY PRENATAL CA, V24, P1151; Owusu-Darko I, 2014, APPL GEN ESTIMATING, P3359; Pal PP, 2013, INT J PREVENTIVE MED, V4, P1213; Pouchieu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070733; Rai S., 2013, COMPLIANCE ITS DETER; Sadore AA, 2015, J ENVIRON PUBLIC HEA, V2015, DOI 10.1155/2015/781973; Saprii L, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0094-3; Seck BC, 2008, PUBLIC HEALTH NUTR, V11, P596, DOI 10.1017/S1368980007000924; Shivalli S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137735; Taye B, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.43.4894, 10.11604/pamj.2015.20.276.4243]; Tenaw Z., 2018, INT J NURS MIDWIFERY, V10, P81, DOI [DOI 10.5897/IJNM2017.0289, 10.5897/IJNM2017.0289]; Titaley CR, 2014, ASIA PAC J CLIN NUTR, V23, P91, DOI 10.6133/apjcn.2014.23.1.18; Wang M., 2014, ADV STAT, P1, DOI [10.1155/2014/303728, DOI 10.1155/2014/303728]; Wendt A, 2014, FASEB J S, P28; WHO, 2017, NUTR AN TOOLS EFF PR; Wiradnyani LAA, 2016, PUBLIC HEALTH NUTR, V19, P2818, DOI 10.1017/S1368980016001002; Yekta Z, 2008, J RES HEALTH SCI, V8, P39; Zafar M, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-437, 10.1186/1471-2393-14-344]	53	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0224361	10.1371/journal.pone.0224361	http://dx.doi.org/10.1371/journal.pone.0224361			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QR	31765422	gold, Green Published			2022-12-26	WOS:000533891000007
J	Kasovic, M; Stefan, L; Zvonar, M				Kasovic, Mario; Stefan, Lovro; Zvonar, Martin			Normative values for relative schoolbag weight in primary school children aged 6-14 from Czech Republic: A pilot study	PLOS ONE			English	Article							BACK-PAIN; SCHOOLCHILDREN; LOAD	Little evidence from observational studies has been provided regarding `optimal' relative schoolbag load during primary education. Also, no study to date has provided reference-based standards for relative schoolbag weight. Therefore, the main purpose of the study was to establish normative values of relative schoolbag weight in a sample of children. In this crosssectional study, we recruited 584 primary school students aged 6-14 (mean(age)+/- SD = 9.6 +/- 2.4 yrs, mean(height)+/- SD = 1.4 +/- 0.2 m, mean(weigh)t +/- SD = 37.5 +/- 13.3 kg, mean(body-mass) (index)+/- SD = 17.6 +/- 3.1 kg/m(2), 44.4% girls) chosen from five schools in the city of Brno. Schoolbag weight and child's body weight were objectively measured by using digital scale. Relative schoolbag weight was calculated by dividing schoolbag weight with child's body weight and the result was expressed in percentage. Lambda, Mu and Sigma (LMS) method was used to create sex- and age-percentile curves. Boys carried slightly heavier schoolbag, compared with girls (mean difference 0.2 kg, p = 0.020). No significant differences between sexes in relative schoolbag weight were observed (p = 0.240). Median values (P50) for boys and girls were similar and the largest observed between ages 6-9 in boys (15-17%) and 6-8 in girls (16-18%). The percentage of children carrying relative schoolbag weight beyond 10% of their body weight was very high, especially between ages 6-10 in boys (85.1-100%) and 6-11 in girls (86.8-95.4%). This study provides first sex- and age- relative schoolbag weight normative values in primary school children. Future studies should use similar methods for generating comparable data.	[Kasovic, Mario; Stefan, Lovro] Univ Zagreb, Fac Kinesiol, Dept Gen & Appl Kinesiol, Zagreb, Croatia; [Kasovic, Mario; Zvonar, Martin] Masaryk Univ, Fac Sport Studies, Brno, Czech Republic	University of Zagreb; University of Zagreb, Faculty of Kinesiology; Masaryk University Brno	Stefan, L (corresponding author), Univ Zagreb, Fac Kinesiol, Dept Gen & Appl Kinesiol, Zagreb, Croatia.	lovro.stefan1510@gmail.com	Kasović, Mario/AAZ-5748-2020					Al-Saleem Saleem Ali, 2016, Epidemiology (Sunnyvale), V6; Olmedo-Buenrostro BA, 2016, J SCH NURS, V32, P172, DOI 10.1177/1059840515606787; [Anonymous], 2015, REPORT WORKING GROUP; Bryant BP, 2014, J SCH NURS, V30, P19, DOI 10.1177/1059840513495417; Chow DHK, 2005, ERGONOMICS, V48, P642, DOI 10.1080/00140130500070921; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Dockrell S, 2013, J SCHOOL HEALTH, V83, P368, DOI 10.1111/josh.12040; Hong YL, 2000, ERGONOMICS, V43, P717, DOI 10.1080/001401300404698; Jones GT, 2009, ARTHRIT CARE RES, V61, P1359, DOI 10.1002/art.24696; Kasovic M, 2018, KINESIOLOGY, V50, P188, DOI 10.26582/k.50.2.14; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Moore MJ, 2007, J SCHOOL HEALTH, V77, P232, DOI 10.1111/j.1746-1561.2007.00198.x; Spiteri K, 2017, BRIT J PAIN, V11, P81, DOI 10.1177/2049463717695144; Syazwan Ai, 2011, J Pain Res, V4, P287, DOI 10.2147/JPR.S22281; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; van Gent C, 2003, SPINE, V28, P916, DOI 10.1097/00007632-200305010-00014; World Health Organization, 2015, BOD MASS IND BMI; Yamato TP, 2018, BRIT J SPORT MED, V52, P1241, DOI 10.1136/bjsports-2017-098927	18	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225741	10.1371/journal.pone.0225741	http://dx.doi.org/10.1371/journal.pone.0225741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8QR	31765420	gold, Green Published			2022-12-26	WOS:000533891000044
J	Al-Ghafari, A; Elmorsy, E; Fikry, E; Alrowaili, M; Carter, WG				Al-Ghafari, Ayat; Elmorsy, Ekramy; Fikry, Emad; Alrowaili, Majed; Carter, Wayne G.			The heavy metals lead and cadmium are cytotoxic to human bone osteoblasts via induction of redox stress	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; OXIDATIVE STRESS; LIPID-PEROXIDATION; RESPIRATORY-CHAIN; INDUCED APOPTOSIS; EXPOSURE; DENSITY; LEVEL; TOXICITY; TISSUES	The heavy metals (HMs) lead and cadmium are persistent environmental pollutants capable of inducing ill-health in exposed individuals. One of the primary sites of accumulation and potential damage from HMs is bone, and we therefore examined the acute effects of lead and cadmium on human bone osteoblasts in vitro over a concentration range of 0.1 mu M to 1mM, and for 3, 6, 12, 24, and 48 hour exposures. Incubation of osteoblasts with either lead or cadmium reduced cell viability in a concentrations and exposure durations dependent manner, as measured using MTT and LDH assays. Cytotoxicity was significant from 0.1 mu M concentrations after 48 hour exposures. Both HMs damaged cellular bioenergetics with reductions of ATP production, mitochondrial complex activities, and aerobic respiration. There was a concomitant elevation of reactive oxygen species, with induction of redox stress measured as increased lipid peroxidation, and depleted cellular redox defense systems via reduced superoxide dismutase and catalase activity and cellular glutathione levels. Both HMs induced nuclear activation of Nrf2, presumably to increase transcription of antioxidant responsive genes to combat oxidative stress. Incubation of osteoblasts with HMs also compromised the secretion of procollagen type 1, osteocalcin, and alkaline phosphatase. Pre-incubation of osteoblasts with reduced glutathione prior to challenge with HMs lessened the cytotoxicity of the HMs, indicative that antioxidants may be a beneficial treatment adjunct in cases of acute lead or cadmium poisoning.	[Al-Ghafari, Ayat] King AbdulAziz Univ, Fac Sci, Biochem Dept, Jeddah, Saudi Arabia; [Elmorsy, Ekramy; Fikry, Emad] Mansoura Univ, Fac Med, Dept Forens Med & Clin Toxicol, Mansoura, Egypt; [Elmorsy, Ekramy] Northern Border Univ, Fac Med, Dept Pathol, Ar Ar, Saudi Arabia; [Elmorsy, Ekramy; Carter, Wayne G.] Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Derby, England; [Alrowaili, Majed] Northern Border Univ, Fac Med, Dept Surg, Ar Ar, Saudi Arabia	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Mansoura University; Northern Borders University; University of Nottingham; Northern Borders University	Carter, WG (corresponding author), Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Derby, England.	Wayne.Carter@nottingham.ac.uk	Al-Ghafari, Ayat/AAX-9591-2020	Al-Ghafari, Ayat/0000-0001-9156-4263; Elmorsy, Ekramy/0000-0002-7444-2499				Alam MN, 2013, SAUDI PHARM J, V21, P143, DOI 10.1016/j.jsps.2012.05.002; Alfven T, 2000, J BONE MINER RES, V15, P1579, DOI 10.1359/jbmr.2000.15.8.1579; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Barry V, 2019, OCCUP ENVIRON MED, V76, P349, DOI 10.1136/oemed-2018-105505; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Brama M, 2012, J ENDOCRINOL INVEST, V35, P198, DOI 10.3275/7801; Briggs D, 2003, BRIT MED BULL, V68, P1, DOI 10.1093/bmb/ldg019; Caito Samuel, 2017, Adv Neurobiol, V18, P3, DOI 10.1007/978-3-319-60189-2_1; Campbell JR, 2007, ENVIRON HEALTH PERSP, V115, P1018, DOI 10.1289/ehp.9716; Campbell JR, 2004, ENVIRON HEALTH PERSP, V112, P1200, DOI 10.1289/ehp.6555; Chalkley SR, 1998, OCCUP ENVIRON MED, V55, P446, DOI 10.1136/oem.55.7.446; CHISOLM JJ, 1980, PEDIATR ANN, V9, P458; Coonse KG, 2007, J TOXICOL ENV HEAL A, V70, P575, DOI 10.1080/15287390600882663; Czekanska EM, 2014, J BIOMED MATER RES A, V102, P2636, DOI 10.1002/jbm.a.34937; Daunt M, 2006, ENDOCRINOLOGY, V147, P1527, DOI 10.1210/en.2005-0873; DAVIS JM, 1990, NEUROTOXICOL TERATOL, V12, P215, DOI 10.1016/0892-0362(90)90093-R; Dorta DJ, 2003, J INORG BIOCHEM, V97, P251, DOI 10.1016/S0162-0134(03)00314-3; Elmorsy E, 2017, HUM EXP TOXICOL, V36, P616, DOI 10.1177/0960327116660751; Elmorsy E, 2017, TOXICOL LETT, V272, P94, DOI 10.1016/j.toxlet.2017.03.018; Elmorsy E, 2015, BIOCHEM BIOPH RES CO, V460, P857, DOI 10.1016/j.bbrc.2015.03.122; Elmorsy E, 2014, BRAIN RES, V1583, P255, DOI 10.1016/j.brainres.2014.08.011; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Finkelstein Y, 1998, BRAIN RES REV, V27, P168, DOI 10.1016/S0165-0173(98)00011-3; Flora SJS, 2010, INT J ENV RES PUB HE, V7, P2745, DOI 10.3390/ijerph7072745; Florencio-Silva R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421746; Garcon G, 2004, J OCCUP ENVIRON MED, V46, P1180, DOI 10.1097/01.jom.0000141665.22881.69; Gurer-Orhan H, 2004, TOXICOLOGY, V195, P147, DOI 10.1016/j.tox.2003.09.009; Hart BA, 1999, TOXICOLOGY, V133, P43, DOI 10.1016/S0300-483X(99)00013-X; He LH, 2000, J BIOL CHEM, V275, P12175, DOI 10.1074/jbc.275.16.12175; He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a; Honda R, 2003, ENVIRON RES, V91, P63, DOI 10.1016/S0013-9351(02)00035-X; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Jilka RL, 2003, MED PEDIATR ONCOL, V41, P182, DOI 10.1002/mpo.10334; JIN Y, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0037841; Kasperczyk S, 2016, TOXICOL IND HEALTH, V32, P1607, DOI 10.1177/0748233715571152; Kianoush Sina, 2015, Acta Med Iran, V53, P327; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; MANCA D, 1991, TOXICOLOGY, V67, P303, DOI 10.1016/0300-483X(91)90030-5; Matovic V, 2015, FOOD CHEM TOXICOL, V78, P130, DOI [10.1016/j.fct.2015.02.011, 10.1016/jict.2015.02.011]; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; McKay CA, 2013, J MED TOXICOL, V9, P339, DOI 10.1007/s13181-013-0341-8; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Mitra P, 2017, CRIT REV CL LAB SCI, V54, P506, DOI 10.1080/10408363.2017.1408562; Moser SC, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00794; Nawrot T, 2010, J BONE MINER RES, V25, P1441, DOI 10.1002/jbmr.22; Nemmiche S, 2017, TOXICOL SCI, V156, P4, DOI 10.1093/toxsci/kfw222; Patra R C, 2011, Vet Med Int, V2011, P457327, DOI 10.4061/2011/457327; Ramachandran Anup, 2018, J Clin Transl Res, V4, P75; Rani A, 2014, INT J ENVIRON HEAL R, V24, P378, DOI 10.1080/09603123.2013.835032; Sachdeva C, 2018, INDIAN J CLIN BIOCHE, V33, P132, DOI 10.1007/s12291-017-0680-3; SANDHIR R, 1995, BIOL TRACE ELEM RES, V48, P91, DOI 10.1007/BF02789081; Singh R, 2008, ARCH BIOCHEM BIOPHYS, V471, P207, DOI 10.1016/j.abb.2007.12.008; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Staessen JA, 1999, LANCET, V353, P1140, DOI 10.1016/S0140-6736(98)09356-8; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; TSURITANI I, 1992, J TOXICOL ENV HEALTH, V37, P519, DOI 10.1080/15287399209531690; Ullah H, 2011, GOMAL UNIVERSITY JOU, V27, P2; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Wallin M, 2016, J BONE MINER RES, V31, P732, DOI 10.1002/jbmr.2743; Wani Ab Latif, 2015, Interdiscip Toxicol, V8, P55, DOI 10.1515/intox-2015-0009; World Health Organization, 2018, LEAD POIS HLTH; Wu KC, 2012, TOXICOL APPL PHARM, V263, P14, DOI 10.1016/j.taap.2012.05.017; Zhao HY, 2015, J VET SCI, V16, P297, DOI 10.4142/jvs.2015.16.3.297; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	67	35	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225341	10.1371/journal.pone.0225341	http://dx.doi.org/10.1371/journal.pone.0225341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756223	Green Published, gold			2022-12-26	WOS:000533889300019
J	Bosire, R; Nanasi, P; Imre, L; Dienes, B; Szoor, A; Mazlo, A; Kovacs, A; Seidel, R; Vamosi, G; Szabo, G				Bosire, Rosevalentine; Nanasi, Peter, Jr.; Imre, Laszlo; Dienes, Beatrix; Szoor, Arpad; Mazlo, Anett; Kovacs, Attila; Seidel, Ralf; Vamosi, Gyorgy; Szabo, Gabor			Intercalation of small molecules into DNA in chromatin is primarily controlled by superhelical constraint	PLOS ONE			English	Article							NUCLEOSOME CORE PARTICLE; ETHIDIUM-BROMIDE; TORSIONAL TENSION; TOPOISOMERASE-II; BINDING; TRANSCRIPTION; PROTEIN; DOMAINS; CELLS; ACCESSIBILITY	The restricted access of regulatory factors to their binding sites on DNA wrapped around the nucleosomes is generally interpreted in terms of molecular shielding exerted by nucleosomal structure and internucleosomal interactions. Binding of proteins to DNA often includes intercalation of hydrophobic amino acids into the DNA. To assess the role of constrained superhelicity in limiting these interactions, we studied the binding of small molecule intercalators to chromatin in close to native conditions by laser scanning cytometry. We demonstrate that the nucleosome-constrained superhelical configuration of DNA is the main barrier to intercalation. As a result, intercalating compounds are virtually excluded from the nucleosome-occupied regions of the chromatin. Binding of intercalators to extranucleosomal regions is limited to a smaller degree, in line with the existence of net supercoiling in the regions comprising linker and nucleosome free DNA. Its relaxation by inducing as few as a single nick per similar to 50 kb increases intercalation in the entire chromatin loop, demonstrating the possibility for long-distance effects of regulatory potential.	[Bosire, Rosevalentine; Nanasi, Peter, Jr.; Imre, Laszlo; Szoor, Arpad; Vamosi, Gyorgy; Szabo, Gabor] Univ Debrecen, Fac Med, Dept Biophys & Cell Biol, Debrecen, Hungary; [Bosire, Rosevalentine; Nanasi, Peter, Jr.] Univ Debrecen, Doctoral Sch Mol Cell & Immune Biol, Debrecen, Hungary; [Dienes, Beatrix] Univ Debrecen, Fac Med, Dept Physiol, Debrecen, Hungary; [Mazlo, Anett] Univ Debrecen, Fac Med, Dept Immunol, Debrecen, Hungary; [Mazlo, Anett] Univ Debrecen, MTA DE Cell Biol & Signalling Res Grp, Debrecen, Hungary; [Kovacs, Attila] Univ Debrecen, Fac Med, Dept Radiat Therapy, Debrecen, Hungary; [Seidel, Ralf] Univ Leipzig, Peter Debye Inst Soft Matter Phys, Leipzig, Germany	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; Leipzig University	Szabo, G (corresponding author), Univ Debrecen, Fac Med, Dept Biophys & Cell Biol, Debrecen, Hungary.	szabog@med.unideb.hu	Seidel, Ralf/A-6531-2010; Szabo, Gabor/AAP-2447-2021	Seidel, Ralf/0000-0002-6642-053X; Turk-Mazlo, Anett/0000-0001-7012-7101; Vamosi, Gyorgy/0000-0002-7940-2787; Szabo, Gabor/0000-0002-9163-3465	Stipendium Hungaricum [GINOP-2.3.2-15-2016-00044, OTKA K128770, COST CA 1521]; Tempus Public foundation	Stipendium Hungaricum; Tempus Public foundation	This work was supported by: GSz GINOP-2.3.2-15-2016-00044 -https://nkfih.gov.hu/funding/otka; GSz OTKA K128770 -https://nkfih.gov.hu/funding/otka; GSz COST CA 1521 -https://nkfih.gov.hu/funding/otka; and Stipendium Hungaricum awarded by the Tempus Public foundation (https://tka.hu/english).	Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Banerjee A, 2014, FEBS OPEN BIO, V4, P251, DOI 10.1016/j.fob.2014.02.006; Bates AD, 2005, DNA TOPOLOGY, P25; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cohen SM, 2000, BIOCHEMISTRY-US, V39, P8259, DOI 10.1021/bi0004495; Corless S, 2017, BRIEF FUNCT GENOMICS, V16, P379, DOI 10.1093/bfgp/elx007; Cui KR, 2012, METHODS MOL BIOL, V833, P413, DOI 10.1007/978-1-61779-477-3_24; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Dikic J, 2019, BIOPHYS J, V116, P1394, DOI 10.1016/j.bpj.2019.03.005; ERARD M, 1979, NUCLEIC ACIDS RES, V6, P3231, DOI 10.1093/nar/6.10.3231; Fernandez X, 2014, EMBO J, V33, P1492, DOI 10.15252/embj.201488091; Grigoryev SA, 2019, ESSAYS BIOCHEM, V63, P109, DOI 10.1042/EBC20180066; Grigoryev SA, 2018, BIOPHYS J, V114, P2290, DOI 10.1016/j.bpj.2018.03.009; Grunwald D, 2008, BIOPHYS J, V94, P2847, DOI 10.1529/biophysj.107.115014; Gupta P, 2009, BIOPHYS J, V97, P3150, DOI 10.1016/j.bpj.2009.09.032; HELLER DP, 1994, BIOPHYS CHEM, V50, P305, DOI 10.1016/0301-4622(93)E0101-A; Imre L, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; JUPE ER, 1993, EMBO J, V12, P1067, DOI 10.1002/j.1460-2075.1993.tb05748.x; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Klass J, 2003, NUCLEIC ACIDS RES, V31, P2852, DOI 10.1093/nar/gkg389; Klein-Brill A, 2019, CELL REP, V26, P279, DOI 10.1016/j.celrep.2018.12.020; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kubik S, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600237; Kumala S, 2012, NUCLEIC ACIDS RES, V40, P9417, DOI 10.1093/nar/gks723; Kwon SY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005969; Lai WKM, 2017, NAT REV MOL CELL BIO, V18, P548, DOI 10.1038/nrm.2017.47; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Liu LF, 1987, P NATL ACAD SCI US; LJUNGMAN M, 1992, P NATL ACAD SCI USA, V89, P6055, DOI 10.1073/pnas.89.13.6055; Lucas I, 2001, EMBO J, V20, P6509, DOI 10.1093/emboj/20.22.6509; LUCHNIK AN, 1988, NUCLEIC ACIDS RES, V16, P5175, DOI 10.1093/nar/16.11.5175; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mayran A, 2018, J BIOL CHEM, V293, P13795, DOI 10.1074/jbc.R117.001232; MCMURRAY CT, 1991, BIOCHEMISTRY-US, V30, P5631, DOI 10.1021/bi00237a001; Muller S, 2001, BIOCHEMISTRY-US, V40, P10254, DOI 10.1021/bi0100900; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Nikitina T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700957; PAOLETTI J, 1977, BIOCHEMISTRY-US, V16, P351, DOI 10.1021/bi00622a002; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Risca VI, 2017, NATURE, V541, P237, DOI 10.1038/nature20781; RODI CP, 1989, J CELL PHYSIOL, V141, P346, DOI 10.1002/jcp.1041410216; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rube HT, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177902; Sanchez-Giraldo R, 2015, ACTA CRYSTALLOGR D, V71, P1423, DOI 10.1107/S1399004715007452; Segura J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06547-w; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sheinin MY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3579; SINDEN RR, 1980, CELL, V21, P773, DOI 10.1016/0092-8674(80)90440-7; Singh RK, 2015, J PHYS CHEM B, V119, P11590, DOI 10.1021/acs.jpcb.5b06229; Song Lingyun, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5384; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; Tsompana M, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-33; Varga T, 1999, BIOCHEM BIOPH RES CO, V264, P388, DOI 10.1006/bbrc.1999.1470; VERGANI L, 1994, BIOCHEMISTRY-US, V33, P6578, DOI 10.1021/bi00187a027; Verschure PJ, 2003, EMBO REP, V4, P861, DOI 10.1038/sj.embor.embor922; VILLEPONTEAU B, 1987, MOL CELL BIOL, V7, P1917, DOI 10.1128/MCB.7.5.1917; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Werner MH, 1996, SCIENCE, V271, P778, DOI 10.1126/science.271.5250.778; YAGER TD, 1989, BIOCHEMISTRY-US, V28, P2271, DOI 10.1021/bi00431a045; Yu HJ, 2014, TRENDS BIOCHEM SCI, V39, P219, DOI 10.1016/j.tibs.2014.02.009; Zhang RT, 2017, BIOPHYS J, V112, P450, DOI 10.1016/j.bpj.2016.11.015	66	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0224936	10.1371/journal.pone.0224936	http://dx.doi.org/10.1371/journal.pone.0224936			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747397	Green Published, gold, Green Accepted			2022-12-26	WOS:000533881900018
J	Scott, TL; Kugelman, M; Tulloch, K				Scott, Theresa L.; Kugelman, Melissa; Tulloch, Kristen			How medical professional students view older people with dementia: Implications for education and practice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ATTITUDES; KNOWLEDGE; DEPRESSION; DIAGNOSIS; BIAS; EXPERIENCE; WORK; AGE	Background Healthcare professionals' attitudes to older people, and especially those living with dementia, may contribute to unsatisfactory healthcare. Despite repeated calls to address increasing need, training an adequate geriatric workforce remains an international concern. Of particular concern are the attitudes and knowledge healthcare workers may hold about people living with dementia. Students' knowledge of dementia has been found to be low at the beginning of their university education and has shown limited improvement throughout their coursework; greater understanding of students' attitudes to ageing and dementia, upon entry and throughout their degrees, may help inform targeted educational interventions to improve the healthcare delivered to older people. Methods This study measured knowledge of and attitudes toward dementia and ageing in an Australian university student sample (n = 183), comparing students from medical professional versus non-medical professional related fields at both undergraduate and postgraduate levels. We examined diagnostic and prognostic biases through age manipulation of a vignette describing a hypothetical patient (aged 42 or 72 years), who was experiencing symptoms that were consistent with DSM-5 criteria for both dementia and depression. Based on information provided in the vignette, student participants were asked to select a primary disorder that they would assign to the patient. Results Showed that while medical professional students held significantly more positive attitudes toward ageing than 'other' students, average attitudinal scores indicated neutrality. Medical professional students indicated a diagnostic bias toward the older vignette patient, who was more likely to be diagnosed with dementia than depression. A history of geriatric-specific training did not predict dementia knowledge; however, having prior contact with people with dementia predicted both dementia knowledge and more positive prognoses. Conclusions Overall, findings indicated medical professional students held neutral attitudes towards older people and showed deficits in knowledge of dementia. Educational interventions that introduce students to people living with dementia may improve knowledge, skills, and attitudes. All university students would benefit from education about dementia and inclusivity to reduce stereotyping and stigma.	[Scott, Theresa L.; Kugelman, Melissa; Tulloch, Kristen] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland	Scott, TL (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	theresa.scott@uq.edu.au	Tulloch, Kris/M-4262-2019; Scott, Theresa Lorraine/C-8791-2016	Tulloch, Kris/0000-0001-5619-2257; Scott, Theresa Lorraine/0000-0002-6434-7121				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Australian Institute of Health and Welfare, 2017, LIF EXP DIS AUSTR EX; Azmi A, 2017, EUR PR MULTIDISCIP S, V1, P7, DOI 10.15405/epms.2017.06.2; Bardach SH, 2012, GERONTOLOGIST, V52, P607, DOI 10.1093/geront/gns006; Baste NV, 2015, J EVIDENCE BASED MED, V2, P1263; Boswell SS, 2012, EDUC GERONTOL, V38, P465, DOI 10.1080/03601277.2011.559864; Brown L, 2017, EC COST DEMENTIA AUS; Cahill S, 2015, ALZ DIS ASSOC DIS, V29, P255, DOI 10.1097/WAD.0000000000000102; Carpenter BD, 2009, GERONTOLOGIST, V49, P236, DOI 10.1093/geront/gnp023; Cations M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196085; Chapman EN, 2013, J GEN INTERN MED, V28, P1504, DOI 10.1007/s11606-013-2441-1; CHENOWETH B, 1986, GERONTOLOGIST, V26, P267, DOI 10.1093/geront/26.3.267; Chesney R, 2018, DEEP FAKES LOOMING C, P1; Chi S, 2015, CURR ALZHEIMER RES, V12, P189, DOI 10.2174/1567205012666150204124310; Corner L, 2004, J AGING STUD, V18, P143, DOI 10.1016/j.jaging.2004.01.007; Eshbaugh EM, 2014, EDUC GERONTOL, V40, P655, DOI 10.1080/03601277.2013.863573; Evans LK, 1997, J AM GERIATR SOC, V45, P675, DOI 10.1111/j.1532-5415.1997.tb01469.x; Fitzgerald JT, 2003, GERONTOLOGIST, V43, P849, DOI 10.1093/geront/43.6.849; GARCIA CA, 1981, J AM GERIATR SOC, V29, P407, DOI 10.1111/j.1532-5415.1981.tb02379.x; Gekoski W. L, 1990, J AGING HEALTH, V2, P15, DOI DOI 10.1177/089826439000200102; Gellis ZD, 2003, EDUC GERONTOL, V29, P1, DOI 10.1080/713844235; GINTNER GG, 1995, J COUNS DEV, V73, P346, DOI 10.1002/j.1556-6676.1995.tb01762.x; Goncalves DC, 2011, INT PSYCHOGERIATR, V23, P315, DOI 10.1017/S1041610210001638; Gonzales E, 2010, GERONTOL GERIATR EDU, V31, P220, DOI 10.1080/02701960.2010.503128; Helmes E, 2003, EDUC GERONTOL, V29, P657, DOI 10.1080/03601270390225640; IBM Corp, 2013, IBM SPSS STAT WIND 2; INTRIERI RC, 1995, GERONTOLOGIST, V35, P616, DOI 10.1093/geront/35.5.616; INTRIERI RC, 1993, GERONTOLOGIST, V33, P373, DOI 10.1093/geront/33.3.373; Isaac MGEKN, 2017, J MENT HEALTH, V26, P419, DOI 10.1080/09638237.2016.1207234; James JW, 1995, PSYCHOL AGING, V10, P610, DOI 10.1037/0882-7974.10.4.610; Jones C, 2013, AUSTRALAS J AGEING, V32, P52, DOI 10.1111/j.1741-6612.2012.00640.x; Jorm AF, 2005, AUST NZ J PSYCHIAT, V39, P959, DOI 10.1111/j.1440-1614.2005.01713.x; Liu YE, 2012, J INTERPROF CARE, V26, P397, DOI 10.3109/13561820.2012.702146; Low LF, 2010, DEMENT GERIATR COGN, V30, P499, DOI 10.1159/000321667; Lu WH, 2010, EDUC GERONTOL, V36, P687, DOI 10.1080/03601270903534630; Maier W, 2016, EUROPEAN PSYCHIAT, V33; Nelson PT, 2010, J NEUROL, V257, P359, DOI 10.1007/s00415-009-5324-y; Nichols E, 2019, LANCET NEUROL, V18, P88, DOI 10.1016/S1474-4422(18)30403-4; PERLICK D, 1984, J CONSULT CLIN PSYCH, V52, P812, DOI 10.1037/0022-006X.52.5.812; Phillipson L, 2012, EXPLORING DEMENTIA S, P15; Prendecki M, 2016, UPDATE ON DEMENTIA, P251, DOI 10.5772/64203; Quinn JF, 2013, DEMENTIA; Saxon RL, 2018, AUSTRALAS J AGEING, V37, P48, DOI 10.1111/ajag.12459; Scerri A, 2013, NURS EDUC TODAY, V33, P962, DOI 10.1016/j.nedt.2012.11.001; Skinner TR, 2016, INT J GEN MED, V9, P137, DOI 10.2147/IJGM.S96741; Stallman HM, 2011, HIGH EDUC RES DEV, V30, P121, DOI 10.1080/07294360.2010.509763; Stewart T, 2007, EDUC GERONTOL, V32, P409; Tinker A, 2002, MECH AGEING DEV, V123, P729, DOI 10.1016/S0047-6374(01)00418-3; Tomko JK, 2013, AGING MENT HEALTH, V17, P233, DOI 10.1080/13607863.2012.715141; Williams B, 2007, J NURS EDUC, V46, P115, DOI 10.3928/01484834-20070301-05; World Health Organization, TOP 10 CAUS DEATH 20; Woudstra Froukje H, 2014, BMC Res Notes, V7, P381, DOI 10.1186/1756-0500-7-381; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604	53	18	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225329	10.1371/journal.pone.0225329	http://dx.doi.org/10.1371/journal.pone.0225329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8NF	31747449	gold, Green Published			2022-12-26	WOS:000533881900035
J	Abeliovich, H				Abeliovich, Hagai			New gadget in the membrane trafficking toolbox: A novel inhibitor of SNARE priming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEIN; IDENTIFICATION; FUSION	NSF (N-ethylmaleimide sensitive factor) and its yeast counterpart Sec18 are highly conserved homohexameric proteins that play vital roles in eukaryotic membrane trafficking. Sec18 functions by disrupting SNARE complexes formed in cis, on the same membrane. However, the molecular mechanisms of this process are poorly understood, in large part due to the lack of selective, reversible inhibitors. A new study by Sparks et al. now reports a small molecule that appears to selectively inhibit Sec18 action in an in vitro assay. Their finding now paves the way to elucidate further details of Sec18-mediated SNARE priming.	[Abeliovich, Hagai] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Abeliovich, H (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Food Sci, IL-76100 Rehovot, Israel.	hagai.abeliovich@mail.huji.ac.il						BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; EAKLE KA, 1988, MOL CELL BIOL, V8, P4098, DOI 10.1128/MCB.8.10.4098; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Rothman JE, 2014, ANGEW CHEM INT EDIT, V53, P12676, DOI 10.1002/anie.201402380; Ryu JK, 2016, BIOPOLYMERS, V105, P518, DOI 10.1002/bip.22854; Sparks RP, 2019, J BIOL CHEM, V294, P17168, DOI 10.1074/jbc.RA119.008865; Starr ML, 2019, J BIOL CHEM, V294, P3100, DOI 10.1074/jbc.RA118.006552; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61	11	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17186	17187		10.1074/jbc.H119.011334	http://dx.doi.org/10.1074/jbc.H119.011334			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31732684	hybrid, Green Published			2022-12-26	WOS:000503173500002
J	Alfian, SD; Denig, P; Coelho, A; Hak, E				Alfian, Sofa D.; Denig, Petra; Coelho, Andre; Hak, Eelko			Pharmacy-based predictors of nonadherence, non-persistence and reinitiation of antihypertensive drugs among patients on oral diabetes drugs in the Netherlands	PLOS ONE			English	Article							MEDICATION ADHERENCE; DIFFERENT BELIEFS; THERAPY; DISCONTINUATION; HYPERTENSION; DETERMINANTS; METAANALYSIS; IMPROVEMENT	Background Adherence to antihypertensive drugs in patients with diabetes is important. To support adherence, attention should be paid to the dynamic process of implementation, persistence and reinitiation of these drugs. We assessed non-adherence, non-persistence and reinitiation patterns for antihypertensive drugs in patients on oral diabetes drugs and identified pharmacy-based predictors of these processes. Methods We conducted a cohort study in patients on oral diabetes drugs who initiated antihypertensive drugs between 1995-2015, as registered in the IADB.nl pharmacy database. Nonadherence was defined as a medication possession ratio <80% and non-persistence as a gap > 180 days. We defined reinitiation as the dispensing of an antihypertensive drug within one year following discontinuation. We provide descriptive statistics for different time periods and applied logistic and Cox regressions to assess associations with sociodemographic and drug-related factors. Results Of 6,669 initiators, non-adherence rates in persistent patients decreased from 11.0% in the first year to 8.5% and 7.7% in the second and third years, respectively. Non-persistence rates decreased from 18.0% in the first year to 3.7% and 2.9% in the second and third years, respectively. Of the 1,201 patients who discontinued in the first year, 22.0% reinitiated treatment within one year. Non-adherence and non-persistence rates were lower in the more recent time period. Predictors of non-adherence were secondary prevention (OR: 1.45; 95% CI: 1.10-1.93) and diuretics as initial drug class (OR: 1.37; 95% CI: 1.08-1.74). Predictors of non-persistence were female gender (HR: 1.18; 95% CI: 1.05-1.32), older age (HR: 1.33; 95% CI: 1.08-1.63) and diuretics, beta-blocking agents or calcium channel blockers as initial drug class. Longer duration of persistence was a predictor of reinitiation. Conclusions Adherence to antihypertensive drugs in patients on oral diabetes drugs has improved over time. The first year after initiation is the most crucial with regard to non-adherence and non-persistence, and the risk groups are different for both processes. Early non-persistence is a risk factor for not reinitiating treatment.	[Alfian, Sofa D.; Hak, Eelko] Univ Groningen, Unit Pharmacotherapy Epidemiol & Econ, Groningen Res Inst Pharm, Groningen, Netherlands; [Alfian, Sofa D.] Univ Padjadjaran, Dept Pharmacol & Clin Pharm, Fac Pharm, Sumedang, Indonesia; [Denig, Petra] Univ Groningen, Dept Clin Pharm & Pharmacol, Univ Med Ctr Groningen, Groningen, Netherlands; [Coelho, Andre] Inst Politecn Lisboa (ESTeSL), Hlth & Technol Res Ctr H&TRC, Escola Super Tecnol Saude, Lisbon, Portugal	University of Groningen; Universitas Padjadjaran; University of Groningen	Alfian, SD (corresponding author), Univ Groningen, Unit Pharmacotherapy Epidemiol & Econ, Groningen Res Inst Pharm, Groningen, Netherlands.; Alfian, SD (corresponding author), Univ Padjadjaran, Dept Pharmacol & Clin Pharm, Fac Pharm, Sumedang, Indonesia.	sofa.alfian@unpad.ac.id	; Denig, Petra/L-9865-2014	Coelho, Andre/0000-0003-1872-8131; Denig, Petra/0000-0002-7929-4739	Indonesia Endowment Fund for Education (LPDP) [PRJ-2361/LPDP/2015]	Indonesia Endowment Fund for Education (LPDP)	SDA is supported by a scholarship from Indonesia Endowment Fund for Education (LPDP no: PRJ-2361/LPDP/2015). This funding body did not have any role in designing the study, in analyzing and interpreting the data, in writing this article, and in deciding to submit it for publication.	Alfian SD, 2019, J CLIN EPIDEMIOL, V108, P44, DOI 10.1016/j.jclinepi.2018.12.003; Alfian SD, 2018, CURR MED RES OPIN, V34, P1013, DOI 10.1080/03007995.2017.1417242; American Diabetes Association, 2019, Diabetes Care, V42, pS103, DOI 10.2337/dc19-S010; Baggarly SA, 2014, RES SOC ADMIN PHARM, V10, pE99, DOI 10.1016/j.sapharm.2014.02.002; Bourgault C, 2005, J HUM HYPERTENS, V19, P607, DOI 10.1038/sj.jhh.1001873; Burke TA, 2006, J HYPERTENS, V24, P1193, DOI 10.1097/01.hjh.0000226211.95936.f5; Centraal Bureau voor de Statistiek, 2014, MOR MOR PEOPL DIAB; Clifford S, 2008, J PSYCHOSOM RES, V64, P41, DOI 10.1016/j.jpsychores.2007.05.004; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; De Geest S, 2018, ANN INTERN MED, V169, P30, DOI 10.7326/M18-0543; Elliott WJ, 2007, J AM BOARD FAM MED, V20, P72, DOI 10.3122/jabfm.2007.01.060094; Erkens JA, 2005, PHARMACOEPIDEM DR S, V14, P795, DOI 10.1002/pds.1156; Esposti ED, 2002, J HUM HYPERTENS, V16, P439, DOI 10.1038/sj/jhh/1001418; Frans K, 2012, NEIGHBOURHOOD STATUS; Friedman O, 2010, AM J MED, V123, P173, DOI 10.1016/j.amjmed.2009.08.008; Halpern MT, 2006, HYPERTENSION, V47, P1039, DOI 10.1161/01.HYP.0000222373.59104.3d; Hasford J, 2007, EUR J CLIN PHARMACOL, V63, P1055, DOI 10.1007/s00228-007-0340-2; Hedna K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137451; Jansen T, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0275-0; Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679; Kronish IM, 2011, CIRCULATION, V123, P1611, DOI 10.1161/CIRCULATIONAHA.110.983874; Ledur PS, 2013, J AM SOC HYPERTENS, V7, P477, DOI 10.1016/j.jash.2013.07.006; Lee JL, 2013, HEALTH AFFAIR, V32, P1251, DOI 10.1377/hlthaff.2012.0902; McHorney CA, 2010, PATIENT PREFER ADHER, V4, P187; Naderi SH, 2012, AM J MED, V125, P882, DOI 10.1016/j.amjmed.2011.12.013; Nederlands Huisartsen Genootschap, 2012, MULT RICHTL POL BIJ; Overheid N, WET MEDISCH WETENSCH; Poluzzi E, 2005, EUR J CLIN PHARMACOL, V61, P603, DOI 10.1007/s00228-005-0957-y; Pouwels KB, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1361-2; Sediq R, 2018, CLIN EPIDEMIOL, V10, P981, DOI 10.2147/CLEP.S163037; Siegel D, 2007, AM J MED, V120, P26, DOI 10.1016/j.amjmed.2006.06.028; Stalman WAB, DUTCH GUIDELINE CARD; Sung SK, 2009, CLIN THER, V31, P1309, DOI 10.1016/j.clinthera.2009.06.011; Tu KR, 2014, CAN J CARDIOL, V30, P647, DOI 10.1016/j.cjca.2014.03.017; van Wijk BLG, 2007, J HYPERTENS, V25, P689, DOI 10.1097/HJH.0b013e3280148a58; Van Wijk BLG, 2005, J HYPERTENS, V23, P2101, DOI 10.1097/01.hjh.0000187261.40190.2e; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Wiersma Tjerk, 2012, Ned Tijdschr Geneeskd, V156, pA5104; Wroe AL, 2002, J BEHAV MED, V25, P355, DOI 10.1023/A:1015866415552	39	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225390	10.1371/journal.pone.0225390	http://dx.doi.org/10.1371/journal.pone.0225390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2YM	31730627	Green Published, gold			2022-12-26	WOS:000532809500037
J	Mumm, LE; Winter, JM; Andersson, KE; Glowacki, GA; Adamovicz, LA; Allender, MC				Mumm, Lauren E.; Winter, John M.; Andersson, Kirsten E.; Glowacki, Gary A.; Adamovicz, Laura A.; Allender, Matthew C.			Hematology and plasma biochemistries in the Blanding's turtle (Emydoidea blandingii) in Lake County, Illinois	PLOS ONE			English	Article							TERRAPENE-CAROLINA-CAROLINA; REFERENCE RANGE VALUES; REFERENCE INTERVALS; PROTEIN ELECTROPHORESIS; BIOCHEMICAL PARAMETERS; STORAGE-TEMPERATURE; ACID CONCENTRATIONS; HEALTH-ASSESSMENT; DESERT TORTOISES; URIC-ACID	Chelonians are one of the most imperiled vertebrate taxa on the planet due to changes in the environment, anthropogenic influences, and disease. Over the last two decades, conservation strategies including nest protection, head-starting and meso-predator control have been successfully adopted by the Lake County Forest Preserve District for a population of state-endangered Blanding's turtles (Emydoidea blandingii) in Illinois. Only recently have efforts expanded to assess the effects of management action on turtle health. The objectives of this study were to 1) establish reference intervals for 16 hematologic and plasma biochemical analytes in free-ranging Blanding's turtles, 2) characterize demographic and temporal drivers of clinical pathology values including age class, sex, month, and year, and 3) describe bloodwork differences between a managed (SBCP) and unmanaged (IBSP) study site. Hematology and plasma biochemistries were performed for 393 turtles from 2017-18 at two sites in the Lake Plain region. Subject or population-based reference intervals were established based on the index of individuality per American Society for Veterinary Clinical Pathology guidelines. Analytes differed by age class [packed cell volume (PCV), total solids (TS), total white blood cell counts (WBC), heterophils, lymphocytes, heterophil:lymphocyte ratio (H:L), total calcium (Ca), calcium:phosphorous (Ca:P), bile acids (BA), aspartate aminotransferase (AST)], sex [H:L, Ca, phosphorus (P), Ca:P, creatine kinase (CK)], month [eosinophils, H:L, Ca, P, uric acid (UA), AST], and year [PCV, WBC, lymphocytes, basophils, H:L, Ca, P, UA]. Several analytes also varied by site [PCV, TS, monocytes, eosinophils, P, UA, AST], suggesting that health status may be affected by habitat management or lack thereof. The results of this study provide a baseline for ongoing health assessments in this region as well as across the Blanding's turtle range.	[Mumm, Lauren E.; Winter, John M.; Andersson, Kirsten E.; Adamovicz, Laura A.; Allender, Matthew C.] Univ Illinois, Coll Vet Med, Wildlife Epidemiol Lab, Urbana, IL 61801 USA; [Glowacki, Gary A.] Lake Cty Forest Preserves, Libertyville, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Allender, MC (corresponding author), Univ Illinois, Coll Vet Med, Wildlife Epidemiol Lab, Urbana, IL 61801 USA.	mcallend@illinois.edu		Winter, John/0000-0002-4262-5450; Adamovicz, Laura/0000-0002-5696-2327	Preservation Foundation of the Lake County Forest Preserve District; Lake County Forest Preserve District	Preservation Foundation of the Lake County Forest Preserve District; Lake County Forest Preserve District	This work was supported by the Preservation Foundation of the Lake County Forest Preserve District. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Lake County Forest Preserve District for funding this project, Callie Golba and the turtle technicians at LCFPD for providing their population data and Blanding's turtle capture skills, and the Wildlife Epidemiology Lab team for their assistance in collecting and processing samples.	Adamovicz L, 2015, J ZOO WILDLIFE MED, V46, P39, DOI 10.1638/2014-0066R.1; AGUIRRE AA, 1995, PHYSIOL ZOOL, V68, P831, DOI 10.1086/physzool.68.5.30163934; Allender M. C., 2009, Journal of Herpetological Medicine and Surgery, V19, P16; Andreani G, 2014, VET CLIN PATH, V43, P573, DOI 10.1111/vcp.12203; Benjamin T, 2018, B ENVIRON CONTAM TOX, V101, P295, DOI 10.1007/s00128-018-2407-4; Bertelsen MF, 2007, J ZOO WILDLIFE MED, V38, P217, DOI 10.1638/1042-7260(2007)038[0217:SBVOCC]2.0.CO;2; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Boers KL, ZOO BIOL; Bonnet X, 2016, J COMP PHYSIOL B, V186, P787, DOI 10.1007/s00360-016-0993-1; CAMPBELL T.W., 2014, CURRENT THERAPY REPT, P70; Campbell TW, 2014, CURRENT THERAPY REPT, P301; Case BC, 2005, APPL ANIM BEHAV SCI, V92, P353, DOI 10.1016/j.applanim.2004.11.011; Chung CS, 2009, J ZOO WILDLIFE MED, V40, P76, DOI 10.1638/2008-0023.1; CONGDON J.D., 2006, BLANDINGS TURTLE EMY; Congdon JD, 1993, J EVOLUTION BIOL, V6, P317, DOI [10.1046/j.1420-9101.1993.6040547.x, DOI 10.1046/J.1420-9101.1993.6040547.X]; Cray C, 2009, J AM ASSOC LAB ANIM, V48, P202; Dantzler WH, 1996, KIDNEY INT, V49, P1549, DOI 10.1038/ki.1996.222; Dickinson VM, 2002, J WILDLIFE DIS, V38, P143, DOI 10.7589/0090-3558-38.1.143; Divers Stephen J., 2000, P205; Eisenhawer E, 2008, J ZOO WILDLIFE MED, V39, P208, DOI 10.1638/2007-0166R.1; Ernst CH., 2009, TURTLES US CANADA, V2nd, P233; Eshar D, 2018, AM J VET RES, V79, P852, DOI 10.2460/ajvr.79.8.852; Eshar D, 2018, CAN J VET RES, V82, P106; Eshar D, 2016, J ZOO WILDLIFE MED, V47, P993, DOI 10.1638/2016-0051.1; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Geffre A, 2011, VET CLIN PATH, V40, P107, DOI 10.1111/j.1939-165X.2011.00287.x; Glowacki G, 2018, BLANDINGS TURTLE REC; Golet WJ, 2001, ENVIRON MONIT ASSESS, V71, P211, DOI 10.1023/A:1011802117198; GOTTDENKER NL, 1995, AM J VET RES, V56, P19; Grimm Kourtney, 2015, Journal of Herpetological Medicine and Surgery, V25, P28, DOI 10.5818/1529-9651-25.1.28; GUTZKE WHN, 1987, J HERPETOL, V21, P161, DOI 10.2307/1564476; Harden LA, 2018, J WILDLIFE DIS, V54, P587, DOI 10.7589/2017-09-222; Knotek Z., 2009, Proceedings of the Association of Reptilian and Amphibian Veterinarians, 16th Annual Conference, Milwaukee, Wisconsin, USA, 8-15 August, 2009, P124; Lindemann, 2017, THESIS; Lloyd TC, 2016, ECOHEALTH, V13, P467, DOI 10.1007/s10393-016-1142-8; Lopez J, 2017, J ZOO WILDLIFE MED, V48, P102, DOI 10.1638/2016-0201.1; Lopez-Olvera JR, 2003, J WILDLIFE DIS, V39, P830, DOI 10.7589/0090-3558-39.4.830; LUMEIJ JT, 1991, AVIAN PATHOL, V20, P79, DOI 10.1080/03079459108418743; LUMEIJ JT, 1992, AVIAN DIS, V36, P1060, DOI 10.2307/1591575; MAIXNER JM, 1987, J ZOO WILDLIFE MED, V18, P62, DOI 10.2307/20460240; March DT, 2018, J VET DIAGN INVEST, V30, P423, DOI 10.1177/1040638718757819; McArthur S., PROBLEM SOLVING APPR; McBride Michael, 2006, Journal of Herpetological Medicine and Surgery, V16, P129; Miller HA, 1998, SEMIN AVIAN EXOT PET, V7, P93, DOI 10.1016/S1055-937X(98)80048-0; Mitchell M.A., 2009, MANUAL EXOTIC PET PR; MOSIMANN JAMES E., 1960, CANADIAN JOUR ZOOL, V38, P19, DOI 10.1139/z60-003; Nagle RD., 2017, HERPETOLOGICAL REV, V48, P327; Nardini Giordano, 2013, Vet Clin North Am Exot Anim Pract, V16, P1, DOI 10.1016/j.cvex.2012.09.001; O'Connor Michael P., 1994, Herpetological Monographs, V8, P5, DOI 10.2307/1467067; Perez JP, 2017, CONSERV PHYSIOL, V5, P1; R Core Team, 2018, R LANG ENV STAT COMP; RAMSAY EC, 1995, AM J VET RES, V56, P423; REED AH, 1971, CLIN CHEM, V17, P275; Rose Brittany M. Way, 2011, Journal of Herpetological Medicine and Surgery, V21, P107, DOI 10.5818/1529-9651-21.4.107; Rosenberg JF, 2018, J ZOO WILDLIFE MED, V49, P520, DOI 10.1638/2017-0183.1; Rousselet E, 2013, J ZOO WILDLIFE MED, V44, P859, DOI 10.1638/2012-0162R1.1; RUSSO EA, 1986, J AM VET MED ASSOC, V189, P1013; Sheldon JD, 2016, J ZOO WILDLIFE MED, V47, P196, DOI 10.1638/2015-0159.1; Smith, 2017, LAKE COUNTY FOREST P; Stay NI, 2011, CLIN LAB MED, V31, P87, DOI 10.1016/j.cll.2010.10.006; Sykes John M., 2015, Veterinary Clinics of North America Exotic Animal Practice, V18, P63, DOI 10.1016/j.cvex.2014.09.011; van Dijk PP, EMYDOIDEA BLANDINGII; Walton RM, 2012, VET CLIN PATH, V41, P175, DOI 10.1111/j.1939-165X.2012.00414.x; Yang PY, 2014, J ZOO WILDLIFE MED, V45, P278, DOI 10.1638/2013-0125R1.1; Zaias J, 2006, VET CLIN PATH, V35, P321, DOI 10.1111/j.1939-165X.2006.tb00139.x	65	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225130	10.1371/journal.pone.0225130	http://dx.doi.org/10.1371/journal.pone.0225130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730637	Green Published, gold			2022-12-26	WOS:000532809500025
J	Di Caro, V; Alcamo, AM; Cummings, JL; Clark, RSB; Novak, EA; Mollen, K; Morowitz, MJ; Aneja, R				Di Caro, Valentina; Alcamo, Alicia M.; Cummings, Jessica L.; Clark, Robert S. B.; Novak, Elizabeth A.; Mollen, Kevin; Morowitz, Michael J.; Aneja, Rajesh			Effect of dietary cellulose supplementation on gut barrier function and apoptosis in a murine model of endotoxemia	PLOS ONE			English	Article							MICROBIOME; SEPSIS; DECONTAMINATION; PROLIFERATION; DISRUPTION; FIBER; PERMEABILITY; DOMINATION; TRACT; MOTOR	The gut plays a vital role in critical illness, and alterations in the gut structure and function have been reported in endotoxemia and sepsis models. Previously, we have demonstrated a novel link between the diet-induced alteration of the gut microbiome with cellulose and improved outcomes in sepsis. As compared to mice receiving basal fiber (BF) diet, mice that were fed a non-fermentable high fiber (HF) diet demonstrated significant improvement in survival and decreased organ injury in both cecal-ligation and puncture (CLP) and endotoxin sepsis models. To understand if the benefit conferred by HF diet extends to the gut structure and function, we hypothesized that HF diet would be associated with a reduction in sepsisinduced gut epithelial loss and permeability in mice. We demonstrate that the use of dietary cellulose decreased LPS-mediated intestinal hyperpermeability and protected the gut from apoptosis. Furthermore, we noted a significant increase in epithelial cell proliferation, as evidenced by an increase in the percentage of bromodeoxyuridine-positive cells in HF fed mice as compared to BF fed mice. Thus, the use of HF diet is a simple and effective tool that confers benefit in a murine model of sepsis, and understanding the intricate relationship between the epithelial barrier, gut microbiota, and diet will open-up additional therapeutic avenues for the treatment of gut dysfunction in critical illness.	[Di Caro, Valentina; Alcamo, Alicia M.; Cummings, Jessica L.; Clark, Robert S. B.; Aneja, Rajesh] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Alcamo, Alicia M.; Clark, Robert S. B.; Aneja, Rajesh] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Alcamo, Alicia M.; Clark, Robert S. B.; Aneja, Rajesh] UPMC Childrens Hosp Pittsburgh, Div Pediat Crit Care Med, Pittsburgh, PA 15224 USA; [Novak, Elizabeth A.; Mollen, Kevin; Morowitz, Michael J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Novak, Elizabeth A.; Mollen, Kevin; Morowitz, Michael J.] UPMC Childrens Hosp Pittsburgh, Div Pediat Gen & Thorac Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aneja, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Aneja, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.; Aneja, R (corresponding author), UPMC Childrens Hosp Pittsburgh, Div Pediat Crit Care Med, Pittsburgh, PA 15224 USA.	anejar@upmc.edu		Alcamo, Alicia/0000-0002-5406-5681	NIH [R01GM098474, T32-HD40686]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK114464, K08DK101753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098474] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NIH grants R01GM098474 to RKA and T32-HD40686 to AMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Cabrera-Perez J, 2017, EXP BIOL MED, V242, P127, DOI 10.1177/1535370216669610; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Di Caro V, 2019, SHOCK, V51, P526, DOI 10.1097/SHK.0000000000001180; Dickson RP, 2016, LANCET RESP MED, V4, P59, DOI 10.1016/S2213-2600(15)00427-0; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; KALHS P, 1995, TRANSPLANTATION, V60, P949, DOI 10.1097/00007890-199511150-00012; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Khosravi A, 2013, CURR OPIN MICROBIOL, V16, P221, DOI 10.1016/j.mib.2013.03.009; Khounlotham M, 2012, IMMUNITY, V37, P563, DOI 10.1016/j.immuni.2012.06.017; Kitsios GD, 2017, J CRIT CARE, V38, P84, DOI 10.1016/j.jcrc.2016.09.029; Kuo SM, 2013, ADV NUTR, V4, P16, DOI 10.3945/an.112.003046; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Li QR, 2009, J PATHOL, V218, P210, DOI 10.1002/path.2525; Lyons JD, 2017, PEDIATR CRIT CARE ME, V18, pS46, DOI 10.1097/PCC.0000000000001046; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; Morowitz MJ, 2017, CRIT CARE MED, V45, pE516, DOI [10.1097/CCM.0000000000002291, 10.1097/ccm.0000000000002291]; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Oostdijk EAN, 2014, JAMA-J AM MED ASSOC, V312, P1429, DOI 10.1001/jama.2014.7247; PODOLSKY DK, 1993, AM J PHYSIOL, V264, pG179, DOI 10.1152/ajpgi.1993.264.2.G179; Potoka DA, 2003, AM J PHYSIOL-GASTR L, V285, pG861, DOI 10.1152/ajpgi.00412.2002; Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008; Saidel-Odes L, 2012, INFECT CONT HOSP EP, V33, P14, DOI 10.1086/663206; Silvestri L, 2012, HEART LUNG VESSEL, V4, P21; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stoutenbeek C P, 1983, Acta Anaesthesiol Belg, V34, P209; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vernazza CL, 2006, J APPL MICROBIOL, V100, P846, DOI 10.1111/j.1365-2672.2006.02832.x; Yoseph BP, 2016, SHOCK, V46, P52, DOI 10.1097/SHK.0000000000000565	36	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224838	10.1371/journal.pone.0224838	http://dx.doi.org/10.1371/journal.pone.0224838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790417	Green Published, gold, Green Submitted			2022-12-26	WOS:000533930800013
J	Harman, B; Kosirnik, C; Philippe, RA				Harman, Brian; Kosirnik, Celine; Philippe, Roberta Antonini			From social interactions to interpersonal relationships: Influences on ultra-runners' race experience	PLOS ONE			English	Article							MOTIVATIONAL CLIMATE; SUPPORT	Objectives Ultra-running's psychological and physiological dimensions have been widely studied. However, the social dimensions of ultra-racing have been largely overlooked. This study aims to identify the different types of social interactions that occur during a multi-day, ultra-race and to understand how these interactions influence ultra-runners' race experience. Methods Athletes competing in Britain's "Spine Race" were recruited for the current study. Twelve male runners aged between 32 and 66 years (M = 50; SD = 10.01) followed the qualitative protocol designed for the study. Specifically, each participant completed a modified version of the Day Reconstruction Method (DRM) instrument and underwent a post-race, self-confrontation interview. Participants were asked to recall and reconstruct their memories about their (a) actions (e.g., What did you do when you encountered other people?); (b) thoughts (e.g., What were your thoughts when you encountered other people?) and (c) feelings (e.g., What were your feelings when you encountered other people?). Results The results show that social interactions and interpersonal relationships are common in ultra-races. Different groups of people play an important role in racers' motivation and goal achievement: fellow racers, volunteers, medics, friends and family, and even the general public. The resulting social interactions and relationships can occur before, during and after the race in both online and offline environments. These social influences have a powerful influence on the athlete's race experience. Conclusion The vast majority of social interactions reported by runners had a positive effect on their race experience and often led to interpersonal relationships. Ultra-runners should be mindful of the impact that social interactions and relationships can have in shaping their race experience.	[Harman, Brian] De Montfort Univ, Leicester Castle Business Sch, Leicester, Leics, England; [Kosirnik, Celine; Philippe, Roberta Antonini] Univ Lausanne, Fac Sci Sociales & Polit, Inst Sci Sport, Lausanne, Switzerland	De Montfort University; University of Lausanne	Harman, B (corresponding author), De Montfort Univ, Leicester Castle Business Sch, Leicester, Leics, England.	brian.harman@dmu.ac.uk		Antonini Philippe, Roberta/0000-0001-9650-5174; Kosirnik, Celine/0000-0002-7234-3569	Department 19 of Business and Law at De Montfort University	Department 19 of Business and Law at De Montfort University	The lead author received Early Career Research (ECR) funding from the Department 19 of Business and Law at De Montfort University in order to support this research.	Acevedo E.O., 1992, SPORT PSYCHOL, V6, P242, DOI DOI 10.1123/TSP.6.3.242; Baruchello G., PHENOMENOLOGY HUMAN; Berscheid E.S., 2016, PSYCHOL INTERPERSONA; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burke SM, 2014, GROUP DYNAMICS IN EXERCISE AND SPORT PSYCHOLOGY, 2ND EDITION, P147; Carlen U, 2017, QUAL RES SPORT EXERC, V9, P18, DOI 10.1080/2159676X.2016.1180636; Carron A.V., 2007, GROUP COHESION SPORT, P135; CARRON AV, 1982, J SPORT PSYCHOL, V4, P123, DOI 10.1123/jsp.4.2.123; Carron AV, 2002, COHESION PERFORMANCE; Carron AV, 2011, ADV SPORT EXERCISE P, P213; Connaughton D, 2008, J SPORT SCI, V26, P83, DOI 10.1080/02640410701310958; Corrion K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206498; Cox RH., 1990, SPORT PSYCHOL CONCEP; Cranmer GA, 2015, COMMUN RES REP, V32, P253, DOI 10.1080/08824096.2015.1052900; Delrue J, 2016, PSYCHOL BELG, V56, P288, DOI 10.5334/pb.280; Gill D., 1986, PSYCHOL DYNAMICS SPO; GUZZO RA, 1993, BRIT J SOC PSYCHOL, V32, P87, DOI 10.1111/j.2044-8309.1993.tb00987.x; Heuze JP, 2006, J APPL SPORT PSYCHOL, V18, P201, DOI 10.1080/10413200600830273; Holt N. L., 2006, LIT REV SPORT PSYCHO, P199; Holt NL, 2014, SPORT PSYCHOL, V28, P22, DOI 10.1123/tsp.2013-0008; Horn T., 2012, SPORT SCI REV, V21, P25, DOI DOI 10.2478/V10237-012-0009-3; Hughes SL, 2003, J APPL SPORT PSYCHOL, V15, P256, DOI 10.1080/10413200305385; Jaeschke AMC, 2016, SPORT PSYCHOL, V30, P242, DOI 10.1123/tsp.2014-0153; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kirkby RJ, 1996, INT J SPORT PSYCHOL, V27, P109; Knechtle B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00634; Knechtle B, 2012, INT J SPORT PHYSIOL, V7, P310, DOI 10.1123/ijspp.7.4.310; Kundert AML, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071200; Lane AM, 2011, J SCI MED SPORT, V14, P358, DOI 10.1016/j.jsams.2011.03.001; Laverty S.M., 2003, INT J QUAL METH, V21-35, P21, DOI [10.1177/160940690300200303, DOI 10.1177/160940690300200303]; Lu FJH, 2016, PSYCHOL SPORT EXERC, V22, P202, DOI 10.1016/j.psychsport.2015.08.005; MANGAN B, 1993, CONSCIOUS COGN, V2, P89, DOI 10.1006/ccog.1993.1008; McCormick A, 2015, SPORTS MED, V45, P997, DOI 10.1007/s40279-015-0319-6; Micklewright D, 2010, S AFR J SPORTS MED, V21; Morgan W P, 1977, Ann N Y Acad Sci, V301, P382, DOI 10.1111/j.1749-6632.1977.tb38215.x; Nikolaidis PT, 2018, FRONTIERS PHYSL, V9; Olympiou A, 2008, SPORT PSYCHOL, V22, P423, DOI 10.1123/tsp.22.4.423; Patton M.Q., 2002, QUALITATIVE INTERVIE, V3, P344; Philippe RA, 2017, SPORTS, V5, DOI 10.3390/sports5040091; Philippe RA, 2016, SPORT PSYCHOL, V30, P361, DOI 10.1123/tsp.2016-0039; Phillippe RA, 2014, INT J SPORT PSYCHOL, V45, P469, DOI 10.7352/IJSP.2014.45.469; Rochat N, 2018, J HUM KINET, V61, P263, DOI 10.1515/hukin-2017-0125; Rochat N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173667; Rust CA, 2012, J SPORT SCI, V30, P1249, DOI 10.1080/02640414.2012.697182; Schuler J, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01275; Schuler J, 2014, J SPORT EXERCISE PSY, V36, P293, DOI 10.1123/jsep.2013-0191; Simpson D, 2014, SPORT PSYCHOL, V28, P176, DOI 10.1123/tsp.2013-0064; Smith R. S., 1998, J SLEEP, V22, P303; Stevinson CD, 1998, BRIT J SPORT MED, V32, P229, DOI 10.1136/bjsm.32.3.229; Tamminen KA, 2014, GROUP DYNAMICS EXERC, V2; Theureau J, 2010, REV ANTHROPOL CONNAI, V4, P287, DOI 10.3917/rac.010.0287; Waskiewicz Z, 2018, PSYCHOL RES BEHAV MA	52	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0225195	10.1371/journal.pone.0225195	http://dx.doi.org/10.1371/journal.pone.0225195			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO9FT	31790446	Green Published, gold, Green Submitted			2022-12-26	WOS:000533930800024
J	Hook, SA; Musa, SM; Ripley, DM; Hibbitt, JD; Grunow, B; Moritz, T; Shiels, HA				Hook, Samantha A.; Musa, Syafiq M.; Ripley, Daniel M.; Hibbitt, Jean-Denis; Grunow, Bianka; Moritz, Timo; Shiels, Holly A.			Twins! Microsatellite analysis of two embryos within one egg case in oviparous elasmobranchs	PLOS ONE			English	Article							REPRODUCTIVE-BIOLOGY; SCYLIORHINUS-CANICULA; RAY; SHARK; CHONDRICHTHYES; INFERENCE	Elasmobranchs display various reproductive modes, which have been key to their evolutionary success. In recent decades there has been a rise in the number of reported cases of foetal abnormalities including fertilised, double-embryos held within one egg capsule, hereafter referred to as twins. Previously, the occurrences of twin egg cases have been reported in two batoid and one shark species. We report the first cases of twins in three species of oviparous elasmobranchs: the undulate ray (Raja undulata), the nursehound (Scyliorhinus stellaris), and the small-spotted catshark (Scyliorhinus canicula). We investigated the genetic relationships between the twins in S. stellaris, and S. canicula using microsatellite markers. Whilst the S. stellaris twins displayed the same genotypes, we found that the S. canicula twin individuals arose through heteropaternal superfecundation. This is the first reported incidence of such a paternity in elasmobranchs. The relationship between environmental change and reproductive strategy in elasmobranchs is unclear and further research is needed to determine its effect on the prevalence and mechanisms of formation of elasmo-branch twins.	[Hook, Samantha A.; Musa, Syafiq M.; Ripley, Daniel M.; Shiels, Holly A.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Hook, Samantha A.] Univ Manchester, Sch Earth & Environm Sci, Manchester, Lancs, England; [Musa, Syafiq M.] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi, Selangor, Malaysia; [Hibbitt, Jean-Denis] SEA LIFE Weymouth, SEA LIFE Programmes & Engagement, Weymouth, England; [Grunow, Bianka] Leibniz Inst Farm Anim Biol, Dummerstorf, Germany; [Moritz, Timo] Deutsch Meeresmuseum, Stralsund, Germany; [Moritz, Timo] Friedrich Schiller Univ Jena, Inst Zool & Evolut Forsch, Jena, Germany	University of Manchester; University of Manchester; Universiti Kebangsaan Malaysia; Forschungsinstitut fur Nutztierbiologie (FBN); Friedrich Schiller University of Jena	Shiels, HA (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.	holly.shiels@manchester.ac.uk	Musa, Syafiq/AAF-9567-2019	Musa, Syafiq/0000-0001-9170-2646; Grunow, Bianka/0000-0001-8503-2754; Ripley, Daniel/0000-0001-5912-6722; Hibbitt, Jean-Denis/0000-0002-2784-0910	Higher Education Innovation Fund through The University of Manchester's Knowledge and Innovation Hub for Environmental Stability (HAS), as part of the Natural Environmental Research Council Doctoral Training Program; Ministry of Higher Education (KPT, Malaysia)	Higher Education Innovation Fund through The University of Manchester's Knowledge and Innovation Hub for Environmental Stability (HAS), as part of the Natural Environmental Research Council Doctoral Training Program; Ministry of Higher Education (KPT, Malaysia)	The project was funded by the Higher Education Innovation Fund through The University of Manchester's Knowledge and Innovation Hub for Environmental Stability (HAS), as part of the Natural Environmental Research Council Doctoral Training Program (SAH) and by the Ministry of Higher Education (KPT, Malaysia) (SMM). Merlin Entertainments, Sea Life, Weymouth Adventures Park provided support in the form of salaries for author JDH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors declare that there are no significant competing professional or personal interests that might have influenced the performance or presentation of the work described in this manuscript. Merlin Entertainments, Sea Life, Weymouth Adventures Park that provided support in the form of salaries for author JDH does not alter our adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 1958, J SHIMONOSEKI COLL F; [Anonymous], 2017, ISOLATE 2 GENOMIC DN; [Anonymous], 2019, QIAGEN MULTIPLEX PCR; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Caldeira BF, 2006, MORFOLOGIA BIOMETRIA; Carrier J, 2004, BIOL SHARKS THEIR RE, P487; Carrier JC, 2012, CRC MAR BIOL SER, P1, DOI 10.1201/b11867; Coelho R, 2006, FISH RES, V81, P80, DOI 10.1016/j.fishres.2006.05.017; Compagno Leonard J.V., 2005, P503; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; DODD JM, 1983, FISH PHYSIOL, V9, P31; Dulvy NK, 2017, CURR BIOL, V27, pR565, DOI 10.1016/j.cub.2017.04.038; Ebert DA, 2007, ZOOTAXA, P1; Ellis JR, 1997, J FISH BIOL, V51, P361; Farrell ED, 2010, J FISH BIOL, V77, P1505, DOI 10.1111/j.1095-8649.2010.02771.x; Gordon CA, 2016, ZOOTAXA, V4150, P255, DOI 10.11646/zootaxa.4150.3.2; Griffiths AM, 2011, CONSERV GENET RESOUR, V3, P705, DOI 10.1007/s12686-011-9438-z; Gubili C, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140175; Hamlett William C., 2005, P301; Henningsen Alan D., 2004, P227; HITZ CR, 1964, J FISH RES BOARD CAN, V21, P851, DOI 10.1139/f64-076; Howard M., 2017, RAYS THEIR RELATIVES, P451; Ishihara Hajime, 2012, Bulletin of the Kanagawa Prefectural Museum Natural Science, V41, P9; Janez JA, 2009, PAN AM J AQUATIC SCI, V4; Janez JA, 2018, NEOTROP ICHTHYOL, V16, DOI 10.1590/1982-0224-20180013; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kang Hee-Woong, 2013, Dev Reprod, V17, P247, DOI 10.12717/DR.2013.17.3.247; Last P. R., 2016, P1; Luer CA, 2007, ENVIRON BIOL FISH, V80, P239, DOI 10.1007/s10641-007-9219-4; Mabragana E, 2015, ESTUAR COAST, V38, P1466, DOI 10.1007/s12237-014-9888-0; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Musa SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206984; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Naylor Gavin J.P., 2005, P1; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richards S., 1963, STUD MAR RESOUR S NE, V18, P5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serra-Pereira B, 2011, MAR COAST FISH, V3, P160, DOI 10.1080/19425120.2011.555707; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x	40	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224397	10.1371/journal.pone.0224397	http://dx.doi.org/10.1371/journal.pone.0224397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790403	gold, Green Published			2022-12-26	WOS:000533930800005
J	Singh-Moodley, A; Strasheim, W; Mogokotleng, R; Ismail, H; Perovic, O				Singh-Moodley, Ashika; Strasheim, Wilhelmina; Mogokotleng, Ruth; Ismail, Husna; Perovic, Olga			Unconventional SCCmec types and low prevalence of the Panton-Valentine Leukocidin exotoxin in South African blood culture Staphylococcus aureus surveillance isolates, 2013-2016	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; HEALTH-CARE; IV; CLASSIFICATION; IDENTIFICATION; BACTEREMIA; ASSIGNMENT; GUIDELINES; RESISTANCE; EMERGENCE	Staphylococcus aureus is a healthcare-associated pathogen that can harbour multiple antimicrobial resistance determinants and express multiple virulence factors e.g. Panton-Valentine Leukocidin (PVL). Unknown staphylococcal cassette chromosome mec (SCCmec) typing patterns were previously observed among 11% (n = 52) of methicillin-resistant S. aureus (MRSA) isolates; we further investigated these as well as the proportion of PVL, encoded by lukS/F-PV, in 761 S. aureus isolates from patients with a diagnosis of pneumonia/lower respiratory tract, skin/soft tissue, bone and joint infection. S. aureus isolates from blood culture were identified and antimicrobial susceptibility testing was performed using automated systems. Conventional PCR assays were used to identify the ccr and mec gene complexes in mecA-positive isolates with an unknown SCCmec type and screen for lukS/FPV. Epidemiological data was used to classify isolates as healthcare- or community-associated infections. Antimicrobial susceptibility profiles according to SCCmec type and PVL were reported. Of the unknown SCCmec types, isolates were interpreted as type I-like (86%, 38/44), type II-like (9%, 4/44) and type III-like (5%, 2/44). Eight isolates did not produce definitive results. Of all MRSA isolates, majority were multidrug-resistant as indicated by their non-susceptibility to most antimicrobial agents; 92% were healthcare-associated. PVL was seen in 14% of the isolates (MRSA: 25%, MSSA: 75%); 56% were classified as healthcare-associated infection. The SCCmec typing method did not definitively classify all unknown isolates into clearly defined types. It showed that majority of these isolates were not the conventional types; untypeable elements appeared to be composite SCCmec elements, consisting of multiple ccr gene complexes. Majority of the MRSA isolates were nonsusceptible to most antibiotics indicating that multiple resistance genes are present in our population. Furthermore, the proportion of PVL was low and more prevalent in MSSA.	[Singh-Moodley, Ashika; Strasheim, Wilhelmina; Mogokotleng, Ruth; Ismail, Husna; Perovic, Olga] Natl Inst Communicable Dis, Ctr Healthcare Associated Infect Antimicrobial Re, Johannesburg, South Africa; [Singh-Moodley, Ashika; Perovic, Olga] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand	Singh-Moodley, A (corresponding author), Natl Inst Communicable Dis, Ctr Healthcare Associated Infect Antimicrobial Re, Johannesburg, South Africa.; Singh-Moodley, A (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa.	ashikas@nicd.ac.za	Perovic, Olga/AAN-8276-2021	Strasheim, Wilhelmina/0000-0002-4162-7673	National Institute for Communicable Diseases	National Institute for Communicable Diseases	This work was funded by the National Institute for Communicable Diseases and received no specific grant from any funding agency. We thank Cheryl Hamman, Jenna Allen, Rubeina Badat, Naseema Bulbulia, Rosah Mobokachaba, Gloria Molaba and Marshagne Smith for assistance with the laboratory work and Boniwe Makwakwa for assistance with the database.	Ahmad N, 2009, J MED MICROBIOL, V58, P1213, DOI 10.1099/jmm.0.011353-0; Badiou C, 2010, J CLIN MICROBIOL, V48, P1384, DOI 10.1128/JCM.02274-09; Baig S, 2018, INFECT GENET EVOL, V61, P74, DOI 10.1016/j.meegid.2018.03.013; Bal AM, 2016, J GLOB ANTIMICROB RE, V6, P95, DOI 10.1016/j.jgar.2016.04.004; Becker K, 2014, INT J MED MICROBIOL, V304, P794, DOI 10.1016/j.ijmm.2014.06.007; Berglund C, 2005, CLIN MICROBIOL INFEC, V11, P447, DOI 10.1111/j.1469-0691.2005.01150.x; CLSI, 2017, PERF STAND ANT SUSC; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; de Carvalho SP, 2017, BRAZ J INFECT DIS, V21, P464, DOI 10.1016/j.bjid.2017.04.001; Fosheim GE, 2011, J CLIN MICROBIOL, V49, P3071, DOI 10.1128/JCM.00795-11; Ganga R, 2009, J CLIN MICROBIOL, V47, P590, DOI 10.1128/JCM.00397-08; Gulmez D, 2012, MIKROBIYOL BUL, V46, P341; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Moroney SM, 2007, J CLIN MICROBIOL, V45, P1019, DOI 10.1128/JCM.01706-06; Perovic O, 2017, EUR J CLIN MICROBIOL, V36, P2519, DOI 10.1007/s10096-017-3096-3; Perovic O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145429; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Saeed K, 2018, INT J ANTIMICROB AG, V51, P16, DOI 10.1016/j.ijantimicag.2017.11.002; Shields Bridget E, 2016, JAAD Case Rep, V2, P428; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Singh-Moodley A, 2015, SOUTH AFR J INFECT D, V30, P122, DOI 10.1080/23120053.2015.1107256; Szczuka E, 2013, ACTA MICROBIOL IMM H, V60, P261, DOI 10.1556/AMicr.60.2013.3.3; Turlej A, 2011, POL J MICROBIOL, V60, P95, DOI 10.33073/pjm-2011-013; Valsesia G, 2010, J CLIN MICROBIOL, V48, P720, DOI 10.1128/JCM.01890-09; Wu ZW, 2015, ANTIMICROB AGENTS CH, V59, P7597, DOI 10.1128/AAC.01692-15	29	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225726	10.1371/journal.pone.0225726	http://dx.doi.org/10.1371/journal.pone.0225726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774877	gold, Green Published			2022-12-26	WOS:000533896400055
J	Bean, DM; Teo, J; Wu, HH; Oliveira, R; Patel, R; Bendayan, R; Shah, AM; Dobson, RJB; Scott, PA				Bean, Daniel M.; Teo, James; Wu, Honghan; Oliveira, Ricardo; Patel, Raj; Bendayan, Rebecca; Shah, Ajay M.; Dobson, Richard J. B.; Scott, Paul A.			Semantic computational analysis of anticoagulation use in atrial fibrillation from real world data	PLOS ONE			English	Article							ORAL ANTICOAGULATION; RISK	Atrial fibrillation (AF) is the most common arrhythmia and significantly increases stroke risk. This risk is effectively managed by oral anticoagulation. Recent studies using national registry data indicate increased use of anticoagulation resulting from changes in guidelines and the availability of newer drugs. The aim of this study is to develop and validate an open source risk scoring pipeline for free-text electronic health record data using natural language processing. AF patients discharged from 1(st) January 2011 to 1(st) October 2017 were identified from discharge summaries (N = 10,030, 64.6% male, average age 75.3 +/- 12.3 years). A natural language processing pipeline was developed to identify risk factors in clinical text and calculate risk for ischaemic stroke (CHA(2)DS(2)-VASc) and bleeding (HAS-BLED). Scores were validated vs two independent experts for 40 patients. Automatic risk scores were in strong agreement with the two independent experts for CHA(2)DS(2)-VASc (average kappa 0.78 vs experts, compared to 0.85 between experts). Agreement was lower for HAS-BLED (average kappa 0.54 vs experts, compared to 0.74 between experts). In high-risk patients (CHA(2)DS(2)-VASc >= 2) OAC use has increased significantly over the last 7 years, driven by the availability of DOACs and the transitioning of patients from AP medication alone to OAC. Factors independently associated with OAC use included components of the CHA(2)DS(2)-VASc and HAS-BLED scores as well as discharging specialty and frailty. OAC use was highest in patients discharged under cardiology (69%). Electronic health record text can be used for automatic calculation of clinical risk scores at scale. Open source tools are available today for this task but require further validation. Analysis of routinely collected EHR data can replicate findings from large-scale curated registries.	[Bean, Daniel M.; Bendayan, Rebecca; Dobson, Richard J. B.] Kings Coll London, Dept Biostat & Hlth Informat, Inst Psychiat Psychol & Neurosci, London, England; [Bean, Daniel M.; Dobson, Richard J. B.] UCL, Hlth Data Res UK London, London, England; [Teo, James] Kings Coll Hosp NHS Fdn Trust, Dept Stroke & Neurol, London, England; [Wu, Honghan] Univ Edinburgh, Ctr Med Informat, Usher Inst, Edinburgh, Midlothian, Scotland; [Wu, Honghan] Nanjing Univ Informat Sci & Technol, Sch Comp & Software, Nanjing, Jiangsu, Peoples R China; [Wu, Honghan] Hlth Data Res UK Scotland, Edinburgh, Midlothian, Scotland; [Oliveira, Ricardo] Hosp Prof Doutor Fernando Fonseca, S Med 4, Unidade Doencas Imunomediadas Sistem UDIMS, Amadora, Portugal; [Patel, Raj] Kings Coll Hosp NHS Fdn Trust, Dept Haematol, London, England; [Bendayan, Rebecca; Dobson, Richard J. B.] NIHR Biomed Res Ctr South London, London, England; [Bendayan, Rebecca; Dobson, Richard J. B.] Maudsley NHS Fdn Trust & Kings Coll London, London, England; [Shah, Ajay M.; Scott, Paul A.] Kings Coll London, British Heart Fdn Ctr, London, England; [Shah, Ajay M.; Scott, Paul A.] Kings Coll Hosp NHS Fdn Trust, Dept Cardiol, London, England; [Dobson, Richard J. B.] UCL, Inst Hlth Informat, London, England	University of London; King's College London; University of London; University College London; King's College Hospital NHS Foundation Trust; University of Edinburgh; Nanjing University of Information Science & Technology; Hospital Professor Doutor Fernando Fonseca, EPE; King's College Hospital NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; University of London; University College London	Bean, DM (corresponding author), Kings Coll London, Dept Biostat & Hlth Informat, Inst Psychiat Psychol & Neurosci, London, England.; Bean, DM (corresponding author), UCL, Hlth Data Res UK London, London, England.; Scott, PA (corresponding author), Kings Coll London, British Heart Fdn Ctr, London, England.; Scott, PA (corresponding author), Kings Coll Hosp NHS Fdn Trust, Dept Cardiol, London, England.	daniel.bean@kcl.ac.uk; paulscott3@nhs.net	Teo, James T/ABA-1819-2020; Wu, Honghan/AAT-6084-2020; Bean, Daniel/AFQ-4601-2022; Teo, James/D-9696-2011; dobson, richard/C-9269-2011	Teo, James T/0000-0002-6899-8319; Teo, James/0000-0002-6899-8319; Bean, Daniel/0000-0002-8594-7804; Bendayan, Rebecca/0000-0003-1461-556X; Shah, Ajay/0000-0002-6547-0631; Wu, Honghan/0000-0002-0213-5668; dobson, richard/0000-0003-4224-9245	UKRI Innovation Fellowship as part of Health Data Research UK [MR/S00310X/1]; UKRI Rutherford Fellowship as part of Health Data Research UK [MR/S004149/1]; UK Medical Research Council (MRC) [MR/R016372/1]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust [IS-BRC-1215-20018]; King's College London; British Heart Foundation; NIHR Biomedical Research Centre funding; KCL; Health Data Research UK - UK Medical Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); Wellcome Trust; Innovative Medicines Initiative-2 Joint Undertaking [116074]; European Union; EFPIA; National Institute for Health Research University College London Hospitals Biomedical Research Centre; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; MRC [MR/S004149/1, MR/S00310X/1] Funding Source: UKRI	UKRI Innovation Fellowship as part of Health Data Research UK; UKRI Rutherford Fellowship as part of Health Data Research UK; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London(General Electric); British Heart Foundation(British Heart Foundation); NIHR Biomedical Research Centre funding; KCL; Health Data Research UK - UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); Wellcome Trust(Wellcome Trust); Innovative Medicines Initiative-2 Joint Undertaking; European Union(European Commission); EFPIA; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DMB is funded by a UKRI Innovation Fellowship as part of Health Data Research UK MR/S00310X/1 (https://www.hdruk.ac.uk).HW is funded by a UKRI Rutherford Fellowship as part of Health Data Research UK MR/S004149/1. RB is funded in part by grant MR/R016372/1 for the King's College London MRC Skills Development Fellowship programme funded by the UK Medical Research Council (MRC, https://mrc.ukri.org) and by grant IS-BRC-1215-20018 for the National Institute for Health Research (NIHR, https://www.nihr.ac.uk) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. AMS is supported by the British Heart Foundation (https://www.bhf.org.uk).NIHR Biomedical Research Centre funding to SLAM/KCL and to GSTT/KCL in partnership with KCL. RJBD is supported by: 1. Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome Trust. 2. The BigData@Heart Consortium, funded by the Innovative Medicines Initiative-2 Joint Undertaking under grant agreement No. 116074. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA; it is chaired, by DE Grobbee and SD Anker, partnering with 20 academic and industry partners and ESC. 3. The National Institute for Health Research University College London Hospitals Biomedical Research Centre. 4. National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. This paper represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahri O, 2015, J AM GERIATR SOC, V63, P71, DOI 10.1111/jgs.13200; Campbell Cowan J, 2018, EUR HEART J, DOI [10.1093/eurheartj/ehy411, DOI 10.1093/EURHEARTJ/EHY41129982405]; CogStack, 2019, COGSTACK PIP; Cowan C, 2013, HEART, V99, P1166, DOI 10.1136/heartjnl-2012-303472; Faxon DP, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.003866; Fosbol EL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000110; Gilbert T, 2018, LANCET, V391, P1775, DOI 10.1016/S0140-6736(18)30668-8; Grouin C, 2011, AMIA ANN S P AMIA S; Hemingway H, 2018, EUR HEART J, V39, P1481, DOI 10.1093/eurheartj/ehx487; Holt TA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656856; Jackson R, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0623-9; Kharrazi H, 2018, J AM GERIATR SOC, V66, P1499, DOI 10.1111/jgs.15411; Kohler S, 2019, NUCLEIC ACIDS RES, V47, pD1018, DOI 10.1093/nar/gky1105; Kreimeyer K, 2017, J BIOMED INFORM, V73, P14, DOI 10.1016/j.jbi.2017.07.012; Lacoin L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015363; Lefebvre MCD, 2016, CAN J CARDIOL, V32, P169, DOI 10.1016/j.cjca.2015.05.012; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Marzec LN, 2017, J AM COLL CARDIOL, V69, P2475, DOI 10.1016/j.jacc.2017.03.540; NICE, 2014, ATR FIBR MAN; Piazza G, 2020, EUR HEART J, V41, P1086, DOI 10.1093/eurheartj/ehz385; Pilotto A, 2016, J AM GERIATR SOC, V64, P1416, DOI 10.1111/jgs.14221; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rosier A, 2016, EUROPACE, V18, P347, DOI 10.1093/europace/euv234; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7; U.S. National Library of Medicine, UN MED LANG SYST UML; Wang SV, 2017, J AM MED INFORM ASSN, V24, P339, DOI 10.1093/jamia/ocw082; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; Wu H, 2019, COGSTACK SEMEHR, P2019; Wu HH, 2018, J AM MED INFORM ASSN, V25, P530, DOI 10.1093/jamia/ocx160; Yiin GSC, 2017, J NEUROL NEUROSUR PS, V88, P12, DOI 10.1136/jnnp-2015-311947	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225625	10.1371/journal.pone.0225625	http://dx.doi.org/10.1371/journal.pone.0225625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JT8MD	31765395	Green Published, gold, Green Submitted			2022-12-26	WOS:000501236800001
J	Homouz, D; Kudlicki, AS				Homouz, Dirar; Kudlicki, Andrzej S.			Maximum parsimony interpretation of chromatin capture experiments	PLOS ONE			English	Article							CHROMOSOME CONFORMATION CAPTURE; CYCLE	We present a new approach to characterizing the global geometric state of chromatin from HiC data. Chromatin conformation capture techniques (3C, and its variants: 4C, 5C, HiC, etc.) probe the spatial structure of the genome by identifying physical contacts between genomic loci within the nuclear space. In whole-genome conformation capture (HiC) experiments, the signal can be interpreted as spatial proximity between genomic loci and physical distances can be estimated from the data. However, observed spatial proximity signal does not directly translate into persistent contacts within the nuclear space. Attempts to infer a single conformation of the genome within the nuclear space lead to internal geometric inconsistencies, notoriously violating the triangle inequality. These inconsistencies have been attributed to the stochastic nature of chromatin conformation or to experimental artifacts. Here we demonstrate that it can be explained by a mixture of cells, each in one of only several conformational states, contained in the sample. We have developed and implemented a graph-theoretic approach that identifies the properties of such postulated subpopulations. We show that the geometrical conflicts in a standard yeast HiC dataset, can be explained by only a small number of homogeneous populations of cells (4 populations are sufficient to reconcile 95,000 most prominent impossible triangles, 8 populations can explain 375,000 top geometric conflicts). Finally, we analyze the functional annotations of genes differentially interacting between the populations, suggesting that each inferred subpopulation may be involved in a functionally different transcriptional program.	[Homouz, Dirar] Khalifa Univ Sci & Technol, Dept Phys, Abu Dhabi, U Arab Emirates; [Homouz, Dirar] Univ Houston, Dept Phys, Houston, TX 77004 USA; [Homouz, Dirar] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA; [Kudlicki, Andrzej S.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Kudlicki, Andrzej S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Khalifa University of Science & Technology; University of Houston System; University of Houston; Rice University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Homouz, D (corresponding author), Khalifa Univ Sci & Technol, Dept Phys, Abu Dhabi, U Arab Emirates.; Homouz, D (corresponding author), Univ Houston, Dept Phys, Houston, TX 77004 USA.; Homouz, D (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.; Kudlicki, AS (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.; Kudlicki, AS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	dirar.homouz@ku.ac.ae; a.kudlicki@utmb.edu			Clinical and Translational Science Award from the National Center for Advancing Translational Sciences [UL1TR000071, UL1TR001439]; NIH [GM112131]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001439] Funding Source: NIH RePORTER	Clinical and Translational Science Award from the National Center for Advancing Translational Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The research was supported by Clinical and Translational Science Award from the National Center for Advancing Translational Sciences UL1TR000071, UL1TR001439 and NIH grant GM112131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Aymard F, 2017, NAT STRUCT MOL BIOL, V24, P353, DOI 10.1038/nsmb.3387; Babaei S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004221; Benedetti F, 2014, NUCLEIC ACIDS RES, V42, P2848, DOI 10.1093/nar/gkt1353; Biernacka A, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0165-9; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; BRELAZ D, 1979, COMMUN ACM, V22, P251, DOI 10.1145/359094.359101; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dong XA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-704; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Duggal G, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-8; Finn EH, 2019, CELL, V176, P1502, DOI 10.1016/j.cell.2019.01.020; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Homouz D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054699; Kim S, 2017, ELIFE, V6, DOI 10.7554/eLife.23623; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu C, 2016, GENOME RES, V26, P1057, DOI 10.1101/gr.204032.116; Liu L, 2019, BIOPHYS J, V117, P613, DOI 10.1016/j.bpj.2019.06.032; Mehrotra A., 1996, INFORMS Journal on Computing, V8, P344, DOI 10.1287/ijoc.8.4.344; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Rosa A, 2006, BIOPHYS J, V90, pL24, DOI 10.1529/biophysj.105.077974; Rowicka M, 2007, P NATL ACAD SCI USA, V104, P16892, DOI 10.1073/pnas.0706022104; Rutledge MT, 2015, NUCLEIC ACIDS RES, V43, P8299, DOI 10.1093/nar/gkv723; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225578	10.1371/journal.pone.0225578	http://dx.doi.org/10.1371/journal.pone.0225578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765406	Green Submitted, gold, Green Published			2022-12-26	WOS:000533891000037
J	Org, T; Hensen, K; Kreevan, R; Mark, E; Sarv, O; Andreson, R; Jaakma, U; Salumets, A; Kurg, A				Org, Tonis; Hensen, Kati; Kreevan, Rita; Mark, Elina; Sarv, Olav; Andreson, Reidar; Jaakma, Ulle; Salumets, Andres; Kurg, Ants			Genome-wide histone modification profiling of inner cell mass and trophectoderm of bovine blastocysts by RAT-ChIP	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CHROMATIN STATE DYNAMICS; IN-VIVO; SEQ; H3K4ME3; PROMOTERS; REVEALS; DIFFERENTIATION; IDENTIFICATION; PLURIPOTENT	Chromatin immunoprecipitation coupled with next-generation sequencing (ChIP-seq) has revolutionized our understanding of chromatin-related biological processes. The method, however, requires thousands of cells and has therefore limited applications in situations where cell numbers are limited. Here we describe a novel method called Restriction Assisted Tagmentation Chromatin Immunoprecipitation (RAT-ChIP) that enables global histone modification profiling from as few as 100 cells. The method is simple, cost-effective and takes a single day to complete. We demonstrate the sensitivity of the method by deriving the first genome-wide maps of histone H3K4me3 and H3K27me3 modifications of inner cell mass and trophectoderm of bovine blastocyst stage embryos.	[Org, Tonis; Hensen, Kati; Kreevan, Rita; Kurg, Ants] Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, Tartu, Estonia; [Mark, Elina; Jaakma, Ulle] Estonian Univ Life Sci, Chair Anim Breeding & Biotechnol, Tartu, Estonia; [Sarv, Olav; Salumets, Andres] Competence Ctr Hlth Technol, Tartu, Estonia; [Andreson, Reidar] Univ Tartu, Inst Mol & Cell Biol, Dept Bioinformat, Tartu, Estonia; [Andreson, Reidar] Univ Tartu, Inst Genom, Tartu, Estonia; [Salumets, Andres] Univ Tartu, Inst Clin Med, Dept Obstet & Gynaecol, Tartu, Estonia; [Salumets, Andres] Univ Tartu, Inst Biomed & Translat Med, Tartu, Estonia; [Salumets, Andres] Univ Helsinki, Dept Obstet & Gynaecol, Helsinki, Finland; [Salumets, Andres] Helsinki Univ Hosp, Helsinki, Finland	University of Tartu; Estonian University of Life Sciences; University of Tartu; University of Tartu; University of Tartu; University of Tartu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Org, T (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, Tartu, Estonia.	toniso@ut.ee	Andreson, Reidar/G-1645-2017; Org, Tõnis/E-8596-2010	Andreson, Reidar/0000-0002-5612-5043; Org, Tõnis/0000-0003-3071-2183; Kurg, Ants/0000-0002-0829-1987	Estonian Research Council [PUT1177]; Estonian Ministry of Education and Research [IUT34-16, IUT 8-1, IUT34-11]; Enterprise Estonia [EU48695]; EU-FP7 Marie Curie IndustryAcademia Partnerships and Pathways (IAPP) [EU324509]; Horizon 2020 innovation programme (WIDENLIFE) [692065]; Horizon 2020 Twinning project [692299 SEARMET]; EU ERDF through the Estonian Centre of Excellence in Genomics and Translational Medicine [2014-2020.4.01.15-0012]; European Union through the European Regional Development Fund [2014-2020.4.01.16-0125]	Estonian Research Council(Estonian Research Council); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Enterprise Estonia; EU-FP7 Marie Curie IndustryAcademia Partnerships and Pathways (IAPP); Horizon 2020 innovation programme (WIDENLIFE); Horizon 2020 Twinning project; EU ERDF through the Estonian Centre of Excellence in Genomics and Translational Medicine; European Union through the European Regional Development Fund(European Commission)	This research was supported by Estonian Research Council (personal research grant PUT1177) to TO; by Estonian Ministry of Education and Research (grant IUT34-16), Enterprise Estonia (grant EU48695) and EU-FP7 Marie Curie IndustryAcademia Partnerships and Pathways (IAPP, grant SARM, EU324509) to AS; by Horizon 2020 innovation programme (WIDENLIFE, 692065) to AS and AK; by Horizon 2020 Twinning project 692299 SEARMET, Estonian Ministry of Education and Research (grant IUT 8-1) toUJ and by the EU ERDF through the Estonian Centre of Excellence in Genomics and Translational Medicine (project No. 2014-2020.4.01.15-0012) and by the Estonian Ministry of Education and Research (institutional grant IUT34-11) and by the European Union through the European Regional Development Fund (project No. 2014-2020.4.01.16-0125) to RA. Authors wish to thank the Sequencing core of Estonian Biocentre, Estonian Genome Center Core Facility and the High Performance Computing Center of University of Tartu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Arrigoni L, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0219-z; Bakhtari A, 2014, EPIGENETICS-US, V9, P1271, DOI 10.4161/epi.32087; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Blankenberg D, 2010, CURR PROTOC MOL BIOL, V10, P11; Bogliotti YS, 2018, P NATL ACAD SCI USA, V115, P2090, DOI 10.1073/pnas.1716161115; Brahma S, 2019, MOL CELL, V73, P238, DOI 10.1016/j.molcel.2018.10.046; Brind'Amour J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7033; Brinkhof B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1448-x; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cao ZN, 2015, NAT METHODS, V12, P959, DOI [10.1038/NMETH.3488, 10.1038/nmeth.3488]; Chen KF, 2016, MOL CELL BIOL, V36, P662, DOI 10.1128/MCB.00970-14; Chen YW, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r11; Cheung MS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr425; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Davies JOJ, 2017, NAT METHODS, V14, P125, DOI 10.1038/nmeth.4146; de Boer BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099844; Destouni A, 2016, GENOME RES, V26, P567, DOI 10.1101/gr.200527.115; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egan B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166438; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Flensburg C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00329; Fogarty NME, 2017, NATURE, V550, P67, DOI 10.1038/nature24033; Frank CL, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0065-5; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gustafsson C, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5299-0; Hainer SJ, 2019, CELL, V177, P1319, DOI 10.1016/j.cell.2019.03.014; Hainer Sarah J, 2019, Curr Protoc Mol Biol, V126, pe85, DOI 10.1002/cpmb.85; Harada A, 2019, NAT CELL BIOL, V21, P287, DOI 10.1038/s41556-018-0248-3; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hosseini SM, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0096-3; Hughes AL, 2014, ANNU REV BIOPHYS, V43, P41, DOI 10.1146/annurev-biophys-051013-023114; Kasinathan S, 2014, NAT METHODS, V11, P203, DOI [10.1038/NMETH.2766, 10.1038/nmeth.2766]; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Ku WL, 2019, NAT METHODS, V16, P323, DOI 10.1038/s41592-019-0361-7; Kubik S, 2015, MOL CELL, V60, P422, DOI 10.1016/j.molcel.2015.10.002; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer TR, 2013, NAT GENET, V45, P852, DOI 10.1038/ng.2677; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagatomo H, 2015, JPN J VET RES, V63, P159; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Ozawa M, 2012, BMC DEV BIOL, V12, P1, DOI 10.1186/1471-213X-12-33; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramani V, 2019, CELL REP, V26, P2465, DOI 10.1016/j.celrep.2019.02.007; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rayon T, 2014, DEV CELL, V30, P410, DOI 10.1016/j.devcel.2014.06.019; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; Santos RR, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-117; Schmidl C, 2015, NAT METHODS; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/NMETH.3542, 10.1038/nmeth.3542]; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/NMETH.1626, 10.1038/nmeth.1626]; Skene PJ, 2018, NAT PROTOC, V13, P1006, DOI 10.1038/nprot.2018.015; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Szalkowski AM, 2011, BRIEF BIOINFORM, V12, P626, DOI 10.1093/bib/bbq068; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Thomas R, 2016, BRIEF BIOINFORM, V18; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Topalovic V, 2017, BIOCHEMISTRY-MOSCOW+, V82, P715, DOI 10.1134/S0006297917060086; Valensisi C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2285-7; van Galen P, 2016, MOL CELL, V61, P170, DOI 10.1016/j.molcel.2015.11.003; Voong LN, 2016, CELL, V167, P1555, DOI 10.1016/j.cell.2016.10.049; Wallerman O, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0017-5; Wang Q, 2019, COBATCH HIGH THROUGH; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zhang Yanfeng, 2012, Zoological Research, V33, pE121, DOI [10.3724/SP.J.1141.2012.E120-06E121, 10.3724/SP.J.1141.2012.E05-06E121]; Zhao S, 2019, J CELL BIOCHEM, V120, P4794, DOI 10.1002/jcb.28063; Zhao XM, 2016, REPROD DOMEST ANIM, V51, P726, DOI 10.1111/rda.12737; Zheng XB, 2015, CELL REP, V13, P1505, DOI 10.1016/j.celrep.2015.10.004; Zwart W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-232	80	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225801	10.1371/journal.pone.0225801	http://dx.doi.org/10.1371/journal.pone.0225801			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765427	Green Published, gold, Green Submitted			2022-12-26	WOS:000533891000047
J	Hendrix, RHJ; Ganushchak, YM; Weerwind, PW				Hendrix, Rik H. J.; Ganushchak, Yuri M.; Weerwind, Patrick W.			Oxygen delivery, oxygen consumption and decreased kidney function after cardiopulmonary bypass	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; RISK-FACTORS; CARDIAC-SURGERY; INJURY; MANAGEMENT	Introduction Low oxygen delivery during cardiopulmonary bypass is related to a range of adverse outcomes. Previous research specified certain critical oxygen delivery levels associated with acute kidney injury. However, a single universal critical oxygen delivery value is not sensible, as oxygen consumption has to be considered when determining critical delivery values. This study examined the associations between oxygen delivery and oxygen consumption and between oxygen delivery and kidney function in patients undergoing cardiopulmonary bypass. Methods Oxygen delivery, oxygen consumption and kidney function decrease were retrospectively studied in 65 adult patients. Results Mean oxygen consumption was 56 +/- 8 ml/min/m(2), mean oxygen delivery was 281 +/- 39 ml/min/m(2). Twenty-seven patients (42%) had an oxygen delivery lower than the previously mentioned critical value of 272 ml/min/m(2). None of the patients developed acute kidney injury according to RIFLE criteria. However, in 10 patients (15%) a decrease in the estimated glomerular filtration rate of more than 10% was noted, which was not associated with oxygen delivery lower than 272 ml/min/m(2). Eighteen patients had a strong correlation (r > 0.500) between DO2 and VO2, but this was not related to low oxygen delivery. Central venous oxygen saturation (77 +/- 3%), oxygen extraction ratio (21 +/- 3%) and blood lactate levels at the end of surgery (1.2 +/- 0.3 mmol/l) showed not to be indicative of insufficient oxygen delivery either. Conclusions This study could not confirm an evident correlation between O-2 delivery and O-2 consumption or kidney function decrease, even at values below previously specified critical levels. The variability in O-2 consumption however, is an indication that every patient has individual O-2 needs, advocating for an individualized O-2 delivery goal.	[Hendrix, Rik H. J.; Ganushchak, Yuri M.; Weerwind, Patrick W.] Maastricht Univ, Dept Extra Corporeal Circulat, Med Ctr, Maastricht, Netherlands; [Weerwind, Patrick W.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University	Hendrix, RHJ (corresponding author), Maastricht Univ, Dept Extra Corporeal Circulat, Med Ctr, Maastricht, Netherlands.	rik.hendrix@mumc.nl						Agresti A., 1990, STAT MED, V11, P1791; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Boldt J, 2003, ANN THORAC SURG, V75, P906, DOI 10.1016/S0003-4975(02)04559-9; Chang TI, 2014, J AM COLL CARDIOL, V64, P985, DOI 10.1016/j.jacc.2014.04.077; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; DANTZKER DR, 1991, AM REV RESPIR DIS, V143, P675, DOI 10.1164/ajrccm/143.3.675; de Somer F, 2011, CRIT CARE, V15, DOI 10.1186/cc10349; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fischer UM, 2002, PERFUSION-UK, V17, P401, DOI 10.1191/0267659102pf610oa; Ganushchak YM, 2002, PERFUSION-UK, V17, P167, DOI 10.1191/0267659102pf561oa; Han SS, 2015, TOHOKU J EXP MED, V237, P287, DOI 10.1620/tjem.237.287; Helgason D, 2016, INTERACT CARDIOV TH, V23, P266, DOI 10.1093/icvts/ivw117; Hori D, 2016, INTERACT CARDIOV TH, V22, P445, DOI 10.1093/icvts/ivv371; Lopes JA, 2013, CLIN KIDNEY J, V6, P8, DOI 10.1093/ckj/sfs160; Magruder JT, 2017, J THORAC CARDIOV SUR, V153, P118, DOI 10.1016/j.jtcvs.2016.09.016; Magruder JT, 2015, ANN THORAC SURG, V100, P1697, DOI 10.1016/j.athoracsur.2015.05.059; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Milano AD, 2015, EUR J CARDIO-THORAC, V47, P291, DOI 10.1093/ejcts/ezu136; O'Neal JB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1352-z; PINSKY MR, 1994, INTENS CARE MED, V20, P1, DOI 10.1007/BF02425045; Ranucci M, 2005, ANN THORAC SURG, V80, P2213, DOI 10.1016/j.athoracsur.2005.05.069; Ranucci M, 2018, J THORAC CARDIOV SUR, V156, P1918, DOI 10.1016/j.jtcvs.2018.04.045; Reinhart K, 2005, CURR OPIN CRIT CARE, V11, P259, DOI 10.1097/01.ccx.0000158092.64795.cf; Ronco C, 2012, CRIT CARE, V16, DOI 10.1186/cc11240; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; SHIBUTANI K, 1983, CRIT CARE MED, V11, P640, DOI 10.1097/00003246-198308000-00010; Sirvinskas E, 2008, PERFUSION-UK, V23, P323, DOI 10.1177/0267659109105251; Svenmarker S, 2011, INTERACT CARDIOV TH, V12, P713, DOI 10.1510/icvts.2010.259432; Yi Q, 2016, CARDIORENAL MED, V6, P237, DOI 10.1159/000444094	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225541	10.1371/journal.pone.0225541	http://dx.doi.org/10.1371/journal.pone.0225541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756180	gold, Green Published			2022-12-26	WOS:000533889300037
J	de Souza, CV; Salvador, MV; Tunes, P; Di Stasi, LC; Guimaraes, E				de Souza, Camila Vaz; Salvador, Maira Vidor; Tunes, Priscila; Di Stasi, Luiz Claudio; Guimaraes, Elza			I've been robbed! - Can changes in floral traits discourage bee pollination?	PLOS ONE			English	Article							NECTAR-ROBBERS; REPRODUCTIVE SUCCESS; PLANT; FLOWERS; EVOLUTION; HYMENOPTERA; BUMBLEBEES; BEHAVIOR; CHEATERS; SCENT	Some floral visitors collect nectar by piercing flower external whorls, acting as nectar robbers. They leave robbery vestiges, which can cause changes in floral characteristics, including physical and chemical signals that may influence flower recognition by pollinators. If pollinating bees associate these changes with absence or reduction in nectar volume, they can avoid these flowers, negatively affecting pollination. We aimed to investigate the effect of robbery on primary and secondary attractants. Additionally, we experimentally investigated if the visual signs present in robbed flowers affect the bee pollination of this plant species by discouraging pollinator visits. This study was performed in a very common pollinator-plant-cheaters system comprised by a bee-pollinated Bignoniaceae species and a nectar-robber bee that lands on the corolla tube and makes slits at its base during the nectar robbery. We experimentally isolated the effect of nectar consumption by this nectar-robber and investigated if the slits caused by the nectar-robbers affected the floral scent emission. In addition, we experimentally evaluated the effect of visual signs (slits) associated to the nectar robbery and the effect of nectar depletion on the pollination of Jacaranda caroba (Bignoniaceae). The robbers visited around 75% of the flowers throughout the day and removed significant amounts of nectar from them. However, the damages the robbers cause did not affect floral scent emission and we did not verify significant differences on pollen deposition neither when comparing flowers with slits and control nor when comparing flowers with and without nectar. We showed that even though nectar-robbers visually honestly signal the robbery and deplete high amounts of nectar, they did not affect pollinator visitation. These results showed that presumably antagonistic interactions might in fact not be so.	[de Souza, Camila Vaz; Tunes, Priscila] Sao Paulo State Univ, Dept Bot, Lab Ecol & Evolut Plant Anim Interact, Grad Program Biol Sci,UNESP, Botucatu, SP, Brazil; [Salvador, Maira Vidor] Sao Paulo State Univ, Undergrad Course Biol Sci, Lab Ecol & Evolut Plant Anim Interact, UNESP, Botucatu, SP, Brazil; [Di Stasi, Luiz Claudio] Sao Paulo State Univ, Dept Pharmacol, Lab Phytomed Pharmacol & Biotechnol, UNESP, Botucatu, SP, Brazil; [Guimaraes, Elza] Sao Paulo State Univ, Dept Bot, Lab Ecol & Evolut Plant Anim Interact, UNESP, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Guimaraes, E (corresponding author), Sao Paulo State Univ, Dept Bot, Lab Ecol & Evolut Plant Anim Interact, UNESP, Botucatu, SP, Brazil.	elza.guimaraes@unesp.br	Di Stasi, Luiz/AAV-6166-2021; Di Stasi, Luiz/GQH-4483-2022; Tunes, Priscila/AAE-9284-2022; Guimarães, Elza/HHN-6023-2022; Tunes, Priscila/D-3761-2018	Di Stasi, Luiz/0000-0002-7864-1073; Di Stasi, Luiz/0000-0002-7864-1073; Tunes, Priscila/0000-0002-5521-5418; Guimarães, Elza/0000-0002-1006-357X; Tunes, Priscila/0000-0002-5521-5418	Sao Paulo Research Foundation [2018/14146-0, 2009/176117]; National Council for Scientific and Technological Development [446949/2014-0]; Coordination of Superior Level Staff Improvement, Brazil [001]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Superior Level Staff Improvement, Brazil	This study was financed in part by the Grant 2018/14146-0, Sao Paulo Research Foundation to EG; Grant 446949/2014-0, National Council for Scientific and Technological Development to EG; Post-Doc Grant 2009/176117, Sao Paulo Research Foundation to EG and by the Coordination of Superior Level Staff Improvement, Brazil, Finance Code 001 to CVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2007, IDENTIFICATION ESSEN, V4th; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Chittka L, 1997, BEHAV ECOL SOCIOBIOL, V41, P385, DOI 10.1007/s002650050400; Chittka L, 2004, COGNITIVE ECOLOGY PO; Chittka L., 2017, CUR BIOL, V27, P1037; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Clarke K.R., 2006, PRIMER V6 USER MANUA; Dafni A, 1998, SEX PLANT REPROD, V11, P177, DOI 10.1007/s004970050138; DEBENEDICTIS PA, 1978, AM NAT, V112, P301, DOI 10.1086/283273; Dobson HEM, 2005, PRACTICAL POLLINATIO, P197; Dotterl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093421; Dotterl S, 2005, PHYTOCHEMISTRY, V66, P203, DOI 10.1016/j.phytochem.2004.12.002; Etl F, 2016, J CHEM ECOL, V42, P300, DOI 10.1007/s10886-016-0688-9; Genini J, 2010, BIOL LETTERS, V6, P494, DOI 10.1098/rsbl.2009.1021; Gottsberger G., 2006, LIFE CERRADO POLLINA; Guimaraes E, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01243; Hazlehurst JA, 2016, OIKOS, V125, P1668, DOI 10.1111/oik.03195; HODGES CM, 1981, BEHAV ECOL SOCIOBIOL, V9, P41, DOI 10.1007/BF00299851; Howell AD, 2007, ANIM BEHAV, V74, P199, DOI 10.1016/j.anbehav.2006.11.012; INOUYE DW, 1980, ECOLOGY, V61, P1251, DOI 10.2307/1936841; Irwin RE, 2015, J ECOL, V103, P1487, DOI 10.1111/1365-2745.12476; Irwin RE, 2010, ANNU REV ECOL EVOL S, V41, P271, DOI 10.1146/annurev.ecolsys.110308.120330; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; LAVERTY TM, 1994, ANIM BEHAV, V47, P531, DOI 10.1006/anbe.1994.1077; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Maloof JE, 2001, AM J BOT, V88, P1960, DOI 10.2307/3558423; Maloof JE, 2000, ECOLOGY, V81, P2651, DOI 10.1890/0012-9658(2000)081[2651:ANRCOM]2.0.CO;2; Melo A.C.G., 2011, PLANO MANEJO ESTACAO; Murphy CM, 2008, J KANSAS ENTOMOL SOC, V81, P73, DOI 10.2317/JKES-704.23.1; Murphy Christina M., 2008, American Entomologist, V54, P36; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Parachnowitsch AL, 2019, ANN BOT-LONDON, V123, P247, DOI 10.1093/aob/mcy132; Pinheiro J, 2020, R PACKAGE VERSION 31; Potts S., 2005, PRACTICAL POLLINATIO, P330; Quinalha MM, 2017, FLORA, V232, P30, DOI 10.1016/j.flora.2016.08.005; R Core Team, 2021, R LANGUAGE ENV STAT; Radford A. E., 1974, VASCULAR PLANT SYSTE; Raguso RA, 2004, ECOLOGY, V85, P1486, DOI 10.1890/03-0410; Raguso RA, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P83, DOI 10.1017/CBO9780511542268.006; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; Rojas-Nossa SV, 2016, ANN BOT-LONDON, V117, P291, DOI 10.1093/aob/mcv165; RUST R W, 1979, Journal of the Kansas Entomological Society, V52, P297; Schaefer HM, 2011, PLANT-ANIMAL COMMUNICATION, P1, DOI 10.1093/acprof:osobl/9780199563609.001.0001; Schiestl FP, 2013, TRENDS ECOL EVOL, V28, P307, DOI 10.1016/j.tree.2013.01.019; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Singh VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102607; Stout JC, 2000, ACTA OECOL, V21, P277, DOI 10.1016/S1146-609X(00)01085-7; Vorobyev M, 1997, ISRAEL J PLANT SCI, V45, P93, DOI 10.1080/07929978.1997.10676676; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x; Wu Y, 2019, PLANT BIOLOGY, V21, P967, DOI 10.1111/plb.13000; ZIMMERMAN M, 1985, AM MIDL NAT, V113, P84, DOI 10.2307/2425350	52	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225252	10.1371/journal.pone.0225252	http://dx.doi.org/10.1371/journal.pone.0225252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751426	gold, Green Published			2022-12-26	WOS:000533886900037
J	Grove, G; Ziauddeen, N; Harris, S; Alwan, NA				Grove, Grace; Ziauddeen, Nida; Harris, Scott; Alwan, Nisreen A.			Maternal interpregnancy weight change and premature birth: Findings from an English population-based cohort study	PLOS ONE			English	Article							BODY-MASS INDEX; PRETERM BIRTH; SYSTEMATIC ANALYSIS; TIME TRENDS; JOB STRAIN; RISK; PREGNANCY; OBESITY; EPIDEMIOLOGY; OUTCOMES	Background The relationship between maternal weight change between pregnancies and premature birth is unclear. This study aimed to investigate whether interpregnancy weight change between first and second, or second and third pregnancy is associated with premature birth. Methods Routinely collected data from 2003 to 2018 from one English maternity centre was used to produce two cohorts. The primary cohort (n = 14,961 women) consisted of first and second live-birth pregnancies. The secondary cohort (n = 5,108 women) consisted of second and third live-birth pregnancies. Logistic regression models were used to examine associations between interpregnancy BMI change and premature births adjusted for confounders. Subgroup analyses were carried out, stratifying by initial pregnancy BMI groups and analysing spontaneous and indicated premature births separately. Results In the primary cohort, 3.4% (n = 514) of births were premature compared to 4.2% (n = 212) in the secondary cohort, with fewer indicated than spontaneous premature births in both cohorts. Primary cohort Weight loss (> 3kg/m(2)) was associated with increased odds of premature birth (adjusted odds ratio (aOR):3.50, 95% CI: 1.78-6.88), and spontaneous premature birth (aOR: 3.34, 95%CI: 1.60-6.98), in women who were normal weight (BMI 18.5-25kg/m(2)) at first pregnancy. Weight gain > 1kg/m(2) was not associated with premature birth regardless of starting BMI. Secondary cohort Losing > 3kg/m(2) was associated with increased odds of premature birth (aOR: 2.01, 95%CI: 1.05-3.87), when analysing the whole sample, but not when restricting the analysis to women who were overweight or obese at second pregnancy. Conclusions Normal-weight women who lose significant weight (> 3kg/m(2)) between their first and second live pregnancies have greater odds of premature birth compared to normal-weight women who remain weight stable in the interpregnancy period. There was no evidence of association between weight change in women who were overweight or obese at the start of their first pregnancy and premature birth.	[Grove, Grace; Ziauddeen, Nida; Harris, Scott; Alwan, Nisreen A.] Univ Southampton, Fac Med, Sch Primary Care Populat Sci & Med Educ, Southampton, Hants, England; [Alwan, Nisreen A.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Alwan, Nisreen A.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Alwan, NA (corresponding author), Univ Southampton, Fac Med, Sch Primary Care Populat Sci & Med Educ, Southampton, Hants, England.; Alwan, NA (corresponding author), Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.; Alwan, NA (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.	N.A.Alwan@soton.ac.uk	Alwan, Nisreen A./AFP-0662-2022	Alwan, Nisreen A./0000-0002-4134-8463; Grove, Grace/0000-0002-8323-5133; Ziauddeen, Nida/0000-0002-8964-5029	Academy of Medical Sciences; Wellcome Trust [AMS_HOP001\1060]; Health Education England; University of Southampton Primary Care and Population Sciences PhD studentship	Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome TrustEuropean Commission); Health Education England; University of Southampton Primary Care and Population Sciences PhD studentship	This research is supported by an Academy of Medical Sciences and Wellcome Trust grant to NAA [Grant no: AMS_HOP001\1060] (https://acmedsci.ac.uk/) (https://wellcome.ac.uk/).In addition, this work was initially undertaken as part of a Public Health MSc which was funded by Health Education England (for GG). This work is also supported by a University of Southampton Primary Care and Population Sciences PhD studentship (to NZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank David Cable (Electronic Patient Records Implementation and Service Manager) and Florina Borca (Senior Information Analyst R&D) at University Hospital Southampton for support in accessing the data used in this study.	Ananth CV, 2006, AM J OBSTET GYNECOL, V195, P643, DOI 10.1016/j.ajog.2006.05.022; [Anonymous], 2000, WHO TECHN REP SER; Auger N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-67; Bastian LA, 2010, WOMEN HEALTH ISS, V20, P133, DOI 10.1016/j.whi.2009.11.005; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brett KM, 1997, AM J PUBLIC HEALTH, V87, P199, DOI 10.2105/AJPH.87.2.199; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Chen AM, 2009, PAEDIATR PERINAT EP, V23, P207, DOI 10.1111/j.1365-3016.2009.01029.x; Culhane JF, 2011, SEMIN PERINATOL, V35, P234, DOI 10.1053/j.semperi.2011.02.020; Davis EM, 2014, MATERN CHILD HLTH J, V18, P554, DOI 10.1007/s10995-013-1272-3; Devaux M, 2013, EUR J PUBLIC HEALTH, V23, P464, DOI 10.1093/eurpub/ckr058; Drewnowski A, 2009, NUTR REV, V67, pS36, DOI 10.1111/j.1753-4887.2009.00157.x; Dunietz GL, 2015, FERTIL STERIL, V103, P974, DOI 10.1016/j.fertnstert.2015.01.015; Edvardsson K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-936; Ehtisham S, 2005, J CLIN ENDOCR METAB, V90, P3963, DOI 10.1210/jc.2004-2001; Frey HA, 2016, SEMIN FETAL NEONAT M, V21, P68, DOI 10.1016/j.siny.2015.12.011; Girsen AI, 2018, J MATERN-FETAL NEO M, V31, P560, DOI 10.1080/14767058.2017.1292243; Goldenberg RL, 2003, J NUTR, V133, p1645S, DOI 10.1093/jn/133.5.1645S; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gravett MG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S2; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Harrison MS, 2016, SEMIN FETAL NEONAT M, V21, P74, DOI 10.1016/j.siny.2015.12.007; Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Hoff GL, 2009, J WOMENS HEALTH, V18, P1413, DOI 10.1089/jwh.2008.1290; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Jans G, 2015, ADV NUTR, V6, P420, DOI 10.3945/an.114.008086; Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Mardby AC, 2017, WOMEN BIRTH, V30, pE207, DOI 10.1016/j.wombi.2017.01.003; McBain RD, 2016, EUR J OBSTET GYN R B, V205, P98, DOI 10.1016/j.ejogrb.2016.07.487; Merlino A, 2006, AM J OBSTET GYNECOL, V195, P818, DOI 10.1016/j.ajog.2006.06.043; National Institute for Health and Care Excellence, 2018, GUID GUID CG62 ANT C; National Institute for Health and Care Excellence, 2010, PUBL HLTH GUID PH27; Neggers Y, 2003, J NUTR, V133, p1737S, DOI 10.1093/jn/133.5.1737S; Newburn-Cook Christine V, 2005, Health Care Women Int, V26, P852, DOI 10.1080/07399330500230912; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Oteng-Ntim E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018778; Petersen CB, 2009, PAEDIATR PERINAT EP, V23, P66, DOI 10.1111/j.1365-3016.2008.00977.x; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Riley KL, 2016, AM J PERINAT, V33, P1017, DOI 10.1055/s-0036-1572533; Royal College of Obstetricians and Gynaecologists, 2017, REC MISC INV TRETM C; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Saurel-Cubizolles MJ, 2004, J EPIDEMIOL COMMUN H, V58, P395, DOI 10.1136/jech.2003.008029; Schempf AH, 2007, PAEDIATR PERINAT EP, V21, P34, DOI 10.1111/j.1365-3016.2007.00785.x; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Smith GCS, 2003, BRIT MED J, V327, P313, DOI 10.1136/bmj.327.7410.313; Smith LK, 2007, ARCH DIS CHILD-FETAL, V92, pF11, DOI 10.1136/adc.2005.090308; Smith L, 2014, MIDWIFERY, V30, P1173, DOI 10.1016/j.midw.2014.04.002; Smith LK, 2015, ARCH DIS CHILD-FETAL, V100, pF486, DOI 10.1136/archdischild-2014-307265; Snijder MB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017873; Sperrin M, 2014, INT J OBESITY, V38, P818, DOI 10.1038/ijo.2013.161; StataCorp, 2017, STATA STAT SOFTWARE; Thompson JMD, 2006, PAEDIATR PERINAT EP, V20, P182, DOI 10.1111/j.1365-3016.2006.00711.x; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Villamor E, 2016, OBESITY, V24, P727, DOI 10.1002/oby.21384; Wallace JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179589; Wallace JM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-40; Wallace JM, 2016, PLOS ONE, V11; Wang JX, 2002, HUM REPROD, V17, P945, DOI 10.1093/humrep/17.4.945; Whiteman VE, 2011, AM J PERINAT, V28, P67, DOI 10.1055/s-0030-1262905; World Health Organization, 2007, REP WHO TECHN CONS B; World Health Organization, 2018, BORN TOO SOON GLOB A; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zeitlin J, 2013, BJOG-INT J OBSTET GY, V120, P1356, DOI 10.1111/1471-0528.12281; Zeitlin J, 2002, HUM REPROD, V17, P2762, DOI 10.1093/humrep/17.10.2762; Ziauddeen N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026220	69	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225400	10.1371/journal.pone.0225400	http://dx.doi.org/10.1371/journal.pone.0225400			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8PC	31751407	Green Published, Green Accepted, gold			2022-12-26	WOS:000533886900059
J	Hartmann, M; Pelzl, MA; Kann, PH; Koehler, U; Betz, M; Hildebrandt, O; Cassel, W				Hartmann, Miria; Pelzl, Michael Alexander; Kann, Peter Herbert; Koehler, Ulrich; Betz, Manfred; Hildebrandt, Olaf; Cassel, Werner			The effects of prolonged single night session of videogaming on sleep and declarative memory	PLOS ONE			English	Article							HEART-RATE; BRIGHT DISPLAY; COMPUTER GAME; VIDEO GAMES; TELEVISION; EXPOSURE; LIGHT; MELATONIN; VIOLENT; IMPACT	Use of electronic media is widespread among adolescents. Many male adolescents spend a major part of their evenings playing video games. The increased exposure to artificial light as well as the exciting nature of this pastime is under suspicion to impair sleep. Sleep is considered to be important for memory consolidation, so there is also a potential risk for memory impairment due to video gaming. As learning and gaining knowledge is a very important part of adolescence, we decided to study the effects of prolonged video gaming on sleep and memory. The study was structured in a repeated measures design. Eighteen male participants played either the violent video game "Counter Strike: Global Offensive" or the board game "Monopoly" for five hours each on two Saturday nights. The game evenings were followed by sleep studies. Memory testing and vigilance evaluation was performed the next morning. During the course of the study, saliva samples were taken to determine melatonin and cortisol levels. The results of this crossover study showed slightly reduced sleep efficiency after "Counter Strike: Global Offensive" (-3.5%, p = .017) and impaired declarative memory recall (p = .005) compared to "Monopoly". Melatonin levels at bedtime were lower after "Counter Strike: Global Offensive" (p = .005), cortisol levels were elevated while playing the video game (p = .031). Negative effects on sleep were not strong but consistent with more wake after sleep onset (+12 min) and a higher arousal index after "Counter Strike: Global Offensive". We conclude that excessive video gaming in the evening can contribute to worsened sleep and impaired memory in male adolescents.	[Hartmann, Miria; Pelzl, Michael Alexander; Koehler, Ulrich; Hildebrandt, Olaf; Cassel, Werner] Philipps Univ, Dept Pneumol Intens Care & Sleep Med, Marburg, Germany; [Kann, Peter Herbert] Philipps Univ, Ctr Endocrinol Diabetol & Osteol, Marburg, Germany; [Betz, Manfred] Univ Appl Sci, Fac Hlth Sci, Giessen, Germany	Philipps University Marburg; Philipps University Marburg	Hartmann, M (corresponding author), Philipps Univ, Dept Pneumol Intens Care & Sleep Med, Marburg, Germany.	miriahartmann@gmx.de			Loewenstein Medical GmbH	Loewenstein Medical GmbH	This study was funded by Loewenstein Medical GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyari H, 2015, BASIC CLIN NEUROSCI, V6, P193; American Academy of Sleep Medicine, 2015, AASM MAN SCOR SLEEP; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bennion KA, 2015, CEREB CORTEX, V25, P646, DOI 10.1093/cercor/bht255; Bernaldo-de-Quiros M, 2020, ADICCIONES, V32, P291, DOI 10.20882/adicciones.1277; Betz M, 2017, AKTUELLE KINDERSCHLA, P146; Betz M, 2016, TPM-PHILOS MAG, P25, DOI 10.5840/tpm20167214; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Cassel W, 2011, SOMNOLOGIE, V15, P97; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Custers K, 2012, BEHAV SLEEP MED, V10, P96, DOI 10.1080/15402002.2011.596599; Deliens G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068727; Dumay N, 2016, CORTEX, V74, P289, DOI 10.1016/j.cortex.2015.06.007; Dworak M, 2007, PEDIATRICS, V120, P978, DOI 10.1542/peds.2007-0476; GADDY JR, 1993, J CLIN ENDOCR METAB, V77, P1398, DOI 10.1210/jc.77.5.1398; Goerke M, 2013, PSYCHONEUROENDOCRINO, V38, P1102, DOI 10.1016/j.psyneuen.2012.10.019; Heins E, 2007, GESUNDHEITSWESEN, V69, P151, DOI 10.1055/s-2007-971061; Helmstaedter C, 2001, VERBALER LERN MERKFA, V1; Higuchi S, 2005, J SLEEP RES, V14, P267, DOI 10.1111/j.1365-2869.2005.00463.x; Higuchi S, 2003, J APPL PHYSIOL, V94, P1773, DOI 10.1152/japplphysiol.00616.2002; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Ivarsson M, 2013, PSYCHOSOM MED, V75, P390, DOI 10.1097/PSY.0b013e3182906a4c; Ivarsson M, 2009, ACTA PAEDIATR, V98, P166, DOI 10.1111/j.1651-2227.2008.01096.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; King DL, 2013, J SLEEP RES, V22, P137, DOI 10.1111/j.1365-2869.2012.01060.x; Liu SY, 2015, CYBERPSYCH BEH SOC N, V18, P647, DOI 10.1089/cyber.2015.0140; Maski KP, 2015, SEMIN PEDIATR NEUROL, V22, P130, DOI 10.1016/j.spen.2015.03.008; Medienpadagogischer Forschungsverbund Sudwest, 2016, JIM 2016 JUG INF MUL; Medienpadagogischer Forschungsverbund Sudwest, 2017, JIM 2017 JUG INF MUL; Peracchia S, 2018, SLEEP SCI, V11, P302, DOI 10.5935/1984-0063.20180046; Strube TB, 2016, SOMNOLOGIE, V20, P61, DOI 10.1007/s11818-016-0044-x; Sugaya N, 2019, BIOPSYCHOSOC MED, V13, DOI 10.1186/s13030-019-0144-5; Tosini G, 2016, MOL VIS, V22, P61; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Weaver E, 2010, J CLIN SLEEP MED, V6, P184; Wilhelm Barbara, 1996, Ophthalmologe, V93, P446; Wood B, 2013, APPL ERGON, V44, P237, DOI 10.1016/j.apergo.2012.07.008; World Health Organization, 1992, ICD 10 CLASSIFICATIO, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; Zenon A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00286	41	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0224893	10.1371/journal.pone.0224893	http://dx.doi.org/10.1371/journal.pone.0224893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8PC	31751354	gold, Green Published			2022-12-26	WOS:000533886900020
J	Suzuki, KS; Suzuki, KW; Kumakura, E; Sato, K; Oe, Y; Sato, T; Sawada, H; Masuda, R; Nogata, Y				Suzuki, Kentaro S.; Suzuki, Keita W.; Kumakura, Emi; Sato, Kana; Oe, Yutaro; Sato, Tasuku; Sawada, Hideki; Masuda, Reiji; Nogata, Yasuyuki			Seasonal alternation of the ontogenetic development of the moon jellyfish Aurelia coerulea in Maizuru Bay, Japan	PLOS ONE			English	Article							S.L. CNIDARIA SCYPHOZOA; AURITA S.L.; VERTICAL-DISTRIBUTION; TOKYO BAY; ASEXUAL REPRODUCTION; POPULATION-DYNAMICS; COMMON JELLYFISH; SEXUAL REPRODUCTION; FORAGE FISH; LIFE-CYCLE	Outbreaks of moon jellyfish Aurelia spp. are frequently reported from many parts of the world's coastal areas. Aurelia spp. canonically show a metagenetic life cycle in which planulae transform into sessile polyps, which can drastically increase in number through asexual reproduction. Therefore, their asexual reproduction has been recognized as one of the major causes of the outbreaks. Aurelia spp. also show direct development that lacks asexual reproduction during the polyp stage, which prevents us from understanding the mechanisms of its outbreaks. To clarify the seasonality of the metagenetic and direct-development life cycles of Aurelia sp. in Maizuru Bay, Japan, we conducted field observations and laboratory experiments throughout the year. Additionally, the two life cycle types were genetically analyzed to confirm that they belong to the single species Aurelia coerulea, which dominates in coastal waters in Japan. From July until October, Aurelia coerulea produced smaller eggs and planulae all of which developed into polyps. However, from December until May, larger eggs and planulae were produced and 90% of the planulae developed into planktonic ephyrae bypassing the sessile polyp stage. Our results demonstrated that a single species, A. coerulea, seasonally shifts between their two life cycle types at a water temperature threshold of 20 degrees C in Maizuru Bay. The higher energy storage of larger planulae was suggested to enable the planulae to develop into ephyrae without external energy input through feeding during the polyp stage. The adaptive significances of the two life cycle types were also discussed.	[Suzuki, Kentaro S.; Nogata, Yasuyuki] Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Abiko, Chiba, Japan; [Suzuki, Keita W.; Sawada, Hideki; Masuda, Reiji] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Maizuru, Kyoto, Japan; [Kumakura, Emi; Sato, Kana] CERES Inc, Abiko, Chiba, Japan; [Oe, Yutaro; Sato, Tasuku] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan	Central Research Institute of Electric Power Industry - Japan; Kyoto University; Nihon University	Suzuki, KS (corresponding author), Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Abiko, Chiba, Japan.	skentaro@criepi.denken.or.jp			CERES Inc.	CERES Inc.	CERES Inc. provided support in the form of salaries for authors EK and KS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contribution' section.	[Anonymous], 2003, SESSILE ORG, DOI DOI 10.4282/SOSJ.20.69; [Anonymous], 2021, LANG ENV STAT COMP; Arai MN, 1997, FUNCTIONAL BIOL SCYP; BAGENAL TB, 1971, J FISH BIOL, V3, P207, DOI 10.1111/j.1095-8649.1971.tb03665.x; BERRILL NJ, 1949, BIOL REV, V24, P393, DOI 10.1111/j.1469-185X.1949.tb00581.x; Carrier TJ, 2018, EVOLUTIONARY ECOLOGY OF MARINE INVERTEBRATE LARVAE, P1, DOI 10.1093/oso/9780198786962.001.0001; Chia FS, 1996, OCEANOL ACTA, V19, P203; Chiaverano LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156588; Conklin EG, 1908, PUBLS CARNEGIE I, V103, P155; Conley K, 2015, J EXP MAR BIOL ECOL, V462, P14, DOI 10.1016/j.jembe.2014.10.018; D'Ambra I, 2018, MAR ECOL PROG SER, V587, P31, DOI 10.3354/meps12419; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; Dawson MN, 2001, HYDROBIOLOGIA, V451, P259, DOI 10.1023/A:1011869215330; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Eckman JE, 1996, J EXP MAR BIOL ECOL, V200, P207, DOI 10.1016/S0022-0981(96)02644-5; Endo Noriyuki, 2011, Bulletin of Plankton Society of Japan, V58, P1; Feng S, 2017, MAR POLLUT BULL, V114, P1046, DOI 10.1016/j.marpolbul.2016.10.062; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goette A., 1893, Z WISS ZOOL, V55, P645; Gotte A, 1887, ABH ENTWICKLUNGSGESC, V4, P1; GRONDAHL F, 1988, MAR ECOL PROG SER, V45, P87, DOI 10.3354/meps045087; Hadzi J., 1912, Biologisches Zentralblatt Leipzig, V32; Haeckel E., 1881, METAGENESIS HYPOGENE; Han Chang-Hoon, 2010, Plankton & Benthos Research, V5, P98; Han Chang-Hoon, 2009, Plankton & Benthos Research, V4, P14; Hargitt C. W., 1910, Journal of Morphology Philadelphia, V21; Helm RR, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0005-7; HERNROTH L, 1985, OPHELIA, V24, P37, DOI 10.1080/00785236.1985.10426617; HIRAI ETURO, 1958, BULL MARINE BIOL STA ASAMUSHI TOHOKU UNIV, V9, P81; Hoover RA, 2012, HYDROBIOLOGIA, V690, P199, DOI 10.1007/s10750-012-1044-x; Hyde IH, 1894, Z FR WIS SENSCHAFTLI, V58, P531; Iguchi N, 2004, PROG OCEANOGR, V61, P213, DOI 10.1016/j.pocean.2004.06.007; Ikeda H, 2011, J MAR BIOL ASSOC UK, V91, P215, DOI 10.1017/S0025315410001244; Ishii H, 2001, HYDROBIOLOGIA, V451, P311, DOI 10.1023/A:1011814525325; Ishii H, 2010, J OCEANOGR, V66, P329, DOI 10.1007/s10872-010-0029-5; Ishii Haruto, 2004, Plankton Biology and Ecology, V51, P26; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; Itoh Hiroshi, 2011, Plankton & Benthos Research, V6, P129; Jarms G, 1999, SARSIA, V84, P55, DOI 10.1080/00364827.1999.10420451; Kakinuma Y., 1975, Bulletin Mar Biol Stn Asamushi, V15, P101; KAKINUMA YOSHIKO, 1962, BULL MAR BIOL STA ASAMUSHI, V11, P81; Kamiyama T., 2017, J OCEANOGR, P1; Ki JS, 2008, ICES J MAR SCI, V65, P443, DOI 10.1093/icesjms/fsn018; Kim Yong Sool, 1998, Journal of the Korean Fisheries Society, V31, P272; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Komai T., 1935, MEM COLL SCI KYOTO U, V10, P290; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lamb PD, 2019, J FISH BIOL, V94, P1026, DOI 10.1111/jfb.13926; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Littleford RA, 1939, BIOL BULL-US, V77, P368, DOI 10.2307/1537646; Liu WC, 2009, HYDROBIOLOGIA, V616, P247, DOI 10.1007/s10750-008-9597-4; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Lucas CH, 1996, J PLANKTON RES, V18, P987, DOI 10.1093/plankt/18.6.987; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Lucas CH, 1998, MAR BIOL, V131, P629, DOI 10.1007/s002270050355; Makabe R, 2014, J OCEANOGR, V70, P447, DOI 10.1007/s10872-014-0249-1; Makabe R, 2012, J PLANKTON RES, V34, P936, DOI 10.1093/plankt/fbs057; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; Marshall DJ, 2012, ANNU REV ECOL EVOL S, V43, P97, DOI 10.1146/annurev-ecolsys-102710-145004; Matsumura K, 2005, J MAR BIOL ASSOC UK, V85, P563, DOI 10.1017/S0025315405011483; METSCHNIKOFF E, 1886, EMBRYOLOGISCHE STUDI; Miyajima-Taga Y, 2016, HYDROBIOLOGIA, V772, P175, DOI 10.1007/s10750-016-2658-1; Miyake Hiroshi, 1997, South Pacific Study, V17, P273; MOLLER H, 1984, SCIENCE, V224, P621, DOI 10.1126/science.224.4649.621; Morandini AC, 2001, SCI MAR, V65, P139, DOI 10.3989/scimar.2001.65n2139; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Robinson KL, 2013, LIMNOL OCEANOGR, V58, P235, DOI 10.4319/lo.2013.58.1.0235; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Schiariti A, 2014, MAR ECOL PROG SER, V510, P241, DOI 10.3354/meps10798; SCHNEIDER G, 1985, HELGOLANDER MEERESUN, V39, P43, DOI 10.1007/BF01997518; SCHNEIDER G, 1988, KIELER MEERESFORSCH, V6, P295; Scorrano S, 2017, ZOOL J LINN SOC-LOND, V180, P243, DOI 10.1111/zoj.12494; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Straehler-Pohl I, 2010, HYDROBIOLOGIA, V645, P3, DOI 10.1007/s10750-010-0226-7; Suzuki Kentaro S., 2017, Bulletin of Plankton Society of Japan, V64, P114; Suzuki KS, 2016, FISHERIES SCI, V82, P923, DOI 10.1007/s12562-016-1034-4; Suzuki KS, 2016, HYDROBIOLOGIA, V766, P151, DOI 10.1007/s10750-015-2451-6; Takao Mariko, 2014, Plankton & Benthos Research, V9, P105; Teissier G., 1929, Archives de Zoologie Experimentale et Generale Paris, V69, P137; Thatje S, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2776-8; Thein H, 2012, HYDROBIOLOGIA, V690, P157, DOI 10.1007/s10750-012-1045-9; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; UCHIDA TOHRU, 1926, JOUR FAC SCI IMP UNIV TOKYO SECT 4 ZOOL, V1, P45; Uye S, 2005, J PLANKTON RES, V27, P237, DOI 10.1093/plankt/fbh172; UYE S-I, 1982, Journal of the Oceanographical Society of Japan, V38, P149, DOI 10.1007/BF02110286; Vendetti JE, 2012, INTEGR COMP BIOL, V52, P138, DOI 10.1093/icb/ics077; Watanabe T, 2001, HYDROBIOLOGIA, V451, P247, DOI 10.1023/A:1011856929443; Willcox S, 2007, J EXP MAR BIOL ECOL, V353, P107, DOI 10.1016/j.jembe.2007.09.006; YASUDA T, 1975, Publications of the Seto Marine Biological Laboratory, V22, P75; YASUDA T, 1971, B JPN SOC SCI FISH, V37, P364; Yasuda T, 2003, JELLYFISH UFO SEA	95	8	10	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225513	10.1371/journal.pone.0225513	http://dx.doi.org/10.1371/journal.pone.0225513			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751435	Green Published, gold			2022-12-26	WOS:000533886900074
J	Wunderlich, M; Manning, N; Sexton, C; Sabulski, A; Byerly, L; O'Brien, E; Perentesis, JP; Mizukawa, B; Mulloy, JC				Wunderlich, Mark; Manning, Nicole; Sexton, Christina; Sabulski, Anthony; Byerly, Luke; O'Brien, Eric; Perentesis, John P.; Mizukawa, Benjamin; Mulloy, James C.			Improved chemotherapy modeling with RAG-based immune deficient mice	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; RADIORESISTANT MODEL; HEART-FAILURE; SCID MUTATION; NULL MICE; CELLS; ASPARAGINASE; CHILDREN; EFFICACY; COLI	We have previously characterized an acute myeloid leukemia (AML) chemotherapy model for SCID-based immune deficient mice (NSG and NSGS), consisting of 5 days of cytarabine (AraC) and 3 days of anthracycline (doxorubicin), to simulate the standard 7+3 chemotherapy regimen many AML patients receive. While this model remains tractable, there are several limitations, presumably due to the constitutional Pkrdc(scid) (SCID, severe combined immune deficiency) mutation which affects DNA repair in all tissues of the mouse. These include the inability to combine preconditioning with subsequent chemotherapy, the inability to repeat chemotherapy cycles, and the increased sensitivity of the host hematopoietic cells to genotoxic stress. Here we attempt to address these drawbacks through the use of alternative strains with RAG-based immune deficiency (NRG and NRGS). We find that RAG-based mice tolerate a busulfan preconditioning regimen in combination with either AML or 4-drug acute lymphoid leukemia (ALL) chemotherapy, expanding the number of samples that can be studied. RAG-based mice also tolerate multiple cycles of therapy, thereby allowing for more aggressive, realistic modeling. Furthermore, standard AML therapy in RAG mice was 3.8-fold more specific for AML cells, relative to SCID mice, demonstrating an improved therapeutic window for genotoxic agents. We conclude that RAG-based mice should be the new standard for preclinical evaluation of therapeutic strategies involving genotoxic agents.	[Wunderlich, Mark; Manning, Nicole; Sexton, Christina; Mulloy, James C.] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Sabulski, Anthony; Byerly, Luke; O'Brien, Eric; Perentesis, John P.; Mizukawa, Benjamin] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Hematol & Oncol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Wunderlich, M; Mulloy, JC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	mark.wunderlich@cchmc.org; james.mulloy@cchmc.org		Perentesis, John/0000-0002-4237-8226	NIH/NCI R50 award [CA21140]; NIH/NCI R01 award [CA215504]; Cincinnati Children's Hospital ARC award; NATIONAL CANCER INSTITUTE [R01CA215504] Funding Source: NIH RePORTER	NIH/NCI R50 award; NIH/NCI R01 award; Cincinnati Children's Hospital ARC award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by an NIH/NCI R50 award (#CA21140, MW), an NIH/NCI R01 award (#CA215504, JCM) and a Cincinnati Children's Hospital ARC award (JCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Anstee NS, 2019, CELL DEATH DIFFER, V26, P1316, DOI 10.1038/s41418-018-0209-1; Baranski Z, 2015, ONCOTARGET, V6, P36113, DOI 10.18632/oncotarget.5333; Barve A, 2018, EXP HEMATOL, V67, P18, DOI 10.1016/j.exphem.2018.08.004; Benito JM, 2015, CELL REP, V13, P2715, DOI 10.1016/j.celrep.2015.12.003; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Brana I, 2017, ONCOTARGET, V8, P84659, DOI 10.18632/oncotarget.19109; Bruedigam C, 2014, CELL STEM CELL, V15, P775, DOI 10.1016/j.stem.2014.11.010; BUCKLEY JD, 1989, MED PEDIATR ONCOL, V17, P382, DOI 10.1002/mpo.2950170507; Creutzig U, 2012, BLOOD, V120, P3187, DOI 10.1182/blood-2012-03-362608; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Fan YW, 2019, CANCER BIOL THER, V20, P617, DOI 10.1080/15384047.2018.1539290; Feijen EAM, 2015, J CLIN ONCOL, V33, P3774, DOI 10.1200/JCO.2015.61.5187; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Hayakawa J, 2009, STEM CELLS, V27, P175, DOI 10.1634/stemcells.2008-0583; Il Yu J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15165-3; Iwanoto T, 2004, CANCER SCI, V95, P454, DOI 10.1111/j.1349-7006.2004.tb03231.x; Izumchenko E, 2017, ANN ONCOL, V28, P2595, DOI 10.1093/annonc/mdx416; Jones L, 2017, CLIN CANCER RES, V23, P3744, DOI 10.1158/1078-0432.CCR-16-2392; Kremer LCM, 2001, J CLIN ONCOL, V19, P191, DOI 10.1200/JCO.2001.19.1.191; Krevvata M, 2018, HAEMATOLOGICA, V103, P959, DOI 10.3324/haematol.2017.183202; Lancet JE, 2018, J CLIN ONCOL, V36, P2684, DOI 10.1200/JCO.2017.77.6112; Lee EM, 2015, HAEMATOLOGICA, V100, P914, DOI 10.3324/haematol.2014.113092; Lin S, 2016, ONCOTARGET, V7, P55939, DOI 10.18632/oncotarget.11093; Miyazaki M, 2015, BIOORGAN MED CHEM, V23, P2360, DOI 10.1016/j.bmc.2015.03.069; Mulloy JC, 2003, BLOOD, V102, P4369, DOI 10.1182/blood-2003-05-1762; Naz S, 2018, CLIN CANCER RES, V24, P3994, DOI 10.1158/1078-0432.CCR-17-3575; O'Steen S, 2017, CANCER RES, V77, P3885, DOI 10.1158/0008-5472.CAN-17-0082; Panetta JC, 2009, CLIN PHARMACOL THER, V86, P651, DOI 10.1038/clpt.2009.162; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Place AE, 2015, LANCET ONCOL, V16, P1677, DOI 10.1016/S1470-2045(15)00363-0; Ribera JM, 2018, LEUKEMIA LYMPHOMA, V59, P1634, DOI 10.1080/10428194.2017.1397661; Samuels AL, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.52; Schramm F, 2019, LEUKEMIA LYMPHOMA, V60, P60, DOI 10.1080/10428194.2018.1473575; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2000, J IMMUNOL, V164, P2496, DOI 10.4049/jimmunol.164.5.2496; Sivagnanalingam U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132375; Sperlazza J, 2015, BLOOD, V126, P1462, DOI 10.1182/blood-2015-03-631606; Szymanska B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033894; Teh TC, 2018, LEUKEMIA, V32, P303, DOI 10.1038/leu.2017.243; Townsend EC, 2016, CANCER CELL, V29, P574, DOI 10.1016/j.ccell.2016.03.008; Velu CS, 2014, J CLIN INVEST, V124, P222, DOI 10.1172/JCI66005; Wang MA, 2018, FASEB J, V32, P1537, DOI 10.1096/fj.201700740R; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Wunderlich M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209034; Wunderlich M, 2014, BLOOD, V123, pE134, DOI 10.1182/blood-2014-02-556340; Wunderlich M, 2013, BLOOD, V121, pE90, DOI 10.1182/blood-2012-10-464677; Wunderlich Mark, 2009, V538, P263, DOI 10.1007/978-1-59745-418-6_13; Zhang C, 2017, REDOX BIOL, V11, P1, DOI 10.1016/j.redox.2016.10.019	50	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225532	10.1371/journal.pone.0225532	http://dx.doi.org/10.1371/journal.pone.0225532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747424	Green Published, gold			2022-12-26	WOS:000533881900050
J	Hagaman, A; Gallis, JA; Bhalotra, S; Baranov, V; Turner, EL; Sikander, S; Maselko, J				Hagaman, Ashley; Gallis, John A.; Bhalotra, Sonia; Baranov, Victoria; Turner, Elizabeth L.; Sikander, Siham; Maselko, Joanna			Psychosocial determinants of sustained maternal functional impairment: Longitudinal findings from a pregnancy-birth cohort study in rural Pakistan	PLOS ONE			English	Article							QUALITY-OF-LIFE; SOCIAL SUPPORT; DEPRESSIVE SYMPTOMS; SYSTEMATIC ANALYSIS; MENTAL-HEALTH; GLOBAL BURDEN; RISK-FACTORS; WHODAS 2.0; DISABILITY; POSTPARTUM	Function is an important marker of health throughout the life course, however, in low-and-middle-income-countries, little is known about the burden of functional impairment as women transition from pregnancy to the first year post-partum. Leveraging longitudinal data from 960 women participating in the Share Child Cohort in Pakistan, this study sought to (1) characterize functional trajectories over time among women in their perinatal period and (2) assess predictors of chronic poor functioning following childbirth. We used a group-based trajectory modeling approach to examine maternal patterns of function from the third trimester of pregnancy through 12 months post-partum. Three trajectory groups were found: persistently well-functioning (51% of women), poor functioning with recovery (39% of women), and chronically poor functioning (10% of women). When compared to mothers in the highest functioning group, psychosocial characteristics (e.g., depression, stress, and serious life events) were significantly associated with sustained poor functioning one-year following child-birth. Mothers living in nuclear households were more likely to experience chronic poor functioning. Higher education independently predicted maternal function recovery, even when controlling for psychosocial characteristics. Education, above and beyond socio-economic assets, appears to play an important protective role in maternal functional trajectories following childbirth. Public health implications related to maternal function and perinatal mental health are discussed.	[Hagaman, Ashley] Yale Sch Publ Hlth, Dept Social Behav Sci, New Haven, CT 06510 USA; [Hagaman, Ashley] Yale Univ, Ctr Methods Implementat & Prevent Sci, New Haven, CT 06520 USA; [Gallis, John A.; Turner, Elizabeth L.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Gallis, John A.; Turner, Elizabeth L.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Bhalotra, Sonia] Univ Essex, Dept Econ, Colchester, Essex, England; [Baranov, Victoria] Univ Melbourne, Dept Econ, Melbourne, Vic, Australia; [Sikander, Siham] Hlth Serv Acad, Maternal & Neonatal Child Hlth Dept, Islamabad, Pakistan; [Sikander, Siham] Human Dev Res Fdn, Islamabad, Pakistan; [Maselko, Joanna] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA	Yale University; Yale University; Duke University; Duke University; University of Essex; University of Melbourne; Health Services Academy; University of North Carolina; University of North Carolina Chapel Hill	Hagaman, A (corresponding author), Yale Sch Publ Hlth, Dept Social Behav Sci, New Haven, CT 06510 USA.; Hagaman, A (corresponding author), Yale Univ, Ctr Methods Implementat & Prevent Sci, New Haven, CT 06520 USA.	ashley.hagaman@yale.edu		Hagaman, Ashley/0000-0002-8016-1036; Baranov, Victoria/0000-0003-4777-6466; Gallis, John/0000-0003-1921-8424	U.S. Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD075875, T32HD007168, P2CHD050924]; U.S. National Institute of Mental Health [U19MH95687]; ESRC [ES/S012486/1, ES/L009153/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007168, R01HD075875, P2CHD050924] Funding Source: NIH RePORTER	U.S. Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study and study team received support from the U.S. Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD075875; T32HD007168; P2CHD050924) and the U.S. National Institute of Mental Health (U19MH95687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 2017, ED SOCIAL STATUS HLT; Baron EC, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1291-z; Bitew T, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1099-1; Chen HH, 2016, ARCH PSYCHIAT NURS, V30, P350, DOI 10.1016/j.apnu.2015.12.008; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; DAHLEM NW, 1991, J CLIN PSYCHOL, V47, P756, DOI 10.1002/1097-4679(199111)47:6<756::AID-JCLP2270470605>3.0.CO;2-L; Downing NR, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.275; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Emmanuel EN, 2014, J CLIN NURS, V23, P1611, DOI 10.1111/jocn.12265; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Halfon N, 2014, MATERN CHILD HLTH J, V18, P344, DOI 10.1007/s10995-013-1346-2; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Kader M, 2018, SPINAL CORD, V56, P239, DOI 10.1038/s41393-017-0001-y; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Li J, 2012, MATERN CHILD HLTH J, V16, P1355, DOI 10.1007/s10995-011-0900-z; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; MacLeod MA, 2016, INT J METH PSYCH RES, V25, P243, DOI 10.1002/mpr.1523; Manuel JI, 2012, SOC SCI MED, V75, P2013, DOI 10.1016/j.socscimed.2012.07.034; Maselko J, 2018, SSM-POPUL HLTH, V4, P1, DOI 10.1016/j.ssmph.2017.10.004; Moilanen KL, 2010, J RES ADOLESCENCE, V20, P114, DOI 10.1111/j.1532-7795.2009.00628.x; Murphy RA, 2016, J GERONTOL A-BIOL, V71, P228, DOI 10.1093/gerona/glv139; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; OHare MA, 2011, OPEN REHAB J, V4, P51; Osborne C, 2012, DEMOGRAPHY, V49, P23, DOI 10.1007/s13524-011-0080-x; Piperata BA, 2016, SOC SCI MED, V171, P9, DOI 10.1016/j.socscimed.2016.10.029; Pritchard KM, 2013, MULTIPLE MOTHERHOODS; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2007, J AFFECT DISORDERS, V100, P115, DOI 10.1016/j.jad.2006.10.004; Rittenour CE, 2012, SEX ROLES, V67, P351, DOI 10.1007/s11199-012-0186-7; Senturk V, 2012, J AFFECT DISORDERS, V136, P340, DOI 10.1016/j.jad.2011.11.028; Setse R, 2009, MATERN CHILD HLTH J, V13, P577, DOI 10.1007/s10995-008-0392-7; Sikander S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025644; Sikander S, 2019, LANCET PSYCHIAT, V6, P128, DOI 10.1016/S2215-0366(18)30467-X; Silveira C, 2013, REV ASSOC MED BRAS, V59, P234, DOI 10.1016/j.ramb.2012.11.005; Tucker JN, 2010, WOMEN HEALTH, V50, P618, DOI 10.1080/03630242.2010.522468; Turner EL, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1530-y; Upton J., 2013, ENCY BEHAV MED, P1580, DOI DOI 10.1007/978-1-4419-1005-9_422; Ustun B., 2010, MEASURING HLTH DISAB; Van der Woude DAA, 2015, EUR J OBSTET GYN R B, V185, P45, DOI 10.1016/j.ejogrb.2014.11.041; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Willie TC, 2016, J URBAN HEALTH, V93, P19, DOI 10.1007/s11524-015-0021-x; Zhong QY, 2018, AM J EPIDEMIOL, V187, P1871, DOI 10.1093/aje/kwy067	47	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225163	10.1371/journal.pone.0225163	http://dx.doi.org/10.1371/journal.pone.0225163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8LN	31743374	Green Published, Green Accepted, gold			2022-12-26	WOS:000533877300020
J	Jin, Y; Bao, H; Le, XN; Fan, XJ; Tang, M; Shi, X; Zhao, J; Yan, JR; Xu, Y; Quek, K; Elamin, YY; Zhang, J; Futreal, PA; Wistuba, II; Heymach, JV; Lou, GY; Shao, L; He, Q; Lin, C; Wu, X; Shao, YW; Wang, XN; He, JC; Chen, YM; Stebbing, J; Chen, M; Zhang, JJ; Yu, XM				Jin, Ying; Bao, Hua; Le, Xiuning; Fan, Xiaojun; Tang, Ming; Shi, Xun; Zhao, Jun; Yan, Junrong; Xu, Yang; Quek, Kelly; Elamin, Yasir Y.; Zhang, Jianhua; Futreal, P. Andrew; Wistuba, Ignacio I.; Heymach, John, V; Lou, Guangyuan; Shao, Lan; He, Qiong; Lin, Chen; Wu, Xue; Shao, Yang W.; Wang, Xiaonan; He, Jiachen; Chen, Yamei; Stebbing, Justin; Chen, Ming; Zhang, Jianjun; Yu, Xinmin			Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; INTRATUMOR GENETIC-HETEROGENEITY; 1ST-LINE TREATMENT; CLINICAL IMPACT; OPEN-LABEL; RESISTANCE; PIK3CA; ADENOCARCINOMAS; DIVERSITY	EGFR-mutant non-small-cell lung cancer (NSCLC) patients inevitably develop drug resistance when treated with EGFR tyrosine kinase inhibitors (TKIs). Systematic genetic analysis is important to understand drug-resistant mechanisms; however, the clinical significance of co-occurring genetic alterations at baseline, co-acquired mutations at progressive disease (PD), and the clonal evolution remain underinvestigated. We performed targeted sequencing of pre-treatment and PD tumor samples from 54 EGFR-mutant NSCLC patients. Ten additional patients were sequenced using whole-exome sequencing to infer the clonal evolution patterns. We observed a domain-dependent effect of PIK3CA mutation at baseline on patient progression-free survival (PFS). In addition, at baseline, 9q34.3/19p13.3 (NOTCH1/STK11/GNA11) showed a co-deletion pattern, which was associated with a significantly worse PFS (p = 0.00079). T790M-postive patients with other concurrent acquired oncogenic mutations had a significantly shorter PFS (p = 0.005). Besides acquired T790M mutation, chromosomal instability (CIN) related genes, including AURKA and TP53 alterations, were the most frequently acquired events. CIN significantly increased during TKI treatment in T790M-negative patients and is a candidate resistance mechanism to the first-generation TKIs. Clonal evolution analyses suggest that the composition and relationship among resistant subclones, particularly relationship with T790M subclone, affect patients' outcomes. Overall, our findings of novel co-occurring alterations and clonal evolution patterns can be served as predictive biomarkers to stratify patients and help to better understand the drug-resistant mechanism to TKIs.	[Jin, Ying; Shi, Xun; Zhao, Jun; Lou, Guangyuan; Shao, Lan; He, Qiong; Lin, Chen; Chen, Yamei; Chen, Ming; Yu, Xinmin] Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Zhejiang, Peoples R China; [Jin, Ying; Shi, Xun; Zhao, Jun; Lou, Guangyuan; Shao, Lan; He, Qiong; Lin, Chen; Yu, Xinmin] Univ Chinese Acad Sci, Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Jin, Ying; Shi, Xun; Zhao, Jun; Lou, Guangyuan; Shao, Lan; He, Qiong; Lin, Chen; Yu, Xinmin] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China; [Jin, Ying; Chen, Yamei; Chen, Ming] Zhejiang Key Lab Radiat Oncol, Hangzhou, Zhejiang, Peoples R China; [Bao, Hua; Fan, Xiaojun; Xu, Yang; Wu, Xue] Geneseeq Technol Inc, Translat Med Res Ctr, Toronto, ON, Canada; [Le, Xiuning; Tang, Ming; Quek, Kelly; Elamin, Yasir Y.; Heymach, John, V; Zhang, Jianjun] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Yan, Junrong; Shao, Yang W.; Wang, Xiaonan; He, Jiachen] Nanjing Geneseeq Technol Inc, Nanjing, Jiangsu, Peoples R China; [Zhang, Jianhua; Futreal, P. Andrew; Zhang, Jianjun] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Stebbing, Justin] Imperial Coll London, ICTEM, Div Canc, Dept Surg & Canc, London W12 0NN, England	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang Cancer Hospital; Geneseeq Technology Inc.; University of Texas System; UTMD Anderson Cancer Center; Geneseeq Technology Inc.; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Imperial College London	Chen, M; Yu, XM (corresponding author), Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Zhejiang, Peoples R China.; Yu, XM (corresponding author), Univ Chinese Acad Sci, Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China.; Yu, XM (corresponding author), Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China.; Chen, M (corresponding author), Zhejiang Key Lab Radiat Oncol, Hangzhou, Zhejiang, Peoples R China.; Zhang, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.; Zhang, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	chenming@zjcc.org.cn; jzhang20@mdanderson.org; yuxm@zjcc.org.cn	Xu, Yang/CAG-8877-2022; Chen, Ming/GYE-1379-2022	Xu, Yang/0000-0003-1670-6131; Chen, Ming/0000-0001-5041-9342; Stebbing, Justin/0000-0002-1117-6947; Bao, Hua/0000-0001-5774-8755	National Natural Science Foundation of China [81702248, 81672972]; Zhejiang Medical and Health Science and Technology Project [2018KY309, 2017KY239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Medical and Health Science and Technology Project	Professor Stebbing sits on SABs for Celltrion, Singapore Biotech, Vor Biopharma, TLC Biopharmaceuticals and Benevolent AI, has consulted with Lansdowne partners, Vitruvian and Social Impact Capital and Chairs the Board of Directors for BB Biotech Healthcare Trust and Xerion Healthcare. This study was supported by the National Natural Science Foundation of China (Grant nos. 81702248, 81672972), and Zhejiang Medical and Health Science and Technology Project (Grant nos. 2018KY309, 2017KY239).	Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Bivona TG, 2016, NAT MED, V22, P472, DOI 10.1038/nm.4091; Blakely CM, 2017, NAT GENET, V49, P1693, DOI 10.1038/ng.3990; Boolell V, 2015, CANCERS, V7, P1815, DOI 10.3390/cancers7030864; Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015; Canale M, 2017, CLIN CANCER RES, V23, P2195, DOI 10.1158/1078-0432.CCR-16-0966; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Eng J, 2015, J THORAC ONCOL, V10, P1713, DOI 10.1097/JTO.0000000000000671; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gill RK, 2011, ONCOGENE, V30, P3784, DOI 10.1038/onc.2011.98; Guo LX, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/520590; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Jin Y, 2016, ONCOTARGET, V7, P61755, DOI 10.18632/oncotarget.11237; Kim HR, 2014, LUNG CANCER, V83, P374, DOI 10.1016/j.lungcan.2013.12.011; Kohno T, 1999, CARCINOGENESIS, V20, P1403, DOI 10.1093/carcin/20.8.1403; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang HR, 2018, J THORAC DIS, V10, P2311, DOI 10.21037/jtd.2018.03.150; Ma GZ, 2017, ONCOTARGET, V8, P99429, DOI 10.18632/oncotarget.19681; Majem M, 2013, TRANSL LUNG CANCER R, V2, P226, DOI 10.3978/j.issn.2218-6751.2013.03.09; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; McNeill RS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200014; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mroz EA, 2013, CANCER-AM CANCER SOC, V119, P3034, DOI 10.1002/cncr.28150; Mroz EA, 2013, ORAL ONCOL, V49, P211, DOI 10.1016/j.oraloncology.2012.09.007; Nadeu F, 2018, LEUKEMIA, V32, P645, DOI 10.1038/leu.2017.291; Nagano T, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110212; Niknafs N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004416; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Ohgaki H, 2004, CANCER LETT, V207, P197, DOI 10.1016/j.canlet.2003.10.020; Pao W., 2005, PLOS MED, V2; Pfarr N, 2016, GENE CHROMOSOME CANC, V55, P821, DOI 10.1002/gcc.22378; Remon J, 2014, CANCER TREAT REV, V40, P93, DOI 10.1016/j.ctrv.2013.06.002; Rosell R, 2013, LANCET, V382, P720, DOI 10.1016/S0140-6736(13)61715-8; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shah KN, 2019, NAT MED, V25, P111, DOI 10.1038/s41591-018-0264-7; Shigemitsu K, 2001, ONCOGENE, V20, P4249, DOI 10.1038/sj.onc.1204557; Skoulidis F, 2018, CANCER DISCOV, V8, P822, DOI 10.1158/2159-8290.CD-18-0099; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Toth LN, 2018, HUM PATHOL, V78, P138, DOI 10.1016/j.humpath.2018.04.014; Turajlic S, 2019, NAT REV GENET, V20, P404, DOI 10.1038/s41576-019-0114-6; VanderLaan PA, 2017, LUNG CANCER, V106, P17, DOI 10.1016/j.lungcan.2017.01.011; Wang J, 2016, ONCOTARGETS THER, V9, P3711, DOI 10.2147/OTT.S106399; Westover D, 2018, ANN ONCOL, V29, pI10, DOI 10.1093/annonc/mdx703; Wu SY, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6030038; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Xie M, 2013, EUR J CANCER, V49, P3559, DOI 10.1016/j.ejca.2013.07.007; Yard BD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11428; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhao RX, 2014, CURR DRUG TARGETS, V15, P32, DOI 10.2174/1389450114666140106095811	64	19	19	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1846	1859		10.1038/s41388-019-1104-z	http://dx.doi.org/10.1038/s41388-019-1104-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31754213				2022-12-26	WOS:000516579800002
J	Mazurkewich, S; Poulsen, JCN; Lo Leggio, L; Larsbrink, J				Mazurkewich, Scott; Poulsen, Jens-Christian N.; Lo Leggio, Leila; Larsbrink, Johan			Structural and biochemical studies of the glucuronoyl esterase OtCE15A illuminate its interaction with lignocellulosic components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme structure; enzyme mutation; enzyme kinetics; carbohydrate processing; cell wall; alpha; beta-hydrolase; carbohydrate-active enzymes; catalytic triad; glucuronoyl esterase; lignin-carbohydrate complexes; glucuronoxylan; biomass	CATALYTIC TRIAD; HALOALKANE DEHALOGENASE; INSIGHTS; ENZYMES; ACID; DOMAIN; XYLAN; MASS; TOOL	Glucuronoyl esterases (GEs) catalyze the cleavage of ester linkages between lignin and glucuronic acid moieties on glucuronoxylan in plant biomass. As such, GEs represent promising biochemical tools in industrial processing of these recalcitrant resources. However, details on how GEs interact and catalyze degradation of their natural substrates are sparse, calling for thorough enzyme structure-function studies. Presented here is a structural and mechanistic investigation of the bacterial GE OtCE15A. GEs belong to the carbohydrate esterase family 15 (CE15), which is in turn part of the larger ?/?-hydrolase superfamily. GEs contain a Ser-His-Asp/Glu catalytic triad, but the location of the catalytic acid in GEs has been shown to be variable, and OtCE15A possesses two putative catalytic acidic residues in the active site. Through site-directed mutagenesis, we demonstrate that these residues are functionally redundant, possibly indicating the evolutionary route toward new functionalities within the family. Structures determined with glucuronate, in both native and covalently bound intermediate states, and galacturonate provide insights into the catalytic mechanism of CE15. A structure of OtCE15A with the glucuronoxylooligosaccharide 2(3)-(4-O-methyl-?-d-glucuronyl)-xylotriose (commonly referred to as XUX) shows that the enzyme can indeed interact with polysaccharides from the plant cell wall, and an additional structure with the disaccharide xylobiose revealed a surface binding site that could possibly indicate a recognition mechanism for long glucuronoxylan chains. Collectively, the results indicate that OtCE15A, and likely most of the CE15 family, can utilize esters of glucuronoxylooligosaccharides and support the proposal that these enzymes work on lignin-carbohydrate complexes in plant biomass.	[Mazurkewich, Scott; Larsbrink, Johan] Chalmers Univ Technol, Wallenberg Wood Sci Ctr, Dept Biol & Biol Engn, Div Ind Biotechnol, SE-41296 Gothenburg, Sweden; [Poulsen, Jens-Christian N.; Lo Leggio, Leila] Univ Copenhagen, Dept Chem, Univ Pk, DK-2100 Copenhagen O, Denmark; [Poulsen, Jens-Christian N.] Univ Copenhagen, Integrat Struct Biol, ISBUC, Copenhagen, Denmark	Chalmers University of Technology; University of Copenhagen; University of Copenhagen	Lo Leggio, L (corresponding author), Univ Copenhagen, Dept Chem, Univ Pk, DK-2100 Copenhagen O, Denmark.; Larsbrink, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Kemivagen 10, SE-41296 Gothenburg, Sweden.	leila@chem.ku.dk; johan.larsbrink@chalmers.se	Larsbrink, Johan/A-3053-2013; Lo Leggio, Leila/B-4287-2015	Larsbrink, Johan/0000-0001-8386-2914; Lo Leggio, Leila/0000-0002-5135-0882; Mazurkewich, Scott/0000-0002-9238-0615	Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center; Novo Nordisk Foundation [NNF17OC0027698]; Danish Ministry of Higher Education and Science through the Instrument Center DANSCATT	Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Ministry of Higher Education and Science through the Instrument Center DANSCATT	The work performed at Chalmers University of Technology was supported by the Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center. Funding for collaborative work between Chalmers University of Technology and Copenhagen University was provided by the Novo Nordisk Foundation (NNF17OC0027698, Biotechnology-based Synthesis and Production Research). Funding for synchrotron travels was provided in part by the Danish Ministry of Higher Education and Science through the Instrument Center DANSCATT. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baath JA, 2019, J BIOL CHEM, V294, P6635, DOI 10.1074/jbc.RA119.007831; Baath JA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1213-x; Baath JA, 2016, FEBS LETT, V590, P2611, DOI 10.1002/1873-3468.12290; Biely P, 2016, APPL ENVIRON MICROB, V82, P7014, DOI 10.1128/AEM.02396-16; Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Charavgi MD, 2013, ACTA CRYSTALLOGR D, V69, P63, DOI 10.1107/S0907444912042400; Copley SD, 1998, CURR OPIN CHEM BIOL, V2, P613, DOI 10.1016/S1367-5931(98)80092-6; COREY DR, 1992, J AM CHEM SOC, V114, P1784, DOI 10.1021/ja00031a037; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; d'Errico C, 2015, BIOTECHNOL BIOENG, V112, P914, DOI 10.1002/bit.25508; De Santi C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17677-4; Duranova M, 2009, BIOSCI BIOTECH BIOCH, V73, P2483, DOI 10.1271/bbb.90486; Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Huynh H, 2018, APPL MICROBIOL BIOT, V102, P2191, DOI 10.1007/s00253-018-8739-5; Hynkova K, 1999, FEBS LETT, V446, P177, DOI 10.1016/S0014-5793(99)00199-4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krooshof GH, 1997, BIOCHEMISTRY-US, V36, P9571, DOI 10.1021/bi971014t; Kulkarni AR, 2012, GLYCOBIOLOGY, V22, P439, DOI 10.1093/glycob/cwr117; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mosbech C, 2019, APPL MICROBIOL BIOT, V103, P4065, DOI 10.1007/s00253-019-09797-w; Mosbech C, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1075-2; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Notenboom V, 1998, NAT STRUCT BIOL, V5, P812, DOI 10.1038/1852; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pokkuluri PR, 2011, PROTEINS, V79, P2588, DOI 10.1002/prot.23088; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Singh MK, 2016, BIOCHEM BIOPH RES CO, V476, P63, DOI 10.1016/j.bbrc.2016.05.061; Spanikova S, 2007, ARCH MICROBIOL, V188, P185, DOI 10.1007/s00203-007-0241-x; Spanikova S, 2006, FEBS LETT, V580, P4597, DOI 10.1016/j.febslet.2006.07.033; TULL D, 1994, BIOCHEMISTRY-US, V33, P6363, DOI 10.1021/bi00186a041; Urbanowicz BR, 2012, P NATL ACAD SCI USA, V109, P14253, DOI 10.1073/pnas.1208097109; Vincent F, 2003, J MOL BIOL, V330, P593, DOI 10.1016/S0022-2836(03)00632-6; Winkler R, 2010, RAPID COMMUN MASS SP, V24, P285, DOI 10.1002/rcm.4384; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	11	11	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19978	19987		10.1074/jbc.RA119.011435	http://dx.doi.org/10.1074/jbc.RA119.011435			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31740581	hybrid, Green Published			2022-12-26	WOS:000505005800013
J	Chow, S; Inaba, N; Nagai, S; Kurogi, H; Nakamura, Y; Yanagimoto, T; Tanaka, H; Hasegawa, D; Asakura, T; Kikuchi, J; Tomoda, T; Kodama, T				Chow, Seinen; Inaba, Nobuharu; Nagai, Satoshi; Kurogi, Hiroaki; Nakamura, Yoji; Yanagimoto, Takashi; Tanaka, Hideki; Hasegawa, Daisuke; Asakura, Taiga; Kikuchi, Jun; Tomoda, Tsutomu; Kodama, Taketoshi			Molecular diet analysis of Anguilliformes leptocephalus larvae collected in the western North Pacific	PLOS ONE			English	Article							EEL-ANGUILLA-JAPONICA; ORGANIC-MATTER; GUT CONTENTS; FOOD; FISH; FEED	Natural diets of leptocephalus larvae have been enigmatic. In this study, we collected DNA samples from the gut contents and body surface of leptocephali belonging to the five Anguilliform families (Anguillidae, Chlopsidae, Congridae, Muraenidae, and Serrivomeridae) from the northwest Pacific and performed next-generation 18S rDNA sequencing. Wide variety of eukaryotes was detected in both samples, from which eight eukaryotic groups (jellyfish, conoid parasite, tunicate, copepod, krill, segmented worm, fungi, and dinoflagellate) were selected on the basis of abundance. All groups except conoid parasites were common in both the samples. Cnidarian 18S rDNA reads were the most abundant in both the samples; however, the number of samples having cnidarian reads and the read counts were significantly higher in the body surface scraping samples than in the gut content samples, regardless of careful rinsing of the body surface. These results indicate that the cnidarian DNAs are most likely found because of cross contamination from the body surface and/or environment. 18S rDNA read counts of copepod and tunicate in the gut contents were greater than or comparable with those in the body surface scraping samples, which may correspond to the previous observations of fecal pellets and larvacean houses in the leptocephali gut. Thus, the present study supports previous implications that leptocephali utilize detritus materials, so called marine snow.	[Chow, Seinen; Inaba, Nobuharu; Nagai, Satoshi; Kurogi, Hiroaki; Nakamura, Yoji; Yanagimoto, Takashi; Kodama, Taketoshi] Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Inaba, Nobuharu] Publ Works Res Inst, Civil Engn Res Inst Cold Reg, Sapporo, Hokkaido, Japan; [Tanaka, Hideki] Kindai Univ, Aquaculture Res Inst, Wakayama, Japan; [Hasegawa, Daisuke] Japan Fisheries Res & Educ Agcy, Tohoku Natl Fisheries Res Inst, Shiogama, Miyagi, Japan; [Asakura, Taiga; Kikuchi, Jun] RIKEN, Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Tomoda, Tsutomu] Japan Fisheries Res & Educ Agcy, Natl Res Inst Aquaculture, Shibushi Stn, Shibushi, Kagoshima, Japan	Japan Fisheries Research & Education Agency (FRA); PWRI: Public Works Research Institute; Japan Fisheries Research & Education Agency (FRA); RIKEN; Japan Fisheries Research & Education Agency (FRA)	Chow, S (corresponding author), Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan.	chow@affrc.go.jp	Hasegawa, Daisuke/ABF-2528-2021; Kikuchi, Jun/O-4725-2019; Kodama, Taketoshi/D-4305-2018	Hasegawa, Daisuke/0000-0002-8685-7042; Kikuchi, Jun/0000-0002-6809-394X; Inaba, Nobuharu/0000-0002-5115-0063; Chow, Seinen/0000-0001-9552-2669; Kodama, Taketoshi/0000-0001-8031-7881	Project of the Bio-oriented Technology Research Advancement Institution, NARO (the special scheme project on advanced research and development for next-generation technology)	Project of the Bio-oriented Technology Research Advancement Institution, NARO (the special scheme project on advanced research and development for next-generation technology)	This work was supported by grants from the Project of the Bio-oriented Technology Research Advancement Institution, NARO (the special scheme project on advanced research and development for next-generation technology) to DH.	Alexander EC, 1961, CONTRIBUTION LIFE HI, V53, P1; Ayala DJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24388-x; Butts IAE, 2016, AQUACULTURE, V464, P451, DOI 10.1016/j.aquaculture.2016.07.028; Cardona L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031329; Chow S, 2017, J FISH BIOL, V91, P1517, DOI 10.1111/jfb.13483; Chow S, 2017, AQUAT LIVING RESOUR, V30, DOI 10.1051/alr/2017037; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; Chow S, 2010, MAR ECOL PROG SER, V402, P233, DOI 10.3354/meps08448; D'Ambra I, 2015, MAR BIOL, V162, P247, DOI 10.1007/s00227-014-2569-5; D'Ambra I, 2014, MAR BIOL, V161, P473, DOI 10.1007/s00227-013-2345-y; Dzhembekova N, 2017, HARMFUL ALGAE, V68, P40, DOI 10.1016/j.hal.2017.07.004; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Feunteun E, 2015, PROG OCEANOGR, V137, P69, DOI 10.1016/j.pocean.2015.05.024; Fleming NEC, 2015, PEERJ, V3, DOI 10.7717/peerj.1110; Govoni JJ, 2010, SCI MAR, V74, P339, DOI 10.3989/scimar.2010.74n2339; Hagiwara A, 2014, AQUACULTURE, V432, P470, DOI 10.1016/j.aquaculture.2014.03.034; HULET WH, 1978, PHILOS T ROY SOC B, V282, P107, DOI 10.1098/rstb.1978.0010; Ingram BA, 2017, J PLANKTON RES, V39, P138, DOI 10.1093/plankt/fbw088; Javidpour J, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2892-0; Landry MR, 2001, DEEP-SEA RES PT II, V48, P2037, DOI 10.1016/S0967-0645(00)00172-7; MacKenzie KM, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3242-6; Miller MJ, 2019, ZOOL ANZ, V279, P138, DOI 10.1016/j.jcz.2019.01.008; Miller MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0826; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Miller MJ, 2011, COAST MAR SCI, V35, P277; Mitchell JR, 1971, THESIS; Miyazaki S, 2011, MAR BIOL, V158, P2555, DOI 10.1007/s00227-011-1756-x; MOCHIOKA N, 1993, ENVIRON BIOL FISH, V36, P381, DOI 10.1007/BF00012416; Mochioka N, 1996, MAR BIOL, V125, P447; Moser HG, 1981, MARINE FISH LARVAE M, P90; NEWMAN MW, 1975, J PARASITOL, V61, P554, DOI 10.2307/3279346; O'Rorke R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042757; OTAKE T, 1993, MAR ECOL PROG SER, V92, P27, DOI 10.3354/meps092027; Otake T, 1996, FISHERIES SCI, V62, P28, DOI 10.2331/fishsci.62.28; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Quattrini AM, 2019, J FISH BIOL, V94, P621, DOI 10.1111/jfb.13933; Riemann L, 2010, BIOL LETTERS, V6, P819, DOI 10.1098/rsbl.2010.0411; Saunders MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036580; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Sun D, 2019, ACTA OCEANOL SIN, V38, P32, DOI 10.1007/s13131-018-1237-x; Sun D, 2017, J MARINE SYST, V169, P52, DOI 10.1016/j.jmarsys.2017.01.011; Suzuki N, 2008, MAR BIOTECHNOL, V10, P49, DOI 10.1007/s10126-007-9038-9; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; TANAKA H, 1995, FISHERIES SCI, V61, P171, DOI 10.2331/fishsci.61.171; Tanaka H, 2001, AQUACULTURE, V201, P51, DOI 10.1016/S0044-8486(01)00553-1; Terahara T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025715; Tilves U, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3381-4; Tomoda T, 2018, NIPPON SUISAN GAKK, V84, P32, DOI 10.2331/suisan.17-00025; Tomoda T, 2015, NIPPON SUISAN GAKK, V81, P715, DOI 10.2331/suisan.81.715; Tremblay J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00771; Wang M, 2014, REV AQUACULT, V6, P270, DOI 10.1111/raq.12044; Wullur S, 2013, AQUAC SCI, V61, P341, DOI DOI 10.11233/aquaculturesci.61.341; Zeman SM, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3404-1	53	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225610	10.1371/journal.pone.0225610	http://dx.doi.org/10.1371/journal.pone.0225610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774866	Green Published, gold			2022-12-26	WOS:000533896400043
J	Gaignon, P; Le Grand, K; Laza-Knoerr, AL; Hurtaud, C; Boudon, A				Gaignon, Pierre; Le Grand, Karine; Laza-Knoerr, Anca-Lucia; Hurtaud, Catherine; Boudon, Anne			Effect of calcium intake and the dietary cation-anion difference during early lactation on the bone mobilization dynamics throughout lactation in dairy cows	PLOS ONE			English	Article							MILK FEVER; PHOSPHORUS; METABOLISM; HYPOCALCEMIA; MAGNESIUM; MARKERS; COAGULATION; HOMEOSTASIS; TRANSITION; PREVENTION	This study investigated the consequences of a low supply of dietary Ca with or without a low dietary cation-anion difference (DCAD) during early lactation on bone mobilization and reconstitution during lactation and on the dynamics of milk Ca content. Fifteen multiparous Holstein cows were distributed among 3 treatments 5 weeks before their expected calving date. These treatments differed based on the provision of diets through the first 10 weeks of lactation. During this period, the control treatment (NCa) consisted of a diet providing 100% of the Ca requirement, with a DCAD of 200 mEq/kg dry matter (DM). The LCa (low Ca) and LCaLD (low Ca, low DCAD) treatments consisted of diets providing 70% of the Ca requirement, with a DCAD of 200 and 0 mEq/kg DM, respectively. After 10 weeks, all cows received the same total mixed ration, which was formulated to meet 100% of the Ca requirement. LCa and LCaLD tended to decrease the body retention of Ca at 3 weeks of lactation compared with NCa but affected neither the dynamics of the blood biomarkers of bone formation and resorption during lactation nor the body retention of Ca at 17 weeks of lactation. Cows almost entirely compensated for the decrease in Ca supply caused by LCa and LCaLD by increasing their apparent digestive absorption of Ca at 3 weeks of lactation, whereas their apparent digestive absorption was unaffected by the treatments at 17 weeks of lactation. Milk production tended to be lower throughout lactation with LCa and LCaLD compared with NCa, with a mean difference of 2 kg/d. The results of this study also indicated that measuring the dynamics of milk Ca content during lactation cannot be considered effective for indirectly estimating the dynamics of bone mobilization in cows. The results also suggested that limited Ca intake at the beginning of lactation may have deleterious effects on milk production.	[Gaignon, Pierre; Hurtaud, Catherine; Boudon, Anne] INRA, PEGASE, Agrocampus Ouest, St Gilles, France; [Le Grand, Karine] Phosphea, Dinard, France; [Laza-Knoerr, Anca-Lucia] CMI, St Malo, France	INRAE; Institut Agro; Agrocampus Ouest	Boudon, A (corresponding author), INRA, PEGASE, Agrocampus Ouest, St Gilles, France.	anne.boudon@inra.fr		Gaignon, Pierre/0000-0002-8533-0134; Hurtaud, Catherine/0000-0002-3965-826X	Agro Innovation International -Centre Mondial de l'Innovation; Region Bretagne; Institut National de la Recherche Agronomique (INRA); Unite Mixte de Recherches INRA -Agrocampus Ouest "Physiologie, Environnement et Genetique pour l'Animal et les Systemes d'E levage"	Agro Innovation International -Centre Mondial de l'Innovation; Region Bretagne(Region Bretagne); Institut National de la Recherche Agronomique (INRA); Unite Mixte de Recherches INRA -Agrocampus Ouest "Physiologie, Environnement et Genetique pour l'Animal et les Systemes d'E levage"	This study was funded by Agro Innovation International -Centre Mondial de l'Innovation (https://www.roullier.com/fr/expertises/innovation) and Region Bretagne (https://www.bretagne.bzh/), recipient Anne Boudon. This study was also funded by Institut National de la Recherche Agronomique (INRAhttp://www.inra.fr/) and Unite Mixte de Recherches INRA -Agrocampus Ouest "Physiologie, Environnement et Genetique pour l'Animal et les Systemes d'E levage" (https://www6.rennes.inra.fr/pegase). Pierre Gaignon salary was funded by Agro Innovation International -Centre Mondial de l'Innovation and Region Bretagne. The funder provided support in the form of salaries for authors AL and KL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	*AFRC, 1991, NUTR ABSTR REV B, V61, P573; Anderson ST, 2017, ANIM PROD SCI, V57, P2291, DOI 10.1071/AN17363; BECKER R. B., 1934, JOUR DAIRY SCI, V17, P1, DOI 10.3168/jds.S0022-0302(34)93213-6; Beighle DE, 1999, J S AFR VET ASSOC, V70, P142; BENZIE D., 1955, Journal of Agricultural Science, V46, P425, DOI 10.1017/S0021859600040491; BRAITHWAITE GD, 1983, BRIT J NUTR, V50, P711, DOI 10.1079/BJN19830143; Bushinsky DA, 2010, CLIN J AM SOC NEPHRO, V5, pS12, DOI 10.2215/CJN.05970809; Caixeta LS, 2017, THERIOGENOLOGY, V94, P1, DOI 10.1016/j.theriogenology.2017.01.039; Charbonneau E, 2006, J DAIRY SCI, V89, P537, DOI 10.3168/jds.S0022-0302(06)72116-6; DeGaris PJ, 2008, VET J, V176, P58, DOI 10.1016/j.tvjl.2007.12.029; Dixon RM, 2017, ANIM PROD SCI, V57, P2280, DOI 10.1071/AN17324; Ekelund A, 2006, LIVEST SCI, V99, P227, DOI 10.1016/j.livprodsci.2005.07.001; Gaignon P, 2018, J DAIRY SCI, V101, P4554, DOI 10.3168/jds.2017-14043; Gaignon P., 2018, THESIS; Goff JP, 2014, J DAIRY SCI, V97, P1520, DOI 10.3168/jds.2013-7467; Goff JP, 2018, J DAIRY SCI, V101, P5033, DOI 10.3168/jds.2017-13832; Goff JP, 2006, ANIM FEED SCI TECH, V126, P237, DOI 10.1016/j.anifeedsci.2005.08.005; HORST RL, 1990, ENDOCRINOLOGY, V126, P1053, DOI 10.1210/endo-126-2-1053; Horst RL, 2005, J MAMMARY GLAND BIOL, V10, P141, DOI 10.1007/s10911-005-5397-x; HORST RL, 1986, J DAIRY SCI, V69, P604, DOI 10.3168/jds.S0022-0302(86)80445-3; Horst RL, 1997, J DAIRY SCI, V80, P1269, DOI 10.3168/jds.S0022-0302(97)76056-9; Horst RL, 1997, J MAMMARY GLAND BIOL, V2, P253, DOI 10.1023/A:1026384421273; HURTAUD C, 1993, J DAIRY SCI, V76, P3011, DOI 10.3168/jds.S0022-0302(93)77640-7; INRA, 2010, AL BOV OV CAPR BES A; INRA, 2018, INRA FEEDING SYSTEM, DOI [10.3920/978-90-8686-292-4, DOI 10.3920/978-90-8686-292-4]; Iwama Yuko, 2004, Animal Science Journal, V75, P213, DOI 10.1111/j.1740-0929.2004.00178.x; Liesegang A, 2000, J DAIRY SCI, V83, P1773, DOI 10.3168/jds.S0022-0302(00)75048-X; Liu SW, 2012, PSYCHOL METHODS, V17, P15, DOI 10.1037/a0026971; Malacarne M, 2014, J DAIRY RES, V81, P129, DOI 10.1017/S0022029913000630; McNeill DM, 2002, AUST J AGR RES, V53, P755, DOI 10.1071/AR01100; Moreira VR, 2009, J DAIRY SCI, V92, P5189, DOI 10.3168/jds.2009-2289; Mundy GR, 1999, CLIN CHEM, V45, P1347; National Research Council (NRC), 2001, NUTR REQ DAIR CATTL; PIEN J, 1969, Lait, V49, P175, DOI 10.1051/lait:1969483-48410; Puggaard L, 2014, LIVEST SCI, V159, P18, DOI 10.1016/j.livsci.2013.10.009; REINHARDT TA, 1988, VET CLIN N AM-FOOD A, V4, P331, DOI 10.1016/S0749-0720(15)31052-5; Salazar JAE, 2013, J ANIM PHYSIOL AN N, V97, P502, DOI 10.1111/j.1439-0396.2012.01291.x; Seibel M J, 2000, Osteoporos Int, V11 Suppl 6, pS18; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P306, DOI 10.1079/9781845934729.0306; Taylor MS, 2009, J DAIRY SCI, V92, P223, DOI 10.3168/jds.2008-1345; van Hulzen KJE, 2009, J DAIRY SCI, V92, P5754, DOI 10.3168/jds.2009-2406; VanHouten J, 2004, J CLIN INVEST, V113, P598, DOI 10.1172/JCI200418776; WOHLT JE, 1986, J DAIRY SCI, V69, P2815, DOI 10.3168/jds.S0022-0302(86)80735-4; Wu Z, 2001, J DAIRY SCI, V84, P1738, DOI 10.3168/jds.S0022-0302(01)74609-7; Pinto MCX, 2015, CELL SIGNAL, V27, P2139, DOI 10.1016/j.cellsig.2015.08.006	45	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0218979	10.1371/journal.pone.0218979	http://dx.doi.org/10.1371/journal.pone.0218979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774817	Green Submitted, Green Published, gold			2022-12-26	WOS:000533896400004
J	Koelmel, JP; Campbell, JE; Guingab-Cagmat, J; Meke, L; Garrett, TJ; Stingl, U				Koelmel, Jeremy P.; Campbell, Justin E.; Guingab-Cagmat, Joy; Meke, Laurel; Garrett, Timothy J.; Stingl, Ulrich			Re-modeling of foliar membrane lipids in a seagrass allows for growth in phosphorus-deplete conditions	PLOS ONE			English	Article							N-P RATIOS; FLORIDA BAY; PHOSPHOLIPIDS; PHYTOPLANKTON; BIOSYNTHESIS; REPLACEMENT; LIMITATION	In this study, we used liquid chromatography high-resolution tandem mass spectrometry to analyze the lipidome of turtlegrass (Thalassia testudinum) leaves with either extremely high phosphorus content or extremely low phosphorus content. Most species of phospholipids were significantly down-regulated in phosphorus-deplete leaves, whereas diacylglyceryl-trimethylhomoserine (DGTS), triglycerides (TG), galactolipid digalactosyldiacylglycerol (DGDG), certain species of glucuronosyldiacylglycerols (GlcADG), and certain species of sulfoquinovosyl diacylglycerol (SQDG) were significantly upregulated, accounting for the change in phosphorus content, as well as structural differences in the leaves of plants growing across regions of varying elemental availability. These data suggest that seagrasses are able to modify the phosphorus content in leaf membranes dependent upon environmental availability.	[Koelmel, Jeremy P.; Guingab-Cagmat, Joy; Meke, Laurel; Garrett, Timothy J.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Campbell, Justin E.] Florida Int Univ, Inst Water & Environm, Dept Biol Sci, North Miami, FL USA; [Stingl, Ulrich] Univ Florida, UF IFAS Ft Lauderdale Res & Educ Ctr, Dept Microbiol & Cell Sci, Davie, FL 33314 USA	State University System of Florida; University of Florida; State University System of Florida; Florida International University; State University System of Florida; University of Florida	Stingl, U (corresponding author), Univ Florida, UF IFAS Ft Lauderdale Res & Educ Ctr, Dept Microbiol & Cell Sci, Davie, FL 33314 USA.	ustingl@ufl.edu	Stingl, Uli/H-1191-2014	Stingl, Uli/0000-0002-0684-2597				Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; [Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Armitage AR, 2011, ECOSYSTEMS, V14, P430, DOI 10.1007/s10021-011-9421-2; ATKINSON MJ, 1983, LIMNOL OCEANOGR, V28, P568, DOI 10.4319/lo.1983.28.3.0568; Barry SC, 2017, MAR ECOL PROG SER, V570, P57, DOI 10.3354/meps12112; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benning C, 1998, ANNU REV PLANT PHYS, V49, P53, DOI 10.1146/annurev.arplant.49.1.53; Campbell JE, 2018, J ECOL, V106, P401, DOI 10.1111/1365-2745.12862; Dean AP, 2010, BIORESOURCE TECHNOL, V101, P4499, DOI 10.1016/j.biortech.2010.01.065; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P201, DOI 10.3354/meps067201; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOURQUREAN JW, 1993, ESTUAR COAST SHELF S, V36, P295, DOI 10.1006/ecss.1993.1018; FOURQUREAN JW, 1992, LIMNOL OCEANOGR, V37, P162, DOI 10.4319/lo.1992.37.1.0162; FOURQUREAN JW, 1992, MAR BIOL, V114, P57; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; KHOTIMCHENKO SV, 1993, PHYTOCHEMISTRY, V33, P369, DOI 10.1016/0031-9422(93)85520-2; Kirpich AS, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2134-1; Koelmel JP, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1744-3; MINNIKIN DE, 1974, NATURE, V249, P268, DOI 10.1038/249268a0; Okazaki Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2512; Patterson RE, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1280-1; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; R Development Core Team, 2016, R LANG ENV STAT COMP; Riekhof WR, 2014, EUKARYOT CELL, V13, P749, DOI 10.1128/EC.00004-14; Tjellstrom H, 2008, PLANT CELL ENVIRON, V31, P1388, DOI 10.1111/j.1365-3040.2008.01851.x; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Xia J, 2011, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]	30	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0218690	10.1371/journal.pone.0218690	http://dx.doi.org/10.1371/journal.pone.0218690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774814	Green Submitted, gold, Green Published			2022-12-26	WOS:000533896400003
J	Konig, M; Sander, A; Demuth, I; Diekmann, D; Steinhagen-Thiessen, E				Koenig, Maximilian; Sander, Andre; Demuth, Ilja; Diekmann, Daniel; Steinhagen-Thiessen, Elisabeth			Knowledge-based best of breed approach for automated detection of clinical events based on German free text digital hospital discharge letters	PLOS ONE			English	Article							PUMP INHIBITOR USE; OLDER-ADULTS; SYSTEM; EXTRACTION	Objectives The secondary use of medical data contained in electronic medical records, such as hospital discharge letters, is a valuable resource for the improvement of clinical care (e.g. in terms of medication safety) or for research purposes. However, the automated processing and analysis of medical free text still poses a huge challenge to available natural language processing (NLP) systems. The aim of this study was to implement a knowledge-based best of breed approach, combining a terminology server with integrated ontology, a NLP pipeline and a rules engine. Methods We tested the performance of this approach in a use case. The clinical event of interest was the particular drug-disease interaction "proton-pump inhibitor [PPI] use and osteoporosis". Cases were to be identified based on free text digital discharge letters as source of information. Automated detection was validated against a gold standard. Results Precision of recognition of osteoporosis was 94.19%, and recall was 97.45%. PPIs were detected with 100% precision and 97.97% recall. The F-score for the detection of the given drug-disease-interaction was 96,13%. Conclusion We could show that our approach of combining a NLP pipeline, a terminology server, and a rules engine for the purpose of automated detection of clinical events such as drug-disease interactions from free text digital hospital discharge letters was effective. There is huge potential for the implementation in clinical and research contexts, as this approach enables analyses of very high numbers of medical free text documents within a short time period.	[Koenig, Maximilian; Demuth, Ilja; Steinhagen-Thiessen, Elisabeth] Charite Univ Med Berlin, Berlin, Germany; [Koenig, Maximilian; Demuth, Ilja; Steinhagen-Thiessen, Elisabeth] Free Univ Berlin, Berlin, Germany; [Koenig, Maximilian; Demuth, Ilja; Steinhagen-Thiessen, Elisabeth] Humboldt Univ, Berlin, Germany; [Koenig, Maximilian; Demuth, Ilja; Steinhagen-Thiessen, Elisabeth] Berlin Inst Hlth, Lipid Clin, Interdisciplinary Metab Ctr, Berlin, Germany; [Koenig, Maximilian] Berlin Inst Hlth, Dept Nephrol & Internal Intens Care Med Berlin, Berlin, Germany; [Sander, Andre; Diekmann, Daniel] ID Informat & Dokumentat Gesundheitswesen GmbH, Berlin, Germany; [Demuth, Ilja] Charite Univ Med Berlin, BCRT Berlin Inst Hlth, Ctr Regenerat Therapies, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Konig, M (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Konig, M (corresponding author), Free Univ Berlin, Berlin, Germany.; Konig, M (corresponding author), Humboldt Univ, Berlin, Germany.; Konig, M (corresponding author), Berlin Inst Hlth, Lipid Clin, Interdisciplinary Metab Ctr, Berlin, Germany.; Konig, M (corresponding author), Berlin Inst Hlth, Dept Nephrol & Internal Intens Care Med Berlin, Berlin, Germany.	koenig.maximilian@charite.de	König, Maximilian/AAD-8221-2021; Demuth, Ilja/ABD-5352-2021	König, Maximilian/0000-0003-4873-5519; Demuth, Ilja/0000-0002-4340-2523	German Federal Ministry of education and Research [BMBF] [16SV5536K, 16SV5537, 16SV5538, 16SV5837, 01UW0808]; Max Planck Society, Munich, Germany; ID Information und Dokumentation im Gesundheitswesen GmbH Co KGaA	German Federal Ministry of education and Research [BMBF](Federal Ministry of Education & Research (BMBF)); Max Planck Society, Munich, Germany(Max Planck Society); ID Information und Dokumentation im Gesundheitswesen GmbH Co KGaA	BASE-II was funded by the German Federal Ministry of education and Research [BMBF (grant numbers 16SV5536K, 16SV5537, 16SV5538, 16SV5837, and 01UW0808) and the Max Planck Society, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ID Information und Dokumentation im Gesundheitswesen GmbH & Co KGaA provided funding in the form of salaries for authors [MK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors did not receive any funding. The authors were licensed to use the software ID LOGIK (R) without charge.	Amancio DR, CONCENTRIC NETWORK S; Ammenwerth E, 2014, DTSCH ARZTEBL INT, V111, P1195; Bache R, 2013, J AM MED INFORM ASSN, V20, pE327, DOI 10.1136/amiajnl-2013-001858; Bertram L, 2014, INT J EPIDEMIOL, V43, P703, DOI 10.1093/ije/dyt018; Cui Licong, 2012, AMIA Annu Symp Proc, V2012, P1191; Davis K, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-37; Ferrisa A., 2015, MEDINFO 2015 EHEALTH; George CJ, 2008, AM J GERIATR PHARMAC, V6, P249, DOI 10.1016/j.amjopharm.2008.12.001; Gerstorf D, 2016, GERONTOLOGY, V62, P311, DOI 10.1159/000441495; Hahn U, 2018, STUD HEALTH TECHNOL, V247, P26, DOI 10.3233/978-1-61499-852-5-26; Hazlehurst B, 2005, J AM MED INFORM ASSN, V12, P517, DOI 10.1197/jamia.M1771; Huynh T, 2016, P 26 INT C COMP LING, P877; Iqbal E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187121; Iqbal E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134208; Jungmann F, 2019, RADIOLOGE, V59, P828, DOI 10.1007/s00117-019-0555-0; Kayaalp Mehmet, 2017, AMIA Annu Symp Proc, V2017, P1044; Khalili H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e372; Kolditz T, 2019, STUD HEALTH TECHNOL, V264, P203, DOI 10.3233/SHTI190212; Liu SY, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/6918381; Lopprich M, 2016, METHOD INFORM MED, V55, P373, DOI 10.3414/ME15-02-0019; Lohr C., 2018, LREC; Maes ML, 2017, THER ADV DRUG SAF, V8, P273, DOI 10.1177/2042098617715381; Melton CB, 2005, J AM MED INFORM ASSN, V12, P448, DOI 10.1197/jamia.M1794; Meystre S M, 2008, Yearb Med Inform, P128; Mossner J, 2016, DTSCH ARZTEBL INT, V113, P477, DOI 10.3238/arztebl.2016.0477; Othman F, 2016, PHARMACOEPIDEM DR S, V25, P1079, DOI 10.1002/pds.4043; PRYOR TA, 1993, INT J CLIN MONIT COM, V10, P215, DOI 10.1007/BF01133012; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Rea S, 2012, J BIOMED INFORM, V45, P763, DOI 10.1016/j.jbi.2012.01.009; Richter-Pechanski Phillip, 2018, Stud Health Technol Inform, V253, P165; Riedl Bill, 2010, AMIA Annu Symp Proc, V2010, P677; Sander A, 2019, J BIOMED SEMANT, V10, DOI 10.1186/s13326-019-0199-z; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Sheikh-Taha M, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0623-1; Tang BZ, 2013, J AM MED INFORM ASSN, V20, P828, DOI 10.1136/amiajnl-2013-001635; Toepfer M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0215-x; Trick WE, 2003, INFECT CONT HOSP EP, V24, P950, DOI 10.1086/502165; WINGERT F, 1987, METHOD INFORM MED, V26, P93; WINGERT F, 1986, METHOD INFORM MED, V25, P22; Yang L, TOPICAL WORD EMBEDDI; Yu H, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P919	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0224916	10.1371/journal.pone.0224916	http://dx.doi.org/10.1371/journal.pone.0224916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8SS	31774830	Green Published, gold, Green Submitted			2022-12-26	WOS:000533896400020
J	Marcusson-Clavertz, D; West, M; Kjell, ONE; Somer, E				Marcusson-Clavertz, David; West, Melina; Kjell, Oscar N. E.; Somer, Eli			A daily diary study on maladaptive daydreaming, mind wandering, and sleep disturbances: Examining within-person and between-persons relations	PLOS ONE			English	Article							METAANALYSIS; DURATION; DEPRIVATION; IMPAIRMENT; SCALE; NIGHT	Cross-sectional and experimental research have shown that task-unrelated thoughts (i.e., mind wandering) relate to sleep disturbances, but there is little research on whether this association generalizes to the day-level and other kinds of task-unrelated mentation. We employed a longitudinal daily diary design to examine the within-person and between-person associations between three self-report instruments measuring mind wandering, maladaptive daydreaming (a condition characterized by having elaborate fantasy daydreams so insistent that they interfere with daily functioning) and sleep disturbances. A final sample of 126 participants self-identified as experiencing maladaptive daydreaming completed up to 8 consecutive daily reports (in total 869 daily observations). The scales showed acceptable-to-excellent within-person reliability (i.e., systematic day-to-day change) and excellent between-person reliability. The proportion of between-person variance was 36% for sleep disturbances, 57% for mind wandering, and 75% for maladaptive daydreaming, respectively (the remaining being stochastic and systematic within-person variance). Contrary to our pre-registered hypothesis, maladaptive daydreaming did not significantly predict sleep disturbances the following night, B = -0.00 (SE = 0.04), p =.956. Exploratory analyses indicated that while nightly sleep disturbances predicted mind wandering the following day, B = 0.20 (SE = 0.04), p <.001, it did not significantly predict maladaptive daydreaming the following day, B = -0.04 (SE = 0.05), p =.452. Moreover, daily mind wandering did not significantly predict sleep disturbances the following night, B = 0.02 (SE = 0.05), p =.731. All variables correlated at the between-person level. We discuss the implications concerning the differences between maladaptive daydreaming and mind wandering and the possibility of targeting sleep for mind wandering interventions.	[Marcusson-Clavertz, David; Kjell, Oscar N. E.] Lund Univ, Dept Psychol, Lund, Sweden; [Marcusson-Clavertz, David] Ludwig Maximilian Univ Munich, Dept Psychol, Munich, Germany; [West, Melina] Univ Connecticut, Dept Psychol Sci, Storrs, CT USA; [Somer, Eli] Univ Haifa, Sch Social Work, Haifa, Israel	Lund University; University of Munich; University of Connecticut; University of Haifa	Marcusson-Clavertz, D (corresponding author), Lund Univ, Dept Psychol, Lund, Sweden.; Marcusson-Clavertz, D (corresponding author), Ludwig Maximilian Univ Munich, Dept Psychol, Munich, Germany.	David.marcusson-clavertz@psy.lu.se		West, Melina/0000-0002-4187-9010; Marcusson-Clavertz, David/0000-0002-0730-9954; Somer, Eli/0000-0002-1435-1763				Abu-Rayya HM, 2019, PSYCHOL CONSCIOUS, V6, P171, DOI 10.1037/cns0000183; Allen M, 2019, WELLCOME OPEN RES, V4, P63, DOI 10.12688/wellcomeopenres.15191.1; Bershtling O., 2018, QUALITATIVE REPORT, V23; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Carciofo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091285; Chee MWL, 2019, PROG BRAIN RES, V246, P159, DOI 10.1016/bs.pbr.2019.02.009; Cox RC, 2016, COGNITIVE THER RES, V40, P107, DOI 10.1007/s10608-015-9713-5; Cranford JA, 2006, PERS SOC PSYCHOL B, V32, P917, DOI 10.1177/0146167206287721; Fergus TA, 2017, BEHAV SLEEP MED, V15, P410, DOI 10.1080/15402002.2016.1141771; Hanish AE, 2017, NURS RES, V66, P246, DOI 10.1097/NNR.0000000000000217; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Jansson-Frojmark M, 2012, J PSYCHOSOM RES, V72, P103, DOI 10.1016/j.jpsychores.2011.10.005; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Koppel S, 2019, ACCIDENT ANAL PREV, V123, P88, DOI 10.1016/j.aap.2018.11.013; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lin CC, 2014, NEUROBIOL LEARN MEM, V116, P69, DOI 10.1016/j.nlm.2014.08.011; Marcusson-Clavertz D, 2019, EUR J PSYCHOL ASSESS, V35, P878, DOI 10.1027/1015-5759/a000470; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; Mrazek MD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00560; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Nobakht HN, 2019, DREAMING, V29, P79, DOI 10.1037/drm0000095; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Ottaviani C, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00524; Poh JH, 2016, J EXP PSYCHOL GEN, V145, P1312, DOI 10.1037/xge0000207; Raman S, 2019, HBK BEHAV NEUROSCI, V30, P707, DOI 10.1016/B978-0-12-813743-7.00047-5; Randall JG, 2014, PSYCHOL BULL, V140, P1411, DOI 10.1037/a0037428; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Schubert JR, 2020, BEHAV SLEEP MED, V18, P500, DOI 10.1080/15402002.2019.1615490; Scott SB, 2018, ASSESSMENT; Seli P, 2018, TRENDS COGN SCI, V22, P479, DOI 10.1016/j.tics.2018.03.010; Seli P, 2015, PSYCHOL RES-PSYCH FO, V79, P750, DOI 10.1007/s00426-014-0617-x; Sheehan CM, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy221; Smallwood J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00441; Soffer-Dudek N, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00194; Somer E., 2002, J CONTEMP PSYCHOTHER, V32, P197, DOI [10.1023/A:1020597026919, DOI 10.1023/A:1020597026919]; Somer E, 2019, INT J MENT HEALTH AD, V17, P206, DOI 10.1007/s11469-018-0011-9; Somer E, 2017, J NERV MENT DIS, V205, P525, DOI 10.1097/NMD.0000000000000685; Somer E, 2016, J TRAUMA DISSOCIATIO, V17, P561, DOI 10.1080/15299732.2016.1160463; Somer E, 2016, CONSCIOUS COGN, V39, P77, DOI 10.1016/j.concog.2015.12.001; STARKER S, 1976, J NERV MENT DIS, V163, P391, DOI 10.1097/00005053-197612000-00002; Van Der Kloet D, 2013, COMPR PSYCHIAT, V54, P658, DOI 10.1016/j.comppsych.2012.12.025; Was CA, 2019, COMPUT EDUC, V135, P113, DOI 10.1016/j.compedu.2019.02.020; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266; Zhao R, 2019, NEUROSCIENCE, V398, P37, DOI 10.1016/j.neuroscience.2018.11.049	45	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0225529	10.1371/journal.pone.0225529	http://dx.doi.org/10.1371/journal.pone.0225529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8SS	31774836	gold, Green Published			2022-12-26	WOS:000533896400038
J	Ellsworth, JL; Gingras, J; Smith, LJ; Rubin, H; Seabrook, TA; Patel, K; Zapata, N; Olivieri, K; O'Callaghan, M; Chlipala, E; Morales, P; Seymour, A				Ellsworth, Jeff L.; Gingras, Jacinthe; Smith, Laura J.; Rubin, Hillard; Seabrook, Tania A.; Patel, Kruti; Zapata, Nicole; Olivieri, Kevin; O'Callaghan, Michael; Chlipala, Elizabeth; Morales, Pablo; Seymour, Albert			Clade F AAVHSCs cross the blood brain barrier and transduce the central nervous system in addition to peripheral tissues following intravenous administration in nonhuman primates	PLOS ONE			English	Article							GENE-TRANSFER; ADULT MICE; DELIVERY; THERAPY; AAV9; TRANSPORT; TRANSCYTOSIS; VECTORS; VIRUSES; BIOLOGY	The biodistribution of AAVHSC7, AAVHSC15, and AAVHSC17 following systemic delivery was assessed in cynomolgus macaques (Macaca fascicularis). Animals received a single intravenous (IV) injection of a self-complementary AAVHSC-enhanced green fluorescent protein (eGFP) vector and tissues were harvested at two weeks post-dose for anti-eGFP immunohistochemistry and vector genome analyses. IV delivery of AAVHSC vectors produced widespread distribution of eGFP staining in glial cells throughout the central nervous system, with the highest levels seen in the pons and lateral geniculate nuclei (LGN). eGFP-positive neurons were also observed throughout the central and peripheral nervous systems for all three AAVHSC vectors including brain, spinal cord, and dorsal root ganglia (DRG) with staining evident in neuronal cell bodies, axons and dendritic arborizations. Co-labeling of sections from brain, spinal cord, and DRG with anti-eGFP antibodies and cell-specific markers confirmed eGFP-staining in neurons and glia, including protoplasmic and fibrous astrocytes and oligodendrocytes. For all capsids tested, 50 to 70% of glial cells (S100-beta+) and on average 8% of neurons (NeuroTrace+) in the LGN were positive for eGFP expression. In the DRG, 45 to 62% of neurons and 8 to 12% of satellite cells were eGFP-positive for the capsids tested. eGFP staining was also observed in peripheral tissues with abundant staining in hepatocytes, skeletal- and cardio-myocytes and in acinar cells of the pancreas. Biodistribution of AAVHSC vector genomes in the central and peripheral organs generally correlated with eGFP staining and were highest in the liver for all AAVHSC vectors tested. These data demonstrate that AAVHSCs have broad tissue tropism and cross the bloodnerve and blood-brain-barriers following systemic delivery in nonhuman primates, making them suitable gene editing or gene transfer vectors for therapeutic application in human genetic diseases.	[Ellsworth, Jeff L.; Gingras, Jacinthe; Smith, Laura J.; Rubin, Hillard; Seabrook, Tania A.; Patel, Kruti; Zapata, Nicole; Olivieri, Kevin; O'Callaghan, Michael; Seymour, Albert] Homol Med Inc, Bedford, MA 01730 USA; [Chlipala, Elizabeth] Premier Lab LLC, Boulder, CO USA; [Morales, Pablo] Mannheimer Fdn Inc, Homestead, FL USA		Ellsworth, JL (corresponding author), Homol Med Inc, Bedford, MA 01730 USA.	jellsworth@homologymedicines.com		Smith, Laura/0000-0002-2242-4213; Chlipala, Elizabeth/0000-0002-2194-7645	Homology Medicines, Inc.	Homology Medicines, Inc.	The work described in this manuscript was funded in its entirety by Homology Medicines, Inc. The funder provided support in the form of salaries for authors [JLE, JG, LJS, HR, TAS, KP, NZ, KO, MO, AS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. EC is an employee of and received salary support from Premier Laboratory, LLC and performed immunohistochemistry under contract with Homology Medicines, Inc. Premier Laboratory, LLC did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. PM is an employee of and received salary support from The Mannheimer Foundation, Inc. and performed the in-life biodistribution studies in nonhuman primates under contract with Homology Medicines, Inc. The Mannheimer Foundation did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2018, MOL THER, V26, P252; Albright BH, 2018, MOL THER, V26, P510, DOI 10.1016/j.ymthe.2017.10.017; [Anonymous], 2019, AVEXIS RECEIVES FDA; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Colella P, 2018, MOL THER-METH CLIN D, V8, P87, DOI 10.1016/j.omtm.2017.11.007; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Dudek AM, 2018, J VIROL, V92, DOI 10.1128/JVI.02213-17; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Edwards TL, 2016, NEW ENGL J MED, V374, P1996, DOI 10.1056/NEJMc1509501; Ellsworth JL, 2018, HUM GENE THER CL DEV, V29, P60, DOI 10.1089/humc.2017.239; Ellsworth JL, 2017, MOL THER, V25, P262; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; George LA, 2017, NEW ENGL J MED, V377, P2215, DOI 10.1056/NEJMoa1708538; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Hinderer C, 2018, HUM GENE THER, V29, P285, DOI 10.1089/hum.2018.015; Hordeaux J, 2019, MOL THER, V27, P912, DOI 10.1016/j.ymthe.2019.02.013; Hordeaux J, 2018, MOL THER, V26, P664, DOI 10.1016/j.ymthe.2018.01.018; Hudry E, 2018, MOL THER-METH CLIN D, V10, P197, DOI 10.1016/j.omtm.2018.07.006; Jackson KL, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.36; Kanaan NM, 2017, MOL THER-NUCL ACIDS, V8, P184, DOI 10.1016/j.omtn.2017.06.011; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Markel SF, 2017, J NEUROCHEM, V140, P216, DOI 10.1111/jnc.13861; Matsuzaki Y, 2018, NEUROSCI LETT, V665, P182, DOI 10.1016/j.neulet.2017.11.049; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Metzner C, 2008, VIROLOGY, V382, P125, DOI 10.1016/j.virol.2008.09.014; Murlidharan G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00076; Nonnenmacher M, 2012, GENE THER, V19, P649, DOI 10.1038/gt.2012.6; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]; Patricio MI, 2018, EXPERT OPIN BIOL TH, V18, P807, DOI 10.1080/14712598.2018.1484448; Penaud-Budloo M, 2018, MOL THER-METH CLIN D, V8, P166, DOI 10.1016/j.omtm.2018.01.002; Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465; Saraiva J, 2016, J CONTROL RELEASE, V241, P94, DOI 10.1016/j.jconrel.2016.09.011; Saunders NR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00404; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Smith LJ, 2018, P NATL ACAD SCI USA, V115, pE7379, DOI 10.1073/pnas.1802343115; Smith LJ, 2014, MOL THER, V22, P1625, DOI 10.1038/mt.2014.107; Smith LJ, 2010, MOL THER, V18, pS1; Wang D, 2018, MOL THER-METH CLIN D, V9, P234, DOI 10.1016/j.omtm.2018.03.004; Wang D, 2018, MOL THER, V26, P336, DOI 10.1016/j.ymthe.2018.01.005; Weber-Adrian D, 2017, J NEUROCHEM, V140, P192, DOI 10.1111/jnc.13898; Yang B, 2014, MOL THER, V22, P1299, DOI 10.1038/mt.2014.68	46	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225582	10.1371/journal.pone.0225582	http://dx.doi.org/10.1371/journal.pone.0225582			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770409	Green Published, gold			2022-12-26	WOS:000533892300027
J	LeBrun, EG; Plowes, RM; Folgarait, PJ; Bollazzi, M; Gilbert, LE				LeBrun, Edward G.; Plowes, Robert M.; Folgarait, Patricia J.; Bollazzi, Martin; Gilbert, Lawrence E.			Ritualized aggressive behavior reveals distinct social structures in native and introduced range tawny crazy ants	PLOS ONE			English	Article							INTRASPECIFIC AGGRESSION; NESTMATE RECOGNITION; INVASIVE ANT; WASMANNIA-AUROPUNCTATA; COLONY STRUCTURE; ARGENTINE ANTS; SUPERCOLONIES; HYMENOPTERA; POPULATIONS; FORMICIDAE	How workers within an ant colony perceive and enforce colony boundaries is a defining biological feature of an ant species. Ants fall along a spectrum of social organizations ranging from single-queen, single nest societies to species with multi-queen societies in which workers exhibit colony-specific, altruistic behaviors towards non-nestmate workers from distant locations. Defining where an ant species falls along this spectrum is critical for understanding its basic ecology. Herein we quantify queen numbers, describe intraspecific aggression, and characterize the distribution of colony sizes for tawny crazy ant (Nylanderia fulva) populations in native range areas in South America as well as in their introduced range in the Southeastern United States. In both ranges, multi-queen nests are common. In the introduced range, aggressive behaviors are absent at all spatial scales tested, indicating that within the population in the Southeastern United States N. fulva is unicolonial. However, this contrasts strongly with intraspecific aggression in its South American native range. In the native range, intraspecific aggression between ants from different nests is common and ritualized. Aggression is typically one-sided and follows a stereotyped sequence of escalating behaviors that stops before actual fighting occurs. Spatial patterns of non-aggressive nest aggregation and the transitivity of non-aggressive interactions demonstrate that results of neutral arena assays usefully delineate colony boundaries. In the native range, both the spatial extent of colonies and the average number of queens encountered per nest differ between sites. This intercontinental comparison presents the first description of intraspecific aggressive behavior for this invasive ant and characterizes the variation in colony organization in the native-range, a pre-requisite to a full understanding of the origins of unicoloniality in its introduced range.	[LeBrun, Edward G.; Plowes, Robert M.] Univ Texas Austin, Dept Integrat Biol, Brackenridge Field Lab, Austin, TX 78712 USA; [Folgarait, Patricia J.] Univ Nacl Quilmes, Ctr Estudios & Invest, Programa Invest Interacc Biol, Buenos Aires, DF, Argentina; [Bollazzi, Martin] Univ Republica, Fac Agron, Dept Protecc Vegetal, Unidad Entomol, Montevideo, Uruguay; [Gilbert, Lawrence E.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Universidad de la Republica, Uruguay; University of Texas System; University of Texas Austin	LeBrun, EG (corresponding author), Univ Texas Austin, Dept Integrat Biol, Brackenridge Field Lab, Austin, TX 78712 USA.	edwardlebrun@austin.utexas.edu		LeBrun, Edward/0000-0002-7262-6585; Bollazzi, Martin/0000-0003-3361-5602	Lee and Ramona Bass Foundation; University of Texas International Office	Lee and Ramona Bass Foundation; University of Texas International Office	This work was supported by the Lee and Ramona Bass Foundation to LEG, and RP and a grant from the University of Texas International Office to LEG. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Arcila A, 2005, IMPACTO HIST INTRO H; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Astruc C, 2001, J CHEM ECOL, V27, P1229, DOI 10.1023/A:1010324230982; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Breed MD, 2003, J KANSAS ENTOMOL SOC, V76, P539; Buczkowski G, 2005, ANIM BEHAV, V69, P741, DOI 10.1016/j.anbehav.2004.06.027; Buczkowski G, 2004, MOL ECOL, V13, P2235, DOI 10.1111/j.1365-294X.2004.02261.x; Chapuisat M, 2005, BEHAV ECOL, V16, P15, DOI 10.1093/beheco/arh128; Chen W, 2018, ECOL ENTOMOL, V43, P263, DOI 10.1111/een.12500; Deyrup M, 2000, T AM ENTOMOL SOC, V126, P293; Drescher J, 2007, MOL ECOL, V16, P1453, DOI 10.1111/j.1365-294X.2007.03260.x; EDDMapS, TAWN CRAZ ANT NYL FU; ESRI, 2016, ARCGIS DESKT VERS 10; Eyer PA, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1336-5; Foucaud J, 2009, MOL ECOL, V18, P5059, DOI 10.1111/j.1365-294X.2009.04440.x; Fournier D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031480; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Gotzek D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045314; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Heller NE, 2004, INSECT SOC, V51, P378, DOI 10.1007/s00040-004-0770-0; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Horn K., 2009, EXAMINING COMPETITIV; Horn KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066912; Hufbauer RA, 2012, EVOL APPL, V5, P89, DOI 10.1111/j.1752-4571.2011.00211.x; JOUVENAZ D P, 1989, Psyche (Cambridge), V96, P161, DOI 10.1155/1989/78697; KLOTZ JH, 1995, FLA ENTOMOL, V78, P109, DOI 10.2307/3495674; Krushelnycky PD, 2010, ANT ECOLOGY, P245; Kumar S, 2015, ECOL EVOL, V5, P4628, DOI 10.1002/ece3.1737; Le Breton J, 2004, J INSECT BEHAV, V17, P263, DOI 10.1023/B:JOIR.0000028575.28700.71; LeBrun EG, 2014, SCIENCE, V343, P1014, DOI 10.1126/science.1245833; LeBrun EG, 2013, BIOL INVASIONS, V15, P2429, DOI 10.1007/s10530-013-0463-6; LEMOLI F, 1982, AGGRESSIVE BEHAV, V8, P145; Mercier JL, 1997, BEHAV PROCESS, V41, P39, DOI 10.1016/S0376-6357(97)00026-0; Meyers JM, 2008, SOCIOBIOLOGY, V52, P589; Moffett MW, 2012, BEHAV ECOL, V23, P925, DOI 10.1093/beheco/ars043; MOREL L, 1990, ANN ENTOMOL SOC AM, V83, P642, DOI 10.1093/aesa/83.3.642; OBIN MS, 1986, J CHEM ECOL, V12, P1965, DOI 10.1007/BF01041858; Orivel J, 2009, ECOL ENTOMOL, V34, P504, DOI 10.1111/j.1365-2311.2009.01096.x; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; Polania I. Z. de, 1992, Revista Colombiana de Entomologia, V18, P14; PORTER SD, 1991, J ECON ENTOMOL, V84, P866, DOI 10.1093/jee/84.3.866; Richard FJ, 2013, INSECT SOC, V60, P275, DOI 10.1007/s00040-013-0306-6; Ross KG, 1996, P NATL ACAD SCI USA, V93, P3021, DOI 10.1073/pnas.93.7.3021; Roulston TH, 2003, INSECT SOC, V50, P151, DOI 10.1007/s00040-003-0624-1; SAS Institute Inc, 2011, JMP 14 0; Suarez AV, 2008, AM NAT, V172, pS72, DOI 10.1086/588638; Suarez AV, 2002, ANIM BEHAV, V64, P697, DOI 10.1006/anbe.2002.4011; SUAREZ AV, 1999, BIOL INVASIONS, V1, P1; Thomas ML, 2006, MOL ECOL, V15, P4303, DOI 10.1111/j.1365-294X.2006.03038.x; Thomas ML, 2005, BEHAV ECOL, V16, P472, DOI 10.1093/beheco/ari014; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vogel V, 2010, DIVERS DISTRIB, V16, P170, DOI 10.1111/j.1472-4642.2009.00630.x; ZENNERPOLANIA I, 1990, WESTV STUD, P290; Zinck L, 2008, ENTOMOL EXP APPL, V126, P211, DOI 10.1111/j.1570-7458.2007.00654.x	55	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225597	10.1371/journal.pone.0225597	http://dx.doi.org/10.1371/journal.pone.0225597			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756233	Green Published, gold			2022-12-26	WOS:000533889300046
J	Wang, PK; Pun, SH; Chen, CH; McCullagh, EA; Klug, A; Li, A; Vai, MI; Mak, PU; Lei, TC				Wang, Pan Ke; Pun, Sio Hang; Chen, Chang Hao; McCullagh, Elizabeth A.; Klug, Achim; Li, Anan; Vai, Mang, I; Mak, Peng Un; Lei, Tim C.			Low-latency single channel real-time neural spike sorting system based on template matching	PLOS ONE			English	Article							FEATURE-EXTRACTION; ALGORITHMS; ACCURATE; QUALITY; FUTURE	Recent technical advancements in neural engineering allow for precise recording and control of neural circuits simultaneously, opening up new opportunities for closed-loop neural control. In this work, a rapid spike sorting system was developed based on template matching to rapidly calculate instantaneous firing rates for each neuron in a multi-unit extracellular recording setting. Cluster templates were first generated by a desktop computer using a non-parameter spike sorting algorithm (Super-paramagnetic clustering) and then transferred to a field-programmable gate array digital circuit for rapid sorting through template matching. Two different matching techniques-Euclidean distance (ED) and correlational matching (CM)-were compared for the accuracy of sorting and the performance of calculating firing rates. The performance of the system was first verified using publicly available artificial data and was further confirmed with pre-recorded neural spikes from an anesthetized Mongolian gerbil. Real-time recording and sorting from an awake mouse were also conducted to confirm the system performance in a typical behavioral neuroscience experimental setting. Experimental results indicated that high sorting accuracies were achieved for both template-matching methods, but CM can better handle spikes with non-Gaussian spike distributions, making it more robust for in vivo recording. The technique was also compared to several other off-line spike sorting algorithms and the results indicated that the sorting accuracy is comparable but sorting time is significantly shorter than these other techniques. A low sorting latency of under 2 ms and a maximum spike sorting rate of 941 spikes/second have been achieved with our hybrid hardware/software system. The low sorting latency and fast sorting rate allow future system developments of neural circuit modulation through analyzing neural activities in real-time.	[Wang, Pan Ke; Pun, Sio Hang; Chen, Chang Hao; Vai, Mang, I; Lei, Tim C.] Univ Macau, Inst Microelect, State Key Lab Analog & Mixed Signal VLSI, Macau, Peoples R China; [Wang, Pan Ke; Vai, Mang, I; Mak, Peng Un] Univ Macau, Fac Sci & Technol, Dept Elect & Comp Engn, Macau, Peoples R China; [McCullagh, Elizabeth A.; Klug, Achim] Univ Colorado, Dept Physiol & Biophys, Anschutz Med Campus, Aurora, CO USA; [Li, Anan] Xuzhou Med Univ, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis & Bioinformat, Xuzhou, Jiangsu, Peoples R China; [Lei, Tim C.] Univ Colorado, Dept Elect Engn, Denver, CO 80202 USA	University of Macau; University of Macau; University of Colorado System; University of Colorado Anschutz Medical Campus; Xuzhou Medical University; University of Colorado System; University of Colorado Denver	Pun, SH (corresponding author), Univ Macau, Inst Microelect, State Key Lab Analog & Mixed Signal VLSI, Macau, Peoples R China.	lodgepun@um.edu.mo	; Mak, Peng Un/C-7511-2015	Klug, Achim/0000-0002-3383-850X; Mak, Peng Un/0000-0003-3813-5800	Science and Technology Development Fund, Macau SAR [093/2015/A3, 088/2016/A2]; Research Committee of the University of Macau [MYRG2015-00178-AMSV, MYRG2016-00157-AMSV, MYRG2018-00146-AMSV, MYRG2019-00056-AMSV]; National Natural Science Foundation of China (NSFC) [31571082, 31872771]; National Institutes of Health (NIH) [R01 DC017924]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC017924] Funding Source: NIH RePORTER	Science and Technology Development Fund, Macau SAR; Research Committee of the University of Macau; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by The Science and Technology Development Fund, Macau SAR (File No. 093/2015/A3, 088/2016/A2), and financially supported by the Research Committee of the University of Macau under Grants MYRG2015-00178-AMSV, MYRG2016-00157-AMSV, MYRG2018-00146-AMSV, MYRG2019-00056-AMSV, the National Natural Science Foundation of China (NSFC, 31571082 & 31872771), and the National Institutes of Health (NIH) Grant R01 DC017924. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aksenova TI, 2003, METHODS, V30, P178, DOI 10.1016/S1046-2023(03)00079-3; Al-Juboori SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067626; Anastassiou CA, 2013, PRINCIPLES OF NEURAL CODING, P15; Bestel R, 2012, J NEUROSCI METH, V211, P168, DOI 10.1016/j.jneumeth.2012.08.015; Blatt M, 1997, NEURAL COMPUT, V9, P1805, DOI 10.1162/neco.1997.9.8.1805; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Bretschneider F, 2006, BOOK, DOI [10.1201/9781439823798, DOI 10.1201/9781439823798]; Brette R, 2012, HANDBOOK OF NEURAL ACTIVITY MEASUREMENT, P1, DOI 10.1017/CBO9780511979958; Chae MS, 2009, IEEE T NEUR SYS REH, V17, P312, DOI 10.1109/TNSRE.2009.2021607; Chen CH, 2017, IEEE T BIO-MED ENG, V64, P557, DOI 10.1109/TBME.2016.2609412; Chen CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/135026; Chibirova OK, 2005, BIOSYSTEMS, V79, P159, DOI 10.1016/j.biosystems.2004.09.028; Cuevas J., 2014, REFERENCE MODULE BIO, DOI [10.1016/B978-0-12-801238-3.04997-7, DOI 10.1016/B978-0-12-801238-3.04997-7]; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dragas J, 2015, IEEE T NEUR SYS REH, V23, P149, DOI 10.1109/TNSRE.2014.2370510; Edward ES, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aa7d62; Fournier J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160494; Franke F, 2015, J COMPUT NEUROSCI, V38, P439, DOI 10.1007/s10827-015-0547-7; Gibson S, 2013, J NEUROSCI METH, V215, P1, DOI 10.1016/j.jneumeth.2013.01.026; Gibson S, 2010, IEEE T NEUR SYS REH, V18, P469, DOI 10.1109/TNSRE.2010.2051683; Gibson S, 2008, IEEE ENG MED BIO, P5015, DOI 10.1109/IEMBS.2008.4650340; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Han YC, 2015, IEEE ENG MED BIO, P6606, DOI 10.1109/EMBC.2015.7319907; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Humphrey DR, 1990, NEUROPHYSIOLOGICAL T, P1, DOI [10.1385/0-89603-185-3:1, DOI 10.1385/0-89603-185-3:1]; Jun J. J., 2017, BIORXIV, DOI [10.1101/101030, DOI 10.1101/101030]; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Karkare V, 2013, IEEE J SOLID-ST CIRC, V48, P2230, DOI 10.1109/JSSC.2013.2264616; Karkare V, 2011, IEEE J SOLID-ST CIRC, V46, P1214, DOI 10.1109/JSSC.2011.2116410; Kim KH, 2000, IEEE T BIO-MED ENG, V47, P1406, DOI 10.1109/10.871415; Kim KH, 2003, IEEE T BIO-MED ENG, V50, P999, DOI 10.1109/TBME.2003.814523; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Li A, 2017, J NEUROSCI, V37, P1835, DOI 10.1523/JNEUROSCI.3132-16.2017; Li A, 2015, J NEUROSCI, V35, P5808, DOI 10.1523/JNEUROSCI.4003-14.2015; Mohammadi Z, 2019, I IEEE EMBS C NEUR E, P1084, DOI 10.1109/NER.2019.8717062; Mohammadi Z, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab208c; Mukhopadhyay S, 1998, IEEE T BIO-MED ENG, V45, P180, DOI 10.1109/10.661266; Navajas J, 2014, J NEUROSCI METH, V230, P51, DOI 10.1016/j.jneumeth.2014.04.018; Newman JP, 2015, ELIFE, V4, DOI 10.7554/eLife.07192; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Olsson RH, 2005, IEEE J SOLID-ST CIRC, V40, P2796, DOI 10.1109/JSSC.2005.858479; Pachitariu M., 2016, BIORXIV, DOI [10.1101/061481, DOI 10.1101/061481]; Park J., 2017, P 2017 IEEE BIOMEDIC, P1, DOI DOI 10.1109/ISCAS.2017.8050697; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pillow JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062123; Porwik P., 2004, Machine Graphics & Vision, V13, P79; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rey HG, 2015, BRAIN RES BULL, V119, P106, DOI 10.1016/j.brainresbull.2015.04.007; Caro-Martin CR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35491-4; Rossant C, 2016, NAT NEUROSCI, V19, P634, DOI 10.1038/nn.4268; Rutishauser U, 2006, J NEUROSCI METH, V154, P204, DOI 10.1016/j.jneumeth.2005.12.033; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Semmlow J., 2004, BIOSIGNAL BIOMEDICAL, DOI [10.1201/9780203024058, DOI 10.1201/9780203024058]; Takekawa T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00005; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; Tsien JZ, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00019; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; WANG JS, 1990, PHYSICA A, V167, P565, DOI 10.1016/0378-4371(90)90275-W; Wang JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep27344; Wickenden Alan D, 2014, Curr Protoc Pharmacol, V64, DOI 10.1002/0471141755.ph1101s64; Williams M., 2007, CURRENT PROTOCOLS PH, P10, DOI [10.1002/0471141755.ph1100s39, DOI 10.1002/0471141755.PH1100S39]; WOLFF U, 1989, PHYS LETT B, V228, P379, DOI 10.1016/0370-2693(89)91563-3; Wouters J, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aace8a; Wu HY, 2010, IEEE INT C BIO BIO W, P555, DOI 10.1109/BIBMW.2010.5703861; Yang Z, 2009, ADV NEURAL INFORM PR, V22, P2160; Yger P, 2018, ELIFE, V7, DOI 10.7554/eLife.34518; Zeinolabedin SMA, 2016, 2016 IEEE S VLSI CIR, P1, DOI [10.1109/VLSIC.2016.7573467, DOI 10.1109/VLSIC.2016.7573467]	67	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225138	10.1371/journal.pone.0225138	http://dx.doi.org/10.1371/journal.pone.0225138			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756211	Green Published, gold			2022-12-26	WOS:000533889300009
J	Bian, JM; Liang, M; Ding, SX; Wang, LY; Ni, WC; Xiong, SS; Li, W; Bao, XX; Gao, X; Wang, R				Bian, Junmei; Liang, Min; Ding, Shuxian; Wang, Liyan; Ni, Wenchang; Xiong, Shisi; Li, Wan; Bao, Xingxing; Gao, Xue; Wang, Rong			iTRAQ-based high-throughput proteomics analysis reveals alterations of plasma proteins in patients infected with human bocavirus	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SYSTEMATIC ANALYSIS; CELL-PROLIFERATION; CHAPERONE; CALRETICULIN; MANIPULATION; EXPRESSION; MORTALITY; CHILDREN; HSP90	Human bocavirus (HBoV) is a member of the genus Bocavirus, family Parvoviridae, and subfamily Parvovirus and was first identified in nasopharyngeal aspirates of Swedish children with acute respiratory tract infection (ARTI) in 2005. It is the causative agent of nasopharyngeal aspirate disease and death in children. The HboV genomic structure is a linear single-stranded DNA (ssDNA). Its clinical pathogenic characteristics have been extensively studied, however, at present the molecular mechanism underlying the pathogenesis of HBoV infection is not completely clear. In this study, a total of 293 differentially expressed proteins (DEPs) between ARTI cases and healthy plasma samples were characterized using isobaric tags for relative and absolute quantitation (iTRAQ)-coupled bioinformatics analysis, among which 148 were up-regulated and 135 were down-regulated. Gene Ontology (GO) and Cluster of Orthologous Groups of proteins (COG) annotated an enrichment of DEPs in complement activation and biological processes like immunity, inflammation, signal transduction, substance synthesis, and metabolism. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis enriched DEPs mainly in the Wnt signaling pathway (ko04310), PPAR signaling pathway (ko03320), intestinal immune network for IgA production (ko04672), complement and coagulation cascades (ko04610), Toll-like receptor signaling pathway (ko04620) and B cell receptor signaling pathway (ko04662). Further, expression levels of three candidate proteins (upregulated PPP2R1A and CUL1, and downregulated CETP) were validated using western blotting. Our investigation is the first analysis of the proteomic profile of HBoV-infected ARTI cases using the iTRAQ approach, providing a foundation for a better molecular understanding of the pathogenesis of ARTI in children.	[Bian, Junmei; Liang, Min; Ding, Shuxian; Wang, Liyan; Ni, Wenchang; Xiong, Shisi; Li, Wan; Bao, Xingxing; Gao, Xue; Wang, Rong] Wuhan Univ, Wuhan Third Hosp, Tongren Hosp, Wuhan, Peoples R China	Wuhan University	Wang, R (corresponding author), Wuhan Univ, Wuhan Third Hosp, Tongren Hosp, Wuhan, Peoples R China.	3169615039@qq.com			Hubei provincial health and family planning commission [WJ2017M186]	Hubei provincial health and family planning commission	This work was supported by grants from Hubei provincial health and family planning commission (grant number: WJ2017M186). Initials of author who received this award are JMB (Junmei Bian). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder website is www.hbwsjs.gov.cn.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Blanchette P, 2009, VIROLOGY, V384, P317, DOI 10.1016/j.virol.2008.10.005; Cervantes-Ortiz SL, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050124; Chen JH, 2004, P NATL ACAD SCI USA, V101, P17039, DOI 10.1073/pnas.0407992101; CHEN KC, 1986, J VIROL, V60, P1085, DOI 10.1128/JVI.60.3.1085-1097.1986; Cheng QH, 2017, INT J BIOL MARKER, V32, pE202, DOI 10.5301/jbm.5000247; Choi S, 2014, PROTEOMICS, V14, P1933, DOI 10.1002/pmic.201400030; Chondrogianni N, 2010, ADV EXP MED BIOL, V694, P38; de Chassey B, 2012, CURR OPIN VIROL, V2, P606, DOI 10.1016/j.coviro.2012.09.001; Dong CF, 2011, J VIROL, V85, P2869, DOI 10.1128/JVI.01444-10; Du JZ, 2016, PROTEOMICS, V16, P1499, DOI 10.1002/pmic.201500275; Dutta D, 2009, VIROLOGY, V391, P325, DOI 10.1016/j.virol.2009.06.044; Fanale D, 2017, PPAR RES, V2017, DOI 10.1155/2017/1830626; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fukushi M, 2012, J VIROL, V86, P11745, DOI 10.1128/JVI.01250-12; Goodwin CM, 2015, TRENDS MICROBIOL, V23, P789, DOI 10.1016/j.tim.2015.08.007; Gough NR, 2015, SCI SIGNAL, V8, pec9, DOI DOI 10.1126/scisignal.aaa6549; Guido M, 2016, WORLD J GASTROENTERO, V22, P8684, DOI 10.3748/wjg.v22.i39.8684; Guo XZ, 2016, J PROTEOMICS, V130, P65, DOI 10.1016/j.jprot.2015.09.002; Han TH, 2009, ARCH VIROL, V154, P1923, DOI 10.1007/s00705-009-0533-3; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Jartti T, 2012, REV MED VIROL, V22, P46, DOI 10.1002/rmv.720; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Kindrachuk J, J VIROLOGY; Lekana-Douki Sonia Etenna, 2018, BMC Res Notes, V11, P495, DOI 10.1186/s13104-018-3605-1; Li N, 2015, P NATL ACAD SCI USA, V112, P238, DOI 10.1073/pnas.1414422112; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Low JS, 2014, PARASITOLOGY, V141, P1192, DOI 10.1017/S0031182014000298; Luksic I, 2013, CROAT MED J, V54, P122, DOI 10.3325/cmj.2013.54.122; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Montalbano R, 2016, ONCOTARGET, V7, P20312, DOI 10.18632/oncotarget.7950; More S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191010; Ping JG, 2016, TUMOR BIOL, V37, P12823, DOI 10.1007/s13277-016-5151-6; Qiu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015; Usami M, 2011, EXPERT REV PROTEOMIC, V8, P153, DOI [10.1586/EPR.11.16, 10.1586/epr.11.16]; Vashist S, 2015, J VIROL, V89, P6352, DOI 10.1128/JVI.00315-15; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Yang SB, 2017, SCI REP-UK, V7, DOI 10.1038/srep45922; Yue X, 2012, J IMMUNOL, V189, P279, DOI 10.4049/jimmunol.1103405; Zeng SL, 2015, PROTEOMICS, V15, P1819, DOI 10.1002/pmic.201400458	52	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225261	10.1371/journal.pone.0225261	http://dx.doi.org/10.1371/journal.pone.0225261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751365	Green Published, gold			2022-12-26	WOS:000533886900038
J	Eckstrom, K; Barlow, JW				Eckstrom, Korin; Barlow, John W.			Resistome metagenomics from plate to farm: The resistome and microbial composition during food waste feeding and composting on a Vermont poultry farm	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANCE; BACTERIAL COMMUNITY; ESCHERICHIA-COLI; VIRULENCE GENES; DAIRY MANURE; SALMONELLA; DIVERSITY; ABUNDANCE	Food waste diversion and composting, either mandated or voluntary, are growing alternatives to traditional waste disposal. An acceptable source of agricultural feed and composting material, methane-emitting food residuals, including post-consumer food scraps, are diverted from landfills allowing recapture of nutrients that would otherwise be lost. However, risk associated with the transfer of antimicrobial resistant bacteria (ARB), antibiotic resistance genes (ARGs), or pathogens from food waste is not well characterized. Using shotgun metagenomic sequencing, ARGs, microbial content, and associated virulence factors were successfully identified across samples from an integrated poultry farm that feeds post-consumer food waste. A total of 495 distinct bacterial species or sub-species, 50 ARGs, and 54 virulence gene sequences were found. ARG sequences related to aminoglycoside, tetracycline, and macrolide resistance were most prominent, while most virulence gene sequences were related to transposon or integron activity. Microbiome content was distinct between on-farm samples and off-farm food waste collection sites, with a reduction in pathogens throughout the composting process. While most samples contained some level of resistance, only 3 resistance gene sequences occurred in both on- and off-farm samples and no multidrug resistance (MDR) gene sequences persisted once on the farm. The risk of incorporating novel or multi-drug resistance from human sources appears to be minimal and the practice of utilizing post-consumer food scraps as feed for poultry and composting material may not present a significant risk for human or animal health. Pearson correlation and coinertia analysis identified a significant interaction between resistance and virulence genes (P = 0.05, RV = 0.67), indicating that ability to undergo gene transfer may be a better marker for ARG risk than presence of specific bacterial species. This work expands the knowledge of ARG fate during food scrap animal feeding and composting and provides a methodology for reproducible analysis.	[Eckstrom, Korin] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Barlow, John W.] Univ Vermont, Dept Anim & Vet Sci, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Barlow, JW (corresponding author), Univ Vermont, Dept Anim & Vet Sci, Burlington, VT 05405 USA.	john.barlow@uvm.edu	; Barlow, John/C-4876-2013	Eckstrom, Korin/0000-0002-6941-7627; Barlow, John/0000-0002-7815-9383	United States Department of Agriculture Northeast Sustainable Agriculture Research Education [GNE16-117]	United States Department of Agriculture Northeast Sustainable Agriculture Research Education	KE and JWB received funding from the United States Department of Agriculture Northeast Sustainable Agriculture Research & Education (USDA-NE-SARE; https://www.northeastsare.org/) Graduate Student grant (project #GNE16-117). The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.	Ahmed HA, 2016, FOODBORNE PATHOG DIS, V13, P281, DOI 10.1089/fpd.2015.2097; Akhtar M, 2009, MICROB ECOL, V58, P509, DOI 10.1007/s00248-009-9533-9; Anand T, 2016, J GEN VIROL, V97, P3458, DOI 10.1099/jgv.0.000639; Andrews S., 2010, FASTQC QUALITY CONTR; Antunes P, 2005, ANTIMICROB AGENTS CH, V49, P836, DOI 10.1128/AAC.49.2.836-839.2005; Arango-Argoty GA, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0703-9; Bell RL, 2016, MICROB BIOTECHNOL, V9, P279, DOI 10.1111/1751-7915.12359; Bengtsson-Palme J, 2014, FRONT MICROBIOL, V5; Bengtsson-Palme J, 2015, ANTIMICROB AGENTS CH, V59, P6551, DOI 10.1128/AAC.00933-15; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Bezanson GS, 2008, INT J FOOD MICROBIOL, V127, P37, DOI 10.1016/j.ijfoodmicro.2008.06.008; Cagle R, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00123-19; Carnelli A, 2017, RES MICROBIOL, V168, P461, DOI 10.1016/j.resmic.2017.02.006; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Daly M, 2005, J ANTIMICROB CHEMOTH, V55, P558, DOI 10.1093/jac/dki015; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; Diarra MS, 2010, APPL ENVIRON MICROB, V76, P8033, DOI 10.1128/AEM.01545-10; Dolka B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185199; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Durso LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048325; EPA, 2016, FOOD WAST MAN US 201; Florez AB, 2006, FEMS MICROBIOL LETT, V263, P21, DOI 10.1111/j.1574-6968.2006.00371.x; Hamner S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071097; Henault-Ethier L, 2016, WASTE MANAGE, V56, P88, DOI 10.1016/j.wasman.2016.07.033; Huang K, 2017, SCI TOTAL ENVIRON, V578, P337, DOI 10.1016/j.scitotenv.2016.10.172; Huson DH, 2018, BIOL DIRECT, V13, DOI 10.1186/s13062-018-0208-7; Hwang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26223; Iwao Y, 2012, J INFECT CHEMOTHER, V18, P228, DOI 10.1007/s10156-012-0379-6; Jalali S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128711; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Jia SY, 2017, WATER RES, V124, P259, DOI 10.1016/j.watres.2017.07.061; Kamathewatta KI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217600; Kevenk TO, 2016, J FOOD SAFETY, V36, P11, DOI 10.1111/jfs.12208; Kim D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0267-5; Liao HP, 2018, ENVIRON SCI TECHNOL, V52, P266, DOI 10.1021/acs.est.7b04483; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Luna VA, 1998, J ANTIMICROB CHEMOTH, V42, P613, DOI 10.1093/jac/42.5.613; Luo G, 2017, ENVIRON SCI TECHNOL, V51, P4069, DOI 10.1021/acs.est.6b05100; McIntyre ABR, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1299-7; Murshed M, 2012, BANGLADESH J MED MIC, V4, P19, DOI [10.3329/bjmm.v4i2.10827, DOI 10.3329/BJMM.V4I2.10827]; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; Ng C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02200; Noyes NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24645; Oksanen EM, 2018, VEGAN COMMUNITY ECOL; Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15; Qian X, 2016, BIORESOURCE TECHNOL, V220, P425, DOI 10.1016/j.biortech.2016.08.101; Ramaraj T, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01033-14; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Rosengren LB, 2009, APPL ENVIRON MICROB, V75, P1373, DOI 10.1128/AEM.01253-08; Ross J, 2015, APPL ENVIRON MICROB, V81, P7905, DOI 10.1128/AEM.02363-15; Rove MT, 2016, J FOOD PROTECT, V68, P2367, DOI [10.4315/0362-028x-68.11.2367, DOI 10.4315/0362-028X-68.11.2367]; Rowe W, 2016, WATER SCI TECHNOL, V73, P1541, DOI 10.2166/wst.2015.634; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Schroeder M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010039; Schurch AC, 2017, ANN NY ACAD SCI, V1388, P108, DOI 10.1111/nyas.13310; Scott KP, 2000, ANTIMICROB AGENTS CH, V44, P775, DOI 10.1128/AAC.44.3.775-777.2000; Sekse C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02029; Silveira VM, 2014, J FOOD PROTECT, V77, P583, DOI 10.4315/0362-028X.JFP-13-343; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; Song AAL, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0669-x; Srinivasan VB, 2009, ANTIMICROB AGENTS CH, V53, P5312, DOI 10.1128/AAC.00748-09; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; Sultana Fouzia, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS268, DOI 10.12980/APJTB.4.2014B85; Szekeres E, 2017, ENVIRON POLLUT, V225, P304, DOI 10.1016/j.envpol.2017.01.054; Tuer S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI [10.1111/j.1550-7408.1999.tb04612.x, DOI 10.1111/J.1550-7408.1999.TB04612.X]; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; US Food and Drug Administration, 2015, PREV SALM ENT SHELL; VENTOLA, 2015, J PHARM THERAPEUTICS, V40, P277, DOI DOI 10.5796/ELECTR0CHEMISTRY.82.749; Vermont Agency of Agriculture Food and markets, 2018, GUID FEED FOOD SCRAP; Volkers G, 2011, FEBS LETT, V585, P1061, DOI 10.1016/j.febslet.2011.03.012; Wang C, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0324-0; Warnes M. G. R, 2016, GPLOTS VARIOUS R PRO; Whiley H, 2015, INT J ENV RES PUB HE, V12, P2543, DOI 10.3390/ijerph120302543; Wichmann F, 2014, MBIO, V5, DOI 10.1128/mBio.01017-13; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang WR, 2004, J BIOL CHEM, V279, P52346, DOI 10.1074/jbc.M409573200; Yang X, 2016, APPL ENVIRON MICROB, V82, P2433, DOI 10.1128/AEM.00078-16; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhang T, 2015, APPL MICROBIOL BIOT, V99, P5033, DOI 10.1007/s00253-015-6556-7; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	85	6	6	10	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0219807	10.1371/journal.pone.0219807	http://dx.doi.org/10.1371/journal.pone.0219807			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751342	gold, Green Submitted, Green Published			2022-12-26	WOS:000533886900003
J	Hayati, M; Shadgar, B; Chindelevitch, L				Hayati, Maryam; Shadgar, Bita; Chindelevitch, Leonid			A new resolution function to evaluate tree shape statistics	PLOS ONE			English	Article							PHYLOGENETIC TREES; 2 MODELS; IMBALANCE; EVOLUTION; YULE	Phylogenetic trees are frequently used in biology to study the relationships between a number of species or organisms. The shape of a phylogenetic tree contains useful information about patterns of speciation and extinction, so powerful tools are needed to investigate the shape of a phylogenetic tree. Tree shape statistics are a common approach to quantifying the shape of a phylogenetic tree by encoding it with a single number. In this article, we propose a new resolution function to evaluate the power of different tree shape statistics to distinguish between dissimilar trees. We show that the new resolution function requires less time and space in comparison with the previously proposed resolution function for tree shape statistics. We also introduce a new class of tree shape statistics, which are linear combinations of two existing statistics that are optimal with respect to a resolution function, and show evidence that the statistics in this class converge to a limiting linear combination as the size of the tree increases. Our implementation is freely available at https://github.com/WGS-TB/TreeShapeStats.	[Hayati, Maryam; Shadgar, Bita; Chindelevitch, Leonid] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada	Simon Fraser University	Chindelevitch, L (corresponding author), Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada.	leonid@sfu.ca		Chindelevitch, Leonid/0000-0002-6619-6013	NSERC [RGPIN/04622-2016]; Sloan Foundation [FG-2016-6392]; SFU President's Startup Grant	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sloan Foundation(Alfred P. Sloan Foundation); SFU President's Startup Grant	LC gratefully acknowledges the support of NSERC grant RGPIN/04622-2016 and the Sloan Foundation grant FG-2016-6392, as well as an SFU President's Startup Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Blum MGB, 2005, MATH BIOSCI, V195, P141, DOI 10.1016/j.mbs.2005.03.003; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Colijn Caroline, 2014, Evolution Medicine and Public Health, P96, DOI 10.1093/emph/eou018; COLLESS DH, 1995, SYST BIOL, V44, P102, DOI 10.2307/2413487; Csardi G, 2006, INTERJOURNAL; DASGUPTA B., 2000, DIMACS SERIES DISCRE, V55, P125; Durbin R., 1998, BIOL SEQUENCE ANAL P; Felsenstein J, 2004, INFERRING PHYLOGENIE; FIEDLER M, 1973, CZECH MATH J, V23, P298; Frost SDW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0208; FUSCO G, 1995, J THEOR BIOL, V175, P235, DOI 10.1006/jtbi.1995.0136; Golub G. H., 2012, MATRIX COMPUTATIONS; Guattery S, 2000, SIAM J MATRIX ANAL A, V21, P703, DOI 10.1137/S0895479897329825; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; Hayati M, 2019, BIORXIV; KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI [10.2307/2409983, 10.1111/j.1558-5646.1993.tb02144.x]; Leventhal GE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002413; Matsen FA, 2006, SYST BIOL, V55, P652, DOI 10.1080/10635150600889617; McKenzie A, 2000, MATH BIOSCI, V164, P81, DOI 10.1016/S0025-5564(99)00060-7; Mir A, 2013, MATH BIOSCI, V241, P125, DOI 10.1016/j.mbs.2012.10.005; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Neher RA, 2014, ELIFE, V3, DOI 10.7554/eLife.03568; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pompei S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044849; Purvis A, 2002, SYST BIOL, V51, P844, DOI 10.1080/10635150290155809; Purvis A, 2002, J THEOR BIOL, V214, P99, DOI 10.1006/jtbi.2001.2443; Purvis Andy, 1996, P153; R Core Team, 2018, R LANG ENV STAT COMP; ROGERS JS, 1993, SYST BIOL, V42, P102, DOI 10.2307/2992561; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; Steel M, 2001, MATH BIOSCI, V170, P91, DOI 10.1016/S0025-5564(00)00061-4; Stich M, 2009, EUR PHYS J B, V70, P583, DOI 10.1140/epjb/e2009-00254-8; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0224197	10.1371/journal.pone.0224197	http://dx.doi.org/10.1371/journal.pone.0224197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751352	Green Published, gold, Green Submitted			2022-12-26	WOS:000533886900008
J	Johnson, MD; Cox, RD; Barnes, MA				Johnson, Mark D.; Cox, Robert D.; Barnes, Matthew A.			The detection of a non-anemophilous plant species using airborne eDNA	PLOS ONE			English	Article							ENVIRONMENTAL DNA; POLLEN; HONEY; IDENTIFICATION; SAMPLERS; PM2.5; DUST; PM10; BSNE	Genetic analysis of airborne plant material has historically focused (generally implicitly rather than as a stated goal) on pollen from anemophilous (wind-pollinated) species, such as in multiple studies examining the relationship of allergens to human health. Inspired by the recent influx of literature applying environmental DNA (eDNA) approaches to targeted-species and whole-ecosystem study, we conducted a proof-of-concept experiment to determine whether airborne samples reliably detect genetic material from non-anemophilous species that may not be releasing large plumes of pollen. We collected airborne eDNA using Big Spring Number Eight dust traps and quantified the amount of eDNA present for a flowering wind-pollinated genus (Bouteloua) and insect-pollinated honey mesquite (Prosopis glandulosa) that was not flowering at the time of the study. We were able to detect airborne eDNA from both species. Since honey mesquite is insect-pollinated and was not flowering during the time of this study, our results confirm that airborne eDNA consists of and can detect species through more than just pollen. Additionally, we were able to detect temporal patterns reflecting Bouteloua reproductive ecology and suggest that airborne honey mesquite eDNA responded to weather conditions during our study. These findings suggest a need for more study of the ecology of airborne eDNA to uncover its potential for single-species and whole-community research and management in terrestrial ecosystems.	[Johnson, Mark D.; Cox, Robert D.; Barnes, Matthew A.] Texas Tech Univ, Dept Nat Resources Management, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Johnson, MD (corresponding author), Texas Tech Univ, Dept Nat Resources Management, Lubbock, TX 79409 USA.	mark.johnson@ttu.edu	Barnes, Matthew A/K-5113-2012	Barnes, Matthew A/0000-0002-5550-8587; Cox, Robert/0000-0002-4005-1019; Johnson, Mark/0000-0002-0460-945X	Texas Tech University; United States Department of Agriculture	Texas Tech University; United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was funded by Texas Tech University as startup funding to Matthew A. Barnes.; Dr. Peter Dotray provided guidance as a member of MDJ's master's thesis committee. Dr. Robert Scott Van Pelt provided the BSNE dust collector traps from the United States Department of Agriculture. Sasha Soto, Elizabeth Roesler, Morgan Jennison, and Tracy Witmer assisted with collection of the airborne eDNA samples. Comments from two anonymous reviewers improved the quality of this manuscript.	Acosta-Martinez V, 2015, AEOLIAN RES, V18, P99, DOI 10.1016/j.aeolia.2015.06.001; Anderson M, 2003, BOUTELOUA GRACILIS E; Bell KL, 2017, APPL PLANT SCI, V5, DOI 10.3732/apps.1600124; Craine JM, 2017, AEROBIOLOGIA, V33, P71, DOI 10.1007/s10453-016-9451-5; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Ellison SLR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-33; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Folloni S, 2012, MOL ECOL RESOUR, V12, P810, DOI 10.1111/j.1755-0998.2012.03168.x; Galliot JN, 2017, J INSECT CONSERV, V21, P827, DOI 10.1007/s10841-017-0022-z; Golubov J, 1999, J ECOL, V87, P955, DOI 10.1046/j.1365-2745.1999.00420.x; Goossens D, 2012, AEOLIAN RES, V5, P43, DOI 10.1016/j.aeolia.2012.03.002; Hawkins J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134735; Hoyt CA, 2000, J BIOGEOGR, V27, P687, DOI 10.1046/j.1365-2699.2000.00437.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jain SA, 2013, FOOD SCI TECH-BRAZIL, V33, P753, DOI 10.1590/S0101-20612013000400022; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Klymus KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177643; Korpelainen H, 2017, NORD J BOT, V35, P602, DOI 10.1111/njb.01623; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Laube I, 2010, FOOD CHEM, V118, P979, DOI 10.1016/j.foodchem.2008.09.063; Leontidou K, 2018, AEROBIOLOGIA, V34, P63, DOI 10.1007/s10453-017-9497-z; Lodge DM, 2016, ANNU REV ENV RESOUR, V41, P453, DOI 10.1146/annurev-environ-110615-085532; Longhi S, 2009, ANN ALLERG ASTHMA IM, V103, P508, DOI 10.1016/S1081-1206(10)60268-2; LOPEZPORTILLO J, 1993, FUNCT ECOL, V7, P452, DOI 10.2307/2390032; Mendez MJ, 2016, AEOLIAN RES, V21, P37, DOI 10.1016/j.aeolia.2016.02.003; Minckley RL, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P69; Mohanty RP, 2017, ANN ALLERG ASTHMA IM, V118, P204, DOI 10.1016/j.anai.2016.11.015; Nunez A, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00472-17; Pornon A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27282; RIEGEL ANDREW, 1941, TRANS KANSAS ACAD SCI, V44, P76, DOI 10.2307/3624869; Sickel W, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0051-y; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Zobeck TM, 2006, ENCY SOIL SCI, V1, P607	34	12	12	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225262	10.1371/journal.pone.0225262	http://dx.doi.org/10.1371/journal.pone.0225262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747439	Green Published, gold, Green Submitted			2022-12-26	WOS:000533881900030
J	Oliveira, DNP; Carlsen, AL; Heegaard, NHH; Prahm, KP; Christensen, IJ; Hogdall, CK; Hogdall, EV				Oliveira, Douglas Nogueira Perez; Carlsen, Anting Liu; Heegaard, Niels H. H.; Prahm, Kira Philipsen; Christensen, Ib Jarle; Hogdall, Claus K.; Hogdall, Estrid V.			Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass	PLOS ONE			English	Article							CIRCULATING MICRORNAS; BIOMARKERS; SERUM; PROGRESSION; SIGNATURES; TARGET; CA125; HE-4	Background Ovarian cancer is the fifth most common cancer in women worldwide. Moreover, there are no reliable minimal invasive tests to secure the diagnosis of malignant pelvic masses. Cell-free, circulating microRNAs have the potential as diagnostic biomarkers in cancer. Here, we performed and validated a miRNA panel with the potential to distinguish OC from benign pelvic masses. Methods The profile of plasma microRNA was determined with a panel of 46 candidates in a discovery group and a validation group, each consisting of 190 pre-surgery plasma samples from age-matched patients with malignant (n = 95) and benign pelvic mass (n = 95), by real time RT-qPCR. Results Four up-regulated (miR-200c-3p, miR-221-3p, miR-21-5p, and miR-484) and two down-regulated (miR-195-5p and miR-451a) microRNAs were discovered. From those, miR-200c-3p and miR-221-3p were further confirmed in a validation cohort. A combination of these 2 microRNAs together with CA-125 yielded an overall diagnostic accuracy of AUC = 0.96. Conclusions We showed consistent plasma microRNA profiles that provide independent diagnostic information of late stage OC.	[Oliveira, Douglas Nogueira Perez; Prahm, Kira Philipsen; Christensen, Ib Jarle; Hogdall, Estrid V.] Univ Copenhagen, Dept Pathol, Herlev Hosp, Herlev, Denmark; [Carlsen, Anting Liu; Heegaard, Niels H. H.] Statens Serum Inst, Dept Autoimmunol & Biomarkers, Copenhagen, Denmark; [Carlsen, Anting Liu] Statens Serum Inst, Dept Congenital Disorders, Copenhagen, Denmark; [Prahm, Kira Philipsen; Hogdall, Claus K.] Univ Copenhagen, Dept Gynaecol, Juliane Marie Ctr, Rigshosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Statens Serum Institut; Statens Serum Institut; Rigshospitalet; University of Copenhagen	Hogdall, EV (corresponding author), Univ Copenhagen, Dept Pathol, Herlev Hosp, Herlev, Denmark.	estrid.hoegdall@regionh.dk		Philipsen Prahm, Kira/0000-0002-8567-6338; Nogueira Perez Oliveira, Douglas/0000-0002-3529-4219; Hogdall, Claus/0000-0002-5959-8874				Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Chen Y, 2011, CANCER PREV RES, V4, P76, DOI 10.1158/1940-6207.CAPR-10-0167; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Garofalo M, 2012, CURR MOL MED, V12, P27, DOI 10.2174/156652412798376170; Gottschau M, 2016, ACTA OBSTET GYN SCAN, V95, P1181, DOI 10.1111/aogs.12948; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hong FZ, 2013, J INT MED RES, V41, P64, DOI 10.1177/0300060513475759; Hosmer DW, 1980, COMMUNICATIONS STAT, V9, P27; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim Young-Kook, 2015, Chonnam Med J, V51, P51, DOI 10.4068/cmj.2015.51.2.51; Koutsaki M, 2017, ONCOTARGET, V8, P66629, DOI 10.18632/oncotarget.18343; Langhe R, 2015, CANCER LETT, V356, P628, DOI 10.1016/j.canlet.2014.10.010; Luo QF, 2014, ONCOL REP, V31, P1096, DOI 10.3892/or.2014.2971; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moore RG, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.043; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Muralidhar GG, 2015, INT J MOL SCI, V16, P16833, DOI 10.3390/ijms160816833; Nakamura K, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0536-0; Ouyang M, 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Flores CP, 2017, INT J ONCOL, V50, P1461, DOI 10.3892/ijo.2017.3948; Prahm KP, 2016, APMIS, V124, P337, DOI 10.1111/apm.12514; R Core Team, 2021, R LANGUAGE ENV STAT; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Romagnolo C, 2016, GYNECOL ONCOL, V141, P303, DOI 10.1016/j.ygyno.2016.01.016; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Shapira I, 2014, BRIT J CANCER, V110, P976, DOI 10.1038/bjc.2013.795; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Suryawanshi S, 2013, CLIN CANCER RES, V19, P1213, DOI 10.1158/1078-0432.CCR-12-2726; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; West-Hielsen M, 2005, ANAL CHEM, V77, P5114, DOI 10.1021/ac050253g; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Wu KL, 2015, TUMOR BIOL, V36, P1973, DOI 10.1007/s13277-014-2803-2; Zearo S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-200; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229	44	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225249	10.1371/journal.pone.0225249	http://dx.doi.org/10.1371/journal.pone.0225249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738788	gold, Green Published			2022-12-26	WOS:000532826300039
J	Wei, Y; Peng, ZR; Kuhbach, M; Breen, A; Legros, M; Larranaga, M; Mompiou, F; Gault, B				Wei, Ye; Peng, Zirong; Kuhbach, Markus; Breen, Andrew; Legros, Marc; Larranaga, Melvyn; Mompiou, Frederic; Gault, Baptiste			3D nanostructural characterisation of grain boundaries in atom probe data utilising machine learning methods	PLOS ONE			English	Article							FOCUSED ION-BEAM; SPECIMEN PREPARATION; LOCAL MAGNIFICATION; FIELD EVAPORATION; SEGREGATION; TOMOGRAPHY; MICROSCOPY	Boosting is a family of supervised learning algorithm that convert a set of weak learners into a single strong one. It is popular in the field of object tracking, where its main purpose is to extract the position, motion, and trajectory from various features of interest within a sequence of video frames. A scientific application explored in this study is to combine the boosting tracker and the Hough transformation, followed by principal component analysis, to extract the location and trace of grain boundaries within atom probe data. Before the implementation of this method, these information could only be extracted manually, which is time-consuming and error-prone. The effectiveness of this method is demonstrated on an experimental dataset obtained from a pure aluminum bi-crystal and validated on simulated data. The information gained from this method can be combined with crystallographic information directly contained within the data, to fully define the grain boundary character to its 5 degrees of freedom at near-atomic resolution in three dimensions. It also enables local atomic compositional and geometric information, i.e. curvature, to be extracted directly at the interface.	[Wei, Ye; Peng, Zirong; Kuhbach, Markus; Gault, Baptiste] Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, Dusseldorf, Germany; [Breen, Andrew; Legros, Marc; Larranaga, Melvyn; Mompiou, Frederic] CNRS, CEMES, 29 Rue Jeanne Marvig, Toulouse, France; [Gault, Baptiste] Imperial Coll, Royal Sch Mines, Dept Mat, London, England	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Imperial College London	Wei, Y (corresponding author), Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, Dusseldorf, Germany.	y.wei@mpie.de; b.gault@mpie.de	Peng, Zirong/AAG-9378-2019; Kuhbach, Markus/F-1792-2016	Peng, Zirong/0000-0001-7844-8313; Breen, Andrew/0000-0002-3600-5108; WEI, YE/0000-0003-1965-2298; Kuhbach, Markus/0000-0002-7117-5196	LAPLACE Project by Max-Planck Society; BIGMax network by Max-Planck Society; Alexander von Humboldt foundation; BiGmax, the Max Planck Society's Research Network on Big-Data-Driven Materials-Science	LAPLACE Project by Max-Planck Society; BIGMax network by Max-Planck Society; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); BiGmax, the Max Planck Society's Research Network on Big-Data-Driven Materials-Science	YW is grateful for funding from the LAPLACE Project, funded by the Max-Planck Society. ZP acknowledges funding from the BIGMax network, funded by the Max-Planck Society. AB is grateful for funding from the Alexander von Humboldt fundation. MK appreciates the funding by BiGmax, the Max Planck Society's Research Network on Big-Data-Driven Materials-Science.	ADAMS BL, 1993, METALL TRANS A, V24, P819, DOI 10.1007/BF02656503; Araullo-Peters VJ, 2015, ULTRAMICROSCOPY, V154, P7, DOI 10.1016/j.ultramic.2015.02.009; Avidan S, 2004, IEEE T PATTERN ANAL, V26, P1064, DOI 10.1109/TPAMI.2004.53; Babinsky K, 2014, ULTRAMICROSCOPY, V144, P9, DOI 10.1016/j.ultramic.2014.04.003; BOLLMANN W., 1970, CRYSTAL DEFECTS CRYS; Breen AJ, 2017, MICROSC MICROANAL, P1; Burnett TL, 2016, ULTRAMICROSCOPY, V161, P119, DOI 10.1016/j.ultramic.2015.11.001; da Silva AK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03591-4; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Felfer P, 2013, ULTRAMICROSCOPY, V132, P100, DOI 10.1016/j.ultramic.2013.03.004; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Gault B, 2011, ULTRAMICROSCOPY, V111, P448, DOI 10.1016/j.ultramic.2010.11.016; Gault B, 2018, INTERFACES DEFECT CO, V33; Gault B, 2012, MATER TODAY, V15, P378, DOI 10.1016/S1369-7021(12)70164-5; Gault B, 2009, J APPL PHYS, V105, DOI 10.1063/1.3068197; Ge XJ, 1999, J APPL PHYS, V85, P3488, DOI 10.1063/1.369706; Grabner H, 2006, P BRIT MACH VIS C 20, V66; Kuhbach M, 2019, MICROSC MICROANAL, V25, P320, DOI 10.1017/S1431927618016252; Larson DJ, 2013, CURR OPIN SOLID ST M, V17, P236, DOI 10.1016/j.cossms.2013.09.002; MILLER MK, 1987, J PHYS-PARIS, V48, P565, DOI 10.1051/jphyscol:1987692; Mompiou F, 2009, ACTA MATER, V57, P2198, DOI 10.1016/j.actamat.2009.01.014; Moody MP, 2011, ULTRAMICROSCOPY, V111, P493, DOI 10.1016/j.ultramic.2010.11.014; MOORE AJW, 1962, J PHYS CHEM SOLIDS, V23, P907, DOI 10.1016/0022-3697(62)90148-8; MULLER EW, 1956, PHYS REV, V102, P618, DOI 10.1103/PhysRev.102.618; NORDEN H, 1988, SURF INTERFACE ANAL, V12, P179, DOI 10.1002/sia.740120302; Oberdorfer C, 2014, TAPSIM; Oberdorfer C, 2014, NUMERIC SIMULATION A; Oberdorfer C, 2013, ULTRAMICROSCOPY, V128, P55, DOI 10.1016/j.ultramic.2013.01.005; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Rajabzadeh A, 2014, ACTA MATER, V77, P223, DOI 10.1016/j.actamat.2014.05.062; Randle V., 2014, INTRO TEXTURE ANAL M; Rosebrock A., 2016, DETECTING MULTIPLE B; Seto K, 1999, SCRIPTA MATER, V40, P1029, DOI 10.1016/S1359-6462(98)00485-0; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; Unocic KA, 2010, J MICROSC-OXFORD, V240, P227, DOI 10.1111/j.1365-2818.2010.03401.x; Viola P, 2005, INT J COMPUT VISION, V63, P153, DOI 10.1007/s11263-005-6644-8; Vurpillot F, 2015, ULTRAMICROSCOPY, V159, P202, DOI 10.1016/j.ultramic.2014.12.013; Vurpillot F, 2000, APPL PHYS LETT, V76, P3127, DOI 10.1063/1.126545; WAUGH AR, 1979, SURF SCI, V89, P718, DOI 10.1016/0039-6028(79)90651-4; WAUGH AR, 1976, SURF SCI, V61, P109, DOI 10.1016/0039-6028(76)90411-8; Wei Y, 2018, ULTRAMICROSCOPY, V194, P15, DOI 10.1016/j.ultramic.2018.06.017; Yao L, 2013, SCRIPTA MATER, V69, P622, DOI 10.1016/j.scriptamat.2013.07.013; Yao L, 2011, ULTRAMICROSCOPY, V111, P458, DOI 10.1016/j.ultramic.2010.11.018	43	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225041	10.1371/journal.pone.0225041	http://dx.doi.org/10.1371/journal.pone.0225041			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738784	gold, Green Published			2022-12-26	WOS:000532826300027
J	Pouranbarani, E; dos Santos, RW; Nygren, A				Pouranbarani, Elnaz; dos Santos, Rodrigo Weber; Nygren, Anders			A robust multi-objective optimization framework to capture both cellular and intercellular properties in cardiac cellular model tuning: Analyzing different regions of membrane resistance profile in parameter fitting	PLOS ONE			English	Article							ACTION-POTENTIALS; REPOLARIZATION; INSIGHTS; K+	Mathematical models of cardiac cells have been established to broaden understanding of cardiac function. In the process of developing electrophysiological models for cardiac myocytes, precise parameter tuning is a crucial step. The membrane resistance (R-m) is an essential feature obtained from cardiac myocytes. This feature reflects intercellular coupling and affects important phenomena, such as conduction velocity, and early after-depolarizations, but it is often overlooked during the phase of parameter fitting. Thus, the traditional parameter fitting that only includes action potential (AP) waveform may yield incorrect values for R-m. In this paper, a novel multi-objective parameter fitting formulation is proposed and tested that includes different regions of the R-m profile as additional objective functions for optimization. As R-m depends on the transmembrane voltage (V-m) and exhibits singularities for some specific values of V-m, analyses are conducted to carefully select the regions of interest for the proper characterization of R-m. Non-dominated sorting genetic algorithm II is utilized to solve the proposed multi-objective optimization problem. To verify the efficacy of the proposed problem formulation, case studies and comparisons are carried out using multiple models of human cardiac ventricular cells. Results demonstrate R-m is correctly reproduced by the tuned cell models after considering the curve of Rm obtained from the late phase of repolarization and R-m value calculated in the rest phase as additional objectives. However, relative deterioration of the AP fit is observed, demonstrating trade-off among the objectives. This framework can be useful for a wide range of applications, including the parameters fitting phase of the cardiac cell model development and investigation of normal and pathological scenarios in which reproducing both cellular and intercellular properties are of great importance.	[Pouranbarani, Elnaz; Nygren, Anders] Univ Calgary, Dept Elect & Comp Engn, Calgary, AB, Canada; [dos Santos, Rodrigo Weber] Univ Fed Juiz de Fora, Dept Comp Sci, Juiz De Fora, MG, Brazil; [dos Santos, Rodrigo Weber] Univ Fed Juiz de Fora, Grad Program Computat Modeling, Juiz De Fora, MG, Brazil	University of Calgary; Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora	Pouranbarani, E (corresponding author), Univ Calgary, Dept Elect & Comp Engn, Calgary, AB, Canada.	elnaz.pouranbarani@ucalgary.ca	dos Santos, Rodrigo Weber/E-6494-2015	dos Santos, Rodrigo Weber/0000-0002-0633-1391	University of Calgary (U of C); Universidade Federal de Juiz de Fora (UFJF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	University of Calgary (U of C); Universidade Federal de Juiz de Fora (UFJF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported in part by the University of Calgary (U of C) and in part by Universidade Federal de Juiz de Fora (UFJF), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG).	Boada Y, 2019, IEEE T CONTROL SYSTE; Boada Y, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0269-0; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Cedersund G, 2016, STUD MECHANOBIOL TIS, V17, P177, DOI 10.1007/978-3-319-21296-8_7; Chen FL, 2012, IEEE T BIO-MED ENG, V59, P3412, DOI 10.1109/TBME.2012.2216265; Cheshmehgaz HR, 2015, ARTIF INTELL REV, V43, P311, DOI 10.1007/s10462-012-9378-3; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Davies MR, 2016, DRUG DISCOV TODAY, V21, P924, DOI 10.1016/j.drudis.2016.02.003; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Dokos S, 2004, PROG BIOPHYS MOL BIO, V85, P407, DOI 10.1016/j.pbiomolbio.2004.02.002; Giudicessi JR, 2012, NAT REV CARDIOL, V9, P319, DOI 10.1038/nrcardio.2012.3; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; Kaur J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107984; King JH, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00154; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Krogh-Madsen T, 2016, J PHYSIOL-LONDON, V594, P2525, DOI 10.1113/JP270618; Lawson BAJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.1701676; Loewe A, 2016, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00209; NOBLE D, 1963, BIOPHYS J, V3, P261, DOI 10.1016/S0006-3495(63)86820-4; Nygren A, 2000, ANN BIOMED ENG, V28, P951, DOI 10.1114/1.1308489; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Sarkar AX, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000914; Sivasubramani S, 2011, INT J ELEC POWER, V33, P745, DOI 10.1016/j.ijepes.2010.12.031; Spitzer Kenneth W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS8, DOI 10.1111/j.1540-8167.2006.00379.x; Syed Z, 2005, MED BIOL ENG COMPUT, V43, P561, DOI 10.1007/BF02351029; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Tian Y, 2017, IEEE COMPUT INTELL M, V12, P73, DOI 10.1109/MCI.2017.2742868; Trenor B, 2018, TRENDS CARDIOVAS MED, V28, P233, DOI 10.1016/j.tcm.2017.11.002; Trenor B, 2017, J PHYSIOL-LONDON, V595, P6599, DOI 10.1113/JP273651; WEIDMANN S, 1951, J PHYSIOL-LONDON, V115, P227, DOI 10.1113/jphysiol.1951.sp004667; Yang PC, 2015, J PHYSIOL-LONDON, V593, P1429, DOI 10.1113/jphysiol.2014.279554; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677; Zaniboni M, 2011, MATH BIOSCI, V233, P98, DOI 10.1016/j.mbs.2011.06.008; Zaniboni M, 2012, IEEE T BIO-MED ENG, V59, P2372, DOI 10.1109/TBME.2012.2204880; Zaniboni M, 2012, IEEE T BIO-MED ENG, V59, P226, DOI 10.1109/TBME.2011.2170987; Zaniboni M, 2010, MATH BIOSCI, V228, P56, DOI 10.1016/j.mbs.2010.08.007	37	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225245	10.1371/journal.pone.0225245	http://dx.doi.org/10.1371/journal.pone.0225245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730631	Green Published, gold			2022-12-26	WOS:000532809500031
J	Sekine, Y; Lindborg, JA; Strittmatter, SM				Sekine, Yuichi; Lindborg, Jane A.; Strittmatter, Stephen M.			A proteolytic C-terminal fragment of Nogo-A (reticulon-4A) is released in exosomes and potently inhibits axon regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						axon; regeneration; exosome (vesicle); -secretase 1 (BACE1); oligodendrocyte; NgR1; Nogo; Nogo receptor; reticulon; spinal cord injury	MYELIN-ASSOCIATED GLYCOPROTEIN; BACE1 ACTIVITY; RECEPTOR; IDENTIFICATION; OUTGROWTH; LIGAND; EXPRESSION; PROTEINS; GROWTH; RNA	Glial signals are known to inhibit axonal regeneration and functional recovery after mammalian central nervous system trauma, including spinal cord injury. Such signals include membrane-associated proteins of the oligodendrocyte plasma membrane and astrocyte-derived, matrix-associated proteins. Here, using cell lines and primary cortical neuron cultures, recombinant protein expression, immunoprecipitation and immunoblot assays, transmission EM of exosomes, and axon regeneration assays, we explored the secretion and activity of the myelin-associated neurite outgrowth inhibitor Nogo-A and observed exosomal release of a 24-kDa C-terminal Nogo-A fragment from cultured cells. We found that the cleavage site in this 1192-amino-acid-long fragment is located between amino acids 961?971. We also detected a Nogo-66 receptor (NgR1)?interacting Nogo-66 domain on the exosome surface. Enzyme inhibitor treatment and siRNA knockdown revealed that ?-secretase 1 (BACE1) is the protease responsible for Nogo-A cleavage. Functionally, exosomes with the Nogo-66 domain on their surface potently inhibited axonal regeneration of mechanically injured cerebral cortex neurons from mice. Production of this fragment was observed in the exosomal fraction from neuronal tissue lysates after spinal cord crush injury of mice. We also noted that, relative to the exosomal marker Alix, a Nogo-immunoreactive, 24-kDa protein is enriched in exosomes 2-fold after injury. We conclude that membrane-associated Nogo-A produced in oligodendrocytes is processed proteolytically by BACE1, is released via exosomes, and is a potent diffusible inhibitor of regenerative growth in NgR1-expressing axons.	[Sekine, Yuichi; Lindborg, Jane A.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA; [Sekine, Yuichi; Lindborg, Jane A.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurosci, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA; [Sekine, Yuichi] Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan	Yale University; Yale University; Wakayama Medical University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, CNNR Program, 295 Congress Ave,BCMM 436, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Sekine, Yuichi/S-8813-2019; Strittmatter, Stephen/F-5739-2011	Sekine, Yuichi/0000-0002-2861-603X; Strittmatter, Stephen/0000-0001-8188-3092	NINDS, National Institutes of Health [R35NS097283]; Falk Medical Research Trust Transformative Research Award	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Falk Medical Research Trust Transformative Research Award	This work was supported by NINDS, National Institutes of Health Grant R35NS097283 and a Falk Medical Research Trust Transformative Research Award (to S. M. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. S.M.S. is a cofounder of ReNetX Bio, which seeks to develop NgR1-based therapeutics.	Lopez-Verrilli MA, 2013, GLIA, V61, P1795, DOI 10.1002/glia.22558; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bakhti M, 2011, J BIOL CHEM, V286, P787, DOI 10.1074/jbc.M110.190009; Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Frohlich D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0510; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; He WX, 2006, J MOL BIOL, V363, P625, DOI 10.1016/j.jmb.2006.07.094; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Huber AB, 2002, J NEUROSCI, V22, P3553; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Lauren J, 2007, J BIOL CHEM, V282, P5715, DOI 10.1074/jbc.M609797200; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Raissi AJ, 2013, MOL CELL NEUROSCI, V57, P23, DOI 10.1016/j.mcn.2013.08.004; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Sekine Y, 2019, J NEUROSCI, V39, P3204, DOI 10.1523/JNEUROSCI.2996-18.2019; Sekine Y, 2018, CELL REP, V23, P415, DOI 10.1016/j.celrep.2018.03.058; Sekine Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao4180; Sharoar MG, 2017, REV NEUROSCIENCE, V28, P145, DOI 10.1515/revneuro-2016-0054; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Teng FYH, 2008, J CELL PHYSIOL, V216, P303, DOI 10.1002/jcp.21434; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2002, J NEUROSCI, V22, P5505; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	35	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2175	2183		10.1074/jbc.RA119.009896	http://dx.doi.org/10.1074/jbc.RA119.009896			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31748413	Green Published, hybrid			2022-12-26	WOS:000517330200002
J	Barak, AF; Lewinsky, H; Perpinial, M; Huber, V; Radomir, L; Kramer, MP; Sever, L; Wolf, Y; Shapiro, M; Herishanu, Y; Jung, S; Becker-Herman, S; Shachar, I				Barak, Avital F.; Lewinsky, Hadas; Perpinial, Michal; Huber, Victoria; Radomir, Lihi; Kramer, Mattias P.; Sever, Lital; Wolf, Yochai; Shapiro, Mika; Herishanu, Yair; Jung, Steffen; Becker-Herman, Shirly; Shachar, Idit			Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner	ONCOGENE			English	Article							IMMUNE SUPPRESSION; B-CELLS; RECEPTOR; MICROENVIRONMENT; MONOCYTES; MOUSE; CLL; PATHOGENESIS; APOPTOSIS; DEPLETION	Chronic lymphocytic leukemia (CLL) is a malignancy of mature B lymphocytes. The microenvironment of the CLL cells is a vital element in the regulation of the survival of these malignant cells. CLL cell longevity is dependent on external signals, originating from cells in their microenvironment including secreted and surface-bound factors. Dendritic cells (DCs) play an important part in tumor microenvironment, but their role in the CLL bone marrow (BM) niche has not been studied. We show here that CLL cells induce accumulation of bone marrow dendritic cells (BMDCs). Depletion of this population attenuates disease expansion. Our results show that the support of the microenvironment is partly dependent on CD84, a cell surface molecule belonging to the Signaling Lymphocyte Activating Molecule (SLAM) family of immunoreceptors. Our results suggest a novel therapeutic strategy whereby eliminating BMDCs or blocking the CD84 expressed on these cells may reduce the tumor load.	[Barak, Avital F.; Lewinsky, Hadas; Perpinial, Michal; Huber, Victoria; Radomir, Lihi; Kramer, Mattias P.; Sever, Lital; Wolf, Yochai; Jung, Steffen; Becker-Herman, Shirly; Shachar, Idit] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Shapiro, Mika; Herishanu, Yair] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Hematol, Tel Aviv, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Shachar, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	idit.shachar@weizmann.ac.il	Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716; Wolf, Yochai/0000-0003-0270-2025; Kramer, Matthias P/0000-0002-0289-5261	DKFZ-MOST cooperation in cancer research; ERA-NET TRANSCAN-2 program JTC 2014-project FIRE-CLL; Binational Science Foundation (BSF) [711979]; Israel Science Foundation	DKFZ-MOST cooperation in cancer research; ERA-NET TRANSCAN-2 program JTC 2014-project FIRE-CLL; Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	The authors wish to thank members of the Shachar lab for fruitful discussion and support. IS is the incumbent of the Dr Morton and Ann Kleiman Professorial Chair. This research was supported by the DKFZ-MOST cooperation in cancer research, ERA-NET TRANSCAN-2 program JTC 2014-project FIRE-CLL and the Binational Science Foundation (BSF) grant no 711979. This research was performed without the support of the Israel Science Foundation.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; BINET JL, 1977, CANCER-AM CANCER SOC, V40, P855, DOI 10.1002/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1; Binsky-Ehrenreich I, 2014, ONCOGENE, V33, P1006, DOI 10.1038/onc.2013.31; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Burger JA, 2007, LEUKEMIA RES, V31, P887, DOI 10.1016/j.leukres.2006.12.004; Cabanas C, 1999, J BIOL REG HOMEOS AG, V13, P134; Caligaris-Cappio F, 1999, J CLIN ONCOL, V17, P399, DOI 10.1200/JCO.1999.17.1.399; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engelhardt JJ, 2012, CANCER CELL, V21, P402, DOI 10.1016/j.ccr.2012.01.008; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; GALE RP, 1994, LEUKEMIA, V8, P1610; Galletti G, 2016, CELL REP, V14, P1748, DOI 10.1016/j.celrep.2016.01.042; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Greaves P, 2013, BLOOD, V121, P734, DOI 10.1182/blood-2012-10-385591; Hanna BS, 2016, LEUKEMIA, V30, P570, DOI 10.1038/leu.2015.305; Hofbauer JP, 2011, LEUKEMIA, V25, P1452, DOI 10.1038/leu.2011.111; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Karthaus N, 2012, AM J PATHOL, V181, P733, DOI 10.1016/j.ajpath.2012.05.012; Kipps T J, 1998, Curr Opin Hematol, V5, P244; Klein U, 2010, SEMIN CANCER BIOL, V20, P377, DOI 10.1016/j.semcancer.2010.10.012; Krempski J, 2011, J IMMUNOL, V186, P6905, DOI 10.4049/jimmunol.1100274; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Lewinsky H, 2018, J CLIN INVEST, V128, P5465, DOI 10.1172/JCI96610; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marom A, 2017, ONCOGENE, V36, P628, DOI 10.1038/onc.2016.238; Martin M, 2001, J IMMUNOL, V167, P3668, DOI 10.4049/jimmunol.167.7.3668; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Montserrat E, 2008, ANN ONCOL, V19, P320, DOI 10.1093/annonc/mdn460; Nicholas NS, 2016, BBA-MOL CELL RES, V1863, P471, DOI 10.1016/j.bbamcr.2015.11.003; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Ramsay AD, 2013, BRIT J HAEMATOL, V162, P15, DOI 10.1111/bjh.12344; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; Sapoznikov A, 2008, IMMUNOL CELL BIOL, V86, P409, DOI 10.1038/icb.2008.23; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Saulep-Easton D, 2014, LEUKEMIA, V28, P2005, DOI 10.1038/leu.2014.105; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Yan QR, 2007, P NATL ACAD SCI USA, V104, P10583, DOI 10.1073/pnas.0703893104; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zlotnikov-Klionsky Y, 2015, IMMUNITY, V43, P776, DOI 10.1016/j.immuni.2015.08.015	48	1	1	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1997	2008		10.1038/s41388-019-1121-y	http://dx.doi.org/10.1038/s41388-019-1121-y			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31772329				2022-12-26	WOS:000516579800013
J	Barrows, JK; Long, DT				Barrows, John K.; Long, David T.			Cell-free transcription in Xenopus egg extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plasmid; Xenopus; transcription; histone; RNA processing; cell-free system; gene regulation; genome activation; in vitro assay; nucleoplasmic extract	CHROMOSOMAL DNA-REPLICATION; RNA POLYMERASE-II; DIVERGENT TRANSCRIPTION; CHROMATIN-STRUCTURE; MECHANISM; INITIATION; RECONSTITUTION; INHIBITION	Soluble extracts prepared from Xenopus eggs have been used extensively to study various aspects of cellular and developmental biology. During early egg development, transcription of the zygotic genome is suppressed. As a result, traditional extracts derived from unfertilized and early stage eggs possess little or no intrinsic transcriptional activity. In this study, we show that Xenopus nucleoplasmic extract (NPE) supports robust transcription of a chromatinized plasmid substrate. Although prepared from eggs in a transcriptionally inactive state, the process of making NPE resembles some aspects of egg fertilization and early embryo development that lead to transcriptional activation. With this system, we observed that promoter-dependent recruitment of transcription factors and RNA polymerase II leads to conventional patterns of divergent transcription and pre-mRNA processing, including intron splicing and 3? cleavage and polyadenylation. We also show that histone density controls transcription factor binding and RNA polymerase II activity, validating a mechanism proposed to regulate genome activation during development. Together, these results establish a new cell-free system to study the regulation, initiation, and processing of mRNA transcripts.	[Barrows, John K.; Long, David T.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Long, DT (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	longdt@musc.edu		Long, David/0000-0001-9232-0316; Barrows, John/0000-0003-0906-1574	National Institutes of Health [R35 GM119512]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [TL1 TR001451, UL1 TR001450]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001451, UL1TR001450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R35 GM119512 (to D. T. L.) and National Center for Advancing Translational Sciences (NCATS), National Institutes of Health Grants TL1 TR001451 and UL1 TR001450 (to J. K. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amodeo AA, 2015, P NATL ACAD SCI USA, V112, pE1086, DOI 10.1073/pnas.1413990112; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; BLOW JJ, 1990, J CELL SCI, V95, P383; Blow JJ, 2001, EMBO J, V20, P3293, DOI 10.1093/emboj/20.13.3293; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cross MK, 2009, DIS MODEL MECH, V2, P541, DOI 10.1242/dmm.002022; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dewar JM, 2015, NATURE, V525, P345, DOI 10.1038/nature14887; EARNSHAW WC, 1980, CELL, V21, P373, DOI 10.1016/0092-8674(80)90474-2; FELIX MA, 1990, NATURE, V346, P379, DOI 10.1038/346379a0; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Fullbright G, 2016, MOL CELL BIOL, V36, P2983, DOI 10.1128/MCB.00434-16; Gillespie PJ, 2012, METHODS, V57, P203, DOI 10.1016/j.ymeth.2012.03.029; Hashimoto Y, 2011, METHODS MOL BIOL, V745, P437, DOI 10.1007/978-1-61779-129-1_25; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HUTCHISON CJ, 1989, J CELL SCI, P197; Hyde AS, 2016, METHODS MOL BIOL, V1481, P101, DOI 10.1007/978-1-4939-6393-5_11; INOUE N, 1991, J BACTERIOL, V173, P1208, DOI 10.1128/jb.173.3.1208-1214.1991; Jimeno-Gonzalez S, 2016, TRANSCR-AUSTIN, V7, P63, DOI 10.1080/21541264.2016.1168507; Jones C. Michael, 2008, V461, P385, DOI 10.1007/978-1-60327-483-8_28; Joseph SR, 2017, ELIFE, V6, DOI 10.7554/eLife.23326; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; KLEINSCHMIDT JA, 1985, J BIOL CHEM, V260, P1166; Klemm SL, 2019, NAT REV GENET, V20, P207, DOI 10.1038/s41576-018-0089-8; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; LENO GH, 1991, METHOD CELL BIOL, V36, P561; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu Z J, 1990, DNA Seq, V1, P125, DOI 10.3109/10425179009016040; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Maresca Thomas J., 2006, V322, P459; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; MUNSON LM, 1981, BIOCHEMISTRY-US, V20, P2081, DOI 10.1021/bi00511a003; Nagai S, 2017, P NATL ACAD SCI USA, V114, P1536, DOI 10.1073/pnas.1620312114; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; PRIOLEAU MN, 1994, CELL, V77, P439, DOI 10.1016/0092-8674(94)90158-9; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Read A, 2018, ENDOCR-RELAT CANCER, V25, pR467, DOI 10.1530/ERC-18-0068; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Srinivasan SV, 2011, METHODS MOL BIOL, V782, P119, DOI 10.1007/978-1-61779-273-1_10; Tanny JC, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/21541264.2014.988093; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; TOYODA T, 1992, DEV BIOL, V153, P150, DOI 10.1016/0012-1606(92)90099-3; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang WL, 2016, INT J DEV BIOL, V60, P315, DOI 10.1387/ijdb.160161ds; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; Wu RA, 2019, NATURE, V567, P267, DOI 10.1038/s41586-019-1002-0; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651; Zierhut C, 2014, NAT STRUCT MOL BIOL, V21, P617, DOI 10.1038/nsmb.2845	61	5	5	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19645	19654		10.1074/jbc.RA119.011350	http://dx.doi.org/10.1074/jbc.RA119.011350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31732562	hybrid, Green Published			2022-12-26	WOS:000504093200016
J	Butler, EM; Derraik, JGB; Glover, M; Morton, SMB; Tautolo, ES; Taylor, RW; Cutfield, WS				Butler, Eadaoin M.; Derraik, Jose G. B.; Glover, Marewa; Morton, Susan M. B.; Tautolo, El-Shadan; Taylor, Rachael W.; Cutfield, Wayne S.			Acceptability of early childhood obesity prediction models to New Zealand families	PLOS ONE			English	Article							PARENTAL PERCEPTIONS; OVERWEIGHT; WEIGHT; RISK; BEHAVIORS; CHILDREN	Objective While prediction models can estimate an infant's risk of developing obesity at a later point in early childhood, caregiver receptiveness to such information is largely unknown. We aimed to assess the acceptability of these models to New Zealand caregivers. Methods An anonymous questionnaire was distributed online. The questionnaire consisted of multiple choice and Likert scale questions. Respondents were parents, caregivers, and grandparents of children aged.5 years. Results 1,934 questionnaires were analysed. Responses were received from caregivers of various ethnicities and levels of education. Nearly two-thirds (62.1%) of respondents would "definitely" or "probably" want to hear if their infant was at risk of early childhood obesity, although "worried" (77.0%) and "upset" (53.0%) were the most frequently anticipated responses to such information. With lower mean scores reflecting higher levels of acceptance, grandparents (mean score = 1.67) were more receptive than parents (2.10; p = 0.0002) and other caregivers (2.13; p = 0.021); males (1.83) were more receptive than females (2.11; p = 0.005); and Asian respondents (1.68) were more receptive than those of European (2.05; p = 0.003), Maori (2.11; p = 0.002), or Pacific (2.03; p = 0.042) ethnicities. There were no differences in acceptance according to socioeconomic status, levels of education, or other ethnicities. Conclusions Almost two-thirds of respondents were receptive to communication regarding their infant's risk of childhood obesity. While our results must be interpreted with some caution due to their hypothetical nature, findings suggest that if delivered in a sensitive manner to minimise caregiver distress, early childhood obesity risk prediction could be a useful tool to inform interventions to reduce childhood obesity in New Zealand.	[Butler, Eadaoin M.; Derraik, Jose G. B.; Morton, Susan M. B.; Tautolo, El-Shadan; Taylor, Rachael W.; Cutfield, Wayne S.] Better Start Natl Sci Challenge, Auckland, New Zealand; [Butler, Eadaoin M.; Derraik, Jose G. B.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Derraik, Jose G. B.] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Glover, Marewa] Massey Univ, Coll Hlth, Sch Hlth Sci, Auckland, New Zealand; [Glover, Marewa] Ctr Res Excellence Indigenous Sovereignty & Smoki, Auckland, New Zealand; [Morton, Susan M. B.] Univ Auckland, Ctr Longitudinal Res He Ara Ki Mua, Auckland, New Zealand; [Morton, Susan M. B.] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Tautolo, El-Shadan] Auckland Univ Technol, Ctr Pacific Hlth & Dev Res, Auckland, New Zealand; [Taylor, Rachael W.] Univ Otago, Dept Med, Dunedin, New Zealand	University of Auckland; Uppsala University; Massey University; University of Auckland; University of Auckland; Auckland University of Technology; University of Otago	Derraik, JGB; Cutfield, WS (corresponding author), Better Start Natl Sci Challenge, Auckland, New Zealand.; Derraik, JGB; Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland, New Zealand.; Derraik, JGB (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	j.derraik@auckland.ac.nz; w.cutfield@auckland.ac.nz	Butler, Eadaoin/GSN-2634-2022; Butler, Éadaoin Máire/AFK-4598-2022; Tautolo, El-Shadan/S-6002-2019	Butler, Éadaoin Máire/0000-0001-5078-1851; Tautolo, El-Shadan/0000-0001-8444-6410	New Zealand Ministry of Business, Innovation and Employment	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work was conducted for A Better Start - National Science Challenge, which is funded by the New Zealand Ministry of Business, Innovation and Employment. The funders had no role in study design, data analysis or interpretation, decision to publish, or preparation of this manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Appleton J, 2017, CONTEMP NURSE, V53, P410, DOI 10.1080/10376178.2017.1358650; Bell LK, 2018, J NUTR EDUC BEHAV, V50, P516, DOI 10.1016/j.jneb.2017.12.007; Bentley F, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4684-y; Butler EM, 2018, HORM RES PAEDIAT, V90, P358, DOI 10.1159/000496563; Butler EM, 2018, J PEDIATR ENDOCR MET, V31, P497, DOI 10.1515/jpem-2018-0110; Craig LCA, P NUTR SOC, pE444; Dawson AM, 2018, PEDIATR OBES, V13, P639, DOI 10.1111/ijpo.12195; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Exeter DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181260; Falconer CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-549; Gillison F, 2014, PUBLIC HEALTH NUTR, V17, P987, DOI 10.1017/S1368980013002425; Gomes AI, 2017, APPETITE, V108, P491, DOI 10.1016/j.appet.2016.11.008; Goodell LS, 2008, QUAL HEALTH RES, V18, P1548, DOI 10.1177/1049732308325537; Grimmett C, 2008, PEDIATRICS, V122, pE682, DOI 10.1542/peds.2007-3526; Heimuli James, 2011, Pac Health Dialog, V17, P33; Jain A, 2001, PEDIATRICS, V107, P1138, DOI 10.1542/peds.107.5.1138; McBride CM, 2013, INT J OBESITY, V37, P1322, DOI 10.1038/ijo.2013.87; Ministry of Health, 2019, ANN SURVEY LARGE; Ministry of Health, 2017, HISO 10001 2017 ETHN; Morgan PJ, 2017, CURR OBES REP, V6, P324, DOI 10.1007/s13679-017-0275-6; Pandita A, 2016, DIABET METAB SYND OB, V9, P83, DOI 10.2147/DMSO.S90783; Pearce A, 2010, INT J OBESITY, V34, P1160, DOI 10.1038/ijo.2010.15; Pocock M, 2010, OBES REV, V11, P338, DOI 10.1111/j.1467-789X.2009.00648.x; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; Redsell SA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017694; Redsell SA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-711; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Research NZ, 2013, AW US PERC EFF GOV F; Rose J, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6616-5; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Schwartz M, 2015, J SCHOOL HEALTH, V85, P714, DOI 10.1111/josh.12300; Shackleton N, 2018, PEDIATR OBES, V13, P766, DOI 10.1111/ijpo.12260; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Statistics NZ, 2017, GRANDP LEND HAND CHI; Syrad H, 2015, J HUM NUTR DIET, V28, P47, DOI 10.1111/jhn.12217; Tanskanen AO, 2013, EVOL PSYCHOL-US, V11, P417, DOI 10.1177/147470491301100212; Tapera R, 2017, PUBLIC HEALTH NUTR, V20, P1090, DOI 10.1017/S1368980016002950; United Nations Children's Fund (UNICEF) World Health Organization International Bank for Reconstruction and Development/The World Bank, 2021, LEVELS TRENDS CHILD; Worrall J. M., 2009, GRANDPARENTS WHANAU	41	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0225212	10.1371/journal.pone.0225212	http://dx.doi.org/10.1371/journal.pone.0225212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO9FT	31790443	Green Published, gold			2022-12-26	WOS:000533930800025
J	Kim, YC; Truax, AD; Giamouridis, D; Lai, NC; Guo, T; Hammond, HK; Gao, MH				Kim, Young Chul; Truax, Agnieszka D.; Giamouridis, Dimosthenis; Lai, N. Chin; Guo, Tracy; Hammond, H. Kirk; Gao, Mei Hua			Significant alteration of liver metabolites by AAV8.Urocortin 2 gene transfer in mice with insulin resistance	PLOS ONE			English	Article							UROCORTIN-II; RECEPTOR; IDENTIFICATION; MODULATION; PHYSIOLOGY; INSIGHTS; PROVIDES; DISEASE; STRESS; FAMILY	Introduction Urocortin 2 (Ucn2) is a 38-amino acid peptide of the corticotropin-releasing factor family. Intravenous (IV) delivery of an adeno-associated virus vector serotype 8 encoding Ucn2 (AAV8.Ucn2) increases insulin sensitivity and glucose disposal in mice with insulin resistance. Objective To determine the effects of Ucn2 on liver metabolome. Methods Six-week-old C57BL6 mice were divided into normal chow (CHOW)-fed and high fat diet (HFD)-fed groups. The animals received saline, AAV8 encoding no gene (AAV8.Empt) or AAV8.Ucn2 (2x10(13) genome copy/kg, IV injection). Livers were isolated from CHOW-fed and HFD-fed mice and analyzed by untargeted metabolomics. Group differences were statistically analyzed. Results In CHOW-fed mice, AAV8.Ucn2 gene transfer (vs. saline) altered the metabolites in glycolysis, pentose phosphate, glycogen synthesis, glycogenolysis, and choline-folate-methionine signaling pathways. In addition, AAV8.Ucn2 gene transfer increased amino acids and peptides, which were associated with reduced protein synthesis. In insulin resistant (HFD-induced) mice, HFD (vs CHOW) altered 448 (112 increased and 336 decreased) metabolites and AAV8.Ucn2 altered 239 metabolites (124 increased and 115 reduced) in multiple pathways. There are 61 metabolites in 5 super pathways showed interactions between diet and AAV8.Ucn2 treatment. Among them, AAV8.Ucn2 gene transfer reversed HFD effects on 13 metabolites. Finally, plasma Ucn2 effects were determined using a 3-group comparison of HFD-fed mice that received AAV8.Ucn2, AAV.Empt or saline, where 18 metabolites that altered by HFD (15 increased and 3 decreased), but restored levels to that seen in CHOW-fed mice by increased plasma Ucn2. Conclusions Metabolomics study revealed that AAV8.Ucn2 gene transfer, through increased plasma Ucn2, provided counter-HFD effects in restoring hepatic metabolites to normal levels, which could be the underlying mechanisms for Ucn2 effects on increasing glucose disposal and reducing insulin assistance.	[Kim, Young Chul; Giamouridis, Dimosthenis; Lai, N. Chin; Guo, Tracy; Hammond, H. Kirk; Gao, Mei Hua] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Kim, Young Chul; Giamouridis, Dimosthenis; Lai, N. Chin; Guo, Tracy; Hammond, H. Kirk; Gao, Mei Hua] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Truax, Agnieszka D.] Metabolon Inc, Morrisville, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Metabolon	Gao, MH (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.; Gao, MH (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	mhgao@vapop.ucsd.edu		Gao, Mei Hua/0000-0002-3826-7662; Kim, Young Chul/0000-0002-6782-2186	VA Merit Grant [I01 BX001515, I01 BX003774]; NHLBI [R42HL122038-2]; NHLBI Gene Therapy [P01 HL066941]; Metabolon Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL122038, P01HL066941] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003774, IS1BX004783] Funding Source: NIH RePORTER	VA Merit Grant; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI Gene Therapy; Metabolon Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by: 1) I01 BX001515, VA Merit Grant, 04/01/2012-09/30/2016. This funding provided partial salary for NCL and MHG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2) I01 BX003774, VA Merit Grant, 04/01/2017-03/31/2021. This funding provided partial salary for NCL and MHG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3) R42HL122038-2, NHLBI, 05/01/2014-11/30/2018. This funding provided partial salary for NCL and MHG, salary for YCK, DG, TG and HKH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 4) P01 HL066941, NHLBI Gene Therapy, 06/30/2019-06/30/2020 (NCE), Translating Basic Science to the Clinic. This funding provided partial salary for NCL and MHG, salary for YCK, DG, TG and HKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 5) Metabolon Inc. is a commercial company provided financial support in the form of AT salary.	Brennan L, 2003, DIABETOLOGIA, V46, P1512, DOI 10.1007/s00125-003-1184-7; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chen A, 2005, MOL ENDOCRINOL, V19, P441, DOI 10.1210/me.2004-0300; Chen A, 2004, ENDOCRINOLOGY, V145, P2445, DOI 10.1210/en.2003-1570; Chen S, 2015, TOXICOL SCI, V148, P581, DOI 10.1093/toxsci/kfv202; Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Elhassan YS, 2017, J ENDOCR SOC, V1, P816, DOI 10.1210/js.2017-00092; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Gao MH, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88322; Gao MH, 2013, HUM GENE THER, V24, P777, DOI 10.1089/hum.2013.088; Giamouridis D, 2018, JACC-BASIC TRANSL SC, V3, P249, DOI 10.1016/j.jacbts.2017.12.004; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim YC, 2019, HUM GENE THER, V30, P693, DOI 10.1089/hum.2018.150; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lai NC, 2015, HUM GENE THER, V26, P347, DOI 10.1089/hum.2014.157; Paruthiyil S, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0208-4; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Richard D, 2002, EUR J PHARMACOL, V440, P189, DOI 10.1016/S0014-2999(02)01428-0; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schugar RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074806; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; STENZEL P, 1995, MOL ENDOCRINOL, V9, P637, DOI 10.1210/me.9.5.637; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhang CB, 2013, CLIN LIPIDOL, V8, P659, DOI 10.2217/clp.13.67	36	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0224428	10.1371/journal.pone.0224428	http://dx.doi.org/10.1371/journal.pone.0224428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790421	Green Published, gold, Green Submitted			2022-12-26	WOS:000533930800006
J	Piirsoo, A; Pink, A; Kasak, L; Kala, M; Kasvandik, S; Ustav, M; Piirsoo, M				Piirsoo, Alla; Pink, Anne; Kasak, Lagle; Kala, Martin; Kasvandik, Sergo; Ustav, Mart; Piirsoo, Marko			Differential phosphorylation determines the repressor and activator potencies of GLI1 proteins and their efficiency in modulating the HPV life cycle	PLOS ONE			English	Article							TRANSCRIPTION; REPLICATION	The Sonic Hedgehog (Shh) signalling pathway plays multiple roles during embryonic development and under pathological conditions. Although the core components of the Shh pathway are conserved, the regulation of signal transduction varies significantly among species and cell types. Protein kinases Ulk3 and Pka are involved in the Shh pathway as modulators of the activities of Gli transcription factors, which are the nuclear mediators of the signal. Here, we investigate the regulation and activities of two GLI1 isoforms, full-length GLI1 (GLI1FL) and GLI1 Delta N. The latter protein lacks the first 128 amino acids including the conserved phosphorylation cluster and the binding motif for SUFU, the key regulator of GLI activity. Both GLI1 isoforms are co-expressed in all human cell lines analysed and possess similar DNA binding activity. ULK3 potentiates the transcriptional activity of both GLI1 proteins, whereas PKA inhibits the activity of GLI1 Delta N, but not GLI1FL. In addition to its wellestablished role as a transcriptional activator, GLI1FL acts as a repressor by inhibiting transcription from the early promoters of human papillomavirus type 18 (HPV18). Additionally, compared to GLI1 Delta N, GLI1FL is a more potent suppressor of replication of several HPV types. Altogether, our data show that the N-terminal part of GLI1FL is crucial for the realization of its full potential as a transcriptional regulator.	[Piirsoo, Alla; Kala, Martin; Kasvandik, Sergo; Ustav, Mart; Piirsoo, Marko] Univ Tartu, Inst Technol, Tartu, Estonia; [Pink, Anne; Kasak, Lagle] Tallinn Univ Technol, Dept Chem & Biotechnol, Tallinn, Estonia; [Pink, Anne] Univ Helsinki, Fac Med, Translat Canc Med Programme, Helsinki, Finland	University of Tartu; Tallinn University of Technology; University of Helsinki	Piirsoo, M (corresponding author), Univ Tartu, Inst Technol, Tartu, Estonia.	marko.piirsoo@ut.ee		Piirsoo, Marko/0000-0002-9447-1350; Pink, Anne/0000-0001-8292-8854	European Regional Development Fund through the Centre of Excellence in Molecular Cell Engineering [20142020.4.01.15-013]; Estonian Research Council [IUT20-27, PRG198, G9478]; Tallinn University of Technology	European Regional Development Fund through the Centre of Excellence in Molecular Cell Engineering; Estonian Research Council(Estonian Research Council); Tallinn University of Technology	This research was funded by European Regional Development Fund through the Centre of Excellence in Molecular Cell Engineering (20142020.4.01.15-013), Estonian Research Council institutional research funding grant (IUT20-27), personal research funding team grant PRG198 (awarded to MU) and research grant G9478 (awarded to MP), and Tallinn University of Technology grant B40 (awarded to MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Geimanen J, 2011, J VIROL, V85, P3315, DOI 10.1128/JVI.01985-10; Graham SV, 2016, J VIROL, V90, P8384, DOI 10.1128/JVI.00502-16; Kadaja M, 2009, VIROLOGY, V384, P360, DOI 10.1016/j.virol.2008.11.032; Kaesler S, 2000, BIOL CHEM, V381, P545, DOI 10.1515/BC.2000.070; Kinzler KW, 1990, MOL CELL BIOL; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kong JH, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.166892; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Maloverjan A, 2010, J BIOL CHEM, V285, P30079, DOI 10.1074/jbc.M110.133991; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Mazzone A, 2019, FASEB J, V33, P6632, DOI 10.1096/fj.201802373R; MEIJER D, 1992, NUCLEIC ACIDS RES, V20, P2241, DOI 10.1093/nar/20.9.2241; Niewiadomski P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020147; Niewiadomski P, 2014, CELL REP, V6, P168, DOI 10.1016/j.celrep.2013.12.003; Orav M, 2013, J VIROL, V87, P12051, DOI 10.1128/JVI.01798-13; Piirsoo A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007788; Reinson T, 2013, J VIROL, V87, P951, DOI 10.1128/JVI.01943-12; Sankovski E, 2014, J VIROL, V88, P961, DOI 10.1128/JVI.01841-13; Sasaki H, 1997, DEVELOPMENT; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Toots M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006168; Toots M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116151; Vishnoi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34377; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Winklmayr M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-2; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200	31	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2019	14	11							e0225775	10.1371/journal.pone.0225775	http://dx.doi.org/10.1371/journal.pone.0225775			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8RE	31770404	Green Published, gold			2022-12-26	WOS:000533892300038
J	Dyke, S; Barrass, I; Pollock, K; Hall, IM				Dyke, Steven; Barrass, Iain; Pollock, Kevin; Hall, Ian M.			Dispersion of Legionella bacteria in atmosphere: A practical source location estimation method	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE OUTBREAK; COMMUNITY OUTBREAK; COOLING-TOWERS; DOSE-RESPONSE; ASSOCIATION; EDINBURGH; MODEL	Legionnaires' disease, a form of pneumonia which can be fatal, is transmitted via the inhalation of water droplets containing Legionella bacteria. These droplets can be dispersed in the atmosphere several kilometers from their source. The most common such sources are contaminated water within cooling towers and other air-conditioning systems but other sources such as ornamental fountains and spa pools have also caused outbreaks of the disease in the past. There is an obvious need to locate and eliminate any such sources as quickly as possible. Here a maximum likelihood model estimating the source of an outbreak from case location data has been developed and implemented. Unlike previous models, the average dose exposure sub-model is formulated using a atmospheric dispersion model. How the uncertainty in inferred parameters can be estimated is discussed. The model is applied to the 2012 Edinburgh Legionnaires' disease outbreak.	[Dyke, Steven; Barrass, Iain; Hall, Ian M.] Publ Hlth England, Emergency Response Dept Sci & Technol ERD S&T, Porton Down SP4 0JG, Wilts, England; [Pollock, Kevin] Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Pollock, Kevin] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Barrass, Iain] Queen Mary Univ London, IT Serv Res, London, England; [Hall, Ian M.] Univ Manchester, Sch Math, Manchester, Lancs, England	Public Health England; Glasgow Caledonian University; University of London; Queen Mary University London; University of Manchester	Hall, IM (corresponding author), Publ Hlth England, Emergency Response Dept Sci & Technol ERD S&T, Porton Down SP4 0JG, Wilts, England.; Hall, IM (corresponding author), Univ Manchester, Sch Math, Manchester, Lancs, England.	ian.hall@manchester.ac.uk	Hall, ian/AAF-9135-2019	Hall, ian/0000-0002-3033-2335	UK Government; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response at King's College London; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial; Public Health England (PHE)	UK Government; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response at King's College London; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial; Public Health England (PHE)	The authors received no specific funding for this work but the authors are workers in Public Health England or Health Protection Scotland, receiving UK Government grant-in-aid funding, and some methods and visualization work was developed on grants funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) (https://www.nihr.ac.uk/) in Emergency Preparedness and Response at King's College London and in Modelling Methodology at Imperial, both in partnership with Public Health England (PHE). IH is also a Member of NIHR Health Protection Research Units in Emerging and Zoonotic Infections and Gastrointestinal Infections at Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of Public Health England, Department of health and Social Care, National Institute for Health Research or Health Protection Scotland.; The research was partially funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response at King's College London and in Modelling Methodology at Imperial, both in partnership with Public Health England (PHE). IMH is also a Member of NIHR Health Protection Research Units in Emerging and Zoonotic Infections and Gastrointestinal Infections at Liverpool. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.	ADDISS DG, 1989, J INFECT DIS, V159, P572, DOI 10.1093/infdis/159.3.572; [Anonymous], 2015, LEG DIS OUTLB S W ED; [Anonymous], 2019, LEG DIS; Armstrong TW, 2007, RISK ANAL, V27, P1581, DOI 10.1111/j.1539-6924.2007.00990.x; Bennett E, 2014, EPIDEMIOL INFECT, V142, P1763, DOI 10.1017/S0950268813002483; Brown CM, 1999, INT J EPIDEMIOL, V28, P353, DOI 10.1093/ije/28.2.353; Brown J, 2001, Commun Dis Intell Q Rep, V25, P63; Bull M, 2012, EUROSURVEILLANCE, V17, P30; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Coetzee N, 2012, EUROSURVEILLANCE, V17, P6; Correia AM., 2001, EUROSURVEILLANCE, V6, P121, DOI [10.2807/esm.06.07.00228-en, DOI 10.2807/ESM.06.07.00228-EN]; Coscolla M, 2010, EMERG INFECT DIS, V16, P1381, DOI 10.3201/eid1609.100248; Currie SL, 2015, PERSPECT PUBLIC HEAL, V135, P309, DOI 10.1177/1757913915611162; Egan JR, 2011, EPIDEMIOLOGY, V22, P188, DOI 10.1097/EDE.0b013e31820937c6; Garcia-Fulgueiras A, 2003, EMERG INFECT DIS, V9, P915; HAMBLETON P, 1983, J HYG-CAMBRIDGE, V90, P451, DOI 10.1017/S0022172400029090; Hancock PA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003809; Hanna S.R., 1982, HDB ATMOSPHERIC DIFF; Irons JF, 2013, QJM-INT J MED, V106, P1087, DOI 10.1093/qjmed/hct167; Jansa JM, 2002, INT J TUBERC LUNG D, V6, P831; Keramarou M, 2010, EUROSURVEILLANCE, V15, P2; Kirrage D, 2007, RESP MED, V101, P1639, DOI 10.1016/j.rmed.2006.11.026; Legrand J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000356; Martinez-Beneito MA, 2006, LECT NOTES STAT, V185, P169; McCormick D, 2012, EUROSURVEILLANCE, V17, P6; Naik FC, 2015, LEGIONNAIRES DIS ENG; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; Nygard K, 2008, CLIN INFECT DIS, V46, P61, DOI 10.1086/524016; Pastoris MC, 1997, EUR J CLIN MICROBIOL, V16, P883, DOI 10.1007/BF01700554; Pourchez J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186042; Prasad B, 2017, RISK ANAL, V37, P291, DOI 10.1111/risa.12630; Sansom P, 2013, STAT MED, V32, P3522, DOI 10.1002/sim.5765; Stockie JM, 2011, SIAM REV, V53, P349, DOI 10.1137/10080991X; van Leuken JPG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080412	34	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0224144	10.1371/journal.pone.0224144	http://dx.doi.org/10.1371/journal.pone.0224144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765384	Green Submitted, Green Published, gold			2022-12-26	WOS:000533891000005
J	Qiao, WT; Yin, XX; Zhao, SY; Wang, D				Qiao, Wentao; Yin, Xiaoxiang; Zhao, Shengying; Wang, Dong			Cyclic loading test study on a new cast-in-situ insulated sandwich concrete wall	PLOS ONE			English	Article							COMPOSITE BEHAVIOR; PANELS; PERFORMANCE	Insulated sandwich concrete panel (ISCP) is widely used because of its high thermal insulation efficiency and low construction cost. Aiming at improving traditional ISCP, a new cast-in-situ concrete wall structure made of ISCP is proposed, which is composed of thin-walled cold-formed steels, slant steel wire connectors, steel wire meshes, concrete layers, expanded polystyrene sheets and reinforced concrete embedded columns. In order to assess the hysteretic properties of the new insulated sandwich concrete wall and the influence of various parameters, low-frequency horizontal cyclic load tests were carried out on seven full-scale specimens of new type cast-in-situ insulated sandwich concrete wall. The specimens were compared and analyzed with respect to failure mode, bearing capacity, ductility, degradation characteristics and energy dissipation capacity. The results show that the final failure pattern of the specimen is two main diagonal cracks intersecting each other; the bearing capacity is greatly affected by concrete thickness and axial compression ratio, regardless of concrete strength. Brittle failure is typically observed when the steel wire spacing is large, while ductility is pronounced when the concrete layer thickness is small and the concrete strength is low; the smaller the thickness of concrete layer, the faster the stiffness degrades. The wall structure shows a better energy dissipation performance with a smaller steel wire spacing, lower concrete strength and smaller axial compression ratio.	[Qiao, Wentao; Yin, Xiaoxiang] Shi Jiazhuang Tiedao Univ, Sch Civil Engn, Shijiazhuang, Peoples R China; [Qiao, Wentao] Shi Jiazhuang Tiedao Univ, Cooperat Innovat Ctr Disaster Prevent & Mitigat L, Shijiazhuang, Peoples R China; [Zhao, Shengying] Harbin Inst Technol, Sch Civil Engn, Harbin, Peoples R China; [Wang, Dong] TRC Co, Baton Rouge, LA USA	Harbin Institute of Technology	Qiao, WT (corresponding author), Shi Jiazhuang Tiedao Univ, Sch Civil Engn, Shijiazhuang, Peoples R China.; Qiao, WT (corresponding author), Shi Jiazhuang Tiedao Univ, Cooperat Innovat Ctr Disaster Prevent & Mitigat L, Shijiazhuang, Peoples R China.	tottyer@126.com		Qiao, Wentao/0000-0003-0624-0008	Natural Science Foundation of HeBei Province [E2016210052]; Science and Technology Research Key Project in Higher Institutions of Hebei Province [ZD2018250]; Hebei Xi Jiefa Construction Engineering Co., Ltd.	Natural Science Foundation of HeBei Province(Natural Science Foundation of Hebei Province); Science and Technology Research Key Project in Higher Institutions of Hebei Province; Hebei Xi Jiefa Construction Engineering Co., Ltd.	This research was funded by Natural Science Foundation of HeBei Province (E2016210052), Science and Technology Research Key Project in Higher Institutions of Hebei Province (ZD2018250). Additionally, this research was also conducted with the financial support of Hebei Xi Jiefa Construction Engineering Co., Ltd. The TRC Companies provided support in the form of salaries for author D.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by the Natural Science Foundation of Hebei Province (No. E2016210052) and Key Funding Project of Science and Technology Research of Higher Education Institution in Hebei Province (No. ZD2018250). Additionally, this research was also conducted with the financial support of Hebei Xi Jiefa Construction Engineering Co., Ltd.	Abbas A, 2019, ENG STRUCT, V181, P476, DOI 10.1016/j.engstruct.2018.12.051; Chen A, 2015, ENG STRUCT, V98, P95, DOI 10.1016/j.engstruct.2015.04.022; China Academy of Building Research, 1996, 10196 JGJ, P9; Choi I, 2016, COMPOS PART B-ENG, V96, P7, DOI 10.1016/j.compositesb.2016.04.030; Choi I, 2015, MATERIALS, V8, P1264, DOI 10.3390/ma8031264; Choi W, 2019, COMPOS PART B-ENG, V157, P36, DOI 10.1016/j.compositesb.2018.08.081; Colombo IG, 2018, J BUILD ENG, V17, P183, DOI 10.1016/j.jobe.2018.02.012; Flansbjer M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9122456; Flansbjer M, 2018, INT J CONCR STRUCT M, V12, DOI 10.1186/s40069-018-0301-4; Guo zhenhai, 2003, PRINCIPLE ANAL REINF, P335; Hashemi SJ, 2018, ARCH CIV MECH ENG, V18, P557, DOI 10.1016/j.acme.2017.10.007; Huang JQ, 2019, COMPOS STRUCT, V207, P136, DOI 10.1016/j.compstruct.2018.09.017; Jiang HZ, 2018, KSCE J CIV ENG, V22, P1889, DOI 10.1007/s12205-017-2050-3; Joseph JDR, 2019, COMPOS PART B-ENG, V166, P446, DOI 10.1016/j.compositesb.2019.02.030; Lameiras R, 2013, COMPOS STRUCT, V105, P446, DOI 10.1016/j.compstruct.2013.06.022; Lameiras R, 2013, COMPOS STRUCT, V105, P460, DOI 10.1016/j.compstruct.2013.06.015; Lu Z, 2019, STRUCT DESIGN TALL S, V28; Norris TG, 2016, COMPOS STRUCT, V152, P444, DOI 10.1016/j.compstruct.2016.05.053; Palermo M, 2014, ENG STRUCT, V76, P75, DOI 10.1016/j.engstruct.2014.06.024; Pavese A, 2011, ENG STRUCT, V33, P2049, DOI 10.1016/j.engstruct.2011.02.043; Ricci I, 2013, ENG STRUCT, V54, P131, DOI 10.1016/j.engstruct.2013.03.046; Tomlinson D, 2016, J STRUCT ENG, V142, DOI 10.1061/(ASCE)ST.1943-541X.0001560; Tomlinson D, 2016, ENG STRUCT, V122, P251, DOI 10.1016/j.engstruct.2016.04.059; Vervloet J, 2019, APPL SCI, V9; Xie Q, 2018, IOP C SER MAT SCI EN, V317; Zhai XM, 2018, ENERG BUILDINGS, V166, P109, DOI 10.1016/j.enbuild.2018.01.070	26	6	6	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2019	14	11							e0225055	10.1371/journal.pone.0225055	http://dx.doi.org/10.1371/journal.pone.0225055			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QR	31765409	Green Published, gold			2022-12-26	WOS:000533891000014
J	Tanaka, T; Akiyoshi, H; Nishida, H; Mie, K; Lin, LS; Iimori, Y; Okamoto, M				Tanaka, Toshiyuki; Akiyoshi, Hideo; Nishida, Hidetaka; Mie, Keiichiro; Lin, Lee-Shuan; Iimori, Yasumasa; Okamoto, Mari			Contrast-enhanced computed tomography findings of canine primary renal tumors including renal cell carcinoma, lymphoma, and hemangiosarcoma	PLOS ONE			English	Article							CT; FEATURES; DOGS; LESIONS; KIDNEY; PHASE; PATTERNS; SPECTRUM; BIOPSY	In veterinary medicine, abdominal ultrasonography is used to rank the differential diagnosis of renal lesions. However, a conventional sonographic examination may show nonspecific findings. The purpose of this study was to assess the computed tomography (CT) findings of canine renal tumors, including renal cell carcinoma (RCC), lymphoma, and hemangiosarcoma (HSA). In this retrospective study, the following CT parameters were recorded for each dog: 1) extent of renal involvement of tumors, 2) enhancement pattern, 3) number of renal tumors, 4) renal tumor vessel enhancement in the corticomedullary phase, 5) presence of lymphadenopathy and lung metastasis, and 6) attenuation values of the renal tumors on the pre- and post-contrast corticomedullary, nephrographic, and excretory phase images. Fifteen dogs met the inclusion criteria, of which nine had RCCs, four had lymphomas, and two had HSAs. RCCs tended to show heterogeneous enhancement and unilateral renal involvement, and vessel enhancement was detected in the corticomedullary phase in dogs with RCC. Conversely, renal lymphomas showed homogeneous enhancement, bilateral renal involvement, and multiple masses; in these dogs, no vessel enhancement was detected in the corticomedullary phase, and the incidence of lymphadenopathy was low. However, in dogs with lymphadenopathy, the renal lymphoma was associated with regionally severe lymphadenopathy. Finally, renal HSAs tended to show heterogeneous enhancement with a non-enhanced area and unilateral renal involvement; in these dogs, vessel enhancement was detected in the nephrographic phase, with the enhancement expanding around the vessel. These findings had no significant differences. Further studies with a larger sample size are required to examine the association between CT and histopathological findings.	[Tanaka, Toshiyuki; Akiyoshi, Hideo; Nishida, Hidetaka; Mie, Keiichiro; Iimori, Yasumasa; Okamoto, Mari] Osaka Prefecture Univ, Dept Grad Sch Life & Environm Sci, Lab Vet Surg, Osaka, Japan; [Tanaka, Toshiyuki] Kinki Anim Med Training Inst & Vet Clin, Osaka, Japan; [Lin, Lee-Shuan] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Med, Lab Vet Diagnost Imaging, Neipu, Taiwan	Osaka Metropolitan University; National Pingtung University Science & Technology	Akiyoshi, H (corresponding author), Osaka Prefecture Univ, Dept Grad Sch Life & Environm Sci, Lab Vet Surg, Osaka, Japan.	akiyoshi@vet.osakafu-u.ac.jp	Tanaka, Toshiyuki/GPC-4658-2022; Lin, Lee-shuan/AGA-4248-2022	Tanaka, Toshiyuki/0000-0002-7911-913X; Lin, Lee-shuan/0000-0003-1590-2253				Bae KT, 2010, RADIOLOGY, V256, P32, DOI 10.1148/radiol.10090908; Ballard DH, 2017, ABDOM RADIOL, V42, P2700, DOI 10.1007/s00261-017-1193-5; BASKIN GB, 1977, VET PATHOL, V14, P591, DOI 10.1177/030098587701400606; Berben L, 2012, INT J NURS STUD, V49, P1039, DOI 10.1016/j.ijnurstu.2012.01.015; Beukers Martijn, 2013, Vet Radiol Ultrasound, V54, P610, DOI 10.1111/vru.12075; Blomley MJK, 1998, RADIOLOGY, V209, P862, DOI 10.1148/radiology.209.3.9844688; Borjesson DL, 2003, VET CLIN N AM-SMALL, V33, P119, DOI 10.1016/S0195-5616(02)00086-4; Bryan JN, 2006, J VET INTERN MED, V20, P1155, DOI 10.1892/0891-6640(2006)20[1155:PRNOD]2.0.CO;2; Cangiano T, 1999, J CLIN ONCOL, V17, P523, DOI 10.1200/JCO.1999.17.2.523; Capitanio U, 2011, EUR UROL, V60, P1212, DOI 10.1016/j.eururo.2011.09.003; Cho H, 2018, J VET SCI, V19, P290, DOI 10.4142/jvs.2018.19.2.290; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Leon AD, 2017, RADIOL CLIN N AM, V55, P1235, DOI 10.1016/j.rcl.2017.06.007; Deborah WK, 2012, WITHROW MACEWENS SMA, P579; Edmondson EF, 2015, VET PATHOL, V52, P260, DOI 10.1177/0300985814533803; Fosmire SP, 2004, LAB INVEST, V84, P562, DOI 10.1038/labinvest.3700080; Fukuda S, 2014, VET RADIOL ULTRASOUN, V55, P374, DOI 10.1111/vru.12136; Gustafson DL, 2018, PHARMACOL THERAPEUT, V188, P80, DOI 10.1016/j.pharmthera.2018.01.012; Haers H, 2010, VET RADIOL ULTRASOUN, V51, P516, DOI 10.1111/j.1740-8261.2010.01690.x; HARTMAN DS, 1988, AM J ROENTGENOL, V150, P1061, DOI 10.2214/ajr.150.5.1061; HARTMAN DS, 1982, RADIOLOGY, V144, P759, DOI 10.1148/radiology.144.4.7111721; Jones ID, 2016, VET RADIOL ULTRASOUN, V57, P144, DOI 10.1111/vru.12336; Katayama K, 2015, RESPIROL CASE REP, V3, P108, DOI 10.1002/rcr2.116; Keegan KA, 2012, J UROLOGY, V188, P391, DOI 10.1016/j.juro.2012.04.006; Kopka L, 1997, AM J ROENTGENOL, V169, P1573, DOI 10.2214/ajr.169.6.9393168; Kutara K, 2017, J VET MED SCI, V79, P1870, DOI 10.1292/jvms.17-0253; Lawindy SM, 2012, BJU INT, V110, P926, DOI 10.1111/j.1464-410X.2012.11174.x; Lee S, 2011, AM J VET RES, V72, P345, DOI 10.2460/ajvr.72.3.345; Limmer S, 2001, PATHOLOGE, V22, P343, DOI 10.1007/s002920100481; Lipsey MW, 2001, PRACTICAL METAANALYS, DOI [10.4142/jvs.2018.19.2.290, DOI 10.4142/JVS.2018.19.2.290]; Locke JE, 2006, J VET INTERN MED, V20, P962; McAloney CA, 2018, JAVMA-J AM VET MED A, V252, P1247, DOI 10.2460/javma.252.10.1247; Moe L, 1997, VET RADIOL ULTRASOUN, V38, P335, DOI 10.1111/j.1740-8261.1997.tb02094.x; Omiyale AO, 2015, TRANSL ANDROL UROL, V4, P464, DOI 10.3978/j.issn.2223-4683.2015.05.04; Pickhardt PJ, 2000, RADIOGRAPHICS, V20, P215, DOI 10.1148/radiographics.20.1.g00ja08215; Russo P, 2000, SEMIN ONCOL, V27, P160; Sapierzynski R, 2016, POL J VET SCI, V19, P433, DOI 10.1515/pjvs-2016-0055; Sato T, 2003, J VET MED A, V50, P366, DOI 10.1046/j.1439-0442.2003.00561.x; Semelka RC, 1996, AM J ROENTGENOL, V166, P823, DOI 10.2214/ajr.166.4.8610558; Sheeran SR, 1998, AM J ROENTGENOL, V171, P1067, DOI 10.2214/ajr.171.4.9762998; Sheth S, 2006, RADIOGRAPHICS, V26, P1151, DOI 10.1148/rg.264055125; Tanaka T, 2019, VET RADIOL ULTRASOUN, V60, P7, DOI 10.1111/vru.12677; Taylor AJ, 2014, VET RADIOL ULTRASOUN, V55, P441, DOI 10.1111/vru.12152; Thiel DD, 2012, INT UROL NEPHROL, V44, P1005, DOI 10.1007/s11255-012-0168-2; Urban BA, 2000, RADIOGRAPHICS, V20, P197, DOI 10.1148/radiographics.20.1.g00ja09197; Vaden SL, 2005, J VET INTERN MED, V19, P794, DOI 10.1892/0891-6640(2005)19[794:RBARSO]2.0.CO;2; Vaden SL, 2005, CLIN TECH SMALL AN P, V20, P11, DOI 10.1053/j.ctsap.2004.12.003; Waller KR, 2007, VET RADIOL ULTRASOUN, V48, P373, DOI 10.1111/j.1740-8261.2007.00259.x; Yang PS, 2001, KOREAN J RADIOL, V2, P132, DOI 10.3348/kjr.2001.2.3.132; YOHN SE, 1994, J AM VET MED ASSOC, V204, P97; Zhu L, 2012, J MED IMAG RADIAT ON, V56, P143, DOI 10.1111/j.1754-9485.2011.02329.x	51	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225211	10.1371/journal.pone.0225211	http://dx.doi.org/10.1371/journal.pone.0225211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756212	Green Published, gold			2022-12-26	WOS:000533889300010
J	De Luca, A; Pezzotti, P; Boucher, C; Doring, M; Incardona, F; Kaiser, R; Lengauer, T; Pfeifer, N; Schulter, E; Vandamme, AM; Zazzi, M; Geretti, AM				De Luca, Andrea; Pezzotti, Patrizio; Boucher, Charles; Doering, Matthias; Incardona, Francesca; Kaiser, Rolf; Lengauer, Thomas; Pfeifer, Nico; Schuelter, Eugen; Vandamme, Anne-Mieke; Zazzi, Maurizio; Geretti, Anna Maria		EucoHIV Study Grp	Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; RITONAVIR-BOOSTED DARUNAVIR; TREATMENT-NAIVE PATIENTS; HIV-INFECTED PATIENTS; SAFETY; TROPISM; EFAVIRENZ; TRIAL; RALTEGRAVIR; PROGRESSION	Objectives The study aimed to survey maraviroc use and assess effectiveness and durability of maraviroc-containing antiretroviral treatment (ART) in routine practice across Europe. Methods Data were retrieved from 26 cohorts in 8 countries comprising adults who started maraviroc in 2005-2016 and had >= 1 follow-up visit. Available V3 sequences were re-analysed centrally for tropism determination by geno2pheno[coreceptor]. Treatment failure (TF) was defined as either virological failure (viral load > 50 copies/mL) or maraviroc discontinuation for any reason over 48 weeks. Predictors of TF were explored by logistic regression analysis. Time to maraviroc discontinuation was estimated by Kaplan-Meier survival analysis. Results At maraviroc initiation (baseline), among 1,381 patients, 67.1% had experienced >= 3 ART classes and 45.6% had a viral load < 50 copies/mL. Maraviroc was occasionally added to the existing regimen as a single agent (7.3%) but it was more commonly introduced alongside other new agents, and was often (70.4%) used with protease inhibitors. Accompanying drugs comprised 1 (40.2%), 2 (48.6%) or.3 (11.2%) ART classes. Among 1,273 patients with available tropism data, 17.6% showed non-R5 virus. Non-standard maraviroc use also comprised reported once daily dosing (20.0%) and a total daily dose of 150mg (12.1%). Over 48 weeks, 41.4% of patients met the definition of TF, although the 1-year estimated retention on maraviroc was 82.1% (95% confidence interval 79.9-84.2). Among 1,010 subjects on maraviroc at week 48, the viral load was > 50 copies/mL in 19.9% and > 200 copies/mL in 10.7%. Independent predictors of TF comprised a low nadir CD4 count, a detectable baseline viral load, previous PI experience, non-R5 tropism, having >= 3 active drugs in the accompanying regimen, and a more recent calendar year of maraviroc initiation. Conclusions This study reports on the largest observation cohort of patients who started maraviroc across 8 European countries. In this overall highly treatment-experienced population, with a small but appreciable subset that received maraviroc outside of standard treatment guidelines, maraviroc was safe and reasonably effective, with relatively low rates of discontinuation over 48 weeks and only 2 cases of serum transaminase elevations reported as reasons for discontinuation.	[De Luca, Andrea; Zazzi, Maurizio] Univ Siena, Dept Med Biotechnol, Siena, Italy; [De Luca, Andrea] Azienda Osped Univ Senese, Unita Operat Complessa Malattie Infett, Siena, Italy; [Pezzotti, Patrizio] Ist Super Sanita, Dept Infect Dis, Rome, Italy; [Boucher, Charles] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Doering, Matthias; Lengauer, Thomas; Pfeifer, Nico] Max Planck Inst Informat, Saarland Informat Campus, Saarbrucken, Germany; [Incardona, Francesca] EuResist Network, Rome, Italy; [Incardona, Francesca] InformaPRO, Rome, Italy; [Kaiser, Rolf; Schuelter, Eugen] Univ Cologne, Inst Virol, Cologne, Germany; [Pfeifer, Nico] Univ Tubingen, Dept Comp Sci, Tubingen, Germany; [Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Dept Microbiol Immunol & Transplantat, Leuven, Belgium; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Global Hlth & Trop Med, Inst Higiene & Med Trop, Unidade Microbiol, Lisbon, Portugal; [Geretti, Anna Maria] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England	University of Siena; University of Siena; University Hospital of Siena; Istituto Superiore di Sanita (ISS); Erasmus University Rotterdam; Erasmus MC; Max Planck Society; University of Cologne; Eberhard Karls University of Tubingen; KU Leuven; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University of Liverpool	Incardona, F (corresponding author), EuResist Network, Rome, Italy.; Incardona, F (corresponding author), InformaPRO, Rome, Italy.	f.incardona@informapro.info	Pfeifer, Nico/G-1559-2016; PEZZOTTI, PATRIZIO/C-6480-2016; De Luca, Andrea/G-8810-2011; Zazzi, Maurizio/K-3422-2018	PEZZOTTI, PATRIZIO/0000-0002-0805-2927; Geretti, Anna Maria/0000-0002-3670-6588; Incardona, Francesca/0000-0002-7386-8551; Pfeifer, Nico/0000-0002-4647-8566; De Luca, Andrea/0000-0002-9561-9193; Zazzi, Maurizio/0000-0002-0344-6281	ViiV Healthcare	ViiV Healthcare	The EucoHIV study group that collected and analysed the data presented in this study has been funded by an unrestricted educational grant from ViiV Healthcare. https://www.viivhealthcare.com one of the authors, Francesca Incardona, is affiliated to a commercial company: InformaPRO, Rome www.informapro.info.InformaPRO provided support in the form of salary for this author but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Bader J, 2017, CLIN INFECT DIS, V64, P295, DOI 10.1093/cid/ciw737; Blanco JR, 2015, AIDS RES HUM RETROV, V31, P893, DOI [10.1089/aid.2015.0016, 10.1089/AID.2015.0016]; Bocket L, 2016, J ANTIMICROB CHEMOTH, V71, P2651, DOI 10.1093/jac/dkw167; Bonjoch A, 2013, J ANTIMICROB CHEMOTH, V68, P1382, DOI 10.1093/jac/dks539; Cillo AR, 2015, AIDS, V29, P2121, DOI 10.1097/QAD.0000000000000810; Cipriani S, 2013, CIRCULATION, V127, P2114, DOI 10.1161/CIRCULATIONAHA.113.001278; Cooper DA, 2014, AIDS, V28, P717, DOI 10.1097/QAD.0000000000000131; Ghidei L, 2013, DRUG AGING, V30, P809, DOI 10.1007/s40266-013-0107-7; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Hardy WD, 2010, JAIDS-J ACQ IMM DEF, V55, P558, DOI 10.1097/QAI.0b013e3181ee3d82; Harrigan PR, 2011, AIDS, V25, P257, DOI 10.1097/QAD.0b013e32834113f9; Lazzarin A, 2015, HIV CLIN TRIALS, V16, P10, DOI 10.1179/1528433614Z.0000000002; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Llibre JM, 2015, ANTIVIR RES, V120, P79, DOI 10.1016/j.antiviral.2015.05.001; Macias J, 2014, HIV MED, V15, P417, DOI 10.1111/hiv.12129; Nozza S, 2010, AIDS, V24, P924, DOI 10.1097/QAD.0b013e3283372d76; Okoli C, 2012, J ANTIMICROB CHEMOTH, V67, P671, DOI 10.1093/jac/dkr493; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; Santos JR, 2015, J ANTIMICROB CHEMOTH, V70, P3087, DOI 10.1093/jac/dkv205; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Rossetti B, 2017, 9 IT C AIDS ANT RES, pP6; Saag M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965; Saumoy M, 2017, AIDS RES HUM RETROV, V33, P29, DOI [10.1089/aid.2015.0386, 10.1089/AID.2015.0386]; Schapiro JM, 2011, ANTIVIR THER, V16, P395, DOI 10.3851/IMP1759; Seclen E, 2010, J ANTIMICROB CHEMOTH, V65, P1486, DOI 10.1093/jac/dkq137; Sierra-Madero J, 2010, HIV CLIN TRIALS, V11, P127, DOI 10.1310/hct1103-125; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; Stockdale AJ, 2018, CLIN INFECT DIS, V66, P1846, DOI 10.1093/cid/cix1108; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; van Lelyveld SFL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132430; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Vandekerckhove L, 2011, J ANTIMICROB CHEMOTH, V66, P265, DOI 10.1093/jac/dkq458; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Waters L, 2015, ANTIVIR THER, V20, P157, DOI 10.3851/IMP2817; Wilkin TJ, 2012, J INFECT DIS, V206, P534, DOI 10.1093/infdis/jis376	35	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225381	10.1371/journal.pone.0225381	http://dx.doi.org/10.1371/journal.pone.0225381			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751385	Green Published, gold, Green Accepted			2022-12-26	WOS:000533886900057
J	Haxel, JH; Matsumoto, H; Meinig, C; Kalbach, G; Lau, TK; Dziak, RP; Stalin, S				Haxel, Joseph H.; Matsumoto, Haru; Meinig, Christian; Kalbach, Gabriella; Lau, T-K; Dziak, Robert P.; Stalin, Scott			Ocean sound levels in the northeast Pacific recorded from an autonomous underwater glider	PLOS ONE			English	Article							AMBIENT NOISE; ACOUSTIC DETECTIONS; RADIATED NOISE; TRENDS; WEST	Ocean gliders are a quiet and efficient mobile autonomous platform for passive acoustic monitoring and oceanographic measurements in remote marine environments. During July 20-August 6 2012, we used a Teledyne Webb Research Slocum G2 glider equipped with a hydrophone logging system to record ocean sound along a 458 km north to south traverse of the outer continental shelf break along the U.S. Pacific Northwest coast. Glider derived recordings yielded a unique perspective on the variation of ambient sound with depth, where natural wind generated surface processes were identified as a dominant acoustic contributor to spectral levels in the region. Near and far-field vessel radiated noise were also found to add significant energy to ambient conditions. Spatially distributed measurements of ambient sound levels recorded from the glider were consistent with long-term spectral estimates from fixed station, deep ocean hydrophone array measurements during the 1990-2000's in the region. Ocean sound level measurements captured by a mobile glider are shown to be an effective and valuable asset for describing ocean surface wind conditions and characterizing spatial and temporal changes in the underwater acoustic environment over a broad regional scale.	[Haxel, Joseph H.; Matsumoto, Haru; Lau, T-K] Oregon State Univ, Newport, OR 97331 USA; [Haxel, Joseph H.; Matsumoto, Haru; Lau, T-K; Dziak, Robert P.] NOAA, Pacific Marine Environm Lab, Newport, OR 97365 USA; [Meinig, Christian; Stalin, Scott] NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA; [Kalbach, Gabriella] Calif State Univ Monterey Bay, Dept Nat Sci, Marina, CA USA	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; California State University System; California State University Monterey Bay	Haxel, JH (corresponding author), Oregon State Univ, Newport, OR 97331 USA.; Haxel, JH (corresponding author), NOAA, Pacific Marine Environm Lab, Newport, OR 97365 USA.	joe.haxel@noaa.gov	Dziak, Robert/AAC-6107-2020	Kalbach, Gabriella/0000-0003-3092-8443	National Science Foundation Research Experience for Undergraduates Grant [NSF OCE-1263349]	National Science Foundation Research Experience for Undergraduates Grant	JH, HM, CM, TKL, RD, SS received no specific funding for this work. GK participated in this study under the National Science Foundation Research Experience for Undergraduates Grant No. NSF OCE-1263349. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew R. K., 2002, Acoustics Research Letters Online, V3, P65, DOI 10.1121/1.1461915; Andrew RK, 2011, J ACOUST SOC AM, V129, P642, DOI 10.1121/1.3518770; Au W. W., 1993, SONAR DOLPHINS; Baumgartner MF, 2013, J ACOUST SOC AM, V134, P1814, DOI 10.1121/1.4816406; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Carey W.M., 1988, SEA SURFACE SOUND, P361; Cauchy P, 2018, J ATMOS OCEAN TECH, V35, P2305, DOI 10.1175/JTECH-D-17-0209.1; Chapman NR, 2011, J ACOUST SOC AM, V129, pE161, DOI 10.1121/1.3567084; CHAPMAN NR, 1993, J ACOUST SOC AM, V93, P782, DOI 10.1121/1.405440; Collins M.D., 1998, J ACOUST SOC AM, V104, P1808, DOI DOI 10.1121/1.423601; Curtis KR, 1999, J ACOUST SOC AM, V106, P3189, DOI 10.1121/1.428173; Davis R E, 2002, TECHNOLOGY APPL AUTO, P37; Ford JH, 2018, PLOS ONE, V13; Gebbie J, 2012, J ACOUST SOC AM, V132, pEL351, DOI 10.1121/1.4754419; HALPERN D, 1974, J GEOPHYS RES, V79, P2223, DOI 10.1029/JC079i015p02223; HALPERN D, 1974, Tethys, V6, P363; Hatch L, 2008, ENVIRON MANAGE, V42, P735, DOI 10.1007/s00267-008-9169-4; Hatch LT, 2016, ENDANGER SPECIES RES, V30, P171, DOI 10.3354/esr00722; Haver SM, 2018, MAR POLICY, V90, P6, DOI 10.1016/j.marpol.2018.01.023; KEWLEY DJ, 1990, J ACOUST SOC AM, V88, P1894, DOI 10.1121/1.400212; Klinck H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036128; KNUDSEN VO, 1948, J MAR RES, V7, P410; Kusel ET, 2017, OCEAN SCI, V13, P273, DOI 10.5194/os-13-273-2017; Ma BB, 2005, J ACOUST SOC AM, V117, P3555, DOI 10.1121/1.1910283; Matsumoto H, 2011, J ACOUST SOC AM, V129, pEL94, DOI 10.1121/1.3547720; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; McKenna MF, 2012, J ACOUST SOC AM, V131, P92, DOI 10.1121/1.3664100; MELLINGER DK, 2001, NOAA TECHNICAL MEMOR, V120, P98115; Merchant ND, 2013, J ACOUST SOC AM, V133, pEL262, DOI 10.1121/1.4794934; Moore SE, 2006, MARINE MAMMAL SCI, V14, P617; Moore SE, 2007, MAR TECHNOL SOC J, V41, P53, DOI 10.4031/002533207787442033; National Science Foundation (NSF) NOaAAN Office of Naval Research (ONR) Schmidt Ocean Institute (SOI), 2019, CASC OP ACC SEISM TR; Norris TF, 1999, J ACOUST SOC AM, V106, P506, DOI 10.1121/1.427071; Oliver M. J., 2017, ANIM BIOTELEM, V5, P1, DOI [10.1186/s40317-017-0129-8, DOI 10.1186/S40317-017-0129-8]; PIGGOTT CL, 1964, J ACOUST SOC AM, V36, P2152, DOI 10.1121/1.1919337; Ross D, 2005, IEEE J OCEANIC ENG, V30, P257, DOI 10.1109/JOE.2005.850879; Ross D, 1976, MECH UNDERWATER SOUN; Rudnick DL, 2004, MAR TECHNOL SOC J, V38, P73, DOI 10.4031/002533204787522703; Schofield O, 2007, J FIELD ROBOT, V24, P473, DOI 10.1002/rob.20200; Sirovic A, 2013, J ACOUST SOC AM, V134, P2681, DOI 10.1121/1.4820884; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Wall CC, 2012, MAR ECOL PROG SER, V449, P55, DOI 10.3354/meps09549; WENZ GM, 1962, J ACOUST SOC AM, V34, P1936, DOI 10.1121/1.1909155; Wiggins S, 2010, OCEANS-IEEE; Wiggins SM, 2013, J ACOUST SOC AM, V133, P3813, DOI 10.1121/1.4802645; Wood SL, 2013, MAR TECHNOL SOC J, V47, P84	47	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225325	10.1371/journal.pone.0225325	http://dx.doi.org/10.1371/journal.pone.0225325			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747444	gold, Green Published			2022-12-26	WOS:000533881900034
J	Anto, EO; Obirikorang, C; Acheampong, E; Adua, E; Donkor, S; Afranie, BO; Ofori, M; Asiamah, EA; Adu, EA				Anto, Enoch Odame; Obirikorang, Christian; Acheampong, Emmanuel; Adua, Eric; Donkor, Sampson; Afranie, Bright Oppong; Ofori, Matthew; Asiamah, Emmanuel Akomanin; Adu, Evans Asamoah			Renal abnormalities among children with sickle cell conditions in highly resource-limited setting in Ghana	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; SERUM CREATININE; PREVALENCE	Sickle cell disease (SCD) is associated with progressive multi-organ failure especially, the brain and kidney and leads to high morbidity and mortality rate. The aim of this study was to determine the prevalence of renal abnormalities among children with SCD. This cross-sectional study recruited 212 sickling positive patients comprising of 96 Hb AS, 48 Hb SC, and 68 Hb SS phenotypes from the Pediatric Unit of Wassa Akropong Government Hospital, Wassa Akropong, Ghana. Early morning urine and venous blood samples were collected from each participant. Urinalysis was conducted and serum urea and creatinine levels were estimated. Estimate glomerular filtration rate (eGFR) was calculated using the Swartz equation. Classification of chronic kidney disease (CKD) was based on 'The Kidney Disease: Improving Global Outcomes (KIDIGO)' criteria. The mean age of the children were 7.90 years. Serum creatinine (p = 0.0310) and urea (p<0.0001) levels were significantly higher among Hb AS participants compared with Hb SS phenotype. The prevalent indicators of renal abnormalities were proteinuria (26.4%), urine granular cast (5.6%) and CKD (39.6%). Proteinuria, urine granular cast and CKD were most prevalent among Hb SS (47.1%, 11.8% and 73.5% respectively) compared with Hb SC (41.7%, 8.3%, and 45.8% respectively) and Hb AS (4.2%, 0.0%, and 14.5%) phenotypes, respectively. Sickle cell conditions were significantly associated with proteinuria (p<0.0001) and CKD (p = 0.0378). Children with Hb SS [aOR = 5.04, 95% CI (2.47-10.3); p<0.0001] and Hb SC [aOR = 3.14 95% CI (1.39-7.01); p = 0.0174] were at increased odds of developing CKD after adjusting for age, BMI and gender. Proteinuria and CKD are associated with sickle cell disease (Hb SC and Hb SS). Renal function should be routinely monitored for children with SCD.	[Anto, Enoch Odame; Obirikorang, Christian; Acheampong, Emmanuel; Donkor, Sampson; Afranie, Bright Oppong; Adu, Evans Asamoah] Kwame Nkrumah Univ Sci & Technol, Sch Med & Dent, Dept Mol Med, Kumasi, Ghana; [Anto, Enoch Odame; Acheampong, Emmanuel; Adua, Eric] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia; [Ofori, Matthew] Royal Ann Coll Hlth, Dept Med Lab Technol, Kumasi, Ghana; [Asiamah, Emmanuel Akomanin] Univ Hlth & Allied Sci, Dept Med Lab Sci, Ho, Ghana	Kwame Nkrumah University Science & Technology; Edith Cowan University	Adu, EA (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med & Dent, Dept Mol Med, Kumasi, Ghana.	evansasamoahadu@gmail.com	Obirikorang, Christian/F-5843-2011; Acheampong, Emmanuel/I-9309-2019; Adu, Evans Asamoah/AAM-4847-2020; ASIAMAH, EMMANUEL AKOMANIN/CAA-5947-2022	Obirikorang, Christian/0000-0002-6128-1358; Acheampong, Emmanuel/0000-0002-5338-3258; Adu, Evans Asamoah/0000-0001-6374-0979; Adua, Eric/0000-0002-6865-3812; Donkor, Sampson/0000-0001-6265-4796; Oppong Afranie, Bright/0000-0001-7179-4977; ASIAMAH, EMMANUEL/0000-0001-7910-3704				ALLON M, 1990, ARCH INTERN MED, V150, P501, DOI 10.1001/archinte.150.3.501; Alvarez O, 2012, PEDIATR BLOOD CANCER, V59, P668, DOI 10.1002/pbc.24100; Anie KA, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-2; Antwi-Boasiako C, 2015, Ghana Med J, V49, P102, DOI 10.4314/gmj.v49i2.7; Antwi-Boasiako Charles, 2018, Diseases, V6, DOI 10.3390/diseases6020029; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Ataga KI, 2014, AM J HEMATOL, V89, P907, DOI 10.1002/ajh.23762; Boadu I, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0241-z; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Camus SM, 2015, BLOOD, V125, P3805, DOI 10.1182/blood-2014-07-589283; Dennis-Antwi JA., 2008, DIVERS HLTH SOC CARE, V5, P241; Emmanuel A. A., 2016, INT J MED SCI, V8, P30, DOI [10.5897/ijmms2015.1206, DOI 10.5897/IJMMS2015.1206]; Ephraim RKD, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0072-y; FALK RJ, 1992, NEW ENGL J MED, V326, P910, DOI 10.1056/NEJM199204023261402; Gargiulo R, 2014, DM-DIS MON, V60, P494, DOI 10.1016/j.disamonth.2014.08.004; Gowda S, 2010, N AM J MED SCI, V2, P170; Guasch A, 2006, J AM SOC NEPHROL, V17, P2228, DOI 10.1681/ASN.2002010084; Hoefield RA, 2011, NEPHROL DIAL TRANSPL, V26, P887, DOI 10.1093/ndt/gfq526; Howard J, 2015, SICKLE CELL DIS CLIN; Kazadi AL, 2017, ANEMIA, V2017, DOI 10.1155/2017/7916348; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marsenic O, 2008, NEPHROL DIAL TRANSPL, V23, P715, DOI 10.1093/ndt/gfm858; Mian AN, 2017, ADV CHRONIC KIDNEY D, V24, P348, DOI 10.1053/j.ackd.2017.09.011; Nath KA, 2015, NAT REV NEPHROL, V11, P161, DOI 10.1038/nrneph.2015.8; Ohene-Frempong K, 2008, PEDIATRICS, V121, pS120, DOI 10.1542/peds.2007-2022UUU; Osei-Yeboah C, 2011, West Afr J Med, V30, P262; Ouyang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162044; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Saborio P, 1999, J AM SOC NEPHROL, V10, P187; Scheinman JI, 2009, PEDIAT NEPHROLOGY SI, P1181; Scheinman JI, 2009, NAT CLIN PRACT NEPHR, V5, P78, DOI 10.1038/ncpneph1008; Schmitt F, 1998, AM J KIDNEY DIS, V32, P208, DOI 10.1053/ajkd.1998.v32.pm9708603; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Stenvinkel P, 2000, NEPHROL DIAL TRANSPL, V15, P953, DOI 10.1093/ndt/15.7.953; World Health Organization, 2008, WHO GLOBAL DATABASE; Yee MM, 2011, CLIN J AM SOC NEPHRO, V6, P2628, DOI 10.2215/CJN.01600211	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225310	10.1371/journal.pone.0225310	http://dx.doi.org/10.1371/journal.pone.0225310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743364	gold, Green Published			2022-12-26	WOS:000533877300026
J	Baba, H; Kanamori, H; Kudo, H; Kuroki, Y; Higashi, S; Oka, K; Takahashi, M; Yoshida, M; Oshima, K; Aoyagi, T; Tokuda, K; Kaku, M				Baba, Hiroaki; Kanamori, Hajime; Kudo, Hayami; Kuroki, Yasutoshi; Higashi, Seiya; Oka, Kentaro; Takahashi, Motomichi; Yoshida, Makiko; Oshima, Kengo; Aoyagi, Tetsuji; Tokuda, Koichi; Kaku, Mitsuo			Genomic analysis of Shiga toxin-producing Escherichia coli from patients and asymptomatic food handlers in Japan	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SURVEILLANCE; SEROGROUPS; ENGLAND; O157	Shiga toxin-producing Escherichia coli (STEC) can cause severe gastrointestinal disease and colonization among food handlers. In Japan, STEC infection is a notifiable disease, and food handlers are required to undergo routine stool examination for STEC. However, the molecular epidemiology of STEC is not entirely known. We investigated the genomic characteristics of STEC from patients and asymptomatic food handlers in Miyagi Prefecture, Japan. Whole-genome sequencing (WGS) was performed on 65 STEC isolates obtained from 38 patients and 27 food handlers by public health surveillance in Miyagi Prefecture between April 2016 and March 2017. Isolates of O157:H7 ST11 and O26:H11 ST21 were predominant (n = 19, 29%, respectively). Non-O157 isolates accounted for 69% (n = 45) of all isolates. Among 48 isolates with serotypes found in the patients (serotype O157:H7 and 5 non-O157 serotypes, O26:H11, O103:H2, O103:H8, O121:H19 and O145:H28), adhesion genes eae, tir, and espB, and type III secretion system genes espA, espJ, nleA, nleB, and nleC were detected in 41 to 47 isolates (85-98%), whereas isolates with other serotypes found only in food handlers were negative for all of these genes. Non-O157 isolates were especially prevalent among patients younger than 5 years old. Shiga-toxin gene stx1a, adhesion gene efa1, secretion system genes espF and cif, and fimbrial gene lpfA were significantly more frequent among non-O157 isolates from patients than among O157 isolates from patients. The most prevalent resistance genes among our STEC isolates were aminoglycoside resistance genes, followed by sulfamethoxazole/trimethoprim resistance genes. WGS revealed that 20 isolates were divided into 9 indistinguishable core genomes (< 5 SNPs), demonstrating clonal expansion of these STEC strains in our region, including an O26:H11 strain with stx1a+stx2a. Non-O157 STEC with multiple virulence genes were prevalent among both patients and food handlers in our region of Japan, highlighting the importance of monitoring the genomic characteristics of STEC.	[Baba, Hiroaki; Kanamori, Hajime; Yoshida, Makiko; Oshima, Kengo; Aoyagi, Tetsuji; Tokuda, Koichi; Kaku, Mitsuo] Tohoku Univ, Dept Infect Dis, Internal Med, Grad Sch Med, Sendai, Miyagi, Japan; [Kudo, Hayami; Kuroki, Yasutoshi; Higashi, Seiya; Oka, Kentaro; Takahashi, Motomichi] Miyarisan Pharmaceut Co Ltd, Saitama, Saitama, Japan	Tohoku University	Baba, H (corresponding author), Tohoku Univ, Dept Infect Dis, Internal Med, Grad Sch Med, Sendai, Miyagi, Japan.	hbaba48@med.tohoku.ac.jp		Kanamori, Hajime/0000-0003-3026-5272	Miyarisan Pharmaceutical Co., Ltd.	Miyarisan Pharmaceutical Co., Ltd.	All named authors have approved this manuscript and have no conflict of interest. The funder, Miyarisan Pharmaceutical Co., Ltd. provided support in the form of salaries for authors [HK, YK, SH, KO, MT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Agger M, 2015, J ANTIMICROB CHEMOTH, V70, P2440, DOI 10.1093/jac/dkv162; Amezquita-Lopez BA, 2018, J MICROBIOL IMMUNOL, V51, P425, DOI 10.1016/j.jmii.2017.07.004; [Anonymous], 2013, EMERG INFECT DIS, DOI [10.3201/eid1912.130265, DOI 10.3201/EID1912.130265]; Bielaszewska M, 2013, CLIN INFECT DIS, V56, P1373, DOI 10.1093/cid/cit055; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Byrne L, 2014, J MED MICROBIOL, V63, P1181, DOI 10.1099/jmm.0.075895-0; Cepeda-Molero M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006706; Dallman TJ, 2015, CLIN INFECT DIS, V61, P305, DOI 10.1093/cid/civ318; Day M, 2017, J ANTIMICROB CHEMOTH, V72, P145, DOI 10.1093/jac/dkw371; DebRoy C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147434; Ferdous M, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.03.028; Harada T, 2013, DIAGN MICR INFEC DIS, V77, P176, DOI 10.1016/j.diagmicrobio.2013.06.012; Haugum K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111788; Hosoi Y, 2014, REV SCI TECH OIE, V33, P1007, DOI 10.20506/rst.33.3.2337; Iguchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023250; Ishijima N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43136; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kanayama A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1259-3; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kobayashi H, 2009, J VET MED SCI, V71, P363, DOI 10.1292/jvms.71.363; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; LAVINA M, 1990, J BACTERIOL, V172, P6585, DOI 10.1128/jb.172.11.6585-6588.1990; Matussek A, 2017, EUR J CLIN MICROBIOL, V36, P1433, DOI 10.1007/s10096-017-2950-7; Mcwilliams BD, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0003-2013; National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division Ministry of Health Labour and Welfare of Japan.  Japan, 2019, INFECT AGENTS SURVEI, V40, P71; Nishijima S, 2016, DNA RES, V23, P125, DOI 10.1093/dnares/dsw002; Rusconi B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00985; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Soborg B, 2013, EURO SURVEILL, V18; Stamatakis A, 2006, NEUROSCIENCE, V140, P1, DOI 10.1016/j.neuroscience.2006.01.035; Steyert SR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00133; Terajima J, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0011-2013; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Valilis E, 2018, INT J INFECT DIS, V76, P82, DOI 10.1016/j.ijid.2018.09.002; World Health Organization, 2019, WORLD HLTH REP 50 FA; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	38	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0225340	10.1371/journal.pone.0225340	http://dx.doi.org/10.1371/journal.pone.0225340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8LN	31743366	Green Published, gold			2022-12-26	WOS:000533877300028
J	Ma, KS; Tang, QL; Liang, PZ; Xia, J; Zhang, BZ; Gao, XW				Ma, Kangsheng; Tang, Qiuling; Liang, Pingzhuo; Xia, Jin; Zhang, Baizhong; Gao, Xiwu			Toxicity and sublethal effects of two plant allelochemicals on the demographical traits of cotton aphid, Aphis gossypii Glover (Hemiptera: Aphididae)	PLOS ONE			English	Article							LIFE-TABLE; POPULATION-GROWTH; SOYBEAN APHID; RESISTANCE; HOMOPTERA; HERBIVORE; PEST; DETOXIFICATION; (-)-GOSSYPOL; REPRODUCTION	Plant allelochemicals are a group of secondary metabolites produced by plants to defend against herbivore. The mortality of two plant allelochemicals (tannic acid and gossypol) on the cotton aphid, Aphis gossypii Glover (Hemiptera: Aphididae), were investigated using feeding assays and the sublethal effects were evaluated using the age-stage, two-sex life table approach. Tannic acid and gossypol have deleterious effects on A. gossypii, and as the concentrations increased, the mortality of cotton aphid increased. The life history traits of A. gossypii including the developmental duration of each nymph stage, the longevity, oviposition days, total preadult survival rate and adult pre-oviposition period were not significantly affected by sublethal concentration of tannic acid (20 mg/L) and gossypol (50 mg/L), while the population parameters (r, lambda and R-0) were significantly affected by these two plant allelochemicals. Furthermore, tannic acid can increase the pre-adult duration time and TPOP but reduce the fecundity of A. gossypii significantly compared to the control and gossypol treatment groups. These results are helpful for comprehensively understanding the effects of plant allelochemicals on A. gossypii.	[Ma, Kangsheng; Tang, Qiuling; Liang, Pingzhuo; Xia, Jin; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Zhang, Baizhong] Henan Inst Sci & Technol, Coll Resources & Environm, Xinxiang, Henan, Peoples R China	China Agricultural University; Henan Institute of Science & Technology	Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.	gaoxiwu@263.net.cn			National Natural Science Foundation of China Key Programme [31330064, 31801760]; China Postdoctoral Science Foundation [2018M630229]	National Natural Science Foundation of China Key Programme(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China Key Programme (No. 31330064, 31801760) and China Postdoctoral Science Foundation (No. 2018M630229).	Aerts RJ, 1999, AGR ECOSYST ENVIRON, V75, P1, DOI 10.1016/S0167-8809(99)00062-6; Akca I, 2015, J ECON ENTOMOL, V108, P1466, DOI 10.1093/jee/tov187; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; BLACKMAN R.L., 1984, ORIENT INSECTS; Boissot N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01420; Celorio-Mancera MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-575; Chaieb I, 2018, ENTOMOL GEN, V37, P63, DOI 10.1127/entomologia/2017/0317; Chen XW, 2017, PEST MANAG SCI, V73, P2353, DOI 10.1002/ps.4622; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1988, ENVIRON ENTOMOL, V17, P18, DOI 10.1093/ee/17.1.18; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Chi H., TWOSEX MS CHART A CO; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2006, ENVIRON ENTOMOL, V35, P1342, DOI 10.1603/0046-225X(2006)35[1342:SOPGOT]2.0.CO;2; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Du L, 2004, J ECON ENTOMOL, V97, P1278, DOI 10.1603/0022-0493-97.4.1278; Ebadollahi A, 2017, J ECON ENTOMOL, V110, P1025, DOI 10.1093/jee/tox065; Efron B., 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Garzo E, 2002, PHYTOPARASITICA, V30, P129, DOI 10.1007/BF02979695; Golawska S, 2014, J PEST SCI, V87, P173, DOI 10.1007/s10340-013-0535-5; Guo JY, 2013, J ECON ENTOMOL, V106, P1379, DOI 10.1603/EC12401; Huang HW, 2018, J ECON ENTOMOL, V111, P1, DOI 10.1093/jee/tox330; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; KAROWE DN, 1989, OECOLOGIA, V80, P507, DOI 10.1007/BF00380074; KLOCKE JA, 1982, J INSECT PHYSIOL, V28, P911, DOI 10.1016/0022-1910(82)90106-8; Krempl C, 2016, INSECT BIOCHEM MOLEC, V78, P69, DOI 10.1016/j.ibmb.2016.09.003; Li XC, 2002, INSECT MOL BIOL, V11, P343, DOI 10.1046/j.1365-2583.2002.00341.x; Ma GM, 2018, J INTEGR AGR, V17, P164, DOI [10.1016/S2095-3119(17)61666-6, 10.1016/s2095-3119(17)61666-6]; Ma KS, 2017, BMC MOL BIOL, V18, DOI 10.1186/s12867-017-0080-5; Ma KS, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew003; Ma KS, 2019, PESTIC BIOCHEM PHYS, V157, P204, DOI 10.1016/j.pestbp.2019.03.021; Ma KS, 2017, PESTIC BIOCHEM PHYS, V138, P71, DOI 10.1016/j.pestbp.2017.03.003; Madadi H, 2011, J PEST SCI, V84, P447, DOI 10.1007/s10340-011-0387-9; Martemyanov V V, 2006, Dokl Biochem Biophys, V409, P219, DOI 10.1134/S1607672906040077; Nishida R, 2014, BIOSCI BIOTECH BIOCH, V78, P1, DOI 10.1080/09168451.2014.877836; Peng T, 2016, INSECT MOL BIOL, V25, P450, DOI 10.1111/imb.12230; Qu YY, 2015, ECOTOXICOLOGY, V24, P479, DOI 10.1007/s10646-014-1396-2; Roh HS, 2015, J PEST SCI, V88, P621, DOI 10.1007/s10340-014-0631-1; Selin-Rani S, 2016, CHEMOSPHERE, V165, P257, DOI 10.1016/j.chemosphere.2016.08.136; Shrestha RB, 2013, INSECT SCI, V20, P778, DOI 10.1111/j.1744-7917.2012.01583.x; Simmonds MSJ, 2001, J CHEM ECOL, V27, P965, DOI 10.1023/A:1010339104206; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Stipanovic RD, 2008, ENVIRON ENTOMOL, V37, P1081, DOI 10.1603/0046-225X(2008)37[1081:EORAGO]2.0.CO;2; Stipanovic RD, 2006, J CHEM ECOL, V32, P959, DOI 10.1007/s10886-006-9052-9; Sun LJ, 2005, J ECON ENTOMOL, V98, P1325, DOI 10.1603/0022-0493-98.4.1325; Tang QL, 2015, J ECON ENTOMOL, V108, P2720, DOI 10.1093/jee/tov221; Wang DL, 2018, PEST MANAG SCI, V74, P210, DOI 10.1002/ps.4698; Wang KY, 2002, J ECON ENTOMOL, V95, P407, DOI 10.1603/0022-0493-95.2.407; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129541; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Xiao D, 2016, ECOTOXICOLOGY, V25, P1782, DOI 10.1007/s10646-016-1721-z; Yousaf HK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34821-w; Zhang L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3277-y; Zhang P, 2014, PESTIC BIOCHEM PHYS, V111, P31, DOI 10.1016/j.pestbp.2014.04.003; Zheng B., 1988, PLANT PROT Q, V1, P55; Zheng B Z, 1989, ACTA PHYTOPHYL SIN, V16, P131	58	7	7	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2019	14	11							e0221646	10.1371/journal.pone.0221646	http://dx.doi.org/10.1371/journal.pone.0221646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX9RC	31743338	gold, Green Published			2022-12-26	WOS:000504063300001
J	Elst, TV; Sercu, M; Van den Broeck, A; Van Hoof, E; Baillien, E; Godderis, L				Elst, Tinne Vander; Sercu, Maarten; Van den Broeck, Anja; Van Hoof, Elke; Baillien, Elfi; Godderis, Lode			Who is more susceptible to job stressors and resources? Sensory-processing sensitivity as a personal resource and vulnerability factor	PLOS ONE			English	Article							DIFFERENTIAL SUSCEPTIBILITY; PERFORMANCE; ENGAGEMENT; BURNOUT; DEPRESSION; SCALE; MODEL	This study aimed to investigate whether people scoring higher (compared to lower) on sensory-processing sensitivity respond differently to the work environment. Specifically, based on the literature on sensory-processing sensitivity and the Job Demands-Resources model, we predicted that the three components of sensory-processing sensitivity (i.e. ease of excitation, aesthetic sensitivity and low sensory threshold) amplify the relationship between job demands (i.e. workload and emotional demands) and emotional exhaustion as well as the relationship between job resources (i.e. task autonomy and social support) and helping behaviour. Survey data from 1019 Belgian employees were analysed using structural equation modelling analysis. The results showed that ease of excitation and low sensory threshold amplified the relationship between job demands and emotional exhaustion. Low sensory threshold also strengthened the job resources-helping behaviour relationship. This study offered first evidence on the greater susceptibility among highly sensitive persons to the work environment and demonstrated that the moderating role might differ for the three components of sensory-processing sensitivity. Additionally, it adds sensory-processing sensitivity to the Job Demands-Resources model and highlights the idea that personal factors may act both as a personal vulnerability factor and a personal resource, depending on the nature of the perceived work environment.	[Elst, Tinne Vander; Sercu, Maarten; Godderis, Lode] IDEWE Grp, Knowledge Informat & Res Ctr, Leuven, Belgium; [Elst, Tinne Vander] Katholieke Univ Leuven, Res Grp Work Org & Personnel Psychol, Leuven, Belgium; [Elst, Tinne Vander] Vrije Univ Brussel, Res Grp Work & Org Psychol, Brussels, Belgium; [Van den Broeck, Anja; Baillien, Elfi] Katholieke Univ Leuven, Res Ctr Work & Org Studies, Brussels, Belgium; [Van den Broeck, Anja] North West Univ, Optentia, Vanderbijlpark, South Africa; [Van Hoof, Elke] Vrije Univ Brussel, Dept Psychol PSYCH, Fac Psychol & Educ Sci, Brussels, Belgium; [Baillien, Elfi] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Godderis, Lode] Katholieke Univ Leuven, Environm & Hlth, Leuven, Belgium	KU Leuven; Vrije Universiteit Brussel; KU Leuven; North West University - South Africa; Vrije Universiteit Brussel; University of Bergen; KU Leuven	Elst, TV (corresponding author), IDEWE Grp, Knowledge Informat & Res Ctr, Leuven, Belgium.; Elst, TV (corresponding author), Katholieke Univ Leuven, Res Grp Work Org & Personnel Psychol, Leuven, Belgium.; Elst, TV (corresponding author), Vrije Univ Brussel, Res Grp Work & Org Psychol, Brussels, Belgium.	tinne.vanderelst@idewe.be	Baillien, Elfi/AAI-4576-2021; Van den Broeck, Anja/B-6186-2016	Baillien, Elfi/0000-0003-1865-0450; Vander Elst, Tinne/0000-0001-8709-2371; Van den Broeck, Anja/0000-0002-5896-9506; Godderis, Lode/0000-0003-4764-8835	Katholieke Universiteit Leuven [VKH-C9278-StG/14/035]	Katholieke Universiteit Leuven(KU Leuven)	Katholieke Universiteit Leuven provided grant funding to AVDB (VKH-C9278-StG/14/035).	Angelo RP, 2015, STRESS HEALTH, V31, P106, DOI 10.1002/smi.2532; Aron E., 1996, HIGHLY SENSITIVE PER; Aron EN, 2012, PERS SOC PSYCHOL REV, V16, P262, DOI 10.1177/1088868311434213; Aron EN, 1997, J PERS SOC PSYCHOL, V73, P345, DOI 10.1037/0022-3514.73.2.345; Aron EN, 2005, PERS SOC PSYCHOL B, V31, P181, DOI 10.1177/0146167204271419; Aron EN, 1996, HOOG SENSITIEVE PERS; BACHARACH SB, 1995, HUM RESOUR MANAGE R, V5, P79, DOI 10.1016/1053-4822(95)90013-6; Baillien E, 2011, J OCCUP ORGAN PSYCH, V84, P191, DOI 10.1348/096317910X508371; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Bakker AB, 2014, ANNU REV ORGAN PSYCH, V1, P389, DOI 10.1146/annurev-orgpsych-031413-091235; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Bowen N. K., 2011, STRUCTURAL EQUATION; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Evers A., 2008, INT J STRESS MANAG, V15, P189, DOI [10.1037/1072-5245.15.2.189, DOI 10.1037/1072-5245.15.2.189]; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Gerstenberg FXR, 2012, PERS INDIV DIFFER, V53, P496, DOI 10.1016/j.paid.2012.04.019; Grover SL, 2017, STRESS HEALTH, V33, P426, DOI 10.1002/smi.2726; Jagiellowicz J, 2011, SOC COGN AFFECT NEUR, V6, P38, DOI 10.1093/scan/nsq001; Jensen MT, 2017, EUR J WORK ORGAN PSY, V26, P30, DOI 10.1080/1359432X.2016.1197206; Lazarus R.S., 1984, EMOTION ADAPTATION; Liss M, 2008, PERS INDIV DIFFER, V45, P255, DOI 10.1016/j.paid.2008.04.009; Lombard A., 2012, THESIS; Lu L, 2015, INT J WORKPLACE HEAL, V8, P78, DOI 10.1108/IJWHM-11-2013-0045; Muthen L. K., 2017, US GUID, V8th; Nielsen K, 2017, WORK STRESS, V31, P101, DOI 10.1080/02678373.2017.1304463; Notelaers G., 2007, MED TRAVAIL ERGONOMI, V44, P11; Pluess M, 2018, DEV PSYCHOL, V54, P51, DOI 10.1037/dev0000406; Pluess M, 2015, PERS INDIV DIFFER, V82, P40, DOI 10.1016/j.paid.2015.03.011; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Podsakoff PM, 1997, J APPL PSYCHOL, V82, P262, DOI 10.1037/0021-9010.82.2.262; Schaufeli W., 2000, UBOS UTRECHTSE BURNO; Schaufeli W.B., 2014, BRIDGING OCCUPATIONA, P43; Slagt M, 2018, DEV PSYCHOL, V54, P543, DOI 10.1037/dev0000431; Smolewska KA, 2006, PERS INDIV DIFFER, V40, P1269, DOI 10.1016/j.paid.2005.09.022; Sobocko K, 2015, PERS INDIV DIFFER, V83, P44, DOI 10.1016/j.paid.2015.03.045; Taris TW, 2014, WORK STRESS, V28, P1, DOI 10.1080/02678373.2014.878494; Van den Broeck A, 2008, WORK STRESS, V22, P277, DOI 10.1080/02678370802393672; Van den Broeck A, 2015, WORK STRESS, V29, P306, DOI 10.1080/02678373.2015.1074955; Van den Broeck A, 2013, ADV POSIT ORGAN PSY, V1, P83, DOI 10.1108/S2046-410X(2013)0000001007; van IJzendoorn MH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.73; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345	41	10	10	7	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225103	10.1371/journal.pone.0225103	http://dx.doi.org/10.1371/journal.pone.0225103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN3EY	31738812	Green Published, gold			2022-12-26	WOS:000532826300033
J	Huang, J; Lan, XW; Wang, T; Lu, HL; Cao, MR; Yan, S; Cui, Y; Jia, DX; Cai, L; Xing, Y				Huang, Jian; Lan, Xiuwen; Wang, Ting; Lu, Hailing; Cao, Mengru; Yan, Shi; Cui, Yue; Jia, Dexin; Cai, Li; Xing, Ying			Targeting the IL-1 beta/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC	ONCOGENE			English	Article							CELL LUNG-CANCER; DOMAIN 1 PROMOTES; III BETA-TUBULIN; BINDING PROTEIN; FOCAL ADHESIONS; STRESS FIBERS; KAPPA-B; INHIBITORS; SENSITIVITY; MICROTUBULES	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) significantly prolong the survival time of non-small-cell lung cancer (NSCLC) patients with EGFR-activating mutations, but resistance develops universally. Activation of the phosphatidyl inositol-3 kinase (PI3K)/AKT signaling pathway and phenotypic alterations in epithelial-mesenchymal transition (EMT) are both mechanisms of acquired resistance to EGFR-TKIs. However, the mechanisms underlying this resistance remain unclear. In this study, EHD1 depletion significantly increased NSCLC cell sensitivity to EGFR-TKI, which was accompanied by EMT reversal. Microarray analysis showed that the PTEN/PI3K/AKT signaling pathway is a crucial pathway regulated by EHD1. Moreover, a PTEN inhibitor abolished EHD1 shRNA regulation of EGFR-TKI sensitivity, EMT, and cancer progression. Mass spectrometry showed that TUBB3 is a novel EHD1-interacting protein. EHD1 modulated microtubule stability by interacting with TUBB3. Furthermore, TUBB3 depletion significantly attenuated EHD1-induced EGFR-TKI resistance and EMT. Bioinformatics analysis revealed that EHD1 is significantly associated with the gene set, "Cellular Response to Interleukin-1 beta (IL-1 beta)". As expected, treatment with IL-1 beta led to increased expression of EHD1, activation of PTEN/PI3K/AKT signaling, and induction of EMT in NSCLC cells. In patient specimens, EHD1 was highly expressed in EGFR-TKI-refractory specimens. EHD1 was positively associated with TUBB3 and IL-1R1 but negatively associated with PTEN. In addition, targeting the IL-1 beta/EHD1/TUBB3 axis mitigated cancer progression by inhibiting cell proliferation and metastasis and promoting apoptosis. Our study demonstrates the involvement of the IL-1 beta/EHD1/TUBB3 axis in EGFR-TKI resistance and provides a potential therapeutic approach for treating patients with NSCLC that has acquired EGFR-TKI resistance.	[Huang, Jian; Wang, Ting; Lu, Hailing; Cao, Mengru; Yan, Shi; Cui, Yue; Jia, Dexin; Cai, Li; Xing, Ying] Harbin Med Univ, Dept Med Oncol 4, Canc Hosp, 150 Haping Rd, Harbin 150040, Peoples R China; [Lan, Xiuwen] Harbin Med Univ, Dept Crit Care Med, Canc Hosp, 150 Haping Rd, Harbin 150040, Peoples R China	Harbin Medical University; Harbin Medical University	Cai, L; Xing, Y (corresponding author), Harbin Med Univ, Dept Med Oncol 4, Canc Hosp, 150 Haping Rd, Harbin 150040, Peoples R China.	caili@ems.hrbmu.edu.cn; xingying0618@163.com		Huang, Jian/0000-0002-2409-0878	Certificate of China Postdoctoral Science Foundation [2015M581477, 2017M621307]; Hei Long Jiang Postdoctoral Foundation [LBH-Z15145, LBH-Z17182]; Natural Science and Technology Foundation of Heilongjiang Province [LC2016037]; Fundamental Research Funds for the Provincial Universities; Hai Yan Youth Fund from Harbin Medical University Cancer Hospital [JJQN2018-11, JJQN2018-02, BJQN2019-07]; Top-Notch Youth Fund from Harbin Medical University Cancer Hospital [JJQN2018-11, JJQN2018-02, BJQN2019-07]; NSFC [81772474, 81572276, 81803023, 81602717]	Certificate of China Postdoctoral Science Foundation; Hei Long Jiang Postdoctoral Foundation; Natural Science and Technology Foundation of Heilongjiang Province; Fundamental Research Funds for the Provincial Universities; Hai Yan Youth Fund from Harbin Medical University Cancer Hospital; Top-Notch Youth Fund from Harbin Medical University Cancer Hospital; NSFC(National Natural Science Foundation of China (NSFC))	This study was supported in part by grants from the Certificate of China Postdoctoral Science Foundation Grant (2015M581477, 2017M621307), the Hei Long Jiang Postdoctoral Foundation (LBH-Z15145, LBH-Z17182), the Natural Science and Technology Foundation of Heilongjiang Province (LC2016037), the Fundamental Research Funds for the Provincial Universities, the Hai Yan Youth Fund and Top-Notch Youth Fund from Harbin Medical University Cancer Hospital (JJQN2018-11, JJQN2018-02 and BJQN2019-07), and the NSFC (Grant Nos. 81772474, 81572276, 81803023 and 81602717).	Amann J, 2005, CANCER RES, V65, P226; Apte RN, 2006, EUR J CANCER, V42, P751, DOI 10.1016/j.ejca.2006.01.010; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burke SJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE715, DOI 10.1152/ajpendo.00153.2015; Chan JK, 2014, GYNECOL ONCOL, V133, P568, DOI 10.1016/j.ygyno.2014.03.564; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Du JT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1553-x; Duran GE, 2017, BRIT J CANCER, V116, P1318, DOI 10.1038/bjc.2017.102; Edgar KA, 2010, CANCER RES, V70, P1164, DOI 10.1158/0008-5472.CAN-09-2525; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Fernando RI, 2016, ONCOTARGET, V7, P42031, DOI 10.18632/oncotarget.9662; Franco-Barraza J, 2010, ARCH MED RES, V41, P170, DOI 10.1016/j.arcmed.2010.04.010; Gan PP, 2007, CANCER RES, V67, P9356, DOI 10.1158/0008-5472.CAN-07-0509; Gelfo V, 2018, CANCERS, V10, DOI 10.3390/cancers10100355; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Hehnly H, 2014, DEV CELL, V28, P497, DOI 10.1016/j.devcel.2014.01.014; Hinsch A, 2017, HUM PATHOL, V61, P210, DOI 10.1016/j.humpath.2016.11.005; Hyman DM, 2015, CANCER CHEMOTH PHARM, V75, P747, DOI 10.1007/s00280-015-2693-z; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Jacobsen K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00450-6; Jean A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172358; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kim SM, 2012, MOL CANCER THER, V11, P2254, DOI 10.1158/1535-7163.MCT-12-0311; Kim SB, 2017, LANCET ONCOL, V18, P1360, DOI 10.1016/S1470-2045(17)30450-3; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lebok P, 2016, ONCOL LETT, V11, P1987, DOI 10.3892/ol.2016.4206; Lee DH, 2017, PHARMACOL THERAPEUT, V174, P1, DOI 10.1016/j.pharmthera.2017.02.001; Li YJ, 2005, WORLD J GASTROENTERO, V11, P2117, DOI 10.3748/wjg.v11.i14.2117; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; Liu Y, 2018, ONCOL LETT, V16, P4263, DOI 10.3892/ol.2018.9200; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mantovani A, 2018, IMMUNOL REV, V281, P57, DOI 10.1111/imr.12614; Mariani M, 2012, CLIN CANCER RES, V18, P2964, DOI 10.1158/1078-0432.CCR-11-2318; McCarroll JA, 2015, CANCER RES, V75, P415, DOI 10.1158/0008-5472.CAN-14-2740; Meng QW, 2017, ONCOTARGET, V8, P22433, DOI 10.18632/oncotarget.11220; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Nickoloff BJ, 2005, J INVEST DERMATOL, V124, pX, DOI 10.1111/j.0022-202X.2005.23724.x; Ono M, 2004, MOL CANCER THER, V3, P465; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parker AL, 2016, CARCINOGENESIS, V37, P787, DOI 10.1093/carcin/bgw058; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Powell S, 2014, ONCOL LETT, V7, P405, DOI 10.3892/ol.2013.1734; Reiman T, 2012, ANN ONCOL, V23, P86, DOI 10.1093/annonc/mdr033; Reinecke JB, 2015, TRAFFIC, V16, P48, DOI 10.1111/tra.12234; Riihimaki M, 2014, LUNG CANCER, V86, P78, DOI 10.1016/j.lungcan.2014.07.020; SATIR P, 1990, CANCER INVEST, V8, P685, DOI 10.3109/07357909009018945; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sobierajska K, 2016, BBA-MOL CELL RES, V1863, P2221, DOI 10.1016/j.bbamcr.2016.05.008; Solinas G, 2010, CANCER METAST REV, V29, P243, DOI 10.1007/s10555-010-9227-2; Soucheray M, 2015, CANCER RES, V75, P4372, DOI 10.1158/0008-5472.CAN-15-0377; Steel JL, 2018, PSYCHOSOM MED, V80, P483, DOI 10.1097/PSY.0000000000000579; Suda K, 2018, MOL CANCER THER, V17, P2257, DOI 10.1158/1535-7163.MCT-17-1279; Sullivan I, 2016, THER ADV RESPIR DIS, V10, P549, DOI 10.1177/1753465816670498; Sun XO, 2011, CELL CYCLE, V10, P3929, DOI 10.4161/cc.10.22.18106; Tong DD, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691010; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wang DY, 2015, INFLAMMATION, V38, P2235, DOI 10.1007/s10753-015-0206-1; Wang XF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0208-z; Weng CH, 2019, ONCOGENE, V38, P455, DOI 10.1038/s41388-018-0454-2; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	68	17	19	1	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1739	1755		10.1038/s41388-019-1099-5	http://dx.doi.org/10.1038/s41388-019-1099-5			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31740781				2022-12-26	WOS:000514923000009
J	Zhong, R; Tian, JB; Fu, MP; Ma, SM; Liu, L; Li, JY; Shen, N; Ke, JT; Yang, Y; Gong, YJ; Zhu, Y; Wang, Y; Gong, J; Chang, J; Lei, P; Cheng, X; Huang, K; Shen, GX; Miao, XP				Zhong, Rong; Tian, Jianbo; Fu, Mingpeng; Ma, Simin; Liu, Li; Li, Jiaoyuan; Shen, Na; Ke, Juntao; Yang, Yang; Gong, Yajie; Zhu, Ying; Wang, Ying; Gong, Jing; Chang, Jiang; Lei, Ping; Cheng, Xiang; Huang, Kun; Shen, Guanxin; Miao, Xiaoping			LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk	ONCOGENE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATIONS; LNCRNAS; CANCER; SUSCEPTIBILITY; SEQUENCE; DATABASE; LIGANDS; CATALOG; ASTHMA	Interpreting disease-causing variants, especially in noncoding regions by genome-wide association studies (GWAS), has become one of the most challenging and demanding tasks. We hypothesized that functional lncRNAs variants in GWAS-identified loci might alter expression level of genes associated with persistent HBV infection and hepatocellular carcinoma (HCC). Integrated bioinformatics approaches were used to prioritize potentially functional variants and a two-stage case-control study (2473 HBV positive HCC patients, 2248 persistent HBV carriers and 2294 spontaneously recovered subjects) was performed to assess the roles of these variants. The rs2844512 G > C variant in LINC01149 was identified to facilitate HBV spontaneous recovery (OR = 0.84, 95% CI = 0.77-0.92) but increase the risk of HCC (OR = 1.21, 95% CI = 1.11-1.32) in combined samples. Subsequent biological assays indicated this variant created a binding site for miR-128-3p and upregulated MICA expression by serving as a miRNA sponge, which might recruit NK-cells to lyse infected cells, but release highly soluble MICA by shedding to induce NK-cells exhaustion and tumor immune evasion. These findings highlight a regulatory circuit between LINC01149 and MICA, mediating by miR-128-3p, and the important role of upregulated MICA in conferring susceptibility to persistent HBV infection and HCC.	[Zhong, Rong; Tian, Jianbo; Li, Jiaoyuan; Ke, Juntao; Yang, Yang; Gong, Yajie; Zhu, Ying; Gong, Jing; Chang, Jiang; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Peoples R China; [Zhong, Rong; Tian, Jianbo; Li, Jiaoyuan; Ke, Juntao; Yang, Yang; Gong, Yajie; Zhu, Ying; Gong, Jing; Chang, Jiang; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, Wuhan, Peoples R China; [Fu, Mingpeng; Ma, Simin; Lei, Ping; Shen, Guanxin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Peoples R China; [Shen, Na] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Peoples R China; [Wang, Ying] Wuhan Ctr Dis Prevent & Control, Dept Virol, Wuhan, Peoples R China; [Cheng, Xiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hepatobiliary Surg, Wuhan, Peoples R China; [Huang, Kun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guangdong Pharmaceutical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Peoples R China.; Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, Wuhan, Peoples R China.	miaoxp@mail.hust.edu.cn	李, 娇元/GVS-6952-2022; miao, xiaoping/C-4336-2011; Chang, Jiang/AAP-6156-2020	miao, xiaoping/0000-0002-6818-9722; Zhong, Rong/0000-0002-5060-895X; Tian, Jianbo/0000-0001-9493-694X; Ma, Simin/0000-0002-0218-2261	National Natural Science Foundation of China [NSFC-81874278, NSFC-81601839]; Wuhan Innovation Development Program of Young Professionals; National Program for Support of Top-notch Young Professionals	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Innovation Development Program of Young Professionals; National Program for Support of Top-notch Young Professionals	We thank all the people who help us accomplish this research. This work was supported by National Natural Science Foundation of China (NSFC-81874278, NSFC-81601839), Wuhan Innovation Development Program of Young Professionals for YW and National Program for Support of Top-notch Young Professionals for XM.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Du Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10982; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; El-Gazzar A, 2013, J IMMUNOL, V191, P1509, DOI 10.4049/jimmunol.1301071; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gong J, 2018, ANN ONCOL, V29, P632, DOI 10.1093/annonc/mdx789; Gong J, 2015, NUCLEIC ACIDS RES, V43, pD181, DOI 10.1093/nar/gku1000; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Holdenrieder S, 2006, INT J CANCER, V118, P684, DOI 10.1002/ijc.21382; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Jiang DK, 2015, HEPATOLOGY, V62, P118, DOI 10.1002/hep.27794; Jinushi M, 2008, P NATL ACAD SCI USA, V105, P1285, DOI 10.1073/pnas.0711293105; Joung J, 2017, NATURE, V548, P343, DOI 10.1038/nature23451; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Koguchi Y, 2015, CANCER RES, V75, P5084, DOI 10.1158/0008-5472.CAN-15-2303; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Li JY, 2018, CANCER EPIDEM BIOMAR, V27, P1029, DOI [10.1158/1055-9965.EPI-18-0099, 10.1158/1055-9965.epi-18-0099]; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Paralkar VR, 2016, MOL CELL, V62, P104, DOI 10.1016/j.molcel.2016.02.029; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Takagi A, 2017, BIOCHEM BIOPH RES CO, V492, P27, DOI 10.1016/j.bbrc.2017.08.045; Tan JY, 2015, GENOME RES, V25, P655, DOI 10.1101/gr.181974.114; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Tokar T, 2018, NUCLEIC ACIDS RES, V46, pD360, DOI 10.1093/nar/gkx1144; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Volders PJ, 2015, NUCLEIC ACIDS RES, V43, P4363, DOI 10.1093/nar/gkv295; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206; Yang FQ, 2014, ACTAS UROL ESP, V38, P172, DOI 10.1016/j.acuro.2013.09.015; Zaritskaya L, 2010, EXPERT REV VACCINES, V9, P601, DOI [10.1586/erv.10.49, 10.1586/ERV.10.49]; Zhang F, 2015, INT IMMUNOPHARMACOL, V24, P110, DOI 10.1016/j.intimp.2014.11.005; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhu M, 2016, HUM MOL GENET, V25, P1225, DOI 10.1093/hmg/ddw003	46	11	12	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	9					1944	1956		10.1038/s41388-019-1117-7	http://dx.doi.org/10.1038/s41388-019-1117-7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KP9VM	31754211				2022-12-26	WOS:000516579800009
J	Hans, F; Glasebach, H; Kahle, PJ				Hans, Friederike; Glasebach, Hanna; Kahle, Philipp J.			Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TAR DNA-binding protein 43 (TDP-43) (TARDBP); ubiquitylation (ubiquitination); protein aggregation; RNA splicing; stress granule; oxidative stress; protein kinase; signal transduction; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); frontotemporal dementia; osmotic shock	DNA-BINDING PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MESSENGER-RNA; 43 KDA; SARCOMA FUS; RECRUITMENT; MODULATION; MUTATIONS; INSIGHTS	Insoluble, hyperubiquitylated TAR DNA-binding protein of 43 kDa (TDP-43) in the central nervous system characterizes frontotemporal dementia and ALS in many individuals with these neurodegenerative diseases. The causes for neuropathological TDP-43 aggregation are unknown, but it has been suggested that stress granule (SG) formation is important in this process. Indeed, in human embryonic kidney HEK293E cells, various SG-forming conditions induced very strong TDP-43 ubiquitylation, insolubility, and reduced splicing activity. Osmotic stress?induced SG formation and TDP-43 ubiquitylation occurred rapidly and coincided with colocalization of TDP-43 and SG markers. Washout experiments confirmed the rapid dissolution of SGs, accompanied by normalization of TDP-43 ubiquitylation and solubility. Surprisingly, interference with the SG process using a protein kinase R?like endoplasmic reticulum kinase inhibitor (GSK2606414) or the translation blocker emetine did not prevent TDP-43 ubiquitylation and insolubility. Thus, parallel pathways may lead to pathological TDP-43 modifications independent of SG formation. Using a panel of kinase inhibitors targeting signaling pathways of the osmotic shock inducer sorbitol, we could largely rule out the stress-activated and extracellular signal?regulated protein kinase modules and glycogen synthase kinase 3?. For arsenite, but not for sorbitol, quenching oxidative stress with N-acetylcysteine did suppress both SG formation and TDP-43 ubiquitylation and insolubility. Thus, sodium arsenite appears to promote SG formation and TDP-43 modifications via oxidative stress, but sorbitol stimulates TDP-43 ubiquitylation and insolubility via a novel pathway(s) independent of SG formation. In conclusion, pathological TDP-43 modifications can be mediated via multiple distinct pathways for which SGs are not essential.	[Hans, Friederike; Kahle, Philipp J.] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Glasebach, Hanna; Kahle, Philipp J.] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kahle, PJ (corresponding author), Univ Tubingen, Lab Funct Neurogenet, Dept Neurodegenerat, German Ctr Neurodegenerat Dis, Otfried Muller Str 27, D-72076 Tubingen, Germany.; Kahle, PJ (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Fac Med, Otfried Muller Str 27, D-72076 Tubingen, Germany.	philipp.kahle@uni-tuebingen.de		Kahle, Philipp/0000-0002-8587-1731	NOMIS Foundation; German Research Foundation (DFG) [KA1675/3-2]; German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; Hertie Foundation	NOMIS Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; Hertie Foundation	This work was supported by the NOMIS Foundation, German Research Foundation (DFG) Grant KA1675/3-2, the German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, and the Hertie Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Aulas A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00423, 10.3339/fncel.2015.00423]; Bentmann E, 2013, FEBS J, V280, P4348, DOI 10.1111/febs.12287; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Bounedjah O, 2012, J BIOL CHEM, V287, P2446, DOI 10.1074/jbc.M111.292748; Brocker Chad, 2012, Biomol Concepts, V3, P345; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chen YJ, 2019, J BIOL CHEM, V294, P3696, DOI 10.1074/jbc.RA118.006351; Chew J, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0310-z; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Dardis A, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0325-4; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fiesel FC, 2012, NUCLEIC ACIDS RES, V40, P2668, DOI 10.1093/nar/gkr1082; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Gasset-Rosa F, 2019, NEURON, V102, P339, DOI 10.1016/j.neuron.2019.02.038; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hamann I, 2013, REDOX BIOL, V1, P104, DOI 10.1016/j.redox.2012.11.010; Hans F, 2018, J BIOL CHEM, V293, P16083, DOI 10.1074/jbc.RA118.003440; Hans F, 2014, J BIOL CHEM, V289, P19164, DOI 10.1074/jbc.M114.561704; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hebron ML, 2013, J BIOL CHEM, V288, P4103, DOI 10.1074/jbc.M112.419945; Hock EM, 2018, CELL REP, V24, P987, DOI 10.1016/j.celrep.2018.06.094; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Jo M, 2019, BIOCHEM BIOPH RES CO, V513, P925, DOI 10.1016/j.bbrc.2019.04.088; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kwon YT, 2017, TRENDS BIOCHEM SCI, V42, P873, DOI 10.1016/j.tibs.2017.09.002; Lee SH, 2010, J BIOL CHEM, V285, P41280, DOI 10.1074/jbc.M110.182188; Lee YC, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0479-4; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Mackenzie IR, 2017, NEURON, V95, P808, DOI 10.1016/j.neuron.2017.07.025; Mackenzie IRA, 2016, J NEUROCHEM, V138, P54, DOI 10.1111/jnc.13588; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mann JR, 2019, NEURON, V102, P321, DOI 10.1016/j.neuron.2019.01.048; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; McGurk L, 2018, MOL CELL, V71, P703, DOI 10.1016/j.molcel.2018.07.002; Mihevc SP, 2016, SCI REP-UK, V6, DOI 10.1038/srep33996; Moujalled D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067433; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Pajares M, 2015, REDOX BIOL, V6, P409, DOI 10.1016/j.redox.2015.07.003; Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Pena-Oyarzun D, 2017, ONCOTARGET, V8, P55984, DOI 10.18632/oncotarget.18995; Plescher M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13828; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Ryu HW, 2017, CELL STRESS CHAPERON, V22, P253, DOI 10.1007/s12192-017-0763-3; Seelaar H, 2010, J NEUROL, V257, P747, DOI 10.1007/s00415-009-5404-z; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Wobst HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177181; Wolozin B, 2019, NEURON, V102, P265, DOI 10.1016/j.neuron.2019.03.041; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Yuan HX, 2015, GENE DEV, V29, P2362, DOI 10.1101/gad.265116.115; Zhang PP, 2019, ELIFE, V8, DOI 10.7554/eLife.39578; Zhou XY, 2016, BBA-GEN SUBJECTS, V1860, P2037, DOI 10.1016/j.bbagen.2016.05.032	69	19	19	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2020	295	3					673	689		10.1074/jbc.RA119.010617	http://dx.doi.org/10.1074/jbc.RA119.010617			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KE2IW	31780563	Green Published, hybrid			2022-12-26	WOS:000508382900001
J	Wu, PT; Su, WR; Li, CL; Hsieh, JL; Ma, CH; Wu, CL; Kuo, LC; Jou, IM; Chen, SY				Wu, Po-Ting; Su, Wei-Ren; Li, Chia-Lung; Hsieh, Jeng-Long; Ma, Ching-Hou; Wu, Chao-Liang; Kuo, Li-Chieh; Jou, I-Ming; Chen, Shih-Yao			Inhibition of CD44 induces apoptosis, inflammation, and matrix metalloproteinase expression in tendinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; tendon; cytokine induction; inflammation; matrix metalloproteinase (MMP); CD44; tendinopathy	ROTATOR CUFF; PROGENITOR CELLS; TENDON CELLS; HYALURONAN; IL-1-BETA; TEARS; VIVO	Apoptosis has emerged as a primary cause of tendinopathy. CD44 signaling pathways exert anti-apoptotic and -inflammatory effects on tumor cells, chondrocytes, and fibroblast-like synoviocytes. The aim of this study was to examine the association among CD44, apoptosis, and inflammation in tendinopathy. Expression of CD44 and apoptotic cell numbers in tendon tissue from patients with long head of biceps (LHB) tendinopathy were determined according to the histological grades of tendinopathy. Primary tenocytes from Achilles tendon of Sprague?Dawley rats 1 week after collagenase injection were cultured with an antagonizing antibody against CD44. Treatment responses were determined by evaluating cell viability and expression of tendon-related proliferation markers, inflammatory mediators, and apoptosis. The expression of CD44 and apoptosis were positively correlated with the severity of tendinopathy in the human LHB tendinopathy. Furthermore, CD44 expression and apoptotic cells were co-stained in tendinopathic tendon. Blocking the CD44 signaling pathways in rat primary tenocytes by OX-50 induced cell apoptosis and the elevated levels of cleaved caspase-3. Furthermore, they had decreased cell viability and expression of collagen type I, type III, tenomodulin, and phosphorylated AKT. In contrast, there were elevated levels of inflammatory mediators, including interleukin (IL)-1?, IL-6, tumor necrosis factor-?, cyclooxygenase-2, and phosphorylated NF-?B, as well as matrix metalloproteinase (MMP) family members including MMP-1, -3, -9, and -13 in tenocytes upon OX-50 treatment. This study is the first to demonstrate the association of CD44 and apoptosis in tendinopathy. Our data imply that CD44 may play a role in tendinopathy via regulating apoptosis, inflammation, and extracellular matrix homeostasis.	[Wu, Po-Ting; Su, Wei-Ren] Natl Cheng Kung Univ, Coll Med, Dept Orthopaed, Tainan, Taiwan; [Wu, Po-Ting; Su, Wei-Ren; Li, Chia-Lung] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Orthopaed, Tainan, Taiwan; [Wu, Po-Ting] Natl Cheng Kung Univ, Coll Engn, Dept Biomed Engn, Tainan, Taiwan; [Wu, Po-Ting; Li, Chia-Lung] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Orthopaed, Dou Liou Branch,Coll Med, Touliu, Yunlin, Taiwan; [Wu, Po-Ting; Kuo, Li-Chieh] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan; [Hsieh, Jeng-Long; Chen, Shih-Yao] Chung Hwa Univ Med Technol, Coll Nursing, Dept Nursing, Tainan, Taiwan; [Ma, Ching-Hou; Jou, I-Ming] E Da Hosp, Dept Orthoped, 1 Yida Rd, Kaohsiung 82445, Taiwan; [Ma, Ching-Hou; Jou, I-Ming] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Wu, Chao-Liang] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Coll Med, Dept Occupat Therapy, Tainan, Taiwan; [Chen, Shih-Yao] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan; [Chen, Shih-Yao] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, 1 Univ Rd, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Chung Hua University; E-Da Hospital; I Shou University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Jou, IM (corresponding author), E Da Hosp, Dept Orthoped, 1 Yida Rd, Kaohsiung 82445, Taiwan.; Chen, SY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Internal Med, 1 Univ Rd, Tainan 70101, Taiwan.	jming@mail.ncku.edu.tw; leonlai50@gmail.com	su, wei/GZM-3986-2022; Chen, Shih-Yao/GXM-5182-2022; Kuo, Li-Chieh/ABC-3826-2021	Chen, Shih-Yao/0000-0003-4929-855X; Kuo, Li-Chieh/0000-0001-7728-0096; Wu, Po-Ting/0000-0001-5534-8993	Ministry of Science and Technology, Taiwan [MOST 106-2622-E-006-029-CC2, MOST 108-2314-B-006-037-MY3, MOST 107-2314-B-006-065-MY3, MOST 105-2622-E-650-001-CC2]; National Cheng Kung University Hospital (Tainan, Taiwan) [NCKUH-10802005, NCKUEDA 10605]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital (Tainan, Taiwan)	This work was supported by Ministry of Science and Technology, Taiwan, Grants MOST 106-2622-E-006-029-CC2, MOST 108-2314-B-006-037-MY3, MOST 107-2314-B-006-065-MY3, and MOST 105-2622-E-650-001-CC2 and National Cheng Kung University Hospital (Tainan, Taiwan) Grants NCKUH-10802005, and NCKUEDA 10605. The authors declare that they have no conflicts of interest with the contents of this article.	Anand V, 2019, J CANCER RES CLIN, V145, P2649, DOI 10.1007/s00432-019-03024-9; Arnoczky SP, 2004, J ORTHOPAED RES, V22, P328, DOI 10.1016/S0736-0266(03)00185-2; Benson RT, 2010, J BONE JOINT SURG BR, V92B, P448, DOI 10.1302/0301-620X.92B3.23074; Chuen FS, 2004, J HISTOCHEM CYTOCHEM, V52, P1151, DOI 10.1369/jhc.3A6232.2004; Del Buono A, 2011, INT J IMMUNOPATH PH, V24, P45, DOI 10.1177/03946320110241S209; Del Buono A, 2012, J SHOULDER ELB SURG, V21, P200, DOI 10.1016/j.jse.2011.10.020; Durgam S, 2016, TISSUE ENG PART C-ME, V22, P801, DOI [10.1089/ten.tec.2016.0152, 10.1089/ten.TEC.2016.0152]; Egerbacher M, 2008, CLIN ORTHOP RELAT R, V466, P1562, DOI 10.1007/s11999-008-0274-8; Fedorchenko O, 2013, BLOOD, V121, P4126, DOI 10.1182/blood-2012-11-466250; Hiraoka N, 2011, J ORTHOP RES, V29, P354, DOI 10.1002/jor.21240; Hsieh JL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204603; Ji RR, 2009, TRENDS PHARMACOL SCI, V30, P336, DOI 10.1016/j.tips.2009.04.002; Lakemeier S, 2011, KNEE SURG SPORT TR A, V19, P1760, DOI 10.1007/s00167-010-1367-y; Lian O, 2007, AM J SPORT MED, V35, P605, DOI 10.1177/0363546506295702; Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; Liu SL, 2017, CANCER RES, V77, P3791, DOI 10.1158/0008-5472.CAN-16-2545; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Longo UG, 2009, SPORTS MED ARTHROSC, V17, P112, DOI 10.1097/JSA.0b013e3181a3d625; Lotz M, 1999, OSTEOARTHR CARTILAGE, V7, P389, DOI 10.1053/joca.1998.0220; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Mikecz K, 1999, ARTHRITIS RHEUM, V42, P659, DOI 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z; Mobasheri A, 2013, HISTOL HISTOPATHOL, V28, P955, DOI 10.14670/HH-28.955; Mongkhon JM, 2014, INFLAMM RES, V63, P691, DOI 10.1007/s00011-014-0742-4; Nell EM, 2012, J ORTHOP RES, V30, P1719, DOI 10.1002/jor.22144; Park YS, 2012, ONCOL REP, V27, P339, DOI 10.3892/or.2011.1532; Pearce CJ, 2009, AM J SPORT MED, V37, P2440, DOI 10.1177/0363546509340264; Raleigh SM, 2009, BRIT J SPORT MED, V43, P514, DOI 10.1136/bjsm.2008.053892; Riley Graham, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405008963; Shakibaei M, 2011, HISTOL HISTOPATHOL, V26, P1173, DOI 10.14670/HH-26.1173; Song JM, 2019, MOL CARCINOGEN, V58, P321, DOI 10.1002/mc.22930; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Wu PT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40840; Wu PT, 2014, J SHOULDER ELB SURG, V23, P1099, DOI 10.1016/j.jse.2013.11.013; Yoshida M, 2008, BIOMED RES-TOKYO, V29, P47, DOI 10.2220/biomedres.29.47; Yuan J, 2002, J ORTHOP RES, V20, P1372, DOI 10.1016/S0736-0266(02)00075-X; Zhang KR, 2015, BIOCHEM BIOPH RES CO, V463, P667, DOI 10.1016/j.bbrc.2015.05.122	36	12	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20177	20184		10.1074/jbc.RA119.009675	http://dx.doi.org/10.1074/jbc.RA119.009675			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31732563	hybrid, Green Published			2022-12-26	WOS:000505005800028
J	Chin, LY; Carroll, C; Raigani, S; Detelich, DM; Tessier, SN; Wojtkiewicz, GR; Schmidt, SP; Weissleder, R; Yeh, H; Uygun, K; Parekkadan, B				Chin, Ling-Yee; Carroll, Cailah; Raigani, Siavash; Detelich, Danielle M.; Tessier, Shannon N.; Wojtkiewicz, Gregory R.; Schmidt, Stephen P.; Weissleder, Ralph; Yeh, Heidi; Uygun, Korkut; Parekkadan, Biju			Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LIVER-TRANSPLANTATION; THERAPY; LUCIFERASE; REPERFUSION; REJECTION; PROGRESS; CULTURE; MODEL	Cellular rejection of liver transplant allografts remains a concern despite immunosuppressant use. Existing transplant biomarkers are often not sensitive enough to detect acute or chronic rejection at an early enough stage to allow successful clinical intervention. We herein developed a cell-based sensor that can potentially be used for monitoring local events following liver transplantation. Utilizing a machine perfusion system as a platform to engraft the cells into a donor liver, we effectively established the biocompatibility of the biosensor cells and confirmed efficient delivery of cells distributed throughout the organ. This work proves an innovative concept of integrating synthetic reporter cells ex vivo into organs as a transplant-within-a-transplant during functional organ preservation with a vision to use cell biosensors as a broad way to monitor and treat tissue transplants.	[Chin, Ling-Yee; Carroll, Cailah; Raigani, Siavash; Detelich, Danielle M.; Tessier, Shannon N.; Yeh, Heidi; Uygun, Korkut; Parekkadan, Biju] Massachusetts Gen Hosp, Dept Surg, Ctr Surg Innovat & Bioengn, Boston, MA 02114 USA; [Chin, Ling-Yee; Carroll, Cailah; Tessier, Shannon N.; Uygun, Korkut; Parekkadan, Biju] Shriners Hosp Children, Boston, MA 02114 USA; [Raigani, Siavash; Detelich, Danielle M.; Yeh, Heidi; Parekkadan, Biju] Massachusetts Gen Hosp, Ctr Transplant Sci, Boston, MA 02114 USA; [Wojtkiewicz, Gregory R.; Schmidt, Stephen P.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Parekkadan, Biju] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Parekkadan, Biju] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Rutgers State University New Brunswick	Parekkadan, B (corresponding author), Massachusetts Gen Hosp, Dept Surg, Ctr Surg Innovat & Bioengn, Boston, MA 02114 USA.; Parekkadan, B (corresponding author), Shriners Hosp Children, Boston, MA 02114 USA.; Parekkadan, B (corresponding author), Massachusetts Gen Hosp, Ctr Transplant Sci, Boston, MA 02114 USA.; Parekkadan, B (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Parekkadan, B (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.	biju.parekkadan@rutgers.edu	; Wojtkiewicz, Gregory/L-3660-2018	Tessier, Shannon/0000-0003-2373-232X; Wojtkiewicz, Gregory/0000-0002-3148-8411; Parekkadan, Biju/0000-0002-3408-8085	National Institutes of Health [R21AI134116]; Shriners Foundation for Children [85130]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL143149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI134116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Foundation for Children; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was conducted with support under Grant No. R21AI134116 (to BP and KU) awarded by the National Institutes of Health and support from the Shriners Foundation for Children Grant No. 85130 (to BP).	Berendsen TA, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-6; Brasile L, 2019, TRANSPLANTATION, V103, P307, DOI 10.1097/TP.0000000000002455; Cai SJ, 2019, CURR GENE THER, V19, P71, DOI 10.2174/1566523219666190603103840; Dahlke MH, 2012, CURR OPIN ORGAN TRAN, V17, P33, DOI 10.1097/MOT.0b013e32834f02de; Delriviere Luc, 1996, Microsurgery, V17, P690, DOI 10.1002/(SICI)1098-2752(1996)17:12<690::AID-MICR6>3.0.CO;2-R; Elman JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089882; Fandrich F, 2010, CURR OPIN ORGAN TRAN, V15, P703, DOI 10.1097/MOT.0b013e328340669a; Garakani R, 2017, INT J TRANSPLANT MED, V8, P125; Germani G, 2015, WORLD J GASTROENTERO, V21, P1061, DOI 10.3748/wjg.v21.i4.1061; Govender L, 2014, EXPERT REV CLIN IMMU, V10, P1197, DOI 10.1586/1744666X.2014.943191; Gruttadauria S, 2005, TRANSPL P, V37, P2611, DOI 10.1016/j.transproceed.2005.06.063; Haarer J, 2015, TRANSPL INT, V28, P1, DOI 10.1111/tri.12415; Hoogduijn MJ, 2010, TRANSPLANTATION, V90, P124, DOI 10.1097/TP.0b013e3181ea4240; Ichim TE, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1536-1; Imber CJ, 2002, TRANSPLANTATION, V73, P701, DOI 10.1097/00007890-200203150-00008; Jadlowiec CC, 2016, WORLD J GASTROENTERO, V22, P4438, DOI 10.3748/wjg.v22.i18.4438; Karimian Negin, 2017, Curr Transplant Rep, V4, P141, DOI 10.1007/s40472-017-0144-y; Lin P, 2012, STEM CELL TRANSL MED, V1, P886, DOI 10.5966/sctm.2012-0086; Maluf DG, 2005, AM J TRANSPLANT, V5, P149, DOI 10.1111/j.1600-6143.2004.00654.x; Mergental H, 2018, LIVER TRANSPLANT, V24, P1453, DOI 10.1002/lt.25291; Nasralla D, 2018, NATURE, V557, P50, DOI 10.1038/s41586-018-0047-9; Petrou P, 2016, JAMA NEUROL, V73, P337, DOI 10.1001/jamaneurol.2015.4321; Reinders MEJ, 2018, TRANSPLANTATION, V102, P35, DOI 10.1097/TP.0000000000001879; Reinders Marlies Ej, 2014, J Stem Cell Res Ther, V4, P1000166; Roemhild A, 2016, TRANSPL INT, V29, P515, DOI 10.1111/tri.12659; Sasaki H, 2018, HUM IMMUNOL, V79, P258, DOI 10.1016/j.humimm.2017.11.008; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Singleton A, 2017, CYTOTHERAPY, V19, P1537, DOI 10.1016/j.jcyt.2017.08.003; Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112; Sprangers B, 2017, AM J TRANSPLANT, V17, P2020, DOI 10.1111/ajt.14251; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; ten Brinke A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00181; Teng J, 2014, STEM CELLS, V32, P2021, DOI 10.1002/stem.1727; Tolboom H, 2007, TISSUE ENG, V13, P2143, DOI 10.1089/ten.2007.0101; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Uygun K, 2010, TRANSPL P, V42, P2463, DOI 10.1016/j.transproceed.2010.04.037; Verhelst XPD, 2013, HEPATOL RES, V43, P165, DOI 10.1111/hepr.12012; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177	39	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0225222	10.1371/journal.pone.0225222	http://dx.doi.org/10.1371/journal.pone.0225222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790444	gold, Green Published			2022-12-26	WOS:000533930800026
J	Diaz-Riano, J; Posada, L; Acosta, IC; Ruiz-Perez, C; Garcia-Castillo, C; Reyes, A; Zambrano, MM				Diaz-Riano, Jorge; Posada, Leonardo; Camilo Acosta, Ivan; Ruiz-Perez, Carlos; Garcia-Castillo, Catalina; Reyes, Alejandro; Mercedes Zambrano, Maria			Computational search for UV radiation resistance strategies in Deinococcus swuensis isolated from Paramo ecosystems	PLOS ONE			English	Article							OXIDATIVE STRESS RESISTANCE; PROTEIN FAMILIES; SEQUENCE; SENSITIVITY; BACTERIA; RNAS; PHYLLOSPHERE; MECHANISMS; DATABASE; RPOS	Ultraviolet radiation (UVR) is widely known as deleterious for many organisms since it can cause damage to biomolecules either directly or indirectly via the formation of reactive oxygen species. The goal of this study was to analyze the capacity of high-mountain Espeletia hartwegiana plant phyllosphere microorganisms to survive UVR and to identify genes related to resistance strategies. A strain of Deinococcus swuensis showed a high survival rate of up to 60% after UVR treatment at 800J/m(2) and was used for differential expression analysis using RNA-seq after exposing cells to 400J/m(2) of UVR (with >95% survival rate). Differentially expressed genes were identified using the R-Bioconductor package NOISeq and compared with other reported resistance strategies reported for this genus. Genes identified as being overexpressed included transcriptional regulators and genes involved in protection against damage by UVR. Non-coding (nc)RNAs were also differentially expressed, some of which have not been previously implicated. This study characterized the immediate radiation response of D. swuensis and indicates the involvement of ncRNAs in the adaptation to extreme environmental conditions.	[Diaz-Riano, Jorge; Posada, Leonardo; Camilo Acosta, Ivan; Mercedes Zambrano, Maria] Corp Corpogen Res Ctr, Bogota, DC, Colombia; [Diaz-Riano, Jorge; Ruiz-Perez, Carlos; Garcia-Castillo, Catalina; Reyes, Alejandro] Univ Los Andes, Dept Biol Sci, Res Grp Computat Biol & Microbial Ecol, Bogota, DC, Colombia; [Diaz-Riano, Jorge; Reyes, Alejandro] Univ Los Andes, Max Planck Tandem Grp Computat Biol, Bogota, DC, Colombia; [Reyes, Alejandro] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Washington University (WUSTL)	Zambrano, MM (corresponding author), Corp Corpogen Res Ctr, Bogota, DC, Colombia.; Reyes, A (corresponding author), Univ Los Andes, Dept Biol Sci, Res Grp Computat Biol & Microbial Ecol, Bogota, DC, Colombia.; Reyes, A (corresponding author), Univ Los Andes, Max Planck Tandem Grp Computat Biol, Bogota, DC, Colombia.; Reyes, A (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.	a.reyes@uniandes.edu.co; mzambrano@corpogen.org		Zambrano, Maria Mercedes/0000-0002-0796-4473; Reyes, Alejandro/0000-0003-2907-3265	Colciencias [657065843848]; Max Planck Tandem Group in Computational Biology; Universidad de Los Andes	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Max Planck Tandem Group in Computational Biology; Universidad de Los Andes	This work was partially supported by Colciencias (https://www.colciencias.gov.co/), Grant No. 657065843848, including support for J. D-R. J.D-R was also funded by the Max Planck Tandem Group in Computational Biology. The authors also acknowledge the Universidad de Los Andes for providing a graduate assistance fellowship to J.D-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dra. Claudia Chica Pratesi for support in the analysis process and corrections about the analysis workflow. The authors also acknowledge the Universidad de Los Andes for providing a graduate assistance fellowship to J.D-R and the High Performance Computing (HPC) Service that contributed to the research results reported within this work.	Agapov AA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1201, DOI 10.1134/S0006297915100016; Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Arrieta JM, 2000, APPL ENVIRON MICROB, V66, P1468, DOI 10.1128/AEM.66.4.1468-1473.2000; Barquist Lars, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.4; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen XG, 2007, GENE DEV, V21, P1328, DOI 10.1101/gad.1548207; Chen XG, 2014, RNA, V20, P1715, DOI 10.1261/rna.047241.114; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Cowan DA, 2015, CURR OPIN MICROBIOL, V25, P97, DOI 10.1016/j.mib.2015.05.005; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Dib J, 2008, CURR MICROBIOL, V56, P510, DOI 10.1007/s00284-008-9103-2; Dulermo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124358; Fields JA, 2008, J BACTERIOL, V190, P3411, DOI 10.1128/JB.01928-07; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gabani P, 2013, APPL MICROBIOL BIOT, V97, P993, DOI 10.1007/s00253-012-4642-7; Gao Q, 2011, NAT REV MICROBIOL, V9, P791, DOI 10.1038/nrmicro2649; GASCON J, 1995, CURR MICROBIOL, V30, P177, DOI 10.1007/BF00296205; Gerber E, 2015, J APPL MICROBIOL, V119, P1, DOI 10.1111/jam.12808; Guerrero-Beltran JA, 2004, FOOD SCI TECHNOL INT, V10, P137, DOI 10.1177/1082013204044359; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Jung KW, 2017, J MICROBIOL, V55, P499, DOI 10.1007/s12275-017-7242-5; Kalvari I, 2017, NUCLEIC ACIDS RES, P1, DOI [10.1093/nar/gkx1038/4588106, DOI 10.1093/NAR/GKX1038/4588106]; Kim MK, 2015, MOL CELL TOXICOL, V11, P315, DOI 10.1007/s13273-015-0031-5; King B, 2011, AEROSOL SCI TECH, V45, P645, DOI 10.1080/02786826.2010.550959; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kowalski MP, 2015, INT J BIOCHEM CELL B, V66, P20, DOI 10.1016/j.biocel.2015.07.003; Kyuma T, 2015, BIOCHIMIE, V119, P166, DOI 10.1016/j.biochi.2015.10.027; Lee JJ, 2013, J MICROBIOL, V51, P305, DOI 10.1007/s12275-013-3023-y; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liesa M, 2012, BBA-MOL CELL RES, V1823, P1945, DOI 10.1016/j.bbamcr.2012.07.013; Lord DM, 2014, BIOCHEMISTRY-US, V53, P7223, DOI 10.1021/bi500871a; Luan HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085649; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Makarova KS, 2000, GENETICA, V108, P25, DOI 10.1023/A:1004035424657; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Ohtani N, 2010, J BACTERIOL, V192, P5499, DOI 10.1128/JB.00662-10; Ott E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189381; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Paulino-Lima IG, 2013, MICROB ECOL, V65, P325, DOI 10.1007/s00248-012-0121-z; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rasis M, 2009, MOL MICROBIOL, V72, P995, DOI 10.1111/j.1365-2958.2009.06705.x; Ruiz-Perez CA, 2016, APPL ENVIRON MICROB, V82, P1807, DOI 10.1128/AEM.02781-15; Sha Y, 2015, IEEE ENG MED BIO, P6461, DOI 10.1109/EMBC.2015.7319872; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Sonnleitner E, SMALL REGULATORY RNA; Sundin GW, 1999, MICROBIAL ECOL, V38, P27, DOI 10.1007/s002489900152; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, P1; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; Tsai CH, 2015, APPL ENVIRON MICROB, V81, P1745, DOI 10.1128/AEM.03709-14; Wang Q, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-69; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Wei L, 2014, ADV NAT SCI, V7, P6; Wurtmann E, 2013, CRIT REV BIOCHEM MOL, V31, P34	62	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2019	14	12							e0221540	10.1371/journal.pone.0221540	http://dx.doi.org/10.1371/journal.pone.0221540			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9FT	31790419	Green Published, Green Submitted, gold			2022-12-26	WOS:000533930800002
J	van Ginkel, HAL; Smit, C; Kuijper, DPJ				van Ginkel, Hermine Annette Lisa; Smit, Christian; Kuijper, Dries Pieter Jan			Behavioral response of naive and non-naive deer to wolf urine	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; PREDATION RISK; LARGE CARNIVORES; TAILED DEER; ANTIPREDATOR RESPONSE; TEMPORAL VARIATION; WOLVES; FEAR; ELK; PREY	Large carnivores are recolonizing many regions in Europe, where their ungulate prey have lived without them for > 150 years. Whether the returning large carnivores will modify ungulate behavior and indirectly affect lower trophic levels, depends on the ability of ungulates to recognize risk based on past encounters and cues indicating carnivore presence. In two case studies, we tested, by means of camera trapping, the behavioral response of deer to wolf urine. The first case study was in the Netherlands where deer (still) live in absence of wolves, and the second in Poland with long-term wolf presence. As controls we used water (no scent) and all-purpose soap (unfamiliar scent). Deer vigilance level on control plots was 20% in both case studies indicating that wolf occupancy per se does not lead to a consistent difference in behavior. Placing wolf urine did not significantly affect deer behavior in either the wolf-absent or the wolf-present area. More intense cues, or a combination of cues, are likely needed to affect deer behavior. Moreover, we found an unexpected reaction of deer towards all-purpose soap of reduced foraging (and tendency for increased vigilance) in the wolf-present area, whereas it did not affect deer behavior in the wolf-absent area. We hypothesize that deer associate all-purpose soap with human presence, causing no response in human-dominated landscapes (the Netherlands), but triggering a behavioral reaction in more remote areas (Poland). This illustrates attention should be paid to controls used in scent experiments as they may be associated differently than intended.	[van Ginkel, Hermine Annette Lisa; Smit, Christian] Univ Groningen, Groningen Inst Evolutionary Life Sci, Conservat Ecol Grp, Groningen, Netherlands; [van Ginkel, Hermine Annette Lisa; Kuijper, Dries Pieter Jan] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland	University of Groningen; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	van Ginkel, HAL (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci, Conservat Ecol Grp, Groningen, Netherlands.; van Ginkel, HAL (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	h.a.l.van.ginkel@rug.nl	; smit, christian/B-9817-2008	van Ginkel, Annelies/0000-0003-1224-0995; Kuijper, Dries/0000-0002-0324-5893; smit, christian/0000-0002-4044-9473	Academic Ecology Fund; National Science Center, Poland [2015/17/B/NZ8/02403]	Academic Ecology Fund; National Science Center, Poland(National Science Centre, Poland)	This work was supported by the Academic Ecology Fund to HALVG. In addition, the work of DPJK was supported by funding of the National Science Center, Poland (grant number 2015/17/B/NZ8/02403)	Altendorf KB, 2001, J MAMMAL, V82, P430, DOI 10.1644/1545-1542(2001)082&lt;0430:AEOPRO&gt;2.0.CO;2; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Arnould C, 1998, J CHEM ECOL, V24, P559, DOI 10.1023/A:1022321104758; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; Banks PB, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1053; Barnier F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0446; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Blanchard P, 2007, OIKOS, V116, P1603, DOI 10.1111/j.2007.0030-1299.15799.x; Blumstein DT, 2006, ETHOLOGY, V112, P209, DOI 10.1111/j.1439-0310.2006.01209.x; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Carthey AJR, 2017, SCI REPORTS, V7, P1, DOI DOI 10.1038/S41598-016-0028-X; Carthey AJR, 2018, TRENDS ECOL EVOL, V33, P106, DOI 10.1016/j.tree.2017.10.009; Carthey AJR, 2016, OIKOS, V125, P918, DOI 10.1111/oik.02723; Carthey AJR, 2014, BIOL REV, V89, P932, DOI 10.1111/brv.12087; Ceausu S, 2015, CONSERV BIOL, V29, P1017, DOI 10.1111/cobi.12533; Chamaille-Jammes S, 2014, OECOLOGIA, V174, P1151, DOI 10.1007/s00442-013-2843-0; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Christensen JW, 2008, APPL ANIM BEHAV SCI, V112, P136, DOI 10.1016/j.applanim.2007.08.003; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Clair CCS, 2009, BEHAVIOUR, V146, P393, DOI 10.1163/156853909X410973; Clinchy M, 2016, BEHAV ECOL, V27, P1826, DOI 10.1093/beheco/arw117; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Cromsigt JPGM, 2013, J APPL ECOL, V50, P544, DOI 10.1111/1365-2664.12076; Dalerum F, 2015, BEHAV ECOL, V26, P215, DOI 10.1093/beheco/aru180; Darimont CT, 2015, SCIENCE, V349, P858, DOI 10.1126/science.aac4249; Eccard J. A., 2015, ETHOLOGY, V121, P1; Elmeros M, 2011, EUR J WILDLIFE RES, V57, P1223, DOI 10.1007/s10344-011-0517-y; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Ford AT, 2014, SCIENCE, V346, P346, DOI 10.1126/science.1252753; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Frank ASK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161447; Gervasi V, 2013, ECOL APPL, V23, P1722, DOI 10.1890/12-1615.1; Jayakody S, 2008, WILDLIFE BIOL, V14, P81, DOI 10.2981/0909-6396(2008)14[81:RDCEVB]2.0.CO;2; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; Jedrzejewska B, 1996, MAMMAL REV, V26, P103; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Karl T, 2018, P NATL ACAD SCI USA, V115, P1186, DOI 10.1073/pnas.1714715115; Kay M., 2019, ARTOOL ALIGNED RANK; Kluever BM, 2009, BEHAV PROCESS, V81, P85, DOI 10.1016/j.beproc.2009.02.004; Kuijper DPJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1625; Kuijper DPJ, 2013, ECOGRAPHY, V36, P1263, DOI 10.1111/j.1600-0587.2013.00266.x; Kuijper DPJ, 2009, FOREST ECOL MANAG, V258, P1528, DOI 10.1016/j.foreco.2009.07.010; Kuijper DPJ, 2015, BEHAV ECOL, V26, P1558, DOI 10.1093/beheco/arv107; Kuijper DPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084607; Lahti DC, 2009, TRENDS ECOL EVOL, V24, P487, DOI 10.1016/j.tree.2009.03.010; Latombe G, 2014, J ANIM ECOL, V83, P185, DOI 10.1111/1365-2656.12108; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Le Saout S, 2014, CAN J ZOOL, V92, P915, DOI 10.1139/cjz-2014-0122; Li CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023623; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Mella VSA, 2014, J ZOOL, V294, P22, DOI 10.1111/jzo.12146; Mery F, 2010, EVOL ECOL, V24, P571, DOI 10.1007/s10682-009-9336-y; Nicholson KL, 2014, OECOLOGIA, V176, P69, DOI 10.1007/s00442-014-3004-9; Okarma H, 1995, ACTA THERIOL, V40, P335, DOI 10.4098/AT.arch.95-35; OKARMA H, 1995, ACTA THERIOL, V40, P197, DOI 10.4098/AT.arch.95-20; Osada K, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00276; Parsons AW, 2016, BIOL CONSERV, V203, P75, DOI 10.1016/j.biocon.2016.09.001; Parsons MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010403; PETERS RP, 1975, AM SCI, V63, P628; Reidsma P, 2006, AGR ECOSYST ENVIRON, V114, P86, DOI 10.1016/j.agee.2005.11.026; Ripple WJ, 2006, FOREST ECOL MANAG, V230, P96, DOI 10.1016/j.foreco.2006.04.023; Rouco C, 2011, EUR J WILDLIFE RES, V57, P395, DOI 10.1007/s10344-010-0443-4; Sahlen E, 2016, ECOL EVOL, V6, P791, DOI 10.1002/ece3.1866; Sand H, 2006, P R SOC B, V273, P1421, DOI 10.1098/rspb.2005.3447; Schmidt K, 2009, ECOL RES, V24, P207, DOI 10.1007/s11284-008-0496-y; Shrader AM, 2008, J ARID ENVIRON, V72, P1811, DOI 10.1016/j.jaridenv.2008.05.004; Sibbald AM, 2011, EUR J WILDLIFE RES, V57, P817, DOI 10.1007/s10344-011-0493-2; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Smith JA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0433; Stillfried M, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00157; SULLIVAN TP, 1985, J CHEM ECOL, V11, P921, DOI 10.1007/BF01012078; Suraci JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10698; SWIHART RK, 1991, J CHEM ECOL, V17, P767, DOI 10.1007/BF00994199; Trouwborst A, 2015, BIODIVERS CONSERV, V24, P1567, DOI 10.1007/s10531-015-0894-8; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Wikenros C, 2015, BEHAVIOUR, V152, P1019, DOI 10.1163/1568539X-00003266; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Worm B, 2015, SCIENCE, V349, P784, DOI 10.1126/science.aac8697; Zottl M, 2013, BEHAV ECOL, V24, P198, DOI 10.1093/beheco/ars154; Zub K, 2003, BEHAVIOUR, V140, P635, DOI 10.1163/156853903322149478	88	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2019	14	11							e0223248	10.1371/journal.pone.0223248	http://dx.doi.org/10.1371/journal.pone.0223248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8SS	31774819	gold, Green Published			2022-12-26	WOS:000533896400008
J	Oh, BK; Choi, Y; Bae, J; Lee, WM; Hoh, JK; Choi, JS				Oh, Bong-Kyeong; Choi, Yoojung; Bae, Jaeman; Lee, Won Moo; Hoh, Jeong-Kyu; Choi, Joong Sub			Increased amounts and stability of telomeric repeat-containing RNA (TERRA) following DNA damage induced by etoposide	PLOS ONE			English	Article							TRF2; TRANSCRIPTION; PROTECTION; ATM; P53	Telomeric repeat-containing RNAs (TERRAs) are long noncoding RNAs transcribed from subtelomeres toward telomeric repeat tracts, which have been implicated in telomere protection and heterochromatin formation. Genotoxic stress leads to upregulation of TERRAs. However, the mechanism of DNA damage-mediated TERRA induction remains elusive. Here, we treated HeLa cells with etoposide, a DNA double-strand break-generating agent, for various times and monitored the levels of TERRAs. Etoposide treatment led to a gradual time-dependent increase in TERRAs. Etoposide-mediated induction was evident in many TERRAs arising from various chromosome loci, including 20q and XpYp. Chromatin immunoprecipitation assays revealed no significant changes in the occupancy of RNA polymerase II at telomeres upon etoposide treatment. Interestingly, TERRAs arising from 20q, XpYp, 10q, and 13q degraded at slower rates in cells treated with etoposide, while degradation rates of TERRAs from many loci tested were nearly identical in both etoposide- and mock-treated cells. Telomere damage occurred from early time points of etoposide treatment, but telomere lengths and abundance of telomeric repeat-binding factor 2 (TRF2) at telomeres remained unchanged. In summary, etoposide treatment led to telomere damage and TERRA accumulation, but telomere lengths and TRF2-mediated telomere integrity were maintained. Etoposide-mediated TERRA accumulation could be attributed partly to RNA stabilization. These findings may provide insight into the post-transcriptional regulation of TERRAs in response to DNA damage.	[Oh, Bong-Kyeong; Choi, Joong Sub] Hanyang Univ, Inst Integrat Med & Innovat Technol, Coll Med, Seoul, South Korea; [Choi, Yoojung] Hanyang Univ, Dept Translat Med, Grad Sch Biomed Sci & Engn, Seoul, South Korea; [Bae, Jaeman; Lee, Won Moo; Hoh, Jeong-Kyu; Choi, Joong Sub] Hanyang Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University	Oh, BK; Choi, JS (corresponding author), Hanyang Univ, Inst Integrat Med & Innovat Technol, Coll Med, Seoul, South Korea.; Choi, JS (corresponding author), Hanyang Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.	bongoh0401@hanyang.ac.kr; choiyjjy1@hanyang.ac.kr		Oh, Bong-Kyeong/0000-0002-5630-6207; Hoh, Jeong Kyu/0000-0003-4783-2026	Basic Science Research Program through the National Research Foundation (NRF) - Ministry of Education [2014R1A1A2054542]; NRF - Ministry of Science and ICT of Republic of Korea [2017R1A2B4004721]	Basic Science Research Program through the National Research Foundation (NRF) - Ministry of Education; NRF - Ministry of Science and ICT of Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) funded by the Ministry of Education (2014R1A1A2054542 to BKO) and by NRF funded by the Ministry of Science and ICT (2017R1A2B4004721 to BKO) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bah A, 2012, NUCLEIC ACIDS RES, V40, P2995, DOI 10.1093/nar/gkr1153; Baker AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019124; Brown Terry, 2004, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0409s67; Burden DA, 1996, J BIOL CHEM, V271, P29238, DOI 10.1074/jbc.271.46.29238; Chu HP, 2017, CELL, V170, P86, DOI 10.1016/j.cell.2017.06.017; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2012, EMBO J, V31, P4165, DOI 10.1038/emboj.2012.266; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Feretzaki M, 2019, RNA, P6333, DOI [10.1093/nar/gkx208, DOI 10.1093/NAR/GKX208]; Feretzaki M, 2017, METHODS, V114, P39, DOI 10.1016/j.ymeth.2016.08.004; Flynn RL, 2015, SCIENCE, V347, P273, DOI 10.1126/science.1257216; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Montero JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12534; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Klapper W, 2003, LEUKEMIA, V17, P2007, DOI 10.1038/sj.leu.2403086; Koskas S, 2017, NUCLEIC ACIDS RES, V45, P6321, DOI 10.1093/nar/gkx208; KRUK PA, 1995, P NATL ACAD SCI USA, V92, P258, DOI 10.1073/pnas.92.1.258; Liu MX, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117754; de Silanes IL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5723; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Oh BK, 2003, J HEPATOL, V39, P786, DOI 10.1016/S0168-8278(03)00395-7; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Porro A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6379; Porro A, 2014, CELL REP, V6, P765, DOI 10.1016/j.celrep.2014.01.022; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Poulet A, 2012, NUCLEIC ACIDS RES, V40, P2566, DOI 10.1093/nar/gkr1116; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2019	14	11							e0225302	10.1371/journal.pone.0225302	http://dx.doi.org/10.1371/journal.pone.0225302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8QA	31756221	Green Published, gold			2022-12-26	WOS:000533889300016
J	D'Souza, S; Ormond, DR; Costabile, J; Thompson, JA				D'Souza, Shawn; Ormond, D. Ryan; Costabile, Jamie; Thompson, John A.			Fiber-tract localized diffusion coefficients highlight patterns of white matter disruption induced by proximity to glioma	PLOS ONE			English	Article							SUPERIOR LONGITUDINAL FASCICULUS; MAGNETIC-RESONANCE TRACTOGRAPHY; CENTRAL-NERVOUS-SYSTEM; GLIOBLASTOMA-MULTIFORME; CORTICOSPINAL TRACT; CORPUS-CALLOSUM; BRAIN; RESECTION; DISEASE; TUMORS	Gliomas account for 26.5% of all primary central nervous system tumors. Recent studies have used diffusion tensor imaging (DTI) to extract white matter fibers and the diffusion coefficients derived from MR processing to provide useful, non-invasive insights into the extent of tumor invasion, axonal integrity, and gross differentiation of glioma from metastasis. Here, we extend this work by examining whether a tract-based analysis can improve non-invasive localization of tumor impact on white matter integrity. This study retrospectively analyzed preoperative magnetic resonance sequences highlighting contrast enhancement and DTI scans of 13 subjects that were biopsy-confirmed to have either high or low-grade glioma. We reconstructed the corticospinal tract and superior longitudinal fasciculus by applying atlas-based regions of interest to fibers derived from whole-brain deterministic streamline tractography. Within-subject comparison of hemispheric diffusion coefficients (e.g., fractional anisotropy and mean diffusivity) indicated higher levels of white matter degradation in the ipsilesional hemisphere. Novel application of along-tract analyses revealed that tracts traversing the tumor region showed significant white matter degradation compared to the contralesional hemisphere and ipsilesional tracts displaced by the tumor.	[D'Souza, Shawn] Univ Colorado, Dept Mol Biol, Boulder, CO 80309 USA; [D'Souza, Shawn; Ormond, D. Ryan; Costabile, Jamie; Thompson, John A.] Univ Colorado, Dept Neurosurg, Anschutz Med Campus, Aurora, CO 80045 USA; [Thompson, John A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Thompson, JA (corresponding author), Univ Colorado, Dept Neurosurg, Anschutz Med Campus, Aurora, CO 80045 USA.; Thompson, JA (corresponding author), Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO 80045 USA.	john.a.thompson@cuanschutz.edu	Thompson, John A/T-6194-2019; Ormond, David Ryan/R-4847-2017	Thompson, John A/0000-0003-2991-5194; D'Souza, Shawn/0000-0003-3297-3424; Ormond, David Ryan/0000-0001-7027-2915	Cancer League of Colorado; American Cancer Society	Cancer League of Colorado; American Cancer Society(American Cancer Society)	This work was supported by Cancer League of Colorado (http://cancerleague.org/), DRO and JAT; American Cancer Society (https://www.cancer.org/), DRO and JAT.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Angeli S, 2018, NEUROIMAGE-CLIN, V20, P664, DOI 10.1016/j.nicl.2018.08.032; Aung Wint Yan, 2013, Imaging Med, V5, P427; Bourbon-Teles J, 2019, NEUROSCIENCE, V403, P79, DOI 10.1016/j.neuroscience.2017.05.042; Bucci M, 2013, NEUROIMAGE-CLIN, V3, P361, DOI 10.1016/j.nicl.2013.08.008; Castellano A, 2012, NEURO-ONCOLOGY, V14, P192, DOI 10.1093/neuonc/nor188; Cavedo E, 2017, NEUROSCIENCE, V357, P119, DOI 10.1016/j.neuroscience.2017.05.048; Caverzasi E, 2016, J NEUROSURG, V125, P33, DOI 10.3171/2015.6.JNS142203; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Costabile JD, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00426; D'Andrea G, 2016, WORLD NEUROSURG, V87, P627, DOI 10.1016/j.wneu.2015.10.076; Della Nave R, 2010, AM J NEURORADIOL, V31, P1675, DOI 10.3174/ajnr.A2128; Della Nave R, 2011, NEURORADIOLOGY, V53, P367, DOI 10.1007/s00234-010-0807-1; Essayed WI, 2017, NEUROIMAGE-CLIN, V15, P659, DOI 10.1016/j.nicl.2017.06.011; Goldbrunner R, 2018, DTSCH ARZTEBL INT, V115, P356, DOI 10.3238/arztebl.2018.0356; HARRELL FE, 1982, BIOMETRIKA, V69, P635; Henry RG, 2004, NEUROIMAGE, V21, P616, DOI 10.1016/j.neuroimage.2003.09.047; Holodny AI, 2001, J NEUROSURG, V95, P1082, DOI 10.3171/jns.2001.95.6.1082; Jellison BJ, 2004, AM J NEURORADIOL, V23, P67; Kamali A, 2014, BRAIN STRUCT FUNCT, V219, P269, DOI 10.1007/s00429-012-0498-y; Kreth FW, 1999, CANCER, V86, P2117, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2117::AID-CNCR33>3.3.CO;2-#; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Li YM, 2016, J NEUROSURG, V124, P977, DOI 10.3171/2015.5.JNS142087; Li ZB, 2018, WORLD NEUROSURG, V116, pE291, DOI 10.1016/j.wneu.2018.04.189; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Madhavan KM, 2014, BRAIN RES, V1562, P11, DOI 10.1016/j.brainres.2014.03.012; Manjon JV, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00030; Manjon JV, 2010, NEUROIMAGE, V53, P480, DOI 10.1016/j.neuroimage.2010.06.046; Meyer EJ, 2017, NEUROSURGERY, V80, P193, DOI 10.1093/neuros/nyw040; Mori S., 2005, MRI ATLAS HUMAN WHIT; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; Nilsson M, 2018, NEUROIMAGE, V182, P232, DOI 10.1016/j.neuroimage.2018.04.075; Odish OFF, 2018, BRAIN IMAGING BEHAV, V12, P1786, DOI 10.1007/s11682-018-9849-5; Ormond DR, 2017, CUREUS, V9, DOI 10.7759/cureus.1660; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Pozorski V, 2018, HUM BRAIN MAPP, V39, P4150, DOI 10.1002/hbm.24239; Provenzale JM, 2006, RADIOLOGY, V239, P632, DOI 10.1148/radiol.2393042031; Puig J, 2017, NEURORADIOLOGY, V59, P343, DOI 10.1007/s00234-017-1816-0; Racine AM, 2014, NEUROIMAGE-CLIN, V4, P604, DOI 10.1016/j.nicl.2014.02.001; Raza SA, 2002, NEUROSURGERY, V51, P2, DOI 10.1097/00006123-200207000-00002; Rong DD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/524096; Rosas HD, 2010, NEUROIMAGE, V49, P2995, DOI 10.1016/j.neuroimage.2009.10.015; Rousselet GA, 2017, EUR J NEUROSCI, V46, P1738, DOI 10.1111/ejn.13610; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Schilling KG, 2019, MAGN RESON MED, V81, P2011, DOI 10.1002/mrm.27512; Sollmann N, 2020, J NEUROSURG, V132, P1033, DOI 10.3171/2018.12.JNS182988; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stadlbauer A, 2007, NEUROIMAGE, V34, P949, DOI 10.1016/j.neuroimage.2006.08.051; STRUGAR JG, 1995, J NEUROSURG, V83, P682, DOI 10.3171/jns.1995.83.4.0682; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vassal F, 2013, BRIT J NEUROSURG, V27, P668, DOI 10.3109/02688697.2013.771730; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wilcox R.R., 1995, J ROY STAT SOC D-STA, V44, P91, DOI 10.2307/2348620; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Yeh FC, 2017, MAGN RESON MED, V77, P603, DOI 10.1002/mrm.26143; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	65	8	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225323	10.1371/journal.pone.0225323	http://dx.doi.org/10.1371/journal.pone.0225323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751402	Green Published, gold			2022-12-26	WOS:000533886900048
J	Flamand, A; Rebout, N; Bordes, C; Guinnefollau, L; Berges, M; Ajak, F; Siutz, C; Millesi, E; Weber, C; Petit, O				Flamand, Anna; Rebout, Nancy; Bordes, Camille; Guinnefollau, Laureline; Berges, Matthieu; Ajak, Fanny; Siutz, Carina; Millesi, Eva; Weber, Christiane; Petit, Odile			Hamsters in the city: A study on the behaviour of a population of common hamsters (Cricetus cricetus) in urban environment	PLOS ONE			English	Article							URBANIZATION; CONSERVATION; FRAMEWORK; WILDLIFE; PATTERNS	Animals in urban environments face challenging situations and have to cope with human activities. This study investigated the ecology and behaviour of a population of European hamsters (Cricetus cricetus) living in the city centre of Vienna (Austria). We recorded the surface activities of 35 hamsters in May 2015. Each focal animal was observed for 15 minutes, and a total of 66 focal samples were analysable. As a prey species in an environment teeming with human activities, we predicted a high level of vigilance by the hamsters. The results show that while animals dedicated a lot of time to vigilance, most of their time was spent foraging. The study also explores whether the frequency of vigilance behaviours differ between males and females. We found that vigilance behaviours were expressed in a different manner by males and females. Finally, we investigated the distribution of the burrows on green spaces depending on proximity to trees and on noise levels. We found a biased distribution of burrows, with a spatial preference for location protected by the vegetation and distant to noise sources. Although burrows were located preferentially under vegetation cover, levels of noise did not determine their positions. Moreover, this species does not respond to disturbances like daily urban noises, probably due to habituation. The common hamster is an endangered species; our results lead to a greater knowledge of its behaviour in a persistent urban population.	[Flamand, Anna] Fac Geog & Amenagement, UMR 7362, Lab Image Ville Environm, Strasbourg, France; [Flamand, Anna; Rebout, Nancy; Petit, Odile] Univ Tours, Cognit & Social Ethol Grp, UMR Physiol Reprod & Comportements, CNRS,IFCE,INRA, Nouzilly, France; [Bordes, Camille] Ecole Natl Super Agron Toulouse, Castanet Tolosan, France; [Guinnefollau, Laureline; Ajak, Fanny] Univ Strasbourg, UMR 7178, IPHC DEPE, CNRS, Strasbourg 2, France; [Berges, Matthieu] Univ Tours, Tours 1, France; [Siutz, Carina; Millesi, Eva] Univ Vienna, Dept Behav Biol, Althanstr, Vienna, Austria; [Weber, Christiane] Univ Montpellier, TETIS, CNRS, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Tours; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Tours; University of Vienna; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Petit, O (corresponding author), Univ Tours, Cognit & Social Ethol Grp, UMR Physiol Reprod & Comportements, CNRS,IFCE,INRA, Nouzilly, France.	odile.petit@inra.fr	FLAMAND, Anna/GRS-0108-2022	FLAMAND, Anna/0000-0003-3253-2362; Millesi, Eva/0000-0003-0740-0413; Bordes, Camille Nina Marion/0000-0002-3561-2811	LIFE + Biodiversity grant [LIFE12 BIO/FR/000979]; Ministere de l'Ecologie, du Developpement durable et de l'Energie	LIFE + Biodiversity grant; Ministere de l'Ecologie, du Developpement durable et de l'Energie	This work was supported by the LIFE + Biodiversity grant No. LIFE12 BIO/FR/000979 and the Ministere de l'Ecologie, du Developpement durable et de l'Energie. CW and OP received this award. URL: https://ec.europa.eu/easme/en/life; https://www.ecologique-solidaire.gouv.fr/.The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Canady Alexander, 2013, Zoology and Ecology, V23, P61, DOI 10.1080/21658005.2013.769701; Chapman T, 2012, NATURWISSENSCHAFTEN, V99, P893, DOI 10.1007/s00114-012-0971-8; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; Evans JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209471; Feoktistova N, 2014, ZOOL POLONIAE, V58, P116, DOI [10.2478/zoop-2013-0009, DOI 10.2478/ZOOP-2013-0009]; Feoktistova N. Yu., 2013, Beitraege zur Jagd- und Wildforschung, V38, P225; Flamand A., 2018, P 25 M INT HAMST WOR, P61; Franceschini C, 2003, C P INT HAMST WORKGR, P12; Franceschini-Zink C, 2008, ZOOLOGY, V111, P76, DOI 10.1016/j.zool.2007.05.001; Francis CD, 2013, FRONT ECOL ENVIRON, V11, P305, DOI 10.1890/120183; GORECKI A, 1977, ACTA THERIOL, V22, P25, DOI 10.4098/AT.arch.77-2; Hedrzak M, 2018, URBAN ECOSYST, V21, P323, DOI 10.1007/s11252-017-0715-9; Hufnagl Silvia, 2011, Saeugetierkundliche Informationen, V8, P69; Kaim Iwona, 2013, Zoologica Poloniae, V58, P59; Lopucki R, 2018, ECOL INDIC, V84, P433, DOI 10.1016/j.ecolind.2017.09.019; Lopucki R, 2013, CAN J ZOOL, V91, P554, DOI 10.1139/cjz-2012-0168; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Luniak M, 2004, P 4 INT URBAN WILDLI, P50; MACWHIRTER RB, 1991, CAN J ZOOL, V69, P2209, DOI 10.1139/z91-308; Magle SB, 2011, BEHAVIOUR, V148, P31, DOI 10.1163/000579510X545810; Marzluff JM, 2001, RESTOR ECOL, V9, P280, DOI 10.1046/j.1526-100x.2001.009003280.x; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Niethammer J, 1982, HDB SAUGETIERE EUROP, V2, P7; O'Brien J, 2015, HYSTRIX, V26, P89, DOI 10.4404/hystrix-26.2-11230; Pflaum C, 2003, P 11 M INT HAMST WOR, P15; Quirici V, 2008, ANIM COGN, V11, P441, DOI 10.1007/s10071-007-0134-z; R Core Team, 2021, R LANGUAGE ENV STAT; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Rusin MY, 2013, FOLIA ZOOL, V62, P207; Rutz C, 2008, J ANIM ECOL, V77, P1008, DOI 10.1111/j.1365-2656.2008.01420.x; Schmelzer E, 2003, C P INT HAMST WORKGR, P19; Siutz C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31520-4; Siutz C, 2016, J COMP PHYSIOL B, V186, P801, DOI 10.1007/s00360-016-0995-z; Siutz C, 2012, GEN COMP ENDOCR, V178, P323, DOI 10.1016/j.ygcen.2012.06.009; Siutz Carina, 2012, P155; Surov A, 2014, P 21 M INT HAMST WOR; Surov A. V., 2016, Russian Journal of Biological Invasions, V7, P69, DOI 10.1134/S2075111716010094; Tsunoda M, 2019, J WILDLIFE MANAGE, V83, P728, DOI 10.1002/jwmg.21610; van der Vinne V, 2015, J EXP BIOL, V218, P2585, DOI 10.1242/jeb.119354; Weinhold U., 2009, 158 AFFL COUNC EUR N; Ziomek J, 2012, P 19 M INT HAMSTERWO, P27; Ziomek J, 2007, FOLIA ZOOL, V56, P235; Ziomek Joanna, 2009, Zoologische Garten, V78, P221	49	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225347	10.1371/journal.pone.0225347	http://dx.doi.org/10.1371/journal.pone.0225347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8PC	31751416	Green Published, gold			2022-12-26	WOS:000533886900052
J	Friedman, J; Karandinos, G; Hart, LK; Castrillo, FM; Graetz, N; Bourgois, P				Friedman, Joseph; Karandinos, George; Hart, Laurie Kain; Castrillo, Fernando Montero; Graetz, Nicholas; Bourgois, Philippe			Structural vulnerability to narcotics-driven firearm violence: An ethnographic and epidemiological study of Philadelphia's Puerto Rican inner-city	PLOS ONE			English	Article							MIXED METHODS RESEARCH; HEALTH; COMMUNITY	Background The United States is experiencing a continuing crisis of gun violence, and economically marginalized and racially segregated inner-city areas are among the most affected. To decrease this violence, public health interventions must engage with the complex social factors and structural drivers-especially with regard to the clandestine sale of narcotics-that have turned the neighborhood streets of specific vulnerable subgroups into concrete killing fields. Here we present a mixed-methods ethnographic and epidemiological assessment of narcotics-driven firearm violence in Philadelphia's impoverished, majority Puerto Rican neighborhoods. Methods Using an exploratory sequential study design, we formulated hypotheses about ethnic/racial vulnerability to violence, based on half a dozen years of intensive participant-observation ethnographic fieldwork. We subsequently tested them statistically, by combining geo-referenced incidents of narcotics-and firearm-related crime from the Philadelphia police department with census information representing race and poverty levels. We explored the racialized relationships between poverty, narcotics, and violence, melding ethnography, graphing, and Poisson regression. Findings Even controlling for poverty levels, impoverished majority-Puerto Rican areas in Philadelphia are exposed to significantly higher levels of gun violence than majority-white or black neighborhoods. Our mixed methods data suggest that this reflects the unique social position of these neighborhoods as a racial meeting ground in deeply segregated Philadelphia, which has converted them into a retail endpoint for the sale of astronomical levels of narcotics. Implications We document racial/ethnic and economic disparities in exposure to firearm violence and contextualize them ethnographically in the lived experience of community members. The exceptionally concentrated and high-volume retail narcotics trade, and the violence it generates in Philadelphia's poor Puerto Rican neighborhoods, reflect unique structural vulnerability and cultural factors. For most young people in these areas, the narcotics economy is the most readily accessible form of employment and social mobility. The performance of violence is an implicit part of survival in these lucrative, illegal narcotics markets, as well as in the overcrowded jails and prisons through which entry-level sellers cycle chronically. To address the structural drivers of violence, an inner-city Marshall Plan is needed that should include well-funded formal employment programs, gun control, re-training police officers to curb the routinization of brutality, reform of criminal justice to prioritize rehabilitation over punishment, and decriminalization of narcotics possession and low-level sales.	[Friedman, Joseph; Bourgois, Philippe] Univ Calif Los Angeles, Ctr Social Med & Humanities, Los Angeles, CA 90095 USA; [Karandinos, George] Harvard Med Sch, Boston, MA 02115 USA; [Hart, Laurie Kain] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Castrillo, Fernando Montero] Columbia Univ, Dept Anthropol, New York, NY 10027 USA; [Graetz, Nicholas] Univ Penn, Dept Demog, Philadelphia, PA 19104 USA	University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Columbia University; University of Pennsylvania	Friedman, J; Bourgois, P (corresponding author), Univ Calif Los Angeles, Ctr Social Med & Humanities, Los Angeles, CA 90095 USA.	joseph.robert.friedman@gamil.com; pbourgois@gmail.com	Friedman, Joseph/ABA-5864-2020; Bourgois, Philippe/AGI-9813-2022	Friedman, Joseph/0000-0002-5225-3267; Bourgois, Philippe/0000-0002-1600-233X; Montero Castrillo, Fernando/0000-0003-4832-4613; , Nick/0000-0002-4362-2059	National Institutes of Health [DA010164, UL1TR001881, DA27599]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The original ethnographic fieldwork was supported by National Institutes of Health grant DA010164 with background/comparative data facilitated by DA27599, UL1TR001881. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboutanos MB, 2011, J TRAUMA, V71, P228, DOI 10.1097/TA.0b013e31821e0c86; Alexander M., 2012, NEW JIM CROW MASS IN; Anguera MT., 2018, QUALITY QUANTITY, V52, P2757, DOI [DOI 10.1007/S11135-018-0700-2, 10.1007/s11135-018-0700-2]; [Anonymous], 2017, B AM COLL SURG; Arbuckle A., 1985, MASHABLE; Auyero J., 2015, VIOLENCE URBAN MARGI; Bauchner H, 2017, JAMA PSYCHIAT, V74, P1195, DOI 10.1001/jamapsychiatry.2017.3616; Bourgois, 2009, RIGHTEOUS DOPEFIEND; Bourgois P, 2016, LHOMME, P31, DOI [10.4000/lhomme.29017, DOI 10.4000/LHOMME.29017]; Bourgois P., 2019, RITUAL EMOTION VIOLE, P32; Bourgois P, 2006, PLOS MED, V3, P1805, DOI 10.1371/journal.pmed.0030452; Bourgois P, 2017, ACAD MED, V92, P299, DOI 10.1097/ACM.0000000000001294; Bourgois P, 2011, ADDICTION, V106, P1975, DOI 10.1111/j.1360-0443.2011.03615.x; Bourgois Philippe, 2003, SEARCH RESPECT SELLI; Boyette Michael., 2013, LET IT BURN MOVE PHI; Chong VE, 2015, AM J SURG, V209, P597, DOI 10.1016/j.amjsurg.2014.11.003; Contreras, 2013, STICKUP KIDS RACE DR; Corso PS, 2007, AM J PREV MED, V32, P474, DOI 10.1016/j.amepre.2007.02.010; Creswell W. C., 2011, DESIGNING CONDUCTING; Denvir D., 2013, MY CITY PAPER NEW YO; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Feldman JM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002399; Friedman J, 2019, JAMA INTERNAL MED; Gonnerman Jennifer, 2018, NEW YORKER; Hansen H, 2014, SOC SCI MED, V103, P76, DOI 10.1016/j.socscimed.2013.06.033; Hari J., 2015, CHASING SCREAM 1 LAS; Hart LK, 2017, DEP ANTHR U HELS, DOI [10.1016/j.socscimed.2013.06.033, DOI 10.1016/J.SOCSCIMED.2013.06.033]; Hemenway D, 2013, NEW ENGL J MED, V368, P2033, DOI 10.1056/NEJMsb1302631; Iroku-Malize Tochi, 2019, FP Essent, V480, P16; Jennings-Bey T, 2015, J URBAN HEALTH, V92, P947, DOI 10.1007/s11524-015-9978-8; Karandinos G, 2019, NEW ENGL J MED, V380, P205, DOI 10.1056/NEJMp1811542; Karandinos G, 2014, CURR ANTHROPOL, V55, P1, DOI 10.1086/674613; Khan R, 2014, EUR ADDICT RES, V20, P200, DOI 10.1159/000357234; Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544; Lopez AM, 2013, INT J DRUG POLICY, V24, P101, DOI 10.1016/j.drugpo.2012.12.004; Malina D, 2016, NEW ENGL J MED, V374, P175, DOI 10.1056/NEJMe1515975; MARMOT M, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L2278; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Messac L, 2013, SOC SCI MED, V99, P176, DOI 10.1016/j.socscimed.2013.04.009; Metzl Jonathan M., 2019, DYING WHITENESS POLI; Neil E., 2019, DA KRASNER ENACTS NE; Netherland J, 2017, BIOSOCIETIES, V12, P217, DOI 10.1057/biosoc.2015.46; Ozawa S, 2014, HEALTH POLICY PLANN, V29, P323, DOI 10.1093/heapol/czt019; Rosenblum D, 2014, INT J DRUG POLICY, V25, P543, DOI 10.1016/j.drugpo.2013.12.008; Ruderman W, 2014, BUSTED TALE CORRUPTI; Sharkey P, 2017, AM SOCIOL REV, V82, P1214, DOI 10.1177/0003122417736289; Shaw J., 2019, REPORT DA KRASNER VE; Singer M, 1992, Med Anthropol, V14, P77; Tracy BM, 2019, J PEDIATR SURG, V54, P2375, DOI 10.1016/j.jpedsurg.2019.03.021; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0	50	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2019	14	11							e0225376	10.1371/journal.pone.0225376	http://dx.doi.org/10.1371/journal.pone.0225376			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LO8PC	31751394	Green Published, gold			2022-12-26	WOS:000533886900055
J	Tomco, PL; Zulueta, RC; Miller, LC; Zito, PA; Campbell, RW; Welker, JM				Tomco, Patrick L.; Zulueta, Rommel C.; Miller, Leland C.; Zito, Phoebe A.; Campbell, Robert W.; Welker, Jeffrey M.			DOC export is exceeded by C fixation in May Creek: A late-successional watershed of the Copper River Basin, Alaska	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; BOREAL FOREST; FLUORESCENCE SPECTROSCOPY; EDDY COVARIANCE; CARBON-DIOXIDE; PERMAFROST; FLUXES; DYNAMICS; QUALITY; MARINE	Understanding the entirety of basin-scale C cycling (DOC fluxes and CO2 exchanges) are central to a holistic perspective of boreal forest biogeochemistry today. Shifts in the timing and magnitude of dissolved organic carbon (DOC) delivery in streams and eventually into oceans can be expected, while simultaneously CO2 emission may exceed CO2 fixation, leading to forests becoming stronger CO2 sources than sinks amplifying rising trace gases in the atmosphere. At May Creek, a representative late-successional boreal forest watershed at the headwaters of the Copper River Basin, Alaska, we quantified the seasonality of DOC flux and landscape-scale CO2 exchange (eddy covariance) over two seasonal cycles. We deployed in situ fDOM and conductivity sensors, performed campaign sampling for water quality (DOC and water isotopes), and used fluorescence spectroscopy to ascertain DOC character. Simultaneously, we quantified net CO2 exchange using a 100 ft eddy covariance tower. Results indicate DOC exports were pulse-driven and mediated by precipitation events. Both frequency and magnitude of pulse-driven DOC events diminished as the seasonal thaw depth deepened, with inputs from terrestrial sources becoming major contributors to the DOC pool with decreasing snowmelt contribution to the hydrograph. A threecomponent parallel factorial analysis (PARAFAC) model indicated DOC liberated in lateseason may be bioavailable (tyrosine-like). Combining Net Ecosystem Exchange (NEE) measurements indicate that the May Creek watershed fixes 142-220 g C m(-2) yr(-1) and only 0.40-0.57 g C m(-2) yr(-1) is leached out as DOC. Thus, the May Creek watershed and similar mature spruce forest dominated watersheds in the Copper River Basin are currently large ecosystem C sinks and exceeding C conservative. An understanding of DOC fluxes from Gulf of Alaska watersheds is important for characterizing future climate change-induced seasonal shifts.	[Tomco, Patrick L.] Univ Alaska Anchorage, Dept Chem, Anchorage, AK 99508 USA; [Zulueta, Rommel C.] Natl Ecol Observ Network Inc, Boulder, CO USA; [Miller, Leland C.; Welker, Jeffrey M.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA; [Zito, Phoebe A.] Univ New Orleans, Dept Chem, New Orleans, LA 70148 USA; [Campbell, Robert W.] Prince William Sound Sci Ctr, Cordova, AK USA; [Welker, Jeffrey M.] Univ Oulu, Ecol & Genet Res Unit, Oulu, Finland	University of Alaska System; University of Alaska Anchorage; University of Alaska System; University of Alaska Anchorage; University of Louisiana System; University of New Orleans; University of Oulu	Tomco, PL (corresponding author), Univ Alaska Anchorage, Dept Chem, Anchorage, AK 99508 USA.	pltomco@alaska.edu		Tomco, Patrick/0000-0001-9139-7266	NASA [NNX10AU07G]	NASA(National Aeronautics & Space Administration (NASA))	Funding for this project was provided to RC and JW by NASA (grant#NNX10AU07G). https://www.nssc.nasa.gov/grantstatus.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken GR, 2014, GLOBAL BIOGEOCHEM CY, V28, P525, DOI 10.1002/2013GB004764; Alstad KP, 1999, OECOLOGIA, V120, P375, DOI 10.1007/s004420050870; Aubinet M., 2012, EDDY COVARIANCE PRAC, DOI DOI 10.1007/978-94-007-2351-1_2; Balcarczyk KL, 2009, BIOGEOCHEMISTRY, V94, P255, DOI 10.1007/s10533-009-9324-x; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; Black TA, 1996, GLOBAL CHANGE BIOL, V2, P219, DOI 10.1111/j.1365-2486.1996.tb00074.x; Burba G, 2012, GLOBAL CHANGE BIOL, V18, P385, DOI 10.1111/j.1365-2486.2011.02536.x; Carey SK, 2003, PERMAFROST PERIGLAC, V14, P161, DOI 10.1002/ppp.444; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; Chen ML, 2017, WATER RES, V121, P150, DOI 10.1016/j.watres.2017.05.022; COBLE PG, 1990, NATURE, V348, P432, DOI 10.1038/348432a0; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Deluca TH, 2012, FORESTRY, V85, P161, DOI 10.1093/forestry/cps003; Downing BD, 2012, LIMNOL OCEANOGR-METH, V10, P767, DOI 10.4319/lom.2012.10.767; Downing BD, 2009, LIMNOL OCEANOGR-METH, V7, P119, DOI 10.4319/lom.2009.7.119; Duffy PA, 2005, ECOL APPL, V15, P1317, DOI 10.1890/04-0739; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Dutton A, 2005, HYDROL PROCESS, V19, P4121, DOI 10.1002/hyp.5876; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Fellman JB, 2010, MAR CHEM, V121, P112, DOI 10.1016/j.marchem.2010.03.009; Fellman JB, 2010, LIMNOL OCEANOGR, V55, P2452, DOI 10.4319/lo.2010.55.6.2452; Fenner N, 2007, ENVIRON SCI TECHNOL, V41, P3146, DOI 10.1021/es061765v; Fichot CG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046152; Finlay J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025754; Fraser CJD, 2001, HYDROL PROCESS, V15, P3151, DOI 10.1002/hyp.322; Froelich N, 2015, AGR FOREST METEOROL, V211, P72, DOI 10.1016/j.agrformet.2015.05.009; Goulden ML, 2011, GLOBAL CHANGE BIOL, V17, P855, DOI 10.1111/j.1365-2486.2010.02274.x; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Gu LH, 2005, AGR FOREST METEOROL, V128, P179, DOI 10.1016/j.agrformet.2004.11.006; Hernes PJ, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000938; Hood E, 2009, NATURE, V462, P1044, DOI 10.1038/nature08580; Hugelius G, 2014, BIOGEOSCIENCES, V11, P6573, DOI 10.5194/bg-11-6573-2014; Ibrom A, 2007, TELLUS B, V59, P937, DOI 10.1111/j.1600-0889.2007.00311.x; JARVIS PG, 1989, PHILOS T R SOC B, V324, P369, DOI 10.1098/rstb.1989.0053; Jencso KG, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007225; Kljun N, 2004, BOUND-LAY METEOROL, V112, P503, DOI 10.1023/B:BOUN.0000030653.71031.96; Koch JC, 2013, HYDROGEOL J, V21, P93, DOI 10.1007/s10040-012-0934-3; Kothawala DN, 2014, GLOBAL CHANGE BIOL, V20, P1101, DOI 10.1111/gcb.12488; Kulkarni HV, 2018, SCI TOTAL ENVIRON, V637, P588, DOI 10.1016/j.scitotenv.2018.05.009; Laudon H, 2011, ECOSYSTEMS, V14, P880, DOI 10.1007/s10021-011-9452-8; Leffler AJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025023; Lepisto A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003175; Litvak M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000854; Mann PJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001798; Mauder M, 2011, DOCUMENTATION INSTRU; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Milner AM, 2009, HYDROL PROCESS, V23, P62, DOI 10.1002/hyp.7197; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Moncrieff J.B., 2004, HDB MICROMETEOROLOGY; Moncrieff JB, 1997, J HYDROL, V188, P589; Murphy KR, 2014, ANAL METHODS-UK, V6, P658, DOI 10.1039/c3ay41935e; Murphy KR, 2013, ANAL METHODS-UK, V5, P6557, DOI 10.1039/c3ay41160e; Neal EG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042385; Neff JC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028222; O'Donnell JA, 2016, J GEOPHYS RES-BIOGEO, V121, P2727, DOI 10.1002/2016JG003431; O'Donnell JA, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001153; O'Neel S, 2015, BIOSCIENCE, V65, P499, DOI 10.1093/biosci/biv027; Ohno T, 2002, ENVIRON SCI TECHNOL, V36, P742, DOI 10.1021/es0155276; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pelletier L, 2014, BIOGEOCHEMISTRY, P1; Prokushkin AS, 2005, CAN J FOREST RES, V35, P2130, DOI 10.1139/X05-150; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; de Dios VR, 2012, GLOBAL CHANGE BIOL, V18, P1956, DOI 10.1111/j.1365-2486.2012.02664.x; Rupp TS, 2007, EARTH INTERACT, V11, DOI 10.1175/EI189.1; Schroth AW, 2011, GEOPHYS RES LETT, V38; Simmons T., 2011, CENTRAL ALASKA NETWO, V454; Spotila JA, 2004, GEOLOGY, V32, P501, DOI 10.1130/G20343.1; Stedmon CA, 2003, MAR CHEM, V82, P239, DOI 10.1016/S0304-4203(03)00072-0; Stedmon CA, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001716; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Stubbins A, 2012, NAT GEOSCI, V5, P198, DOI [10.1038/ngeo1403, 10.1038/NGEO1403]; Tanaka K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05292; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Vachon RW, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014105; Vickers D, 1997, J ATMOS OCEAN TECH, V14, P512, DOI 10.1175/1520-0426(1997)014<0512:QCAFSP>2.0.CO;2; Vidon P, 2014, APPL GEOCHEM, V46, P10, DOI 10.1016/j.apgeochem.2014.04.008; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Welker JM, 2000, HYDROL PROCESS, V14, P1449, DOI [10.1002/1099-1085(20000615)14:8<1449::AID-HYP993>3.0.CO;2-7, 10.1002/1099-1085(20000615)14:8&lt;1449::AID-HYP993&gt;3.0.CO;2-7]; Wickland KP, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004342; Wickland KP, 2007, ECOSYSTEMS, V10, P1323, DOI 10.1007/s10021-007-9101-4; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Williams CJ, 2010, LIMNOL OCEANOGR, V55, P1159, DOI 10.4319/lo.2010.55.3.1159; Wilson HF, 2013, ECOSYSTEMS, V16, P604, DOI 10.1007/s10021-013-9635-6; Wunsch UJ, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00098; Yamashita Y, 2013, CONT SHELF RES, V66, P136, DOI 10.1016/j.csr.2013.06.010; Yamashita Y, 2011, ECOSYSTEMS, V14, P1110, DOI 10.1007/s10021-011-9469-z; Yoshikawa K, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000438; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	91	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2019	14	11							e0225271	10.1371/journal.pone.0225271	http://dx.doi.org/10.1371/journal.pone.0225271			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO8NF	31747438	Green Published, gold			2022-12-26	WOS:000533881900031
J	Azeez, OI; Myburgh, JG; Bosman, AM; Featherston, J; Sibeko-Matjilla, KP; Oosthuizen, MC; Chamunorwa, JP				Azeez, Odunayo I.; Myburgh, Jan G.; Bosman, Ana-Mari; Featherston, Jonathan; Sibeko-Matjilla, Kgomotso P.; Oosthuizen, Marinda C.; Chamunorwa, Joseph P.			Next generation sequencing and RNA-seq characterization of adipose tissue in the Nile crocodile (Crocodylus niloticus) in South Africa: Possible mechanism(s) of pathogenesis and pathophysiology of pansteatitis	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; KRUGER-NATIONAL-PARK; APOPTOSIS; SPHINGOSINE-1-PHOSPHATE; CONSERVATION; INFLAMMATION; METHYLATION; MACROPHAGES; VALIDATION; MUTATIONS	Background Concerted efforts to identify the pathogenesis and mechanism(s) involved in pansteatitis, (a generalized inflammation of the adipose tissue), that was attributed to the recent crocodile die off in the Olifants River and Loskop Dam in Kruger National Park, Mpumalanga, South Africa have been in the forefront of research in recent time. As part of the efforts, molecular characterization of healthy and pansteatitis adipose tissue was carried out by RNA sequencing (RNA-Seq) using Next Generation Sequencing (NGS) and de novo assembly of the adipose transcriptome, followed by differential gene expression analysis. Methodology Healthy adipose tissue consisting of fifty samples was collected from the subcutaneous, visceral, intermuscular adipose tissues and the abdominal fat body of ten 4 years old juvenile crocodiles from a local crocodile farm in Pretoria, South Africa. Ten pansteatitis samples were collected from visceral and intermuscular adipose tissues of five crocodiles that were dying of pansteatitis. Results Forty-two thousand, two hundred and one (42,201) transcripts were assembled, out of which 37, 835 had previously been characterized. The de novo assembled transcriptome had an N50 (average sequence) of 436 bp, percentage GC content of 43.92, which compared well with previously assembled transcripts in the saltwater crocodile. Seventy genes were differentially expressed and upregulated in pansteatitis. These included genes coding for extracellular matrix (ECM) signaling ligands, inflammatory cytokines and tumour necrosis factor alpha (TNF alpha) receptors, fatty acid synthase and fatty acid binding proteins, peroxisome proliferator-activated receptor gamma (PPAR gamma), nuclear factor and apoptosis signaling ligands, and mitogen activated protein kinase enzymes among others. Majority (88.6%) of the upregulated genes were found to be involved in hypoxia inducible pathways for activation of NFk beta and inflammation, apoptosis, Toll-like receptor pathway and PPAR gamma. Bicaudal homologous 2 Drosophila gene (BICD2) associated with spinal and lower extremity muscle atrophy was also upregulated in pansteatitis while Sphingosine-1-phosphate phosphatase 2 (SGPP2) involved in Sphingosine-1-phosphate metabolism was downregulated. Futhermore, Double-sex-mab-related transcription factor 1 (DMRT1) responsible for sex gonad development and germ cell differentiation was also downregulated. Conclusion Thus, from the present study, based on differentially expressed genes in pansteatitis, affected Nile crocodiles might have died partly due to their inability to utilize stored triglycerides as a result of inflammation induced insulin resistance, leading to starvation in the midst of plenty. Affected animals may have also suffered muscular atrophy of the lower extremities and poor fertility.	[Azeez, Odunayo I.; Chamunorwa, Joseph P.] Univ Pretoria, Fac Vet Sci, Anat & Physiol Dept, Pretoria, South Africa; [Azeez, Odunayo I.] Univ Ibadan, Dept Vet Physiol & Biochem, Ibadan, Nigeria; [Myburgh, Jan G.] Univ Pretoria, Fac Vet Sci, Paraclin Sci Dept, Pretoria, South Africa; [Bosman, Ana-Mari; Sibeko-Matjilla, Kgomotso P.; Oosthuizen, Marinda C.] Univ Pretoria, Fac Vet Sci, Vet Trop Dis Dept, Pretoria, South Africa; [Featherston, Jonathan] Agr Res Council, Biotechnol Platform, Pretoria, South Africa	University of Pretoria; University of Ibadan; University of Pretoria; University of Pretoria; Agricultural Research Council of South Africa	Azeez, OI (corresponding author), Univ Pretoria, Fac Vet Sci, Anat & Physiol Dept, Pretoria, South Africa.; Azeez, OI (corresponding author), Univ Ibadan, Dept Vet Physiol & Biochem, Ibadan, Nigeria.	odunayoazeez@gmail.com	Oosthuizen, Marinda C/N-8706-2014; Chamunorwa, Joseph Panashe/G-7936-2014; Sibeko-Matjila, Kgomotso/O-6028-2014	Oosthuizen, Marinda C/0000-0002-1893-0818; Azeez, Odunayo/0000-0003-2379-9946; Chamunorwa, Joseph Panashe/0000-0001-5524-8773; Sibeko-Matjila, Kgomotso/0000-0003-1139-7333	Tertiary Education Fund (TETFund), University of Ibadan, Nigeria; University of Pretoria Post Graduate Support Bursary	Tertiary Education Fund (TETFund), University of Ibadan, Nigeria; University of Pretoria Post Graduate Support Bursary	The Study was part of PhD Program supported by the Tertiary Education Fund (TETFund), University of Ibadan, Nigeria and University of Pretoria Post Graduate Support Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Ashton PJ, 2010, AQUAT CONSERV, V20, P489, DOI 10.1002/aqc.1132; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Bolger AM, 2014, BIOINFORMATICS; Bolshoy A., 2002, APPL BIOINFORMATICS, V2, P103; Botha PJ, 2011, DISTRIBUTION CONSERV; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Chang Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0596-2; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dzoma BM, 2008, TROP ANIM HEALTH PRO, V40, P377, DOI 10.1007/s11250-007-9103-4; Esser N, 2015, EXPERT OPIN INV DRUG, V24, P283, DOI 10.1517/13543784.2015.974804; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Feng H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157185; Flisiak R, 2000, CYTOKINE, V12, P677, DOI 10.1006/cyto.1999.0660; Francis WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-167; Frenkel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032076; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gomez-Martin C, 2018, PREDICTION CPG ISLAN, P31; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hoogenraad CC, 2016, TRENDS CELL BIOL, V26, P327, DOI 10.1016/j.tcb.2016.01.001; Huchzermeyer KDA, 2013, J FISH DIS, V36, P897, DOI 10.1111/jfd.12010; Huchzermeyer KDA, 2012, J S AFR VET ASSOC, V83, DOI 10.4102/jsava.v83i1.916; Jiang BG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001344; Keuper M, 2016, APOPTOSIS, V2, P484; Kwon MJ, 2013, BIOCHEM BIOPH RES CO, V431, P415, DOI 10.1016/j.bbrc.2012.12.155; Lane EP, 2013, J ZOO WILDLIFE MED, V44, P899, DOI 10.1638/2012-0264R.1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin L, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0247-7; Long HK, 2016, NUCLEIC ACIDS RES, V44, P6693, DOI 10.1093/nar/gkw258; Lubick N., 2009, SCI AM, P12; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Mendizabal I, 2015, HUM MOL GENET; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Miller HC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-439; Montero-Mendieta S, 2017, PEERJ, V5, DOI 10.7717/peerj.3702; Murphy MW, 2010, P NATL ACAD SCI USA, V107, P13360, DOI 10.1073/pnas.1006243107; Nolan CJ, 2015, DIABETES, V64, P673, DOI 10.2337/db14-0694; O'Neil D., 2013, CURRENT PROTOCOLS MO; Oates EC, 2013, AM J HUM GENET, V92, P965, DOI 10.1016/j.ajhg.2013.04.018; Oberholster PJ, 2016, CHEMOSPHERE, V144, P319, DOI 10.1016/j.chemosphere.2015.08.024; Oberholster PJ, 2012, ECOTOX ENVIRON SAFE, V75, P134, DOI 10.1016/j.ecoenv.2011.08.018; Oh T, 2013, J MOL DIAGN, V15, P498, DOI 10.1016/j.jmoldx.2013.03.004; Osthoff G, 2010, COMP BIOCHEM PHYS A, V155, P64, DOI 10.1016/j.cbpa.2009.09.025; Park SY, 2015, BBA-MOL CELL RES, V1853, P2722, DOI 10.1016/j.bbamcr.2015.07.024; Park SY, 2015, CANCER LETT, V357, P419, DOI 10.1016/j.canlet.2014.12.005; PATWARDHAN A, 2015, R PACKAGE VERSION, V7, DOI DOI 10.1186/S13073-015-0197-4; Pfaffl MW, 2008, BIOTECHNOL BIOTEC EQ, V22, P829, DOI 10.1080/13102818.2008.10817562; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; REVOL B, 1995, BIODIVERS CONSERV, V4, P299, DOI 10.1007/BF00055975; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rossor AM, 2015, BRAIN, V138, P293, DOI 10.1093/brain/awu356; Schieck M, 2016, J ALLERGY CLIN IMMUN, V138, P421, DOI 10.1016/j.jaci.2015.12.1305; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Smith-Unna R, 2016, GENOME RES; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tan CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18366; Tanti J.-F., 2013, FRONT ENDOCRINOL, V3, P6; Tanti JF., 2012, FRONT ENDOCRINOL, V3, P181, DOI [DOI 10.3389/FENDO.2012.00181, 10.3389/fendo.2012.00181]; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P679, DOI 10.1093/bioinformatics/18.5.679; Tzika AC, 2015, GENOME BIOL EVOL, V7, P1827, DOI 10.1093/gbe/evv106; Tzika AC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-19; Varriale A, 2010, GENOMICS, V95, P25, DOI 10.1016/j.ygeno.2009.09.006; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Wan QH, 2013, CELL RES, V23, P1091, DOI 10.1038/cr.2013.104; Wang N, 2007, APOPTOSIS, V12, P1433, DOI 10.1007/s10495-007-0070-z; Xu LJ, 2012, APOPTOSIS, V17, P1235, DOI 10.1007/s10495-012-0754-x; Yin JJ, 2015, INT J MOL MED, V35, P932, DOI 10.3892/ijmm.2015.2085	84	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0225073	10.1371/journal.pone.0225073	http://dx.doi.org/10.1371/journal.pone.0225073			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738794	Green Published, gold			2022-12-26	WOS:000532826300029
J	Binka, C; Doku, DT; Nyarko, SH; Awusabo-Asare, K				Binka, Charity; Doku, David Teye; Nyarko, Samuel H.; Awusabo-Asare, Kofi			Male support for cervical cancer screening and treatment in rural Ghana	PLOS ONE			English	Article							KNOWLEDGE	Men have a critical role to play in reducing cervical cancer burden. Yet, there is little information on male involvement in the cervical cancer screening and treatment process in Ghana. In this study, we explore male knowledge and support during cervical cancer screening and treatment in a rural setting in Ghana. In-depth interviews and focus group discussions were conducted among a total of 41 respondents to collect qualitative data from cervical cancer patients, their male partners and other married men in the North Tongu District, Ghana. A thematic approach was used for data analysis and presentation of the results. The results show that male partners have little or no knowledge about cervical cancer. Some men provide various forms of support-financial, social, material and emotional-to their partners during the screening and treatment stages of the disease. Some men, however, abandoned their partners during the screening and treatment process of the disease. Men whose partners did not have cervical cancer said they were willing to provide financial, social, emotional and material support to their partners if they should contract the disease. Some men said they were willing to support their female partners but lacked education on the disease. This study underscores the need for cervical cancer education programmes to target Ghanaian men. The education should focus on the causes of the disease, screening and treatment methods of the disease, and, ultimately, promote spousal support during the screening and treatment processes.	[Binka, Charity] Ghana Inst Management & Publ Adm, Sch Publ Serv & Governance, Achimota, Accra, Ghana; [Doku, David Teye; Awusabo-Asare, Kofi] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Nyarko, Samuel H.] Univ Texas San Antonio, Inst Demog & Socioecon Res, San Antonio, TX USA	University of Cape Coast; University of Texas System; University of Texas at San Antonio (UTSA)	Binka, C (corresponding author), Ghana Inst Management & Publ Adm, Sch Publ Serv & Governance, Achimota, Accra, Ghana.	cbinka@gmail.com		Doku, David/0000-0001-9503-2520				Adegboyega A, 2019, HEALTH CARE WOMEN IN, V40, P665, DOI 10.1080/07399332.2019.1615914; Aswathy S, 2012, INDIAN J MED RES, V136, P205; Castellsague X, 2003, SALUD PUBLICA MEXICO, V45, pS345; de Bocanegra HT, 2009, J IMMIGR MINOR HEALT, V11, P326, DOI 10.1007/s10903-008-9161-3; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; ICO/IARC HPV Information Centre, 2019, FACT SHEET 2018; Kuhnert P., 2005, INTRO R SOFTWARE STA; Maree JE, 2011, EUR J CANCER CARE, V20, P662, DOI 10.1111/j.1365-2354.2011.01250.x; Matloff N., 2009, ART R PROGRAMMING; Ministry_of_Health, 2011, NAT STRAT CANC CONTR; Moses E, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00106; Pitts M, 2009, VACCINE, V27, P2989, DOI 10.1016/j.vaccine.2009.02.101; Reeves T.C., 2003, INTERACTIVE LEARNING; Rosser JI, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0138-1; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Trevino M, 2012, J COMMUN HEALTH, V37, P694, DOI 10.1007/s10900-011-9501-4; WHO, 2019, CERV CANC; Williams M S, 2012, Ghana Med J, V46, P147	18	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2019	14	11							e0224692	10.1371/journal.pone.0224692	http://dx.doi.org/10.1371/journal.pone.0224692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN3EY	31738796	Green Published, gold			2022-12-26	WOS:000532826300019
